A . . . E> A . . . E> A . . . E>0 A AMOXICILLIN; CLAVULANATE d00089A B J01.9 Acute sinusitis, unspecified A@ E>0 A BENZONATATE d00796A B R05 Cough A@ E>0 A FLUTICASONE NASAL d04283A B J30.9 R09.81 Allergic rhinitis, unspecified Nasal congestion A@ E>0 A IBUPROFEN d00015A B J02 R51 Acute pharyngitis Headache A@ E>@ A DOXYCYCLINE d00037A B R60.9 Edema, unspecified Ap E>@ A HYDROCORTISONE TOPICAL d03205A B= R21 Rash and other nonspecific skin eruption Ap E>@ A INSULIN GLARGINE d04538A C- E11 Type 2 diabetes mellitus Ap E>@ A LISINOPRIL d00732A C E11.2 Type 2 diabetes mellitus with kidney complications Ap E>@ A METFORMIN d03807A C E11 Type 2 diabetes mellitus Ap E>@ A NYSTATIN TOPICAL d04399A A R21 Rash and other nonspecific skin eruption Ap E>@ A SITAGLIPTIN d05896A C- E11 Type 2 diabetes mellitus Ap E>P A . . . E>` A ESOMEPRAZOLE d04749A C K21 Gastro-esophageal reflux disease AP E>` A HYDROCODONE d03075A C M25.5 Pain in joint AP E>` A METFORMIN d03807A C E28 Ovarian dysfunction AP E>` A NORETHINDRONE d00555A Bz E28 Ovarian dysfunction AP E>` A ROPINIROLE d04215A C[@ G25.81 Restless legs syndrome AP E>p A . . . E> A . . . E> A . . . E> A . . . E> A . . . E> A OMEPRAZOLE d00325A C K21 Gastro-esophageal reflux disease A E> A . . . E> A ALBUTEROL d00749A A J45 Asthma A E> A ARIPIPRAZOLE d04825A D= F32.9 G47.9 Major depressive disorder, single episode, unspecified Sleep disorder, unspecified A@ E> A BENZTROPINE d00175A D= G25.81 Restless legs syndrome A@ E> A CITALOPRAM d04332A D= F32.9 Major depressive disorder, single episode, unspecified A@ E> A TRAZODONE d00395A C F32.9 Major depressive disorder, single episode, unspecified A@ E? A . . . E? A . . . E? A . . . E?0 A . . . E?@ A ALBUTEROL d00749A Cr R06.02 Shortness of breath A` E?@ A AMLODIPINE d00689A Cr I10 Essential (primary) hypertension A` E?@ A LISINOPRIL d00732A C I10 Essential (primary) hypertension A` E?@ A METFORMIN d03807A C E11 Type 2 diabetes mellitus A` E?@ A SIMVASTATIN d00746A C- E78.0 Pure hypercholesterolemia A` E?@ A TIOTROPIUM d04829A Cr J44.9 Chronic obstructive pulmonary disease, unspecified A` E?P A . . . E?` A . . . E?p A . . . E? A LEVOTHYROXINE d00278A Cr E07.9 Disorder of thyroid, unspecified A E? A OXYBUTYNIN d00328A C N32.81 Overactive bladder A E? A AMLODIPINE d00689A B I10 Essential (primary) hypertension A0 E? A LISINOPRIL d00732A B I10 Essential (primary) hypertension A0 E? A METFORMIN; SITAGLIPTIN d06720A B E11 Type 2 diabetes mellitus A0 E? A ALBUTEROL d00749A D J44.9 J45 Chronic obstructive pulmonary disease, unspecified Asthma A E? A . . . E? A . . . E? A LISINOPRIL d00732A Bp I10 Essential (primary) hypertension A E? A . . . E? A . . . E@ A IBUPROFEN d00015A B= M79.1 Myalgia A E@ A . . . E@ A . . . E@0 A . . . E@@ A . . . E@P A LOSARTAN d03821A CDp I10 Essential (primary) hypertension A E@` A AMOXICILLIN d00088A A J03 Acute tonsillitis A E@` A LISDEXAMFETAMINE d06663A C- F90 Attention-deficit hyperactivity disorders A E@p A . . . E@ A ALBUTEROL d00749A A R06.2 Wheezing A E@ A CEFDINIR d04256A A J40 Bronchitis, not specified as acute or chronic A E@ A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A@ E@ A CYCLOBENZAPRINE d00963A A M79.1 Myalgia A@ E@ A FINASTERIDE d00563A D N40 Enlarged prostate A@ E@ A OMEPRAZOLE d00325A C K21 Gastro-esophageal reflux disease A@ E@ A . . . E@ A . . . E@ A . . . E@ A ALBUTEROL d00749A D* J44.9 Chronic obstructive pulmonary disease, unspecified A0 E@ A ALBUTEROL; IPRATROPIUM d04066A C J44.9 Chronic obstructive pulmonary disease, unspecified A0 E@ A FLUTICASONE; VILANTEROL d08100A Cr J44.9 Chronic obstructive pulmonary disease, unspecified A0 E@ A . . . E@ A ACETAMINOPHEN; HYDROCODONE d03428A C M13 M79.1 Other arthritis Myalgia A E@ A DIVALPROEX SODIUM d03833A C F39 Unspecified mood [affective] disorder A E@ A DULOXETINE d05355A C F32.9 M79.1 Major depressive disorder, single episode, unspecified Myalgia A E@ A FUROSEMIDE d00070A C R60.9 Edema, unspecified A E@ A GABAPENTIN d03182A B M54 Dorsalgia A E@ A GABAPENTIN d03182A B= G30.9 Alzheimer's disease, unspecified A E@ A LIOTHYRONINE d00658A C- E03.9 Hypothyroidism, unspecified A E@ A METOPROLOL d00134A CDp I10 Essential (primary) hypertension A E@ A POTASSIUM CHLORIDE d00345A Cr E87.6P Prevent hypokalemia A E@ A RIVAROXABAN d07356A CDp D75.9P Prevent blood clots A E@ A ROPINIROLE d04215A C[@ G25.81 Restless legs syndrome A E@ A TRAZODONE d00395A C G47.0 Insomnia A EA A EMPAGLIFLOZIN; METFORMIN d08384A B[ E11 Type 2 diabetes mellitus A EA A . . . EA A BENAZEPRIL d00730A C- I10 Essential (primary) hypertension A EA0 A ALFUZOSIN d04797A C N42.9 Disorder of prostate, unspecified AP EA0 A LISINOPRIL d00732A C I10 Essential (primary) hypertension AP EA0 A PREGABALIN d05508A C M79.2 Neuralgia and neuritis, unspecified AP EA0 A ROSUVASTATIN d04851A C E78.0 Pure hypercholesterolemia AP EA0 A TRAMADOL d03826A Dc M79.2 Neuralgia and neuritis, unspecified AP EA@ A . . . EAP A . . . EA` A MONTELUKAST d04289A B J30.9 R06.2 Allergic rhinitis, unspecified Wheezing A EA` A VARENICLINE d05807A B[ F17.2 Nicotine dependence A EAp A CYCLOBENZAPRINE d00963A A M62.83 Muscle spasm A` EAp A GABAPENTIN d03182A C- M54 Dorsalgia A` EAp A NITROGLYCERIN d00321A C I20.9 Angina pectoris, unspecified A` EAp A RAMIPRIL d00728A Cr I10 Essential (primary) hypertension A` EAp A TAMSULOSIN d04121A Cr R35 Polyuria A` EAp A VENLAFAXINE d03181A C F32.9 F41.9 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified A` EA A 99999 . . A EA A METOPROLOL d00134A Cr I10 Essential (primary) hypertension A EA A ATORVASTATIN d04105A D& E78.0 Pure hypercholesterolemia A` EA A GLIPIZIDE d00246A D& E11 Type 2 diabetes mellitus A` EA A IBUPROFEN d00015A B M25.5 Pain in joint A` EA A LISINOPRIL d00732A D& I10 Essential (primary) hypertension A` EA A OMEPRAZOLE d00325A C K21 Gastro-esophageal reflux disease A` EA A TAMOXIFEN d00381A Cf C50 Malignant neoplasm of breast A` EA A AMLODIPINE d00689A C- I10 Essential (primary) hypertension AP EA A ATORVASTATIN d04105A Cr E78.0 Pure hypercholesterolemia AP EA A LISINOPRIL d00732A C- I10 Essential (primary) hypertension AP EA A PANTOPRAZOLE d04514A C- K31.9 Disease of stomach and duodenum, unspecified AP EA A SITAGLIPTIN d05896A C- E11 Type 2 diabetes mellitus AP EA A FLUOXETINE d00236A B F41.9 Anxiety disorder, unspecified A EA A LOSARTAN d03821A C- I10 Essential (primary) hypertension A EA A . . . EA A . . . EA A . . . EA A AMLODIPINE d00689A D ^ I10 I20.9 R07.9 Essential (primary) hypertension Angina pectoris, unspecified Chest pain, unspecified AP EA A BENAZEPRIL d00730A D ^ I10 Essential (primary) hypertension AP EA A BETAMETHASONE; CLOTRIMAZOLE TOPICAL d03561A D@) B35 Dermatophytosis AP EA A CARVEDILOL d03847A D ^ I10 Essential (primary) hypertension AP EA A SIMVASTATIN d00746A D ^ E78.0P I21.P Prevent high cholesterol Prevent heart attack/myocardial infarction AP EB A . . . EB A INSULIN ISOPHANE (NPH) d04370A B R73 Elevated blood glucose level A EB A METFORMIN d03807A C E11 Type 2 diabetes mellitus A EB A . . . EB0 A . . . EB@ A ETHINYL ESTRADIOL; LEVONORGESTREL d03242A B Z79.3 Long term (current) use of hormonal contraceptives A EBP A MONTELUKAST d04289A B= J30.9 R06.9 Allergic rhinitis, unspecified Unspecified abnormalities of breathing A EB` A ESTRADIOL d00537A C Z79.890 Hormone replacement therapy A EB` A SPIRONOLACTONE d00373A C Z79.890 Hormone replacement therapy A EBp A . . . EB A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A@ EB A GLIPIZIDE d00246A Cr E11 Type 2 diabetes mellitus A@ EB A LOSARTAN d03821A C I10 Essential (primary) hypertension A@ EB A METFORMIN d03807A D E11 Type 2 diabetes mellitus A@ EB A . . . EB A . . . EB A . . . EB A . . . EB A LEVOTHYROXINE d00278A C- E03.9 Hypothyroidism, unspecified A EB A . . . EB A ALENDRONATE d03849A C M81.P Prevent bone loss/osteoporosis A@ EB A FLUTICASONE; SALMETEROL d04611A CDp J20.9 Acute bronchitis, unspecified A@ EB A LOSARTAN d03821A C I10 Essential (primary) hypertension A@ EB A ROSUVASTATIN d04851A C E78.0 Pure hypercholesterolemia A@ EC A AMLODIPINE d00689A CDp I10 Essential (primary) hypertension A@ EC A BENAZEPRIL; HYDROCHLOROTHIAZIDE d03265A CDp I10 Essential (primary) hypertension A@ EC A SIMVASTATIN d00746A CDp E78.0 Pure hypercholesterolemia A@ EC A TAMSULOSIN d04121A C- N40 Enlarged prostate A@ EC A . . . EC A CHLORTHALIDONE d00192A A I10 Essential (primary) hypertension Ap EC A IBUPROFEN d00015A B R10 Abdominal and pelvic pain Ap EC A LORAZEPAM d00149A C- F41.0 F41.9 Panic disorder [episodic paroxysmal anxiety] without agoraphobia Anxiety disorder, unspecified Ap EC A METOPROLOL d00134A Bz I10 Essential (primary) hypertension Ap EC A MIRTAZAPINE d04025A C F32.9 F41.9 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified Ap EC A PANTOPRAZOLE d04514A Cr K21 Gastro-esophageal reflux disease Ap EC A TIZANIDINE d04102A C M54 Dorsalgia Ap EC0 A ALPRAZOLAM d00168A Bz F41.9 Anxiety disorder, unspecified A EC@ A ALPRAZOLAM d00168A C F41.9 Anxiety disorder, unspecified A@ EC@ A AMLODIPINE d00689A C I10 Essential (primary) hypertension A@ EC@ A HYDROCHLOROTHIAZIDE d00253A Dc I10 Essential (primary) hypertension A@ EC@ A LISINOPRIL d00732A Dc I10 Essential (primary) hypertension A@ ECP A ALBUTEROL d00749A C J45 Asthma A EC` A ATENOLOL d00004A B I10 Essential (primary) hypertension A EC` A CYPROHEPTADINE d00790A D T78.40 Allergy, unspecified A ECp A TERBINAFINE d04012A A B35 Dermatophytosis A EC A DILTIAZEM d00045A D I10 Essential (primary) hypertension AP EC A OMEPRAZOLE d00325A D K21 K30 Gastro-esophageal reflux disease Functional dyspepsia AP EC A SERTRALINE d00880A D 99999 AP EC A SODIUM CHLORIDE d00438A B= 55555 AP EC A WARFARIN d00022A D* D75.9P Prevent blood clots AP EC A . . . EC A CLONAZEPAM d00197A C G47.9 Sleep disorder, unspecified A EC A VALACYCLOVIR d03838A Cr B00.9 Herpesviral infection, unspecified A EC A . . . EC A . . . EC A BENAZEPRIL d00730A Cr I10 Essential (primary) hypertension Ap EC A DOXYCYCLINE d00037A AP L08.9 Local infection of the skin and subcutaneous tissue, unspecified Ap EC A FUROSEMIDE d00070A Cr R60.9 Edema, unspecified Ap EC A GLIMEPIRIDE d03864A B E11 Type 2 diabetes mellitus Ap EC A POTASSIUM CHLORIDE d00345A C I51.9 Heart disease, unspecified Ap EC A TIOTROPIUM d04829A C J45 Asthma Ap EC A WARFARIN d00022A Cr D75.9P Prevent blood clots Ap EC A HYDROCHLOROTHIAZIDE d00253A C- I10 Essential (primary) hypertension A ED A . . . ED A BUPROPION d00181A C F32.9 Major depressive disorder, single episode, unspecified A ED A SERTRALINE d00880A CDp F41.9 Anxiety disorder, unspecified A ED A . . . ED0 A NITROFURANTOIN d00112A A0 N39.0 Urinary tract infection, site not specified A ED@ A ESCITALOPRAM d04812A B= F32.9 Major depressive disorder, single episode, unspecified A EDP A . . . ED` A . . . EDp A . . . ED A OSELTAMIVIR d04462A Ap J09 Influenza due to certain identified influenza viruses A ED A . . . ED A AMOXICILLIN d00088A A0 J40 Bronchitis, not specified as acute or chronic A ED A PREDNISONE d00350A A0 J42 Unspecified chronic bronchitis A ED A . . . ED A . . . ED A ACETAMINOPHEN; BUTALBITAL d03456A C G43 Migraine A ED A . . . ED A . . . EE A . . . EE A . . . EE A BUSPIRONE d00182A B F41.9 Anxiety disorder, unspecified A@ EE A DILTIAZEM d00045A B I49.9 Cardiac arrhythmia, unspecified A@ EE A FLUTICASONE; UMECLIDINIUM; VILANTEROL d08666A B< J44.9 Chronic obstructive pulmonary disease, unspecified A@ EE A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A C"0 I10 Essential (primary) hypertension A@ EE0 A . . . EE@ A . . . EEP A ATORVASTATIN d04105A C 99999 A EEP A DIGOXIN d00210A C 99999 A EEP A DOXAZOSIN d00726A C 99999 A EEP A FINASTERIDE d00563A C 99999 A EEP A FUROSEMIDE d00070A C 99999 A EEP A GLIPIZIDE d00246A C 99999 A EEP A METOPROLOL d00134A C 99999 A EEP A WARFARIN d00022A C 99999 A EE` A . . . EEp A AMLODIPINE d00689A C I10 Essential (primary) hypertension A EEp A LEVOCETIRIZINE d05851A C T78.40 Allergy, unspecified A EE A INSULIN ASPART; INSULIN ASPART PROTAMINE d04839A C- E11 Type 2 diabetes mellitus A EE A LISINOPRIL d00732A B I10 Essential (primary) hypertension A0 EE A METHOTREXATE d00060A B M06.9 Rheumatoid arthritis, unspecified A0 EE A PREDNISONE d00350A B M06.9 Rheumatoid arthritis, unspecified A0 EE A BROMPHENIRAMINE; DEXTROMETHORPHAN; PSEUDOEPHEDRINE d03368A Ap R05 R09.81 Cough Nasal congestion A0 EE A CETIRIZINE d03827A C- T78.40 Allergy, unspecified A0 EE A MONTELUKAST d04289A C- T78.40 Allergy, unspecified A0 EE A AMLODIPINE d00689A C E78.0 Pure hypercholesterolemia Ap EE A ATENOLOL d00004A Dc I10 Essential (primary) hypertension Ap EE A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia Ap EE A FINASTERIDE d00563A C N40 Enlarged prostate Ap EE A HYDROCHLOROTHIAZIDE d00253A C- I10 Essential (primary) hypertension Ap EE A LOSARTAN d03821A C- I10 Essential (primary) hypertension Ap EE A RIVAROXABAN d07356A B D75.9P Prevent blood clots Ap EE A ALBUTEROL d00749A Ap R06.02 R06.2 R06.9P Shortness of breath Wheezing Prevent breathing difficulty A` EE A ALBUTEROL d00749A Ap J42 J45 Unspecified chronic bronchitis Asthma A` EE A FUROSEMIDE d00070A B I10 I50.9 N18.9 Essential (primary) hypertension Heart failure, unspecified Chronic kidney disease, unspecified A` EE A LEVOTHYROXINE d00278A D E03.9 Hypothyroidism, unspecified A` EE A LISINOPRIL d00732A C[@ I10 Essential (primary) hypertension A` EE A PREDNISONE d00350A C R09 Other symptoms and signs involving the circulatory and respiratory system A` EE A . . . EE A . . . EE A . . . EF A ALBUTEROL d00749A D# J98.9 Respiratory disorder, unspecified A EF A BECLOMETHASONE d00760A D# R06.9 Unspecified abnormalities of breathing A EF A . . . EF A . . . EF0 A . . . EF@ A GLYBURIDE d00248A C- E11 Type 2 diabetes mellitus A@ EF@ A LISINOPRIL d00732A C[@ I10 Essential (primary) hypertension A@ EF@ A METFORMIN d03807A Cr E11 Type 2 diabetes mellitus A@ EF@ A PRAVASTATIN d00348A C[@ E78.0 Pure hypercholesterolemia A@ EFP A . . . EF` A . . . EFp A . . . EF A . . . EF A ALBUTEROL d00749A C J20.9 Acute bronchitis, unspecified A EF A . . . EF A AMLODIPINE d00689A C- I10 Essential (primary) hypertension A` EF A FENOFIBRATE d04286A D* E78.1 Pure hyperglyceridemia A` EF A LOSARTAN d03821A C I10 Essential (primary) hypertension A` EF A METFORMIN d03807A C- R73 Elevated blood glucose level A` EF A PANTOPRAZOLE d04514A D9 K21 Gastro-esophageal reflux disease A` EF A PAROXETINE d03157A B F32.9 F41.9 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified A` EF A ETHINYL ESTRADIOL; LEVONORGESTREL d03242A C Z79.3 Long term (current) use of hormonal contraceptives A EF A AMIODARONE d00002A Cr I48.9 Unspecified atrial fibrillation and atrial flutter A@ EF A ASPIRIN d00170A D I21.P I63.P Prevent heart attack/myocardial infarction Prevent stroke A@ EF A DOCUSATE d01021A CDp K59.0 Constipation A@ EF A TRAMADOL d03826A C M25.5 Pain in joint A@ EF A AMITRIPTYLINE d00146A CDp F41.9 Anxiety disorder, unspecified A EF A ATORVASTATIN d04105A C E78.0 I10 Pure hypercholesterolemia Essential (primary) hypertension A EF A . . . EG A GABAPENTIN d03182A D# M79.2 Neuralgia and neuritis, unspecified AP EG A HYDROCODONE d03075A D* M25.5 M54 Pain in joint Dorsalgia AP EG A MELOXICAM d04532A B M06.9 Rheumatoid arthritis, unspecified AP EG A OMEPRAZOLE d00325A D K30 Functional dyspepsia AP EG A OXYBUTYNIN d00328A B N32.81 Overactive bladder AP EG A . . . EG A . . . EG0 A DEXTROAMPHETAMINE d00804A C- F99 Mental disorder, not otherwise specified A EG0 A ETHINYL ESTRADIOL; NORETHINDRONE d03238A Cr N92 Z79.3 Excessive, frequent and irregular menstruation Long term (current) use of hormonal contraceptives A EG@ A VALSARTAN d04113A B I10 Essential (primary) hypertension A EGP A . . . EG` A CLONIDINE d00044A CDp F31.9 Bipolar disorder, unspecified A` EG` A INSULIN DEGLUDEC d08054A B E10 Type 1 diabetes mellitus A` EG` A LAMOTRIGINE d03809A CDp F31.9 Bipolar disorder, unspecified A` EG` A LITHIUM d00061A Cr F31.9 Bipolar disorder, unspecified A` EG` A SITAGLIPTIN d05896A B E10 Type 1 diabetes mellitus A` EG` A TRAZODONE d00395A B G47.0 Insomnia A` EGp A . . . EG A ASPIRIN d00170A C- D75.9P Prevent blood clots A EG A CONJUGATED ESTROGENS TOPICAL d04396A B[ N95 Menopausal and other perimenopausal disorders A EG A DESOXIMETASONE TOPICAL d01291A A L29.9 Pruritus, unspecified A EG A ESTRADIOL TOPICAL d04210A B[ N95 Menopausal and other perimenopausal disorders A EG A LEVOTHYROXINE d00278A D E06 Thyroiditis A EG A LOSARTAN d03821A CDp I10 Essential (primary) hypertension A EG A MELOXICAM d04532A C M13 Other arthritis A EG A VENLAFAXINE d03181A D F32.9 Major depressive disorder, single episode, unspecified A EG A ALBUTEROL d00749A C"0 J44.9 Chronic obstructive pulmonary disease, unspecified A EG A AMLODIPINE d00689A C I10 Essential (primary) hypertension A EG A CLONIDINE d00044A C I10 Essential (primary) hypertension A EG A CLOPIDOGREL d04258A C 99999 A EG A INSULIN DEGLUDEC d08054A B E11 Type 2 diabetes mellitus A EG A LISINOPRIL d00732A C I10 Essential (primary) hypertension A EG A METFORMIN d03807A C R73 Elevated blood glucose level A EG A OMEPRAZOLE d00325A C K21 Gastro-esophageal reflux disease A EG A PIOGLITAZONE d04442A B= 99999 A EG A . . . EG A . . . EG A . . . EG A LEVOTHYROXINE d00278A D* E03.9 Hypothyroidism, unspecified A EG A . . . EG A ALBUTEROL d00749A Bz J20.9 J42 J45 Acute bronchitis, unspecified Unspecified chronic bronchitis Asthma A EH A . . . EH A CLOPIDOGREL d04258A C D75.9P Z79.0 Prevent blood clots Long term (current) use of anticoagulants and antithrombotics/antiplatelets A EH A LEVOTHYROXINE d00278A D E03.9 Hypothyroidism, unspecified A EH A LISINOPRIL d00732A C I10 Essential (primary) hypertension A EH A METFORMIN d03807A C E11 Type 2 diabetes mellitus A EH A METOPROLOL d00134A C I10 Essential (primary) hypertension A EH A ROSUVASTATIN d04851A C- E78.0 Pure hypercholesterolemia A EH A SILDENAFIL d04299A D N52.9 Male erectile dysfunction, unspecified A EH A TESTOSTERONE d00558A D# E29.1 Testicular hypofunction A EH A DROSPIRENONE; ETHINYL ESTRADIOL d04760A Cr Z79.3 Long term (current) use of hormonal contraceptives A EH A FLUOXETINE d00236A C F41.9 Anxiety disorder, unspecified A EH0 A . . . EH@ A AMOXICILLIN d00088A Ap J02 Acute pharyngitis A EH@ A METHYLPHENIDATE d00900A CDp F90 Attention-deficit hyperactivity disorders A EHP A ATENOLOL d00004A C I51.9P Prevent heart disease A EH` A . . . EHp A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A C I10 Essential (primary) hypertension A EH A BENZTROPINE d00175A C T88.7P Prevent drug side effect A EH A BUPROPION; NALTREXONE d08288A C- E66 Overweight and obesity A EH A CLONAZEPAM d00197A C F41.9 Anxiety disorder, unspecified A EH A DIVALPROEX SODIUM d03833A D F39 Unspecified mood [affective] disorder A EH A GABAPENTIN d03182A C F39 Unspecified mood [affective] disorder A EH A GUANFACINE d00717A C- F90 Attention-deficit hyperactivity disorders A EH A PROPRANOLOL d00032A Cr R25.1 Tremor, unspecified A EH A TAMSULOSIN d04121A C- N40 Enlarged prostate A EH A ZIPRASIDONE d04747A D F31.9 Bipolar disorder, unspecified A EH A . . . EH A EMPAGLIFLOZIN; LINAGLIPTIN d08344A C E11 Type 2 diabetes mellitus A@ EH A LISINOPRIL d00732A C E11.2P Prevent diabetic kidney disease A@ EH A METFORMIN d03807A C E11 Type 2 diabetes mellitus A@ EH A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia A@ EH A . . . EH A . . . EH A . . . EH A TRETINOIN TOPICAL d01244A B L70 Acne A EH A . . . EI A RIVAROXABAN d07356A C I80.3 Phlebitis and thrombophlebitis of lower extremities, unspecified A EI A . . . EI A . . . EI0 A ALBUTEROL d00749A D1 J44.9 J45 R06.02 Chronic obstructive pulmonary disease, unspecified Asthma Shortness of breath A EI0 A ALBUTEROL; IPRATROPIUM d04066A D* J44.9 J45 Chronic obstructive pulmonary disease, unspecified Asthma A EI0 A CARVEDILOL d03847A Cr I49.9 Cardiac arrhythmia, unspecified A EI0 A CETIRIZINE d03827A B T78.40 Allergy, unspecified A EI0 A FLUTICASONE; SALMETEROL d04611A D J44.9 J45 Chronic obstructive pulmonary disease, unspecified Asthma A EI0 A FUROSEMIDE d00070A DE I10 I51.9 Essential (primary) hypertension Heart disease, unspecified A EI0 A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified A EI0 A MONTELUKAST d04289A D* J44.9 J45 Chronic obstructive pulmonary disease, unspecified Asthma A EI0 A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia A EI0 A VALSARTAN d04113A D I10 Essential (primary) hypertension A EI@ A . . . EIP A . . . EI` A . . . EIp A . . . EI A . . . EI A . . . EI A CETIRIZINE d03827A B R09.81 Nasal congestion A EI A HYDROCHLOROTHIAZIDE d00253A B I10 Essential (primary) hypertension A EI A . . . EI A . . . EI A ETHINYL ESTRADIOL; NORELGESTROMIN d04779A B[ N92 Excessive, frequent and irregular menstruation A EI A . . . EI A . . . EJ A ACETAMINOPHEN; HYDROCODONE d03428A0 Cr L93 M79.2 M79.7 Lupus erythematosus Neuralgia and neuritis, unspecified Fibromyalgia B EJ A ALBUTEROL d00749A0 Cr J45 Asthma B EJ A AMLODIPINE d00689A0 C I10 Essential (primary) hypertension B EJ A CHLORTHALIDONE d00192A0 C I10 Essential (primary) hypertension B EJ A CYCLOBENZAPRINE d00963A0 C M25.5 M54 Pain in joint Dorsalgia B EJ A DULOXETINE d05355A0 Cr F32.9 M54 Major depressive disorder, single episode, unspecified Dorsalgia B EJ A FLUTICASONE NASAL d04283A0 Cr J30.2 J30.9 Other seasonal allergic rhinitis Allergic rhinitis, unspecified B EJ A GABAPENTIN d03182A0 Cr M54 M79.2 M79.7 Dorsalgia Neuralgia and neuritis, unspecified Fibromyalgia B EJ A HYDROXYCHLOROQUINE d00817A0 Cr L93 M06.9 Lupus erythematosus Rheumatoid arthritis, unspecified B EJ A LOSARTAN d03821A0 Cr I10 Essential (primary) hypertension B EJ A MELOXICAM d04532A0 C L93 M19.9 Lupus erythematosus Osteoarthritis, unspecified site B EJ A METFORMIN d03807A0 C E11 Type 2 diabetes mellitus B EJ A METOPROLOL d00134A0 C I10 Essential (primary) hypertension B EJ A MYCOPHENOLATE MOFETIL d03839A0 C L93 M06.9 Lupus erythematosus Rheumatoid arthritis, unspecified B EJ A RANITIDINE d00021A0 C[@ K21 Gastro-esophageal reflux disease B EJ A ROSUVASTATIN d04851A0 CDp E78.0 Pure hypercholesterolemia B EJ A . . . EJ A ADAPALENE TOPICAL d04015A B L70 Acne A EJ A BENZOYL PEROXIDE; CLINDAMYCIN TOPICAL d04742A B L70 L71 Acne Rosacea A EJ0 A GLIPIZIDE d00246A C I10 Essential (primary) hypertension A` EJ0 A LISINOPRIL d00732A C- I10 Essential (primary) hypertension A` EJ0 A METFORMIN d03807A C E11 Type 2 diabetes mellitus A` EJ0 A METOPROLOL d00134A D I10 Essential (primary) hypertension A` EJ0 A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia A` EJ0 A SITAGLIPTIN d05896A C E11 Type 2 diabetes mellitus A` EJ@ A . . . EJP A AMLODIPINE d00689A C"@ I10 Essential (primary) hypertension Ap EJP A HYDROCHLOROTHIAZIDE d00253A D ^ I63.P Prevent stroke Ap EJP A IPRATROPIUM d00265A Bz R09.8 Other specified symptoms and signs involving the circulatory and respiratory systems Ap EJP A MELOXICAM d04532A C[@ M79.1 Myalgia Ap EJP A PANTOPRAZOLE d04514A C K30 Functional dyspepsia Ap EJP A PHENTERMINE d00806A A E66 Overweight and obesity Ap EJP A VENLAFAXINE d03181A D F41.9 Anxiety disorder, unspecified Ap EJ` A . . . EJp A CLOPIDOGREL d04258A0 C I63.P Prevent stroke B EJp A CLOPIDOGREL d04258A0 Cr I63 Cerebral infarction B EJp A EZETIMIBE d04824A0 C E78.0 Pure hypercholesterolemia B EJp A HYDROCHLOROTHIAZIDE d00253A0 C R60.9 Edema, unspecified B EJp A HYDROXYZINE d00907A0 C- L23 Allergic contact dermatitis B EJp A INSULIN ASPART d04697A0 Cr E11 Type 2 diabetes mellitus B EJp A INSULIN DETEMIR d05436A0 C E11 Type 2 diabetes mellitus B EJp A LINAGLIPTIN d07767A0 C R73 Elevated blood glucose level B EJp A LOPERAMIDE d01025A0 Dc N39.4 Other specified urinary incontinence B EJp A LOVASTATIN d00280A0 Cr E78.0 I63.P Pure hypercholesterolemia Prevent stroke B EJp A METOPROLOL d00134A0 D I10 Essential (primary) hypertension B EJp A MIRTAZAPINE d04025A0 C G47.0 Insomnia B EJp A OXYBUTYNIN d00328A0 C N32.81 Overactive bladder B EJp A PANTOPRAZOLE d04514A0 Cr K21 Gastro-esophageal reflux disease B EJp A SAXAGLIPTIN d07467A0 C E11 Type 2 diabetes mellitus B EJp A TEMAZEPAM d00384A0 C G47.0 Insomnia B EJ A 77777 . . Ap EJ A 99999 . . Ap EJ A AMLODIPINE d00689A D ^ I10 Essential (primary) hypertension Ap EJ A METOPROLOL d00134A D ^ I10 Essential (primary) hypertension Ap EJ A MONTELUKAST d04289A C J44.9 Chronic obstructive pulmonary disease, unspecified Ap EJ A OMEPRAZOLE d00325A D ^ K21 Gastro-esophageal reflux disease Ap EJ A ROSUVASTATIN d04851A D ^ E78.0 Pure hypercholesterolemia Ap EJ A INSULIN ASPART d04697A C E11 Type 2 diabetes mellitus A EJ A FLUTICASONE NASAL d04283A CDp J30.9 Allergic rhinitis, unspecified A0 EJ A LOSARTAN d03821A C[@ 99999 A0 EJ A METOPROLOL d00134A C[@ 99999 A0 EJ A IBUPROFEN d00015A B M54 Dorsalgia A EJ A . . . EJ A . . . EJ A AMLODIPINE d00689A C I10 Essential (primary) hypertension Ap EJ A GLIMEPIRIDE d03864A C[@ E11 Type 2 diabetes mellitus Ap EJ A LISINOPRIL d00732A C I10 Essential (primary) hypertension Ap EJ A METFORMIN d03807A C E11 Type 2 diabetes mellitus Ap EJ A METOPROLOL d00134A C[@ I10 Essential (primary) hypertension Ap EJ A ROSUVASTATIN d04851A C E78.0 Pure hypercholesterolemia Ap EJ A VENLAFAXINE d03181A D F32.9 Major depressive disorder, single episode, unspecified Ap EJ A CLONAZEPAM d00197A C- F41.9 Anxiety disorder, unspecified AP EJ A ESCITALOPRAM d04812A Dc F32.9 Major depressive disorder, single episode, unspecified AP EJ A METFORMIN d03807A Dc E11 Type 2 diabetes mellitus AP EJ A ROPINIROLE d04215A B G25.81 Restless legs syndrome AP EJ A TRAMADOL d03826A C- M79.1 Myalgia AP EK A 77777 . . A EK A . . . EK A . . . EK0 A ACYCLOVIR d00001A C A49.9P Prevent bacterial infection A EK0 A BUPROPION d00181A C F33.9 Major depressive disorder, recurrent, unspecified A EK0 A COLESTIPOL d00744A C- R19.7 Diarrhea, unspecified A EK0 A HYDROCHLOROTHIAZIDE d00253A C- I10 Essential (primary) hypertension A EK0 A IMIQUIMOD TOPICAL d04125A B B34.9 Viral infection, unspecified A EK0 A METOPROLOL d00134A C I10 Essential (primary) hypertension A EK0 A PAMIDRONATE d00601A CDp M81 Osteoporosis without current pathological fracture A EK0 A RIVAROXABAN d07356A CP I80.3 Phlebitis and thrombophlebitis of lower extremities, unspecified A EK0 A TADALAFIL d04896A Cr N52.9 Male erectile dysfunction, unspecified A EK@ A FINASTERIDE d00563A Cr L65.9 Nonscarring hair loss, unspecified A EKP A CANAGLIFLOZIN d08080A B E11 Type 2 diabetes mellitus A EK` A ATENOLOL d00004A C I10 Essential (primary) hypertension A EK` A DICYCLOMINE d00999A C R10 Abdominal and pelvic pain A EK` A FLUTICASONE NASAL d04283A Cr J30.2 Other seasonal allergic rhinitis A EK` A FUROSEMIDE d00070A C- J98.9 Respiratory disorder, unspecified A EK` A LEVOTHYROXINE d00278A D% E03.9 Hypothyroidism, unspecified A EK` A LISINOPRIL d00732A C[@ I10 Essential (primary) hypertension A EK` A MECLIZINE d00859A D9 R42 Dizziness and giddiness A EK` A OMEPRAZOLE d00325A D B96.81 Helicobacter pylori [H. pylori] as the cause of diseases classified elsewhere A EK` A PITAVASTATIN d07637A CDp E78.0 Pure hypercholesterolemia A EK` A SPIRONOLACTONE d00373A CDp I10 Essential (primary) hypertension A EKp A HYDROCHLOROTHIAZIDE; IRBESARTAN d04245A D I10 Essential (primary) hypertension A EKp A PRAVASTATIN d00348A D E78.0 Pure hypercholesterolemia A EK A . . . EK A . . . EK A ETHINYL ESTRADIOL; NORGESTIMATE d03781A B[ Z79.3 Long term (current) use of hormonal contraceptives A EK A . . . EK A HYDROCHLOROTHIAZIDE d00253A C I10 Essential (primary) hypertension A EK A METOPROLOL d00134A C I10 Essential (primary) hypertension A EK A . . . EK A CARVEDILOL d03847A C ` G47.0 Insomnia A` EK A FUROSEMIDE d00070A C ` R60.9 Edema, unspecified A` EK A LISINOPRIL d00732A C ` I10 Essential (primary) hypertension A` EK A PANTOPRAZOLE d04514A B[ K21 Gastro-esophageal reflux disease A` EK A SPIRONOLACTONE d00373A B< I50.9 Heart failure, unspecified A` EK A WARFARIN d00022A C ` D75.9P Prevent blood clots A` EK A . . . EL A . . . EL A ESTERIFIED ESTROGENS d00542A B[ Z79.890 Hormone replacement therapy A EL A ALFUZOSIN d04797A C N32.9 Bladder disorder, unspecified AP EL A ATORVASTATIN d04105A D E78.0 Pure hypercholesterolemia AP EL A FINASTERIDE d00563A C N40 Enlarged prostate AP EL A HYDROCHLOROTHIAZIDE; LOSARTAN d03830A C I10 Essential (primary) hypertension AP EL A METFORMIN d03807A C- R73 Elevated blood glucose level AP EL0 A . . . EL@ A . . . ELP A . . . EL` A MOMETASONE NASAL d04223A CDp J30.9 Allergic rhinitis, unspecified A ELp A . . . EL A CHLORTHALIDONE d00192A C N28.9 Disorder of kidney and ureter, unspecified A0 EL A LOSARTAN d03821A C I10 Essential (primary) hypertension A0 EL A METOPROLOL d00134A C I10 Essential (primary) hypertension A0 EL A . . . EL A . . . EL A ALBUTEROL d00749A Cr J45 R06.2 R07.9 Asthma Wheezing Chest pain, unspecified A EL A ETHINYL ESTRADIOL; ETONOGESTREL d04773A A Z79.3 Long term (current) use of hormonal contraceptives A EL A PREDNISONE d00350A B[ H57.9 J42 Unspecified disorder of eye and adnexa Unspecified chronic bronchitis A EL A AMOXICILLIN d00088A A H66.9 Otitis media, unspecified A EL A FLUCONAZOLE d00071A A B37 Candidiasis A EL A . . . EL A LISINOPRIL d00732A C I10 Essential (primary) hypertension A EL A PROPRANOLOL d00032A C F41.9 Anxiety disorder, unspecified A EM A ATORVASTATIN d04105A C- E78.0 Pure hypercholesterolemia A EM A . . . EM A DONEPEZIL d04099A C R41 Other symptoms and signs involving cognitive functions and awareness A0 EM A LISINOPRIL d00732A D I10 Essential (primary) hypertension A0 EM A SIMVASTATIN d00746A D E78.0 Pure hypercholesterolemia A0 EM0 A METHADONE d00050A C F11.23 Opioid dependence with withdrawal A EM@ A . . . EMP A ATORVASTATIN d04105A CDp E78.0 Pure hypercholesterolemia A EMP A BUPROPION d00181A CDp F31.9 Bipolar disorder, unspecified A EMP A FLUTICASONE NASAL d04283A C J30.2 Other seasonal allergic rhinitis A EMP A HYDROCODONE d03075A C[@ M54 Dorsalgia A EMP A HYDROXYZINE d00907A B F41.9 Anxiety disorder, unspecified A EMP A INSULIN ISOPHANE (NPH) d04370A Dc E11 Type 2 diabetes mellitus A EMP A INSULIN REGULAR d04369A Dc E11 Type 2 diabetes mellitus A EMP A LAMOTRIGINE d03809A CDp F31.9 Bipolar disorder, unspecified A EMP A LISINOPRIL d00732A C E11.2P Prevent diabetic kidney disease A EMP A NAPROXEN d00019A C M54 Dorsalgia A EMP A PROPRANOLOL d00032A C R25.1 Tremor, unspecified A EMP A ROPINIROLE d04215A Ap G25.81 Restless legs syndrome A EMP A TEMAZEPAM d00384A C- G47.0 Insomnia A EMP A TOPIRAMATE d04115A CDp F31.9 Bipolar disorder, unspecified A EM` A ETHINYL ESTRADIOL; NORGESTIMATE d03781A B 55555 A0 EM` A FLUOXETINE d00236A B F32.9 F41.9 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified A0 EM` A MONTELUKAST d04289A C J30.9 Allergic rhinitis, unspecified A0 EMp A . . . EM A . . . EM A ALBUTEROL d00749A D# J45 Asthma A EM A . . . EM A . . . EM A ALBUTEROL d00749A A` J20.9 Acute bronchitis, unspecified Ap EM A ALBUTEROL d00749A A` J20.9 Acute bronchitis, unspecified Ap EM A AZITHROMYCIN d00091A AP J20.9 J42 Acute bronchitis, unspecified Unspecified chronic bronchitis Ap EM A DEXTROMETHORPHAN; PROMETHAZINE d03360A A` J20.9 R05 R09.81 Acute bronchitis, unspecified Cough Nasal congestion Ap EM A FLUTICASONE d01296A A` J20.9 Acute bronchitis, unspecified Ap EM A IBUPROFEN d00015A A0 R50.9 Fever, unspecified Ap EM A MONTELUKAST d04289A A` J42 Unspecified chronic bronchitis Ap EM A . . . EM A . . . EM A DILTIAZEM d00045A C[@ I10 Essential (primary) hypertension A0 EM A ESCITALOPRAM d04812A CDp F41.9 Anxiety disorder, unspecified A0 EM A LISINOPRIL d00732A C I10 Essential (primary) hypertension A0 EN A AMITRIPTYLINE d00146A Cr K21 Gastro-esophageal reflux disease A` EN A ENALAPRIL d00013A C I10 Essential (primary) hypertension A` EN A LATANOPROST OPHTHALMIC d04017A C H40 Glaucoma A` EN A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified A` EN A PANTOPRAZOLE d04514A C K21 Gastro-esophageal reflux disease A` EN A PREDNISONE d00350A C E27.9 Disorder of adrenal gland, unspecified A` EN A . . . EN A . . . EN0 A . . . EN@ A CEPHALEXIN d00096A A0 K04.7P Prevent tooth infection A ENP A . . . EN` A . . . ENp A CLOPIDOGREL d04258A C I63.P Prevent stroke AP ENp A GABAPENTIN d03182A CDp I63 Cerebral infarction AP ENp A LEVETIRACETAM d04499A CDp G47.0 Insomnia AP ENp A OMEPRAZOLE d00325A Dc T88.7P Prevent drug side effect AP ENp A ZONISAMIDE d04527A CDp I63 Cerebral infarction AP EN A AMLODIPINE d00689A Ei 99999 AP EN A ATORVASTATIN d04105A Ei 99999 AP EN A ENALAPRIL d00013A Ei 99999 AP EN A INSULIN d00262A Ei R73 Elevated blood glucose level AP EN A METFORMIN d03807A Ei E11 Type 2 diabetes mellitus AP EN A LEVOTHYROXINE d00278A Dc E03.9 Hypothyroidism, unspecified A EN A TELMISARTAN d04364A Cr I10 Essential (primary) hypertension A EN A BUPROPION d00181A0 C F17.2 Nicotine dependence A` EN A DULOXETINE d05355A C F41.9 Anxiety disorder, unspecified A` EN A LEVOTHYROXINE d00278A0 CDp E03.9 Hypothyroidism, unspecified A` EN A LIRAGLUTIDE d07466A B E66 Overweight and obesity A` EN A MINOCYCLINE d00110A0 C L71 Rosacea A` EN A OMEPRAZOLE d00325A C K21 Gastro-esophageal reflux disease A` EN A . . . EN A MONTELUKAST d04289A C[@ T78.40 Allergy, unspecified A EN A . . . EN A . . . EN A . . . EO A . . . EO A ATORVASTATIN d04105A B E78.0P Prevent high cholesterol A0 EO A LISINOPRIL d00732A B N28.9P Prevent kidney disease A0 EO A METFORMIN d03807A B E11 Type 2 diabetes mellitus A0 EO A . . . EO0 A GLIPIZIDE d00246A C E11 Type 2 diabetes mellitus AP EO0 A INSULIN ASPART d04697A C E11 Type 2 diabetes mellitus AP EO0 A INSULIN DETEMIR d05436A C E11 Type 2 diabetes mellitus AP EO0 A METFORMIN d03807A CP E11 Type 2 diabetes mellitus AP EO0 A SERTRALINE d00880A B[ F41.9 F43.9 Anxiety disorder, unspecified Reaction to severe stress, unspecified AP EO@ A DONEPEZIL d04099A C F32.9 Major depressive disorder, single episode, unspecified A EO@ A GABAPENTIN d03182A CDp E11.4 Type 2 diabetes mellitus with neurological complications A EO@ A GLIMEPIRIDE d03864A CDp E11 Type 2 diabetes mellitus A EO@ A LISINOPRIL d00732A B I10 Essential (primary) hypertension A EO@ A LORAZEPAM d00149A C G47.0 Insomnia A EO@ A METFORMIN d03807A D E11 Type 2 diabetes mellitus A EO@ A METOPROLOL d00134A C I10 Essential (primary) hypertension A EO@ A SIMVASTATIN d00746A C- E78.0 Pure hypercholesterolemia A EO@ A VENLAFAXINE d03181A Dc F32.9 Major depressive disorder, single episode, unspecified A EOP A . . . EO` A . . . EOp A GABAPENTIN d03182A C M79.2 Neuralgia and neuritis, unspecified A@ EOp A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified A@ EOp A LISINOPRIL d00732A C I10 Essential (primary) hypertension A@ EOp A METOPROLOL d00134A C I48.9 Unspecified atrial fibrillation and atrial flutter A@ EO A METOPROLOL d00134A Cr R00 Abnormalities of heart beat A EO A . . . EO A ATENOLOL d00004A D ^ I49.9 Cardiac arrhythmia, unspecified A` EO A ATORVASTATIN d04105A D E78.0 Pure hypercholesterolemia A` EO A CLOPIDOGREL d04258A D ^ D75.9P Prevent blood clots A` EO A FINASTERIDE d00563A D R39.9 Unspecified symptoms and signs involving the genitourinary system A` EO A OMEPRAZOLE d00325A C K30 Functional dyspepsia A` EO A TAMSULOSIN d04121A D R39.9 Unspecified symptoms and signs involving the genitourinary system A` EO A . . . EO A ACETAMINOPHEN; CODEINE d03423A C R52 Pain, unspecified A EO A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A EO A CARVEDILOL d03847A C I10 Essential (primary) hypertension A EO A DULOXETINE d05355A C 99999 A EO A ESOMEPRAZOLE d04749A C K21 Gastro-esophageal reflux disease A EO A ESOMEPRAZOLE; NAPROXEN d07631A Bz G43 Migraine A EO A FUROSEMIDE d00070A C R60.9 Edema, unspecified A EO A LEVOCETIRIZINE d05851A CDp M79.2 Neuralgia and neuritis, unspecified A EO A LINACLOTIDE d07902A B K59.0 Constipation A EO A MONTELUKAST d04289A C J30.9 Allergic rhinitis, unspecified A EO A POTASSIUM CHLORIDE d00345A C E87.6 Hypokalemia A EO A SUMATRIPTAN d03160A C[@ G43 Migraine A EO A TIZANIDINE d04102A C M62.83 Muscle spasm A EO A TOPIRAMATE d04115A C G43 Migraine A EO A TRAZODONE d00395A C G47.0 Insomnia A EO A AMLODIPINE d00689A B= I10 Essential (primary) hypertension AP EO A DICLOFENAC d00848A B G43 Migraine AP EO A PREDNISONE d00350A A@ T78.40 Allergy, unspecified AP EO A TIZANIDINE d04102A B= M79.7 Fibromyalgia AP EO A TOPIRAMATE d04115A B G43 Migraine AP EO A . . . EO A IBUPROFEN d00015A CDp M79.1 Myalgia A EP A . . . EP A . . . EP A ATORVASTATIN d04105A A E78.0 Pure hypercholesterolemia A@ EP A GABAPENTIN d03182A C M79.2 Neuralgia and neuritis, unspecified A@ EP A LOSARTAN d03821A A I10 Essential (primary) hypertension A@ EP A METFORMIN d03807A C E11 Type 2 diabetes mellitus A@ EP0 A . . . EP@ A METFORMIN d03807A B E11.P E66 Prevent diabetes Overweight and obesity A EP@ A VARENICLINE d05807A B* F17.2 Nicotine dependence A EPP A . . . EP` A ALBUTEROL d00749A B J45 Asthma A EP` A ENTECAVIR d05525A B K76.9 Liver disease, unspecified A EPp A 55555 A B= D64.9 Anemia, unspecified A EPp A ALLOPURINOL d00023A C R60.9 Edema, unspecified A EPp A ASPIRIN d00170A C I63.P Prevent stroke A EPp A HYDRALAZINE d00132A Cr I10 Essential (primary) hypertension A EPp A NEBIVOLOL d05265A Cr I10 Essential (primary) hypertension A EPp A OMEGA-3 POLYUNSATURATED FATTY ACIDS d00497A C[@ E78.0 Pure hypercholesterolemia A EPp A ROSUVASTATIN d04851A Cr E78.0 Pure hypercholesterolemia A EPp A SIROLIMUS d04453A CP T86.9P Prevent transplanted organ and tissue rejection A EP A . . . EP A . . . EP A HYDROXYCHLOROQUINE d00817A B[ M06.9 Rheumatoid arthritis, unspecified A@ EP A MELOXICAM d04532A C M06.9 Rheumatoid arthritis, unspecified A@ EP A PREDNISONE d00350A B M06.9 Rheumatoid arthritis, unspecified A@ EP A TRAMADOL d03826A B[ M06.9 Rheumatoid arthritis, unspecified A@ EP A AMLODIPINE d00689A C[@ I10 Essential (primary) hypertension AP EP A ATORVASTATIN d04105A C[@ E78.0 Pure hypercholesterolemia AP EP A LISINOPRIL d00732A C[@ I10 Essential (primary) hypertension AP EP A METOPROLOL d00134A C[@ I10 Essential (primary) hypertension AP EP A TAMSULOSIN d04121A C[@ N40 Enlarged prostate AP EP A AMLODIPINE d00689A Cr I10 Essential (primary) hypertension A EP A BUSPIRONE d00182A B F41.9 Anxiety disorder, unspecified A EP A LISINOPRIL d00732A CDp I10 Essential (primary) hypertension A EP A . . . EP A . . . EQ A . . . EQ A . . . EQ A ACETAMINOPHEN; HYDROCODONE d03428A C M25.5 Pain in joint A` EQ A AMLODIPINE d00689A C I10 Essential (primary) hypertension A` EQ A GABAPENTIN d03182A Cr F32.9 Major depressive disorder, single episode, unspecified A` EQ A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A C I10 Essential (primary) hypertension A` EQ A IBUPROFEN d00015A C G89 T14.9 Pain, not elsewhere classified Unspecified injury A` EQ A SERTRALINE d00880A Cr F32.9 F41.9 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified A` EQ0 A . . . EQ@ A . . . EQP A . . . EQ` A . . . EQp A 99999 . . A EQ A METFORMIN d03807A B E11 Type 2 diabetes mellitus A0 EQ A METOPROLOL d00134A D I10 Essential (primary) hypertension A0 EQ A ROSUVASTATIN d04851A D E78.0 Pure hypercholesterolemia A0 EQ A . . . EQ A FUROSEMIDE d00070A C I10 Essential (primary) hypertension A@ EQ A GLIMEPIRIDE d03864A C E11 Type 2 diabetes mellitus A@ EQ A LISINOPRIL d00732A C I10 Essential (primary) hypertension A@ EQ A METFORMIN d03807A C E11 Type 2 diabetes mellitus A@ EQ A . . . EQ A AMOXICILLIN d00088A A A49.9P Prevent bacterial infection AP EQ A ATENOLOL d00004A C I10 Essential (primary) hypertension AP EQ A ATORVASTATIN d04105A C- E78.0 Pure hypercholesterolemia AP EQ A LISINOPRIL d00732A C I10 Essential (primary) hypertension AP EQ A TRAMADOL d03826A CDp K08.8 Other specified disorders of teeth and supporting structures AP EQ A GLIMEPIRIDE d03864A B E11 Type 2 diabetes mellitus A@ EQ A LISINOPRIL d00732A B I10 Essential (primary) hypertension A@ EQ A METFORMIN d03807A B E11 Type 2 diabetes mellitus A@ EQ A ROSUVASTATIN d04851A B E78.0P Prevent high cholesterol A@ EQ A . . . EQ A . . . ER A ETHINYL ESTRADIOL; ETONOGESTREL d04773A C Z79.3 Long term (current) use of hormonal contraceptives A ER A CLONIDINE d00044A C G47.0 G47.9 Insomnia Sleep disorder, unspecified A ER A METHYLPHENIDATE d00900A C- F90 Attention-deficit hyperactivity disorders A ER A VERAPAMIL d00048A C- I10 Essential (primary) hypertension A ER0 A . . . ER@ A CITALOPRAM d04332A C N95 Menopausal and other perimenopausal disorders A@ ER@ A HYDROCHLOROTHIAZIDE d00253A D I10 R60.9 Essential (primary) hypertension Edema, unspecified A@ ER@ A LEVOTHYROXINE d00278A D E03.9 Hypothyroidism, unspecified A@ ER@ A LISINOPRIL d00732A D I10 I50.9 Essential (primary) hypertension Heart failure, unspecified A@ ERP A ATORVASTATIN d04105A B< E78.0 Pure hypercholesterolemia AP ERP A HYDROCHLOROTHIAZIDE d00253A C I10 Essential (primary) hypertension AP ERP A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A C I10 Essential (primary) hypertension AP ERP A METOPROLOL d00134A C I10 Essential (primary) hypertension AP ERP A RANITIDINE d00021A C K30 R12 Functional dyspepsia Heartburn AP ER` A . . . ERp A PANTOPRAZOLE d04514A Cr K30 Functional dyspepsia A ER A . . . ER A AMLODIPINE d00689A C- I10 Essential (primary) hypertension A0 ER A HYDROCHLOROTHIAZIDE; LOSARTAN d03830A C- I10 Essential (primary) hypertension A0 ER A PRAVASTATIN d00348A C- E78.0P Prevent high cholesterol A0 ER A . . . ER A . . . ER A MONTELUKAST d04289A CDp J30.9 Allergic rhinitis, unspecified A ER A ENALAPRIL d00013A CDp I10 Essential (primary) hypertension A@ ER A GLIPIZIDE d00246A CDp E11 Type 2 diabetes mellitus A@ ER A METFORMIN d03807A CDp E11 Type 2 diabetes mellitus A@ ER A SIMVASTATIN d00746A CDp E78.0 Pure hypercholesterolemia A@ ER A FUROSEMIDE d00070A D R60.9 Edema, unspecified A ER A GABAPENTIN d03182A Ei R52 Pain, unspecified A ER A METOPROLOL d00134A C I48.9 Unspecified atrial fibrillation and atrial flutter A ER A OMEPRAZOLE d00325A Ei K21 Gastro-esophageal reflux disease A ER A RAMIPRIL d00728A D 99999 A ER A ROPINIROLE d04215A Cr G25.81 Restless legs syndrome A ER A SERTRALINE d00880A D R45 Symptoms and signs involving emotional state A ER A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia A ER A SPIRONOLACTONE d00373A Ei 99999 A ER A WARFARIN d00022A C I48.9 Unspecified atrial fibrillation and atrial flutter A ER A . . . ES A LISINOPRIL d00732A CP I10 Essential (primary) hypertension A0 ES A RANITIDINE d00021A CP K25 Gastric ulcer A0 ES A WARFARIN d00022A CP I80.3 Phlebitis and thrombophlebitis of lower extremities, unspecified A0 ES A LISINOPRIL d00732A C[@ I10 Essential (primary) hypertension A ES A OMEPRAZOLE d00325A A K21 R12 Gastro-esophageal reflux disease Heartburn A ES0 A ALPRAZOLAM d00168A C F31.9 Bipolar disorder, unspecified A0 ES0 A ASPIRIN d00170A C Z79.0 Long term (current) use of anticoagulants and antithrombotics/antiplatelets A0 ES0 A METFORMIN d03807A C R73 Elevated blood glucose level A0 ES@ A ALBUTEROL d00749A Ap R05 Cough A@ ES@ A AZITHROMYCIN d00091A Ap J01.9 Acute sinusitis, unspecified A@ ES@ A FLUTICASONE NASAL d04283A Ap J30.9 Allergic rhinitis, unspecified A@ ES@ A IBUPROFEN d00015A Ap R60.9 Edema, unspecified A@ ESP A . . . ES` A . . . ESp A AMLODIPINE d00689A C- I10 Essential (primary) hypertension A ESp A PRAVASTATIN d00348A B[ E78.0 Pure hypercholesterolemia A ES A IBUPROFEN d00015A B= M79.1 Myalgia A ES A LISINOPRIL d00732A CDp I10 Essential (primary) hypertension A@ ES A METFORMIN d03807A C E11 Type 2 diabetes mellitus A@ ES A PRAVASTATIN d00348A C E78.0 Pure hypercholesterolemia A@ ES A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia A@ ES A 99999 . . A ES A CEPHALEXIN d00096A A J18.9 Pneumonia, unspecified organism A0 ES A CYCLOSPORINE d00079A C9 L65.9 Nonscarring hair loss, unspecified A0 ES A TOFACITINIB d07925A C L65.9 Nonscarring hair loss, unspecified A0 ES A . . . ES A . . . ES A ESTRADIOL d00537A CDp Z79.890 Hormone replacement therapy A0 ES A LEVOTHYROXINE d00278A B= E03.9 Hypothyroidism, unspecified A0 ES A OMEPRAZOLE d00325A C[@ K27 Peptic ulcer, site unspecified A0 ES A . . . ET A . . . ET A . . . ET A . . . ET0 A . . . ET@ A . . . ETP A . . . ET` A . . . ETp A ALBUTEROL; IPRATROPIUM d04066A B J44.9 Chronic obstructive pulmonary disease, unspecified A ETp A ATENOLOL d00004A Cr I51.9 Heart disease, unspecified A ETp A ATORVASTATIN d04105A Ei E78.0 Pure hypercholesterolemia A ETp A CLOPIDOGREL d04258A C I51.9 Heart disease, unspecified A ETp A FINASTERIDE d00563A C N40 R39.1 Enlarged prostate Other difficulties with micturition A ETp A GABAPENTIN d03182A C M79.2 Neuralgia and neuritis, unspecified A ETp A METFORMIN d03807A D E11 Type 2 diabetes mellitus A ETp A NITROGLYCERIN d00321A C R07.9 Chest pain, unspecified A ETp A PANTOPRAZOLE d04514A CDp K21 Gastro-esophageal reflux disease A ETp A RANOLAZINE d05719A C- I51.9 Heart disease, unspecified A ETp A SPIRONOLACTONE d00373A B R60.9 Edema, unspecified A ETp A TAMSULOSIN d04121A C N40 R39.1 Enlarged prostate Other difficulties with micturition A ET A . . . ET A ALBUTEROL d00749A C J43 J44.9 Emphysema Chronic obstructive pulmonary disease, unspecified A ET A ALBUTEROL d00749A C J43 J44.9 Emphysema Chronic obstructive pulmonary disease, unspecified A ET A ARFORMOTEROL d05893A C J43 J44.9 Emphysema Chronic obstructive pulmonary disease, unspecified A ET A BUDESONIDE d04276A C J43 J44.9 Emphysema Chronic obstructive pulmonary disease, unspecified A ET A COLESTIPOL d00744A D9 E78.0 R19.7 Pure hypercholesterolemia Diarrhea, unspecified A ET A CYANOCOBALAMIN d00413A D9 55555 A ET A DONEPEZIL d04099A CDp G30.9 Alzheimer's disease, unspecified A ET A MEMANTINE d04899A C[@ G30.9 Alzheimer's disease, unspecified A ET A PANTOPRAZOLE d04514A CDp K21 Gastro-esophageal reflux disease A ET A SELEGILINE d00976A C[@ G31.9 Degenerative disease of nervous system, unspecified A ET A SODIUM CHLORIDE d00438A C J43 J44.9 Emphysema Chronic obstructive pulmonary disease, unspecified A ET A THEOPHYLLINE d00142A C J42 J43 J44.9 Unspecified chronic bronchitis Emphysema Chronic obstructive pulmonary disease, unspecified A ET A TIOTROPIUM d04829A C J43 J44.9 Emphysema Chronic obstructive pulmonary disease, unspecified A ET A TRAZODONE d00395A D# G47.0 Insomnia A ET A WARFARIN d00022A D9 I80.3 Phlebitis and thrombophlebitis of lower extremities, unspecified A ET A DOXEPIN d00217A C- G47.0 Insomnia A ET A . . . ET A . . . ET A INSULIN GLARGINE d04538A B E11 Type 2 diabetes mellitus A@ ET A LATANOPROST OPHTHALMIC d04017A B H40 Glaucoma A@ ET A LISINOPRIL d00732A CDp I10 Essential (primary) hypertension A@ ET A TIMOLOL OPHTHALMIC d04037A C H40 Glaucoma A@ ET A . . . ET A ETHINYL ESTRADIOL; NORETHINDRONE d03238A B N94 Pain and other conditions associated with female genital organs and menstrual cycle A0 ET A IBUPROFEN d00015A A@ N20.0 Calculus of kidney A0 ET A NITROFURANTOIN d00112A A@ N39.0 Urinary tract infection, site not specified A0 EU A . . . EU A . . . EU A . . . EU0 A . . . EU@ A CARVEDILOL d03847A B R07.9 Chest pain, unspecified A EU@ A CLOPIDOGREL d04258A Cr Z79.0 Long term (current) use of anticoagulants and antithrombotics/antiplatelets A EU@ A ESCITALOPRAM d04812A C- F41.9 Anxiety disorder, unspecified A EU@ A ISOSORBIDE MONONITRATE d00269A C R07.9 Chest pain, unspecified A EU@ A LEDIPASVIR; SOFOSBUVIR d08296A B B19 Unspecified viral hepatitis A EU@ A LUBIPROSTONE d05736A C- K59.0 Constipation A EU@ A PANTOPRAZOLE d04514A Cr K21 Gastro-esophageal reflux disease A EU@ A PRAVASTATIN d00348A C[@ E78.0 Pure hypercholesterolemia A EU@ A RANOLAZINE d05719A B R07.9 Chest pain, unspecified A EUP A . . . EU` A ACETAMINOPHEN; HYDROCODONE d03428A C M79.1 Myalgia A EU` A BUMETANIDE d00179A B= R60.9 Edema, unspecified A EU` A DOXEPIN d00217A B= L50 Urticaria A EU` A PANTOPRAZOLE d04514A C- K21 Gastro-esophageal reflux disease A EU` A TADALAFIL d04896A CDp I27.9 Pulmonary heart disease, unspecified A EU` A TIZANIDINE d04102A C[@ M62.83 M79.1 Muscle spasm Myalgia A EU` A TREPROSTINIL d04802A C[@ I27.9 Pulmonary heart disease, unspecified A EU` A WARFARIN d00022A C[@ I27.9 Pulmonary heart disease, unspecified A EUp A . . . EU A IBUPROFEN d00015A C- M54 Dorsalgia A EU A . . . EU A AMOXICILLIN; CLAVULANATE d00089A A H66.9 Otitis media, unspecified A EU A ALBUTEROL d00749A B( J20.9 R06.02 Acute bronchitis, unspecified Shortness of breath AP EU A BENZONATATE d00796A C[@ J00 Acute nasopharyngitis [common cold] AP EU A BROMPHENIRAMINE; PSEUDOEPHEDRINE d03301A A J00 Acute nasopharyngitis [common cold] AP EU A IBUPROFEN d00015A A H93.9 Unspecified disorder of ear AP EU A PROMETHAZINE d00787A B( J40 Bronchitis, not specified as acute or chronic AP EU A . . . EU A . . . EU A HYDROCHLOROTHIAZIDE d00253A C"0 I10 Essential (primary) hypertension A EU A . . . EV A CLOPIDOGREL d04258A D Z95 Presence of cardiac and vascular implants and grafts A0 EV A RIVAROXABAN d07356A B Z95 Presence of cardiac and vascular implants and grafts A0 EV A SOTALOL d00371A B I10 Essential (primary) hypertension A0 EV A . . . EV A CLONAZEPAM d00197A C- F41.9 Anxiety disorder, unspecified A EV A PAROXETINE d03157A C- F32.9 F41.9 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified A EV0 A OMEPRAZOLE d00325A C- K30 Functional dyspepsia A EV0 A VENLAFAXINE d03181A C F32.9 Major depressive disorder, single episode, unspecified A EV@ A . . . EVP A PANTOPRAZOLE d04514A Ap K30 Functional dyspepsia A EV` A AMOXICILLIN; CLAVULANATE d00089A Ap J40 Bronchitis, not specified as acute or chronic A EV` A POLYMYXIN B SULFATE d00344A A N39.0 Urinary tract infection, site not specified A EVp A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified A EVp A METOPROLOL d00134A Bz I10 Essential (primary) hypertension A EV A CLONIDINE d00044A C[@ F90 Attention-deficit hyperactivity disorders A EV A METHYLPHENIDATE d00900A C[@ F90 Attention-deficit hyperactivity disorders A EV A ATORVASTATIN d04105A Dc E78.0 Pure hypercholesterolemia A@ EV A INSULIN GLARGINE d04538A C- R73 Elevated blood glucose level A@ EV A LISINOPRIL d00732A D I10 Essential (primary) hypertension A@ EV A METFORMIN d03807A D E11 R73 Type 2 diabetes mellitus Elevated blood glucose level A@ EV A . . . EV A . . . EV A ATORVASTATIN d04105A B= E78.0 Pure hypercholesterolemia A0 EV A CELECOXIB d04380A A M79.6 Pain in limb, hand, foot, fingers and toes A0 EV A METFORMIN d03807A B E11 Type 2 diabetes mellitus A0 EV A . . . EV A . . . EV A ATORVASTATIN d04105A D E78.0 Pure hypercholesterolemia A EV A HYDROCHLOROTHIAZIDE; LOSARTAN d03830A D I10 Essential (primary) hypertension A EW A . . . EW A . . . EW A . . . EW0 A . . . EW@ A . . . EWP A . . . EW` A LISINOPRIL d00732A C- I10 Essential (primary) hypertension A@ EW` A METOPROLOL d00134A Cr I10 Essential (primary) hypertension A@ EW` A OMEPRAZOLE d00325A C K30 Functional dyspepsia A@ EW` A PRAVASTATIN d00348A Cr E78.0 Pure hypercholesterolemia A@ EWp A FENOFIBRATE d04286A C E78.1 Pure hyperglyceridemia A@ EWp A HYDROCHLOROTHIAZIDE; LOSARTAN d03830A CDp I10 Essential (primary) hypertension A@ EWp A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified A@ EWp A METOPROLOL d00134A C I10 Essential (primary) hypertension A@ EW A RANITIDINE d00021A B= K21 Gastro-esophageal reflux disease A EW A . . . EW A FAMOTIDINE d00141A C K30 Functional dyspepsia A EW A SIMVASTATIN d00746A C- E78.0 Pure hypercholesterolemia A EW A . . . EW A . . . EW A LISINOPRIL d00732A C I10 Essential (primary) hypertension A EW A OMEPRAZOLE d00325A C K21 Gastro-esophageal reflux disease A EW A . . . EW A ATORVASTATIN d04105A C E78.0P Prevent high cholesterol AP EW A CHLORTHALIDONE d00192A C R60.9 Edema, unspecified AP EW A LABETALOL d00016A C I50.9 Heart failure, unspecified AP EW A LISINOPRIL d00732A C I10 Essential (primary) hypertension AP EW A PRASUGREL d07409A C I21 ST elevation (STEMI) and non-ST elevation (NSTEMI) myocardial infarction AP EX A . . . EX A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A@ EX A CANAGLIFLOZIN d08080A C- E11 Type 2 diabetes mellitus A@ EX A HYDROCHLOROTHIAZIDE; VALSARTAN d04293A D I10 Essential (primary) hypertension A@ EX A ICOSAPENT d07891A C- E78.1 Pure hyperglyceridemia A@ EX A NORETHINDRONE d00555A B Z79.3 Long term (current) use of hormonal contraceptives A EX0 A . . . EX@ A . . . EXP A AMLODIPINE d00689A C- I10 Essential (primary) hypertension AP EXP A METFORMIN d03807A C- E11.P Prevent diabetes AP EXP A METOPROLOL d00134A C I10 Essential (primary) hypertension AP EXP A SERTRALINE d00880A C"0 F32.9 Major depressive disorder, single episode, unspecified AP EXP A TAMSULOSIN d04121A Cr N40 Enlarged prostate AP EX` A DEXAMETHASONE; TOBRAMYCIN OPHTHALMIC d03536A A H10 Conjunctivitis A EXp A POLYMYXIN B; TRIMETHOPRIM OPHTHALMIC d03529A A0 H10 Conjunctivitis A EX A AMLODIPINE d00689A C I10 Essential (primary) hypertension A EX A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A EX A . . . EX A . . . EX A MINOXIDIL d00135A Dc I10 Essential (primary) hypertension A0 EX A OLMESARTAN d04801A C I10 Essential (primary) hypertension A0 EX A VERAPAMIL d00048A C I10 Essential (primary) hypertension A0 EX A . . . EX A . . . EX A RISPERIDONE d03180A D F20 Schizophrenia A EX A ALBUTEROL d00749A C J45 Asthma A EX A BRIMONIDINE OPHTHALMIC d04048A C H40 Glaucoma A EX A DICLOFENAC TOPICAL d04722A B M54 Dorsalgia A EX A FLUTICASONE; SALMETEROL d04611A C J45 Asthma A EX A HYDRALAZINE d00132A C I10 Essential (primary) hypertension A EX A HYDROCHLOROTHIAZIDE d00253A CDp I50.9 Heart failure, unspecified A EX A LIDOCAINE TOPICAL d00683A A M54 Dorsalgia A EX A LOSARTAN d03821A C I21.P Prevent heart attack/myocardial infarction A EX A LOTEPREDNOL OPHTHALMIC d04292A Cr H10.1 Acute atopic conjunctivitis A EY A GLYBURIDE d00248A Cr E11 Type 2 diabetes mellitus A@ EY A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A Cr I10 Essential (primary) hypertension A@ EY A IBUPROFEN d00015A C[@ N94 Pain and other conditions associated with female genital organs and menstrual cycle A@ EY A SIMVASTATIN d00746A C- E78.0 Pure hypercholesterolemia A@ EY A . . . EY A . . . EY0 A SIMVASTATIN d00746A D E78.0 Pure hypercholesterolemia A EY@ A . . . EYP A . . . EY` A ACETAMINOPHEN; OXYCODONE d03431A C M79.6 Pain in limb, hand, foot, fingers and toes A EY` A ALBUTEROL d00749A Cr J45 Asthma A EY` A BISOPROLOL; HYDROCHLOROTHIAZIDE d03744A Cr I10 Essential (primary) hypertension A EY` A DILTIAZEM d00045A Cr I10 Essential (primary) hypertension A EY` A DOXAZOSIN d00726A CDp I10 Essential (primary) hypertension A EY` A INSULIN GLARGINE d04538A C E11 Type 2 diabetes mellitus A EY` A INSULIN LISPRO d04373A Cr E11 Type 2 diabetes mellitus A EY` A ISOSORBIDE MONONITRATE d00269A Ei I21.P Prevent heart attack/myocardial infarction A EY` A LATANOPROST OPHTHALMIC d04017A CDp H40 Glaucoma A EY` A LOSARTAN d03821A CDp I10 Essential (primary) hypertension A EY` A MINOXIDIL d00135A C[@ I10 Essential (primary) hypertension A EY` A PRAVASTATIN d00348A C E78.0 Pure hypercholesterolemia A EY` A TRIAMCINOLONE TOPICAL d03206A C L23 Allergic contact dermatitis A EY` A ZOLPIDEM d00910A C[@ G47.0 Insomnia A EYp A . . . EY A . . . EY A LOSARTAN d03821A C I10 Essential (primary) hypertension A EY A . . . EY A . . . EY A ALBUTEROL d00749A CDp J45 Asthma Ap EY A CYCLOSPORINE OPHTHALMIC d04836A C- H04 Disorders of lacrimal system Ap EY A DIAZEPAM d00148A C[@ G47.0 Insomnia Ap EY A FLUTICASONE d01296A C J44.9 Chronic obstructive pulmonary disease, unspecified Ap EY A HYDROCODONE d03075A C M19.9 M25.5 M54 Osteoarthritis, unspecified site Pain in joint Dorsalgia Ap EY A IBUPROFEN d00015A C M25.5 M54 T14.9 Pain in joint Dorsalgia Unspecified injury Ap EY A LEVOTHYROXINE d00278A D' E03.9 Hypothyroidism, unspecified Ap EY A . . . EY A CARVEDILOL d03847A CDp I21.P Prevent heart attack/myocardial infarction A EY A SIMVASTATIN d00746A C- E78.0 Pure hypercholesterolemia A EY A FLUTICASONE NASAL d04283A C J30.9 Allergic rhinitis, unspecified A EZ A . . . EZ A . . . EZ A ETHINYL ESTRADIOL; NORGESTIMATE d03781A C Z79.3 Long term (current) use of hormonal contraceptives A0 EZ A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified A0 EZ A MINOCYCLINE d00110A Cr L08.9 L70 Local infection of the skin and subcutaneous tissue, unspecified Acne A0 EZ0 A . . . EZ@ A . . . EZP A . . . EZ` A . . . EZp A EPINEPHRINE d00699A Cr T78.40 Allergy, unspecified A EZp A METHYLPHENIDATE d00900A C' F90 Attention-deficit hyperactivity disorders A EZ A . . . EZ A BENZTROPINE d00175A C 99999 A0 EZ A OXCARBAZEPINE d04513A A 99999 A0 EZ A RISPERIDONE d03180A A 99999 A0 EZ A . . . EZ A . . . EZ A 77777 . . A EZ A ACETAMINOPHEN; HYDROCODONE d03428A Cr T14.9 Unspecified injury Ap EZ A BACLOFEN d00967A B= M62.83 Muscle spasm Ap EZ A ENALAPRIL d00013A Cr I10 Essential (primary) hypertension Ap EZ A INSULIN GLARGINE d04538A C E11 Type 2 diabetes mellitus Ap EZ A INSULIN LISPRO d04373A C- R73 Elevated blood glucose level Ap EZ A SIMVASTATIN d00746A Cr E78.0 Pure hypercholesterolemia Ap EZ A TRAZODONE d00395A C- G47.0 Insomnia Ap EZ A AMANTADINE d00086A B[ F90 R41 Attention-deficit hyperactivity disorders Other symptoms and signs involving cognitive functions and awareness A EZ A ARIPIPRAZOLE d04825A Cr R45 Symptoms and signs involving emotional state A EZ A . . . E[ A . . . E[ A . . . E[ A . . . E[0 A . . . E[@ A ACETAMINOPHEN; HYDROCODONE d03428A C M54 Dorsalgia A E[@ A AMPHETAMINE; DEXTROAMPHETAMINE d04035A C"0 F90 Attention-deficit hyperactivity disorders A E[@ A FENOFIBRATE d04286A CDp E78.1 Pure hyperglyceridemia A E[@ A GABAPENTIN d03182A B M54 Dorsalgia A E[@ A HYDROCHLOROTHIAZIDE; METOPROLOL d03264A D I10 Essential (primary) hypertension A E[@ A LOSARTAN d03821A Cr I10 Essential (primary) hypertension A E[@ A METFORMIN d03807A C- R73 Elevated blood glucose level A E[@ A METOPROLOL d00134A D I10 Essential (primary) hypertension A E[@ A OMEPRAZOLE d00325A Cr K21 R12 Gastro-esophageal reflux disease Heartburn A E[@ A PAROXETINE d03157A D ^ F32.9 F41.9 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified A E[@ A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia A E[@ A TESTOSTERONE d00558A C E29.1 Testicular hypofunction A E[P A PAROXETINE d03157A C I10 Essential (primary) hypertension A E[P A ZOLPIDEM d00910A C G47.9 Sleep disorder, unspecified A E[` A HYDROCHLOROTHIAZIDE d00253A Cr I10 Essential (primary) hypertension A E[` A LISINOPRIL d00732A Cr I10 Essential (primary) hypertension A E[p A . . . E[ A . . . E[ A FLUTICASONE d01296A CDp J45 Asthma A E[ A PROMETHAZINE d00787A Ap R05 Cough A E[ A . . . E[ A FAMOTIDINE d00141A A@ K21 Gastro-esophageal reflux disease A E[ A NAPROXEN d00019A A@ M25.5 R07.9 Pain in joint Chest pain, unspecified A E[ A . . . E[ A . . . E[ A 77777 . . A E\ A . . . E\ A BUPROPION d00181A D F32.9 Major depressive disorder, single episode, unspecified A@ E\ A CARVEDILOL d03847A D9 I10 Essential (primary) hypertension A@ E\ A LEVOTHYROXINE d00278A D1 E03.9 Hypothyroidism, unspecified A@ E\ A MESALAMINE d01031A C K51 Ulcerative colitis A@ E\ A . . . E\0 A . . . E\@ A . . . E\P A . . . E\` A . . . E\p A . . . E\ A LEVOTHYROXINE d00278A . E03.9 Hypothyroidism, unspecified A E\ A LISINOPRIL d00732A B I10 Essential (primary) hypertension A E\ A PREDNISOLONE d00084A CDp H40 Glaucoma A E\ A BUPRENORPHINE; NALOXONE d04819A C[@ F11.23 Opioid dependence with withdrawal A E\ A . . . E\ A . . . E\ A . . . E\ A AMLODIPINE d00689A C[@ I10 Essential (primary) hypertension A0 E\ A HYDROCHLOROTHIAZIDE d00253A C I10 Essential (primary) hypertension A0 E\ A LISINOPRIL d00732A C I10 Essential (primary) hypertension A0 E\ A ENALAPRIL d00013A C[@ I10 Essential (primary) hypertension A` E\ A FAMOTIDINE d00141A C K21 Gastro-esophageal reflux disease A` E\ A LEVOTHYROXINE d00278A D E03.9 Hypothyroidism, unspecified A` E\ A METFORMIN d03807A C E11 Type 2 diabetes mellitus A` E\ A PANTOPRAZOLE d04514A B K21 Gastro-esophageal reflux disease A` E\ A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia A` E] A . . . E] A EZETIMIBE d04824A D* E78.0 Pure hypercholesterolemia A E] A PANTOPRAZOLE d04514A D1 K21 Gastro-esophageal reflux disease A E] A . . . E]0 A . . . E]@ A ATORVASTATIN d04105A Cr E78.0 Pure hypercholesterolemia Ap E]@ A FENOFIBRATE d04286A Cr E78.1 Pure hyperglyceridemia Ap E]@ A GLIPIZIDE d00246A C[@ E11 R73 Type 2 diabetes mellitus Elevated blood glucose level Ap E]@ A INSULIN GLARGINE d04538A B E11 Type 2 diabetes mellitus Ap E]@ A LISINOPRIL d00732A Cr K76.9P Prevent liver disease Ap E]@ A METFORMIN d03807A Cr E11 Type 2 diabetes mellitus Ap E]@ A PIOGLITAZONE d04442A B E11 Type 2 diabetes mellitus Ap E]P A . . . E]` A . . . E]p A . . . E] A . . . E] A . . . E] A METFORMIN d03807A CDp E11 Type 2 diabetes mellitus A E] A METOPROLOL d00134A C I10 Essential (primary) hypertension A E] A . . . E] A . . . E] A . . . E] A . . . E] A EMPAGLIFLOZIN d08275A AP E11 Type 2 diabetes mellitus A@ E] A INSULIN LISPRO d04373A B E11 Type 2 diabetes mellitus A@ E] A METFORMIN d03807A Ei E11 Type 2 diabetes mellitus A@ E] A TRAMADOL d03826A A M25.5 Pain in joint A@ E^ A . . . E^ A . . . E^ A . . . E^0 A CARVEDILOL d03847A0 CDp I10 Essential (primary) hypertension A E^0 A GABAPENTIN d03182A CDp K92.9 Disease of digestive system, unspecified A E^0 A HYDRALAZINE d00132A0 CDp I10 Essential (primary) hypertension A E^0 A LEVOTHYROXINE d00278A0 D' E07.9 Disorder of thyroid, unspecified A E^0 A LOSARTAN d03821A C I10 Essential (primary) hypertension A E^0 A METFORMIN d03807A0 D E11 Type 2 diabetes mellitus A E^0 A MONTELUKAST d04289A0 C- R06.2 Wheezing A E^0 A PANTOPRAZOLE d04514A0 CDp K21 Gastro-esophageal reflux disease A E^0 A PRAVASTATIN d00348A0 D& E78.0 Pure hypercholesterolemia A E^@ A . . . E^P A . . . E^` A . . . E^p A . . . E^ A 77777 . . A E^ A ACETAMINOPHEN; HYDROCODONE d03428A Dc M54 Dorsalgia A0 E^ A MECLIZINE d00859A A@ R42 Dizziness and giddiness A0 E^ A ONDANSETRON d00867A A@ R42 Dizziness and giddiness A0 E^ A AMLODIPINE d00689A C- I10 Essential (primary) hypertension A0 E^ A FERRIC CITRATE d08336A C 55555 A0 E^ A METOPROLOL d00134A C- I10 Essential (primary) hypertension A0 E^ A CETIRIZINE d03827A A J30.9 T78.40 Allergic rhinitis, unspecified Allergy, unspecified A E^ A ATENOLOL d00004A C- I10 Essential (primary) hypertension A@ E^ A HYDROCHLOROTHIAZIDE d00253A C- I10 Essential (primary) hypertension A@ E^ A LOSARTAN d03821A C- I10 Essential (primary) hypertension A@ E^ A METHIMAZOLE d00290A C"0 E05 Thyrotoxicosis [hyperthyroidism] A@ E^ A . . . E^ A . . . E^ A . . . E_ A . . . E_ A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A0 E_ A CLOPIDOGREL d04258A C D75.9P Prevent blood clots A0 E_ A SERTRALINE d00880A Bz F32.9 Major depressive disorder, single episode, unspecified A0 E_ A . . . E_0 A AMLODIPINE d00689A C I10 Essential (primary) hypertension A E_0 A METFORMIN d03807A Dc E11 Type 2 diabetes mellitus A E_@ A IRBESARTAN d04222A C I10 Essential (primary) hypertension A E_P A DIGOXIN d00210A C I49.9 Cardiac arrhythmia, unspecified Ap E_P A LOSARTAN d03821A C I21.P Prevent heart attack/myocardial infarction Ap E_P A METFORMIN d03807A C E11.P R73 Prevent diabetes Elevated blood glucose level Ap E_P A METOPROLOL d00134A C I49.9 Cardiac arrhythmia, unspecified Ap E_P A PRAVASTATIN d00348A C E78.0 Pure hypercholesterolemia Ap E_P A TAMSULOSIN d04121A C N40 Enlarged prostate Ap E_P A WARFARIN d00022A C D75.9P Prevent blood clots Ap E_` A 99999 . . A E_p A . . . E_ A ETHINYL ESTRADIOL; LEVONORGESTREL d03242A C"@ N92 Excessive, frequent and irregular menstruation A E_ A . . . E_ A . . . E_ A COLCHICINE d00150A C M10.9 Gout, unspecified A E_ A INSULIN ISOPHANE (NPH) d04370A C E11 Type 2 diabetes mellitus A E_ A INSULIN REGULAR d04369A C[@ E11 Type 2 diabetes mellitus A E_ A LISINOPRIL d00732A D I10 Essential (primary) hypertension A E_ A LOVASTATIN d00280A C E78.0 Pure hypercholesterolemia A E_ A METFORMIN d03807A D R73 Elevated blood glucose level A E_ A METOPROLOL d00134A C I50.9 Heart failure, unspecified A E_ A PRAMIPEXOLE d04145A C G25.81 Restless legs syndrome A E_ A TEMAZEPAM d00384A C- G47.9 Sleep disorder, unspecified A E_ A ENALAPRIL d00013A C I10 Essential (primary) hypertension A E_ A . . . E_ A CLOPIDOGREL d04258A Cr I51.9P Z79.0 Prevent heart disease Long term (current) use of anticoagulants and antithrombotics/antiplatelets A@ E_ A LOSARTAN d03821A C- I10 Essential (primary) hypertension A@ E_ A METOPROLOL d00134A Cr I51.9 Heart disease, unspecified A@ E_ A SIMVASTATIN d00746A CDp E78.0 Pure hypercholesterolemia A@ E_ A BUPROPION; NALTREXONE d08288A CDp E66 Overweight and obesity A0 E_ A HYDROCHLOROTHIAZIDE d00253A C I10 Essential (primary) hypertension A0 E_ A LOSARTAN d03821A C I10 Essential (primary) hypertension A0 E` A CITALOPRAM d04332A C F32.9 F41.9 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified A E` A INSULIN GLARGINE d04538A C E11 Type 2 diabetes mellitus A E` A INSULIN LISPRO d04373A C E11 Type 2 diabetes mellitus A E` A ISOSORBIDE MONONITRATE d00269A C Z95 Presence of cardiac and vascular implants and grafts A E` A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified A E` A LOSARTAN d03821A C I51.9 Heart disease, unspecified A E` A MIRABEGRON d07876A C- N32.81 Overactive bladder A E` A PANTOPRAZOLE d04514A C 99999 A E` A ROSUVASTATIN d04851A C E78.0 Pure hypercholesterolemia A E` A . . . E` A CETIRIZINE d03827A AP J00 Acute nasopharyngitis [common cold] A E`0 A . . . E`@ A ATORVASTATIN d04105A Cr E78.0 Pure hypercholesterolemia A@ E`@ A GABAPENTIN d03182A Cr G25.81 Restless legs syndrome A@ E`@ A LISINOPRIL d00732A Cr I10 Essential (primary) hypertension A@ E`@ A METFORMIN d03807A Cr E11 Type 2 diabetes mellitus A@ E`P A . . . E`` A AMLODIPINE d00689A C 99999 A` E`` A ATORVASTATIN d04105A C 99999 A` E`` A HYDROCHLOROTHIAZIDE d00253A C 99999 A` E`` A LEVOTHYROXINE d00278A C 99999 A` E`` A MELOXICAM d04532A C 99999 A` E`` A VALSARTAN d04113A C 99999 A` E`p A DESLORATADINE d04785A B R06.2 Wheezing A E`p A RANITIDINE d00021A B= K21 Gastro-esophageal reflux disease A E` A ATORVASTATIN d04105A B E78.0 Pure hypercholesterolemia A0 E` A CHLORTHALIDONE d00192A B I10 Essential (primary) hypertension A0 E` A LOSARTAN d03821A B I10 Essential (primary) hypertension A0 E` A GLIPIZIDE d00246A C- E11 Type 2 diabetes mellitus A E` A METFORMIN d03807A C- E11 Type 2 diabetes mellitus A E` A . . . E` A AZITHROMYCIN d00091A A@ J42 Unspecified chronic bronchitis A E` A DEXTROMETHORPHAN; PROMETHAZINE d03360A A0 J09 Influenza due to certain identified influenza viruses A E` A . . . E` A 99999 . . A E` A ATORVASTATIN d04105A0 C 99999 A E` A FENOFIBRATE d04286A0 C E78.0 Pure hypercholesterolemia A E` A GABAPENTIN d03182A0 C M79.2 Neuralgia and neuritis, unspecified A E` A GLIPIZIDE d00246A0 C R73 Elevated blood glucose level A E` A LORAZEPAM d00149A0 C F41.9 Anxiety disorder, unspecified A E` A MEPERIDINE d00017A0 C M25.5 M54 M79.6 Pain in joint Dorsalgia Pain in limb, hand, foot, fingers and toes A E` A METFORMIN d03807A0 C E11 Type 2 diabetes mellitus A E` A METOPROLOL d00134A0 C I21.P Prevent heart attack/myocardial infarction A E` A PANTOPRAZOLE d04514A0 C 99999 A E` A PROMETHAZINE d00787A0 C R11 Nausea and vomiting A E` A TICAGRELOR d07721A0 A@ D75.9P I21 Prevent blood clots ST elevation (STEMI) and non-ST elevation (NSTEMI) myocardial infarction A E` A ZOLPIDEM d00910A0 A@ G47.9 Sleep disorder, unspecified A E` A . . . Ea A . . . Ea A ALBUTEROL d00749A C J45 Asthma A Ea A CETIRIZINE d03827A B[ T78.40 Allergy, unspecified A Ea A . . . Ea0 A . . . Ea@ A DAPSONE TOPICAL d05543A C L70 Acne AP Ea@ A ETHINYL ESTRADIOL; NORGESTIMATE d03781A D= E28 L70 Ovarian dysfunction Acne AP Ea@ A FLUORIDE TOPICAL d04397A C K02 Dental caries AP Ea@ A SPIRONOLACTONE d00373A Cr L70 Acne AP Ea@ A TRETINOIN d03863A Cr L70 Acne AP EaP A AMLODIPINE d00689A C- I10 Essential (primary) hypertension A EaP A NEBIVOLOL d05265A C- I10 Essential (primary) hypertension A Ea` A . . . Eap A . . . Ea A . . . Ea A . . . Ea A AMLODIPINE d00689A C I21.P Prevent heart attack/myocardial infarction A Ea A ATORVASTATIN d04105A D E78.0 Pure hypercholesterolemia A Ea A CLOPIDOGREL d04258A CDp Z79.0 Long term (current) use of anticoagulants and antithrombotics/antiplatelets A Ea A GABAPENTIN d03182A C 99999 A Ea A GLIPIZIDE d00246A D' E11 Type 2 diabetes mellitus A Ea A INSULIN d00262A CDp E11 Type 2 diabetes mellitus A Ea A LISINOPRIL d00732A CDp I10 Essential (primary) hypertension A Ea A METOPROLOL d00134A Dc I10 Essential (primary) hypertension A Ea A OXYBUTYNIN d00328A C R35 Polyuria A Ea A TAMSULOSIN d04121A C N40 Enlarged prostate A Ea A . . . Ea A . . . Ea A HYDROCORTISONE TOPICAL d03205A A L20.9 Atopic dermatitis, unspecified A0 Ea A MOMETASONE TOPICAL d01300A A L20.9 Atopic dermatitis, unspecified A0 Ea A MONTELUKAST d04289A Bz J30.9 J45 Allergic rhinitis, unspecified Asthma A0 Ea A . . . Ea A HYDROCHLOROTHIAZIDE d00253A D* I10 Essential (primary) hypertension A Eb A . . . Eb A . . . Eb A . . . Eb0 A . . . Eb@ A BUPROPION d00181A B= F32.9 Major depressive disorder, single episode, unspecified A@ Eb@ A ETHINYL ESTRADIOL; NORETHINDRONE d03238A Bz N92 Excessive, frequent and irregular menstruation A@ Eb@ A FLUOXETINE d00236A C- F32.9 Major depressive disorder, single episode, unspecified A@ Eb@ A LEVOCETIRIZINE d05851A C T78.40 Allergy, unspecified A@ EbP A . . . Eb` A . . . Ebp A . . . Eb A LISINOPRIL d00732A CDp I10 Essential (primary) hypertension A Eb A AMLODIPINE d00689A B= I10 I63.P Essential (primary) hypertension Prevent stroke A Eb A ATORVASTATIN d04105A B= E78.0 Pure hypercholesterolemia A Eb A BUPROPION d00181A C F32.9 Major depressive disorder, single episode, unspecified A Eb A CYCLOBENZAPRINE d00963A B= M79.1 Myalgia A Eb A FLUOXETINE d00236A C F32.9 Major depressive disorder, single episode, unspecified A Eb A LOSARTAN d03821A C I10 Essential (primary) hypertension A Eb A NORTRIPTYLINE d00144A CDp M79.2 Neuralgia and neuritis, unspecified A Eb A WARFARIN d00022A D D75.9P Prevent blood clots A Eb A CLONAZEPAM d00197A A F41.9 Anxiety disorder, unspecified A@ Eb A ESCITALOPRAM d04812A A F32.9 Major depressive disorder, single episode, unspecified A@ Eb A LEVOTHYROXINE d00278A Dc E03.9 Hypothyroidism, unspecified A@ Eb A ZOLPIDEM d00910A Dc G47.0 Insomnia A@ Eb A AMLODIPINE d00689A C[@ I10 Essential (primary) hypertension A0 Eb A LOSARTAN d03821A C I10 Essential (primary) hypertension A0 Eb A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia A0 Eb A SERTRALINE d00880A C F32.9 F41.9 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified A Eb A . . . Eb A CALCIUM ACETATE d03689A C[@ E83.3 Disorders of phosphorus metabolism and phosphatases AP Eb A CARVEDILOL d03847A C I49.9 Cardiac arrhythmia, unspecified AP Eb A HYDROCHLOROTHIAZIDE d00253A C[@ 55555 AP Eb A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified AP Eb A OMEPRAZOLE d00325A D K21 Gastro-esophageal reflux disease AP Eb A . . . Ec A ATORVASTATIN d04105A Cr E78.0 Pure hypercholesterolemia A` Ec A BETHANECHOL d01427A Cr R39.9 Unspecified symptoms and signs involving the genitourinary system A` Ec A DOXAZOSIN d00726A DO R39.1 Other difficulties with micturition A` Ec A FINASTERIDE d00563A Cr R39.9 Unspecified symptoms and signs involving the genitourinary system A` Ec A METOPROLOL d00134A Cr 99999 A` Ec A PANTOPRAZOLE d04514A C R12 Heartburn A` Ec A . . . Ec A 99999 . . A Ec0 A . . . Ec@ A 55555 A CDp I51.9 Heart disease, unspecified A` Ec@ A ACARBOSE d03846A CDp E11 Type 2 diabetes mellitus A` Ec@ A AMLODIPINE d00689A CDp I10 Essential (primary) hypertension A` Ec@ A ATORVASTATIN d04105A CDp E78.0 Pure hypercholesterolemia A` Ec@ A LEVOTHYROXINE d00278A B E03.9 Hypothyroidism, unspecified A` Ec@ A METFORMIN d03807A CDp E11 Type 2 diabetes mellitus A` EcP A . . . Ec` A ALOGLIPTIN; PIOGLITAZONE d07965A C ` E11 Type 2 diabetes mellitus AP Ec` A ATORVASTATIN d04105A C ` E78.0 Pure hypercholesterolemia AP Ec` A FLUTICASONE NASAL d04283A C[@ J30.9 Allergic rhinitis, unspecified AP Ec` A LISINOPRIL d00732A C ` E11.2 Type 2 diabetes mellitus with kidney complications AP Ec` A METFORMIN d03807A C ` E11 Type 2 diabetes mellitus AP Ecp A . . . Ec A PANTOPRAZOLE d04514A B K21 Gastro-esophageal reflux disease A Ec A PREDNISONE d00350A A M54 Dorsalgia A Ec A . . . Ec A HYDROXYCHLOROQUINE d00817A Dc D89.9 Disorder involving the immune mechanism, unspecified A0 Ec A LISINOPRIL d00732A C I10 Essential (primary) hypertension A0 Ec A METOPROLOL d00134A Cr I10 Essential (primary) hypertension A0 Ec A . . . Ec A . . . Ec A ALBUTEROL d00749A C- J45 Asthma A Ec A AMLODIPINE d00689A C I10 Essential (primary) hypertension Ap Ec A CLOPIDOGREL d04258A Cr D75.9P Prevent blood clots Ap Ec A INSULIN LISPRO; INSULIN LISPRO PROTAMINE d04510A Dc E11 Type 2 diabetes mellitus Ap Ec A METFORMIN d03807A Dc R73 Elevated blood glucose level Ap Ec A METOPROLOL d00134A D Z79.0 Long term (current) use of anticoagulants and antithrombotics/antiplatelets Ap Ec A RAMIPRIL d00728A CDp N28.9P Prevent kidney disease Ap Ec A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia Ap Ec A . . . Ed A ACARBOSE d03846A C R73 Elevated blood glucose level A Ed A AMLODIPINE d00689A C I10 Essential (primary) hypertension A Ed A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A Ed A BUMETANIDE d00179A C- R60.9 Edema, unspecified A Ed A CARVEDILOL d03847A C- I10 Essential (primary) hypertension A Ed A CLOPIDOGREL d04258A C- I80.3 Phlebitis and thrombophlebitis of lower extremities, unspecified A Ed A GABAPENTIN d03182A C[@ M79.2 Neuralgia and neuritis, unspecified A Ed A GLIPIZIDE d00246A C- R73 Elevated blood glucose level A Ed A HYDROCODONE d03075A B T14.9 Unspecified injury A Ed A INSULIN DEGLUDEC d08054A B E11 Type 2 diabetes mellitus A Ed A MINOXIDIL d00135A B I10 Essential (primary) hypertension A Ed A PANTOPRAZOLE d04514A C"0 K21 Gastro-esophageal reflux disease A Ed A ATORVASTATIN d04105A Dc E78.0 Pure hypercholesterolemia AP Ed A GLIMEPIRIDE d03864A D E11 Type 2 diabetes mellitus AP Ed A HYDROCHLOROTHIAZIDE; IRBESARTAN d04245A D I10 Essential (primary) hypertension AP Ed A METFORMIN d03807A D E11 Type 2 diabetes mellitus AP Ed A TAMSULOSIN d04121A C N40 R35 R39.1 Enlarged prostate Polyuria Other difficulties with micturition AP Ed A BISOPROLOL d00709A C I48.9 Unspecified atrial fibrillation and atrial flutter Ap Ed A BRIMONIDINE OPHTHALMIC d04048A Cr H40 Glaucoma Ap Ed A DORZOLAMIDE; TIMOLOL OPHTHALMIC d04303A Cr H40 Glaucoma Ap Ed A ESOMEPRAZOLE d04749A C[@ R10 T88.7P Abdominal and pelvic pain Prevent drug side effect Ap Ed A LATANOPROST OPHTHALMIC d04017A C- H40 Glaucoma Ap Ed A MELOXICAM d04532A C M19.9 Osteoarthritis, unspecified site Ap Ed A RANITIDINE d00021A C[@ K30 Functional dyspepsia Ap Ed0 A ATENOLOL d00004A C R00 Abnormalities of heart beat A@ Ed0 A ENALAPRIL d00013A C I10 Essential (primary) hypertension A@ Ed0 A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified A@ Ed0 A SERTRALINE d00880A C F41.9 Anxiety disorder, unspecified A@ Ed@ A . . . EdP A . . . Ed` A . . . Edp A . . . Ed A MONTELUKAST d04289A C J30.9 Allergic rhinitis, unspecified AP Ed A OXYBUTYNIN d00328A B N32.81 Overactive bladder AP Ed A SIMVASTATIN d00746A D E78.0 Pure hypercholesterolemia AP Ed A TAMSULOSIN d04121A Cr R39.9 Unspecified symptoms and signs involving the genitourinary system AP Ed A TELMISARTAN d04364A Dc I10 Essential (primary) hypertension AP Ed A AMOXICILLIN d00088A B J42 Unspecified chronic bronchitis A Ed A BENZONATATE d00796A B J42 R05 Unspecified chronic bronchitis Cough A Ed A . . . Ed A . . . Ed A . . . Ed A . . . Ed A INSULIN GLARGINE d04538A C R73 Elevated blood glucose level A Ed A INSULIN LISPRO d04373A C R73 Elevated blood glucose level A Ed A BENZONATATE d00796A A R05 Cough A0 Ed A MONTELUKAST d04289A A R05 Cough A0 Ed A RANITIDINE d00021A A T78.40 Allergy, unspecified A0 Ee A 99999 . . A Ee A IBUPROFEN d00015A C R51 Headache A Ee A CLOPIDOGREL d04258A C Z48.8 Encounter for other specified postprocedural aftercare A` Ee A EMPAGLIFLOZIN d08275A C E11 Type 2 diabetes mellitus A` Ee A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified A` Ee A METFORMIN d03807A C E11 Type 2 diabetes mellitus A` Ee A METOPROLOL d00134A C Z48.8 Encounter for other specified postprocedural aftercare A` Ee A ROSUVASTATIN d04851A C E78.0P I21.P Prevent high cholesterol Prevent heart attack/myocardial infarction A` Ee0 A . . . Ee@ A BUPROPION d00181A C F32.9 Major depressive disorder, single episode, unspecified A Ee@ A CETIRIZINE d03827A C- J30.1 R09.81 Allergic rhinitis due to pollen Nasal congestion A Ee@ A CYCLOBENZAPRINE d00963A D# M62.83 Muscle spasm A Ee@ A DOCUSATE d01021A D K59.0 Constipation A Ee@ A FENOFIBRATE d04286A Cr E78.0 Pure hypercholesterolemia A Ee@ A GABAPENTIN d03182A Cr M54 Dorsalgia A Ee@ A LISINOPRIL d00732A D# I10 Essential (primary) hypertension A Ee@ A MORPHINE d00308A D# M54 Dorsalgia A Ee@ A SIMVASTATIN d00746A D E78.0 Pure hypercholesterolemia A EeP A PROPRANOLOL d00032A CDp I10 Essential (primary) hypertension A Ee` A . . . Eep A AMLODIPINE d00689A C I10 Essential (primary) hypertension A Ee A . . . Ee A . . . Ee A . . . Ee A . . . Ee A . . . Ee A ANASTROZOLE d03873A B= Z79.890 Hormone replacement therapy A Ee A ASPIRIN; BUTALBITAL; CAFFEINE; CODEINE d03426A Dc G43 Migraine A Ee A . . . Ee A . . . Ef A . . . Ef A BECLOMETHASONE d00760A C- J45 Asthma A Ef A ATORVASTATIN d04105A C E78.0P I21.P Prevent high cholesterol Prevent heart attack/myocardial infarction Ap Ef A DOXAZOSIN d00726A C I10 Essential (primary) hypertension Ap Ef A HYDROCHLOROTHIAZIDE d00253A C I10 Essential (primary) hypertension Ap Ef A METFORMIN d03807A Cr E11 Type 2 diabetes mellitus Ap Ef A METOPROLOL d00134A C I10 Essential (primary) hypertension Ap Ef A OLMESARTAN d04801A C I51.9 Heart disease, unspecified Ap Ef A PREDNISOLONE d00084A C H57.9 Unspecified disorder of eye and adnexa Ap Ef0 A . . . Ef@ A . . . EfP A . . . Ef` A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A C I10 Essential (primary) hypertension A Efp A . . . Ef A . . . Ef A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A C I10 Essential (primary) hypertension A Ef A AMLODIPINE d00689A CDp I10 Essential (primary) hypertension Ap Ef A ATORVASTATIN d04105A D# E78.0 Pure hypercholesterolemia Ap Ef A INSULIN GLARGINE d04538A B[ R73 Elevated blood glucose level Ap Ef A INSULIN LISPRO d04373A B[ E11 Type 2 diabetes mellitus Ap Ef A LISINOPRIL d00732A D# I10 Essential (primary) hypertension Ap Ef A METFORMIN; SITAGLIPTIN d06720A CDp E11 Type 2 diabetes mellitus Ap Ef A METOPROLOL d00134A D# I10 Essential (primary) hypertension Ap Ef A . . . Ef A . . . Ef A DILTIAZEM d00045A C I10 Essential (primary) hypertension A@ Ef A EZETIMIBE d04824A C E78.0 Pure hypercholesterolemia A@ Ef A METFORMIN d03807A C R73 Elevated blood glucose level A@ Ef A ROSUVASTATIN d04851A C[@ E78.0 Pure hypercholesterolemia A@ Ef A GLIPIZIDE d00246A C- E11 Type 2 diabetes mellitus AP Ef A LEVOTHYROXINE d00278A D E07.9 Disorder of thyroid, unspecified AP Ef A LISINOPRIL d00732A Dc I10 Essential (primary) hypertension AP Ef A METFORMIN d03807A Dc E11 Type 2 diabetes mellitus AP Ef A PRAVASTATIN d00348A Dc E78.0 Pure hypercholesterolemia AP Ef A DROSPIRENONE; ETHINYL ESTRADIOL d04760A C- Z79.3 Long term (current) use of hormonal contraceptives A Eg A . . . Eg A ESOMEPRAZOLE d04749A A K30 Functional dyspepsia A` Eg A LAMOTRIGINE d03809A CP F31.9 Bipolar disorder, unspecified A` Eg A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified A` Eg A METFORMIN d03807A CDp R73 Elevated blood glucose level A` Eg A MODAFINIL d04378A0 C- R53 Malaise and fatigue A` Eg A TOPIRAMATE d04115A B E66 Overweight and obesity A` Eg A . . . Eg0 A HYDROCHLOROTHIAZIDE; TRIAMTERENE d03052A D I10 Essential (primary) hypertension A0 Eg0 A LEVOTHYROXINE d00278A D)Y E03.9 Hypothyroidism, unspecified A0 Eg0 A LISINOPRIL d00732A D I10 Essential (primary) hypertension A0 Eg@ A ATORVASTATIN d04105A Ei I10 Essential (primary) hypertension A@ Eg@ A IBUPROFEN d00015A A T14.9 Unspecified injury A@ Eg@ A KETOCONAZOLE TOPICAL d03202A B= R39.9 Unspecified symptoms and signs involving the genitourinary system A@ Eg@ A LOSARTAN d03821A B= 99999 A@ EgP A RANITIDINE d00021A Cr K21 Gastro-esophageal reflux disease A Eg` A . . . Egp A . . . Eg A . . . Eg A . . . Eg A CLOMIPRAMINE d00876A A F32.9 F41.9 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified A Eg A PAROXETINE d03157A Bz F90 Attention-deficit hyperactivity disorders A Eg A . . . Eg A FLUTICASONE; SALMETEROL d04611A D J45 Asthma A Eg A MONTELUKAST d04289A D J45 Asthma A Eg A FLUOCINONIDE TOPICAL d01294A A R21 Rash and other nonspecific skin eruption A Eg A . . . Eg A . . . Eh A . . . Eh A CETIRIZINE d03827A C T78.40 Allergy, unspecified A Eh A . . . Eh0 A . . . Eh@ A . . . EhP A . . . Eh` A . . . Ehp A . . . Eh A . . . Eh A . . . Eh A . . . Eh A . . . Eh A DILTIAZEM d00045A C I10 Essential (primary) hypertension A0 Eh A PRAVASTATIN d00348A C E78.0 Pure hypercholesterolemia A0 Eh A RIVAROXABAN d07356A C+ I48.9 Unspecified atrial fibrillation and atrial flutter A0 Eh A ALPRAZOLAM d00168A Cr F41.9 Anxiety disorder, unspecified A0 Eh A ATENOLOL d00004A C I10 Essential (primary) hypertension A0 Eh A FAMOTIDINE d00141A C K30 Functional dyspepsia A0 Eh A ATORVASTATIN d04105A C- E78.0 Pure hypercholesterolemia AP Eh A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A B I10 Essential (primary) hypertension AP Eh A LORAZEPAM d00149A Cr F41.9 Anxiety disorder, unspecified AP Eh A METFORMIN d03807A C E11 Type 2 diabetes mellitus AP Eh A NAPROXEN d00019A Cr M54 M79.1 Dorsalgia Myalgia AP Eh A CARVEDILOL d03847A C 99999 A` Eh A ESOMEPRAZOLE d04749A B[ K30 Functional dyspepsia A` Eh A FUROSEMIDE d00070A C 99999 A` Eh A LOSARTAN d03821A C 99999 A` Eh A NITROGLYCERIN d00321A C I21 ST elevation (STEMI) and non-ST elevation (NSTEMI) myocardial infarction A` Eh A SIMVASTATIN d00746A C 99999 A` Ei A . . . Ei A 99999 . . A Ei A . . . Ei0 A . . . Ei@ A . . . EiP A LISINOPRIL d00732A B= I10 Essential (primary) hypertension A EiP A RIFAMPIN d00047A A A49.9 Bacterial infection, unspecified A Ei` A . . . Eip A . . . Ei A AMLODIPINE d00689A C- I10 Essential (primary) hypertension A Ei A ATORVASTATIN d04105A C- E78.0 Pure hypercholesterolemia A Ei A TEMAZEPAM d00384A Bz G47.0 G47.9 Insomnia Sleep disorder, unspecified A Ei A TRAMADOL d03826A B= R52 Pain, unspecified A Ei A FLUOXETINE d00236A B F32.9 Major depressive disorder, single episode, unspecified A Ei A . . . Ei A . . . Ei A . . . Ei A MONTELUKAST d04289A Cr J45 Asthma A Ei A ALENDRONATE d03849A Cr M81 Osteoporosis without current pathological fracture A@ Ei A HYDROCHLOROTHIAZIDE; LOSARTAN d03830A CDp I10 Essential (primary) hypertension A@ Ei A LOVASTATIN d00280A C- E78.0 Pure hypercholesterolemia A@ Ei A OMEPRAZOLE d00325A Cr K21 Gastro-esophageal reflux disease A@ Ej A . . . Ej A CITALOPRAM d04332A C F41.9 Anxiety disorder, unspecified A Ej A QUETIAPINE d04220A C F29 F32.9 G47.0 Unspecified psychosis not due to a substance or known physiological condition Major depressive disorder, single episode, unspecified Insomnia A Ej A BECLOMETHASONE d00760A C[@ J45 Asthma A Ej0 A ACETAMINOPHEN; HYDROCODONE d03428A CDp M54 Dorsalgia A Ej@ A . . . EjP A . . . Ej` A . . . Ejp A . . . Ej A . . . Ej A . . . Ej A . . . Ej A . . . Ej A CARVEDILOL d03847A D I10 Essential (primary) hypertension A Ej A DEXLANSOPRAZOLE d07395A C K21 Gastro-esophageal reflux disease A Ej A DICYCLOMINE d00999A C R12 Heartburn A Ej A DOXYCYCLINE d00037A C- A49.9 Bacterial infection, unspecified A Ej A EMPAGLIFLOZIN d08275A C E11 Type 2 diabetes mellitus A Ej A GEMFIBROZIL d00245A C E78.0 Pure hypercholesterolemia A Ej A GLYBURIDE d00248A C E11 Type 2 diabetes mellitus A Ej A INSULIN DETEMIR d05436A C- E11 Type 2 diabetes mellitus A Ej A RAMIPRIL d00728A Dc I10 Essential (primary) hypertension A Ej A SIMVASTATIN d00746A Dc E78.0 Pure hypercholesterolemia A Ej A SITAGLIPTIN d05896A C E11 Type 2 diabetes mellitus A Ej A . . . Ej A . . . Ej A ACETAMINOPHEN; CODEINE d03423A A M25.5 Pain in joint A0 Ej A CEPHALEXIN d00096A0 Ap T14.9 Unspecified injury A0 Ej A SULFAMETHOXAZOLE; TRIMETHOPRIM d00124A0 A A49.9P Prevent bacterial infection A0 Ek A . . . Ek A ACETAMINOPHEN; OXYCODONE d03431A Cr L93 M54 Lupus erythematosus Dorsalgia A Ek A AMLODIPINE d00689A D' I10 Essential (primary) hypertension A Ek A BROMFENAC OPHTHALMIC d05518A A H57.9 Unspecified disorder of eye and adnexa A Ek A DIFLUPREDNATE OPHTHALMIC d07298A A H57.9 Unspecified disorder of eye and adnexa A Ek A FUROSEMIDE d00070A D' I51.9 Heart disease, unspecified A Ek A HYDROXYCHLOROQUINE d00817A D' L93 Lupus erythematosus A Ek A LEVOTHYROXINE d00278A Cr E03.9 Hypothyroidism, unspecified A Ek A LOSARTAN d03821A D' I10 Essential (primary) hypertension A Ek A METHYLDOPA d00133A D' I10 Essential (primary) hypertension A Ek A METOPROLOL d00134A D' I10 Essential (primary) hypertension A Ek A MOXIFLOXACIN OPHTHALMIC d04860A A H26.9 Unspecified cataract A Ek A NAPROXEN d00019A D' L93 Lupus erythematosus A Ek A POTASSIUM CHLORIDE d00345A CDp E87.6 Hypokalemia A Ek A PREDNISONE d00350A D' L93 Lupus erythematosus A Ek A . . . Ek0 A DESVENLAFAXINE d07113A C"0 F32.9 Major depressive disorder, single episode, unspecified A0 Ek0 A OMEGA-3 POLYUNSATURATED FATTY ACIDS d00497A C F90 Attention-deficit hyperactivity disorders A0 Ek0 A TRAMADOL d03826A Ap M54 R51 Dorsalgia Headache A0 Ek@ A ETHINYL ESTRADIOL; LEVONORGESTREL d03242A C Z79.3 Long term (current) use of hormonal contraceptives A EkP A . . . Ek` A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A@ Ek` A CARVEDILOL d03847A C I21.P Prevent heart attack/myocardial infarction A@ Ek` A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified A@ Ek` A LISINOPRIL d00732A C I10 Essential (primary) hypertension A@ Ekp A . . . Ek A ANASTROZOLE d03873A B Z79.890 Hormone replacement therapy AP Ek A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia AP Ek A LISINOPRIL d00732A C I10 Essential (primary) hypertension AP Ek A PANTOPRAZOLE d04514A B K21 R12 Gastro-esophageal reflux disease Heartburn AP Ek A TESTOSTERONE d00558A B E29.1 Testicular hypofunction AP Ek A . . . Ek A AMLODIPINE d00689A C- I10 N28.9P Essential (primary) hypertension Prevent kidney disease AP Ek A DULAGLUTIDE d08290A B R73 Elevated blood glucose level AP Ek A INSULIN ISOPHANE; INSULIN REGULAR d04374A C R73 Elevated blood glucose level AP Ek A METFORMIN d03807A Cr R73 Elevated blood glucose level AP Ek A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia AP Ek A ASPIRIN d00170A C- D75.9P Prevent blood clots A Ek A DICLOFENAC d00848A C- M19.9 Osteoarthritis, unspecified site A Ek A BUPROPION d00181A Ap F32.9 Major depressive disorder, single episode, unspecified A0 Ek A DULOXETINE d05355A C- F32.9 Major depressive disorder, single episode, unspecified A0 Ek A OMEPRAZOLE d00325A D K21 Gastro-esophageal reflux disease A0 Ek A FENOFIBRATE d04286A0 Ei 99999 A0 Ek A METOPROLOL d00134A0 Ei 99999 A0 Ek A SERTRALINE d00880A0 Ei 99999 A0 Ek A . . . Ek A SERTRALINE d00880A C- F32.9 F41.9 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified A El A ATORVASTATIN d04105A CDp E78.0 Pure hypercholesterolemia AP El A CLINDAMYCIN d00043A B[ K04.7 Periapical abscess without sinus AP El A DIPHENHYDRAMINE d00212A CDp J30.1 J30.9 L29.9 Allergic rhinitis due to pollen Allergic rhinitis, unspecified Pruritus, unspecified AP El A INSULIN ISOPHANE; INSULIN REGULAR d04374A CDp E11 Type 2 diabetes mellitus AP El A LISINOPRIL d00732A CDp I10 Essential (primary) hypertension AP El A LISINOPRIL d00732A CP I10 Essential (primary) hypertension A El A BUDESONIDE; FORMOTEROL d04795A C J45 Asthma A El0 A . . . El@ A . . . ElP A . . . El` A FUROSEMIDE d00070A B[ I51.9 Heart disease, unspecified A Elp A ATENOLOL d00004A C I10 Essential (primary) hypertension A0 Elp A FUROSEMIDE d00070A C R60.9 Edema, unspecified A0 Elp A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A C I10 Essential (primary) hypertension A0 El A GLIMEPIRIDE d03864A C E11 Type 2 diabetes mellitus A@ El A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A C I10 Essential (primary) hypertension A@ El A INSULIN ASPART d04697A C R73 Elevated blood glucose level A@ El A METFORMIN d03807A C E11 Type 2 diabetes mellitus A@ El A . . . El A AMLODIPINE d00689A C I10 Essential (primary) hypertension A0 El A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A C I10 Essential (primary) hypertension A0 El A METOPROLOL d00134A C[@ I10 Essential (primary) hypertension A0 El A GLIPIZIDE d00246A C E11 Type 2 diabetes mellitus A@ El A INSULIN GLARGINE d04538A C E11 Type 2 diabetes mellitus A@ El A METFORMIN d03807A D E11 Type 2 diabetes mellitus A@ El A ROSUVASTATIN d04851A D E11 E78.0 Type 2 diabetes mellitus Pure hypercholesterolemia A@ El A HYDROCHLOROTHIAZIDE d00253A C I10 Essential (primary) hypertension A El A LOSARTAN d03821A C I10 Essential (primary) hypertension A El A . . . El A . . . El A . . . Em A . . . Em A . . . Em A 55555 A Cr 55555 AP Em A AMINOCAPROIC ACID d00528A Cr 55555 AP Em A DESMOPRESSIN d00583A C[@ 55555 AP Em A FLUTICASONE d01296A Cr J45 Asthma AP Em A PREDNISOLONE d00084A Cr J45 Asthma AP Em0 A . . . Em@ A . . . EmP A . . . Em` A ALBUTEROL d00749A D J45 Asthma A Em` A FLUTICASONE; SALMETEROL d04611A C J45 Asthma A Emp A . . . Em A 99999 . . A Em A . . . Em A 77777 . . A Em A . . . Em A . . . Em A ALLOPURINOL d00023A Dc M10.9P Prevent gout A Em A ATORVASTATIN d04105A Cr 99999 A Em A BUPROPION d00181A D# F32.9 Major depressive disorder, single episode, unspecified A Em A DULAGLUTIDE d08290A C E11 Type 2 diabetes mellitus A Em A ESCITALOPRAM d04812A C F32.9 Major depressive disorder, single episode, unspecified A Em A FUROSEMIDE d00070A D N32.9 Bladder disorder, unspecified A Em A INSULIN LISPRO d04373A CDp E11 Type 2 diabetes mellitus A Em A METOPROLOL d00134A Dc I10 Essential (primary) hypertension A Em A OMEPRAZOLE d00325A C K21 Gastro-esophageal reflux disease A Em A RAMIPRIL d00728A D* I10 Essential (primary) hypertension A Em A BREXPIPRAZOLE d08373A C F32.9 Major depressive disorder, single episode, unspecified A Em A BUPROPION d00181A Bz F32.9 Major depressive disorder, single episode, unspecified A Em A CITALOPRAM d04332A C[@ F32.9 F41.9 F43.1 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified Post-traumatic stress disorder (PTSD) A Em A CYCLOBENZAPRINE d00963A B M62.83 Muscle spasm A Em A GABAPENTIN d03182A B M79.2 Neuralgia and neuritis, unspecified A Em A LORAZEPAM d00149A C[@ F41.9 Anxiety disorder, unspecified A Em A MIRTAZAPINE d04025A C[@ G47.9 Sleep disorder, unspecified A Em A MORPHINE d00308A B M25.5 Pain in joint A Em A OMEPRAZOLE d00325A D ^ K21 Gastro-esophageal reflux disease A Em A OXYBUTYNIN d00328A CDp N32.81 Overactive bladder A Em A PRAZOSIN d00138A C[@ F43.1 G47.9 Post-traumatic stress disorder (PTSD) Sleep disorder, unspecified A Em A . . . En A . . . En A ALBUTEROL d00749A C T78.40 Allergy, unspecified A0 En A MONTELUKAST d04289A B J30.9 Allergic rhinitis, unspecified A0 En A PREDNISOLONE d00084A AP J06.9 Acute upper respiratory infection, unspecified A0 En A CITALOPRAM d04332A CDp F41.9 Anxiety disorder, unspecified AP En A FENOFIBRATE d04286A B E78.0 Pure hypercholesterolemia AP En A FINASTERIDE d00563A CDp L65.9 Nonscarring hair loss, unspecified AP En A LISINOPRIL d00732A C I10 Essential (primary) hypertension AP En A OMEPRAZOLE d00325A C- K92.9 Disease of digestive system, unspecified AP En0 A BUPRENORPHINE; NALOXONE d04819A Ap F11.23 Opioid dependence with withdrawal Ap En0 A CLONIDINE d00044A Ap F11.23 Opioid dependence with withdrawal Ap En0 A DESVENLAFAXINE d07113A Bz F32.9 F41.9 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified Ap En0 A DEXLANSOPRAZOLE d07395A C K21 Gastro-esophageal reflux disease Ap En0 A GUANFACINE d00717A Ap F11.23 Opioid dependence with withdrawal Ap En0 A LISDEXAMFETAMINE d06663A B[ F90 Attention-deficit hyperactivity disorders Ap En0 A PHENOBARBITAL d00340A Ap F11.23 Opioid dependence with withdrawal Ap En@ A . . . EnP A . . . En` A 99999 . . A Enp A BICALUTAMIDE d03850A0 C9 C61 Malignant neoplasm of prostate AP Enp A LEUPROLIDE d01353A0 CDp C61 Malignant neoplasm of prostate AP Enp A MORPHINE d00308A0 B[ G89 Pain, not elsewhere classified AP Enp A NYSTATIN; TRIAMCINOLONE TOPICAL d03562A B[ L29.9 Pruritus, unspecified AP Enp A TRIPTORELIN d04696A0 C9 C61 Malignant neoplasm of prostate AP En A LOSARTAN d03821A CDp I10 Essential (primary) hypertension A En A LISINOPRIL d00732A C[@ I10 Essential (primary) hypertension A En A ROSUVASTATIN d04851A CDp E78.0 Pure hypercholesterolemia A En A AMLODIPINE d00689A C I10 Essential (primary) hypertension A0 En A BICTEGRAVIR; EMTRICITABINE; TENOFOVIR d08736A B B20 Human immunodeficiency virus [HIV] disease A0 En A LOSARTAN d03821A B I10 Essential (primary) hypertension A0 En A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A En A . . . En A HYDROCHLOROTHIAZIDE; IRBESARTAN d04245A Bz I10 Essential (primary) hypertension A En A . . . En A . . . Eo A ALLOPURINOL d00023A Dc M1A Chronic gout A Eo A LOSARTAN d03821A C I10 Essential (primary) hypertension A Eo A . . . Eo A . . . Eo0 A DESONIDE TOPICAL d01290A Bz L20.9 Atopic dermatitis, unspecified A Eo@ A CYPROHEPTADINE d00790A C G43 Migraine AP Eo@ A FLUTICASONE NASAL d04283A B[ T78.40 Allergy, unspecified AP Eo@ A NAPROXEN d00019A B[ G43 Migraine AP Eo@ A RIZATRIPTAN d04328A C G43 Migraine AP Eo@ A TOPIRAMATE d04115A B[ G43 Migraine AP EoP A . . . Eo` A . . . Eop A . . . Eo A . . . Eo A . . . Eo A . . . Eo A . . . Eo A DILTIAZEM d00045A B I10 Essential (primary) hypertension A0 Eo A HYDROCHLOROTHIAZIDE d00253A C- R60.9 Edema, unspecified A0 Eo A OMEPRAZOLE d00325A C- R12 Heartburn A0 Eo A . . . Eo A BUPROPION d00181A B F32.9 Major depressive disorder, single episode, unspecified A Eo A . . . Ep A . . . Ep A . . . Ep A CLOPIDOGREL d04258A D I21.P Prevent heart attack/myocardial infarction A@ Ep A METOPROLOL d00134A D I21.P Prevent heart attack/myocardial infarction A@ Ep A RAMIPRIL d00728A D I21.P Prevent heart attack/myocardial infarction A@ Ep A SIMVASTATIN d00746A D I21.P Prevent heart attack/myocardial infarction A@ Ep0 A AMLODIPINE d00689A C I10 Essential (primary) hypertension A Ep0 A GLIMEPIRIDE d03864A Cr E11 Type 2 diabetes mellitus A Ep0 A HYDROCHLOROTHIAZIDE d00253A C I10 Essential (primary) hypertension A Ep0 A INSULIN GLARGINE d04538A C- R73 Elevated blood glucose level A Ep0 A LISINOPRIL d00732A Cr I10 Essential (primary) hypertension A Ep0 A METFORMIN d03807A Cr E11 Type 2 diabetes mellitus A Ep0 A NEBIVOLOL d05265A C- I10 Essential (primary) hypertension A Ep0 A SITAGLIPTIN d05896A C[@ E11 Type 2 diabetes mellitus A Ep@ A . . . EpP A ACETAMINOPHEN; HYDROCODONE d03428A B N20.0 Calculus of kidney A@ EpP A CETIRIZINE d03827A Cr T78.40 Allergy, unspecified A@ EpP A IBUPROFEN d00015A B N20.0 Calculus of kidney A@ EpP A ONDANSETRON d00867A B N20.0 Calculus of kidney A@ Ep` A . . . Epp A AMLODIPINE d00689A C I10 Essential (primary) hypertension A0 Epp A CITALOPRAM d04332A C I10 Essential (primary) hypertension A0 Epp A ROSUVASTATIN d04851A CP E78.0 Pure hypercholesterolemia A0 Ep A ALBUTEROL d00749A C1` R05 R06.2 Cough Wheezing AP Ep A ALBUTEROL d00749A C1` R05 R06.2 Cough Wheezing AP Ep A BECLOMETHASONE d00760A C1` R05 R06.2 Cough Wheezing AP Ep A CETIRIZINE d03827A C T78.40 Allergy, unspecified AP Ep A MONTELUKAST d04289A C J42 R06.2 Unspecified chronic bronchitis Wheezing AP Ep A . . . Ep A LEVOTHYROXINE d00278A D E06 Thyroiditis A Ep A VALACYCLOVIR d03838A D B00.9 Herpesviral infection, unspecified A Ep A LANSOPRAZOLE d03828A B[ K21 Gastro-esophageal reflux disease A Ep A . . . Ep A CARBAMAZEPINE d00058A D% G40 Epilepsy and recurrent seizures A Ep A . . . Ep A COLESTIPOL d00744A Cr E78.0 Pure hypercholesterolemia A0 Ep A LEVOTHYROXINE d00278A D; E03.9 Hypothyroidism, unspecified A0 Ep A LOSARTAN d03821A C[@ I10 Essential (primary) hypertension A0 Eq A . . . Eq A . . . Eq A ALENDRONATE d03849A C[@ M81 Osteoporosis without current pathological fracture AP Eq A ATORVASTATIN d04105A CDp E78.0 Pure hypercholesterolemia AP Eq A CETIRIZINE d03827A C L50 Urticaria AP Eq A OMEPRAZOLE d00325A C K21 Gastro-esophageal reflux disease AP Eq A RANITIDINE d00021A B K21 Gastro-esophageal reflux disease AP Eq0 A . . . Eq@ A CARVEDILOL d03847A CDp I10 Essential (primary) hypertension AP Eq@ A FINASTERIDE d00563A B N42.9 Disorder of prostate, unspecified AP Eq@ A GLIPIZIDE d00246A B= E11 Type 2 diabetes mellitus AP Eq@ A ISOSORBIDE MONONITRATE d00269A B I50.9 Heart failure, unspecified AP Eq@ A TORSEMIDE d03189A B I51.9 Heart disease, unspecified AP EqP A . . . Eq` A . . . Eqp A . . . Eq A . . . Eq A . . . Eq A ALLOPURINOL d00023A B M10.9P Prevent gout AP Eq A AMLODIPINE d00689A CDp I10 Essential (primary) hypertension AP Eq A HYDROXYCHLOROQUINE d00817A Cr M06.9 Rheumatoid arthritis, unspecified AP Eq A LISINOPRIL d00732A C I10 Essential (primary) hypertension AP Eq A NABUMETONE d00310A Cr M19.9 Osteoarthritis, unspecified site AP Eq A BUDESONIDE d04276A C R05 R06.2 Cough Wheezing A0 Eq A CETIRIZINE d03827A C T78.40 Allergy, unspecified A0 Eq A FLUTICASONE NASAL d04283A C J30.9 Allergic rhinitis, unspecified A0 Eq A . . . Eq A . . . Eq A APIXABAN d07804A C[@ D75.9P Prevent blood clots A` Eq A CITALOPRAM d04332A C- F32.9 Major depressive disorder, single episode, unspecified A` Eq A FUROSEMIDE d00070A Cr I51.9 Heart disease, unspecified A` Eq A GABAPENTIN d03182A C M79.2 Neuralgia and neuritis, unspecified A` Eq A PANTOPRAZOLE d04514A C- K21 Gastro-esophageal reflux disease A` Eq A SPIRONOLACTONE d00373A CDp I10 Essential (primary) hypertension A` Eq A ESCITALOPRAM d04812A CDp F32.9 F41.9 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified A0 Eq A LORAZEPAM d00149A CDp F41.0 F41.9 Panic disorder [episodic paroxysmal anxiety] without agoraphobia Anxiety disorder, unspecified A0 Eq A METOPROLOL d00134A Cr I10 Essential (primary) hypertension A0 Er A LISINOPRIL d00732A Dc I10 Essential (primary) hypertension A Er A SIMVASTATIN d00746A D E78.0 Pure hypercholesterolemia A Er A . . . Er A . . . Er0 A . . . Er@ A . . . ErP A ATORVASTATIN d04105A Cr E78.0 Pure hypercholesterolemia A@ ErP A GLIMEPIRIDE d03864A B E11 Type 2 diabetes mellitus A@ ErP A LOSARTAN d03821A Cr I10 Essential (primary) hypertension A@ ErP A METFORMIN d03807A B E11 Type 2 diabetes mellitus A@ Er` A AMLODIPINE d00689A C I10 Essential (primary) hypertension A Er` A AMOXICILLIN d00088A A K04.7 Periapical abscess without sinus A Er` A ATORVASTATIN d04105A C- E78.0 Pure hypercholesterolemia A Er` A CHLORTHALIDONE d00192A C I10 Essential (primary) hypertension A Er` A GLIMEPIRIDE d03864A D E11 Type 2 diabetes mellitus A Er` A HYDRALAZINE d00132A C I10 Essential (primary) hypertension A Er` A METFORMIN d03807A B E11 Type 2 diabetes mellitus A Er` A OLMESARTAN d04801A C I10 Essential (primary) hypertension A Erp A . . . Er A . . . Er A . . . Er A AMLODIPINE d00689A Cr I10 Essential (primary) hypertension A Er A SPIRONOLACTONE d00373A A I10 Essential (primary) hypertension A Er A LEVOTHYROXINE d00278A CDp E03.9 Hypothyroidism, unspecified A Er A . . . Er A . . . Er A . . . Er A . . . Es A . . . Es A . . . Es A . . . Es0 A ALLOPURINOL d00023A C M10.9 Gout, unspecified A Es0 A ATORVASTATIN d04105A D E78.0 Pure hypercholesterolemia A Es0 A FUROSEMIDE d00070A C- R60.9 Edema, unspecified A Es0 A GLIPIZIDE d00246A D# E11 Type 2 diabetes mellitus A Es0 A HYDRALAZINE; ISOSORBIDE DINITRATE d05540A C- R60.9 Edema, unspecified A Es0 A METOPROLOL d00134A C[@ I51.9 Heart disease, unspecified A Es0 A SITAGLIPTIN d05896A C- E11 Type 2 diabetes mellitus A Es0 A UMECLIDINIUM; VILANTEROL d08188A B R06.02 Shortness of breath A Es@ A . . . EsP A FLUTICASONE; SALMETEROL d04611A C J44.9 Chronic obstructive pulmonary disease, unspecified A@ EsP A LATANOPROST OPHTHALMIC d04017A CDp H40 Glaucoma A@ EsP A LOSARTAN d03821A Bz I10 Essential (primary) hypertension A@ EsP A NIFEDIPINE d00051A Bz I10 Essential (primary) hypertension A@ Es` A METHYLPREDNISOLONE d00293A A@ M54 Dorsalgia A Esp A . . . Es A ATORVASTATIN d04105A CDp E78.0 Pure hypercholesterolemia A0 Es A FUROSEMIDE d00070A C- R60.9 Edema, unspecified A0 Es A WARFARIN d00022A C- D75.9P Prevent blood clots A0 Es A . . . Es A . . . Es A . . . Es A ALBUTEROL d00749A Dc J45 Asthma A Es A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A Es A GABAPENTIN d03182A C[@ M79.7 Fibromyalgia A Es A IBUPROFEN d00015A D* M13 Other arthritis A Es A LISINOPRIL d00732A B I10 Essential (primary) hypertension A Es A METFORMIN d03807A CDp E11 Type 2 diabetes mellitus A Es A METOPROLOL d00134A C R60.9 Edema, unspecified A Es A MONTELUKAST d04289A C J45 Asthma A Es A NAPROXEN d00019A C[@ M06.9 Rheumatoid arthritis, unspecified A Es A . . . Es A . . . Es A BUSPIRONE d00182A B F41.9 Anxiety disorder, unspecified A Et A ATENOLOL d00004A D I48.9 R00 Unspecified atrial fibrillation and atrial flutter Abnormalities of heart beat A Et A ATORVASTATIN d04105A D E78.0P Prevent high cholesterol A Et A ETANERCEPT d04365A Dc K50 L40 Crohn's disease [regional enteritis] Psoriasis A Et A FUROSEMIDE d00070A D I51.9 Heart disease, unspecified A Et A GLIPIZIDE d00246A D E11 Type 2 diabetes mellitus A Et A LEVOTHYROXINE d00278A Dc E03.9 Hypothyroidism, unspecified A Et A LISINOPRIL d00732A D I10 Essential (primary) hypertension A Et A METFORMIN d03807A C E11 Type 2 diabetes mellitus A Et A SPIRONOLACTONE d00373A D I10 R00 Essential (primary) hypertension Abnormalities of heart beat A Et A SULFASALAZINE d00379A D* K51 Ulcerative colitis A Et A WARFARIN d00022A D D75.9P I48.9 Prevent blood clots Unspecified atrial fibrillation and atrial flutter A Et A . . . Et A AMLODIPINE d00689A C I10 Essential (primary) hypertension A Et A GLYBURIDE d00248A C- E11 Type 2 diabetes mellitus A Et0 A . . . Et@ A BUPROPION d00181A D F32.9 Major depressive disorder, single episode, unspecified AP Et@ A ESCITALOPRAM d04812A D F41.9 Anxiety disorder, unspecified AP Et@ A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A D I10 R60.9 Essential (primary) hypertension Edema, unspecified AP Et@ A OMEPRAZOLE d00325A D K21 Gastro-esophageal reflux disease AP Et@ A SIMVASTATIN d00746A D E78.0 Pure hypercholesterolemia AP EtP A . . . Et` A CIPROFLOXACIN d00011A Ap N30 Cystitis A Etp A . . . Et A CLOPIDOGREL d04258A C D75.9P Prevent blood clots A@ Et A HYDROCHLOROTHIAZIDE d00253A Cr I10 Essential (primary) hypertension A@ Et A LOSARTAN d03821A Cr I10 Essential (primary) hypertension A@ Et A METOPROLOL d00134A Cr 99999 A@ Et A . . . Et A LEVOTHYROXINE d00278A CYP 55555 A Et A 99999 . . A Et A CLONIDINE d00044A Cr 99999 A Et A CLOPIDOGREL d04258A Cr I49.9 Cardiac arrhythmia, unspecified A Et A GLIPIZIDE d00246A Cr E11 Type 2 diabetes mellitus A Et A HYDRALAZINE; ISOSORBIDE DINITRATE d05540A Cr 99999 A Et A METFORMIN d03807A B= E11 Type 2 diabetes mellitus A Et A METOPROLOL d00134A Cr 99999 A Et A OLMESARTAN d04801A CDp 99999 A Et A ROSUVASTATIN d04851A C"0 E78.0 Pure hypercholesterolemia A Et A . . . Et A FLUTICASONE; VILANTEROL d08100A Bz J45 Asthma A Et A . . . Eu A ATORVASTATIN d04105A Dc E78.0 Pure hypercholesterolemia A@ Eu A LIDOCAINE TOPICAL d00683A Dc M79.6 Pain in limb, hand, foot, fingers and toes A@ Eu A LOSARTAN d03821A Dc E11.2 Type 2 diabetes mellitus with kidney complications A@ Eu A METFORMIN d03807A Dc E11 Type 2 diabetes mellitus A@ Eu A ASPIRIN d00170A C D75.9P Prevent blood clots B Eu A CARVEDILOL d03847A Cr I10 Essential (primary) hypertension B Eu A CLOPIDOGREL d04258A B D75.9P I21.P Prevent blood clots Prevent heart attack/myocardial infarction B Eu A FLUCONAZOLE d00071A C 99999 B Eu A LEVOTHYROXINE d00278A C E07.9 Disorder of thyroid, unspecified B Eu A METOCLOPRAMIDE d00298A B K21 K30 R11 Gastro-esophageal reflux disease Functional dyspepsia Nausea and vomiting B Eu A MIRTAZAPINE d04025A C9 R63 Symptoms and signs concerning food and fluid intake B Eu A MYCOPHENOLIC ACID d05217A C9 T86.9P Prevent transplanted organ and tissue rejection B Eu A ONDANSETRON d00867A B I99.9 Unspecified disorder of circulatory system B Eu A PRAVASTATIN d00348A B 99999 B Eu A PREDNISONE d00350A D T86.9P Prevent transplanted organ and tissue rejection B Eu A RABEPRAZOLE d04448A C K21 K30 Gastro-esophageal reflux disease Functional dyspepsia B Eu A TACROLIMUS d03752A D T86.9P Prevent transplanted organ and tissue rejection B Eu A TEMAZEPAM d00384A C G47.0 Insomnia B Eu A TERIPARATIDE d04828A C- M81 Osteoporosis without current pathological fracture B Eu A VALGANCICLOVIR d04755A B A49.9 Bacterial infection, unspecified B Eu A . . . Eu0 A ATENOLOL d00004A CDp I21.P Prevent heart attack/myocardial infarction AP Eu0 A GLIPIZIDE d00246A Cr E11 Type 2 diabetes mellitus AP Eu0 A LISINOPRIL d00732A CDp I10 Essential (primary) hypertension AP Eu0 A METFORMIN d03807A C- 99999 AP Eu0 A SIMVASTATIN d00746A C- E78.0 Pure hypercholesterolemia AP Eu@ A MONTELUKAST d04289A B J45 Asthma A EuP A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A EuP A METFORMIN d03807A CDp E11 Type 2 diabetes mellitus A Eu` A . . . Eup A AMLODIPINE d00689A C- I10 Essential (primary) hypertension A` Eup A BENZONATATE d00796A B R05 Cough A` Eup A HYDROCHLOROTHIAZIDE; LOSARTAN d03830A Cr I10 Essential (primary) hypertension A` Eup A OMEPRAZOLE d00325A C- K21 R12 Gastro-esophageal reflux disease Heartburn A` Eup A RALOXIFENE d04261A C- M81 Osteoporosis without current pathological fracture A` Eup A ROPINIROLE d04215A B G25.81 Restless legs syndrome A` Eu A . . . Eu A AMPHETAMINE; DEXTROAMPHETAMINE d04035A AP I10 Essential (primary) hypertension A0 Eu A GUANFACINE d00717A C- I10 Essential (primary) hypertension A0 Eu A METHYLPHENIDATE d00900A B= I99.9 Unspecified disorder of circulatory system A0 Eu A . . . Eu A BACLOFEN d00967A C- M62.83 Muscle spasm A Eu A . . . Eu A . . . Eu A . . . Eu A METHOTREXATE d00060A C- M06.9 Rheumatoid arthritis, unspecified A Ev A . . . Ev A . . . Ev A CEPHALEXIN d00096A Ap N39.0 Urinary tract infection, site not specified A0 Ev A OXYBUTYNIN d00328A C N32.81 Overactive bladder A0 Ev A RANITIDINE d00021A C K21 Gastro-esophageal reflux disease A0 Ev0 A BRIMONIDINE OPHTHALMIC d04048A C[@ H40 Glaucoma A Ev@ A . . . EvP A . . . Ev` A AMLODIPINE d00689A C 99999 A Ev` A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A Ev` A ESCITALOPRAM d04812A C F41.9 Anxiety disorder, unspecified A Ev` A FAMOTIDINE d00141A Cr K21 Gastro-esophageal reflux disease A Ev` A GLIPIZIDE d00246A C E11 Type 2 diabetes mellitus A Ev` A LOSARTAN d03821A CDp 99999 A Ev` A METFORMIN d03807A C E11 Type 2 diabetes mellitus A Ev` A METOPROLOL d00134A C I10 Essential (primary) hypertension A Ev` A TAMSULOSIN d04121A Cr N40 R39.1 Enlarged prostate Other difficulties with micturition A Evp A . . . Ev A . . . Ev A . . . Ev A . . . Ev A . . . Ev A ACETAMINOPHEN; HYDROCODONE d03428A B M54 Dorsalgia A Ev A ONDANSETRON d00867A B R11 Nausea and vomiting A Ev A . . . Ev A AMLODIPINE d00689A C I10 Essential (primary) hypertension A Ev A AMOXICILLIN d00088A AP H66.9 Otitis media, unspecified A Ew A . . . Ew A . . . Ew A . . . Ew0 A . . . Ew@ A . . . EwP A . . . Ew` A . . . Ewp A HYDROCHLOROTHIAZIDE; LOSARTAN d03830A C I10 Essential (primary) hypertension A0 Ewp A LEVOTHYROXINE d00278A D E03.9 Hypothyroidism, unspecified A0 Ewp A VENLAFAXINE d03181A D F32.9 Major depressive disorder, single episode, unspecified A0 Ew A . . . Ew A EZETIMIBE d04824A C E78.0 Pure hypercholesterolemia AP Ew A INDOMETHACIN d00039A D M54 Dorsalgia AP Ew A LEVOTHYROXINE d00278A Cr E07.9 Disorder of thyroid, unspecified AP Ew A METFORMIN d03807A C[@ E11 Type 2 diabetes mellitus AP Ew A PREDNISONE d00350A C M54 Dorsalgia AP Ew A . . . Ew A . . . Ew A . . . Ew A . . . Ew A APIXABAN d07804A C I48.9 Unspecified atrial fibrillation and atrial flutter A0 Ew A METOPROLOL d00134A Cr I10 Essential (primary) hypertension A0 Ew A SIMVASTATIN d00746A Dc E78.0 Pure hypercholesterolemia A0 Ew A . . . Ex A LEVETIRACETAM d04499A Cr G40 Epilepsy and recurrent seizures A@ Ex A METHYLPREDNISOLONE d00293A Ap M25.5 Pain in joint A@ Ex A PREDNISONE d00350A B M25.5 Pain in joint A@ Ex A TRAZODONE d00395A D G47.9 Sleep disorder, unspecified A@ Ex A ATORVASTATIN d04105A A 99999 A` Ex A BACLOFEN d00967A C M54 Dorsalgia A` Ex A FLUOXETINE d00236A Cr F32.9 Major depressive disorder, single episode, unspecified A` Ex A METFORMIN d03807A C E11 Type 2 diabetes mellitus A` Ex A OMEPRAZOLE d00325A C R12 Heartburn A` Ex A ONDANSETRON d00867A C R42 Dizziness and giddiness A` Ex A . . . Ex0 A ALBUTEROL d00749A B J42 Unspecified chronic bronchitis A@ Ex0 A ATENOLOL d00004A C I10 Essential (primary) hypertension A@ Ex0 A HYDROXYZINE d00907A C- L23 Allergic contact dermatitis A@ Ex0 A ROSUVASTATIN d04851A C E78.0 Pure hypercholesterolemia A@ Ex@ A ASPIRIN d00170A D I63.P Prevent stroke A@ Ex@ A ATORVASTATIN d04105A D E78.0 Pure hypercholesterolemia A@ Ex@ A DICLOFENAC d00848A B Z79 Long term (current) drug therapy A@ Ex@ A SILDENAFIL d04299A C N52.9 Male erectile dysfunction, unspecified A@ ExP A . . . Ex` A . . . Exp A . . . Ex A ESOMEPRAZOLE d04749A Dc K30 Functional dyspepsia A Ex A . . . Ex A . . . Ex A . . . Ex A . . . Ex A CLONIDINE d00044A D I10 Essential (primary) hypertension A` Ex A LOSARTAN d03821A C"@ I10 Essential (primary) hypertension A` Ex A OMEPRAZOLE d00325A C K21 Gastro-esophageal reflux disease A` Ex A OXCARBAZEPINE d04513A D F39 Unspecified mood [affective] disorder A` Ex A SERTRALINE d00880A D F31.9 Bipolar disorder, unspecified A` Ex A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia A` Ex A . . . Ex A . . . Ey A AMOXICILLIN d00088A A@ H66.9 Otitis media, unspecified A Ey A . . . Ey A DABIGATRAN d07137A C I49.9 Cardiac arrhythmia, unspecified A Ey0 A DULOXETINE d05355A C- F41.9 Anxiety disorder, unspecified AP Ey0 A GABAPENTIN d03182A B M79.7 Fibromyalgia AP Ey0 A LEVOTHYROXINE d00278A D= E03.9 Hypothyroidism, unspecified AP Ey0 A METHOTREXATE d00060A B M06.9 Rheumatoid arthritis, unspecified AP Ey0 A PANTOPRAZOLE d04514A B K21 Gastro-esophageal reflux disease AP Ey@ A . . . EyP A CETIRIZINE d03827A B[ T78.40 Allergy, unspecified A Ey` A ALBUTEROL d00749A D* J45 Asthma A` Ey` A CETIRIZINE d03827A C T78.40 Allergy, unspecified A` Ey` A DICLOFENAC d00848A C T14.9 Unspecified injury A` Ey` A LOPERAMIDE d01025A D K51 K58 Ulcerative colitis Irritable bowel syndrome A` Ey` A OMEPRAZOLE d00325A C K21 K30 Gastro-esophageal reflux disease Functional dyspepsia A` Ey` A VENLAFAXINE d03181A C F32.9 F41.9 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified A` Eyp A LISINOPRIL d00732A CDp I10 Essential (primary) hypertension A Ey A . . . Ey A . . . Ey A BETAMETHASONE TOPICAL d03197A D# L40 Psoriasis A Ey A . . . Ey A . . . Ey A FLUOCINOLONE TOPICAL d01293A B L20.9 Atopic dermatitis, unspecified A Ey A ALBUTEROL d00749A C J45 Asthma B Ey A ALLOPURINOL d00023A C[@ I51.9 Heart disease, unspecified B Ey A CITALOPRAM d04332A C- F32.9 Major depressive disorder, single episode, unspecified B Ey A COLCHICINE d00150A CDp M1A Chronic gout B Ey A DOCUSATE d01021A C K58 Irritable bowel syndrome B Ey A FEXOFENADINE d04040A CDp R09.81 T78.40 Nasal congestion Allergy, unspecified B Ey A FLUTICASONE NASAL d04283A C- J45 R09.81 Asthma Nasal congestion B Ey A FLUTICASONE; VILANTEROL d08100A B J44.9 J45 R06.9 Chronic obstructive pulmonary disease, unspecified Asthma Unspecified abnormalities of breathing B Ey A GABAPENTIN d03182A B M79.2 Neuralgia and neuritis, unspecified B Ey A INSULIN DEGLUDEC d08054A C E11 Type 2 diabetes mellitus B Ey A INSULIN REGULAR d04369A C- E11 Type 2 diabetes mellitus B Ey A LEVOTHYROXINE d00278A D E03.9 Hypothyroidism, unspecified B Ey A METOPROLOL d00134A C I50.9 Heart failure, unspecified B Ey A MIRABEGRON d07876A C N28.9 Disorder of kidney and ureter, unspecified B Ey A OMEPRAZOLE d00325A Cr K21 Gastro-esophageal reflux disease B Ey A PRAVASTATIN d00348A Cr E78.0 Pure hypercholesterolemia B Ey A PRIMIDONE d00352A B 55555 B Ey A SACUBITRIL; VALSARTAN d08369A B I50.9 Heart failure, unspecified B Ey A SPIRONOLACTONE d00373A B R60.9 Edema, unspecified B Ey A TORSEMIDE d03189A C R60.9 Edema, unspecified B Ey A VENLAFAXINE d03181A B F41.9 Anxiety disorder, unspecified B Ey A WARFARIN d00022A D* D75.9P Prevent blood clots B Ey A PRAZOSIN d00138A C- F29 F43.1 G47.9 Unspecified psychosis not due to a substance or known physiological condition Post-traumatic stress disorder (PTSD) Sleep disorder, unspecified A0 Ey A QUETIAPINE d04220A CDp F31.9 Bipolar disorder, unspecified A0 Ey A TRAZODONE d00395A Cr F41.9 Anxiety disorder, unspecified A0 Ez A ETHINYL ESTRADIOL; NORETHINDRONE d03238A C Z79.3 Long term (current) use of hormonal contraceptives A Ez A MOMETASONE d05262A B R06.2 Wheezing A Ez A . . . Ez A NORETHINDRONE d00555A C N92 Excessive, frequent and irregular menstruation A Ez0 A . . . Ez@ A ATORVASTATIN d04105A CDp I21.P Prevent heart attack/myocardial infarction A Ez@ A CARBAMAZEPINE d00058A CDp 99999 A Ez@ A DILTIAZEM d00045A CDp I48.9 Unspecified atrial fibrillation and atrial flutter A Ez@ A FUROSEMIDE d00070A Cr I51.9 Heart disease, unspecified A Ez@ A LEVOTHYROXINE d00278A D9 E03.9 Hypothyroidism, unspecified A Ez@ A METOPROLOL d00134A CDp R00 Abnormalities of heart beat A Ez@ A POTASSIUM CHLORIDE d00345A Cr E87.6 Hypokalemia A Ez@ A WARFARIN d00022A CDp I80.3 Phlebitis and thrombophlebitis of lower extremities, unspecified A EzP A . . . Ez` A . . . Ezp A FLUOCINONIDE TOPICAL d01294A C- L40 Psoriasis A Ezp A TRIAMCINOLONE TOPICAL d03206A A L40 Psoriasis A Ez A ATENOLOL d00004A D I10 Essential (primary) hypertension A@ Ez A DICLOFENAC d00848A D- Z79.1 Long term (current) use of non-steroidal anti-inflammatories (NSAID) A@ Ez A LOSARTAN d03821A C I10 Essential (primary) hypertension A@ Ez A ROSUVASTATIN d04851A B E78.0 Pure hypercholesterolemia A@ Ez A PANTOPRAZOLE d04514A Cr K30 Functional dyspepsia A Ez A . . . Ez A . . . Ez A . . . Ez A . . . Ez A METFORMIN d03807A B E28 Ovarian dysfunction A Ez A . . . E{ A NIFEDIPINE d00051A Cr I99.9 Unspecified disorder of circulatory system A E{ A SILDENAFIL d04299A C- I99.9 Unspecified disorder of circulatory system A E{ A . . . E{ A COLESEVELAM d04695A CDp E78.0 Pure hypercholesterolemia A@ E{ A HYDROCHLOROTHIAZIDE; OLMESARTAN d04878A B[ I10 Essential (primary) hypertension A@ E{ A METFORMIN d03807A C E11 Type 2 diabetes mellitus A@ E{ A ROSUVASTATIN d04851A B[ E78.0 Pure hypercholesterolemia A@ E{0 A 99999 . . A E{@ A . . . E{P A . . . E{` A OSELTAMIVIR d04462A A J09 Influenza due to certain identified influenza viruses A E{p A ALLOPURINOL d00023A C M10.9P Prevent gout A E{p A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A E{p A CARVEDILOL d03847A C I10 Essential (primary) hypertension A E{p A DIGOXIN d00210A C I50.9 Heart failure, unspecified A E{p A FUROSEMIDE d00070A C I51.9 Heart disease, unspecified A E{p A INSULIN GLARGINE d04538A C E11 Type 2 diabetes mellitus A E{p A LISINOPRIL d00732A C I10 Essential (primary) hypertension A E{p A NITROGLYCERIN d00321A C R07.9 Chest pain, unspecified A E{p A WARFARIN d00022A C D75.9P Prevent blood clots A E{ A . . . E{ A . . . E{ A . . . E{ A . . . E{ A . . . E{ A . . . E{ A ASPIRIN d00170A CDp I21.P Prevent heart attack/myocardial infarction A` E{ A ATORVASTATIN d04105A CDp E78.0 Pure hypercholesterolemia A` E{ A CARVEDILOL d03847A CDp I10 Essential (primary) hypertension A` E{ A CLOPIDOGREL d04258A CDp 99999 A` E{ A LISINOPRIL d00732A CDp I50.9 Heart failure, unspecified A` E{ A PANTOPRAZOLE d04514A CDp K21 Gastro-esophageal reflux disease A` E{ A . . . E| A . . . E| A . . . E| A . . . E|0 A ETHINYL ESTRADIOL; NORGESTIMATE d03781A C Z79.3 Long term (current) use of hormonal contraceptives A E|0 A MONTELUKAST d04289A C- T78.40 Allergy, unspecified A E|@ A ALLOPURINOL d00023A0 Ei 99999 A E|@ A AMLODIPINE d00689A0 Ei 99999 A E|@ A ATENOLOL d00004A0 Ei 99999 A E|@ A ATORVASTATIN d04105A0 Ei 99999 A E|@ A CITALOPRAM d04332A0 Ei 99999 A E|@ A DIVALPROEX SODIUM d03833A0 Ei 99999 A E|@ A GLIPIZIDE d00246A0 Ei 99999 A E|@ A LEVOTHYROXINE d00278A0 C E03.9 Hypothyroidism, unspecified A E|@ A OLANZAPINE d04050A0 Ei 99999 A E|P A CLOPIDOGREL d04258A C D75.9P Prevent blood clots A E|P A DICLOFENAC d00848A B M06.9 M79.1 Rheumatoid arthritis, unspecified Myalgia A E|P A DULAGLUTIDE d08290A C E11 Type 2 diabetes mellitus A E|P A FLUOXETINE d00236A C F41.9 Anxiety disorder, unspecified A E|P A FUROSEMIDE d00070A C[@ I50.9 Heart failure, unspecified A E|P A GABAPENTIN d03182A C G25.81 Restless legs syndrome A E|P A IPRATROPIUM NASAL d04235A C J30.9 Allergic rhinitis, unspecified A E|P A LISINOPRIL d00732A C I10 Essential (primary) hypertension A E|P A POTASSIUM CHLORIDE d00345A CDp E87.6 R25.2 Hypokalemia Cramp and spasm A E|P A PRAVASTATIN d00348A C E78.0 Pure hypercholesterolemia A E|P A RANITIDINE d00021A Dc K21 Gastro-esophageal reflux disease A E|P A TRAZODONE d00395A C G47.9 Sleep disorder, unspecified A E|` A . . . E|p A AMLODIPINE d00689A B I10 Essential (primary) hypertension A E|p A CETIRIZINE d03827A C H10.1 Acute atopic conjunctivitis A E| A LEVOTHYROXINE d00278A CP C80.1 Malignant (primary) neoplasm, unspecified A@ E| A METFORMIN d03807A C E11 Type 2 diabetes mellitus A@ E| A METOPROLOL d00134A C I10 Essential (primary) hypertension A@ E| A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia A@ E| A ATORVASTATIN d04105A D E78.0 Pure hypercholesterolemia Ap E| A CLOPIDOGREL d04258A D D75.9P Prevent blood clots Ap E| A EZETIMIBE d04824A Dc I21.P Prevent heart attack/myocardial infarction Ap E| A GABAPENTIN d03182A C M79.2 Neuralgia and neuritis, unspecified Ap E| A HYDROCHLOROTHIAZIDE d00253A C I10 Essential (primary) hypertension Ap E| A PANTOPRAZOLE d04514A Dc K21 Gastro-esophageal reflux disease Ap E| A TAMSULOSIN d04121A B= R39.9 Unspecified symptoms and signs involving the genitourinary system Ap E| A . . . E| A . . . E| A . . . E| A APIXABAN d07804A Cr I48.9 Unspecified atrial fibrillation and atrial flutter A E| A GABAPENTIN d03182A D M79.2 Neuralgia and neuritis, unspecified A E| A GLYBURIDE d00248A Dc E11 Type 2 diabetes mellitus A E| A LISINOPRIL d00732A Dc I10 Essential (primary) hypertension A E| A METFORMIN d03807A Dc E11 Type 2 diabetes mellitus A E| A SIMVASTATIN d00746A Dc E78.0 Pure hypercholesterolemia A E| A SITAGLIPTIN d05896A Dc E11 Type 2 diabetes mellitus A E| A TRIAMTERENE d00396A D I10 Essential (primary) hypertension A E| A 99999 . . A E| A . . . E} A CANDESARTAN d04322A C I63.P Prevent stroke Ap E} A HYDRALAZINE d00132A C[@ I10 Essential (primary) hypertension Ap E} A METOPROLOL d00134A C[@ I10 Essential (primary) hypertension Ap E} A MIRABEGRON d07876A C N32.81 Overactive bladder Ap E} A SIMVASTATIN d00746A D I63.P Prevent stroke Ap E} A TRAMADOL d03826A C M19.9 Osteoarthritis, unspecified site Ap E} A ZOLPIDEM d00910A C G47.0 G47.9 Insomnia Sleep disorder, unspecified Ap E} A ALLOPURINOL d00023A D E79.9 Disorder of purine and pyrimidine metabolism, unspecified A E} A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A E} A CANAGLIFLOZIN; METFORMIN d08280A C- E11.P R73 Prevent diabetes Elevated blood glucose level A E} A FENOFIBRATE d04286A C[@ E78.0 E78.1 Pure hypercholesterolemia Pure hyperglyceridemia A E} A LISINOPRIL d00732A C- K76.9P Prevent liver disease A E} A RANITIDINE d00021A CDp K30 Functional dyspepsia A E} A USTEKINUMAB d07396A C L40 Psoriasis A E} A ZOLPIDEM d00910A Cr G47.0 Insomnia A E} A ATORVASTATIN d04105A Dc E78.0 Pure hypercholesterolemia A E}0 A ALBUTEROL d00749A C R06.02 Shortness of breath A E}@ A ACETAMINOPHEN; HYDROCODONE d03428A C M54 M79.1 M79.6 Dorsalgia Myalgia Pain in limb, hand, foot, fingers and toes A0 E}@ A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A0 E}@ A ZOLPIDEM d00910A Cr G47.0 Insomnia A0 E}P A . . . E}` A . . . E}p A . . . E} A ALBUTEROL d00749A A J01.9 J45 Acute sinusitis, unspecified Asthma A@ E} A ALBUTEROL d00749A D J45 R09.81 Asthma Nasal congestion A@ E} A DOXYCYCLINE d00037A A J01.9 Acute sinusitis, unspecified A@ E} A FLUTICASONE NASAL d04283A CDp J30.9 R09.81 Allergic rhinitis, unspecified Nasal congestion A@ E} A . . . E} A ALBUTEROL d00749A C J45 Asthma A E} A . . . E} A AMLODIPINE d00689A Cr I10 Essential (primary) hypertension A` E} A ATORVASTATIN d04105A Cr E78.0 Pure hypercholesterolemia A` E} A LISINOPRIL d00732A Cr E11.2 Type 2 diabetes mellitus with kidney complications A` E} A METFORMIN d03807A Cr E11 Type 2 diabetes mellitus A` E} A METOPROLOL d00134A Cr I10 Essential (primary) hypertension A` E} A RANITIDINE d00021A Cr K30 Functional dyspepsia A` E} A FLUTICASONE NASAL d04283A C- J30.2 Other seasonal allergic rhinitis A E} A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified A E} A PHENTERMINE d00806A B E66 Overweight and obesity A E~ A BUSPIRONE d00182A Bz F41.9 Anxiety disorder, unspecified A@ E~ A MEDROXYPROGESTERONE d00284A D Z79.3 Long term (current) use of hormonal contraceptives A@ E~ A NAPROXEN d00019A Bz R52 Pain, unspecified A@ E~ A PAROXETINE d03157A Bz F41.9 Anxiety disorder, unspecified A@ E~ A AMLODIPINE d00689A Cr I10 Essential (primary) hypertension A@ E~ A LISINOPRIL d00732A Cr E11.2 Type 2 diabetes mellitus with kidney complications A@ E~ A METFORMIN d03807A Cr R73 Elevated blood glucose level A@ E~ A SIMVASTATIN d00746A Cr E78.0 Pure hypercholesterolemia A@ E~ A . . . E~0 A . . . E~@ A AMLODIPINE d00689A Cr I10 Essential (primary) hypertension A0 E~@ A BENAZEPRIL d00730A C I10 Essential (primary) hypertension A0 E~@ A METFORMIN d03807A C E11 Type 2 diabetes mellitus A0 E~P A . . . E~` A . . . E~p A IBUPROFEN d00015A A T14.9 Unspecified injury A E~ A . . . E~ A . . . E~ A . . . E~ A IBUPROFEN d00015A B R52 Pain, unspecified A E~ A AMLODIPINE d00689A B[ I10 Essential (primary) hypertension A E~ A LISINOPRIL d00732A B[ I10 Essential (primary) hypertension A E~ A MIRTAZAPINE d04025A C- F32.9 F41.9 G47.0 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified Insomnia A E~ A . . . E~ A . . . E A . . . E A . . . E A . . . E0 A DOXYCYCLINE d00037A Ap L08.9 Local infection of the skin and subcutaneous tissue, unspecified A E@ A . . . EP A . . . E` A . . . Ep A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E A HYDROCHLOROTHIAZIDE; TRIAMTERENE d03052A C 99999 AP E A MELOXICAM d04532A C[@ M54 Dorsalgia AP E A METOPROLOL d00134A C I10 Essential (primary) hypertension AP E A POTASSIUM CHLORIDE d00345A Ei Z95 Presence of cardiac and vascular implants and grafts AP E A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia AP E A METHYLPHENIDATE d00900A C F90 Attention-deficit hyperactivity disorders A E A CEPHALEXIN d00096A A L98.9 Disorder of the skin and subcutaneous tissue, unspecified A E A AMLODIPINE d00689A Ei I10 Essential (primary) hypertension B E A ATORVASTATIN d04105A Ei E78.0 Pure hypercholesterolemia B E A BRIMONIDINE OPHTHALMIC d04048A Ei H57.9 Unspecified disorder of eye and adnexa B E A BUDESONIDE; FORMOTEROL d04795A Ei J45 Asthma B E A CLONIDINE d00044A Ei I10 Essential (primary) hypertension B E A DORZOLAMIDE OPHTHALMIC d03805A Ei H57.9 Unspecified disorder of eye and adnexa B E A FINASTERIDE d00563A Ei R39.9 Unspecified symptoms and signs involving the genitourinary system B E A GLIPIZIDE d00246A Ei E11 Type 2 diabetes mellitus B E A GUAIFENESIN; PSEUDOEPHEDRINE d03379A Ei R09.3 Abnormal sputum B E A HYDRALAZINE; HYDROCHLOROTHIAZIDE d03257A Ei I10 Essential (primary) hypertension B E A HYDROCHLOROTHIAZIDE; TRIAMTERENE d03052A Ei R60.9 Edema, unspecified B E A INSULIN GLARGINE d04538A Ei E11 Type 2 diabetes mellitus B E A INSULIN LISPRO d04373A Ei E11 Type 2 diabetes mellitus B E A LINACLOTIDE d07902A Ei K59.0 Constipation B E A OMEPRAZOLE d00325A Ei K21 Gastro-esophageal reflux disease B E A TAMSULOSIN d04121A Ei R39.9 Unspecified symptoms and signs involving the genitourinary system B E0 A . . . E@ A ALLOPURINOL d00023A C E79.9 M10.9P Disorder of purine and pyrimidine metabolism, unspecified Prevent gout Ap E@ A AMIODARONE d00002A B I48.9 Unspecified atrial fibrillation and atrial flutter Ap E@ A APIXABAN d07804A B D75.9P I48.9 I63.P Prevent blood clots Unspecified atrial fibrillation and atrial flutter Prevent stroke Ap E@ A CYCLOBENZAPRINE d00963A B= M25.5 M54 Pain in joint Dorsalgia Ap E@ A OMEPRAZOLE d00325A C- K30 Functional dyspepsia Ap E@ A PRAVASTATIN d00348A D E78.0 Pure hypercholesterolemia Ap E@ A PROPRANOLOL d00032A B R00 R25.1 Abnormalities of heart beat Tremor, unspecified Ap EP A ACETAMINOPHEN; HYDROCODONE d03428A B G89 M79.6 Pain, not elsewhere classified Pain in limb, hand, foot, fingers and toes A@ EP A AMITRIPTYLINE d00146A C F32.9 Major depressive disorder, single episode, unspecified A@ EP A ETHINYL ESTRADIOL; NORETHINDRONE d03238A Cr N92 Excessive, frequent and irregular menstruation A@ EP A SERTRALINE d00880A B F32.9 Major depressive disorder, single episode, unspecified A@ E` A CARVEDILOL d03847A0 Cr I21.P Prevent heart attack/myocardial infarction Ap E` A CETIRIZINE d03827A0 CDp R09.81 Nasal congestion Ap E` A DIAZEPAM d00148A C F33.9 Major depressive disorder, recurrent, unspecified Ap E` A MONTELUKAST d04289A0 CDp J30.9 Allergic rhinitis, unspecified Ap E` A PANTOPRAZOLE d04514A C K21 Gastro-esophageal reflux disease Ap E` A RAMIPRIL d00728A0 CDp I10 Essential (primary) hypertension Ap E` A SIMVASTATIN d00746A0 C E78.0 Pure hypercholesterolemia Ap Ep A CETIRIZINE d03827A C[@ J30.9 Allergic rhinitis, unspecified A E A . . . E A FLUCONAZOLE d00071A C- B35 Dermatophytosis A E A BUPROPION d00181A C F41.9 Anxiety disorder, unspecified A0 E A LOVASTATIN d00280A C E78.0 Pure hypercholesterolemia A0 E A MELOXICAM d04532A C- M13 Other arthritis A0 E A DEXAMETHASONE; TOBRAMYCIN OPHTHALMIC d03536A A H66.9 Otitis media, unspecified A E A . . . E A . . . E A . . . E A . . . E A METHYLPHENIDATE d00900A CDp F90 Attention-deficit hyperactivity disorders A E A CEPHALEXIN d00096A Ap L08.9 Local infection of the skin and subcutaneous tissue, unspecified A E A AMOXICILLIN d00088A A0 H66.9 Otitis media, unspecified A E A IBUPROFEN d00015A A0 H93.9 Unspecified disorder of ear A E0 A . . . E@ A AMOXICILLIN; CLAVULANATE d00089A A J01.9 Acute sinusitis, unspecified A EP A ATENOLOL d00004A CDp I10 Essential (primary) hypertension A EP A BUPROPION d00181A Bz F17.2 Nicotine dependence A EP A FLUTICASONE NASAL d04283A C- J30.9 Allergic rhinitis, unspecified A EP A IPRATROPIUM NASAL d04235A C- J30.9 R09.81 Allergic rhinitis, unspecified Nasal congestion A EP A LEVOTHYROXINE d00278A CDp E03.9 Hypothyroidism, unspecified A EP A LISINOPRIL d00732A CDp I10 Essential (primary) hypertension A EP A METFORMIN d03807A C- E11 Type 2 diabetes mellitus A EP A MONTELUKAST d04289A C- J30.9 Allergic rhinitis, unspecified A EP A PROGESTERONE d00550A CDp Z79.890 Hormone replacement therapy A EP A THYROID DESICCATED d00655A CDp E03.9 Hypothyroidism, unspecified A E` A METHYLPHENIDATE d00900A C} F90 Attention-deficit hyperactivity disorders A Ep A . . . E A . . . E A . . . E A . . . E A . . . E A DAPSONE TOPICAL d05543A B L70 Acne A E A . . . E A ESOMEPRAZOLE d04749A B= K30 Functional dyspepsia A E A . . . E A ACETAMINOPHEN; OXYCODONE d03431A C M19.9 M79.1 Osteoarthritis, unspecified site Myalgia A E A APIXABAN d07804A C D75.9P Prevent blood clots A E A ATORVASTATIN d04105A C- E78.0 Pure hypercholesterolemia A E A CITALOPRAM d04332A C[@ F39 Unspecified mood [affective] disorder A E A DONEPEZIL d04099A C[@ R41 Other symptoms and signs involving cognitive functions and awareness A E A HYDRALAZINE d00132A C I10 Essential (primary) hypertension A E A ISOSORBIDE MONONITRATE d00269A C I21.P Prevent heart attack/myocardial infarction A E A METOPROLOL d00134A C I50.9 Heart failure, unspecified A E A PANTOPRAZOLE d04514A C K21 K30 Gastro-esophageal reflux disease Functional dyspepsia A E A PREDNISONE d00350A AP M06.9 N18.9 Rheumatoid arthritis, unspecified Chronic kidney disease, unspecified A E A SITAGLIPTIN d05896A C E11 Type 2 diabetes mellitus A E A TAMSULOSIN d04121A Cr N40 R35 Enlarged prostate Polyuria A E A TORSEMIDE d03189A B= I50.9 R60.9 Heart failure, unspecified Edema, unspecified A E A . . . E A . . . E0 A WARFARIN d00022A D 55555 A E@ A ALPRAZOLAM d00168A C- F41.9 Anxiety disorder, unspecified A` E@ A FLUOXETINE d00236A D 99999 A` E@ A METFORMIN d03807A C- R73 Elevated blood glucose level A` E@ A OLANZAPINE d04050A D F20 Schizophrenia A` E@ A PRAVASTATIN d00348A C- E78.0 Pure hypercholesterolemia A` E@ A QUETIAPINE d04220A C- F20 Schizophrenia A` EP A . . . E` A . . . Ep A . . . E A . . . E A 99999 . . A E A FUROSEMIDE d00070A CDp R60.9 Edema, unspecified A` E A LEVOTHYROXINE d00278A C E07.9 Disorder of thyroid, unspecified A` E A LOSARTAN d03821A C[@ I10 Essential (primary) hypertension A` E A METFORMIN d03807A C E11 Type 2 diabetes mellitus A` E A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia A` E A WARFARIN d00022A C Z79.0 Long term (current) use of anticoagulants and antithrombotics/antiplatelets A` E A . . . E A AMLODIPINE d00689A CDp I10 Essential (primary) hypertension A E A . . . E A . . . E A AMLODIPINE d00689A Cr I10 Essential (primary) hypertension Ap E A CARVEDILOL d03847A Cr I10 Essential (primary) hypertension Ap E A FUROSEMIDE d00070A Cr I10 Essential (primary) hypertension Ap E A LISINOPRIL d00732A Cr I10 Essential (primary) hypertension Ap E A METHOTREXATE d00060A B L29.9 N95 Pruritus, unspecified Menopausal and other perimenopausal disorders Ap E A PAROXETINE d03157A B N95 Menopausal and other perimenopausal disorders Ap E A POTASSIUM CHLORIDE d00345A Cr E87.6 Hypokalemia Ap E A . . . E A . . . E A . . . E0 A . . . E@ A ABACAVIR; LAMIVUDINE d05354A0 D B20 Human immunodeficiency virus [HIV] disease A@ E@ A AZITHROMYCIN d00091A0 D 99999 A@ E@ A DARUNAVIR d05825A0 D B20 Human immunodeficiency virus [HIV] disease A@ E@ A MONTELUKAST d04289A0 D 99999 A@ EP A . . . E` A . . . Ep A . . . E A . . . E A . . . E A OXCARBAZEPINE d04513A A F31.9 Bipolar disorder, unspecified A E A QUETIAPINE d04220A B= G47.9 Sleep disorder, unspecified A E A GABAPENTIN d03182A C F41.9 Anxiety disorder, unspecified A E A ROPINIROLE d04215A C F29 Unspecified psychosis not due to a substance or known physiological condition A E A ATORVASTATIN d04105A C- E78.0 Pure hypercholesterolemia A E A IRBESARTAN d04222A C- I10 Essential (primary) hypertension A E A . . . E A DICYCLOMINE d00999A C R10 Abdominal and pelvic pain A@ E A ETHINYL ESTRADIOL; LEVONORGESTREL d03242A B N92 Excessive, frequent and irregular menstruation A@ E A RANITIDINE d00021A C R10 Abdominal and pelvic pain A@ E A SUCRALFATE d00377A C K31.9 Disease of stomach and duodenum, unspecified A@ E A AMLODIPINE d00689A C[@ I10 Essential (primary) hypertension A0 E A FLUOXETINE d00236A D F32.9 Major depressive disorder, single episode, unspecified A0 E A TRAZODONE d00395A D F41.9 G47.0 Anxiety disorder, unspecified Insomnia A0 E A AMIODARONE d00002A Cr I48.9 Unspecified atrial fibrillation and atrial flutter A E A ATORVASTATIN d04105A Cr E78.1 Pure hyperglyceridemia A E A CARBIDOPA; LEVODOPA d03473A C R25.1 Tremor, unspecified A E A CARVEDILOL d03847A C I49.9 Cardiac arrhythmia, unspecified A E A CYANOCOBALAMIN d00413A C- R25.1 Tremor, unspecified A E A DABIGATRAN d07137A C I48.9 Unspecified atrial fibrillation and atrial flutter A E A DIGOXIN d00210A C I48.9 Unspecified atrial fibrillation and atrial flutter A E A LINACLOTIDE d07902A C K30 Functional dyspepsia A E A RAMIPRIL d00728A C I10 Essential (primary) hypertension A E A . . . E A 77777 . . A E0 A AMOXICILLIN d00088A C A49.9P Prevent bacterial infection A E@ A . . . EP A DICYCLOMINE d00999A C K51 Ulcerative colitis A0 EP A MIRTAZAPINE d04025A B F32.9 F41.9 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified A0 EP A ONDANSETRON d00867A C K51 Ulcerative colitis A0 E` A AMLODIPINE d00689A0 Cr I10 Essential (primary) hypertension Ap E` A ATENOLOL d00004A D I10 Essential (primary) hypertension Ap E` A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia Ap E` A BENAZEPRIL d00730A C I10 Essential (primary) hypertension Ap E` A DOXAZOSIN d00726A D Z79.0 Long term (current) use of anticoagulants and antithrombotics/antiplatelets Ap E` A INSULIN GLARGINE d04538A C- E11 Type 2 diabetes mellitus Ap E` A SITAGLIPTIN d05896A C R73 Elevated blood glucose level Ap Ep A AMLODIPINE d00689A CDp I10 Essential (primary) hypertension A Ep A VALSARTAN d04113A CDp I10 Essential (primary) hypertension A E A . . . E A ATORVASTATIN d04105A D I10 Essential (primary) hypertension A E A LISINOPRIL d00732A D I10 Essential (primary) hypertension A E A . . . E A . . . E A AMITRIPTYLINE d00146A B G47.0 Insomnia AP E A CLONIDINE d00044A CDp I10 Essential (primary) hypertension AP E A ESCITALOPRAM d04812A C F32.9 Major depressive disorder, single episode, unspecified AP E A HYDROXYZINE d00907A B F41.9 Anxiety disorder, unspecified AP E A OLANZAPINE d04050A B[ F39 Unspecified mood [affective] disorder AP E A . . . E A ALOGLIPTIN d07963A B E11 Type 2 diabetes mellitus A E A ATORVASTATIN d04105A C"0 E78.0 Pure hypercholesterolemia A E A GLIPIZIDE d00246A C- E11 Type 2 diabetes mellitus A E A LISINOPRIL d00732A B E11.2P I10 Prevent diabetic kidney disease Essential (primary) hypertension A E A METFORMIN d03807A C E11 Type 2 diabetes mellitus A E A METHYLCELLULOSE d04248A CDp H04 Disorders of lacrimal system A E A OMEPRAZOLE d00325A D"8 K21 Gastro-esophageal reflux disease A E A PROPRANOLOL d00032A C R25.1 Tremor, unspecified A E A RANITIDINE d00021A D"8 K21 Gastro-esophageal reflux disease A E A TRAZODONE d00395A C G47.0 Insomnia A E A BRIMONIDINE OPHTHALMIC d04048A C[@ H40 Glaucoma A0 E A FLUVASTATIN d03183A Cr E78.0 Pure hypercholesterolemia A0 E A TIMOLOL OPHTHALMIC d04037A C[@ H40 Glaucoma A0 E A AMLODIPINE d00689A CP I10 Essential (primary) hypertension A E A . . . E A . . . E0 A . . . E@ A . . . EP A ATORVASTATIN d04105A D E78.0 Pure hypercholesterolemia A@ EP A LISINOPRIL d00732A D I10 Essential (primary) hypertension A@ EP A METFORMIN d03807A D E11 Type 2 diabetes mellitus A@ EP A METOPROLOL d00134A D I10 Essential (primary) hypertension A@ E` A HYDROCHLOROTHIAZIDE d00253A Cr I10 Essential (primary) hypertension A E` A METOPROLOL d00134A Cr I10 Essential (primary) hypertension A Ep A . . . E A . . . E A . . . E A . . . E A ESCITALOPRAM d04812A Cr F33.9 Major depressive disorder, recurrent, unspecified A E A OMEPRAZOLE d00325A B= K30 Functional dyspepsia A E A . . . E A BENAZEPRIL d00730A D E11.2P Prevent diabetic kidney disease A` E A GLIMEPIRIDE d03864A C E11 Type 2 diabetes mellitus A` E A HYDROCHLOROTHIAZIDE d00253A Dc 99999 A` E A LEVOTHYROXINE d00278A D E03.9 Hypothyroidism, unspecified A` E A METFORMIN; SITAGLIPTIN d06720A C E11 Type 2 diabetes mellitus A` E A TAMSULOSIN d04121A C R39.1 Other difficulties with micturition A` E A ALBUTEROL d00749A C J45 Asthma A E A MONTELUKAST d04289A C J30.1 J45 Allergic rhinitis due to pollen Asthma A E A APIXABAN d07804A C I48.9 Unspecified atrial fibrillation and atrial flutter A E A ATORVASTATIN d04105A B E78.0 Pure hypercholesterolemia A E A BUMETANIDE d00179A B[ I10 Essential (primary) hypertension A E A EMPAGLIFLOZIN d08275A C E11 Type 2 diabetes mellitus A E A GABAPENTIN d03182A C[@ M79.2 Neuralgia and neuritis, unspecified A E A GLIMEPIRIDE d03864A C E11 Type 2 diabetes mellitus A E A IBUPROFEN d00015A C[@ M19.9 Osteoarthritis, unspecified site A E A LISINOPRIL d00732A C I10 Essential (primary) hypertension A E A METFORMIN d03807A C E11 Type 2 diabetes mellitus A E A METOPROLOL d00134A C I10 Essential (primary) hypertension A E A OMEPRAZOLE d00325A C[@ K21 Gastro-esophageal reflux disease A E A TAMSULOSIN d04121A C- N40 Enlarged prostate A E A . . . E A ALBUTEROL d00749A C J44.9 Chronic obstructive pulmonary disease, unspecified A E A ATORVASTATIN d04105A C[@ E78.0 Pure hypercholesterolemia A E A FLUTICASONE NASAL d04283A C R09.81 Nasal congestion A E A FUROSEMIDE d00070A C N28.9 Disorder of kidney and ureter, unspecified A E A GLIPIZIDE d00246A C E11.P Prevent diabetes A E A INSULIN DETEMIR d05436A Dc E11 Type 2 diabetes mellitus A E A LISINOPRIL d00732A C E11.2 Type 2 diabetes mellitus with kidney complications A E A METOPROLOL d00134A C I10 Essential (primary) hypertension A E A NITROGLYCERIN d00321A D I20.9 Angina pectoris, unspecified A E A PRAMIPEXOLE d04145A C G25.81 Restless legs syndrome A E A RANITIDINE d00021A Cr K30 Functional dyspepsia A E0 A HYDROCHLOROTHIAZIDE d00253A Cr I10 Essential (primary) hypertension A E0 A LEVOTHYROXINE d00278A Cr E03.9 Hypothyroidism, unspecified A E@ A CLOZAPINE d00199A C F41.0 Panic disorder [episodic paroxysmal anxiety] without agoraphobia A0 E@ A ESCITALOPRAM d04812A C F41.9 Anxiety disorder, unspecified A0 E@ A ETHINYL ESTRADIOL; NORETHINDRONE d03238A D* Z79.3 Long term (current) use of hormonal contraceptives A0 EP A . . . E` A . . . Ep A . . . E A TRIAMCINOLONE TOPICAL d03206A CDp L20.9 Atopic dermatitis, unspecified A E A QUETIAPINE d04220A C"0 F31.9 F32.9 G47.0 Bipolar disorder, unspecified Major depressive disorder, single episode, unspecified Insomnia A E A . . . E A LISINOPRIL d00732A Cr I10 Essential (primary) hypertension A E A METFORMIN d03807A Cr E11 Type 2 diabetes mellitus A E A . . . E A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A CDp I10 Essential (primary) hypertension A E A . . . E A . . . E A . . . E A . . . E A ATORVASTATIN d04105A C- E78.0 Pure hypercholesterolemia A E0 A . . . E@ A . . . EP A . . . E` A . . . Ep A . . . E A . . . E A AMOXICILLIN d00088A Ap H66.9 J02.0 Otitis media, unspecified Streptococcal pharyngitis A E A GUANFACINE d00717A C- F90 Attention-deficit hyperactivity disorders A E A LISDEXAMFETAMINE d06663A C[@ F90 Attention-deficit hyperactivity disorders A E A AMPHETAMINE; DEXTROAMPHETAMINE d04035A C- R41 Other symptoms and signs involving cognitive functions and awareness A E A QUETIAPINE d04220A C[@ F90 Attention-deficit hyperactivity disorders A E A HYDROCHLOROTHIAZIDE d00253A A I10 Essential (primary) hypertension A0 E A LOSARTAN d03821A C- I10 Essential (primary) hypertension A0 E A ROSUVASTATIN d04851A B E78.0 Pure hypercholesterolemia A0 E A . . . E A . . . E A ATORVASTATIN d04105A C[@ E78.0P Prevent high cholesterol A@ E A ETANERCEPT d04365A CP L40 Psoriasis A@ E A GABAPENTIN d03182A C- G47.0 Insomnia A@ E A TAMOXIFEN d00381A C9 55555 A@ E A . . . E A . . . E A SIMVASTATIN d00746A Cr E78.0 Pure hypercholesterolemia A E0 A . . . E@ A . . . EP A HYDROCHLOROTHIAZIDE d00253A CDp I10 Essential (primary) hypertension A EP A LISINOPRIL d00732A C I10 Essential (primary) hypertension A E` A . . . Ep A ACETAMINOPHEN; TRAMADOL d04766A C M79.1 Myalgia A@ Ep A DOXAZOSIN d00726A Cr I99.9 Unspecified disorder of circulatory system A@ Ep A METFORMIN d03807A C R73 Elevated blood glucose level A@ Ep A PANTOPRAZOLE d04514A C- K30 Functional dyspepsia A@ E A . . . E A . . . E A . . . E A ETHOSUXIMIDE d00227A C[@ G40 Epilepsy and recurrent seizures A E A . . . E A LOSARTAN d03821A D ^ I10 Essential (primary) hypertension A0 E A METOPROLOL d00134A D ^ I10 Essential (primary) hypertension A0 E A VENLAFAXINE d03181A D ^ F32.9 Major depressive disorder, single episode, unspecified A0 E A . . . E A HYDROCHLOROTHIAZIDE d00253A C I10 Essential (primary) hypertension A@ E A LISINOPRIL d00732A C I10 Essential (primary) hypertension A@ E A POTASSIUM CHLORIDE d00345A C E87.6 Hypokalemia A@ E A PRAVASTATIN d00348A C E78.0 Pure hypercholesterolemia A@ E A BUPROPION d00181A C F32.9 F41.9 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified A0 E A ETONOGESTREL d04772A C Z79.3 Long term (current) use of hormonal contraceptives A0 E A TOPIRAMATE d04115A C E66 F41.9 Overweight and obesity Anxiety disorder, unspecified A0 E A . . . E A FINASTERIDE d00563A B N40 Enlarged prostate A E A TADALAFIL d04896A C- N52.9 Male erectile dysfunction, unspecified A E0 A ALBUTEROL d00749A Bz R06.2 Wheezing A E0 A BECLOMETHASONE d00760A B= J45 Asthma A E@ A . . . EP A . . . E` A DICLOFENAC d00848A B[ M19.9 Osteoarthritis, unspecified site A Ep A . . . E A . . . E A . . . E A . . . E A . . . E A IBUPROFEN d00015A B R50.9 Fever, unspecified A E A . . . E A LOSARTAN d03821A C I10 Essential (primary) hypertension A E A TAMSULOSIN d04121A Cr 99999 A E A . . . E A . . . E A INSULIN ISOPHANE (NPH) d04370A D E11 Type 2 diabetes mellitus AP E A INSULIN ISOPHANE; INSULIN REGULAR d04374A C E11 Type 2 diabetes mellitus AP E A LISINOPRIL d00732A Dc E11.2 Type 2 diabetes mellitus with kidney complications AP E A METFORMIN; SITAGLIPTIN d06720A D E11 Type 2 diabetes mellitus AP E A TAMSULOSIN d04121A C N40 Enlarged prostate AP E0 A OMEPRAZOLE d00325A C K21 Gastro-esophageal reflux disease A E@ A . . . EP A AMLODIPINE d00689A C I10 Essential (primary) hypertension A EP A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A EP A DONEPEZIL d04099A Cr R41 Other symptoms and signs involving cognitive functions and awareness A EP A FUROSEMIDE d00070A C R60.9 Edema, unspecified A EP A HYDROCHLOROTHIAZIDE; IRBESARTAN d04245A B= R60.9 Edema, unspecified A EP A INSULIN ASPART d04697A C- E11 Type 2 diabetes mellitus A EP A INSULIN DETEMIR d05436A C- E11 Type 2 diabetes mellitus A EP A LEVOCETIRIZINE d05851A B= J30.9 T78.40 Allergic rhinitis, unspecified Allergy, unspecified A EP A LUBIPROSTONE d05736A C- K59.0 Constipation A EP A MEGESTROL d01348A Cr R63 Symptoms and signs concerning food and fluid intake A EP A RANOLAZINE d05719A Ei R07.9 Chest pain, unspecified A EP A VORAPAXAR d08260A C- D75.9P I63 Prevent blood clots Cerebral infarction A E` A . . . Ep A ALBUTEROL d00749A C[@ J42 J45 Unspecified chronic bronchitis Asthma A E A ATORVASTATIN d04105A B E78.0 Pure hypercholesterolemia AP E A CARVEDILOL d03847A B I10 Essential (primary) hypertension AP E A FUROSEMIDE d00070A B I50.9 Heart failure, unspecified AP E A LISINOPRIL d00732A B E78.0 Pure hypercholesterolemia AP E A SPIRONOLACTONE d00373A B I50.9 Heart failure, unspecified AP E A . . . E A . . . E A METHYLPHENIDATE d00900A C- 55555 A E A AMOXICILLIN d00088A A J00 Acute nasopharyngitis [common cold] A E A . . . E A . . . E A . . . E A LEVOTHYROXINE d00278A D E03.9 Hypothyroidism, unspecified A E A . . . E A . . . E0 A . . . E@ A LEVOCETIRIZINE d05851A C- J30.1 Allergic rhinitis due to pollen A EP A . . . E` A . . . Ep A ALBUTEROL d00749A D J44.9 Chronic obstructive pulmonary disease, unspecified A Ep A BUDESONIDE; FORMOTEROL d04795A D J44.9 Chronic obstructive pulmonary disease, unspecified A Ep A ENALAPRIL d00013A D I10 Essential (primary) hypertension A Ep A FLUTICASONE NASAL d04283A D J30.2 Other seasonal allergic rhinitis A Ep A FUROSEMIDE d00070A D R60.9 Edema, unspecified A Ep A GUAIFENESIN d00797A D R09.3 Abnormal sputum A Ep A IPRATROPIUM NASAL d04235A D R09.81 Nasal congestion A Ep A POTASSIUM CHLORIDE d00345A D E87.6 Hypokalemia A Ep A SPIRONOLACTONE d00373A D I10 Essential (primary) hypertension A Ep A TAMSULOSIN d04121A D N40 R35 Enlarged prostate Polyuria A Ep A WARFARIN d00022A D Z79.0 Long term (current) use of anticoagulants and antithrombotics/antiplatelets A E A ACETAMINOPHEN; HYDROCODONE d03428A C M54 Dorsalgia A E A CYCLOBENZAPRINE d00963A CDp M79.1 Myalgia A E A DICLOFENAC d00848A C- M19.9 Osteoarthritis, unspecified site A E A DULOXETINE d05355A C M54 Dorsalgia A E A GABAPENTIN d03182A C M79.2 Neuralgia and neuritis, unspecified A E A LORAZEPAM d00149A CDp G47.0 Insomnia A E A LOVASTATIN d00280A C E78.0 Pure hypercholesterolemia A E A ROPINIROLE d04215A CDp G25.81 Restless legs syndrome A E A SUCRALFATE d00377A B K27 Peptic ulcer, site unspecified A E A . . . E A LEVETIRACETAM d04499A D G40 Epilepsy and recurrent seizures A E A . . . E A . . . E A . . . E A . . . E A IBUPROFEN d00015A C[@ N94 Pain and other conditions associated with female genital organs and menstrual cycle A E A . . . E A . . . E A MONTELUKAST d04289A CDp R06.2 Wheezing A E0 A . . . E@ A . . . EP A . . . E` A ALLOPURINOL d00023A D M10.9P Prevent gout Ap E` A ATORVASTATIN d04105A Dc E78.0 Pure hypercholesterolemia Ap E` A FUROSEMIDE d00070A D0z R60.9 Edema, unspecified Ap E` A GABAPENTIN d03182A D M79.2 Neuralgia and neuritis, unspecified Ap E` A OXYCODONE d00329A C M25.5 Pain in joint Ap E` A POTASSIUM CHLORIDE d00345A Dc E87.6 Hypokalemia Ap E` A WARFARIN d00022A D0z Z79.0 Long term (current) use of anticoagulants and antithrombotics/antiplatelets Ap Ep A ETHINYL ESTRADIOL; GESTODENE h00015A C Z79.3 Long term (current) use of hormonal contraceptives A E A ATORVASTATIN d04105A C[@ E78.0 Pure hypercholesterolemia Ap E A BRIMONIDINE; TIMOLOL OPHTHALMIC d05283A C H40 Glaucoma Ap E A LACTULOSE d01024A C- K59.0 Constipation Ap E A LATANOPROST OPHTHALMIC d04017A C H40 Glaucoma Ap E A LEVOTHYROXINE d00278A C[@ E03.9 Hypothyroidism, unspecified Ap E A TIMOLOL OPHTHALMIC d04037A C H40 Glaucoma Ap E A WARFARIN d00022A C[@ I51.9P Prevent heart disease Ap E A DONEPEZIL d04099A C R41 Other symptoms and signs involving cognitive functions and awareness A0 E A FUROSEMIDE d00070A C 99999 A0 E A LOVASTATIN d00280A C I21.P Prevent heart attack/myocardial infarction A0 E A DULOXETINE d05355A Dc M79.1 Myalgia A0 E A LEFLUNOMIDE d04349A C- M06.9 Rheumatoid arthritis, unspecified A0 E A OMEPRAZOLE d00325A Dc K21 Gastro-esophageal reflux disease A0 E A METHYLPHENIDATE d00900A B F90 Attention-deficit hyperactivity disorders A E A MONTELUKAST d04289A C J30.9 Allergic rhinitis, unspecified A E A . . . E A . . . E A BISOPROLOL; HYDROCHLOROTHIAZIDE d03744A Dc I10 Essential (primary) hypertension A` E A GABAPENTIN d03182A B M19.9 Osteoarthritis, unspecified site A` E A HYDROXYCHLOROQUINE d00817A C- M19.9 Osteoarthritis, unspecified site A` E A MELOXICAM d04532A CDp M19.9 Osteoarthritis, unspecified site A` E A METFORMIN d03807A Cr E11 Type 2 diabetes mellitus A` E A PRAVASTATIN d00348A D E78.0 Pure hypercholesterolemia A` E A LEVONORGESTREL d00557A C- Z79.3 Long term (current) use of hormonal contraceptives A E A . . . E A . . . E A . . . E0 A ATORVASTATIN d04105A Dc E78.0 Pure hypercholesterolemia A E0 A BUPROPION d00181A C- F32.9 Major depressive disorder, single episode, unspecified A E0 A CARBIDOPA; LEVODOPA d03473A C- G20 Parkinson's disease A E0 A ESCITALOPRAM d04812A C- F32.9 Major depressive disorder, single episode, unspecified A E0 A GLIMEPIRIDE d03864A Dc E11 Type 2 diabetes mellitus A E0 A LOSARTAN d03821A Dc I10 Essential (primary) hypertension A E0 A METFORMIN d03807A Dc E11 Type 2 diabetes mellitus A E0 A METOPROLOL d00134A Dc I10 Essential (primary) hypertension A E0 A RASAGILINE d05612A C- G20 Parkinson's disease A E0 A ROTIGOTINE d05848A C- G20 Parkinson's disease A E0 A TOPIRAMATE d04115A C- R25.1 Tremor, unspecified A E@ A AMLODIPINE d00689A D"8 I10 Essential (primary) hypertension AP E@ A CARBAMAZEPINE d00058A C G99.8 Other specified disorders of nervous system in diseases classified elsewhere AP E@ A ENALAPRIL d00013A D"8 I10 Essential (primary) hypertension AP E@ A MELOXICAM d04532A C- M25.5 Pain in joint AP E@ A PANTOPRAZOLE d04514A C- K21 Gastro-esophageal reflux disease AP EP A INSULIN DETEMIR d05436A C E11 Type 2 diabetes mellitus A0 EP A LISINOPRIL d00732A CDp I10 Essential (primary) hypertension A0 EP A OMEPRAZOLE d00325A CDp K30 R12 Functional dyspepsia Heartburn A0 E` A . . . Ep A . . . E A . . . E A TRIAMCINOLONE TOPICAL d03206A C L20.9 Atopic dermatitis, unspecified A E A . . . E A ZOLPIDEM d00910A C"0 G47.0 Insomnia A E A LEVOTHYROXINE d00278A DNk E03.9 Hypothyroidism, unspecified A@ E A OMEPRAZOLE d00325A C- K21 Gastro-esophageal reflux disease A@ E A OXYBUTYNIN d00328A C N32.81 Overactive bladder A@ E A TRAMADOL d03826A D B02 Zoster [herpes zoster] A@ E A CARVEDILOL d03847A D I10 Essential (primary) hypertension A E A FENOFIBRATE d04286A C E78.1 Pure hyperglyceridemia A E A LEVOTHYROXINE d00278A B E03.9 Hypothyroidism, unspecified A E A LINACLOTIDE d07902A C K59.0 Constipation A E A LISINOPRIL d00732A D I10 Essential (primary) hypertension A E A OXYCODONE d00329A CP M54 Dorsalgia A E A OXYCODONE d00329A CP M54 Dorsalgia A E A ROSUVASTATIN d04851A C E78.0 Pure hypercholesterolemia A E A TAMSULOSIN d04121A C- R35 Polyuria A E A . . . E A . . . E A . . . E A FLUTICASONE; SALMETEROL d04611A C[@ J45 Asthma A E A ALBUTEROL d00749A D J45 Asthma B E A AMLODIPINE d00689A C I10 Essential (primary) hypertension B E A BRIMONIDINE OPHTHALMIC d04048A B[ 99999 B E A BRIMONIDINE OPHTHALMIC d04048A C H40 Glaucoma B E A DICYCLOMINE d00999A CDp R10 Abdominal and pelvic pain B E A DULOXETINE d05355A B[ F32.9 R52 Major depressive disorder, single episode, unspecified Pain, unspecified B E A FLUTICASONE d01296A D' R06.9 Unspecified abnormalities of breathing B E A HYDROCHLOROTHIAZIDE d00253A C I10 Essential (primary) hypertension B E A LIDOCAINE TOPICAL d00683A D R52 Pain, unspecified B E A MELOXICAM d04532A B M25.9 Joint disorder, unspecified B E A METFORMIN d03807A C E11 Type 2 diabetes mellitus B E A NORTRIPTYLINE d00144A CDp M79.2 Neuralgia and neuritis, unspecified B E A PANTOPRAZOLE d04514A D K21 K30 Gastro-esophageal reflux disease Functional dyspepsia B E A POTASSIUM CHLORIDE d00345A C"0 E87.6 Hypokalemia B E A SALMETEROL d03759A D R06.9 Unspecified abnormalities of breathing B E A TIMOLOL OPHTHALMIC d04037A C H26.9 Unspecified cataract B E0 A . . . E@ A . . . EP A . . . E` A . . . Ep A ALBUTEROL d00749A Ap J45 Asthma A@ Ep A MONTELUKAST d04289A C"0 J30.9 Allergic rhinitis, unspecified A@ Ep A OFLOXACIN d00114A Cr H66.9 Otitis media, unspecified A@ Ep A PREDNISONE d00350A Ap J45 Asthma A@ E A . . . E A ALBUTEROL d00749A B J45 Asthma A` E A ALBUTEROL d00749A C J45 Asthma A` E A BECLOMETHASONE d00760A C J45 Asthma A` E A CETIRIZINE d03827A C T78.40 Allergy, unspecified A` E A MONTELUKAST d04289A C J45 T78.40 Asthma Allergy, unspecified A` E A OMEPRAZOLE d00325A C K21 Gastro-esophageal reflux disease A` E A . . . E A . . . E A ETHINYL ESTRADIOL; LEVONORGESTREL d03242A CDp N92 Z79.3 Excessive, frequent and irregular menstruation Long term (current) use of hormonal contraceptives A E A ETHINYL ESTRADIOL; NORGESTIMATE d03781A C- Z79.3 Long term (current) use of hormonal contraceptives A E A CLOPIDOGREL d04258A C[@ 99999 A E A DOXAZOSIN d00726A CDp 99999 A E A FUROSEMIDE d00070A C I51.9 Heart disease, unspecified A E A INSULIN ASPART d04697A C E11 Type 2 diabetes mellitus A E A INSULIN GLARGINE d04538A C E11 Type 2 diabetes mellitus A E A LISINOPRIL d00732A C I10 Essential (primary) hypertension A E A MECLIZINE d00859A C- R42 Dizziness and giddiness A E A METOPROLOL d00134A C 99999 A E A POTASSIUM CHLORIDE d00345A C E87.6 Hypokalemia A E A SERTRALINE d00880A C 99999 A E A SIMVASTATIN d00746A C 99999 A E A SPIRONOLACTONE d00373A C 99999 A E A . . . E A ALBUTEROL; IPRATROPIUM d04066A B= J45 Asthma A0 E A LEVOCETIRIZINE d05851A B= R09.81 Nasal congestion A0 E A MONTELUKAST d04289A B= J30.9 Allergic rhinitis, unspecified A0 E A 99999 . . A0 E A ARIPIPRAZOLE d04825A C F31.9 Bipolar disorder, unspecified A0 E A BUSPIRONE d00182A C- F41.9 Anxiety disorder, unspecified A0 E A . . . E0 A ATORVASTATIN d04105A CDp E78.0 Pure hypercholesterolemia A0 E0 A FLUTICASONE; VILANTEROL d08100A C- J44.9 Chronic obstructive pulmonary disease, unspecified A0 E0 A PREDNISONE d00350A A J44.9 Chronic obstructive pulmonary disease, unspecified A0 E@ A ALBUTEROL d00749A Cr J42 J45 R06.02 Unspecified chronic bronchitis Asthma Shortness of breath A E@ A CETIRIZINE d03827A CDp R06.2 T78.40 Wheezing Allergy, unspecified A E@ A EPINEPHRINE d00699A CDp T78.40 Allergy, unspecified A E@ A HYDROXYZINE d00907A C- F41.9 T78.40 Anxiety disorder, unspecified Allergy, unspecified A E@ A KETOROLAC OPHTHALMIC d03214A B= H10.1 Acute atopic conjunctivitis A E@ A MONTELUKAST d04289A C[@ J45 Asthma A E@ A PANTOPRAZOLE d04514A CDp K21 Gastro-esophageal reflux disease A E@ A SERTRALINE d00880A CDp F32.9 F43.1 N94 Major depressive disorder, single episode, unspecified Post-traumatic stress disorder (PTSD) Pain and other conditions associated with female genital organs and menstrual cycle A EP A . . . E` A . . . Ep A . . . E A . . . E A ALPRAZOLAM d00168A AP F41.9 Anxiety disorder, unspecified A E A ATENOLOL d00004A C I10 Essential (primary) hypertension A E A ATORVASTATIN d04105A CDp E78.0 Pure hypercholesterolemia A E A ESCITALOPRAM d04812A A@ F32.9 Major depressive disorder, single episode, unspecified A E A HYDROCHLOROTHIAZIDE d00253A C R60.9 Edema, unspecified A E A INSULIN GLARGINE d04538A Bz R73 Elevated blood glucose level A E A LOSARTAN d03821A C I10 Essential (primary) hypertension A E A METFORMIN d03807A C E11 Type 2 diabetes mellitus A E A RANITIDINE d00021A Bz K21 Gastro-esophageal reflux disease A E A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E A ALLOPURINOL d00023A C M10.9P Prevent gout A` E A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A` E A LEVOTHYROXINE d00278A Cr E03.9 Hypothyroidism, unspecified A` E A LOSARTAN d03821A C I10 Essential (primary) hypertension A` E A METOPROLOL d00134A C I10 Essential (primary) hypertension A` E A POTASSIUM CHLORIDE d00345A Cr E87.6 Hypokalemia A` E0 A CITALOPRAM d04332A C F32.9 Major depressive disorder, single episode, unspecified A E0 A ELETRIPTAN d04849A C"0 G43 Migraine A E0 A GABAPENTIN d03182A C"0 M79.2 Neuralgia and neuritis, unspecified A E0 A NAPROXEN d00019A C"0 G43 Migraine A E0 A NORTRIPTYLINE d00144A B= G43 Migraine A E0 A PROPRANOLOL d00032A C"0 G43 I10 Migraine Essential (primary) hypertension A E0 A SUMATRIPTAN d03160A C G43 Migraine A E0 A TIZANIDINE d04102A C"0 G43 G47.9 Migraine Sleep disorder, unspecified A E0 A TOPIRAMATE d04115A C"0 G43 Migraine A E@ A AMITRIPTYLINE d00146A C M79.2 M79.7 R51 Neuralgia and neuritis, unspecified Fibromyalgia Headache A` E@ A DULOXETINE d05355A C M79.7 Fibromyalgia A` E@ A HYDROCHLOROTHIAZIDE d00253A CDp I10 Essential (primary) hypertension A` E@ A NAPROXEN d00019A C M54 M79.1 Dorsalgia Myalgia A` E@ A NIFEDIPINE d00051A C I10 Essential (primary) hypertension A` E@ A RANITIDINE d00021A Cr K21 Gastro-esophageal reflux disease A` EP A HYDROXYZINE d00907A C L23 Allergic contact dermatitis AP EP A LEVOTHYROXINE d00278A D9 E03.9 Hypothyroidism, unspecified AP EP A METOPROLOL d00134A Cr I10 Essential (primary) hypertension AP EP A NAPROXEN d00019A CDp M25.5 Pain in joint AP EP A VENLAFAXINE d03181A D F32.9 F41.9 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified AP E` A . . . Ep A DESMOPRESSIN d00583A CDp R32 Unspecified urinary incontinence A E A . . . E A . . . E A . . . E A ATORVASTATIN d04105A CDp E78.1 Pure hyperglyceridemia A E A OMEPRAZOLE d00325A Dc K21 Gastro-esophageal reflux disease A E A ALBUTEROL d00749A C J44.9 Chronic obstructive pulmonary disease, unspecified A` E A ATENOLOL d00004A C I10 I51.9 Essential (primary) hypertension Heart disease, unspecified A` E A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A` E A CLOPIDOGREL d04258A C D75.9P Prevent blood clots A` E A LISINOPRIL d00732A C I10 Essential (primary) hypertension A` E A SERTRALINE d00880A C F32.9 Major depressive disorder, single episode, unspecified A` E A . . . E A NIFEDIPINE d00051A C[@ I27.9 Pulmonary heart disease, unspecified A E A . . . E A . . . E A ALLOPURINOL d00023A CDp M10.9P Prevent gout AP E A AMLODIPINE; OLMESARTAN d06905A D I10 Essential (primary) hypertension AP E A ATENOLOL d00004A Cr I10 Essential (primary) hypertension AP E A ATORVASTATIN d04105A Cr E78.0 Pure hypercholesterolemia AP E A DOXYCYCLINE d00037A B= H57.9 Unspecified disorder of eye and adnexa AP E A METHYLPHENIDATE d00900A C F90 Attention-deficit hyperactivity disorders A E0 A . . . E@ A AMOXICILLIN d00088A A0 J02 Acute pharyngitis A EP A . . . E` A ATORVASTATIN d04105A Cr E78.0 Pure hypercholesterolemia A0 E` A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A C I10 Essential (primary) hypertension A0 E` A METOPROLOL d00134A C} I10 Essential (primary) hypertension A0 Ep A . . . E A DEXAMETHASONE d00206A A B34.9 R05 R09.81 Viral infection, unspecified Cough Nasal congestion A E A CLONIDINE d00044A C- 99999 A E A DICYCLOMINE d00999A C- 99999 A E A . . . E A . . . E A . . . E A LEVOTHYROXINE d00278A CDp E03.9 Hypothyroidism, unspecified A E A ATORVASTATIN d04105A D# E78.0P Prevent high cholesterol A@ E A LEVOTHYROXINE d00278A D# E03.9 Hypothyroidism, unspecified A@ E A PANTOPRAZOLE d04514A C K21 Gastro-esophageal reflux disease A@ E A TERAZOSIN d00386A C N42.9 Disorder of prostate, unspecified A@ E A 99999 . . A E A . . . E A ATORVASTATIN d04105A CDp E78.0 Pure hypercholesterolemia A E A BUPROPION d00181A A E66 Overweight and obesity A E A CETIRIZINE d03827A A0 R09.81 Nasal congestion A E A DOXEPIN d00217A A0 G47.0 G47.9 Insomnia Sleep disorder, unspecified A E A HYDROCHLOROTHIAZIDE; OLMESARTAN d04878A A0 I10 Essential (primary) hypertension A E A METFORMIN d03807A C- R73 Elevated blood glucose level A E A PANTOPRAZOLE d04514A CDp K21 Gastro-esophageal reflux disease A E A SERTRALINE d00880A CDp F32.9 Major depressive disorder, single episode, unspecified A E A APIXABAN d07804A C D75.9P Prevent blood clots A E A ROSUVASTATIN d04851A D E78.0 Pure hypercholesterolemia A E0 A . . . E@ A . . . EP A . . . E` A AMPHETAMINE d00803A C[@ F90 Attention-deficit hyperactivity disorders A Ep A ATORVASTATIN d04105A B E78.0 Pure hypercholesterolemia A@ Ep A HYDROCHLOROTHIAZIDE d00253A B I10 Essential (primary) hypertension A@ Ep A LOSARTAN d03821A C"0 I10 Essential (primary) hypertension A@ Ep A METFORMIN d03807A C- E11 Type 2 diabetes mellitus A@ E A ACEBUTOLOL d00128A D"8 I10 Essential (primary) hypertension A E A ACETAMINOPHEN; HYDROCODONE d03428A CO M54 M79.1 M79.6 Dorsalgia Myalgia Pain in limb, hand, foot, fingers and toes A E A APREMILAST d08247A B L40 Psoriasis A E A CANDESARTAN d04322A D I10 Essential (primary) hypertension A E A CEPHALEXIN d00096A C L08.9 Local infection of the skin and subcutaneous tissue, unspecified A E A DILTIAZEM d00045A D"8 I10 Essential (primary) hypertension A E A EZETIMIBE d04824A C E78.0 Pure hypercholesterolemia A E A HYDROCHLOROTHIAZIDE d00253A C[@ I10 Essential (primary) hypertension A E A . . . E A . . . E A . . . E A . . . E A . . . E A AMPHETAMINE; DEXTROAMPHETAMINE d04035A C F90 Attention-deficit hyperactivity disorders A@ E A DIAZEPAM d00148A B[ G43 R51 Migraine Headache A@ E A DOXYCYCLINE d00037A A J01.9 Acute sinusitis, unspecified A@ E A OXYCODONE d00329A D R52 Pain, unspecified A@ E A . . . E A ATORVASTATIN d04105A Cr E78.0 Pure hypercholesterolemia A` E A GLIPIZIDE d00246A Cr R73 Elevated blood glucose level A` E A INSULIN ISOPHANE (NPH) d04370A C- E11 Type 2 diabetes mellitus A` E A LISINOPRIL d00732A Cr I10 Essential (primary) hypertension A` E A METFORMIN d03807A Cr R73 Elevated blood glucose level A` E A NAPROXEN d00019A B M25.5 Pain in joint A` E A . . . E A . . . E0 A ALPRAZOLAM d00168A C F41.9 Anxiety disorder, unspecified AP E0 A AMLODIPINE d00689A C I10 Essential (primary) hypertension AP E0 A LEVOTHYROXINE d00278A D# E03.9 Hypothyroidism, unspecified AP E0 A MECLIZINE d00859A C- R42 Dizziness and giddiness AP E0 A POTASSIUM CHLORIDE d00345A C- 99999 AP E@ A . . . EP A AMLODIPINE d00689A C I10 Essential (primary) hypertension A0 EP A PHENTERMINE d00806A A E66 Overweight and obesity A0 EP A RANITIDINE d00021A B K30 Functional dyspepsia A0 E` A NAPROXEN d00019A B R51 Headache A Ep A CELECOXIB d04380A B[ M79.1 Myalgia A Ep A LISINOPRIL d00732A C- I10 Essential (primary) hypertension A E A . . . E A . . . E A . . . E A MONTELUKAST d04289A Bz 55555 A E A . . . E A METFORMIN d03807A B= R73 Elevated blood glucose level A E A AMLODIPINE d00689A B I10 Essential (primary) hypertension A0 E A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A A I10 Essential (primary) hypertension A0 E A POTASSIUM CHLORIDE d00345A B E87.6 Hypokalemia A0 E A . . . E A . . . E A . . . E A PHENYTOIN d00143A B= G40 Epilepsy and recurrent seizures A E0 A . . . E@ A . . . EP A . . . E` A 99999 . . A Ep A CYANOCOBALAMIN d00413A Dc E63.9 Nutritional deficiency, unspecified A@ Ep A FUROSEMIDE d00070A C R60.9 Edema, unspecified A@ Ep A LOSARTAN d03821A C I10 Essential (primary) hypertension A@ Ep A POTASSIUM CHLORIDE d00345A C E87.6 Hypokalemia A@ E A OMEPRAZOLE d00325A C"0 R14 Flatulence and related conditions A E A METHYLPHENIDATE d00900A B F90 Attention-deficit hyperactivity disorders A E A . . . E A . . . E A SERTRALINE d00880A C F41.9 Anxiety disorder, unspecified A E A . . . E A ATENOLOL d00004A C I10 Essential (primary) hypertension A` E A GLIPIZIDE d00246A C- E11 Type 2 diabetes mellitus A` E A METFORMIN d03807A C[@ E11 Type 2 diabetes mellitus A` E A PRAVASTATIN d00348A C- E78.0 Pure hypercholesterolemia A` E A SITAGLIPTIN d05896A A@ R73 Elevated blood glucose level A` E A SPIRONOLACTONE d00373A Cr I10 Essential (primary) hypertension A` E A . . . E A . . . E A . . . E A COLESTIPOL d00744A B R19.7 Diarrhea, unspecified AP E A DABIGATRAN d07137A C[@ D75.9P Prevent blood clots AP E A LEVOTHYROXINE d00278A Dc E07.9 Disorder of thyroid, unspecified AP E A METFORMIN d03807A D R73 Elevated blood glucose level AP E A METOPROLOL d00134A C[@ I49.9 Cardiac arrhythmia, unspecified AP E0 A LEVOTHYROXINE d00278A C- E03.9 Hypothyroidism, unspecified A E@ A AMOXICILLIN d00088A A H66.9 Otitis media, unspecified A EP A . . . E` A . . . Ep A . . . E A . . . E A ALBUTEROL d00749A B J45 R06.2 Asthma Wheezing A@ E A CETIRIZINE d03827A B T78.40 Allergy, unspecified A@ E A FLUTICASONE d01296A C J45 R06.2 Asthma Wheezing A@ E A MONTELUKAST d04289A B; J45 R06.2 R06.9 Asthma Wheezing Unspecified abnormalities of breathing A@ E A . . . E A ALLOPURINOL d00023A B M10.9P Prevent gout A E A SIMVASTATIN d00746A B E78.0 Pure hypercholesterolemia A E A AMOXICILLIN d00088A A J02 Acute pharyngitis A E A . . . E A SIMVASTATIN d00746A CDp E78.0 Pure hypercholesterolemia A E A . . . E A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia AP E A FUROSEMIDE d00070A C I51.9 Heart disease, unspecified AP E A LOSARTAN d03821A Cr I10 Essential (primary) hypertension AP E A POTASSIUM CHLORIDE d00345A C R60.9 Edema, unspecified AP E A TAMSULOSIN d04121A CDp R35 Polyuria AP E A . . . E A . . . E0 A ATORVASTATIN d04105A Ei 99999 Ap E0 A FUROSEMIDE d00070A Ei Z79 Long term (current) drug therapy Ap E0 A LINAGLIPTIN d07767A Ei 99999 Ap E0 A LOSARTAN d03821A Ei I10 Essential (primary) hypertension Ap E0 A METOPROLOL d00134A Ei I10 Essential (primary) hypertension Ap E0 A POTASSIUM CHLORIDE d00345A D 99999 Ap E0 A RANITIDINE d00021A Ei K21 Gastro-esophageal reflux disease Ap E@ A . . . EP A DIVALPROEX SODIUM d03833A CDp M54 Dorsalgia A0 EP A SIMVASTATIN d00746A C[@ E78.0 Pure hypercholesterolemia A0 EP A SUMATRIPTAN d03160A CDp G43 Migraine A0 E` A . . . Ep A GLIPIZIDE d00246A C R73 Elevated blood glucose level Ap Ep A INSULIN GLARGINE d04538A B E11 Type 2 diabetes mellitus Ap Ep A METFORMIN; SITAGLIPTIN d06720A C"0 R73 Elevated blood glucose level Ap Ep A METOPROLOL d00134A CDp I10 Essential (primary) hypertension Ap Ep A SIMVASTATIN d00746A CDp E78.0 Pure hypercholesterolemia Ap Ep A SPIRONOLACTONE d00373A B N28.9P Prevent kidney disease Ap Ep A VALSARTAN d04113A C- I10 Essential (primary) hypertension Ap E A AMLODIPINE d00689A Dc I10 Essential (primary) hypertension A E A LISINOPRIL d00732A Dc I10 Essential (primary) hypertension A E A ACETAMINOPHEN; OXYCODONE d03431A B L93 R52 Lupus erythematosus Pain, unspecified B E A CLONAZEPAM d00197A D F32.9 Major depressive disorder, single episode, unspecified B E A ESCITALOPRAM d04812A C F32.9 Major depressive disorder, single episode, unspecified B E A ESOMEPRAZOLE d04749A D K21 K22 Gastro-esophageal reflux disease Other diseases of esophagus B E A FLUTICASONE; VILANTEROL d08100A C- J44.9 Chronic obstructive pulmonary disease, unspecified B E A GABAPENTIN d03182A D M79.2 M79.7 Neuralgia and neuritis, unspecified Fibromyalgia B E A HYDROXYCHLOROQUINE d00817A D L93 Lupus erythematosus B E A LEVOFLOXACIN d04109A C J18.9 J40 Pneumonia, unspecified organism Bronchitis, not specified as acute or chronic B E A LUBIPROSTONE d05736A Cr K58 Irritable bowel syndrome B E A METHYLPHENIDATE d00900A Dc F90 Attention-deficit hyperactivity disorders B E A METOPROLOL d00134A C- R00 Abnormalities of heart beat B E A MISOPROSTOL d00303A C K58 Irritable bowel syndrome B E A MONTELUKAST d04289A D R06.9 Unspecified abnormalities of breathing B E A POTASSIUM CHLORIDE d00345A C E87.6 Hypokalemia B E A PREDNISONE d00350A C- J44.9 Chronic obstructive pulmonary disease, unspecified B E A RIZATRIPTAN d04328A D G43 Migraine B E A TAMOXIFEN d00381A C C50 Malignant neoplasm of breast B E A TOPIRAMATE d04115A Dc M79.2 Neuralgia and neuritis, unspecified B E A VALACYCLOVIR d03838A D B02 Zoster [herpes zoster] B E A VERAPAMIL d00048A C I63 Cerebral infarction B E A AMOXICILLIN d00088A Ap J02 Acute pharyngitis A0 E A CETIRIZINE d03827A Bz T78.40 Allergy, unspecified A0 E A RANITIDINE d00021A C K92.9 Disease of digestive system, unspecified A0 E A . . . E A ATORVASTATIN d04105A D= E78.0 Pure hypercholesterolemia A` E A CLOPIDOGREL d04258A C D75.9P Prevent blood clots A` E A LISINOPRIL d00732A D= I10 Essential (primary) hypertension A` E A METOPROLOL d00134A D= I10 Essential (primary) hypertension A` E A OMEPRAZOLE d00325A D= K21 Gastro-esophageal reflux disease A` E A RANOLAZINE d05719A C I20.9 Angina pectoris, unspecified A` E A . . . E A . . . E A . . . E A ALBUTEROL d00749A Ei R06.02 Shortness of breath AP E A AMLODIPINE d00689A Ei I10 Essential (primary) hypertension AP E A ATORVASTATIN d04105A Ei I10 Essential (primary) hypertension AP E A CETIRIZINE d03827A Ei T78.40 Allergy, unspecified AP E A ROSUVASTATIN d04851A B E78.0 Pure hypercholesterolemia AP E A . . . E A AMLODIPINE d00689A Cr I10 Essential (primary) hypertension A E A CYCLOBENZAPRINE d00963A C M54 Dorsalgia A E A DULOXETINE d05355A CDp F32.9 F33.9 F41.9 Major depressive disorder, single episode, unspecified Major depressive disorder, recurrent, unspecified Anxiety disorder, unspecified A E A HYDROXYZINE d00907A CDp F41.9 Anxiety disorder, unspecified A E A IBUPROFEN d00015A C M54 Dorsalgia A E A LISINOPRIL d00732A Cr I10 Essential (primary) hypertension A E A OXCARBAZEPINE d04513A CDp F39 Unspecified mood [affective] disorder A E A TRAMADOL d03826A Cr M54 Dorsalgia A E0 A ALBUTEROL d00749A C J44.9 Chronic obstructive pulmonary disease, unspecified A E0 A ALLOPURINOL d00023A D M1A Chronic gout A E0 A CARVEDILOL d03847A D I49.9 Cardiac arrhythmia, unspecified A E0 A DIGOXIN d00210A D I48.9 I49.9 Unspecified atrial fibrillation and atrial flutter Cardiac arrhythmia, unspecified A E0 A FUROSEMIDE d00070A D I50.9 Heart failure, unspecified A E0 A GLIPIZIDE d00246A D E11 Type 2 diabetes mellitus A E0 A INSULIN ASPART d04697A C- E11 Type 2 diabetes mellitus A E0 A LEVOTHYROXINE d00278A Dc E03.9 Hypothyroidism, unspecified A E0 A LISINOPRIL d00732A Dc I10 I50.9 Essential (primary) hypertension Heart failure, unspecified A E0 A METFORMIN d03807A D E11 Type 2 diabetes mellitus A E0 A POTASSIUM CHLORIDE d00345A C E87.6 Hypokalemia A E0 A ROSUVASTATIN d04851A B E78.0 Pure hypercholesterolemia A E@ A ALBUTEROL d00749A C J45 Asthma AP E@ A ALBUTEROL d00749A C J45 Asthma AP E@ A FLUTICASONE NASAL d04283A CDp J30.2 J30.9 Other seasonal allergic rhinitis Allergic rhinitis, unspecified AP E@ A FLUTICASONE; SALMETEROL d04611A CDp J45 Asthma AP E@ A MONTELUKAST d04289A CDp J45 Asthma AP EP A AMLODIPINE d00689A Cr I10 Essential (primary) hypertension AP EP A CARVEDILOL d03847A Cr I10 Essential (primary) hypertension AP EP A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A Cr I10 Essential (primary) hypertension AP EP A RANITIDINE d00021A B. K21 Gastro-esophageal reflux disease AP EP A SIMVASTATIN d00746A CP E78.0 Pure hypercholesterolemia AP E` A ALBUTEROL d00749A0 C R06.02 R06.9 Shortness of breath Unspecified abnormalities of breathing A E` A ATENOLOL d00004A0 B I49.9 Cardiac arrhythmia, unspecified A E` A FLUOXETINE d00236A0 Cr F32.9 F41.9 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified A E` A IBUPROFEN d00015A0 Cr M19.9 M25.5 Osteoarthritis, unspecified site Pain in joint A E` A KETOROLAC OPHTHALMIC d03214A0 C H04 Disorders of lacrimal system A E` A RISPERIDONE d03180A0 Cr F99 Mental disorder, not otherwise specified A E` A SIMVASTATIN d00746A0 Ei E78.0 Pure hypercholesterolemia A E` A SOLIFENACIN d05413A0 Cr N32.81 N39.4 Overactive bladder Other specified urinary incontinence A E` A TRAZODONE d00395A0 C G47.0 Insomnia A Ep A . . . E A . . . E A . . . E A FUROSEMIDE d00070A C R60.9 Edema, unspecified A@ E A LEVOTHYROXINE d00278A C E07.9 Disorder of thyroid, unspecified A@ E A NAPROXEN d00019A C- I10 Essential (primary) hypertension A@ E A OMEPRAZOLE d00325A C- K21 Gastro-esophageal reflux disease A@ E A . . . E A ATORVASTATIN d04105A Bz E78.0 Pure hypercholesterolemia A` E A CARVEDILOL d03847A C[@ I10 I50.9 Essential (primary) hypertension Heart failure, unspecified A` E A CLOPIDOGREL d04258A C[@ D75.9P Prevent blood clots A` E A LOSARTAN d03821A Cr I10 Essential (primary) hypertension A` E A METFORMIN d03807A C E11 Type 2 diabetes mellitus A` E A SPIRONOLACTONE d00373A C I50.9 Heart failure, unspecified A` E A AMLODIPINE d00689A CDp I10 Essential (primary) hypertension A E A GABAPENTIN d03182A CDp M79.2 Neuralgia and neuritis, unspecified A E A HYDROXYZINE d00907A C F41.9 Anxiety disorder, unspecified A E A INSULIN ISOPHANE (NPH) d04370A C- E11 Type 2 diabetes mellitus A E A LISINOPRIL d00732A C[@ I10 Essential (primary) hypertension A E A MORPHINE d00308A C- R52 Pain, unspecified A E A OXYCODONE d00329A C[@ R52 Pain, unspecified A E A PROMETHAZINE d00787A C R11 Nausea and vomiting A E A TIZANIDINE d04102A B M62.83 Muscle spasm A E A . . . E A . . . E A DEXMETHYLPHENIDATE d04777A CDp F90 Attention-deficit hyperactivity disorders A E A RISPERIDONE d03180A C- G47.0 Insomnia A E A . . . E A . . . E0 A . . . E@ A . . . EP A . . . E` A . . . Ep A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E A CONJUGATED ESTROGENS d00541A Cr N95 Menopausal and other perimenopausal disorders A E A METFORMIN d03807A C- R73 Elevated blood glucose level A E A . . . E A . . . E A . . . E A . . . E A . . . E0 A . . . E@ A . . . EP A . . . E` A ATENOLOL; CHLORTHALIDONE d03258A Cr I10 Essential (primary) hypertension A E` A NITROFURANTOIN d00112A C N32.81 N39.0P Overactive bladder Prevent urinary tract infection A Ep A ALBUTEROL; IPRATROPIUM d04066A C- R06.9 Unspecified abnormalities of breathing AP Ep A BUDESONIDE; FORMOTEROL d04795A C[@ J43 Emphysema AP Ep A GUAIFENESIN d00797A C- J42 Unspecified chronic bronchitis AP Ep A LEVOTHYROXINE d00278A D E03.9 Hypothyroidism, unspecified AP Ep A PRAVASTATIN d00348A B E78.0 Pure hypercholesterolemia AP E A . . . E A GLIPIZIDE d00246A D E11 Type 2 diabetes mellitus A E A POLYETHYLENE GLYCOL 3350 d05350A C K59.0 Constipation A E A . . . E A . . . E A . . . E A . . . E A NORETHINDRONE d00555A B Z79.3 Long term (current) use of hormonal contraceptives A E A . . . E A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A Dc I10 Essential (primary) hypertension A@ E A HYOSCYAMINE; METHENA; MBLUE; PHENYLSAL; SODIUM BIPHOSPHATE d08274A B= N32.81 Overactive bladder A@ E A METFORMIN d03807A Dc E11 Type 2 diabetes mellitus A@ E A OXYBUTYNIN d00328A B N32.81 Overactive bladder A@ E A . . . E0 A QUETIAPINE d04220A D= F31.9 Bipolar disorder, unspecified A E0 A VALPROIC ACID d00083A D= F31.9 Bipolar disorder, unspecified A E@ A . . . EP A FLUCONAZOLE d00071A A B99.9 Unspecified infectious disease A0 EP A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified A0 EP A METRONIDAZOLE d00108A A A49.9 Bacterial infection, unspecified A0 E` A AMOXICILLIN d00088A A H66.9 Otitis media, unspecified A Ep A ALENDRONATE d03849A C- M81 Osteoporosis without current pathological fracture A E A INSULIN ASPART d04697A Cr E11 Type 2 diabetes mellitus A0 E A INSULIN GLARGINE d04538A Cr E11 Type 2 diabetes mellitus A0 E A SIMVASTATIN d00746A Cr E78.0 Pure hypercholesterolemia A0 E A . . . E A CEPHALEXIN d00096A B L08.9 Local infection of the skin and subcutaneous tissue, unspecified A E A CLOTRIMAZOLE TOPICAL d04395A B L08.9 Local infection of the skin and subcutaneous tissue, unspecified A E A . . . E A . . . E A . . . E A AZELASTINE NASAL d04068A C J30.2 Other seasonal allergic rhinitis A@ E A BUDESONIDE; FORMOTEROL d04795A C J45 Asthma A@ E A FLUTICASONE NASAL d04283A C J30.2 Other seasonal allergic rhinitis A@ E A LEVOCETIRIZINE d05851A C J30.2 Other seasonal allergic rhinitis A@ E A . . . E A FENOFIBRATE d04286A0 D E78.1 Pure hyperglyceridemia AP E A LISINOPRIL d00732A0 D I10 Essential (primary) hypertension AP E A METFORMIN d03807A0 D E11 Type 2 diabetes mellitus AP E A OXYBUTYNIN d00328A0 B N32.81 Overactive bladder AP E A SIMVASTATIN d00746A0 D* E78.0 Pure hypercholesterolemia AP E A AMLODIPINE d00689A Cr I10 Essential (primary) hypertension AP E A HYDROCHLOROTHIAZIDE; LOSARTAN d03830A Cr I10 Essential (primary) hypertension AP E A METFORMIN d03807A Cr E11 R73 Type 2 diabetes mellitus Elevated blood glucose level AP E A SITAGLIPTIN d05896A C R73 Elevated blood glucose level AP E A TAMSULOSIN d04121A C N40 Enlarged prostate AP E A ALBUTEROL d00749A Ei J44.9 Chronic obstructive pulmonary disease, unspecified A` E A CYCLOBENZAPRINE d00963A C- 99999 A` E A FLUTICASONE; VILANTEROL d08100A Ei J42 Unspecified chronic bronchitis A` E A HYDROXYZINE d00907A C 99999 A` E A LATANOPROST OPHTHALMIC d04017A C- H40 Glaucoma A` E A NAPROXEN d00019A Ei M79.7 Fibromyalgia A` E0 A . . . E@ A . . . EP A LEVOTHYROXINE d00278A C E04 Other nontoxic goiter A E` A DOXYCYCLINE d00037A B B99.9 Unspecified infectious disease A0 E` A MECLIZINE d00859A B R11 Nausea and vomiting A0 E` A PROPRANOLOL d00032A C F41.9 Anxiety disorder, unspecified A0 Ep A DESOGESTREL; ETHINYL ESTRADIOL d03782A B[ N92 Excessive, frequent and irregular menstruation A E A . . . E A . . . E A ESCITALOPRAM d04812A D F32.9 Major depressive disorder, single episode, unspecified A E A HYDROXYZINE d00907A D F41.9 T88.7P Anxiety disorder, unspecified Prevent drug side effect A E A AMOXICILLIN d00088A Ap K04.7 Periapical abscess without sinus A E A MELOXICAM d04532A C M13 Other arthritis A E A . . . E A . . . E A . . . E A ALBUTEROL d00749A C J44.9 Chronic obstructive pulmonary disease, unspecified Ap E A ALPRAZOLAM d00168A D M79.2 Neuralgia and neuritis, unspecified Ap E A ATORVASTATIN d04105A Cr E78.0 Pure hypercholesterolemia Ap E A CYCLOBENZAPRINE d00963A D ^ M79.2 Neuralgia and neuritis, unspecified Ap E A GABAPENTIN d03182A D ^ M79.2 Neuralgia and neuritis, unspecified Ap E A SERTRALINE d00880A D ^ F32.9 Major depressive disorder, single episode, unspecified Ap E A TIOTROPIUM d04829A C J44.9 Chronic obstructive pulmonary disease, unspecified Ap E A AMLODIPINE d00689A CDp I10 Essential (primary) hypertension A E A HYDRALAZINE d00132A CDp I10 Essential (primary) hypertension A E A CYPROHEPTADINE d00790A A R63 Symptoms and signs concerning food and fluid intake A@ E A FLUTICASONE NASAL d04283A CDp J30.9 Allergic rhinitis, unspecified A@ E A METHYLPHENIDATE d00900A B F90 Attention-deficit hyperactivity disorders A@ E A MONTELUKAST d04289A CDp J45 R06.9 Asthma Unspecified abnormalities of breathing A@ E A . . . E0 A . . . E@ A . . . EP A ACETAMINOPHEN; HYDROCODONE d03428A C- M54 M79.2 Dorsalgia Neuralgia and neuritis, unspecified A EP A GABAPENTIN d03182A C E11.4 M79.2 Type 2 diabetes mellitus with neurological complications Neuralgia and neuritis, unspecified A EP A GLIMEPIRIDE d03864A C- E11 Type 2 diabetes mellitus A EP A IRBESARTAN d04222A C E11 Type 2 diabetes mellitus A EP A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified A EP A MELOXICAM d04532A C- M79.2 Neuralgia and neuritis, unspecified A EP A METFORMIN; SITAGLIPTIN d06720A C E11 Type 2 diabetes mellitus A EP A PIOGLITAZONE d04442A C- E11 Type 2 diabetes mellitus A EP A TRAMADOL d03826A C- M79.2 Neuralgia and neuritis, unspecified A E` A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified A Ep A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E0 A . . . E@ A . . . EP A ATORVASTATIN d04105A0 C E78.0 Pure hypercholesterolemia A0 EP A DICLOFENAC d00848A0 C M25.5 Pain in joint A0 EP A METFORMIN d03807A0 C E11 Type 2 diabetes mellitus A0 E` A . . . Ep A GLIMEPIRIDE d03864A C- E11 Type 2 diabetes mellitus A@ Ep A METFORMIN d03807A CDp E11 Type 2 diabetes mellitus A@ Ep A PIOGLITAZONE d04442A C"0 E11 Type 2 diabetes mellitus A@ Ep A TELMISARTAN d04364A CP I10 Essential (primary) hypertension A@ E A . . . E A HYDROCHLOROTHIAZIDE; TRIAMTERENE d03052A C I10 Essential (primary) hypertension A E A POTASSIUM CHLORIDE d00345A C- E87.6 Hypokalemia A E A . . . E A . . . E A AMLODIPINE d00689A D I10 Essential (primary) hypertension AP E A ATORVASTATIN d04105A Dc E78.0 Pure hypercholesterolemia AP E A GLIPIZIDE d00246A Dc E11 Type 2 diabetes mellitus AP E A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A D I10 Essential (primary) hypertension AP E A METFORMIN d03807A Dc E11 Type 2 diabetes mellitus AP E A ADALIMUMAB d04835A C L40 Psoriasis A E A ALBUTEROL d00749A0 B R06.9P Prevent breathing difficulty A E A ARIPIPRAZOLE d04825A0 C- F32.9 Major depressive disorder, single episode, unspecified A E A BUDESONIDE; FORMOTEROL d04795A0 B R06.2 Wheezing A E A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A0 CDp I10 Essential (primary) hypertension A E A HYDROXYZINE d00907A0 C- F41.9 Anxiety disorder, unspecified A E A OMEPRAZOLE d00325A0 C R12 Heartburn A E A SIMVASTATIN d00746A0 C E78.0 Pure hypercholesterolemia A E A VENLAFAXINE d03181A0 B# F32.9 Major depressive disorder, single episode, unspecified A E A ZOLPIDEM d00910A0 C G47.9 Sleep disorder, unspecified A E A . . . E A . . . E A . . . E A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A0 E A LOSARTAN d03821A Cr I10 Essential (primary) hypertension A0 E A METFORMIN d03807A C E11 Type 2 diabetes mellitus A0 E0 A . . . E@ A . . . EP A . . . E` A OXCARBAZEPINE d04513A C F39 Unspecified mood [affective] disorder A@ E` A PAROXETINE d03157A C F32.9 Major depressive disorder, single episode, unspecified A@ E` A QUETIAPINE d04220A C F31.9 Bipolar disorder, unspecified A@ E` A TRAZODONE d00395A C F31.9 Bipolar disorder, unspecified A@ Ep A ALBUTEROL d00749A0 C R05 Cough A Ep A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A Ep A CLOPIDOGREL d04258A CDp I21.P Prevent heart attack/myocardial infarction A Ep A ESCITALOPRAM d04812A C- E07.9 Disorder of thyroid, unspecified A Ep A INSULIN REGULAR d04369A0 C- E11 Type 2 diabetes mellitus A Ep A KETOCONAZOLE TOPICAL d03202A0 B B35 Dermatophytosis A Ep A LEVOTHYROXINE d00278A C- E03.9 Hypothyroidism, unspecified A Ep A LISINOPRIL d00732A0 C I10 Essential (primary) hypertension A Ep A METFORMIN d03807A0 C E11 Type 2 diabetes mellitus A Ep A METOPROLOL d00134A0 CDp I10 Essential (primary) hypertension A Ep A OMEPRAZOLE d00325A0 B= K21 Gastro-esophageal reflux disease A Ep A OXYBUTYNIN d00328A0 A0 R32 Unspecified urinary incontinence A E A ALBUTEROL d00749A B R09.3 Abnormal sputum A0 E A BENZONATATE d00796A B J00 Acute nasopharyngitis [common cold] A0 E A FEXOFENADINE d04040A B J00 Acute nasopharyngitis [common cold] A0 E A METOPROLOL d00134A Ap I49.9 R00 Cardiac arrhythmia, unspecified Abnormalities of heart beat A E A PRAVASTATIN d00348A C[@ E78.0 Pure hypercholesterolemia A E A RANITIDINE d00021A B K21 Gastro-esophageal reflux disease A E A ATENOLOL d00004A CDp E11 Type 2 diabetes mellitus A` E A ATORVASTATIN d04105A Cr E78.0 Pure hypercholesterolemia A` E A LEVOTHYROXINE d00278A CDp E03.9 Hypothyroidism, unspecified A` E A METFORMIN d03807A C E11 Type 2 diabetes mellitus A` E A RAMIPRIL d00728A Cr I10 Essential (primary) hypertension A` E A RANITIDINE d00021A Bz K31.9 R14 Disease of stomach and duodenum, unspecified Flatulence and related conditions A` E A . . . E A . . . E A CARVEDILOL d03847A B I10 Essential (primary) hypertension A0 E A NIFEDIPINE d00051A B I10 Essential (primary) hypertension A0 E A SEVELAMER d04363A B E83.3 Disorders of phosphorus metabolism and phosphatases A0 E A . . . E A . . . E A FINASTERIDE d00563A D N40 Enlarged prostate A@ E A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A C I10 Essential (primary) hypertension A@ E A SIMVASTATIN d00746A D# E78.0 Pure hypercholesterolemia A@ E A TAMSULOSIN d04121A B= N40 Enlarged prostate A@ E A INSULIN LISPRO d04373A D E11 Type 2 diabetes mellitus A E0 A LEVOTHYROXINE d00278A CDp E03.9 Hypothyroidism, unspecified A E0 A RANITIDINE d00021A CDp K30 Functional dyspepsia A E@ A ACETAMINOPHEN; HYDROCODONE d03428A A0 Z98 Other postprocedural states A EP A . . . E` A OMEPRAZOLE d00325A C/ K25 Gastric ulcer A E` A RIZATRIPTAN d04328A B[ G43 R51 Migraine Headache A Ep A SULFAMETHOXAZOLE; TRIMETHOPRIM d00124A A0 B99.9 Unspecified infectious disease A Ep A TRAMADOL d03826A A T14.9 Unspecified injury A E A . . . E A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A@ E A HYDROCHLOROTHIAZIDE d00253A C I10 Essential (primary) hypertension A@ E A MONTELUKAST d04289A C R06.2 Wheezing A@ E A VALSARTAN d04113A B I10 Essential (primary) hypertension A@ E A . . . E A . . . E A . . . E A AMOXICILLIN d00088A Bm H66.9 Otitis media, unspecified A E A . . . E A . . . E A ESTRADIOL d00537A D* N95 Menopausal and other perimenopausal disorders AP E A LEVOTHYROXINE d00278A D# E03.9 Hypothyroidism, unspecified AP E A QUINAPRIL d00365A D I10 Essential (primary) hypertension AP E A SERTRALINE d00880A D# F32.9 Major depressive disorder, single episode, unspecified AP E A SIMVASTATIN d00746A D E78.0 Pure hypercholesterolemia AP E A LISINOPRIL d00732A Cr N28.9P Prevent kidney disease A E A OXYBUTYNIN d00328A B N32.81 R35 R39.1 Overactive bladder Polyuria Other difficulties with micturition A E A BUPROPION d00181A C- F39 Unspecified mood [affective] disorder A E A PAROXETINE d03157A B[ F32.9 Major depressive disorder, single episode, unspecified A E0 A ATORVASTATIN d04105A C- E78.0 Pure hypercholesterolemia A@ E0 A HYDROCHLOROTHIAZIDE d00253A C I10 Essential (primary) hypertension A@ E0 A LOSARTAN d03821A C- I10 Essential (primary) hypertension A@ E0 A PAROXETINE d03157A D F32.9 Major depressive disorder, single episode, unspecified A@ E@ A . . . EP A . . . E` A . . . Ep A . . . E A . . . E A METFORMIN d03807A C- E11 Type 2 diabetes mellitus A E A AMLODIPINE d00689A Dc I10 Essential (primary) hypertension A0 E A ATORVASTATIN d04105A B[ E78.0 Pure hypercholesterolemia A0 E A CLOPIDOGREL d04258A D I63.P Prevent stroke A0 E A DONEPEZIL d04099A C- R41 Other symptoms and signs involving cognitive functions and awareness A E A HYDROCHLOROTHIAZIDE; LOSARTAN d03830A C I10 Essential (primary) hypertension A E A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia AP E A GABAPENTIN d03182A Dc M79.2 Neuralgia and neuritis, unspecified AP E A LOSARTAN d03821A C E11.2 I10 Type 2 diabetes mellitus with kidney complications Essential (primary) hypertension AP E A METFORMIN d03807A D E11 Type 2 diabetes mellitus AP E A OXYBUTYNIN d00328A C- N32.81 Overactive bladder AP E A . . . E A AMLODIPINE d00689A C- I10 Essential (primary) hypertension A0 E A MONTELUKAST d04289A B T78.40 Allergy, unspecified A0 E A SIMVASTATIN d00746A B E78.0 Pure hypercholesterolemia A0 E A . . . E A ACETAMINOPHEN; HYDROCODONE d03428A Cr M19.9 M25.5 M54 Osteoarthritis, unspecified site Pain in joint Dorsalgia A E A ACETAMINOPHEN; OXYCODONE d03431A Cr G47.9 Sleep disorder, unspecified A E A AMIODARONE d00002A Cr I20.9 I49.9 Angina pectoris, unspecified Cardiac arrhythmia, unspecified A E A ATORVASTATIN d04105A Cr E78.0 Pure hypercholesterolemia A E A DIAZEPAM d00148A Cr F41.9 Anxiety disorder, unspecified A E A DONEPEZIL d04099A B G30.9 R41 Alzheimer's disease, unspecified Other symptoms and signs involving cognitive functions and awareness A E A DULOXETINE d05355A C F32.9 Major depressive disorder, single episode, unspecified A E A MEMANTINE d04899A C G30.9 R41 Alzheimer's disease, unspecified Other symptoms and signs involving cognitive functions and awareness A E A METOPROLOL d00134A B I20.9 I49.9 Angina pectoris, unspecified Cardiac arrhythmia, unspecified A E A MONTELUKAST d04289A C J45 R06.2 Asthma Wheezing A E A PANTOPRAZOLE d04514A B K27 Peptic ulcer, site unspecified A E A QUETIAPINE d04220A B F41.9 Anxiety disorder, unspecified A E A LEVONORGESTREL d00557A Cr Z79.3 Long term (current) use of hormonal contraceptives A E A . . . E0 A . . . E@ A . . . EP A . . . E` A . . . Ep A ATORVASTATIN d04105A D E78.0 Pure hypercholesterolemia A Ep A BUPROPION d00181A C F32.9 Major depressive disorder, single episode, unspecified A Ep A CITALOPRAM d04332A B F32.9 Major depressive disorder, single episode, unspecified A Ep A DESONIDE TOPICAL d01290A CDp B35 Dermatophytosis A Ep A DICLOFENAC d00848A C M19.9 Osteoarthritis, unspecified site A Ep A DONEPEZIL d04099A CDp R41 Other symptoms and signs involving cognitive functions and awareness A Ep A KETOCONAZOLE TOPICAL d03202A CDp B35 Dermatophytosis A Ep A LEVOTHYROXINE d00278A DJ$ E03.9 Hypothyroidism, unspecified A Ep A LORAZEPAM d00149A CDp F41.9 Anxiety disorder, unspecified A Ep A METRONIDAZOLE TOPICAL d03208A C"0 L71 Rosacea A Ep A TRAZODONE d00395A Dc G47.0 Insomnia A Ep A TRIAMCINOLONE TOPICAL d03206A C- L98.9 Disorder of the skin and subcutaneous tissue, unspecified A Ep A ZOLPIDEM d00910A Dc G47.0 Insomnia A E A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E A ACETAMINOPHEN; HYDROCODONE d03428A C M54 Dorsalgia Ap E A DOXYCYCLINE d00037A Ap L08.9 Local infection of the skin and subcutaneous tissue, unspecified Ap E A DRONEDARONE d07458A Cr I49.9 Cardiac arrhythmia, unspecified Ap E A ISOSORBIDE d00653A Cr H40 Glaucoma Ap E A LEVOTHYROXINE d00278A C- E03.9 Hypothyroidism, unspecified Ap E A PREDNISONE d00350A Cr 55555 Ap E A SIMVASTATIN d00746A Cr I21.P Prevent heart attack/myocardial infarction Ap E A ALBUTEROL d00749A CDp R06.9P Prevent breathing difficulty A E A . . . E A . . . E0 A . . . E@ A INSULIN GLARGINE d04538A CDp E11 Type 2 diabetes mellitus A EP A AMLODIPINE d00689A C- I63.P Prevent stroke AP EP A GABAPENTIN d03182A C- M79.2 Neuralgia and neuritis, unspecified AP EP A HYDROCHLOROTHIAZIDE d00253A C- I10 Essential (primary) hypertension AP EP A LEVETIRACETAM d04499A C- G40 Epilepsy and recurrent seizures AP EP A METOPROLOL d00134A C- I10 Essential (primary) hypertension AP E` A . . . Ep A ATORVASTATIN d04105A C[@ E78.0 Pure hypercholesterolemia AP Ep A DULOXETINE d05355A C[@ F41.9 Anxiety disorder, unspecified AP Ep A MELOXICAM d04532A C M13 Other arthritis AP Ep A MEMANTINE d04899A C R41 Other symptoms and signs involving cognitive functions and awareness AP Ep A MEMANTINE d04899A C[@ R41 Other symptoms and signs involving cognitive functions and awareness AP E A . . . E A . . . E A . . . E A BACLOFEN d00967A B M62.83 Muscle spasm A E A OXCARBAZEPINE d04513A CDp G40 Epilepsy and recurrent seizures A E A . . . E A . . . E A . . . E A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A@ E A HYDROXYCHLOROQUINE d00817A C- M06.9 Rheumatoid arthritis, unspecified A@ E A OMEPRAZOLE d00325A C- R12 Heartburn A@ E A PREDNISONE d00350A C- M06.9 Rheumatoid arthritis, unspecified A@ E A LEVOTHYROXINE d00278A Cr E03.9 Hypothyroidism, unspecified A E A ESTRADIOL d00537A C N95 Menopausal and other perimenopausal disorders A E A GLIMEPIRIDE d03864A C R73 Elevated blood glucose level AP E A LABETALOL d00016A C I10 Essential (primary) hypertension AP E A LEVOTHYROXINE d00278A Bz E03.9 Hypothyroidism, unspecified AP E A LISINOPRIL d00732A C I10 Essential (primary) hypertension AP E A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia AP E0 A . . . E@ A . . . EP A . . . E` A . . . Ep A . . . E A . . . E A DICYCLOMINE d00999A C R10 Abdominal and pelvic pain A` E A NORTRIPTYLINE d00144A D G43 Migraine A` E A OMEPRAZOLE d00325A C K21 Gastro-esophageal reflux disease A` E A ONDANSETRON d00867A Cr R11 Nausea and vomiting A` E A PROMETHAZINE d00787A C R11 Nausea and vomiting A` E A VENLAFAXINE d03181A Ap N95 Menopausal and other perimenopausal disorders A` E A . . . E A . . . E A PANTOPRAZOLE d04514A C K21 Gastro-esophageal reflux disease A@ E A PROPRANOLOL d00032A D F41.9 Anxiety disorder, unspecified A@ E A RANITIDINE d00021A D K21 Gastro-esophageal reflux disease A@ E A VENLAFAXINE d03181A D F32.9 F41.9 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified A@ E A CIPROFLOXACIN d00011A Ap H66.9 Otitis media, unspecified A E A TOBRAMYCIN d00069A AP H66.9 Otitis media, unspecified A E A . . . E A . . . E A . . . E A . . . E A . . . E0 A . . . E@ A . . . EP A . . . E` A . . . Ep A AMLODIPINE; HYDROCHLOROTHIAZIDE; OLMESARTAN d07668A CDp I10 Essential (primary) hypertension A@ Ep A AMOXICILLIN d00088A A B99.9 Unspecified infectious disease A@ Ep A BENZONATATE d00796A A J42 Unspecified chronic bronchitis A@ Ep A CLARITHROMYCIN d00097A A J20.9 Acute bronchitis, unspecified A@ E A . . . E A . . . E A . . . E A CETIRIZINE d03827A A@ T78.40 Allergy, unspecified AP E A DULOXETINE d05355A C F41.9 M79.2 Anxiety disorder, unspecified Neuralgia and neuritis, unspecified AP E A FLUTICASONE NASAL d04283A A@ J30.2 Other seasonal allergic rhinitis AP E A GABAPENTIN d03182A C M79.2 Neuralgia and neuritis, unspecified AP E A NORTRIPTYLINE d00144A C M79.2 Neuralgia and neuritis, unspecified AP E A . . . E A . . . E A . . . E A ACETAMINOPHEN; HYDROCODONE d03428A B- M25.5 Pain in joint AP E A HYDROCHLOROTHIAZIDE; LOSARTAN d03830A C I10 Essential (primary) hypertension AP E A RANITIDINE d00021A A K21 Gastro-esophageal reflux disease AP E A TIZANIDINE d04102A A M79.1 Myalgia AP E A VARENICLINE d05807A B= F17.2 Nicotine dependence AP E A . . . E A BENZONATATE d00796A A J40 Bronchitis, not specified as acute or chronic A E A LEVOTHYROXINE d00278A D ^ E03.9 Hypothyroidism, unspecified A E A . . . E0 A CYPROHEPTADINE d00790A B G43 Migraine A E@ A AMITRIPTYLINE d00146A A F32.9 Major depressive disorder, single episode, unspecified A@ E@ A CIPROFLOXACIN d00011A A B96.81 Helicobacter pylori [H. pylori] as the cause of diseases classified elsewhere A@ E@ A IBUPROFEN d00015A A R10 Abdominal and pelvic pain A@ E@ A PENTOSAN POLYSULFATE SODIUM d04052A A K25.P Prevent gastric ulcer A@ EP A . . . E` A . . . Ep A CONTRACEPTIVES - UNSPECIFIED c00102A B Z79.3 Long term (current) use of hormonal contraceptives A E A 99999 . . A E A ASPIRIN d00170A C- Z79.0 Long term (current) use of anticoagulants and antithrombotics/antiplatelets A` E A CLOPIDOGREL d04258A C- Z79.0 Long term (current) use of anticoagulants and antithrombotics/antiplatelets A` E A DULOXETINE d05355A C F32.9 M19.9 Major depressive disorder, single episode, unspecified Osteoarthritis, unspecified site A` E A LORAZEPAM d00149A Cr F41.9 Anxiety disorder, unspecified A` E A LOVASTATIN d00280A C[@ E78.0 Pure hypercholesterolemia A` E A MIRTAZAPINE d04025A Cr G47.0 Insomnia A` E A BUDESONIDE; FORMOTEROL d04795A C- J44.9 Chronic obstructive pulmonary disease, unspecified Ap E A CELECOXIB d04380A C[@ M13 Other arthritis Ap E A EZETIMIBE d04824A CDp E78.0 Pure hypercholesterolemia Ap E A LISINOPRIL d00732A C[@ I10 Essential (primary) hypertension Ap E A METFORMIN d03807A C E11 Type 2 diabetes mellitus Ap E A PANTOPRAZOLE d04514A Cr K30 Functional dyspepsia Ap E A TAMSULOSIN d04121A B N40 Enlarged prostate Ap E A ETHINYL ESTRADIOL; NORGESTREL d03241A C[@ N92 Excessive, frequent and irregular menstruation A E A . . . E A . . . E A CYCLOSPORINE OPHTHALMIC d04836A C H04 Disorders of lacrimal system A E A ROSUVASTATIN d04851A Cr E78.0 Pure hypercholesterolemia A E A . . . E A . . . E A LAMOTRIGINE d03809A CDp G47.0 Insomnia A0 E A LITHIUM d00061A C F31.9 Bipolar disorder, unspecified A0 E A TEMAZEPAM d00384A CDp G47.9 Sleep disorder, unspecified A0 E A . . . E0 A . . . E@ A . . . EP A . . . E` A AZATHIOPRINE d00024A D,3 K76.9 Liver disease, unspecified A E` A LEVOTHYROXINE d00278A D& E03.9 Hypothyroidism, unspecified A Ep A . . . E A LISINOPRIL d00732A CDp I10 Essential (primary) hypertension A E A THYROID DESICCATED d00655A C[@ E03.9 Hypothyroidism, unspecified A E A ACETAMINOPHEN; HYDROCODONE d03428A D M25.5 M79.6 Pain in joint Pain in limb, hand, foot, fingers and toes A E A 99999 . . A E A . . . E A . . . E A AMLODIPINE d00689A D# G40 I10 Epilepsy and recurrent seizures Essential (primary) hypertension A E A ATORVASTATIN d04105A D G40 Epilepsy and recurrent seizures A E A BENZTROPINE d00175A D# G40 Epilepsy and recurrent seizures A E A DIVALPROEX SODIUM d03833A D# G40 Epilepsy and recurrent seizures A E A HYDROCHLOROTHIAZIDE d00253A C G40 Epilepsy and recurrent seizures A E A LEVETIRACETAM d04499A D G40 Epilepsy and recurrent seizures A E A LISINOPRIL d00732A D G40 Epilepsy and recurrent seizures A E A METFORMIN d03807A D ^ G40 Epilepsy and recurrent seizures A E A PHENYTOIN d00143A D* G40 Epilepsy and recurrent seizures A E A POTASSIUM CHLORIDE d00345A Dc G40 Epilepsy and recurrent seizures A E A . . . E A . . . E A . . . E A . . . E0 A NABUMETONE d00310A C M19.9 M54 Osteoarthritis, unspecified site Dorsalgia A0 E0 A NITROFURANTOIN d00112A A@ N39.0 Urinary tract infection, site not specified A0 E0 A SIMVASTATIN d00746A Dc E78.0 Pure hypercholesterolemia A0 E@ A LEVETIRACETAM d04499A Cr G40 Epilepsy and recurrent seizures A E@ A PHENOBARBITAL d00340A D=O G40 Epilepsy and recurrent seizures A EP A . . . E` A . . . Ep A . . . E A . . . E A ATENOLOL d00004A D I10 Essential (primary) hypertension AP E A FUROSEMIDE d00070A Dc R60.9 Edema, unspecified AP E A METOCLOPRAMIDE d00298A C 99999 AP E A OMEPRAZOLE d00325A C K21 Gastro-esophageal reflux disease AP E A POLYETHYLENE GLYCOL 3350 d05350A C K59.0 Constipation AP E A LOVASTATIN d00280A C E78.0 I21.P Pure hypercholesterolemia Prevent heart attack/myocardial infarction A@ E A METOPROLOL d00134A C I10 Essential (primary) hypertension A@ E A OMEPRAZOLE d00325A C- R11 Nausea and vomiting A@ E A PROPAFENONE d00358A C I49.9 Cardiac arrhythmia, unspecified A@ E A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A E A . . . E A . . . E A ACETAMINOPHEN; CODEINE d03423A A K08.8 Other specified disorders of teeth and supporting structures A E A AZITHROMYCIN d00091A A K04.7P Prevent tooth infection A E A AMLODIPINE d00689A Cr I10 Essential (primary) hypertension A E A LOSARTAN d03821A Cr I10 Essential (primary) hypertension A E A 99999 . . A E A . . . E A . . . E0 A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified A E@ A . . . EP A . . . E` A . . . Ep A ALPRAZOLAM d00168A C F41.9 G47.0 Anxiety disorder, unspecified Insomnia A Ep A LOSARTAN d03821A C[@ I10 Essential (primary) hypertension A E A DESONIDE TOPICAL d01290A C L20.9 Atopic dermatitis, unspecified A E A ALBUTEROL d00749A B R06.9P Prevent breathing difficulty AP E A CLONAZEPAM d00197A D# F41.9 Anxiety disorder, unspecified AP E A LEVOTHYROXINE d00278A Ei E03.9 Hypothyroidism, unspecified AP E A PRAVASTATIN d00348A Ei E78.0 Pure hypercholesterolemia AP E A VENLAFAXINE d03181A Ei F32.9 Major depressive disorder, single episode, unspecified AP E A . . . E A . . . E A DIURETICS - UNSPECIFIED c00049A C- I10 Essential (primary) hypertension A E A . . . E A AZELASTINE; FLUTICASONE NASAL d07868A C& J30.2 Other seasonal allergic rhinitis A E A . . . E A . . . E A . . . E A AMLODIPINE d00689A C[@ I10 Essential (primary) hypertension A E A CLONIDINE d00044A C I10 Essential (primary) hypertension A E A ESCITALOPRAM d04812A B F32.9 Major depressive disorder, single episode, unspecified A E A HYDRALAZINE d00132A C[@ I10 Essential (primary) hypertension A E A INSULIN ISOPHANE (NPH) d04370A C[@ E11 Type 2 diabetes mellitus A E A LISINOPRIL d00732A C[@ I10 Essential (primary) hypertension A E A METFORMIN d03807A Cr E11 Type 2 diabetes mellitus A E A METOPROLOL d00134A C I10 Essential (primary) hypertension A E A MONTELUKAST d04289A C J45 Asthma A E A OMEPRAZOLE d00325A C K31.9 Disease of stomach and duodenum, unspecified A E A POTASSIUM CHLORIDE d00345A C E87.6 Hypokalemia A E A SIMVASTATIN d00746A CDp E78.0 Pure hypercholesterolemia A E0 A . . . E@ A DAPAGLIFLOZIN d07928A C- E11 Type 2 diabetes mellitus A0 E@ A LISINOPRIL d00732A C"0 I10 Essential (primary) hypertension A0 E@ A METFORMIN d03807A CDp E11 Type 2 diabetes mellitus A0 EP A LISINOPRIL d00732A C I10 Essential (primary) hypertension A E` A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified A E` A TOFACITINIB d07925A B= L65.9 Nonscarring hair loss, unspecified A Ep A ATORVASTATIN d04105A Cr E78.0 Pure hypercholesterolemia A0 Ep A ETHINYL ESTRADIOL; NORGESTIMATE d03781A C Z79.3 Long term (current) use of hormonal contraceptives A0 Ep A LEVOTHYROXINE d00278A Cr E03.9 Hypothyroidism, unspecified A0 E A . . . E A DESVENLAFAXINE d07113A CDp F32.9 Major depressive disorder, single episode, unspecified A E A . . . E A . . . E A ATORVASTATIN d04105A B= E78.0 Pure hypercholesterolemia A0 E A HYDROCHLOROTHIAZIDE; TELMISARTAN d04737A Cr I10 Essential (primary) hypertension A0 E A METFORMIN d03807A Cr E11 Type 2 diabetes mellitus A0 E A . . . E A . . . E A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A0 E A OMEPRAZOLE d00325A Cr K21 Gastro-esophageal reflux disease A0 E A TAMSULOSIN d04121A C N40 Enlarged prostate A0 E A . . . E A . . . E A . . . E0 A . . . E@ A . . . EP A . . . E` A . . . Ep A . . . E A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A E A LOSARTAN d03821A CDp I10 Essential (primary) hypertension A E A . . . E A . . . E A . . . E A ALIROCUMAB d08374A C- E78.0 Pure hypercholesterolemia A E A AMLODIPINE d00689A C[@ R07.9 Chest pain, unspecified A E A CARVEDILOL d03847A C[@ R07.9 Chest pain, unspecified A E A CLOPIDOGREL d04258A C[@ Z79.0 Long term (current) use of anticoagulants and antithrombotics/antiplatelets A E A EPLERENONE d04815A C[@ I10 Essential (primary) hypertension A E A EZETIMIBE d04824A C E78.0 Pure hypercholesterolemia A E A FINASTERIDE d00563A Cr N40 Enlarged prostate A E A FLUTICASONE; SALMETEROL d04611A D J45 Asthma A E A FUROSEMIDE d00070A C[@ R60.9 Edema, unspecified A E A ISOSORBIDE MONONITRATE d00269A C[@ R07.9 Chest pain, unspecified A E A LOSARTAN d03821A C[@ I10 Essential (primary) hypertension A E A POTASSIUM CHLORIDE d00345A C[@ E87.6 Hypokalemia A E A RANOLAZINE d05719A C[@ R06.9 Unspecified abnormalities of breathing A E A WARFARIN d00022A C[@ D75.9P Prevent blood clots A E A AMOXICILLIN; CLAVULANATE d00089A AP 55555 A E A ATORVASTATIN d04105A B= E78.0 Pure hypercholesterolemia A@ E A BUSPIRONE d00182A C F32.9 Major depressive disorder, single episode, unspecified A@ E A FLUOXETINE d00236A C F32.9 Major depressive disorder, single episode, unspecified A@ E A HYDROCODONE d03075A CDp M19.9 Osteoarthritis, unspecified site A@ E A IBUPROFEN d00015A B K08.8 Other specified disorders of teeth and supporting structures A E A TRAZODONE d00395A B F32.9 G47.9 Major depressive disorder, single episode, unspecified Sleep disorder, unspecified A E A . . . E A 99999 A B[ Z79.3 Long term (current) use of hormonal contraceptives A E A TRIAMCINOLONE TOPICAL d03206A B# L20.9 Atopic dermatitis, unspecified A E0 A AMLODIPINE d00689A C I10 Essential (primary) hypertension A E@ A AMOXICILLIN; CLAVULANATE d00089A A0 J01.9 Acute sinusitis, unspecified A E@ A PREDNISONE d00350A A0 J01.9 Acute sinusitis, unspecified A EP A . . . E` A LANSOPRAZOLE d03828A B K21 Gastro-esophageal reflux disease A E` A RANITIDINE d00021A C K21 Gastro-esophageal reflux disease A Ep A ALBUTEROL d00749A CDp J45 Asthma A Ep A FLUTICASONE NASAL d04283A CDp J30.2 Other seasonal allergic rhinitis A E A . . . E A GLIPIZIDE d00246A C- E11 Type 2 diabetes mellitus A E A METFORMIN d03807A C- E11 Type 2 diabetes mellitus A E A . . . E A . . . E A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A@ E A ENTECAVIR d05525A Dc B19 Unspecified viral hepatitis A@ E A NEBIVOLOL d05265A CDp I49.9 Cardiac arrhythmia, unspecified A@ E A NIFEDIPINE d00051A D I10 Essential (primary) hypertension A@ E A . . . E A . . . E A ATORVASTATIN d04105A Dc 99999 A E A CETIRIZINE d03827A C- R52 Pain, unspecified A E A FLUOXETINE d00236A Dc 99999 A E A GABAPENTIN d03182A C- M79.2 Neuralgia and neuritis, unspecified A E A HYDROXYCHLOROQUINE d00817A C- 99999 A E A INSULIN ASPART d04697A D E11 Type 2 diabetes mellitus A E A INSULIN GLARGINE d04538A D E11 Type 2 diabetes mellitus A E A LISINOPRIL d00732A Dc 99999 A E A MELOXICAM d04532A C- M19.9 Osteoarthritis, unspecified site A E A MIRTAZAPINE d04025A Dc 99999 A E A OMEPRAZOLE d00325A Dc 99999 A E A . . . E A . . . E A AMOXICILLIN d00088A A J02 Acute pharyngitis A E0 A 99999 . . A E@ A AMLODIPINE d00689A C I10 Essential (primary) hypertension A E@ A ATORVASTATIN d04105A C 99999 A E@ A FLUOXETINE d00236A C F39 Unspecified mood [affective] disorder A E@ A FUROSEMIDE d00070A C R60.9 Edema, unspecified A E@ A GABAPENTIN d03182A C- E11.4 Type 2 diabetes mellitus with neurological complications A E@ A GLIMEPIRIDE d03864A C E11 Type 2 diabetes mellitus A E@ A LOSARTAN d03821A C I10 Essential (primary) hypertension A E@ A WARFARIN d00022A C D75.9P Prevent blood clots A EP A . . . E` A ESCITALOPRAM d04812A B* F32.9 Major depressive disorder, single episode, unspecified A0 E` A LABETALOL d00016A B 55555 A0 E` A NITROFURANTOIN d00112A B* N30 Cystitis A0 Ep A . . . E A . . . E A ACETAMINOPHEN; OXYCODONE d03431A D M25.5 M54 Pain in joint Dorsalgia A@ E A ATENOLOL d00004A Bz I49.9 Cardiac arrhythmia, unspecified A@ E A METHIMAZOLE d00290A Bz E05 Thyrotoxicosis [hyperthyroidism] A@ E A SUMATRIPTAN d03160A AP G43 Migraine A@ E A RANITIDINE d00021A B= K21 Gastro-esophageal reflux disease A E A LISINOPRIL d00732A D* I10 Essential (primary) hypertension A E A OMEPRAZOLE d00325A C K21 Gastro-esophageal reflux disease A E A . . . E A IRBESARTAN d04222A C I10 Essential (primary) hypertension AP E A LETROZOLE d04156A C C50 Malignant neoplasm of breast AP E A PIOGLITAZONE d04442A CDp E11 Type 2 diabetes mellitus AP E A ROSUVASTATIN d04851A D E78.0 Pure hypercholesterolemia AP E A SITAGLIPTIN d05896A C E11 Type 2 diabetes mellitus AP E A . . . E A . . . E A . . . E A AMOXICILLIN d00088A AP H66.9 J42 Otitis media, unspecified Unspecified chronic bronchitis A E A ALPRAZOLAM d00168A C[@ R45 Symptoms and signs involving emotional state A E0 A CYCLOBENZAPRINE d00963A D M62.83 Muscle spasm A` E0 A DULOXETINE d05355A C F32.9 F41.9 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified A` E0 A GABAPENTIN d03182A B G47.0 M79.2 M79.7 Insomnia Neuralgia and neuritis, unspecified Fibromyalgia A` E0 A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A C I10 Essential (primary) hypertension A` E0 A LOVASTATIN d00280A D E78.0 Pure hypercholesterolemia A` E0 A METFORMIN d03807A CP E11 Type 2 diabetes mellitus A` E@ A . . . EP A . . . E` A . . . Ep A ATORVASTATIN d04105A D E78.0 I21.P Pure hypercholesterolemia Prevent heart attack/myocardial infarction A@ Ep A LISINOPRIL d00732A D I10 Essential (primary) hypertension A@ Ep A METFORMIN d03807A D E11 Type 2 diabetes mellitus A@ Ep A METOPROLOL d00134A D I21.P Prevent heart attack/myocardial infarction A@ E A LISINOPRIL d00732A C I10 Essential (primary) hypertension A E A 99999 . . A E A LISINOPRIL d00732A0 C E78.0 Pure hypercholesterolemia A E A SIMVASTATIN d00746A0 C I10 Essential (primary) hypertension A E A BENZONATATE d00796A B J09 R05 Influenza due to certain identified influenza viruses Cough Ap E A DICLOFENAC d00848A CDp M19.9 Osteoarthritis, unspecified site Ap E A HYDROCHLOROTHIAZIDE d00253A D I10 Essential (primary) hypertension Ap E A LEVOTHYROXINE d00278A CDp I51.9P Prevent heart disease Ap E A LISINOPRIL d00732A D I21.P Prevent heart attack/myocardial infarction Ap E A MONTELUKAST d04289A C- J45 Asthma Ap E A TRAMADOL d03826A CDp M19.9 Osteoarthritis, unspecified site Ap E A BENAZEPRIL; HYDROCHLOROTHIAZIDE d03265A C[@ I10 Essential (primary) hypertension A E A MONTELUKAST d04289A C- R05 R09.81 Cough Nasal congestion A E A POTASSIUM CITRATE d01423A C N20.0 Calculus of kidney A E A . . . E A METOPROLOL d00134A C I10 Essential (primary) hypertension A@ E A OXYBUTYNIN d00328A B R35 Polyuria A@ E A PREDNISONE d00350A C- 55555 A@ E A TAMSULOSIN d04121A Ap B99.9 Unspecified infectious disease A@ E A HYDROCHLOROTHIAZIDE d00253A C- I10 Essential (primary) hypertension A E A . . . E A DABIGATRAN d07137A C I48.9 Unspecified atrial fibrillation and atrial flutter A E A DRONEDARONE d07458A C I48.9 Unspecified atrial fibrillation and atrial flutter A E A ESOMEPRAZOLE d04749A Dc K21 Gastro-esophageal reflux disease A E A FLUTICASONE NASAL d04283A Dc J30.2 Other seasonal allergic rhinitis A E A LEVOTHYROXINE d00278A D* E03.9 Hypothyroidism, unspecified A E A METOPROLOL d00134A C I48.9 Unspecified atrial fibrillation and atrial flutter A E A ROSUVASTATIN d04851A C E78.0 Pure hypercholesterolemia A E A TELMISARTAN d04364A C I48.9 Unspecified atrial fibrillation and atrial flutter A E0 A ATORVASTATIN d04105A D E78.0 Pure hypercholesterolemia A E0 A LISINOPRIL d00732A D I51.9P Prevent heart disease A E@ A . . . EP A . . . E` A . . . Ep A ACETAMINOPHEN; OXYCODONE d03431A B G89 Pain, not elsewhere classified A@ Ep A FLUCONAZOLE d00071A0 A B37 Candidiasis A@ Ep A ONDANSETRON d00867A A R11 Nausea and vomiting A@ Ep A SULFAMETHOXAZOLE; TRIMETHOPRIM d00124A B L08.9 Local infection of the skin and subcutaneous tissue, unspecified A@ E A . . . E A . . . E A . . . E A ALBUTEROL d00749A CDp R06.02 Shortness of breath AP E A CARVEDILOL d03847A D I10 Essential (primary) hypertension AP E A CITALOPRAM d04332A Dc F43.9 Reaction to severe stress, unspecified AP E A LISINOPRIL d00732A Dc I10 Essential (primary) hypertension AP E A LORAZEPAM d00149A Dc F41.9 Anxiety disorder, unspecified AP E A . . . E A . . . E A . . . E A . . . E A ATORVASTATIN d04105A B E78.0 Pure hypercholesterolemia A0 E A GLIPIZIDE d00246A B E11 Type 2 diabetes mellitus A0 E A METFORMIN; SITAGLIPTIN d06720A C- E11 Type 2 diabetes mellitus A0 E A . . . E A . . . E0 A DICLOFENAC TOPICAL d04722A B H93.9 Unspecified disorder of ear AP E0 A EZETIMIBE d04824A Cr E78.0 Pure hypercholesterolemia AP E0 A GABAPENTIN d03182A B M79.2 Neuralgia and neuritis, unspecified AP E0 A LIDOCAINE TOPICAL d00683A B[ H93.9 Unspecified disorder of ear AP E0 A SIMVASTATIN d00746A Cr E78.0 Pure hypercholesterolemia AP E@ A . . . EP A AMLODIPINE d00689A C[@ I10 Essential (primary) hypertension A@ EP A CEFDINIR d04256A A J01.9 Acute sinusitis, unspecified A@ EP A METOPROLOL d00134A CDp I10 Essential (primary) hypertension A@ EP A PRAVASTATIN d00348A C[@ E78.0 Pure hypercholesterolemia A@ E` A . . . Ep A . . . E A ACETAMINOPHEN; BUTALBITAL; CAFFEINE d03455A Ei M54 Dorsalgia A@ E A CYCLOBENZAPRINE d00963A B 99999 A@ E A HYDROCHLOROTHIAZIDE d00253A Ei 99999 A@ E A HYDROXYCHLOROQUINE d00817A C L93 Lupus erythematosus A@ E A ETHINYL ESTRADIOL; NORGESTIMATE d03781A Bz L70 Acne A E A . . . E A AMLODIPINE d00689A C I10 Essential (primary) hypertension A E A IRBESARTAN d04222A C I10 Essential (primary) hypertension A E A AMLODIPINE d00689A CDp I10 Essential (primary) hypertension A E A CYCLOBENZAPRINE d00963A CDp M62.83 Muscle spasm A E A GABAPENTIN d03182A CDp E11.4 Type 2 diabetes mellitus with neurological complications A E A HYDROCODONE d03075A CDp M54 Dorsalgia A E A LOSARTAN d03821A CDp I10 Essential (primary) hypertension A E A MYCOPHENOLATE MOFETIL d03839A CDp T86.9P Prevent transplanted organ and tissue rejection A E A OMEPRAZOLE d00325A CDp K30 Functional dyspepsia A E A SULFAMETHOXAZOLE; TRIMETHOPRIM d00124A CDp N28.9 Disorder of kidney and ureter, unspecified A E A TACROLIMUS d03752A CDp T86.9P Prevent transplanted organ and tissue rejection A E A TRAMADOL d03826A CDp M54 Dorsalgia A E A . . . E A AMPHETAMINE; DEXTROAMPHETAMINE d04035A CDp F90 Attention-deficit hyperactivity disorders A E A AMLODIPINE d00689A B I63 Cerebral infarction A E A . . . E A AMITRIPTYLINE d00146A B R19.7 Diarrhea, unspecified A E A . . . E0 A . . . E@ A . . . EP A . . . E` A . . . Ep A NORETHINDRONE d00555A B N92 Excessive, frequent and irregular menstruation A E A . . . E A . . . E A CLONIDINE d00044A C F43.1 G47.0 Post-traumatic stress disorder (PTSD) Insomnia A E A . . . E A ETORICOXIB h00039A C M25.9 Joint disorder, unspecified A E A LOSARTAN d03821A D I10 Essential (primary) hypertension A E A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E0 A HYDROCHLOROTHIAZIDE; LOSARTAN d03830A C I10 Essential (primary) hypertension A0 E0 A NABUMETONE d00310A C R52 Pain, unspecified A0 E0 A OMEPRAZOLE d00325A C K21 Gastro-esophageal reflux disease A0 E@ A . . . EP A CYANOCOBALAMIN d00413A Dc D64.9 E63.9 Anemia, unspecified Nutritional deficiency, unspecified A E` A ATORVASTATIN d04105A C- E78.0P Prevent high cholesterol A E` A LOSARTAN d03821A C I10 Essential (primary) hypertension A Ep A BUSPIRONE d00182A C- G40 Epilepsy and recurrent seizures A Ep A CARBAMAZEPINE d00058A C- F41.9 Anxiety disorder, unspecified A E A CETIRIZINE d03827A Cr T78.40 Allergy, unspecified A E A . . . E A . . . E A ETHINYL ESTRADIOL; NORETHINDRONE d03238A C- Z79.3 Long term (current) use of hormonal contraceptives A E A . . . E A HYDROCHLOROTHIAZIDE; LOSARTAN d03830A CDp I10 Essential (primary) hypertension A E A ROSUVASTATIN d04851A CDp E78.0 Pure hypercholesterolemia A E A . . . E A . . . E A ALBUTEROL d00749A D* J45 Asthma A E A BUPROPION d00181A C- F32.9 F41.9 F90 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified Attention-deficit hyperactivity disorders A E A ESTRADIOL d00537A C N95 Menopausal and other perimenopausal disorders A E A FLUOXETINE d00236A C& F32.9 F41.9 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified A E A FLUTICASONE; SALMETEROL d04611A D* J45 Asthma A E A LEVOTHYROXINE d00278A D E03.9 Hypothyroidism, unspecified A E A METFORMIN d03807A CDp E66 Overweight and obesity A E A MONTELUKAST d04289A CDp J30.9 J42 Allergic rhinitis, unspecified Unspecified chronic bronchitis A E A TOPIRAMATE d04115A CDp E66 F31.9 Overweight and obesity Bipolar disorder, unspecified A E A TRAZODONE d00395A C G47.0 G47.9 Insomnia Sleep disorder, unspecified A E A . . . E A TERBINAFINE d04012A B B35 Dermatophytosis A E0 A ACETAMINOPHEN; HYDROCODONE d03428A A M79.6 Pain in limb, hand, foot, fingers and toes Ap E0 A CETIRIZINE d03827A C R09.81 Nasal congestion Ap E0 A FENOFIBRATE d04286A C- E78.0P Prevent high cholesterol Ap E0 A LANSOPRAZOLE d03828A C K21 Gastro-esophageal reflux disease Ap E0 A METFORMIN d03807A Cr E11 Type 2 diabetes mellitus Ap E0 A METOPROLOL d00134A C I10.P Prevent hypertension Ap E0 A WARFARIN d00022A C Z95 Presence of cardiac and vascular implants and grafts Ap E@ A . . . EP A . . . E` A . . . Ep A . . . E A . . . E A . . . E A ACETAMINOPHEN; HYDROCODONE d03428A Cr M54 Dorsalgia A0 E A DIURETICS - UNSPECIFIED c00049A Dc R60.9 Edema, unspecified A0 E A LISINOPRIL d00732A Dc I10 Essential (primary) hypertension A0 E A CHLORTHALIDONE d00192A C I10 Essential (primary) hypertension A E A VENLAFAXINE d03181A C[@ F32.9 Major depressive disorder, single episode, unspecified A E A IRBESARTAN d04222A C- 99999 A E A PRAVASTATIN d00348A C- 99999 A E A . . . E A . . . E A CYCLOBENZAPRINE d00963A B M79.1 Myalgia A E A ALBUTEROL d00749A0 B R07.9 Chest pain, unspecified A E A APIXABAN d07804A0 Ei D75.9P Prevent blood clots A E A BUDESONIDE; FORMOTEROL d04795A0 Ei R06.2 Wheezing A E A DILTIAZEM d00045A0 Ei I10 Essential (primary) hypertension A E A FLUTICASONE d01296A0 C R07.9 Chest pain, unspecified A E A FUROSEMIDE d00070A0 DU I51.9 Heart disease, unspecified A E A LATANOPROST OPHTHALMIC d04017A0 Ei H40 Glaucoma A E A LEVOTHYROXINE d00278A0 DGJ E03.9 Hypothyroidism, unspecified A E A MECLIZINE d00859A0 Ei R42 Dizziness and giddiness A E A METFORMIN d03807A0 DGJ E11 Type 2 diabetes mellitus A E A METOPROLOL d00134A0 Ei 99999 A E A POTASSIUM CHLORIDE d00345A0 Ei 99999 A E A PRAVASTATIN d00348A0 Ei 99999 A E A TIMOLOL OPHTHALMIC d04037A0 D 99999 A E A TOPIRAMATE d04115A0 Ei 99999 A E A CLOPIDOGREL d04258A CDp I21.P Prevent heart attack/myocardial infarction AP E A FUROSEMIDE d00070A CDp R60.9 Edema, unspecified AP E A METOPROLOL d00134A CDp I10 Essential (primary) hypertension AP E A OXYBUTYNIN d00328A CDp N39.4 Other specified urinary incontinence AP E A SIMVASTATIN d00746A CDp E78.0 Pure hypercholesterolemia AP E A . . . E0 A . . . E@ A ALLOPURINOL d00023A Ei M1A Chronic gout A E@ A ATORVASTATIN d04105A Ei E78.0 Pure hypercholesterolemia A E@ A FUROSEMIDE d00070A Ei I50.9 Heart failure, unspecified A E@ A ISOSORBIDE MONONITRATE d00269A Ei I20.9 Angina pectoris, unspecified A E@ A MEMANTINE d04899A Ei R41 Other symptoms and signs involving cognitive functions and awareness A E@ A METOPROLOL d00134A Ei I51.9 Heart disease, unspecified A E@ A NIFEDIPINE d00051A Ei I10 Essential (primary) hypertension A E@ A OMEPRAZOLE d00325A Ei K31.9 Disease of stomach and duodenum, unspecified A E@ A SERTRALINE d00880A Ei 99999 A EP A ALLOPURINOL d00023A Cr M1A Chronic gout A0 EP A CLOBETASOL TOPICAL d01288A C L23 Allergic contact dermatitis A0 EP A ROSUVASTATIN d04851A Cr E78.0 Pure hypercholesterolemia A0 E` A . . . Ep A . . . E A FLUOXETINE d00236A B F41.9 Anxiety disorder, unspecified A E A TRAZODONE d00395A B= G47.0 Insomnia A E A CETIRIZINE d03827A C T78.40 Allergy, unspecified A E A . . . E A ESTRADIOL d00537A CDp N95 Z79.890 Menopausal and other perimenopausal disorders Hormone replacement therapy A0 E A PROGESTERONE d00550A CDp M81 N95 Osteoporosis without current pathological fracture Menopausal and other perimenopausal disorders A0 E A THYROID DESICCATED d00655A C E03.9 Hypothyroidism, unspecified A0 E A . . . E A . . . E A DOXYLAMINE; PYRIDOXINE d04654A B[ R11 Nausea and vomiting A0 E A LEVOTHYROXINE d00278A B E03.9 Hypothyroidism, unspecified A0 E A PROGESTERONE d00550A A Z79.890 Hormone replacement therapy A0 E A . . . E A . . . E A BUPROPION d00181A C F32.9 F41.9 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified A@ E A CHLORHEXIDINE TOPICAL d01231A D A49.9P Prevent bacterial infection A@ E A FLUOCINOLONE OTIC d06032A DGJ H93.9 Unspecified disorder of ear A@ E A FLUTICASONE NASAL d04283A D9 J30.9 Allergic rhinitis, unspecified A@ E A . . . E0 A . . . E@ A CETIRIZINE d03827A A J00 Acute nasopharyngitis [common cold] A EP A ESCITALOPRAM d04812A A F32.9 F41.9 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified A` EP A INSULIN DETEMIR d05436A Dc E11 Type 2 diabetes mellitus A` EP A LISINOPRIL d00732A C I10 Essential (primary) hypertension A` EP A METFORMIN d03807A Dc E11 Type 2 diabetes mellitus A` EP A NAPROXEN d00019A C M79.1 Myalgia A` EP A PRAVASTATIN d00348A C E78.0 Pure hypercholesterolemia A` E` A CITALOPRAM d04332A B F32.9 Major depressive disorder, single episode, unspecified A Ep A ALENDRONATE d03849A C M81 Osteoporosis without current pathological fracture A Ep A BENZONATATE d00796A C J42 Unspecified chronic bronchitis A Ep A BUTALBITAL d03061A C G43 Migraine A Ep A FENTANYL d00233A C 55555 A Ep A FLUTICASONE d01296A C R06.2 Wheezing A Ep A IBUPROFEN d00015A C- M54 Dorsalgia A Ep A LIDOCAINE TOPICAL d00683A B M79.2 Neuralgia and neuritis, unspecified A Ep A MONTELUKAST d04289A DU J30.9 Allergic rhinitis, unspecified A Ep A PRAMIPEXOLE d04145A Dc R25 Abnormal involuntary movements A Ep A ZOLPIDEM d00910A Cr G47.0 Insomnia A E A . . . E A . . . E A SIMVASTATIN d00746A C I70 Atherosclerosis A E A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia AP E A FLUTICASONE NASAL d04283A B J30.2 Other seasonal allergic rhinitis AP E A LOSARTAN d03821A C I10 Essential (primary) hypertension AP E A METOPROLOL d00134A C I10 Essential (primary) hypertension AP E A NIFEDIPINE d00051A C I10 Essential (primary) hypertension AP E A . . . E A . . . E A . . . E A ALBUTEROL d00749A CDp J45 Asthma A` E A AMLODIPINE d00689A C[@ I10 Essential (primary) hypertension A` E A LEVETIRACETAM d04499A B= G40 Epilepsy and recurrent seizures A` E A LOSARTAN d03821A C I10 Essential (primary) hypertension A` E A METOPROLOL d00134A C I10 Essential (primary) hypertension A` E A OMEPRAZOLE d00325A D K21 Gastro-esophageal reflux disease A` E A AMANTADINE d00086A CDp G25.81 Restless legs syndrome Ap E A BETHANECHOL d01427A C[@ R39.1 Other difficulties with micturition Ap E A GABAPENTIN d03182A CDp M54 Dorsalgia Ap E A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified Ap E A PANTOPRAZOLE d04514A C- R12 Heartburn Ap E A ROSUVASTATIN d04851A C E78.0 Pure hypercholesterolemia Ap E A TRAZODONE d00395A C M54 Dorsalgia Ap E A LEVETIRACETAM d04499A D G40 Epilepsy and recurrent seizures A E A . . . E0 A . . . E@ A AMLODIPINE d00689A CDp I10 Essential (primary) hypertension A E@ A LISINOPRIL d00732A CDp I10 Essential (primary) hypertension A EP A ESCITALOPRAM d04812A Cr F32.9 Major depressive disorder, single episode, unspecified A EP A LORAZEPAM d00149A Cr F41.9 Anxiety disorder, unspecified A E` A . . . Ep A . . . E A . . . E A . . . E A . . . E A . . . E A LEVOTHYROXINE d00278A DU E03.9 Hypothyroidism, unspecified A@ E A MEMANTINE d04899A C G30.9 G31.9 Alzheimer's disease, unspecified Degenerative disease of nervous system, unspecified A@ E A PAROXETINE d03157A Dc F32.9 Major depressive disorder, single episode, unspecified A@ E A SIMVASTATIN d00746A D E78.0 Pure hypercholesterolemia A@ E A DOCUSATE d01021A A K59.0 Constipation A E A IBUPROFEN d00015A B K08.8 Other specified disorders of teeth and supporting structures A E A . . . E A ATENOLOL d00004A C I10 Essential (primary) hypertension A@ E A ATROPINE; DIPHENOXYLATE d03506A Cr R19.7 Diarrhea, unspecified A@ E A ESOMEPRAZOLE d04749A Cr K21 Gastro-esophageal reflux disease A@ E A HYDROCHLOROTHIAZIDE; TRIAMTERENE d03052A C I10 Essential (primary) hypertension A@ E A . . . E A PROGESTERONE d00550A Ap E34.9 Endocrine disorder, unspecified A E A . . . E0 A ETHINYL ESTRADIOL; LEVONORGESTREL d03242A CDp N92 Excessive, frequent and irregular menstruation A E0 A MINOCYCLINE d00110A B[ L70 Acne A E@ A . . . EP A . . . E` A CIPROFLOXACIN; HYDROCORTISONE OTIC d04288A AP H60 Otitis externa A E` A FLUTICASONE NASAL d04283A C J30.9 Allergic rhinitis, unspecified A E` A LEVOCETIRIZINE d05851A C T78.40 Allergy, unspecified A E` A LISINOPRIL d00732A D I10 Essential (primary) hypertension A E` A METFORMIN d03807A C R73 Elevated blood glucose level A E` A MONTELUKAST d04289A Dc T78.40 Allergy, unspecified A E` A NIFEDIPINE d00051A D I10 Essential (primary) hypertension A E` A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia A E` A SPIRONOLACTONE d00373A B L70 Acne A Ep A 77777 . . A E A MUPIROCIN TOPICAL d01267A A L08.9 Local infection of the skin and subcutaneous tissue, unspecified A E A . . . E A ATORVASTATIN d04105A Cr E78.0 Pure hypercholesterolemia AP E A CLONAZEPAM d00197A C F32.9 G47.9 Major depressive disorder, single episode, unspecified Sleep disorder, unspecified AP E A FLUOXETINE d00236A C F41.9 Anxiety disorder, unspecified AP E A METOPROLOL d00134A Cr I10 Essential (primary) hypertension AP E A OMEPRAZOLE d00325A C K21 Gastro-esophageal reflux disease AP E A CARVEDILOL d03847A Cr I10 Essential (primary) hypertension Ap E A EMPAGLIFLOZIN d08275A C E11 Type 2 diabetes mellitus Ap E A FUROSEMIDE d00070A C R60.9 Edema, unspecified Ap E A INSULIN ASPART d04697A C E11 Type 2 diabetes mellitus Ap E A NIFEDIPINE d00051A C I10 Essential (primary) hypertension Ap E A OXYBUTYNIN d00328A C[@ N32.81 Overactive bladder Ap E A PRAVASTATIN d00348A C E78.0 Pure hypercholesterolemia Ap E A ALPRAZOLAM d00168A D= F32.9 F41.9 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified A E A ATORVASTATIN d04105A D* E78.0 Pure hypercholesterolemia A E A ESOMEPRAZOLE d04749A D* K21 Gastro-esophageal reflux disease A E A EZETIMIBE d04824A C E78.0 Pure hypercholesterolemia A E A LEVOTHYROXINE d00278A D= E03.9 Hypothyroidism, unspecified A E A LOSARTAN d03821A B= I10 Essential (primary) hypertension A E A RANITIDINE d00021A B= K21 Gastro-esophageal reflux disease A E A SERTRALINE d00880A D= F32.9 Major depressive disorder, single episode, unspecified A E A . . . E A ATENOLOL d00004A Ei I10 Essential (primary) hypertension A` E A LEVOTHYROXINE d00278A Ei E03.9 Hypothyroidism, unspecified A` E A OXYCODONE d00329A Cr T14.9 Unspecified injury A` E A SERTRALINE d00880A C- F32.9 Major depressive disorder, single episode, unspecified A` E A SPIRONOLACTONE d00373A Ei R60.9 Edema, unspecified A` E A ZOLPIDEM d00910A Ei G47.0 Insomnia A` E A OMEPRAZOLE d00325A B[ B96.81 Helicobacter pylori [H. pylori] as the cause of diseases classified elsewhere A E A . . . E A LISINOPRIL d00732A C- I10 Essential (primary) hypertension A0 E A LORAZEPAM d00149A D# F41.9 Anxiety disorder, unspecified A0 E A TAMSULOSIN d04121A C- N40 Enlarged prostate A0 E A ALBUTEROL d00749A C[@ J45 Asthma A E0 A OFLOXACIN OPHTHALMIC d03977A Ap H10 Conjunctivitis A E0 A SULFAMETHOXAZOLE; TRIMETHOPRIM d00124A Ap A49.9 Bacterial infection, unspecified A E@ A . . . EP A AMOXICILLIN d00088A A H66.9 Otitis media, unspecified A EP A CEFDINIR d04256A A H66.9 Otitis media, unspecified A E` A . . . Ep A . . . E A DIGOXIN d00210A CDp I48.9 I49.9 Unspecified atrial fibrillation and atrial flutter Cardiac arrhythmia, unspecified A E A GABAPENTIN d03182A B[ M79.2 Neuralgia and neuritis, unspecified A E A GLIMEPIRIDE d03864A Cr E11 Type 2 diabetes mellitus A E A INSULIN GLARGINE d04538A Cr E11 Type 2 diabetes mellitus A E A METOPROLOL d00134A Cr I48.9 I50.9 Unspecified atrial fibrillation and atrial flutter Heart failure, unspecified A E A SACUBITRIL; VALSARTAN d08369A B I50.9 Heart failure, unspecified A E A SERTRALINE d00880A Cr F32.9 Major depressive disorder, single episode, unspecified A E A SIMVASTATIN d00746A CP E78.0 Pure hypercholesterolemia A E A WARFARIN d00022A Cr I48.9 Unspecified atrial fibrillation and atrial flutter A E A . . . E A . . . E A . . . E A . . . E A . . . E A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia Ap E A BENAZEPRIL d00730A C I10 Essential (primary) hypertension Ap E A INSULIN ASPART d04697A Dc E11 Type 2 diabetes mellitus Ap E A INSULIN GLARGINE d04538A Dc E11 Type 2 diabetes mellitus Ap E A METFORMIN d03807A C E11 R73 Type 2 diabetes mellitus Elevated blood glucose level Ap E A METOPROLOL d00134A C I10 Essential (primary) hypertension Ap E A OMEPRAZOLE d00325A B K21 Gastro-esophageal reflux disease Ap E A . . . E A . . . E A . . . E A . . . E0 A FLUTICASONE; SALMETEROL d04611A Dc J45 Asthma A E@ A . . . EP A HYDROCHLOROTHIAZIDE d00253A C- I10 Essential (primary) hypertension A0 EP A PRAVASTATIN d00348A C E78.0 Pure hypercholesterolemia A0 EP A PROPRANOLOL d00032A C- R25.1 Tremor, unspecified A0 E` A LOSARTAN d03821A C- I10 Essential (primary) hypertension A Ep A . . . E A . . . E A . . . E A . . . E A AMLODIPINE d00689A D I10 Essential (primary) hypertension A E A ATENOLOL d00004A D I10 Essential (primary) hypertension A E A DOXYCYCLINE d00037A Ap L08.9 Local infection of the skin and subcutaneous tissue, unspecified A E A FLUOXETINE d00236A D* F32.9 Major depressive disorder, single episode, unspecified A E A FUROSEMIDE d00070A Cr R60.9 Edema, unspecified A E A GABAPENTIN d03182A Cr M54 Dorsalgia A E A LISINOPRIL d00732A D I10 Essential (primary) hypertension A E A METFORMIN d03807A C E11 Type 2 diabetes mellitus A E A METHIMAZOLE d00290A C- E05 Thyrotoxicosis [hyperthyroidism] A E A POTASSIUM CHLORIDE d00345A D E87.6P Prevent hypokalemia A E A PRAVASTATIN d00348A C E78.0 Pure hypercholesterolemia A E A LOSARTAN d03821A D# I10 Essential (primary) hypertension A E A ALENDRONATE d03849A C M81 Osteoporosis without current pathological fracture A E A AMLODIPINE d00689A C- I10 Essential (primary) hypertension A E A DIAZEPAM d00148A C F33.9 Major depressive disorder, recurrent, unspecified A E A DICYCLOMINE d00999A C[@ K58 Irritable bowel syndrome A E A DULOXETINE d05355A Cr F32.9 Major depressive disorder, single episode, unspecified A E A ISOSORBIDE MONONITRATE d00269A B I21.P Prevent heart attack/myocardial infarction A E A LEVOTHYROXINE d00278A D# E03.9 Hypothyroidism, unspecified A E A OMEPRAZOLE d00325A CDp K27 Peptic ulcer, site unspecified A E A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia A E A ZOLPIDEM d00910A C G47.0 Insomnia A E A . . . E A . . . E A CARBIDOPA; LEVODOPA d03473A C- R25.1 Tremor, unspecified A E A DONEPEZIL d04099A Ap R41 Other symptoms and signs involving cognitive functions and awareness A E A ESCITALOPRAM d04812A C F32.9 Major depressive disorder, single episode, unspecified A E A HYDROCHLOROTHIAZIDE d00253A C I10 Essential (primary) hypertension A E A LEVOTHYROXINE d00278A CDp E03.9 Hypothyroidism, unspecified A E A LOSARTAN d03821A C I10 Essential (primary) hypertension A E A MEMANTINE d04899A B R41 Other symptoms and signs involving cognitive functions and awareness A E A MIRABEGRON d07876A B R32 Unspecified urinary incontinence A E A OXYBUTYNIN d00328A A R32 Unspecified urinary incontinence A E A PROPRANOLOL d00032A B R25.1 Tremor, unspecified A E A TAMSULOSIN d04121A C N40 Enlarged prostate A E A . . . E A . . . E0 A . . . E@ A . . . EP A . . . E` A . . . Ep A . . . E A LOSARTAN d03821A C I10 Essential (primary) hypertension A E A BECLOMETHASONE d00760A CDp J45 Asthma A0 E A CETIRIZINE d03827A C J30.9 J45 Allergic rhinitis, unspecified Asthma A0 E A FLUTICASONE NASAL d04283A C J30.9 Allergic rhinitis, unspecified A0 E A . . . E A . . . E A . . . E A . . . E A HYDROCHLOROTHIAZIDE; OLMESARTAN d04878A Ap I10 Essential (primary) hypertension A0 E A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified A0 E A VALSARTAN d04113A Cr I10 Essential (primary) hypertension A0 E A . . . E A . . . E A . . . E A RANITIDINE d00021A B= K21 Gastro-esophageal reflux disease A E0 A . . . E@ A . . . EP A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A Cr I10 Essential (primary) hypertension AP EP A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified AP EP A MECLIZINE d00859A D= R42 Dizziness and giddiness AP EP A ONDANSETRON d00867A Cr R11 Nausea and vomiting AP EP A PAROXETINE d03157A D= F32.9 Major depressive disorder, single episode, unspecified AP E` A CITALOPRAM d04332A C F41.9 Anxiety disorder, unspecified A E` A LISINOPRIL d00732A C I10 Essential (primary) hypertension A Ep A . . . E A . . . E A DICLOFENAC d00848A B= M79.1 Myalgia A E A HYDROCHLOROTHIAZIDE d00253A C I10 Essential (primary) hypertension A E A . . . E A . . . E A AMLODIPINE d00689A CDp I10 Essential (primary) hypertension AP E A AZELASTINE NASAL d04068A C- J30.1 R09.81 Allergic rhinitis due to pollen Nasal congestion AP E A LOSARTAN d03821A CDp I10 Essential (primary) hypertension AP E A METOPROLOL d00134A C Z79 Long term (current) drug therapy AP E A ROSUVASTATIN d04851A C E78.0 Pure hypercholesterolemia AP E A LEVOTHYROXINE d00278A Cr E03.9 Hypothyroidism, unspecified A0 E A METFORMIN d03807A C E11 Type 2 diabetes mellitus A0 E A TIMOLOL OPHTHALMIC d04037A C H40 Glaucoma A0 E A ASPIRIN d00170A C- Z79.0 Long term (current) use of anticoagulants and antithrombotics/antiplatelets A@ E A CARVEDILOL d03847A C- I10 I50.9 Essential (primary) hypertension Heart failure, unspecified A@ E A FUROSEMIDE d00070A C- I51.9 R60.9 Heart disease, unspecified Edema, unspecified A@ E A TRIAMCINOLONE TOPICAL d03206A C L23 Allergic contact dermatitis A@ E A . . . E A ESTRADIOL TOPICAL d04210A C N95 Menopausal and other perimenopausal disorders Ap E A FLUTICASONE; VILANTEROL d08100A B[ J45 Asthma Ap E A HYOSCYAMINE d00985A C K58 Irritable bowel syndrome Ap E A SUMATRIPTAN d03160A Cr G43 Migraine Ap E A TIOTROPIUM d04829A B[ J45 Asthma Ap E A TRAMADOL d03826A C M19.9 M25.5 M54 Osteoarthritis, unspecified site Pain in joint Dorsalgia Ap E A ZAFIRLUKAST d04053A B= J45 Asthma Ap E A . . . E A AMLODIPINE d00689A Dc I10 Essential (primary) hypertension A` E A FLUTICASONE NASAL d04283A C J30.2 Other seasonal allergic rhinitis A` E A IBUPROFEN d00015A D M54 M79.1 R51 Dorsalgia Myalgia Headache A` E A RABEPRAZOLE d04448A C K21 Gastro-esophageal reflux disease A` E A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia A` E A TELMISARTAN d04364A Dc I10 Essential (primary) hypertension A` E0 A AMLODIPINE d00689A Cr I10 Essential (primary) hypertension A E@ A CARVEDILOL d03847A CDp I51.9 Heart disease, unspecified A E@ A CYCLOBENZAPRINE d00963A C[@ M62.83 Muscle spasm A E@ A DAPAGLIFLOZIN d07928A CDp E11 Type 2 diabetes mellitus A E@ A HYDROCHLOROTHIAZIDE d00253A CDp R60.9 Edema, unspecified A E@ A LISINOPRIL d00732A C I10 Essential (primary) hypertension A E@ A METFORMIN; SITAGLIPTIN d06720A C- E11 Type 2 diabetes mellitus A E@ A NISOLDIPINE d03825A C I10 Essential (primary) hypertension A E@ A ROSUVASTATIN d04851A C[@ E78.0 Pure hypercholesterolemia A E@ A TESTOSTERONE d00558A C[@ E29.1 Testicular hypofunction A EP A . . . E` A LEVOTHYROXINE d00278A C E07.9 Disorder of thyroid, unspecified A0 E` A OMEPRAZOLE d00325A B K21 Gastro-esophageal reflux disease A0 E` A TAMSULOSIN d04121A B R35 Polyuria A0 Ep A HALOPERIDOL d00027A C P G31.9 R25 Degenerative disease of nervous system, unspecified Abnormal involuntary movements Ap Ep A HYOSCYAMINE d00985A B R09.3 Abnormal sputum Ap Ep A LACTULOSE d01024A B K59.0 Constipation Ap Ep A LISINOPRIL d00732A C I10 Essential (primary) hypertension Ap Ep A LORAZEPAM d00149A C F41.9 Anxiety disorder, unspecified Ap Ep A MORPHINE d00308A B M79.1 R52 Myalgia Pain, unspecified Ap Ep A OXYCODONE d00329A B5 M79.1 Myalgia Ap E A ETHINYL ESTRADIOL; NORGESTIMATE d03781A C N92 Excessive, frequent and irregular menstruation A E A AMOXICILLIN d00088A A K08.4 Partial loss of teeth A@ E A CLONIDINE d00044A B F41.9 Anxiety disorder, unspecified A@ E A LAMOTRIGINE d03809A B F39 Unspecified mood [affective] disorder A@ E A QUETIAPINE d04220A B G47.0 Insomnia A@ E A . . . E A . . . E A ATORVASTATIN d04105A C 99999 A@ E A BENZTROPINE d00175A C 99999 A@ E A BUDESONIDE; FORMOTEROL d04795A C J45 R05 Asthma Cough A@ E A OLANZAPINE d04050A C F20 Schizophrenia A@ E A ATORVASTATIN d04105A Cf E78.0 Pure hypercholesterolemia AP E A LISINOPRIL d00732A Dc I10 Essential (primary) hypertension AP E A METOPROLOL d00134A Cf I10 Essential (primary) hypertension AP E A SULFASALAZINE d00379A D; K51 Ulcerative colitis AP E A TRIAMCINOLONE TOPICAL d03206A B L23 Allergic contact dermatitis AP E A . . . E A . . . E A ATENOLOL d00004A C I10 Essential (primary) hypertension AP E A FLUTICASONE NASAL d04283A Dc R09.81 Nasal congestion AP E A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified AP E A LOSARTAN d03821A C I10 Essential (primary) hypertension AP E A SERTRALINE d00880A C[@ F32.9 Major depressive disorder, single episode, unspecified AP E A . . . E A . . . E0 A . . . E@ A METHYLPHENIDATE d00900A C"@ F90 Attention-deficit hyperactivity disorders A EP A . . . E` A . . . Ep A . . . E A . . . E A AMPHETAMINE; DEXTROAMPHETAMINE d04035A0 CDp F90 Attention-deficit hyperactivity disorders A0 E A CYPROHEPTADINE d00790A C- R63 Symptoms and signs concerning food and fluid intake A0 E A FLUOXETINE d00236A B F32.9 F39 Major depressive disorder, single episode, unspecified Unspecified mood [affective] disorder A0 E A . . . E A . . . E A RIZATRIPTAN d04328A CP G43 Migraine A E A . . . E A . . . E A NAPROXEN d00019A D% G43 M25.5 T14.9 Migraine Pain in joint Unspecified injury A E A ATORVASTATIN d04105A C- E78.0 Pure hypercholesterolemia A E A LISINOPRIL d00732A Bz I10 Essential (primary) hypertension A E A . . . E A . . . E0 A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia AP E0 A CITALOPRAM d04332A Cr F41.9 Anxiety disorder, unspecified AP E0 A FENOFIBRATE d04286A C E78.1 Pure hyperglyceridemia AP E0 A HYDROCHLOROTHIAZIDE; TRIAMTERENE d03052A C I10 Essential (primary) hypertension AP E0 A LEVOTHYROXINE d00278A D9 E03.9 Hypothyroidism, unspecified AP E@ A . . . EP A . . . E` A . . . Ep A . . . E A . . . E A . . . E A . . . E A . . . E A AMLODIPINE d00689A C I10 Essential (primary) hypertension A E A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A E A . . . E A . . . E A INSULIN DETEMIR d05436A C- E11 Type 2 diabetes mellitus A@ E A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified A@ E A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified A@ E A LOSARTAN d03821A CDp I10 Essential (primary) hypertension A@ E A . . . E A . . . E A . . . E0 A BUDESONIDE; FORMOTEROL d04795A CDp J44.9 Chronic obstructive pulmonary disease, unspecified A` E0 A DABIGATRAN d07137A C D75.9P Prevent blood clots A` E0 A GABAPENTIN d03182A C- M79.2 Neuralgia and neuritis, unspecified A` E0 A LISINOPRIL d00732A Dc I10 Essential (primary) hypertension A` E0 A OMEPRAZOLE d00325A C- K21 Gastro-esophageal reflux disease A` E0 A POTASSIUM CHLORIDE d00345A B E87.6 Hypokalemia A` E@ A . . . EP A . . . E` A 99999 . . A E` A SULFAMETHOXAZOLE; TRIMETHOPRIM d00124A A L08.9 Local infection of the skin and subcutaneous tissue, unspecified A Ep A LOSARTAN d03821A C I10 Essential (primary) hypertension A@ Ep A PANTOPRAZOLE d04514A Cr K21 Gastro-esophageal reflux disease A@ Ep A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia A@ Ep A TAMSULOSIN d04121A C R35 Polyuria A@ E A . . . E A . . . E A . . . E A TRIAMCINOLONE TOPICAL d03206A B[ L20.9 Atopic dermatitis, unspecified A E A . . . E A . . . E A 77777 . . A E A ATORVASTATIN d04105A CDp E78.0 Pure hypercholesterolemia A E A SILDENAFIL d04299A C N52.9 Male erectile dysfunction, unspecified A E A CLOPIDOGREL d04258A C[@ I63 Cerebral infarction Ap E A DULAGLUTIDE d08290A C- E11.P Prevent diabetes Ap E A LOSARTAN d03821A C I63.P Prevent stroke Ap E A METFORMIN d03807A C- E11 Type 2 diabetes mellitus Ap E A METOPROLOL d00134A C I10 Essential (primary) hypertension Ap E A SIMVASTATIN d00746A D E78.0 Pure hypercholesterolemia Ap E A TAMSULOSIN d04121A C N40 Enlarged prostate Ap E A AMITRIPTYLINE d00146A Cr M79.2 Neuralgia and neuritis, unspecified A E A CARVEDILOL d03847A C I21.P I50.9 Prevent heart attack/myocardial infarction Heart failure, unspecified A E A CLOPIDOGREL d04258A Cr D75.9P I21 Prevent blood clots ST elevation (STEMI) and non-ST elevation (NSTEMI) myocardial infarction A E A DILTIAZEM d00045A Cr I20.9 I21 Angina pectoris, unspecified ST elevation (STEMI) and non-ST elevation (NSTEMI) myocardial infarction A E A EZETIMIBE; SIMVASTATIN d05348A B E78.0 Pure hypercholesterolemia A E A FUROSEMIDE d00070A B R60.9 Edema, unspecified A E A LEVOTHYROXINE d00278A Cr E03.9 Hypothyroidism, unspecified A E A LISINOPRIL d00732A C I10 Essential (primary) hypertension A E A METFORMIN d03807A Cr E11 Type 2 diabetes mellitus A E A OMEPRAZOLE d00325A C K21 K30 Gastro-esophageal reflux disease Functional dyspepsia A E A PIOGLITAZONE d04442A C E11 Type 2 diabetes mellitus A E A ROPINIROLE d04215A CDp G25.81 Restless legs syndrome A E A SITAGLIPTIN d05896A B E11 Type 2 diabetes mellitus A E A TOPIRAMATE d04115A C G43 Migraine A E A VENLAFAXINE d03181A C[@ E11.4 Type 2 diabetes mellitus with neurological complications A E A . . . E0 A ACETAMINOPHEN; OXYCODONE d03431A C M25.5 M54 Pain in joint Dorsalgia Ap E0 A ATORVASTATIN d04105A Cr E78.0 Pure hypercholesterolemia Ap E0 A BISOPROLOL d00709A Cr I10 Essential (primary) hypertension Ap E0 A FAMOTIDINE d00141A C- K21 Gastro-esophageal reflux disease Ap E0 A LETROZOLE d04156A C- C80.1 Malignant (primary) neoplasm, unspecified Ap E0 A MONTELUKAST d04289A C[@ J45 Asthma Ap E0 A PIOGLITAZONE d04442A B E11 Type 2 diabetes mellitus Ap E@ A . . . EP A TRIAMTERENE d00396A Cr I10 Essential (primary) hypertension A E` A . . . Ep A . . . E A FLUTICASONE; SALMETEROL d04611A CDp J45 Asthma A E A LEVALBUTEROL d04427A Cr J45 Asthma A E A . . . E A . . . E A . . . E A . . . E A ETHINYL ESTRADIOL; NORGESTIMATE d03781A C- N94 Z79.3 Pain and other conditions associated with female genital organs and menstrual cycle Long term (current) use of hormonal contraceptives A E A LEVOTHYROXINE d00278A B E03.9 Hypothyroidism, unspecified A E A . . . E A ATENOLOL; CHLORTHALIDONE d03258A C- I10 Essential (primary) hypertension A E A CALCIUM ACETATE d03689A D N18.9 Chronic kidney disease, unspecified A E A CINACALCET d05218A D N19 Unspecified kidney failure A E A . . . E A ALPRAZOLAM d00168A C- F41.9 Anxiety disorder, unspecified A0 E A SILDENAFIL d04299A C E29.1 N52.9 Testicular hypofunction Male erectile dysfunction, unspecified A0 E A TESTOSTERONE d00558A B E29.1 Testicular hypofunction A0 E0 A ALBUTEROL d00749A C J44.9 J45 Chronic obstructive pulmonary disease, unspecified Asthma Ap E0 A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia Ap E0 A BUSPIRONE d00182A B= F41.9 Anxiety disorder, unspecified Ap E0 A METFORMIN d03807A C- E11 Type 2 diabetes mellitus Ap E0 A MIRTAZAPINE d04025A B= F32.9 G47.0 Major depressive disorder, single episode, unspecified Insomnia Ap E0 A PANTOPRAZOLE d04514A C R12 Heartburn Ap E0 A TOPIRAMATE d04115A B= F41.9 Anxiety disorder, unspecified Ap E@ A AMLODIPINE d00689A C I10 Essential (primary) hypertension A E@ A CARVEDILOL d03847A C- 99999 A E@ A CLONIDINE d00044A C I10 Essential (primary) hypertension A E@ A HYDRALAZINE d00132A C I10 Essential (primary) hypertension A E@ A INSULIN GLARGINE d04538A D R73 Elevated blood glucose level A E@ A INSULIN ISOPHANE; INSULIN REGULAR d04374A CDp R73 Elevated blood glucose level A E@ A LOSARTAN d03821A C I10 Essential (primary) hypertension A E@ A PRAVASTATIN d00348A C E78.0 Pure hypercholesterolemia A E@ A RANITIDINE d00021A C K27 Peptic ulcer, site unspecified A E@ A TAMSULOSIN d04121A C N40 Enlarged prostate A EP A . . . E` A ESOMEPRAZOLE d04749A C- K30 Functional dyspepsia A Ep A . . . E A NAPROXEN d00019A B[ M79.1 T14.9 Myalgia Unspecified injury A E A . . . E A AMLODIPINE d00689A D' I10 Essential (primary) hypertension A0 E A HYDROCHLOROTHIAZIDE d00253A D* I10 R60.9 Essential (primary) hypertension Edema, unspecified A0 E A RAMIPRIL d00728A D* I10 Essential (primary) hypertension A0 E A . . . E A . . . E A ESTRADIOL d00537A C Z79.890 Hormone replacement therapy A E A PROGESTERONE d00550A C Z79.890 Hormone replacement therapy A E A . . . E A . . . E A . . . E A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A0 E A LATANOPROST OPHTHALMIC d04017A CDp H40 Glaucoma A0 E A TAMSULOSIN d04121A CDp N40 Enlarged prostate A0 E A . . . E0 A . . . E@ A AZELASTINE NASAL d04068A B[ J02 Acute pharyngitis AP E@ A FLUOXETINE d00236A C- F32.9 Major depressive disorder, single episode, unspecified AP E@ A FLUTICASONE NASAL d04283A B J02 Acute pharyngitis AP E@ A HYDROCHLOROTHIAZIDE; TRIAMTERENE d03052A Dc I10 Essential (primary) hypertension AP E@ A QUINAPRIL d00365A Dc I10 Essential (primary) hypertension AP EP A . . . E` A . . . Ep A DULAGLUTIDE d08290A C- E11 Type 2 diabetes mellitus A Ep A METFORMIN d03807A C[@ E11 Type 2 diabetes mellitus A E A . . . E A . . . E A ACETAMINOPHEN; OXYCODONE d03431A B= G89 T14.9 Pain, not elsewhere classified Unspecified injury A E A LEVOTHYROXINE d00278A C E04 Other nontoxic goiter A E A CITALOPRAM d04332A CDp F32.9 F41.9 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified A E A ETHINYL ESTRADIOL; NORETHINDRONE d03238A C[@ Z79.3 Long term (current) use of hormonal contraceptives A E A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E0 A ASPIRIN d00170A C I21.P Prevent heart attack/myocardial infarction A@ E0 A CHLORTHALIDONE d00192A B R60.9 Edema, unspecified A@ E0 A DONEPEZIL d04099A B I10 Essential (primary) hypertension A@ E0 A LOSARTAN d03821A B[ G31.9 Degenerative disease of nervous system, unspecified A@ E@ A . . . EP A . . . E` A ATORVASTATIN d04105A C[@ E78.0 Pure hypercholesterolemia A E` A LOSARTAN d03821A C[@ I10 Essential (primary) hypertension A Ep A . . . E A . . . E A . . . E A . . . E° A CEPHALEXIN d00096A B M25.9 Joint disorder, unspecified A E A ETHINYL ESTRADIOL; NORETHINDRONE d03238A Dc Z79.3 Long term (current) use of hormonal contraceptives A E A LISINOPRIL d00732A B I10 Essential (primary) hypertension A E A . . . E A . . . E A . . . E A ESCITALOPRAM d04812A B F41.9 Anxiety disorder, unspecified A E A . . . E A . . . E0 A ATORVASTATIN d04105A Dc E78.0 Pure hypercholesterolemia A@ E0 A CITALOPRAM d04332A C F32.9 F41.9 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified A@ E0 A LISINOPRIL d00732A Cr I10 Essential (primary) hypertension A@ E0 A TAMSULOSIN d04121A C R35 Polyuria A@ E@ A . . . EP A LEVOTHYROXINE d00278A D E03.9 Hypothyroidism, unspecified A EP A REPAGLINIDE d04267A C E11 Type 2 diabetes mellitus A E` A OLMESARTAN d04801A CDp I10 Essential (primary) hypertension A Ep A MOXIFLOXACIN OPHTHALMIC d04860A Ap H10 Conjunctivitis A EÀ A MOMETASONE NASAL d04223A CDp R09.8 Other specified symptoms and signs involving the circulatory and respiratory systems A EÐ A FLUORIDE TOPICAL d04397A B K02 Dental caries A Eà A . . . Eð A . . . E A . . . E A . . . E A . . . E A CONTRACEPTIVES - UNSPECIFIED c00102A Dc N92 Z79.3 Excessive, frequent and irregular menstruation Long term (current) use of hormonal contraceptives A E A MONTELUKAST d04289A C J45 Asthma A E A . . . E A AMOXICILLIN d00088A AP J40 Bronchitis, not specified as acute or chronic A E A ALLOPURINOL d00023A D M1A Chronic gout A E A CLOPIDOGREL d04258A C- D75.9P Prevent blood clots A E A COLESTIPOL d00744A Dc K31.9 Disease of stomach and duodenum, unspecified A E A FUROSEMIDE d00070A D R60.9 Edema, unspecified A E A METOPROLOL d00134A C- I49.9 Cardiac arrhythmia, unspecified A E A OMEPRAZOLE d00325A C K25 Gastric ulcer A E A ROPINIROLE d04215A C G25.81 Restless legs syndrome A E A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia A E0 A . . . E@ A . . . EP A CARVEDILOL d03847A C I51.9P Prevent heart disease A` EP A FINASTERIDE d00563A C N42.9 Disorder of prostate, unspecified A` EP A HYDROCHLOROTHIAZIDE d00253A C I10 Essential (primary) hypertension A` EP A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A C I10 Essential (primary) hypertension A` EP A METFORMIN d03807A C E11 Type 2 diabetes mellitus A` EP A TAMSULOSIN d04121A C N40 Enlarged prostate A` E` A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A0 E` A IBUPROFEN d00015A C[@ M13 Other arthritis A0 E` A LEVETIRACETAM d04499A B R25.1 Tremor, unspecified A0 Ep A . . . EĀ A . . . EĐ A BENAZEPRIL d00730A C[@ I10 Essential (primary) hypertension A@ EĐ A LEVOTHYROXINE d00278A C E66 Overweight and obesity A@ EĐ A RANITIDINE d00021A C- K21 Gastro-esophageal reflux disease A@ EĐ A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia A@ EĠ A . . . Eİ A . . . E A AMLODIPINE d00689A C I10 Essential (primary) hypertension A0 E A HYDROCHLOROTHIAZIDE; LOSARTAN d03830A C I10 Essential (primary) hypertension A0 E A LEVETIRACETAM d04499A C G40 Epilepsy and recurrent seizures A0 E A 99999 . . A E A . . . E A . . . E A BROMPHENIRAMINE; DEXTROMETHORPHAN; PSEUDOEPHEDRINE d03368A B R05 Cough A E A PREDNISONE d00350A B J42 Unspecified chronic bronchitis A E A . . . E A . . . E0 A OMEPRAZOLE d00325A C K21 Gastro-esophageal reflux disease A E@ A AMITRIPTYLINE d00146A C G43 Migraine A E@ A CETIRIZINE d03827A A J30.2 Other seasonal allergic rhinitis A E@ A CITALOPRAM d04332A Cr F32.9 Major depressive disorder, single episode, unspecified A E@ A DIVALPROEX SODIUM d03833A C G43 Migraine A E@ A FLUTICASONE d01296A B[ J45 Asthma A E@ A LEVOTHYROXINE d00278A CDp E03.9 Hypothyroidism, unspecified A E@ A NAPROXEN d00019A C- G43 Migraine A E@ A PANTOPRAZOLE d04514A C- K21 Gastro-esophageal reflux disease A E@ A RANITIDINE d00021A C K21 Gastro-esophageal reflux disease A E@ A TRAZODONE d00395A Cr G47.0 Insomnia A EP A AMOXICILLIN d00088A A@ H66.9 Otitis media, unspecified A E` A CLONAZEPAM d00197A C G47.0 Insomnia A@ E` A IRBESARTAN d04222A C I10 Essential (primary) hypertension A@ E` A METFORMIN d03807A C R73 Elevated blood glucose level A@ E` A METOPROLOL d00134A C I10 Essential (primary) hypertension A@ Ep A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia AP Ep A CLOPIDOGREL d04258A C D75.9P Prevent blood clots AP Ep A LISINOPRIL d00732A Cr I10 Essential (primary) hypertension AP Ep A METFORMIN; SITAGLIPTIN d06720A Cr E11 Type 2 diabetes mellitus AP Ep A METOPROLOL d00134A C I10 Essential (primary) hypertension AP Eŀ A MONTELUKAST d04289A B= J42 T78.40 Unspecified chronic bronchitis Allergy, unspecified A EŐ A ALBUTEROL d00749A C J42 Unspecified chronic bronchitis A EŐ A ALBUTEROL; IPRATROPIUM d04066A C J42 Unspecified chronic bronchitis A EŐ A ASPIRIN; DIPYRIDAMOLE d04497A CDp I63.P Prevent stroke A EŐ A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A EŐ A CARVEDILOL d03847A C I10 Essential (primary) hypertension A EŐ A DICLOFENAC d00848A C- M79.2 Neuralgia and neuritis, unspecified A EŐ A DONEPEZIL d04099A C R41 Other symptoms and signs involving cognitive functions and awareness A EŐ A GABAPENTIN d03182A C M79.2 Neuralgia and neuritis, unspecified A EŐ A HYDROCORTISONE d00254A D E27.9 Disorder of adrenal gland, unspecified A EŐ A NITROGLYCERIN d00321A D I50.9 Heart failure, unspecified A EŐ A SPIRONOLACTONE d00373A C I10 Essential (primary) hypertension A EŠ A ETHINYL ESTRADIOL; NORETHINDRONE d03238A Cr Z79.3 Long term (current) use of hormonal contraceptives A0 EŠ A LEVOTHYROXINE d00278A Cr E03.9 Hypothyroidism, unspecified A0 EŠ A TOFACITINIB d07925A AP M06.9 Rheumatoid arthritis, unspecified A0 EŰ A . . . E A . . . E A . . . E A . . . E A . . . E A APIXABAN d07804A C- I48.9 Unspecified atrial fibrillation and atrial flutter A E A CARBIDOPA; LEVODOPA d03473A C G20 Parkinson's disease A E A FUROSEMIDE d00070A B R60.9 Edema, unspecified A E A LEVOFLOXACIN d04109A A J18.9 Pneumonia, unspecified organism A E A LOSARTAN d03821A C I10 Essential (primary) hypertension A E A METOPROLOL d00134A CDp I49.9 Cardiac arrhythmia, unspecified A E A POTASSIUM CHLORIDE d00345A B E87.6 Hypokalemia A E A ZOLPIDEM d00910A C- G47.9 Sleep disorder, unspecified A E A ALBUTEROL d00749A D J45 Asthma A E A RANITIDINE d00021A B K21 Gastro-esophageal reflux disease A E0 A ETHINYL ESTRADIOL; NORETHINDRONE d03238A C- Z79.3 Long term (current) use of hormonal contraceptives A E@ A . . . EP A CARBIDOPA d00184A B R25.1 Tremor, unspecified A E` A . . . Ep A . . . Eƀ A ENALAPRIL d00013A C I10 Essential (primary) hypertension A Eƀ A TRAZODONE d00395A Cr F32.9 G47.9 Major depressive disorder, single episode, unspecified Sleep disorder, unspecified A EƐ A . . . EƠ A . . . Eư A . . . E A . . . E A ATORVASTATIN d04105A Cr E78.0 Pure hypercholesterolemia A E A . . . E A LEVOTHYROXINE d00278A D E03.9 Hypothyroidism, unspecified A E A MELOXICAM d04532A A M25.5 Pain in joint A E A LOSARTAN d03821A Cr I10 Essential (primary) hypertension A0 E A METOPROLOL d00134A Cr I10 Essential (primary) hypertension A0 E A WARFARIN d00022A Cr D75.9P Prevent blood clots A0 E A ALLOPURINOL d00023A C M1A Chronic gout AP E A AMLODIPINE d00689A C I10 Essential (primary) hypertension AP E A IRBESARTAN d04222A C I10 Essential (primary) hypertension AP E A METOPROLOL d00134A C"0 I10 Essential (primary) hypertension AP E A ROSUVASTATIN d04851A Cr E78.0 Pure hypercholesterolemia AP E A POTASSIUM CHLORIDE d00345A C E87.6 Hypokalemia A0 E A SIMVASTATIN d00746A B E78.0 Pure hypercholesterolemia A0 E A TORSEMIDE d03189A C R60.9 Edema, unspecified A0 E0 A . . . E@ A 99999 . . A EP A . . . E` A . . . Ep A . . . Eǀ A METHYLPHENIDATE d00900A C[@ F90 Attention-deficit hyperactivity disorders A Eǐ A LISINOPRIL d00732A D I10 Essential (primary) hypertension A EǠ A . . . Eǰ A CLOPIDOGREL d04258A C D75.9P Prevent blood clots A@ Eǰ A LISINOPRIL d00732A C I21.P Prevent heart attack/myocardial infarction A@ Eǰ A METOPROLOL d00134A C I21.P Prevent heart attack/myocardial infarction A@ Eǰ A SIMVASTATIN d00746A C I21.P Prevent heart attack/myocardial infarction A@ E A ALBUTEROL d00749A C J45 Asthma A E A FLUTICASONE; SALMETEROL d04611A C J45 Asthma A E A . . . E A . . . E A DROSPIRENONE; ETHINYL ESTRADIOL; LEVOMEFOLATE d07697A Cr L70 N92 Z79.3 Acne Excessive, frequent and irregular menstruation Long term (current) use of hormonal contraceptives A E A . . . E A . . . E A . . . E0 A BENZTROPINE d00175A C- F20 Schizophrenia A` E0 A CEPHALEXIN d00096A A L08.9 Local infection of the skin and subcutaneous tissue, unspecified A` E0 A HALOPERIDOL d00027A C- F20 Schizophrenia A` E0 A LITHIUM d00061A C- F20 Schizophrenia A` E0 A LORAZEPAM d00149A C- F20 Schizophrenia A` E0 A MUPIROCIN TOPICAL d01267A A L08.9 Local infection of the skin and subcutaneous tissue, unspecified A` E@ A RANITIDINE d00021A B= K21 Gastro-esophageal reflux disease A EP A AMLODIPINE d00689A CDp N39.0 Urinary tract infection, site not specified AP EP A CITALOPRAM d04332A C F32.9 Major depressive disorder, single episode, unspecified AP EP A LORAZEPAM d00149A C F41.9 Anxiety disorder, unspecified AP EP A MIRABEGRON d07876A C N39.0 Urinary tract infection, site not specified AP EP A TAMSULOSIN d04121A CDp N40 Enlarged prostate AP E` A . . . Ep A . . . EȀ A . . . EȐ A CARVEDILOL d03847A C I10 Essential (primary) hypertension A0 EȐ A HYDROCHLOROTHIAZIDE d00253A B= R60.9 Edema, unspecified A0 EȐ A LOSARTAN d03821A C I10 Essential (primary) hypertension A0 EȠ A . . . EȰ A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E0 A . . . E@ A . . . EP A . . . E` A . . . Ep A 77777 . . A Eɀ A . . . Eɐ A . . . Eɠ A AMLODIPINE d00689A B I10 Essential (primary) hypertension A Eɠ A BACLOFEN d00967A C M62.83 Muscle spasm A Eɠ A DULOXETINE d05355A C R07.9 Chest pain, unspecified A Eɠ A GABAPENTIN d03182A C M54 Dorsalgia A Eɠ A OMEPRAZOLE d00325A C K21 Gastro-esophageal reflux disease A Eɠ A TAMSULOSIN d04121A C R35 Polyuria A Eɠ A TRAMADOL d03826A C R51 Headache A Eɠ A VALACYCLOVIR d03838A C R52 Pain, unspecified A Eɠ A ZOLPIDEM d00910A Cr G47.0 Insomnia A Eɰ A ALLOPURINOL d00023A C M1A Chronic gout A@ Eɰ A AMLODIPINE d00689A C I10 Essential (primary) hypertension A@ Eɰ A HYDROCHLOROTHIAZIDE; LOSARTAN d03830A C I10 Essential (primary) hypertension A@ Eɰ A METFORMIN d03807A C R73 Elevated blood glucose level A@ E A ACETAMINOPHEN; HYDROCODONE d03428A C G43 M79.1 Migraine Myalgia Ap E A ASPIRIN d00170A B= D75.9P Prevent blood clots Ap E A ESOMEPRAZOLE d04749A CDp K30 Functional dyspepsia Ap E A IBUPROFEN d00015A C- G43 M25.5 M79.1 Migraine Pain in joint Myalgia Ap E A INTERFERON BETA-1A d04011A C- G99.8 Other specified disorders of nervous system in diseases classified elsewhere Ap E A LEVOTHYROXINE d00278A C[@ E03.9 Hypothyroidism, unspecified Ap E A METHYLPREDNISOLONE d00293A C- G99.8 Other specified disorders of nervous system in diseases classified elsewhere Ap E A . . . E A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A E A . . . E A . . . E A HYDROCHLOROTHIAZIDE d00253A D I10 Essential (primary) hypertension A E A PRAVASTATIN d00348A Cr E78.0 Pure hypercholesterolemia A E A LOSARTAN d03821A Bz I10 Essential (primary) hypertension A E0 A CARVEDILOL d03847A C- I10 Essential (primary) hypertension A E0 A SIMVASTATIN d00746A C[@ E78.0 Pure hypercholesterolemia A E@ A . . . EP A . . . E` A . . . Ep A ACETAMINOPHEN; HYDROCODONE d03428A D M54 Dorsalgia A Ep A AMLODIPINE d00689A0 C 99999 A Ep A ATORVASTATIN d04105A0 C E78.0 Pure hypercholesterolemia A Ep A CLONIDINE d00044A0 Cr I10 Essential (primary) hypertension A Ep A FUROSEMIDE d00070A C- R60.9 Edema, unspecified A Ep A LEVOTHYROXINE d00278A0 D9 E03.9 Hypothyroidism, unspecified A Ep A METOPROLOL d00134A0 C I10 Essential (primary) hypertension A Ep A NITROGLYCERIN d00321A D R07.9 Chest pain, unspecified A Ep A SEVELAMER d04363A C N19 Unspecified kidney failure A Eʀ A . . . Eʐ A . . . Eʠ A . . . Eʰ A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E A LISINOPRIL d00732A C I10 Essential (primary) hypertension A0 E A METFORMIN d03807A C E11.P Prevent diabetes A0 E A ROSUVASTATIN d04851A C E78.0 Pure hypercholesterolemia A0 E A . . . E0 A BUPROPION d00181A0 Cr 99999 Ap E0 A HYDROCHLOROTHIAZIDE; LOSARTAN d03830A0 Ei I10 Essential (primary) hypertension Ap E0 A LEVOTHYROXINE d00278A0 D* E03.9 Hypothyroidism, unspecified Ap E0 A METOPROLOL d00134A0 Cr I48.9 Unspecified atrial fibrillation and atrial flutter Ap E0 A MOMETASONE NASAL d04223A0 Dc J30.9 Allergic rhinitis, unspecified Ap E0 A SIMVASTATIN d00746A0 Cr E78.0 Pure hypercholesterolemia Ap E0 A WARFARIN d00022A0 C I48.9 Unspecified atrial fibrillation and atrial flutter Ap E@ A . . . EP A . . . E` A . . . Ep A . . . Eˀ A . . . Eː A . . . Eˠ A . . . E˰ A AMLODIPINE d00689A0 Cr I10 Essential (primary) hypertension A0 E˰ A HYDROCHLOROTHIAZIDE d00253A0 Cr I10 Essential (primary) hypertension A0 E˰ A VALSARTAN d04113A0 Cr I10 Essential (primary) hypertension A0 E A ALBUTEROL d00749A C J45 Asthma Ap E A AMLODIPINE d00689A CDp I10 Essential (primary) hypertension Ap E A ATENOLOL d00004A D I10 Essential (primary) hypertension Ap E A FLUTICASONE d01296A C R06.2 Wheezing Ap E A LATANOPROST OPHTHALMIC d04017A C H40 Glaucoma Ap E A PANTOPRAZOLE d04514A C K21 Gastro-esophageal reflux disease Ap E A RANITIDINE d00021A C K21 Gastro-esophageal reflux disease Ap E A . . . E A APIXABAN d07804A B[ I48.9 Unspecified atrial fibrillation and atrial flutter A@ E A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A@ E A CARVEDILOL d03847A B[ I10 Essential (primary) hypertension A@ E A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A C I10 R60.9 Essential (primary) hypertension Edema, unspecified A@ E A BECLOMETHASONE d00760A C J45 Asthma A E A SOMATROPIN d00577A Bz Z79.890 Hormone replacement therapy A E A AMLODIPINE d00689A C- I10 Essential (primary) hypertension A E A ATORVASTATIN d04105A Cr E78.0 Pure hypercholesterolemia A E A CETIRIZINE d03827A B[ T78.40 Allergy, unspecified A E A DULOXETINE d05355A Cr M54 Dorsalgia A E A FUROSEMIDE d00070A Cr R60.9 Edema, unspecified A E A INSULIN DETEMIR d05436A C- E11 Type 2 diabetes mellitus A E A METFORMIN d03807A C E11 Type 2 diabetes mellitus A E A MONTELUKAST d04289A C J44.9 Chronic obstructive pulmonary disease, unspecified A E A OMEPRAZOLE d00325A C R12 Heartburn A E A OXYBUTYNIN d00328A C- N39.4 Other specified urinary incontinence A E A POTASSIUM CHLORIDE d00345A Cr E87.6 Hypokalemia A E A TIZANIDINE d04102A Cr M54 Dorsalgia A E A METFORMIN d03807A C- E11 Type 2 diabetes mellitus A E A . . . E0 A ATORVASTATIN d04105A A E78.0 Pure hypercholesterolemia A E0 A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia A E@ A AMLODIPINE d00689A C I10 Essential (primary) hypertension Ap E@ A ATORVASTATIN d04105A Dc E78.0 Pure hypercholesterolemia Ap E@ A EMPAGLIFLOZIN d08275A Bz E11 Type 2 diabetes mellitus Ap E@ A INSULIN GLARGINE; LIXISENATIDE d08501A C- E11 Type 2 diabetes mellitus Ap E@ A INSULIN LISPRO d04373A C[@ E11 Type 2 diabetes mellitus Ap E@ A METFORMIN d03807A Dc E11 Type 2 diabetes mellitus Ap E@ A VALSARTAN d04113A Dc E11.2 Type 2 diabetes mellitus with kidney complications Ap EP A FLUORIDE TOPICAL d04397A C K02 Dental caries A E` A AMLODIPINE d00689A C I10 Essential (primary) hypertension A` E` A DIAZEPAM d00148A C F41.9 Anxiety disorder, unspecified A` E` A PANTOPRAZOLE d04514A C K30 Functional dyspepsia A` E` A SUCRALFATE d00377A C R10 Abdominal and pelvic pain A` E` A TRAMADOL d03826A CDp M54 R10 Dorsalgia Abdominal and pelvic pain A` E` A TRIMETHOBENZAMIDE d00862A C R10 Abdominal and pelvic pain A` Ep A CONJUGATED ESTROGENS d00541A D* Z79.890 Hormone replacement therapy A@ Ep A LEVOTHYROXINE d00278A Cr E03.9 Hypothyroidism, unspecified A@ Ep A OLMESARTAN d04801A C[@ I10 Essential (primary) hypertension A@ Ep A TRIAMTERENE d00396A Cr I10 Essential (primary) hypertension A@ È A CEFDINIR d04256A AP L08.9 Local infection of the skin and subcutaneous tissue, unspecified A È A MUPIROCIN TOPICAL d01267A AP L08.9 Local infection of the skin and subcutaneous tissue, unspecified A E̐ A RANITIDINE d00021A B[ K30 Functional dyspepsia A E̠ A ALENDRONATE d03849A C M81 Osteoporosis without current pathological fracture AP E̠ A LOSARTAN d03821A C I10 Essential (primary) hypertension AP E̠ A MYCOPHENOLIC ACID d05217A C- T86.9P Prevent transplanted organ and tissue rejection AP E̠ A PREDNISONE d00350A C- T86.9P Prevent transplanted organ and tissue rejection AP E̠ A TACROLIMUS d03752A C- T86.9P Prevent transplanted organ and tissue rejection AP Ḛ A . . . E A AMITRIPTYLINE d00146A C- F41.9 Anxiety disorder, unspecified A E A ATORVASTATIN d04105A CDp E78.0 Pure hypercholesterolemia A E A INSULIN DETEMIR d05436A Cr E11 Type 2 diabetes mellitus A E A LABETALOL d00016A C[@ I10 Essential (primary) hypertension A E A LEVOTHYROXINE d00278A Cr E03.9 Hypothyroidism, unspecified A E A METFORMIN d03807A CDp E11 Type 2 diabetes mellitus A E A RANITIDINE d00021A C[@ R12 Heartburn A E A SUMATRIPTAN d03160A CDp G43 Migraine A E A FINASTERIDE d00563A C N40 Enlarged prostate A E A LOSARTAN d03821A C I10 Essential (primary) hypertension A E A ALBUTEROL d00749A C R06.2 Wheezing A E A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A E A CARVEDILOL d03847A C I25.9 Chronic ischemic heart disease, unspecified A E A CLOPIDOGREL d04258A C D75.9P Prevent blood clots A E A FLUTICASONE; SALMETEROL d04611A C J45 R06.9 Asthma Unspecified abnormalities of breathing A E A LEVOTHYROXINE d00278A Cr E03.9 Hypothyroidism, unspecified A E A LOSARTAN d03821A Cr I10 Essential (primary) hypertension A E A METFORMIN d03807A C R73 Elevated blood glucose level A E A LEVOTHYROXINE d00278A C[@ E03.9 Hypothyroidism, unspecified A E A TAMSULOSIN d04121A C[@ R39.1 Other difficulties with micturition A E A AMITRIPTYLINE d00146A C M79.2 Neuralgia and neuritis, unspecified Ap E A ATORVASTATIN d04105A C[@ E78.0 Pure hypercholesterolemia Ap E A BACLOFEN d00967A C M62.83 Muscle spasm Ap E A COBICISTAT; ELVITEGRAVIR; EMTRICITABINE; TENOFOVIR d07899A D B20 Human immunodeficiency virus [HIV] disease Ap E A DARUNAVIR d05825A D B20 Human immunodeficiency virus [HIV] disease Ap E A METOPROLOL d00134A C I10 Essential (primary) hypertension Ap E A OMEPRAZOLE d00325A C K21 Gastro-esophageal reflux disease Ap E A RANITIDINE d00021A C- K21 Gastro-esophageal reflux disease A E A AZITHROMYCIN d00091A AP B99.9 Unspecified infectious disease A0 E A IBUPROFEN d00015A AP J09 Influenza due to certain identified influenza viruses A0 E A SILDENAFIL d04299A Ei N52.9 Male erectile dysfunction, unspecified A0 E0 A . . . E@ A . . . EP A . . . E` A . . . Ep A . . . È A CETIRIZINE d03827A C[@ T78.40 Allergy, unspecified AP È A HYDROXYUREA d01373A Dc 99999 AP È A LEVOTHYROXINE d00278A C- E03.9 Hypothyroidism, unspecified AP È A MELOXICAM d04532A C[@ M19.9 M54 M79.7 Osteoarthritis, unspecified site Dorsalgia Fibromyalgia AP È A OMEPRAZOLE d00325A C K21 R12 Gastro-esophageal reflux disease Heartburn AP E͐ A AMLODIPINE d00689A Cr I10 Essential (primary) hypertension A0 E͐ A BENAZEPRIL; HYDROCHLOROTHIAZIDE d03265A A I10 Essential (primary) hypertension A0 E͐ A METFORMIN d03807A C E11 Type 2 diabetes mellitus A0 E͠ A . . . EͰ A . . . E A TRAMADOL d03826A B# M54 Dorsalgia A E A . . . E A . . . E A . . . E A ACETAMINOPHEN; HYDROCODONE d03428A A0 G89 Pain, not elsewhere classified A E A HYDROCHLOROTHIAZIDE d00253A B I10 Essential (primary) hypertension AP E A METOPROLOL d00134A B I10 Essential (primary) hypertension AP E A OMEPRAZOLE d00325A B R12 Heartburn AP E A PRAVASTATIN d00348A B E78.0 Pure hypercholesterolemia AP E A TRAZODONE d00395A B G47.0 Insomnia AP E A . . . E0 A ALPRAZOLAM d00168A C F41.9 G47.0 Anxiety disorder, unspecified Insomnia A E@ A . . . EP A . . . E` A ALBUTEROL d00749A D J45 Asthma A E` A IPRATROPIUM d00265A D J45 Asthma A Ep A . . . E A ALPRAZOLAM d00168A D M62.83 Muscle spasm A E A CARVEDILOL d03847A CDp I10 Essential (primary) hypertension A E A CITALOPRAM d04332A B F32.9 Major depressive disorder, single episode, unspecified A E A FLUDROCORTISONE d00608A C- 55555 A E A GLIMEPIRIDE d03864A C E11 Type 2 diabetes mellitus A E A LEVOTHYROXINE d00278A C- E03.9 Hypothyroidism, unspecified A E A LOSARTAN d03821A CDp I10 Essential (primary) hypertension A E A METFORMIN d03807A C- R73 Elevated blood glucose level A E A NIFEDIPINE d00051A CDp I10 Essential (primary) hypertension A E A ROSUVASTATIN d04851A CDp E78.0 Pure hypercholesterolemia A Eΐ A 77777 . . A EΠ A . . . Eΰ A ERTUGLIFLOZIN; SITAGLIPTIN d08692A B[ E11 Type 2 diabetes mellitus A0 Eΰ A FENOFIBRATE d04286A B E78.0 Pure hypercholesterolemia A0 Eΰ A LOSARTAN d03821A C N28.9P Prevent kidney disease A0 E A PREDNISONE d00350A Ap L40 Psoriasis A E A . . . E A . . . E A ESTRADIOL d00537A C N95 Menopausal and other perimenopausal disorders A0 E A OXYBUTYNIN d00328A C N32.81 Overactive bladder A0 E A VENLAFAXINE d03181A Dc F32.9 Major depressive disorder, single episode, unspecified A0 E A FLUTICASONE; VILANTEROL d08100A C- J44.9 Chronic obstructive pulmonary disease, unspecified A@ E A IPRATROPIUM d00265A C J44.9 Chronic obstructive pulmonary disease, unspecified A@ E A LEVALBUTEROL d04427A C J44.9 Chronic obstructive pulmonary disease, unspecified A@ E A ROSUVASTATIN d04851A A E78.0 Pure hypercholesterolemia A@ E A . . . E A HYDROCODONE d03075A A M79.6 Pain in limb, hand, foot, fingers and toes A E0 A FLUOXETINE d00236A CDp F32.9 Major depressive disorder, single episode, unspecified A0 E0 A LISINOPRIL d00732A C- I10 Essential (primary) hypertension A0 E0 A LORAZEPAM d00149A C- F41.9 Anxiety disorder, unspecified A0 E@ A . . . EP A . . . E` A . . . Ep A DIGOXIN d00210A C I50.9 Heart failure, unspecified Ap Ep A LAMOTRIGINE d03809A C G40 Epilepsy and recurrent seizures Ap Ep A LEVOTHYROXINE d00278A B[ E03.9 Hypothyroidism, unspecified Ap Ep A RIVAROXABAN d07356A CDp D75.9P Z95 Prevent blood clots Presence of cardiac and vascular implants and grafts Ap Ep A SULFAMETHOXAZOLE; TRIMETHOPRIM d00124A B= N39.0 Urinary tract infection, site not specified Ap Ep A VENLAFAXINE d03181A BZ F41.9 Anxiety disorder, unspecified Ap Ep A VENLAFAXINE d03181A C F41.9 Anxiety disorder, unspecified Ap Eπ A FLECAINIDE d00234A C I48.9 Unspecified atrial fibrillation and atrial flutter A Eπ A METOPROLOL d00134A C I10 Essential (primary) hypertension A Eϐ A ENALAPRIL d00013A C[@ I21.P Prevent heart attack/myocardial infarction A Eϐ A OMEPRAZOLE d00325A C K21 Gastro-esophageal reflux disease A EϠ A . . . Eϰ A . . . E A . . . E A . . . E A COLESEVELAM d04695A C K58 Irritable bowel syndrome A@ E A LORAZEPAM d00149A Dc F41.9 Anxiety disorder, unspecified A@ E A OLANZAPINE d04050A Dc F31.9 Bipolar disorder, unspecified A@ E A PROMETHAZINE d00787A B= R11 Nausea and vomiting A@ E A ALBUTEROL d00749A Cr J45 Asthma AP E A ALBUTEROL d00749A Cr J45 Asthma AP E A FLUTICASONE NASAL d04283A C[@ T78.40 Allergy, unspecified AP E A FLUTICASONE; SALMETEROL d04611A B= J45 Asthma AP E A PREDNISOLONE d00084A Cr J45 Asthma AP E A AMOXICILLIN d00088A A J20.9 Acute bronchitis, unspecified A E A HYDROCHLOROTHIAZIDE d00253A C I10 Essential (primary) hypertension A E A LISINOPRIL d00732A Cr I10 Essential (primary) hypertension A E A . . . E0 A . . . E@ A LEVOTHYROXINE d00278A B E03.9 Hypothyroidism, unspecified A EP A SULFAMETHOXAZOLE; TRIMETHOPRIM d00124A B# L70 Acne A E` A . . . Ep A . . . EЀ A . . . EА A . . . EР A . . . Eа A . . . E A . . . E A . . . E A GABAPENTIN d03182A B M54 Dorsalgia A E A PANTOPRAZOLE d04514A B K21 K30 R12 Gastro-esophageal reflux disease Functional dyspepsia Heartburn A E A ALLOPURINOL d00023A C- M1A Chronic gout AP E A AMLODIPINE d00689A D I10 Essential (primary) hypertension AP E A CLONIDINE d00044A D I10 Essential (primary) hypertension AP E A HYDROCHLOROTHIAZIDE d00253A D I10 Essential (primary) hypertension AP E A LOSARTAN d03821A D I10 Essential (primary) hypertension AP E A . . . E A . . . E0 A . . . E@ A . . . EP A ACETAMINOPHEN; CODEINE d03423A B K87 Disorders of gallbladder, biliary tract and pancreas in diseases classified elsewhere A EP A ALBUTEROL d00749A D J45 R06.02 R06.2 Asthma Shortness of breath Wheezing A EP A AMITRIPTYLINE d00146A B F32.9 G47.0 Major depressive disorder, single episode, unspecified Insomnia A EP A ATORVASTATIN d04105A B[ E78.0 Pure hypercholesterolemia A EP A FLUTICASONE; VILANTEROL d08100A C- R06.2 Wheezing A EP A FUROSEMIDE d00070A C I50.9 Heart failure, unspecified A EP A GABAPENTIN d03182A D= M79.2 Neuralgia and neuritis, unspecified A EP A INSULIN ASPART d04697A D= E11 R73 Type 2 diabetes mellitus Elevated blood glucose level A EP A INSULIN DETEMIR d05436A D= E11 R73 Type 2 diabetes mellitus Elevated blood glucose level A EP A LISINOPRIL d00732A Cr I10 Essential (primary) hypertension A EP A METFORMIN d03807A Bz R73 Elevated blood glucose level A EP A METOPROLOL d00134A C"0 I10 R00 Essential (primary) hypertension Abnormalities of heart beat A EP A PROMETHAZINE d00787A B R11 Nausea and vomiting A E` A ESOMEPRAZOLE d04749A Cr J09 Influenza due to certain identified influenza viruses AP E` A FLUTICASONE NASAL d04283A0 C J45 Asthma AP E` A FORMOTEROL; MOMETASONE d07660A0 C- J45 Asthma AP E` A MONTELUKAST d04289A0 C J45 Asthma AP E` A PREDNISONE d00350A0 C J45 Asthma AP Ep A . . . Eр A AMLODIPINE d00689A C I10 Essential (primary) hypertension A Eр A BUPROPION d00181A C F41.9 Anxiety disorder, unspecified A Eр A CLOPIDOGREL d04258A C D75.9P Prevent blood clots A Eр A ISOSORBIDE MONONITRATE d00269A C I21.P R07.9 Prevent heart attack/myocardial infarction Chest pain, unspecified A Eр A LISINOPRIL d00732A C I10 I50.9 Essential (primary) hypertension Heart failure, unspecified A Eр A METOPROLOL d00134A C I10 I50.9 R00 Essential (primary) hypertension Heart failure, unspecified Abnormalities of heart beat A Eр A NITROGLYCERIN d00321A C R07.9 Chest pain, unspecified A Eр A ROSUVASTATIN d04851A C E78.0P Prevent high cholesterol A Eр A SERTRALINE d00880A CDp F32.9 Major depressive disorder, single episode, unspecified A Eр A SERTRALINE d00880A C F32.9 Major depressive disorder, single episode, unspecified A Eѐ A . . . EѠ A . . . EѰ A . . . E A CEFDINIR d04256A A0 J02 Acute pharyngitis A E A AMLODIPINE d00689A C[@ I10 Essential (primary) hypertension A0 E A ATORVASTATIN d04105A B[ E78.0 Pure hypercholesterolemia A0 E A HYDROCHLOROTHIAZIDE d00253A C[@ I10 Essential (primary) hypertension A0 E A DEXMETHYLPHENIDATE d04777A C R41 Other symptoms and signs involving cognitive functions and awareness A E A . . . E A . . . E A . . . E A . . . E0 A NYSTATIN d01233A A B37 Candidiasis A E@ A . . . EP A LISINOPRIL d00732A B I10 Essential (primary) hypertension A E` A . . . Ep A ESOMEPRAZOLE d04749A C- K21 Gastro-esophageal reflux disease A EҀ A . . . EҐ A . . . EҠ A . . . EҰ A . . . E A . . . E A . . . E A . . . E A . . . E A MONTELUKAST d04289A C J30.9 Allergic rhinitis, unspecified A0 E A OMEPRAZOLE d00325A Ap K21 Gastro-esophageal reflux disease A0 E A SUCRALFATE d00377A B K27 Peptic ulcer, site unspecified A0 E A . . . E A ATORVASTATIN d04105A Cr E78.0 Pure hypercholesterolemia Ap E A GABAPENTIN d03182A B M79.7 Fibromyalgia Ap E A HYDROCHLOROTHIAZIDE d00253A D R60.9 Edema, unspecified Ap E A LOSARTAN d03821A Cr I10 Essential (primary) hypertension Ap E A METOPROLOL d00134A B Z79 Long term (current) drug therapy Ap E A OMEPRAZOLE d00325A C K21 Gastro-esophageal reflux disease Ap E A OXYBUTYNIN d00328A D R32 Unspecified urinary incontinence Ap E0 A DORZOLAMIDE OPHTHALMIC d03805A D H40 Glaucoma A@ E0 A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A D I10 Essential (primary) hypertension A@ E0 A NAPROXEN d00019A Dc M13 Other arthritis A@ E0 A TIMOLOL OPHTHALMIC d04037A D H40 Glaucoma A@ E@ A . . . EP A AMITRIPTYLINE d00146A C- N95 Menopausal and other perimenopausal disorders A` EP A HYDROCHLOROTHIAZIDE d00253A C- I10 Essential (primary) hypertension A` EP A HYDROXYCHLOROQUINE d00817A C- L93 Lupus erythematosus A` EP A LOSARTAN d03821A C- I10 Essential (primary) hypertension A` EP A METHOTREXATE d00060A C- L93 Lupus erythematosus A` EP A SIMVASTATIN d00746A C- E78.0 Pure hypercholesterolemia A` E` A . . . Ep A . . . EӀ A . . . EӐ A ATORVASTATIN d04105A Cr E78.0 Pure hypercholesterolemia A EӐ A TAMSULOSIN d04121A Cr R39.9 Unspecified symptoms and signs involving the genitourinary system A EӠ A ANASTROZOLE d03873A Ei C50.P Prevent breast cancer Ap EӠ A ATORVASTATIN d04105A Ei 99999 Ap EӠ A CEPHALEXIN d00096A B[ B99.9 Unspecified infectious disease Ap EӠ A HYDRALAZINE d00132A Ei I10 Essential (primary) hypertension Ap EӠ A LISINOPRIL d00732A Ei 99999 Ap EӠ A METOPROLOL d00134A Ei 99999 Ap EӠ A SERTRALINE d00880A CDp F32.9 Major depressive disorder, single episode, unspecified Ap EӰ A ETHINYL ESTRADIOL; NORGESTIMATE d03781A C- Z79.3 Long term (current) use of hormonal contraceptives A E A ATORVASTATIN d04105A Cr E78.0 Pure hypercholesterolemia AP E A GLIPIZIDE d00246A C R73 Elevated blood glucose level AP E A LIRAGLUTIDE d07466A C R73 Elevated blood glucose level AP E A LISINOPRIL d00732A Cr I10 Essential (primary) hypertension AP E A METFORMIN d03807A C R73 Elevated blood glucose level AP E A AMLODIPINE; BENAZEPRIL d03829A C- I10 Essential (primary) hypertension AP E A ATENOLOL; CHLORTHALIDONE d03258A Dc I10 Essential (primary) hypertension AP E A ATORVASTATIN d04105A Dc E78.0 Pure hypercholesterolemia AP E A ESTRADIOL d00537A D Z79.890 Hormone replacement therapy AP E A POTASSIUM CHLORIDE d00345A Dc E87.6 Hypokalemia AP E A HYDROCHLOROTHIAZIDE d00253A C- I10 Essential (primary) hypertension A0 E A LISINOPRIL d00732A C- I10 Essential (primary) hypertension A0 E A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia A0 E A 77777 . . A E A CLOMIPHENE d00569A C"0 E29.1 Testicular hypofunction A E A . . . E A CELECOXIB d04380A C- M06.9 Rheumatoid arthritis, unspecified Ap E A CLINDAMYCIN d00043A B= L08.9 Local infection of the skin and subcutaneous tissue, unspecified Ap E A FUROSEMIDE d00070A B N28.9 R60.9 Disorder of kidney and ureter, unspecified Edema, unspecified Ap E A LISINOPRIL d00732A CDp I10 Essential (primary) hypertension Ap E A METOPROLOL d00134A B= I10 Essential (primary) hypertension Ap E A POTASSIUM CHLORIDE d00345A B E87.6 Hypokalemia Ap E A TRIAMCINOLONE TOPICAL d03206A Bz R21 Rash and other nonspecific skin eruption Ap E0 A LISDEXAMFETAMINE d06663A CDp R41 Other symptoms and signs involving cognitive functions and awareness A E@ A . . . EP A . . . E` A . . . Ep A . . . EԀ A . . . EԐ A CLOPIDOGREL d04258A CDp I49.9 Cardiac arrhythmia, unspecified A EԐ A DILTIAZEM d00045A C I10 I49.9 Essential (primary) hypertension Cardiac arrhythmia, unspecified A EԐ A ESCITALOPRAM d04812A C- F39 G47.9 Unspecified mood [affective] disorder Sleep disorder, unspecified A EԐ A LEFLUNOMIDE d04349A CDp M06.9 Rheumatoid arthritis, unspecified A EԐ A LEVETIRACETAM d04499A C- G40 Epilepsy and recurrent seizures A EԐ A LEVOTHYROXINE d00278A D4 E03.9 Hypothyroidism, unspecified A EԐ A MIRTAZAPINE d04025A Dc G47.0 G47.9 Insomnia Sleep disorder, unspecified A EԐ A PANCRELIPASE d01002A C K87 Disorders of gallbladder, biliary tract and pancreas in diseases classified elsewhere A EԐ A PRAVASTATIN d00348A CDp E78.0P I63.P Prevent high cholesterol Prevent stroke A EԠ A . . . E A METHYLPHENIDATE d00900A C F90 Attention-deficit hyperactivity disorders A E A . . . E A . . . E A ATORVASTATIN d04105A0 C E78.0 Pure hypercholesterolemia A@ E A ESTRADIOL; NORETHINDRONE d04375A CDp N95 Menopausal and other perimenopausal disorders A@ E A NAPROXEN d00019A0 C M54 Dorsalgia A@ E A NITROFURANTOIN d00112A C N39.0 Urinary tract infection, site not specified A@ E A . . . E A . . . E A ETHINYL ESTRADIOL; ETONOGESTREL d04773A C L70 N92 Acne Excessive, frequent and irregular menstruation A E A RISPERIDONE d03180A A F31.9 F90 Bipolar disorder, unspecified Attention-deficit hyperactivity disorders A E0 A . . . E@ A . . . EP A . . . E` A . . . Ep A . . . EՀ A CALCIUM ACETATE d03689A C N19 Unspecified kidney failure A0 EՀ A GLIPIZIDE d00246A C E11 Type 2 diabetes mellitus A0 EՀ A LABETALOL d00016A C I10 Essential (primary) hypertension A0 EՐ A . . . Eՠ A . . . Eհ A . . . E A METHYLPHENIDATE d00900A C F90 Attention-deficit hyperactivity disorders A E A . . . E A . . . E A AMLODIPINE; BENAZEPRIL d03829A C I50.9 Heart failure, unspecified A` E A CARVEDILOL d03847A C I50.9 Heart failure, unspecified A` E A FENOFIBRATE d04286A C E78.0 Pure hypercholesterolemia A` E A FUROSEMIDE d00070A C I51.9 Heart disease, unspecified A` E A LEVOTHYROXINE d00278A D4 E03.9 Hypothyroidism, unspecified A` E A SPIRONOLACTONE d00373A C I50.9 Heart failure, unspecified A` E A . . . E A . . . E A ALBUTEROL d00749A B J45 Asthma A0 E A AMOXICILLIN d00088A A` H66.9 Otitis media, unspecified A0 E A BECLOMETHASONE d00760A BT J45 Asthma A0 E0 A BENAZEPRIL; HYDROCHLOROTHIAZIDE d03265A C- I10 Essential (primary) hypertension A0 E0 A ROSUVASTATIN d04851A C E78.0 Pure hypercholesterolemia A0 E0 A TAMSULOSIN d04121A C- N40 Enlarged prostate A0 E@ A . . . EP A . . . E` A . . . Ep A . . . Eր A ALBUTEROL d00749A Cr J45 Asthma A Eր A BECLOMETHASONE NASAL d04275A C- J30.9 Allergic rhinitis, unspecified A Eր A FLUOXETINE d00236A B F32.9 Major depressive disorder, single episode, unspecified A Eր A GUANFACINE d00717A C F90 Attention-deficit hyperactivity disorders A Eր A HYDROXYZINE d00907A B F41.9 Anxiety disorder, unspecified A Eր A METHYLPHENIDATE d00900A C F90 Attention-deficit hyperactivity disorders A Eր A MOMETASONE d05262A C J45 Asthma A Eր A MONTELUKAST d04289A Cr J45 Asthma A E A INSULIN LISPRO d04373A D E10 Type 1 diabetes mellitus A E֠ A AMPHETAMINE; DEXTROAMPHETAMINE d04035A C- F90 Attention-deficit hyperactivity disorders A Eְ A METOPROLOL d00134A D= I10 Essential (primary) hypertension A E A ASPIRIN d00170A B= I21.P I51.9P I63.P Prevent heart attack/myocardial infarction Prevent heart disease Prevent stroke A` E A ATORVASTATIN d04105A C"0 E78.0 Pure hypercholesterolemia A` E A GLIPIZIDE d00246A C[@ E11 Type 2 diabetes mellitus A` E A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A C I10.P Prevent hypertension A` E A LEVOTHYROXINE d00278A B E07.9 Disorder of thyroid, unspecified A` E A SAXAGLIPTIN d07467A B E11 Type 2 diabetes mellitus A` E A . . . E A . . . E A FENOFIBRATE d04286A D* E78.0 Pure hypercholesterolemia Ap E A INSULIN GLARGINE d04538A C E11 Type 2 diabetes mellitus Ap E A INSULIN LISPRO d04373A D E11 Type 2 diabetes mellitus Ap E A LANSOPRAZOLE d03828A D* K30 Functional dyspepsia Ap E A LOSARTAN d03821A D E11.2 Type 2 diabetes mellitus with kidney complications Ap E A PRAVASTATIN d00348A D E78.0 Pure hypercholesterolemia Ap E A VILAZODONE d07740A CDp F32.9 Major depressive disorder, single episode, unspecified Ap E A CONJUGATED ESTROGENS d00541A D= Z79.890 Hormone replacement therapy A E A PROGESTERONE d00550A D= Z79.890 Hormone replacement therapy A E A . . . E A ARIPIPRAZOLE d04825A C- F32.9 F43.1 Major depressive disorder, single episode, unspecified Post-traumatic stress disorder (PTSD) A` E A BUPROPION d00181A Dc F32.9 F41.9 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified A` E A CETIRIZINE d03827A C T78.40 Allergy, unspecified A` E A MELOXICAM d04532A B[ M79.1 Myalgia A` E A OXYBUTYNIN d00328A B N32.81 Overactive bladder A` E A PRAVASTATIN d00348A C E78.0 Pure hypercholesterolemia A` E0 A ARIPIPRAZOLE d04825A C F32.9 Major depressive disorder, single episode, unspecified A` E0 A CITALOPRAM d04332A Dc F32.9 Major depressive disorder, single episode, unspecified A` E0 A FENOFIBRATE d04286A D E78.1 Pure hyperglyceridemia A` E0 A HYDROCHLOROTHIAZIDE d00253A C[@ N28.9 Disorder of kidney and ureter, unspecified A` E0 A OMEPRAZOLE d00325A C R12 Heartburn A` E0 A RISPERIDONE d03180A Dc F31.9 R45 Bipolar disorder, unspecified Symptoms and signs involving emotional state A` E@ A HYDROCHLOROTHIAZIDE d00253A C[@ I10 Essential (primary) hypertension A E@ A LISINOPRIL d00732A C[@ I10 Essential (primary) hypertension A EP A MELOXICAM d04532A D M79.1 Myalgia A E` A AMITRIPTYLINE d00146A C E11 Type 2 diabetes mellitus A` E` A GLIPIZIDE d00246A C 99999 A` E` A LISINOPRIL d00732A C 99999 A` E` A METFORMIN d03807A C E11 Type 2 diabetes mellitus A` E` A OMEPRAZOLE d00325A B[ R12 Heartburn A` E` A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia A` Ep A CITALOPRAM d04332A CDp I10 Essential (primary) hypertension A E׀ A DIVALPROEX SODIUM d03833A Bz F20 F32.9 Schizophrenia Major depressive disorder, single episode, unspecified A0 E׀ A PALIPERIDONE d06297A C F31.9 Bipolar disorder, unspecified A0 E׀ A TRIHEXYPHENIDYL d00970A C T88.7P Prevent drug side effect A0 Eא A . . . Eנ A DAPAGLIFLOZIN; METFORMIN d08245A CDp R73 Elevated blood glucose level A` Eנ A GABAPENTIN d03182A B M79.2 Neuralgia and neuritis, unspecified A` Eנ A HYDROCHLOROTHIAZIDE; LOSARTAN d03830A C N28.9 Disorder of kidney and ureter, unspecified A` Eנ A INSULIN ASPART d04697A C- R73 Elevated blood glucose level A` Eנ A INSULIN DEGLUDEC d08054A CDp R73 Elevated blood glucose level A` Eנ A LEVOTHYROXINE d00278A C[@ E03.9 Hypothyroidism, unspecified A` Eװ A AMLODIPINE d00689A C I10 Essential (primary) hypertension AP Eװ A HYDROCHLOROTHIAZIDE d00253A C I10 Essential (primary) hypertension AP Eװ A LOSARTAN d03821A C I10 Essential (primary) hypertension AP Eװ A METOPROLOL d00134A C I10 Essential (primary) hypertension AP Eװ A PRAVASTATIN d00348A C E78.0 Pure hypercholesterolemia AP E A . . . E A ALLOPURINOL d00023A CDp M10.9P Prevent gout A E A . . . E A . . . E A . . . E A AMLODIPINE d00689A D= I10 Essential (primary) hypertension A E A ATORVASTATIN d04105A CDp E78.0 Pure hypercholesterolemia A E A IRBESARTAN d04222A C I10 Essential (primary) hypertension A E A MELOXICAM d04532A D* M19.9 Osteoarthritis, unspecified site A E A METFORMIN d03807A D= E11 Type 2 diabetes mellitus A E A METOPROLOL d00134A CDp I10 Essential (primary) hypertension A E A MONTELUKAST d04289A D= T78.40 Allergy, unspecified A E A PANTOPRAZOLE d04514A D= K21 Gastro-esophageal reflux disease A E A . . . E0 A . . . E@ A ABIRATERONE d07766A CDp C61 Malignant neoplasm of prostate A0 E@ A LISINOPRIL d00732A CDp I10 Essential (primary) hypertension A0 E@ A PREDNISONE d00350A C- C80.1 Malignant (primary) neoplasm, unspecified A0 EP A . . . E` A ATORVASTATIN d04105A Cr I21.P Prevent heart attack/myocardial infarction A@ E` A CANAGLIFLOZIN d08080A B E11 Type 2 diabetes mellitus A@ E` A INSULIN DETEMIR d05436A B[ E11 Type 2 diabetes mellitus A@ E` A METFORMIN d03807A B E11 Type 2 diabetes mellitus A@ Ep A METHYLPHENIDATE d00900A B F90 Attention-deficit hyperactivity disorders A E A EVOLOCUMAB d08383A B E78.0 Pure hypercholesterolemia A E A LOSARTAN d03821A C- I10 Essential (primary) hypertension A Eؐ A . . . Eؠ A . . . Eذ A METFORMIN d03807A Cr E11 Type 2 diabetes mellitus A0 Eذ A RAMIPRIL d00728A C[@ I10.P Prevent hypertension A0 Eذ A SIMVASTATIN d00746A B* E78.0 Pure hypercholesterolemia A0 E A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E0 A ALBUTEROL d00749A CDp J44.9 Chronic obstructive pulmonary disease, unspecified Ap E0 A FLUTICASONE; SALMETEROL d04611A CDp J44.9 Chronic obstructive pulmonary disease, unspecified Ap E0 A HYDROCHLOROTHIAZIDE d00253A CDp I10 Essential (primary) hypertension Ap E0 A LISINOPRIL d00732A CDp I10 Essential (primary) hypertension Ap E0 A METOPROLOL d00134A CDp I10 Essential (primary) hypertension Ap E0 A ROSUVASTATIN d04851A B E78.0 Pure hypercholesterolemia Ap E0 A UMECLIDINIUM d08187A CDp J44.9 Chronic obstructive pulmonary disease, unspecified Ap E@ A LISINOPRIL d00732A Bz I10 Essential (primary) hypertension A EP A . . . E` A . . . Ep A ABACAVIR; DOLUTEGRAVIR; LAMIVUDINE d08284A C B20 Human immunodeficiency virus [HIV] disease A@ Ep A AMLODIPINE d00689A C I10 Essential (primary) hypertension A@ Ep A ROSUVASTATIN d04851A C- 55555 A@ Ep A TRIAMTERENE d00396A CDp I10 Essential (primary) hypertension A@ Eـ A . . . Eِ A . . . E٠ A . . . Eٰ A ETHINYL ESTRADIOL; NORELGESTROMIN d04779A C Z79.3 Long term (current) use of hormonal contraceptives A E A ALBUTEROL d00749A B[ J45 Asthma A E A TIMOLOL OPHTHALMIC d04037A C 55555 A E A . . . E A . . . E A . . . E A ALBUTEROL d00749A A@ J45 Asthma A E A FLUTICASONE d01296A Ap J45 Asthma A E A METOPROLOL d00134A0 B= I10 Essential (primary) hypertension A0 E A NAPROXEN d00019A B M54 Dorsalgia A0 E A RANITIDINE d00021A C- K21 Gastro-esophageal reflux disease A0 E A AMLODIPINE d00689A C I10 Essential (primary) hypertension Ap E A CLOPIDOGREL d04258A C I63.P Prevent stroke Ap E A DONEPEZIL d04099A C R41 Other symptoms and signs involving cognitive functions and awareness Ap E A FLUOXETINE d00236A CDp F41.9 Anxiety disorder, unspecified Ap E A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified Ap E A LISINOPRIL d00732A C I10 Essential (primary) hypertension Ap E A SPIRONOLACTONE d00373A C- R60.9 Edema, unspecified Ap E0 A FLUDROCORTISONE d00608A D- E27.9 Disorder of adrenal gland, unspecified A` E0 A HYDROCORTISONE d00254A D- E27.9 Disorder of adrenal gland, unspecified A` E0 A LATANOPROST OPHTHALMIC d04017A CDp H40 Glaucoma A` E0 A LEVOTHYROXINE d00278A D1 E03.9 Hypothyroidism, unspecified A` E0 A SILDENAFIL d04299A Bz N42.9 Disorder of prostate, unspecified A` E0 A SIMVASTATIN d00746A Dc E78.0 Pure hypercholesterolemia A` E@ A ESTRADIOL TOPICAL d04210A C[@ N95 Menopausal and other perimenopausal disorders A EP A . . . E` A . . . Ep A . . . Eڀ A . . . Eڐ A AMOXICILLIN d00088A A H66.9 Otitis media, unspecified A Eڠ A ADALIMUMAB d04835A Cr M06.9 Rheumatoid arthritis, unspecified AP Eڠ A IBANDRONATE d05357A B[ M81 Osteoporosis without current pathological fracture AP Eڠ A LATANOPROST OPHTHALMIC d04017A AP H40 Glaucoma AP Eڠ A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified AP Eڠ A METHOTREXATE d00060A C M06.9 Rheumatoid arthritis, unspecified AP Eڰ A ALBUTEROL d00749A CDp J45 Asthma A Eڰ A BUDESONIDE; FORMOTEROL d04795A CDp J45 Asthma A E A AMITRIPTYLINE d00146A C F33.9 M79.2 Major depressive disorder, recurrent, unspecified Neuralgia and neuritis, unspecified Ap E A AMLODIPINE d00689A C I10 Essential (primary) hypertension Ap E A CHLORTHALIDONE d00192A C I10 Essential (primary) hypertension Ap E A CYCLOBENZAPRINE d00963A C M62.83 M79.1 Muscle spasm Myalgia Ap E A FLUOXETINE d00236A C F32.9 Major depressive disorder, single episode, unspecified Ap E A MELOXICAM d04532A C M25.5 Pain in joint Ap E A OMEPRAZOLE d00325A C[@ K21 R12 Gastro-esophageal reflux disease Heartburn Ap E A . . . E A . . . E A . . . E A LOSARTAN d03821A C- I10 Essential (primary) hypertension A E A SIMVASTATIN d00746A CDp E78.0 Pure hypercholesterolemia A E A FLUOXETINE d00236A C F32.9 Major depressive disorder, single episode, unspecified A0 E A HYDROXYZINE d00907A C F41.9 Anxiety disorder, unspecified A0 E A MIRTAZAPINE d04025A C G47.0 Insomnia A0 E A PHENTERMINE d00806A B E66 Overweight and obesity A E0 A FLUOXETINE d00236A C[@ F32.9 Major depressive disorder, single episode, unspecified A E@ A . . . EP A . . . E` A AMOXICILLIN d00088A Ap H66.9 Otitis media, unspecified A Ep A CANDESARTAN d04322A CP I10 Essential (primary) hypertension A0 Ep A OMEPRAZOLE d00325A Cr K21 Gastro-esophageal reflux disease A0 Ep A PRAVASTATIN d00348A CP E78.0 Pure hypercholesterolemia A0 Eۀ A GABAPENTIN d03182A C 99999 A` Eۀ A LEVOTHYROXINE d00278A Dc E03.9 Hypothyroidism, unspecified A` Eۀ A OXYBUTYNIN d00328A C N39.4 Other specified urinary incontinence A` Eۀ A RIVAROXABAN d07356A Cr D75.9P Prevent blood clots A` Eۀ A SOTALOL d00371A C I51.9 Heart disease, unspecified A` Eۀ A TAMSULOSIN d04121A C N40 Enlarged prostate A` Eې A AMLODIPINE d00689A C I10 Essential (primary) hypertension Ap Eې A ATORVASTATIN d04105A C- E78.0 Pure hypercholesterolemia Ap Eې A HYDROCHLOROTHIAZIDE d00253A CDp R60.9 Edema, unspecified Ap Eې A LEVOTHYROXINE d00278A C- 99999 Ap Eې A METFORMIN d03807A C E11 Type 2 diabetes mellitus Ap Eې A METOPROLOL d00134A C I10 Essential (primary) hypertension Ap Eې A MOMETASONE d05262A CDp R06.9 Unspecified abnormalities of breathing Ap E۠ A CARVEDILOL d03847A0 C I21.P Prevent heart attack/myocardial infarction A E۠ A GLIMEPIRIDE d03864A0 D E11 Type 2 diabetes mellitus A E۠ A HYDROCODONE d03075A0 D M79.1 Myalgia A E۠ A IRBESARTAN d04222A0 C I10 Essential (primary) hypertension A E۠ A ISOSORBIDE d00653A0 B I51.9 Heart disease, unspecified A E۠ A LEVOTHYROXINE d00278A0 Bz E03.9 Hypothyroidism, unspecified A E۠ A METFORMIN d03807A0 D# E11 Type 2 diabetes mellitus A E۠ A NITROGLYCERIN d00321A0 CDp I20.9 R07.9 Angina pectoris, unspecified Chest pain, unspecified A E۠ A OMEPRAZOLE d00325A B K30 Functional dyspepsia A E۠ A ROPINIROLE d04215A0 C- G25.81 Restless legs syndrome A E۠ A SERTRALINE d00880A0 D' F32.9 Major depressive disorder, single episode, unspecified A E۰ A RANITIDINE d00021A C R63 Symptoms and signs concerning food and fluid intake A E A THYROID DESICCATED d00655A D E03.9 Hypothyroidism, unspecified A E A . . . E A . . . E A . . . E A . . . E A 77777 . . A E A . . . E0 A POLYETHYLENE GLYCOL 3350 d05350A C K59.0 Constipation A E@ A . . . EP A ACETAMINOPHEN; HYDROCODONE d03428A C M54 Dorsalgia A E` A ALLOPURINOL d00023A C- M10.9 Gout, unspecified A Ep A . . . E܀ A . . . Eܐ A . . . Eܠ A . . . Eܰ A AMLODIPINE d00689A B= I10 Essential (primary) hypertension A Eܰ A LOSARTAN d03821A B= I10 Essential (primary) hypertension A E A . . . E A . . . E A ATOMOXETINE d04827A C F90 Attention-deficit hyperactivity disorders A E A RISPERIDONE d03180A C F90 Attention-deficit hyperactivity disorders A E A ATOMOXETINE d04827A B= F90 Attention-deficit hyperactivity disorders A E A DIVALPROEX SODIUM d03833A C[@ G40 Epilepsy and recurrent seizures A E A AMLODIPINE d00689A C I10 Essential (primary) hypertension A E A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A E A CLOPIDOGREL d04258A C D75.9P Prevent blood clots A E A ESCITALOPRAM d04812A C F32.9 Major depressive disorder, single episode, unspecified A E A FINASTERIDE d00563A C- N40 Enlarged prostate A E A GABAPENTIN d03182A B M79.2 Neuralgia and neuritis, unspecified A E A GLIPIZIDE d00246A C- R73 Elevated blood glucose level A E A HYDROCHLOROTHIAZIDE d00253A C- I10 I51.9 R60.9 Essential (primary) hypertension Heart disease, unspecified Edema, unspecified A E A LINAGLIPTIN d07767A C E11 Type 2 diabetes mellitus A E A RABEPRAZOLE d04448A C[@ R12 Heartburn A E A TAMSULOSIN d04121A C R35 Polyuria A E A UMECLIDINIUM; VILANTEROL d08188A B J44.9 Chronic obstructive pulmonary disease, unspecified A E A . . . E A RALOXIFENE d04261A Cr M85.9 Disorder of bone density and structure, unspecified A0 E A SIMVASTATIN d00746A C- I21.P Prevent heart attack/myocardial infarction A0 E A VALSARTAN d04113A D I10 Essential (primary) hypertension A0 E0 A BACLOFEN d00967A D)Y M62.83 Muscle spasm A E0 A METHOCARBAMOL d00965A B8 T14.9 Unspecified injury A E@ A . . . EP A . . . E` A . . . Ep A . . . E݀ A . . . Eݐ A . . . Eݠ A RANITIDINE d00021A B[ K21 Gastro-esophageal reflux disease A Eݰ A CETIRIZINE d03827A B R09.81 T78.40 Nasal congestion Allergy, unspecified A Eݰ A FLUTICASONE NASAL d04283A B J30.2 J30.9 Other seasonal allergic rhinitis Allergic rhinitis, unspecified A E A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E0 A . . . E@ A AMLODIPINE d00689A B= I10 Essential (primary) hypertension A@ E@ A ATENOLOL; CHLORTHALIDONE d03258A B= I10 Essential (primary) hypertension A@ E@ A ROSUVASTATIN d04851A B= E78.0 Pure hypercholesterolemia A@ E@ A SERTRALINE d00880A C F32.9 Major depressive disorder, single episode, unspecified A@ EP A DEXAMETHASONE; TOBRAMYCIN OPHTHALMIC d03536A B H10.1 Acute atopic conjunctivitis A@ EP A GENTAMICIN OPHTHALMIC d03974A B H57.9 Unspecified disorder of eye and adnexa A@ EP A OPHTHALMIC PREPARATIONS - UNSPECIFIED c00147A Ap H10.1 Acute atopic conjunctivitis A@ EP A TRAMADOL d03826A B R10 Abdominal and pelvic pain A@ E` A OFLOXACIN OPHTHALMIC d03977A A0 H66.9P Prevent ear infection A Ep A HYDROXYZINE d00907A Ap L23 Allergic contact dermatitis A Eހ A CETIRIZINE d03827A C- T78.40 Allergy, unspecified A Eސ A . . . Eޠ A AMPHETAMINE; DEXTROAMPHETAMINE d04035A B= F90 Attention-deficit hyperactivity disorders A0 Eޠ A CLONIDINE d00044A B F90 Attention-deficit hyperactivity disorders A0 Eޠ A GUANFACINE d00717A B F90 Attention-deficit hyperactivity disorders A0 Eް A METHYLPHENIDATE d00900A B F90 Attention-deficit hyperactivity disorders A E A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E A AMLODIPINE d00689A D I99.9 Unspecified disorder of circulatory system A E A ATORVASTATIN d04105A D E78.0 Pure hypercholesterolemia A E A BENAZEPRIL d00730A D I10 Essential (primary) hypertension A E A CARVEDILOL d03847A D I10 Essential (primary) hypertension A E A CILOSTAZOL d04382A D I70 Atherosclerosis A E A CLOPIDOGREL d04258A D D75.9P Prevent blood clots A E A DAPAGLIFLOZIN d07928A D E11 Type 2 diabetes mellitus A E A FUROSEMIDE d00070A D R60.9 Edema, unspecified A E A GLIPIZIDE d00246A D I70 Atherosclerosis A E A HYDRALAZINE d00132A D I10 Essential (primary) hypertension A E A LINAGLIPTIN d07767A D E11 Type 2 diabetes mellitus A E A METFORMIN d03807A D E11 Type 2 diabetes mellitus A E A OMEPRAZOLE d00325A Cr K21 Gastro-esophageal reflux disease A E0 A LEVOTHYROXINE d00278A D E03.9 Hypothyroidism, unspecified A E@ A . . . EP A ICOSAPENT d07891A B E78.0 Z79 Pure hypercholesterolemia Long term (current) drug therapy A E` A . . . Ep A . . . E߀ A BREXPIPRAZOLE d08373A Bz F32.9 Major depressive disorder, single episode, unspecified Ap E߀ A CETIRIZINE d03827A C- T78.40 Allergy, unspecified Ap E߀ A HYDROXYZINE d00907A C G47.9 Sleep disorder, unspecified Ap E߀ A OMEGA-3 POLYUNSATURATED FATTY ACIDS d00497A C 99999 Ap E߀ A OMEPRAZOLE d00325A C K21 Gastro-esophageal reflux disease Ap E߀ A PAROXETINE d03157A C F32.9 F41.9 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified Ap E߀ A PRAZOSIN d00138A C F41.9 Anxiety disorder, unspecified Ap Eߐ A AMLODIPINE d00689A D I10 Essential (primary) hypertension Ap Eߐ A GLIPIZIDE d00246A C E11 Type 2 diabetes mellitus Ap Eߐ A METFORMIN d03807A D E11 Type 2 diabetes mellitus Ap Eߐ A PAROXETINE d03157A B F32.9 F39 M79.2 Major depressive disorder, single episode, unspecified Unspecified mood [affective] disorder Neuralgia and neuritis, unspecified Ap Eߐ A RAMIPRIL d00728A D I10 Essential (primary) hypertension Ap Eߐ A ROSUVASTATIN d04851A D E78.0 Pure hypercholesterolemia Ap Eߐ A TAMSULOSIN d04121A C"0 R35 Polyuria Ap Eߠ A . . . E߰ A . . . E A . . . E A 77777 . . A E A . . . E A . . . E A . . . E A CLONAZEPAM d00197A Bz F41.9 Anxiety disorder, unspecified Ap E A INSULIN ASPART d04697A D% E11 Type 2 diabetes mellitus Ap E A METOPROLOL d00134A Ei I10 Essential (primary) hypertension Ap E A MUPIROCIN TOPICAL d01267A Ap 55555 Ap E A SERTRALINE d00880A B F43.9 Reaction to severe stress, unspecified Ap E A SEVELAMER d04363A Ei N19 Unspecified kidney failure Ap E A TRAMADOL d03826A B G47.9 M25.5 Sleep disorder, unspecified Pain in joint Ap E A . . . E0 A ALOGLIPTIN d07963A C E11 R73 Type 2 diabetes mellitus Elevated blood glucose level A E0 A AMLODIPINE d00689A CDp I10 Essential (primary) hypertension A E0 A CARVEDILOL d03847A C[@ I48.9 Unspecified atrial fibrillation and atrial flutter A E0 A FUROSEMIDE d00070A C R60.9 Edema, unspecified A E0 A LIRAGLUTIDE d07466A C E11 R73 Type 2 diabetes mellitus Elevated blood glucose level A E0 A METFORMIN d03807A C E11 Type 2 diabetes mellitus A E0 A PRAVASTATIN d00348A Cr E78.0 Pure hypercholesterolemia A E0 A RIVAROXABAN d07356A C D75.9P Prevent blood clots A E0 A SILDENAFIL d04299A C- N52.9 Male erectile dysfunction, unspecified A E0 A VALSARTAN d04113A C I21.P I63.P Prevent heart attack/myocardial infarction Prevent stroke A E@ A . . . EP A ATORVASTATIN d04105A B[ E78.0 Pure hypercholesterolemia A0 EP A LOSARTAN d03821A B I10 Essential (primary) hypertension A0 EP A SERTRALINE d00880A C F32.9 Major depressive disorder, single episode, unspecified A0 E` A ATORVASTATIN d04105A Cr E78.0 Pure hypercholesterolemia A E` A AZATHIOPRINE d00024A D# L93 Lupus erythematosus A E` A GABAPENTIN d03182A C M79.2 Neuralgia and neuritis, unspecified A E` A HYDROCHLOROTHIAZIDE d00253A B= R60.9 Edema, unspecified A E` A LEVOTHYROXINE d00278A Cr E07.9 Disorder of thyroid, unspecified A E` A RALOXIFENE d04261A Cr C50.P Prevent breast cancer A E` A TRAMADOL d03826A Cr M25.5 R52 Pain in joint Pain, unspecified A E` A VALSARTAN d04113A C I10 Essential (primary) hypertension A Ep A TERCONAZOLE TOPICAL d01238A A` B37 Candidiasis A E A ATROPINE; DIPHENOXYLATE d03506A C[@ R19.7 Diarrhea, unspecified Ap E A ESCITALOPRAM d04812A B[ F41.9 Anxiety disorder, unspecified Ap E A HYDRALAZINE d00132A B[ I10 Essential (primary) hypertension Ap E A MECLIZINE d00859A C R42 Dizziness and giddiness Ap E A METFORMIN d03807A D E11 Type 2 diabetes mellitus Ap E A METOPROLOL d00134A C I10 Essential (primary) hypertension Ap E A PRAVASTATIN d00348A B E78.0 Pure hypercholesterolemia Ap E A ESOMEPRAZOLE d04749A B[ B96.81 K21 Helicobacter pylori [H. pylori] as the cause of diseases classified elsewhere Gastro-esophageal reflux disease A0 E A FLUOXETINE d00236A B[ F41.0 F41.9 Panic disorder [episodic paroxysmal anxiety] without agoraphobia Anxiety disorder, unspecified A0 E A GABAPENTIN d03182A B= M79.6 Pain in limb, hand, foot, fingers and toes A0 E A LOVASTATIN d00280A C- E78.0 Pure hypercholesterolemia A E A . . . E A . . . E A ATORVASTATIN d04105A C- E78.0P Prevent high cholesterol Ap E A EMPAGLIFLOZIN d08275A C E11 Type 2 diabetes mellitus Ap E A GLIMEPIRIDE d03864A C E11 Type 2 diabetes mellitus Ap E A INSULIN GLARGINE d04538A C- E11 Type 2 diabetes mellitus Ap E A LISINOPRIL d00732A C- I21.P Prevent heart attack/myocardial infarction Ap E A METFORMIN d03807A D E11 Type 2 diabetes mellitus Ap E A METOPROLOL d00134A C- I21.P Prevent heart attack/myocardial infarction Ap E A . . . E A . . . E A . . . E A . . . E A BUPROPION d00181A CDp F41.9 Anxiety disorder, unspecified A E0 A LOSARTAN d03821A C I10 Essential (primary) hypertension A E0 A NORETHINDRONE d00555A C Z79.3 Long term (current) use of hormonal contraceptives A E@ A . . . EP A CYCLOBENZAPRINE d00963A C[@ M62.83 Muscle spasm A` EP A FENOFIBRATE d04286A Cr E78.0 Pure hypercholesterolemia A` EP A GABAPENTIN d03182A Cr G25.81 Restless legs syndrome A` EP A ISOSORBIDE MONONITRATE d00269A Cr I20.9 Angina pectoris, unspecified A` EP A MELOXICAM d04532A Cr M13 Other arthritis A` EP A PANTOPRAZOLE d04514A C- R10 Abdominal and pelvic pain A` E` A . . . Ep A CLONAZEPAM d00197A A F41.9 Anxiety disorder, unspecified A0 Ep A CYCLOBENZAPRINE d00963A A0 M79.1 Myalgia A0 Ep A IBUPROFEN d00015A C M54 Dorsalgia A0 E A ALBUTEROL d00749A A R06.9P Prevent breathing difficulty A E A PREDNISOLONE d00084A A J42 Unspecified chronic bronchitis A E A . . . E A . . . E A LISINOPRIL d00732A B I10 Essential (primary) hypertension A E A LISINOPRIL d00732A Cr I10 Essential (primary) hypertension A E A SIMVASTATIN d00746A Cr E78.0 Pure hypercholesterolemia A E A LISINOPRIL d00732A C I10 Essential (primary) hypertension A E A PRAVASTATIN d00348A C E78.0 Pure hypercholesterolemia A E A . . . E A IBUPROFEN d00015A C J02.0 Streptococcal pharyngitis A E A ALBUTEROL d00749A B R05 Cough A E A . . . E A DOXYCYCLINE d00037A B L70 Acne A E0 A . . . E@ A . . . EP A CARVEDILOL d03847A C[@ I10 Essential (primary) hypertension A` EP A CLOPIDOGREL d04258A B[ D75.9P Prevent blood clots A` EP A DOCUSATE d01021A B[ K59.0 Constipation A` EP A GLIPIZIDE d00246A C E11 Type 2 diabetes mellitus A` EP A PANTOPRAZOLE d04514A C K21 Gastro-esophageal reflux disease A` EP A SIMVASTATIN d00746A Dc E78.0 Pure hypercholesterolemia A` E` A . . . Ep A . . . E A . . . E A . . . E A . . . E A ACYCLOVIR d00001A A0 R52 Pain, unspecified A0 E A LISINOPRIL d00732A CDp I10 Essential (primary) hypertension A0 E A METHYLPREDNISOLONE d00293A A0 R07.9 Chest pain, unspecified A0 E A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E0 A . . . E@ A . . . EP A . . . E` A . . . Ep A . . . E A AZITHROMYCIN d00091A0 A` J18.9 Pneumonia, unspecified organism A E A FEXOFENADINE d04040A C J30.1 J30.9 T78.40 Allergic rhinitis due to pollen Allergic rhinitis, unspecified Allergy, unspecified A E A BROMPHENIRAMINE; PSEUDOEPHEDRINE d03301A B J00 Acute nasopharyngitis [common cold] A E A ATORVASTATIN d04105A C[@ E78.0 Pure hypercholesterolemia A0 E A LISINOPRIL d00732A C I10 Essential (primary) hypertension A0 E A METFORMIN d03807A Dc E11 Type 2 diabetes mellitus A0 E A . . . E A ATENOLOL d00004A C I10 Essential (primary) hypertension A E A PANTOPRAZOLE d04514A A R10 Abdominal and pelvic pain A E A . . . E A . . . E A ENALAPRIL; HYDROCHLOROTHIAZIDE d03740A0 D I10 Essential (primary) hypertension AP E A METHENAMINE d00106A0 C N39.0 Urinary tract infection, site not specified AP E A MIRABEGRON d07876A0 B R32 Unspecified urinary incontinence AP E A OXYBUTYNIN d00328A0 Dc R32 Unspecified urinary incontinence AP E A RALOXIFENE d04261A D# M81.P Prevent bone loss/osteoporosis AP E A . . . E A . . . E0 A AMLODIPINE d00689A Cr I10 Essential (primary) hypertension A E0 A DILTIAZEM d00045A Cr I10 Essential (primary) hypertension A E0 A GABAPENTIN d03182A CDp M79.2 Neuralgia and neuritis, unspecified A E0 A HYDROCHLOROTHIAZIDE; TRIAMTERENE d03052A C I10 R60.9 Essential (primary) hypertension Edema, unspecified A E0 A LOSARTAN d03821A Cr I10 Essential (primary) hypertension A E0 A LOVASTATIN d00280A Cr I21.P Prevent heart attack/myocardial infarction A E0 A METFORMIN d03807A C[@ E11 Type 2 diabetes mellitus A E0 A MIRABEGRON d07876A CDp R32 Unspecified urinary incontinence A E@ A . . . EP A . . . E` A . . . Ep A ALLOPURINOL d00023A C[@ M10.9P Prevent gout A0 Ep A HYDROCHLOROTHIAZIDE d00253A D* I10 Essential (primary) hypertension A0 Ep A LISINOPRIL d00732A D* I10 Essential (primary) hypertension A0 E A ACARBOSE d03846A Dc E11 Type 2 diabetes mellitus Ap E A GLIPIZIDE d00246A Dc E11 Type 2 diabetes mellitus Ap E A ICOSAPENT d07891A C- E78.1 Pure hyperglyceridemia Ap E A METFORMIN; SITAGLIPTIN d06720A Dc E11 Type 2 diabetes mellitus Ap E A OLMESARTAN d04801A Dc I10 Essential (primary) hypertension Ap E A SIMVASTATIN d00746A Cr E78.0 Pure hypercholesterolemia Ap E A TAMSULOSIN d04121A Cr N40 Enlarged prostate Ap E A AMOXICILLIN d00088A Ap J01.9 Acute sinusitis, unspecified A E A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E A DULOXETINE d05355A Cr 99999 A` E A FINASTERIDE d00563A D 99999 A` E A GLIPIZIDE; METFORMIN d04823A D E11 Type 2 diabetes mellitus A` E A HYDROCHLOROTHIAZIDE; TELMISARTAN d04737A Dc I10 Essential (primary) hypertension A` E A SIMVASTATIN d00746A D E78.0 Pure hypercholesterolemia A` E A TAMSULOSIN d04121A D N40 Enlarged prostate A` E A PAROXETINE d03157A B F41.9 Anxiety disorder, unspecified A E A . . . E0 A 99999 . . A` E0 A ATOMOXETINE d04827A D* F90 Attention-deficit hyperactivity disorders A` E0 A LISINOPRIL d00732A CDp I10 Essential (primary) hypertension A` E0 A LOVASTATIN d00280A CDp E78.0 Pure hypercholesterolemia A` E0 A OXYBUTYNIN d00328A C 55555 A` E0 A RANITIDINE d00021A CDp K21 Gastro-esophageal reflux disease A` E@ A LISINOPRIL d00732A C- I10 Essential (primary) hypertension A E@ A NIFEDIPINE d00051A C- I10 Essential (primary) hypertension A EP A ATORVASTATIN d04105A Cr E78.0 Pure hypercholesterolemia A` EP A FUROSEMIDE d00070A C R60.9 Edema, unspecified A` EP A HYDRALAZINE d00132A A I10 Essential (primary) hypertension A` EP A LISINOPRIL d00732A C- I10 Essential (primary) hypertension A` EP A NIFEDIPINE d00051A B[ I10 Essential (primary) hypertension A` EP A SITAGLIPTIN d05896A B[ E11 Type 2 diabetes mellitus A` E` A . . . Ep A . . . E A . . . E A . . . E A . . . E A AMOXICILLIN; CLAVULANATE d00089A AP H66.9 Otitis media, unspecified A E A BUPROPION d00181A B 99999 AP E A CLOPIDOGREL d04258A B 99999 AP E A FUROSEMIDE d00070A B 99999 AP E A LISINOPRIL d00732A B I10 Essential (primary) hypertension AP E A METOPROLOL d00134A B 99999 AP E A EZETIMIBE d04824A D E78.0 Pure hypercholesterolemia A@ E A LEVOTHYROXINE d00278A D1 E05 Thyrotoxicosis [hyperthyroidism] A@ E A LISINOPRIL d00732A D I10 Essential (primary) hypertension A@ E A SIMVASTATIN d00746A D E78.0 Pure hypercholesterolemia A@ E A . . . E A . . . E A . . . E A CARVEDILOL d03847A C9 I10 Essential (primary) hypertension A E A NIFEDIPINE d00051A C9 I10 Essential (primary) hypertension A E A . . . E0 A . . . E@ A AMOXICILLIN d00088A C A49.9P Prevent bacterial infection A E@ A WARFARIN d00022A Dc Z95 Presence of cardiac and vascular implants and grafts A EP A NAPROXEN d00019A C K08.8 Other specified disorders of teeth and supporting structures A E` A . . . Ep A INSULIN DEGLUDEC d08054A B* E11 Type 2 diabetes mellitus A` Ep A LOSARTAN d03821A C I63.P Prevent stroke A` Ep A MELOXICAM d04532A C M19.9 Osteoarthritis, unspecified site A` Ep A METOPROLOL d00134A C I10 Essential (primary) hypertension A` Ep A SEMAGLUTIDE d08688A B E11 Type 2 diabetes mellitus A` Ep A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia A` E A . . . E A . . . E A . . . E A . . . E A . . . E A ALPRAZOLAM d00168A Cr G47.0 Insomnia A@ E A AMLODIPINE d00689A C G47.0 Insomnia A@ E A NADOLOL d00018A C I10 Essential (primary) hypertension A@ E A POTASSIUM CHLORIDE d00345A Cr 99999 A@ E A . . . E A . . . E A . . . E A . . . E A . . . E0 A METFORMIN d03807A C E11 Type 2 diabetes mellitus A E@ A . . . EP A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A C[@ I10 Essential (primary) hypertension A EP A NAPROXEN d00019A C[@ R10 Abdominal and pelvic pain A E` A IBUPROFEN d00015A Bz M85.9 Disorder of bone density and structure, unspecified A Ep A PROMETHAZINE d00787A B R05 Cough A E A BUPROPION d00181A C- F32.9 F41.9 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified A E A DULOXETINE d05355A B F32.9 F41.9 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified A E A HYDROCHLOROTHIAZIDE; VALSARTAN d04293A CDp I10 Essential (primary) hypertension A E A ICOSAPENT d07891A B E78.1 Pure hyperglyceridemia A E A METFORMIN d03807A B E11 Type 2 diabetes mellitus A E A PIOGLITAZONE d04442A B E11 Type 2 diabetes mellitus A E A ROSUVASTATIN d04851A B E78.0 Pure hypercholesterolemia A E A TADALAFIL d04896A B I27.9 N40 Pulmonary heart disease, unspecified Enlarged prostate A E A ISOSORBIDE d00653A C R07.9 Chest pain, unspecified AP E A METOPROLOL d00134A D I10 Essential (primary) hypertension AP E A SIMVASTATIN d00746A D E78.0 Pure hypercholesterolemia AP E A SUCRALFATE d00377A Cr G89 Pain, not elsewhere classified AP E A TERAZOSIN d00386A D N40 Enlarged prostate AP E A ESCITALOPRAM d04812A C- F41.9 Anxiety disorder, unspecified A0 E A TELMISARTAN d04364A C- I10 Essential (primary) hypertension A0 E A TEMAZEPAM d00384A B G47.9 Sleep disorder, unspecified A0 E A ATENOLOL d00004A Cr I10 Essential (primary) hypertension Ap E A HYDRALAZINE d00132A C I10 Essential (primary) hypertension Ap E A HYDROCHLOROTHIAZIDE d00253A C I10 Essential (primary) hypertension Ap E A LEVOTHYROXINE d00278A C[@ E03.9 Hypothyroidism, unspecified Ap E A LOSARTAN d03821A C[@ I10 Essential (primary) hypertension Ap E A METFORMIN d03807A C[@ E11 Type 2 diabetes mellitus Ap E A SIMVASTATIN d00746A C[@ E78.0 Pure hypercholesterolemia Ap E A AMLODIPINE d00689A0 Cr I10 Essential (primary) hypertension B E A ATORVASTATIN d04105A0 C[@ E78.0 Pure hypercholesterolemia B E A CETIRIZINE d03827A0 C- T78.40 Allergy, unspecified B E A CYANOCOBALAMIN d00413A C D64.9 Anemia, unspecified B E A DIAZEPAM d00148A0 C- G47.0 Insomnia B E A DIPHENHYDRAMINE d00212A0 Bz L23 Allergic contact dermatitis B E A DOCUSATE d01021A0 Cr K59.0 Constipation B E A DONEPEZIL d04099A0 C- G31.9 Degenerative disease of nervous system, unspecified B E A DOXEPIN d00217A0 B F32.9 Major depressive disorder, single episode, unspecified B E A LOSARTAN d03821A0 Cr I10 Essential (primary) hypertension B E A MEMANTINE d04899A0 C- G31.9 Degenerative disease of nervous system, unspecified B E A METOPROLOL d00134A0 C[@ I10 Essential (primary) hypertension B E A MIRTAZAPINE d04025A0 C- F32.9 F41.9 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified B E A MOMETASONE TOPICAL d01300A0 Cr L40 Psoriasis B E A MONTELUKAST d04289A0 B[ L29.9 Pruritus, unspecified B E A NYSTATIN TOPICAL d04399A0 B[ B35 Dermatophytosis B E A OMEPRAZOLE d00325A0 Cr K21 Gastro-esophageal reflux disease B E A TIZANIDINE d04102A0 C- M62.83 Muscle spasm B E A TRIAMCINOLONE TOPICAL d03206A0 Cr R21 Rash and other nonspecific skin eruption B E A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E0 A AMLODIPINE d00689A C- I10 Essential (primary) hypertension A E0 A CARVEDILOL d03847A Cr I10 Essential (primary) hypertension A E0 A COBICISTAT; DARUNAVIR d08305A C- B20 Human immunodeficiency virus [HIV] disease A E0 A DOLUTEGRAVIR d08117A Cr B20 Human immunodeficiency virus [HIV] disease A E0 A ENTECAVIR d05525A C[@ B19 Unspecified viral hepatitis A E0 A METOCLOPRAMIDE d00298A Cr R11 Nausea and vomiting A E0 A PANCRELIPASE d01002A C- K87 Disorders of gallbladder, biliary tract and pancreas in diseases classified elsewhere A E0 A RANITIDINE d00021A Cr K21 K30 Gastro-esophageal reflux disease Functional dyspepsia A E@ A . . . EP A . . . E` A . . . Ep A METFORMIN d03807A D E11 Type 2 diabetes mellitus A Ep A METOPROLOL d00134A C I10 Essential (primary) hypertension A E A . . . E A . . . E A . . . E A FLUTICASONE NASAL d04283A D J30.2 Other seasonal allergic rhinitis A0 E A MONTELUKAST d04289A CDp J30.9 Allergic rhinitis, unspecified A0 E A SIMVASTATIN d00746A D E78.0 Pure hypercholesterolemia A0 E A . . . E A . . . E A . . . E A . . . E A AMLODIPINE d00689A C I10 Essential (primary) hypertension Ap E A ATENOLOL d00004A C I10 Essential (primary) hypertension Ap E A HYDROCHLOROTHIAZIDE d00253A C I10 R60.9 Essential (primary) hypertension Edema, unspecified Ap E A LISINOPRIL d00732A C- I10 Essential (primary) hypertension Ap E A METFORMIN d03807A B E11 Type 2 diabetes mellitus Ap E A SERTRALINE d00880A C F32.9 F41.9 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified Ap E A SIMVASTATIN d00746A B< I21.P Prevent heart attack/myocardial infarction Ap E A RANITIDINE d00021A Bz K21 Gastro-esophageal reflux disease A E A . . . E0 A LEVOTHYROXINE d00278A D E03.9 Hypothyroidism, unspecified A E@ A APIXABAN d07804A C D75.9P I48.9 Prevent blood clots Unspecified atrial fibrillation and atrial flutter A0 E@ A PANTOPRAZOLE d04514A CDp K27 Peptic ulcer, site unspecified A0 E@ A VERAPAMIL d00048A C- I49.9 Cardiac arrhythmia, unspecified A0 EP A . . . E` A . . . Ep A BUPROPION d00181A C- F32.9 F41.9 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified A0 Ep A MECLIZINE d00859A C[@ H93.9 Unspecified disorder of ear A0 Ep A TOPIRAMATE d04115A C[@ G43 Migraine A0 E A CLOPIDOGREL d04258A B[ I63.P Prevent stroke Ap E A DONEPEZIL; MEMANTINE d08337A CDp R41 Other symptoms and signs involving cognitive functions and awareness Ap E A ESCITALOPRAM d04812A C[@ F32.9 Major depressive disorder, single episode, unspecified Ap E A GLIMEPIRIDE d03864A C E11 Type 2 diabetes mellitus Ap E A HYDROCHLOROTHIAZIDE; LOSARTAN d03830A B= I10 Essential (primary) hypertension Ap E A LANSOPRAZOLE d03828A D K21 Gastro-esophageal reflux disease Ap E A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified Ap E A BUSPIRONE d00182A C[@ F41.9 Anxiety disorder, unspecified A0 E A HYDROCHLOROTHIAZIDE; LOSARTAN d03830A C[@ I10 Essential (primary) hypertension A0 E A OMEPRAZOLE d00325A B K21 Gastro-esophageal reflux disease A0 E A . . . E A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia A E A BUDESONIDE; FORMOTEROL d04795A CP J45 Asthma A E A CELECOXIB d04380A D M13 Other arthritis A E A ESTROPIPATE d00543A Cr N95 Menopausal and other perimenopausal disorders A E A GABAPENTIN d03182A D M79.2 Neuralgia and neuritis, unspecified A E A LOSARTAN d03821A C I10 Essential (primary) hypertension A E A PRIMIDONE d00352A D R25.1 Tremor, unspecified A E A RABEPRAZOLE d04448A C K30 Functional dyspepsia A E A ROSUVASTATIN d04851A C- E78.0 Pure hypercholesterolemia A E A SERTRALINE d00880A D* F41.9 Anxiety disorder, unspecified A E A . . . E A ALPRAZOLAM d00168A C- F41.0 Panic disorder [episodic paroxysmal anxiety] without agoraphobia Ap E A DIVALPROEX SODIUM d03833A C G40 Epilepsy and recurrent seizures Ap E A ESCITALOPRAM d04812A Cr F32.9 Major depressive disorder, single episode, unspecified Ap E A LAMOTRIGINE d03809A C G40 Epilepsy and recurrent seizures Ap E A LEVETIRACETAM d04499A D G40 Epilepsy and recurrent seizures Ap E A PRIMIDONE d00352A C R06.9 R25.1 Unspecified abnormalities of breathing Tremor, unspecified Ap E A PROMETHAZINE d00787A B R11 Nausea and vomiting Ap E A ATORVASTATIN d04105A Ap E11 Type 2 diabetes mellitus AP E A BUPROPION d00181A D* F31.9 F32.9 F41.9 Bipolar disorder, unspecified Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified AP E A CHLORPROMAZINE d00064A D* F31.9 F32.9 F41.9 Bipolar disorder, unspecified Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified AP E A METFORMIN d03807A Ap E11 Type 2 diabetes mellitus AP E A RISPERIDONE d03180A D* F20 F31.9 F32.9 Schizophrenia Bipolar disorder, unspecified Major depressive disorder, single episode, unspecified AP E A . . . E A HYDROCHLOROTHIAZIDE d00253A C- I10 R60.9 Essential (primary) hypertension Edema, unspecified A E A OMEPRAZOLE d00325A C- K21 Gastro-esophageal reflux disease A E A BUPROPION d00181A C F41.9 Anxiety disorder, unspecified A0 E A CITALOPRAM d04332A A F32.9 Major depressive disorder, single episode, unspecified A0 E A SERTRALINE d00880A A F32.9 Major depressive disorder, single episode, unspecified A0 E0 A . . . E@ A . . . EP A . . . E` A . . . Ep A FLUTICASONE NASAL d04283A C J30.2 Other seasonal allergic rhinitis A Ep A PAROXETINE d03157A C F41.9 Anxiety disorder, unspecified A E A . . . E A . . . E A AMOXICILLIN d00088A Ap K04.7 Periapical abscess without sinus A0 E A GLIPIZIDE d00246A CDp E11 Type 2 diabetes mellitus A0 E A IBUPROFEN d00015A D M79.1 Z96 Myalgia Presence of other functional implants A0 E A AMLODIPINE d00689A C I10 Essential (primary) hypertension Ap E A CITALOPRAM d04332A Cr F32.9 F41.9 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified Ap E A CLOPIDOGREL d04258A C D75.9P I63.P Prevent blood clots Prevent stroke Ap E A LEVOTHYROXINE d00278A Cr E03.9 Hypothyroidism, unspecified Ap E A METFORMIN d03807A C R73 Elevated blood glucose level Ap E A METOPROLOL d00134A CDp I10 Essential (primary) hypertension Ap E A PRAVASTATIN d00348A C E78.0 Pure hypercholesterolemia Ap E A . . . E A . . . E A . . . E A DIURETICS - UNSPECIFIED c00049A Cr R60.9 Edema, unspecified A E A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A D* I10 Essential (primary) hypertension A E A . . . E A AMLODIPINE; OLMESARTAN d06905A D I10 Essential (primary) hypertension A E A RIFAMPIN d00047A B A49.9P Prevent bacterial infection A E0 A . . . E@ A . . . EP A AMLODIPINE d00689A C I10 Essential (primary) hypertension A EP A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia A E` A . . . Ep A . . . E A . . . E A . . . E A . . . E A ALBUTEROL d00749A C J45 Asthma A E A ALLOPURINOL d00023A Dc M1A Chronic gout A E A CARVEDILOL d03847A C- I50.9 Heart failure, unspecified A E A CHLORZOXAZONE d00962A DGJ M79.1 Myalgia A E A CLOBETASOL TOPICAL d01288A Dc L40 Psoriasis A E A FLUTICASONE NASAL d04283A Cr J30.9 Allergic rhinitis, unspecified A E A FLUTICASONE; SALMETEROL d04611A B- J45 Asthma A E A HYDROCHLOROTHIAZIDE; OLMESARTAN d04878A C I10 Essential (primary) hypertension A E A LATANOPROST OPHTHALMIC d04017A C H40 Glaucoma A E A METFORMIN d03807A C R73 Elevated blood glucose level A E A NIACIN d00314A C E78.0 Pure hypercholesterolemia A E A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia A E A ACETAMINOPHEN; OXYCODONE d03431A D* M19.9 M85.9 Osteoarthritis, unspecified site Disorder of bone density and structure, unspecified A E A ATORVASTATIN d04105A D E78.0 Pure hypercholesterolemia A E A FLUTICASONE; VILANTEROL d08100A C J44.9 Chronic obstructive pulmonary disease, unspecified A E A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified A E A PREDNISONE d00350A C J44.9 Chronic obstructive pulmonary disease, unspecified A E A SERTRALINE d00880A C- F32.9 F41.9 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified A E A SILDENAFIL d04299A B I27.9 Pulmonary heart disease, unspecified A E A UMECLIDINIUM d08187A C J44.9 Chronic obstructive pulmonary disease, unspecified A E A . . . E A ATORVASTATIN d04105A Dc E78.0 Pure hypercholesterolemia A@ E A LEFLUNOMIDE d04349A A M06.9 Rheumatoid arthritis, unspecified A@ E A SUCRALFATE d00377A B K25.P Prevent gastric ulcer A@ E A TELMISARTAN d04364A0 D* I10 Essential (primary) hypertension A@ E A . . . E A . . . E A . . . E A CYPROHEPTADINE d00790A Ap T78.40 Allergy, unspecified A E0 A LATANOPROST OPHTHALMIC d04017A0 C H40 Glaucoma A E0 A METFORMIN d03807A0 C[@ E11 Type 2 diabetes mellitus A E0 A MIRABEGRON d07876A0 C"0 R32 Unspecified urinary incontinence A E0 A MIRTAZAPINE d04025A0 CDp G47.9 Sleep disorder, unspecified A E0 A OMEPRAZOLE d00325A0 D# K30 Functional dyspepsia A E0 A PRAVASTATIN d00348A0 C[@ E78.0P Prevent high cholesterol A E0 A RISPERIDONE d03180A0 C[@ F39 Unspecified mood [affective] disorder A E0 A TAMSULOSIN d04121A0 Bz R39.1 Other difficulties with micturition A E0 A VENLAFAXINE d03181A0 C- F32.9 Major depressive disorder, single episode, unspecified A E@ A CLINDAMYCIN d00043A B 55555 A@ E@ A CLONAZEPAM d00197A CDp F32.9 F41.9 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified A@ E@ A LEVOFLOXACIN d04109A Ap L08.9 Local infection of the skin and subcutaneous tissue, unspecified A@ E@ A METOPROLOL d00134A B[ I48.9 Unspecified atrial fibrillation and atrial flutter A@ EP A . . . E` A . . . Ep A ALBUTEROL d00749A C J45 Asthma A Ep A SULFACETAMIDE SODIUM OPHTHALMIC d01208A A H10 Conjunctivitis A E A . . . E A . . . E A . . . E A . . . E A ALBUTEROL; IPRATROPIUM d04066A CDp J44.9 Chronic obstructive pulmonary disease, unspecified A E A ASPIRIN d00170A C- D75.9P Prevent blood clots A E A ATORVASTATIN d04105A CDp E78.0 Pure hypercholesterolemia A E A BUPROPION d00181A Cr F32.9 Major depressive disorder, single episode, unspecified A E A BUSPIRONE d00182A D ^ F41.9 Anxiety disorder, unspecified A E A CALCIPOTRIENE TOPICAL d03788A C L40 Psoriasis A E A FLUOXETINE d00236A D ^ F32.9 Major depressive disorder, single episode, unspecified A E A LORAZEPAM d00149A C F41.9 Anxiety disorder, unspecified A E A . . . E A . . . E A FINASTERIDE d00563A C"0 99999 A0 E A OMEPRAZOLE d00325A C"0 99999 A0 E A TAMSULOSIN d04121A C"0 99999 A0 E A METOPROLOL d00134A C I10 Essential (primary) hypertension AP E A RIVAROXABAN d07356A C D75.9P Prevent blood clots AP E A THYROID DESICCATED d00655A D- E03.9 Hypothyroidism, unspecified AP E A TRAZODONE d00395A C[@ G47.0 Insomnia AP E A VILAZODONE d07740A B F32.9 Major depressive disorder, single episode, unspecified AP E A . . . E A ALENDRONATE d03849A C M81 Osteoporosis without current pathological fracture A0 E A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A0 E A LOSARTAN d03821A D I10 Essential (primary) hypertension A0 E0 A CIPROFLOXACIN d00011A Ap N39.0 Urinary tract infection, site not specified A E0 A TRAMADOL d03826A A@ N94 Pain and other conditions associated with female genital organs and menstrual cycle A E@ A . . . EP A CANAGLIFLOZIN; METFORMIN d08280A C- E11 Type 2 diabetes mellitus A EP A CARVEDILOL d03847A D I10 Essential (primary) hypertension A EP A DILTIAZEM d00045A CDp R00 Abnormalities of heart beat A EP A FUROSEMIDE d00070A B I51.9 Heart disease, unspecified A EP A POTASSIUM CHLORIDE d00345A B[ E87.6 Hypokalemia A EP A RAMIPRIL d00728A Cr I50.9 Heart failure, unspecified A EP A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia A EP A WARFARIN d00022A D D75.9P Prevent blood clots A E` A AMLODIPINE d00689A C I10 Essential (primary) hypertension A` E` A ATORVASTATIN d04105A CP E78.0 Pure hypercholesterolemia A` E` A DORZOLAMIDE; TIMOLOL OPHTHALMIC d04303A C H40 Glaucoma A` E` A LATANOPROST OPHTHALMIC d04017A C H40 Glaucoma A` E` A LOSARTAN d03821A C[@ 99999 A` E` A METFORMIN d03807A C R73 Elevated blood glucose level A` Ep A ATORVASTATIN d04105A C"0 E11.2 Type 2 diabetes mellitus with kidney complications A0 Ep A INSULIN LISPRO d04373A C"0 E11 Type 2 diabetes mellitus A0 Ep A LISINOPRIL d00732A C"0 E11.2P Prevent diabetic kidney disease A0 E A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E A ALBUTEROL d00749A A R06.9P Prevent breathing difficulty A E A . . . E0 A . . . E@ A AMLODIPINE d00689A CP I10 Essential (primary) hypertension AP E@ A ASPIRIN d00170A CP I21.P I51.9P Prevent heart attack/myocardial infarction Prevent heart disease AP E@ A HYDROCHLOROTHIAZIDE d00253A CP I10 Essential (primary) hypertension AP E@ A LISINOPRIL d00732A CP I10 Essential (primary) hypertension AP E@ A PRAVASTATIN d00348A CP E78.0 Pure hypercholesterolemia AP EP A . . . E` A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A@ E` A CHLORTHALIDONE d00192A C[@ I10 Essential (primary) hypertension A@ E` A METFORMIN d03807A C R73 Elevated blood glucose level A@ E` A METOPROLOL d00134A C I10 Essential (primary) hypertension A@ Ep A GLIPIZIDE d00246A C E11 Type 2 diabetes mellitus A@ Ep A HYDROCHLOROTHIAZIDE d00253A C- I10 Essential (primary) hypertension A@ Ep A LISINOPRIL d00732A C- E78.0 Pure hypercholesterolemia A@ Ep A METFORMIN d03807A C E11 Type 2 diabetes mellitus A@ E A . . . E A IRBESARTAN d04222A C I10 Essential (primary) hypertension A0 E A LEVOTHYROXINE d00278A Dc E03.9 Hypothyroidism, unspecified A0 E A METFORMIN d03807A CDp E11 Type 2 diabetes mellitus A0 E A AMLODIPINE d00689A C I10 Essential (primary) hypertension A E A ATORVASTATIN d04105A C"0 E78.0 Pure hypercholesterolemia A E A CYCLOBENZAPRINE d00963A D9 M62.83 Muscle spasm A E A GLIPIZIDE d00246A D E11 R73 Type 2 diabetes mellitus Elevated blood glucose level A E A GUAIFENESIN d00797A B J00 Acute nasopharyngitis [common cold] A E A METFORMIN d03807A D R73 Elevated blood glucose level A E A OMEPRAZOLE d00325A D K27 Peptic ulcer, site unspecified A E A SILDENAFIL d04299A C[@ I99.9 Unspecified disorder of circulatory system A E A . . . E A . . . E A AMLODIPINE d00689A A I10 Essential (primary) hypertension AP E A BACLOFEN d00967A B M62.83 Muscle spasm AP E A CLONAZEPAM d00197A Ei F41.0 F41.9 Panic disorder [episodic paroxysmal anxiety] without agoraphobia Anxiety disorder, unspecified AP E A FLUOXETINE d00236A Ei I10 Essential (primary) hypertension AP E A LEVOTHYROXINE d00278A Ei E07.9 Disorder of thyroid, unspecified AP E A CARVEDILOL d03847A B= I10 I48.9 Essential (primary) hypertension Unspecified atrial fibrillation and atrial flutter A0 E A CLOPIDOGREL d04258A B I21.P Prevent heart attack/myocardial infarction A0 E A PANTOPRAZOLE d04514A B= K21 Gastro-esophageal reflux disease A0 E A . . . E A . . . E A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A E A ALBUTEROL d00749A C- J45 Asthma A@ E A AMOXICILLIN d00088A A H66.9 Otitis media, unspecified A@ E A CETIRIZINE d03827A Ap R05 Cough A@ E A FLUTICASONE NASAL d04283A C J30.9 Allergic rhinitis, unspecified A@ E0 A AMLODIPINE d00689A CDp I10 Essential (primary) hypertension A` E0 A ATORVASTATIN d04105A CDp E78.0 Pure hypercholesterolemia A` E0 A FLUOXETINE d00236A C F32.9 Major depressive disorder, single episode, unspecified A` E0 A LISINOPRIL d00732A CDp I10 Essential (primary) hypertension A` E0 A LORAZEPAM d00149A Cr F41.0 F41.9 Panic disorder [episodic paroxysmal anxiety] without agoraphobia Anxiety disorder, unspecified A` E0 A SUMATRIPTAN d03160A CDp G43 Migraine A` E@ A CETIRIZINE d03827A C T78.40 Allergy, unspecified A0 E@ A DICYCLOMINE d00999A D R10 Abdominal and pelvic pain A0 E@ A FLUTICASONE NASAL d04283A Cr J30.9 Allergic rhinitis, unspecified A0 EP A . . . E` A . . . Ep A IBANDRONATE d05357A C- M81 Osteoporosis without current pathological fracture A Ep A METFORMIN d03807A C- R73 Elevated blood glucose level A E A . . . E A . . . E A . . . E A . . . E A . . . E A AMLODIPINE d00689A C I10 Essential (primary) hypertension A E A CLONIDINE d00044A C I10 Essential (primary) hypertension A E A ESOMEPRAZOLE d04749A C K21 Gastro-esophageal reflux disease A E A FUROSEMIDE d00070A C R60.9 Edema, unspecified A E A METFORMIN d03807A D E11 Type 2 diabetes mellitus A E A POTASSIUM CHLORIDE d00345A C E87.6 Hypokalemia A E A RAMIPRIL d00728A C I10 Essential (primary) hypertension A E A ROSUVASTATIN d04851A B E78.0 Pure hypercholesterolemia A E A ROSUVASTATIN d04851A C E78.0 Pure hypercholesterolemia A E A FEXOFENADINE d04040A C L23 R09.81 T78.40 Allergic contact dermatitis Nasal congestion Allergy, unspecified A@ E A MONTELUKAST d04289A Bz J30.9 Allergic rhinitis, unspecified A@ E A PROMETHAZINE d00787A A G43 Migraine A@ E A TRAZODONE d00395A Cr F33.9 F41.9 G47.0 Major depressive disorder, recurrent, unspecified Anxiety disorder, unspecified Insomnia A@ E A HYDROCHLOROTHIAZIDE d00253A C I10 Essential (primary) hypertension A E A RANITIDINE d00021A A K30 Functional dyspepsia A E A AMOXICILLIN d00088A B H66.9 Otitis media, unspecified A E A ALBUTEROL d00749A B J45 Asthma A E A BECLOMETHASONE d00760A B J45 Asthma A E A . . . E0 A . . . E@ A . . . EP A ETHINYL ESTRADIOL; NORETHINDRONE d03238A C N92 Excessive, frequent and irregular menstruation A E` A . . . Ep A ALBUTEROL d00749A C[@ R05 R06.02 R06.2 Cough Shortness of breath Wheezing A Ep A PREDNISONE d00350A Cr T78.40 Allergy, unspecified A E A FENOFIBRATE d04286A B E78.0 E78.1 Pure hypercholesterolemia Pure hyperglyceridemia Ap E A FLUTICASONE NASAL d04283A B J30.2 Other seasonal allergic rhinitis Ap E A GABAPENTIN d03182A C[@ G25.81 Restless legs syndrome Ap E A LOSARTAN d03821A C I10 Essential (primary) hypertension Ap E A METOPROLOL d00134A C[@ I10 Essential (primary) hypertension Ap E A SERTRALINE d00880A C[@ R10 Abdominal and pelvic pain Ap E A SITAGLIPTIN d05896A C R73 Elevated blood glucose level Ap E A BROMPHENIRAMINE; DEXTROMETHORPHAN; PSEUDOEPHEDRINE d03368A A R05 R09.81 Cough Nasal congestion A E A OSELTAMIVIR d04462A A J09 Influenza due to certain identified influenza viruses A E A . . . E A . . . E A GABAPENTIN d03182A Cr R20 Disturbances of skin sensation A0 E A HYDROXYCHLOROQUINE d00817A C[@ L93 Lupus erythematosus A0 E A TAMSULOSIN d04121A Cr N40 Enlarged prostate A0 E A . . . E A FINASTERIDE d00563A Dc L65.9 Nonscarring hair loss, unspecified A E A . . . E A SERTRALINE d00880A C[@ F41.9 Anxiety disorder, unspecified A E A . . . E A AMLODIPINE d00689A Cr I10 Essential (primary) hypertension A` E A BUPROPION d00181A CDp F32.9 Major depressive disorder, single episode, unspecified A` E A LISINOPRIL d00732A D# I10 Essential (primary) hypertension A` E A METOPROLOL d00134A Cr R00 Abnormalities of heart beat A` E A SPIRONOLACTONE d00373A Cr I10 Essential (primary) hypertension A` E A TRAZODONE d00395A CDp G47.0 G47.9 Insomnia Sleep disorder, unspecified A` E0 A . . . E@ A . . . EP A . . . E` A . . . Ep A . . . E A APIXABAN d07804A B D75.9P Prevent blood clots A@ E A ATENOLOL d00004A Dc I10 Essential (primary) hypertension A@ E A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A@ E A LOSARTAN d03821A C I10 Essential (primary) hypertension A@ E A . . . E A 99999 . . A E A . . . E A . . . E A . . . E A ACETAMINOPHEN; HYDROCODONE d03428A C M25.5 M54 Pain in joint Dorsalgia A0 E A GABAPENTIN d03182A C- M79.2 Neuralgia and neuritis, unspecified A0 E A IBUPROFEN d00015A C Z79.1 Long term (current) use of non-steroidal anti-inflammatories (NSAID) A0 E A ACETAMINOPHEN; HYDROCODONE d03428A A K08.8 Other specified disorders of teeth and supporting structures A E A PENICILLIN V POTASSIUM d07730A A A49.9P Prevent bacterial infection A E A . . . E A . . . E A ALBUTEROL d00749A D% J45 Asthma A E A BUDESONIDE; FORMOTEROL d04795A C- J45 Asthma A E0 A LISINOPRIL d00732A C I10 Essential (primary) hypertension A E@ A . . . EP A . . . E` A OMEPRAZOLE d00325A B[ R12 Heartburn A Ep A . . . E A . . . E A TAMSULOSIN d04121A D N40 R35 Enlarged prostate Polyuria A E A ALBUTEROL d00749A C J45 Asthma A E A ATORVASTATIN d04105A C- E78.0 Pure hypercholesterolemia A0 E A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A C- I10 Essential (primary) hypertension A0 E A NAPROXEN d00019A C- M54 Dorsalgia A0 E A . . . E A PAROXETINE d03157A C- F41.9 Anxiety disorder, unspecified A E A . . . E A . . . E A . . . E A ATORVASTATIN d04105A Bz E78.0 Pure hypercholesterolemia A@ E A GLIPIZIDE d00246A Bz R73 Elevated blood glucose level A@ E A LISINOPRIL d00732A Bz I10 Essential (primary) hypertension A@ E A METFORMIN d03807A Bz R73 Elevated blood glucose level A@ E A ENALAPRIL d00013A0 Dc I10 Essential (primary) hypertension A E A FLUOXETINE d00236A0 CDp F32.9 Major depressive disorder, single episode, unspecified A E A GABAPENTIN d03182A0 D M54 M79.2 Dorsalgia Neuralgia and neuritis, unspecified A E A LEVOTHYROXINE d00278A0 C E03.9 Hypothyroidism, unspecified A E A METOPROLOL d00134A0 C I10 Essential (primary) hypertension A E A METRONIDAZOLE TOPICAL d03208A0 D* L71 Rosacea A E A NORTRIPTYLINE d00144A0 Dc M79.2 Neuralgia and neuritis, unspecified A E A PANTOPRAZOLE d04514A0 C[@ K21 Gastro-esophageal reflux disease A E0 A HYDROCHLOROTHIAZIDE d00253A D# I10 Essential (primary) hypertension AP E0 A LISINOPRIL d00732A B I10 Essential (primary) hypertension AP E0 A METOPROLOL d00134A D I10 Essential (primary) hypertension AP E0 A PAROXETINE d03157A D F41.9 Anxiety disorder, unspecified AP E0 A ROSUVASTATIN d04851A C E78.0 Pure hypercholesterolemia AP E@ A . . . EP A . . . E` A AMLODIPINE d00689A C I10 Essential (primary) hypertension A0 E` A METOPROLOL d00134A C I10 Essential (primary) hypertension A0 E` A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia A0 Ep A AMLODIPINE d00689A C I10 Essential (primary) hypertension A@ Ep A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A C- I10 Essential (primary) hypertension A@ Ep A LEVOTHYROXINE d00278A CDp E03.9 Hypothyroidism, unspecified A@ Ep A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia A@ E A AMOXICILLIN d00088A Ap K04.7 Periapical abscess without sinus A0 E A IBUPROFEN d00015A C M54 N94 R51 Dorsalgia Pain and other conditions associated with female genital organs and menstrual cycle Headache A0 E A LEVONORGESTREL d00557A C F39 Z79.3 Unspecified mood [affective] disorder Long term (current) use of hormonal contraceptives A0 E A ATORVASTATIN d04105A C- E78.0 Pure hypercholesterolemia AP E A CANAGLIFLOZIN d08080A C- E11 Type 2 diabetes mellitus AP E A DILTIAZEM d00045A CDp I10 Essential (primary) hypertension AP E A HYDROCHLOROTHIAZIDE; LOSARTAN d03830A C- I10 Essential (primary) hypertension AP E A METFORMIN d03807A C- E11 Type 2 diabetes mellitus AP E A ESCITALOPRAM d04812A B= F32.9 Major depressive disorder, single episode, unspecified A` E A INSULIN ASPART d04697A D E11 Type 2 diabetes mellitus A` E A LISINOPRIL d00732A D E11.2 Type 2 diabetes mellitus with kidney complications A` E A METFORMIN d03807A CDp E11 Type 2 diabetes mellitus A` E A RIVAROXABAN d07356A Cr I80.3 Phlebitis and thrombophlebitis of lower extremities, unspecified A` E A ROSUVASTATIN d04851A C E78.0 Pure hypercholesterolemia A` E A . . . E A . . . E A CLONIDINE d00044A C I10 Essential (primary) hypertension A E A NIFEDIPINE d00051A C- I10 Essential (primary) hypertension A E A . . . E A SALMETEROL d03759A B[ J44.9 Chronic obstructive pulmonary disease, unspecified A E A SERTRALINE d00880A B[ F43.9 Reaction to severe stress, unspecified A E A ETHINYL ESTRADIOL; NORGESTIMATE d03781A C N92 Excessive, frequent and irregular menstruation A E A HYDROCHLOROTHIAZIDE d00253A C- I10 Essential (primary) hypertension A0 E A OMEPRAZOLE d00325A C- K21 Gastro-esophageal reflux disease A0 E A VALACYCLOVIR d03838A CDp B00.9 Herpesviral infection, unspecified A0 E A . . . E0 A . . . E@ A ACETAMINOPHEN; OXYCODONE d03431A A K08.8 Other specified disorders of teeth and supporting structures A EP A . . . E` A . . . Ep A . . . E A AMOXICILLIN d00088A AP J40 Bronchitis, not specified as acute or chronic A@ E A APIXABAN d07804A C- I21.P Prevent heart attack/myocardial infarction A@ E A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A@ E A CARVEDILOL d03847A CDp Z79.0 Long term (current) use of anticoagulants and antithrombotics/antiplatelets A@ E A RIZATRIPTAN d04328A C- G43 Migraine A E A . . . E A TOPIRAMATE d04115A Ap R51 Headache A E A . . . E A AMOXICILLIN d00088A A J02 Acute pharyngitis A E A . . . E A . . . E A TRAMADOL d03826A C M54 Dorsalgia A E A ZOLPIDEM d00910A B= G47.0 Insomnia A E A ETHINYL ESTRADIOL; NORGESTIMATE d03781A B= Z79.3 Long term (current) use of hormonal contraceptives A E A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified AP E A QUETIAPINE d04220A D F39 G47.0 Unspecified mood [affective] disorder Insomnia AP E A RISPERIDONE d03180A D F39 F90 F91 Unspecified mood [affective] disorder Attention-deficit hyperactivity disorders Conduct disorders AP E A TRAZODONE d00395A D F31.9 F32.9 F39 Bipolar disorder, unspecified Major depressive disorder, single episode, unspecified Unspecified mood [affective] disorder AP E A ZIPRASIDONE d04747A D F31.9 F90 G47.0 Bipolar disorder, unspecified Attention-deficit hyperactivity disorders Insomnia AP E0 A . . . E@ A SODIUM CHLORIDE d00438A B J30.2 R05 Other seasonal allergic rhinitis Cough A EP A TELMISARTAN d04364A C I10 Essential (primary) hypertension A E` A ALBUTEROL d00749A CP J45 Asthma A0 E` A ALBUTEROL d00749A CP J45 Asthma A0 E` A MONTELUKAST d04289A CP J45 Asthma A0 Ep A INSULIN ISOPHANE (NPH) d04370A CDp E11 Type 2 diabetes mellitus A@ Ep A LOSARTAN d03821A CP I10 Essential (primary) hypertension A@ Ep A METFORMIN d03807A CP E11 Type 2 diabetes mellitus A@ Ep A SIMVASTATIN d00746A CP E78.0 Pure hypercholesterolemia A@ E A . . . E A FEXOFENADINE d04040A C R06.2 Wheezing A@ E A IBANDRONATE d05357A C M81 M85.9 Osteoporosis without current pathological fracture Disorder of bone density and structure, unspecified A@ E A MONTELUKAST d04289A C R06.2 Wheezing A@ E A MONTELUKAST d04289A C E07.9 Disorder of thyroid, unspecified A@ E A . . . E A FLUOXETINE d00236A C9 F39 F41.9 F90 Unspecified mood [affective] disorder Anxiety disorder, unspecified Attention-deficit hyperactivity disorders A@ E A RISPERIDONE d03180A C- F29 G47.0 R63 Unspecified psychosis not due to a substance or known physiological condition Insomnia Symptoms and signs concerning food and fluid intake A@ E A RISPERIDONE d03180A CDp G47.0 R63 Insomnia Symptoms and signs concerning food and fluid intake A@ E A RISPERIDONE d03180A CDp F29 G47.0 R63 Unspecified psychosis not due to a substance or known physiological condition Insomnia Symptoms and signs concerning food and fluid intake A@ E A . . . E A ETHINYL ESTRADIOL; NORGESTIMATE d03781A B N94 Pain and other conditions associated with female genital organs and menstrual cycle A E A ALENDRONATE d03849A C M81 Osteoporosis without current pathological fracture A E A CITALOPRAM d04332A C F32.9 Major depressive disorder, single episode, unspecified A E A FUROSEMIDE d00070A D I50.9 Heart failure, unspecified A E A LEVOTHYROXINE d00278A D E03.9 Hypothyroidism, unspecified A E A LISINOPRIL d00732A D I10 Essential (primary) hypertension A E A LOVASTATIN d00280A D E78.0 Pure hypercholesterolemia A E A METFORMIN d03807A CDp E11 Type 2 diabetes mellitus A E A POTASSIUM CHLORIDE d00345A CDp E87.6 Hypokalemia A E A . . . E A ASPIRIN d00170A C- I99.9 Unspecified disorder of circulatory system A0 E A METFORMIN d03807A C- E11 Type 2 diabetes mellitus A0 E A METOPROLOL d00134A C- I10 Essential (primary) hypertension A0 E A ATENOLOL d00004A D I21.P Prevent heart attack/myocardial infarction A E A DOXEPIN d00217A D9 F32.9 Major depressive disorder, single episode, unspecified A E A DULAGLUTIDE d08290A C- E11 Type 2 diabetes mellitus A E A FLUOXETINE d00236A D9 F32.9 Major depressive disorder, single episode, unspecified A E A GLIPIZIDE d00246A C- E11 Type 2 diabetes mellitus A E A HYDROCHLOROTHIAZIDE; TRIAMTERENE d03052A C R60.9 Edema, unspecified A E A LEVOTHYROXINE d00278A CDp E03.9 Hypothyroidism, unspecified A E A LOSARTAN d03821A Cr I21.P Prevent heart attack/myocardial infarction A E A METFORMIN d03807A D E11 Type 2 diabetes mellitus A E A PIOGLITAZONE d04442A Bz E11 Type 2 diabetes mellitus A E A ROSUVASTATIN d04851A C- E78.0 Pure hypercholesterolemia A E A ATORVASTATIN d04105A C[@ E78.0 Pure hypercholesterolemia A0 E A DEXLANSOPRAZOLE d07395A A 99999 A0 E A HYDROCHLOROTHIAZIDE d00253A C[@ I10 Essential (primary) hypertension A0 E0 A 99999 . . A E@ A CYCLOBENZAPRINE d00963A0 D M54 Dorsalgia A E@ A ESOMEPRAZOLE d04749A0 D K30 Functional dyspepsia A E@ A GABAPENTIN d03182A0 C M79.2 Neuralgia and neuritis, unspecified A E@ A INSULIN d00262A C E11 Type 2 diabetes mellitus A E@ A ISOSORBIDE MONONITRATE d00269A0 Dc R07.9 Chest pain, unspecified A E@ A LEVOTHYROXINE d00278A0 Dc E03.9 Hypothyroidism, unspecified A E@ A METOPROLOL d00134A0 Dc I10 Essential (primary) hypertension A E@ A NITROGLYCERIN d00321A0 D R07.9 Chest pain, unspecified A EP A . . . E` A GABAPENTIN d03182A C M79.2 Neuralgia and neuritis, unspecified Ap E` A HYDROCHLOROTHIAZIDE d00253A C- R60.9 Edema, unspecified Ap E` A LOSARTAN d03821A C[@ 99999 Ap E` A METOPROLOL d00134A C- I10 Essential (primary) hypertension Ap E` A OMEPRAZOLE d00325A CDp K46 Unspecified abdominal hernia Ap E` A SIMVASTATIN d00746A C- E78.0 Pure hypercholesterolemia Ap E` A WARFARIN d00022A C- I48.9 Unspecified atrial fibrillation and atrial flutter Ap Ep A ATORVASTATIN d04105A Dc E78.0 Pure hypercholesterolemia A0 Ep A HYDROCHLOROTHIAZIDE; LOSARTAN d03830A Dc I10 Essential (primary) hypertension A0 Ep A TAMSULOSIN d04121A CDp R39.1 Other difficulties with micturition A0 E A ACETAMINOPHEN; CODEINE d03423A A R52 Pain, unspecified A0 E A ACYCLOVIR d00001A CP A60.9 Anogenital herpesviral infection, unspecified A0 E A AMOXICILLIN d00088A A K04.7 Periapical abscess without sinus A0 E A ALBUTEROL d00749A C- J45 Asthma A E A MONTELUKAST d04289A C- J30.1 J45 Allergic rhinitis due to pollen Asthma A E A . . . E A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A C- I10 Essential (primary) hypertension A0 E A OXYBUTYNIN d00328A C N32.81 Overactive bladder A0 E A PRAVASTATIN d00348A C E78.0 Pure hypercholesterolemia A0 E A ATORVASTATIN d04105A CDp I63.P Prevent stroke A0 E A LOSARTAN d03821A CDp I63.P Prevent stroke A0 E A RIVAROXABAN d07356A CDp D75.9P I63 Prevent blood clots Cerebral infarction A0 E A ALBUTEROL d00749A B J45 Asthma A0 E A ALBUTEROL d00749A C J45 Asthma A0 E A BUDESONIDE d04276A C J45 Asthma A0 E A . . . E A . . . E A AZELASTINE NASAL d04068A C[@ J30.9 Allergic rhinitis, unspecified A@ E A BUSPIRONE d00182A CDp F41.9 Anxiety disorder, unspecified A@ E A CITALOPRAM d04332A CDp F32.9 Major depressive disorder, single episode, unspecified A@ E A METHYLPHENIDATE d00900A BZ F90 Attention-deficit hyperactivity disorders A@ E A BICALUTAMIDE d03850A B C61 Malignant neoplasm of prostate Ap E A CLONAZEPAM d00197A D* G25.81 Restless legs syndrome Ap E A DONEPEZIL d04099A B R41 Other symptoms and signs involving cognitive functions and awareness Ap E A EZETIMIBE d04824A D E78.0 Pure hypercholesterolemia Ap E A SPIRONOLACTONE d00373A C[@ E03.9 Hypothyroidism, unspecified Ap E A SPIRONOLACTONE d00373A D I10 Essential (primary) hypertension Ap E A VALSARTAN d04113A C I10 Essential (primary) hypertension Ap E A . . . E0 A ACETAMINOPHEN; HYDROCODONE d03428A D M54 Dorsalgia B E0 A ALPRAZOLAM d00168A Cr F32.9 F41.9 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified B E0 A AMLODIPINE d00689A C I10 Essential (primary) hypertension B E0 A ASPIRIN d00170A Dc I21.P Prevent heart attack/myocardial infarction B E0 A ATENOLOL d00004A C I10 Essential (primary) hypertension B E0 A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia B E0 A CLOPIDOGREL d04258A C I80.3 Phlebitis and thrombophlebitis of lower extremities, unspecified B E0 A DULOXETINE d05355A C F32.9 Major depressive disorder, single episode, unspecified B E0 A GABAPENTIN d03182A C E11.4 Type 2 diabetes mellitus with neurological complications B E0 A GLYCOPYRROLATE TOPICAL d07348A CDp 55555 B E0 A LISINOPRIL d00732A C I10 Essential (primary) hypertension B E0 A MELOXICAM d04532A C M79.1 Myalgia B E0 A METFORMIN d03807A C E11 R73 Type 2 diabetes mellitus Elevated blood glucose level B E0 A ONDANSETRON d00867A C- R11 Nausea and vomiting B E0 A PANTOPRAZOLE d04514A C K21 Gastro-esophageal reflux disease B E0 A TAMSULOSIN d04121A C R35 Polyuria B E0 A TESTOSTERONE d00558A C E29.1 Testicular hypofunction B E0 A TRIAMTERENE d00396A C I10 Essential (primary) hypertension B E@ A ALLOPURINOL d00023A Cr M1A Chronic gout A@ E@ A ATORVASTATIN d04105A CDp E78.0 Pure hypercholesterolemia A@ E@ A ESOMEPRAZOLE d04749A Dc K21 Gastro-esophageal reflux disease A@ E@ A METOPROLOL d00134A CDp R00 Abnormalities of heart beat A@ EP A BROMPHENIRAMINE; DEXTROMETHORPHAN; PSEUDOEPHEDRINE d03368A B R05 Cough A E` A . . . Ep A AMOXICILLIN d00088A Ap J01.9 J42 Acute sinusitis, unspecified Unspecified chronic bronchitis A E A . . . E A . . . E A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A E A CARVEDILOL d03847A CDp I10 Essential (primary) hypertension A E A MYCOPHENOLATE MOFETIL d03839A CDp T86.9P Prevent transplanted organ and tissue rejection A E A MYCOPHENOLIC ACID d05217A CDp T86.9P Prevent transplanted organ and tissue rejection A E A NIFEDIPINE d00051A CDp I10 Essential (primary) hypertension A E A PREDNISONE d00350A CDp T86.9P Prevent transplanted organ and tissue rejection A E A RANITIDINE d00021A CDp K21 Gastro-esophageal reflux disease A E A SIMVASTATIN d00746A CDp E78.0 Pure hypercholesterolemia A E A TACROLIMUS d03752A CDp T86.9P Prevent transplanted organ and tissue rejection A E A . . . E A CYCLOBENZAPRINE d00963A AP M54 M62.83 Dorsalgia Muscle spasm A E A PREDNISONE d00350A AP M54 Dorsalgia A E A . . . E A BUPRENORPHINE; NALOXONE d04819A Cr F11.23 Opioid dependence with withdrawal A E A . . . E A DOXYCYCLINE d00037A Ap L70 Acne A E A . . . E0 A . . . E@ A . . . EP A . . . E` A BENAZEPRIL d00730A Cr I10 Essential (primary) hypertension A Ep A . . . E A . . . E A . . . E A AMOXICILLIN d00088A0 A H66.9 Otitis media, unspecified A E A CEFDINIR d04256A0 A H66.9 Otitis media, unspecified A E A ALBUTEROL d00749A D9 J45 Asthma A` E A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A` E A CLONIDINE d00044A C[@ F41.9 Anxiety disorder, unspecified A` E A FLUTICASONE; SALMETEROL d04611A C- J45 Asthma A` E A LISINOPRIL d00732A C[@ I10 Essential (primary) hypertension A` E A OMEPRAZOLE d00325A B R12 Heartburn A` E A DILTIAZEM d00045A C[@ R00 Abnormalities of heart beat Ap E A FLUTICASONE d01296A D# J44.9 Chronic obstructive pulmonary disease, unspecified Ap E A LEVOTHYROXINE d00278A C- E03.9 Hypothyroidism, unspecified Ap E A METOLAZONE d00299A C R60.9 Edema, unspecified Ap E A METOPROLOL d00134A C[@ I10 Essential (primary) hypertension Ap E A TORSEMIDE d03189A C R60.9 Edema, unspecified Ap E A WARFARIN d00022A Dc D75.9P Prevent blood clots Ap E A . . . E A . . . E A . . . E A TRIAMCINOLONE TOPICAL d03206A A R21 Rash and other nonspecific skin eruption A E A . . . E A GABAPENTIN d03182A B M54 Dorsalgia A E0 A . . . E@ A . . . EP A . . . E` A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified A Ep A . . . E A ALBUTEROL d00749A CDp J45 Asthma A E A TRIAMCINOLONE TOPICAL d03206A B L20.9 Atopic dermatitis, unspecified A E A . . . E A BISOPROLOL d00709A Dc I49.9 Cardiac arrhythmia, unspecified AP E A EZETIMIBE d04824A B E78.0 Pure hypercholesterolemia AP E A LEVOTHYROXINE d00278A CDp E03.9 Hypothyroidism, unspecified AP E A OMEPRAZOLE d00325A B K21 Gastro-esophageal reflux disease AP E A SIMVASTATIN d00746A B E78.0 Pure hypercholesterolemia AP E A . . . E A ALBUTEROL d00749A A R06.02 Shortness of breath A E A TRIAMCINOLONE TOPICAL d03206A C L20.9 Atopic dermatitis, unspecified A E A ATORVASTATIN d04105A C I63.P Prevent stroke A E A CARVEDILOL d03847A C I50.9 Heart failure, unspecified A E A CYANOCOBALAMIN d00413A Dc E63.9 Nutritional deficiency, unspecified A E A DIGOXIN d00210A C[@ I51.9 Heart disease, unspecified A E A FUROSEMIDE d00070A C[@ 99999 A E A LEVOTHYROXINE d00278A D E03.9 Hypothyroidism, unspecified A E A SACUBITRIL; VALSARTAN d08369A B= I50.9 Heart failure, unspecified A E A TRAVOPROST OPHTHALMIC d04753A D H40 Glaucoma A E A WARFARIN d00022A Dc D75.9P Prevent blood clots A E A ACETAMINOPHEN; HYDROCODONE d03428A A M54 Dorsalgia A E A IBUPROFEN d00015A A M54 Dorsalgia A E A CARVEDILOL d03847A CDp I10 Essential (primary) hypertension A0 E A CLOPIDOGREL d04258A CD` I21 ST elevation (STEMI) and non-ST elevation (NSTEMI) myocardial infarction A0 E A PITAVASTATIN d07637A C- E78.0 Pure hypercholesterolemia A0 E A . . . E A . . . E A ACETAMINOPHEN; OXYCODONE d03431A C[@ M54 Dorsalgia A E A IBUPROFEN d00015A C[@ Z79.1 Long term (current) use of non-steroidal anti-inflammatories (NSAID) A E0 A . . . E@ A ISOSORBIDE MONONITRATE d00269A C"0 I21.P Prevent heart attack/myocardial infarction A@ E@ A LOSARTAN d03821A Cr I10 Essential (primary) hypertension A@ E@ A METOPROLOL d00134A C"0 I21.P Prevent heart attack/myocardial infarction A@ E@ A OMEPRAZOLE d00325A C[@ K30 Functional dyspepsia A@ EP A AMPHETAMINE; DEXTROAMPHETAMINE d04035A B R41 Other symptoms and signs involving cognitive functions and awareness A EP A ETHINYL ESTRADIOL; NORETHINDRONE d03238A C N94 Pain and other conditions associated with female genital organs and menstrual cycle A E` A . . . Ep A . . . E A . . . E A . . . E A ANALGESICS - UNSPECIFIED c00058A C N94 Pain and other conditions associated with female genital organs and menstrual cycle A E A . . . E A SULFAMETHOXAZOLE; TRIMETHOPRIM d00124A B[ 55555 A E A AMOXICILLIN d00088A AP J20.9 Acute bronchitis, unspecified A E A ANASTROZOLE d03873A B K92.9 Disease of digestive system, unspecified A E A MEGESTROL d01348A C K30 Functional dyspepsia A E A . . . E A ALPRAZOLAM d00168A C[@ F41.9 Anxiety disorder, unspecified Ap E A BUPROPION d00181A C[@ F41.9 Anxiety disorder, unspecified Ap E A CITALOPRAM d04332A C[@ F41.9 Anxiety disorder, unspecified Ap E A HYDROCHLOROTHIAZIDE d00253A C I10 Essential (primary) hypertension Ap E A LISINOPRIL d00732A Cr I10 Essential (primary) hypertension Ap E A PRAVASTATIN d00348A C E78.0 Pure hypercholesterolemia Ap E A SITAGLIPTIN d05896A C R73 Elevated blood glucose level Ap E A . . . E A . . . E0 A CITALOPRAM d04332A D F32.9 Major depressive disorder, single episode, unspecified A0 E0 A THYROID DESICCATED d00655A C E03.9 Hypothyroidism, unspecified A0 E0 A TRIAMTERENE d00396A D' I10 Essential (primary) hypertension A0 E@ A CHLORTHALIDONE d00192A C I10 Essential (primary) hypertension A E@ A POTASSIUM CHLORIDE d00345A C"0 E87.6 Hypokalemia A EP A LISDEXAMFETAMINE d06663A B F90 Attention-deficit hyperactivity disorders A0 EP A METHYLPHENIDATE d00900A B F31.9 F90 Bipolar disorder, unspecified Attention-deficit hyperactivity disorders A0 EP A RISPERIDONE d03180A B F31.9 F90 Bipolar disorder, unspecified Attention-deficit hyperactivity disorders A0 E` A . . . Ep A ALBUTEROL d00749A B J45 Asthma A` Ep A AMOXICILLIN d00088A C B96.81 H66.9 Helicobacter pylori [H. pylori] as the cause of diseases classified elsewhere Otitis media, unspecified A` Ep A FLUTICASONE NASAL d04283A C[@ J30.9 Allergic rhinitis, unspecified A` Ep A FLUTICASONE; SALMETEROL d04611A Bz J45 Asthma A` Ep A NAPROXEN d00019A C G43 M54 M79.1 Migraine Dorsalgia Myalgia A` Ep A RANITIDINE d00021A C K21 Gastro-esophageal reflux disease A` E A DILTIAZEM d00045A Dc I20.9 Angina pectoris, unspecified A@ E A MELOXICAM d04532A C- M19.9 Osteoarthritis, unspecified site A@ E A NIACIN d00314A CDp E78.0 Pure hypercholesterolemia A@ E A PAROXETINE d03157A C F41.9 Anxiety disorder, unspecified A@ E A LEVOTHYROXINE d00278A C- E03.9 Hypothyroidism, unspecified A E A . . . E A ALLOPURINOL d00023A C M1A Chronic gout A E A BENZONATATE d00796A Ap J40 Bronchitis, not specified as acute or chronic A E A CEPHALEXIN d00096A A0 A49.9P Prevent bacterial infection A E A DOXYCYCLINE d00037A Ap J40 Bronchitis, not specified as acute or chronic A E A HYDROXYCHLOROQUINE d00817A C- M06.9 Rheumatoid arthritis, unspecified A E A LISINOPRIL d00732A C I10 Essential (primary) hypertension A E A MELOXICAM d04532A C- M19.9 Osteoarthritis, unspecified site A E A OMEPRAZOLE d00325A C K21 Gastro-esophageal reflux disease A E A PITAVASTATIN d07637A CDp E78.0 Pure hypercholesterolemia A E A PRAMIPEXOLE d04145A C- G25.81 Restless legs syndrome A E A SULFASALAZINE d00379A CDp M06.9 Rheumatoid arthritis, unspecified A E A TRAMADOL d03826A Cr M54 Dorsalgia A E A LIFITEGRAST OPHTHALMIC d08472A B H04 Disorders of lacrimal system A E A . . . E A APIXABAN d07804A B- I48.9 Unspecified atrial fibrillation and atrial flutter AP E A DILTIAZEM d00045A B- I49.9 Cardiac arrhythmia, unspecified AP E A DOXAZOSIN d00726A A I10 Essential (primary) hypertension AP E A LISINOPRIL d00732A Cr I10 Essential (primary) hypertension AP E A PYRIDOSTIGMINE d00363A C 55555 AP E A . . . E A . . . E A . . . E A . . . E0 A FLUCONAZOLE d00071A Ap B37 Candidiasis A E@ A . . . EP A . . . E` A . . . Ep A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A C[@ I10 Essential (primary) hypertension A E A METFORMIN d03807A C[@ E11 Type 2 diabetes mellitus A E A ALLOPURINOL d00023A Cr M10.9P Prevent gout A E A AMLODIPINE d00689A Cr I10 Essential (primary) hypertension A E A ATORVASTATIN d04105A C[@ E78.0 Pure hypercholesterolemia A E A CITALOPRAM d04332A Cr F31.9 F32.9 Bipolar disorder, unspecified Major depressive disorder, single episode, unspecified A E A ESOMEPRAZOLE d04749A Cr K21 Gastro-esophageal reflux disease A E A LIRAGLUTIDE d07466A C"0 E11 Type 2 diabetes mellitus A E A LISINOPRIL d00732A Cr I10 Essential (primary) hypertension A E A METFORMIN d03807A CDp E11 Type 2 diabetes mellitus A E A TRAMADOL d03826A Cr M25.5 M54 Pain in joint Dorsalgia A E A . . . E A . . . E A . . . E A AMLODIPINE d00689A Cr I10 Essential (primary) hypertension A E0 A PLECANATIDE d08521A B[ K59.0 Constipation A E@ A . . . EP A ALPRAZOLAM d00168A Cr F41.9 Anxiety disorder, unspecified A0 EP A CITALOPRAM d04332A Cr F32.9 Major depressive disorder, single episode, unspecified A0 EP A LISINOPRIL d00732A Cr I10 Essential (primary) hypertension A0 E` A . . . Ep A BUPROPION d00181A CDp F41.9 Anxiety disorder, unspecified A` Ep A DILTIAZEM d00045A CDp I10 Essential (primary) hypertension A` Ep A GABAPENTIN d03182A A M79.2 Neuralgia and neuritis, unspecified A` Ep A HYDRALAZINE d00132A B I10 Essential (primary) hypertension A` Ep A OXCARBAZEPINE d04513A B G40 Epilepsy and recurrent seizures A` Ep A TRAZODONE d00395A CDp F32.9 Major depressive disorder, single episode, unspecified A` E A AMLODIPINE d00689A B I10 Essential (primary) hypertension A0 E A CALCIUM ACETATE d03689A B E63.9 Nutritional deficiency, unspecified A0 E A FUROSEMIDE d00070A B 99999 A0 E A CETIRIZINE d03827A A R05 Cough A E A AMLODIPINE d00689A C I10 Essential (primary) hypertension A E A VALSARTAN d04113A C I10 Essential (primary) hypertension A E A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E A CYCLOBENZAPRINE d00963A A M54 Dorsalgia A E A IBUPROFEN d00015A A M54 Dorsalgia A E A AMOXICILLIN d00088A A J01.9 Acute sinusitis, unspecified A E A PREDNISONE d00350A A J30.1 Allergic rhinitis due to pollen A E0 A LEVOTHYROXINE d00278A CDp E07.9 Disorder of thyroid, unspecified A E@ A . . . EP A . . . E` A AMPHETAMINE; DEXTROAMPHETAMINE d04035A CDp F90 Attention-deficit hyperactivity disorders A Ep A ATORVASTATIN d04105A B E78.0 Pure hypercholesterolemia A@ Ep A LISINOPRIL d00732A B E11.2P Prevent diabetic kidney disease A@ Ep A METFORMIN d03807A C"0 E11 Type 2 diabetes mellitus A@ Ep A TERBINAFINE d04012A B B35 Dermatophytosis A@ E A . . . E A . . . E A . . . E A OSELTAMIVIR d04462A A J09 Influenza due to certain identified influenza viruses A E A AMOXICILLIN d00088A Ap H66.9 Otitis media, unspecified A E A . . . E A . . . E A . . . E A FLUTICASONE; VILANTEROL d08100A C J45 Asthma A@ E A LEVOTHYROXINE d00278A C"0 E03.9 Hypothyroidism, unspecified A@ E A METFORMIN d03807A C"0 E11 Type 2 diabetes mellitus A@ E A TIOTROPIUM d04829A C J45 R06.9 Asthma Unspecified abnormalities of breathing A@ E A CANAGLIFLOZIN; METFORMIN d08280A C- E11 Type 2 diabetes mellitus A0 E A PRAVASTATIN d00348A C E78.0 Pure hypercholesterolemia A0 E A SERTRALINE d00880A C[@ F41.9 Anxiety disorder, unspecified A0 E A . . . E0 A HYDROCHLOROTHIAZIDE d00253A C I10 Essential (primary) hypertension A E@ A HYDROCHLOROTHIAZIDE; LOSARTAN d03830A C I10 Essential (primary) hypertension A0 E@ A METFORMIN d03807A C"0 E11.P Prevent diabetes A0 E@ A PRAVASTATIN d00348A B= E78.0 Pure hypercholesterolemia A0 EP A BENZTROPINE d00175A Dc T88.7P Prevent drug side effect Ap EP A DIVALPROEX SODIUM d03833A Dc F31.9 Bipolar disorder, unspecified Ap EP A INSULIN DETEMIR d05436A C E11 Type 2 diabetes mellitus Ap EP A METFORMIN d03807A C- E11 Type 2 diabetes mellitus Ap EP A PALIPERIDONE d06297A C[@ F32.9 Major depressive disorder, single episode, unspecified Ap EP A QUETIAPINE d04220A CDp G47.9 Sleep disorder, unspecified Ap EP A SIMVASTATIN d00746A C[@ E78.0 Pure hypercholesterolemia Ap E` A . . . Ep A POLYETHYLENE GLYCOL 3350 d05350A C- K59.0 Constipation A E A FINASTERIDE d00563A Dc N40 Enlarged prostate AP E A INDOMETHACIN d00039A D M1A Chronic gout AP E A ISOSORBIDE d00653A Cr I10 Essential (primary) hypertension AP E A METFORMIN d03807A D E11 Type 2 diabetes mellitus AP E A SIMVASTATIN d00746A Cr E78.0 Pure hypercholesterolemia AP E A GLIPIZIDE d00246A B= R73 Elevated blood glucose level A E A METFORMIN d03807A B= E11.P Prevent diabetes A E A . . . E A . . . E A . . . E A . . . E A FUROSEMIDE d00070A B R60.9 Edema, unspecified AP E A LOSARTAN d03821A C I10 Essential (primary) hypertension AP E A METOPROLOL d00134A CDp I10 Essential (primary) hypertension AP E A PRAVASTATIN d00348A CDp E78.0 Pure hypercholesterolemia AP E A RIVAROXABAN d07356A CDp I80.3 Phlebitis and thrombophlebitis of lower extremities, unspecified AP E A ACETAMINOPHEN; HYDROCODONE d03428A C- M13 M54 M79.1 Other arthritis Dorsalgia Myalgia A0 E A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A Cr I10 Essential (primary) hypertension A0 E A METHOTREXATE d00060A C M06.9 Rheumatoid arthritis, unspecified A0 E A . . . E A AMOXICILLIN; CLAVULANATE d00089A A0 H66.9 Otitis media, unspecified A E A CODEINE; PROMETHAZINE d03357A A0 R05 Cough A E A . . . E 0 A SERTRALINE d00880A B F32.9 F41.9 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified A E @ A . . . E P A AMLODIPINE d00689A B I10 Essential (primary) hypertension A E P A ESTRADIOL d00537A C N95 Menopausal and other perimenopausal disorders A E P A HYDROXYCHLOROQUINE d00817A C- M06.9 Rheumatoid arthritis, unspecified A E P A HYDROXYZINE d00907A B F41.9 Anxiety disorder, unspecified A E P A LISINOPRIL d00732A C I10 Essential (primary) hypertension A E P A MIRTAZAPINE d04025A B G47.0 Insomnia A E P A NAPROXEN d00019A C M06.9 Rheumatoid arthritis, unspecified A E P A OMEPRAZOLE d00325A CDp K21 Gastro-esophageal reflux disease A E P A VENLAFAXINE d03181A B F41.9 Anxiety disorder, unspecified A E ` A . . . E p A METFORMIN d03807A C E11 Type 2 diabetes mellitus A E A FLUOXETINE d00236A C F32.9 Major depressive disorder, single episode, unspecified A E A . . . E A NEBIVOLOL d05265A C- R00 Abnormalities of heart beat A0 E A OMEPRAZOLE d00325A Cr K21 Gastro-esophageal reflux disease A0 E A PRAVASTATIN d00348A B= E78.0 Pure hypercholesterolemia A0 E A PRAVASTATIN d00348A C E78.0 Pure hypercholesterolemia A E A AMLODIPINE d00689A C- I21.P Prevent heart attack/myocardial infarction A E A CETIRIZINE d03827A B T78.40 Allergy, unspecified A E A DAPAGLIFLOZIN d07928A CDp R73 Elevated blood glucose level A E A INSULIN GLARGINE d04538A C"0 E11 Type 2 diabetes mellitus A E A LOSARTAN d03821A Cr I10 Essential (primary) hypertension A E A METFORMIN; SAXAGLIPTIN d07709A C- R73 Elevated blood glucose level A E A METOPROLOL d00134A C- I10 Essential (primary) hypertension A E A OMEPRAZOLE d00325A D K21 Gastro-esophageal reflux disease A E A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia A E A . . . E A . . . E A ATORVASTATIN d04105A Bz E78.0 Pure hypercholesterolemia A@ E A CLONIDINE d00044A B I10 Essential (primary) hypertension A@ E A LOSARTAN d03821A B[ I10 Essential (primary) hypertension A@ E A OMEPRAZOLE d00325A B[ K21 K30 Gastro-esophageal reflux disease Functional dyspepsia A@ E A . . . E A . . . E A . . . E 0 A AMLODIPINE d00689A A I20.9 Angina pectoris, unspecified A E 0 A AZITHROMYCIN d00091A A J18.9 Pneumonia, unspecified organism A E 0 A DOXYCYCLINE d00037A A B99.9 Unspecified infectious disease A E 0 A FUROSEMIDE d00070A A I51.9 Heart disease, unspecified A E 0 A HYDRALAZINE d00132A A I10 Essential (primary) hypertension A E 0 A METHYLPREDNISOLONE d00293A A Z79 Long term (current) drug therapy A E 0 A METOPROLOL d00134A A I10 Essential (primary) hypertension A E 0 A SULFAMETHOXAZOLE; TRIMETHOPRIM d00124A A A49.9P Prevent bacterial infection A E @ A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A E @ A OMEPRAZOLE d00325A C K21 Gastro-esophageal reflux disease A E P A . . . E ` A . . . E p A . . . E A AMOXICILLIN d00088A A K04.7 Periapical abscess without sinus A E A PREDNISONE d00350A A` 55555 A E A AMOXICILLIN d00088A A J02 Acute pharyngitis A E A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E 0 A . . . E @ A DULAGLUTIDE d08290A CDp E11 Type 2 diabetes mellitus A E @ A GLIPIZIDE d00246A D E11 Type 2 diabetes mellitus A E P A . . . E ` A ATENOLOL d00004A0 B[ I21.P Prevent heart attack/myocardial infarction A E ` A ATORVASTATIN d04105A0 B[ E78.0P Prevent high cholesterol A E ` A CLONAZEPAM d00197A0 D F41.9 Anxiety disorder, unspecified A E ` A CLOPIDOGREL d04258A0 B[ D75.9P Prevent blood clots A E ` A LEVOTHYROXINE d00278A0 Dc E03.9 Hypothyroidism, unspecified A E ` A LOSARTAN d03821A0 Bz I21.P Prevent heart attack/myocardial infarction A E ` A MEMANTINE d04899A0 CDp G30.9 Alzheimer's disease, unspecified A E ` A TRAMADOL d03826A Bz M19.9 Osteoarthritis, unspecified site A E ` A TRAZODONE d00395A0 B G47.9 Sleep disorder, unspecified A E p A . . . E A ETHINYL ESTRADIOL; NORGESTIMATE d03781A D"8 N92 Excessive, frequent and irregular menstruation A E A AMLODIPINE d00689A B[ I10 Essential (primary) hypertension A0 E A ATORVASTATIN d04105A B[ E78.0 Pure hypercholesterolemia A0 E A LISINOPRIL d00732A B[ I10 Essential (primary) hypertension A0 E A . . . E A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A E A FLUTICASONE; SALMETEROL d04611A Cr J45 Asthma A E A . . . E A . . . E A ACETAMINOPHEN; OXYCODONE d03431A A M54 Dorsalgia A0 E A ATORVASTATIN d04105A Bz E78.0 Pure hypercholesterolemia A0 E A LISINOPRIL d00732A B I10 Essential (primary) hypertension A0 E A LOSARTAN d03821A C I10 Essential (primary) hypertension A E A METOPROLOL d00134A C I10 Essential (primary) hypertension A E A TAMSULOSIN d04121A Cr 55555 A E A TIMOLOL OPHTHALMIC d04037A C[@ H40 Glaucoma A E A . . . E 0 A AMLODIPINE d00689A C I10 Essential (primary) hypertension AP E 0 A ATORVASTATIN d04105A B= E78.0 Pure hypercholesterolemia AP E 0 A CLONAZEPAM d00197A Cr F41.9 G47.0 Anxiety disorder, unspecified Insomnia AP E 0 A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A Dc I10 Essential (primary) hypertension AP E 0 A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified AP E @ A OMEPRAZOLE d00325A B K30 Functional dyspepsia A E P A . . . E ` A . . . E p A . . . E A . . . E A SILDENAFIL d04299A B N52.9 Male erectile dysfunction, unspecified A E A AMLODIPINE d00689A C[@ I10 Essential (primary) hypertension A E A . . . E A . . . E A . . . E A . . . E A ALPRAZOLAM d00168A C F41.9 Anxiety disorder, unspecified A E A CARVEDILOL d03847A C- I10 Essential (primary) hypertension A E A CYCLOBENZAPRINE d00963A B M62.83 Muscle spasm A E A GABAPENTIN d03182A CDp M54 Dorsalgia A E A GLIPIZIDE d00246A C E11 Type 2 diabetes mellitus A E A LEVOTHYROXINE d00278A C E05 Thyrotoxicosis [hyperthyroidism] A E A MONTELUKAST d04289A C J30.9 Allergic rhinitis, unspecified A E A NITROGLYCERIN d00321A C- I51.9 Heart disease, unspecified A E A PREDNISONE d00350A C J44.9 Chronic obstructive pulmonary disease, unspecified A E A ROFLUMILAST d07684A Bz J44.9 Chronic obstructive pulmonary disease, unspecified A E A ROSUVASTATIN d04851A C E78.0 Pure hypercholesterolemia A E A SPIRONOLACTONE d00373A C- R60.9 Edema, unspecified A E A TORSEMIDE d03189A C- R60.9 Edema, unspecified A E A CLINDAMYCIN d00043A A0 L08.9 R21 Local infection of the skin and subcutaneous tissue, unspecified Rash and other nonspecific skin eruption A E A ETHINYL ESTRADIOL; NORGESTIMATE d03781A Cr N92 Excessive, frequent and irregular menstruation A E A GLIPIZIDE d00246A C E11 Type 2 diabetes mellitus AP E A HYDROCHLOROTHIAZIDE d00253A C P I10 Essential (primary) hypertension AP E A LOSARTAN d03821A C I10 Essential (primary) hypertension AP E A METFORMIN d03807A C P E11 Type 2 diabetes mellitus AP E A PRAVASTATIN d00348A B E78.0 Pure hypercholesterolemia AP E 0 A . . . E @ A . . . E P A SIMVASTATIN d00746A C- E78.0 Pure hypercholesterolemia A E ` A AMLODIPINE d00689A C[@ I51.9 Heart disease, unspecified A E ` A ATENOLOL d00004A C[@ 99999 A E ` A ATORVASTATIN d04105A C[@ E78.0 Pure hypercholesterolemia A E ` A DOXEPIN d00217A C[@ G47.9 Sleep disorder, unspecified A E ` A FUROSEMIDE d00070A C[@ R12 Heartburn A E ` A GABAPENTIN d03182A C[@ M54 Dorsalgia A E ` A OMEPRAZOLE d00325A C[@ K21 Gastro-esophageal reflux disease A E ` A POTASSIUM CHLORIDE d00345A C[@ 99999 A E ` A TIOTROPIUM d04829A B J44.9 Chronic obstructive pulmonary disease, unspecified A E ` A TRAMADOL d03826A Cr M54 Dorsalgia A E p A . . . E A FLUTICASONE d01296A Cr J45 Asthma A E A AMLODIPINE d00689A C- I10 Essential (primary) hypertension AP E A CARVEDILOL d03847A C- I10 Essential (primary) hypertension AP E A CHLORTHALIDONE d00192A C- R60.9 Edema, unspecified AP E A IRBESARTAN d04222A C- I10 Essential (primary) hypertension AP E A PRAVASTATIN d00348A C- E78.0 Pure hypercholesterolemia AP E A . . . E A . . . E A ATORVASTATIN d04105A C- E78.0 Pure hypercholesterolemia A` E A ISOSORBIDE MONONITRATE d00269A Ei 99999 A` E A LEVOTHYROXINE d00278A Ei 99999 A` E A MEMANTINE d04899A Ei 99999 A` E A METOPROLOL d00134A Ei I10 Essential (primary) hypertension A` E A TRAMADOL d03826A Ei 99999 A` E A IRBESARTAN d04222A C I10 Essential (primary) hypertension A E A . . . E A 99999 . . A E A . . . E A ESOMEPRAZOLE d04749A C K30 K92.9 Functional dyspepsia Disease of digestive system, unspecified A0 E A FUROSEMIDE d00070A C R60.9 Edema, unspecified A0 E A METHOTREXATE d00060A Cr M06.9 Rheumatoid arthritis, unspecified A0 E A . . . E 0 A CETIRIZINE d03827A Bz J30.2 Other seasonal allergic rhinitis A E @ A . . . E P A BUMETANIDE d00179A B[ R60.9 Edema, unspecified AP E P A FINASTERIDE d00563A C N40 Enlarged prostate AP E P A LOSARTAN d03821A C I10 Essential (primary) hypertension AP E P A OMEPRAZOLE d00325A Cr K21 Gastro-esophageal reflux disease AP E P A TAMSULOSIN d04121A Cr R39.1 Other difficulties with micturition AP E ` A . . . E p A . . . E A . . . E A . . . E A . . . E A . . . E A FLUTICASONE NASAL d04283A B8 H93.9 Unspecified disorder of ear A E A . . . E A . . . E A . . . E A AMOXICILLIN d00088A A H66.9 J01.9 Otitis media, unspecified Acute sinusitis, unspecified A E A . . . E A . . . E 0 A GABAPENTIN d03182A Ei R20 R52 Disturbances of skin sensation Pain, unspecified Ap E 0 A HYDROCHLOROTHIAZIDE d00253A Ei 99999 Ap E 0 A LEVOTHYROXINE d00278A Ei 99999 Ap E 0 A OMEPRAZOLE d00325A Ei 99999 Ap E 0 A PERPHENAZINE d00855A Ei F99 Mental disorder, not otherwise specified Ap E 0 A PRAVASTATIN d00348A Ei 99999 Ap E 0 A TOLTERODINE d04294A Ei R32 Unspecified urinary incontinence Ap E @ A . . . E P A ACETAMINOPHEN; OXYCODONE d03431A Cr M54 Dorsalgia A E P A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A E P A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A D I10 Essential (primary) hypertension A E P A INDOMETHACIN d00039A D# M10.9 Gout, unspecified A E P A INSULIN GLARGINE d04538A D E11 Type 2 diabetes mellitus A E P A METFORMIN d03807A D E11 Type 2 diabetes mellitus A E P A METOPROLOL d00134A Ei I10 Essential (primary) hypertension A E P A MORPHINE d00308A Cr M54 Dorsalgia A E ` A GABAPENTIN d03182A C G47.0 Insomnia A` E ` A IBUPROFEN d00015A B R51 Headache A` E ` A LISINOPRIL d00732A C I10 Essential (primary) hypertension A` E ` A MONTELUKAST d04289A C T78.40 Allergy, unspecified A` E ` A OMEPRAZOLE d00325A C- R12 Heartburn A` E ` A ZOLPIDEM d00910A Cr G47.0 Insomnia A` E p A . . . E A DEXAMETHASONE d00206A A R05 Cough A E A . . . E A . . . E A AMLODIPINE d00689A C- I21.P Prevent heart attack/myocardial infarction AP E A BENAZEPRIL d00730A C 99999 AP E A CLOPIDOGREL d04258A C- D75.9P Prevent blood clots AP E A METFORMIN d03807A C E11 Type 2 diabetes mellitus AP E A METOPROLOL d00134A C I21.P Prevent heart attack/myocardial infarction AP E A CEFDINIR d04256A A H66.9 Otitis media, unspecified A E A DOXAZOSIN d00726A C[@ N40 Enlarged prostate A0 E A FAMOTIDINE d00141A B R39.9 Unspecified symptoms and signs involving the genitourinary system A0 E A IBUPROFEN d00015A Bz M25.5 Pain in joint A0 E A . . . E A . . . E A . . . E A AMOXICILLIN d00088A C Z98 Other postprocedural states A` E A CELECOXIB d04380A C- M54 Dorsalgia A` E A FUROSEMIDE d00070A C- R60.9 Edema, unspecified A` E A HYDROCHLOROTHIAZIDE; VALSARTAN d04293A D I10 Essential (primary) hypertension A` E A NIFEDIPINE d00051A D I10 Essential (primary) hypertension A` E A OXYBUTYNIN d00328A C[@ R32 Unspecified urinary incontinence A` E A ACYCLOVIR d00001A C B99.9 Unspecified infectious disease AP E A ALBUTEROL d00749A C J45 Asthma AP E A IBUPROFEN d00015A C- M54 Dorsalgia AP E A MECLIZINE d00859A C R42 Dizziness and giddiness AP E A NAPROXEN d00019A Cr M54 Dorsalgia AP E 0 A . . . E @ A . . . E P A . . . E ` A CITALOPRAM d04332A B= F32.9 Major depressive disorder, single episode, unspecified A E ` A HYDROXYZINE d00907A Bz L23 Allergic contact dermatitis A E p A . . . E A . . . E A . . . E A . . . E A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A E A FAMOTIDINE d00141A B K21 K30 Gastro-esophageal reflux disease Functional dyspepsia A E A . . . E A AMLODIPINE d00689A C I10 Essential (primary) hypertension A0 E A LISINOPRIL d00732A C I10 Essential (primary) hypertension A0 E A ONDANSETRON d00867A A R11 Nausea and vomiting A0 E A . . . E A . . . E A . . . E A . . . E A 99999 . . A E 0 A ETHINYL ESTRADIOL; LEVONORGESTREL d03242A C[@ Z79.3 Long term (current) use of hormonal contraceptives A E @ A . . . E P A . . . E ` A HYDROCHLOROTHIAZIDE; LOSARTAN d03830A C[@ R60.9 Edema, unspecified A0 E ` A METOPROLOL d00134A C I10 Essential (primary) hypertension A0 E ` A SIMVASTATIN d00746A C[@ E78.0 Pure hypercholesterolemia A0 E p A . . . E A . . . E A BRIMONIDINE OPHTHALMIC d04048A Cr H40 Glaucoma A E A ATORVASTATIN d04105A B E78.0 Pure hypercholesterolemia A E A LISINOPRIL d00732A C I10 Essential (primary) hypertension A E A . . . E A GLIMEPIRIDE d03864A C E11 Type 2 diabetes mellitus A@ E A INSULIN DETEMIR d05436A C R73 Elevated blood glucose level A@ E A PRAVASTATIN d00348A C 99999 A@ E A RANITIDINE d00021A C 99999 A@ E A ESOMEPRAZOLE d04749A B* K21 Gastro-esophageal reflux disease A E A RANITIDINE d00021A B K21 Gastro-esophageal reflux disease A E A . . . E A HYDROCHLOROTHIAZIDE; LOSARTAN d03830A C I10 Essential (primary) hypertension A E A . . . E A . . . E A . . . E 0 A ACETAMINOPHEN; BUTALBITAL d03456A C R51 Headache A E 0 A ALBUTEROL d00749A C R05 Cough A E 0 A BUDESONIDE d04276A B R05 Cough A E 0 A DOXYCYCLINE d00037A Ap J01.9 Acute sinusitis, unspecified A E 0 A NITROFURANTOIN d00112A Ap N39.0 Urinary tract infection, site not specified A E 0 A OMEPRAZOLE d00325A Cr K21 Gastro-esophageal reflux disease A E 0 A SUCRALFATE d00377A B= K21 Gastro-esophageal reflux disease A E 0 A TIZANIDINE d04102A C R51 Headache A E 0 A TOPIRAMATE d04115A C R51 Headache A E @ A . . . E P A . . . E ` A GLIMEPIRIDE d03864A C[@ E11 Type 2 diabetes mellitus A@ E ` A METFORMIN d03807A C[@ E11 Type 2 diabetes mellitus A@ E ` A METOPROLOL d00134A C[@ I10 Essential (primary) hypertension A@ E ` A SIMVASTATIN d00746A A E78.0 Pure hypercholesterolemia A@ E p A . . . E A ALFUZOSIN d04797A C N40 Enlarged prostate AP E A ATORVASTATIN d04105A D E78.0 Pure hypercholesterolemia AP E A CARBIDOPA; LEVODOPA d03473A B[ G20 Parkinson's disease AP E A DILTIAZEM d00045A D I48.9 Unspecified atrial fibrillation and atrial flutter AP E A METOPROLOL d00134A D I48.9 Unspecified atrial fibrillation and atrial flutter AP E A . . . E A AMLODIPINE d00689A Cr I51.9 Heart disease, unspecified AP E A ATENOLOL d00004A Dc I51.9 Heart disease, unspecified AP E A ATORVASTATIN d04105A D E78.0 Pure hypercholesterolemia AP E A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified AP E A OXYBUTYNIN d00328A D N39.4 Other specified urinary incontinence AP E A . . . E A IBUPROFEN d00015A C[@ Z90 Acquired absence of organs, not elsewhere classified A E A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia AP E A HYDROCHLOROTHIAZIDE d00253A C I10 Essential (primary) hypertension AP E A LOSARTAN d03821A C I10 Essential (primary) hypertension AP E A PANTOPRAZOLE d04514A C[@ K21 Gastro-esophageal reflux disease AP E A POTASSIUM CHLORIDE d00345A B E87.6 Hypokalemia AP E A ALLOPURINOL d00023A D M10.9P Prevent gout Ap E A ATORVASTATIN d04105A D E78.0 Pure hypercholesterolemia Ap E A FUROSEMIDE d00070A D I10 Essential (primary) hypertension Ap E A LISINOPRIL d00732A D I10 Essential (primary) hypertension Ap E A METOPROLOL d00134A D I10 Essential (primary) hypertension Ap E A OMEPRAZOLE d00325A D K21 Gastro-esophageal reflux disease Ap E A PHENYTOIN d00143A C G40 Epilepsy and recurrent seizures Ap E A . . . E A ETHINYL ESTRADIOL; NORETHINDRONE d03238A CP Z79.3 Long term (current) use of hormonal contraceptives A0 E A LOSARTAN d03821A C[@ I10 Essential (primary) hypertension A0 E A TRAZODONE d00395A C[@ G47.9 Sleep disorder, unspecified A0 E A . . . E A BUSPIRONE d00182A B[ F41.9 Anxiety disorder, unspecified A@ E A FLUOXETINE d00236A C F32.9 Major depressive disorder, single episode, unspecified A@ E A OXCARBAZEPINE d04513A C F31.9 F32.9 Bipolar disorder, unspecified Major depressive disorder, single episode, unspecified A@ E A RANITIDINE d00021A C K30 Functional dyspepsia A@ E 0 A AMPHETAMINE; DEXTROAMPHETAMINE d04035A C F90 Attention-deficit hyperactivity disorders A E @ A CLOBAZAM d04557A C G40 Epilepsy and recurrent seizures A0 E @ A LEVOTHYROXINE d00278A D E03.9 Hypothyroidism, unspecified A0 E @ A TOPIRAMATE d04115A Cr G40 Epilepsy and recurrent seizures A0 E P A OMEPRAZOLE d00325A C[@ K30 Functional dyspepsia A E ` A OSELTAMIVIR d04462A AP J09 Influenza due to certain identified influenza viruses A E p A . . . E A OMEPRAZOLE d00325A B- K21 Gastro-esophageal reflux disease A E A AMOXICILLIN d00088A A H66.9 Otitis media, unspecified A E A CLOTRIMAZOLE TOPICAL d04395A Ap B35 Dermatophytosis A E A ATENOLOL d00004A D1 I10 Essential (primary) hypertension A` E A ATORVASTATIN d04105A B* I70.P Prevent atherosclerosis A` E A ESOMEPRAZOLE d04749A BK K30 Functional dyspepsia A` E A HYDROCHLOROTHIAZIDE d00253A D1 I10 Essential (primary) hypertension A` E A PREDNISONE d00350A C1` 55555 A` E A TAMSULOSIN d04121A Cr N40 Enlarged prostate A` E A . . . E A DONEPEZIL d04099A C- R41 Other symptoms and signs involving cognitive functions and awareness A E A PRAVASTATIN d00348A CDp E78.0 Pure hypercholesterolemia A E A AMLODIPINE d00689A C- I10 Essential (primary) hypertension AP E A ATORVASTATIN d04105A CDp E78.0 Pure hypercholesterolemia AP E A DOXAZOSIN d00726A C- N40 Enlarged prostate AP E A GLIPIZIDE d00246A B R73 Elevated blood glucose level AP E A METFORMIN d03807A CDp R73 Elevated blood glucose level AP E A AMLODIPINE d00689A C I10 Essential (primary) hypertension A@ E A BENAZEPRIL d00730A C I10 Essential (primary) hypertension A@ E A HYDROCODONE d03075A B M25.5 Pain in joint A@ E A OMEPRAZOLE d00325A D* K21 Gastro-esophageal reflux disease A@ E A MEDROXYPROGESTERONE d00284A C[@ N92 Excessive, frequent and irregular menstruation A E A . . . E A . . . E 0 A DILTIAZEM d00045A D I10 Essential (primary) hypertension AP E 0 A FUROSEMIDE d00070A CDp I50.9 Heart failure, unspecified AP E 0 A METOPROLOL d00134A C[@ I49.9 Cardiac arrhythmia, unspecified AP E 0 A SPIRONOLACTONE d00373A B I50.9 Heart failure, unspecified AP E 0 A TERAZOSIN d00386A D# N40 Enlarged prostate AP E @ A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified A E P A . . . E ` A . . . E p A LEVOTHYROXINE d00278A D E03.9 Hypothyroidism, unspecified A E p A TESTOSTERONE d00558A C- Z79.890 Hormone replacement therapy A E A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E A ROSUVASTATIN d04851A C I21.P Prevent heart attack/myocardial infarction A E A SERTRALINE d00880A C F32.9 Major depressive disorder, single episode, unspecified A E A SULFAMETHOXAZOLE; TRIMETHOPRIM d00124A A0 N39.0 Urinary tract infection, site not specified A E A . . . E A . . . E 0 A . . . E @ A ATENOLOL d00004A C I10 Essential (primary) hypertension Ap E @ A CITALOPRAM d04332A B F32.9 Major depressive disorder, single episode, unspecified Ap E @ A GABAPENTIN d03182A C- M79.7 Fibromyalgia Ap E @ A HYDROCHLOROTHIAZIDE d00253A Cr I10 Essential (primary) hypertension Ap E @ A OMEPRAZOLE d00325A C K25 K92.9 Gastric ulcer Disease of digestive system, unspecified Ap E @ A TEMAZEPAM d00384A C- G47.0 Insomnia Ap E @ A TRAMADOL d03826A B M79.1 Myalgia Ap E P A . . . E ` A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified A E p A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E A SULFAMETHOXAZOLE; TRIMETHOPRIM d00124A A R19.7 Diarrhea, unspecified A E A CLONIDINE d00044A C I10 Essential (primary) hypertension A0 E A IMATINIB d04758A C C80.1P Prevent cancer A0 E A VALSARTAN d04113A Cr I10 Essential (primary) hypertension A0 E A ISOSORBIDE d00653A C H40 Glaucoma A` E A LEVOTHYROXINE d00278A C 99999 A` E A METFORMIN d03807A C E11 Type 2 diabetes mellitus A` E A METOPROLOL d00134A C I10 Essential (primary) hypertension A` E A PRAVASTATIN d00348A C E78.0 Pure hypercholesterolemia A` E A SITAGLIPTIN d05896A C E11 Type 2 diabetes mellitus A` E 0 A . . . E @ A . . . E P A . . . E ` A APIXABAN d07804A C- I48.9 Unspecified atrial fibrillation and atrial flutter A E ` A ATORVASTATIN d04105A Cr E78.0 Pure hypercholesterolemia A E ` A CARBIDOPA; LEVODOPA d03473A B[ G20 Parkinson's disease A E ` A CELECOXIB d04380A Cr M19.9 Osteoarthritis, unspecified site A E ` A DILTIAZEM d00045A C- I48.9 Unspecified atrial fibrillation and atrial flutter A E ` A FLUOXETINE d00236A C F32.9 Major depressive disorder, single episode, unspecified A E ` A ISOSORBIDE MONONITRATE d00269A C- I21.P Prevent heart attack/myocardial infarction A E ` A PROPRANOLOL d00032A Cr R25.1 Tremor, unspecified A E ` A RABEPRAZOLE d04448A B= K30 Functional dyspepsia A E ` A ROPINIROLE d04215A B G20 Parkinson's disease A E ` A VALSARTAN d04113A B I10 Essential (primary) hypertension A E p A AMLODIPINE d00689A Bz I10 Essential (primary) hypertension A E p A ATORVASTATIN d04105A CDp E78.0 Pure hypercholesterolemia A E p A FAMOTIDINE d00141A C K21 Gastro-esophageal reflux disease A E p A HYDROCHLOROTHIAZIDE; VALSARTAN d04293A C- I10 Essential (primary) hypertension A E p A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified A E p A METOPROLOL d00134A B I10 Essential (primary) hypertension A E p A RANITIDINE d00021A Bz K21 Gastro-esophageal reflux disease A E p A URSODIOL d01005A CDp K87 Disorders of gallbladder, biliary tract and pancreas in diseases classified elsewhere A E p A WARFARIN d00022A C[@ I63 Cerebral infarction A E A . . . E A . . . E A . . . E A . . . E A LOSARTAN d03821A C I10 Essential (primary) hypertension A E A . . . E A METHADONE d00050A B F11.23 Opioid dependence with withdrawal A E A . . . E A . . . E A AMLODIPINE d00689A B[ I10 Essential (primary) hypertension A E A DIAZEPAM d00148A B M62.83 Muscle spasm A E 0 A SPIRONOLACTONE d00373A C[@ L70 Acne A E @ Ap . . . E P A ATENOLOL d00004A Dc I10 Essential (primary) hypertension A E P A HYDROCHLOROTHIAZIDE d00253A C I10 Essential (primary) hypertension A E ` A . . . E p A . . . E A . . . E A . . . E A AMLODIPINE d00689A Cr I10 Essential (primary) hypertension A E A RAMIPRIL d00728A Cr I10 Essential (primary) hypertension A E A . . . E A ATORVASTATIN d04105A CDp E78.0 Pure hypercholesterolemia AP E A HYDROXYZINE d00907A Bz F41.9 Anxiety disorder, unspecified AP E A LEVOTHYROXINE d00278A CDp E03.9 Hypothyroidism, unspecified AP E A SERTRALINE d00880A D* F32.9 Major depressive disorder, single episode, unspecified AP E A TRAZODONE d00395A D* G47.0 Insomnia AP E A . . . E A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A Ap I10 Essential (primary) hypertension A E A NORTRIPTYLINE d00144A C G43 Migraine A0 E A PROPRANOLOL d00032A C R25.1 Tremor, unspecified A0 E A SUMATRIPTAN d03160A C G43 Migraine A0 E A . . . E A CANNABIS d03879A C F41.9 R52 Anxiety disorder, unspecified Pain, unspecified A0 E A EFAVIRENZ; EMTRICITABINE; TENOFOVIR d05847A Cr B20 Human immunodeficiency virus [HIV] disease A0 E A IBUPROFEN d00015A C M25.5 Pain in joint A0 E A . . . E 0 A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A C- I10 Essential (primary) hypertension A E 0 A OMEPRAZOLE d00325A B[ K30 Functional dyspepsia A E @ A . . . E P A . . . E ` A FLUVOXAMINE d03804A D* F41.9 Anxiety disorder, unspecified A@ E ` A OMEPRAZOLE d00325A D* R12 Heartburn A@ E ` A QUETIAPINE d04220A D* F41.9 Anxiety disorder, unspecified A@ E ` A VENLAFAXINE d03181A D* F41.9 Anxiety disorder, unspecified A@ E p A SULFAMETHOXAZOLE; TRIMETHOPRIM d00124A A` A49.9 Bacterial infection, unspecified A E A . . . E A AMLODIPINE d00689A C[@ I10 Essential (primary) hypertension AP E A HYDROCHLOROTHIAZIDE d00253A C[@ I10 Essential (primary) hypertension AP E A LISINOPRIL d00732A C[@ I10 Essential (primary) hypertension AP E A METFORMIN d03807A C[@ E11 Type 2 diabetes mellitus AP E A METOPROLOL d00134A C[@ I10 Essential (primary) hypertension AP E A MINOCYCLINE d00110A C- L70 Acne A E A . . . E A DIVALPROEX SODIUM d03833A C- F33.9 F43.1 Major depressive disorder, recurrent, unspecified Post-traumatic stress disorder (PTSD) A@ E A LITHIUM d00061A B F31.9 Bipolar disorder, unspecified A@ E A LOSARTAN d03821A C I10 Essential (primary) hypertension A@ E A VENLAFAXINE d03181A C F32.9 F41.9 F43.1 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified Post-traumatic stress disorder (PTSD) A@ E A FLUOXETINE d00236A C- F32.9 F41.9 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified A E A ESCITALOPRAM d04812A C- F41.9 Anxiety disorder, unspecified A E A AMOXICILLIN d00088A A A49.9P Prevent bacterial infection AP E A BUPROPION d00181A Bz E66 F33.9 Overweight and obesity Major depressive disorder, recurrent, unspecified AP E A BUSPIRONE d00182A B F41.9 Anxiety disorder, unspecified AP E A ONDANSETRON d00867A A R11.P Prevent nausea or vomiting AP E A SERTRALINE d00880A C9 F33.9 N94 Major depressive disorder, recurrent, unspecified Pain and other conditions associated with female genital organs and menstrual cycle AP E A . . . E A . . . E A . . . E 0 A AMOXICILLIN d00088A A J01.9 J02 Acute sinusitis, unspecified Acute pharyngitis A E @ A . . . E P A . . . E ` A . . . E p A . . . E A . . . E A . . . E A . . . E A . . . E A AMPHETAMINE; DEXTROAMPHETAMINE d04035A C- F90 Attention-deficit hyperactivity disorders A E A DEXMETHYLPHENIDATE d04777A Cr F90 Attention-deficit hyperactivity disorders A E A ATORVASTATIN d04105A CDp 99999 A E A BUPROPION d00181A C- F32.9 F41.9 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified A E A CARISOPRODOL d00960A D M79.1 T14.9 Myalgia Unspecified injury A E A ESCITALOPRAM d04812A C[@ 99999 A E A FUROSEMIDE d00070A CDp 99999 A E A GLIMEPIRIDE d03864A C- 99999 A E A HYDROCODONE d03075A D M54 Dorsalgia A E A LOSARTAN d03821A C- 99999 A E A MONTELUKAST d04289A C[@ J45 Asthma A E A OMEPRAZOLE d00325A C[@ K30 Functional dyspepsia A E A TERAZOSIN d00386A C[@ N40 Enlarged prostate A E A . . . E A AMOXICILLIN d00088A Ap H66.9 Otitis media, unspecified A E A AMLODIPINE d00689A D# I10 Essential (primary) hypertension A@ E A LORAZEPAM d00149A CS R45 Symptoms and signs involving emotional state A@ E A LOSARTAN d03821A C I10 Essential (primary) hypertension A@ E A MELOXICAM d04532A Cr M79.6 Pain in limb, hand, foot, fingers and toes A@ E A ATORVASTATIN d04105A Ei E78.0 Pure hypercholesterolemia A E A INSULIN ASPART d04697A D* E10 Type 1 diabetes mellitus A E A INSULIN GLARGINE d04538A Cr E10 Type 1 diabetes mellitus A E A LISINOPRIL d00732A D I10 Essential (primary) hypertension A E A METOPROLOL d00134A D I10 Essential (primary) hypertension A E A MORPHINE d00308A Cr E10.4 Type 1 diabetes mellitus with neurological complications A E A PREGABALIN d05508A B M79.2 Neuralgia and neuritis, unspecified A E A TOPIRAMATE d04115A C F41.9 Anxiety disorder, unspecified A E 0 A . . . E @ A DEXMETHYLPHENIDATE d04777A B= R41 Other symptoms and signs involving cognitive functions and awareness A E P A . . . E ` A . . . E p A DIVALPROEX SODIUM d03833A Dc G40 Epilepsy and recurrent seizures A E p A ESCITALOPRAM d04812A Dc F32.9 Major depressive disorder, single episode, unspecified A E p A FUROSEMIDE d00070A Dc R60.9 Edema, unspecified A E p A LISINOPRIL d00732A Dc I10 Essential (primary) hypertension A E p A METFORMIN d03807A Dc E11 Type 2 diabetes mellitus A E p A METOPROLOL d00134A Dc I10 Essential (primary) hypertension A E p A POTASSIUM CHLORIDE d00345A Dc E87.6 Hypokalemia A E p A SITAGLIPTIN d05896A Dc E11 Type 2 diabetes mellitus A E p A SPIRONOLACTONE d00373A Dc R60.9 Edema, unspecified A E p A TRAMADOL d03826A Dc M62.83 Muscle spasm A E A . . . E A . . . E A BUPROPION d00181A CDp F32.9 Major depressive disorder, single episode, unspecified AP E A METFORMIN d03807A CDp E28 Ovarian dysfunction AP E A MONTELUKAST d04289A B T78.40 Allergy, unspecified AP E A OMEPRAZOLE d00325A Cr K21 Gastro-esophageal reflux disease AP E A SERTRALINE d00880A CDp F32.9 Major depressive disorder, single episode, unspecified AP E A METOPROLOL d00134A C I10 Essential (primary) hypertension A E A OMEPRAZOLE d00325A C R12 Heartburn A E A CEPHALEXIN d00096A A J01.9 Acute sinusitis, unspecified A E A AMLODIPINE d00689A C I10 Essential (primary) hypertension A E A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A E A . . . E A . . . E A ALBUTEROL d00749A C- J45 Asthma A@ E A FLUTICASONE d01296A C- J45 R05 R06.2 Asthma Cough Wheezing A@ E A FLUTICASONE NASAL d04283A C- J30.2 R09.81 Other seasonal allergic rhinitis Nasal congestion A@ E A POLYETHYLENE GLYCOL 3350 d05350A C- K59.0 Constipation A@ E A ATORVASTATIN d04105A0 CDp E78.0 Pure hypercholesterolemia A E A CARVEDILOL d03847A0 CDp I10 Essential (primary) hypertension A E A CIPROFLOXACIN d00011A0 CDp A49.9P N39.0 Prevent bacterial infection Urinary tract infection, site not specified A E A CITALOPRAM d04332A0 CDp F32.9 Major depressive disorder, single episode, unspecified A E A CLONAZEPAM d00197A0 CDp F32.9 Major depressive disorder, single episode, unspecified A E A DONEPEZIL d04099A0 CDp G31.9 Degenerative disease of nervous system, unspecified A E A GLIPIZIDE d00246A0 CDp E11 Type 2 diabetes mellitus A E A INSULIN DETEMIR d05436A0 CDp E11 Type 2 diabetes mellitus A E A LISINOPRIL d00732A0 CDp I10 Essential (primary) hypertension A E A NAPROXEN d00019A0 B M13 M79.1 Other arthritis Myalgia A E A OMEPRAZOLE d00325A0 CDp K21 Gastro-esophageal reflux disease A E A POLYETHYLENE GLYCOL 3350 d05350A0 CDp K59.0 Constipation A E A QUETIAPINE d04220A0 CDp F31.9 Bipolar disorder, unspecified A E A RISPERIDONE d03180A0 CDp F31.9 Bipolar disorder, unspecified A E A SUCRALFATE d00377A0 CDp K25 Gastric ulcer A E A ETHINYL ESTRADIOL; NORGESTIMATE d03781A C"0 Z79.3 Long term (current) use of hormonal contraceptives A E A FLUORIDE TOPICAL d04397A B= K05.6 Periodontal disease, unspecified A E 0 A INSULIN ASPART d04697A Ap R73 Elevated blood glucose level A0 E 0 A INSULIN GLARGINE d04538A B E11 Type 2 diabetes mellitus A0 E 0 A METFORMIN d03807A A E11 Type 2 diabetes mellitus A0 E @ A . . . E P A . . . E ` A ATENOLOL d00004A C I10 Essential (primary) hypertension A0 E ` A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A0 E ` A CLOPIDOGREL d04258A C I21.P Prevent heart attack/myocardial infarction A0 E p A . . . E A . . . E A ALLOPURINOL d00023A C M10.9 Gout, unspecified A` E A AMMONIUM LACTATE TOPICAL d04049A CP L40 Psoriasis A` E A CARVEDILOL d03847A C I10 Essential (primary) hypertension A` E A LEVOTHYROXINE d00278A D E03.9 Hypothyroidism, unspecified A` E A LISINOPRIL d00732A Dc I10 Essential (primary) hypertension A` E A TAMSULOSIN d04121A C N40 R35 Enlarged prostate Polyuria A` E A DICYCLOMINE d00999A C- K58 Irritable bowel syndrome A E A FLUOXETINE d00236A D F32.9 Major depressive disorder, single episode, unspecified A E A GABAPENTIN d03182A Dc F31.9 Bipolar disorder, unspecified A E A HYDROCHLOROTHIAZIDE d00253A C I10 Essential (primary) hypertension A E A LAMOTRIGINE d03809A Dc F31.9 Bipolar disorder, unspecified A E A LISINOPRIL d00732A Cr I10 Essential (primary) hypertension A E A MELOXICAM d04532A C"0 M79.1 Myalgia A E A METFORMIN d03807A D= E11 Type 2 diabetes mellitus A E A OMEPRAZOLE d00325A C K21 Gastro-esophageal reflux disease A E A RISPERIDONE d03180A Dc F31.9 Bipolar disorder, unspecified A E A SITAGLIPTIN d05896A C- E11 Type 2 diabetes mellitus A E A . . . E A GLIPIZIDE d00246A Cr E11 Type 2 diabetes mellitus A@ E A LISINOPRIL d00732A CDp E11.2 Type 2 diabetes mellitus with kidney complications A@ E A METFORMIN d03807A C E11 Type 2 diabetes mellitus A@ E A SIMVASTATIN d00746A Cr E78.0 Pure hypercholesterolemia A@ E A ATORVASTATIN d04105A Cr E78.0 Pure hypercholesterolemia A E A LEVOTHYROXINE d00278A C- E03.9 Hypothyroidism, unspecified A E A ETONOGESTREL d04772A Cr Z79.3 Long term (current) use of hormonal contraceptives A E A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A Cr I10 Essential (primary) hypertension A E A . . . E A . . . E A . . . E 0 A FENOFIBRATE d04286A C R73 Elevated blood glucose level A@ E 0 A IBUPROFEN d00015A C M25.5 Pain in joint A@ E 0 A LEVOTHYROXINE d00278A B= E03.9 Hypothyroidism, unspecified A@ E 0 A METFORMIN; SAXAGLIPTIN d07709A C R73 Elevated blood glucose level A@ E @ A ALBUTEROL d00749A C[@ J45 Asthma A@ E @ A METHOTREXATE d00060A B H57.9 Unspecified disorder of eye and adnexa A@ E @ A PREDNISOLONE OPHTHALMIC d03221A C H57.9 Unspecified disorder of eye and adnexa A@ E @ A PREDNISONE d00350A C- H57.9 Unspecified disorder of eye and adnexa A@ E P A . . . E ` A ATENOLOL d00004A C I50.9 Heart failure, unspecified A E ` A GABAPENTIN d03182A C M79.2 Neuralgia and neuritis, unspecified A E ` A GLIPIZIDE d00246A C E11 Type 2 diabetes mellitus A E ` A HYDRALAZINE d00132A B= I10 Essential (primary) hypertension A E ` A ISOSORBIDE d00653A C H40 Glaucoma A E ` A LISINOPRIL d00732A C N19 Unspecified kidney failure A E ` A METFORMIN d03807A C E11 Type 2 diabetes mellitus A E ` A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia A E p A . . . E A . . . E A . . . E A . . . E A . . . E A MONTELUKAST d04289A C J30.9 J45 Allergic rhinitis, unspecified Asthma A E A AMOXICILLIN d00088A Ap K04.7P Prevent tooth infection A E A IBUPROFEN d00015A C K08.8 N28.9 Other specified disorders of teeth and supporting structures Disorder of kidney and ureter, unspecified A E A . . . E A AMLODIPINE d00689A C- I10 Essential (primary) hypertension A@ E A OMEPRAZOLE d00325A Cr K21 Gastro-esophageal reflux disease A@ E A PRAVASTATIN d00348A B E78.0 Pure hypercholesterolemia A@ E A TELMISARTAN d04364A B[ I10 Essential (primary) hypertension A@ E A . . . E A CITALOPRAM d04332A C[@ F32.9 F41.9 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified A E A DEXTROAMPHETAMINE d00804A C F90 Attention-deficit hyperactivity disorders A E A . . . E 0 A . . . E @ A AMLODIPINE d00689A Ei I10 Essential (primary) hypertension A` E @ A CARVEDILOL d03847A C- I10 Essential (primary) hypertension A` E @ A CINACALCET d05218A C9 N19 Unspecified kidney failure A` E @ A CLOTRIMAZOLE TOPICAL d04395A B[ H66.9 Otitis media, unspecified A` E @ A LINAGLIPTIN d07767A Cr E11 Type 2 diabetes mellitus A` E @ A SEVELAMER d04363A CDp N19 Unspecified kidney failure A` E P A . . . E ` A . . . E p A GEMFIBROZIL d00245A Cr E78.0 Pure hypercholesterolemia A` E p A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A Cr I10 Essential (primary) hypertension A` E p A LISINOPRIL d00732A Cr I10 Essential (primary) hypertension A` E p A METOPROLOL d00134A Cr I10 Essential (primary) hypertension A` E p A POTASSIUM CHLORIDE d00345A Cr E87.6 Hypokalemia A` E p A PRAVASTATIN d00348A Cr E78.0 Pure hypercholesterolemia A` E A . . . E A ALBUTEROL d00749A C- J45 Asthma A E A TRIAMCINOLONE TOPICAL d03206A C L20.9 Atopic dermatitis, unspecified A E A ENALAPRIL d00013A Cr I10 Essential (primary) hypertension A0 E A PRAVASTATIN d00348A B[ E78.0 Pure hypercholesterolemia A0 E A RANITIDINE d00021A C- K21 Gastro-esophageal reflux disease A0 E A PENICILLIN d00116A C 55555 A E A ALBUTEROL d00749A C J45 Asthma A E A . . . E A . . . E A . . . E A . . . E A ALBUTEROL d00749A CDp J44.9 Chronic obstructive pulmonary disease, unspecified AP E A HYDROCODONE d03075A CO J44.9 Chronic obstructive pulmonary disease, unspecified AP E A METOPROLOL d00134A CDp I10 Essential (primary) hypertension AP E A PREDNISONE d00350A CDp J44.9 Chronic obstructive pulmonary disease, unspecified AP E A SERTRALINE d00880A CDp F32.9 Major depressive disorder, single episode, unspecified AP E A . . . E 0 A . . . E @ A . . . E P A . . . E ` A ACETAMINOPHEN; HYDROCODONE d03428A C M25.5 M54 Pain in joint Dorsalgia A` E ` A ALBUTEROL d00749A C R06.02 Shortness of breath A` E ` A CONJUGATED ESTROGENS; MEDROXYPROGESTERONE d03819A C Z79.890 Hormone replacement therapy A` E ` A DICLOFENAC d00848A Cr Z79.1 Long term (current) use of non-steroidal anti-inflammatories (NSAID) A` E ` A OXYBUTYNIN d00328A C N32.81 Overactive bladder A` E ` A TRIAMCINOLONE d00620A Cr M06.9 Rheumatoid arthritis, unspecified A` E p A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E A RANITIDINE d00021A B K21 Gastro-esophageal reflux disease A E A ALLOPURINOL d00023A C M1A Chronic gout AP E A AMLODIPINE d00689A C I10 Essential (primary) hypertension AP E A AMOXICILLIN; CLAVULANATE d00089A AP J02 Acute pharyngitis AP E A METFORMIN d03807A C[@ E11 Type 2 diabetes mellitus AP E A OMEPRAZOLE d00325A C- K30 Functional dyspepsia AP E A . . . E A . . . E A . . . E 0 A RISPERIDONE d03180A D F84 Pervasive developmental disorders A E @ A . . . E P A . . . E ` A . . . E p A AMLODIPINE d00689A C I10 Essential (primary) hypertension A E p A CYCLOBENZAPRINE d00963A CD` M79.1 Myalgia A E p A HYDROCHLOROTHIAZIDE; LOSARTAN d03830A C R60.9 Edema, unspecified A E p A MELOXICAM d04532A B[ M54 Dorsalgia A E p A METFORMIN; SITAGLIPTIN d06720A CD` E11 Type 2 diabetes mellitus A E p A MONTELUKAST d04289A C J45 Asthma A E p A OMEPRAZOLE d00325A C K21 Gastro-esophageal reflux disease A E p A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia A E A ALLOPURINOL d00023A DGJ M1A Chronic gout A E A . . . E A ACETAMINOPHEN; HYDROCODONE d03428A C M25.5 Pain in joint A E A AMLODIPINE d00689A Cr I10 Essential (primary) hypertension A E A CARBAMAZEPINE d00058A C9 G99.8 Other specified disorders of nervous system in diseases classified elsewhere A E A CLOPIDOGREL d04258A Cr I63.P Prevent stroke A E A DESONIDE TOPICAL d01290A C L29.9 R21 Pruritus, unspecified Rash and other nonspecific skin eruption A E A FINASTERIDE d00563A C N40 Enlarged prostate A E A LORAZEPAM d00149A C- F41.9 Anxiety disorder, unspecified A E A METRONIDAZOLE TOPICAL d03208A C L71 Rosacea A E A OLMESARTAN d04801A C I21.P I63.P Prevent heart attack/myocardial infarction Prevent stroke A E A PRAVASTATIN d00348A C- E78.0 Pure hypercholesterolemia A E A TRIAMCINOLONE TOPICAL d03206A C R21 Rash and other nonspecific skin eruption A E A VENLAFAXINE d03181A B F32.9 Major depressive disorder, single episode, unspecified A E A . . . E A . . . E A ETHINYL ESTRADIOL; NORELGESTROMIN d04779A B Z79.3 Long term (current) use of hormonal contraceptives A E A ACETAMINOPHEN; BUTALBITAL; CAFFEINE d03455A C- G43 Migraine A@ E A OXCARBAZEPINE d04513A B F39 Unspecified mood [affective] disorder A@ E A PAROXETINE d03157A C- F39 F41.9 Unspecified mood [affective] disorder Anxiety disorder, unspecified A@ E A TOPIRAMATE d04115A C- G43 Migraine A@ E A ETHINYL ESTRADIOL; NORGESTREL d03241A C Z79.3 Long term (current) use of hormonal contraceptives A E A ESCITALOPRAM d04812A C F32.9 F41.9 F90 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified Attention-deficit hyperactivity disorders A E A ALLOPURINOL d00023A C M1A Chronic gout A` E A AMILORIDE; HYDROCHLOROTHIAZIDE d03193A C I10 Essential (primary) hypertension A` E A CARVEDILOL d03847A Dc I10 Essential (primary) hypertension A` E A LOSARTAN d03821A C I10 Essential (primary) hypertension A` E A OMEPRAZOLE d00325A Dc K21 Gastro-esophageal reflux disease A` E A POTASSIUM CHLORIDE d00345A Dc E87.6 Hypokalemia A` E A . . . E 0 A . . . E @ A BUSPIRONE d00182A B F41.9 Anxiety disorder, unspecified A@ E @ A ESOMEPRAZOLE d04749A A K30 Functional dyspepsia A@ E @ A FLUOXETINE d00236A B F32.9 Major depressive disorder, single episode, unspecified A@ E @ A PROPRANOLOL d00032A B F41.9 Anxiety disorder, unspecified A@ E P A OXCARBAZEPINE d04513A Cr G40 Epilepsy and recurrent seizures A E ` A . . . E p A AMLODIPINE; OLMESARTAN d06905A C[@ I10 Essential (primary) hypertension A0 E p A COLCHICINE d00150A C M1A Chronic gout A0 E p A ROSUVASTATIN d04851A B E78.0 Pure hypercholesterolemia A0 E A BUTALBITAL d03061A D# G43 Migraine A E A FLUTICASONE NASAL d04283A D R09.81 Nasal congestion A E A FLUTICASONE; SALMETEROL d04611A D# J45 Asthma A E A GABAPENTIN d03182A D# G43 Migraine A E A LISINOPRIL d00732A C"0 I10 Essential (primary) hypertension A E A NAPROXEN d00019A D Z79 Long term (current) drug therapy A E A OLANZAPINE d04050A D F20 F32.9 Schizophrenia Major depressive disorder, single episode, unspecified A E A PERPHENAZINE d00855A B F20 Schizophrenia A E A SERTRALINE d00880A D F32.9 F41.9 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified A E A TRAZODONE d00395A D G47.9 Sleep disorder, unspecified A E A . . . E A . . . E A . . . E A . . . E A MINOCYCLINE d00110A B L70 Acne A E A MIRTAZAPINE d04025A B[ F32.9 Major depressive disorder, single episode, unspecified A E A . . . E A . . . E A . . . E A ATORVASTATIN d04105A Cr 99999 AP E A DONEPEZIL d04099A Ei R41 Other symptoms and signs involving cognitive functions and awareness AP E A HYDROCHLOROTHIAZIDE; LOSARTAN d03830A Cr I10 Essential (primary) hypertension AP E A MEMANTINE d04899A Ei R41 Other symptoms and signs involving cognitive functions and awareness AP E A MONTELUKAST d04289A Cr J45 Asthma AP E A TESTOSTERONE d00558A C E29.1 Testicular hypofunction A E 0 A . . . E @ A ALBUTEROL d00749A Ap J42 Unspecified chronic bronchitis A E @ A BECLOMETHASONE d00760A Ap J42 Unspecified chronic bronchitis A E P A . . . E ` A . . . E p A . . . E A AMLODIPINE; BENAZEPRIL d03829A C I10 Essential (primary) hypertension A E A AMITRIPTYLINE d00146A D G47.0 Insomnia AP E A ATORVASTATIN d04105A D E78.0P Prevent high cholesterol AP E A DILTIAZEM d00045A D I10 Essential (primary) hypertension AP E A HYDROCHLOROTHIAZIDE; LOSARTAN d03830A D I50.9 Heart failure, unspecified AP E A METOPROLOL d00134A D I10 Essential (primary) hypertension AP E A ROSUVASTATIN d04851A C- E78.0 Pure hypercholesterolemia A E A VALSARTAN d04113A C- I10 Essential (primary) hypertension A E A CONJUGATED ESTROGENS TOPICAL d04396A CDp N95 Menopausal and other perimenopausal disorders A E A . . . E A AMLODIPINE d00689A C I10 Essential (primary) hypertension Ap E A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia Ap E A CLOPIDOGREL d04258A C I21 ST elevation (STEMI) and non-ST elevation (NSTEMI) myocardial infarction Ap E A GLIPIZIDE d00246A C E11 Type 2 diabetes mellitus Ap E A LISINOPRIL d00732A C I10 Essential (primary) hypertension Ap E A METFORMIN d03807A CDp E11 Type 2 diabetes mellitus Ap E A PAROXETINE d03157A C 99999 Ap E A . . . E A . . . E A ETHINYL ESTRADIOL; NORETHINDRONE d03238A Bz Z79.3 Long term (current) use of hormonal contraceptives A E A ALPRAZOLAM d00168A D F41.0 F41.9 Panic disorder [episodic paroxysmal anxiety] without agoraphobia Anxiety disorder, unspecified A` E A CYCLOBENZAPRINE d00963A C M62.83 Muscle spasm A` E A DIAZEPAM d00148A D1 G47.9 M62.83 Sleep disorder, unspecified Muscle spasm A` E A HYDROCODONE d03075A D% M54 M79.2 Dorsalgia Neuralgia and neuritis, unspecified A` E A LETROZOLE d04156A B C50 Malignant neoplasm of breast A` E A PREGABALIN d05508A C- M79.2 Neuralgia and neuritis, unspecified A` E A ATORVASTATIN d04105A0 C- E78.0 Pure hypercholesterolemia A` E A CARVEDILOL d03847A0 B= I10 Essential (primary) hypertension A` E A CLOPIDOGREL d04258A0 B= D75.9P Prevent blood clots A` E A HYDROCHLOROTHIAZIDE; TRIAMTERENE d03052A0 C- I10 R60.9 Essential (primary) hypertension Edema, unspecified A` E A LOSARTAN d03821A0 C- I10 Essential (primary) hypertension A` E A METFORMIN d03807A0 C- E11 Type 2 diabetes mellitus A` E 0 A IBUPROFEN d00015A C M54 Dorsalgia A E 0 A TADALAFIL d04896A B[ N52.9 Male erectile dysfunction, unspecified A E @ A . . . E P A . . . E ` A . . . E p A . . . E A APIXABAN d07804A A I63.P Prevent stroke A` E A ENALAPRIL d00013A D ^ I10 Essential (primary) hypertension A` E A METOPROLOL d00134A C- R00 Abnormalities of heart beat A` E A SIMVASTATIN d00746A D ^ E78.0 Pure hypercholesterolemia A` E A TEMAZEPAM d00384A D G47.0 Insomnia A` E A TERAZOSIN d00386A D N40 Enlarged prostate A` E A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A D I10 Essential (primary) hypertension A0 E A LEVOTHYROXINE d00278A Dc E04 Other nontoxic goiter A0 E A SIMVASTATIN d00746A D E78.0 Pure hypercholesterolemia A0 E A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E A HYDROCHLOROTHIAZIDE; TRIAMTERENE d03052A C I10 Essential (primary) hypertension A` E A IPRATROPIUM d00265A B T78.40 Allergy, unspecified A` E A LOSARTAN d03821A Cr I10 Essential (primary) hypertension A` E A NORTRIPTYLINE d00144A CDp M54 Dorsalgia A` E A OMEPRAZOLE d00325A B[ R12 Heartburn A` E A ROSUVASTATIN d04851A Cr E78.0 Pure hypercholesterolemia A` E A METHIMAZOLE d00290A B E05 Thyrotoxicosis [hyperthyroidism] A E A . . . E 0 A . . . E @ A ONDANSETRON d00867A A R11 Nausea and vomiting A E P A SACUBITRIL; VALSARTAN d08369A B* I51.9 Heart disease, unspecified A0 E P A SOTALOL d00371A D ^ I48.9 Unspecified atrial fibrillation and atrial flutter A0 E P A WARFARIN d00022A D ^ D75.9P I48.9 Prevent blood clots Unspecified atrial fibrillation and atrial flutter A0 E ` A . . . E p A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E A FLUTICASONE NASAL d04283A C- J30.9 Allergic rhinitis, unspecified A0 E A FORMOTEROL; MOMETASONE d07660A C- J45 Asthma A0 E A MONTELUKAST d04289A C- J45 Asthma A0 E A AMOXICILLIN d00088A A H66.9 Otitis media, unspecified A E A CARVEDILOL d03847A C I51.9 Heart disease, unspecified A@ E A GLIMEPIRIDE d03864A C E11 R73 Type 2 diabetes mellitus Elevated blood glucose level A@ E A LISINOPRIL d00732A C I10 Essential (primary) hypertension A@ E A PRAVASTATIN d00348A C E78.0 Pure hypercholesterolemia A@ E A . . . E A ALBUTEROL d00749A D J45 Asthma A` E A FLUTICASONE NASAL d04283A C J30.2 Other seasonal allergic rhinitis A` E A MONTELUKAST d04289A C[@ J45 R06.2 Asthma Wheezing A` E A OMEPRAZOLE d00325A C- K21 Gastro-esophageal reflux disease A` E A SUMATRIPTAN d03160A C G43 Migraine A` E A VILAZODONE d07740A C- F41.9 Anxiety disorder, unspecified A` E 0 A ALENDRONATE d03849A B= M81 Osteoporosis without current pathological fracture A E 0 A BIMATOPROST OPHTHALMIC d04754A C"0 H40 Glaucoma A E 0 A CYCLOSPORINE OPHTHALMIC d04836A B[ H04 Disorders of lacrimal system A E 0 A ESCITALOPRAM d04812A C F41.9 Anxiety disorder, unspecified A E 0 A LISINOPRIL d00732A C I10 Essential (primary) hypertension A E 0 A MECLIZINE d00859A C R42 Dizziness and giddiness A E 0 A OMEPRAZOLE d00325A C K21 Gastro-esophageal reflux disease A E 0 A ROSUVASTATIN d04851A D= E78.0 Pure hypercholesterolemia A E 0 A TIZANIDINE d04102A C M62.83 Muscle spasm A E @ A ALBUTEROL d00749A D J45 Asthma A0 E @ A FLUTICASONE NASAL d04283A C- J30.9 Allergic rhinitis, unspecified A0 E @ A MONTELUKAST d04289A C J45 Asthma A0 E P A . . . E ` A ESCITALOPRAM d04812A0 Bz F32.9 Major depressive disorder, single episode, unspecified A0 E ` A HYDROCHLOROTHIAZIDE d00253A B[ R60.9 Edema, unspecified A0 E ` A LISINOPRIL d00732A0 Bz I10 Essential (primary) hypertension A0 E p A ACETAMINOPHEN; OXYCODONE d03431A CDp M79.2 Neuralgia and neuritis, unspecified A E p A CLONAZEPAM d00197A C F41.9 Anxiety disorder, unspecified A E p A MELOXICAM d04532A C- M54 Dorsalgia A E p A METHOCARBAMOL d00965A B M25.5 Pain in joint A E p A MUPIROCIN TOPICAL d01267A B[ L08.9 Local infection of the skin and subcutaneous tissue, unspecified A E p A SUMATRIPTAN d03160A C"0 G43 Migraine A E p A TOPIRAMATE d04115A C[@ G43 Migraine A E p A TRAMADOL d03826A C9 M79.1 Myalgia A E A . . . E A HYDROCODONE d03075A A0 K05.6 K08.4 Periodontal disease, unspecified Partial loss of teeth A0 E A PENICILLIN d00116A Ap K08.4 Partial loss of teeth A0 E A PROMETHAZINE d00787A Ap R11 T88.7P Nausea and vomiting Prevent drug side effect A0 E A . . . E A . . . E A . . . E A ALBUTEROL d00749A D J45 Asthma A0 E A MONTELUKAST d04289A C J45 Asthma A0 E A TIZANIDINE d04102A B M54 M79.6 Dorsalgia Pain in limb, hand, foot, fingers and toes A0 E A . . . E A . . . E A . . . E A ALLOPURINOL d00023A C- M10.9P Prevent gout A` E A LISINOPRIL d00732A C- E11.2P I10 Prevent diabetic kidney disease Essential (primary) hypertension A` E A LORAZEPAM d00149A C- F41.9 Anxiety disorder, unspecified A` E A METFORMIN d03807A B[ R73 Elevated blood glucose level A` E A SIMVASTATIN d00746A C- E78.0 Pure hypercholesterolemia A` E A SIMVASTATIN d00746A Cr E78.0 Pure hypercholesterolemia A` E A AMLODIPINE d00689A C I10 Essential (primary) hypertension A E A ATORVASTATIN d04105A C- E78.0 Pure hypercholesterolemia A E A CLONIDINE d00044A CDp I10 Essential (primary) hypertension A E A CLOPIDOGREL d04258A C- I21.P Prevent heart attack/myocardial infarction A E A FUROSEMIDE d00070A Cr R60.9 Edema, unspecified A E A HYDRALAZINE d00132A C- I50.9 Heart failure, unspecified A E A INSULIN ISOPHANE; INSULIN REGULAR d04374A C E11 Type 2 diabetes mellitus A E A LOSARTAN d03821A C- I21.P I50.9 Prevent heart attack/myocardial infarction Heart failure, unspecified A E 0 A . . . E @ A DONEPEZIL d04099A C R41 Other symptoms and signs involving cognitive functions and awareness AP E @ A METOPROLOL d00134A Cr I10 Essential (primary) hypertension AP E @ A OMEGA-3 POLYUNSATURATED FATTY ACIDS d00497A C H57.9 Unspecified disorder of eye and adnexa AP E @ A PRAVASTATIN d00348A Cr E78.0 Pure hypercholesterolemia AP E @ A TAMSULOSIN d04121A C R35 Polyuria AP E P A . . . E ` A GABAPENTIN d03182A B* G40 M79.2 Epilepsy and recurrent seizures Neuralgia and neuritis, unspecified A E p A . . . E A COBICISTAT; DARUNAVIR; EMTRICITABINE; TENOFOVIR d08738A C- B20 Human immunodeficiency virus [HIV] disease AP E A DOLUTEGRAVIR d08117A C- B20 Human immunodeficiency virus [HIV] disease AP E A EMTRICITABINE; TENOFOVIR d05352A C- B20 Human immunodeficiency virus [HIV] disease AP E A HYDROCHLOROTHIAZIDE d00253A B I10 Essential (primary) hypertension AP E A IBUPROFEN d00015A C- M25.5 Pain in joint AP E A . . . E A ATORVASTATIN d04105A D E78.0 Pure hypercholesterolemia AP E A CHLORTHALIDONE d00192A D I50.9 Heart failure, unspecified AP E A LOSARTAN d03821A D I10 Essential (primary) hypertension AP E A METOPROLOL d00134A D I10 Essential (primary) hypertension AP E A WARFARIN d00022A D D75.9P Prevent blood clots AP E A LISINOPRIL d00732A B I10 Essential (primary) hypertension A E A POLYETHYLENE GLYCOL 3350 d05350A B K59.0 Constipation A E A . . . E A . . . E A GLIPIZIDE d00246A C E11 Type 2 diabetes mellitus A0 E A METFORMIN d03807A Dc E11 Type 2 diabetes mellitus A0 E A METOPROLOL d00134A B I10 Essential (primary) hypertension A0 E A . . . E A . . . E A AMLODIPINE d00689A Ei 99999 A E A ATORVASTATIN d04105A Ei 99999 A E A CARBIDOPA; LEVODOPA d03473A Ei 99999 A E A CARVEDILOL d03847A Ei 99999 A E A ESOMEPRAZOLE d04749A Ei 99999 A E A INSULIN ASPART; INSULIN ASPART PROTAMINE d04839A C E11 Type 2 diabetes mellitus A E A LEVOTHYROXINE d00278A Ei 99999 A E A LISINOPRIL d00732A Ei 99999 A E A METFORMIN d03807A Ei 99999 A E A TRIHEXYPHENIDYL d00970A Ei 99999 A E 0 A . . . E @ A GLIPIZIDE d00246A C E11 Type 2 diabetes mellitus A@ E @ A HYDROCHLOROTHIAZIDE; OLMESARTAN d04878A C- I10 Essential (primary) hypertension A@ E @ A METFORMIN d03807A C E11 Type 2 diabetes mellitus A@ E @ A PRAVASTATIN d00348A C E78.0 Pure hypercholesterolemia A@ E P A LINAGLIPTIN; METFORMIN d07825A C- E11 Type 2 diabetes mellitus A E ` A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified A E p A AMLODIPINE d00689A C9 I10 Essential (primary) hypertension A0 E p A CHLORTHALIDONE d00192A C9 I10 Essential (primary) hypertension A0 E p A LEVOTHYROXINE d00278A B E03.9 Hypothyroidism, unspecified A0 E A . . . E A COLCHICINE d00150A CDp M1A Chronic gout A E A TAMSULOSIN d04121A C- N40 Enlarged prostate A E A . . . E A . . . E A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia A E A GUANFACINE d00717A B F90 Attention-deficit hyperactivity disorders A E A . . . E A . . . E A ATENOLOL d00004A Dc I10 Essential (primary) hypertension A0 E A ATORVASTATIN d04105A Cr I51.9P Prevent heart disease A0 E A ENALAPRIL; HYDROCHLOROTHIAZIDE d03740A CDp I10 Essential (primary) hypertension A0 E A . . . E A . . . E 0 A ATENOLOL d00004A Ei 99999 AP E 0 A ATORVASTATIN d04105A Ei E78.0 Pure hypercholesterolemia AP E 0 A COLCHICINE d00150A B M19.9 Osteoarthritis, unspecified site AP E 0 A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A Ei I10 Essential (primary) hypertension AP E 0 A SITAGLIPTIN d05896A Ei E11 Type 2 diabetes mellitus AP E @ A . . . E P A GEMFIBROZIL d00245A Dc E78.0 Pure hypercholesterolemia A` E P A ISOSORBIDE MONONITRATE d00269A C[@ 99999 A` E P A METOPROLOL d00134A C[@ I10 Essential (primary) hypertension A` E P A OMEPRAZOLE d00325A C[@ 99999 A` E P A PIOGLITAZONE d04442A C- E11 Type 2 diabetes mellitus A` E P A SIMVASTATIN d00746A CDp I21.P Prevent heart attack/myocardial infarction A` E ` A . . . E p A BIMATOPROST OPHTHALMIC d04754A CDp H40 Glaucoma A E p A COLESEVELAM d04695A Cr R19.7 Diarrhea, unspecified A E p A DORZOLAMIDE OPHTHALMIC d03805A CDp H40 Glaucoma A E p A GABAPENTIN d03182A C M79.2 Neuralgia and neuritis, unspecified A E p A KETOCONAZOLE TOPICAL d03202A Bz B35 Dermatophytosis A E p A LENALIDOMIDE d05696A C D49.9 Neoplasm of unspecified behavior of unspecified site A E p A LORAZEPAM d00149A CDp G47.0 Insomnia A E p A NETARSUDIL OPHTHALMIC d08690A C H40 Glaucoma A E p A OMEPRAZOLE d00325A Cr K27 Peptic ulcer, site unspecified A E p A RIVAROXABAN d07356A C I26 Pulmonary embolism A E p A VALACYCLOVIR d03838A C B34.9 Viral infection, unspecified A E A CETIRIZINE d03827A CDp T78.40 Allergy, unspecified A E A MONTELUKAST d04289A C J30.9 Allergic rhinitis, unspecified A E A . . . E A DOXYCYCLINE d00037A C- L70 Acne A E A PROGESTERONE d00550A B 55555 A E A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E A ATORVASTATIN d04105A C- E78.0 Pure hypercholesterolemia A` E A FENOFIBRATE d04286A C E78.0 Pure hypercholesterolemia A` E A METFORMIN d03807A CDp E11 Type 2 diabetes mellitus A` E A OMEPRAZOLE d00325A Cr K21 Gastro-esophageal reflux disease A` E A RAMIPRIL d00728A C"0 I10 Essential (primary) hypertension A` E A SITAGLIPTIN d05896A C E11 Type 2 diabetes mellitus A` E A . . . E 0 A . . . E @ A . . . E P A ATORVASTATIN d04105A A E78.0 Pure hypercholesterolemia A E ` A . . . E p A . . . E A ATENOLOL d00004A CP I48.9 Unspecified atrial fibrillation and atrial flutter A E A HYDROCHLOROTHIAZIDE; LOSARTAN d03830A C- I10 Essential (primary) hypertension A E A LISINOPRIL d00732A C- I10 Essential (primary) hypertension A E A . . . E A . . . E A ALPRAZOLAM d00168A C F41.9 Anxiety disorder, unspecified A0 E A LEVOTHYROXINE d00278A D# E03.9 Hypothyroidism, unspecified A0 E A METOPROLOL d00134A D I10 Essential (primary) hypertension A0 E A . . . E A . . . E A . . . E A . . . E A LATANOPROST OPHTHALMIC d04017A C H40 Glaucoma A E A OMEPRAZOLE d00325A D* K21 Gastro-esophageal reflux disease A E A BUPROPION d00181A0 CDp F32.9 F41.9 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified AP E A CINACALCET d05218A Ei E34.9 Endocrine disorder, unspecified AP E A LACTULOSE d01024A B= K59.0 Constipation AP E A ROSUVASTATIN d04851A0 B E78.0 Pure hypercholesterolemia AP E A TRAZODONE d00395A0 Cr G47.0 Insomnia AP E 0 A AMLODIPINE d00689A Cr I10 Essential (primary) hypertension A E 0 A ASPIRIN d00170A B# Z79.0 Long term (current) use of anticoagulants and antithrombotics/antiplatelets A E 0 A ATORVASTATIN d04105A Cr E78.0 Pure hypercholesterolemia A E 0 A GLIPIZIDE d00246A Cr E11 Type 2 diabetes mellitus A E 0 A HYDROCHLOROTHIAZIDE d00253A Cr R60.9 Edema, unspecified A E 0 A METFORMIN d03807A Cr E11 Type 2 diabetes mellitus A E 0 A METOPROLOL d00134A B# Z79.0 Long term (current) use of anticoagulants and antithrombotics/antiplatelets A E 0 A OMEPRAZOLE d00325A CDp K21 Gastro-esophageal reflux disease A E 0 A RAMIPRIL d00728A Cr I10 Essential (primary) hypertension A E 0 A TICAGRELOR d07721A B# Z79.0 Long term (current) use of anticoagulants and antithrombotics/antiplatelets A E @ A . . . E P A . . . E ` A ALPRAZOLAM d00168A D* F41.0 F41.9 Panic disorder [episodic paroxysmal anxiety] without agoraphobia Anxiety disorder, unspecified Ap E ` A ATORVASTATIN d04105A C[@ E78.0 Pure hypercholesterolemia Ap E ` A BUPROPION d00181A C[@ F31.9 Bipolar disorder, unspecified Ap E ` A METOPROLOL d00134A C[@ I10 Essential (primary) hypertension Ap E ` A OMEGA-3 POLYUNSATURATED FATTY ACIDS d00497A C[@ I51.9 Heart disease, unspecified Ap E ` A OXCARBAZEPINE d04513A CDp F39 Unspecified mood [affective] disorder Ap E ` A PRAMIPEXOLE d04145A C"0 G25.81 Restless legs syndrome Ap E p A CETIRIZINE d03827A A0 R09.81 Nasal congestion A E A DESOGESTREL; ETHINYL ESTRADIOL d03782A C- Z79.3 Long term (current) use of hormonal contraceptives A E A SERTRALINE d00880A Cr F32.9 Major depressive disorder, single episode, unspecified A E A . . . E A . . . E A . . . E A CLINDAMYCIN d00043A Ap A49.9P Z98 Prevent bacterial infection Other postprocedural states A E A 99999 . . A E A METFORMIN d03807A C E11 Type 2 diabetes mellitus A E A . . . E A AMLODIPINE d00689A D I10 Essential (primary) hypertension Ap E A DULOXETINE d05355A C- F32.9 Major depressive disorder, single episode, unspecified Ap E A ESOMEPRAZOLE d04749A D# K21 K30 Gastro-esophageal reflux disease Functional dyspepsia Ap E A FAMOTIDINE d00141A Bz K21 Gastro-esophageal reflux disease Ap E A FAMOTIDINE d00141A Cr L29.9 Pruritus, unspecified Ap E A GABAPENTIN d03182A Dc G25.81 Restless legs syndrome Ap E A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A D# I10 Essential (primary) hypertension Ap E ! A . . . E ! A AMLODIPINE d00689A Cr I10 Essential (primary) hypertension A E ! A APIXABAN d07804A C[@ D75.9P Prevent blood clots A E ! A DILTIAZEM d00045A C[@ R00 Abnormalities of heart beat A E ! A DRONEDARONE d07458A B I48.9 Unspecified atrial fibrillation and atrial flutter A E ! A FUROSEMIDE d00070A B R60.9 Edema, unspecified A E ! A ICOSAPENT d07891A Cr E78.1 Pure hyperglyceridemia A E ! A LEVOTHYROXINE d00278A DGJ E03.9 Hypothyroidism, unspecified A E ! A LOSARTAN d03821A Cr I21.P Prevent heart attack/myocardial infarction A E ! A POTASSIUM CHLORIDE d00345A B E87.6 Hypokalemia A E ! A PRAVASTATIN d00348A C[@ E78.0 Pure hypercholesterolemia A E ! A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A CDp I10 Essential (primary) hypertension A E !0 A . . . E !@ A BENZONATATE d00796A B J18.9 R05 Pneumonia, unspecified organism Cough A0 E !@ A IBUPROFEN d00015A A0 J09 Influenza due to certain identified influenza viruses A0 E !@ A OSELTAMIVIR d04462A AP J09 Influenza due to certain identified influenza viruses A0 E !P A AMLODIPINE d00689A C"0 I10 Essential (primary) hypertension A@ E !P A GEMFIBROZIL d00245A A E78.0 Pure hypercholesterolemia A@ E !P A LISINOPRIL d00732A C"0 I10 Essential (primary) hypertension A@ E !P A METOPROLOL d00134A C"0 I10 Essential (primary) hypertension A@ E !` A . . . E !p A . . . E ! A HYDROCORTISONE TOPICAL d03205A B= R21 Rash and other nonspecific skin eruption A E ! A CYCLOBENZAPRINE d00963A D0z T14.9 Unspecified injury A0 E ! A ESZOPICLONE d05421A C G47.0 Insomnia A0 E ! A LORAZEPAM d00149A C F41.9 Anxiety disorder, unspecified A0 E ! A HYDROCHLOROTHIAZIDE d00253A D I10 Essential (primary) hypertension A@ E ! A OMEPRAZOLE d00325A Cr K30 Functional dyspepsia A@ E ! A SERTRALINE d00880A Cr F41.9 Anxiety disorder, unspecified A@ E ! A VALSARTAN d04113A D I10 Essential (primary) hypertension A@ E ! A . . . E ! A . . . E ! A . . . E ! A . . . E ! A CYCLOBENZAPRINE d00963A C M79.1 Myalgia AP E ! A ESCITALOPRAM d04812A C F32.9 Major depressive disorder, single episode, unspecified AP E ! A HYDROCHLOROTHIAZIDE; LOSARTAN d03830A C I10 Essential (primary) hypertension AP E ! A MELOXICAM d04532A C M19.9 Osteoarthritis, unspecified site AP E ! A ONDANSETRON d00867A C R11 Nausea and vomiting AP E " A LISINOPRIL d00732A C[@ I10 Essential (primary) hypertension A E " A METFORMIN d03807A C[@ E11 Type 2 diabetes mellitus A E " A . . . E " A CARVEDILOL d03847A D I51.9P Prevent heart disease A` E " A FUROSEMIDE d00070A D R60.9 Edema, unspecified A` E " A GLIPIZIDE d00246A D E11 Type 2 diabetes mellitus A` E " A LOSARTAN d03821A C- E11.2 Type 2 diabetes mellitus with kidney complications A` E " A METFORMIN d03807A D E11 Type 2 diabetes mellitus A` E " A SIMVASTATIN d00746A D E78.0 Pure hypercholesterolemia A` E "0 A DIAZEPAM d00148A D F41.9 Anxiety disorder, unspecified AP E "0 A LEVOTHYROXINE d00278A D ^ E03.9 Hypothyroidism, unspecified AP E "0 A METOPROLOL d00134A C[@ I10 Essential (primary) hypertension AP E "0 A PRAZOSIN d00138A D F41.9 Anxiety disorder, unspecified AP E "0 A QUETIAPINE d04220A D F41.9 Anxiety disorder, unspecified AP E "@ A . . . E "P A . . . E "` A ESCITALOPRAM d04812A C F41.9 Anxiety disorder, unspecified A E "p A . . . E " A . . . E " A AZITHROMYCIN d00091A AP H66.9 R50.9 Otitis media, unspecified Fever, unspecified A E " A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia AP E " A FLUOXETINE d00236A D,3 F32.9 Major depressive disorder, single episode, unspecified AP E " A GLIPIZIDE d00246A C E11 Type 2 diabetes mellitus AP E " A LISINOPRIL d00732A D N19 Unspecified kidney failure AP E " A METFORMIN d03807A D% E11 Type 2 diabetes mellitus AP E " A . . . E " A . . . E " A BUPROPION d00181A Cr F32.9 Major depressive disorder, single episode, unspecified A0 E " A GABAPENTIN d03182A C- F39 M79.2 Unspecified mood [affective] disorder Neuralgia and neuritis, unspecified A0 E " A LISINOPRIL d00732A C- I10 Essential (primary) hypertension A0 E " A . . . E " A DORZOLAMIDE OPHTHALMIC d03805A C H40 Glaucoma A@ E " A HYDROCHLOROTHIAZIDE d00253A CDp R60.9 Edema, unspecified A@ E " A LATANOPROST OPHTHALMIC d04017A C[@ H40 Glaucoma A@ E " A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified A@ E # A . . . E # A 99999 . . A E # A . . . E #0 A . . . E #@ A . . . E #P A OMEPRAZOLE d00325A B K30 Functional dyspepsia A E #` A AMLODIPINE d00689A C I10 Essential (primary) hypertension A E #` A ATORVASTATIN d04105A C[@ I63.P Prevent stroke A E #` A CANAGLIFLOZIN d08080A C- E11 Type 2 diabetes mellitus A E #` A CARVEDILOL d03847A C[@ I21.P Prevent heart attack/myocardial infarction A E #` A CLOPIDOGREL d04258A C[@ D75.9P Prevent blood clots A E #` A DULAGLUTIDE d08290A C[@ E11 Type 2 diabetes mellitus A E #` A FENOFIBRATE d04286A C[@ D75.9P Prevent blood clots A E #` A INSULIN DEGLUDEC d08054A C[@ E11 Type 2 diabetes mellitus A E #` A ISOSORBIDE MONONITRATE d00269A C- I21.P Prevent heart attack/myocardial infarction A E #` A LOSARTAN d03821A CDp 99999 A E #` A PANTOPRAZOLE d04514A C- 99999 A E #p A ALPRAZOLAM d00168A C[@ F41.9 Anxiety disorder, unspecified A E # A . . . E # A DIAZEPAM d00148A B[ M62.83 Muscle spasm AP E # A DICLOFENAC d00848A A0 T14.9 Unspecified injury AP E # A FENTANYL d00233A B[ M54 Dorsalgia AP E # A LISINOPRIL d00732A Bz I10 Essential (primary) hypertension AP E # A METAXALONE d00964A B[ M54 Dorsalgia AP E # A . . . E # A . . . E # A . . . E # A AMLODIPINE d00689A D I10 Essential (primary) hypertension Ap E # A ATENOLOL d00004A D I10 Essential (primary) hypertension Ap E # A CETIRIZINE d03827A C- T78.40 Allergy, unspecified Ap E # A HYDRALAZINE d00132A D I10 Essential (primary) hypertension Ap E # A INSULIN GLARGINE d04538A D E11 Type 2 diabetes mellitus Ap E # A INSULIN LISPRO d04373A D E11 Type 2 diabetes mellitus Ap E # A SIMVASTATIN d00746A D E78.0 Pure hypercholesterolemia Ap E # A APIXABAN d07804A C"0 I48.9 Unspecified atrial fibrillation and atrial flutter Ap E # A ATORVASTATIN d04105A A D75.9P I21.P I63.P Prevent blood clots Prevent heart attack/myocardial infarction Prevent stroke Ap E # A CARVEDILOL d03847A Cr I10 Essential (primary) hypertension Ap E # A CLONIDINE d00044A Cr I10 Essential (primary) hypertension Ap E # A HYDROCHLOROTHIAZIDE d00253A C"0 R60.9 Edema, unspecified Ap E # A LOSARTAN d03821A Cr I10 Essential (primary) hypertension Ap E # A OMEPRAZOLE d00325A Cr K30 Functional dyspepsia Ap E # A AZELASTINE NASAL d04068A C R09.8 Other specified symptoms and signs involving the circulatory and respiratory systems A E # A BENAZEPRIL d00730A C I10 Essential (primary) hypertension A E # A BIMATOPROST OPHTHALMIC d04754A C H40 Glaucoma A E # A BRIMONIDINE; TIMOLOL OPHTHALMIC d05283A C H40 Glaucoma A E # A BRINZOLAMIDE OPHTHALMIC d04301A C- H40 Glaucoma A E # A CHLORDIAZEPOXIDE d00189A D* F41.9 Anxiety disorder, unspecified A E # A NIACIN d00314A Cr E78.0 Pure hypercholesterolemia A E # A TAMSULOSIN d04121A A M62.83 Muscle spasm A E $ A . . . E $ A AMLODIPINE d00689A C- I10 Essential (primary) hypertension A@ E $ A CYCLOSPORINE OPHTHALMIC d04836A B= H04 Disorders of lacrimal system A@ E $ A LEVOTHYROXINE d00278A B E07.9 Disorder of thyroid, unspecified A@ E $ A LOSARTAN d03821A C"0 I10 Essential (primary) hypertension A@ E $ A GLIPIZIDE d00246A Cr E11 R73 Type 2 diabetes mellitus Elevated blood glucose level A@ E $ A METFORMIN d03807A C E11 Type 2 diabetes mellitus A@ E $ A METOPROLOL d00134A D R00 Abnormalities of heart beat A@ E $ A PRAVASTATIN d00348A D E78.0 Pure hypercholesterolemia A@ E $0 A . . . E $@ A . . . E $P A . . . E $` A . . . E $p A . . . E $ A LORAZEPAM d00149A CDp F41.9 Anxiety disorder, unspecified AP E $ A QUETIAPINE d04220A C F32.9 Major depressive disorder, single episode, unspecified AP E $ A ROPINIROLE d04215A C G25.81 Restless legs syndrome AP E $ A TADALAFIL d04896A C N32.9 Bladder disorder, unspecified AP E $ A VENLAFAXINE d03181A C F32.9 Major depressive disorder, single episode, unspecified AP E $ A APIXABAN d07804A B= Z79.0 Long term (current) use of anticoagulants and antithrombotics/antiplatelets A` E $ A ATORVASTATIN d04105A CDp I10 Essential (primary) hypertension A` E $ A BICALUTAMIDE d03850A CDp C61 Malignant neoplasm of prostate A` E $ A CARVEDILOL d03847A C- I10 Essential (primary) hypertension A` E $ A EMPAGLIFLOZIN d08275A B[ R73 Elevated blood glucose level A` E $ A ISOSORBIDE d00653A C I51.9 Heart disease, unspecified A` E $ A . . . E $ A . . . E $ A . . . E $ A ERYTHROMYCIN OPHTHALMIC d03973A A@ H10 Conjunctivitis A@ E $ A IBUPROFEN d00015A D N94 Pain and other conditions associated with female genital organs and menstrual cycle A@ E $ A LISINOPRIL d00732A C- I10 Essential (primary) hypertension A@ E $ A RANITIDINE d00021A CDp K21 Gastro-esophageal reflux disease A@ E $ A AMOXICILLIN; CLAVULANATE d00089A A H66.9 Otitis media, unspecified A E $ A FEBUXOSTAT d07397A D M1A Chronic gout A0 E $ A INDAPAMIDE d00260A C I10 Essential (primary) hypertension A0 E $ A LOSARTAN d03821A C I10 Essential (primary) hypertension A0 E % A . . . E % A AMLODIPINE d00689A B[ I10 Essential (primary) hypertension A0 E % A HYDROCHLOROTHIAZIDE; TRIAMTERENE d03052A B= R60.9 Edema, unspecified A0 E % A SIMVASTATIN d00746A CDp E78.0 Pure hypercholesterolemia A0 E % A . . . E %0 A DICLOFENAC d00848A B M13 Other arthritis A E %0 A METFORMIN d03807A C E11 Type 2 diabetes mellitus A E %@ A . . . E %P A . . . E %` A AMLODIPINE d00689A C- I10 Essential (primary) hypertension AP E %` A ATORVASTATIN d04105A C[@ E78.0 Pure hypercholesterolemia AP E %` A DULOXETINE d05355A Cr F32.9 F41.9 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified AP E %` A MELOXICAM d04532A C L40 Psoriasis AP E %` A OMEPRAZOLE d00325A C[@ K21 Gastro-esophageal reflux disease AP E %p A VARDENAFIL d04893A C- N52.9 Male erectile dysfunction, unspecified A E % A ACETAMINOPHEN; HYDROCODONE d03428A C- M79.7 Fibromyalgia AP E % A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A Cr I10 Essential (primary) hypertension AP E % A NAPROXEN d00019A C Z79.1 Long term (current) use of non-steroidal anti-inflammatories (NSAID) AP E % A TERBINAFINE d04012A A B35 Dermatophytosis AP E % A TIZANIDINE d04102A B M62.83 Muscle spasm AP E % A . . . E % A OLMESARTAN d04801A C- I10 Essential (primary) hypertension A E % A OSELTAMIVIR d04462A A J09 Influenza due to certain identified influenza viruses A E % A . . . E % A . . . E % A ETHINYL ESTRADIOL; NORETHINDRONE d03238A C E28.P Z79.3 Prevent ovarian problem Long term (current) use of hormonal contraceptives A E % A ACETAZOLAMIDE d00161A Cr H40 Glaucoma A E % A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A E % A ESOMEPRAZOLE d04749A B K21 Gastro-esophageal reflux disease A E % A FUROSEMIDE d00070A Cr R60.9 Edema, unspecified A E % A GABAPENTIN d03182A C- M79.2 Neuralgia and neuritis, unspecified A E % A METFORMIN d03807A D E11 Type 2 diabetes mellitus A E % A METOCLOPRAMIDE d00298A B K21 Gastro-esophageal reflux disease A E % A POTASSIUM CHLORIDE d00345A Cr R60.9 Edema, unspecified A E % A RANITIDINE d00021A A K21 Gastro-esophageal reflux disease A E % A TOPIRAMATE d04115A C[@ F31.9 G43 Bipolar disorder, unspecified Migraine A E & A CEPHALEXIN d00096A A J01.9 J06.9 Acute sinusitis, unspecified Acute upper respiratory infection, unspecified A E & A DOXYCYCLINE d00037A AP M25.9 R09.8 Joint disorder, unspecified Other specified symptoms and signs involving the circulatory and respiratory systems A E & A . . . E &0 A . . . E &@ A . . . E &P A . . . E &` A . . . E &p A ACETAMINOPHEN; OXYCODONE d03431A Cr M25.5 M54 M79.2 Pain in joint Dorsalgia Neuralgia and neuritis, unspecified B E &p A ALBUTEROL d00749A Cr J42 Unspecified chronic bronchitis B E &p A AMITRIPTYLINE d00146A CDp G47.0 Insomnia B E &p A ATORVASTATIN d04105A Cr E78.0 Pure hypercholesterolemia B E &p A CLOPIDOGREL d04258A Cr D75.9P Prevent blood clots B E &p A DEXLANSOPRAZOLE d07395A Cr R10 Abdominal and pelvic pain B E &p A DULOXETINE d05355A Dc F32.9 Major depressive disorder, single episode, unspecified B E &p A FUROSEMIDE d00070A Cr I51.9 N28.9 Heart disease, unspecified Disorder of kidney and ureter, unspecified B E &p A GABAPENTIN d03182A Cr M79.2 Neuralgia and neuritis, unspecified B E &p A GLUCAGON d00593A CDp 55555 B E &p A INSULIN ASPART d04697A Cr R73 Elevated blood glucose level B E &p A INSULIN GLARGINE d04538A D E11 Type 2 diabetes mellitus B E &p A LISINOPRIL d00732A Ei E11.2P I10 Prevent diabetic kidney disease Essential (primary) hypertension B E &p A METFORMIN d03807A D E11 Type 2 diabetes mellitus B E &p A METOPROLOL d00134A Cr I10 Essential (primary) hypertension B E &p A PIOGLITAZONE d04442A Dc E11.2P E11.P R73 Prevent diabetic kidney disease Prevent diabetes Elevated blood glucose level B E &p A PROMETHAZINE d00787A Cr K30 Functional dyspepsia B E &p A ROPINIROLE d04215A Cr G25.81 Restless legs syndrome B E &p A SUMATRIPTAN d03160A C- G43 Migraine B E & A FAMOTIDINE d00141A C"0 K30 Functional dyspepsia A E & A FLUTICASONE NASAL d04283A D# J30.2 Other seasonal allergic rhinitis A E & A HYDRALAZINE d00132A C I10 Essential (primary) hypertension A E & A IPRATROPIUM NASAL d04235A C R09.81 Nasal congestion A E & A LEVOTHYROXINE d00278A D E03.9 Hypothyroidism, unspecified A E & A MONTELUKAST d04289A D T78.40 Allergy, unspecified A E & A SIMVASTATIN d00746A Dc E78.0 Pure hypercholesterolemia A E & A TRAZODONE d00395A Dc G47.0 Insomnia A E & A METFORMIN d03807A C E11.P Prevent diabetes A E & A OMEPRAZOLE d00325A C- R12 Heartburn A E & A . . . E & A ADALIMUMAB d04835A0 C L40 Psoriasis A0 E & A FLUOCINONIDE TOPICAL d01294A C- L40 Psoriasis A0 E & A LEVONORGESTREL d00557A0 C- Z79.3 Long term (current) use of hormonal contraceptives A0 E & A . . . E & A ATORVASTATIN d04105A D* E78.0 I21.P Pure hypercholesterolemia Prevent heart attack/myocardial infarction A E & A CELECOXIB d04380A C- M79.1 Myalgia A E & A INSULIN GLARGINE d04538A D E11 Type 2 diabetes mellitus A E & A INSULIN LISPRO d04373A D E11 Type 2 diabetes mellitus A E & A INSULIN LISPRO; INSULIN LISPRO PROTAMINE d04510A D E11 Type 2 diabetes mellitus A E & A LOSARTAN d03821A C N28.9P Prevent kidney disease A E & A PIOGLITAZONE d04442A D E11 Type 2 diabetes mellitus A E & A TAMSULOSIN d04121A CDp N40 Enlarged prostate A E & A GABAPENTIN d03182A Cr M79.2 Neuralgia and neuritis, unspecified Ap E & A GLIPIZIDE d00246A Cr E11 Type 2 diabetes mellitus Ap E & A LISINOPRIL d00732A Cr I10 Essential (primary) hypertension Ap E & A MELOXICAM d04532A Cr M79.1 Myalgia Ap E & A MONTELUKAST d04289A Cr J30.9 Allergic rhinitis, unspecified Ap E & A OMEPRAZOLE d00325A Cr K21 Gastro-esophageal reflux disease Ap E & A ROSUVASTATIN d04851A Cr E78.0 Pure hypercholesterolemia Ap E & A . . . E ' A ATORVASTATIN d04105A B[ E78.0 Pure hypercholesterolemia AP E ' A CARVEDILOL d03847A CDp I10 Essential (primary) hypertension AP E ' A ITRACONAZOLE d00102A B= B35 Dermatophytosis AP E ' A METHYLPHENIDATE d00900A C- F43.1 Post-traumatic stress disorder (PTSD) AP E ' A TEMAZEPAM d00384A Cr G47.0 Insomnia AP E ' A METFORMIN d03807A Cr E11.P R73 Prevent diabetes Elevated blood glucose level A E ' A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A E ' A METFORMIN d03807A C9 E11 Type 2 diabetes mellitus A E '0 A . . . E '@ A . . . E 'P A . . . E '` A . . . E 'p A HYDRALAZINE d00132A B Z79 Long term (current) drug therapy A@ E 'p A LISINOPRIL d00732A B 99999 A@ E 'p A METFORMIN d03807A B E11 Type 2 diabetes mellitus A@ E 'p A POTASSIUM CHLORIDE d00345A B M85.9 Disorder of bone density and structure, unspecified A@ E ' A . . . E ' A . . . E ' A . . . E ' A SUMATRIPTAN d03160A C G43 Migraine A E ' A . . . E ' A . . . E ' A . . . E ' A . . . E ( A LISINOPRIL d00732A C- I10 Essential (primary) hypertension A E ( A AMOXICILLIN; CLAVULANATE d00089A A J02 Acute pharyngitis A E ( A 77777 . . A E (0 A ACYCLOVIR d00001A D B34.9P Prevent viral infection A E (0 A ATORVASTATIN d04105A B E78.0 Pure hypercholesterolemia A E (0 A BUPROPION; NALTREXONE d08288A B} E66 Overweight and obesity A E (0 A DESVENLAFAXINE d07113A A F32.9 Major depressive disorder, single episode, unspecified A E (0 A LOSARTAN d03821A D I10 Essential (primary) hypertension A E (0 A METFORMIN d03807A C E66 Overweight and obesity A E (0 A PROPRANOLOL d00032A A I10 Essential (primary) hypertension A E (0 A TRIAMCINOLONE TOPICAL d03206A D* L20.9 Atopic dermatitis, unspecified A E (@ A ESTRADIOL d00537A CP Z79.890 Hormone replacement therapy A E (P A THYROID DESICCATED d00655A C E03.9 Hypothyroidism, unspecified A E (` A . . . E (p A AMITRIPTYLINE d00146A B= G47.0 Insomnia A E (p A GABAPENTIN d03182A B[ G25.81 M79.2 Restless legs syndrome Neuralgia and neuritis, unspecified A E ( A . . . E ( A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A E ( A LEVOTHYROXINE d00278A Cr E06 Thyroiditis A E ( A . . . E ( A . . . E ( A . . . E ( A . . . E ( A . . . E ) A . . . E ) A . . . E ) A . . . E )0 A 99999 . . A E )@ A . . . E )P A CLONIDINE d00044A C G47.0 Insomnia AP E )P A DEXMETHYLPHENIDATE d04777A C F90 Attention-deficit hyperactivity disorders AP E )P A FLUTICASONE NASAL d04283A C R09.81 Nasal congestion AP E )P A ONDANSETRON d00867A C R11 Nausea and vomiting AP E )P A SERTRALINE d00880A C F90 Attention-deficit hyperactivity disorders AP E )` A ESTRADIOL d00537A CDp Z79.3 Long term (current) use of hormonal contraceptives A E )p A ALBUTEROL d00749A C[@ J45 Asthma AP E )p A ALPRAZOLAM d00168A D R45 Symptoms and signs involving emotional state AP E )p A FUROSEMIDE d00070A A@ R60.9 Edema, unspecified AP E )p A LEVOTHYROXINE d00278A D E04 Other nontoxic goiter AP E )p A PANTOPRAZOLE d04514A Bz K21 Gastro-esophageal reflux disease AP E ) A . . . E ) A . . . E ) A AMPHETAMINE; DEXTROAMPHETAMINE d04035A C F90 Attention-deficit hyperactivity disorders A E ) A NAPROXEN d00019A C- M19.9 M54 M79.1 Osteoarthritis, unspecified site Dorsalgia Myalgia A E ) A ESCITALOPRAM d04812A Bz F32.9 F41.9 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified A E ) A ETHINYL ESTRADIOL; NORETHINDRONE d03238A C"0 N92 Excessive, frequent and irregular menstruation A E ) A BUSPIRONE d00182A B= F41.9 Anxiety disorder, unspecified A0 E ) A MONTELUKAST d04289A C J30.1 Allergic rhinitis due to pollen A0 E ) A SERTRALINE d00880A B= F32.9 Major depressive disorder, single episode, unspecified A0 E ) A ATORVASTATIN d04105A Cr E78.0 Pure hypercholesterolemia AP E ) A LOSARTAN d03821A C[@ I10 Essential (primary) hypertension AP E ) A MECLIZINE d00859A C- R42 Dizziness and giddiness AP E ) A OMEPRAZOLE d00325A C K30 Functional dyspepsia AP E ) A SERTRALINE d00880A Cr F39 Unspecified mood [affective] disorder AP E ) A . . . E * A . . . E * A . . . E * A . . . E *0 A NAPROXEN d00019A B M25.5 Pain in joint A E *@ A . . . E *P A CODEINE; PROMETHAZINE d03357A A R05 Cough A E *` A . . . E *p A . . . E * A . . . E * A CYCLOBENZAPRINE d00963A B= M79.1 T14.9 Myalgia Unspecified injury A@ E * A HYDROCHLOROTHIAZIDE d00253A CDp I10 Essential (primary) hypertension A@ E * A IBUPROFEN d00015A B[ T14.9 Unspecified injury A@ E * A LISINOPRIL d00732A B= I10 Essential (primary) hypertension A@ E * A . . . E * A . . . E * A . . . E * A POLYETHYLENE GLYCOL 3350 d05350A Bz R39.9 Unspecified symptoms and signs involving the genitourinary system A E * A . . . E * A . . . E + A ACETAMINOPHEN; OXYCODONE d03431A B K22 R10 Other diseases of esophagus Abdominal and pelvic pain AP E + A DILTIAZEM d00045A B I48.9 I49.9 R00 Unspecified atrial fibrillation and atrial flutter Cardiac arrhythmia, unspecified Abnormalities of heart beat AP E + A FLUCONAZOLE d00071A B B37 Candidiasis AP E + A PANTOPRAZOLE d04514A C K21 Gastro-esophageal reflux disease AP E + A SUCRALFATE d00377A B K27 Peptic ulcer, site unspecified AP E + A . . . E + A . . . E +0 A METHYLPHENIDATE d00900A C- F90 Attention-deficit hyperactivity disorders A E +@ A AMLODIPINE d00689A C R09.81 Nasal congestion A@ E +@ A BUMETANIDE d00179A C I10 Essential (primary) hypertension A@ E +@ A LISINOPRIL d00732A C I10 Essential (primary) hypertension A@ E +@ A MONTELUKAST d04289A Dc R09.81 Nasal congestion A@ E +P A . . . E +` A CYCLOBENZAPRINE d00963A C M54 Dorsalgia A E +` A EMTRICITABINE; TENOFOVIR d05352A C- B34.9P Prevent viral infection A E +` A FINASTERIDE d00563A C L65.9 Nonscarring hair loss, unspecified A E +` A GABAPENTIN d03182A CDp F41.9 Anxiety disorder, unspecified A E +` A OMEPRAZOLE d00325A D K21 Gastro-esophageal reflux disease A E +` A OXCARBAZEPINE d04513A C F31.9 Bipolar disorder, unspecified A E +` A PROPRANOLOL d00032A C F41.9 Anxiety disorder, unspecified A E +` A QUETIAPINE d04220A D F31.9 Bipolar disorder, unspecified A E +p A . . . E + A . . . E + A . . . E + A GABAPENTIN d03182A C M54 M79.2 M79.7 Dorsalgia Neuralgia and neuritis, unspecified Fibromyalgia A0 E + A MECLIZINE d00859A C R42 Dizziness and giddiness A0 E + A MELOXICAM d04532A C M06.9 M79.1 M79.7 Rheumatoid arthritis, unspecified Myalgia Fibromyalgia A0 E + A CLONAZEPAM d00197A Cr F41.9 Anxiety disorder, unspecified A E + A ESCITALOPRAM d04812A Cr F39 F41.9 Unspecified mood [affective] disorder Anxiety disorder, unspecified A E + A . . . E + A . . . E + A ESTRADIOL d00537A C Z79.890 Hormone replacement therapy A@ E + A PROGESTERONE d00550A C[@ Z79.890 Hormone replacement therapy A@ E + A SPIRONOLACTONE d00373A B E28 Ovarian dysfunction A@ E + A THYROID DESICCATED d00655A C[@ E03.9 Hypothyroidism, unspecified A@ E + A MONTELUKAST d04289A C T78.40 Allergy, unspecified A E , A . . . E , A . . . E , A DOXYCYCLINE d00037A B B96.81 Helicobacter pylori [H. pylori] as the cause of diseases classified elsewhere A E ,0 A . . . E ,@ A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified A0 E ,@ A LOSARTAN d03821A C I51.9P Prevent heart disease A0 E ,@ A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia A0 E ,P A . . . E ,` A . . . E ,p A AMPHETAMINE; DEXTROAMPHETAMINE d04035A C F90 Attention-deficit hyperactivity disorders A E , A . . . E , A . . . E , A GABAPENTIN d03182A Cr M79.7 Fibromyalgia A@ E , A LEVOTHYROXINE d00278A Dc E03.9 E05 Hypothyroidism, unspecified Thyrotoxicosis [hyperthyroidism] A@ E , A METHOTREXATE d00060A Bz M06.9 Rheumatoid arthritis, unspecified A@ E , A VENLAFAXINE d03181A C F32.9 Major depressive disorder, single episode, unspecified A@ E , A . . . E , A ALBUTEROL d00749A CDp J45 Asthma A E , A CETIRIZINE d03827A C T78.40 Allergy, unspecified A E , A . . . E , A . . . E , A ALBUTEROL d00749A C J45 Asthma A E , A ATORVASTATIN d04105A0 C 99999 A E , A CETIRIZINE d03827A C H10.1 Acute atopic conjunctivitis A E , A EZETIMIBE d04824A C E78.0 Pure hypercholesterolemia A E , A FLUOXETINE d00236A0 C 99999 A E , A FLUTICASONE d01296A C J45 Asthma A E , A FLUTICASONE NASAL d04283A C T78.40 Allergy, unspecified A E , A HYDROCHLOROTHIAZIDE d00253A0 C 99999 A E , A LISINOPRIL d00732A C I10 Essential (primary) hypertension A E , A METFORMIN d03807A C- E11 Type 2 diabetes mellitus A E , A PANTOPRAZOLE d04514A B[ K21 Gastro-esophageal reflux disease A E , A PENTOSAN POLYSULFATE SODIUM d04052A0 C 99999 A E , A PIOGLITAZONE d04442A C E11 Type 2 diabetes mellitus A E , A RISPERIDONE d03180A0 C 99999 A E , A SUMATRIPTAN d03160A C G43 Migraine A E - A . . . E - A ATENOLOL d00004A C I10 Essential (primary) hypertension AP E - A FUROSEMIDE d00070A C R60.9 Edema, unspecified AP E - A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A C I10 Essential (primary) hypertension AP E - A MONTELUKAST d04289A C J30.9 Allergic rhinitis, unspecified AP E - A PANTOPRAZOLE d04514A C[@ K21 Gastro-esophageal reflux disease AP E - A ALBUTEROL d00749A D J45 Asthma A E -0 A . . . E -@ A ESOMEPRAZOLE d04749A CDp R14 Flatulence and related conditions A0 E -@ A LEVOTHYROXINE d00278A Cr E07.9 Disorder of thyroid, unspecified A0 E -@ A TACROLIMUS d03752A CP T86.9P Prevent transplanted organ and tissue rejection A0 E -P A ALBUTEROL d00749A C J45 Asthma A E -` A . . . E -p A . . . E - A . . . E - A PROPRANOLOL d00032A B[ I10 Essential (primary) hypertension A E - A TRIAMCINOLONE TOPICAL d03206A Cr L20.9 Atopic dermatitis, unspecified A E - A . . . E - A . . . E - A . . . E - A 99999 . . A E - A CEPHALEXIN d00096A B= J42 Unspecified chronic bronchitis A@ E - A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A B I10 Essential (primary) hypertension A@ E - A LEVOTHYROXINE d00278A C- E03.9 Hypothyroidism, unspecified A@ E - A PANTOPRAZOLE d04514A B K21 Gastro-esophageal reflux disease A@ E - A . . . E . A . . . E . A . . . E . A DOXAZOSIN d00726A Cr I10 Essential (primary) hypertension A0 E . A HYDROCHLOROTHIAZIDE; OLMESARTAN d04878A Dc I10 Essential (primary) hypertension A0 E . A RALOXIFENE d04261A Cr M81 Osteoporosis without current pathological fracture A0 E .0 A DESONIDE TOPICAL d01290A C L20.9 Atopic dermatitis, unspecified A E .0 A TRIAMCINOLONE TOPICAL d03206A C L20.9 Atopic dermatitis, unspecified A E .@ A . . . E .P A . . . E .` A . . . E .p A . . . E . A . . . E . A . . . E . A . . . E . A . . . E . A . . . E . A AMLODIPINE d00689A C I10 Essential (primary) hypertension A E . A ATORVASTATIN d04105A D E78.0 Pure hypercholesterolemia A E . A . . . E . A ESLICARBAZEPINE d07507A C G40 Epilepsy and recurrent seizures A` E . A GALANTAMINE d04750A Cr G31.9 Degenerative disease of nervous system, unspecified A` E . A LATANOPROST OPHTHALMIC d04017A C H40 Glaucoma A` E . A LEVETIRACETAM d04499A C G40 Epilepsy and recurrent seizures A` E . A MEMANTINE d04899A C[@ G30.9 Alzheimer's disease, unspecified A` E . A URSODIOL d01005A CDp K87 Disorders of gallbladder, biliary tract and pancreas in diseases classified elsewhere A` E / A CELECOXIB d04380A CDp M79.1 Myalgia A E / A FLUTICASONE NASAL d04283A CDp J30.9 Allergic rhinitis, unspecified A E / A GABAPENTIN d03182A CDp 99999 A E / A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified A E / A METOPROLOL d00134A C"0 I49.9 Cardiac arrhythmia, unspecified A E / A MIRABEGRON d07876A C- R32 Unspecified urinary incontinence A E / A PANTOPRAZOLE d04514A CDp K21 Gastro-esophageal reflux disease A E / A PAROXETINE d03157A B F32.9 Major depressive disorder, single episode, unspecified A E / A PRAVASTATIN d00348A Ei E78.0 Pure hypercholesterolemia A E / A SULFASALAZINE d00379A B K51 Ulcerative colitis A E / A LISINOPRIL d00732A D* I10 Essential (primary) hypertension A E / A LOVASTATIN d00280A D* E78.0 Pure hypercholesterolemia A E / A AMOXICILLIN d00088A C- A49.9P Z96 Prevent bacterial infection Presence of other functional implants A E / A SIMVASTATIN d00746A D E78.0 Pure hypercholesterolemia A E /0 A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A0 E /0 A GLIPIZIDE d00246A C E11 Type 2 diabetes mellitus A0 E /0 A METFORMIN d03807A C E11 Type 2 diabetes mellitus A0 E /@ A . . . E /P A HYDROCHLOROTHIAZIDE; LOSARTAN d03830A C I10 Essential (primary) hypertension A0 E /P A OXAPROZIN d00853A C M06.9 Rheumatoid arthritis, unspecified A0 E /P A POTASSIUM CHLORIDE d00345A Ap E87.6 Hypokalemia A0 E /` A ATORVASTATIN d04105A B= I25.9 Chronic ischemic heart disease, unspecified Ap E /` A CLOPIDOGREL d04258A B= I25.9 Chronic ischemic heart disease, unspecified Ap E /` A GEMFIBROZIL d00245A CDp E78.0 Pure hypercholesterolemia Ap E /` A LISINOPRIL d00732A CDp R73 Elevated blood glucose level Ap E /` A METFORMIN d03807A CDp E11 Type 2 diabetes mellitus Ap E /` A METOPROLOL d00134A B= I50.9 I51.9 Heart failure, unspecified Heart disease, unspecified Ap E /` A NITROGLYCERIN d00321A B= I20.9 Angina pectoris, unspecified Ap E /p A . . . E / A . . . E / A LINAGLIPTIN; METFORMIN d07825A Bz E11 E78.0 Type 2 diabetes mellitus Pure hypercholesterolemia A E / A . . . E / A . . . E / A . . . E / A . . . E / A AMLODIPINE d00689A D I10 Essential (primary) hypertension A E / A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A0 E / A LOSARTAN d03821A C I10 Essential (primary) hypertension A0 E / A METFORMIN d03807A Cr E11 Type 2 diabetes mellitus A0 E 0 A AMOXICILLIN d00088A A H66.9 Otitis media, unspecified A E 0 A CETIRIZINE d03827A A R09.81 Nasal congestion A E 0 A . . . E 0 A CANAGLIFLOZIN d08080A C E11 Type 2 diabetes mellitus A0 E 0 A LOSARTAN d03821A C- I10 Essential (primary) hypertension A0 E 0 A SITAGLIPTIN d05896A C E11 Type 2 diabetes mellitus A0 E 00 A DESMOPRESSIN d00583A B G47.0 Insomnia A E 00 A FOSINOPRIL d00242A D I10 Essential (primary) hypertension A E 00 A HYDROCODONE d03075A B M25.5 Pain in joint A E 00 A LEVOTHYROXINE d00278A CDp E03.9 Hypothyroidism, unspecified A E 00 A MIRABEGRON d07876A B R35 Polyuria A E 00 A OMEPRAZOLE d00325A Cr K30 Functional dyspepsia A E 00 A PRAMIPEXOLE d04145A C[@ G25.81 Restless legs syndrome A E 00 A ROSUVASTATIN d04851A C E78.0 Pure hypercholesterolemia A E 00 A TAMSULOSIN d04121A C R35 Polyuria A E 00 A TEMAZEPAM d00384A C- G47.0 Insomnia A E 00 A TIZANIDINE d04102A C M54 Dorsalgia A E 0@ A . . . E 0P A . . . E 0` A GUANFACINE d00717A C- F39 Unspecified mood [affective] disorder A E 0` A METHYLPHENIDATE d00900A Cr F90 Attention-deficit hyperactivity disorders A E 0p A AMOXICILLIN d00088A AP J02 Acute pharyngitis A E 0 A . . . E 0 A . . . E 0 A ATORVASTATIN d04105A0 C E78.0 Pure hypercholesterolemia AP E 0 A GLIMEPIRIDE d03864A0 C E11.P Prevent diabetes AP E 0 A LISINOPRIL d00732A0 C I10 Essential (primary) hypertension AP E 0 A METFORMIN d03807A0 C E11.P Prevent diabetes AP E 0 A OMEPRAZOLE d00325A0 CDp K25 Gastric ulcer AP E 0 A . . . E 0 A ATORVASTATIN d04105A Ei E78.0 Pure hypercholesterolemia A E 0 A FLUVOXAMINE d03804A Ei 99999 A E 0 A GABAPENTIN d03182A C E11 Type 2 diabetes mellitus A E 0 A GLIPIZIDE d00246A C 99999 A E 0 A HYDROCHLOROTHIAZIDE d00253A C 99999 A E 0 A INSULIN GLARGINE d04538A CDp E11 Type 2 diabetes mellitus A E 0 A INSULIN LISPRO d04373A CDp E11 Type 2 diabetes mellitus A E 0 A LISINOPRIL d00732A Ei 99999 A E 0 A OMEPRAZOLE d00325A C[@ K30 Functional dyspepsia A E 0 A ATORVASTATIN d04105A C- E78.0P Prevent high cholesterol A@ E 0 A GLIPIZIDE d00246A C E11 Type 2 diabetes mellitus A@ E 0 A LISINOPRIL d00732A CDp E11.8 Type 2 diabetes mellitus with unspecified complications A@ E 0 A METFORMIN d03807A CDp E11 Type 2 diabetes mellitus A@ E 0 A . . . E 0 A . . . E 1 A ETHINYL ESTRADIOL; NORGESTREL d03241A C- N92 Excessive, frequent and irregular menstruation A E 1 A METFORMIN d03807A B E11 Type 2 diabetes mellitus A E 1 A . . . E 1 A ALENDRONATE d03849A C M81.P Prevent bone loss/osteoporosis A@ E 1 A LISINOPRIL d00732A D I10 Essential (primary) hypertension A@ E 1 A RISPERIDONE d03180A C F39 Unspecified mood [affective] disorder A@ E 1 A SIMVASTATIN d00746A C E78.0P Prevent high cholesterol A@ E 10 A ALBUTEROL d00749A C J45.P R05 R06.2 Prevent asthma Cough Wheezing A0 E 10 A AMOXICILLIN; CLAVULANATE d00089A A H66.9 J18.9 Otitis media, unspecified Pneumonia, unspecified organism A0 E 10 A BUDESONIDE d04276A C Z79 Long term (current) drug therapy A0 E 1@ A . . . E 1P A . . . E 1` A PAROXETINE d03157A D* F32.9 F41.0 Major depressive disorder, single episode, unspecified Panic disorder [episodic paroxysmal anxiety] without agoraphobia A E 1p A ALPRAZOLAM d00168A C F41.9 Anxiety disorder, unspecified A E 1 A . . . E 1 A . . . E 1 A . . . E 1 A BECLOMETHASONE d00760A C- J45 Asthma A E 1 A CLONAZEPAM d00197A C- F41.9 G47.0 Anxiety disorder, unspecified Insomnia A E 1 A INSULIN ASPART d04697A D E11 Type 2 diabetes mellitus A E 1 A ACETAMINOPHEN; HYDROCODONE d03428A Dc 55555 Ap E 1 A ALENDRONATE d03849A C M85.9 Disorder of bone density and structure, unspecified Ap E 1 A AMLODIPINE d00689A Dc I10 Essential (primary) hypertension Ap E 1 A CITALOPRAM d04332A Dc F41.9 Anxiety disorder, unspecified Ap E 1 A LATANOPROST OPHTHALMIC d04017A B H40 Glaucoma Ap E 1 A PANTOPRAZOLE d04514A C K30 Functional dyspepsia Ap E 1 A SUCRALFATE d00377A CP K30 Functional dyspepsia Ap E 1 A . . . E 1 A CLORAZEPATE d00198A C F41.9 Anxiety disorder, unspecified A E 2 A . . . E 2 A AMITRIPTYLINE d00146A C G47.0 Insomnia A@ E 2 A BUDESONIDE; FORMOTEROL d04795A C- J44.9 Chronic obstructive pulmonary disease, unspecified A@ E 2 A INSULIN DEGLUDEC d08054A C E10 Type 1 diabetes mellitus A@ E 2 A SIMVASTATIN d00746A B= E78.0 Pure hypercholesterolemia A@ E 2 A AMITRIPTYLINE d00146A B G47.0 Insomnia A E 2 A AMLODIPINE d00689A C I10 Essential (primary) hypertension A E 2 A ASPIRIN d00170A C[@ I21.P Prevent heart attack/myocardial infarction A E 2 A BACLOFEN d00967A C[@ M79.6 Pain in limb, hand, foot, fingers and toes A E 2 A CILOSTAZOL d04382A C I70 Atherosclerosis A E 2 A CLOPIDOGREL d04258A C- I21.P Prevent heart attack/myocardial infarction A E 2 A GABAPENTIN d03182A B[ M79.2 Neuralgia and neuritis, unspecified A E 2 A LOSARTAN d03821A B I10 Essential (primary) hypertension A E 2 A METOPROLOL d00134A C I10 Essential (primary) hypertension A E 20 A . . . E 2@ A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia Ap E 2@ A GLIMEPIRIDE d03864A C E11 Type 2 diabetes mellitus Ap E 2@ A ICOSAPENT d07891A C- E78.1 Pure hyperglyceridemia Ap E 2@ A INSULIN GLARGINE d04538A C E11 Type 2 diabetes mellitus Ap E 2@ A METFORMIN d03807A CDp E11 Type 2 diabetes mellitus Ap E 2@ A METOPROLOL d00134A C I10 Essential (primary) hypertension Ap E 2@ A MONTELUKAST d04289A CDp J30.2 Other seasonal allergic rhinitis Ap E 2P A AMLODIPINE d00689A C I63.P Prevent stroke A E 2P A APIXABAN d07804A C I48.9 Unspecified atrial fibrillation and atrial flutter A E 2P A CYCLOBENZAPRINE d00963A D M54 Dorsalgia A E 2P A FUROSEMIDE d00070A D I50.9 Heart failure, unspecified A E 2P A GABAPENTIN d03182A Cr M79.2 Neuralgia and neuritis, unspecified A E 2P A INSULIN GLARGINE d04538A D# E11 Type 2 diabetes mellitus A E 2P A INSULIN LISPRO d04373A D# E11 R73 Type 2 diabetes mellitus Elevated blood glucose level A E 2P A LOSARTAN d03821A Cr I10 I50.9 Essential (primary) hypertension Heart failure, unspecified A E 2P A METOPROLOL d00134A D I49.9 Cardiac arrhythmia, unspecified A E 2P A OMEPRAZOLE d00325A Cr K92.9 Disease of digestive system, unspecified A E 2P A POTASSIUM CHLORIDE d00345A D# E87.6 Hypokalemia A E 2P A SIMVASTATIN d00746A C I21.P Prevent heart attack/myocardial infarction A E 2` A BENAZEPRIL d00730A Dc I10 Essential (primary) hypertension Ap E 2` A DOXAZOSIN d00726A C- R35 Polyuria Ap E 2` A GABAPENTIN d03182A B E11.4 Type 2 diabetes mellitus with neurological complications Ap E 2` A HYDROCHLOROTHIAZIDE d00253A Dc R60.9 Edema, unspecified Ap E 2` A METFORMIN d03807A Dc R73 Elevated blood glucose level Ap E 2` A RANITIDINE d00021A CDp K21 Gastro-esophageal reflux disease Ap E 2` A ROSUVASTATIN d04851A C E78.0 Pure hypercholesterolemia Ap E 2p A LOSARTAN d03821A C- I10 Essential (primary) hypertension A E 2 A . . . E 2 A . . . E 2 A AMLODIPINE d00689A C[@ I10 Essential (primary) hypertension AP E 2 A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia AP E 2 A LEVOTHYROXINE d00278A D E03.9 Hypothyroidism, unspecified AP E 2 A MONTELUKAST d04289A D J30.1 J45 Allergic rhinitis due to pollen Asthma AP E 2 A SERTRALINE d00880A D# F32.9 Major depressive disorder, single episode, unspecified AP E 2 A . . . E 2 A . . . E 2 A ATENOLOL d00004A C I10 R00 Essential (primary) hypertension Abnormalities of heart beat A@ E 2 A LORAZEPAM d00149A CDp G47.0 G47.9 Insomnia Sleep disorder, unspecified A@ E 2 A SERTRALINE d00880A Cr F32.9 Major depressive disorder, single episode, unspecified A@ E 2 A TRAMADOL d03826A C M79.2 Neuralgia and neuritis, unspecified A@ E 2 A . . . E 2 A AMLODIPINE d00689A0 D I10 Essential (primary) hypertension A E 2 A ATORVASTATIN d04105A0 D E78.0 Pure hypercholesterolemia A E 2 A BENAZEPRIL d00730A0 D I10 Essential (primary) hypertension A E 2 A CLOPIDOGREL d04258A0 CDp D75.9P I63 Prevent blood clots Cerebral infarction A E 2 A DOXYCYCLINE d00037A0 D L70 Acne A E 2 A GABAPENTIN d03182A0 Cr M79.2 Neuralgia and neuritis, unspecified A E 2 A LEVOTHYROXINE d00278A0 D E03.9 Hypothyroidism, unspecified A E 2 A SERTRALINE d00880A0 C- F43.1 Post-traumatic stress disorder (PTSD) A E 2 A TRAMADOL d03826A0 D M19.9 M25.5 M54 Osteoarthritis, unspecified site Pain in joint Dorsalgia A E 3 A ATORVASTATIN d04105A Dc E78.0 Pure hypercholesterolemia AP E 3 A GLIPIZIDE d00246A Dc 99999 AP E 3 A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A Dc I10 Essential (primary) hypertension AP E 3 A METFORMIN d03807A Dc 99999 AP E 3 A SITAGLIPTIN d05896A Dc E11 Type 2 diabetes mellitus AP E 3 A . . . E 3 A . . . E 30 A . . . E 3@ A . . . E 3P A . . . E 3` A FLUTICASONE NASAL d04283A C J30.2 Other seasonal allergic rhinitis A E 3` A MONTELUKAST d04289A B T78.40 Allergy, unspecified A E 3p A . . . E 3 A . . . E 3 A . . . E 3 A . . . E 3 A ATORVASTATIN d04105A Ei E78.0 Pure hypercholesterolemia A@ E 3 A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A Ei I10 Essential (primary) hypertension A@ E 3 A INSULIN ASPART d04697A C R73 Elevated blood glucose level A@ E 3 A INSULIN DETEMIR d05436A B R73 Elevated blood glucose level A@ E 3 A ATORVASTATIN d04105A D 99999 A@ E 3 A HYDROCHLOROTHIAZIDE; VALSARTAN d04293A D E11 Type 2 diabetes mellitus A@ E 3 A METFORMIN d03807A D E11 Type 2 diabetes mellitus A@ E 3 A NATEGLINIDE d04743A D E11 Type 2 diabetes mellitus A@ E 3 A . . . E 3 A CARVEDILOL d03847A C I10 Essential (primary) hypertension Ap E 3 A CLONIDINE d00044A C I10 Essential (primary) hypertension Ap E 3 A INSULIN ASPART d04697A CDp E11 Type 2 diabetes mellitus Ap E 3 A OMEPRAZOLE d00325A D K31.9 Disease of stomach and duodenum, unspecified Ap E 3 A POTASSIUM CHLORIDE d00345A D* E87.6 Hypokalemia Ap E 3 A PROMETHAZINE d00787A B R11 Nausea and vomiting Ap E 3 A TRAMADOL d03826A C[@ M06.9 Rheumatoid arthritis, unspecified Ap E 3 A AMOXICILLIN d00088A Ap H66.9 Otitis media, unspecified A E 4 A . . . E 4 A AMOXICILLIN d00088A A K04.7P Prevent tooth infection A@ E 4 A FUROSEMIDE d00070A A R60.9 Edema, unspecified A@ E 4 A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A C- I10 Essential (primary) hypertension A@ E 4 A POTASSIUM CITRATE d01423A A E87.6 Hypokalemia A@ E 4 A . . . E 40 A . . . E 4@ A . . . E 4P A . . . E 4` A GABAPENTIN d03182A CDp M79.2 Neuralgia and neuritis, unspecified A0 E 4` A LATANOPROST OPHTHALMIC d04017A C H40 Glaucoma A0 E 4` A TIMOLOL d00139A D I49.9 Cardiac arrhythmia, unspecified A0 E 4p A . . . E 4 A . . . E 4 A . . . E 4 A . . . E 4 A AMLODIPINE d00689A Cr 99999 B E 4 A ARIPIPRAZOLE d04825A0 C[@ F32.9 Major depressive disorder, single episode, unspecified B E 4 A ATORVASTATIN d04105A0 Cr 99999 B E 4 A BENZTROPINE d00175A0 Cr F32.9 Major depressive disorder, single episode, unspecified B E 4 A CLOPIDOGREL d04258A0 Cr I70 Atherosclerosis B E 4 A DIPHENHYDRAMINE d00212A0 B= F32.9 Major depressive disorder, single episode, unspecified B E 4 A ESCITALOPRAM d04812A0 Cr F32.9 Major depressive disorder, single episode, unspecified B E 4 A ESCITALOPRAM d04812A0 Cr 99999 B E 4 A GABAPENTIN d03182A0 Cr M54 Dorsalgia B E 4 A LEVOTHYROXINE d00278A0 Cr 99999 B E 4 A LISINOPRIL d00732A0 Cr 99999 B E 4 A METFORMIN d03807A0 C E11 Type 2 diabetes mellitus B E 4 A METOPROLOL d00134A0 Cr M54 Dorsalgia B E 4 A PANTOPRAZOLE d04514A0 Cr K92.9 Disease of digestive system, unspecified B E 4 A POTASSIUM CHLORIDE d00345A0 Cr F32.9 Major depressive disorder, single episode, unspecified B E 4 A RISPERIDONE d03180A0 Cr F32.9 Major depressive disorder, single episode, unspecified B E 4 A TRAZODONE d00395A0 C[@ G47.0 Insomnia B E 4 A GLIPIZIDE d00246A C E11 Type 2 diabetes mellitus A E 4 A METFORMIN d03807A C[@ E11 Type 2 diabetes mellitus A E 4 A . . . E 4 A CYCLOBENZAPRINE d00963A B[ M62.83 Muscle spasm AP E 4 A GABAPENTIN d03182A Bz R25.2 R52 Cramp and spasm Pain, unspecified AP E 4 A METFORMIN d03807A D E11 Type 2 diabetes mellitus AP E 4 A OXYCODONE d00329A C[@ R52 Pain, unspecified AP E 4 A VENLAFAXINE d03181A C F32.9 Major depressive disorder, single episode, unspecified AP E 4 A . . . E 5 A . . . E 5 A . . . E 5 A . . . E 50 A . . . E 5@ A . . . E 5P A . . . E 5` A ARIPIPRAZOLE d04825A B= G47.9 Sleep disorder, unspecified A E 5` A CITALOPRAM d04332A D F32.9 F41.9 R53 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified Malaise and fatigue A E 5p A . . . E 5 A ACYCLOVIR d00001A B A60.9 B00.1 Anogenital herpesviral infection, unspecified Herpesviral vesicular dermatitis A E 5 A . . . E 5 A NIFEDIPINE d00051A CDp I27.9 Pulmonary heart disease, unspecified A E 5 A PANTOPRAZOLE d04514A B K21 Gastro-esophageal reflux disease A E 5 A CLONIDINE d00044A B I10 Essential (primary) hypertension A E 5 A DILTIAZEM d00045A B I10 Essential (primary) hypertension A E 5 A DOXAZOSIN d00726A C I99.9 Unspecified disorder of circulatory system A E 5 A ENALAPRIL d00013A C I10 Essential (primary) hypertension A E 5 A ESOMEPRAZOLE d04749A C K31.9 Disease of stomach and duodenum, unspecified A E 5 A FAMOTIDINE d00141A C K30 Functional dyspepsia A E 5 A FUROSEMIDE d00070A C R60.9 Edema, unspecified A E 5 A GABAPENTIN d03182A CDp M19.9 Osteoarthritis, unspecified site A E 5 A MECLIZINE d00859A CDp R42 Dizziness and giddiness A E 5 A PREDNISONE d00350A Cr M06.9 Rheumatoid arthritis, unspecified A E 5 A ALBUTEROL d00749A C J45 R05 R06.2 Asthma Cough Wheezing A E 5 A ALBUTEROL d00749A C J45 R06.02 Asthma Shortness of breath A E 5 A . . . E 5 A AMLODIPINE d00689A C I10 Essential (primary) hypertension A E 5 A . . . E 6 A AMOXICILLIN d00088A A H66.9 Otitis media, unspecified A E 6 A . . . E 6 A ALPRAZOLAM d00168A C F41.9 Anxiety disorder, unspecified AP E 6 A HYDROCHLOROTHIAZIDE; TRIAMTERENE d03052A D I51.9 Heart disease, unspecified AP E 6 A NIFEDIPINE d00051A D I10 Essential (primary) hypertension AP E 6 A SIMVASTATIN d00746A C- E78.0 Pure hypercholesterolemia AP E 6 A TRAZODONE d00395A D# G47.9 Sleep disorder, unspecified AP E 60 A . . . E 6@ A GUANFACINE d00717A C- F90 Attention-deficit hyperactivity disorders A E 6@ A LISDEXAMFETAMINE d06663A C- F90 Attention-deficit hyperactivity disorders A E 6P A AMOXICILLIN d00088A A H66.9 Otitis media, unspecified A E 6` A AMPHETAMINE; DEXTROAMPHETAMINE d04035A C"0 F90 Attention-deficit hyperactivity disorders A E 6` A LISDEXAMFETAMINE d06663A Ap F90 Attention-deficit hyperactivity disorders A E 6p A . . . E 6 A ALBUTEROL d00749A C R06.02 Shortness of breath A E 6 A FENOFIBRATE d04286A CDp E78.0 Pure hypercholesterolemia A E 6 A FLUTICASONE NASAL d04283A C J30.2 Other seasonal allergic rhinitis A E 6 A GABAPENTIN d03182A C M79.7 Fibromyalgia A E 6 A IBUPROFEN d00015A C G43 Migraine A E 6 A LEVOTHYROXINE d00278A D E03.9 Hypothyroidism, unspecified A E 6 A OMEPRAZOLE d00325A C K21 Gastro-esophageal reflux disease A E 6 A ROPINIROLE d04215A C G25.81 Restless legs syndrome A E 6 A TOPIRAMATE d04115A C"0 E66 Overweight and obesity A E 6 A TRIAMTERENE d00396A D R60.9 Edema, unspecified A E 6 A VENLAFAXINE d03181A C F31.9 Bipolar disorder, unspecified A E 6 A ZOLPIDEM d00910A C G47.0 Insomnia A E 6 A . . . E 6 A . . . E 6 A LEVOTHYROXINE d00278A A@ E03.9 Hypothyroidism, unspecified A E 6 A ALBUTEROL d00749A C R06.02 Shortness of breath A E 6 A . . . E 6 A APIXABAN d07804A C D75.9P I48.9 I63.P Prevent blood clots Unspecified atrial fibrillation and atrial flutter Prevent stroke AP E 6 A ATORVASTATIN d04105A D# E78.0 Pure hypercholesterolemia AP E 6 A DOXAZOSIN d00726A D I10 Essential (primary) hypertension AP E 6 A LISINOPRIL d00732A D# I10 Essential (primary) hypertension AP E 6 A MEMANTINE d04899A B G31.9 Degenerative disease of nervous system, unspecified AP E 6 A . . . E 7 A . . . E 7 A ATORVASTATIN d04105A C- 99999 A` E 7 A GEMFIBROZIL d00245A C- 99999 A` E 7 A GLIPIZIDE d00246A C- 99999 A` E 7 A LISINOPRIL d00732A C- 99999 A` E 7 A METFORMIN d03807A C- 99999 A` E 7 A OMEPRAZOLE d00325A C K31.9 Disease of stomach and duodenum, unspecified A` E 7 A HYDROCHLOROTHIAZIDE; TRIAMTERENE d03052A D I10 Essential (primary) hypertension A E 70 A . . . E 7@ A METHYLPHENIDATE d00900A C F90 Attention-deficit hyperactivity disorders A E 7P A . . . E 7` A . . . E 7p A ALENDRONATE d03849A C M81 Osteoporosis without current pathological fracture A@ E 7p A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A Cr I10 Essential (primary) hypertension A@ E 7p A METFORMIN d03807A C E11 Type 2 diabetes mellitus A@ E 7p A SIMVASTATIN d00746A Cr E78.0 Pure hypercholesterolemia A@ E 7 A . . . E 7 A CANAGLIFLOZIN d08080A C E11 Type 2 diabetes mellitus A0 E 7 A LOSARTAN d03821A C E11.2 Type 2 diabetes mellitus with kidney complications A0 E 7 A METFORMIN d03807A Cr E11 Type 2 diabetes mellitus A0 E 7 A ALBUTEROL d00749A B J45 Asthma A0 E 7 A AZITHROMYCIN d00091A AP J42 Unspecified chronic bronchitis A0 E 7 A FLUTICASONE; VILANTEROL d08100A Ap J45 Asthma A0 E 7 A METFORMIN d03807A C E11 Type 2 diabetes mellitus A E 7 A SPIRONOLACTONE d00373A C[@ R60.9 Edema, unspecified A E 7 A FUROSEMIDE d00070A B R60.9 Edema, unspecified A E 7 A PHENYTOIN d00143A DGJ G40 Epilepsy and recurrent seizures A E 7 A AMLODIPINE d00689A C- I10 Essential (primary) hypertension A E 7 A . . . E 7 A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A B I10 Essential (primary) hypertension A E 8 A ACETAMINOPHEN; HYDROCODONE d03428A B M54 Dorsalgia A E 8 A ATORVASTATIN d04105A Cr K21 Gastro-esophageal reflux disease A E 8 A OMEPRAZOLE d00325A C E78.0 Pure hypercholesterolemia A E 8 A . . . E 80 A ATORVASTATIN d04105A C[@ E78.0P Prevent high cholesterol A` E 80 A BACLOFEN d00967A C[@ M62.83 Muscle spasm A` E 80 A LEVETIRACETAM d04499A C[@ G40 Epilepsy and recurrent seizures A` E 80 A LEVOTHYROXINE d00278A C[@ E03.9 Hypothyroidism, unspecified A` E 80 A MELOXICAM d04532A C[@ M19.9 Osteoarthritis, unspecified site A` E 80 A ZOLPIDEM d00910A Cr G47.0 Insomnia A` E 8@ A METFORMIN d03807A D E11 Type 2 diabetes mellitus A0 E 8@ A OMEPRAZOLE d00325A D K30 Functional dyspepsia A0 E 8@ A PRAVASTATIN d00348A D E78.0 Pure hypercholesterolemia A0 E 8P A . . . E 8` A SIMVASTATIN d00746A C- E78.0 Pure hypercholesterolemia A E 8p A ALBUTEROL d00749A C J43 J44.9 Emphysema Chronic obstructive pulmonary disease, unspecified A E 8p A ATORVASTATIN d04105A C- E78.0 Pure hypercholesterolemia A E 8p A BUDESONIDE; FORMOTEROL d04795A C J44.9 Chronic obstructive pulmonary disease, unspecified A E 8p A BUSPIRONE d00182A C- F32.9 Major depressive disorder, single episode, unspecified A E 8p A DIAZEPAM d00148A D G47.0 Insomnia A E 8p A LEVOTHYROXINE d00278A D"8 E03.9 Hypothyroidism, unspecified A E 8p A LITHIUM d00061A B F39 Unspecified mood [affective] disorder A E 8p A METOPROLOL d00134A C I10 Essential (primary) hypertension A E 8p A NITROGLYCERIN d00321A C R07.9 Chest pain, unspecified A E 8p A SERTRALINE d00880A D F32.9 Major depressive disorder, single episode, unspecified A E 8 A AMOXICILLIN; CLAVULANATE d00089A B K04.7 Periapical abscess without sinus A E 8 A . . . E 8 A . . . E 8 A ATORVASTATIN d04105A C[@ E78.0 Pure hypercholesterolemia A E 8 A METOPROLOL d00134A C I10.P Prevent hypertension A E 8 A TRIAMTERENE d00396A C- I10 Essential (primary) hypertension A E 8 A . . . E 8 A . . . E 8 A . . . E 9 A AMLODIPINE d00689A CDp I10 Essential (primary) hypertension A E 9 A CARVEDILOL d03847A C@ I50.9 Heart failure, unspecified A E 9 A FINASTERIDE d00563A C N40 Enlarged prostate A E 9 A GLIPIZIDE d00246A C R73 Elevated blood glucose level A E 9 A INSULIN ISOPHANE; INSULIN REGULAR d04374A C E11 Type 2 diabetes mellitus A E 9 A LOSARTAN d03821A Cr I10 Essential (primary) hypertension A E 9 A MESALAMINE d01031A C- K50 Crohn's disease [regional enteritis] A E 9 A MICONAZOLE TOPICAL d03195A B B35 Dermatophytosis A E 9 A . . . E 9 A AMOXICILLIN d00088A A H66.9 Otitis media, unspecified A E 9 A AMOXICILLIN; CLAVULANATE d00089A A H66.9 Otitis media, unspecified A E 90 A AMLODIPINE d00689A C I10 Essential (primary) hypertension AP E 90 A DULOXETINE d05355A Bz R52 Pain, unspecified AP E 90 A GABAPENTIN d03182A C R52 Pain, unspecified AP E 90 A METOPROLOL d00134A Cr I10 Essential (primary) hypertension AP E 90 A OMEPRAZOLE d00325A C K21 Gastro-esophageal reflux disease AP E 9@ A ALFUZOSIN d04797A C[@ N40 Enlarged prostate AP E 9@ A FUROSEMIDE d00070A C R60.9 Edema, unspecified AP E 9@ A METFORMIN d03807A C E11 Type 2 diabetes mellitus AP E 9@ A OMEPRAZOLE d00325A C K21 K25 Gastro-esophageal reflux disease Gastric ulcer AP E 9@ A ONDANSETRON d00867A B R11 Nausea and vomiting AP E 9P A AMLODIPINE d00689A D I10 Essential (primary) hypertension A E 9P A ATORVASTATIN d04105A C[@ E78.0 Pure hypercholesterolemia A E 9P A CLOPIDOGREL d04258A CDp Z79.0 Long term (current) use of anticoagulants and antithrombotics/antiplatelets A E 9P A FAMOTIDINE d00141A B= R10 Abdominal and pelvic pain A E 9P A FUROSEMIDE d00070A B= I51.9 Heart disease, unspecified A E 9P A HYDROCODONE d03075A C- M25.5 Pain in joint A E 9P A LISINOPRIL d00732A D= I10 Essential (primary) hypertension A E 9P A NAPROXEN d00019A C"0 M25.5 Pain in joint A E 9P A TRAMADOL d03826A C M25.5 Pain in joint A E 9` A LOSARTAN d03821A C R51 Headache A E 9p A AMOXICILLIN d00088A A J02 Acute pharyngitis A E 9 A . . . E 9 A CLINDAMYCIN d00043A B= A49.9P Prevent bacterial infection A0 E 9 A IBUPROFEN d00015A B* R52 Pain, unspecified A0 E 9 A METFORMIN d03807A C E11 Type 2 diabetes mellitus A0 E 9 A . . . E 9 A CITALOPRAM d04332A C F32.9 Major depressive disorder, single episode, unspecified AP E 9 A EPROSARTAN; HYDROCHLOROTHIAZIDE d04837A D I10 Essential (primary) hypertension AP E 9 A MONTELUKAST d04289A C- J30.1 J45 Allergic rhinitis due to pollen Asthma AP E 9 A NEBIVOLOL d05265A CDp I10 Essential (primary) hypertension AP E 9 A SEMAGLUTIDE d08688A B[ E11 Type 2 diabetes mellitus AP E 9 A . . . E 9 A ALBUTEROL d00749A C J45 Asthma A E 9 A DULOXETINE d05355A C M79.1 Myalgia A E 9 A ESOMEPRAZOLE d04749A C K21 K27 Gastro-esophageal reflux disease Peptic ulcer, site unspecified A E 9 A GABAPENTIN d03182A C M79.2 Neuralgia and neuritis, unspecified A E 9 A LISINOPRIL d00732A C I10 Essential (primary) hypertension A E 9 A RANITIDINE d00021A C K25.P Prevent gastric ulcer A E 9 A ROSUVASTATIN d04851A C I21.P Prevent heart attack/myocardial infarction A E 9 A TRAMADOL d03826A C M79.2 Neuralgia and neuritis, unspecified A E 9 A . . . E 9 A . . . E : A . . . E : A . . . E : A ALBUTEROL d00749A C J45 Asthma A E : A AMPHETAMINE; DEXTROAMPHETAMINE d04035A B F90 Attention-deficit hyperactivity disorders A E : A BECLOMETHASONE NASAL d04275A C J30.9 Allergic rhinitis, unspecified A E : A FLUTICASONE d01296A C J45 Asthma A E : A LEVOCETIRIZINE d05851A Cr T78.40 Allergy, unspecified A E : A MONTELUKAST d04289A C J45 Asthma A E : A POLYETHYLENE GLYCOL 3350 d05350A B[ K59.0 Constipation A E : A QUETIAPINE d04220A B* F90 Attention-deficit hyperactivity disorders A E :0 A . . . E :@ A . . . E :P A TAMOXIFEN d00381A Cr C50.P Prevent breast cancer A E :` A CETIRIZINE d03827A C T78.40 Allergy, unspecified A E :p A HYDROXYZINE d00907A C G47.0 Insomnia A E :p A OXCARBAZEPINE d04513A C F39 Unspecified mood [affective] disorder A E : A . . . E : A ALBUTEROL d00749A B J45 Asthma A0 E : A AMOXICILLIN d00088A A H66.9 Otitis media, unspecified A0 E : A PREDNISONE d00350A AP J45 Asthma A0 E : A . . . E : A . . . E : A . . . E : A . . . E : A . . . E : A . . . E ; A ACETAMINOPHEN; CODEINE d03423A C M54 Dorsalgia A E ; A . . . E ; A . . . E ;0 A . . . E ;@ A AMLODIPINE; BENAZEPRIL d03829A C I10 Essential (primary) hypertension A E ;P A . . . E ;` A . . . E ;p A ATORVASTATIN d04105A D I21.P Prevent heart attack/myocardial infarction A@ E ;p A LEVOTHYROXINE d00278A D@) E03.9 Hypothyroidism, unspecified A@ E ;p A LISINOPRIL d00732A D I21.P Prevent heart attack/myocardial infarction A@ E ;p A METOPROLOL d00134A D I21.P Prevent heart attack/myocardial infarction A@ E ; A . . . E ; A . . . E ; A . . . E ; A . . . E ; A LISINOPRIL d00732A B I10 Essential (primary) hypertension A E ; A METFORMIN d03807A B E11 Type 2 diabetes mellitus A E ; A . . . E ; A . . . E ; A ATORVASTATIN d04105A Cr E78.0 Pure hypercholesterolemia Ap E ; A HYDROCHLOROTHIAZIDE d00253A B[ N20.0 Calculus of kidney Ap E ; A LISINOPRIL d00732A Cr I10 Essential (primary) hypertension Ap E ; A MECLIZINE d00859A CDp R42 Dizziness and giddiness Ap E ; A METFORMIN d03807A C- E11 Type 2 diabetes mellitus Ap E ; A METOPROLOL d00134A C- I10 Essential (primary) hypertension Ap E ; A SITAGLIPTIN d05896A C E11 Type 2 diabetes mellitus Ap E < A ETHINYL ESTRADIOL; NORELGESTROMIN d04779A C N92 Excessive, frequent and irregular menstruation A E < A . . . E < A . . . E <0 A . . . E <@ A . . . E
A ESCITALOPRAM d04812A B F41.9 Anxiety disorder, unspecified A E > A ETHINYL ESTRADIOL; NORETHINDRONE d03238A C Z79.3 Long term (current) use of hormonal contraceptives A E > A AMOXICILLIN d00088A A H66.9 Otitis media, unspecified A E > A CETIRIZINE d03827A A T78.40 Allergy, unspecified A E > A HYDROCORTISONE TOPICAL d03205A C L20.9 Atopic dermatitis, unspecified A E >0 A . . . E >@ A . . . E >P A . . . E >` A . . . E >p A ESCITALOPRAM d04812A B F32.9 Major depressive disorder, single episode, unspecified A E > A . . . E > A . . . E > A . . . E > A . . . E > A ATORVASTATIN d04105A CDp E78.0 Pure hypercholesterolemia A E > A VALSARTAN d04113A C I10 Essential (primary) hypertension A E > A . . . E > A ALBUTEROL d00749A Cr J45 Asthma A0 E > A BECLOMETHASONE d00760A Cr J45 Asthma A0 E > A MONTELUKAST d04289A C J45 Asthma A0 E > A . . . E ? A . . . E ? A METFORMIN d03807A C"0 E11 Type 2 diabetes mellitus A E ? A AMLODIPINE; BENAZEPRIL d03829A C[@ I10 Essential (primary) hypertension A0 E ? A ATORVASTATIN d04105A C[@ E78.0 Pure hypercholesterolemia A0 E ? A METFORMIN d03807A C[@ E11 Type 2 diabetes mellitus A0 E ?0 A . . . E ?@ A . . . E ?P A ALENDRONATE d03849A Cr M81 Osteoporosis without current pathological fracture A0 E ?P A SIMVASTATIN d00746A Dc E78.0 Pure hypercholesterolemia A0 E ?P A TRIAMTERENE d00396A Dc I10 Essential (primary) hypertension A0 E ?` A IBUPROFEN d00015A B M54 Dorsalgia A E ?p A . . . E ? A . . . E ? A AMLODIPINE d00689A Bz I10 Essential (primary) hypertension A0 E ? A LISINOPRIL d00732A Bz I10 Essential (primary) hypertension A0 E ? A METFORMIN d03807A B[ R73 Elevated blood glucose level A0 E ? A . . . E ? A . . . E ? A 99999 . . A E ? A CARVEDILOL d03847A Dc I10 Essential (primary) hypertension A E ? A CLOPIDOGREL d04258A C Z79.0 Long term (current) use of anticoagulants and antithrombotics/antiplatelets A E ? A DONEPEZIL; MEMANTINE d08337A B[ R41 Other symptoms and signs involving cognitive functions and awareness A E ? A EZETIMIBE; SIMVASTATIN d05348A Dc E78.0 Pure hypercholesterolemia A E ? A ISOSORBIDE MONONITRATE d00269A C I49.9 Cardiac arrhythmia, unspecified A E ? A LEVOTHYROXINE d00278A D* E03.9 Hypothyroidism, unspecified A E ? A LISINOPRIL d00732A C I21.P Prevent heart attack/myocardial infarction A E ? A NITROGLYCERIN d00321A D I20.9 Angina pectoris, unspecified A E ? A PANTOPRAZOLE d04514A C T88.7P Prevent drug side effect A E ? A . . . E ? A AMLODIPINE d00689A D I10 Essential (primary) hypertension A0 E ? A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A0 E ? A BENAZEPRIL d00730A D E11.2 Type 2 diabetes mellitus with kidney complications A0 E @ A . . . E @ A BRIMONIDINE OPHTHALMIC d04048A Cr H40 Glaucoma A0 E @ A DORZOLAMIDE; TIMOLOL OPHTHALMIC d04303A Cr H40 Glaucoma A0 E @ A LATANOPROST OPHTHALMIC d04017A Cr H40 Glaucoma A0 E @ A . . . E @0 A . . . E @@ A . . . E @P A . . . E @` A . . . E @p A . . . E @ A 99999 . . A0 E @ A ANTIHYPERTENSIVE AGENTS - UNSPECIFIED h00024. . A0 E @ A GABAPENTIN d03182A Cr 99999 A0 E @ A . . . E @ A . . . E @ A . . . E @ A . . . E @ A . . . E @ A AMOXICILLIN d00088A Ap H66.9 Otitis media, unspecified A E @ A FAMOTIDINE d00141A C K25 Gastric ulcer A` E @ A LEVOTHYROXINE d00278A D- C80.1 Malignant (primary) neoplasm, unspecified A` E @ A METOPROLOL d00134A D I10 Essential (primary) hypertension A` E @ A MONTELUKAST d04289A B R06.9 Unspecified abnormalities of breathing A` E @ A POTASSIUM CHLORIDE d00345A C E87.6 Hypokalemia A` E @ A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia A` E A A . . . E A A CARVEDILOL d03847A C I10 Essential (primary) hypertension A0 E A A LISINOPRIL d00732A C I10 Essential (primary) hypertension A0 E A A OMEPRAZOLE d00325A C K21 Gastro-esophageal reflux disease A0 E A A . . . E A0 A QUETIAPINE d04220A A G47.9 Sleep disorder, unspecified A E A@ A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified A E A@ A METOPROLOL d00134A C E07.9 Disorder of thyroid, unspecified A E AP A ETONOGESTREL d04772A C Z79.3 Long term (current) use of hormonal contraceptives A E A` A . . . E Ap A HYDROCHLOROTHIAZIDE; TRIAMTERENE d03052A C I10 Essential (primary) hypertension A E A A DULOXETINE d05355A CDp 99999 A E A A GABAPENTIN d03182A CDp 99999 A E A A HYDROXYZINE d00907A CDp F32.9 Major depressive disorder, single episode, unspecified A E A A KETOROLAC OPHTHALMIC d03214A Ap H57.9 Unspecified disorder of eye and adnexa A E A A LISINOPRIL d00732A CDp I10 Essential (primary) hypertension A E A A METFORMIN d03807A B E11 Type 2 diabetes mellitus A E A A MIRTAZAPINE d04025A CDp G47.9 Sleep disorder, unspecified A E A A NAPROXEN d00019A B M25.5 Pain in joint A E A A OFLOXACIN OPHTHALMIC d03977A Ap H57.9 Unspecified disorder of eye and adnexa A E A A PRAZOSIN d00138A C- G47.9 Sleep disorder, unspecified A E A A PREDNISOLONE OPHTHALMIC d03221A Ap H57.9 Unspecified disorder of eye and adnexa A E A A APIXABAN d07804A C- I48.9 Unspecified atrial fibrillation and atrial flutter Ap E A A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia Ap E A A DILTIAZEM d00045A Cr I48.9 Unspecified atrial fibrillation and atrial flutter Ap E A A ESCITALOPRAM d04812A C F41.9 Anxiety disorder, unspecified Ap E A A LISINOPRIL d00732A C I10 Essential (primary) hypertension Ap E A A METOPROLOL d00134A C- I48.9 Unspecified atrial fibrillation and atrial flutter Ap E A A PANTOPRAZOLE d04514A Cr K25 Gastric ulcer Ap E A A . . . E A A LEVOTHYROXINE d00278A C 99999 A0 E A A METFORMIN d03807A C E11.P Prevent diabetes A0 E A A ROSUVASTATIN d04851A C E78.0 Pure hypercholesterolemia A0 E A A HYDROCHLOROTHIAZIDE d00253A B I10 Essential (primary) hypertension A` E A A HYDROCHLOROTHIAZIDE; LOSARTAN d03830A B[ I10 Essential (primary) hypertension A` E A A LABETALOL d00016A C[@ I10 Essential (primary) hypertension A` E A A LISINOPRIL d00732A B I10 Essential (primary) hypertension A` E A A PREGABALIN d05508A C[@ M79.2 Neuralgia and neuritis, unspecified A` E A A SIMVASTATIN d00746A B E78.0 Pure hypercholesterolemia A` E A A . . . E A A . . . E A A AMLODIPINE d00689A C I10 Essential (primary) hypertension A0 E A A ATENOLOL d00004A D% I10 Essential (primary) hypertension A0 E A A LOSARTAN d03821A C I10 Essential (primary) hypertension A0 E B A ASPIRIN d00170A C- D75.9P Prevent blood clots A E B A ATORVASTATIN d04105A C- E78.0 Pure hypercholesterolemia A E B A CITALOPRAM d04332A B= F39 Unspecified mood [affective] disorder A E B A CLOPIDOGREL d04258A C- D75.9P Prevent blood clots A E B A CYANOCOBALAMIN d00413A B E63.9 Nutritional deficiency, unspecified A E B A ISOSORBIDE MONONITRATE d00269A C- R07.9 Chest pain, unspecified A E B A LOSARTAN d03821A C- I10 Essential (primary) hypertension A E B A METOPROLOL d00134A C- I21.P Prevent heart attack/myocardial infarction A E B A OMEPRAZOLE d00325A B[ K30 Functional dyspepsia A E B A AMOXICILLIN d00088A Ap K04.7 Periapical abscess without sinus A E B A LEVOTHYROXINE d00278A C- E03.9 Hypothyroidism, unspecified A0 E B A METOPROLOL d00134A C- I49.9 R00 Cardiac arrhythmia, unspecified Abnormalities of heart beat A0 E B A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia A0 E B0 A . . . E B@ A . . . E BP A . . . E B` A LIOTHYRONINE d00658A C E03.9 Hypothyroidism, unspecified A0 E B` A OXYTOCIN d00584A B F32.9 Major depressive disorder, single episode, unspecified A0 E B` A SEX HORMONES COMBINATION - UNSPECIFIED c00186A Cr E34.9 Endocrine disorder, unspecified A0 E Bp A . . . E B A ATORVASTATIN d04105A CDp E78.0 Pure hypercholesterolemia A` E B A CLONAZEPAM d00197A CDp F32.9 Major depressive disorder, single episode, unspecified A` E B A CLOPIDOGREL d04258A CDp I21.P Prevent heart attack/myocardial infarction A` E B A FLUOXETINE d00236A CDp F41.9 Anxiety disorder, unspecified A` E B A LISINOPRIL d00732A CDp I10 Essential (primary) hypertension A` E B A TEMAZEPAM d00384A CDp G47.0 Insomnia A` E B A ATORVASTATIN d04105A D9 E78.0 Pure hypercholesterolemia A@ E B A EZETIMIBE d04824A C E78.0 Pure hypercholesterolemia A@ E B A METOPROLOL d00134A C I10 Essential (primary) hypertension A@ E B A NITROGLYCERIN d00321A C R07.9 Chest pain, unspecified A@ E B A . . . E B A AMOXICILLIN d00088A A B34.9 Viral infection, unspecified A E B A . . . E B A BENAZEPRIL d00730A C- 99999 A@ E B A DONEPEZIL d04099A CDp 99999 A@ E B A LOVASTATIN d00280A CDp I10 Essential (primary) hypertension A@ E B A TERAZOSIN d00386A C- 99999 A@ E B A 99999 . . A E B A ANTI-INFECTIVES - UNSPECIFIED c00001A . H66.9 J40 Otitis media, unspecified Bronchitis, not specified as acute or chronic A E B A . . . E C A ALLOPURINOL d00023A C[@ M1A Chronic gout A E C A AMLODIPINE d00689A C- I10 Essential (primary) hypertension A E C A EZETIMIBE d04824A C E78.0 Pure hypercholesterolemia A E C A INSULIN DETEMIR d05436A C E11 Type 2 diabetes mellitus A E C A INSULIN LISPRO d04373A C E11 Type 2 diabetes mellitus A E C A OLMESARTAN d04801A C I10 Essential (primary) hypertension A E C A PANTOPRAZOLE d04514A C- K21 Gastro-esophageal reflux disease A E C A PAROXETINE d03157A B= F32.9 Major depressive disorder, single episode, unspecified A E C A SPIRONOLACTONE d00373A C R60.9 Edema, unspecified A E C A TORSEMIDE d03189A Cr E11 Type 2 diabetes mellitus A E C A WARFARIN d00022A C- D75.9P Prevent blood clots A E C A . . . E C A ATORVASTATIN d04105A C"0 E78.0 Pure hypercholesterolemia A E C A BRIMONIDINE OPHTHALMIC d04048A C[@ H40 Glaucoma A E C A CARVEDILOL d03847A CO I10 Essential (primary) hypertension A E C A DORZOLAMIDE OPHTHALMIC d03805A C[@ H40 Glaucoma A E C A EMPAGLIFLOZIN d08275A C"0 R73 Elevated blood glucose level A E C A GABAPENTIN d03182A B E11.4 M79.2 Type 2 diabetes mellitus with neurological complications Neuralgia and neuritis, unspecified A E C A GLYBURIDE d00248A C- E11 R73 Type 2 diabetes mellitus Elevated blood glucose level A E C A HYDROCHLOROTHIAZIDE; LOSARTAN d03830A C[@ I10 Essential (primary) hypertension A E C A INSULIN DETEMIR d05436A Cr R73 Elevated blood glucose level A E C A LATANOPROST OPHTHALMIC d04017A Cr H40 Glaucoma A E C A METFORMIN d03807A C- R73 Elevated blood glucose level A E C0 A . . . E C@ A . . . E CP A . . . E C` A . . . E Cp A . . . E C A ALBUTEROL d00749A A R06.2 Wheezing A E C A AMOXICILLIN d00088A A H66.9 Otitis media, unspecified A E C A . . . E C A ESCITALOPRAM d04812A C"0 F41.9 Anxiety disorder, unspecified A E C A . . . E C A . . . E C A . . . E C A . . . E C A ALBUTEROL d00749A D T78.40 Allergy, unspecified A E D A . . . E D A . . . E D A AMLODIPINE d00689A Ap I10 Essential (primary) hypertension AP E D A CITALOPRAM d04332A B F32.9 Major depressive disorder, single episode, unspecified AP E D A LISINOPRIL d00732A B I10 Essential (primary) hypertension AP E D A PRAZOSIN d00138A C G47.9 Sleep disorder, unspecified AP E D A QUETIAPINE d04220A B G47.0 Insomnia AP E D0 A DICLOFENAC d00848A C R25.2 Cramp and spasm AP E D0 A IRBESARTAN d04222A Dc I10 Essential (primary) hypertension AP E D0 A OMEPRAZOLE d00325A C K31.9 Disease of stomach and duodenum, unspecified AP E D0 A POTASSIUM CHLORIDE d00345A C 99999 AP E D0 A TAMSULOSIN d04121A C- N42.9 Disorder of prostate, unspecified AP E D@ A . . . E DP A . . . E D` A ALLOPURINOL d00023A C[@ M10.9P Prevent gout A0 E D` A AMLODIPINE d00689A Dc I10 Essential (primary) hypertension A0 E D` A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified A0 E Dp A . . . E D A CETIRIZINE d03827A C"0 J30.9 R09.81 T78.40 Allergic rhinitis, unspecified Nasal congestion Allergy, unspecified A E D A . . . E D A . . . E D A . . . E D A LISINOPRIL d00732A D# I10 Essential (primary) hypertension A E D A LORAZEPAM d00149A C[@ F41.9 Anxiety disorder, unspecified A E D A . . . E D A . . . E D A . . . E E A . . . E E A . . . E E A . . . E E0 A ALBUTEROL d00749A C J45 Asthma A E E@ A . . . E EP A CARVEDILOL d03847A C I10 Essential (primary) hypertension A E EP A LISINOPRIL d00732A D I10 Essential (primary) hypertension A E E` A AMLODIPINE d00689A Cr I10 Essential (primary) hypertension A E E` A COLESEVELAM d04695A Cr E78.0 Pure hypercholesterolemia A E Ep A . . . E E A . . . E E A . . . E E A . . . E E A . . . E E A LATANOPROST OPHTHALMIC d04017A0 D H40 Glaucoma A0 E E A SIMVASTATIN d00746A0 Dc E78.0 Pure hypercholesterolemia A0 E E A VALACYCLOVIR d03838A0 C- B00.1 Herpesviral vesicular dermatitis A0 E E A . . . E E A DESOGESTREL; ETHINYL ESTRADIOL d03782A B Z79.3 Long term (current) use of hormonal contraceptives A E E A ATORVASTATIN d04105A CDp E78.0 Pure hypercholesterolemia Ap E E A DULOXETINE d05355A A M54 Dorsalgia Ap E E A FINASTERIDE d00563A C- N40 Enlarged prostate Ap E E A LEVOTHYROXINE d00278A CDp E03.9 Hypothyroidism, unspecified Ap E E A LISINOPRIL d00732A B I10 Essential (primary) hypertension Ap E E A METFORMIN d03807A C- E11 Type 2 diabetes mellitus Ap E E A TAMSULOSIN d04121A C- N40 Enlarged prostate Ap E F A FINASTERIDE d00563A C R39.9 Unspecified symptoms and signs involving the genitourinary system A` E F A GLIPIZIDE d00246A B= R73 Elevated blood glucose level A` E F A INSULIN ISOPHANE (NPH) d04370A A E11 Type 2 diabetes mellitus A` E F A METOPROLOL d00134A C I48.9 Unspecified atrial fibrillation and atrial flutter A` E F A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia A` E F A TAMSULOSIN d04121A C R39.9 Unspecified symptoms and signs involving the genitourinary system A` E F A AMLODIPINE d00689A0 C I10 Essential (primary) hypertension AP E F A HYDROCHLOROTHIAZIDE; TRIAMTERENE d03052A0 C I10 Essential (primary) hypertension AP E F A LISINOPRIL d00732A0 C I10 Essential (primary) hypertension AP E F A METOPROLOL d00134A0 C I10 Essential (primary) hypertension AP E F A SIMVASTATIN d00746A0 C E78.0 Pure hypercholesterolemia AP E F A LEVOCETIRIZINE d05851A B T78.40 Allergy, unspecified A E F0 A CETIRIZINE d03827A Cr H10.1 R09.81 T78.40 Acute atopic conjunctivitis Nasal congestion Allergy, unspecified A0 E F0 A ETHINYL ESTRADIOL; NORELGESTROMIN d04779A C- N92 Excessive, frequent and irregular menstruation A0 E F0 A IBUPROFEN d00015A C- N94 R51 T14.9 Pain and other conditions associated with female genital organs and menstrual cycle Headache Unspecified injury A0 E F@ A . . . E FP A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A Dc I10 Essential (primary) hypertension A@ E FP A INSULIN DETEMIR d05436A CO R73 Elevated blood glucose level A@ E FP A METFORMIN d03807A C E11 R73 Type 2 diabetes mellitus Elevated blood glucose level A@ E FP A METOPROLOL d00134A C I10 Essential (primary) hypertension A@ E F` A . . . E Fp A CITALOPRAM d04332A D# F41.9 Anxiety disorder, unspecified AP E Fp A FENOFIBRATE d04286A D# E78.0 Pure hypercholesterolemia AP E Fp A LISINOPRIL d00732A D# I10 Essential (primary) hypertension AP E Fp A OMEPRAZOLE d00325A D# K30 Functional dyspepsia AP E Fp A SIMVASTATIN d00746A D# E78.0 Pure hypercholesterolemia AP E F A MONTELUKAST d04289A B J45 Asthma A E F A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia A E F A ACETAMINOPHEN; OXYCODONE d03431A C- M54 Dorsalgia B E F A ALPRAZOLAM d00168A Dc F41.9 Anxiety disorder, unspecified B E F A ATENOLOL d00004A Dc F41.9 Anxiety disorder, unspecified B E F A BENAZEPRIL d00730A B I10 Essential (primary) hypertension B E F A DICYCLOMINE d00999A B K58 Irritable bowel syndrome B E F A DULOXETINE d05355A C F32.9 Major depressive disorder, single episode, unspecified B E F A GABAPENTIN d03182A C- M54 Dorsalgia B E F A HYDROXYZINE d00907A B R11 Nausea and vomiting B E F A ISOSORBIDE MONONITRATE d00269A C- I21.P Prevent heart attack/myocardial infarction B E F A LOPERAMIDE d01025A B K51 Ulcerative colitis B E F A METOPROLOL d00134A CDp I10 R00 Essential (primary) hypertension Abnormalities of heart beat B E F A NIFEDIPINE d00051A C- I10 I20.9 R07.9 Essential (primary) hypertension Angina pectoris, unspecified Chest pain, unspecified B E F A ONDANSETRON d00867A B R11 Nausea and vomiting B E F A PANTOPRAZOLE d04514A B K21 K30 R12 Gastro-esophageal reflux disease Functional dyspepsia Heartburn B E F A SIMVASTATIN d00746A Dc E78.0 Pure hypercholesterolemia B E F A VALACYCLOVIR d03838A C A60.9 Anogenital herpesviral infection, unspecified B E F A AMLODIPINE d00689A CDp I10 Essential (primary) hypertension A0 E F A ATORVASTATIN d04105A CDp E78.0 Pure hypercholesterolemia A0 E F A FENOFIBRATE d04286A C E78.1 Pure hyperglyceridemia A0 E F A . . . E F A . . . E F A . . . E F A AMLODIPINE d00689A C- I10 Essential (primary) hypertension A0 E F A DEXLANSOPRAZOLE d07395A C K30 Functional dyspepsia A0 E F A HYDROCHLOROTHIAZIDE d00253A C[@ I10 Essential (primary) hypertension A0 E F A 99999 . . A E G A LOSARTAN d03821A Bz I10 Essential (primary) hypertension A E G A . . . E G A . . . E G0 A . . . E G@ A . . . E GP A . . . E G` A . . . E Gp A BUPROPION d00181A B F17.2 F32.9 Nicotine dependence Major depressive disorder, single episode, unspecified A E Gp A SERTRALINE d00880A D F32.9 Major depressive disorder, single episode, unspecified A E G A . . . E G A BUPRENORPHINE; NALOXONE d04819A Cr F11.23 Opioid dependence with withdrawal A E G A ESCITALOPRAM d04812A B F41.9 Anxiety disorder, unspecified A E G A HYDROCHLOROTHIAZIDE d00253A C I10 Essential (primary) hypertension A0 E G A POTASSIUM CHLORIDE d00345A C E87.6 Hypokalemia A0 E G A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia A0 E G A . . . E G A . . . E G A . . . E G A . . . E G A . . . E H A . . . E H A CARVEDILOL d03847A C- I21.P Prevent heart attack/myocardial infarction Ap E H A FUROSEMIDE d00070A C R60.9 Edema, unspecified Ap E H A LOSARTAN d03821A C- I50.9 Heart failure, unspecified Ap E H A PAROXETINE d03157A C- F41.9 Anxiety disorder, unspecified Ap E H A POTASSIUM CHLORIDE d00345A C- E87.6 Hypokalemia Ap E H A SPIRONOLACTONE d00373A C I51.9 Heart disease, unspecified Ap E H A ZOLPIDEM d00910A B G47.0 Insomnia Ap E H A POTASSIUM CHLORIDE d00345A B E87.6 Hypokalemia A E H0 A ATORVASTATIN d04105A C- E78.0 Pure hypercholesterolemia A0 E H0 A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified A0 E H0 A LOSARTAN d03821A C I10 Essential (primary) hypertension A0 E H@ A . . . E HP A INSULIN LISPRO d04373A B E10 Type 1 diabetes mellitus A E H` A . . . E Hp A . . . E H A FLUTICASONE; SALMETEROL d04611A Dc J45 Asthma A E H A LOSARTAN d03821A C[@ I10 Essential (primary) hypertension A E H A . . . E H A . . . E H A LAMOTRIGINE d03809A Bz G47.0 Insomnia A E H A SERTRALINE d00880A Bz F41.9 Anxiety disorder, unspecified A E H A METHYLPHENIDATE d00900A C F90 Attention-deficit hyperactivity disorders A E H A . . . E H A . . . E H A ATORVASTATIN d04105A CDp E78.0 Pure hypercholesterolemia A E I A BUMETANIDE d00179A B R60.9 Edema, unspecified A E I A FEXOFENADINE d04040A Bz R09.81 Nasal congestion A E I A INSULIN ASPART d04697A C[@ E11 Type 2 diabetes mellitus A E I A INSULIN DETEMIR d05436A C[@ E11 Type 2 diabetes mellitus A E I A LISINOPRIL d00732A C[@ I10 Essential (primary) hypertension A E I A METFORMIN d03807A C"0 E11 Type 2 diabetes mellitus A E I A METOPROLOL d00134A C"0 I10 Essential (primary) hypertension A E I A PRAVASTATIN d00348A C"0 E78.0 Pure hypercholesterolemia A E I A PREGABALIN d05508A C- M79.2 Neuralgia and neuritis, unspecified A E I A . . . E I A LISINOPRIL d00732A Dc I10.P Prevent hypertension A E I0 A . . . E I@ A . . . E IP A ESCITALOPRAM d04812A CDp F32.9 Major depressive disorder, single episode, unspecified A` E IP A EZETIMIBE d04824A B E78.0 Pure hypercholesterolemia A` E IP A HYDROCHLOROTHIAZIDE d00253A C I10 Essential (primary) hypertension A` E IP A LANSOPRAZOLE d03828A D K21 Gastro-esophageal reflux disease A` E IP A LISINOPRIL d00732A B I10 Essential (primary) hypertension A` E IP A POTASSIUM CHLORIDE d00345A B E87.6 Hypokalemia A` E I` A . . . E Ip A ALBUTEROL d00749A Cr J45 Asthma A` E Ip A BUDESONIDE; FORMOTEROL d04795A CDp J45 Asthma A` E Ip A CETIRIZINE d03827A CDp T78.40 Allergy, unspecified A` E Ip A DEXAMETHASONE d00206A A J45 Asthma A` E Ip A MONTELUKAST d04289A C J45 T78.40 Asthma Allergy, unspecified A` E Ip A PREDNISOLONE d00084A AP J45 Asthma A` E I A . . . E I A . . . E I A . . . E I A . . . E I A HYDROCHLOROTHIAZIDE; TRIAMTERENE d03052A B I10 Essential (primary) hypertension A@ E I A LEVOCETIRIZINE d05851A B[ T78.40 Allergy, unspecified A@ E I A PHENYTOIN d00143A D G40 Epilepsy and recurrent seizures A@ E I A PRAVASTATIN d00348A B[ E78.0 Pure hypercholesterolemia A@ E I A AMOXICILLIN; CLAVULANATE d00089A A H10 H66.9 Conjunctivitis Otitis media, unspecified A E I A . . . E I A . . . E J A . . . E J A DESONIDE TOPICAL d01290A C- L20.9 Atopic dermatitis, unspecified A E J A AMLODIPINE d00689A D* I10 Essential (primary) hypertension A E J0 A . . . E J@ A AMLODIPINE d00689A C I10 Essential (primary) hypertension Ap E J@ A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia Ap E J@ A GABAPENTIN d03182A B M79.2 Neuralgia and neuritis, unspecified Ap E J@ A HYDROCHLOROTHIAZIDE d00253A C I10 Essential (primary) hypertension Ap E J@ A INSULIN DETEMIR d05436A B E11 Type 2 diabetes mellitus Ap E J@ A METFORMIN d03807A D* R73 Elevated blood glucose level Ap E J@ A PANTOPRAZOLE d04514A B K21 Gastro-esophageal reflux disease Ap E JP A POTASSIUM CHLORIDE d00345A A 99999 A E J` A . . . E Jp A DESOXIMETASONE TOPICAL d01291A C L40 Psoriasis A E J A IBUPROFEN d00015A A M54 Dorsalgia A E J A CEFDINIR d04256A A H66.9 Otitis media, unspecified A E J A ATENOLOL d00004A CDp I49.9 Cardiac arrhythmia, unspecified A` E J A CHLORDIAZEPOXIDE; CLIDINIUM d03492A D K21 Gastro-esophageal reflux disease A` E J A ESOMEPRAZOLE d04749A B R10 Abdominal and pelvic pain A` E J A HYDROXYZINE d00907A C[@ K76.9 L29.9 Liver disease, unspecified Pruritus, unspecified A` E J A MELOXICAM d04532A Dc M19.9 Osteoarthritis, unspecified site A` E J A URSODIOL d01005A D# K87 Disorders of gallbladder, biliary tract and pancreas in diseases classified elsewhere A` E J A PREGABALIN d05508A0 B= M79.2 Neuralgia and neuritis, unspecified A E J A APIXABAN d07804A B I48.9 Unspecified atrial fibrillation and atrial flutter A E J A CHOLESTYRAMINE d00193A C- 55555 A E J A CITALOPRAM d04332A Cr F32.9 Major depressive disorder, single episode, unspecified A E J A FUROSEMIDE d00070A Cr I51.9 Heart disease, unspecified A E J A LEVOTHYROXINE d00278A Cr E03.9 Hypothyroidism, unspecified A E J A METOCLOPRAMIDE d00298A C K92.9 Disease of digestive system, unspecified A E J A MYCOPHENOLATE MOFETIL d03839A CDp M06.9 Rheumatoid arthritis, unspecified A E J A OMEPRAZOLE d00325A C R12 Heartburn A E J A PREDNISONE d00350A CJ J98.9 Respiratory disorder, unspecified A E J A SPIRONOLACTONE d00373A C I51.9 Heart disease, unspecified A E J A ACETAMINOPHEN; OXYCODONE d03431A A K08.8 Other specified disorders of teeth and supporting structures A E J A PENICILLIN V POTASSIUM d07730A A K04.7 Periapical abscess without sinus A E J A ESCITALOPRAM d04812A CDp F32.9 Major depressive disorder, single episode, unspecified A@ E J A LOSARTAN d03821A C- I10 Essential (primary) hypertension A@ E J A METOPROLOL d00134A C G43.P R42 Prevent migraine Dizziness and giddiness A@ E J A OMEPRAZOLE d00325A CDp K30 Functional dyspepsia A@ E J A THYROID DESICCATED d00655A C E03.9 Hypothyroidism, unspecified A E K A FLUTICASONE NASAL d04283A Cr J30.1 Allergic rhinitis due to pollen A@ E K A LOSARTAN d03821A C I10 Essential (primary) hypertension A@ E K A TRAMADOL d03826A B M54 Dorsalgia A@ E K A TRAZODONE d00395A C G47.0 Insomnia A@ E K A AMLODIPINE d00689A Ei I10 Essential (primary) hypertension B E K A ATORVASTATIN d04105A Ei E78.0 Pure hypercholesterolemia B E K A CETIRIZINE d03827A Ei L29.9 Pruritus, unspecified B E K A CLOPIDOGREL d04258A Ei D75.9P Prevent blood clots B E K A DOXEPIN TOPICAL d03774A Ei L29.9 Pruritus, unspecified B E K A FLUOCINOLONE TOPICAL d01293A Ei L29.9 R21 Pruritus, unspecified Rash and other nonspecific skin eruption B E K A LATANOPROST OPHTHALMIC d04017A Ei H40 Glaucoma B E K A LEVOTHYROXINE d00278A Ei E07.9 Disorder of thyroid, unspecified B E K A LISINOPRIL d00732A Ei I10 I21.P Essential (primary) hypertension Prevent heart attack/myocardial infarction B E K A MELOXICAM d04532A Ei 99999 B E K A METFORMIN d03807A Ei E11 Type 2 diabetes mellitus B E K A METOPROLOL d00134A Ei I10 Essential (primary) hypertension B E K A NITROGLYCERIN d00321A Ei I20.9 Angina pectoris, unspecified B E K A OMEPRAZOLE d00325A Ei K25.P Prevent gastric ulcer B E K A RIVAROXABAN d07356A Ei D75.9P Prevent blood clots B E K A TIZANIDINE d04102A Ei M62.83 M79.1 Muscle spasm Myalgia B E K A . . . E K0 A COLESEVELAM d04695A C E11 Type 2 diabetes mellitus A@ E K0 A LISINOPRIL d00732A C I10 Essential (primary) hypertension A@ E K0 A METFORMIN d03807A C E11 Type 2 diabetes mellitus A@ E K0 A VENLAFAXINE d03181A C G43.P Prevent migraine A@ E K@ A . . . E KP A METHYLPHENIDATE d00900A B F90 Attention-deficit hyperactivity disorders A E K` A CEPHALEXIN d00096A A N39.0 Urinary tract infection, site not specified A E K` A CIPROFLOXACIN d00011A A N39.0 Urinary tract infection, site not specified A E K` A LANSOPRAZOLE d03828A D ^ K21 Gastro-esophageal reflux disease A E K` A LEVOTHYROXINE d00278A D% E03.9 Hypothyroidism, unspecified A E K` A LORAZEPAM d00149A B F41.9 Anxiety disorder, unspecified A E K` A METOPROLOL d00134A C[@ I10 Essential (primary) hypertension A E K` A MIRTAZAPINE d04025A C F32.9 G47.9 Major depressive disorder, single episode, unspecified Sleep disorder, unspecified A E K` A SIMVASTATIN d00746A C- E78.0 Pure hypercholesterolemia A E Kp A ATORVASTATIN d04105A CDp E78.0 Pure hypercholesterolemia A E Kp A RANITIDINE d00021A D K21 Gastro-esophageal reflux disease A E K A . . . E K A ETHINYL ESTRADIOL; NORELGESTROMIN d04779A A N92 Excessive, frequent and irregular menstruation A E K A . . . E K A . . . E K A 77777 . . A E K A . . . E K A . . . E K A . . . E L A AMLODIPINE d00689A C- I10 Essential (primary) hypertension AP E L A BUSPIRONE d00182A C- F41.9 Anxiety disorder, unspecified AP E L A FINASTERIDE d00563A C N40 Enlarged prostate AP E L A GABAPENTIN d03182A C- G47.0 Insomnia AP E L A TAMSULOSIN d04121A C N40 Enlarged prostate AP E L A . . . E L A . . . E L0 A ASPIRIN d00170A C[@ D75.9P Prevent blood clots A0 E L0 A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A0 E L0 A HYDROCHLOROTHIAZIDE; VALSARTAN d04293A C I10 Essential (primary) hypertension A0 E L@ A . . . E LP A HYDROCHLOROTHIAZIDE; LOSARTAN d03830A C- I10 Essential (primary) hypertension A E L` A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia Ap E L` A BACLOFEN d00967A C 99999 Ap E L` A CHLORTHALIDONE d00192A C I10 Essential (primary) hypertension Ap E L` A DONEPEZIL d04099A C[@ R41 Other symptoms and signs involving cognitive functions and awareness Ap E L` A GABAPENTIN d03182A Cr 99999 Ap E L` A LISINOPRIL d00732A C I10 Essential (primary) hypertension Ap E L` A PHENYTOIN d00143A D* G40 Epilepsy and recurrent seizures Ap E Lp A . . . E L A . . . E L A . . . E L A AMLODIPINE d00689A C I10 Essential (primary) hypertension A` E L A BRIMONIDINE OPHTHALMIC d04048A C- H40 Glaucoma A` E L A DONEPEZIL d04099A D G31.9 Degenerative disease of nervous system, unspecified A` E L A HYDROCHLOROTHIAZIDE; LOSARTAN d03830A CDp I10 Essential (primary) hypertension A` E L A POTASSIUM CHLORIDE d00345A C- E87.6 Hypokalemia A` E L A TIMOLOL OPHTHALMIC d04037A C- H40 Glaucoma A` E L A . . . E L A . . . E L A . . . E L A AMOXICILLIN d00088A Ap H66.9 J01.9 Otitis media, unspecified Acute sinusitis, unspecified A E L A . . . E M A . . . E M A . . . E M A . . . E M0 A . . . E M@ A . . . E MP A . . . E M` A . . . E Mp A ETHINYL ESTRADIOL; NORETHINDRONE d03238A C[@ Z79.3 Long term (current) use of hormonal contraceptives A E M A DEXAMETHASONE d00206A C"@ H57.9 Unspecified disorder of eye and adnexa A@ E M A DONEPEZIL d04099A C[@ R41 Other symptoms and signs involving cognitive functions and awareness A@ E M A OMEPRAZOLE d00325A CDp K30 Functional dyspepsia A@ E M A PRAVASTATIN d00348A Cr E78.0 Pure hypercholesterolemia A@ E M A . . . E M A . . . E M A ALBUTEROL d00749A D# R06.02 Shortness of breath A E M A . . . E M A ETHINYL ESTRADIOL; NORETHINDRONE d03238A B= N94 Pain and other conditions associated with female genital organs and menstrual cycle A E M A DIAZEPAM d00148A C F41.9 Anxiety disorder, unspecified A E M A OLMESARTAN d04801A CDp I10 Essential (primary) hypertension A E M A AMLODIPINE d00689A C I10 Essential (primary) hypertension A E M A LISINOPRIL d00732A C I10 Essential (primary) hypertension A E N A ALPRAZOLAM d00168A C F41.9 Anxiety disorder, unspecified Ap E N A DULOXETINE d05355A CDp F32.9 M79.1 Major depressive disorder, single episode, unspecified Myalgia Ap E N A ESTRADIOL d00537A C Z79.890 Hormone replacement therapy Ap E N A METHOCARBAMOL d00965A CP M54 M79.1 Dorsalgia Myalgia Ap E N A PRAMIPEXOLE d04145A C- G25.81 Restless legs syndrome Ap E N A TRAMADOL d03826A CDp M54 Dorsalgia Ap E N A TRAZODONE d00395A CDp G47.0 Insomnia Ap E N A . . . E N A . . . E N0 A . . . E N@ A . . . E NP A . . . E N` A ESCITALOPRAM d04812A C[@ F32.9 Major depressive disorder, single episode, unspecified A0 E N` A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A Dc I10 Essential (primary) hypertension A0 E N` A LOVASTATIN d00280A Dc E78.0 Pure hypercholesterolemia A0 E Np A LOSARTAN d03821A C- 99999 A@ E Np A METOPROLOL d00134A D I10 Essential (primary) hypertension A@ E Np A PRAVASTATIN d00348A B I10 Essential (primary) hypertension A@ E Np A ROPINIROLE d04215A D* G25.81 Restless legs syndrome A@ E N A ALPRAZOLAM d00168A C F32.9 F41.9 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified A` E N A DULOXETINE d05355A B F32.9 Major depressive disorder, single episode, unspecified A` E N A LISDEXAMFETAMINE d06663A C F90 Attention-deficit hyperactivity disorders A` E N A MELOXICAM d04532A CDp M54 Dorsalgia A` E N A RISPERIDONE d03180A C F39 Unspecified mood [affective] disorder A` E N A TIZANIDINE d04102A CDp M54 M79.6 Dorsalgia Pain in limb, hand, foot, fingers and toes A` E N A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A0 E N A EZETIMIBE d04824A C E78.0 Pure hypercholesterolemia A0 E N A LISINOPRIL d00732A C I10 Essential (primary) hypertension A0 E N A . . . E N A ALLOPURINOL d00023A Cr M1A Chronic gout AP E N A ATORVASTATIN d04105A Cr E78.0 Pure hypercholesterolemia AP E N A HYDROCHLOROTHIAZIDE; LOSARTAN d03830A Cr I10 Essential (primary) hypertension AP E N A INSULIN ISOPHANE; INSULIN REGULAR d04374A CDp E11 Type 2 diabetes mellitus AP E N A METOPROLOL d00134A Cr I10 Essential (primary) hypertension AP E N A . . . E N A OSELTAMIVIR d04462A AP J09 Influenza due to certain identified influenza viruses A E N A ALBUTEROL d00749A C J45 R06.9P R07.9 Asthma Prevent breathing difficulty Chest pain, unspecified A@ E N A FORMOTEROL; MOMETASONE d07660A C- J45 R06.2 R07.9 Asthma Wheezing Chest pain, unspecified A@ E N A OMEPRAZOLE d00325A C K30 R12 Functional dyspepsia Heartburn A@ E N A TIOTROPIUM d04829A C"0 J45 R06.2 R07.9 Asthma Wheezing Chest pain, unspecified A@ E N A TRAMADOL d03826A C M54 Dorsalgia A E O A LEVETIRACETAM d04499A C"0 G40 Epilepsy and recurrent seizures A E O A . . . E O A . . . E O0 A ATORVASTATIN d04105A C- E78.0 Pure hypercholesterolemia A E O0 A METFORMIN d03807A C E11 Type 2 diabetes mellitus A E O@ A ACETAMINOPHEN; HYDROCODONE d03428A0 A T14.9 Unspecified injury A@ E O@ A DEXAMETHASONE d00206A Ap R60.9 Edema, unspecified A@ E O@ A METHOCARBAMOL d00965A B T14.9 Unspecified injury A@ E O@ A PANTOPRAZOLE d04514A A K25.P Prevent gastric ulcer A@ E OP A AMLODIPINE d00689A0 C- I10 Essential (primary) hypertension Ap E OP A ATORVASTATIN d04105A0 CDp E78.0 Pure hypercholesterolemia Ap E OP A CYANOCOBALAMIN d00413A0 C- M79.2 Neuralgia and neuritis, unspecified Ap E OP A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A C"0 I10 Essential (primary) hypertension Ap E OP A HYDROXYUREA d01373A CDp D49.9 Neoplasm of unspecified behavior of unspecified site Ap E OP A OMEPRAZOLE d00325A C- K21 Gastro-esophageal reflux disease Ap E OP A SALICYLIC ACID TOPICAL d01307A C R21 Rash and other nonspecific skin eruption Ap E O` A ALBUTEROL d00749A Cr J45 Asthma AP E O` A CYCLOBENZAPRINE d00963A C[@ M19.9 M79.1 Osteoarthritis, unspecified site Myalgia AP E O` A GABAPENTIN d03182A C[@ G25.81 Restless legs syndrome AP E O` A METHYLPREDNISOLONE d00293A A` R52 Z79 Pain, unspecified Long term (current) drug therapy AP E O` A PIROXICAM d00343A B= M19.9 Osteoarthritis, unspecified site AP E Op A . . . E O A AMOXICILLIN d00088A A H66.9 Otitis media, unspecified A E O A AMOXICILLIN; CLAVULANATE d00089A A@ H66.9 Otitis media, unspecified A E O A . . . E O A . . . E O A AMLODIPINE; BENAZEPRIL d03829A C- I10 R52 Essential (primary) hypertension Pain, unspecified A@ E O A BICALUTAMIDE d03850A C C61 Malignant neoplasm of prostate A@ E O A CLOPIDOGREL d04258A C D75.9P I21.P Prevent blood clots Prevent heart attack/myocardial infarction A@ E O A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia A@ E O A . . . E O A GLIMEPIRIDE d03864A Dc E11 Type 2 diabetes mellitus A@ E O A HYDROCHLOROTHIAZIDE d00253A D= I10 Essential (primary) hypertension A@ E O A MELOXICAM d04532A C M54 Dorsalgia A@ E O A VERAPAMIL d00048A D= I10 Essential (primary) hypertension A@ E O A . . . E O A . . . E P A FAMOTIDINE d00141A Cr K21 Gastro-esophageal reflux disease A E P A AMLODIPINE d00689A Cr I10 Essential (primary) hypertension A E P A . . . E P0 A . . . E P@ A ATORVASTATIN d04105A C- E78.0 Pure hypercholesterolemia A0 E P@ A CLOPIDOGREL d04258A C- D75.9P Prevent blood clots A0 E P@ A GLIPIZIDE; METFORMIN d04823A C- E11 Type 2 diabetes mellitus A0 E PP A . . . E P` A 99999 . . A E Pp A . . . E P A . . . E P A MONTELUKAST d04289A C J30.2 Other seasonal allergic rhinitis A E P A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A C- I10 Essential (primary) hypertension A E P A DROSPIRENONE; ETHINYL ESTRADIOL d04760A C Z79.3 Long term (current) use of hormonal contraceptives A E P A . . . E P A ALBUTEROL d00749A D J45 Asthma A E P A CETIRIZINE d03827A C T78.40 Allergy, unspecified A E P A . . . E P A ALPRAZOLAM d00168A C F41.9 Anxiety disorder, unspecified A@ E P A LEVOTHYROXINE d00278A D* E03.9 Hypothyroidism, unspecified A@ E P A LISINOPRIL d00732A C I10 Essential (primary) hypertension A@ E P A VENLAFAXINE d03181A C"0 F32.9 Major depressive disorder, single episode, unspecified A@ E Q A ALBUTEROL d00749A C"0 J45 Asthma A E Q A FLUTICASONE d01296A C"0 J45 Asthma A E Q A AMLODIPINE d00689A Cr I10 Essential (primary) hypertension Ap E Q A CARVEDILOL d03847A C I10 Essential (primary) hypertension Ap E Q A INSULIN ASPART d04697A Cr E11 Type 2 diabetes mellitus Ap E Q A INSULIN GLARGINE d04538A C E11 Type 2 diabetes mellitus Ap E Q A LISINOPRIL d00732A D I10 Essential (primary) hypertension Ap E Q A METFORMIN d03807A C E11 Type 2 diabetes mellitus Ap E Q A ROSUVASTATIN d04851A C- E78.0 Pure hypercholesterolemia Ap E Q A PAROXETINE d03157A B F32.9 F41.9 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified A E Q0 A . . . E Q@ A CLONAZEPAM d00197A C G25.81 Restless legs syndrome A` E Q@ A ESTRADIOL; NORETHINDRONE d04375A C Z79.890 Hormone replacement therapy A` E Q@ A NARATRIPTAN d04285A Cr G43 Migraine A` E Q@ A ONABOTULINUMTOXINA d07645A C G43 Migraine A` E Q@ A TRAZODONE d00395A C[@ G47.0 G47.9 Insomnia Sleep disorder, unspecified A` E Q@ A VORTIOXETINE d08125A C"0 F32.9 Major depressive disorder, single episode, unspecified A` E QP A HYDROCHLOROTHIAZIDE; LOSARTAN d03830A CDp I10 Essential (primary) hypertension AP E QP A MELOXICAM d04532A CDp 99999 AP E QP A METFORMIN d03807A CDp E11 Type 2 diabetes mellitus AP E QP A PRAVASTATIN d00348A CDp E78.0 Pure hypercholesterolemia AP E QP A SERTRALINE d00880A CDp F32.9 Major depressive disorder, single episode, unspecified AP E Q` A . . . E Qp A . . . E Q A ATORVASTATIN d04105A CP E78.0 Pure hypercholesterolemia A` E Q A CLONIDINE d00044A CP I10 Essential (primary) hypertension A` E Q A FUROSEMIDE d00070A C I50.9 I51.9 Heart failure, unspecified Heart disease, unspecified A` E Q A LOSARTAN d03821A CDp I10 Essential (primary) hypertension A` E Q A METOPROLOL d00134A CP I50.9 Heart failure, unspecified A` E Q A OMEPRAZOLE d00325A C K21 Gastro-esophageal reflux disease A` E Q A LISINOPRIL d00732A Cr I10 Essential (primary) hypertension A0 E Q A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia A0 E Q A WARFARIN d00022A Cr I63 Cerebral infarction A0 E Q A BUDESONIDE NASAL d03640A B J30.9 Allergic rhinitis, unspecified A0 E Q A DIAZEPAM d00148A C 55555 A0 E Q A MONTELUKAST d04289A CDp J30.9 R06.2 Allergic rhinitis, unspecified Wheezing A0 E Q A OMEPRAZOLE d00325A Ap K21 Gastro-esophageal reflux disease A E Q A SERTRALINE d00880A C"0 F43.1 Post-traumatic stress disorder (PTSD) A E Q A CARVEDILOL d03847A C I10 Essential (primary) hypertension A E Q A CINACALCET d05218A CDp N18.9 Chronic kidney disease, unspecified A E Q A CYCLOSPORINE d00079A C T86.9P Prevent transplanted organ and tissue rejection A E Q A DOXAZOSIN d00726A C I10 Essential (primary) hypertension A E Q A HYDRALAZINE d00132A Cr I10 Essential (primary) hypertension A E Q A INSULIN DETEMIR d05436A C E11 Type 2 diabetes mellitus A E Q A LEVOTHYROXINE d00278A C- E03.9 Hypothyroidism, unspecified A E Q A LINAGLIPTIN d07767A C E11 Type 2 diabetes mellitus A E Q A NIFEDIPINE d00051A C I10 Essential (primary) hypertension A E Q A PREDNISONE d00350A C N18.9 Chronic kidney disease, unspecified A E Q A . . . E Q A . . . E Q A . . . E R A ETHINYL ESTRADIOL; NORGESTREL d03241A C"0 Z79.3 Long term (current) use of hormonal contraceptives A E R A NAPROXEN d00019A C M25.9 Joint disorder, unspecified A E R A . . . E R A . . . E R0 A . . . E R@ A ALENDRONATE d03849A CDp M81 Osteoporosis without current pathological fracture A0 E R@ A AMLODIPINE d00689A C I10 Essential (primary) hypertension A0 E R@ A ENALAPRIL d00013A C I10 Essential (primary) hypertension A0 E RP A AMLODIPINE; BENAZEPRIL d03829A Bz I10 Essential (primary) hypertension A E RP A ATENOLOL; CHLORTHALIDONE d03258A Bz I10 Essential (primary) hypertension A E R` A AZITHROMYCIN d00091A AP J42 Unspecified chronic bronchitis A E Rp A . . . E R A AMOXICILLIN d00088A A K04.7 Periapical abscess without sinus AP E R A ATORVASTATIN d04105A C I70.P Prevent atherosclerosis AP E R A LOSARTAN d03821A C I10 Essential (primary) hypertension AP E R A SOTALOL d00371A Cr I49.9 Cardiac arrhythmia, unspecified AP E R A WARFARIN d00022A C I48.9 Unspecified atrial fibrillation and atrial flutter AP E R A . . . E R A ALBUTEROL d00749A C- T78.40 Allergy, unspecified AP E R A AMLODIPINE d00689A C I10 Essential (primary) hypertension AP E R A CETIRIZINE d03827A C T78.40 Allergy, unspecified AP E R A FLUTICASONE NASAL d04283A C T78.40 Allergy, unspecified AP E R A OMEPRAZOLE d00325A C K21 Gastro-esophageal reflux disease AP E R A . . . E R A 99999 . . A0 E R A ATORVASTATIN d04105A Cr E78.0 Pure hypercholesterolemia A0 E R A INSULIN DEGLUDEC d08054A C E11 Type 2 diabetes mellitus A0 E R A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia A E R A . . . E R A . . . E S A ALBUTEROL; IPRATROPIUM d04066A CDp J44.9 Chronic obstructive pulmonary disease, unspecified AP E S A AMLODIPINE d00689A CDp I10 Essential (primary) hypertension AP E S A LOSARTAN d03821A CDp I10 Essential (primary) hypertension AP E S A SIMVASTATIN d00746A CDp E78.0 Pure hypercholesterolemia AP E S A TRAZODONE d00395A B= G47.0 Insomnia AP E S A . . . E S A DUTASTERIDE d04788A Cr N40 Enlarged prostate A E S A NEBIVOLOL d05265A C[@ I10 Essential (primary) hypertension A E S0 A ATORVASTATIN d04105A Cr E78.0P Prevent high cholesterol A0 E S0 A LISINOPRIL d00732A Cr I10.P Prevent hypertension A0 E S0 A PIOGLITAZONE d04442A A R73 Elevated blood glucose level A0 E S@ A . . . E SP A PANTOPRAZOLE d04514A B K87 Disorders of gallbladder, biliary tract and pancreas in diseases classified elsewhere A E S` A AMITRIPTYLINE d00146A C G47.0 Insomnia A E S` A AMLODIPINE d00689A C- I10 Essential (primary) hypertension A E S` A DICYCLOMINE d00999A C R10 Abdominal and pelvic pain A E S` A HYDROCHLOROTHIAZIDE d00253A B I10 Essential (primary) hypertension A E S` A METHOCARBAMOL d00965A C T14.9 Unspecified injury A E S` A PAROXETINE d03157A C- F32.9 Major depressive disorder, single episode, unspecified A E S` A PROPRANOLOL d00032A C R07.9 Chest pain, unspecified A E S` A ROPINIROLE d04215A C G25.81 Restless legs syndrome A E S` A TOPIRAMATE d04115A C G43 Migraine A E S` A TRAMADOL d03826A B= M25.5 Pain in joint A E Sp A . . . E S A AMOXICILLIN d00088A A` N30 Cystitis A E S A . . . E S A . . . E S A . . . E S A ETHINYL ESTRADIOL; LEVONORGESTREL d03242A D% N94 Pain and other conditions associated with female genital organs and menstrual cycle A E S A . . . E S A AMLODIPINE d00689A C- I10 Essential (primary) hypertension A E S A CARVEDILOL d03847A B 99999 A E S A CHLORTHALIDONE d00192A C I50.9 Heart failure, unspecified A E S A ISOSORBIDE MONONITRATE d00269A C- I21.P Prevent heart attack/myocardial infarction A E S A LISINOPRIL d00732A C- I10 Essential (primary) hypertension A E S A METFORMIN d03807A C E11 R73 Type 2 diabetes mellitus Elevated blood glucose level A E S A RANITIDINE d00021A CDp B96.81 Helicobacter pylori [H. pylori] as the cause of diseases classified elsewhere A E S A ROSUVASTATIN d04851A C E78.0 Pure hypercholesterolemia A E S A TAMSULOSIN d04121A Ei N40 Enlarged prostate A E S A . . . E T A . . . E T A . . . E T A . . . E T0 A . . . E T@ A ZOLPIDEM d00910A B G47.0 Insomnia A E TP A . . . E T` A DIVALPROEX SODIUM d03833A D* G40 Epilepsy and recurrent seizures A E T` A SIMVASTATIN d00746A C- E78.0 Pure hypercholesterolemia A E Tp A . . . E T A . . . E T A ATORVASTATIN d04105A D E78.0 Pure hypercholesterolemia A E T A CARVEDILOL d03847A C I10 I50.9 Essential (primary) hypertension Heart failure, unspecified A E T A CLOPIDOGREL d04258A D I80.3 Phlebitis and thrombophlebitis of lower extremities, unspecified A E T A FENOFIBRATE d04286A Cr E78.1 Pure hyperglyceridemia A E T A INSULIN ASPART d04697A D E11 Type 2 diabetes mellitus A E T A INSULIN GLARGINE d04538A Cr E11 Type 2 diabetes mellitus A E T A ISOSORBIDE MONONITRATE d00269A C R07.9 Chest pain, unspecified A E T A LISINOPRIL d00732A C- I10 I50.9 Essential (primary) hypertension Heart failure, unspecified A E T A METFORMIN d03807A D E11 Type 2 diabetes mellitus A E T A . . . E T A ATENOLOL d00004A Dc I10 Essential (primary) hypertension A0 E T A LISINOPRIL d00732A Dc I10 Essential (primary) hypertension A0 E T A SIMVASTATIN d00746A Dc E78.0 Pure hypercholesterolemia A0 E T A COLESTIPOL d00744A0 C- R19.7 Diarrhea, unspecified A E T A MELOXICAM d04532A0 C M19.9 M25.5 Osteoarthritis, unspecified site Pain in joint A E T A MONTELUKAST d04289A0 C J45 Asthma A E T A OMEPRAZOLE d00325A0 C K21 K58 Gastro-esophageal reflux disease Irritable bowel syndrome A E T A OXYBUTYNIN d00328A0 CDp N32.81 R39.1 Overactive bladder Other difficulties with micturition A E T A PHENYTOIN d00143A0 D% 55555 A E T A PROPRANOLOL d00032A0 DE I49.9 Cardiac arrhythmia, unspecified A E T A TEMAZEPAM d00384A0 C G47.0 Insomnia A E T A . . . E T A ALBUTEROL d00749A C- J45 Asthma A E T A LISDEXAMFETAMINE d06663A B F90 Attention-deficit hyperactivity disorders A E U A . . . E U A . . . E U A . . . E U0 A ALBUTEROL d00749A C- J45 Asthma A E U0 A ATORVASTATIN d04105A B E78.0 Pure hypercholesterolemia A E U0 A BENZONATATE d00796A B R05 Cough A E U0 A ETANERCEPT d04365A CDp M06.9 Rheumatoid arthritis, unspecified A E U0 A FLUOXETINE d00236A C F41.9 Anxiety disorder, unspecified A E U0 A HYDROXYCHLOROQUINE d00817A C M06.9 Rheumatoid arthritis, unspecified A E U0 A LOSARTAN d03821A Cr I10 Essential (primary) hypertension A E U0 A PREDNISONE d00350A CDp M06.9 Rheumatoid arthritis, unspecified A E U@ A AMOXICILLIN d00088A A B34.9 Viral infection, unspecified Ap E U@ A FLUDROCORTISONE d00608A C I99.9 Unspecified disorder of circulatory system Ap E U@ A LAMOTRIGINE d03809A B= F31.9 Bipolar disorder, unspecified Ap E U@ A LIDOCAINE TOPICAL d00683A A J02 Acute pharyngitis Ap E U@ A MIDODRINE d04047A C I99.9 Unspecified disorder of circulatory system Ap E U@ A QUETIAPINE d04220A C F31.9 Bipolar disorder, unspecified Ap E U@ A TOPIRAMATE d04115A C G43 Migraine Ap E UP A . . . E U` A . . . E Up A AMOXICILLIN d00088A B J02 Acute pharyngitis A E U A ATORVASTATIN d04105A B= E78.0 Pure hypercholesterolemia A0 E U A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified A0 E U A VENLAFAXINE d03181A C F32.9 Major depressive disorder, single episode, unspecified A0 E U A ACETAMINOPHEN; BUTALBITAL; CAFFEINE d03455A D9 R51 Headache A E U A OMEPRAZOLE d00325A C[@ K21 Gastro-esophageal reflux disease A E U A MONTELUKAST d04289A Cr J30.9 Allergic rhinitis, unspecified A E U A . . . E U A . . . E U A AMLODIPINE d00689A Ei I10 Essential (primary) hypertension A E U A PRAVASTATIN d00348A Ei E78.0 Pure hypercholesterolemia A E U A . . . E U A AMOXICILLIN d00088A A N30 Cystitis A E V A . . . E V A AMLODIPINE d00689A C- I10 Essential (primary) hypertension Ap E V A HYDROCHLOROTHIAZIDE d00253A B R60.9 Edema, unspecified Ap E V A LIRAGLUTIDE d07466A B E11 Type 2 diabetes mellitus Ap E V A LOSARTAN d03821A C- I10 Essential (primary) hypertension Ap E V A METFORMIN d03807A C E11 Type 2 diabetes mellitus Ap E V A MONTELUKAST d04289A A J30.9 Allergic rhinitis, unspecified Ap E V A PRAVASTATIN d00348A C- I21.P Prevent heart attack/myocardial infarction Ap E V A DONEPEZIL; MEMANTINE d08337A Cr G31.9 Degenerative disease of nervous system, unspecified A@ E V A METOPROLOL d00134A Cr I50.9 Heart failure, unspecified A@ E V A OMEPRAZOLE d00325A C K21 Gastro-esophageal reflux disease A@ E V A QUETIAPINE d04220A Cr G31.9 Degenerative disease of nervous system, unspecified A@ E V0 A BACLOFEN d00967A C[@ M54 M62.83 Dorsalgia Muscle spasm A0 E V0 A BUPROPION d00181A B[ F32.9 Major depressive disorder, single episode, unspecified A0 E V0 A NAPROXEN d00019A C[@ M25.5 M54 R51 Pain in joint Dorsalgia Headache A0 E V@ A . . . E VP A . . . E V` A LISINOPRIL d00732A C I10 Essential (primary) hypertension A E Vp A ESCITALOPRAM d04812A C F41.9 Anxiety disorder, unspecified A E V A FLUDROCORTISONE d00608A D 55555 A E V A . . . E V A . . . E V A ETHINYL ESTRADIOL; NORGESTIMATE d03781A C Z79.3 Long term (current) use of hormonal contraceptives A0 E V A METOPROLOL d00134A C I10 Essential (primary) hypertension A0 E V A TOPIRAMATE d04115A C G43 Migraine A0 E V A SULFISOXAZOLE d00120A AP N39.0 Urinary tract infection, site not specified A E V A LISINOPRIL d00732A C I10 Essential (primary) hypertension A E V A . . . E V A . . . E W A . . . E W A . . . E W A . . . E W0 A . . . E W@ A HYDRALAZINE d00132A D I10 Essential (primary) hypertension A` E W@ A ISOSORBIDE MONONITRATE d00269A D I20.9 Angina pectoris, unspecified A` E W@ A PREDNISONE d00350A C N18.9 Chronic kidney disease, unspecified A` E W@ A ROSUVASTATIN d04851A D E78.0 Pure hypercholesterolemia A` E W@ A SEVELAMER d04363A D N19 Unspecified kidney failure A` E W@ A TACROLIMUS d03752A D N19 Unspecified kidney failure A` E WP A FLUTICASONE; SALMETEROL d04611A C[@ J45 Asthma A E W` A . . . E Wp A . . . E W A . . . E W A ZOLPIDEM d00910A B[ G47.0 Insomnia A E W A . . . E W A . . . E W A . . . E W A . . . E W A . . . E W A AMLODIPINE d00689A C I10 Essential (primary) hypertension A@ E W A HYDRALAZINE d00132A C I10 Essential (primary) hypertension A@ E W A INSULIN DEGLUDEC d08054A B E11 Type 2 diabetes mellitus A@ E W A TRAMADOL d03826A B R52 Pain, unspecified A@ E X A . . . E X A . . . E X A . . . E X0 A . . . E X@ A . . . E XP A AMIODARONE d00002A A I48.9 Unspecified atrial fibrillation and atrial flutter A` E XP A AMLODIPINE d00689A C I10 Essential (primary) hypertension A` E XP A APIXABAN d07804A C I48.9 Unspecified atrial fibrillation and atrial flutter A` E XP A CITALOPRAM d04332A C[@ F32.9 Major depressive disorder, single episode, unspecified A` E XP A FUROSEMIDE d00070A C R60.9 Edema, unspecified A` E XP A METOPROLOL d00134A C I10 Essential (primary) hypertension A` E X` A LOSARTAN d03821A CDp I10 Essential (primary) hypertension A0 E X` A METFORMIN d03807A CDp E11 Type 2 diabetes mellitus A0 E X` A OMEPRAZOLE d00325A CDp 99999 A0 E Xp A . . . E X A . . . E X A . . . E X A BACLOFEN d00967A D M62.83 Muscle spasm A E X A AMIODARONE d00002A B 99999 A@ E X A ATORVASTATIN d04105A B 99999 A@ E X A CLOPIDOGREL d04258A B 99999 A@ E X A METOPROLOL d00134A CDp I10 Essential (primary) hypertension A@ E X A . . . E X A AMLODIPINE d00689A B= I10 Essential (primary) hypertension A` E X A ETHINYL ESTRADIOL; NORGESTREL d03241A D Z79.3 Long term (current) use of hormonal contraceptives A` E X A LOSARTAN d03821A B= I10 Essential (primary) hypertension A` E X A OMEPRAZOLE d00325A CDp K21 Gastro-esophageal reflux disease A` E X A PRAVASTATIN d00348A B E78.0 Pure hypercholesterolemia A` E X A VENLAFAXINE d03181A C F32.9 Major depressive disorder, single episode, unspecified A` E X A LEVOTHYROXINE d00278A D E03.9 Hypothyroidism, unspecified A E X A SERTRALINE d00880A C F41.9 Anxiety disorder, unspecified A E X A . . . E Y A ATORVASTATIN d04105A B E78.0 Pure hypercholesterolemia A` E Y A BUPROPION d00181A B F32.9 Major depressive disorder, single episode, unspecified A` E Y A LEVOTHYROXINE d00278A D)Y E03.9 Hypothyroidism, unspecified A` E Y A LOSARTAN d03821A C I10 Essential (primary) hypertension A` E Y A MELOXICAM d04532A C M25.5 Pain in joint A` E Y A SERTRALINE d00880A D)Y F32.9 Major depressive disorder, single episode, unspecified A` E Y A . . . E Y A ETHINYL ESTRADIOL; ETONOGESTREL d04773A D N92 Z79.3 Excessive, frequent and irregular menstruation Long term (current) use of hormonal contraceptives A E Y A LIFITEGRAST OPHTHALMIC d08472A B[ H04 Disorders of lacrimal system A E Y0 A . . . E Y@ A CARBAMAZEPINE d00058A C F39 Unspecified mood [affective] disorder A0 E Y@ A PANTOPRAZOLE d04514A B= K21 Gastro-esophageal reflux disease A0 E Y@ A SERTRALINE d00880A C- F32.9 Major depressive disorder, single episode, unspecified A0 E YP A . . . E Y` A ESCITALOPRAM d04812A B N95 Menopausal and other perimenopausal disorders A0 E Y` A METHYLPREDNISOLONE d00293A A R09 Other symptoms and signs involving the circulatory and respiratory system A0 E Y` A OSELTAMIVIR d04462A A J09 Influenza due to certain identified influenza viruses A0 E Yp A DOXYLAMINE; PYRIDOXINE d04654A B R11 Nausea and vomiting A@ E Yp A FLUTICASONE NASAL d04283A C J30.2 Other seasonal allergic rhinitis A@ E Yp A FLUTICASONE; SALMETEROL d04611A Dc J45 Asthma A@ E Yp A INSULIN ISOPHANE (NPH) d04370A A 55555 A@ E Y A . . . E Y A . . . E Y A LAMOTRIGINE d03809A C- G40 Epilepsy and recurrent seizures A E Y A BUPROPION d00181A B F32.9 F39 F41.9 Major depressive disorder, single episode, unspecified Unspecified mood [affective] disorder Anxiety disorder, unspecified A E Y A CLONAZEPAM d00197A B F41.9 Anxiety disorder, unspecified A E Y A GLIMEPIRIDE d03864A C- E11 Type 2 diabetes mellitus A E Y A LISINOPRIL d00732A Cr I10 Essential (primary) hypertension A E Y A METFORMIN; PIOGLITAZONE d05635A C- E11 Type 2 diabetes mellitus A E Y A METOPROLOL d00134A B[ R00 Abnormalities of heart beat A E Y A PANTOPRAZOLE d04514A B K21 Gastro-esophageal reflux disease A E Y A SIMVASTATIN d00746A Cr E78.0 Pure hypercholesterolemia A E Y A ALBUTEROL d00749A C J45 Asthma A@ E Y A AZITHROMYCIN d00091A Ap R09.81 T78.40 Nasal congestion Allergy, unspecified A@ E Y A BECLOMETHASONE d00760A Ap J45 Asthma A@ E Y A MONTELUKAST d04289A Ap J30.2 Other seasonal allergic rhinitis A@ E Y A . . . E Y A ETHINYL ESTRADIOL; NORGESTIMATE d03781A B[ N92 Excessive, frequent and irregular menstruation A E Y A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia Ap E Y A BRIMONIDINE OPHTHALMIC d04048A C[@ H40 Glaucoma Ap E Y A FUROSEMIDE d00070A C I51.9 Heart disease, unspecified Ap E Y A LATANOPROST OPHTHALMIC d04017A C[@ H40 Glaucoma Ap E Y A LOSARTAN d03821A Cr I50.9 Heart failure, unspecified Ap E Y A METOPROLOL d00134A C I50.9 Heart failure, unspecified Ap E Y A SPIRONOLACTONE d00373A C I50.9 Heart failure, unspecified Ap E Z A . . . E Z A AMLODIPINE d00689A0 C I10 Essential (primary) hypertension A` E Z A GABAPENTIN d03182A0 C- I99.9 Unspecified disorder of circulatory system A` E Z A HYDROCHLOROTHIAZIDE d00253A0 C I10 Essential (primary) hypertension A` E Z A METFORMIN d03807A0 C R73 Elevated blood glucose level A` E Z A METOPROLOL d00134A0 C I10 Essential (primary) hypertension A` E Z A TAMSULOSIN d04121A0 C- N40 Enlarged prostate A` E Z A . . . E Z0 A AMOXICILLIN d00088A A` K04.7P Prevent tooth infection A E Z0 A KETOROLAC d00273A A` K08.8 Other specified disorders of teeth and supporting structures A E Z@ A . . . E ZP A . . . E Z` A AMOXICILLIN d00088A AP J02.0 Streptococcal pharyngitis A0 E Z` A ESCITALOPRAM d04812A C[@ F32.9 Major depressive disorder, single episode, unspecified A0 E Z` A IBUPROFEN d00015A B= R51 Headache A0 E Zp A INSULIN GLARGINE d04538A C E11 Type 2 diabetes mellitus A0 E Zp A INSULIN GLARGINE d04538A C E11 Type 2 diabetes mellitus A0 E Zp A METFORMIN d03807A C R73 Elevated blood glucose level A0 E Z A . . . E Z A ZOLPIDEM d00910A C G47.0 Insomnia A E Z A HYDROCHLOROTHIAZIDE; LOSARTAN d03830A Cr I10 Essential (primary) hypertension A0 E Z A HYDROXYCHLOROQUINE d00817A D# L40 Psoriasis A0 E Z A METHOTREXATE d00060A D"8 L40 Psoriasis A0 E Z A . . . E Z A . . . E Z A . . . E Z A ALBUTEROL d00749A C J45 Asthma A` E Z A ALPRAZOLAM d00168A C G47.9 Sleep disorder, unspecified A` E Z A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A` E Z A FENTANYL d00233A CDp M54 Dorsalgia A` E Z A FLUTICASONE; SALMETEROL d04611A C J45 Asthma A` E Z A OXYCODONE d00329A CDp M54 Dorsalgia A` E Z A ACETAMINOPHEN; HYDROCODONE d03428A A M25.5 M54 Pain in joint Dorsalgia A E Z A AMLODIPINE d00689A CDp I10 Essential (primary) hypertension A E Z A ATORVASTATIN d04105A CDp E78.0 Pure hypercholesterolemia A E Z A CETIRIZINE d03827A A L29.9 Pruritus, unspecified A E Z A MECLIZINE d00859A B[ H93.9 R42 Unspecified disorder of ear Dizziness and giddiness A E Z A METFORMIN d03807A Cr E11 Type 2 diabetes mellitus A E Z A PREDNISONE d00350A A M79.2 Neuralgia and neuritis, unspecified A E Z A PREGABALIN d05508A CDp M79.2 Neuralgia and neuritis, unspecified A E Z A SERTRALINE d00880A B F32.9 F41.9 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified A E [ A AMLODIPINE d00689A C I10 Essential (primary) hypertension A E [ A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A E [ A CETIRIZINE d03827A C T78.40 Allergy, unspecified A E [ A GABAPENTIN d03182A CDp M79.2 Neuralgia and neuritis, unspecified A E [ A HYDROCODONE d03075A CP M54 Dorsalgia A E [ A LEVOTHYROXINE d00278A C- E07.9 Disorder of thyroid, unspecified A E [ A TAMSULOSIN d04121A C- N40 Enlarged prostate A E [ A TRIAMTERENE d00396A CP I10 Essential (primary) hypertension A E [ A . . . E [ A . . . E [0 A . . . E [@ A ACETAMINOPHEN; HYDROCODONE d03428A C- M79.6 Pain in limb, hand, foot, fingers and toes A@ E [@ A HYDROCHLOROTHIAZIDE d00253A C R60.9 Edema, unspecified A@ E [@ A IBUPROFEN d00015A C M79.6 R51 Pain in limb, hand, foot, fingers and toes Headache A@ E [@ A PHENTERMINE d00806A C E66 Overweight and obesity A@ E [P A . . . E [` A AMITRIPTYLINE d00146A C M79.2 Neuralgia and neuritis, unspecified A E [` A DIAZEPAM d00148A B M62.83 Muscle spasm A E [p A ACETAMINOPHEN; BUTALBITAL; CAFFEINE d03455A Cr R51 Headache A E [p A ATORVASTATIN d04105A C E78.0P Prevent high cholesterol A E [p A CLONIDINE d00044A CDp I10 Essential (primary) hypertension A E [p A HYDRALAZINE d00132A C I10 Essential (primary) hypertension A E [p A LOSARTAN d03821A Cr I10 Essential (primary) hypertension A E [p A METOPROLOL d00134A C I10 Essential (primary) hypertension A E [p A NIFEDIPINE d00051A Cr I10 Essential (primary) hypertension A E [p A SPIRONOLACTONE d00373A C I10 Essential (primary) hypertension A E [ A . . . E [ A ALBUTEROL; IPRATROPIUM d04066A C R06.9P Prevent breathing difficulty A E [ A AMLODIPINE d00689A C- 99999 A E [ A CILOSTAZOL d04382A Cr 99999 A E [ A FLUTICASONE NASAL d04283A C T78.40 Allergy, unspecified A E [ A METOPROLOL d00134A CDp 99999 A E [ A PANTOPRAZOLE d04514A C- R12 Heartburn A E [ A PRAZOSIN d00138A Cr G47.9 Sleep disorder, unspecified A E [ A TIOTROPIUM d04829A CDp J44.9 J45 Chronic obstructive pulmonary disease, unspecified Asthma A E [ A VENLAFAXINE d03181A C F43.1 Post-traumatic stress disorder (PTSD) A E [ A . . . E [ A ACETAMINOPHEN; BUTALBITAL; CAFFEINE d03455A C G43 Migraine Ap E [ A ACETAMINOPHEN; CODEINE d03423A C G43 Migraine Ap E [ A CLINDAMYCIN d00043A A L08.9 Local infection of the skin and subcutaneous tissue, unspecified Ap E [ A IMIPRAMINE d00259A C"0 G43 Migraine Ap E [ A METHYLPHENIDATE d00900A Bz F90 Attention-deficit hyperactivity disorders Ap E [ A METHYLPHENIDATE d00900A Bz F90 Attention-deficit hyperactivity disorders Ap E [ A VENLAFAXINE d03181A B G43.P Prevent migraine Ap E [ A . . . E [ A OSPEMIFENE d08070A C[@ N95 Menopausal and other perimenopausal disorders A E [ A . . . E [ A . . . E \ A . . . E \ A . . . E \ A . . . E \0 A PANTOPRAZOLE d04514A C K21 Gastro-esophageal reflux disease A0 E \0 A SERTRALINE d00880A C[@ F41.9 Anxiety disorder, unspecified A0 E \0 A TOPIRAMATE d04115A C G43 Migraine A0 E \@ A MONTELUKAST d04289A Bz J30.9 J45 R06.2 Allergic rhinitis, unspecified Asthma Wheezing A E \@ A SERTRALINE d00880A C F32.9 F39 F41.9 Major depressive disorder, single episode, unspecified Unspecified mood [affective] disorder Anxiety disorder, unspecified A E \P A LETROZOLE d04156A A0 C50 Malignant neoplasm of breast A E \P A VENLAFAXINE d03181A CDp F32.9 Major depressive disorder, single episode, unspecified A E \` A 99999 . . A E \` A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified A E \p A GLIPIZIDE d00246A CDp E11 Type 2 diabetes mellitus A0 E \p A METFORMIN d03807A CDp E11 Type 2 diabetes mellitus A0 E \p A ROSUVASTATIN d04851A CDp E78.0 Pure hypercholesterolemia A0 E \ A . . . E \ A ALENDRONATE d03849A C- M81 Osteoporosis without current pathological fracture A E \ A ALPRAZOLAM d00168A C- F41.9 Anxiety disorder, unspecified A E \ A AMITRIPTYLINE d00146A C G47.0 Insomnia A E \ A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A E \ A BUPROPION d00181A C F32.9 F41.9 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified A E \ A CITALOPRAM d04332A C F32.9 F41.9 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified A E \ A CYCLOBENZAPRINE d00963A B M62.83 Muscle spasm A E \ A DICYCLOMINE d00999A C- K58 Irritable bowel syndrome A E \ A DIVALPROEX SODIUM d03833A C G43 Migraine A E \ A DULOXETINE d05355A A R25.1 Tremor, unspecified A E \ A INDOMETHACIN d00039A A M19.9 Osteoarthritis, unspecified site A E \ A METOCLOPRAMIDE d00298A C K21 Gastro-esophageal reflux disease A E \ A PANTOPRAZOLE d04514A C K30 Functional dyspepsia A E \ A TIMOLOL OPHTHALMIC d04037A C- H40 Glaucoma A E \ A OLOPATADINE OPHTHALMIC d04117A C"0 H10.1 Acute atopic conjunctivitis A E \ A . . . E \ A . . . E \ A . . . E \ A CARVEDILOL d03847A D I10 Essential (primary) hypertension A0 E \ A LOSARTAN d03821A D I10 Essential (primary) hypertension A0 E \ A ROSUVASTATIN d04851A D E78.0 Pure hypercholesterolemia A0 E \ A . . . E ] A . . . E ] A . . . E ] A . . . E ]0 A . . . E ]@ A . . . E ]P A . . . E ]` A . . . E ]p A MEDROXYPROGESTERONE d00284A D ^ G43 N92 Migraine Excessive, frequent and irregular menstruation A E ] A . . . E ] A ALBUTEROL d00749A D J45 Asthma A E ] A FLUNISOLIDE d00761A C J45 Asthma A E ] A BREXPIPRAZOLE d08373A B F20 F31.9 F32.9 Schizophrenia Bipolar disorder, unspecified Major depressive disorder, single episode, unspecified A@ E ] A BUPROPION d00181A B R53 Malaise and fatigue A@ E ] A PALIPERIDONE d06297A B F31.9 Bipolar disorder, unspecified A@ E ] A TRAZODONE d00395A B F32.9 Major depressive disorder, single episode, unspecified A@ E ] A CYCLOBENZAPRINE d00963A C M79.1 Myalgia A E ] A ESCITALOPRAM d04812A CO F32.9 F90 Major depressive disorder, single episode, unspecified Attention-deficit hyperactivity disorders A E ] A ESTRADIOL d00537A D Z79.890 Hormone replacement therapy A E ] A FUROSEMIDE d00070A C I51.9 Heart disease, unspecified A E ] A NADOLOL d00018A C G43.P Prevent migraine A E ] A PANTOPRAZOLE d04514A CDp K21 Gastro-esophageal reflux disease A E ] A POTASSIUM CHLORIDE d00345A CP E87.6 Hypokalemia A E ] A ROSUVASTATIN d04851A B= E78.0 Pure hypercholesterolemia A E ] A . . . E ] A . . . E ] A . . . E ] A AMOXICILLIN d00088A A H66.9 Otitis media, unspecified A E ^ A . . . E ^ A . . . E ^ A HYDROCHLOROTHIAZIDE d00253A A I10 Essential (primary) hypertension A0 E ^ A MORPHINE d00308A A R45 Symptoms and signs involving emotional state A0 E ^ A NITROGLYCERIN d00321A A I10 I21.P Essential (primary) hypertension Prevent heart attack/myocardial infarction A0 E ^0 A . . . E ^@ A METOPROLOL d00134A Cr I48.9 Unspecified atrial fibrillation and atrial flutter A E ^@ A PANTOPRAZOLE d04514A Cr K21 Gastro-esophageal reflux disease A E ^P A . . . E ^` A . . . E ^p A . . . E ^ A ALBUTEROL d00749A C J45 Asthma A` E ^ A AMITRIPTYLINE d00146A C[@ G47.0 Insomnia A` E ^ A APIXABAN d07804A A D75.9P Prevent blood clots A` E ^ A CLONIDINE d00044A CDp I10 Essential (primary) hypertension A` E ^ A METFORMIN d03807A CDp E11 Type 2 diabetes mellitus A` E ^ A NIFEDIPINE d00051A C- I10 Essential (primary) hypertension A` E ^ A SULFAMETHOXAZOLE; TRIMETHOPRIM d00124A Ap J09 Influenza due to certain identified influenza viruses A E ^ A . . . E ^ A 77777 . . A E ^ A . . . E ^ A . . . E ^ A . . . E ^ A BUSPIRONE d00182A C F32.9 F41.9 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified Ap E ^ A ETHINYL ESTRADIOL; NORETHINDRONE d03238A C N92 Excessive, frequent and irregular menstruation Ap E ^ A LEVOTHYROXINE d00278A B E03.9 Hypothyroidism, unspecified Ap E ^ A OXCARBAZEPINE d04513A Cr F32.9 G40 Major depressive disorder, single episode, unspecified Epilepsy and recurrent seizures Ap E ^ A OXYBUTYNIN d00328A CDp R32 Unspecified urinary incontinence Ap E ^ A PANTOPRAZOLE d04514A C K21 Gastro-esophageal reflux disease Ap E ^ A SERTRALINE d00880A Cr F33.9 Major depressive disorder, recurrent, unspecified Ap E _ A . . . E _ A . . . E _ A DULOXETINE d05355A B M79.1 Myalgia A E _ A LEFLUNOMIDE d04349A C M06.9 Rheumatoid arthritis, unspecified A E _0 A ATORVASTATIN d04105A B E78.0 Pure hypercholesterolemia A E _0 A OMEPRAZOLE d00325A C K21 Gastro-esophageal reflux disease A E _@ A . . . E _P A ALLOPURINOL d00023A D M1A Chronic gout AP E _P A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia AP E _P A CLOPIDOGREL d04258A C D75.9P Prevent blood clots AP E _P A METFORMIN d03807A C E11 Type 2 diabetes mellitus AP E _P A METOPROLOL d00134A D I10 Essential (primary) hypertension AP E _` A . . . E _p A . . . E _ A ALBUTEROL d00749A0 C J45 Asthma A E _ A AMITRIPTYLINE d00146A0 DGJ F32.9 F41.9 G47.0 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified Insomnia A E _ A DIGOXIN d00210A0 Cr I50.9 Heart failure, unspecified A E _ A ESCITALOPRAM d04812A C[@ F41.9 Anxiety disorder, unspecified A E _ A FAMOTIDINE d00141A0 C K21 Gastro-esophageal reflux disease A E _ A LEVOTHYROXINE d00278A0 C[@ E07.9 Disorder of thyroid, unspecified A E _ A METOPROLOL d00134A0 Cr I50.9 Heart failure, unspecified A E _ A OLODATEROL; TIOTROPIUM d08362A0 C- J44.9 Chronic obstructive pulmonary disease, unspecified A E _ A SIMVASTATIN d00746A0 C[@ E78.0 Pure hypercholesterolemia A E _ A SPIRONOLACTONE d00373A0 Cr N18.9 Chronic kidney disease, unspecified A E _ A THEOPHYLLINE d00142A0 C- J44.9 Chronic obstructive pulmonary disease, unspecified A E _ A ANTIHISTAMINES - UNSPECIFIED c00123A C P T78.40 Allergy, unspecified A E _ A . . . E _ A . . . E _ A . . . E _ A . . . E _ A LEVOTHYROXINE d00278A D E03.9 Hypothyroidism, unspecified A E _ A . . . E ` A . . . E ` A . . . E ` A . . . E `0 A . . . E `@ A ETHINYL ESTRADIOL; NORGESTIMATE d03781A Bz Z79.3 Long term (current) use of hormonal contraceptives A E `P A . . . E `` A . . . E `p A ACYCLOVIR d00001A C"0 B00.1 Herpesviral vesicular dermatitis A E ` A . . . E ` A . . . E ` A . . . E ` A . . . E ` A . . . E ` A . . . E ` A METOPROLOL d00134A CDp I10 Essential (primary) hypertension A E ` A . . . E a A AMLODIPINE d00689A C- I10 Essential (primary) hypertension A E a A ATORVASTATIN d04105A C- E78.0 Pure hypercholesterolemia A E a A FUROSEMIDE d00070A C- R60.9 Edema, unspecified A E a A GABAPENTIN d03182A A M54 Dorsalgia A E a A HYDRALAZINE d00132A C- N28.9 Disorder of kidney and ureter, unspecified A E a A INSULIN ISOPHANE (NPH) d04370A C[@ E11 Type 2 diabetes mellitus A E a A LISINOPRIL d00732A C I10 Essential (primary) hypertension A E a A TENOFOVIR d04774A C- B19 Unspecified viral hepatitis A E a A . . . E a A . . . E a0 A CYCLOSPORINE OPHTHALMIC d04836A B= H04 Disorders of lacrimal system AP E a0 A LORAZEPAM d00149A B[ F41.9 Anxiety disorder, unspecified AP E a0 A MELOXICAM d04532A B[ M06.9 M19.9 Rheumatoid arthritis, unspecified Osteoarthritis, unspecified site AP E a0 A OLOPATADINE OPHTHALMIC d04117A B H40 Glaucoma AP E a0 A TRAZODONE d00395A C G47.0 Insomnia AP E a@ A . . . E aP A . . . E a` A ALBUTEROL d00749A CP J45 Asthma A E a` A MONTELUKAST d04289A CDp J45 Asthma A E ap A ETHINYL ESTRADIOL; LEVONORGESTREL d03242A B[ E28 N92 Ovarian dysfunction Excessive, frequent and irregular menstruation A E a A . . . E a A . . . E a A . . . E a A GABAPENTIN d03182A CDp M79.2 Neuralgia and neuritis, unspecified A0 E a A LISINOPRIL d00732A C I10 Essential (primary) hypertension A0 E a A METOPROLOL d00134A C I10 Essential (primary) hypertension A0 E a A . . . E a A IBUPROFEN d00015A C M79.2 Neuralgia and neuritis, unspecified A E a A . . . E a A . . . E b A . . . E b A 99999 . . A E b A . . . E b0 A OXCARBAZEPINE d04513A C G40 Epilepsy and recurrent seizures A E b0 A SULFAMETHOXAZOLE; TRIMETHOPRIM d00124A A L08.9 Local infection of the skin and subcutaneous tissue, unspecified A E b@ A . . . E bP A FLUTICASONE NASAL d04283A CDp J30.9 Allergic rhinitis, unspecified A E bP A METHYLPREDNISOLONE d00293A A@ M25.9 R60.9 Joint disorder, unspecified Edema, unspecified A E b` A . . . E bp A . . . E b A BETAMETHASONE; CLOTRIMAZOLE TOPICAL d03561A C- B35 Dermatophytosis A0 E b A CLOTRIMAZOLE TOPICAL d04395A C L40 Psoriasis A0 E b A ETHINYL ESTRADIOL; LEVONORGESTREL d03242A C- N92 Excessive, frequent and irregular menstruation A0 E b A AZITHROMYCIN d00091A Ap J00 J09 Acute nasopharyngitis [common cold] Influenza due to certain identified influenza viruses A E b A AMOXICILLIN d00088A A H66.9 Otitis media, unspecified A E b A ENALAPRIL; HYDROCHLOROTHIAZIDE d03740A D I10 Essential (primary) hypertension A E b A MELOXICAM d04532A C M19.9 Osteoarthritis, unspecified site A E b A AMITRIPTYLINE d00146A D M79.7 Fibromyalgia AP E b A METOPROLOL d00134A B I10 Essential (primary) hypertension AP E b A PREDNISONE d00350A A@ M19.9 Osteoarthritis, unspecified site AP E b A SERTRALINE d00880A C F32.9 Major depressive disorder, single episode, unspecified AP E b A SIMVASTATIN d00746A B= E78.0 Pure hypercholesterolemia AP E b A . . . E b A MELOXICAM d04532A A M54 Dorsalgia A E b A ALCLOMETASONE TOPICAL d01282A A@ L20.9 Atopic dermatitis, unspecified A E c A . . . E c A . . . E c A LISINOPRIL d00732A C[@ I10 Essential (primary) hypertension A E c0 A ETHINYL ESTRADIOL; NORGESTIMATE d03781A D L70 N94 Z79.3 Acne Pain and other conditions associated with female genital organs and menstrual cycle Long term (current) use of hormonal contraceptives A E c@ A AMLODIPINE d00689A C I10 Essential (primary) hypertension A E cP A ATENOLOL d00004A Cr I10 I20.9 Essential (primary) hypertension Angina pectoris, unspecified A@ E cP A ATORVASTATIN d04105A Cr E78.0 Pure hypercholesterolemia A@ E cP A HYDROCHLOROTHIAZIDE d00253A Cr I10 Essential (primary) hypertension A@ E cP A LOSARTAN d03821A Cr I10 Essential (primary) hypertension A@ E c` A DILTIAZEM d00045A CP I48.9 Unspecified atrial fibrillation and atrial flutter A0 E c` A FLUOXETINE d00236A CDp F41.9 Anxiety disorder, unspecified A0 E c` A TRAZODONE d00395A C- F41.9 Anxiety disorder, unspecified A0 E cp A . . . E c A . . . E c A GLIPIZIDE d00246A0 Dc E11 Type 2 diabetes mellitus A E c A INSULIN GLARGINE d04538A0 Cr E11 Type 2 diabetes mellitus A E c A LATANOPROST OPHTHALMIC d04017A0 CDp H40 Glaucoma A E c A LOSARTAN d03821A0 CDp I10 Essential (primary) hypertension A E c A METFORMIN d03807A0 Dc E11 Type 2 diabetes mellitus A E c A METHOTREXATE d00060A0 D M06.9 Rheumatoid arthritis, unspecified A E c A METOPROLOL d00134A0 C I10 Essential (primary) hypertension A E c A OMEPRAZOLE d00325A0 Cr K21 Gastro-esophageal reflux disease A E c A SIMVASTATIN d00746A0 D E78.0 Pure hypercholesterolemia A E c A TAMSULOSIN d04121A0 C[@ R39.1 Other difficulties with micturition A E c A TRAZODONE d00395A C[@ G47.0 G47.9 Insomnia Sleep disorder, unspecified A E c A CETIRIZINE d03827A C- R06.2 T78.40 Wheezing Allergy, unspecified A E c A FLUTICASONE NASAL d04283A C- J30.2 Other seasonal allergic rhinitis A E c A FINASTERIDE d00563A D L65.9 Nonscarring hair loss, unspecified A E c A . . . E c A . . . E c A . . . E c A SERTRALINE d00880A CDp F41.9 Anxiety disorder, unspecified A E d A . . . E d A . . . E d A . . . E d0 Ap . . . E d@ A . . . E dP A . . . E d` A . . . E dp A METOPROLOL d00134A CDp I10 Essential (primary) hypertension A0 E dp A POTASSIUM CHLORIDE d00345A C- E87.6 Hypokalemia A0 E dp A QUETIAPINE d04220A C- G47.0 G47.9 Insomnia Sleep disorder, unspecified A0 E d A . . . E d A . . . E d A . . . E d A ALENDRONATE d03849A C[@ M81 Osteoporosis without current pathological fracture AP E d A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A C I10 Essential (primary) hypertension AP E d A LATANOPROST OPHTHALMIC d04017A D H40 Glaucoma AP E d A METHOTREXATE d00060A C M06.9 Rheumatoid arthritis, unspecified AP E d A PILOCARPINE OPHTHALMIC d01191A D H40 Glaucoma AP E d A PRAZOSIN d00138A C F43.1 Post-traumatic stress disorder (PTSD) A E d A . . . E d A . . . E d A RAMIPRIL d00728A C I10 Essential (primary) hypertension A E e A . . . E e A . . . E e A ALBUTEROL d00749A C J45 Asthma A E e A ALBUTEROL d00749A CDp J45 Asthma A E e0 A ALPRAZOLAM d00168A0 D* G47.0 Insomnia A E e0 A CARVEDILOL d03847A0 C- I21.P Prevent heart attack/myocardial infarction A E e0 A CLOPIDOGREL d04258A0 C- Z79.0 Long term (current) use of anticoagulants and antithrombotics/antiplatelets A E e0 A CYCLOSPORINE OPHTHALMIC d04836A0 Cr H04 Disorders of lacrimal system A E e0 A DOXAZOSIN d00726A0 Cr I10 Essential (primary) hypertension A E e0 A FINASTERIDE d00563A0 Cr N40 Enlarged prostate A E e0 A IPRATROPIUM NASAL d04235A0 C R09.81 Nasal congestion A E e0 A ISOSORBIDE DINITRATE d00268A0 CDp I25.9 Chronic ischemic heart disease, unspecified A E e0 A ROSUVASTATIN d04851A0 D9 E78.0 Pure hypercholesterolemia A E e@ A . . . E eP A . . . E e` A . . . E ep A . . . E e A . . . E e A ATORVASTATIN d04105A B M85.9 Disorder of bone density and structure, unspecified Ap E e A CYCLOBENZAPRINE d00963A C M54 Dorsalgia Ap E e A FLUOXETINE d00236A B F33.9 Major depressive disorder, recurrent, unspecified Ap E e A FUROSEMIDE d00070A C I50.9 Heart failure, unspecified Ap E e A MELOXICAM d04532A C M25.5 M54 Pain in joint Dorsalgia Ap E e A METOPROLOL d00134A C I10 I50.9 Essential (primary) hypertension Heart failure, unspecified Ap E e A TRAZODONE d00395A C G47.0 Insomnia Ap E e A . . . E e A AMLODIPINE d00689A B I10 Essential (primary) hypertension A E e A BUDESONIDE d04276A CDp K51 Ulcerative colitis A E e A CEPHALEXIN d00096A C"0 N39.0 Urinary tract infection, site not specified A E e A EZETIMIBE d04824A Cr E78.0 Pure hypercholesterolemia A E e A FERRIC CITRATE d08336A C[@ E83.3 Disorders of phosphorus metabolism and phosphatases A E e A FINASTERIDE d00563A C"0 N40 Enlarged prostate A E e A LOSARTAN d03821A C I10 Essential (primary) hypertension A E e A PAROXETINE d03157A B F32.9 F41.9 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified A E e A RANITIDINE d00021A B[ K21 Gastro-esophageal reflux disease A E e A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia A E e A TRAMADOL d03826A C M13 Other arthritis A E e A TRAZODONE d00395A C G47.0 Insomnia A E e A ALBUTEROL d00749A C R05 R06.2 Cough Wheezing A@ E e A AMOXICILLIN; CLAVULANATE d00089A A H66.9 J01.9 Otitis media, unspecified Acute sinusitis, unspecified A@ E e A BUDESONIDE d04276A B A49.9P J42 R05 Prevent bacterial infection Unspecified chronic bronchitis Cough A@ E e A CIPROFLOXACIN; DEXAMETHASONE OTIC d04890A C H60 Otitis externa A@ E e A AMOXICILLIN d00088A A@ K04.7 Periapical abscess without sinus A E e A ETHINYL ESTRADIOL; NORGESTIMATE d03781A B[ L70 Acne A E e A . . . E f A . . . E f A CITALOPRAM d04332A C F41.9 Anxiety disorder, unspecified A0 E f A HYOSCYAMINE d00985A Dc K58 Irritable bowel syndrome A0 E f A METOPROLOL d00134A C I10 Essential (primary) hypertension A0 E f A ALBUTEROL d00749A C[@ J45 Asthma A@ E f A AZELASTINE NASAL d04068A CDp T78.40 Allergy, unspecified A@ E f A BUDESONIDE; FORMOTEROL d04795A CDp R05 Cough A@ E f A FLUTICASONE NASAL d04283A CDp J30.2 Other seasonal allergic rhinitis A@ E f0 A . . . E f@ A . . . E fP A ALBUTEROL d00749A C J45 Asthma A` E fP A ALLOPURINOL d00023A C M1A Chronic gout A` E fP A AMLODIPINE d00689A C I10 Essential (primary) hypertension A` E fP A ATENOLOL; CHLORTHALIDONE d03258A C I10 Essential (primary) hypertension A` E fP A CETIRIZINE d03827A C- 99999 A` E fP A MELOXICAM d04532A C M54 M79.1 Dorsalgia Myalgia A` E f` A . . . E fp A . . . E f A AMLODIPINE d00689A C I10 Essential (primary) hypertension A` E f A ASPIRIN d00170A C I21.P Prevent heart attack/myocardial infarction A` E f A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A` E f A FUROSEMIDE d00070A C R60.9 Edema, unspecified A` E f A LISINOPRIL d00732A C I10 Essential (primary) hypertension A` E f A METOPROLOL d00134A C R00 Abnormalities of heart beat A` E f A . . . E f A . . . E f A . . . E f A ANTIHYPERLIPIDEMIC AGENTS - UNSPECIFIED c00019A B E78.0 Pure hypercholesterolemia A@ E f A FAMOTIDINE d00141A B I50.9 Heart failure, unspecified A@ E f A INSULIN DETEMIR d05436A B= E11 Type 2 diabetes mellitus A@ E f A LISINOPRIL d00732A B I10 Essential (primary) hypertension A@ E f A ATENOLOL d00004A C[@ R00 Abnormalities of heart beat A E f A FLUOXETINE d00236A C"0 F41.9 Anxiety disorder, unspecified A E f A LISINOPRIL d00732A C I10 Essential (primary) hypertension A E f A ATORVASTATIN d04105A CDp E78.0 Pure hypercholesterolemia A E f A CLOPIDOGREL d04258A C I21.P Prevent heart attack/myocardial infarction A E f A FUROSEMIDE d00070A C- R60.9 Edema, unspecified A E f A HYDRALAZINE d00132A C I10 Essential (primary) hypertension A E f A INSULIN ASPART d04697A C E11 Type 2 diabetes mellitus A E f A INSULIN GLARGINE d04538A C E11 Type 2 diabetes mellitus A E f A ISOSORBIDE MONONITRATE d00269A C R07.9 Chest pain, unspecified A E f A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified A E f A QUINAPRIL d00365A C I21.P Prevent heart attack/myocardial infarction A E f A RANITIDINE d00021A C K21 Gastro-esophageal reflux disease A E g A FEXOFENADINE d04040A C J30.9 Allergic rhinitis, unspecified Ap E g A LAMOTRIGINE d03809A B F31.9 F32.9 F41.9 Bipolar disorder, unspecified Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified Ap E g A MONTELUKAST d04289A B J30.9 Allergic rhinitis, unspecified Ap E g A PANTOPRAZOLE d04514A CDp K31.9 Disease of stomach and duodenum, unspecified Ap E g A PHENTERMINE d00806A B( E66 Overweight and obesity Ap E g A PREGABALIN d05508A C M79.7 Fibromyalgia Ap E g A TOPIRAMATE d04115A C- G43 Migraine Ap E g A AMPHETAMINE; DEXTROAMPHETAMINE d04035A C9 F90 Attention-deficit hyperactivity disorders A E g A CETIRIZINE d03827A C J30.2 T78.40 Other seasonal allergic rhinitis Allergy, unspecified A E g A . . . E g0 A AMIODARONE d00002A D I49.9 Cardiac arrhythmia, unspecified A E g0 A ATORVASTATIN d04105A CDp 99999 A E g0 A CLOPIDOGREL d04258A C 99999 A E g0 A DAPAGLIFLOZIN d07928A C E11 Type 2 diabetes mellitus A E g0 A GLIPIZIDE d00246A C[@ E11 Type 2 diabetes mellitus A E g0 A LEVOTHYROXINE d00278A C- 99999 A E g0 A LINACLOTIDE d07902A C K59.0 Constipation A E g0 A LINAGLIPTIN d07767A C E11 Type 2 diabetes mellitus A E g0 A LOSARTAN d03821A C 99999 A E g0 A METOPROLOL d00134A C R00 Abnormalities of heart beat A E g0 A OMEPRAZOLE d00325A Dc K21 Gastro-esophageal reflux disease A E g0 A POTASSIUM CHLORIDE d00345A D E87.6 Hypokalemia A E g0 A RIVAROXABAN d07356A D D75.9P Prevent blood clots A E g0 A TIZANIDINE d04102A C 99999 A E g0 A TRAMADOL d03826A C M25.5 M54 Pain in joint Dorsalgia A E g@ A . . . E gP A METOPROLOL d00134A C I10 Essential (primary) hypertension A E g` A . . . E gp A ALBUTEROL d00749A B R06.9P Prevent breathing difficulty A E g A CLOPIDOGREL d04258A0 C I63 Cerebral infarction Ap E g A DILTIAZEM d00045A0 C I10 I63 Essential (primary) hypertension Cerebral infarction Ap E g A FINASTERIDE d00563A0 D1 N40 Enlarged prostate Ap E g A LISINOPRIL d00732A0 C I10 I63.P Essential (primary) hypertension Prevent stroke Ap E g A PANTOPRAZOLE d04514A0 C- K21 Gastro-esophageal reflux disease Ap E g A PRAVASTATIN d00348A0 C- E78.0 Pure hypercholesterolemia Ap E g A TAMSULOSIN d04121A0 C- N40 Enlarged prostate Ap E g A FENOFIBRATE d04286A Cr E78.1 Pure hyperglyceridemia A E g A LOSARTAN d03821A Ap I10 Essential (primary) hypertension A E g A . . . E g A CANAGLIFLOZIN d08080A B= E11 Type 2 diabetes mellitus A E g A GLIPIZIDE d00246A C E11 Type 2 diabetes mellitus A E g A HYDROCHLOROTHIAZIDE d00253A C R60.9 Edema, unspecified A E g A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified A E g A LISINOPRIL d00732A C E11.2P I10 Prevent diabetic kidney disease Essential (primary) hypertension A E g A METFORMIN d03807A C E11 Type 2 diabetes mellitus A E g A METOPROLOL d00134A C I10 I21.P Essential (primary) hypertension Prevent heart attack/myocardial infarction A E g A TIOTROPIUM d04829A B[ J44.9 Chronic obstructive pulmonary disease, unspecified A E g A . . . E g A AMLODIPINE d00689A C[@ I10 Essential (primary) hypertension A@ E g A DONEPEZIL d04099A C[@ R41 Other symptoms and signs involving cognitive functions and awareness A@ E g A LOSARTAN d03821A C[@ I10 Essential (primary) hypertension A@ E g A MEMANTINE d04899A C[@ R41 Other symptoms and signs involving cognitive functions and awareness A@ E g A . . . E g A ACETAMINOPHEN; HYDROCODONE d03428A A M54 Dorsalgia A E g A ENALAPRIL d00013A Cr I10 Essential (primary) hypertension A E g A ESOMEPRAZOLE d04749A C K21 Gastro-esophageal reflux disease A E g A EZETIMIBE d04824A CDp E78.0 Pure hypercholesterolemia A E g A LORAZEPAM d00149A B F41.9 Anxiety disorder, unspecified A E g A MELOXICAM d04532A B M54 Dorsalgia A E g A METHOCARBAMOL d00965A B M54 Dorsalgia A E g A SERTRALINE d00880A C F32.9 Major depressive disorder, single episode, unspecified A E h A . . . E h A ACETAMINOPHEN; CODEINE d03423A Ap T14.9 Unspecified injury A E h A IBUPROFEN d00015A A0 T14.9 Unspecified injury A E h A IBUPROFEN d00015A C M25.5 M79.1 Pain in joint Myalgia A E h A RANITIDINE d00021A B K30 Functional dyspepsia A E h0 A IBUPROFEN d00015A B M25.5 Pain in joint A E h@ A . . . E hP A METHIMAZOLE d00290A B[ E07.9 Disorder of thyroid, unspecified A@ E hP A METOPROLOL d00134A CDp R00 Abnormalities of heart beat A@ E hP A ROSUVASTATIN d04851A B[ E78.0 Pure hypercholesterolemia A@ E hP A VENLAFAXINE d03181A C- F41.9 Anxiety disorder, unspecified A@ E h` A . . . E hp A ATORVASTATIN d04105A0 Ei E78.0 Pure hypercholesterolemia A` E hp A CANNABIS d03879A C G20 Parkinson's disease A` E hp A CARBIDOPA; LEVODOPA d03473A0 C G20 Parkinson's disease A` E hp A METOPROLOL d00134A0 Ei I10 Essential (primary) hypertension A` E hp A MONTELUKAST d04289A0 Ei J45 Asthma A` E hp A OMEPRAZOLE d00325A0 Ei K21 Gastro-esophageal reflux disease A` E h A . . . E h A ETHINYL ESTRADIOL; NORGESTREL d03241A C N92 Excessive, frequent and irregular menstruation A0 E h A LISDEXAMFETAMINE d06663A C- F90 Attention-deficit hyperactivity disorders A0 E h A NAPROXEN d00019A C N94 Pain and other conditions associated with female genital organs and menstrual cycle A0 E h A . . . E h A . . . E h A . . . E h A LEVOTHYROXINE d00278A Dc E03.9 Hypothyroidism, unspecified A0 E h A MELOXICAM d04532A D M13 Other arthritis A0 E h A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia A0 E h A . . . E h A ALBUTEROL d00749A D 55555 A E i A . . . E i A ALLOPURINOL d00023A D M1A Chronic gout AP E i A COLCHICINE d00150A Dc M1A Chronic gout AP E i A FLUDROCORTISONE d00608A D= E07.9 Disorder of thyroid, unspecified AP E i A LEVOTHYROXINE d00278A D E03.9 Hypothyroidism, unspecified AP E i A ROSUVASTATIN d04851A B E78.0 Pure hypercholesterolemia AP E i A . . . E i0 A 99999 . . A E i@ A . . . E iP A ATORVASTATIN d04105A C 99999 A` E iP A INSULIN GLARGINE d04538A C"0 E11 Type 2 diabetes mellitus A` E iP A LEVOTHYROXINE d00278A C[@ E03.9 Hypothyroidism, unspecified A` E iP A LOSARTAN d03821A C 99999 A` E iP A METFORMIN d03807A C E11 Type 2 diabetes mellitus A` E iP A PANTOPRAZOLE d04514A C- 99999 A` E i` A . . . E ip A ATORVASTATIN d04105A B[ E78.0 Pure hypercholesterolemia Ap E ip A GLIMEPIRIDE d03864A C[@ E11 Type 2 diabetes mellitus Ap E ip A HYDROCHLOROTHIAZIDE; VALSARTAN d04293A C- I10 Essential (primary) hypertension Ap E ip A METFORMIN d03807A C[@ E11 Type 2 diabetes mellitus Ap E ip A METOPROLOL d00134A C I49.9 R00 Cardiac arrhythmia, unspecified Abnormalities of heart beat Ap E ip A PRAMIPEXOLE d04145A C G25.81 Restless legs syndrome Ap E ip A SITAGLIPTIN d05896A C- E11 Type 2 diabetes mellitus Ap E i A APIXABAN d07804A C D75.9P I48.9 Prevent blood clots Unspecified atrial fibrillation and atrial flutter A` E i A ATORVASTATIN d04105A C 99999 A` E i A CLINDAMYCIN d00043A D K04.7 Periapical abscess without sinus A` E i A DIGOXIN d00210A C I48.9 Unspecified atrial fibrillation and atrial flutter A` E i A FINASTERIDE d00563A C[@ 99999 A` E i A SOLIFENACIN d05413A C[@ R35 Polyuria A` E i A . . . E i A . . . E i A . . . E i A ATORVASTATIN d04105A C- E78.0 Pure hypercholesterolemia A0 E i A LEVOTHYROXINE d00278A C- E03.9 Hypothyroidism, unspecified A0 E i A METFORMIN d03807A CDp E11 Type 2 diabetes mellitus A0 E i A . . . E i A . . . E i A ALPRAZOLAM d00168A C- F41.9 Anxiety disorder, unspecified A@ E i A BUPROPION d00181A B F32.9 Major depressive disorder, single episode, unspecified A@ E i A PANTOPRAZOLE d04514A C- K21 Gastro-esophageal reflux disease A@ E i A ZOLPIDEM d00910A B= G47.0 Insomnia A@ E j A . . . E j A ALLOPURINOL d00023A CDp M1A Chronic gout A E j A ATORVASTATIN d04105A C9 E78.0 Pure hypercholesterolemia A E j A CARISOPRODOL d00960A C- M54 M62.83 Dorsalgia Muscle spasm A E j A CHLORTHALIDONE d00192A C"0 I10 Essential (primary) hypertension A E j A ESTRADIOL d00537A C M81 Osteoporosis without current pathological fracture A E j A FUROSEMIDE d00070A D* I10 R60.9 Essential (primary) hypertension Edema, unspecified A E j A HYDROCHLOROTHIAZIDE d00253A C"0 I10 I49.9 Essential (primary) hypertension Cardiac arrhythmia, unspecified A E j A LEVOTHYROXINE d00278A B E03.9 Hypothyroidism, unspecified A E j A NAPROXEN d00019A C"0 M19.9 M25.5 M54 Osteoarthritis, unspecified site Pain in joint Dorsalgia A E j A NEBIVOLOL d05265A B I49.9 R00 Cardiac arrhythmia, unspecified Abnormalities of heart beat A E j A OMEPRAZOLE d00325A C"0 K21 K30 Gastro-esophageal reflux disease Functional dyspepsia A E j A PREGABALIN d05508A C[@ M79.2 Neuralgia and neuritis, unspecified A E j A RANITIDINE d00021A C"0 K30 Functional dyspepsia A E j A TRAMADOL d03826A C M25.5 Pain in joint A E j A BRIMONIDINE; TIMOLOL OPHTHALMIC d05283A C- H40 Glaucoma A@ E j A BRINZOLAMIDE OPHTHALMIC d04301A B H40 Glaucoma A@ E j A BUPROPION d00181A C F32.9 Major depressive disorder, single episode, unspecified A@ E j A TRAVOPROST OPHTHALMIC d04753A C- H40 Glaucoma A@ E j0 A AMLODIPINE d00689A C I10 Essential (primary) hypertension AP E j0 A FEBUXOSTAT d07397A CDp E79.9 Disorder of purine and pyrimidine metabolism, unspecified AP E j0 A GABAPENTIN d03182A B M10.9 Gout, unspecified AP E j0 A PRAMIPEXOLE d04145A B G25.81 Restless legs syndrome AP E j0 A PRAVASTATIN d00348A C E78.0 Pure hypercholesterolemia AP E j@ A . . . E jP A AMLODIPINE d00689A D& I10 Essential (primary) hypertension AP E jP A LEVOTHYROXINE d00278A D& E04 Other nontoxic goiter AP E jP A LOSARTAN d03821A D= I10 Essential (primary) hypertension AP E jP A METOPROLOL d00134A D& I10 Essential (primary) hypertension AP E jP A OMEPRAZOLE d00325A D K21 Gastro-esophageal reflux disease AP E j` A CARVEDILOL d03847A Cr I10 Essential (primary) hypertension A E j` A DILTIAZEM d00045A C I10 Essential (primary) hypertension A E j` A FLUTICASONE NASAL d04283A C[@ J30.9 R09.81 Allergic rhinitis, unspecified Nasal congestion A E j` A HYDROCHLOROTHIAZIDE; LOSARTAN d03830A C I10 Essential (primary) hypertension A E j` A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified A E j` A MELOXICAM d04532A Cr M19.9 Osteoarthritis, unspecified site A E j` A OMEPRAZOLE d00325A C K21 K46 Gastro-esophageal reflux disease Unspecified abdominal hernia A E j` A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia A E jp A . . . E j A . . . E j A . . . E j A . . . E j A . . . E j A . . . E j A . . . E j A . . . E j A . . . E k A ATORVASTATIN d04105A B E78.0 Pure hypercholesterolemia AP E k A FINASTERIDE d00563A C- N40 R39.1 Enlarged prostate Other difficulties with micturition AP E k A LOSARTAN d03821A B I10 Essential (primary) hypertension AP E k A METFORMIN d03807A D R73 Elevated blood glucose level AP E k A METOPROLOL d00134A D I10 Essential (primary) hypertension AP E k A . . . E k A . . . E k0 A . . . E k@ A . . . E kP A CLONAZEPAM d00197A C F41.9 Anxiety disorder, unspecified A@ E kP A LISINOPRIL d00732A C I10 Essential (primary) hypertension A@ E kP A LOVASTATIN d00280A C- E78.0 Pure hypercholesterolemia A@ E kP A METFORMIN; SITAGLIPTIN d06720A CP E11 Type 2 diabetes mellitus A@ E k` A AMLODIPINE d00689A AP I10 Essential (primary) hypertension A E kp A HYDROCHLOROTHIAZIDE; TRIAMTERENE d03052A D I10 Essential (primary) hypertension A E kp A NIFEDIPINE d00051A D I10 Essential (primary) hypertension A E k A AMOXICILLIN d00088A A H66.9 Otitis media, unspecified A E k A CETIRIZINE d03827A C"0 T78.40 Allergy, unspecified A E k A . . . E k A AMLODIPINE d00689A C I10 Essential (primary) hypertension A@ E k A CARVEDILOL d03847A C I48.9 Unspecified atrial fibrillation and atrial flutter A@ E k A FUROSEMIDE d00070A C I51.9 Heart disease, unspecified A@ E k A LOSARTAN d03821A C I10 Essential (primary) hypertension A@ E k A . . . E k A . . . E k A BRIMONIDINE OPHTHALMIC d04048A CDp H40 Glaucoma A@ E k A DORZOLAMIDE OPHTHALMIC d03805A CDp H40 Glaucoma A@ E k A LATANOPROST OPHTHALMIC d04017A CDp H40 Glaucoma A@ E k A THYROID DESICCATED d00655A CDp E07.9 Disorder of thyroid, unspecified A@ E k A 77777 . . A E l A PROPYLTHIOURACIL d00361A B E05 Thyrotoxicosis [hyperthyroidism] A E l A NAPROXEN d00019A C R51 Headache A E l A CETIRIZINE d03827A B T78.40 Allergy, unspecified A0 E l A DEXMETHYLPHENIDATE d04777A B F90 Attention-deficit hyperactivity disorders A0 E l A FLUTICASONE NASAL d04283A C J30.2 Other seasonal allergic rhinitis A0 E l0 A . . . E l@ A . . . E lP A ATENOLOL d00004A D& I10 Essential (primary) hypertension A` E lP A GABAPENTIN d03182A Cr M79.2 Neuralgia and neuritis, unspecified A` E lP A HYDROCHLOROTHIAZIDE d00253A D& I10 Essential (primary) hypertension A` E lP A LISINOPRIL d00732A D& I10 Essential (primary) hypertension A` E lP A TRAZODONE d00395A C G47.0 Insomnia A` E lP A ZOLPIDEM d00910A CDp G47.9 Sleep disorder, unspecified A` E l` A . . . E lp A MELOXICAM d04532A C M19.9 Osteoarthritis, unspecified site A E l A . . . E l A . . . E l A . . . E l A . . . E l A LISINOPRIL d00732A Cr I50.9 Heart failure, unspecified A E l A . . . E l A HYDROCHLOROTHIAZIDE d00253A C I10 Essential (primary) hypertension A E l A . . . E m A PREDNISOLONE OPHTHALMIC d03221A B H57.9 Unspecified disorder of eye and adnexa A E m A DEXAMETHASONE; NEOMYCIN; POLYMYXIN B OPHTHALMIC d03537A B H57.9 Unspecified disorder of eye and adnexa A E m A LEVONORGESTREL d00557A CDp Z79.3 Long term (current) use of hormonal contraceptives A E m A DEXTROAMPHETAMINE d00804A D F90 Attention-deficit hyperactivity disorders A E m0 A LEVOTHYROXINE d00278A D E03.9 Hypothyroidism, unspecified A E m@ A MINOCYCLINE d00110A B[ L70 Acne A E mP A 99999 . . A E m` A . . . E mp A ALBUTEROL d00749A Ei R06.9 Unspecified abnormalities of breathing A E mp A AMLODIPINE d00689A0 Ei I10 Essential (primary) hypertension A E mp A ATENOLOL d00004A0 Ei I10 Essential (primary) hypertension A E mp A CLONIDINE d00044A0 Ei I10 Essential (primary) hypertension A E mp A FUROSEMIDE d00070A0 Ei I10 Essential (primary) hypertension A E mp A HYDRALAZINE d00132A0 Ei I10 Essential (primary) hypertension A E mp A IPRATROPIUM d00265A0 DGJ R06.9 Unspecified abnormalities of breathing A E mp A ISOSORBIDE MONONITRATE d00269A0 Ei I10 Essential (primary) hypertension A E mp A LOVASTATIN d00280A Ei E78.0 Pure hypercholesterolemia A E mp A VALSARTAN d04113A0 Ei I10 Essential (primary) hypertension A E m A . . . E m A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia AP E m A DABIGATRAN d07137A C- D75.9P I49.9 Prevent blood clots Cardiac arrhythmia, unspecified AP E m A FINASTERIDE d00563A Cr N40 Enlarged prostate AP E m A LISINOPRIL d00732A C I10 Essential (primary) hypertension AP E m A PANTOPRAZOLE d04514A B= K30 Functional dyspepsia AP E m A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A@ E m A LEVOTHYROXINE d00278A C[@ E03.9 Hypothyroidism, unspecified A@ E m A TRAZODONE d00395A C- G47.0 Insomnia A@ E m A VENLAFAXINE d03181A C F32.9 F41.9 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified A@ E m A ALBUTEROL d00749A C J45 Asthma A0 E m A CETIRIZINE d03827A C T78.40 Allergy, unspecified A0 E m A MONTELUKAST d04289A C J45 Asthma A0 E m A ALBUTEROL d00749A C J45 Asthma A E m A . . . E m A . . . E m A LEVOTHYROXINE d00278A D E03.9 Hypothyroidism, unspecified A E n A AZELAIC ACID TOPICAL d03848A C- L70 Acne A E n A ETHINYL ESTRADIOL; NORETHINDRONE d03238A C- N92 Excessive, frequent and irregular menstruation A E n A NIFEDIPINE d00051A B I10 Essential (primary) hypertension A E n A 99999 . . A E n0 A INSULIN LISPRO d04373A C E11 Type 2 diabetes mellitus A E n@ A . . . E nP A BUPROPION d00181A A F32.9 Major depressive disorder, single episode, unspecified A0 E nP A METFORMIN d03807A Cr 55555 A0 E nP A ROPINIROLE d04215A C G25.81 Restless legs syndrome A0 E n` A . . . E np A AMOXICILLIN d00088A Ap K04.7P Prevent tooth infection A E np A IBUPROFEN d00015A Ap K08.8 Z48.8 Other specified disorders of teeth and supporting structures Encounter for other specified postprocedural aftercare A E n A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A0 E n A DEXTRANOMER; SODIUM HYALURONATE d08128A C- H04 Disorders of lacrimal system A0 E n A LISINOPRIL d00732A C- I10 Essential (primary) hypertension A0 E n A ACYCLOVIR d00001A C- B34.9P Prevent viral infection A E n A BUDESONIDE d04276A B R06.9 Unspecified abnormalities of breathing A E n A GABAPENTIN d03182A C- M79.2 Neuralgia and neuritis, unspecified A E n A HYDROCHLOROTHIAZIDE; TRIAMTERENE d03052A Dc I10 Essential (primary) hypertension A E n A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified A E n A METOPROLOL d00134A Dc I10 Essential (primary) hypertension A E n A OMEPRAZOLE d00325A Ei K21 Gastro-esophageal reflux disease A E n A TRAMADOL d03826A C[@ M79.2 Neuralgia and neuritis, unspecified A E n A . . . E n A METOPROLOL d00134A D I48.9 Unspecified atrial fibrillation and atrial flutter A E n A . . . E n A FENOFIBRATE d04286A CDp E78.0 Pure hypercholesterolemia A E n A METFORMIN d03807A CDp E11 Type 2 diabetes mellitus A E n A . . . E n A . . . E o A HYDROCHLOROTHIAZIDE d00253A C I10 Essential (primary) hypertension A E o A LISINOPRIL d00732A C I10 Essential (primary) hypertension A E o A . . . E o A . . . E o0 A . . . E o@ A AMLODIPINE d00689A CDp I10 Essential (primary) hypertension A` E o@ A APIXABAN d07804A0 CDp D75.9P Prevent blood clots A` E o@ A DONEPEZIL d04099A0 CDp R41 Other symptoms and signs involving cognitive functions and awareness A` E o@ A DULOXETINE d05355A0 C- F32.9 F41.9 G47.0 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified Insomnia A` E o@ A GABAPENTIN d03182A0 CDp F31.9 Bipolar disorder, unspecified A` E o@ A METHADONE d00050A C M25.5 M54 M79.1 Pain in joint Dorsalgia Myalgia A` E oP A . . . E o` A . . . E op A . . . E o A CETIRIZINE d03827A C J30.9 R09.81 Allergic rhinitis, unspecified Nasal congestion A` E o A FLUTICASONE NASAL d04283A C J30.9 Allergic rhinitis, unspecified A` E o A LOSARTAN d03821A C I10 Essential (primary) hypertension A` E o A MELOXICAM d04532A C M25.5 Pain in joint A` E o A OMEPRAZOLE d00325A B K21 Gastro-esophageal reflux disease A` E o A SERTRALINE d00880A B F32.9 Major depressive disorder, single episode, unspecified A` E o A . . . E o A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A` E o A FINASTERIDE d00563A C R39.9 Unspecified symptoms and signs involving the genitourinary system A` E o A LISINOPRIL d00732A C I10 Essential (primary) hypertension A` E o A METFORMIN d03807A C[@ E11 Type 2 diabetes mellitus A` E o A TAMSULOSIN d04121A Dc R39.1 Other difficulties with micturition A` E o A VERAPAMIL d00048A D I10 Essential (primary) hypertension A` E o A . . . E o A . . . E o A . . . E o A . . . E o A . . . E p A GEMFIBROZIL d00245A C- E78.0 E78.1 Pure hypercholesterolemia Pure hyperglyceridemia A@ E p A GLIPIZIDE d00246A C- R73 Elevated blood glucose level A@ E p A LISINOPRIL d00732A C- I10 Essential (primary) hypertension A@ E p A METFORMIN d03807A C- E11 R73 Type 2 diabetes mellitus Elevated blood glucose level A@ E p A . . . E p A AMITRIPTYLINE d00146A D F32.9 G47.0 K58 Major depressive disorder, single episode, unspecified Insomnia Irritable bowel syndrome A` E p A ATORVASTATIN d04105A C- E78.0 Pure hypercholesterolemia A` E p A DULOXETINE d05355A C F32.9 Major depressive disorder, single episode, unspecified A` E p A FENOFIBRATE d04286A B E78.0 Pure hypercholesterolemia A` E p A GABAPENTIN d03182A Dc G99.8 M54 Other specified disorders of nervous system in diseases classified elsewhere Dorsalgia A` E p A TRAMADOL d03826A C[@ M54 Dorsalgia A` E p0 A DULOXETINE d05355A C M79.7 Fibromyalgia Ap E p0 A HYDROCODONE d03075A C M54 M79.2 Dorsalgia Neuralgia and neuritis, unspecified Ap E p0 A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified Ap E p0 A METHOCARBAMOL d00965A C M62.83 Muscle spasm Ap E p0 A OMEPRAZOLE d00325A AP K30 Functional dyspepsia Ap E p0 A PANCRELIPASE d01002A Cr K87 Disorders of gallbladder, biliary tract and pancreas in diseases classified elsewhere Ap E p0 A PREGABALIN d05508A C M79.7 Fibromyalgia Ap E p@ A LATANOPROST OPHTHALMIC d04017A B[ H40 Glaucoma AP E p@ A METOPROLOL d00134A C I10 Essential (primary) hypertension AP E p@ A PIRFENIDONE d08031A B= J98.9 Respiratory disorder, unspecified AP E p@ A PRAVASTATIN d00348A C E78.0 Pure hypercholesterolemia AP E p@ A PREDNISONE d00350A B= J44.9 Chronic obstructive pulmonary disease, unspecified AP E pP A . . . E p` A . . . E pp A LUBIPROSTONE d05736A B K58 Irritable bowel syndrome A E pp A PANTOPRAZOLE d04514A B K21 Gastro-esophageal reflux disease A E p A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A@ E p A CARVEDILOL d03847A C I21.P Prevent heart attack/myocardial infarction A@ E p A CLOPIDOGREL d04258A C I21 ST elevation (STEMI) and non-ST elevation (NSTEMI) myocardial infarction A@ E p A FLUTICASONE; UMECLIDINIUM; VILANTEROL d08666A B= J44.9 Chronic obstructive pulmonary disease, unspecified A@ E p A BUPROPION d00181A C F39 Unspecified mood [affective] disorder A0 E p A CLONIDINE d00044A C F41.9 Anxiety disorder, unspecified A0 E p A LURASIDONE d07705A Cr F20 Schizophrenia A0 E p A CLONAZEPAM d00197A Cr F41.9 Anxiety disorder, unspecified AP E p A FAMOTIDINE; IBUPROFEN d07764A Bz M54 Dorsalgia AP E p A MIRTAZAPINE d04025A C F32.9 Major depressive disorder, single episode, unspecified AP E p A PHENTERMINE d00806A B E66 Overweight and obesity AP E p A SERTRALINE d00880A D# F32.9 Major depressive disorder, single episode, unspecified AP E p A . . . E p A . . . E p A AMLODIPINE; BENAZEPRIL d03829A D I10 Essential (primary) hypertension A` E p A APIXABAN d07804A B= Z79.0 Long term (current) use of anticoagulants and antithrombotics/antiplatelets A` E p A ATENOLOL d00004A B- I10 Essential (primary) hypertension A` E p A ATORVASTATIN d04105A Cr E78.0 Pure hypercholesterolemia A` E p A FLECAINIDE d00234A CDp I49.9 Cardiac arrhythmia, unspecified A` E p A METFORMIN d03807A Cr R73 Elevated blood glucose level A` E p A . . . E p A SERTRALINE d00880A Cr F32.9 Major depressive disorder, single episode, unspecified A E q A ALLOPURINOL d00023A C M1A Chronic gout A0 E q A HYDROCHLOROTHIAZIDE; LOSARTAN d03830A C- I10 Essential (primary) hypertension A0 E q A SIMVASTATIN d00746A C[@ E78.0 Pure hypercholesterolemia A0 E q A ATOMOXETINE d04827A Ap F90 Attention-deficit hyperactivity disorders A0 E q A FLUOXETINE d00236A C F32.9 F41.9 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified A0 E q A QUETIAPINE d04220A C F39 Unspecified mood [affective] disorder A0 E q A . . . E q0 A CELECOXIB d04380A B R52 Pain, unspecified A` E q0 A CETIRIZINE d03827A C[@ T78.40 Allergy, unspecified A` E q0 A CYCLOBENZAPRINE d00963A Cr R52 Pain, unspecified A` E q0 A HYDROXYZINE d00907A Cr L29.9 Pruritus, unspecified A` E q0 A PREGABALIN d05508A C R52 Pain, unspecified A` E q0 A SIMVASTATIN d00746A C[@ E78.0 Pure hypercholesterolemia A` E q@ A BUPRENORPHINE; NALOXONE d04819A C F11.23 Opioid dependence with withdrawal A0 E q@ A LISINOPRIL d00732A CDp I10 Essential (primary) hypertension A0 E q@ A TAMSULOSIN d04121A C[@ N40 Enlarged prostate A0 E qP A . . . E q` A ATORVASTATIN d04105A B= E78.0 Pure hypercholesterolemia AP E q` A DULOXETINE d05355A C- F39 Unspecified mood [affective] disorder AP E q` A LOSARTAN d03821A C I10 Essential (primary) hypertension AP E q` A MECLIZINE d00859A D/ R42 Dizziness and giddiness AP E q` A TRAZODONE d00395A C G47.0 Insomnia AP E qp A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A@ E qp A GLIMEPIRIDE d03864A B E11 Type 2 diabetes mellitus A@ E qp A LISINOPRIL d00732A C I10 Essential (primary) hypertension A@ E qp A METFORMIN d03807A Cr E11 Type 2 diabetes mellitus A@ E q A AMLODIPINE d00689A B I10 Essential (primary) hypertension A` E q A CELECOXIB d04380A Bz M06.9 Rheumatoid arthritis, unspecified A` E q A GLIPIZIDE d00246A Cr E11 Type 2 diabetes mellitus A` E q A HYDROCHLOROTHIAZIDE d00253A CDp I10 Essential (primary) hypertension A` E q A PANTOPRAZOLE d04514A C K30 Functional dyspepsia A` E q A VALSARTAN d04113A C I10 Essential (primary) hypertension A` E q A . . . E q A GLIPIZIDE d00246A C E11 Type 2 diabetes mellitus A@ E q A LISINOPRIL d00732A C I10 Essential (primary) hypertension A@ E q A METFORMIN d03807A C E11 Type 2 diabetes mellitus A@ E q A METOPROLOL d00134A C I10 Essential (primary) hypertension A@ E q A . . . E q A . . . E q A CLONIDINE d00044A C I10 Essential (primary) hypertension A0 E q A HYDROCODONE d03075A C- M54 Dorsalgia A0 E q A OLMESARTAN d04801A CDp I10 Essential (primary) hypertension A0 E q A . . . E q A ACETAMINOPHEN; CODEINE d03423A CDp G43 Migraine A0 E q A CLONAZEPAM d00197A CDp F41.9 Anxiety disorder, unspecified A0 E q A SUMATRIPTAN d03160A D* G43 Migraine A0 E r A . . . E r A . . . E r A . . . E r0 A . . . E r@ A . . . E rP A . . . E r` A . . . E rp A . . . E r A ACETAMINOPHEN; OXYCODONE d03431A B M54 Dorsalgia A0 E r A LISINOPRIL d00732A CDp I10 Essential (primary) hypertension A0 E r A METFORMIN d03807A CDp E11 Type 2 diabetes mellitus A0 E r A . . . E r A . . . E r A . . . E r A . . . E r A . . . E r A HYDROCHLOROTHIAZIDE; LOSARTAN d03830A B I10 Essential (primary) hypertension A E r A . . . E s A AMOXICILLIN; CLAVULANATE d00089A Ap A49.9P Prevent bacterial infection A E s A . . . E s A ATORVASTATIN d04105A D ^ E78.0 Pure hypercholesterolemia A` E s A CLOPIDOGREL d04258A D D75.9P Prevent blood clots A` E s A FINASTERIDE d00563A D N40 Enlarged prostate A` E s A METOPROLOL d00134A D ^ I10 R00 Essential (primary) hypertension Abnormalities of heart beat A` E s A RAMIPRIL d00728A D ^ I10 Essential (primary) hypertension A` E s A SILODOSIN d07354A D N40 Enlarged prostate A` E s0 A AMLODIPINE d00689A B[ I10 Essential (primary) hypertension A E s@ A BUPRENORPHINE; NALOXONE d04819A C[@ F11.23 Opioid dependence with withdrawal AP E s@ A CLONIDINE d00044A B F41.9 Anxiety disorder, unspecified AP E s@ A GABAPENTIN d03182A B[ F41.9 Anxiety disorder, unspecified AP E s@ A LAMOTRIGINE d03809A B= F31.9 Bipolar disorder, unspecified AP E s@ A LITHIUM d00061A B= F31.9 Bipolar disorder, unspecified AP E sP A DEXTROAMPHETAMINE d00804A CDp F90 Attention-deficit hyperactivity disorders A@ E sP A ETHINYL ESTRADIOL; NORETHINDRONE d03238A B N94 Pain and other conditions associated with female genital organs and menstrual cycle A@ E sP A FLUOXETINE d00236A D F32.9 Major depressive disorder, single episode, unspecified A@ E sP A LANSOPRAZOLE d03828A C K25 Gastric ulcer A@ E s` A . . . E sp A . . . E s A . . . E s A AMPHETAMINE; DEXTROAMPHETAMINE d04035A0 B F90 Attention-deficit hyperactivity disorders A E s A . . . E s A . . . E s A . . . E s A . . . E s A ALBUTEROL d00749A C- J45 Asthma A E s A ALENDRONATE d03849A C- M81.P Prevent bone loss/osteoporosis A E s A AZITHROMYCIN d00091A C- T86.9P Prevent transplanted organ and tissue rejection A E s A CLOTRIMAZOLE d01236A C- B35 B37 Dermatophytosis Candidiasis A E s A DULOXETINE d05355A B= F32.9 Major depressive disorder, single episode, unspecified A E s A FUROSEMIDE d00070A C- J98.9 Respiratory disorder, unspecified A E s A GABAPENTIN d03182A C- E11.4 M79.2 Type 2 diabetes mellitus with neurological complications Neuralgia and neuritis, unspecified A E s A GLIPIZIDE d00246A C- E11 Type 2 diabetes mellitus A E s A INSULIN LISPRO d04373A C- E11 Type 2 diabetes mellitus A E s A PANTOPRAZOLE d04514A C- K30 Functional dyspepsia A E s A PRAVASTATIN d00348A C- E78.1 Pure hyperglyceridemia A E s A PREDNISONE d00350A C- J44.9 Chronic obstructive pulmonary disease, unspecified A E s A SULFAMETHOXAZOLE; TRIMETHOPRIM d00124A C- A49.9P Prevent bacterial infection A E s A TACROLIMUS d03752A C- T86.9P Prevent transplanted organ and tissue rejection A E s A ALBUTEROL d00749A B J45 Asthma Ap E s A ALBUTEROL d00749A B J45 Asthma Ap E s A BECLOMETHASONE d00760A B J45 Asthma Ap E s A DEXMETHYLPHENIDATE d04777A C F90 Attention-deficit hyperactivity disorders Ap E s A FLUTICASONE NASAL d04283A C J30.9 Allergic rhinitis, unspecified Ap E s A MONTELUKAST d04289A C J30.9 Allergic rhinitis, unspecified Ap E s A SERTRALINE d00880A C F90 Attention-deficit hyperactivity disorders Ap E t A MONTELUKAST d04289A B[ J03 Acute tonsillitis A E t A TRIAMCINOLONE NASAL d04233A B[ J03 Acute tonsillitis A E t A . . . E t A . . . E t0 A . . . E t@ A . . . E tP A . . . E t` A CETIRIZINE d03827A C- T78.40 Allergy, unspecified A E t` A FLUTICASONE NASAL d04283A C- J30.2 Other seasonal allergic rhinitis A E tp A ALBUTEROL d00749A C J45 Asthma A0 E tp A FLUTICASONE d01296A C- J45 Asthma A0 E tp A PHENTERMINE d00806A CDp E66 Overweight and obesity A0 E t A ALENDRONATE d03849A C- M81 Osteoporosis without current pathological fracture A E t A AMLODIPINE d00689A D I10 Essential (primary) hypertension A E t A CETIRIZINE d03827A C- J30.9 Allergic rhinitis, unspecified A E t A . . . E t A . . . E t A . . . E t A . . . E t A . . . E t A BUDESONIDE d04276A C[@ K51 Ulcerative colitis A E t A MESALAMINE d01031A C[@ K51 Ulcerative colitis A E u A ROSUVASTATIN d04851A C E78.0 Pure hypercholesterolemia A E u A . . . E u A AMLODIPINE d00689A Cr 99999 A E u A ASPIRIN d00170A C I21.P Prevent heart attack/myocardial infarction A E u A FUROSEMIDE d00070A C- R60.9 Edema, unspecified A E u A GLIPIZIDE d00246A Cr R73 Elevated blood glucose level A E u A LOSARTAN d03821A C I10 Essential (primary) hypertension A E u A METFORMIN d03807A C E11 Type 2 diabetes mellitus A E u A RANITIDINE d00021A C R12 Heartburn A E u A SIMVASTATIN d00746A Cr E78.0 Pure hypercholesterolemia A E u0 A IBUPROFEN d00015A A K08.8 Other specified disorders of teeth and supporting structures A0 E u0 A METHADONE d00050A Bz F11.23 M54 M79.2 Opioid dependence with withdrawal Dorsalgia Neuralgia and neuritis, unspecified A0 E u0 A PENICILLIN d00116A Ap K08.4 Partial loss of teeth A0 E u@ A . . . E uP A PITAVASTATIN d07637A A E78.0 Pure hypercholesterolemia A0 E uP A SOTALOL d00371A B I48.9 Unspecified atrial fibrillation and atrial flutter A0 E uP A WARFARIN d00022A C[@ I48.9 Unspecified atrial fibrillation and atrial flutter A0 E u` A . . . E up A . . . E u A . . . E u A ATORVASTATIN d04105A C E78.0P Prevent high cholesterol A@ E u A BUPROPION d00181A C- F17.2 Nicotine dependence A@ E u A LISINOPRIL d00732A C I10 Essential (primary) hypertension A@ E u A METOPROLOL d00134A C I10 Essential (primary) hypertension A@ E u A . . . E u A . . . E u A ALBUTEROL d00749A D J45 Asthma A E u A BUDESONIDE; FORMOTEROL d04795A C[@ J45 Asthma A E u A LISINOPRIL d00732A C[@ I51.9 Heart disease, unspecified A E u A METOPROLOL d00134A C[@ I51.9 Heart disease, unspecified A E u A MONTELUKAST d04289A C[@ I51.9 Heart disease, unspecified A E u A TAMSULOSIN d04121A C[@ R35 Polyuria A E u A TIOTROPIUM d04829A C[@ J45 Asthma A E u A WARFARIN d00022A C[@ I51.9 Heart disease, unspecified A E u A . . . E u A ALENDRONATE d03849A A M81 Osteoporosis without current pathological fracture A@ E u A BISOPROLOL d00709A C I10 Essential (primary) hypertension A@ E u A CITALOPRAM d04332A CDp F41.9 Anxiety disorder, unspecified A@ E u A MELOXICAM d04532A C R52 Pain, unspecified A@ E u A ETHINYL ESTRADIOL; NORGESTIMATE d03781A CDp Z79.3 Long term (current) use of hormonal contraceptives A E v A RANITIDINE d00021A Ap K21 Gastro-esophageal reflux disease A E v A . . . E v A . . . E v0 A . . . E v@ A CITALOPRAM d04332A0 CDp F41.9 Anxiety disorder, unspecified A0 E v@ A LISINOPRIL d00732A0 CDp I10 Essential (primary) hypertension A0 E v@ A SIMVASTATIN d00746A0 C- E78.0 Pure hypercholesterolemia A0 E vP A . . . E v` A ATORVASTATIN d04105A B[ E78.0 Pure hypercholesterolemia A E vp A . . . E v A CLONAZEPAM d00197A D F41.9 Anxiety disorder, unspecified AP E v A DEXTROMETHORPHAN; QUINIDINE d07707A D R52 Pain, unspecified AP E v A HYDROCODONE d03075A D R52 Pain, unspecified AP E v A LIDOCAINE TOPICAL d00683A D R52 Pain, unspecified AP E v A OXYCODONE d00329A D R52 Pain, unspecified AP E v A MONTELUKAST d04289A CDp T78.40 Allergy, unspecified A E v A ALBUTEROL d00749A C J45 Asthma A E v A CETIRIZINE d03827A CDp J30.9 T78.40 Allergic rhinitis, unspecified Allergy, unspecified A E v A ALLOPURINOL d00023A C M10.9P Prevent gout A E v A AMLODIPINE d00689A C[@ I10 Essential (primary) hypertension A E v A ATORVASTATIN d04105A CDp E78.0 Pure hypercholesterolemia A E v A DAPAGLIFLOZIN; METFORMIN d08245A B= E11 Type 2 diabetes mellitus A E v A INSULIN GLARGINE d04538A C E11 Type 2 diabetes mellitus A E v A LISINOPRIL d00732A CDp I10 Essential (primary) hypertension A E v A METFORMIN d03807A C- E11 Type 2 diabetes mellitus A E v A METOPROLOL d00134A CDp I10 Essential (primary) hypertension A E v A SEMAGLUTIDE d08688A B R73 Elevated blood glucose level A E v A . . . E v A ALBUTEROL d00749A D@) J45 Asthma A E v A BUDESONIDE; FORMOTEROL d04795A C J45 Asthma A E v A CARVEDILOL d03847A C I51.9 Heart disease, unspecified A E v A CETIRIZINE d03827A B[ J30.1 Allergic rhinitis due to pollen A E v A CLOPIDOGREL d04258A C I51.9 Heart disease, unspecified A E v A FLUTICASONE NASAL d04283A C R09.81 Nasal congestion A E v A GLIPIZIDE d00246A C R73 Elevated blood glucose level A E v A METFORMIN d03807A C E11 Type 2 diabetes mellitus A E v A TAMSULOSIN d04121A C N40 Enlarged prostate A E v A . . . E v A AMOXICILLIN; CLAVULANATE d00089A A H66.9 Otitis media, unspecified A E w A . . . E w A . . . E w A . . . E w0 A . . . E w@ A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A E w@ A FLECAINIDE d00234A C I49.9 Cardiac arrhythmia, unspecified A E wP A . . . E w` A . . . E wp A CETIRIZINE d03827A A J45 Asthma A E wp A FLUTICASONE d01296A CP J45 Asthma A E w A AMLODIPINE; BENAZEPRIL d03829A C I10 Essential (primary) hypertension A E w A . . . E w A . . . E w A . . . E w A AMOXICILLIN d00088A A@ A49.9P J01.9 Prevent bacterial infection Acute sinusitis, unspecified A0 E w A CETIRIZINE d03827A A H10.1 J30.9 T78.40 Acute atopic conjunctivitis Allergic rhinitis, unspecified Allergy, unspecified A0 E w A POLYETHYLENE GLYCOL 3350 d05350A A K59.0 Constipation A0 E w A ALBIGLUTIDE d08251A B E11 Type 2 diabetes mellitus AP E w A AMLODIPINE d00689A D I10 Essential (primary) hypertension AP E w A DAPAGLIFLOZIN; METFORMIN d08245A B E11 Type 2 diabetes mellitus AP E w A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A D I10 Essential (primary) hypertension AP E w A SIMVASTATIN d00746A C E78.0P Prevent high cholesterol AP E w A . . . E w A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A CDp I10 Essential (primary) hypertension AP E w A PROGESTERONE d00550A C Z79.890 Hormone replacement therapy AP E w A RANITIDINE d00021A B K21 Gastro-esophageal reflux disease AP E w A SERTRALINE d00880A Bz F41.9 Anxiety disorder, unspecified AP E w A THYROID DESICCATED d00655A C E03.9 Hypothyroidism, unspecified AP E x A APIXABAN d07804A B= I48.9 Unspecified atrial fibrillation and atrial flutter A E x A CARVEDILOL d03847A C[@ I50.9 Heart failure, unspecified A E x A DIGOXIN d00210A Cr I50.9 Heart failure, unspecified A E x A FUROSEMIDE d00070A Cr I50.9 Heart failure, unspecified A E x A GLIMEPIRIDE d03864A C E11 Type 2 diabetes mellitus A E x A INSULIN ASPART d04697A C E11 Type 2 diabetes mellitus A E x A INSULIN GLARGINE d04538A C- E11 Type 2 diabetes mellitus A E x A LOSARTAN d03821A C[@ I50.9 Heart failure, unspecified A E x A METFORMIN d03807A C E11 Type 2 diabetes mellitus A E x A OXYBUTYNIN d00328A B R32 Unspecified urinary incontinence A E x A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia A E x A VALACYCLOVIR d03838A C A60.9 Anogenital herpesviral infection, unspecified A E x A . . . E x A HYDROXYCHLOROQUINE d00817A C M06.9 Rheumatoid arthritis, unspecified A0 E x A LEFLUNOMIDE d04349A C M06.9 Rheumatoid arthritis, unspecified A0 E x A LEVOTHYROXINE d00278A D' E03.9 Hypothyroidism, unspecified A0 E x0 A . . . E x@ A METHYLPHENIDATE d00900A C F90 Attention-deficit hyperactivity disorders A E xP A . . . E x` A BREXPIPRAZOLE d08373A C9 F31.9 Bipolar disorder, unspecified A E x` A OLANZAPINE d04050A CDp F31.9 Bipolar disorder, unspecified A E xp A . . . E x A . . . E x A TADALAFIL d04896A C N52.9 Male erectile dysfunction, unspecified A E x A AMLODIPINE d00689A Cr I10 Essential (primary) hypertension A@ E x A HYDROCHLOROTHIAZIDE; LOSARTAN d03830A C- I10 Essential (primary) hypertension A@ E x A PRAVASTATIN d00348A Cr E78.0 Pure hypercholesterolemia A@ E x A TOPIRAMATE d04115A CDp G43 Migraine A@ E x A . . . E x A ACETAMINOPHEN; HYDROCODONE d03428A CDp M54 Dorsalgia A E x A ALLOPURINOL d00023A C M1A Chronic gout A E x A APREMILAST d08247A C- L40 Psoriasis A E x A FUROSEMIDE d00070A CDp I51.9 Heart disease, unspecified A E x A GABAPENTIN d03182A C M54 Dorsalgia A E x A OLMESARTAN d04801A A I10 Essential (primary) hypertension A E x A RIVAROXABAN d07356A C I48.9 Unspecified atrial fibrillation and atrial flutter A E x A ROSUVASTATIN d04851A Cr E78.0 Pure hypercholesterolemia A E x A TAMSULOSIN d04121A CDp R35 Polyuria A E x A TAPENTADOL d07453A C M54 Dorsalgia A E x A . . . E x A ALBUTEROL d00749A C[@ J44.9 Chronic obstructive pulmonary disease, unspecified A E x A FLUTICASONE; VILANTEROL d08100A C[@ J44.9 Chronic obstructive pulmonary disease, unspecified A E x A GLIMEPIRIDE d03864A B E11 Type 2 diabetes mellitus A E x A LOSARTAN d03821A B- I21.P Prevent heart attack/myocardial infarction A E x A METFORMIN d03807A B E11 Type 2 diabetes mellitus A E x A PANCRELIPASE d01002A B K30 Functional dyspepsia A E x A PANTOPRAZOLE d04514A B K30 Functional dyspepsia A E x A UMECLIDINIUM d08187A C[@ J44.9 Chronic obstructive pulmonary disease, unspecified A E x A HYDROCHLOROTHIAZIDE d00253A B[ I10 Essential (primary) hypertension A E y A . . . E y A CLONAZEPAM d00197A Cr G47.9 Sleep disorder, unspecified A@ E y A FLUOXETINE d00236A C F32.9 Major depressive disorder, single episode, unspecified A@ E y A GABAPENTIN d03182A C G25.81 Restless legs syndrome A@ E y A ROTIGOTINE d05848A B G25.81 Restless legs syndrome A@ E y A . . . E y0 A . . . E y@ A ATORVASTATIN d04105A C- E78.0 Pure hypercholesterolemia A E y@ A BENZONATATE d00796A B R05 R06.2 Cough Wheezing A E y@ A DABIGATRAN d07137A A D75.9P Prevent blood clots A E y@ A FINASTERIDE d00563A C"0 R39.1 Other difficulties with micturition A E y@ A FLECAINIDE d00234A A I49.9 Cardiac arrhythmia, unspecified A E y@ A LEVOTHYROXINE d00278A C- E07.9 Disorder of thyroid, unspecified A E y@ A LISINOPRIL d00732A B I21.P Prevent heart attack/myocardial infarction A E y@ A MEMANTINE d04899A C"0 R41 Other symptoms and signs involving cognitive functions and awareness A E y@ A OMEPRAZOLE d00325A C- K21 Gastro-esophageal reflux disease A E y@ A RAMIPRIL d00728A C- I10 Essential (primary) hypertension A E y@ A TAMSULOSIN d04121A C"0 R32 Unspecified urinary incontinence A E yP A . . . E y` A DESVENLAFAXINE d07113A C F32.9 Major depressive disorder, single episode, unspecified A E yp A . . . E y A PAZOPANIB d07499A C C80.1 Malignant (primary) neoplasm, unspecified A E y A . . . E y A AMLODIPINE; BENAZEPRIL d03829A C[@ I10 Essential (primary) hypertension AP E y A LABETALOL d00016A C[@ I10 Essential (primary) hypertension AP E y A SIMVASTATIN d00746A Cr E78.0 Pure hypercholesterolemia AP E y A SOLIFENACIN d05413A Cr N32.81 Overactive bladder AP E y A TAMSULOSIN d04121A Cr N40 Enlarged prostate AP E y A HYDROXYZINE d00907A C F32.9 Major depressive disorder, single episode, unspecified A E y A LABETALOL d00016A B I10 Essential (primary) hypertension A E y A . . . E y A NITROFURANTOIN d00112A Ap N39.0 Urinary tract infection, site not specified A E y A ERYTHROMYCIN OPHTHALMIC d03973A A0 H04 Disorders of lacrimal system A E y A ALBUTEROL d00749A Cr J45 Asthma A E y A MONTELUKAST d04289A C J45 Asthma A E z A ATENOLOL d00004A C I10 Essential (primary) hypertension A0 E z A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A0 E z A MELOXICAM d04532A Dc M19.9 Osteoarthritis, unspecified site A0 E z A 99999 . . A E z A CALCITONIN d00598A Cr M81 Osteoporosis without current pathological fracture A@ E z A CYCLOBENZAPRINE d00963A Cr M62.83 Muscle spasm A@ E z A OMEPRAZOLE d00325A D K21 K46 Gastro-esophageal reflux disease Unspecified abdominal hernia A@ E z A SIMVASTATIN d00746A D E78.0 Pure hypercholesterolemia A@ E z0 A . . . E z@ A . . . E zP A . . . E z` A ATORVASTATIN d04105A C- E78.0 Pure hypercholesterolemia A E zp A . . . E z A . . . E z A ALENDRONATE d03849A C M81.P Prevent bone loss/osteoporosis A E z A GABAPENTIN d03182A B M54 Dorsalgia A E z A . . . E z A DEXMETHYLPHENIDATE d04777A CDp F90 Attention-deficit hyperactivity disorders A E z A ATORVASTATIN d04105A CDp 99999 A E z A CLONAZEPAM d00197A C F32.9 Major depressive disorder, single episode, unspecified A E z A DOXEPIN d00217A C G47.0 Insomnia A E z A FUROSEMIDE d00070A CDp 99999 A E z A GABAPENTIN d03182A C M79.2 M79.7 Neuralgia and neuritis, unspecified Fibromyalgia A E z A LISINOPRIL d00732A CDp I10 Essential (primary) hypertension A E z A METFORMIN d03807A B E11 Type 2 diabetes mellitus A E z A METOPROLOL d00134A CDp I50.9 Heart failure, unspecified A E z A WARFARIN d00022A CDp Z95 Presence of cardiac and vascular implants and grafts A E z A . . . E z A . . . E z A . . . E { A . . . E { A ETHINYL ESTRADIOL; ETHYNODIOL d03388A D Z79.3 Long term (current) use of hormonal contraceptives A E { A . . . E {0 A LISDEXAMFETAMINE d06663A C F90 Attention-deficit hyperactivity disorders A E {@ A ACETAMINOPHEN; OXYCODONE d03431A C M54 Dorsalgia Ap E {@ A CLONAZEPAM d00197A Cr F41.9 Anxiety disorder, unspecified Ap E {@ A DIAZEPAM d00148A C G47.9 M62.83 Sleep disorder, unspecified Muscle spasm Ap E {@ A DICLOFENAC d00848A C- M19.9 Osteoarthritis, unspecified site Ap E {@ A GABAPENTIN d03182A C- M79.2 Neuralgia and neuritis, unspecified Ap E {@ A OXYCODONE d00329A C M54 Dorsalgia Ap E {@ A SERTRALINE d00880A Cr F32.9 Major depressive disorder, single episode, unspecified Ap E {P A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A E {P A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A Dc I10 Essential (primary) hypertension A E {` A AMLODIPINE d00689A C I10 Essential (primary) hypertension A E {p A TERBINAFINE d04012A B B35 Dermatophytosis A E { A . . . E { A AMOXICILLIN; CLAVULANATE d00089A AP A49.9P Prevent bacterial infection A E { A AMLODIPINE d00689A Cr I10 Essential (primary) hypertension A@ E { A CARVEDILOL d03847A Cr I21.P I50.9 Prevent heart attack/myocardial infarction Heart failure, unspecified A@ E { A HYDROCHLOROTHIAZIDE; LOSARTAN d03830A C[@ I10 Essential (primary) hypertension A@ E { A METFORMIN d03807A C- E11 Type 2 diabetes mellitus A@ E { A . . . E { A . . . E { A RANITIDINE d00021A B# K21 Gastro-esophageal reflux disease A E { A METOPROLOL d00134A C I10 Essential (primary) hypertension A E { A ZOLPIDEM d00910A CDp G47.9 Sleep disorder, unspecified A E { A CLONIDINE d00044A C[@ F43.1 Post-traumatic stress disorder (PTSD) A E { A FLUOXETINE d00236A C[@ F41.9 Anxiety disorder, unspecified A E | A . . . E | A . . . E | A LISDEXAMFETAMINE d06663A CP F90 Attention-deficit hyperactivity disorders A E |0 A HYDROCHLOROTHIAZIDE d00253A Cr I10 Essential (primary) hypertension A0 E |0 A HYDROXYCHLOROQUINE d00817A C L93 M06.9 Lupus erythematosus Rheumatoid arthritis, unspecified A0 E |0 A PREDNISONE d00350A C L93 M06.9 Lupus erythematosus Rheumatoid arthritis, unspecified A0 E |@ A ALBUTEROL d00749A Dc J45 Asthma A E |@ A MELOXICAM d04532A B M54 Dorsalgia A E |P A . . . E |` A 99999 . . A E |p A . . . E | A VENLAFAXINE d03181A C F32.9 Major depressive disorder, single episode, unspecified A E | A . . . E | A AZITHROMYCIN d00091A B J42 Unspecified chronic bronchitis A E | A ATOMOXETINE d04827A C- F90 Attention-deficit hyperactivity disorders A` E | A CLINDAMYCIN d00043A A@ 99999 A` E | A CLONIDINE d00044A C- F90 Attention-deficit hyperactivity disorders A` E | A OXCARBAZEPINE d04513A C- F31.9 Bipolar disorder, unspecified A` E | A POLYETHYLENE GLYCOL 3350 d05350A C K58 Irritable bowel syndrome A` E | A QUETIAPINE d04220A C- F20 F31.9 F90 Schizophrenia Bipolar disorder, unspecified Attention-deficit hyperactivity disorders A` E | A . . . E | A DIVALPROEX SODIUM d03833A Cf G40 Epilepsy and recurrent seizures A0 E | A PERAMPANEL d07904A C"@ G40 Epilepsy and recurrent seizures A0 E | A VALPROIC ACID d00083A Cf G40 Epilepsy and recurrent seizures A0 E | A ALBUTEROL d00749A C[@ J45 R05 Asthma Cough A E | A FLUTICASONE d01296A C[@ J45 R05 R06.2 Asthma Cough Wheezing A E | A . . . E } A AMLODIPINE d00689A Cr I10 Essential (primary) hypertension A@ E } A LEVOTHYROXINE d00278A D E03.9 Hypothyroidism, unspecified A@ E } A LOSARTAN d03821A Cr I10 Essential (primary) hypertension A@ E } A PREGABALIN d05508A Dc M79.2 Neuralgia and neuritis, unspecified A@ E } A . . . E } A . . . E }0 A . . . E }@ A . . . E }P A HYDROCHLOROTHIAZIDE; LOSARTAN d03830A D I10 Essential (primary) hypertension A0 E }P A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia A0 E }P A TAMSULOSIN d04121A C N42.9 Disorder of prostate, unspecified A0 E }` A . . . E }p A . . . E } A LISINOPRIL d00732A B I10 Essential (primary) hypertension A E } A . . . E } A . . . E } A FAMOTIDINE d00141A B K25 K27 Gastric ulcer Peptic ulcer, site unspecified A E } A LOSARTAN d03821A C- I10 Essential (primary) hypertension A E } A . . . E } A . . . E } A . . . E } A IBUPROFEN d00015A Ap G43 Migraine A E } A TIZANIDINE d04102A A M54 Dorsalgia A E ~ A ETHINYL ESTRADIOL; NORGESTIMATE d03781A C Z79.3 Long term (current) use of hormonal contraceptives A E ~ A 99999 . . A E ~ A . . . E ~0 A . . . E ~@ A AMLODIPINE d00689A C I10 Essential (primary) hypertension A` E ~@ A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A` E ~@ A CLOPIDOGREL d04258A C- I48.9 Unspecified atrial fibrillation and atrial flutter A` E ~@ A ESOMEPRAZOLE d04749A C K21 Gastro-esophageal reflux disease A` E ~@ A LOSARTAN d03821A C I10 Essential (primary) hypertension A` E ~@ A TRAMADOL d03826A C R10 Abdominal and pelvic pain A` E ~P A LISINOPRIL d00732A D I10 Essential (primary) hypertension A E ~P A PALBOCICLIB d08342A C- C50 Malignant neoplasm of breast A E ~` A ACETAMINOPHEN; HYDROCODONE d03428A Dc M54 R52 Dorsalgia Pain, unspecified A E ~` A ALBUTEROL d00749A B J44.9 Chronic obstructive pulmonary disease, unspecified A E ~` A ATORVASTATIN d04105A B E78.0 Pure hypercholesterolemia A E ~` A BUPROPION d00181A C F32.9 Major depressive disorder, single episode, unspecified A E ~` A GABAPENTIN d03182A D M79.2 Neuralgia and neuritis, unspecified A E ~` A OMEPRAZOLE d00325A CDp K30 R12 Functional dyspepsia Heartburn A E ~` A RANITIDINE d00021A C- K30 R12 Functional dyspepsia Heartburn A E ~` A UMECLIDINIUM; VILANTEROL d08188A B J44.9 Chronic obstructive pulmonary disease, unspecified A E ~` A VERAPAMIL d00048A B I10 Essential (primary) hypertension A E ~p A . . . E ~ A . . . E ~ A . . . E ~ A . . . E ~ A BECLOMETHASONE d00760A C J45 Asthma A E ~ A CETIRIZINE d03827A C[@ J45 Asthma A E ~ A . . . E ~ A . . . E ~ A . . . E ~ A . . . E A 99999 . . A E A . . . E A NYSTATIN TOPICAL d04399A A0 B35 B37 Dermatophytosis Candidiasis A E 0 A . . . E @ A IBUPROFEN d00015A B M79.1 Myalgia A E @ A METFORMIN d03807A C"0 E11 Type 2 diabetes mellitus A E P A . . . E ` A . . . E p A . . . E A . . . E A . . . E A AMLODIPINE d00689A C I10 Essential (primary) hypertension A` E A CARVEDILOL d03847A C I10 Essential (primary) hypertension A` E A FUROSEMIDE d00070A C R60.9 Edema, unspecified A` E A LISINOPRIL d00732A C I10 Essential (primary) hypertension A` E A LOVASTATIN d00280A C E78.0 Pure hypercholesterolemia A` E A MORPHINE d00308A B= M54 Dorsalgia A` E A . . . E A ACETAMINOPHEN; HYDROCODONE d03428A C- M54 Dorsalgia A E A ALPRAZOLAM d00168A B= F41.9 Anxiety disorder, unspecified A E A AMIODARONE d00002A B= I49.9 Cardiac arrhythmia, unspecified A E A AMLODIPINE d00689A Cr 99999 A E A APIXABAN d07804A B D75.9P Prevent blood clots A E A ASPIRIN d00170A D D75.9P Prevent blood clots A E A ATORVASTATIN d04105A D 99999 A E A ISOSORBIDE d00653A D 99999 A E A METOPROLOL d00134A B I49.9 Cardiac arrhythmia, unspecified A E A ONDANSETRON d00867A B R11 Nausea and vomiting A E A ROPINIROLE d04215A D 99999 A E A . . . E A ACETAMINOPHEN; OXYCODONE d03431A B[ M25.5 M54 Pain in joint Dorsalgia A0 E A LISINOPRIL d00732A C- I10 Essential (primary) hypertension A0 E A OMEPRAZOLE d00325A B R12 Heartburn A0 E A . . . E A LISDEXAMFETAMINE d06663A C F90 Attention-deficit hyperactivity disorders A E A . . . E A . . . E 0 A CODEINE d00012A AP R05 Cough A E @ A . . . E P A . . . E ` A . . . E p A . . . E A . . . E A . . . E A ALPRAZOLAM d00168A C- F41.9 Anxiety disorder, unspecified A E A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A E A CARBAMAZEPINE d00058A C- G40 Epilepsy and recurrent seizures A E A GABAPENTIN d03182A D M54 Dorsalgia A E A IPRATROPIUM d00265A C J45 Asthma A E A LEVETIRACETAM d04499A C G40 Epilepsy and recurrent seizures A E A LEVOTHYROXINE d00278A C[@ E03.9 Hypothyroidism, unspecified A E A MECLIZINE d00859A C- R42 Dizziness and giddiness A E A NITROGLYCERIN d00321A C R07.9 Chest pain, unspecified A E A OMEGA-3 POLYUNSATURATED FATTY ACIDS d00497A C[@ E78.0 Pure hypercholesterolemia A E A PENTOXIFYLLINE d00336A B[ I70 Atherosclerosis A E A . . . E A . . . E A . . . E A TAMOXIFEN d00381A C C50.P Prevent breast cancer A E A . . . E A . . . E A . . . E A AMOXICILLIN d00088A A0 J02 Acute pharyngitis A E 0 A . . . E @ A . . . E P A . . . E ` A . . . E p A . . . E A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia AP E A INSULIN GLARGINE d04538A B R73 Elevated blood glucose level AP E A LISINOPRIL d00732A CDp I10 Essential (primary) hypertension AP E A METFORMIN d03807A C[@ R73 Elevated blood glucose level AP E A SITAGLIPTIN d05896A C R73 Elevated blood glucose level AP E A . . . E A AMLODIPINE d00689A B I10 Essential (primary) hypertension A E A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A C- I10 Essential (primary) hypertension A E A . . . E A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A E A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A C I10 Essential (primary) hypertension A E A . . . E A AMLODIPINE d00689A C[@ I10 Essential (primary) hypertension A E A ATORVASTATIN d04105A CP E78.0 Pure hypercholesterolemia A E A CETIRIZINE d03827A B R09.81 Nasal congestion A E A GLIMEPIRIDE d03864A B E11 Type 2 diabetes mellitus A E A HYDROCHLOROTHIAZIDE d00253A C[@ I10 Essential (primary) hypertension A E A MELOXICAM d04532A B M54 Dorsalgia A E A METFORMIN d03807A C[@ E11 Type 2 diabetes mellitus A E A QUETIAPINE d04220A C F31.9 Bipolar disorder, unspecified A E A RANITIDINE d00021A C K21 Gastro-esophageal reflux disease A E A VENLAFAXINE d03181A C F31.9 Bipolar disorder, unspecified A E A OMEPRAZOLE d00325A C- K21 Gastro-esophageal reflux disease A0 E A PROCHLORPERAZINE d00355A C- R11 Nausea and vomiting A0 E A SUMATRIPTAN d03160A B[ R11 Nausea and vomiting A0 E A ETHINYL ESTRADIOL; NORGESTIMATE d03781A Cr Z79.3 Long term (current) use of hormonal contraceptives A E A . . . E A ASPIRIN d00170A C I21.P Prevent heart attack/myocardial infarction AP E A LOSARTAN d03821A Bz I10 Essential (primary) hypertension AP E A METFORMIN d03807A C R73 Elevated blood glucose level AP E A SIMVASTATIN d00746A CP E78.0 Pure hypercholesterolemia AP E A TEMAZEPAM d00384A C G47.0 Insomnia AP E 0 A . . . E @ A . . . E P A CYCLOBENZAPRINE d00963A C- M62.83 Muscle spasm A0 E P A TIZANIDINE d04102A B= M54 Dorsalgia A0 E P A TRAMADOL d03826A C- M54 Dorsalgia A0 E ` A AMOXICILLIN d00088A C J03 Acute tonsillitis A0 E ` A LISDEXAMFETAMINE d06663A C- F90 Attention-deficit hyperactivity disorders A0 E ` A METHYLPHENIDATE d00900A C- F90 Attention-deficit hyperactivity disorders A0 E p A OMEPRAZOLE d00325A D K21 Gastro-esophageal reflux disease A E A ALLOPURINOL d00023A C M10.9 Gout, unspecified AP E A CITALOPRAM d04332A C F41.9 Anxiety disorder, unspecified AP E A MELOXICAM d04532A C M13 Other arthritis AP E A TESTOSTERONE d00558A B* E29.1 Testicular hypofunction AP E A TRAZODONE d00395A C G47.0 Insomnia AP E A . . . E A . . . E A . . . E A ATORVASTATIN d04105A B E78.0P Prevent high cholesterol A E A NABUMETONE d00310A C M79.1 Myalgia A E A AMOXICILLIN; CLAVULANATE d00089A A J02.0 Streptococcal pharyngitis A E A . . . E A . . . E A METFORMIN d03807A C[@ E11 Type 2 diabetes mellitus A0 E A RAMIPRIL d00728A B 55555 A0 E A SIMVASTATIN d00746A C[@ E78.0 Pure hypercholesterolemia A0 E A . . . E A GABAPENTIN d03182A C- E11.4 Type 2 diabetes mellitus with neurological complications AP E A METFORMIN d03807A CDp E11 Type 2 diabetes mellitus AP E A NAPROXEN d00019A Cr M25.5 T14.9 Pain in joint Unspecified injury AP E A SIMVASTATIN d00746A CDp E78.0 Pure hypercholesterolemia AP E A TRAMADOL d03826A B M54 Dorsalgia AP E 0 A . . . E @ A . . . E P A . . . E ` A . . . E p A DULAGLUTIDE d08290A C E11 Type 2 diabetes mellitus AP E p A EMPAGLIFLOZIN; METFORMIN d08384A C- E11 Type 2 diabetes mellitus AP E p A LOSARTAN d03821A B[ I10 Essential (primary) hypertension AP E p A NEBIVOLOL d05265A Cr I10 Essential (primary) hypertension AP E p A SIMVASTATIN d00746A Cr E78.0 Pure hypercholesterolemia AP E A GRISEOFULVIN d00100A B B35 Dermatophytosis A E A CARVEDILOL d03847A Ei 99999 A E A DIVALPROEX SODIUM d03833A C- G40 Epilepsy and recurrent seizures A E A FUROSEMIDE d00070A B 99999 A E A NITROGLYCERIN d00321A D4 R00 Abnormalities of heart beat A E A PANTOPRAZOLE d04514A Ei 99999 A E A RIVAROXABAN d07356A CDp I10 Essential (primary) hypertension A E A ROSUVASTATIN d04851A Cr E78.0 Pure hypercholesterolemia A E A SACUBITRIL; VALSARTAN d08369A C- I51.9 Heart disease, unspecified A E A SPIRONOLACTONE d00373A B 99999 A E A AMLODIPINE d00689A D I10 Essential (primary) hypertension A E A ASPIRIN d00170A D Z79.0 Long term (current) use of anticoagulants and antithrombotics/antiplatelets A E A ATORVASTATIN d04105A D E78.0 Pure hypercholesterolemia A E A CLOPIDOGREL d04258A D Z79.0 Long term (current) use of anticoagulants and antithrombotics/antiplatelets A E A GLIPIZIDE d00246A C- R73 Elevated blood glucose level A E A METOPROLOL d00134A D I10 Essential (primary) hypertension A E A PANTOPRAZOLE d04514A C"0 R12 Heartburn A E A SITAGLIPTIN d05896A Ap R73 Elevated blood glucose level A E A 55555 A Cr 55555 A E A 55555 A D 55555 A E A 55555 A D R63 Symptoms and signs concerning food and fluid intake A E A ALBUTEROL d00749A CDp 55555 A E A ALBUTEROL d00749A D 55555 A E A AZITHROMYCIN d00091A C T78.40 Allergy, unspecified A E A PANCRELIPASE d01002A D 55555 A E A SODIUM CHLORIDE d00438A D 55555 A E A TOBRAMYCIN d00069A CDp 55555 A E A . . . E A . . . E A . . . E A ATORVASTATIN d04105A Dc E78.0 Pure hypercholesterolemia AP E A ENALAPRIL d00013A Dc I10 Essential (primary) hypertension AP E A LEVOTHYROXINE d00278A D E03.9 Hypothyroidism, unspecified AP E A METFORMIN d03807A C E11 Type 2 diabetes mellitus AP E A SERTRALINE d00880A C- F32.9 Major depressive disorder, single episode, unspecified AP E A . . . E A LOSARTAN d03821A CDp I10 Essential (primary) hypertension A E A RANITIDINE d00021A C- K30 Functional dyspepsia A E A FAMOTIDINE d00141A C K25 Gastric ulcer A E A FUROSEMIDE d00070A C[@ R60.9 Edema, unspecified A E A GABAPENTIN d03182A C[@ M79.2 Neuralgia and neuritis, unspecified A E A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A B= I10 Essential (primary) hypertension A E A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified A E A METHOCARBAMOL d00965A C- M62.83 Muscle spasm A E A ONDANSETRON d00867A C[@ R11 Nausea and vomiting A E A OXYCODONE d00329A C M25.5 M54 Pain in joint Dorsalgia A E A RIFAXIMIN d05294A CDp K76.9 Liver disease, unspecified A E A SPIRONOLACTONE d00373A Cr E87.6 Hypokalemia A E 0 A . . . E @ A . . . E P A ATENOLOL d00004A Ei I10 I20.9 I21.P Essential (primary) hypertension Angina pectoris, unspecified Prevent heart attack/myocardial infarction A E P A ATORVASTATIN d04105A Ei E78.0 Pure hypercholesterolemia A E P A DULAGLUTIDE d08290A CDp E11 Type 2 diabetes mellitus A E P A EZETIMIBE d04824A Ei E78.0 Pure hypercholesterolemia A E P A FUROSEMIDE d00070A Ei R60.9 Edema, unspecified A E P A GLIPIZIDE d00246A Ei E11 R73 Type 2 diabetes mellitus Elevated blood glucose level A E P A LEVOTHYROXINE d00278A Ei E03.9 Hypothyroidism, unspecified A E P A LORAZEPAM d00149A Ei F41.9 Anxiety disorder, unspecified A E P A LOSARTAN d03821A Ei I10 Essential (primary) hypertension A E P A OXYBUTYNIN d00328A Ei R32 Unspecified urinary incontinence A E P A SERTRALINE d00880A Ei F32.9 Major depressive disorder, single episode, unspecified A E P A SITAGLIPTIN d05896A Ei R73 Elevated blood glucose level A E ` A ESTRADIOL TOPICAL d04210A B[ N95 Menopausal and other perimenopausal disorders A E ` A FLUOROURACIL d00235A B8 C80.1 Malignant (primary) neoplasm, unspecified A E p A AMLODIPINE d00689A0 B I10 I51.9 Essential (primary) hypertension Heart disease, unspecified Ap E p A ATORVASTATIN d04105A0 Cr I51.9 Heart disease, unspecified Ap E p A CARVEDILOL d03847A0 B I10 I51.9P Essential (primary) hypertension Prevent heart disease Ap E p A CLOPIDOGREL d04258A0 B I51.9 Heart disease, unspecified Ap E p A LEVETIRACETAM d04499A0 B G40 Epilepsy and recurrent seizures Ap E p A LISINOPRIL d00732A0 B I10 Essential (primary) hypertension Ap E p A PANTOPRAZOLE d04514A0 CDp K21 Gastro-esophageal reflux disease Ap E A . . . E A CYANOCOBALAMIN d00413A C A E A DONEPEZIL d04099A Bz R41 Other symptoms and signs involving cognitive functions and awareness A E A . . . E A ACETAMINOPHEN; HYDROCODONE d03428A A K08.8 Other specified disorders of teeth and supporting structures A E A NORTRIPTYLINE d00144A B G43 Migraine A E A . . . E A AMLODIPINE d00689A C I10 Essential (primary) hypertension A E A CLONIDINE d00044A C I10 Essential (primary) hypertension A E A . . . E A ACYCLOVIR d00001A D* A60.9 Anogenital herpesviral infection, unspecified A@ E A CARVEDILOL d03847A D I49.9 Cardiac arrhythmia, unspecified A@ E A FOSINOPRIL d00242A C I51.9 Heart disease, unspecified A@ E A TAMSULOSIN d04121A D1 N42.9 Disorder of prostate, unspecified A@ E A . . . E A DESMOPRESSIN d00583A B R32 Unspecified urinary incontinence A E 0 A GABAPENTIN d03182A CDp M54 Dorsalgia AP E 0 A HYDROXYZINE d00907A Cr I10 Essential (primary) hypertension AP E 0 A LIDOCAINE TOPICAL d00683A CDp M25.5 Pain in joint AP E 0 A MELOXICAM d04532A CDp M25.5 Pain in joint AP E 0 A METHOCARBAMOL d00965A CDp M25.5 Pain in joint AP E @ A HYDROCHLOROTHIAZIDE; LOSARTAN d03830A0 C- I10 Essential (primary) hypertension A E @ A LEVOTHYROXINE d00278A0 Dc E03.9 Hypothyroidism, unspecified A E P A . . . E ` A . . . E p A ATORVASTATIN d04105A C I21.P Prevent heart attack/myocardial infarction A@ E p A CARVEDILOL d03847A C I10 Essential (primary) hypertension A@ E p A ISOSORBIDE MONONITRATE d00269A A R07.9 Chest pain, unspecified A@ E p A VALSARTAN d04113A C I10 Essential (primary) hypertension A@ E A ACETAMINOPHEN; HYDROCODONE d03428A C M54 Dorsalgia A E A AMLODIPINE d00689A C I10 Essential (primary) hypertension A E A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A E A CARVEDILOL d03847A C I10 Essential (primary) hypertension A E A CLOPIDOGREL d04258A C D75.9P Prevent blood clots A E A EZETIMIBE d04824A C E78.0 Pure hypercholesterolemia A E A INSULIN ASPART d04697A D E11 Type 2 diabetes mellitus A E A INSULIN GLARGINE d04538A D E11 Type 2 diabetes mellitus A E A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified A E A LISINOPRIL d00732A C I10 Essential (primary) hypertension A E A LORAZEPAM d00149A C F41.9 Anxiety disorder, unspecified A E A VENLAFAXINE d03181A CDp F32.9 Major depressive disorder, single episode, unspecified A E A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E A AMLODIPINE d00689A C I10 Essential (primary) hypertension A@ E A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A@ E A HYDROCHLOROTHIAZIDE d00253A C R60.9 Edema, unspecified A@ E A LISINOPRIL d00732A C I10 Essential (primary) hypertension A@ E A . . . E A . . . E A . . . E 0 A . . . E @ A . . . E P A . . . E ` A AMPHETAMINE; DEXTROAMPHETAMINE d04035A C"0 F90 Attention-deficit hyperactivity disorders A E p A . . . E A CITALOPRAM d04332A Bz F41.9 Anxiety disorder, unspecified A` E A CLONIDINE d00044A Cr F41.9 Anxiety disorder, unspecified A` E A ETHINYL ESTRADIOL; NORETHINDRONE d03238A C- Z79.3 Long term (current) use of hormonal contraceptives A` E A GABAPENTIN d03182A Cr F39 Unspecified mood [affective] disorder A` E A METHADONE d00050A C[@ 55555 A` E A QUETIAPINE d04220A Cr G47.0 Insomnia A` E A LEVETIRACETAM d04499A D G40 Epilepsy and recurrent seizures A E A RANITIDINE d00021A D# K21 Gastro-esophageal reflux disease A E A . . . E A . . . E A . . . E A . . . E A LANSOPRAZOLE d03828A C K30 Functional dyspepsia A E A . . . E A ALBUTEROL d00749A C- J45 Asthma A0 E A CETIRIZINE d03827A C- H10.1 J45 Acute atopic conjunctivitis Asthma A0 E A FLUTICASONE NASAL d04283A C- J30.9 Allergic rhinitis, unspecified A0 E A . . . E A . . . E 0 A . . . E @ A . . . E P A . . . E ` A METHYLPHENIDATE d00900A CDp F90 Attention-deficit hyperactivity disorders A E p A MELOXICAM d04532A0 CDp M13 M25.5 Other arthritis Pain in joint A E p A OMEPRAZOLE d00325A0 CDp K25 R12 Gastric ulcer Heartburn A E A . . . E A ATENOLOL d00004A Cr I10 Essential (primary) hypertension A E A PRAVASTATIN d00348A Cr E78.0 Pure hypercholesterolemia A E A . . . E A . . . E A . . . E A DULOXETINE d05355A C[@ M79.1 Myalgia A0 E A GABAPENTIN d03182A D M79.2 Neuralgia and neuritis, unspecified A0 E A TOPIRAMATE d04115A C- G43 Migraine A0 E A LISINOPRIL d00732A CDp I10 Essential (primary) hypertension A E A . . . E A HYDROCHLOROTHIAZIDE; LOSARTAN d03830A C"0 I10 Essential (primary) hypertension A E A . . . E A THYROID DESICCATED d00655A C E03.9 Hypothyroidism, unspecified A E 0 A . . . E @ A . . . E P A ACETAMINOPHEN; BUTALBITAL; CAFFEINE d03455A C"0 R51 Headache A E P A ALPRAZOLAM d00168A D= F41.9 Anxiety disorder, unspecified A E P A AMLODIPINE d00689A C I10 Essential (primary) hypertension A E P A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A E P A CLOPIDOGREL d04258A C D75.9P Prevent blood clots A E P A HYDROCHLOROTHIAZIDE d00253A D I10 Essential (primary) hypertension A E P A LISINOPRIL d00732A C I10 Essential (primary) hypertension A E P A ONDANSETRON d00867A C R11 Nausea and vomiting A E ` A . . . E p A LISINOPRIL d00732A C- I10 Essential (primary) hypertension A E A . . . E A . . . E A . . . E A . . . E A LISDEXAMFETAMINE d06663A C F90 Attention-deficit hyperactivity disorders A E A . . . E A . . . E A LISDEXAMFETAMINE d06663A C F90 Attention-deficit hyperactivity disorders A E A ALBUTEROL d00749A C[@ J45 Asthma A E A FLUTICASONE d01296A C J45 Asthma A E A . . . E A . . . E 0 A . . . E @ A . . . E P A DAPAGLIFLOZIN d07928A B E11 Type 2 diabetes mellitus A@ E P A INSULIN REGULAR d04369A B E11 Type 2 diabetes mellitus A@ E P A LIRAGLUTIDE d07466A C- E11 Type 2 diabetes mellitus A@ E P A METFORMIN d03807A C E11 Type 2 diabetes mellitus A@ E ` A . . . E p A FLUTICASONE NASAL d04283A Cr R09.81 Nasal congestion A E p A FLUTICASONE; SALMETEROL d04611A C J45 Asthma A E A IBUPROFEN d00015A C M54 M79.1 R51 Dorsalgia Myalgia Headache A0 E A SEX HORMONES COMBINATION - UNSPECIFIED c00186A B Z79.890 Hormone replacement therapy A0 E A THYROID DESICCATED d00655A B E03.9 Hypothyroidism, unspecified A0 E A HYDROCHLOROTHIAZIDE d00253A C[@ I10 Essential (primary) hypertension A E A LISINOPRIL d00732A C[@ I10 Essential (primary) hypertension A E A ALPRAZOLAM d00168A Bz F41.9 Anxiety disorder, unspecified AP E A BUPROPION d00181A A@ E66 F41.9 Overweight and obesity Anxiety disorder, unspecified AP E A HYDROCHLOROTHIAZIDE d00253A Cr I10 Essential (primary) hypertension AP E A METOCLOPRAMIDE d00298A C- G43 Migraine AP E A TOPIRAMATE d04115A CDp E66 G43 Overweight and obesity Migraine AP E A . . . E A AMPHETAMINE d00803A C F90 Attention-deficit hyperactivity disorders A E A . . . E A . . . E A . . . E A . . . E A . . . E A AMLODIPINE d00689A Dc I10 Essential (primary) hypertension AP E A DICLOFENAC; MISOPROSTOL d04271A Cr M13 M54 Other arthritis Dorsalgia AP E A ESOMEPRAZOLE d04749A C- K30 Functional dyspepsia AP E A LEVOTHYROXINE d00278A D# E03.9 Hypothyroidism, unspecified AP E A LOSARTAN d03821A Dc I10 Essential (primary) hypertension AP E 0 A CETIRIZINE d03827A CDp J30.9 T78.40 Allergic rhinitis, unspecified Allergy, unspecified A E 0 A CLONAZEPAM d00197A C F41.9 G25.81 Anxiety disorder, unspecified Restless legs syndrome A E 0 A DEXLANSOPRAZOLE d07395A CDp K21 Gastro-esophageal reflux disease A E 0 A FLUTICASONE NASAL d04283A B= J30.9 R09.81 Allergic rhinitis, unspecified Nasal congestion A E 0 A FLUVOXAMINE d03804A CDp F33.9 F41.9 M79.7 Major depressive disorder, recurrent, unspecified Anxiety disorder, unspecified Fibromyalgia A E 0 A OLMESARTAN d04801A Dc I10 Essential (primary) hypertension A E 0 A RISPERIDONE d03180A A F33.9 F39 F84 Major depressive disorder, recurrent, unspecified Unspecified mood [affective] disorder Pervasive developmental disorders A E 0 A ROPINIROLE d04215A CDp G25.81 Restless legs syndrome A E 0 A TESTOSTERONE d00558A C[@ E29.1 Testicular hypofunction A E @ A . . . E P A ACETAMINOPHEN; HYDROCODONE d03428A C M54 M79.2 M79.6 Dorsalgia Neuralgia and neuritis, unspecified Pain in limb, hand, foot, fingers and toes A0 E P A GABAPENTIN d03182A C M79.6 Pain in limb, hand, foot, fingers and toes A0 E P A TRAZODONE d00395A B[ G47.0 Insomnia A0 E ` A BETAMETHASONE; CLOTRIMAZOLE TOPICAL d03561A B L20.9 Atopic dermatitis, unspecified A E p A DEXMETHYLPHENIDATE d04777A B F90 Attention-deficit hyperactivity disorders A E A . . . E A EZETIMIBE d04824A C E78.0 Pure hypercholesterolemia A E A ENALAPRIL; HYDROCHLOROTHIAZIDE d03740A Dc I10 Essential (primary) hypertension A0 E A MELOXICAM d04532A B= M06.9 Rheumatoid arthritis, unspecified A0 E A OMEPRAZOLE d00325A C R12 Heartburn A0 E A CARVEDILOL d03847A C I49.9 Cardiac arrhythmia, unspecified A@ E A EZETIMIBE d04824A C- E78.0 Pure hypercholesterolemia A@ E A OMEPRAZOLE d00325A C K21 Gastro-esophageal reflux disease A@ E A PITAVASTATIN d07637A C- E78.0 Pure hypercholesterolemia A@ E A . . . E A . . . E A . . . E A . . . E A . . . E A CYCLOBENZAPRINE d00963A B= M62.83 Muscle spasm A` E A ESCITALOPRAM d04812A C F41.9 Anxiety disorder, unspecified A` E A LISINOPRIL d00732A C I10 Essential (primary) hypertension A` E A PRAVASTATIN d00348A C[@ E78.0 Pure hypercholesterolemia A` E A QUETIAPINE d04220A C G47.0 Insomnia A` E A ZOLPIDEM d00910A C F41.9 Anxiety disorder, unspecified A` E A . . . E 0 A AMLODIPINE d00689A C"0 I10 Essential (primary) hypertension AP E 0 A ATENOLOL; CHLORTHALIDONE d03258A D; I10 Essential (primary) hypertension AP E 0 A EZETIMIBE d04824A B E78.0 Pure hypercholesterolemia AP E 0 A METFORMIN d03807A D"8 R73 Elevated blood glucose level AP E 0 A RAMIPRIL d00728A Dc E11.2P Prevent diabetic kidney disease AP E @ A . . . E P A ALBUTEROL d00749A CDp J45 Asthma A E P A ATORVASTATIN d04105A C 99999 A E P A BRIMONIDINE; TIMOLOL OPHTHALMIC d05283A B[ H40 Glaucoma A E P A CARVEDILOL d03847A C 99999 A E P A CETIRIZINE d03827A B T78.40 Allergy, unspecified A E P A ESCITALOPRAM d04812A C 99999 A E P A ESTRADIOL d00537A C[@ 99999 A E P A GABAPENTIN d03182A C- M54 Dorsalgia A E P A LEVOTHYROXINE d00278A C 99999 A E P A MONTELUKAST d04289A B 99999 A E P A RIVAROXABAN d07356A C- I51.9 Heart disease, unspecified A E ` A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified A0 E ` A ROSUVASTATIN d04851A C E78.0 Pure hypercholesterolemia A0 E ` A TIZANIDINE d04102A C- G47.0 Insomnia A0 E p A . . . E A . . . E A . . . E A . . . E A ATENOLOL d00004A C I10 Essential (primary) hypertension A0 E A NAPROXEN d00019A C- M19.9 Osteoarthritis, unspecified site A0 E A PRAVASTATIN d00348A CDp E78.0 Pure hypercholesterolemia A0 E A . . . E A . . . E A ALBUTEROL d00749A C J45 Asthma A E A . . . E A AMLODIPINE d00689A C[@ I10 Essential (primary) hypertension A E A ATORVASTATIN d04105A C[@ E78.0 Pure hypercholesterolemia A E A BACLOFEN d00967A C M54 Dorsalgia A E A CLONIDINE d00044A C I10 Essential (primary) hypertension A E A HYDRALAZINE d00132A Bz I10 Essential (primary) hypertension A E A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A C I10 Essential (primary) hypertension A E A INSULIN DETEMIR d05436A C- E11 Type 2 diabetes mellitus A E A RANITIDINE d00021A C K30 Functional dyspepsia A E A SERTRALINE d00880A C F32.9 Major depressive disorder, single episode, unspecified A E A . . . E A . . . E 0 A . . . E @ A ETHINYL ESTRADIOL; NORETHINDRONE d03238A B N92 Excessive, frequent and irregular menstruation A E P A . . . E ` A AMOXICILLIN d00088A A J02 R05 Acute pharyngitis Cough A E p A . . . E A . . . E A . . . E A AMOXICILLIN d00088A A B99.9 Unspecified infectious disease A E A . . . E A PAROXETINE d03157A C- F32.9 Major depressive disorder, single episode, unspecified A E A . . . E A BROMPHENIRAMINE; DEXTROMETHORPHAN; PSEUDOEPHEDRINE d03368A Ap R05 Cough A E A CEFDINIR d04256A A@ J42 Unspecified chronic bronchitis A E A . . . E A . . . E A . . . E A . . . E 0 A . . . E @ A CETIRIZINE d03827A B L23 T78.40 Allergic contact dermatitis Allergy, unspecified A E @ A MONTELUKAST d04289A C- J30.1 J30.9 Allergic rhinitis due to pollen Allergic rhinitis, unspecified A E P A . . . E ` A . . . E p A . . . E A . . . E A . . . E A DEXMETHYLPHENIDATE d04777A C F90 Attention-deficit hyperactivity disorders A E A CLOPIDOGREL d04258A C I63 Cerebral infarction AP E A DONEPEZIL d04099A C R41 Other symptoms and signs involving cognitive functions and awareness AP E A LEVOTHYROXINE d00278A B= E03.9 Hypothyroidism, unspecified AP E A MECLIZINE d00859A B R42 Dizziness and giddiness AP E A TAMSULOSIN d04121A C N40 Enlarged prostate AP E A GLIMEPIRIDE d03864A C- E11 Type 2 diabetes mellitus A E A METFORMIN d03807A C- E11 Type 2 diabetes mellitus A E A . . . E A . . . E A AMLODIPINE d00689A C I10 Essential (primary) hypertension AP E A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia AP E A LISINOPRIL d00732A C I10 Essential (primary) hypertension AP E A METFORMIN d03807A C E11 Type 2 diabetes mellitus AP E A METOPROLOL d00134A C I10 R07.9 Essential (primary) hypertension Chest pain, unspecified AP E A . . . E A LEVOTHYROXINE d00278A CDp E03.9 Hypothyroidism, unspecified A@ E A NAPROXEN d00019A CDp M25.5 M79.1 Pain in joint Myalgia A@ E A SERTRALINE d00880A D F32.9 Major depressive disorder, single episode, unspecified A@ E A TRAMADOL d03826A C[@ M06.9 M25.5 Rheumatoid arthritis, unspecified Pain in joint A@ E A . . . E 0 A SIMVASTATIN d00746A B E78.0 Pure hypercholesterolemia A E @ A . . . E P A 99999 . . A E ` A NEBIVOLOL d05265A C[@ I10 Essential (primary) hypertension A E ` A PRAVASTATIN d00348A C[@ E78.0 Pure hypercholesterolemia A E p A . . . E A FAMOTIDINE d00141A Cr K21 Gastro-esophageal reflux disease AP E A FINASTERIDE d00563A C N40 Enlarged prostate AP E A FUROSEMIDE d00070A C- I51.9 Heart disease, unspecified AP E A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia AP E A WARFARIN d00022A C I48.9 Unspecified atrial fibrillation and atrial flutter AP E A ALPRAZOLAM d00168A B= F41.9 Anxiety disorder, unspecified A0 E A ETHINYL ESTRADIOL; NORELGESTROMIN d04779A CDp Z79.3 Long term (current) use of hormonal contraceptives A0 E A LISDEXAMFETAMINE d06663A C"0 F90 Attention-deficit hyperactivity disorders A0 E A . . . E A . . . E A METOPROLOL d00134A C I10 Essential (primary) hypertension A E A GABAPENTIN d03182A B M79.2 Neuralgia and neuritis, unspecified A E A HYDROCHLOROTHIAZIDE; LOSARTAN d03830A Cr I10 Essential (primary) hypertension A E A LOVASTATIN d00280A Cr E78.0 Pure hypercholesterolemia A E A METFORMIN d03807A C E11 Type 2 diabetes mellitus A E A METOPROLOL d00134A C- I10 Essential (primary) hypertension A E A PANTOPRAZOLE d04514A C- K21 Gastro-esophageal reflux disease A E A PIOGLITAZONE d04442A C- E11 Type 2 diabetes mellitus A E A PROBENECID d00031A C M10.9 Gout, unspecified A E A RANITIDINE d00021A C- K21 Gastro-esophageal reflux disease A E A . . . E A ALBUTEROL d00749A D# J98.9 Respiratory disorder, unspecified A E A ALBUTEROL d00749A D1 J98.9 Respiratory disorder, unspecified A E A BECLOMETHASONE NASAL d04275A C"0 R09.81 Nasal congestion A E A BENRALIZUMAB d08675A0 Bz J98.9 Respiratory disorder, unspecified A E A BENZONATATE d00796A Cr R05 Cough A E A BUDESONIDE; FORMOTEROL d04795A C J98.9 Respiratory disorder, unspecified A E A EPINEPHRINE d00699A CDp J98.9 Respiratory disorder, unspecified A E A FLUTICASONE; SALMETEROL d04611A C J98.9 Respiratory disorder, unspecified A E A IPRATROPIUM d00265A C- J98.9 Respiratory disorder, unspecified A E A MONTELUKAST d04289A Dc R09 Other symptoms and signs involving the circulatory and respiratory system A E A OMEPRAZOLE d00325A CDp R12 Heartburn A E A PANTOPRAZOLE d04514A C R12 Heartburn A E A TESTOSTERONE d00558A C- E29.1 Testicular hypofunction A E A TIOTROPIUM d04829A C J98.9 Respiratory disorder, unspecified A E A TOPIRAMATE d04115A D G43 Migraine A E A ATORVASTATIN d04105A C- E78.0 Pure hypercholesterolemia A@ E A LISINOPRIL d00732A C- I10 Essential (primary) hypertension A@ E A METFORMIN d03807A C- E11 Type 2 diabetes mellitus A@ E A METOPROLOL d00134A C- I21.P I50.9 Prevent heart attack/myocardial infarction Heart failure, unspecified A@ E A . . . E A LOSARTAN d03821A C I10 Essential (primary) hypertension A E A METOPROLOL d00134A C I10 I21.P Essential (primary) hypertension Prevent heart attack/myocardial infarction A E 0 A . . . E @ A . . . E P A ANTIHYPERTENSIVE AGENTS - UNSPECIFIED h00024. . A0 E P A LEFLUNOMIDE d04349A BZ D89.9 Disorder involving the immune mechanism, unspecified A0 E P A PREDNISONE d00350A CDp D89.9 Disorder involving the immune mechanism, unspecified A0 E ` A . . . E p A . . . E A DILTIAZEM d00045A Cr I48.9 Unspecified atrial fibrillation and atrial flutter A E A FLECAINIDE d00234A C[@ I48.9 Unspecified atrial fibrillation and atrial flutter A E A . . . E A . . . E A AMLODIPINE d00689A C I10 Essential (primary) hypertension A0 E A CARVEDILOL d03847A C I10 Essential (primary) hypertension A0 E A LEVOTHYROXINE d00278A C E07.9 Disorder of thyroid, unspecified A0 E A . . . E A BUSPIRONE d00182A D F41.9 Anxiety disorder, unspecified A@ E A LISINOPRIL d00732A C- I10 Essential (primary) hypertension A@ E A MONTELUKAST d04289A D# J30.9 Allergic rhinitis, unspecified A@ E A OMEPRAZOLE d00325A D= K21 Gastro-esophageal reflux disease A@ E A QUETIAPINE d04220A C F32.9 Major depressive disorder, single episode, unspecified A E A VALPROIC ACID d00083A C F39 Unspecified mood [affective] disorder A E A . . . E A . . . E A AMPHETAMINE; DEXTROAMPHETAMINE d04035A D F90 Attention-deficit hyperactivity disorders A E A . . . E 0 A . . . E @ A CLINDAMYCIN TOPICAL d01241A C- L70 Acne A E @ A TRETINOIN TOPICAL d01244A C- L70 Acne A E P A AMLODIPINE d00689A CDp I10 Essential (primary) hypertension A E ` A . . . E p A . . . E A ASPIRIN d00170A C I51.9P Prevent heart disease AP E A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia AP E A CLOPIDOGREL d04258A C I21.P Prevent heart attack/myocardial infarction AP E A METFORMIN d03807A C E11 Type 2 diabetes mellitus AP E A RAMIPRIL d00728A C I50.9 Heart failure, unspecified AP E A AMOXICILLIN d00088A A J01.9 Acute sinusitis, unspecified A E A . . . E A . . . E A ALBUTEROL d00749A B- J45 Asthma A E A ALBUTEROL d00749A B- J45 Asthma A E A CINACALCET d05218A B N18.9 Chronic kidney disease, unspecified A E A FEBUXOSTAT d07397A C M10.9 Gout, unspecified A E A FLUTICASONE d01296A B= J45 Asthma A E A METOPROLOL d00134A Dc I10 Essential (primary) hypertension A E A PREDNISOLONE d00084A Ap J45 Asthma A E A PREDNISONE d00350A D= T86.9P Prevent transplanted organ and tissue rejection A E A SEVELAMER d04363A C9 N19 Unspecified kidney failure A E A VALSARTAN d04113A Dc I10 Essential (primary) hypertension A E A . . . E A ANASTROZOLE d03873A C- C50 Malignant neoplasm of breast A E A ESOMEPRAZOLE d04749A D* K21 Gastro-esophageal reflux disease A E A . . . E A ACETAMINOPHEN; HYDROCODONE d03428A B M54 Dorsalgia A E A CARISOPRODOL d00960A C[@ M79.1 Myalgia A E A CLOPIDOGREL d04258A Cr D75.9P Prevent blood clots A E A GABAPENTIN d03182A C[@ E11.4 Type 2 diabetes mellitus with neurological complications A E A GLIPIZIDE d00246A Cr E11 R73 Type 2 diabetes mellitus Elevated blood glucose level A E A ISOSORBIDE MONONITRATE d00269A C"0 I21.P Prevent heart attack/myocardial infarction A E A LINAGLIPTIN d07767A C"0 E11 Type 2 diabetes mellitus A E A NAPROXEN d00019A C"0 M19.9 M25.5 M79.2 Osteoarthritis, unspecified site Pain in joint Neuralgia and neuritis, unspecified A E A ASPIRIN d00170A C M54 Dorsalgia A@ E A BENZONATATE d00796A B R05 Cough A@ E A DILTIAZEM d00045A C I51.9 Heart disease, unspecified A@ E A FUROSEMIDE d00070A C R60.9 Edema, unspecified A@ E A GLIPIZIDE d00246A C E11 Type 2 diabetes mellitus A E A LISINOPRIL d00732A C I10 Essential (primary) hypertension A E 0 A LETROZOLE d04156A C[@ C50 Malignant neoplasm of breast A0 E 0 A LEVOTHYROXINE d00278A C E04 Other nontoxic goiter A0 E 0 A LOSARTAN d03821A C I10 Essential (primary) hypertension A0 E @ A . . . E P A AMLODIPINE d00689A C9 I51.9P Prevent heart disease A E P A ASPIRIN; DIPYRIDAMOLE d04497A C9 D75.9P I63.P Prevent blood clots Prevent stroke A E P A ATORVASTATIN d04105A C9 E78.0 Pure hypercholesterolemia A E P A LAMOTRIGINE d03809A C9 G99.8 Other specified disorders of nervous system in diseases classified elsewhere A E P A MELOXICAM d04532A C M19.9 Osteoarthritis, unspecified site A E P A METFORMIN d03807A C E11 Type 2 diabetes mellitus A E P A METOPROLOL d00134A C9 I51.9P Prevent heart disease A E P A OMEPRAZOLE d00325A C[@ K30 Functional dyspepsia A E P A ONDANSETRON d00867A B K30 R11 Functional dyspepsia Nausea and vomiting A E P A TOLTERODINE d04294A C9 R32 Unspecified urinary incontinence A E ` A . . . E p A METFORMIN d03807A D1 R73 Elevated blood glucose level A E A . . . E A PRAVASTATIN d00348A B E78.0 Pure hypercholesterolemia A E A . . . E A ATORVASTATIN d04105A C[@ E78.0 Pure hypercholesterolemia A@ E A GLIPIZIDE d00246A C E11 Type 2 diabetes mellitus A@ E A LISINOPRIL d00732A C I10 Essential (primary) hypertension A@ E A METFORMIN d03807A C E11 Type 2 diabetes mellitus A@ E A . . . E A . . . E A ALENDRONATE d03849A Cr M81 Osteoporosis without current pathological fracture A E A DIURETICS - UNSPECIFIED c00049A Ap N28.9P Prevent kidney disease A E A GABAPENTIN d03182A C- M25.5 M54 Pain in joint Dorsalgia A E A INSULIN ASPART d04697A C E11 Type 2 diabetes mellitus A E A INSULIN GLARGINE d04538A C E11 Type 2 diabetes mellitus A E A LISINOPRIL d00732A Cr I10 Essential (primary) hypertension A E A METOPROLOL d00134A B R00 Abnormalities of heart beat A E A MONTELUKAST d04289A C J42 J45 Unspecified chronic bronchitis Asthma A E A RANITIDINE d00021A Cr K30 Functional dyspepsia A E A ROSUVASTATIN d04851A B E78.0 Pure hypercholesterolemia A E A SITAGLIPTIN d05896A B E11 Type 2 diabetes mellitus A E A ALOGLIPTIN d07963A C- E11 Type 2 diabetes mellitus A E A AMLODIPINE d00689A C 99999 A E A HYDRALAZINE d00132A C 99999 A E A HYDROCHLOROTHIAZIDE d00253A C I50.9 Heart failure, unspecified A E A INSULIN GLARGINE d04538A C[@ E11 Type 2 diabetes mellitus A E A LOSARTAN d03821A C I10 Essential (primary) hypertension A E A METOPROLOL d00134A C I10 Essential (primary) hypertension A E A NATEGLINIDE d04743A Cr R73 Elevated blood glucose level A E A PRAVASTATIN d00348A Cr E78.0 Pure hypercholesterolemia A E A ROPINIROLE d04215A CDp G20 Parkinson's disease A E A . . . E A OSELTAMIVIR d04462A AP J09 Influenza due to certain identified influenza viruses A E A . . . E 0 A . . . E @ A BUPROPION d00181A CDp F32.9 Major depressive disorder, single episode, unspecified A E @ A CIPROFLOXACIN OPHTHALMIC d03211A A0 H57.9 Unspecified disorder of eye and adnexa A E @ A FLUOXETINE d00236A Cr F32.9 Major depressive disorder, single episode, unspecified A E @ A FLUTICASONE NASAL d04283A Cr J30.9 Allergic rhinitis, unspecified A E @ A IBUPROFEN d00015A C M54 Dorsalgia A E @ A KETOROLAC OPHTHALMIC d03214A A0 H57.9 Unspecified disorder of eye and adnexa A E @ A OMEPRAZOLE d00325A C K21 Gastro-esophageal reflux disease A E @ A OXYBUTYNIN d00328A Cr N32.81 Overactive bladder A E @ A PREDNISOLONE d00084A A0 H57.9 Unspecified disorder of eye and adnexa A E @ A VALACYCLOVIR d03838A C A60.9 Anogenital herpesviral infection, unspecified A E P A . . . E ` A . . . E p A ABACAVIR; DOLUTEGRAVIR; LAMIVUDINE d08284A C B20 Human immunodeficiency virus [HIV] disease A E A . . . E A . . . E A . . . E A . . . E A . . . E A ALBUTEROL d00749A CDp J44.9 Chronic obstructive pulmonary disease, unspecified A E A AMLODIPINE d00689A CDp I10 Essential (primary) hypertension A E A FLUTICASONE; SALMETEROL d04611A CDp J44.9 Chronic obstructive pulmonary disease, unspecified A E A HYDROCHLOROTHIAZIDE d00253A CDp I10 Essential (primary) hypertension A E A LISINOPRIL d00732A CDp I10 Essential (primary) hypertension A E A METFORMIN d03807A CDp R73 Elevated blood glucose level A E A MONTELUKAST d04289A B= R06.2 Wheezing A E A TIOTROPIUM d04829A CDp J44.9 Chronic obstructive pulmonary disease, unspecified A E A . . . E A . . . E A . . . E A . . . E A AMOXICILLIN; CLAVULANATE d00089A AP J02 Acute pharyngitis A E 0 A . . . E @ A GLIPIZIDE d00246A Cr E11 Type 2 diabetes mellitus A E @ A METFORMIN d03807A D E11 Type 2 diabetes mellitus A E P A ATENOLOL d00004A D# I10 Essential (primary) hypertension Ap E P A CYCLOBENZAPRINE d00963A B M62.83 Muscle spasm Ap E P A HYDROCHLOROTHIAZIDE d00253A Cr R60.9 Edema, unspecified Ap E P A LEVOTHYROXINE d00278A D E03.9 Hypothyroidism, unspecified Ap E P A LOVASTATIN d00280A Dc E78.0 Pure hypercholesterolemia Ap E P A MELOXICAM d04532A B= M13 Other arthritis Ap E P A POTASSIUM CHLORIDE d00345A Dc E87.6 Hypokalemia Ap E ` A METFORMIN d03807A C E11 Type 2 diabetes mellitus A E p A . . . E A LISINOPRIL d00732A D# I10 Essential (primary) hypertension A E A PAROXETINE d03157A D# F32.9 F41.9 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified A E A . . . E A FINASTERIDE d00563A Cr C61 Malignant neoplasm of prostate A@ E A LEVOTHYROXINE d00278A CDp E03.9 Hypothyroidism, unspecified A@ E A LOSARTAN d03821A D I10 Essential (primary) hypertension A@ E A OMEPRAZOLE d00325A C- 99999 A@ E A HYDROCORTISONE TOPICAL d03205A C[@ L20.9 Atopic dermatitis, unspecified A E A DILTIAZEM d00045A C I10 Essential (primary) hypertension A@ E A FUROSEMIDE d00070A B[ R60.9 Edema, unspecified A@ E A RANITIDINE d00021A B K30 Functional dyspepsia A@ E A ZAFIRLUKAST d04053A C J45 Asthma A@ E A . . . E A . . . E A MELOXICAM d04532A C M06.9 Rheumatoid arthritis, unspecified A E A OMEPRAZOLE d00325A C K21 Gastro-esophageal reflux disease A E A . . . E A . . . E A . . . E 0 A EZETIMIBE d04824A C- E78.0 Pure hypercholesterolemia A E 0 A ROSUVASTATIN d04851A C- E78.0 Pure hypercholesterolemia A E @ A . . . E P A ETHINYL ESTRADIOL; NORETHINDRONE d03238A B[ N92 Excessive, frequent and irregular menstruation A E P A ISOTRETINOIN d01245A B L70 Acne A E ` A AMOXICILLIN; CLAVULANATE d00089A A J01.9 Acute sinusitis, unspecified A0 E ` A BROMPHENIRAMINE d00785A A J40 Bronchitis, not specified as acute or chronic A0 E ` A ETHINYL ESTRADIOL; NORETHINDRONE d03238A C- Z79.3 Long term (current) use of hormonal contraceptives A0 E p A . . . E A FUROSEMIDE d00070A D* R60.9 Edema, unspecified A0 E A METOPROLOL d00134A B I10 Essential (primary) hypertension A0 E A SIMVASTATIN d00746A C[@ E78.0 Pure hypercholesterolemia A0 E A . . . E A FLUTICASONE NASAL d04283A B J30.2 Other seasonal allergic rhinitis A E A AMLODIPINE d00689A C I10 Essential (primary) hypertension AP E A LISINOPRIL d00732A C I10 Essential (primary) hypertension AP E A METOPROLOL d00134A C I10 Essential (primary) hypertension AP E A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia AP E A TRAZODONE d00395A C G47.0 Insomnia AP E A . . . E A . . . E A . . . E A . . . E A . . . E A ATENOLOL d00004A C I10 Essential (primary) hypertension A@ E A CLONAZEPAM d00197A C F41.9 Anxiety disorder, unspecified A@ E A CLONIDINE d00044A B F41.9 Anxiety disorder, unspecified A@ E A MIRTAZAPINE d04025A C F32.9 F41.9 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified A@ E A . . . E 0 A AMOXICILLIN d00088A A H66.9 Otitis media, unspecified A E @ A ATORVASTATIN d04105A C& E78.0 Pure hypercholesterolemia A0 E @ A GLIPIZIDE d00246A C& E11 Type 2 diabetes mellitus A0 E @ A METFORMIN d03807A C& E11 Type 2 diabetes mellitus A0 E P A METFORMIN d03807A Cr R73 Elevated blood glucose level A E P A SIMVASTATIN d00746A Cr E78.0 Pure hypercholesterolemia A E ` A . . . E p A . . . E A . . . E A ETHINYL ESTRADIOL; NORETHINDRONE d03238A C Z79.3 Long term (current) use of hormonal contraceptives A E A OMEPRAZOLE d00325A Cr K21 R12 Gastro-esophageal reflux disease Heartburn A E A . . . E A . . . E A . . . E A AMOXICILLIN d00088A A K04.7 Periapical abscess without sinus A E A AMLODIPINE d00689A C I10 I21.P Essential (primary) hypertension Prevent heart attack/myocardial infarction A E A ATORVASTATIN d04105A CDp I21.P Prevent heart attack/myocardial infarction A E A BUMETANIDE d00179A C R60.9 Edema, unspecified A E A CARVEDILOL d03847A C I50.9 Heart failure, unspecified A E A DABIGATRAN d07137A C I48.9 Unspecified atrial fibrillation and atrial flutter A E A GABAPENTIN d03182A C M79.1 Myalgia A E A LOSARTAN d03821A C I10 Essential (primary) hypertension A E A MIRABEGRON d07876A C- N32.81 Overactive bladder A E A POTASSIUM CHLORIDE d00345A C E87.6 Hypokalemia A E A . . . E A . . . E A . . . E 0 A BUSPIRONE d00182A0 B F33.9 Major depressive disorder, recurrent, unspecified A` E 0 A COBICISTAT; ELVITEGRAVIR; EMTRICITABINE; TENOFOVIR d07899A0 Cr B20 Human immunodeficiency virus [HIV] disease A` E 0 A ESCITALOPRAM d04812A0 Cr F31.9 Bipolar disorder, unspecified A` E 0 A LAMOTRIGINE d03809A0 Cr F31.9 Bipolar disorder, unspecified A` E 0 A ROSUVASTATIN d04851A0 CDp E78.0 Pure hypercholesterolemia A` E 0 A TERAZOSIN d00386A0 CDp N40 Enlarged prostate A` E @ A BUPROPION d00181A C F41.9 Anxiety disorder, unspecified Ap E @ A HYDROCHLOROTHIAZIDE d00253A C[@ I10 Essential (primary) hypertension Ap E @ A LOSARTAN d03821A C I10 Essential (primary) hypertension Ap E @ A MELOXICAM d04532A C M25.5 Pain in joint Ap E @ A OMEPRAZOLE d00325A Cr K21 Gastro-esophageal reflux disease Ap E @ A SERTRALINE d00880A CDp F41.9 Anxiety disorder, unspecified Ap E @ A SIMVASTATIN d00746A CDp E78.0 Pure hypercholesterolemia Ap E P A . . . E ` A . . . E p A DIVALPROEX SODIUM d03833A D,3 G40 Epilepsy and recurrent seizures A E A DULOXETINE d05355A B[ F41.9 Anxiety disorder, unspecified Ap E A GABAPENTIN d03182A B F41.9 G40 Anxiety disorder, unspecified Epilepsy and recurrent seizures Ap E A MEDROXYPROGESTERONE d00284A B N92 Excessive, frequent and irregular menstruation Ap E A OMEPRAZOLE d00325A C R10 Abdominal and pelvic pain Ap E A PRAZOSIN d00138A C- F32.9 F41.9 F43.1 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified Post-traumatic stress disorder (PTSD) Ap E A RIZATRIPTAN d04328A C- G43 Migraine Ap E A ZONISAMIDE d04527A C- G43 Migraine Ap E A . . . E A . . . E A . . . E A . . . E A SERTRALINE d00880A B N94 Pain and other conditions associated with female genital organs and menstrual cycle A E A LISINOPRIL d00732A CDp N28.9 Disorder of kidney and ureter, unspecified A E A . . . E A AMOXICILLIN d00088A Ap H66.9 Otitis media, unspecified A0 E A ARIPIPRAZOLE d04825A C- F39 F90 Unspecified mood [affective] disorder Attention-deficit hyperactivity disorders A0 E A METHYLPHENIDATE d00900A C- F39 F90 Unspecified mood [affective] disorder Attention-deficit hyperactivity disorders A0 E A . . . E A ATORVASTATIN d04105A D E78.0 Pure hypercholesterolemia A` E A GLIMEPIRIDE d03864A D E11 Type 2 diabetes mellitus A` E A INSULIN DETEMIR d05436A Cr E11 Type 2 diabetes mellitus A` E A LISINOPRIL d00732A D E11.2P N19 Prevent diabetic kidney disease Unspecified kidney failure A` E A METFORMIN d03807A D E11 Type 2 diabetes mellitus A` E A OXYBUTYNIN d00328A D N32.81 Overactive bladder A` E 0 A CARVEDILOL d03847A D E78.0 Pure hypercholesterolemia Ap E 0 A ENALAPRIL d00013A Dc I10 Essential (primary) hypertension Ap E 0 A FINASTERIDE d00563A C N40 Enlarged prostate Ap E 0 A OMEPRAZOLE d00325A C- K22 Other diseases of esophagus Ap E 0 A PRAVASTATIN d00348A D I50.9 Heart failure, unspecified Ap E 0 A TAMSULOSIN d04121A C[@ N40 Enlarged prostate Ap E 0 A UMECLIDINIUM; VILANTEROL d08188A C J44.9 Chronic obstructive pulmonary disease, unspecified Ap E @ A METOPROLOL d00134A B[ I10 Essential (primary) hypertension A E P A . . . E ` A . . . E p A CLONIDINE d00044A C G47.0 Insomnia A E p A GUANFACINE d00717A C F90 Attention-deficit hyperactivity disorders A E A . . . E A ADALIMUMAB d04835A Cr M06.9 Rheumatoid arthritis, unspecified Ap E A AMLODIPINE d00689A Cr I10 Essential (primary) hypertension Ap E A DENOSUMAB d07640A Cr M81 Osteoporosis without current pathological fracture Ap E A EZETIMIBE d04824A Cr E78.0 Pure hypercholesterolemia Ap E A LOSARTAN d03821A Cr I10 Essential (primary) hypertension Ap E A PRAVASTATIN d00348A Cr E78.0 Pure hypercholesterolemia Ap E A RIFAMPIN d00047A Cr 99999 Ap E A ACETAMINOPHEN; HYDROCODONE d03428A C"0 R52 Pain, unspecified AP E A ALPRAZOLAM d00168A C- F41.9 Anxiety disorder, unspecified AP E A HYDROXYZINE d00907A C"0 L23 Allergic contact dermatitis AP E A METOPROLOL d00134A B R00 Abnormalities of heart beat AP E A SERTRALINE d00880A C- F32.9 Major depressive disorder, single episode, unspecified AP E A . . . E A . . . E A FENOFIBRATE d04286A0 C 99999 A E A FLECAINIDE d00234A0 C 99999 A E A HYDROCHLOROTHIAZIDE d00253A0 C 99999 A E A LOSARTAN d03821A0 Ei E78.0 Pure hypercholesterolemia A E A METFORMIN d03807A0 C E11 Type 2 diabetes mellitus A E A METOPROLOL d00134A0 C 99999 A E A POTASSIUM CHLORIDE d00345A0 C E87.6 Hypokalemia A E A PRAVASTATIN d00348A0 C 99999 A E A . . . E A . . . E A . . . E A RANITIDINE d00021A B R10 Abdominal and pelvic pain A E A . . . E 0 A . . . E @ A . . . E P A . . . E ` A . . . E p A . . . E A AMPHETAMINE; DEXTROAMPHETAMINE d04035A C F90 Attention-deficit hyperactivity disorders A E A . . . E A 99999 . . A E A ESOMEPRAZOLE d04749A B[ K30 Functional dyspepsia A E A AMLODIPINE d00689A B[ I10 Essential (primary) hypertension A E A LOSARTAN d03821A C- I10 Essential (primary) hypertension A E A ALENDRONATE d03849A C[@ M85.9 Disorder of bone density and structure, unspecified A@ E A LEVOTHYROXINE d00278A Dc E03.9 Hypothyroidism, unspecified A@ E A LOSARTAN d03821A C- I10 Essential (primary) hypertension A@ E A PRAVASTATIN d00348A C- E78.0 Pure hypercholesterolemia A@ E A HYDROCHLOROTHIAZIDE d00253A C[@ I10 Essential (primary) hypertension A E A ATORVASTATIN d04105A B E78.0 Pure hypercholesterolemia A E A LISINOPRIL d00732A C I10 I50.9 Essential (primary) hypertension Heart failure, unspecified A E A . . . E A . . . E A BECLOMETHASONE d00760A CDp R05 R06.2 Cough Wheezing A E A ACETAMINOPHEN; HYDROCODONE d03428A C- M79.6 Pain in limb, hand, foot, fingers and toes A E A ALBUTEROL d00749A B= J20.9 J42 Acute bronchitis, unspecified Unspecified chronic bronchitis A E A ALBUTEROL d00749A C J42 Unspecified chronic bronchitis A E A CITALOPRAM d04332A C F32.9 Major depressive disorder, single episode, unspecified A E A DICLOFENAC d00848A Cr M79.6 Pain in limb, hand, foot, fingers and toes A E A FLUTICASONE NASAL d04283A CDp J45 Asthma A E A GLYBURIDE d00248A D E11 Type 2 diabetes mellitus A E A LISINOPRIL d00732A CDp I51.9P Prevent heart disease A E A LORAZEPAM d00149A C F41.9 G47.9 Anxiety disorder, unspecified Sleep disorder, unspecified A E A METFORMIN d03807A D E11 Type 2 diabetes mellitus A E A OMEPRAZOLE d00325A CDp K21 Gastro-esophageal reflux disease A E 0 A . . . E @ A . . . E P A . . . E ` A . . . E p A . . . E A . . . E A ATORVASTATIN d04105A C- E78.0 Pure hypercholesterolemia A0 E A HYDROCHLOROTHIAZIDE d00253A C- I10 Essential (primary) hypertension A0 E A OMEPRAZOLE d00325A B K30 R12 Functional dyspepsia Heartburn A0 E A . . . E A . . . E A . . . E A AMOXICILLIN d00088A AP H66.9 Otitis media, unspecified A E A ARIPIPRAZOLE d04825A D# F90 Attention-deficit hyperactivity disorders A` E A BUPROPION d00181A D# F90 Attention-deficit hyperactivity disorders A` E A FLUVOXAMINE d03804A D# F41.9 F90 Anxiety disorder, unspecified Attention-deficit hyperactivity disorders A` E A LORAZEPAM d00149A D# F41.9 Anxiety disorder, unspecified A` E A TADALAFIL d04896A C N52.9 Male erectile dysfunction, unspecified A` E A TAMSULOSIN d04121A C N40 Enlarged prostate A` E A . . . E A . . . E Ap . . . E A 77777 . . A E 0 A . . . E @ A METFORMIN d03807A B E11 Type 2 diabetes mellitus A E P A LAMOTRIGINE d03809A C F39 Unspecified mood [affective] disorder A E ` A AMLODIPINE d00689A C I10 Essential (primary) hypertension A@ E ` A NAPROXEN d00019A C L40 M54 R51 Psoriasis Dorsalgia Headache A@ E ` A SERTRALINE d00880A C F32.9 Major depressive disorder, single episode, unspecified A@ E ` A TAMSULOSIN d04121A Cr R39.9 Unspecified symptoms and signs involving the genitourinary system A@ E p A . . . E A . . . E A ATENOLOL d00004A D I49.9 Cardiac arrhythmia, unspecified A@ E A ESOMEPRAZOLE d04749A Ap K21 Gastro-esophageal reflux disease A@ E A LAMOTRIGINE d03809A Bz G40 Epilepsy and recurrent seizures A@ E A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia A@ E A . . . E A . . . E A . . . E A 99999 . . A` E A CLOPIDOGREL d04258A C"0 I21.P Prevent heart attack/myocardial infarction A` E A FUROSEMIDE d00070A C"0 I51.9 Heart disease, unspecified A` E A GABAPENTIN d03182A Cr M79.2 Neuralgia and neuritis, unspecified A` E A INSULIN GLARGINE d04538A C- E11 Type 2 diabetes mellitus A` E A METFORMIN d03807A C- E11 Type 2 diabetes mellitus A` E A . . . E A . . . E A ETHINYL ESTRADIOL; NORETHINDRONE d03238A D Z79.3 Long term (current) use of hormonal contraceptives A E A AMLODIPINE d00689A C I10 Essential (primary) hypertension A0 E A ATORVASTATIN d04105A C- E78.0 Pure hypercholesterolemia A0 E A CETIRIZINE d03827A C- T78.40 Allergy, unspecified A0 E A INSULIN ASPART d04697A Dc E11 Type 2 diabetes mellitus A E 0 A AMLODIPINE d00689A D I10 Essential (primary) hypertension A@ E 0 A APIXABAN d07804A C I21.P Prevent heart attack/myocardial infarction A@ E 0 A ATENOLOL d00004A D I10 Essential (primary) hypertension A@ E 0 A ENALAPRIL d00013A D I10 Essential (primary) hypertension A@ E @ A . . . E P A ALLOPURINOL d00023A C M10.9P Prevent gout A E P A BUMETANIDE d00179A Dc I51.9 Heart disease, unspecified A E P A COLCHICINE d00150A C- M1A Chronic gout A E P A FLUTICASONE; SALMETEROL d04611A Dc J45 Asthma A E P A HYDROCHLOROTHIAZIDE; LOSARTAN d03830A Dc I10 R60.9 Essential (primary) hypertension Edema, unspecified A E P A MONTELUKAST d04289A Dc J45 Asthma A E P A OMEPRAZOLE d00325A Dc K21 Gastro-esophageal reflux disease A E P A PENTOXIFYLLINE d00336A C I70 Atherosclerosis A E P A POTASSIUM CHLORIDE d00345A Dc E87.6P Prevent hypokalemia A E P A TIOTROPIUM d04829A Dc J45 Asthma A E P A TRIAMCINOLONE TOPICAL d03206A Cr L98.9 Disorder of the skin and subcutaneous tissue, unspecified A E ` A . . . E p A . . . E A . . . E A . . . E A . . . E A . . . E A SULFAMETHOXAZOLE d00119A B N39.0 Urinary tract infection, site not specified A E A . . . E A ALBUTEROL d00749A Dc J45 Asthma A0 E A CHLORHEXIDINE TOPICAL d01231A A A49.9P L08.9 Prevent bacterial infection Local infection of the skin and subcutaneous tissue, unspecified A0 E A FLUTICASONE; SALMETEROL d04611A B J44.9 Chronic obstructive pulmonary disease, unspecified A0 E A MESALAMINE d01031A C K50 Crohn's disease [regional enteritis] A E A METHOTREXATE d00060A Cr K50 Crohn's disease [regional enteritis] A E A . . . E A . . . E A . . . E 0 A ALLOPURINOL d00023A D M1A Chronic gout A0 E 0 A HYDROCHLOROTHIAZIDE d00253A D I10 Essential (primary) hypertension A0 E 0 A LISINOPRIL d00732A D I10 Essential (primary) hypertension A0 E @ A ENALAPRIL d00013A C I10 Essential (primary) hypertension Ap E @ A GLIPIZIDE d00246A C[@ R73 Elevated blood glucose level Ap E @ A LEVOTHYROXINE d00278A D* E03.9 Hypothyroidism, unspecified Ap E @ A METFORMIN d03807A C[@ R73 Elevated blood glucose level Ap E @ A PANTOPRAZOLE d04514A D K21 Gastro-esophageal reflux disease Ap E @ A ROSUVASTATIN d04851A D* E78.0 Pure hypercholesterolemia Ap E @ A SUCRALFATE d00377A D K27 Peptic ulcer, site unspecified Ap E P A . . . E ` A . . . E p A . . . E A AMLODIPINE d00689A C- I10 Essential (primary) hypertension A E A IBUPROFEN d00015A C M79.6 Pain in limb, hand, foot, fingers and toes A E A LISINOPRIL d00732A C I10 Essential (primary) hypertension A E A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E A IBUPROFEN d00015A Ap R07.9 Chest pain, unspecified A E A AMOXICILLIN d00088A A J01.9 Acute sinusitis, unspecified A E A AMPHETAMINE d00803A C- F90 Attention-deficit hyperactivity disorders A E 0 A AMLODIPINE d00689A C I10 Essential (primary) hypertension A` E 0 A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A` E 0 A HYDROCHLOROTHIAZIDE d00253A C I10 R60.9 Essential (primary) hypertension Edema, unspecified A` E 0 A INSULIN LISPRO; INSULIN LISPRO PROTAMINE d04510A C E11 Type 2 diabetes mellitus A` E 0 A LISINOPRIL d00732A C I10 Essential (primary) hypertension A` E 0 A METFORMIN d03807A C E11 Type 2 diabetes mellitus A` E @ A HYDROCHLOROTHIAZIDE; LOSARTAN d03830A Dc I10 Essential (primary) hypertension A0 E @ A LEVOTHYROXINE d00278A Dc E03.9 Hypothyroidism, unspecified A0 E @ A PRAVASTATIN d00348A Cr E78.0 Pure hypercholesterolemia A0 E P A . . . E ` A . . . E p A POLYETHYLENE GLYCOL 3350 d05350A C- K59.0 Constipation A E A ALBUTEROL d00749A D* J45 Asthma A E A DICLOFENAC TOPICAL d04722A CDp M19.9 Osteoarthritis, unspecified site A E A DIPHENHYDRAMINE d00212A D H10.1 J30.9 L23 Acute atopic conjunctivitis Allergic rhinitis, unspecified Allergic contact dermatitis A E A DULOXETINE d05355A Cr M79.7 Fibromyalgia A E A FLUTICASONE d01296A C J45 Asthma A E A LEVOTHYROXINE d00278A CDp E04 Other nontoxic goiter A E A LIDOCAINE TOPICAL d00683A C R52 Pain, unspecified A E A LISINOPRIL d00732A C[@ I10 Essential (primary) hypertension A E A MELOXICAM d04532A B L40 Psoriasis A E A TRAZODONE d00395A C- G47.0 M79.2 Insomnia Neuralgia and neuritis, unspecified A E A DICLOFENAC d00848A CDp G43 Migraine A0 E A DULOXETINE d05355A C- F41.9 Anxiety disorder, unspecified A0 E A TERBINAFINE d04012A B B35 Dermatophytosis A0 E A . . . E A LEVETIRACETAM d04499A C R39.9 Unspecified symptoms and signs involving the genitourinary system A E A TAMSULOSIN d04121A C G40 Epilepsy and recurrent seizures A E A METHADONE d00050A Cr R10 Abdominal and pelvic pain A E A . . . E A METHYLPHENIDATE d00900A C- F90 Attention-deficit hyperactivity disorders A E A . . . E A IBUPROFEN d00015A C N94 Pain and other conditions associated with female genital organs and menstrual cycle A E A ATENOLOL d00004A D I10 Essential (primary) hypertension AP E A ATORVASTATIN d04105A D 99999 AP E A ENALAPRIL d00013A D I10 Essential (primary) hypertension AP E A FINASTERIDE d00563A C N40 Enlarged prostate AP E A TERAZOSIN d00386A C N40 Enlarged prostate AP E A . . . E 0 A LEVOTHYROXINE d00278A C E07.9 Disorder of thyroid, unspecified A E @ A . . . E P A ANASTROZOLE d03873A CDp C50 Malignant neoplasm of breast A E P A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia A E ` A . . . E p A . . . E A . . . E A . . . E A FLUOXETINE d00236A D"8 F33.9 Major depressive disorder, recurrent, unspecified A@ E A HYDROXYZINE d00907A B= G47.0 Insomnia A@ E A PROGESTERONE d00550A C[@ N95 Menopausal and other perimenopausal disorders A@ E A SEX HORMONES COMBINATION - UNSPECIFIED c00186A C[@ N95 Menopausal and other perimenopausal disorders A@ E A . . . E A . . . E A GUANFACINE d00717A Bz F43.1 F90 F91 Post-traumatic stress disorder (PTSD) Attention-deficit hyperactivity disorders Conduct disorders A E A ALPRAZOLAM d00168A C- F41.9 Anxiety disorder, unspecified A E A CLONIDINE d00044A C[@ I10 Essential (primary) hypertension A E A HYDROCODONE d03075A C- M54 Dorsalgia A E A LABETALOL d00016A C[@ I10 Essential (primary) hypertension A E A METFORMIN d03807A C E11 Type 2 diabetes mellitus A E A METHOCARBAMOL d00965A C"@ M54 M79.1 Dorsalgia Myalgia A E A QUETIAPINE d04220A0 C- F31.9 Bipolar disorder, unspecified A E A VORTIOXETINE d08125A0 C- F32.9 Major depressive disorder, single episode, unspecified A E A ADRENAL CORTICAL STEROIDS - UNSPECIFIED c00098A AP 55555 A E A ALBUTEROL; IPRATROPIUM d04066A A J45 Asthma A E A . . . E A . . . E A 99999 . . A` E A AMLODIPINE; BENAZEPRIL d03829A B I10 Essential (primary) hypertension A` E A ASPIRIN d00170A Cr I21.P Prevent heart attack/myocardial infarction A` E A FUROSEMIDE d00070A CDp R60.9 Edema, unspecified A` E A INSULIN GLARGINE d04538A C R73 Elevated blood glucose level A` E A SIMVASTATIN d00746A Cr E78.0 Pure hypercholesterolemia A` E 0 A . . . E @ A . . . E P A . . . E ` A . . . E p A . . . E A . . . E A LISINOPRIL d00732A C- I10 Essential (primary) hypertension A E A PAROXETINE d03157A C- F32.9 Major depressive disorder, single episode, unspecified A E A OMEPRAZOLE d00325A A R05 Cough A E A TRAMADOL d03826A B M25.5 Pain in joint A E A CONJUGATED ESTROGENS; MEDROXYPROGESTERONE d03819A CDp N95 Menopausal and other perimenopausal disorders A E A . . . E A . . . E A . . . E A . . . E A . . . E A AMLODIPINE d00689A CDp I10 Essential (primary) hypertension A E A APIXABAN d07804A CDp D75.9P Prevent blood clots A E A DEXLANSOPRAZOLE d07395A D R12 Heartburn A E A HYDROXYCHLOROQUINE d00817A CDp L93 Lupus erythematosus A E A METOCLOPRAMIDE d00298A CDp I10 Essential (primary) hypertension A E A METOPROLOL d00134A Cr I10 Essential (primary) hypertension A E A RAMIPRIL d00728A CDp N28.9P Prevent kidney disease A E A SPIRONOLACTONE d00373A Cr 99999 A E A TRAMADOL d03826A D M19.9 Osteoarthritis, unspecified site A E A ATORVASTATIN d04105A Bz E78.0 Pure hypercholesterolemia A` E A GLYBURIDE d00248A C E11 Type 2 diabetes mellitus A` E A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A C I10 Essential (primary) hypertension A` E A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified A` E A METFORMIN d03807A C E11 Type 2 diabetes mellitus A` E A OMEPRAZOLE d00325A C K31.9 T88.7P Disease of stomach and duodenum, unspecified Prevent drug side effect A` E 0 A AMLODIPINE d00689A C I10 Essential (primary) hypertension A@ E 0 A GLIPIZIDE d00246A D R73 Elevated blood glucose level A@ E 0 A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A D I10 Essential (primary) hypertension A@ E 0 A METFORMIN d03807A D R73 Elevated blood glucose level A@ E @ A . . . E P A . . . E ` A IBUPROFEN d00015A B T14.9 Unspecified injury A E p A IBUPROFEN d00015A C R50.9 Fever, unspecified A E A . . . E A AMOXICILLIN d00088A A J02 Acute pharyngitis A E A OSELTAMIVIR d04462A AP J09 Influenza due to certain identified influenza viruses A E A . . . E A . . . E A ALBUTEROL d00749A0 C J44.9 Chronic obstructive pulmonary disease, unspecified A E A ATORVASTATIN d04105A0 Cr E78.0 Pure hypercholesterolemia A E A BUDESONIDE d04276A0 B J44.9 Chronic obstructive pulmonary disease, unspecified A E A CARVEDILOL d03847A0 C- I50.9 Heart failure, unspecified A E A DICLOFENAC d00848A0 B M25.5 Pain in joint A E A FOSINOPRIL d00242A0 B[ I50.9 Heart failure, unspecified A E A FUROSEMIDE d00070A0 C- R60.9 Edema, unspecified A E A HYDROXYCHLOROQUINE d00817A0 Cr M06.9 Rheumatoid arthritis, unspecified A E A INSULIN d00262A0 Cr E11 Type 2 diabetes mellitus A E A TIOTROPIUM d04829A0 B J44.9 Chronic obstructive pulmonary disease, unspecified A E A TRIAMCINOLONE TOPICAL d03206A0 B[ R21 Rash and other nonspecific skin eruption A E A ATORVASTATIN d04105A Cr E78.0 Pure hypercholesterolemia Ap E A DIGOXIN d00210A Cr I48.9 I49.9 Unspecified atrial fibrillation and atrial flutter Cardiac arrhythmia, unspecified Ap E A DILTIAZEM d00045A Cr I48.9 Unspecified atrial fibrillation and atrial flutter Ap E A FLUTICASONE NASAL d04283A C[@ R09.81 Nasal congestion Ap E A HYDROCODONE d03075A C[@ M25.5 Z96 Pain in joint Presence of other functional implants Ap E A LISINOPRIL d00732A CDp I10 Essential (primary) hypertension Ap E A WARFARIN d00022A CDp D75.9P Prevent blood clots Ap E A . . . E A MELOXICAM d04532A Ap M54 Dorsalgia A0 E A ORPHENADRINE d00966A Ap M62.83 Muscle spasm A0 E A PREDNISONE d00350A Ap M54 Dorsalgia A0 E A . . . E A . . . E A METOPROLOL d00134A CDp I49.9 Cardiac arrhythmia, unspecified A0 E A OMEPRAZOLE d00325A B= K25 Gastric ulcer A0 E A ROSUVASTATIN d04851A Ap E78.0 Pure hypercholesterolemia A0 E 0 A . . . E @ A . . . E P A . . . E ` A FLUDROCORTISONE d00608A C- I99.9 Unspecified disorder of circulatory system A0 E ` A HYDROCORTISONE d00254A C- E27.9 Disorder of adrenal gland, unspecified A0 E ` A LEVOTHYROXINE d00278A C- E03.9 Hypothyroidism, unspecified A0 E p A . . . E A ALBUTEROL d00749A D J45 Asthma A E A PREDNISONE d00350A C M35 Other systemic involvement of connective tissue A E A . . . E A ATORVASTATIN d04105A CDp E78.1 Pure hyperglyceridemia A E A BETHANECHOL d01427A B K30 Functional dyspepsia A E A CARVEDILOL d03847A CDp I10 Essential (primary) hypertension A E A CLONIDINE d00044A CDp I10 Essential (primary) hypertension A E A HYDRALAZINE d00132A C- I10 Essential (primary) hypertension A E A LISINOPRIL d00732A B I10 Essential (primary) hypertension A E A LORAZEPAM d00149A B F41.9 Anxiety disorder, unspecified A E A NIFEDIPINE d00051A CDp I10 Essential (primary) hypertension A E A PANTOPRAZOLE d04514A B[ K21 Gastro-esophageal reflux disease A E A PREGABALIN d05508A C M79.2 Neuralgia and neuritis, unspecified A E A TRAMADOL d03826A CDp M54 Dorsalgia A E A TRAZODONE d00395A A F41.9 Anxiety disorder, unspecified A E A ZOLPIDEM d00910A C- G47.0 Insomnia A E A . . . E A BUSPIRONE d00182A CDp F41.9 Anxiety disorder, unspecified A@ E A ETHINYL ESTRADIOL; NORGESTIMATE d03781A C N92 N94 Excessive, frequent and irregular menstruation Pain and other conditions associated with female genital organs and menstrual cycle A@ E A OLANZAPINE d04050A CDp F32.9 F41.9 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified A@ E A OXYBUTYNIN d00328A C[@ R35 Polyuria A@ E A . . . E A ESTERIFIED ESTROGENS; METHYLTESTOSTERONE d03245A D N95 Menopausal and other perimenopausal disorders A E A FAMOTIDINE; IBUPROFEN d07764A B K25.P M19.9 Prevent gastric ulcer Osteoarthritis, unspecified site A E A ALLOPURINOL d00023A B E79.9 Disorder of purine and pyrimidine metabolism, unspecified A@ E A ATENOLOL d00004A C I10 Essential (primary) hypertension A@ E A BENAZEPRIL d00730A C I10 Essential (primary) hypertension A@ E A METFORMIN d03807A C E11 Type 2 diabetes mellitus A@ E A . . . E 0 A . . . E @ A . . . E P A METHADONE d00050A C[@ F11.23 Opioid dependence with withdrawal A E ` A BUPROPION d00181A CDp F33.9 Major depressive disorder, recurrent, unspecified A0 E ` A LAMOTRIGINE d03809A CDp F32.9 Major depressive disorder, single episode, unspecified A0 E ` A SERTRALINE d00880A Dc F41.9 Anxiety disorder, unspecified A0 E p A ACETAMINOPHEN; OXYCODONE d03431A C[@ M54 M79.7 Dorsalgia Fibromyalgia A E p A ALPRAZOLAM d00168A C F41.9 Anxiety disorder, unspecified A E p A LEVOTHYROXINE d00278A C- E03.9 Hypothyroidism, unspecified A E p A MONTELUKAST d04289A C R06.9 Unspecified abnormalities of breathing A E p A NIACIN d00314A C- E78.0 Pure hypercholesterolemia A E p A PAROXETINE d03157A C F32.9 Major depressive disorder, single episode, unspecified A E p A PHENTERMINE d00806A B E66 Overweight and obesity A E p A ROSUVASTATIN d04851A C E78.0 Pure hypercholesterolemia A E p A TOPIRAMATE d04115A C E66 G43 M79.2 Overweight and obesity Migraine Neuralgia and neuritis, unspecified A E p A TRAZODONE d00395A CDp G47.0 Insomnia A E A . . . E A . . . E A . . . E A BUPROPION d00181A B F32.9 F41.9 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified A0 E A MEDROXYPROGESTERONE d00284A Cr Z79.3 Long term (current) use of hormonal contraceptives A0 E A OMEPRAZOLE d00325A B K21 Gastro-esophageal reflux disease A0 E A ALBUTEROL d00749A CDp R06.02 R06.2 R07.9 Shortness of breath Wheezing Chest pain, unspecified AP E A BUDESONIDE; FORMOTEROL d04795A CDp J43 R07.9 Emphysema Chest pain, unspecified AP E A IPRATROPIUM d00265A CDp R06.9 Unspecified abnormalities of breathing AP E A SOTALOL d00371A CDp I50.9 Heart failure, unspecified AP E A TAMSULOSIN d04121A CDp R39.9 Unspecified symptoms and signs involving the genitourinary system AP E A PRAVASTATIN d00348A Cr E78.0 Pure hypercholesterolemia A E A ALPRAZOLAM d00168A CP I51.9 Heart disease, unspecified A0 E A AMLODIPINE d00689A C I10 Essential (primary) hypertension A0 E A HYDROCHLOROTHIAZIDE; TRIAMTERENE d03052A C I10 Essential (primary) hypertension A0 E A HYDROCHLOROTHIAZIDE; LOSARTAN d03830A C I10 Essential (primary) hypertension A` E A METFORMIN d03807A C E11 Type 2 diabetes mellitus A` E A METHOTREXATE d00060A C M06.9 Rheumatoid arthritis, unspecified A` E A PRAVASTATIN d00348A Cr E78.0 Pure hypercholesterolemia A` E A PREDNISONE d00350A Dc M06.9 Rheumatoid arthritis, unspecified A` E A PROPRANOLOL d00032A C I10 Essential (primary) hypertension A` E A . . . E A . . . E A ATORVASTATIN d04105A A0 E78.0 Pure hypercholesterolemia A E 0 A . . . E @ A . . . E P A HYDROCHLOROTHIAZIDE d00253A C[@ I10 Essential (primary) hypertension A E ` A . . . E p A . . . E A ETHINYL ESTRADIOL; NORGESTIMATE d03781A C N92 Excessive, frequent and irregular menstruation A E A AMLODIPINE d00689A Cr I10 Essential (primary) hypertension AP E A LOSARTAN d03821A Cr I10 Essential (primary) hypertension AP E A LOVASTATIN d00280A D E78.0 Pure hypercholesterolemia AP E A METFORMIN d03807A C R73 Elevated blood glucose level AP E A METOPROLOL d00134A D I10 Essential (primary) hypertension AP E A . . . E A SUMATRIPTAN d03160A C G43 Migraine A E A . . . E A . . . E A AMLODIPINE d00689A C I10 Essential (primary) hypertension A E A ATENOLOL d00004A CP I10 Essential (primary) hypertension A E A ATORVASTATIN d04105A CDp E78.0 Pure hypercholesterolemia A E A AZELASTINE NASAL d04068A C- T78.40 Allergy, unspecified A E A FLUTICASONE NASAL d04283A Dc J30.1 Allergic rhinitis due to pollen A E A GLIMEPIRIDE d03864A C E11 Type 2 diabetes mellitus A E A HYDROCHLOROTHIAZIDE d00253A D R60.9 Edema, unspecified A E A LISINOPRIL d00732A D I10 Essential (primary) hypertension A E A OMEPRAZOLE d00325A D K21 Gastro-esophageal reflux disease A E A WARFARIN d00022A D D75.9P Prevent blood clots A E A . . . E A AMLODIPINE d00689A C- I10 Essential (primary) hypertension A E A ATENOLOL d00004A C- I10 Essential (primary) hypertension A E A ETHINYL ESTRADIOL; NORGESTIMATE d03781A C Z79.3 Long term (current) use of hormonal contraceptives A E A CEPHALEXIN d00096A B= L08.9 Local infection of the skin and subcutaneous tissue, unspecified A@ E A OMEPRAZOLE d00325A C- K21 Gastro-esophageal reflux disease A@ E A PAROXETINE d03157A Cr F32.9 Major depressive disorder, single episode, unspecified A@ E A PROPRANOLOL d00032A CDp G43 Migraine A@ E 0 A DAPAGLIFLOZIN d07928A C[@ E11 Type 2 diabetes mellitus A@ E 0 A LISINOPRIL d00732A C[@ K76.9 Liver disease, unspecified A@ E 0 A OMEPRAZOLE d00325A C K25.P Prevent gastric ulcer A@ E 0 A ROSUVASTATIN d04851A C E78.0 Pure hypercholesterolemia A@ E @ A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A@ E @ A FLUTICASONE NASAL d04283A Cr J30.9 Allergic rhinitis, unspecified A@ E @ A LISINOPRIL d00732A C I10 Essential (primary) hypertension A@ E @ A NIFEDIPINE d00051A C I10 Essential (primary) hypertension A@ E P A METHYLPHENIDATE d00900A Cr F90 Attention-deficit hyperactivity disorders A E P A METHYLPHENIDATE d00900A Cr F90 Attention-deficit hyperactivity disorders A E ` A PREDNISONE d00350A A J06.9 Acute upper respiratory infection, unspecified A E p A PENICILLIN d00116A A K04.7 Periapical abscess without sinus A E A CITALOPRAM d04332A A G47.0 Insomnia A E A LISINOPRIL d00732A A I10 Essential (primary) hypertension A E A BACLOFEN d00967A Bz M25.5 Pain in joint A E A CYANOCOBALAMIN d00413A C D64.9 Anemia, unspecified A E A ESTRADIOL TOPICAL d04210A C N39.0 Urinary tract infection, site not specified A E A FLUTICASONE NASAL d04283A C[@ J30.2 Other seasonal allergic rhinitis A E A LEVOCETIRIZINE d05851A CDp T78.40 Allergy, unspecified A E A LEVOTHYROXINE d00278A D1 E03.9 Hypothyroidism, unspecified A E A LOTEPREDNOL OPHTHALMIC d04292A C[@ T78.40 Allergy, unspecified A E A MONTELUKAST d04289A C J30.9 Allergic rhinitis, unspecified A E A PANTOPRAZOLE d04514A C K21 Gastro-esophageal reflux disease A E A ROSUVASTATIN d04851A CDp E78.0 Pure hypercholesterolemia A E A SUCRALFATE d00377A Bz K21 Gastro-esophageal reflux disease A E A TRAZODONE d00395A C[@ G47.0 Insomnia A E A LOSARTAN d03821A C I10 Essential (primary) hypertension A E A . . . E A AMLODIPINE d00689A D I10 Essential (primary) hypertension A E A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E 0 A ACETAMINOPHEN; HYDROCODONE d03428A CDp M54 Dorsalgia A` E 0 A CYCLOBENZAPRINE d00963A B M54 Dorsalgia A` E 0 A FUROSEMIDE d00070A C R60.9 Edema, unspecified A` E 0 A HYDROCHLOROTHIAZIDE; VALSARTAN d04293A D I10 Essential (primary) hypertension A` E 0 A OMEPRAZOLE d00325A C K21 Gastro-esophageal reflux disease A` E 0 A SIMVASTATIN d00746A D E78.0 Pure hypercholesterolemia A` E @ A . . . E P A ALBUTEROL d00749A Cr J45 Asthma A E ` A . . . E p A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A@ E p A LISINOPRIL d00732A C I10 Essential (primary) hypertension A@ E p A METFORMIN d03807A C R73 Elevated blood glucose level A@ E p A TAMSULOSIN d04121A C N42.9 Disorder of prostate, unspecified A@ E A . . . E A . . . E A . . . E A APIXABAN d07804A C- D75.9P Prevent blood clots Ap E A FUROSEMIDE d00070A C- J98.9 Respiratory disorder, unspecified Ap E A GLIPIZIDE d00246A CDp 99999 Ap E A INSULIN GLARGINE d04538A D9 E11 Type 2 diabetes mellitus Ap E A METOPROLOL d00134A C 99999 Ap E A OMEPRAZOLE d00325A CDp K21 Gastro-esophageal reflux disease Ap E A SIMVASTATIN d00746A C- E78.0 Pure hypercholesterolemia Ap E A . . . E A . . . E A . . . E A PALIPERIDONE d06297A C F20 F31.9 Schizophrenia Bipolar disorder, unspecified A@ E A QUETIAPINE d04220A C F20 F31.9 F32.9 Schizophrenia Bipolar disorder, unspecified Major depressive disorder, single episode, unspecified A@ E A SERTRALINE d00880A C F31.9 Bipolar disorder, unspecified A@ E A TRAZODONE d00395A C G47.0 Insomnia A@ E A . . . E A IBUPROFEN d00015A CDp M54 R51 Dorsalgia Headache A E A ALBUTEROL d00749A Dc J45 Asthma A E A CYCLOBENZAPRINE d00963A Cr M62.83 Muscle spasm A E A FLUTICASONE; UMECLIDINIUM; VILANTEROL d08666A B J44.9 Chronic obstructive pulmonary disease, unspecified A E A GABAPENTIN d03182A C M79.2 Neuralgia and neuritis, unspecified A E A HYDROXYZINE d00907A Cr G47.0 Insomnia A E A LEVETIRACETAM d04499A C G40 Epilepsy and recurrent seizures A E A LORAZEPAM d00149A Cr G40 Epilepsy and recurrent seizures A E A MONTELUKAST d04289A C- R06.2 Wheezing A E A OMEPRAZOLE d00325A C R12 Heartburn A E A PHENOBARBITAL d00340A Dc G40 Epilepsy and recurrent seizures A E A SERTRALINE d00880A C F32.9 Major depressive disorder, single episode, unspecified A E A TOPIRAMATE d04115A C G40 Epilepsy and recurrent seizures A E 0 A . . . E @ A . . . E P A . . . E ` A . . . E p A . . . E A MONTELUKAST d04289A C J30.9 R06.2 Allergic rhinitis, unspecified Wheezing A E A . . . E A CLONIDINE d00044A C I10 Essential (primary) hypertension A E A LOSARTAN d03821A C I10 Essential (primary) hypertension A E A METHENAMINE d00106A Cr N39.0 Urinary tract infection, site not specified A E A METOPROLOL d00134A Cr I49.9 Cardiac arrhythmia, unspecified A E A MIRTAZAPINE d04025A Cr F32.9 Major depressive disorder, single episode, unspecified A E A OMEPRAZOLE d00325A Cr K30 Functional dyspepsia A E A ONDANSETRON d00867A Cr R11 Nausea and vomiting A E A VENLAFAXINE d03181A Cr F32.9 Major depressive disorder, single episode, unspecified A E A . . . E A . . . E A . . . E A . . . E A HYDROCHLOROTHIAZIDE; LOSARTAN d03830A B= I10 Essential (primary) hypertension A E A . . . E A TRETINOIN TOPICAL d01244A C- L70 Acne A E A METHYLPHENIDATE d00900A B F90 Attention-deficit hyperactivity disorders A E 0 A FUROSEMIDE d00070A C R60.9 Edema, unspecified A@ E 0 A LISINOPRIL d00732A D* I10 Essential (primary) hypertension A@ E 0 A METOPROLOL d00134A D* I10 Essential (primary) hypertension A@ E 0 A TRAMADOL d03826A Cr M19.9 Osteoarthritis, unspecified site A@ E @ A . . . E P A . . . E ` A LISDEXAMFETAMINE d06663A C F90 Attention-deficit hyperactivity disorders A E p A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E A DILTIAZEM d00045A Ei 99999 A E A INSULIN ASPART d04697A B E11 Type 2 diabetes mellitus A E A INSULIN GLARGINE d04538A B E11 Type 2 diabetes mellitus A E A LOSARTAN d03821A Ei 99999 A E A MIRTAZAPINE d04025A Ei 99999 A E A POTASSIUM CHLORIDE d00345A Ei 99999 A E A PRIMIDONE d00352A Ei R25.1 Tremor, unspecified A E A PYRIDOSTIGMINE d00363A Ei 99999 A E A ROSUVASTATIN d04851A Ei 99999 A E A AMITRIPTYLINE d00146A B[ G43.P Prevent migraine A E A BUPROPION d00181A D"8 F31.9 F32.9 Bipolar disorder, unspecified Major depressive disorder, single episode, unspecified A E A CETIRIZINE d03827A Bz T78.40 Allergy, unspecified A E A FLUTICASONE NASAL d04283A B[ J30.1 Allergic rhinitis due to pollen A E A HYDROCHLOROTHIAZIDE d00253A CDp I10 Essential (primary) hypertension A E A IBUPROFEN d00015A D"8 M25.5 Pain in joint A E A PRAZOSIN d00138A Cr F43.1 Post-traumatic stress disorder (PTSD) A E A RANITIDINE d00021A CDp K30 Functional dyspepsia A E A . . . E A ETHINYL ESTRADIOL; NORETHINDRONE d03238A C Z79.3 Long term (current) use of hormonal contraceptives A E A . . . E 0 A BUPROPION d00181A CDp F32.9 Major depressive disorder, single episode, unspecified A E 0 A LEVOTHYROXINE d00278A D E03.9 Hypothyroidism, unspecified A E @ A . . . E P A . . . E ` A . . . E p A . . . E A ENALAPRIL d00013A C I10 Essential (primary) hypertension A E A . . . E A . . . E A CELECOXIB d04380A B[ 55555 A E A ETANERCEPT d04365A B 55555 A E A . . . E A . . . E A . . . E A DOXYCYCLINE d00037A B= B99.9 Unspecified infectious disease A E A . . . E A . . . E A FAMOTIDINE d00141A Bz K21 K30 R12 Gastro-esophageal reflux disease Functional dyspepsia Heartburn A E A GLYBURIDE d00248A B E11 Type 2 diabetes mellitus A E 0 A FUROSEMIDE d00070A C- K21 Gastro-esophageal reflux disease A E 0 A OMEPRAZOLE d00325A C- K21 Gastro-esophageal reflux disease A E @ A . . . E P A . . . E ` A ALBUTEROL d00749A D J44.9 J45 R06.02 Chronic obstructive pulmonary disease, unspecified Asthma Shortness of breath A@ E ` A FORMOTEROL; MOMETASONE d07660A C- J44.9 J45 Chronic obstructive pulmonary disease, unspecified Asthma A@ E ` A MONTELUKAST d04289A C J44.9 J45 Chronic obstructive pulmonary disease, unspecified Asthma A@ E ` A TIOTROPIUM d04829A C J44.9 J45 Chronic obstructive pulmonary disease, unspecified Asthma A@ E p A . . . E A BIMATOPROST OPHTHALMIC d04754A CDp H40 Glaucoma A E A . . . E A ACETAMINOPHEN; HYDROCODONE d03428A B# T14.9 Unspecified injury AP E A CITALOPRAM d04332A B F32.9 Major depressive disorder, single episode, unspecified AP E A ELUXADOLINE d08401A B[ K58 Irritable bowel syndrome AP E A OMEPRAZOLE d00325A Cr K21 Gastro-esophageal reflux disease AP E A ROSUVASTATIN d04851A C- E78.0 Pure hypercholesterolemia AP E A . . . E A AMPHETAMINE; DEXTROAMPHETAMINE d04035A CDp F90 Attention-deficit hyperactivity disorders A E A CETIRIZINE d03827A C- T78.40 Allergy, unspecified A E A CIPROFLOXACIN; DEXAMETHASONE OTIC d04890A A H60 Otitis externa A E A FAMOTIDINE d00141A C K92.9 Disease of digestive system, unspecified A E A FLUOXETINE d00236A C F39 F91 Unspecified mood [affective] disorder Conduct disorders A E A FLUTICASONE NASAL d04283A C J30.9 Allergic rhinitis, unspecified A E A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A C N19 Unspecified kidney failure A E A LAMOTRIGINE d03809A C- F39 F91 Unspecified mood [affective] disorder Conduct disorders A E A NITROFURANTOIN d00112A C- N39.0P Prevent urinary tract infection A E A POLYETHYLENE GLYCOL 3350 d05350A C K59.0 Constipation A E A LEVOTHYROXINE d00278A Cr E03.9 Hypothyroidism, unspecified A0 E A LOSARTAN d03821A C I10 Essential (primary) hypertension A0 E A SERTRALINE d00880A C- F32.9 Major depressive disorder, single episode, unspecified A0 E A . . . E A . . . E A . . . E A . . . E A . . . E 0 A INSULIN GLARGINE d04538A D# E11 Type 2 diabetes mellitus A E 0 A LEVOFLOXACIN d04109A AP N42.9 Disorder of prostate, unspecified A E 0 A LISINOPRIL d00732A C- K76.9P Prevent liver disease A E 0 A METFORMIN d03807A D E11 Type 2 diabetes mellitus A E 0 A OMEPRAZOLE d00325A C K31.9 Disease of stomach and duodenum, unspecified A E 0 A PREGABALIN d05508A C M79.6 Pain in limb, hand, foot, fingers and toes A E 0 A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia A E 0 A SUCRALFATE d00377A AP N42.9 Disorder of prostate, unspecified A E @ A 99999 . . A E P A . . . E ` A . . . E p A . . . E A . . . E A . . . E A CLONIDINE d00044A C G47.0 Insomnia A` E A DIAZEPAM d00148A C F41.9 Anxiety disorder, unspecified A` E A FLUOXETINE d00236A CP F32.9 Major depressive disorder, single episode, unspecified A` E A GABAPENTIN d03182A Cr F41.9 Anxiety disorder, unspecified A` E A RISPERIDONE d03180A C F43.1 G47.9 Post-traumatic stress disorder (PTSD) Sleep disorder, unspecified A` E A TRAZODONE d00395A CDp F43.1 G47.9 Post-traumatic stress disorder (PTSD) Sleep disorder, unspecified A` E A . . . E A AMLODIPINE d00689A C I10 R07.9 Essential (primary) hypertension Chest pain, unspecified A E A CARVEDILOL d03847A C[@ I10 Essential (primary) hypertension A E A CELECOXIB d04380A C- M06.9 M79.2 Rheumatoid arthritis, unspecified Neuralgia and neuritis, unspecified A E A DULAGLUTIDE d08290A C- E11 Type 2 diabetes mellitus A E A FLUOXETINE d00236A C F32.9 Major depressive disorder, single episode, unspecified A E A INSULIN DEGLUDEC d08054A C- E11 Type 2 diabetes mellitus A E A INSULIN LISPRO d04373A C E11 Type 2 diabetes mellitus A E A PANTOPRAZOLE d04514A C K31.9 Disease of stomach and duodenum, unspecified A E A SIMVASTATIN d00746A C[@ E78.0 Pure hypercholesterolemia A E A VALSARTAN d04113A B I10 Essential (primary) hypertension A E A . . . E A . . . E A . . . E A AMLODIPINE; BENAZEPRIL d03829A C I10 Essential (primary) hypertension A0 E A BENAZEPRIL d00730A Ei 99999 A0 E A EZETIMIBE d04824A Ei E78.0 Pure hypercholesterolemia A0 E A . . . E A . . . E 0 A . . . E @ A . . . E P A CARVEDILOL d03847A C[@ I10 Essential (primary) hypertension A E ` A . . . E p A LIRAGLUTIDE d07466A C- E11 R73 Type 2 diabetes mellitus Elevated blood glucose level A` E p A METFORMIN d03807A C- E11 R73 Type 2 diabetes mellitus Elevated blood glucose level A` E p A METOPROLOL d00134A Cr I10 Essential (primary) hypertension A` E p A OLANZAPINE d04050A Cr F32.9 Major depressive disorder, single episode, unspecified A` E p A VENLAFAXINE d03181A Cr F32.9 Major depressive disorder, single episode, unspecified A` E p A ZOLPIDEM d00910A Cr G47.0 Insomnia A` E A AMLODIPINE d00689A C[@ I10 Essential (primary) hypertension A E A . . . E A . . . E A AMLODIPINE d00689A C- I10 Essential (primary) hypertension A E A DULAGLUTIDE d08290A C"0 E11 Type 2 diabetes mellitus A E A GABAPENTIN d03182A C- M79.2 Neuralgia and neuritis, unspecified A E A HYDROCHLOROTHIAZIDE; LOSARTAN d03830A B I10 Essential (primary) hypertension A E A INSULIN GLARGINE d04538A C"0 E11 Type 2 diabetes mellitus A E A INSULIN LISPRO d04373A CDp E11 Type 2 diabetes mellitus A E A MONTELUKAST d04289A B R06.2 R06.9 Wheezing Unspecified abnormalities of breathing A E A ROSUVASTATIN d04851A CDp E78.0 Pure hypercholesterolemia A E A SPIRONOLACTONE d00373A C"0 55555 A E A ASPIRIN d00170A Cr I21.P Prevent heart attack/myocardial infarction A` E A ATORVASTATIN d04105A CDp E78.0 Pure hypercholesterolemia A` E A CARVEDILOL d03847A CDp E78.0 Pure hypercholesterolemia A` E A HYDRALAZINE d00132A Cr I10 Essential (primary) hypertension A` E A HYDROCHLOROTHIAZIDE; OLMESARTAN d04878A Cr I51.9P Prevent heart disease A` E A NIFEDIPINE d00051A CDp I51.9 Heart disease, unspecified A` E A MONTELUKAST d04289A CDp J45 Asthma A E A FLUOXETINE d00236A C F33.9 Major depressive disorder, recurrent, unspecified A E A AMITRIPTYLINE d00146A0 D4 M79.7 Fibromyalgia A E A ATORVASTATIN d04105A0 C E78.0 Pure hypercholesterolemia A E A DICLOFENAC d00848A0 D M19.9 M79.7 Osteoarthritis, unspecified site Fibromyalgia A E A ESOMEPRAZOLE d04749A0 D K21 Gastro-esophageal reflux disease A E A MONTELUKAST d04289A0 C J42 Unspecified chronic bronchitis A E A NEBIVOLOL d05265A0 C I10 Essential (primary) hypertension A E A SULFAMETHOXAZOLE; TRIMETHOPRIM d00124A A B99.9 Unspecified infectious disease A E A TELMISARTAN d04364A0 C I10 Essential (primary) hypertension A E A PANTOPRAZOLE d04514A D K21 Gastro-esophageal reflux disease A E A SIMVASTATIN d00746A D E78.0 Pure hypercholesterolemia A E A AMLODIPINE d00689A C I10 Essential (primary) hypertension A` E A ATORVASTATIN d04105A D E78.0 Pure hypercholesterolemia A` E A ESOMEPRAZOLE d04749A C[@ K21 Gastro-esophageal reflux disease A` E A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified A` E A LISINOPRIL d00732A C I10 Essential (primary) hypertension A` E A PIRFENIDONE d08031A C"0 J98.9 Respiratory disorder, unspecified A` E A ALBUTEROL d00749A C R06.02 Shortness of breath A@ E A ATORVASTATIN d04105A B E78.0 Pure hypercholesterolemia A@ E A LISINOPRIL d00732A C I10 Essential (primary) hypertension A@ E A RANITIDINE d00021A C K30 Functional dyspepsia A@ E 0 A . . . E @ A ALBUTEROL d00749A C J45 Asthma A@ E @ A CARBINOXAMINE d03569A C T78.40 Allergy, unspecified A@ E @ A MONTELUKAST d04289A Cr R06.2 Wheezing A@ E @ A TIOTROPIUM d04829A C J45 Asthma A@ E P A CARBIDOPA d00184A C G20 Parkinson's disease A0 E P A CYCLOBENZAPRINE d00963A C M79.1 Myalgia A0 E P A HYDROCODONE d03075A C M25.5 M54 Pain in joint Dorsalgia A0 E ` A . . . E p A . . . E A . . . E A . . . E A . . . E A AMLODIPINE d00689A0 B[ 99999 A E A BUDESONIDE; FORMOTEROL d04795A C J45 Asthma A E A CLINDAMYCIN d00043A A L08.9 Local infection of the skin and subcutaneous tissue, unspecified A E A CLOPIDOGREL d04258A0 B[ 99999 A E A IPRATROPIUM d00265A0 C[@ J45 Asthma A E A LISINOPRIL d00732A0 Cr I10 Essential (primary) hypertension A E A METOPROLOL d00134A0 B[ I10 I20.9 R07.9 Essential (primary) hypertension Angina pectoris, unspecified Chest pain, unspecified A E A MOMETASONE NASAL d04223A0 C J98.9 Respiratory disorder, unspecified A E A MONTELUKAST d04289A0 C T78.40 Allergy, unspecified A E A ROSUVASTATIN d04851A0 B[ E78.0 Pure hypercholesterolemia A E A . . . E A ALBUTEROL d00749A Dc J45 Asthma A E A CETIRIZINE d03827A C T78.40 Allergy, unspecified A E A ETHINYL ESTRADIOL; LEVONORGESTREL d03242A D= Z79.3 Long term (current) use of hormonal contraceptives A E A FORMOTEROL; MOMETASONE d07660A Cr J45 Asthma A E A LEVOTHYROXINE d00278A Cr E07.9 Disorder of thyroid, unspecified A E A MONTELUKAST d04289A C- T78.40 Allergy, unspecified A E A PHENTERMINE d00806A C E66 J45 Overweight and obesity Asthma A E A SPIRONOLACTONE d00373A CDp L70 Acne A E A . . . E A ALBUTEROL d00749A A J20.9 Acute bronchitis, unspecified A E A OSELTAMIVIR d04462A AP J09 Influenza due to certain identified influenza viruses A E A AZITHROMYCIN d00091A AP J06.9 Acute upper respiratory infection, unspecified A E A . . . E A BACLOFEN d00967A B= M62.83 Muscle spasm A@ E A CITALOPRAM d04332A C- F32.9 Major depressive disorder, single episode, unspecified A@ E A GABAPENTIN d03182A CDp M79.2 Neuralgia and neuritis, unspecified A@ E A PILOCARPINE d04031A B[ 55555 A@ E 0 A . . . E @ A AMLODIPINE d00689A CDp I10 Essential (primary) hypertension AP E @ A ATORVASTATIN d04105A A E78.0 Pure hypercholesterolemia AP E @ A HYDROCHLOROTHIAZIDE d00253A CDp I10 Essential (primary) hypertension AP E @ A LISINOPRIL d00732A CDp I10 Essential (primary) hypertension AP E @ A METFORMIN d03807A A R73 Elevated blood glucose level AP E P A AMOXICILLIN; CLAVULANATE d00089A A H66.9 Otitis media, unspecified A E ` A . . . E p A . . . E A . . . E A IBANDRONATE d05357A Cr M81 Osteoporosis without current pathological fracture A E A LOSARTAN d03821A C I10 Essential (primary) hypertension A E A MELOXICAM d04532A C F41.9 M54 M62.83 Anxiety disorder, unspecified Dorsalgia Muscle spasm A E A PANTOPRAZOLE d04514A C K21 Gastro-esophageal reflux disease A E A PRAVASTATIN d00348A C E78.0 Pure hypercholesterolemia A E A PREDNISONE d00350A AP J42 Unspecified chronic bronchitis A E A RANITIDINE d00021A C K21 Gastro-esophageal reflux disease A E A TRAZODONE d00395A C G47.0 Insomnia A E A . . . E A . . . E A . . . E A . . . E A . . . E A APIXABAN d07804A B D75.9P Prevent blood clots A` E A CITALOPRAM d04332A C 99999 A` E A LEVOTHYROXINE d00278A C"0 99999 A` E A LOSARTAN d03821A C 99999 A` E A METOPROLOL d00134A B 99999 A` E A SIMVASTATIN d00746A C 99999 A` E A . . . E A . . . E A . . . E 0 A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A0 E 0 A CELECOXIB d04380A D M54 Dorsalgia A0 E 0 A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A C I10 Essential (primary) hypertension A0 E @ A . . . E P A . . . E ` A DONEPEZIL d04099A C R41 Other symptoms and signs involving cognitive functions and awareness Ap E ` A LOSARTAN d03821A B I10 Essential (primary) hypertension Ap E ` A MEGESTROL d01348A B= R63 Symptoms and signs concerning food and fluid intake Ap E ` A OXYBUTYNIN d00328A B[ R35 Polyuria Ap E ` A PAROXETINE d03157A B[ R45 Symptoms and signs involving emotional state Ap E ` A TRAMADOL d03826A CDp M25.5 Pain in joint Ap E ` A TRAZODONE d00395A C G47.0 Insomnia Ap E p A . . . E A . . . E A MONTELUKAST d04289A CDp R06.2 Wheezing A E A . . . E A . . . E A . . . E A ALBUTEROL d00749A C[@ J45 Asthma A@ E A DICYCLOMINE d00999A C[@ K58 Irritable bowel syndrome A@ E A LINACLOTIDE d07902A C[@ K59.0 Constipation A@ E A PREDNISONE d00350A B= J45 Asthma A@ E A . . . E A . . . E A . . . E A . . . E A . . . E 0 A . . . E @ A . . . E P A . . . E ` A LEVOTHYROXINE d00278A D E03.9 Hypothyroidism, unspecified A E p A . . . E A . . . E A . . . E A ALENDRONATE d03849A D M85.9 Disorder of bone density and structure, unspecified A0 E A LISINOPRIL d00732A C[@ I10 Essential (primary) hypertension A0 E A PRAVASTATIN d00348A B E78.0 Pure hypercholesterolemia A0 E A . . . E A . . . E A . . . E A ALENDRONATE d03849A0 B M81 Osteoporosis without current pathological fracture Ap E A BACLOFEN d00967A0 C M62.83 Muscle spasm Ap E A FENOFIBRATE d04286A0 C E78.0 Pure hypercholesterolemia Ap E A MECLIZINE d00859A0 C R42 Dizziness and giddiness Ap E A MELOXICAM d04532A0 C M19.9 Osteoarthritis, unspecified site Ap E A POLYETHYLENE GLYCOL 3350 d05350A0 C K59.0 Constipation Ap E A ROPINIROLE d04215A0 C G25.81 Restless legs syndrome Ap E A . . . E A LEVOTHYROXINE d00278A Dc E03.9 Hypothyroidism, unspecified A E A ACETAMINOPHEN; HYDROCODONE d03428A C- M54 Dorsalgia A E A CYCLOBENZAPRINE d00963A C- M54 Dorsalgia A E A . . . E 0 A MEGESTROL d01348A CDp N95 Menopausal and other perimenopausal disorders A E 0 A SIMVASTATIN d00746A Cr E78.0 Pure hypercholesterolemia A E @ A . . . E P A ETHINYL ESTRADIOL; NORGESTIMATE d03781A C[@ Z79.3 Long term (current) use of hormonal contraceptives A E P A LEVOTHYROXINE d00278A B 99999 A E ` A . . . E p A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified A0 E p A PROPRANOLOL d00032A C- G43 Migraine A0 E p A SIMVASTATIN d00746A C- E78.0 Pure hypercholesterolemia A0 E A . . . E A ATORVASTATIN d04105A B[ E78.0 Pure hypercholesterolemia A E A CLOPIDOGREL d04258A C[@ D75.9P Prevent blood clots A E A LEVOTHYROXINE d00278A D# E04 Other nontoxic goiter A E A . . . E A CARVEDILOL d03847A C I10 Essential (primary) hypertension A E A DULAGLUTIDE d08290A B# E11 Type 2 diabetes mellitus A E A ECONAZOLE TOPICAL d01271A B B35 Dermatophytosis A E A FLUTICASONE TOPICAL d04284A C L20.9 R21 Atopic dermatitis, unspecified Rash and other nonspecific skin eruption A E A INSULIN LISPRO; INSULIN LISPRO PROTAMINE d04510A C E11 Type 2 diabetes mellitus A E A RANITIDINE d00021A B K21 R12 Gastro-esophageal reflux disease Heartburn A E A ROSUVASTATIN d04851A C E78.0 E78.1 K21 Pure hypercholesterolemia Pure hyperglyceridemia Gastro-esophageal reflux disease A E A SERTRALINE d00880A C F41.9 Anxiety disorder, unspecified A E A SEVELAMER d04363A CDp N19 Unspecified kidney failure A E A . . . E A AMLODIPINE d00689A C I10 Essential (primary) hypertension A0 E A LOSARTAN d03821A C I10 Essential (primary) hypertension A0 E A LOVASTATIN d00280A C E78.0 Pure hypercholesterolemia A0 E A . . . E A . . . E A . . . E A . . . E 0 A ACETAMINOPHEN; CODEINE d03423A Ap M54 Dorsalgia A E 0 A EZETIMIBE d04824A C E78.0 Pure hypercholesterolemia A E 0 A FLUTICASONE NASAL d04283A CDp J30.2 Other seasonal allergic rhinitis A E 0 A HYDROCHLOROTHIAZIDE d00253A C I10 Essential (primary) hypertension A E 0 A LANSOPRAZOLE d03828A Ap K21 Gastro-esophageal reflux disease A E 0 A LEVOTHYROXINE d00278A Ap E03.9 Hypothyroidism, unspecified A E 0 A NIMODIPINE d00318A B 55555 A E 0 A PAROXETINE d03157A C F41.9 Anxiety disorder, unspecified A E @ A . . . E P A . . . E ` A . . . E p A ESCITALOPRAM d04812A C F32.9 Major depressive disorder, single episode, unspecified A E A . . . E A . . . E A . . . E A . . . E A AMOXICILLIN d00088A AP J02 Acute pharyngitis AP E A BROMPHENIRAMINE; DEXTROMETHORPHAN; PSEUDOEPHEDRINE d03368A Ap R05 Cough AP E A CETIRIZINE d03827A Cr T78.40 Allergy, unspecified AP E A FLUTICASONE NASAL d04283A C[@ T78.40 Allergy, unspecified AP E A MONTELUKAST d04289A C[@ T78.40 Allergy, unspecified AP E A AMOXICILLIN d00088A A J02.0 Streptococcal pharyngitis A E A . . . E A . . . E A ARIPIPRAZOLE d04825A B= F32.9 Major depressive disorder, single episode, unspecified A E A BUSPIRONE d00182A D F41.9 Anxiety disorder, unspecified A E A CITALOPRAM d04332A Cr F32.9 Major depressive disorder, single episode, unspecified A E A CLONAZEPAM d00197A B F41.9 Anxiety disorder, unspecified A E A GABAPENTIN d03182A C[@ M79.2 Neuralgia and neuritis, unspecified A E A GLIPIZIDE d00246A C E11 Type 2 diabetes mellitus A E A LAMOTRIGINE d03809A Cr F32.9 Major depressive disorder, single episode, unspecified A E A LEVOTHYROXINE d00278A B E07.9 Disorder of thyroid, unspecified A E A LOSARTAN d03821A B N28.9P Prevent kidney disease A E A METFORMIN d03807A D E11 Type 2 diabetes mellitus A E A OMEPRAZOLE d00325A B R12 Heartburn A E A SITAGLIPTIN d05896A D E11 Type 2 diabetes mellitus A E A . . . E A . . . E 0 A . . . E @ A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A CDp I10 Essential (primary) hypertension A E P A GLIPIZIDE d00246A C[@ E11 Type 2 diabetes mellitus A0 E P A LISINOPRIL d00732A C[@ I10 Essential (primary) hypertension A0 E P A METFORMIN d03807A C[@ E11 Type 2 diabetes mellitus A0 E ` A APIXABAN d07804A C[@ I48.9 Unspecified atrial fibrillation and atrial flutter AP E ` A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia AP E ` A CHLORTHALIDONE d00192A C R60.9 Edema, unspecified AP E ` A METOPROLOL d00134A C I48.9 Unspecified atrial fibrillation and atrial flutter AP E ` A OMEPRAZOLE d00325A C K21 R12 Gastro-esophageal reflux disease Heartburn AP E p A . . . E A . . . E A ALBUTEROL d00749A A J20.9 Acute bronchitis, unspecified A E A CEFDINIR d04256A A H66.9 Otitis media, unspecified A E A INSULIN DETEMIR d05436A C E11 Type 2 diabetes mellitus A0 E A LISINOPRIL d00732A CDp I10 Essential (primary) hypertension A0 E A METFORMIN d03807A C R73 Elevated blood glucose level A0 E A . . . E A 99999 . . A E A ADALIMUMAB d04835A C- K50 Crohn's disease [regional enteritis] A0 E A CLONAZEPAM d00197A C F41.9 Anxiety disorder, unspecified A0 E A VORTIOXETINE d08125A C- F32.9 Major depressive disorder, single episode, unspecified A0 E A . . . E A ATORVASTATIN d04105A C- E78.0 Pure hypercholesterolemia A` E A CETIRIZINE d03827A C- H10.1 J30.9 T78.40 Acute atopic conjunctivitis Allergic rhinitis, unspecified Allergy, unspecified A` E A HYOSCYAMINE; METHENAM; M-BLUE; SODIUM BIPHOSPHATE d07726A A N39.0 Urinary tract infection, site not specified A` E A LOSARTAN d03821A C- I10 Essential (primary) hypertension A` E A METFORMIN d03807A C E11 Type 2 diabetes mellitus A` E A TAMSULOSIN d04121A B= N42.9 Disorder of prostate, unspecified A` E A CETIRIZINE d03827A A T78.40 Allergy, unspecified A0 E A FLUTICASONE d01296A C- J45 Asthma A0 E A MOMETASONE d05262A B J45 Asthma A0 E A . . . E A METOPROLOL d00134A C[@ I48.9 Unspecified atrial fibrillation and atrial flutter A E 0 A . . . E @ A . . . E P A CEFDINIR d04256A A H66.9 Otitis media, unspecified A E ` A . . . E p A . . . E A . . . E A . . . E A . . . E A LISDEXAMFETAMINE d06663A C- F90 Attention-deficit hyperactivity disorders A E A DEXMETHYLPHENIDATE d04777A Bz F90 Attention-deficit hyperactivity disorders A E A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E 0 A . . . E @ A . . . E P A . . . E ` A CLOBETASOL TOPICAL d01288A C- L29.9 Pruritus, unspecified A E p A ALBUTEROL d00749A CDp J44.9 Chronic obstructive pulmonary disease, unspecified A E p A CITALOPRAM d04332A Cr F32.9 Major depressive disorder, single episode, unspecified A E p A CLONIDINE d00044A Cr I10 Essential (primary) hypertension A E p A FLUTICASONE; VILANTEROL d08100A CDp J44.9 Chronic obstructive pulmonary disease, unspecified A E p A FUROSEMIDE d00070A Cr R60.9 Edema, unspecified A E p A GABAPENTIN d03182A Cr M79.2 Neuralgia and neuritis, unspecified A E p A HYDROCHLOROTHIAZIDE d00253A Cr R60.9 Edema, unspecified A E p A QUETIAPINE d04220A Cr F32.9 G47.9 Major depressive disorder, single episode, unspecified Sleep disorder, unspecified A E p A SIMVASTATIN d00746A Cr E78.0 Pure hypercholesterolemia A E A . . . E A . . . E A ALBUTEROL d00749A B R05 Cough A E A . . . E A . . . E A CLINDAMYCIN d00043A B L70 Acne A E A . . . E A TRAMADOL d03826A A M79.6 T14.9 Pain in limb, hand, foot, fingers and toes Unspecified injury A E A ALBUTEROL d00749A C J20.9 J45 R06.2 Acute bronchitis, unspecified Asthma Wheezing A@ E A ALBUTEROL d00749A C J20.9 J45 R06.2 Acute bronchitis, unspecified Asthma Wheezing A@ E A FLUTICASONE d01296A Cr J45 R06.2 R07.9 Asthma Wheezing Chest pain, unspecified A@ E A FLUTICASONE NASAL d04283A C J30.2 J30.9 R09.81 Other seasonal allergic rhinitis Allergic rhinitis, unspecified Nasal congestion A@ E A . . . E A MONTELUKAST d04289A C J45 Asthma A E A RANITIDINE d00021A CDp R12 Heartburn A E 0 A . . . E @ A AMOXICILLIN d00088A A H66.9 Otitis media, unspecified A E @ A CETIRIZINE d03827A A T78.40 Allergy, unspecified A E P A . . . E ` A . . . E p A ALBUTEROL d00749A B[ J20.9 J45 R05 Acute bronchitis, unspecified Asthma Cough A E A . . . E A AMLODIPINE d00689A D)Y I10 Essential (primary) hypertension A0 E A BENAZEPRIL d00730A D)Y I10 Essential (primary) hypertension A0 E A CALCITONIN d00598A D)Y M81 Osteoporosis without current pathological fracture A0 E A . . . E A 99999 . . A E A . . . E A . . . E A BENAZEPRIL d00730A Ei I10 Essential (primary) hypertension AP E A DOXAZOSIN d00726A Ei 99999 AP E A FUROSEMIDE d00070A Ei Z79 Long term (current) drug therapy AP E A OMEPRAZOLE d00325A Ei I10 Essential (primary) hypertension AP E A ROSUVASTATIN d04851A Ei E78.0 Pure hypercholesterolemia AP E A ACETAMINOPHEN; HYDROCODONE d03428A A` K08.8 Other specified disorders of teeth and supporting structures A E A ALBUTEROL d00749A CDp J42 Unspecified chronic bronchitis A E A ATORVASTATIN d04105A Cr E78.0 Pure hypercholesterolemia A E A CLINDAMYCIN d00043A A` K04.7 Periapical abscess without sinus A E A CLONIDINE d00044A Cr I10 Essential (primary) hypertension A E A HYDROCHLOROTHIAZIDE d00253A Cr I10 Essential (primary) hypertension A E A MINOXIDIL d00135A Cr I10 Essential (primary) hypertension A E A OLANZAPINE d04050A Cr F29 Unspecified psychosis not due to a substance or known physiological condition A E A PROPRANOLOL d00032A Cr I10 Essential (primary) hypertension A E A DROSPIRENONE; ETHINYL ESTRADIOL d04760A B[ N92 Z79.3 Excessive, frequent and irregular menstruation Long term (current) use of hormonal contraceptives A E A LEVETIRACETAM d04499A B G40 Epilepsy and recurrent seizures A E A . . . E A AMOXICILLIN d00088A A` H66.9 Otitis media, unspecified A E 0 A . . . E @ A AMLODIPINE d00689A Ei I10 Essential (primary) hypertension A E @ A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A E @ A GABAPENTIN d03182A Bz M54 Dorsalgia A E @ A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A Ei 99999 A E @ A METFORMIN d03807A C E11 Type 2 diabetes mellitus A E @ A METOPROLOL d00134A D ^ I21.P Prevent heart attack/myocardial infarction A E @ A NAPROXEN d00019A B M25.5 M54 Pain in joint Dorsalgia A E @ A OMEPRAZOLE d00325A B K21 K30 Gastro-esophageal reflux disease Functional dyspepsia A E @ A POTASSIUM CHLORIDE d00345A C E87.6 Hypokalemia A E @ A ROPINIROLE d04215A C G25.81 Restless legs syndrome A E @ A SERTRALINE d00880A C- F32.9 Major depressive disorder, single episode, unspecified A E P A . . . E ` A . . . E p A . . . E A . . . E A ALPRAZOLAM d00168A Ei F41.9 Anxiety disorder, unspecified AP E A GABAPENTIN d03182A Ei M54 Dorsalgia AP E A NORTRIPTYLINE d00144A CP R51 Headache AP E A TOPIRAMATE d04115A C- G43 Migraine AP E A TRAMADOL d03826A Ap M54 Dorsalgia AP E A . . . E A CEPHALEXIN d00096A A L08.9 Local infection of the skin and subcutaneous tissue, unspecified A E A ALBUTEROL d00749A Ap R06.02 Shortness of breath A E A CEFDINIR d04256A A J02 Acute pharyngitis A E A . . . E A . . . E A MONTELUKAST d04289A Cr J45 T78.40 Asthma Allergy, unspecified A E A SERTRALINE d00880A CDp F32.9 F41.9 F91 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified Conduct disorders A E A ATORVASTATIN d04105A D E78.0 Pure hypercholesterolemia A0 E A LORAZEPAM d00149A C[@ F41.9 Anxiety disorder, unspecified A0 E A TIOTROPIUM d04829A C- J44.9 Chronic obstructive pulmonary disease, unspecified A0 E A BACLOFEN d00967A Ap M54 Dorsalgia A E A NAPROXEN d00019A Ap M54 Dorsalgia A E A CEFUROXIME d00056A A N30 Cystitis A E A DEXMETHYLPHENIDATE d04777A B= R41 Other symptoms and signs involving cognitive functions and awareness A E 0 A . . . E @ A . . . E P A . . . E ` A . . . E p A GLIPIZIDE d00246A Bz E11 Type 2 diabetes mellitus A E p A METFORMIN d03807A Bz E11 Type 2 diabetes mellitus A E A ATORVASTATIN d04105A Cr E78.0 Pure hypercholesterolemia A0 E A CITALOPRAM d04332A C F32.9 F41.9 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified A0 E A LORAZEPAM d00149A C F41.0 Panic disorder [episodic paroxysmal anxiety] without agoraphobia A0 E A . . . E A . . . E A . . . E A . . . E A . . . E A HYDROCHLOROTHIAZIDE d00253A D I10 Essential (primary) hypertension A E A ALBUTEROL d00749A C J45 Asthma AP E A DESLORATADINE d04785A C J45 Asthma AP E A EZETIMIBE d04824A C E78.0 Pure hypercholesterolemia AP E A FLUVASTATIN d03183A Dc E78.0 Pure hypercholesterolemia AP E A OLODATEROL; TIOTROPIUM d08362A A J45 Asthma AP E A . . . E A . . . E A . . . E 0 A ACETAMINOPHEN; OXYCODONE d03431A C- M54 Dorsalgia A E 0 A AMLODIPINE d00689A C I10 Essential (primary) hypertension A E 0 A APIXABAN d07804A B D75.9P Prevent blood clots A E 0 A ATORVASTATIN d04105A C[@ E78.0 Pure hypercholesterolemia A E 0 A CARVEDILOL d03847A C I49.9 Cardiac arrhythmia, unspecified A E 0 A GABAPENTIN d03182A C"@ M79.2 Neuralgia and neuritis, unspecified A E 0 A HYDRALAZINE d00132A C[@ I10 Essential (primary) hypertension A E 0 A PANTOPRAZOLE d04514A . K21 Gastro-esophageal reflux disease A E 0 A ZOLPIDEM d00910A B= G47.9 Sleep disorder, unspecified A E @ A . . . E P A PREGABALIN d05508A C[@ M79.2 Neuralgia and neuritis, unspecified A E ` A ACETAMINOPHEN; OXYCODONE d03431A C[@ M25.5 T88.7P Pain in joint Prevent drug side effect AP E ` A AMLODIPINE d00689A C I10 Essential (primary) hypertension AP E ` A EZETIMIBE d04824A Bz E78.0 Pure hypercholesterolemia AP E ` A HYDROCHLOROTHIAZIDE; SPIRONOLACTONE d03247A C I10 Essential (primary) hypertension AP E ` A IRBESARTAN d04222A C I10 Essential (primary) hypertension AP E p A HYDROCHLOROTHIAZIDE; OLMESARTAN d04878A C[@ I10 Essential (primary) hypertension A E A DOXEPIN d00217A C F32.9 Major depressive disorder, single episode, unspecified A` E A DULOXETINE d05355A CDp F32.9 Major depressive disorder, single episode, unspecified A` E A GLIPIZIDE d00246A CDp E11 Type 2 diabetes mellitus A` E A LITHIUM d00061A B F32.9 Major depressive disorder, single episode, unspecified A` E A METFORMIN d03807A C E11 Type 2 diabetes mellitus A` E A PROPRANOLOL d00032A C I10 Essential (primary) hypertension A` E A . . . E A . . . E A CELECOXIB d04380A B G99.8 Other specified disorders of nervous system in diseases classified elsewhere A0 E A CYANOCOBALAMIN d00413A B A0 E A OMEPRAZOLE d00325A C R12 Heartburn A0 E A . . . E A . . . E A ACETAMINOPHEN; HYDROCODONE d03428A A0 K08.8 Other specified disorders of teeth and supporting structures A E A CLINDAMYCIN d00043A A0 K04.7 Periapical abscess without sinus A E A CLINDAMYCIN d00043A A K04.7 Periapical abscess without sinus A E A . . . E A . . . E A ALENDRONATE d03849A CDp M81 Osteoporosis without current pathological fracture Ap E A ATORVASTATIN d04105A C[@ E78.0 Pure hypercholesterolemia Ap E A BRIMONIDINE; TIMOLOL OPHTHALMIC d05283A C[@ H40 Glaucoma Ap E A GABAPENTIN d03182A C- R52 Pain, unspecified Ap E A LATANOPROST OPHTHALMIC d04017A C[@ H40 Glaucoma Ap E A LOSARTAN d03821A C I10 Essential (primary) hypertension Ap E A NITROFURANTOIN d00112A A N30 Cystitis Ap E 0 A . . . E @ A . . . E P A . . . E ` A ACETAMINOPHEN; HYDROCODONE d03428A C- M54 Dorsalgia A@ E ` A FENTANYL d00233A C- M54 Dorsalgia A@ E ` A LISINOPRIL d00732A B= I10 Essential (primary) hypertension A@ E ` A OMEPRAZOLE d00325A B K92.9 Disease of digestive system, unspecified A@ E p A CETIRIZINE d03827A C T78.40 Allergy, unspecified A E A . . . E A ATORVASTATIN d04105A CDp E78.0 Pure hypercholesterolemia A0 E A DULOXETINE d05355A C F41.9 Anxiety disorder, unspecified A0 E A METOPROLOL d00134A C I99.9 Unspecified disorder of circulatory system A0 E A ETHINYL ESTRADIOL; NORGESTIMATE d03781A C N92 Excessive, frequent and irregular menstruation A E A . . . E A AMLODIPINE d00689A Cr I10 Essential (primary) hypertension A` E A DOXYCYCLINE d00037A C[@ L71 Rosacea A` E A FAMOTIDINE d00141A CDp K30 Functional dyspepsia A` E A LOSARTAN d03821A Cr I10 Essential (primary) hypertension A` E A ROSUVASTATIN d04851A B E78.0 Pure hypercholesterolemia A` E A SPIRONOLACTONE d00373A Cr I10 Essential (primary) hypertension A` E A METFORMIN d03807A B= E11 Type 2 diabetes mellitus A E A . . . E A . . . E A . . . E A ALBUTEROL d00749A C J45 Asthma A` E A BECLOMETHASONE d00760A C J44.9 J45 R06.2 Chronic obstructive pulmonary disease, unspecified Asthma Wheezing A` E A DIAZEPAM d00148A D F41.9 G47.0 Anxiety disorder, unspecified Insomnia A` E A MONTELUKAST d04289A C J42 J44.9 J45 Unspecified chronic bronchitis Chronic obstructive pulmonary disease, unspecified Asthma A` E A OXYBUTYNIN d00328A D= R32 Unspecified urinary incontinence A` E A PAROXETINE d03157A C F32.9 F41.9 F43.1 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified Post-traumatic stress disorder (PTSD) A` E A INDOMETHACIN d00039A Ap R60.9 Edema, unspecified A0 E A LEVOTHYROXINE d00278A Dc E03.9 Hypothyroidism, unspecified A0 E A METFORMIN d03807A CP E11.P Prevent diabetes A0 E 0 A OXCARBAZEPINE d04513A C G40 Epilepsy and recurrent seizures A E @ A . . . E P A . . . E ` A . . . E p A . . . E A ALBUTEROL d00749A CDp R06.02 Shortness of breath A E A . . . E A . . . E A ALENDRONATE d03849A B[ M81 Osteoporosis without current pathological fracture A` E A ASPIRIN d00170A C I21.P I63.P Prevent heart attack/myocardial infarction Prevent stroke A` E A HYDROCHLOROTHIAZIDE; OLMESARTAN d04878A Cr I10 Essential (primary) hypertension A` E A MECLIZINE d00859A B R42 Dizziness and giddiness A` E A NIFEDIPINE d00051A B[ 99999 A` E A OMEPRAZOLE d00325A B[ M19.9 Osteoarthritis, unspecified site A` E A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified A0 E A LISINOPRIL d00732A B I10 Essential (primary) hypertension A0 E A METFORMIN d03807A B E66 Overweight and obesity A0 E A HYDROXYCHLOROQUINE d00817A B[ M35 Other systemic involvement of connective tissue AP E A HYDROXYZINE d00907A C L29.9 Pruritus, unspecified AP E A PANTOPRAZOLE d04514A C- K21 Gastro-esophageal reflux disease AP E A RITUXIMAB d04255A C"0 M35 Other systemic involvement of connective tissue AP E A RIVAROXABAN d07356A C7 55555 AP E A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia AP E A METFORMIN d03807A C E11 Type 2 diabetes mellitus AP E A METOPROLOL d00134A C I10 Essential (primary) hypertension AP E A OMEPRAZOLE d00325A C K21 Gastro-esophageal reflux disease AP E A TRAMADOL d03826A C- M79.1 Myalgia AP E A . . . E A . . . E A ETHINYL ESTRADIOL; NORETHINDRONE d03238A C N95 Menopausal and other perimenopausal disorders A0 E A HYDROCHLOROTHIAZIDE; LOSARTAN d03830A B= I10 Essential (primary) hypertension A0 E A MELOXICAM d04532A C M19.9 Osteoarthritis, unspecified site A0 E A BACLOFEN d00967A B= M54 Dorsalgia A0 E A CITALOPRAM d04332A C F41.9 Anxiety disorder, unspecified A0 E A OXYBUTYNIN d00328A C N32.81 Overactive bladder A0 E 0 A AMLODIPINE d00689A C I10 Essential (primary) hypertension A E 0 A APIXABAN d07804A C I21.P Prevent heart attack/myocardial infarction A E 0 A FUROSEMIDE d00070A CDp J98.9 Respiratory disorder, unspecified A E 0 A GABAPENTIN d03182A C M79.2 Neuralgia and neuritis, unspecified A E 0 A METOPROLOL d00134A C- I10 Essential (primary) hypertension A E 0 A POTASSIUM CHLORIDE d00345A Cr E87.6 Hypokalemia A E 0 A SERTRALINE d00880A CDp 99999 A E 0 A SIMVASTATIN d00746A C 99999 A E @ A . . . E P A LEVOTHYROXINE d00278A C Z90 Acquired absence of organs, not elsewhere classified A E ` A . . . E p A ALBUTEROL d00749A D J45 Asthma A@ E p A IRBESARTAN d04222A Ap I10 Essential (primary) hypertension A@ E p A LEVOTHYROXINE d00278A Dc E03.9 Hypothyroidism, unspecified A@ E p A METFORMIN d03807A C- R73 Elevated blood glucose level A@ E A . . . E A DOXYCYCLINE d00037A C L70 Acne A@ E A ETHINYL ESTRADIOL; NORGESTIMATE d03781A B N92 Excessive, frequent and irregular menstruation A@ E A FLUTICASONE NASAL d04283A C- J30.2 R09.81 Other seasonal allergic rhinitis Nasal congestion A@ E A METRONIDAZOLE TOPICAL d03208A C L70 Acne A@ E A ALBUTEROL d00749A A J45 Asthma A E A METHADONE d00050A Bz F11.23 Opioid dependence with withdrawal A E A . . . E A ALBUTEROL d00749A C R06.02 Shortness of breath A@ E A AMLODIPINE d00689A C- I10 Essential (primary) hypertension A@ E A CYCLOBENZAPRINE d00963A Cr M25.5 Pain in joint A@ E A METOPROLOL d00134A C I10 Essential (primary) hypertension A@ E A CELECOXIB d04380A D M19.9 Osteoarthritis, unspecified site A` E A LEVOCETIRIZINE d05851A C- T78.40 Allergy, unspecified A` E A MONTELUKAST d04289A C R06.2 Wheezing A` E A PRAVASTATIN d00348A Dc E78.0 Pure hypercholesterolemia A` E A RANOLAZINE d05719A C I20.9 Angina pectoris, unspecified A` E A TAMSULOSIN d04121A C N40 Enlarged prostate A` E A . . . E A EZETIMIBE d04824A C E78.0 Pure hypercholesterolemia A E A HYDROCHLOROTHIAZIDE d00253A Cr I10 Essential (primary) hypertension A E A LIRAGLUTIDE d07466A CDp E11 Type 2 diabetes mellitus A E A METFORMIN d03807A Cr E11 Type 2 diabetes mellitus A E A METOPROLOL d00134A Cr I10 Essential (primary) hypertension A E A PANTOPRAZOLE d04514A Cr K30 Functional dyspepsia A E A ROSUVASTATIN d04851A Cr E78.0 Pure hypercholesterolemia A E A TAMOXIFEN d00381A C[@ C50 Malignant neoplasm of breast A E A TRIAMCINOLONE TOPICAL d03206A C L23 Allergic contact dermatitis A E A VENLAFAXINE d03181A C[@ N95 Menopausal and other perimenopausal disorders A E A . . . E A . . . E A . . . E 0 A AMLODIPINE d00689A Cr I10 Essential (primary) hypertension AP E 0 A DULOXETINE d05355A C- F41.9 Anxiety disorder, unspecified AP E 0 A GABAPENTIN d03182A Cr M79.2 Neuralgia and neuritis, unspecified AP E 0 A MONTELUKAST d04289A C- J45 Asthma AP E 0 A TIZANIDINE d04102A Cr M62.83 Muscle spasm AP E @ A ATENOLOL d00004A D* I10 Essential (primary) hypertension A E P A METHOCARBAMOL d00965A B M54 Dorsalgia A E ` A . . . E p A . . . E A HYDROCHLOROTHIAZIDE; VALSARTAN d04293A CDp I10 Essential (primary) hypertension A E A . . . E A . . . E A . . . E A AMLODIPINE d00689A CDp I10 Essential (primary) hypertension AP E A ATORVASTATIN d04105A CDp I21.P Prevent heart attack/myocardial infarction AP E A CLOPIDOGREL d04258A CDp I49.9 Cardiac arrhythmia, unspecified AP E A LOSARTAN d03821A CDp I10 Essential (primary) hypertension AP E A METOPROLOL d00134A CDp I10 R00 Essential (primary) hypertension Abnormalities of heart beat AP E A . . . E A ATORVASTATIN d04105A C[@ E78.0 Pure hypercholesterolemia A0 E A CARVEDILOL d03847A C[@ I10 Essential (primary) hypertension A0 E A SERTRALINE d00880A Dc F41.9 Anxiety disorder, unspecified A0 E A MIRTAZAPINE d04025A CDp F32.9 G47.0 Major depressive disorder, single episode, unspecified Insomnia A E A RISPERIDONE d03180A CDp F29 Unspecified psychosis not due to a substance or known physiological condition A E A . . . E A . . . E A . . . E 0 A . . . E @ A . . . E P A AMOXICILLIN d00088A A H66.9 J01.9 Otitis media, unspecified Acute sinusitis, unspecified A E ` A CNS STIMULANTS - UNSPECIFIED c00071A C- F90 Attention-deficit hyperactivity disorders A E ` A FLUTICASONE NASAL d04283A A J30.9 Allergic rhinitis, unspecified A E p A . . . E A . . . E A . . . E A . . . E A . . . E A TRIAMCINOLONE TOPICAL d03206A B= L30.9 Dermatitis, unspecified A E A DOXYCYCLINE d00037A Ap L70 Acne A E A METHYLPHENIDATE d00900A B F90 Attention-deficit hyperactivity disorders A E A AMLODIPINE d00689A CDp I10 Essential (primary) hypertension A0 E A ATORVASTATIN d04105A Cr E78.0 Pure hypercholesterolemia A0 E A FAMOTIDINE d00141A C- K21 Gastro-esophageal reflux disease A0 E A CLINDAMYCIN d00043A C- K04.7P Prevent tooth infection A E A FINASTERIDE d00563A C[@ R39.9 Unspecified symptoms and signs involving the genitourinary system A E A GLIMEPIRIDE d03864A CDp E11 Type 2 diabetes mellitus A E A LISINOPRIL d00732A C I10 Essential (primary) hypertension A E A METFORMIN d03807A C E11 Type 2 diabetes mellitus A E A PANTOPRAZOLE d04514A Cr K21 Gastro-esophageal reflux disease A E A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia A E A SITAGLIPTIN d05896A A E11 Type 2 diabetes mellitus A E A TRAMADOL d03826A C- M25.5 Pain in joint A E A AMLODIPINE; BENAZEPRIL d03829A B? I10 Essential (primary) hypertension A0 E A HYDROCHLOROTHIAZIDE d00253A B? I10 Essential (primary) hypertension A0 E A NAPROXEN d00019A B= M13 M54 Other arthritis Dorsalgia A0 E A . . . E 0 A ALBUTEROL d00749A CDp J45 Asthma AP E 0 A ALBUTEROL d00749A CDp J45 Asthma AP E 0 A FLUTICASONE d01296A CDp J45 Asthma AP E 0 A POLYETHYLENE GLYCOL 3350 d05350A Bz K92.9 Disease of digestive system, unspecified AP E 0 A PREDNISOLONE d00084A B R06.9 Unspecified abnormalities of breathing AP E @ A OLMESARTAN d04801A B I10 Essential (primary) hypertension A E P A LISINOPRIL d00732A B= I10 Essential (primary) hypertension A E ` A . . . E p A . . . E A AMLODIPINE d00689A C I10 Essential (primary) hypertension A0 E A MELOXICAM d04532A B[ M54 Dorsalgia A0 E A OMEPRAZOLE d00325A Cr K21 Gastro-esophageal reflux disease A0 E A . . . E A . . . E A . . . E A AMOXICILLIN d00088A A H66.9 Otitis media, unspecified A E A SULFAMETHOXAZOLE d00119A A B99.9 Unspecified infectious disease A E A . . . E A CYPROHEPTADINE d00790A B G43 Migraine A E A TOPIRAMATE d04115A B 99999 A E A . . . E A . . . E A ACETAMINOPHEN; OXYCODONE d03431A B* G89 M25.5 T14.9 Pain, not elsewhere classified Pain in joint Unspecified injury Ap E A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia Ap E A DIAZEPAM d00148A B* F41.9 Anxiety disorder, unspecified Ap E A GABAPENTIN d03182A B* M79.2 Neuralgia and neuritis, unspecified Ap E A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A C- I10 Essential (primary) hypertension Ap E A METFORMIN d03807A CDp E11 Type 2 diabetes mellitus Ap E A ZOLPIDEM d00910A C G47.0 G47.9 Insomnia Sleep disorder, unspecified Ap E 0 A 77777 . . A E @ A ATORVASTATIN d04105A CDp E78.0 Pure hypercholesterolemia A0 E @ A LISINOPRIL d00732A CDp I10 Essential (primary) hypertension A0 E @ A METOPROLOL d00134A CDp I20.9 Angina pectoris, unspecified A0 E P A . . . E ` A . . . E p A . . . E A ESZOPICLONE d05421A C G47.9 Sleep disorder, unspecified A E A LEVOTHYROXINE d00278A Bz E03.9 Hypothyroidism, unspecified A E A SIMVASTATIN d00746A Bz E78.0 Pure hypercholesterolemia A E A . . . E A MELOXICAM d04532A B= M25.5 Pain in joint A E A . . . E A . . . E A THYROID DESICCATED d00655A C E03.9 Hypothyroidism, unspecified A E A DEXMETHYLPHENIDATE d04777A C F90 Attention-deficit hyperactivity disorders A E A . . . E A . . . E A . . . E 0 A . . . E @ A . . . E P A ACETAMINOPHEN; OXYCODONE d03431A A@ Z98 Other postprocedural states A E ` A . . . E p A GLIPIZIDE d00246A C E11 Type 2 diabetes mellitus A` E p A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A C I10 Essential (primary) hypertension A` E p A INSULIN GLARGINE d04538A C E11 Type 2 diabetes mellitus A` E p A METFORMIN d03807A C E11 Type 2 diabetes mellitus A` E p A TRAMADOL d03826A CDp M79.1 Myalgia A` E p A ZOLPIDEM d00910A C G47.0 Insomnia A` E A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E A OLANZAPINE d04050A C[@ F31.9 Bipolar disorder, unspecified A E A VALPROIC ACID d00083A Cr F31.9 Bipolar disorder, unspecified A E A . . . E A . . . E A SERTRALINE d00880A B F41.9 Anxiety disorder, unspecified A E 0 A . . . E @ A METFORMIN; SITAGLIPTIN d06720A C- E11 Type 2 diabetes mellitus A0 E @ A METOPROLOL d00134A C I10 Essential (primary) hypertension A0 E @ A SIMVASTATIN d00746A Cr E78.0 Pure hypercholesterolemia A0 E P A . . . E ` A CEFDINIR d04256A A J01.9 Acute sinusitis, unspecified A E p A . . . E A ALLOPURINOL d00023A C M25.5 Pain in joint A E A ATENOLOL d00004A C I10 Essential (primary) hypertension A E A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A E A DONEPEZIL; MEMANTINE d08337A C R41 Other symptoms and signs involving cognitive functions and awareness A E A GLIMEPIRIDE d03864A C E11.P Prevent diabetes A E A LEVOCETIRIZINE d05851A CDp L29.9 Pruritus, unspecified A E A LISINOPRIL d00732A C I10 Essential (primary) hypertension A E A MELOXICAM d04532A Cr M79.1 Myalgia A E A METFORMIN d03807A C E11 Type 2 diabetes mellitus A E A ESCITALOPRAM d04812A C- F41.9 Anxiety disorder, unspecified A E A . . . E A LEVOTHYROXINE d00278A Dc E03.9 Hypothyroidism, unspecified A E A . . . E A ATENOLOL d00004A C I10 Essential (primary) hypertension A@ E A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A@ E A LORAZEPAM d00149A Cr F43.9 R45 Reaction to severe stress, unspecified Symptoms and signs involving emotional state A@ E A OMEPRAZOLE d00325A C K25 Gastric ulcer A@ E A . . . E A . . . E A HYDROCHLOROTHIAZIDE d00253A C"0 I10 Essential (primary) hypertension A E A LOSARTAN d03821A C"0 I10 Essential (primary) hypertension A E A HYDROCHLOROTHIAZIDE d00253A C- I10 Essential (primary) hypertension Ap E A INSULIN GLARGINE d04538A D E11 Type 2 diabetes mellitus Ap E A INSULIN LISPRO d04373A D E11 Type 2 diabetes mellitus Ap E A LOSARTAN d03821A D I10 Essential (primary) hypertension Ap E A OMEPRAZOLE d00325A B[ K30 Functional dyspepsia Ap E A SERTRALINE d00880A B F32.9 Major depressive disorder, single episode, unspecified Ap E A TRAZODONE d00395A B= G47.9 Sleep disorder, unspecified Ap E A CHOLESTYRAMINE d00193A C E78.0 Pure hypercholesterolemia A` E A MESALAMINE d01031A C- K51 Ulcerative colitis A` E A OMEPRAZOLE d00325A C K21 Gastro-esophageal reflux disease A` E A PAROXETINE d03157A C[@ F32.9 Major depressive disorder, single episode, unspecified A` E A RANITIDINE d00021A Ap K21 Gastro-esophageal reflux disease A` E A VERAPAMIL d00048A D' I10 Essential (primary) hypertension A` E 0 A AMOXICILLIN d00088A A H66.9 Otitis media, unspecified Ap E 0 A CLONAZEPAM d00197A C"0 G47.9 Sleep disorder, unspecified Ap E 0 A CLOPIDOGREL d04258A C Z79.0 Long term (current) use of anticoagulants and antithrombotics/antiplatelets Ap E 0 A MECLIZINE d00859A B R42 Dizziness and giddiness Ap E 0 A OMEPRAZOLE d00325A Cr K21 Gastro-esophageal reflux disease Ap E 0 A PROMETHAZINE d00787A B R11 Nausea and vomiting Ap E 0 A SERTRALINE d00880A CDp F41.0 Panic disorder [episodic paroxysmal anxiety] without agoraphobia Ap E @ A . . . E P A . . . E ` A . . . E p A . . . E A AMLODIPINE d00689A C- I10 Essential (primary) hypertension A` E A ATORVASTATIN d04105A CDp E78.0 Pure hypercholesterolemia A` E A BUSPIRONE d00182A C- F41.9 Anxiety disorder, unspecified A` E A HYDROCHLOROTHIAZIDE; LOSARTAN d03830A CDp I10 Essential (primary) hypertension A` E A METFORMIN d03807A B R73 Elevated blood glucose level A` E A MONTELUKAST d04289A B J30.9 Allergic rhinitis, unspecified A` E A . . . E A . . . E ° A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E A POLYETHYLENE GLYCOL 3350 d05350A C- K59.0 Constipation A E A . . . E 0 A AMOXICILLIN d00088A A B96.81 Helicobacter pylori [H. pylori] as the cause of diseases classified elsewhere A E 0 A METRONIDAZOLE d00108A A B96.81 Helicobacter pylori [H. pylori] as the cause of diseases classified elsewhere A E @ A . . . E P A FLUTICASONE d01296A CDp J45 Asthma A E P A MONTELUKAST d04289A C J45 Asthma A E ` A . . . E p A . . . E À A ATORVASTATIN d04105A C- E78.0 Pure hypercholesterolemia A E À A METOPROLOL d00134A C- R07.9 Chest pain, unspecified A E Ð A OMEPRAZOLE d00325A A K25.P K92.9 Prevent gastric ulcer Disease of digestive system, unspecified A E à A AMITRIPTYLINE d00146A D1 F41.9 Anxiety disorder, unspecified A@ E à A CYCLOBENZAPRINE d00963A B M54 M79.1 T14.9 Dorsalgia Myalgia Unspecified injury A@ E à A PERPHENAZINE d00855A D1 F41.9 Anxiety disorder, unspecified A@ E à A ZOLPIDEM d00910A B G47.9 Sleep disorder, unspecified A@ E ð A . . . E A AMIODARONE d00002A Dc I51.9 Heart disease, unspecified Ap E A ASPIRIN d00170A D D75.9P Prevent blood clots Ap E A CLOPIDOGREL d04258A D 99999 Ap E A ISOSORBIDE d00653A B I51.9 Heart disease, unspecified Ap E A LISINOPRIL d00732A Cr I51.9 Heart disease, unspecified Ap E A METOPROLOL d00134A B I49.9 R07.9 Cardiac arrhythmia, unspecified Chest pain, unspecified Ap E A RANOLAZINE d05719A B I51.9 Heart disease, unspecified Ap E A . . . E A BUPROPION d00181A C 77777 AP E A BUSPIRONE d00182A C F32.9 Major depressive disorder, single episode, unspecified AP E A CITALOPRAM d04332A C F41.9 Anxiety disorder, unspecified AP E A HYDROXYZINE d00907A C G47.0 Insomnia AP E A LISINOPRIL d00732A C I10 Essential (primary) hypertension AP E A . . . E A AZELASTINE NASAL d04068A B[ R09.81 Nasal congestion AP E A ETHINYL ESTRADIOL; NORGESTREL d03241A B[ Z79.3 Long term (current) use of hormonal contraceptives AP E A METHOCARBAMOL d00965A B M54 Dorsalgia AP E A MONTELUKAST d04289A B[ J30.9 Allergic rhinitis, unspecified AP E A SUMATRIPTAN d03160A CDp G43 Migraine AP E A . . . E A METHOTREXATE d00060A C M06.9 Rheumatoid arthritis, unspecified A E 0 A ATENOLOL d00004A Cr I10 Essential (primary) hypertension A0 E 0 A HYDROCHLOROTHIAZIDE d00253A C- I10 Essential (primary) hypertension A0 E 0 A LOVASTATIN d00280A C E78.0 Pure hypercholesterolemia A0 E @ A METRONIDAZOLE d00108A A A49.9 Bacterial infection, unspecified A E P A . . . E ` A . . . E p A HYDROCHLOROTHIAZIDE d00253A C I10 Essential (primary) hypertension A E Ā A . . . E Đ A . . . E Ġ A . . . E İ A DILTIAZEM d00045A C[@ I10 Essential (primary) hypertension A E İ A HYDROCHLOROTHIAZIDE; LOSARTAN d03830A C I10 Essential (primary) hypertension A E A . . . E A . . . E A CARIPRAZINE d08379A B[ F31.9 Bipolar disorder, unspecified A E A VORTIOXETINE d08125A Ap F32.9 Major depressive disorder, single episode, unspecified A E A OXCARBAZEPINE d04513A B G40 Epilepsy and recurrent seizures A E A . . . E A OSELTAMIVIR d04462A A@ J09 Influenza due to certain identified influenza viruses A E A . . . E 0 A . . . E @ A . . . E P A . . . E ` A . . . E p A . . . E ŀ A . . . E Ő A . . . E Š A . . . E Ű A . . . E A . . . E A ATORVASTATIN d04105A B I21.P Prevent heart attack/myocardial infarction A E A GABAPENTIN d03182A Cr M79.2 Neuralgia and neuritis, unspecified A E A GLIPIZIDE d00246A C[@ E11 Type 2 diabetes mellitus A E A INSULIN GLARGINE d04538A C- E11 Type 2 diabetes mellitus A E A INSULIN LISPRO d04373A B E11 Type 2 diabetes mellitus A E A LINAGLIPTIN d07767A CDp E11 Type 2 diabetes mellitus A E A LOSARTAN d03821A A N28.9P Prevent kidney disease A E A MELOXICAM d04532A C- M13 Other arthritis A E A METFORMIN d03807A Cr E11 Type 2 diabetes mellitus A E A NORTRIPTYLINE d00144A C- M79.2 Neuralgia and neuritis, unspecified A E A OLOPATADINE OPHTHALMIC d04117A B H04 Disorders of lacrimal system A E A BUDESONIDE; FORMOTEROL d04795A Cr J45 Asthma A E A . . . E A . . . E A . . . E A . . . E 0 A . . . E @ A . . . E P A . . . E ` A AMLODIPINE; VALSARTAN d06662A Cr I10 Essential (primary) hypertension A E ` A SIMVASTATIN d00746A Cr E78.0 Pure hypercholesterolemia A E p A . . . E ƀ A ATORVASTATIN d04105A C E78.0P Prevent high cholesterol A E ƀ A LEVOTHYROXINE d00278A D=O E05 Thyrotoxicosis [hyperthyroidism] A E Ɛ A . . . E Ơ A . . . E ư A AMLODIPINE d00689A Cr I10 Essential (primary) hypertension AP E ư A ATORVASTATIN d04105A B= E78.0 Pure hypercholesterolemia AP E ư A INSULIN LISPRO d04373A C E10 R73 Type 1 diabetes mellitus Elevated blood glucose level AP E ư A IRBESARTAN d04222A B I10 Essential (primary) hypertension AP E ư A LISDEXAMFETAMINE d06663A C F90 Attention-deficit hyperactivity disorders AP E A . . . E A AMLODIPINE d00689A Cr 99999 AP E A INSULIN DETEMIR d05436A C R73 Elevated blood glucose level AP E A INSULIN REGULAR d04369A C E11 R73 Type 2 diabetes mellitus Elevated blood glucose level AP E A LISINOPRIL d00732A Cr 99999 AP E A METFORMIN d03807A C 99999 AP E A . . . E A . . . E A . . . E A AMLODIPINE d00689A C[@ 99999 A@ E A ATORVASTATIN d04105A Ei 99999 A@ E A HYDROCHLOROTHIAZIDE d00253A C[@ 99999 A@ E A LISINOPRIL d00732A C[@ 99999 A@ E A . . . E 0 A BENZONATATE d00796A B= J42 Unspecified chronic bronchitis A` E 0 A CITALOPRAM d04332A CDp R60.9 Edema, unspecified A` E 0 A IBUPROFEN d00015A B M79.6 Pain in limb, hand, foot, fingers and toes A` E 0 A OXYBUTYNIN d00328A C- 99999 A` E 0 A PANTOPRAZOLE d04514A C 99999 A` E 0 A SULFAMETHOXAZOLE d00119A C 99999 A` E @ A . . . E P A . . . E ` A DIVALPROEX SODIUM d03833A C G40 Epilepsy and recurrent seizures AP E ` A FAMOTIDINE d00141A C- R63 Symptoms and signs concerning food and fluid intake AP E ` A MYCOPHENOLATE MOFETIL d03839A C T86.9P Prevent transplanted organ and tissue rejection AP E ` A PREDNISONE d00350A C 99999 AP E ` A TACROLIMUS d03752A C T86.9P Prevent transplanted organ and tissue rejection AP E p A . . . E ǀ A AMOXICILLIN; CLAVULANATE d00089A A H66.9 Otitis media, unspecified A E ǀ A OFLOXACIN OPHTHALMIC d03977A A@ H10 Conjunctivitis A E ǐ A . . . E Ǡ A HYDROCHLOROTHIAZIDE d00253A C- I10 Essential (primary) hypertension A E ǰ A . . . E A LOSARTAN d03821A C I10 Essential (primary) hypertension A E A OMEPRAZOLE d00325A C K21 Gastro-esophageal reflux disease A E A DEXTROAMPHETAMINE d00804A D# F90 Attention-deficit hyperactivity disorders A E A ESCITALOPRAM d04812A C F32.9 Major depressive disorder, single episode, unspecified AP E A LOSARTAN d03821A Cr I10 Essential (primary) hypertension AP E A METFORMIN d03807A C E11 Type 2 diabetes mellitus AP E A OMEPRAZOLE d00325A Cr K21 Gastro-esophageal reflux disease AP E A SIMVASTATIN d00746A Cr E78.0 Pure hypercholesterolemia AP E A . . . E A . . . E A . . . E A ATENOLOL d00004A C[@ I51.9 Heart disease, unspecified A E A ENALAPRIL d00013A C[@ I10 Essential (primary) hypertension A E 0 A . . . E @ A AMOXICILLIN d00088A B J42 Unspecified chronic bronchitis A E @ A BROMPHENIRAMINE; PSEUDOEPHEDRINE d03301A A J42 Unspecified chronic bronchitis A E P A . . . E ` A 77777 . . A E p A HYDROXYZINE d00907A AP J00 Acute nasopharyngitis [common cold] A E Ȁ A . . . E Ȑ A . . . E Ƞ A . . . E Ȱ A ETHINYL ESTRADIOL; NORETHINDRONE d03238A B N94 Pain and other conditions associated with female genital organs and menstrual cycle A E A . . . E A . . . E A . . . E A ATORVASTATIN d04105A B E78.0 Pure hypercholesterolemia A E A CITALOPRAM d04332A CDp F41.9 Anxiety disorder, unspecified A E A . . . E A BRIMONIDINE OPHTHALMIC d04048A Ei 99999 AP E A CLOPIDOGREL d04258A Ei 99999 AP E A METOPROLOL d00134A Ei 99999 AP E A OLOPATADINE OPHTHALMIC d04117A Ei 99999 AP E A ROSUVASTATIN d04851A Ei 99999 AP E A . . . E 0 A . . . E @ A . . . E P A . . . E ` A CETIRIZINE d03827A CDp T78.40 Allergy, unspecified AP E ` A FUROSEMIDE d00070A Cr J98.9 R60.9 Respiratory disorder, unspecified Edema, unspecified AP E ` A NEBIVOLOL d05265A C I50.9 Heart failure, unspecified AP E ` A POTASSIUM CHLORIDE d00345A Cr E87.6 Hypokalemia AP E ` A VALSARTAN d04113A Cr I10 Essential (primary) hypertension AP E p A . . . E ɀ A ALBUTEROL d00749A D J45 Asthma A E ɀ A ATENOLOL d00004A C 99999 A E ɀ A FLUTICASONE; SALMETEROL d04611A B= J45 Asthma A E ɀ A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified A E ɀ A LISINOPRIL d00732A C I10 Essential (primary) hypertension A E ɀ A LOVASTATIN d00280A C E78.0 Pure hypercholesterolemia A E ɀ A METFORMIN d03807A Cr E11 Type 2 diabetes mellitus A E ɀ A MONTELUKAST d04289A CDp 99999 A E ɀ A OMEPRAZOLE d00325A B K31.9 Disease of stomach and duodenum, unspecified A E ɐ A . . . E ɠ A . . . E ɰ A . . . E A CARVEDILOL d03847A C- I10 Essential (primary) hypertension A` E A FAMOTIDINE d00141A C- K21 Gastro-esophageal reflux disease A` E A HYDROCHLOROTHIAZIDE d00253A B R60.9 Edema, unspecified A` E A LOSARTAN d03821A C- I10 Essential (primary) hypertension A` E A PREDNISONE d00350A C- L93 Lupus erythematosus A` E A TAMSULOSIN d04121A C- R39.1 Other difficulties with micturition A` E A CARVEDILOL d03847A Cr I49.9 Cardiac arrhythmia, unspecified A@ E A INSULIN LISPRO d04373A D E11 Type 2 diabetes mellitus A@ E A PANTOPRAZOLE d04514A Cr K21 Gastro-esophageal reflux disease A@ E A ROSUVASTATIN d04851A Cr E78.0 Pure hypercholesterolemia A@ E A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia A E A . . . E A ALBUTEROL d00749A C J45 Asthma A E A ALBUTEROL d00749A C J45 Asthma A E A . . . E A . . . E 0 A CLONIDINE d00044A A I10 Essential (primary) hypertension A@ E 0 A FLUOXETINE d00236A B= F32.9 Major depressive disorder, single episode, unspecified A@ E 0 A HYDRALAZINE d00132A A I10 Essential (primary) hypertension A@ E 0 A VERAPAMIL d00048A A I10 Essential (primary) hypertension A@ E @ A ALBUTEROL d00749A B B34.9 R06.9P Viral infection, unspecified Prevent breathing difficulty A@ E @ A AZITHROMYCIN d00091A0 AP R06.9 Unspecified abnormalities of breathing A@ E @ A OSELTAMIVIR d04462A AP J09 Influenza due to certain identified influenza viruses A@ E @ A PREDNISOLONE d00084A Ap R06.9 Unspecified abnormalities of breathing A@ E P A . . . E ` A . . . E p A . . . E ʀ A . . . E ʐ A . . . E ʠ A . . . E ʰ A . . . E A . . . E A HYDROCHLOROTHIAZIDE d00253A C I10 Essential (primary) hypertension A E A NIFEDIPINE d00051A C I10 Essential (primary) hypertension A` E A POTASSIUM CHLORIDE d00345A B E87.6 Hypokalemia A` E A PRAVASTATIN d00348A C E78.0 Pure hypercholesterolemia A` E A PREDNISONE d00350A B M35 Other systemic involvement of connective tissue A` E A SUCRALFATE d00377A Cr K21 Gastro-esophageal reflux disease A` E A TRAMADOL d03826A B R10 Abdominal and pelvic pain A` E A . . . E A . . . E A ALBUTEROL d00749A Ap J42 Unspecified chronic bronchitis Ap E A AMOXICILLIN; CLAVULANATE d00089A A0 J42 Unspecified chronic bronchitis Ap E A BENZONATATE d00796A A0 J42 Unspecified chronic bronchitis Ap E A BROMPHENIRAMINE; PSEUDOEPHEDRINE d03301A A R05 Cough Ap E A DOXYCYCLINE d00037A Ap H66.9 J42 Otitis media, unspecified Unspecified chronic bronchitis Ap E A FLUCONAZOLE d00071A A B37 Candidiasis Ap E A HOMATROPINE; HYDROCODONE d03340A Ap R05 Cough Ap E A . . . E 0 A . . . E @ A . . . E P A . . . E ` A . . . E p A . . . E ˀ A . . . E ː A . . . E ˠ A . . . E ˰ A CIPROFLOXACIN; DEXAMETHASONE OTIC d04890A A H60 Otitis externa A E A . . . E A AMOXICILLIN d00088A Ap J18.9 Pneumonia, unspecified organism A E A MONTELUKAST d04289A A J18.9 Pneumonia, unspecified organism A E A . . . E A ALLOPURINOL d00023A D M10.9P Prevent gout A` E A CARVEDILOL d03847A C I10 Essential (primary) hypertension A` E A CHOLESTYRAMINE d00193A C E78.0 Pure hypercholesterolemia A` E A CLOPIDOGREL d04258A C D75.9P Prevent blood clots A` E A GEMFIBROZIL d00245A C[@ E78.1 Pure hyperglyceridemia A` E A LOSARTAN d03821A C- I10 Essential (primary) hypertension A` E A . . . E A ESCITALOPRAM d04812A B[ F41.9 Anxiety disorder, unspecified A0 E A GABAPENTIN d03182A C B02 G25.81 M79.2 Zoster [herpes zoster] Restless legs syndrome Neuralgia and neuritis, unspecified A0 E A TRAZODONE d00395A B G47.9 Sleep disorder, unspecified A0 E A . . . E 0 A . . . E @ A . . . E P A AMLODIPINE d00689A B[ I10 Essential (primary) hypertension AP E P A FUROSEMIDE d00070A B I10 Essential (primary) hypertension AP E P A HYDRALAZINE d00132A B I10 Essential (primary) hypertension AP E P A LOSARTAN d03821A B I10 Essential (primary) hypertension AP E P A SPIRONOLACTONE d00373A B I10 Essential (primary) hypertension AP E ` A . . . E p A . . . E ̀ A CLOPIDOGREL d04258A C I63 Cerebral infarction Ap E ̀ A HYDROCHLOROTHIAZIDE d00253A C"0 I10 Essential (primary) hypertension Ap E ̀ A LISINOPRIL d00732A D I10 Essential (primary) hypertension Ap E ̀ A METFORMIN d03807A D E11 Type 2 diabetes mellitus Ap E ̀ A METOPROLOL d00134A D I10 Essential (primary) hypertension Ap E ̀ A OMEPRAZOLE d00325A D K30 R12 Functional dyspepsia Heartburn Ap E ̀ A SIMVASTATIN d00746A D E78.0 I63.P Pure hypercholesterolemia Prevent stroke Ap E ̐ A . . . E ̠ A AMLODIPINE d00689A B[ I21.P Prevent heart attack/myocardial infarction A E ̠ A GLIPIZIDE d00246A C E11 Type 2 diabetes mellitus A E ̠ A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A C R60.9 Edema, unspecified A E ̠ A INSULIN DETEMIR d05436A C E11 Type 2 diabetes mellitus A E ̠ A METFORMIN d03807A C E11 Type 2 diabetes mellitus A E ̠ A METOPROLOL d00134A B[ I21.P Prevent heart attack/myocardial infarction A E ̠ A RANITIDINE d00021A B K30 Functional dyspepsia A E ̠ A SIMVASTATIN d00746A CDp E78.0 Pure hypercholesterolemia A E ̰ A . . . E A . . . E A ALPRAZOLAM d00168A0 D# F32.9 R45 Major depressive disorder, single episode, unspecified Symptoms and signs involving emotional state B E A AMLODIPINE d00689A0 D I21.P Prevent heart attack/myocardial infarction B E A ASPIRIN d00170A0 D I21.P I51.9P Prevent heart attack/myocardial infarction Prevent heart disease B E A GABAPENTIN d03182A0 B M79.2 Neuralgia and neuritis, unspecified B E A GLIPIZIDE d00246A0 Cr E11 Type 2 diabetes mellitus B E A INSULIN ASPART d04697A B E11 R73 Type 2 diabetes mellitus Elevated blood glucose level B E A INSULIN GLARGINE d04538A B E11 Type 2 diabetes mellitus B E A LISINOPRIL d00732A0 D I10 Essential (primary) hypertension B E A METFORMIN d03807A0 Cr E11 Type 2 diabetes mellitus B E A METHYLPHENIDATE d00900A C F90 Attention-deficit hyperactivity disorders B E A METOPROLOL d00134A0 Ei I10 I20.9 Essential (primary) hypertension Angina pectoris, unspecified B E A NITROGLYCERIN d00321A D I20.9 R07.9 Angina pectoris, unspecified Chest pain, unspecified B E A OLANZAPINE d04050A0 D F32.9 F39 G47.0 Major depressive disorder, single episode, unspecified Unspecified mood [affective] disorder Insomnia B E A OMEPRAZOLE d00325A0 Dc K21 Gastro-esophageal reflux disease B E A OXYCODONE d00329A Cr M25.5 M54 T14.9 Pain in joint Dorsalgia Unspecified injury B E A PAROXETINE d03157A D F32.9 R45 Major depressive disorder, single episode, unspecified Symptoms and signs involving emotional state B E A SIMVASTATIN d00746A0 D E78.0 Pure hypercholesterolemia B E A . . . E A . . . E A . . . E A . . . E A . . . E 0 A . . . E @ A . . . E P A . . . E ` A THYROID DESICCATED d00655A C"0 E03.9 Hypothyroidism, unspecified A E p A METFORMIN d03807A B E28 Ovarian dysfunction A E ̀ A ONDANSETRON d00867A B R11 Nausea and vomiting A E ̀ A RANITIDINE d00021A C- K21 R11 Gastro-esophageal reflux disease Nausea and vomiting A E ͐ A . . . E ͠ A . . . E Ͱ A . . . E A . . . E A AMPHETAMINE; DEXTROAMPHETAMINE d04035A C F90 Attention-deficit hyperactivity disorders A E A . . . E A . . . E A AMLODIPINE d00689A Dc I10 Essential (primary) hypertension A0 E A ATENOLOL d00004A Dc I10 Essential (primary) hypertension A0 E A TRIAMTERENE d00396A C"0 I10 Essential (primary) hypertension A0 E A . . . E A . . . E 0 A BUDESONIDE; FORMOTEROL d04795A D J43 J45 Emphysema Asthma A@ E 0 A LISINOPRIL d00732A Cr I10 Essential (primary) hypertension A@ E 0 A METFORMIN d03807A D# E11 Type 2 diabetes mellitus A@ E 0 A OMEPRAZOLE d00325A C[@ K21 R12 Gastro-esophageal reflux disease Heartburn A@ E @ A . . . E P A AMLODIPINE d00689A C I10 Essential (primary) hypertension A@ E P A BENAZEPRIL d00730A C I10 Essential (primary) hypertension A@ E P A FLUTICASONE NASAL d04283A Cr J30.2 Other seasonal allergic rhinitis A@ E P A ROSUVASTATIN d04851A C- E78.0 Pure hypercholesterolemia A@ E ` A MONTELUKAST d04289A C"0 J30.9 R06.2 Allergic rhinitis, unspecified Wheezing A E p A . . . E A AMOXICILLIN d00088A AP H66.9 Otitis media, unspecified A E ΐ A . . . E Π A DIAZEPAM d00148A C"0 F41.9 Anxiety disorder, unspecified AP E Π A FUROSEMIDE d00070A Bz I51.9 Heart disease, unspecified AP E Π A OMEPRAZOLE d00325A D K21 Gastro-esophageal reflux disease AP E Π A ONDANSETRON d00867A Bz R11 Nausea and vomiting AP E Π A POTASSIUM CHLORIDE d00345A Bz E87.6 Hypokalemia AP E ΰ A . . . E A BIMATOPROST OPHTHALMIC d04754A C H40 Glaucoma A E A TIMOLOL OPHTHALMIC d04037A C H40 Glaucoma A E A ACETAMINOPHEN; HYDROCODONE d03428A0 C M54 Dorsalgia Ap E A DESIPRAMINE d00145A0 C- G47.9 Sleep disorder, unspecified Ap E A LOSARTAN d03821A0 Cr I10 Essential (primary) hypertension Ap E A METFORMIN d03807A0 CDp R73 Elevated blood glucose level Ap E A METOPROLOL d00134A0 C[@ I10 Essential (primary) hypertension Ap E A OMEPRAZOLE d00325A0 D,3 K21 K30 R12 Gastro-esophageal reflux disease Functional dyspepsia Heartburn Ap E A SIMVASTATIN d00746A0 CDp E78.0 Pure hypercholesterolemia Ap E A . . . E A . . . E A . . . E A PREDNISOLONE OPHTHALMIC d03221A B* H57.9 Unspecified disorder of eye and adnexa A E A ALBUTEROL d00749A . J45 Asthma A E A MONTELUKAST d04289A A J30.9 Allergic rhinitis, unspecified A E 0 A ATORVASTATIN d04105A B= I21.P Prevent heart attack/myocardial infarction A E 0 A CLOPIDOGREL d04258A B[ I21.P Prevent heart attack/myocardial infarction A E @ A DULOXETINE d05355A C- M54 Dorsalgia AP E @ A GABAPENTIN d03182A C M79.2 Neuralgia and neuritis, unspecified AP E @ A MIRTAZAPINE d04025A CDp G47.9 Sleep disorder, unspecified AP E @ A TIZANIDINE d04102A C M54 Dorsalgia AP E @ A TRAMADOL d03826A C M54 Dorsalgia AP E P A . . . E ` A ETHINYL ESTRADIOL; NORETHINDRONE d03238A C[@ Z79.3 Long term (current) use of hormonal contraceptives A E p A . . . E π A . . . E ϐ A . . . E Ϡ A ACETAMINOPHEN; HYDROCODONE d03428A B[ M25.5 Pain in joint A E Ϡ A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A E Ϡ A DIAZEPAM d00148A Cr M62.83 Muscle spasm A E Ϡ A DULOXETINE d05355A C F32.9 Major depressive disorder, single episode, unspecified A E Ϡ A HYDROCHLOROTHIAZIDE; VALSARTAN d04293A C I10 R60.9 Essential (primary) hypertension Edema, unspecified A E Ϡ A OXYBUTYNIN d00328A CDp N32.81 Overactive bladder A E Ϡ A PRAMIPEXOLE d04145A C G25.81 Restless legs syndrome A E Ϡ A PREGABALIN d05508A Dc M79.2 Neuralgia and neuritis, unspecified A E ϰ A FLUORIDE TOPICAL d04397A A K02 Dental caries A E A . . . E A METFORMIN d03807A B E11 Type 2 diabetes mellitus A E A ROSUVASTATIN d04851A B E78.0 Pure hypercholesterolemia A E A AMLODIPINE d00689A C- I10 Essential (primary) hypertension A@ E A INSULIN GLARGINE d04538A B E11 Type 2 diabetes mellitus A@ E A LOSARTAN d03821A C- I10 Essential (primary) hypertension A@ E A SIMVASTATIN d00746A Cr E78.0 Pure hypercholesterolemia A@ E A . . . E A . . . E A ATORVASTATIN d04105A C"0 E78.0 Pure hypercholesterolemia A E A LEVOTHYROXINE d00278A Dc E03.9 Hypothyroidism, unspecified A E A . . . E 0 A ALLOPURINOL d00023A CDp M1A Chronic gout Ap E 0 A AMLODIPINE d00689A A I10 Essential (primary) hypertension Ap E 0 A DOCUSATE d01021A A K59.0 Constipation Ap E 0 A METOPROLOL d00134A C I10 Essential (primary) hypertension Ap E 0 A OMEPRAZOLE d00325A A K21 Gastro-esophageal reflux disease Ap E 0 A SIMVASTATIN d00746A CDp I63.P Prevent stroke Ap E 0 A TAMSULOSIN d04121A A N40 Enlarged prostate Ap E @ A . . . E P A . . . E ` A LATANOPROST OPHTHALMIC d04017A C H40 Glaucoma A0 E ` A METRONIDAZOLE TOPICAL d03208A D L71 Rosacea A0 E ` A SULFACETAMIDE SODIUM TOPICAL d01265A D L71 Rosacea A0 E p A . . . E Ѐ A NIFEDIPINE d00051A B I10 Essential (primary) hypertension A E А A AMLODIPINE d00689A C I10 Essential (primary) hypertension A0 E А A CITALOPRAM d04332A C F32.9 F41.9 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified A0 E А A METOPROLOL d00134A C I10 Essential (primary) hypertension A0 E Р A AMLODIPINE d00689A C I10 Essential (primary) hypertension A@ E Р A HYDROCHLOROTHIAZIDE; QUINAPRIL d04509A C I10 Essential (primary) hypertension A@ E Р A METHOCARBAMOL d00965A B M54 Dorsalgia A@ E Р A METOPROLOL d00134A C I10 Essential (primary) hypertension A@ E а A . . . E A . . . E A 55555 A C G47.9 Sleep disorder, unspecified A E A 77777 . . A E A ALBUTEROL d00749A Cr J44.9 Chronic obstructive pulmonary disease, unspecified A E A ALBUTEROL d00749A Cr J44.9 Chronic obstructive pulmonary disease, unspecified A E A BUSPIRONE d00182A C- F41.9 Anxiety disorder, unspecified A E A FORMOTEROL; MOMETASONE d07660A C[@ J44.9 Chronic obstructive pulmonary disease, unspecified A E A OXYBUTYNIN d00328A C R32 Unspecified urinary incontinence A E A ROPINIROLE d04215A C- G25.81 Restless legs syndrome A E A THEOPHYLLINE d00142A CDp J44.9 Chronic obstructive pulmonary disease, unspecified A E A TIOTROPIUM d04829A Cr J44.9 Chronic obstructive pulmonary disease, unspecified A E A . . . E A . . . E A . . . E 0 A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified A E @ A . . . E P A . . . E ` A . . . E p A ATORVASTATIN d04105A D E78.0 Pure hypercholesterolemia A@ E p A CARVEDILOL d03847A Dc I21.P Prevent heart attack/myocardial infarction A@ E p A LISINOPRIL d00732A D I10 Essential (primary) hypertension A@ E p A VENLAFAXINE d03181A D F41.9 Anxiety disorder, unspecified A@ E р A ALBUTEROL d00749A D* J45 Asthma A E ѐ A . . . E Ѡ A HYDROXYZINE d00907A C- F41.9 Anxiety disorder, unspecified A E Ѡ A VENLAFAXINE d03181A C- F32.9 Major depressive disorder, single episode, unspecified A E Ѱ A ARIPIPRAZOLE d04825A C"0 F39 Unspecified mood [affective] disorder A0 E Ѱ A FLUOXETINE d00236A CDp F32.9 Major depressive disorder, single episode, unspecified A0 E Ѱ A LAMOTRIGINE d03809A B[ F39 Unspecified mood [affective] disorder A0 E A NAPROXEN d00019A C R52 Pain, unspecified A E A . . . E A ARIPIPRAZOLE d04825A B F32.9 Major depressive disorder, single episode, unspecified Ap E A DICLOFENAC d00848A Ei M19.9 Osteoarthritis, unspecified site Ap E A FUROSEMIDE d00070A C I51.9 Heart disease, unspecified Ap E A INSULIN ASPART d04697A D# E11 Type 2 diabetes mellitus Ap E A INSULIN GLARGINE d04538A D# E11 Type 2 diabetes mellitus Ap E A MIRTAZAPINE d04025A B 99999 Ap E A QUETIAPINE d04220A B R52 Pain, unspecified Ap E A . . . E A PREDNISOLONE d00084A B J42 R07.9 Unspecified chronic bronchitis Chest pain, unspecified A E A . . . E A ATORVASTATIN d04105A0 C[@ E78.0 Pure hypercholesterolemia A` E A FINASTERIDE d00563A0 CDp R35 Polyuria A` E A GLIPIZIDE d00246A0 C[@ E11 Type 2 diabetes mellitus A` E A LOSARTAN d03821A0 CDp I10 Essential (primary) hypertension A` E A METFORMIN d03807A0 C E11 Type 2 diabetes mellitus A` E A TAMSULOSIN d04121A0 CDp R39.1 Other difficulties with micturition A` E 0 A AMLODIPINE d00689A D I10 Essential (primary) hypertension A` E 0 A ATORVASTATIN d04105A CDp E78.0 Pure hypercholesterolemia A` E 0 A LATANOPROST OPHTHALMIC d04017A B[ H40 Glaucoma A` E 0 A LEVOTHYROXINE d00278A D1 E03.9 Hypothyroidism, unspecified A` E 0 A LISINOPRIL d00732A D I10 Essential (primary) hypertension A` E 0 A METRONIDAZOLE TOPICAL d03208A D L71 Rosacea A` E @ A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A B I10 Essential (primary) hypertension A E @ A METFORMIN d03807A B[ E78.0 Pure hypercholesterolemia A E P A . . . E ` A . . . E p A . . . E Ҁ A . . . E Ґ A . . . E Ҡ A CELECOXIB d04380A C M65.9 Synovitis and tenosynovitis, unspecified A E Ұ A . . . E A . . . E A . . . E A CIPROFLOXACIN d00011A A0 K05.6 N39.0 Periodontal disease, unspecified Urinary tract infection, site not specified A@ E A PANTOPRAZOLE d04514A C K21 Gastro-esophageal reflux disease A@ E A PROMETHAZINE d00787A B R11 Nausea and vomiting A@ E A PROPRANOLOL d00032A C R25.1 Tremor, unspecified A@ E A . . . E A . . . E A . . . E A . . . E 0 A LISDEXAMFETAMINE d06663A C- F90 Attention-deficit hyperactivity disorders A E @ A . . . E P A LETROZOLE d04156A C 55555 A E P A METFORMIN d03807A C- R73 Elevated blood glucose level A E ` A . . . E p A . . . E Ӏ A ALPRAZOLAM d00168A C F41.0 F41.9 Panic disorder [episodic paroxysmal anxiety] without agoraphobia Anxiety disorder, unspecified A0 E Ӏ A MELOXICAM d04532A B[ T14.9 Unspecified injury A0 E Ӏ A TAMOXIFEN d00381A C[@ C50 Malignant neoplasm of breast A0 E Ӑ A . . . E Ӡ A AMLODIPINE; BENAZEPRIL d03829A D I10 Essential (primary) hypertension A@ E Ӡ A HYDROCHLOROTHIAZIDE d00253A Dc R60.9 Edema, unspecified A@ E Ӡ A METFORMIN d03807A Dc E11 Type 2 diabetes mellitus A@ E Ӡ A TAMSULOSIN d04121A C- R35 Polyuria A@ E Ӱ A AMOXICILLIN; CLAVULANATE d00089A C J02.0 Streptococcal pharyngitis A E A . . . E A 99999 . . A E A . . . E A . . . E A . . . E A . . . E A . . . E 0 A . . . E @ A . . . E P A METHADONE d00050A C[@ F11.23 Opioid dependence with withdrawal A E ` A . . . E p A TRAZODONE d00395A Cr G47.9 Sleep disorder, unspecified A E Ԁ A ETHINYL ESTRADIOL; NORGESTREL d03241A Ap Z79.3 Long term (current) use of hormonal contraceptives A E Ԑ A ACETAMINOPHEN; HYDROCODONE d03428A Ap R10 Abdominal and pelvic pain A E Ԡ A . . . E A ADALIMUMAB d04835A C M06.9 Rheumatoid arthritis, unspecified A E A ATORVASTATIN d04105A Cr E78.0 Pure hypercholesterolemia A E A ESOMEPRAZOLE d04749A Cr K30 Functional dyspepsia A E A FLUTICASONE; VILANTEROL d08100A CDp J44.9 Chronic obstructive pulmonary disease, unspecified A E A IBUPROFEN d00015A C M19.9 Osteoarthritis, unspecified site A E A METHOTREXATE d00060A C M06.9 Rheumatoid arthritis, unspecified A E A METOPROLOL d00134A Cr I10 Essential (primary) hypertension A E A PREDNISONE d00350A D M06.9 Rheumatoid arthritis, unspecified A E A TRAMADOL d03826A CDp M06.9 Rheumatoid arthritis, unspecified A E A ETHINYL ESTRADIOL; NORGESTIMATE d03781A B Z79.3 Long term (current) use of hormonal contraceptives A E A . . . E A . . . E A AMOXICILLIN d00088A A H66.9 Otitis media, unspecified A E A . . . E A . . . E A . . . E 0 A . . . E @ A . . . E P A . . . E ` A . . . E p A ACETAMINOPHEN; HYDROCODONE d03428A D M54 Dorsalgia A E p A ESOMEPRAZOLE d04749A C K30 Functional dyspepsia A E Հ A AMLODIPINE d00689A C I10 Essential (primary) hypertension A E Հ A BUSPIRONE d00182A B F41.9 Anxiety disorder, unspecified A E Հ A DEXLANSOPRAZOLE d07395A Cr K21 K30 Gastro-esophageal reflux disease Functional dyspepsia A E Հ A EZETIMIBE d04824A B[ E78.0 Pure hypercholesterolemia A E Հ A GABAPENTIN d03182A Cr M79.2 Neuralgia and neuritis, unspecified A E Հ A ISOSORBIDE MONONITRATE d00269A Cr I20.9 I21.P Angina pectoris, unspecified Prevent heart attack/myocardial infarction A E Հ A LEVOTHYROXINE d00278A Cr E03.9 Hypothyroidism, unspecified A E Հ A METOCLOPRAMIDE d00298A C K21 Gastro-esophageal reflux disease A E Հ A PRAVASTATIN d00348A C E78.0 Pure hypercholesterolemia A E Հ A SITAGLIPTIN d05896A C- E11 Type 2 diabetes mellitus A E Հ A VALSARTAN d04113A CDp I50.9 Heart failure, unspecified A E Հ A ZOLPIDEM d00910A C[@ G47.0 Insomnia A E Հ A ZONISAMIDE d04527A Cr M79.2 Neuralgia and neuritis, unspecified A E Ր A OLMESARTAN d04801A CDp I10 Essential (primary) hypertension A0 E Ր A PANTOPRAZOLE d04514A C- K30 Functional dyspepsia A0 E Ր A TRAMADOL d03826A C- M25.5 Pain in joint A0 E ՠ A . . . E հ A AMLODIPINE d00689A C- I10 Essential (primary) hypertension A0 E հ A CHLORTHALIDONE d00192A C- I10 Essential (primary) hypertension A0 E հ A FENOFIBRATE d04286A C- E78.0 Pure hypercholesterolemia A0 E A . . . E A . . . E A INSULIN ASPART d04697A C E10 Type 1 diabetes mellitus A E A FLUOXETINE d00236A C- F41.9 N95 Anxiety disorder, unspecified Menopausal and other perimenopausal disorders A0 E A LOSARTAN d03821A C- I10 Essential (primary) hypertension A0 E A METOPROLOL d00134A C- I10 R00 Essential (primary) hypertension Abnormalities of heart beat A0 E A . . . E A LOSARTAN d03821A Cr I10 Essential (primary) hypertension A E A ZOLPIDEM d00910A D* G47.9 Sleep disorder, unspecified A E A LEVOTHYROXINE d00278A D E03.9 Hypothyroidism, unspecified A E 0 A GLIPIZIDE d00246A C E11 Type 2 diabetes mellitus AP E 0 A LEVOTHYROXINE d00278A B E07.9 Disorder of thyroid, unspecified AP E 0 A LISINOPRIL d00732A C 99999 AP E 0 A METFORMIN d03807A C R73 Elevated blood glucose level AP E 0 A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia AP E @ A . . . E P A . . . E ` A FLUNISOLIDE NASAL d04279A C J30.9 Allergic rhinitis, unspecified A@ E ` A GLATIRAMER d04111A D G99.8 Other specified disorders of nervous system in diseases classified elsewhere A@ E ` A MODAFINIL d04378A C R53 Malaise and fatigue A@ E ` A PAROXETINE d03157A C F41.9 Anxiety disorder, unspecified A@ E p A AZITHROMYCIN d00091A AP H66.9 J42 Otitis media, unspecified Unspecified chronic bronchitis A@ E p A IBUPROFEN d00015A AP R50.9 Fever, unspecified A@ E p A OSELTAMIVIR d04462A AP J09 Influenza due to certain identified influenza viruses A@ E p A RANITIDINE d00021A C- K21 Gastro-esophageal reflux disease A@ E ր A ALBUTEROL d00749A C[@ J45 Asthma A@ E ր A FLUTICASONE d01296A Bz J45 Asthma A@ E ր A LEVOTHYROXINE d00278A Cr E03.9 Hypothyroidism, unspecified A@ E ր A OMEPRAZOLE d00325A C K21 K30 R12 Gastro-esophageal reflux disease Functional dyspepsia Heartburn A@ E A POLYETHYLENE GLYCOL 3350 d05350A A K92.9 Disease of digestive system, unspecified A E ֠ A . . . E ְ A AMLODIPINE d00689A B[ 99999 A E ְ A EXENATIDE d05529A B* E11 Type 2 diabetes mellitus A E ְ A FUROSEMIDE d00070A Dc R60.9 Edema, unspecified A E ְ A GLIMEPIRIDE d03864A C E11 Type 2 diabetes mellitus A E ְ A INSULIN DETEMIR d05436A C- E11 Type 2 diabetes mellitus A E ְ A LOSARTAN d03821A B I10 Essential (primary) hypertension A E ְ A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia A E ְ A SITAGLIPTIN d05896A C E11 Type 2 diabetes mellitus A E A LEVOTHYROXINE d00278A Cr E03.9 Hypothyroidism, unspecified A E A ROSUVASTATIN d04851A C- E78.0 Pure hypercholesterolemia A E A HYDROCHLOROTHIAZIDE; VALSARTAN d04293A C[@ I10 Essential (primary) hypertension A E A PRAVASTATIN d00348A C[@ E78.0 Pure hypercholesterolemia A E A CYCLOBENZAPRINE d00963A C G47.9 M62.83 Sleep disorder, unspecified Muscle spasm A0 E A GABAPENTIN d03182A C F39 M79.2 Unspecified mood [affective] disorder Neuralgia and neuritis, unspecified A0 E A IBUPROFEN d00015A C M54 M79.2 Dorsalgia Neuralgia and neuritis, unspecified A0 E A . . . E A . . . E A ALBUTEROL d00749A B[ J20.9 J42 R05 Acute bronchitis, unspecified Unspecified chronic bronchitis Cough A E A . . . E 0 A . . . E @ A . . . E P A . . . E ` A ACEBUTOLOL d00128A0 D I10 I48.9 I49.9 Essential (primary) hypertension Unspecified atrial fibrillation and atrial flutter Cardiac arrhythmia, unspecified A E ` A CELECOXIB d04380A0 D M06.9 Rheumatoid arthritis, unspecified A E ` A DOXAZOSIN d00726A0 D N40 Enlarged prostate A E ` A FINASTERIDE d00563A0 D N40 Enlarged prostate A E ` A FUROSEMIDE d00070A0 D I51.9 Heart disease, unspecified A E ` A LISINOPRIL d00732A0 D I21.P Prevent heart attack/myocardial infarction A E ` A POTASSIUM CHLORIDE d00345A0 D R60.9 Edema, unspecified A E ` A ROSUVASTATIN d04851A0 D E78.0 Pure hypercholesterolemia A E ` A WARFARIN d00022A0 D D75.9P Prevent blood clots A E p A AMLODIPINE d00689A B[ I10 Essential (primary) hypertension A E ׀ A ALBUTEROL d00749A D0z J45 Asthma A E ׀ A BUDESONIDE d04276A D0z J45 Asthma A E א A . . . E נ A SULFAMETHOXAZOLE; TRIMETHOPRIM d00124A B D49.9 Neoplasm of unspecified behavior of unspecified site A E װ A . . . E A AMLODIPINE d00689A0 Cr I10 Essential (primary) hypertension A E A ATORVASTATIN d04105A0 Ei E78.0 Pure hypercholesterolemia A E A BUPROPION d00181A0 C"@ F41.9 Anxiety disorder, unspecified A E A FLUTICASONE NASAL d04283A0 C R09.81 Nasal congestion A E A HYDROCHLOROTHIAZIDE d00253A0 C- I10 Essential (primary) hypertension A E A LAMOTRIGINE d03809A0 C 99999 A E A LEVOTHYROXINE d00278A0 D> E03.9 Hypothyroidism, unspecified A E A OMEPRAZOLE d00325A0 Ei 99999 A E A SUMATRIPTAN d03160A0 Ei 99999 A E A TRAMADOL d03826A0 C M54 Dorsalgia A E A . . . E A 77777 . . A E A . . . E A CILOSTAZOL d04382A C I70 Atherosclerosis A E A GABAPENTIN d03182A Cr B02 Zoster [herpes zoster] A E A INSULIN ISOPHANE; INSULIN REGULAR d04374A Dc E11 Type 2 diabetes mellitus A E A LATANOPROST OPHTHALMIC d04017A C H57.9 Unspecified disorder of eye and adnexa A E A METOPROLOL d00134A C- I10 Essential (primary) hypertension A E A POTASSIUM CHLORIDE d00345A C E87.6 Hypokalemia A E A SIMVASTATIN d00746A C[@ E78.0 Pure hypercholesterolemia A E A TIMOLOL OPHTHALMIC d04037A C H40 Glaucoma A E A . . . E A ALPRAZOLAM d00168A C F41.9 G47.0 Anxiety disorder, unspecified Insomnia A E A ANASTROZOLE d03873A Ap R52 Pain, unspecified A E A ATORVASTATIN d04105A D E78.0 Pure hypercholesterolemia A E A CILOSTAZOL d04382A C- I70 Atherosclerosis A E A GABAPENTIN d03182A C[@ M79.2 Neuralgia and neuritis, unspecified A E A GLIMEPIRIDE d03864A D E11 Type 2 diabetes mellitus A E A LISINOPRIL d00732A Dc I10 Essential (primary) hypertension A E A METFORMIN; SAXAGLIPTIN d07709A D E11 Type 2 diabetes mellitus A E 0 A . . . E @ A FLUTICASONE d01296A C- J45 Asthma A E P A ALLOPURINOL d00023A C M25.5 Pain in joint Ap E P A AMLODIPINE d00689A Cr I10 Essential (primary) hypertension Ap E P A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia Ap E P A CARVEDILOL d03847A C I10 Essential (primary) hypertension Ap E P A HYDROCHLOROTHIAZIDE; IRBESARTAN d04245A C- I10 Essential (primary) hypertension Ap E P A METFORMIN d03807A C E11 Type 2 diabetes mellitus Ap E P A POTASSIUM CHLORIDE d00345A C E87.6 Hypokalemia Ap E ` A ACETAMINOPHEN; HYDROCODONE d03428A B[ M25.5 Pain in joint A` E ` A EZETIMIBE; SIMVASTATIN d05348A C- E78.0 Pure hypercholesterolemia A` E ` A GLIMEPIRIDE d03864A CDp E11 Type 2 diabetes mellitus A` E ` A MELOXICAM d04532A B[ M25.5 Pain in joint A` E ` A METFORMIN d03807A CDp E11 Type 2 diabetes mellitus A` E ` A SITAGLIPTIN d05896A CDp E11 Type 2 diabetes mellitus A` E p A . . . E A . . . E ؐ A ATORVASTATIN d04105A C- E78.0 Pure hypercholesterolemia A0 E ؐ A CLONIDINE d00044A C- I10 Essential (primary) hypertension A0 E ؐ A HYDROCHLOROTHIAZIDE; LOSARTAN d03830A C- I10 Essential (primary) hypertension A0 E ؠ A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A Dc I10 Essential (primary) hypertension A E ؠ A PANTOPRAZOLE d04514A C"0 K21 Gastro-esophageal reflux disease A E ذ A 99999 . . A0 E ذ A ATORVASTATIN d04105A C9 E78.0 Pure hypercholesterolemia A0 E ذ A METFORMIN d03807A C9 E11 Type 2 diabetes mellitus A0 E A LEVOTHYROXINE d00278A D E03.9 Hypothyroidism, unspecified A E A TOPIRAMATE d04115A C G43 Migraine A E A FORMOTEROL; MOMETASONE d07660A C J45 Asthma A E A . . . E A . . . E A . . . E A AMLODIPINE d00689A C I10 Essential (primary) hypertension A` E A LISINOPRIL d00732A C I10 Essential (primary) hypertension A` E A METOPROLOL d00134A C I10 Essential (primary) hypertension A` E A PRAVASTATIN d00348A B E78.0 Pure hypercholesterolemia A` E A QUETIAPINE d04220A C F32.9 Major depressive disorder, single episode, unspecified A` E A SERTRALINE d00880A C F32.9 Major depressive disorder, single episode, unspecified A` E A ALBUTEROL d00749A C J45 Asthma A E A BUDESONIDE; FORMOTEROL d04795A C J44.9 J45 Chronic obstructive pulmonary disease, unspecified Asthma A E 0 A AMLODIPINE d00689A C I10 Essential (primary) hypertension A` E 0 A CARVEDILOL d03847A B M54 Dorsalgia A` E 0 A CYCLOBENZAPRINE d00963A C M54 Dorsalgia A` E 0 A GABAPENTIN d03182A B M54 Dorsalgia A` E 0 A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A C I10 Essential (primary) hypertension A` E 0 A LOVASTATIN d00280A C E78.0P Prevent high cholesterol A` E @ A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A@ E @ A HYDROCHLOROTHIAZIDE; LOSARTAN d03830A C I10 Essential (primary) hypertension A@ E @ A LIRAGLUTIDE d07466A C E11 Type 2 diabetes mellitus A@ E @ A METFORMIN d03807A C E11 Type 2 diabetes mellitus A@ E P A . . . E ` A . . . E p A . . . E ـ A . . . E ِ A DUTASTERIDE d04788A C C61.P Prevent prostate cancer AP E ِ A GLIPIZIDE d00246A B E11 Type 2 diabetes mellitus AP E ِ A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified AP E ِ A PANTOPRAZOLE d04514A C"0 K22 Other diseases of esophagus AP E ِ A WARFARIN d00022A C D75.9P Prevent blood clots AP E ٠ A . . . E ٰ A . . . E A . . . E A MONTELUKAST d04289A C- J30.9 Allergic rhinitis, unspecified A E A RANITIDINE d00021A C"0 K21 Gastro-esophageal reflux disease A E A . . . E A . . . E A ETHINYL ESTRADIOL; NORETHINDRONE d03238A C Z79.3 Long term (current) use of hormonal contraceptives A E A AMOXICILLIN d00088A A H66.9 Otitis media, unspecified A E A AZELASTINE NASAL d04068A B J30.9 R09.81 Allergic rhinitis, unspecified Nasal congestion A0 E A LISINOPRIL d00732A C I10 Essential (primary) hypertension A0 E A TAMSULOSIN d04121A C C61 N40 Malignant neoplasm of prostate Enlarged prostate A0 E 0 A . . . E @ A . . . E P A . . . E ` A ETHINYL ESTRADIOL; NORGESTIMATE d03781A B= L70 Acne A E p A . . . E ڀ A . . . E ڐ A . . . E ڠ A . . . E ڰ A HYDROCORTISONE TOPICAL d03205A A0 R21 Rash and other nonspecific skin eruption A E A . . . E A METOPROLOL d00134A CDp I10 Essential (primary) hypertension A E A . . . E A LEVOTHYROXINE d00278A CDp E03.9 Hypothyroidism, unspecified A E A . . . E A . . . E A AMIODARONE d00002A C- I48.9 Unspecified atrial fibrillation and atrial flutter A` E A APIXABAN d07804A C- I48.9 Unspecified atrial fibrillation and atrial flutter A` E A ATORVASTATIN d04105A C- E78.0 Pure hypercholesterolemia A` E A LISINOPRIL d00732A B I10 Essential (primary) hypertension A` E A NIFEDIPINE d00051A B I10 Essential (primary) hypertension A` E A POTASSIUM CHLORIDE d00345A C- E87.6 Hypokalemia A` E 0 A . . . E @ A . . . E P A CITALOPRAM d04332A C- F41.9 Anxiety disorder, unspecified A@ E P A CLONAZEPAM d00197A C- 99999 A@ E P A MIRABEGRON d07876A Bz R35 Polyuria A@ E P A PANTOPRAZOLE d04514A B[ K30 Functional dyspepsia A@ E ` A . . . E p A . . . E ۀ A DEXMETHYLPHENIDATE d04777A CDp F90 Attention-deficit hyperactivity disorders A E ې A . . . E ۠ A . . . E ۰ A . . . E A APIXABAN d07804A BZ 99999 A E A ATORVASTATIN d04105A BZ 99999 A E A CLOPIDOGREL d04258A BZ 99999 A E A DILTIAZEM d00045A BZ 99999 A E A DRONEDARONE d07458A BZ 99999 A E A FAMOTIDINE d00141A BZ K30 Functional dyspepsia A E A METOPROLOL d00134A BZ 99999 A E A MIDODRINE d04047A BZ 99999 A E A SODIUM CHLORIDE d00438A BZ 99999 A E A . . . E A . . . E A HYDROCHLOROTHIAZIDE; TRIAMTERENE d03052A D I10 Essential (primary) hypertension A E A ROSUVASTATIN d04851A C- E78.0 Pure hypercholesterolemia A E A . . . E A ALPRAZOLAM d00168A CDp R45 Symptoms and signs involving emotional state A` E A AMLODIPINE d00689A C I10 Essential (primary) hypertension A` E A CODEINE d00012A D G43 Migraine A` E A HYDROCHLOROTHIAZIDE; TRIAMTERENE d03052A Cr R60.9 Edema, unspecified A` E A OLMESARTAN d04801A CDp I10 Essential (primary) hypertension A` E A POTASSIUM CITRATE d01423A Dc N20.0 Calculus of kidney A` E A LISINOPRIL d00732A C I10 Essential (primary) hypertension A E A RANITIDINE d00021A C K21 Gastro-esophageal reflux disease A E 0 A AMOXICILLIN d00088A AP K04.7 Periapical abscess without sinus A E @ A . . . E P A FUROSEMIDE d00070A CDp 99999 A0 E P A METOPROLOL d00134A C- 99999 A0 E P A TAMSULOSIN d04121A C 99999 A0 E ` A . . . E p A AMLODIPINE d00689A Cr I10 Essential (primary) hypertension AP E p A AMOXICILLIN d00088A AP K04.7 Periapical abscess without sinus AP E p A LOSARTAN d03821A C I10 Essential (primary) hypertension AP E p A METOPROLOL d00134A C I10 Essential (primary) hypertension AP E p A ROSUVASTATIN d04851A C E78.0 Pure hypercholesterolemia AP E ܀ A ESOMEPRAZOLE d04749A C- K30 Functional dyspepsia A E ܐ A . . . E ܠ A . . . E ܰ A ACETAMINOPHEN; HYDROCODONE d03428A B= M79.1 Myalgia A@ E ܰ A CIPROFLOXACIN d00011A B N30 Cystitis A@ E ܰ A FUROSEMIDE d00070A B= N28.9 Disorder of kidney and ureter, unspecified A@ E ܰ A POTASSIUM CHLORIDE d00345A B= E87.6 Hypokalemia A@ E A ETHINYL ESTRADIOL; NORETHINDRONE d03238A C Z79.3 Long term (current) use of hormonal contraceptives A E A HYDROXYZINE d00907A C F41.9 L23 Anxiety disorder, unspecified Allergic contact dermatitis A E A LISINOPRIL d00732A CDp I10 Essential (primary) hypertension A E A . . . E A . . . E A . . . E A . . . E A PHENTERMINE d00806A B E66 Overweight and obesity A E 0 A . . . E @ A AMLODIPINE d00689A B I10 Essential (primary) hypertension A` E @ A GLIMEPIRIDE d03864A C E11 Type 2 diabetes mellitus A` E @ A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified A` E @ A LOSARTAN d03821A C I10 Essential (primary) hypertension A` E @ A METFORMIN d03807A C E11 Type 2 diabetes mellitus A` E @ A SAXAGLIPTIN d07467A C E11 Type 2 diabetes mellitus A` E P A . . . E ` A . . . E p A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified A E p A LOSARTAN d03821A C"0 I10 Essential (primary) hypertension A E ݀ A . . . E ݐ A . . . E ݠ A . . . E ݰ A . . . E A . . . E A . . . E A . . . E A . . . E A ACETAMINOPHEN; HYDROCODONE d03428A C M54 M79.2 Dorsalgia Neuralgia and neuritis, unspecified Ap E A GLIPIZIDE d00246A D E11 Type 2 diabetes mellitus Ap E A INSULIN GLARGINE d04538A D E11 Type 2 diabetes mellitus Ap E A LOSARTAN d03821A D I10 Essential (primary) hypertension Ap E A OMEPRAZOLE d00325A D K21 Gastro-esophageal reflux disease Ap E A SERTRALINE d00880A C F32.9 Major depressive disorder, single episode, unspecified Ap E A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia Ap E A . . . E A HYDROCHLOROTHIAZIDE d00253A C R60.9 Edema, unspecified A@ E A LISINOPRIL d00732A C- E11.2P Prevent diabetic kidney disease A@ E A LOVASTATIN d00280A D E78.0 Pure hypercholesterolemia A@ E A METFORMIN d03807A B= E11 Type 2 diabetes mellitus A@ E 0 A . . . E @ A BUPROPION d00181A D F32.9 Major depressive disorder, single episode, unspecified Ap E @ A CETIRIZINE d03827A D T78.40 Allergy, unspecified Ap E @ A CYCLOBENZAPRINE d00963A C M79.1 Myalgia Ap E @ A PRAVASTATIN d00348A C E78.0 Pure hypercholesterolemia Ap E @ A THYROID DESICCATED d00655A D E03.9 Hypothyroidism, unspecified Ap E @ A TRAMADOL d03826A C M54 Dorsalgia Ap E @ A VALSARTAN d04113A D I10 Essential (primary) hypertension Ap E P A . . . E ` A . . . E p A AMLODIPINE d00689A C I10 Essential (primary) hypertension A E p A CONJUGATED ESTROGENS d00541A D Z79.890 Hormone replacement therapy A E p A DONEPEZIL d04099A C- G31.9 Degenerative disease of nervous system, unspecified A E p A ESCITALOPRAM d04812A CDp F32.9 Major depressive disorder, single episode, unspecified A E p A FUROSEMIDE d00070A B[ R60.9 Edema, unspecified A E p A GLIMEPIRIDE d03864A B E11 Type 2 diabetes mellitus A E p A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A Dc I10 Essential (primary) hypertension A E p A INSULIN GLARGINE d04538A Bz E11 Type 2 diabetes mellitus A E p A MEMANTINE d04899A C- G31.9 Degenerative disease of nervous system, unspecified A E p A ROSUVASTATIN d04851A C E78.0 Pure hypercholesterolemia A E ހ A LOSARTAN d03821A A I10 Essential (primary) hypertension A E ސ A . . . E ޠ A . . . E ް A . . . E A . . . E A . . . E A . . . E A AMITRIPTYLINE d00146A C G43 Migraine A E A FLUTICASONE d01296A C J45 Asthma A E A . . . E A OMEPRAZOLE d00325A C- K21 Gastro-esophageal reflux disease A E A RANITIDINE d00021A C- K21 Gastro-esophageal reflux disease A E A BUPROPION d00181A C"@ F41.9 Anxiety disorder, unspecified A@ E A BUSPIRONE d00182A C"@ F41.9 Anxiety disorder, unspecified A@ E A CITALOPRAM d04332A C"@ F41.9 Anxiety disorder, unspecified A@ E A ETONOGESTREL d04772A0 Bz Z79.3 Long term (current) use of hormonal contraceptives A@ E 0 A . . . E @ A ALBUTEROL d00749A C J45 Asthma A E @ A MONTELUKAST d04289A C J45 Asthma A E P A . . . E ` A . . . E p A DULOXETINE d05355A B F32.9 M54 Major depressive disorder, single episode, unspecified Dorsalgia A0 E p A FLUOXETINE d00236A C F32.9 F41.9 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified A0 E p A GABAPENTIN d03182A C"0 M54 Dorsalgia A0 E ߀ A ACETAMINOPHEN; CODEINE d03423A A M54 M79.2 T14.9 Dorsalgia Neuralgia and neuritis, unspecified Unspecified injury A E ߀ A METHOCARBAMOL d00965A Ap M54 Dorsalgia A E ߐ A . . . E ߠ A ATORVASTATIN d04105A B E78.0 Pure hypercholesterolemia A E ߠ A LOVASTATIN d00280A C- E78.0 Pure hypercholesterolemia A E ߰ A . . . E A AMLODIPINE d00689A D I10 Essential (primary) hypertension AP E A ATENOLOL; CHLORTHALIDONE d03258A D I10 Essential (primary) hypertension AP E A LEVOTHYROXINE d00278A C- E07.9 Disorder of thyroid, unspecified AP E A NITROGLYCERIN d00321A D R07.9 Chest pain, unspecified AP E A PRAVASTATIN d00348A C E78.0 Pure hypercholesterolemia AP E A AMITRIPTYLINE d00146A C- G43 Migraine A@ E A NADOLOL d00018A B[ G43.P Prevent migraine A@ E A NAPROXEN d00019A C- G43 Migraine A@ E A RANITIDINE d00021A C- K21 Gastro-esophageal reflux disease A@ E A . . . E A BRIMONIDINE OPHTHALMIC d04048A0 C[@ H04 H40 Disorders of lacrimal system Glaucoma A E A CLONIDINE d00044A0 Cr I10 Essential (primary) hypertension A E A CLOPIDOGREL d04258A0 C I63 Cerebral infarction A E A FUROSEMIDE d00070A0 C R60.9 Edema, unspecified A E A GABAPENTIN d03182A0 C M79.2 Neuralgia and neuritis, unspecified A E A HYDRALAZINE d00132A0 C[@ I10 Essential (primary) hypertension A E A LABETALOL d00016A0 C[@ I10 Essential (primary) hypertension A E A LOSARTAN d03821A0 C I10 Essential (primary) hypertension A E A PANTOPRAZOLE d04514A0 B= K21 Gastro-esophageal reflux disease A E A TIMOLOL OPHTHALMIC d04037A0 B H04 H40 Disorders of lacrimal system Glaucoma A E A . . . E A . . . E A LISINOPRIL d00732A CDp I10 Essential (primary) hypertension A E 0 A MINOCYCLINE d00110A B= L70 Acne A E @ A CYANOCOBALAMIN d00413A B E63.9 Nutritional deficiency, unspecified A E P A FAMOTIDINE d00141A C K30 Functional dyspepsia A E P A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia A E ` A . . . E p A ATORVASTATIN d04105A Dc E78.0 Pure hypercholesterolemia A E p A LEVOTHYROXINE d00278A D* E03.9 Hypothyroidism, unspecified A E A . . . E A . . . E A . . . E A INSULIN LISPRO; INSULIN LISPRO PROTAMINE d04510A C[@ E11 Type 2 diabetes mellitus A E A METFORMIN d03807A C[@ E28 Ovarian dysfunction A E A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified A E A ALLOPURINOL d00023A Cr M1A N20.0 Chronic gout Calculus of kidney A` E A ATORVASTATIN d04105A D E78.0 Pure hypercholesterolemia A` E A LEVOTHYROXINE d00278A D# E03.9 Hypothyroidism, unspecified A` E A LISINOPRIL d00732A D I10 Essential (primary) hypertension A` E A METFORMIN d03807A C R73 Elevated blood glucose level A` E A NAPROXEN d00019A Cr 55555 A` E A CYCLOBENZAPRINE d00963A C M79.1 Myalgia A` E A GABAPENTIN d03182A C M54 Dorsalgia A` E A MELOXICAM d04532A B= M79.1 Myalgia A` E A METOPROLOL d00134A CDp I10 Essential (primary) hypertension A` E A SERTRALINE d00880A B F32.9 Major depressive disorder, single episode, unspecified A` E A TRAZODONE d00395A C G47.9 Sleep disorder, unspecified A` E A . . . E A CETIRIZINE d03827A D T78.40 Allergy, unspecified A E A FLUTICASONE NASAL d04283A D J30.9 Allergic rhinitis, unspecified A E A . . . E A . . . E 0 A ACETAMINOPHEN; CODEINE d03423A B[ R51 Headache A E 0 A SPIRONOLACTONE d00373A B[ L65.9 Nonscarring hair loss, unspecified A E @ A . . . E P A INSULIN GLARGINE d04538A C E11 Type 2 diabetes mellitus A` E P A INSULIN LISPRO d04373A C[@ E11 Type 2 diabetes mellitus A` E P A LOSARTAN d03821A C N28.9 Disorder of kidney and ureter, unspecified A` E P A METOPROLOL d00134A C I10 Essential (primary) hypertension A` E P A NIFEDIPINE d00051A C- I10 Essential (primary) hypertension A` E P A TRIAMTERENE d00396A C I10 Essential (primary) hypertension A` E ` A . . . E p A . . . E A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A` E A DILTIAZEM d00045A Bz 99999 A` E A ENALAPRIL d00013A C 99999 A` E A FUROSEMIDE d00070A Bz 99999 A` E A POTASSIUM CHLORIDE d00345A Bz 99999 A` E A SOTALOL d00371A B I49.9 Cardiac arrhythmia, unspecified A` E A TELMISARTAN d04364A C I10 Essential (primary) hypertension A E A FLUTICASONE NASAL d04283A Dc J30.2 Other seasonal allergic rhinitis AP E A LOSARTAN d03821A C I10 Essential (primary) hypertension AP E A OMEGA-3 POLYUNSATURATED FATTY ACIDS d00497A C I51.9P Prevent heart disease AP E A OMEPRAZOLE d00325A Cr K21 Gastro-esophageal reflux disease AP E A ROSUVASTATIN d04851A C E78.0P Prevent high cholesterol AP E A . . . E A FLUTICASONE NASAL d04283A0 C J30.9 Allergic rhinitis, unspecified A@ E A POLYETHYLENE GLYCOL 3350 d05350A0 C- K59.0 Constipation A@ E A PRAVASTATIN d00348A0 Cr E78.0 Pure hypercholesterolemia A@ E A RANITIDINE d00021A0 Dc K21 Gastro-esophageal reflux disease A@ E A FAMOTIDINE d00141A C- K21 Gastro-esophageal reflux disease A E A LISINOPRIL d00732A B= I10 N19 Essential (primary) hypertension Unspecified kidney failure A E A . . . E A . . . E A AMLODIPINE d00689A C I10 Essential (primary) hypertension AP E A LISINOPRIL d00732A C I10 Essential (primary) hypertension AP E A MELOXICAM d04532A B M13 Other arthritis AP E A ROSUVASTATIN d04851A C[@ E78.0 Pure hypercholesterolemia AP E A SERTRALINE d00880A C F32.9 Major depressive disorder, single episode, unspecified AP E A BUPROPION d00181A C F32.9 Major depressive disorder, single episode, unspecified A` E A FENOFIBRIC ACID d07371A C E78.0 Pure hypercholesterolemia A` E A LISINOPRIL d00732A Dc I10 Essential (primary) hypertension A` E A METFORMIN d03807A C R73 Elevated blood glucose level A` E A ROSUVASTATIN d04851A C E78.0 Pure hypercholesterolemia A` E A SERTRALINE d00880A C F32.9 Major depressive disorder, single episode, unspecified A` E A MEDROXYPROGESTERONE d00284A Cr Z79.3 Long term (current) use of hormonal contraceptives A E 0 A . . . E @ A AMLODIPINE d00689A Bz I10 Essential (primary) hypertension A E P A . . . E ` A . . . E p A . . . E A VALSARTAN d04113A B= I10 Essential (primary) hypertension A E A . . . E A . . . E A . . . E A LEVOTHYROXINE d00278A Dc E03.9 Hypothyroidism, unspecified A E A ROSUVASTATIN d04851A D E78.0 Pure hypercholesterolemia A E A ACETAZOLAMIDE d00161A Cr H40 Glaucoma Ap E A AMMONIUM LACTATE TOPICAL d04049A Ap B35 Dermatophytosis Ap E A ARIPIPRAZOLE d04825A C F32.9 Major depressive disorder, single episode, unspecified Ap E A BRIMONIDINE OPHTHALMIC d04048A Cr H40 Glaucoma Ap E A DESMOPRESSIN d00583A C R32 Unspecified urinary incontinence Ap E A DORZOLAMIDE; TIMOLOL OPHTHALMIC d04303A Cr H40 Glaucoma Ap E A LATANOPROST OPHTHALMIC d04017A Cr H40 Glaucoma Ap E A ALBUTEROL d00749A C J44.9 Chronic obstructive pulmonary disease, unspecified A E A ATENOLOL d00004A B I10 Essential (primary) hypertension A E A DULOXETINE d05355A C F32.9 Major depressive disorder, single episode, unspecified A E A FLUTICASONE; SALMETEROL d04611A C J44.9 Chronic obstructive pulmonary disease, unspecified A E A GABAPENTIN d03182A C M79.2 Neuralgia and neuritis, unspecified A E A GLIPIZIDE d00246A C E11 Type 2 diabetes mellitus A E A HYDROXYZINE d00907A C F41.9 Anxiety disorder, unspecified A E A MELOXICAM d04532A B 99999 A E A METFORMIN d03807A C E11 Type 2 diabetes mellitus A E A MONTELUKAST d04289A Ei J30.9 Allergic rhinitis, unspecified A E A OMEPRAZOLE d00325A C K21 Gastro-esophageal reflux disease A E A SIMVASTATIN d00746A Ei E78.0 Pure hypercholesterolemia A E A TIOTROPIUM d04829A C J44.9 Chronic obstructive pulmonary disease, unspecified A E A TIZANIDINE d04102A Ap M79.1 Myalgia A E A . . . E A . . . E A . . . E A AMLODIPINE d00689A C- I10 Essential (primary) hypertension A` E A ASPIRIN d00170A C I21.P Prevent heart attack/myocardial infarction A` E A INSULIN d00262A C[@ R73 Elevated blood glucose level A` E A METFORMIN d03807A A R73 Elevated blood glucose level A` E A RANITIDINE d00021A Cr 99999 A` E A SIMVASTATIN d00746A Cr 99999 A` E 0 A . . . E @ A . . . E P A FLUOXETINE d00236A C F32.9 Major depressive disorder, single episode, unspecified A E ` A . . . E p A . . . E A HYDROCHLOROTHIAZIDE d00253A CP I10 Essential (primary) hypertension A E A SIMVASTATIN d00746A D E78.0 Pure hypercholesterolemia A E A 99999 . . A E A BROMPHENIRAMINE; HYDROCODONE; PSEUDOEPHEDRINE d04880A Ap R05 Cough A E A AMLODIPINE d00689A Dc I10 Essential (primary) hypertension A@ E A FLUTICASONE NASAL d04283A Dc J30.2 Other seasonal allergic rhinitis A@ E A LEVOCETIRIZINE d05851A C T78.40 Allergy, unspecified A@ E A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia A@ E A AMLODIPINE d00689A C- I10 Essential (primary) hypertension A E A DULOXETINE d05355A Bz M79.2 Neuralgia and neuritis, unspecified A E A GALANTAMINE d04750A Dc G47.9 Sleep disorder, unspecified A E A LAMOTRIGINE d03809A D F39 Unspecified mood [affective] disorder A E A LISINOPRIL d00732A C I10 Essential (primary) hypertension A E A METOPROLOL d00134A C I10 Essential (primary) hypertension A E A OMEPRAZOLE d00325A D K21 Gastro-esophageal reflux disease A E A PRAVASTATIN d00348A C E78.0 Pure hypercholesterolemia A E A . . . E A ATORVASTATIN d04105A C"0 E78.0 Pure hypercholesterolemia A E A . . . E A . . . E A BENAZEPRIL d00730A Cr I10 Essential (primary) hypertension Ap E A FELODIPINE d00231A Cr I10 Essential (primary) hypertension Ap E A GLIPIZIDE d00246A Cr E11 Type 2 diabetes mellitus Ap E A HYDROCHLOROTHIAZIDE d00253A CDp I10 Essential (primary) hypertension Ap E A IBUPROFEN d00015A B M25.5 M54 Pain in joint Dorsalgia Ap E A METFORMIN d03807A CDp E11 Type 2 diabetes mellitus Ap E A SIMVASTATIN d00746A CDp E78.0 Pure hypercholesterolemia Ap E A SERTRALINE d00880A B F32.9 F41.9 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified A E A AMLODIPINE; BENAZEPRIL d03829A C I10 Essential (primary) hypertension A0 E A FLUTICASONE NASAL d04283A C J30.1 J30.2 J30.9 Allergic rhinitis due to pollen Other seasonal allergic rhinitis Allergic rhinitis, unspecified A0 E A RANITIDINE d00021A C K21 Gastro-esophageal reflux disease A0 E 0 A . . . E @ A . . . E P A . . . E ` A . . . E p A ACETAMINOPHEN; BUTALBITAL; CAFFEINE d03455A C- G43 R51 Migraine Headache A@ E p A ALPRAZOLAM d00168A C- M62.83 Muscle spasm A@ E p A OMEPRAZOLE d00325A B[ K21 Gastro-esophageal reflux disease A@ E p A URSODIOL d01005A Ap K87 Disorders of gallbladder, biliary tract and pancreas in diseases classified elsewhere A@ E A LOSARTAN d03821A Cr I10 Essential (primary) hypertension A E A . . . E A . . . E A . . . E A BISOPROLOL; HYDROCHLOROTHIAZIDE d03744A C- I10 Essential (primary) hypertension A E A MELOXICAM d04532A B K21 Gastro-esophageal reflux disease A E A ALBUTEROL d00749A CDp J45 Asthma A E A AMLODIPINE d00689A C I10 Essential (primary) hypertension A E A CHLORTHALIDONE d00192A C I10 Essential (primary) hypertension A E A CITALOPRAM d04332A C F32.9 Major depressive disorder, single episode, unspecified A E A CYCLOBENZAPRINE d00963A C M62.83 Muscle spasm A E A FLUTICASONE NASAL d04283A B J30.9 Allergic rhinitis, unspecified A E A GABAPENTIN d03182A C M79.2 Neuralgia and neuritis, unspecified A E A MONTELUKAST d04289A Cr J30.9 Allergic rhinitis, unspecified A E A TOPIRAMATE d04115A C M79.2 Neuralgia and neuritis, unspecified A E A TRAMADOL d03826A C M54 M79.6 Dorsalgia Pain in limb, hand, foot, fingers and toes A E A VALSARTAN d04113A C I10 Essential (primary) hypertension A E A . . . E A DICLOFENAC d00848A C M79.1 M79.7 T14.9 Myalgia Fibromyalgia Unspecified injury A E A ANASTROZOLE d03873A C- C50.P Prevent breast cancer Ap E A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia Ap E A CHLORPROMAZINE d00064A B F20 Schizophrenia Ap E A METOPROLOL d00134A CDp I10 Essential (primary) hypertension Ap E A OMEPRAZOLE d00325A C- R12 Heartburn Ap E A SERTRALINE d00880A C F32.9 Major depressive disorder, single episode, unspecified Ap E A SIMVASTATIN d00746A C- E78.0 Pure hypercholesterolemia Ap E A GABAPENTIN d03182A CDp G89 M79.2 Pain, not elsewhere classified Neuralgia and neuritis, unspecified A E A . . . E 0 A . . . E @ A . . . E P A . . . E ` A . . . E p A . . . E A . . . E A LEVOTHYROXINE d00278A Dc E03.9 Hypothyroidism, unspecified A` E A LISINOPRIL d00732A C I10 Essential (primary) hypertension A` E A LORAZEPAM d00149A D G47.9 Sleep disorder, unspecified A` E A MECLIZINE d00859A C R42 Dizziness and giddiness A` E A METOPROLOL d00134A D I10 I21.P Essential (primary) hypertension Prevent heart attack/myocardial infarction A` E A OMEPRAZOLE d00325A Ei K21 Gastro-esophageal reflux disease A` E A LEVOTHYROXINE d00278A Dc E03.9 Hypothyroidism, unspecified A@ E A LOSARTAN d03821A D I10 Essential (primary) hypertension A@ E A NEBIVOLOL d05265A D I10 Essential (primary) hypertension A@ E A SIMVASTATIN d00746A C[@ E78.0 Pure hypercholesterolemia A@ E A . . . E A CLOTRIMAZOLE TOPICAL d04395A C[@ B35 Dermatophytosis A E A ENALAPRIL d00013A C[@ I10 Essential (primary) hypertension A E A FUROSEMIDE d00070A Cr R60.9 Edema, unspecified A E A GABAPENTIN d03182A Dc M79.2 Neuralgia and neuritis, unspecified A E A IBUPROFEN d00015A B R51 Headache A E A INSULIN LISPRO d04373A D E11 Type 2 diabetes mellitus A E A OMEPRAZOLE d00325A Dc K21 Gastro-esophageal reflux disease A E A POTASSIUM CHLORIDE d00345A D# E87.6 Hypokalemia A E A SELENIUM SULFIDE TOPICAL d03210A C[@ B35 Dermatophytosis A E A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia A E A AMLODIPINE d00689A Dc I10 Essential (primary) hypertension AP E A CARVEDILOL d03847A D# I50.9 Heart failure, unspecified AP E A FUROSEMIDE d00070A CDp R60.9 Edema, unspecified AP E A GLIMEPIRIDE d03864A D* E11 Type 2 diabetes mellitus AP E A SIMVASTATIN d00746A D E78.0 Pure hypercholesterolemia AP E A . . . E A . . . E A . . . E A ACETAMINOPHEN; CODEINE d03423A B M54 Dorsalgia A E A ACETAMINOPHEN; HYDROCODONE d03428A A Z98 Other postprocedural states A E A AMOXICILLIN d00088A A K04.7 Periapical abscess without sinus A E A CYCLOBENZAPRINE d00963A Bz M62.83 Muscle spasm A E A DULOXETINE d05355A B F32.9 Major depressive disorder, single episode, unspecified A E A IBUPROFEN d00015A CDp M54 Dorsalgia A E A LOSARTAN d03821A CDp I10 Essential (primary) hypertension A E A MELOXICAM d04532A B M06.9 M19.9 M54 Rheumatoid arthritis, unspecified Osteoarthritis, unspecified site Dorsalgia A E A METFORMIN d03807A C E11 Type 2 diabetes mellitus A E A BUPROPION d00181A Cr M79.2 Neuralgia and neuritis, unspecified A0 E A PRAVASTATIN d00348A CDp E78.0 Pure hypercholesterolemia A0 E A TOPIRAMATE d04115A Cr M79.2 Neuralgia and neuritis, unspecified A0 E 0 A FOSINOPRIL d00242A D* E11.2 Type 2 diabetes mellitus with kidney complications A` E 0 A METFORMIN d03807A D* E11 Type 2 diabetes mellitus A` E 0 A OMEPRAZOLE d00325A Cr K87 Disorders of gallbladder, biliary tract and pancreas in diseases classified elsewhere A` E 0 A PIOGLITAZONE d04442A Cr E11 Type 2 diabetes mellitus A` E 0 A SIMVASTATIN d00746A D* E78.0 Pure hypercholesterolemia A` E 0 A URSODIOL d01005A Cr K87 Disorders of gallbladder, biliary tract and pancreas in diseases classified elsewhere A` E @ A . . . E P A DESOGESTREL; ETHINYL ESTRADIOL d03782A B Z79.3 Long term (current) use of hormonal contraceptives A E ` A . . . E p A CITALOPRAM d04332A C F39 F43.1 Unspecified mood [affective] disorder Post-traumatic stress disorder (PTSD) Ap E p A LACOSAMIDE d07349A CDp G40 Epilepsy and recurrent seizures Ap E p A LEVETIRACETAM d04499A C G40 Epilepsy and recurrent seizures Ap E p A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified Ap E p A PRAZOSIN d00138A Cr F43.1 Post-traumatic stress disorder (PTSD) Ap E p A RISPERIDONE d03180A C F39 F91 Unspecified mood [affective] disorder Conduct disorders Ap E p A TRAZODONE d00395A D G47.9 Sleep disorder, unspecified Ap E A . . . E A . . . E A . . . E A METHYLPHENIDATE d00900A C- F90 Attention-deficit hyperactivity disorders A E A . . . E A AMLODIPINE d00689A C I10 Essential (primary) hypertension A E A METOPROLOL d00134A C I10 Essential (primary) hypertension A E A AMLODIPINE d00689A0 CDp I10 Essential (primary) hypertension A E A ATENOLOL d00004A0 D* I51.9 Heart disease, unspecified A E A ATORVASTATIN d04105A0 D I51.9 Heart disease, unspecified A E A CLOPIDOGREL d04258A0 D I99.9 Z79.0 Unspecified disorder of circulatory system Long term (current) use of anticoagulants and antithrombotics/antiplatelets A E A DOXAZOSIN d00726A0 D N40 Enlarged prostate A E A FINASTERIDE d00563A0 D N40 Enlarged prostate A E A NITROGLYCERIN d00321A0 D* I51.9 Heart disease, unspecified A E A RAMIPRIL d00728A0 D I51.9 Heart disease, unspecified A E A . . . E A . . . E A . . . E A ALLOPURINOL d00023A Dc 99999 A` E A CARVEDILOL d03847A Dc I50.9 Heart failure, unspecified A` E A FUROSEMIDE d00070A Dc I50.9 I51.9 Heart failure, unspecified Heart disease, unspecified A` E A LEVOTHYROXINE d00278A Dc E03.9 Hypothyroidism, unspecified A` E A LISINOPRIL d00732A Dc I50.9 Heart failure, unspecified A` E A PANTOPRAZOLE d04514A Dc K21 Gastro-esophageal reflux disease A` E 0 A LISINOPRIL d00732A C- E11.2P Prevent diabetic kidney disease A0 E 0 A LOVASTATIN d00280A Cr E78.0 Pure hypercholesterolemia A0 E 0 A METFORMIN d03807A D R73 Elevated blood glucose level A0 E @ A . . . E P A . . . E ` A . . . E p A . . . E A AMPHETAMINE; DEXTROAMPHETAMINE d04035A CDp F90 Attention-deficit hyperactivity disorders A E A BUMETANIDE d00179A Bz I50.9 Heart failure, unspecified A@ E A LEVOTHYROXINE d00278A D# E03.9 Hypothyroidism, unspecified A@ E A LISINOPRIL d00732A Bz I10 Essential (primary) hypertension A@ E A METOPROLOL d00134A Bz I50.9 Heart failure, unspecified A@ E A . . . E A ACETAMINOPHEN; CODEINE d03423A B M54 Dorsalgia Ap E A ALBUTEROL d00749A B J44.9 R06.02 Chronic obstructive pulmonary disease, unspecified Shortness of breath Ap E A ALBUTEROL d00749A CDp D89.9 J44.9 Disorder involving the immune mechanism, unspecified Chronic obstructive pulmonary disease, unspecified Ap E A BUDESONIDE; FORMOTEROL d04795A CDp J44.9 R06.02 Chronic obstructive pulmonary disease, unspecified Shortness of breath Ap E A IPRATROPIUM d00265A CDp J44.9 R06.02 Chronic obstructive pulmonary disease, unspecified Shortness of breath Ap E A OMEPRAZOLE d00325A Dc K21 Gastro-esophageal reflux disease Ap E A POTASSIUM CITRATE d01423A C- E87.6 N20.0 Hypokalemia Calculus of kidney Ap E A . . . E A . . . E A . . . E A AMLODIPINE d00689A Cr I10 Essential (primary) hypertension A0 E A CARVEDILOL d03847A Cr I10 Essential (primary) hypertension A0 E A DOXAZOSIN d00726A Cr I10 Essential (primary) hypertension A0 E A . . . E A . . . E A . . . E 0 A . . . E @ A ALBUTEROL d00749A C J45 Asthma A@ E @ A CETIRIZINE d03827A C[@ T78.40 Allergy, unspecified A@ E @ A FLUTICASONE d01296A C J45 Asthma A@ E @ A FLUTICASONE NASAL d04283A C R09.81 Nasal congestion A@ E P A OSELTAMIVIR d04462A Bz E63.9 Nutritional deficiency, unspecified A E ` A . . . E p A . . . E A . . . E A BUPROPION d00181A CDp F32.9 F41.9 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified A@ E A ETHINYL ESTRADIOL; LEVONORGESTREL d03242A CDp Z79.3 Long term (current) use of hormonal contraceptives A@ E A FLUTICASONE NASAL d04283A C- J30.9 Allergic rhinitis, unspecified A@ E A RANITIDINE d00021A C K21 Gastro-esophageal reflux disease A@ E A . . . E A . . . E A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A E A VALSARTAN d04113A C I10 Essential (primary) hypertension A E A . . . E A 99999 . . A E A ALBUTEROL d00749A CDp J45 Asthma A@ E A ALBUTEROL d00749A C[@ J45 Asthma A@ E A BUDESONIDE; FORMOTEROL d04795A C[@ J45 Asthma A@ E A TIOTROPIUM d04829A C J44.9 Chronic obstructive pulmonary disease, unspecified A@ E A LATANOPROST OPHTHALMIC d04017A Dc H40 Glaucoma A E A OMEPRAZOLE d00325A C[@ K21 K30 Gastro-esophageal reflux disease Functional dyspepsia A E A . . . E A . . . E 0 A . . . E @ A . . . E P A . . . E ` A . . . E p A EMPAGLIFLOZIN d08275A C E78.0 Pure hypercholesterolemia AP E p A INSULIN ASPART d04697A CDp E11 Type 2 diabetes mellitus AP E p A INSULIN GLARGINE d04538A C E11 Type 2 diabetes mellitus AP E p A LISINOPRIL d00732A C I10 Essential (primary) hypertension AP E p A SERTRALINE d00880A C F41.9 Anxiety disorder, unspecified AP E A BUSPIRONE d00182A C[@ F41.9 Anxiety disorder, unspecified A E A CLOPIDOGREL d04258A D* I80.3 Phlebitis and thrombophlebitis of lower extremities, unspecified A E A DULOXETINE d05355A C[@ F32.9 M79.2 Major depressive disorder, single episode, unspecified Neuralgia and neuritis, unspecified A E A GABAPENTIN d03182A C M79.2 Neuralgia and neuritis, unspecified A E A LISINOPRIL d00732A C I10 Essential (primary) hypertension A E A MELOXICAM d04532A C Z79.1 Long term (current) use of non-steroidal anti-inflammatories (NSAID) A E A METFORMIN; SITAGLIPTIN d06720A C[@ R73 Elevated blood glucose level A E A OMEPRAZOLE d00325A C R10 Abdominal and pelvic pain A E A ROSUVASTATIN d04851A C- E78.0 Pure hypercholesterolemia A E A ZOLPIDEM d00910A C G47.9 Sleep disorder, unspecified A E A BENAZEPRIL d00730A C I10 Essential (primary) hypertension A E A HYDRALAZINE d00132A C I10 Essential (primary) hypertension A E A INSULIN GLARGINE d04538A Cr E11 Type 2 diabetes mellitus A E A INSULIN LISPRO d04373A Cr E11 Type 2 diabetes mellitus A E A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified A E A LORAZEPAM d00149A C F41.9 Anxiety disorder, unspecified A E A OXYBUTYNIN d00328A C R32 Unspecified urinary incontinence A E A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia A E A TRAMADOL d03826A B M54 Dorsalgia A E A FUROSEMIDE d00070A D R60.9 Edema, unspecified A@ E A LEVOTHYROXINE d00278A D E07.9 Disorder of thyroid, unspecified A@ E A RASAGILINE d05612A D G20 Parkinson's disease A@ E A SIMVASTATIN d00746A D E78.0 Pure hypercholesterolemia A@ E A . . . E A . . . E A AMOXICILLIN d00088A Ap H66.9 Otitis media, unspecified A E A . . . E A . . . E A . . . E A . . . E A . . . E 0 A HYDRALAZINE d00132A Ei I10 Essential (primary) hypertension AP E 0 A HYDROCHLOROTHIAZIDE; TRIAMTERENE d03052A Ei I10 Essential (primary) hypertension AP E 0 A LEVOTHYROXINE d00278A C E07.9 Disorder of thyroid, unspecified AP E 0 A MELOXICAM d04532A Ei M19.9 Osteoarthritis, unspecified site AP E 0 A PANTOPRAZOLE d04514A C[@ K21 Gastro-esophageal reflux disease AP E @ A . . . E P A ACETAMINOPHEN; HYDROCODONE d03428A B M54 Dorsalgia A E P A ALBUTEROL d00749A B= J45 Asthma A E P A BUDESONIDE; FORMOTEROL d04795A B= J45 Asthma A E P A GLIPIZIDE d00246A B[ E11 Type 2 diabetes mellitus A E P A METFORMIN d03807A D E11 Type 2 diabetes mellitus A E P A NAPROXEN d00019A B Z79.1 Long term (current) use of non-steroidal anti-inflammatories (NSAID) A E P A OMEPRAZOLE d00325A D* K30 R12 Functional dyspepsia Heartburn A E P A PRAVASTATIN d00348A C E78.0 Pure hypercholesterolemia A E P A UMECLIDINIUM d08187A B J45 Asthma A E ` A . . . E p A FAMOTIDINE d00141A C K30 Functional dyspepsia Ap E p A LISINOPRIL d00732A Cr I10 Essential (primary) hypertension Ap E p A LORAZEPAM d00149A C- F41.9 Anxiety disorder, unspecified Ap E p A METOPROLOL d00134A C I49.9 Cardiac arrhythmia, unspecified Ap E p A MIRTAZAPINE d04025A CDp G47.0 Insomnia Ap E p A SUCRALFATE d00377A D K25 Gastric ulcer Ap E p A WARFARIN d00022A CDp D75.9P Prevent blood clots Ap E A . . . E A . . . E A . . . E A . . . E A ACETAMINOPHEN; CODEINE d03423A B K08.8 Other specified disorders of teeth and supporting structures A@ E A ALBUTEROL d00749A C J45 Asthma A@ E A BECLOMETHASONE d00760A C J45 Asthma A@ E A LEVOCETIRIZINE d05851A B T78.40 Allergy, unspecified A@ E A ALPRAZOLAM d00168A Bz F41.0 F41.9 Panic disorder [episodic paroxysmal anxiety] without agoraphobia Anxiety disorder, unspecified AP E A AMPHETAMINE; DEXTROAMPHETAMINE d04035A CDp F90 Attention-deficit hyperactivity disorders AP E A DEXTROAMPHETAMINE d00804A C- F90 Attention-deficit hyperactivity disorders AP E A LITHIUM d00061A A F31.9 Bipolar disorder, unspecified AP E A LURASIDONE d07705A A F31.9 Bipolar disorder, unspecified AP E A . . . E A . . . E A . . . E A . . . E A ALPRAZOLAM d00168A C F41.0 Panic disorder [episodic paroxysmal anxiety] without agoraphobia A E A AMPHETAMINE; DEXTROAMPHETAMINE d04035A B F90 Attention-deficit hyperactivity disorders A E 0 A . . . E @ A ATENOLOL d00004A D# I10 Essential (primary) hypertension A E @ A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A E @ A CITALOPRAM d04332A C"0 F32.9 Major depressive disorder, single episode, unspecified A E @ A GLIMEPIRIDE d03864A CDp I10 Essential (primary) hypertension A E @ A INSULIN GLARGINE d04538A C E11 Type 2 diabetes mellitus A E @ A LISINOPRIL d00732A D# I10 Essential (primary) hypertension A E @ A OMEPRAZOLE d00325A C- K21 Gastro-esophageal reflux disease A E @ A ZOLPIDEM d00910A B[ G47.0 Insomnia A E P A AMLODIPINE d00689A0 C I10 Essential (primary) hypertension A E P A ATENOLOL d00004A0 D I10 Essential (primary) hypertension A E P A CLOPIDOGREL d04258A0 B I63.P Prevent stroke A E P A ERYTHROMYCIN OPHTHALMIC d03973A0 CDp H04 Disorders of lacrimal system A E P A FEXOFENADINE d04040A0 C- T78.40 Allergy, unspecified A E P A FLUTICASONE NASAL d04283A0 CDp J30.9 Allergic rhinitis, unspecified A E P A PANTOPRAZOLE d04514A0 C"0 K30 Functional dyspepsia A E P A SERTRALINE d00880A C F32.9 F41.9 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified A E ` A ETHINYL ESTRADIOL; NORETHINDRONE d03238A B Z79.3 Long term (current) use of hormonal contraceptives A E p A . . . E A . . . E A ETODOLAC d00851A Dc M19.9 Osteoarthritis, unspecified site A@ E A FINASTERIDE d00563A Dc N40 Enlarged prostate A@ E A SIMVASTATIN d00746A Dc E78.0 Pure hypercholesterolemia A@ E A TAMSULOSIN d04121A Dc N40 Enlarged prostate A@ E A BUPROPION d00181A C F33.9 Major depressive disorder, recurrent, unspecified A E A CYANOCOBALAMIN d00413A CDp E63.9 Nutritional deficiency, unspecified A E A DULOXETINE d05355A C F32.9 Major depressive disorder, single episode, unspecified A E A LEVOTHYROXINE d00278A C 99999 A E A LORAZEPAM d00149A C G47.0 Insomnia A E A PROPRANOLOL d00032A Dc G43 Migraine A E A SIMVASTATIN d00746A Dc E78.0 Pure hypercholesterolemia A E A SUMATRIPTAN d03160A D G43 Migraine A E A TOPIRAMATE d04115A CDp G43 Migraine A E Ap . . . E A . . . E A . . . E A . . . E A ACETAMINOPHEN; HYDROCODONE d03428A B R52 Pain, unspecified A@ E A ATORVASTATIN d04105A B M85.9 Disorder of bone density and structure, unspecified A@ E A CYPROHEPTADINE d00790A B= 55555 A@ E A HYDROCHLOROTHIAZIDE; LOSARTAN d03830A CDp I10 Essential (primary) hypertension A@ E A . . . E A . . . E A ACETAMINOPHEN; HYDROCODONE d03428A C M54 Dorsalgia A E A CHLORZOXAZONE d00962A B[ M62.83 Muscle spasm A E A NEBIVOLOL d05265A B[ I10 Essential (primary) hypertension A E A OMEPRAZOLE d00325A D K21 Gastro-esophageal reflux disease A E A PAROXETINE d03157A B= F32.9 R52 Major depressive disorder, single episode, unspecified Pain, unspecified A E A PREDNISONE d00350A C- M85.9 Disorder of bone density and structure, unspecified A E A PRIMIDONE d00352A A R25.1 Tremor, unspecified A E A RISEDRONATE d04300A C- M81 Osteoporosis without current pathological fracture A E A TAMSULOSIN d04121A C N40 Enlarged prostate A E 0 A . . . E @ A . . . E P A INSULIN ASPART d04697A C"0 E11 Type 2 diabetes mellitus A0 E P A INSULIN GLARGINE d04538A C"0 E11 Type 2 diabetes mellitus A0 E P A METFORMIN d03807A B[ E11 Type 2 diabetes mellitus A0 E ` A . . . E p A ACETAMINOPHEN; OXYCODONE d03431A B[ M54 Dorsalgia A E p A ALBUTEROL; IPRATROPIUM d04066A CDp R06.9 Unspecified abnormalities of breathing A E p A BENZONATATE d00796A C R05 Cough A E p A CYCLOBENZAPRINE d00963A Bz M54 Dorsalgia A E p A DILTIAZEM d00045A B[ I10 Essential (primary) hypertension A E p A FLUTICASONE; VILANTEROL d08100A B J44.9 Chronic obstructive pulmonary disease, unspecified A E p A FUROSEMIDE d00070A C[@ R60.9 Edema, unspecified A E p A HOMATROPINE; HYDROCODONE d03340A B R05 Cough A E p A MELOXICAM d04532A Bz M79.6 Pain in limb, hand, foot, fingers and toes A E p A POLYETHYLENE GLYCOL 3350 d05350A B K59.0 Constipation A E p A PREDNISONE d00350A CDp J44.9 Chronic obstructive pulmonary disease, unspecified A E p A THEOPHYLLINE d00142A Bz R07.9 Chest pain, unspecified A E A . . . E A . . . E A . . . E A ATORVASTATIN d04105A0 B E78.0 Pure hypercholesterolemia Ap E A FLUTICASONE NASAL d04283A0 C R09.81 Nasal congestion Ap E A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A0 C I10 Essential (primary) hypertension Ap E A KETOCONAZOLE TOPICAL d03202A0 B= B35 R21 Dermatophytosis Rash and other nonspecific skin eruption Ap E A METOPROLOL d00134A0 C I10 Essential (primary) hypertension Ap E A NIFEDIPINE d00051A B I10 Essential (primary) hypertension Ap E A TADALAFIL d04896A0 C N40 Enlarged prostate Ap E A . . . E A LEVETIRACETAM d04499A CDp G40 Epilepsy and recurrent seizures A E A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A@ E A HYDROCHLOROTHIAZIDE; OLMESARTAN d04878A C I10 Essential (primary) hypertension A@ E A OMEPRAZOLE d00325A C K30 Functional dyspepsia A@ E A PIOGLITAZONE d04442A C E11 Type 2 diabetes mellitus A@ E A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A` E A CANAGLIFLOZIN d08080A C- E11 Type 2 diabetes mellitus A` E A GLIPIZIDE d00246A C E11 Type 2 diabetes mellitus A` E A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified A` E A METFORMIN d03807A C E11 Type 2 diabetes mellitus A` E A RAMIPRIL d00728A C I10 Essential (primary) hypertension A` E A AMLODIPINE d00689A C- I10 Essential (primary) hypertension A@ E A GLIMEPIRIDE d03864A B 99999 A@ E A LOSARTAN d03821A C 99999 A@ E A METFORMIN d03807A C- E11 Type 2 diabetes mellitus A@ E A . . . E A ALBUTEROL d00749A C J45 Asthma A E A BACLOFEN d00967A Cr M79.1 Myalgia A E A BUPROPION d00181A CDp R53 Malaise and fatigue A E A FAMOTIDINE d00141A CDp R07.9 Chest pain, unspecified A E A FLUTICASONE d01296A C J45 Asthma A E A FLUTICASONE NASAL d04283A C T78.40 Allergy, unspecified A E A LORAZEPAM d00149A B F41.9 Anxiety disorder, unspecified A E A MONTELUKAST d04289A CDp R06.2 Wheezing A E A PANTOPRAZOLE d04514A C- R07.9 Chest pain, unspecified A E A TRAMADOL d03826A C M54 Dorsalgia A E 0 A . . . E @ A . . . E P A . . . E ` A . . . E p A . . . E A . . . E A ALLOPURINOL d00023A CDp M10.9 Gout, unspecified A E A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A E A GABAPENTIN d03182A B= 99999 A E A GLIPIZIDE d00246A CDp E11 Type 2 diabetes mellitus A E A HYDRALAZINE d00132A CDp I10 Essential (primary) hypertension A E A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A C- I10 R60.9 Essential (primary) hypertension Edema, unspecified A E A METFORMIN; PIOGLITAZONE d05635A CDp E11 Type 2 diabetes mellitus A E A METOPROLOL d00134A C M79.6 Pain in limb, hand, foot, fingers and toes A E A POTASSIUM CHLORIDE d00345A C E87.6 Hypokalemia A E A . . . E A LISINOPRIL d00732A C I10 Essential (primary) hypertension A@ E A METOPROLOL d00134A D I10 Essential (primary) hypertension A@ E A ROSUVASTATIN d04851A C E78.0 Pure hypercholesterolemia A@ E A TAMSULOSIN d04121A C R35 Polyuria A@ E A CLARITHROMYCIN d00097A A K04.7 Periapical abscess without sinus A E A ALLOPURINOL d00023A D* M10.9P Prevent gout A E A ATORVASTATIN d04105A Cr I21.P Prevent heart attack/myocardial infarction A E A DILTIAZEM d00045A C I10 Essential (primary) hypertension A E A LEVOTHYROXINE d00278A D9 E03.9 Hypothyroidism, unspecified A E A METOPROLOL d00134A D* I10 I21.P Essential (primary) hypertension Prevent heart attack/myocardial infarction A E A OMEPRAZOLE d00325A Dc K21 K30 Gastro-esophageal reflux disease Functional dyspepsia A E A ROPINIROLE d04215A C G25.81 Restless legs syndrome A E A SPIRONOLACTONE d00373A D& R60.9 Edema, unspecified A E A TAMSULOSIN d04121A C[@ R39.1 Other difficulties with micturition A E A LOSARTAN d03821A C I10 Essential (primary) hypertension A E A HYDROXYZINE d00907A C F41.9 G47.0 Anxiety disorder, unspecified Insomnia A@ E A PALIPERIDONE d06297A B F32.9 Major depressive disorder, single episode, unspecified A@ E A SERTRALINE d00880A C- F32.9 F33.9 F41.9 Major depressive disorder, single episode, unspecified Major depressive disorder, recurrent, unspecified Anxiety disorder, unspecified A@ E A TRAZODONE d00395A C F41.9 G47.0 Anxiety disorder, unspecified Insomnia A@ E A . . . E A . . . E A . . . E 0 A . . . E @ A . . . E P A . . . E ` A . . . E p A RANITIDINE d00021A B K30 Functional dyspepsia A E A . . . E A ATORVASTATIN d04105A C[@ E78.0 Pure hypercholesterolemia A0 E A IBUPROFEN d00015A C M25.5 Pain in joint A0 E A METFORMIN d03807A C[@ E11 Type 2 diabetes mellitus A0 E A CEFDINIR d04256A A J02 Acute pharyngitis A E A OSELTAMIVIR d04462A A J09 Influenza due to certain identified influenza viruses A E A . . . E A . . . E A RAMIPRIL d00728A B 99999 A E A . . . E A . . . E A . . . E A ACETAMINOPHEN; HYDROCODONE d03428A Cr M54 Dorsalgia AP E A AMITRIPTYLINE d00146A C- G47.0 Insomnia AP E A ATENOLOL d00004A D,3 I10 Essential (primary) hypertension AP E A LEVOTHYROXINE d00278A D,3 E03.9 E04 Hypothyroidism, unspecified Other nontoxic goiter AP E A VENLAFAXINE d03181A C- F32.9 Major depressive disorder, single episode, unspecified AP E A ALPRAZOLAM d00168A C F41.0 F41.9 Panic disorder [episodic paroxysmal anxiety] without agoraphobia Anxiety disorder, unspecified A@ E A ATENOLOL d00004A C R00 Abnormalities of heart beat A@ E A ATORVASTATIN d04105A B[ E78.0 Pure hypercholesterolemia A@ E A SERTRALINE d00880A C F32.9 Major depressive disorder, single episode, unspecified A@ E 0 A BIMATOPROST OPHTHALMIC d04754A C H40 Glaucoma AP E 0 A BRIMONIDINE; TIMOLOL OPHTHALMIC d05283A C H40 Glaucoma AP E 0 A GABAPENTIN d03182A C E11.4 Type 2 diabetes mellitus with neurological complications AP E 0 A GLIPIZIDE d00246A C E11 Type 2 diabetes mellitus AP E 0 A ROSUVASTATIN d04851A C E78.0 Pure hypercholesterolemia AP E @ A . . . E P A . . . E ` A . . . E p A . . . E A INSULIN ISOPHANE; INSULIN REGULAR d04374A C E11 Type 2 diabetes mellitus A0 E A LOSARTAN d03821A C I10 Essential (primary) hypertension A0 E A METOCLOPRAMIDE d00298A C K31.9 Disease of stomach and duodenum, unspecified A0 E A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia Ap E A BRIMONIDINE OPHTHALMIC d04048A B# H40 Glaucoma Ap E A CYCLOSPORINE OPHTHALMIC d04836A B# H04 Disorders of lacrimal system Ap E A HYDROCHLOROTHIAZIDE d00253A C[@ R60.9 Edema, unspecified Ap E A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified Ap E A LOSARTAN d03821A C[@ I10 Essential (primary) hypertension Ap E A TRAZODONE d00395A C G47.0 Insomnia Ap E A INSULIN LISPRO d04373A C"0 E11 R73 Type 2 diabetes mellitus Elevated blood glucose level A0 E A PROPRANOLOL d00032A C I10 Essential (primary) hypertension A0 E A TELMISARTAN d04364A B[ I10 Essential (primary) hypertension A0 E A MIRABEGRON d07876A C- R35 R39.1 Polyuria Other difficulties with micturition A E A . . . E A AMLODIPINE d00689A C I10 Essential (primary) hypertension A@ E A DICLOFENAC d00848A B R52 Pain, unspecified A@ E A DULOXETINE d05355A A M62.83 M79.2 Muscle spasm Neuralgia and neuritis, unspecified A@ E A TIZANIDINE d04102A B M54 Dorsalgia A@ E A . . . E A AMLODIPINE d00689A0 D I10 Essential (primary) hypertension Ap E A CLOPIDOGREL d04258A0 B= D75.9P Prevent blood clots Ap E A FUROSEMIDE d00070A0 CDp I10 Essential (primary) hypertension Ap E A LEVOTHYROXINE d00278A0 D E03.9 Hypothyroidism, unspecified Ap E A METOPROLOL d00134A0 B= I49.9 Cardiac arrhythmia, unspecified Ap E A POTASSIUM CHLORIDE d00345A0 C E87.6 Hypokalemia Ap E A SPIRONOLACTONE d00373A0 CDp I10 Essential (primary) hypertension Ap E A . . . E A . . . E A . . . E 0 A . . . E @ A ALBUTEROL d00749A C- R06.02 Shortness of breath A` E @ A BUDESONIDE; FORMOTEROL d04795A C- R06.9 Unspecified abnormalities of breathing A` E @ A LEVOTHYROXINE d00278A C 99999 A` E @ A LOVASTATIN d00280A Dc E78.0 Pure hypercholesterolemia A` E @ A OXYBUTYNIN d00328A B R35 Polyuria A` E @ A PREDNISONE d00350A B 99999 A` E P A . . . E ` A . . . E p A . . . E A CYCLOSPORINE OPHTHALMIC d04836A C- H04 Disorders of lacrimal system A0 E A PROGESTERONE d00550A C- 55555 A0 E A THYROID DESICCATED d00655A C- E03.9 Hypothyroidism, unspecified A0 E A . . . E A AMOXICILLIN d00088A A J34.9 Unspecified disorder of nose and nasal sinuses A E A 55555 A A A49.9 Bacterial infection, unspecified A E A ATENOLOL d00004A Ei 99999 A E A HYDROCHLOROTHIAZIDE d00253A Ei 99999 A E A . . . E A . . . E A GABAPENTIN d03182A C- G99.8 Other specified disorders of nervous system in diseases classified elsewhere A0 E A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified A0 E A LISINOPRIL d00732A C I10 Essential (primary) hypertension A0 E A . . . E A . . . E A . . . E 0 A . . . E @ A BUPROPION d00181A CDp F33.9 Major depressive disorder, recurrent, unspecified A E @ A ESCITALOPRAM d04812A C- F41.9 Anxiety disorder, unspecified A E P A . . . E ` A . . . E p A . . . E A . . . E A AMLODIPINE; BENAZEPRIL d03829A CDp I10 Essential (primary) hypertension A E A . . . E A ALBUTEROL d00749A B J45 Asthma A E A FLUTICASONE d01296A C J45 Asthma A E A ENALAPRIL d00013A C I10 Essential (primary) hypertension AP E A GABAPENTIN d03182A C M79.2 Neuralgia and neuritis, unspecified AP E A GLIMEPIRIDE d03864A C E11 Type 2 diabetes mellitus AP E A METFORMIN d03807A CP E11 Type 2 diabetes mellitus AP E A TRAZODONE d00395A C G47.0 Insomnia AP E A . . . E A . . . E A SERTRALINE d00880A C F32.9 F41.0 F41.9 Major depressive disorder, single episode, unspecified Panic disorder [episodic paroxysmal anxiety] without agoraphobia Anxiety disorder, unspecified A E A AMOXICILLIN; CLAVULANATE d00089A A0 J01.9 Acute sinusitis, unspecified A E A ATORVASTATIN d04105A C- E78.0 Pure hypercholesterolemia A0 E A LISINOPRIL d00732A C- I10 Essential (primary) hypertension A0 E A METFORMIN d03807A C- E11 Type 2 diabetes mellitus A0 E A . . . E 0 A ALBUTEROL d00749A C- J45 Asthma A E 0 A ALPRAZOLAM d00168A C- F41.9 Anxiety disorder, unspecified A E 0 A CLOPIDOGREL d04258A CDp D75.9P Prevent blood clots A E 0 A EMPAGLIFLOZIN d08275A B= I51.9P R73 Prevent heart disease Elevated blood glucose level A E 0 A GLYBURIDE d00248A Cr R73 Elevated blood glucose level A E 0 A LEVOTHYROXINE d00278A Cr E07.9 Disorder of thyroid, unspecified A E 0 A QUINAPRIL d00365A Cr I10 Essential (primary) hypertension A E 0 A TESTOSTERONE d00558A B R53 Malaise and fatigue A E @ A ALLOPURINOL d00023A CDp 99999 A E @ A ATORVASTATIN d04105A Cr 99999 A E @ A CARVEDILOL d03847A Cr 99999 A E @ A FUROSEMIDE d00070A Cr R60.9 Edema, unspecified A E @ A INSULIN GLARGINE d04538A C- E11 Type 2 diabetes mellitus A E @ A INSULIN LISPRO d04373A C- E11 Type 2 diabetes mellitus A E @ A LISINOPRIL d00732A CDp I21.P Prevent heart attack/myocardial infarction A E @ A OMEPRAZOLE d00325A C- K21 Gastro-esophageal reflux disease A E P A LEVOTHYROXINE d00278A CDp E03.9 Hypothyroidism, unspecified A E P A OMEPRAZOLE d00325A C K21 Gastro-esophageal reflux disease A E ` A BACLOFEN d00967A C- M79.1 Myalgia AP E ` A GABAPENTIN d03182A C- F41.9 Anxiety disorder, unspecified AP E ` A ONDANSETRON d00867A C R11 Nausea and vomiting AP E ` A OXYCODONE d00329A C- G43 Migraine AP E ` A PROPRANOLOL d00032A Bz G43 Migraine AP E p A . . . E A . . . E A ATENOLOL d00004A CDp I10 Essential (primary) hypertension A0 E A FUROSEMIDE d00070A CDp I10 R60.9 Essential (primary) hypertension Edema, unspecified A0 E A LISINOPRIL d00732A CDp I10 Essential (primary) hypertension A0 E A . . . E A AMLODIPINE d00689A B 99999 A0 E A ATORVASTATIN d04105A C 99999 A0 E A LOSARTAN d03821A C I10 Essential (primary) hypertension A0 E A CLONIDINE d00044A B G47.0 Insomnia A E A DEXMETHYLPHENIDATE d04777A B F90 Attention-deficit hyperactivity disorders A E A CIPROFLOXACIN d00011A D N39.0 R09.81 Urinary tract infection, site not specified Nasal congestion A E A . . . E A . . . E A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A0 E A ICOSAPENT d07891A C E78.1 Pure hyperglyceridemia A0 E A METFORMIN d03807A C E11 Type 2 diabetes mellitus A0 E A AMLODIPINE d00689A C- I21.P Prevent heart attack/myocardial infarction A` E A CLOPIDOGREL d04258A C- I21.P Prevent heart attack/myocardial infarction A` E A LATANOPROST OPHTHALMIC d04017A C H40 Glaucoma A` E A LISINOPRIL d00732A C- I10 I21.P Essential (primary) hypertension Prevent heart attack/myocardial infarction A` E A METOPROLOL d00134A C- I21.P Prevent heart attack/myocardial infarction A` E A OFLOXACIN OTIC d04265A B H60 Otitis externa A` E A . . . E 0 A METHYLPREDNISOLONE d00293A B M10.9 Gout, unspecified A E @ A ALBUTEROL d00749A C J45 Asthma AP E @ A BUPROPION d00181A C"0 F41.9 Anxiety disorder, unspecified AP E @ A CYCLOBENZAPRINE d00963A C"0 M79.1 Myalgia AP E @ A GABAPENTIN d03182A C- M79.2 Neuralgia and neuritis, unspecified AP E @ A METOPROLOL d00134A C R00 Abnormalities of heart beat AP E P A AMLODIPINE d00689A B[ I10 Essential (primary) hypertension A E P A ATORVASTATIN d04105A C[@ E78.0 Pure hypercholesterolemia A E P A BACLOFEN d00967A B M54 Dorsalgia A E P A BECLOMETHASONE d00760A CDp R06.2 Wheezing A E P A CYCLOBENZAPRINE d00963A B M54 Dorsalgia A E P A FLUOXETINE d00236A C- F41.9 Anxiety disorder, unspecified A E P A LATANOPROST OPHTHALMIC d04017A Cr H40 Glaucoma A E P A METOPROLOL d00134A B[ I10 Essential (primary) hypertension A E P A MORPHINE d00308A B= M54 Dorsalgia A E P A OMEPRAZOLE d00325A C- K21 Gastro-esophageal reflux disease A E P A TRAMADOL d03826A C M79.1 Myalgia A E ` A LAMOTRIGINE d03809A C G40 Epilepsy and recurrent seizures A E ` A SERTRALINE d00880A C[@ G40 Epilepsy and recurrent seizures A E p A ALBUTEROL d00749A C[@ R06.9P Prevent breathing difficulty A@ E p A CEPHALEXIN d00096A A N30 Cystitis A@ E p A FLUTICASONE d01296A C[@ J42 Unspecified chronic bronchitis A@ E p A FLUTICASONE NASAL d04283A CDp J30.2 J30.9 Other seasonal allergic rhinitis Allergic rhinitis, unspecified A@ E A . . . E A ALENDRONATE d03849A C M85.9 Disorder of bone density and structure, unspecified A E A ALLOPURINOL d00023A C M10.9P Prevent gout A E A ATENOLOL d00004A Dc I10 Essential (primary) hypertension A E A FUROSEMIDE d00070A C R60.9 Edema, unspecified A E A GLIPIZIDE d00246A C E11 Type 2 diabetes mellitus A E A INSULIN GLARGINE d04538A C E11 Type 2 diabetes mellitus A E A LOSARTAN d03821A C I10 Essential (primary) hypertension A E A SIMVASTATIN d00746A Ei E78.0 Pure hypercholesterolemia A E A LEVOTHYROXINE d00278A D E03.9 Hypothyroidism, unspecified A E A METFORMIN d03807A B[ R73 Elevated blood glucose level A E A 99999 . . A E A . . . E A BENAZEPRIL; HYDROCHLOROTHIAZIDE d03265A C I10 Essential (primary) hypertension A0 E A LEVETIRACETAM d04499A D G40 Epilepsy and recurrent seizures A0 E A TRAZODONE d00395A D G47.0 Insomnia A0 E A . . . E A . . . E A ATENOLOL d00004A C R00 Abnormalities of heart beat A@ E A METHADONE d00050A Cr M54 Dorsalgia A@ E A OMEPRAZOLE d00325A C[@ K21 Gastro-esophageal reflux disease A@ E A PROMETHAZINE d00787A C K46 R11 Unspecified abdominal hernia Nausea and vomiting A@ E A . . . E A . . . E 0 A AMLODIPINE d00689A Cr I10 Essential (primary) hypertension A E 0 A OMEPRAZOLE d00325A C K21 K30 Gastro-esophageal reflux disease Functional dyspepsia A E @ A ALBUTEROL d00749A Dc J44.9 J45 Chronic obstructive pulmonary disease, unspecified Asthma A E @ A BUDESONIDE d04276A C J44.9 Chronic obstructive pulmonary disease, unspecified A E @ A DILTIAZEM d00045A D Z95 Presence of cardiac and vascular implants and grafts A E @ A ENALAPRIL d00013A Dc I10 Essential (primary) hypertension A E @ A EVOLOCUMAB d08383A C E78.0 Pure hypercholesterolemia A E @ A FUROSEMIDE d00070A D I10 R60.9 Essential (primary) hypertension Edema, unspecified A E @ A LEVOTHYROXINE d00278A DJ$ E07.9 Disorder of thyroid, unspecified A E @ A MONTELUKAST d04289A D"8 J45 Asthma A E @ A UMECLIDINIUM; VILANTEROL d08188A C- J44.9 Chronic obstructive pulmonary disease, unspecified A E P A LEVOTHYROXINE d00278A B E05 Thyrotoxicosis [hyperthyroidism] A E ` A ACETAMINOPHEN; HYDROCODONE d03428A C- M79.1 N94 Myalgia Pain and other conditions associated with female genital organs and menstrual cycle A E ` A ALBUTEROL d00749A C- J44.9 J45 Chronic obstructive pulmonary disease, unspecified Asthma A E ` A ALBUTEROL d00749A Cr J42 J45 Unspecified chronic bronchitis Asthma A E ` A CLONIDINE d00044A C I10 Essential (primary) hypertension A E ` A CYCLOBENZAPRINE d00963A Cr M62.83 M79.1 Muscle spasm Myalgia A E ` A HYDROCHLOROTHIAZIDE d00253A C R60.9 Edema, unspecified A E ` A LIDOCAINE TOPICAL d00683A Ap M25.5 Pain in joint A E ` A LISINOPRIL d00732A Cr I10 Essential (primary) hypertension A E ` A METOPROLOL d00134A CDp I10 Essential (primary) hypertension A E p A ALBUTEROL d00749A C R06.9P Prevent breathing difficulty A0 E p A METHOTREXATE d00060A C M06.9 Rheumatoid arthritis, unspecified A0 E p A VALSARTAN d04113A B[ I10 Essential (primary) hypertension A0 E A . . . E A ALBUTEROL d00749A B[ J45 Asthma A` E A FLUTICASONE NASAL d04283A B[ J30.9 Allergic rhinitis, unspecified A` E A FLUTICASONE; SALMETEROL d04611A C J45 Asthma A` E A LEVOTHYROXINE d00278A D E03.9 Hypothyroidism, unspecified A` E A MONTELUKAST d04289A B[ J45 Asthma A` E A RANITIDINE d00021A C K21 Gastro-esophageal reflux disease A` E A GLIPIZIDE d00246A D E11 Type 2 diabetes mellitus AP E A INSULIN ISOPHANE (NPH) d04370A C[@ R73 Elevated blood glucose level AP E A LISINOPRIL d00732A D E11.2 Type 2 diabetes mellitus with kidney complications AP E A METFORMIN d03807A D E11 Type 2 diabetes mellitus AP E A NAPROXEN d00019A Cr M79.1 Myalgia AP E A . . . E A . . . E A . . . E A . . . E A 77777 . . A E A AMLODIPINE d00689A C D64.9 M81 N28.9 Anemia, unspecified Osteoporosis without current pathological fracture Disorder of kidney and ureter, unspecified A` E A CHLORTHALIDONE d00192A D I10 Essential (primary) hypertension A` E A LEVOTHYROXINE d00278A D* Z90 Acquired absence of organs, not elsewhere classified A` E A METOPROLOL d00134A C 99999 A` E A POTASSIUM CHLORIDE d00345A B[ E87.6 Hypokalemia A` E A URSODIOL d01005A D K87 Disorders of gallbladder, biliary tract and pancreas in diseases classified elsewhere A` E A . . . E A . . . E 0 A . . . E @ A TOPIRAMATE d04115A Ei G40 Epilepsy and recurrent seizures A E P A . . . E ` A ATORVASTATIN d04105A D E78.0 Pure hypercholesterolemia AP E ` A DULOXETINE d05355A B M79.7 Fibromyalgia AP E ` A PANTOPRAZOLE d04514A CDp K21 Gastro-esophageal reflux disease AP E ` A PREGABALIN d05508A C M79.7 Fibromyalgia AP E ` A RANITIDINE d00021A CDp K21 Gastro-esophageal reflux disease AP E p A . . . E A . . . E A 99999 . . A E A BENAZEPRIL d00730A D I10 Essential (primary) hypertension A E A POTASSIUM CHLORIDE d00345A D E87.6 Hypokalemia A E A . . . E A CHLORTHALIDONE d00192A C I10 Essential (primary) hypertension A E A DULOXETINE d05355A A F41.9 Anxiety disorder, unspecified A E A GABAPENTIN d03182A C[@ M54 Dorsalgia A E A AMLODIPINE d00689A C I10 Essential (primary) hypertension A@ E A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A@ E A LISINOPRIL d00732A C I10 Essential (primary) hypertension A@ E A METOPROLOL d00134A C I10 Essential (primary) hypertension A@ E A 55555 A C I51.9P Prevent heart disease A E A ATORVASTATIN d04105A D E78.0 Pure hypercholesterolemia A E A . . . E A . . . E A . . . E 0 A . . . E @ A . . . E P A . . . E ` A ATENOLOL d00004A C I10 Essential (primary) hypertension A E p A . . . E A HYDROCHLOROTHIAZIDE d00253A B= I10 Essential (primary) hypertension A0 E A ISONIAZID d00101A B J18.9 Pneumonia, unspecified organism A0 E A METFORMIN d03807A B= E78.0 Pure hypercholesterolemia A0 E A BACLOFEN d00967A C- M54 T14.9 Dorsalgia Unspecified injury A0 E A PANTOPRAZOLE d04514A C[@ K25 Gastric ulcer A0 E A ZOLPIDEM d00910A C[@ G47.0 Insomnia A0 E A ACETAMINOPHEN; HYDROCODONE d03428A B M79.7 Fibromyalgia A@ E A GABAPENTIN d03182A C E11.4 Type 2 diabetes mellitus with neurological complications A@ E A LEVOTHYROXINE d00278A D E03.9 Hypothyroidism, unspecified A@ E A TIZANIDINE d04102A C- M79.7 Fibromyalgia A@ E A . . . E A AMITRIPTYLINE d00146A C R51 Headache A E A . . . E A ALENDRONATE d03849A C M81 Osteoporosis without current pathological fracture A E A . . . E A ALLOPURINOL d00023A B E79.9 Disorder of purine and pyrimidine metabolism, unspecified A0 E A LISINOPRIL d00732A C I10 Essential (primary) hypertension A0 E A PRAVASTATIN d00348A B[ E78.0 Pure hypercholesterolemia A0 E A TRAMADOL d03826A CDp M54 Dorsalgia A E A . . . E 0 A . . . E @ A CETIRIZINE d03827A CDp R09.81 Nasal congestion A0 E @ A FLUTICASONE NASAL d04283A C J34.9 Unspecified disorder of nose and nasal sinuses A0 E @ A RISPERIDONE d03180A Cr F31.9 R45 Bipolar disorder, unspecified Symptoms and signs involving emotional state A0 E P A . . . E ` A . . . E p A 99999 . . A E A . . . E A AMOXICILLIN d00088A A J01.9 Acute sinusitis, unspecified A E A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E A APIXABAN d07804A B Z79.0 Long term (current) use of anticoagulants and antithrombotics/antiplatelets Ap E A GLIMEPIRIDE d03864A C- E11.P R73 Prevent diabetes Elevated blood glucose level Ap E A LEVETIRACETAM d04499A C[@ G40 Epilepsy and recurrent seizures Ap E A LEVOTHYROXINE d00278A CDp E07.9 Disorder of thyroid, unspecified Ap E A LOSARTAN d03821A C I10 Essential (primary) hypertension Ap E A METOPROLOL d00134A C I10 Essential (primary) hypertension Ap E A ROSUVASTATIN d04851A C E78.0 Pure hypercholesterolemia Ap E A RANITIDINE d00021A B= K21 Gastro-esophageal reflux disease A E A . . . E 0 A GABAPENTIN d03182A C- M79.2 Neuralgia and neuritis, unspecified A E @ A . . . E P A . . . E ` A ACETAMINOPHEN; OXYCODONE d03431A C M25.5 Z96 Pain in joint Presence of other functional implants Ap E ` A ATORVASTATIN d04105A0 C- E78.0P Prevent high cholesterol Ap E ` A CLOPIDOGREL d04258A C- D75.9P Prevent blood clots Ap E ` A GABAPENTIN d03182A C- M79.2 Neuralgia and neuritis, unspecified Ap E ` A INSULIN GLARGINE d04538A CDp E11 Type 2 diabetes mellitus Ap E ` A LISINOPRIL d00732A C- I10.P Prevent hypertension Ap E ` A METFORMIN d03807A C E11 Type 2 diabetes mellitus Ap E p A . . . E A . . . E A AMLODIPINE; BENAZEPRIL d03829A D I10 Essential (primary) hypertension A0 E A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A0 E A TAMSULOSIN d04121A C- R39.1 Other difficulties with micturition A0 E A DEXMETHYLPHENIDATE d04777A B F90 Attention-deficit hyperactivity disorders A E A AMPHETAMINE; DEXTROAMPHETAMINE d04035A C[@ F90 Attention-deficit hyperactivity disorders A@ E A FLUOXETINE d00236A C F32.9 F41.9 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified A@ E A GUANFACINE d00717A C F90 F91 Attention-deficit hyperactivity disorders Conduct disorders A@ E A OMEPRAZOLE d00325A Cr K21 Gastro-esophageal reflux disease A@ E A . . . E A . . . E A . . . E A AMLODIPINE d00689A D"8 I10 Essential (primary) hypertension AP E A CODEINE d00012A D M79.1 Myalgia AP E A DEXLANSOPRAZOLE d07395A D"8 K27 K30 R12 Peptic ulcer, site unspecified Functional dyspepsia Heartburn AP E A LISINOPRIL d00732A D"8 I10 Essential (primary) hypertension AP E A METHOCARBAMOL d00965A D"8 M79.1 Myalgia AP E A AMOXICILLIN d00088A Ap H66.9 Otitis media, unspecified A E A TRIAMCINOLONE TOPICAL d03206A Ap L20.9 Atopic dermatitis, unspecified A E A . . . E A ETHINYL ESTRADIOL; NORGESTIMATE d03781A B N92 Excessive, frequent and irregular menstruation A E A FLUORIDE TOPICAL d04397A C K08.8 Other specified disorders of teeth and supporting structures A E 0 A CARVEDILOL d03847A D I21.P Prevent heart attack/myocardial infarction A@ E 0 A LISINOPRIL d00732A D I10 Essential (primary) hypertension A@ E 0 A ROSUVASTATIN d04851A D E78.0P Prevent high cholesterol A@ E 0 A TICAGRELOR d07721A D D75.9P Prevent blood clots A@ E @ A . . . E P A 99999 . . A E P A ASPIRIN d00170A C D75.9P Prevent blood clots A E P A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A E P A DULAGLUTIDE d08290A B E11 Type 2 diabetes mellitus A E P A GABAPENTIN d03182A B G47.0 Insomnia A E P A INSULIN ASPART d04697A C- E11 Type 2 diabetes mellitus A E P A INSULIN GLARGINE d04538A C- E11 Type 2 diabetes mellitus A E P A METFORMIN d03807A C- E11 Type 2 diabetes mellitus A E P A METOCLOPRAMIDE d00298A B R11.P Prevent nausea or vomiting A E P A OMEPRAZOLE d00325A B= R10 Abdominal and pelvic pain A E P A TOPIRAMATE d04115A B[ G43 Migraine A E ` A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia Ap E ` A DILTIAZEM d00045A B= I10.P Prevent hypertension Ap E ` A FUROSEMIDE d00070A C I51.9 Heart disease, unspecified Ap E ` A GABAPENTIN d03182A D M79.2 T14.9 Neuralgia and neuritis, unspecified Unspecified injury Ap E ` A HYDROCHLOROTHIAZIDE d00253A C I51.9P Prevent heart disease Ap E ` A PANTOPRAZOLE d04514A D3T K21 Gastro-esophageal reflux disease Ap E ` A POTASSIUM CHLORIDE d00345A C E87.6 Hypokalemia Ap E p A ESCITALOPRAM d04812A B F41.9 Anxiety disorder, unspecified A E A . . . E A CLOPIDOGREL d04258A B[ Z79.0 Long term (current) use of anticoagulants and antithrombotics/antiplatelets A@ E A METFORMIN d03807A C I51.9 Heart disease, unspecified A@ E A METOPROLOL d00134A C I50.9 Heart failure, unspecified A@ E A SIMVASTATIN d00746A C I51.9 Heart disease, unspecified A@ E A MIRABEGRON d07876A B# R35 Polyuria A E A . . . E A LEVOTHYROXINE d00278A D E03.9 Hypothyroidism, unspecified A E A . . . E A . . . E A FLUOXETINE d00236A B= F32.9 Major depressive disorder, single episode, unspecified A@ E A OXYBUTYNIN d00328A C[@ N32.81 Overactive bladder A@ E A VENLAFAXINE d03181A C F32.9 Major depressive disorder, single episode, unspecified A@ E A ZOLPIDEM d00910A C G47.0 Insomnia A@ E A DEXTROMETHORPHAN; QUINIDINE d07707A C G31.9 Degenerative disease of nervous system, unspecified A E A HYDROCHLOROTHIAZIDE; LOSARTAN d03830A C I10 Essential (primary) hypertension A E A INSULIN GLARGINE d04538A C E11 Type 2 diabetes mellitus A E A METOPROLOL d00134A Cr I10 Essential (primary) hypertension A E A OMEPRAZOLE d00325A Cr K21 Gastro-esophageal reflux disease A E A PRAVASTATIN d00348A Cr E78.0 Pure hypercholesterolemia A E A QUETIAPINE d04220A C G31.9 Degenerative disease of nervous system, unspecified A E A WARFARIN d00022A C D75.9P I63 Prevent blood clots Cerebral infarction A E A . . . E A MECLIZINE d00859A C R42 Dizziness and giddiness A E 0 A . . . E @ A AMIODARONE d00002A C- 55555 Ap E @ A AMLODIPINE; BENAZEPRIL d03829A C I10 Essential (primary) hypertension Ap E @ A ASPIRIN d00170A C- I21.P Prevent heart attack/myocardial infarction Ap E @ A ATORVASTATIN d04105A C- E78.0 Pure hypercholesterolemia Ap E @ A HYDROCHLOROTHIAZIDE d00253A C- Z79.0 Long term (current) use of anticoagulants and antithrombotics/antiplatelets Ap E @ A METOPROLOL d00134A C- I10 Essential (primary) hypertension Ap E @ A PRAVASTATIN d00348A C G47.0 Insomnia Ap E P A . . . E ` A LISDEXAMFETAMINE d06663A C- F90 Attention-deficit hyperactivity disorders A E p A . . . E A . . . E A . . . E A . . . E A LOVASTATIN d00280A Cr E78.0 Pure hypercholesterolemia A E A SERTRALINE d00880A C[@ F41.9 Anxiety disorder, unspecified A E A . . . E A ALBUTEROL d00749A B J42 R07.9 Unspecified chronic bronchitis Chest pain, unspecified A0 E A AMLODIPINE d00689A C I10 Essential (primary) hypertension A0 E A HOMATROPINE; HYDROCODONE d03340A Ap R05 Cough A0 E A CYCLOBENZAPRINE d00963A B M54 Dorsalgia A E A MELOXICAM d04532A B M54 Dorsalgia A E A . . . E A . . . E A . . . E A . . . E 0 A . . . E @ A . . . E P A . . . E ` A . . . E p A . . . E A . . . E A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A@ E A LOSARTAN d03821A C I10 Essential (primary) hypertension A@ E A METFORMIN d03807A C E11.P Prevent diabetes A@ E A TAMSULOSIN d04121A C R35 Polyuria A@ E A HYDROCHLOROTHIAZIDE d00253A B I10 Essential (primary) hypertension A E A MIRABEGRON d07876A A R32 Unspecified urinary incontinence A E A . . . E A . . . E A . . . E A . . . E A ALBUTEROL d00749A D J45 Asthma A E A . . . E A LOSARTAN d03821A C I10 Essential (primary) hypertension A@ E A METFORMIN d03807A C E11 Type 2 diabetes mellitus A@ E A METOPROLOL d00134A C I10 Essential (primary) hypertension A@ E A SIMVASTATIN d00746A C E78.0P Prevent high cholesterol A@ E A ACETAMINOPHEN; OXYCODONE d03431A Cr M79.2 Neuralgia and neuritis, unspecified A` E A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A` E A GLIPIZIDE d00246A C E11 Type 2 diabetes mellitus A` E A HYDROCHLOROTHIAZIDE; LOSARTAN d03830A C I10 Essential (primary) hypertension A` E A METOPROLOL d00134A C I10 Essential (primary) hypertension A` E A PIOGLITAZONE d04442A C[@ E11 Type 2 diabetes mellitus A` E 0 A . . . E @ A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A C I10 Essential (primary) hypertension A E P A ETHINYL ESTRADIOL; NORETHINDRONE d03238A B Z79.3 Long term (current) use of hormonal contraceptives A E P A LOSARTAN d03821A C I10 Essential (primary) hypertension A E ` A . . . E p A FEXOFENADINE d04040A B[ T78.40 Allergy, unspecified A E p A SERTRALINE d00880A B F32.9 F43.9 Major depressive disorder, single episode, unspecified Reaction to severe stress, unspecified A E A DICLOFENAC TOPICAL d04722A A M79.6 Pain in limb, hand, foot, fingers and toes A E A OLANZAPINE d04050A C[@ F42 Obsessive-compulsive disorder A E A VENLAFAXINE d03181A C[@ F32.9 F41.9 G47.0 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified Insomnia A E A . . . E A AMLODIPINE d00689A B I10 Essential (primary) hypertension A@ E A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A@ E A CLOPIDOGREL d04258A B I63 Cerebral infarction A@ E A LOSARTAN d03821A B I10 Essential (primary) hypertension A@ E A DICLOFENAC d00848A C- Z79.1 Long term (current) use of non-steroidal anti-inflammatories (NSAID) A E A DULOXETINE d05355A A F32.9 Major depressive disorder, single episode, unspecified A E A GABAPENTIN d03182A C M79.2 Neuralgia and neuritis, unspecified A E A IBUPROFEN d00015A C T14.9 Unspecified injury A E A INDOMETHACIN d00039A B Z79.1 Long term (current) use of non-steroidal anti-inflammatories (NSAID) A E A METHOCARBAMOL d00965A B= M79.1 M79.7 Myalgia Fibromyalgia A E A PREDNISONE d00350A C Z79 Long term (current) drug therapy A E A ROSUVASTATIN d04851A B E78.0 Pure hypercholesterolemia A E A . . . E A ALBUTEROL d00749A C- R06.02 Shortness of breath A E A ALBUTEROL d00749A D* R06.02 Shortness of breath A E A AMLODIPINE d00689A C I10 Essential (primary) hypertension AP E A LEVOTHYROXINE d00278A Dc 99999 AP E A LISINOPRIL d00732A D I10 Essential (primary) hypertension AP E A LOVASTATIN d00280A D* E78.0 Pure hypercholesterolemia AP E A METOPROLOL d00134A D* I10 Essential (primary) hypertension AP E A LEVOTHYROXINE d00278A Cr E03.9 Hypothyroidism, unspecified A E A LOSARTAN d03821A C I10 Essential (primary) hypertension A E A . . . E A HYDROCHLOROTHIAZIDE; LOSARTAN d03830A B I10 Essential (primary) hypertension A E A IBUPROFEN d00015A B M25.5 Pain in joint A E 0 A AZITHROMYCIN d00091A A@ J06.9 Acute upper respiratory infection, unspecified A E @ A . . . E P A . . . E ` A ESOMEPRAZOLE d04749A Ap 55555 A@ E ` A FLECAINIDE d00234A C I48.9 Unspecified atrial fibrillation and atrial flutter A@ E ` A LEVOTHYROXINE d00278A DK E03.9 Hypothyroidism, unspecified A@ E ` A PAROXETINE d03157A C F32.9 G47.9 Major depressive disorder, single episode, unspecified Sleep disorder, unspecified A@ E p A CELECOXIB d04380A D* M19.9 Osteoarthritis, unspecified site A` E p A IRBESARTAN d04222A C I10 Essential (primary) hypertension A` E p A METOPROLOL d00134A Cr I10 Essential (primary) hypertension A` E p A OMEPRAZOLE d00325A D K30 Functional dyspepsia A` E p A PRAVASTATIN d00348A Dc E78.0 Pure hypercholesterolemia A` E p A RANITIDINE d00021A C K30 Functional dyspepsia A` E A . . . E A . . . E A DESOGESTREL; ETHINYL ESTRADIOL d03782A C Z79.3 Long term (current) use of hormonal contraceptives A E A . . . E A . . . E A . . . E A LISDEXAMFETAMINE d06663A C[@ F90 R41 Attention-deficit hyperactivity disorders Other symptoms and signs involving cognitive functions and awareness A E A . . . E A 55555 A0 C[@ M79.1 Myalgia AP E A ALBUTEROL d00749A0 D J45 R06.02 R06.2 Asthma Shortness of breath Wheezing AP E A ETHINYL ESTRADIOL; NORGESTIMATE d03781A0 D N92 Excessive, frequent and irregular menstruation AP E A IVERMECTIN TOPICAL d07842A0 C L71 Rosacea AP E A METFORMIN d03807A0 CDp E11.P E28 R73 Prevent diabetes Ovarian dysfunction Elevated blood glucose level AP E A ATORVASTATIN d04105A D E78.0 Pure hypercholesterolemia A@ E A GLIPIZIDE d00246A Dc R73 Elevated blood glucose level A@ E A LISINOPRIL d00732A D I10 Essential (primary) hypertension A@ E A METFORMIN d03807A D E11 Type 2 diabetes mellitus A@ E A . . . E 0 A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A C I10 Essential (primary) hypertension A E @ A . . . E P A . . . E ` A FINASTERIDE d00563A CDp N40 Enlarged prostate A` E ` A HYDROCHLOROTHIAZIDE d00253A CDp I10 Essential (primary) hypertension A` E ` A LOSARTAN d03821A CDp I10 Essential (primary) hypertension A` E ` A METOPROLOL d00134A Ei I10 Essential (primary) hypertension A` E ` A SERTRALINE d00880A C F32.9 Major depressive disorder, single episode, unspecified A` E ` A SIMVASTATIN d00746A Ei E78.0 Pure hypercholesterolemia A` E p A ALBUTEROL d00749A CP J45 Asthma A@ E p A ALPRAZOLAM d00168A CP F41.9 Anxiety disorder, unspecified A@ E p A FLUTICASONE; SALMETEROL d04611A B= R07.9 Chest pain, unspecified A@ E p A HYDROCHLOROTHIAZIDE d00253A C I10 Essential (primary) hypertension A@ E A . . . E A ALBUTEROL d00749A D J45 Asthma A@ E A ALBUTEROL d00749A Dc J45 Asthma A@ E A CETIRIZINE d03827A C J45 T78.40 Asthma Allergy, unspecified A@ E A FLUTICASONE; SALMETEROL d04611A C J45 Asthma A@ E A . . . E A TRIAMCINOLONE TOPICAL d03206A B= L40 Psoriasis A E A ACETAMINOPHEN; CODEINE d03423A Dc M19.9 Osteoarthritis, unspecified site A E A ALENDRONATE d03849A C- M81 Osteoporosis without current pathological fracture A E A CARVEDILOL d03847A Cr I10 Essential (primary) hypertension A E A FUROSEMIDE d00070A C R60.9 Edema, unspecified A E A INSULIN GLARGINE d04538A C E11 Type 2 diabetes mellitus A E A OMEPRAZOLE d00325A CDp K21 Gastro-esophageal reflux disease A E A PREGABALIN d05508A B E11.4 Type 2 diabetes mellitus with neurological complications A E A SIMVASTATIN d00746A Dc E78.0 Pure hypercholesterolemia A E A . . . E A CELECOXIB d04380A C M54 M79.7 Dorsalgia Fibromyalgia A@ E A CETIRIZINE d03827A C R09.81 T78.40 Nasal congestion Allergy, unspecified A@ E A CITALOPRAM d04332A C F32.9 F41.9 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified A@ E A PREGABALIN d05508A C M79.7 Fibromyalgia A@ E A METFORMIN d03807A C E11.P Prevent diabetes A E A . . . E A DOXAZOSIN d00726A D* N40 Enlarged prostate A E A FUROSEMIDE d00070A D I51.9 Heart disease, unspecified A E A POTASSIUM CHLORIDE d00345A D E87.6 Hypokalemia A E A SERTRALINE d00880A C F41.9 Anxiety disorder, unspecified A E A SIMVASTATIN d00746A D E78.0 Pure hypercholesterolemia A E A SOTALOL d00371A B= I49.9 Cardiac arrhythmia, unspecified A E A TELMISARTAN d04364A C I10 Essential (primary) hypertension A E A WARFARIN d00022A B= I49.9 Cardiac arrhythmia, unspecified A E A GLIMEPIRIDE d03864A C E11 Type 2 diabetes mellitus A0 E A HYDRALAZINE d00132A B I10 Essential (primary) hypertension A0 E A METFORMIN d03807A C E11 Type 2 diabetes mellitus A0 E 0 A . . . E @ A . . . E P A . . . E ` A . . . E p A LEVOTHYROXINE d00278A C- E03.9 Hypothyroidism, unspecified A E A . . . E A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia AP E A CARVEDILOL d03847A C I10 I50.9 Essential (primary) hypertension Heart failure, unspecified AP E A PROMETHAZINE d00787A C"0 R11 Nausea and vomiting AP E A TIOTROPIUM d04829A B J44.9 Chronic obstructive pulmonary disease, unspecified AP E A VARENICLINE d05807A A F17.2 Nicotine dependence AP E A ATORVASTATIN d04105A D I21.P Prevent heart attack/myocardial infarction A E A CILOSTAZOL d04382A D I70 Atherosclerosis A E A GABAPENTIN d03182A C[@ R25.2 Cramp and spasm A E A INSULIN GLARGINE d04538A C- R73 Elevated blood glucose level A E A LEVOTHYROXINE d00278A C C80.1 Malignant (primary) neoplasm, unspecified A E A NATEGLINIDE d04743A C- E11 Type 2 diabetes mellitus A E A NORTRIPTYLINE d00144A A0 R25.2 Cramp and spasm A E A PIOGLITAZONE d04442A C- E11 Type 2 diabetes mellitus A E A SOMATROPIN d00577A C- E34.9 Endocrine disorder, unspecified A E A ALBUTEROL d00749A C- J45 R06.02 R06.2 Asthma Shortness of breath Wheezing A E A ALBUTEROL d00749A C[@ J45.P R06.2 R06.9P Prevent asthma Wheezing Prevent breathing difficulty A E A . . . E A AZELASTINE NASAL d04068A C J01.9 Acute sinusitis, unspecified A0 E A CLONAZEPAM d00197A C G47.9 Sleep disorder, unspecified A0 E A FLUTICASONE NASAL d04283A C J01.9 Acute sinusitis, unspecified A0 E A . . . E A . . . E A GLIPIZIDE; METFORMIN d04823A C E11 Type 2 diabetes mellitus AP E A LOSARTAN d03821A CP N28.9P Prevent kidney disease AP E A PIOGLITAZONE d04442A CP E11 Type 2 diabetes mellitus AP E A PRAVASTATIN d00348A CP E78.0P Prevent high cholesterol AP E A SITAGLIPTIN d05896A CP E11 Type 2 diabetes mellitus AP E 0 A . . . E @ A OMEPRAZOLE d00325A B[ K21 Gastro-esophageal reflux disease A E P A OLANZAPINE d04050A B[ F31.9 Bipolar disorder, unspecified A E ` A . . . E p A . . . E A LOSARTAN d03821A C- I10 Essential (primary) hypertension A E A AMOXICILLIN d00088A A J02 Acute pharyngitis A E A 99999 . . AP E A CELECOXIB d04380A C M79.7 Fibromyalgia AP E A METFORMIN d03807A C- E11 Type 2 diabetes mellitus AP E A PRAMIPEXOLE d04145A C G25.81 Restless legs syndrome AP E A TRAMADOL d03826A C M25.5 M54 Pain in joint Dorsalgia AP E A . . . E A ATORVASTATIN d04105A D# E78.0 Pure hypercholesterolemia A E A DULAGLUTIDE d08290A C[@ E11 Type 2 diabetes mellitus A E A EMPAGLIFLOZIN d08275A C E11 Type 2 diabetes mellitus A E A ENALAPRIL d00013A D% I50.9 Heart failure, unspecified A E A INSULIN GLARGINE d04538A Cr E11 Type 2 diabetes mellitus A E A INSULIN LISPRO d04373A D E11 Type 2 diabetes mellitus A E A METFORMIN d03807A D# E11 Type 2 diabetes mellitus A E A METOPROLOL d00134A D% I49.9 Cardiac arrhythmia, unspecified A E A . . . E A . . . E A . . . E A ARIPIPRAZOLE d04825A C- F20 F32.9 Schizophrenia Major depressive disorder, single episode, unspecified Ap E A BUDESONIDE; FORMOTEROL d04795A C[@ J44.9 J45 Chronic obstructive pulmonary disease, unspecified Asthma Ap E A FLUOXETINE d00236A C F32.9 Major depressive disorder, single episode, unspecified Ap E A IBUPROFEN d00015A CDp M19.9 Osteoarthritis, unspecified site Ap E A LISINOPRIL d00732A C[@ I10 Essential (primary) hypertension Ap E A LORAZEPAM d00149A B F41.9 Anxiety disorder, unspecified Ap E A QUETIAPINE d04220A C F20 Schizophrenia Ap E A LEVOTHYROXINE d00278A D9 E03.9 Hypothyroidism, unspecified A@ E A LOVASTATIN d00280A D E78.0 Pure hypercholesterolemia A@ E A METOPROLOL d00134A C I10 Essential (primary) hypertension A@ E A WARFARIN d00022A C I80.3 Phlebitis and thrombophlebitis of lower extremities, unspecified A@ E A . . . E 0 A BUPROPION d00181A Bz F43.1 F90 Post-traumatic stress disorder (PTSD) Attention-deficit hyperactivity disorders A E @ A . . . E P A DICLOFENAC d00848A C M79.1 M79.2 Myalgia Neuralgia and neuritis, unspecified A@ E P A LISINOPRIL d00732A B I10 Essential (primary) hypertension A@ E P A NEBIVOLOL d05265A B I10 Essential (primary) hypertension A@ E P A ROSUVASTATIN d04851A C E78.0 Pure hypercholesterolemia A@ E ` A DEXTROMETHORPHAN; PHENYLEPHRINE; THONZYLAMINE d08112A Ap J09 R05 Influenza due to certain identified influenza viruses Cough A E p A . . . E A . . . E A LEVOTHYROXINE d00278A D E03.9 Hypothyroidism, unspecified AP E A LOSARTAN d03821A C E87.6 Hypokalemia AP E A METFORMIN d03807A C E11 Type 2 diabetes mellitus AP E A OMEPRAZOLE d00325A C[@ K21 Gastro-esophageal reflux disease AP E A ROSUVASTATIN d04851A Cr E78.0 Pure hypercholesterolemia AP E A . . . E A . . . E A . . . E A ATORVASTATIN d04105A D E78.0 Pure hypercholesterolemia A E A . . . E A GABAPENTIN d03182A C E11.4 Type 2 diabetes mellitus with neurological complications A0 E A GLIMEPIRIDE d03864A C E11 R73 Type 2 diabetes mellitus Elevated blood glucose level A0 E A NAPROXEN d00019A C M79.1 Myalgia A0 E A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified A E A BACLOFEN d00967A C G99.8 M79.1 Other specified disorders of nervous system in diseases classified elsewhere Myalgia A E A BUPROPION d00181A D F41.9 Anxiety disorder, unspecified A E A CIPROFLOXACIN d00011A C N39.0 Urinary tract infection, site not specified A E A CITALOPRAM d04332A D ^ F32.9 F41.0 F42 Major depressive disorder, single episode, unspecified Panic disorder [episodic paroxysmal anxiety] without agoraphobia Obsessive-compulsive disorder A E A DIAZEPAM d00148A CDp F32.9 F41.9 M62.83 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified Muscle spasm A E A DONEPEZIL d04099A C- R41 Other symptoms and signs involving cognitive functions and awareness A E A GABAPENTIN d03182A C M79.2 Neuralgia and neuritis, unspecified A E A MODAFINIL d04378A D F33.9 R53 Major depressive disorder, recurrent, unspecified Malaise and fatigue A E A OXYBUTYNIN d00328A C N39.4 R32 R39.1 Other specified urinary incontinence Unspecified urinary incontinence Other difficulties with micturition A E A . . . E 0 A . . . E @ A . . . E P A BUSPIRONE d00182A C F41.9 Anxiety disorder, unspecified A@ E P A GUANFACINE d00717A B[ F41.9 Anxiety disorder, unspecified A@ E P A LISDEXAMFETAMINE d06663A Bz F90 Attention-deficit hyperactivity disorders A@ E P A PRAZOSIN d00138A C F41.0 Panic disorder [episodic paroxysmal anxiety] without agoraphobia A@ E ` A . . . E p A . . . E A ARIPIPRAZOLE d04825A B= F31.9 F42 F90 Bipolar disorder, unspecified Obsessive-compulsive disorder Attention-deficit hyperactivity disorders A E A . . . E A AMOXICILLIN d00088A A J02 Acute pharyngitis A E A . . . E A 99999 . . A E A AMLODIPINE d00689A C I10 Essential (primary) hypertension A@ E A ATORVASTATIN d04105A B E78.0 Pure hypercholesterolemia A@ E A FLUTICASONE NASAL d04283A Bz R09.81 Nasal congestion A@ E A IBUPROFEN d00015A D M54 Dorsalgia A@ E A . . . E A ATORVASTATIN d04105A C- E78.0 Pure hypercholesterolemia A E A EPINEPHRINE d00699A C- 55555 A E A METOPROLOL d00134A B I10 Essential (primary) hypertension A E A . . . E 0 A ALBUTEROL d00749A Ap J45 Asthma A0 E 0 A CETIRIZINE d03827A Ap T78.40 Allergy, unspecified A0 E 0 A OLOPATADINE NASAL d07132A Ap J30.9 Allergic rhinitis, unspecified A0 E @ A . . . E P A HYDROXYZINE d00907A C G47.9 Sleep disorder, unspecified A E P A RISPERIDONE d03180A C 55555 A E ` A . . . E p A ATORVASTATIN d04105A C ` E78.0 Pure hypercholesterolemia A E A DROSPIRENONE; ETHINYL ESTRADIOL d04760A B N92 Excessive, frequent and irregular menstruation A E A ATORVASTATIN d04105A C[@ E78.0 Pure hypercholesterolemia A@ E A ENALAPRIL d00013A C[@ N19 Unspecified kidney failure A@ E A MEMANTINE d04899A B= R41 Other symptoms and signs involving cognitive functions and awareness A@ E A METFORMIN d03807A C[@ E11 Type 2 diabetes mellitus A@ E A ATORVASTATIN d04105A Dc E78.0 Pure hypercholesterolemia A E A AZITHROMYCIN d00091A AP J40 Bronchitis, not specified as acute or chronic A E A DIGOXIN d00210A C I48.9 Unspecified atrial fibrillation and atrial flutter A E A FUROSEMIDE d00070A C I51.9 Heart disease, unspecified A E A GABAPENTIN d03182A D M79.2 Neuralgia and neuritis, unspecified A E A METOPROLOL d00134A D I48.9 Unspecified atrial fibrillation and atrial flutter A E A OMEPRAZOLE d00325A C K21 Gastro-esophageal reflux disease A E A POTASSIUM CHLORIDE d00345A C E87.6 Hypokalemia A E A WARFARIN d00022A D Z79.0 Long term (current) use of anticoagulants and antithrombotics/antiplatelets A E A . . . E A . . . E A AMLODIPINE d00689A C[@ I21.P Prevent heart attack/myocardial infarction A0 E A ATORVASTATIN d04105A C[@ E78.0 Pure hypercholesterolemia A0 E A CLOPIDOGREL d04258A C[@ I80.3 Phlebitis and thrombophlebitis of lower extremities, unspecified A0 E A . . . E A . . . E A . . . E A . . . E A . . . E 0 A . . . E @ A ALLOPURINOL d00023A C- M10.9P Prevent gout A E @ A INDOMETHACIN d00039A C- M10.9 Gout, unspecified A E P A . . . E ` A . . . E p A . . . E A . . . E A AMLODIPINE d00689A C I10 Essential (primary) hypertension AP E A HYDROXYCHLOROQUINE d00817A C L93 Lupus erythematosus AP E A LOSARTAN d03821A C I10 Essential (primary) hypertension AP E A MELOXICAM d04532A C M13 Other arthritis AP E A OMEPRAZOLE d00325A C K21 Gastro-esophageal reflux disease AP E A . . . E A . . . E A . . . E A . . . E A . . . E A IRBESARTAN d04222A0 C[@ I10 Essential (primary) hypertension A E A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A E A GLIPIZIDE d00246A C E11 Type 2 diabetes mellitus A E A INSULIN ASPART d04697A C E11 Type 2 diabetes mellitus A E A INSULIN GLARGINE d04538A C E11 Type 2 diabetes mellitus A E A KETOCONAZOLE TOPICAL d03202A Bz R21 Rash and other nonspecific skin eruption A E A LEVOTHYROXINE d00278A DGJ E03.9 E04 Hypothyroidism, unspecified Other nontoxic goiter A E A METFORMIN d03807A C E11 Type 2 diabetes mellitus A E A NYSTATIN TOPICAL d04399A B[ B37 Candidiasis A E A WARFARIN d00022A C D75.9P Prevent blood clots A E A . . . E A CLONIDINE d00044A C F41.9 Anxiety disorder, unspecified A0 E A RANITIDINE d00021A C K21 Gastro-esophageal reflux disease A0 E A RISPERIDONE d03180A C[@ F41.9 R45 Anxiety disorder, unspecified Symptoms and signs involving emotional state A0 E 0 A . . . E @ A ALBUTEROL d00749A Cr J45 Asthma A E P A . . . E ` A ADALIMUMAB d04835A C M06.9 Rheumatoid arthritis, unspecified A0 E ` A OMEPRAZOLE d00325A CDp K21 Gastro-esophageal reflux disease A0 E ` A OXYCODONE d00329A CDp M25.5 M79.1 M79.2 Pain in joint Myalgia Neuralgia and neuritis, unspecified A0 E p A CARVEDILOL d03847A C[@ I10 Essential (primary) hypertension A0 E p A FENOFIBRATE d04286A C[@ E63.9 Nutritional deficiency, unspecified A0 E p A HYDROCHLOROTHIAZIDE; SPIRONOLACTONE d03247A Cr I10 Essential (primary) hypertension A0 E A LANSOPRAZOLE d03828A C K30 Functional dyspepsia A E A . . . E A . . . E A . . . E A METFORMIN d03807A CDp R73 Elevated blood glucose level A E A LEVOTHYROXINE d00278A D E03.9 Hypothyroidism, unspecified A E A . . . E A ETHINYL ESTRADIOL; NORETHINDRONE d03238A CDp 55555 A E A LEVOTHYROXINE d00278A C- E03.9 Hypothyroidism, unspecified A E A . . . E A . . . E A . . . E 0 A . . . E @ A EVOLOCUMAB d08383A B E78.0 Pure hypercholesterolemia A` E @ A GABAPENTIN d03182A C E11.4 Type 2 diabetes mellitus with neurological complications A` E @ A INSULIN LISPRO d04373A C E11 R73 Type 2 diabetes mellitus Elevated blood glucose level A` E @ A LETROZOLE d04156A CDp C50 Malignant neoplasm of breast A` E @ A LOSARTAN d03821A Ap I10 Essential (primary) hypertension A` E @ A PREGABALIN d05508A C- E11.4 Type 2 diabetes mellitus with neurological complications A` E P A . . . E ` A . . . E p A AMLODIPINE d00689A A F43.9 R51 Reaction to severe stress, unspecified Headache A E A . . . E A LEVOTHYROXINE d00278A CP E06 Thyroiditis A E A ATORVASTATIN d04105A0 D E78.0 Pure hypercholesterolemia A@ E A LOSARTAN d03821A0 D* I10 Essential (primary) hypertension A@ E A METFORMIN d03807A0 C E11 Type 2 diabetes mellitus A@ E A OMEPRAZOLE d00325A0 D* K21 Gastro-esophageal reflux disease A@ E A CEPHALEXIN d00096A Ap L08.9 Local infection of the skin and subcutaneous tissue, unspecified A E A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E A ONDANSETRON d00867A C- R11 Nausea and vomiting A E A PANTOPRAZOLE d04514A C- K30 Functional dyspepsia A E 0 A . . . E @ A . . . E P A . . . E ` A . . . E p A 99999 . . A E A LISINOPRIL d00732A C I50.9 Heart failure, unspecified A E A MESALAMINE d01031A C K51 Ulcerative colitis A E A ATAZANAVIR d04882A D B20 Human immunodeficiency virus [HIV] disease A@ E A ESCITALOPRAM d04812A C- F41.9 Anxiety disorder, unspecified A@ E A LAMIVUDINE; ZIDOVUDINE d04219A D B20 Human immunodeficiency virus [HIV] disease A@ E A QUETIAPINE d04220A C F29 Unspecified psychosis not due to a substance or known physiological condition A@ E A CARVEDILOL d03847A C I10 Essential (primary) hypertension A E A SIMVASTATIN d00746A C E78.0P Prevent high cholesterol A E A AMOXICILLIN d00088A A@ J02 Acute pharyngitis A E A . . . E A . . . E A . . . E A CLOTRIMAZOLE TOPICAL d04395A A0 B35 Dermatophytosis A E A . . . E A METHADONE d00050A C- F11.23 Opioid dependence with withdrawal A E A FENOFIBRATE d04286A C- E78.0 Pure hypercholesterolemia A E A METFORMIN d03807A C E11 R73 Type 2 diabetes mellitus Elevated blood glucose level A E 0 A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified A E 0 A VALACYCLOVIR d03838A C B00.1 Herpesviral vesicular dermatitis A E @ A . . . E P A . . . E ` A . . . E p A FLUTICASONE d01296A B[ R06.2 Wheezing A0 E p A MONTELUKAST d04289A B R06.2 R06.9 Wheezing Unspecified abnormalities of breathing A0 E p A RANITIDINE d00021A B K21 Gastro-esophageal reflux disease A0 E A . . . E A AMLODIPINE; OLMESARTAN d06905A C[@ I10 Essential (primary) hypertension A0 E A METHYLDOPA d00133A C[@ I10 Essential (primary) hypertension A0 E A ROSUVASTATIN d04851A C[@ E78.0 Pure hypercholesterolemia A0 E A . . . E A . . . E A ACETAMINOPHEN; HYDROCODONE d03428A C P R52 Pain, unspecified A E A LISINOPRIL d00732A C[@ I10 Essential (primary) hypertension A E A AMLODIPINE d00689A CDp I10 Essential (primary) hypertension AP E A ENALAPRIL d00013A C I10 Essential (primary) hypertension AP E A HYDRALAZINE d00132A C[@ I10 Essential (primary) hypertension AP E A PRAVASTATIN d00348A Cr E78.0 Pure hypercholesterolemia AP E A TAMSULOSIN d04121A CDp I51.9P Prevent heart disease AP E A . . . E A . . . E A . . . E A . . . E A . . . E 0 A OMEPRAZOLE d00325A Ei K21 Gastro-esophageal reflux disease A@ E 0 A SERTRALINE d00880A C& F32.9 Major depressive disorder, single episode, unspecified A@ E 0 A SIMVASTATIN d00746A Ei E78.0 Pure hypercholesterolemia A@ E 0 A TRAMADOL d03826A B M25.5 Pain in joint A@ E @ A . . . E P A AMLODIPINE d00689A C I10 Essential (primary) hypertension A` E P A ATENOLOL d00004A D R00 Abnormalities of heart beat A` E P A CETIRIZINE d03827A Bz R09.81 Nasal congestion A` E P A EZETIMIBE d04824A D E78.0 Pure hypercholesterolemia A` E P A LISINOPRIL d00732A D I10 Essential (primary) hypertension A` E P A ROSUVASTATIN d04851A D* E78.0 Pure hypercholesterolemia A` E ` A . . . E p A AMOXICILLIN d00088A B K05.6 Periodontal disease, unspecified A` E p A CLOPIDOGREL d04258A B I51.9 Heart disease, unspecified A` E p A CLOTRIMAZOLE TOPICAL d04395A C R21 Rash and other nonspecific skin eruption A` E p A METOPROLOL d00134A Cr I10 Essential (primary) hypertension A` E p A OXYCODONE d00329A C- M25.5 M54 Pain in joint Dorsalgia A` E p A SIMVASTATIN d00746A C[@ E78.0 Pure hypercholesterolemia A` E A LATANOPROST OPHTHALMIC d04017A C- H40 Glaucoma A E A AMLODIPINE d00689A Ei 99999 A E A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A E A ETODOLAC d00851A Ei 99999 A E A FINASTERIDE d00563A Ei 99999 A E A FLUTICASONE; SALMETEROL d04611A Ei 99999 A E A FUROSEMIDE d00070A Ei 99999 A E A PREDNISONE d00350A Ei 99999 A E A RIVAROXABAN d07356A C[@ 55555 A E A SERTRALINE d00880A Ei F39 Unspecified mood [affective] disorder A E A TRAMADOL d03826A Ei 99999 A E A ZOLPIDEM d00910A Dc G47.9 Sleep disorder, unspecified A E A METRONIDAZOLE d00108A AP B99.9 Unspecified infectious disease A E A . . . E A ALBUTEROL d00749A C J44.9 J45 Chronic obstructive pulmonary disease, unspecified Asthma A E A ALBUTEROL d00749A C J44.9 J45 Chronic obstructive pulmonary disease, unspecified Asthma A E A BUDESONIDE; FORMOTEROL d04795A C ` J44.9 Chronic obstructive pulmonary disease, unspecified A E A CEPHALEXIN d00096A B= K04.7 Periapical abscess without sinus A E A FLUTICASONE NASAL d04283A C ` R09.81 Nasal congestion A E A HYDROCHLOROTHIAZIDE d00253A C"0 R60.9 Edema, unspecified A E A NIFEDIPINE d00051A C"0 R07.9 Chest pain, unspecified A E A POTASSIUM CHLORIDE d00345A C"0 99999 A E A PRAVASTATIN d00348A Bz E78.0 Pure hypercholesterolemia A E A . . . E A . . . E A RISPERIDONE d03180A C F20 Schizophrenia A E A DORZOLAMIDE; TIMOLOL OPHTHALMIC d04303A B H40 Glaucoma A E A PREDNISONE d00350A D' D89.9 Disorder involving the immune mechanism, unspecified A E A . . . E A . . . E 0 A ATENOLOL d00004A C I10 Essential (primary) hypertension A0 E 0 A LEVOTHYROXINE d00278A D E03.9 Hypothyroidism, unspecified A0 E 0 A OMEPRAZOLE d00325A C R12 Heartburn A0 E @ A . . . E P A BENAZEPRIL d00730A C I10 Essential (primary) hypertension A E P A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified A E ` A . . . E p A LISINOPRIL d00732A C"0 I10 Essential (primary) hypertension A E A AMPHETAMINE; DEXTROAMPHETAMINE d04035A Dc F90 Attention-deficit hyperactivity disorders A E A ACETAMINOPHEN; TRAMADOL d04766A DO M79.1 Myalgia A E A CARVEDILOL d03847A D I21.P Prevent heart attack/myocardial infarction A E A CIPROFLOXACIN d00011A C"@ A49.9P Prevent bacterial infection A E A CLOPIDOGREL d04258A D I21 ST elevation (STEMI) and non-ST elevation (NSTEMI) myocardial infarction A E A DULOXETINE d05355A C- F32.9 Major depressive disorder, single episode, unspecified A E A GABAPENTIN d03182A D M79.2 Neuralgia and neuritis, unspecified A E A INSULIN ASPART d04697A B E11 Type 2 diabetes mellitus A E A INSULIN ISOPHANE (NPH) d04370A B E11 Type 2 diabetes mellitus A E A METFORMIN d03807A D# R73 Elevated blood glucose level A E A NITROGLYCERIN d00321A C R07.9 Chest pain, unspecified A E A OMEPRAZOLE d00325A Dc K21 Gastro-esophageal reflux disease A E A PRAVASTATIN d00348A Dc E78.0 Pure hypercholesterolemia A E A RALOXIFENE d04261A D* C50.P Prevent breast cancer A E A VALSARTAN d04113A C- I10 Essential (primary) hypertension A E A AMLODIPINE d00689A Cr I10 Essential (primary) hypertension Ap E A CYCLOBENZAPRINE d00963A Bz M79.1 Myalgia Ap E A DAPAGLIFLOZIN d07928A B R73 Elevated blood glucose level Ap E A MONTELUKAST d04289A C[@ J30.9 J45 Allergic rhinitis, unspecified Asthma Ap E A ROSUVASTATIN d04851A C E78.0 Pure hypercholesterolemia Ap E A TELMISARTAN d04364A Cr I10 Essential (primary) hypertension Ap E A TRAMADOL d03826A Bz M25.5 Pain in joint Ap E A . . . E A DORZOLAMIDE; TIMOLOL OPHTHALMIC d04303A CDp H40 Glaucoma A E A LATANOPROST OPHTHALMIC d04017A C- H40 Glaucoma A E A METFORMIN d03807A C E11 Type 2 diabetes mellitus A E A . . . E A . . . E A . . . E A . . . E A AMLODIPINE d00689A Cr I10 Essential (primary) hypertension A0 E A ATORVASTATIN d04105A Cr E78.0P Prevent high cholesterol A0 E A LOSARTAN d03821A Cr I10 Essential (primary) hypertension A0 E 0 A AMOXICILLIN; CLAVULANATE d00089A A H66.9 Otitis media, unspecified A E @ A . . . E P A AMOXICILLIN d00088A A H66.9 Otitis media, unspecified A E ` Ap . . . E p A SULFAMETHOXAZOLE; TRIMETHOPRIM d00124A A@ L08.9 Local infection of the skin and subcutaneous tissue, unspecified A E A . . . E A . . . E A . . . E A ATORVASTATIN d04105A B E78.0 Pure hypercholesterolemia A E A . . . E A OSELTAMIVIR d04462A Ap J09 Influenza due to certain identified influenza viruses A E A . . . E A . . . E A . . . E A . . . E A OSELTAMIVIR d04462A AP J09 Influenza due to certain identified influenza viruses A E 0 A . . . E @ A . . . E P A . . . E ` A . . . E p A . . . E A . . . E A AMOXICILLIN; CLAVULANATE d00089A A K04.7 Periapical abscess without sinus A E A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia AP E A LISINOPRIL d00732A C I10 Essential (primary) hypertension AP E A METFORMIN d03807A Cr E11 Type 2 diabetes mellitus AP E A OMEPRAZOLE d00325A C K21 Gastro-esophageal reflux disease AP E A RANITIDINE d00021A B K21 Gastro-esophageal reflux disease AP E A ATENOLOL d00004A D I10 Essential (primary) hypertension A E A BUPRENORPHINE d00840A Bz R52 Pain, unspecified A E A CANAGLIFLOZIN d08080A Cr E11 Type 2 diabetes mellitus A E A CLOPIDOGREL d04258A D= D75.9P Prevent blood clots A E A GLIMEPIRIDE d03864A D E11 Type 2 diabetes mellitus A E A LEVOTHYROXINE d00278A D* E03.9 Hypothyroidism, unspecified A E A LISINOPRIL d00732A D= I51.9P Prevent heart disease A E A PREGABALIN d05508A C M79.7 Fibromyalgia A E A ROPINIROLE d04215A B R25.2 Cramp and spasm A E A ROSUVASTATIN d04851A C M79.6 Pain in limb, hand, foot, fingers and toes A E A SERTRALINE d00880A C- F32.9 F41.9 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified A E A SITAGLIPTIN d05896A C E11 Type 2 diabetes mellitus A E A TRAZODONE d00395A B= G47.9 Sleep disorder, unspecified A E A . . . E A FLUTICASONE NASAL d04283A C J30.1 J30.9 Allergic rhinitis due to pollen Allergic rhinitis, unspecified A E A ACETAMINOPHEN; HYDROCODONE d03428A D T14.9 Unspecified injury A E A AMLODIPINE d00689A Dc I10 Essential (primary) hypertension A E A CLONIDINE d00044A CP I10 Essential (primary) hypertension A E A HYDROCHLOROTHIAZIDE d00253A B I10 Essential (primary) hypertension A E A INSULIN ASPART d04697A Dc E11 Type 2 diabetes mellitus A E A INSULIN GLARGINE d04538A Dc E11 Type 2 diabetes mellitus A E A LINAGLIPTIN d07767A Cr R73 Elevated blood glucose level A E A LISINOPRIL d00732A C I10 Essential (primary) hypertension A E A OMEPRAZOLE d00325A Cr K21 Gastro-esophageal reflux disease A E A TRAZODONE d00395A C G47.9 Sleep disorder, unspecified A E A . . . E A BENZONATATE d00796A B R05 Cough A E A CLONAZEPAM d00197A Cr G47.0 Insomnia A E A CODEINE; GUAIFENESIN d03393A B R05 Cough A E A ELUXADOLINE d08401A C"0 R19.7 Diarrhea, unspecified A E A ESCITALOPRAM d04812A C[@ F41.9 Anxiety disorder, unspecified A E A EZETIMIBE d04824A B E78.0 Pure hypercholesterolemia A E A FLUTICASONE NASAL d04283A C[@ J30.2 Other seasonal allergic rhinitis A E A FLUVOXAMINE d03804A Cr F41.9 Anxiety disorder, unspecified A E A IBUPROFEN d00015A B M13 Other arthritis A E A LIRAGLUTIDE d07466A B E11 Type 2 diabetes mellitus A E A LISINOPRIL d00732A C I10 Essential (primary) hypertension A E A METFORMIN d03807A C E11 Type 2 diabetes mellitus A E A OMEPRAZOLE d00325A C[@ K21 Gastro-esophageal reflux disease A E A ROSUVASTATIN d04851A C E78.0 Pure hypercholesterolemia A E A TRAMADOL d03826A C- M25.5 T14.9 Pain in joint Unspecified injury A E A ALBUTEROL d00749A A J98.9 Respiratory disorder, unspecified A E A BUDESONIDE d04276A A R05 R06.9 Cough Unspecified abnormalities of breathing A E A . . . E 0 A RANITIDINE d00021A B= K21 Gastro-esophageal reflux disease A E @ A . . . E P A CYCLOBENZAPRINE d00963A CDp M79.1 Myalgia A E P A DAPAGLIFLOZIN d07928A C E11 Type 2 diabetes mellitus A E P A FUROSEMIDE d00070A C"0 55555 A E P A INSULIN DEGLUDEC d08054A C[@ E11 Type 2 diabetes mellitus A E P A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified A E P A MELOXICAM d04532A C- M79.1 Myalgia A E P A OMEPRAZOLE d00325A C R12 Heartburn A E P A SERTRALINE d00880A C- F39 Unspecified mood [affective] disorder A E P A SIMVASTATIN d00746A C- E78.0 Pure hypercholesterolemia A E ` A . . . E p A GABAPENTIN d03182A CDp M79.2 Neuralgia and neuritis, unspecified A E A ATORVASTATIN d04105A D E78.0 Pure hypercholesterolemia A0 E A CARVEDILOL d03847A B I10 I21.P Essential (primary) hypertension Prevent heart attack/myocardial infarction A0 E A CLOPIDOGREL d04258A B I80.3 Phlebitis and thrombophlebitis of lower extremities, unspecified A0 E A ATORVASTATIN d04105A CDp K21 Gastro-esophageal reflux disease A@ E A LABETALOL d00016A Cr I10 Essential (primary) hypertension A@ E A LOSARTAN d03821A C[@ I10 Essential (primary) hypertension A@ E A PANTOPRAZOLE d04514A CDp K21 Gastro-esophageal reflux disease A@ E A . . . E A . . . E A . . . E A . . . E A METHYLPHENIDATE d00900A C F90 Attention-deficit hyperactivity disorders A E A . . . E A ALBUTEROL d00749A Dc J45 R06.2 R07.9 Asthma Wheezing Chest pain, unspecified A E A AMLODIPINE d00689A C- I10 Essential (primary) hypertension A@ E A BUSPIRONE d00182A B F41.9 Anxiety disorder, unspecified A@ E A METFORMIN d03807A C- E11 Type 2 diabetes mellitus A@ E A METOPROLOL d00134A C- I10 Essential (primary) hypertension A@ E A . . . E 0 A . . . E @ A . . . E P A AMLODIPINE d00689A0 Cr I10 Essential (primary) hypertension A E P A CLONIDINE d00044A0 Cr I10 Essential (primary) hypertension A E P A FLUTICASONE NASAL d04283A0 C R09.81 Nasal congestion A E P A HYDROCHLOROTHIAZIDE; LOSARTAN d03830A0 Cr I10 Essential (primary) hypertension A E P A LATANOPROST OPHTHALMIC d04017A0 Cr H40 Glaucoma A E P A METFORMIN d03807A0 Cr E11 Type 2 diabetes mellitus A E P A OMEPRAZOLE d00325A0 Cr K30 Functional dyspepsia A E P A POTASSIUM CHLORIDE d00345A0 Cr E87.6 I49.9 Hypokalemia Cardiac arrhythmia, unspecified A E ` A NYSTATIN d01233A B B37 Candidiasis A E p A . . . E A . . . E A CLONIDINE d00044A C- I10 Essential (primary) hypertension Ap E A GLIMEPIRIDE d03864A D R73 Elevated blood glucose level Ap E A LISINOPRIL d00732A D I10 Essential (primary) hypertension Ap E A METFORMIN d03807A D R73 Elevated blood glucose level Ap E A METOPROLOL d00134A D I50.9 Heart failure, unspecified Ap E A TAMSULOSIN d04121A C N40 Enlarged prostate Ap E A TRAZODONE d00395A C G47.0 Insomnia Ap E A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E 0 A AMLODIPINE d00689A C I10 Essential (primary) hypertension AP E 0 A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia AP E 0 A LISINOPRIL d00732A C E11.2P I10 Prevent diabetic kidney disease Essential (primary) hypertension AP E 0 A METOPROLOL d00134A C I10 Essential (primary) hypertension AP E 0 A PROPAFENONE d00358A C I48.9 Unspecified atrial fibrillation and atrial flutter AP E @ A . . . E P A . . . E ` A AMLODIPINE d00689A B I10 Essential (primary) hypertension A E ` A CEFUROXIME d00056A A J06.9 Acute upper respiratory infection, unspecified A E p A DICLOFENAC d00848A0 B M25.5 Pain in joint A` E p A LISINOPRIL d00732A0 Cr I10 Essential (primary) hypertension A` E p A MELOXICAM d04532A0 C M25.5 M79.1 Pain in joint Myalgia A` E p A SIMVASTATIN d00746A0 Cr E78.0P Prevent high cholesterol A` E p A TEMAZEPAM d00384A0 C G47.0 Insomnia A` E p A TRIAMCINOLONE TOPICAL d03206A0 C B35 Dermatophytosis A` E A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E A ALENDRONATE d03849A C M81 Osteoporosis without current pathological fracture A E A SIMVASTATIN d00746A Cr E78.0 Pure hypercholesterolemia A E A . . . E A AMLODIPINE d00689A Cr I10 Essential (primary) hypertension Ap E A BICALUTAMIDE d03850A C C61 Malignant neoplasm of prostate Ap E A LISINOPRIL d00732A D* I10 Essential (primary) hypertension Ap E A METFORMIN d03807A C[@ E11 Type 2 diabetes mellitus Ap E A NEBIVOLOL d05265A Cr I10 Essential (primary) hypertension Ap E A ROSUVASTATIN d04851A D E78.0 Pure hypercholesterolemia Ap E A SERTRALINE d00880A C- F32.9 Major depressive disorder, single episode, unspecified Ap E 0 A ACETAMINOPHEN; CODEINE d03423A B M25.5 Pain in joint A0 E 0 A AMLODIPINE d00689A C I10 Essential (primary) hypertension A0 E 0 A OMEPRAZOLE d00325A D K21 Gastro-esophageal reflux disease A0 E @ A ARIPIPRAZOLE d04825A C- F39 F99 Unspecified mood [affective] disorder Mental disorder, not otherwise specified A E @ A ESCITALOPRAM d04812A C F32.9 Major depressive disorder, single episode, unspecified A E P A INSULIN GLARGINE d04538A C E10 Type 1 diabetes mellitus A E P A INSULIN LISPRO d04373A CDp E10 Type 1 diabetes mellitus A E ` A . . . E p A . . . E A . . . E A LOSARTAN d03821A C[@ I10 Essential (primary) hypertension A E A OMEPRAZOLE d00325A B= K27 Peptic ulcer, site unspecified A E A METHYLPHENIDATE d00900A B F90 Attention-deficit hyperactivity disorders A E A . . . E A . . . E A 77777 . . A E A . . . E A ACETAMINOPHEN; HYDROCODONE d03428A C M13 M79.2 M79.6 Other arthritis Neuralgia and neuritis, unspecified Pain in limb, hand, foot, fingers and toes Ap E A CITALOPRAM d04332A C F32.9 Major depressive disorder, single episode, unspecified Ap E A DICYCLOMINE d00999A C K58 Irritable bowel syndrome Ap E A FINASTERIDE d00563A C N40 Enlarged prostate Ap E A GABAPENTIN d03182A C G43 Migraine Ap E A OMEPRAZOLE d00325A C K58 Irritable bowel syndrome Ap E A TAMSULOSIN d04121A C N40 Enlarged prostate Ap E A AMLODIPINE d00689A B= I10 Essential (primary) hypertension A@ E A GABAPENTIN d03182A B M79.6 Pain in limb, hand, foot, fingers and toes A@ E A INDOMETHACIN d00039A D ^ M10.9 Gout, unspecified A@ E A OLMESARTAN d04801A B= I10 Essential (primary) hypertension A@ E A . . . E A ATENOLOL d00004A D I10 Essential (primary) hypertension A@ E A HYDROCHLOROTHIAZIDE d00253A DO I10 Essential (primary) hypertension A@ E A LEVOTHYROXINE d00278A Cr E03.9 Hypothyroidism, unspecified A@ E A PRAVASTATIN d00348A DO E78.0 Pure hypercholesterolemia A@ E 0 A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A C I10 Essential (primary) hypertension A@ E 0 A LEVOTHYROXINE d00278A D E03.9 Hypothyroidism, unspecified A@ E 0 A METFORMIN d03807A C- E11 Type 2 diabetes mellitus A@ E 0 A SERTRALINE d00880A C F32.9 Major depressive disorder, single episode, unspecified A@ E @ A ALBUTEROL d00749A B R06.9P Prevent breathing difficulty A@ E @ A BUPRENORPHINE; NALOXONE d04819A B[ F11.23 Opioid dependence with withdrawal A@ E @ A GABAPENTIN d03182A C M79.2 Neuralgia and neuritis, unspecified A@ E @ A IBUPROFEN d00015A B M54 T14.9 Dorsalgia Unspecified injury A@ E P A . . . E ` A . . . E p A . . . E A AMIODARONE d00002A D I51.9 Heart disease, unspecified A E A AMLODIPINE d00689A B I10 Essential (primary) hypertension A E A APIXABAN d07804A C- I51.9P Prevent heart disease A E A ATORVASTATIN d04105A C- E78.0 Pure hypercholesterolemia A E A BENZONATATE d00796A A R05 R09.3 Cough Abnormal sputum A E A DICLOFENAC TOPICAL d04722A C M25.5 M79.6 Pain in joint Pain in limb, hand, foot, fingers and toes A E A DONEPEZIL d04099A C R41 Other symptoms and signs involving cognitive functions and awareness A E A GABAPENTIN d03182A A M25.5 M79.6 Pain in joint Pain in limb, hand, foot, fingers and toes A E A HYDROCHLOROTHIAZIDE d00253A C I51.9 Heart disease, unspecified A E A PANTOPRAZOLE d04514A C K31.9 Disease of stomach and duodenum, unspecified A E A POTASSIUM CHLORIDE d00345A C- R60.9 Edema, unspecified A E A . . . E A . . . E A PAROXETINE d03157A C F32.9 F41.9 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified A E A APIXABAN d07804A Cr D75.9P Prevent blood clots A E A ATORVASTATIN d04105A Cr E78.0 Pure hypercholesterolemia A E A AZITHROMYCIN d00091A AP Z79 Long term (current) drug therapy A E A BUMETANIDE d00179A Cr I50.9 Heart failure, unspecified A E A CARVEDILOL d03847A Cr I50.9 Heart failure, unspecified A E A IPRATROPIUM NASAL d04235A C R09.81 Nasal congestion A E A LISINOPRIL d00732A Cr I50.9 Heart failure, unspecified A E A METFORMIN d03807A Cr E11 Type 2 diabetes mellitus A E A MONTELUKAST d04289A B R06.9 Unspecified abnormalities of breathing A E A TAMSULOSIN d04121A C N32.9 Bladder disorder, unspecified A E A . . . E A . . . E A . . . E A . . . E A ATORVASTATIN d04105A Ei 99999 A E A CLOPIDOGREL d04258A Ei 99999 A E A FUROSEMIDE d00070A Ei 99999 A E A GABAPENTIN d03182A Ei 99999 A E A GLIMEPIRIDE d03864A Ei 99999 A E A INSULIN GLARGINE d04538A Ei 99999 A E A LOSARTAN d03821A Ei 99999 A E A METOPROLOL d00134A Ei 99999 A E A SITAGLIPTIN d05896A Ei 99999 A E A . . . E 0 A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A E 0 A LEVOTHYROXINE d00278A D E03.9 Hypothyroidism, unspecified A E @ A ALBUTEROL d00749A C R06.9P Prevent breathing difficulty AP E @ A AMITRIPTYLINE d00146A C[@ G47.0 Insomnia AP E @ A FUROSEMIDE d00070A C[@ J98.9 R60.9 Respiratory disorder, unspecified Edema, unspecified AP E @ A LINACLOTIDE d07902A C K58 K59.0 Irritable bowel syndrome Constipation AP E @ A POTASSIUM CHLORIDE d00345A CDp R25.2 Cramp and spasm AP E P A . . . E ` A ALLOPURINOL d00023A B M1A Chronic gout A@ E ` A GLIMEPIRIDE d03864A Dc E11 Type 2 diabetes mellitus A@ E ` A LISINOPRIL d00732A Dc E11 Type 2 diabetes mellitus A@ E ` A METFORMIN d03807A Dc E11.P Prevent diabetes A@ E p A . . . E A CIPROFLOXACIN d00011A CDp N39.0 Urinary tract infection, site not specified A@ E A NORETHINDRONE d00555A CDp Z79.3 Long term (current) use of hormonal contraceptives A@ E A PAROXETINE d03157A CDp F32.9 Major depressive disorder, single episode, unspecified A@ E A SPIRONOLACTONE d00373A Cr L70 Acne A@ E A . . . E A AMLODIPINE d00689A D I10 Essential (primary) hypertension AP E A LISINOPRIL d00732A D I10 Essential (primary) hypertension AP E A METFORMIN d03807A C 99999 AP E A PRAVASTATIN d00348A D E78.0 Pure hypercholesterolemia AP E A TAMSULOSIN d04121A Ap R35 Polyuria AP E A ALBUTEROL d00749A Cr J44.9 Chronic obstructive pulmonary disease, unspecified A E A ALLOPURINOL d00023A C E79.9 M10.9 Disorder of purine and pyrimidine metabolism, unspecified Gout, unspecified A E A AMLODIPINE d00689A Ei I10 Essential (primary) hypertension A E A ATORVASTATIN d04105A Ei E78.0 Pure hypercholesterolemia A E A ESTRADIOL d00537A Dc Z79.890 Hormone replacement therapy A E A FUROSEMIDE d00070A C R60.9 Edema, unspecified A E A IPRATROPIUM d00265A C J44.9 Chronic obstructive pulmonary disease, unspecified A E A LEVOTHYROXINE d00278A D E03.9 Hypothyroidism, unspecified A E A LORAZEPAM d00149A C- F41.9 G47.0 Anxiety disorder, unspecified Insomnia A E A POTASSIUM CHLORIDE d00345A Ei E87.6 Hypokalemia A E A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E 0 A . . . E @ A . . . E P A . . . E ` A LISINOPRIL d00732A B I10 Essential (primary) hypertension A E p A CARVEDILOL d03847A Dc I51.9 Heart disease, unspecified Ap E p A DIGOXIN d00210A Dc I51.9 Heart disease, unspecified Ap E p A ENALAPRIL d00013A Dc I10 Essential (primary) hypertension Ap E p A FUROSEMIDE d00070A Dc I50.9 I51.9 Heart failure, unspecified Heart disease, unspecified Ap E p A HYDROXYZINE d00907A Dc I10 Essential (primary) hypertension Ap E p A OMEPRAZOLE d00325A CDp K21 Gastro-esophageal reflux disease Ap E p A POTASSIUM IODIDE d00800A Dc I51.9 Heart disease, unspecified Ap E A . . . E A . . . E A . . . E A ALBUTEROL d00749A C J44.9 Chronic obstructive pulmonary disease, unspecified A E A BUDESONIDE; FORMOTEROL d04795A CDp J44.9 Chronic obstructive pulmonary disease, unspecified A E A BUPROPION d00181A B F17.2 Nicotine dependence A E A FLUTICASONE d01296A C[@ J44.9 Chronic obstructive pulmonary disease, unspecified A E A FLUTICASONE NASAL d04283A C 99999 A E A METOPROLOL d00134A CP R00 Abnormalities of heart beat A E A MONTELUKAST d04289A CP J44.9 Chronic obstructive pulmonary disease, unspecified A E A OXYBUTYNIN d00328A B N32.81 Overactive bladder A E A PREDNISONE d00350A CDp J44.9 Chronic obstructive pulmonary disease, unspecified A E A SERTRALINE d00880A Bz F43.1 Post-traumatic stress disorder (PTSD) A E A ACETAMINOPHEN; HYDROCODONE d03428A Cr M54 Dorsalgia A E A ALLOPURINOL d00023A Ei M1A Chronic gout A E A ALPRAZOLAM d00168A C G47.0 Insomnia A E A ATORVASTATIN d04105A Ei 99999 A E A DOXAZOSIN d00726A Cr I10 R35 Essential (primary) hypertension Polyuria A E A FUROSEMIDE d00070A Ei I51.9 R60.9 Heart disease, unspecified Edema, unspecified A E A LEVOTHYROXINE d00278A Ei 99999 A E A MEMANTINE d04899A B R41 Other symptoms and signs involving cognitive functions and awareness A E A METOPROLOL d00134A Ei 99999 A E A RIVAROXABAN d07356A C I48.9 Unspecified atrial fibrillation and atrial flutter A E A HYDROCHLOROTHIAZIDE; LOSARTAN d03830A C I10 Essential (primary) hypertension A@ E A OMEPRAZOLE d00325A A R12 Heartburn A@ E A PIOGLITAZONE d04442A C E11 Type 2 diabetes mellitus A@ E A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia A@ E A . . . E A . . . E A AMLODIPINE d00689A Bz I10 Essential (primary) hypertension A E A AMPHETAMINE; DEXTROAMPHETAMINE d04035A Cr F43.1 F90 Post-traumatic stress disorder (PTSD) Attention-deficit hyperactivity disorders A E A BUPRENORPHINE d00840A CDp R52 Pain, unspecified A E A DICLOFENAC d00848A C- R52 Pain, unspecified A E A ESCITALOPRAM d04812A B< R52 Pain, unspecified A E A LEVOTHYROXINE d00278A D# E03.9 Hypothyroidism, unspecified A E A METOPROLOL d00134A Dc I10 Essential (primary) hypertension A E A PREGABALIN d05508A Dc M79.2 Neuralgia and neuritis, unspecified A E A ROSUVASTATIN d04851A B[ E78.0 Pure hypercholesterolemia A E A . . . E 0 A . . . E @ A AMLODIPINE d00689A Cr I10 Essential (primary) hypertension A E @ A CARBIDOPA; LEVODOPA d03473A C- G20 Parkinson's disease A E @ A CARVEDILOL d03847A C I10 Essential (primary) hypertension A E @ A DULOXETINE d05355A CDp F41.9 Anxiety disorder, unspecified A E @ A EZETIMIBE d04824A C E78.0 Pure hypercholesterolemia A E @ A LOSARTAN d03821A C I10 Essential (primary) hypertension A E @ A MEMANTINE d04899A Cr G31.9 Degenerative disease of nervous system, unspecified A E @ A TAMSULOSIN d04121A C R35 Polyuria A E P A NAPROXEN d00019A B G43 Migraine A E ` A . . . E p A . . . E A . . . E A HYDROCORTISONE TOPICAL d03205A B L20.9 Atopic dermatitis, unspecified A E A TIMOLOL OPHTHALMIC d04037A B 55555 A E A . . . E A . . . E A . . . E A . . . E A INSULIN LISPRO d04373A C[@ E10 Type 1 diabetes mellitus A E A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified A@ E A PENTOSAN POLYSULFATE SODIUM d04052A B N30 Cystitis A@ E A RIVAROXABAN d07356A CDp D75.9P Prevent blood clots A@ E A TOPIRAMATE d04115A C G40 Epilepsy and recurrent seizures A@ E A . . . E A . . . E A AZITHROMYCIN d00091A A J18.9 J40 Pneumonia, unspecified organism Bronchitis, not specified as acute or chronic A E A PREDNISONE d00350A A J40 Bronchitis, not specified as acute or chronic A E 0 A ATORVASTATIN d04105A B E78.0 Pure hypercholesterolemia A@ E 0 A GLIPIZIDE d00246A B E11 Type 2 diabetes mellitus A@ E 0 A LOSARTAN d03821A B I10 Essential (primary) hypertension A@ E 0 A SITAGLIPTIN d05896A B E11 Type 2 diabetes mellitus A@ E @ A LEVOTHYROXINE d00278A D E03.9 Hypothyroidism, unspecified A E P A . . . E ` A . . . E p A ADALIMUMAB d04835A C 55555 A E p A CELECOXIB d04380A C 55555 A E A . . . E A . . . E A . . . E A FLUTICASONE NASAL d04283A CDp J30.9 Allergic rhinitis, unspecified A E A MONTELUKAST d04289A CDp J30.9 Allergic rhinitis, unspecified A E A CLONAZEPAM d00197A C F41.9 G47.0 Anxiety disorder, unspecified Insomnia A0 E A LISDEXAMFETAMINE d06663A D F90 Attention-deficit hyperactivity disorders A0 E A ROPINIROLE d04215A C[@ G25.81 Restless legs syndrome A0 E A ETHINYL ESTRADIOL; NORETHINDRONE d03238A CDp N92 Z79.3 Excessive, frequent and irregular menstruation Long term (current) use of hormonal contraceptives A E A . . . E A . . . E A GABAPENTIN d03182A C M79.2 Neuralgia and neuritis, unspecified A@ E A QUETIAPINE d04220A Cr G47.0 G47.9 Insomnia Sleep disorder, unspecified A@ E A SILDENAFIL d04299A C- N52.9 Male erectile dysfunction, unspecified A@ E A TIMOLOL OPHTHALMIC d04037A C H40 Glaucoma A@ E A . . . E A ATOMOXETINE d04827A C- F90 Attention-deficit hyperactivity disorders A E A KETOCONAZOLE TOPICAL d03202A C 55555 A E 0 A . . . E @ A . . . E P A . . . E ` A DILTIAZEM d00045A C I10 Essential (primary) hypertension A@ E ` A HYDROCHLOROTHIAZIDE; TRIAMTERENE d03052A B= R60.9 Edema, unspecified A@ E ` A PRAVASTATIN d00348A Ei E78.0 Pure hypercholesterolemia A@ E ` A TAMSULOSIN d04121A C N40 Enlarged prostate A@ E p A . . . E A 55555 A Bz R00 Abnormalities of heart beat A0 E A PROPRANOLOL d00032A Bz E05 Thyrotoxicosis [hyperthyroidism] A0 E A TRAMADOL d03826A B[ E07.9 Disorder of thyroid, unspecified A0 E A . . . E A . . . E A 99999 . . A E A PHENDIMETRAZINE d00809A Cr E66 Overweight and obesity A E A TRAZODONE d00395A CDp G47.0 Insomnia A E A . . . E A METFORMIN d03807A CDp E11 Type 2 diabetes mellitus A E A . . . E A . . . E A . . . E A . . . E 0 A ALBUTEROL d00749A C R06.02 Shortness of breath A E 0 A ALLOPURINOL d00023A Cr M10.9P Prevent gout A E 0 A CARVEDILOL d03847A Cr R60.9 Edema, unspecified A E 0 A DIGOXIN d00210A Cr I50.9 Heart failure, unspecified A E 0 A FUROSEMIDE d00070A Cr R60.9 Edema, unspecified A E 0 A INSULIN GLARGINE d04538A C- E11 Type 2 diabetes mellitus A E 0 A METFORMIN d03807A Cr E11 Type 2 diabetes mellitus A E 0 A OXYGEN a54115A C J43 Emphysema A E 0 A SPIRONOLACTONE d00373A Cr I51.9 Heart disease, unspecified A E 0 A WARFARIN d00022A Cr D75.9P Prevent blood clots A E @ A . . . E P A CLONIDINE d00044A A I10 Essential (primary) hypertension AP E P A HYDROCHLOROTHIAZIDE d00253A A0 I10 Essential (primary) hypertension AP E P A INSULIN ISOPHANE (NPH) d04370A B E11 Type 2 diabetes mellitus AP E P A LOSARTAN d03821A C I10 Essential (primary) hypertension AP E P A METFORMIN d03807A B[ E11 Type 2 diabetes mellitus AP E ` A . . . E p A . . . E A AMLODIPINE d00689A C[@ I10 Essential (primary) hypertension A E A HYDROCHLOROTHIAZIDE d00253A Cr I10 Essential (primary) hypertension A E A LANSOPRAZOLE d03828A D K30 Functional dyspepsia A E A LORAZEPAM d00149A D G47.9 Sleep disorder, unspecified A E A OLMESARTAN d04801A CDp I10 Essential (primary) hypertension A E A PRAVASTATIN d00348A C E78.0 Pure hypercholesterolemia A E A RIVAROXABAN d07356A C I80.3 Phlebitis and thrombophlebitis of lower extremities, unspecified A E A SERTRALINE d00880A C F32.9 Major depressive disorder, single episode, unspecified A E A NITROFURANTOIN d00112A Ap N39.0 Urinary tract infection, site not specified A E A AMPHETAMINE; DEXTROAMPHETAMINE d04035A B F90 R41 Attention-deficit hyperactivity disorders Other symptoms and signs involving cognitive functions and awareness A0 E A CLONIDINE d00044A C G47.0 Insomnia A0 E A DEXTROAMPHETAMINE d00804A B F90 Attention-deficit hyperactivity disorders A0 E A AMOXICILLIN d00088A A H66.9 Otitis media, unspecified A E A AMLODIPINE d00689A B[ I10 Essential (primary) hypertension Ap E A EMPAGLIFLOZIN d08275A B E11 Type 2 diabetes mellitus Ap E A GLIPIZIDE d00246A CDp E11 Type 2 diabetes mellitus Ap E A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified Ap E A LOVASTATIN d00280A Cr E78.0 Pure hypercholesterolemia Ap E A METFORMIN d03807A C E11 Type 2 diabetes mellitus Ap E A TAMSULOSIN d04121A B[ N40 Enlarged prostate Ap E A . . . E A HYDROCHLOROTHIAZIDE d00253A CDp I10 Essential (primary) hypertension A E A LISINOPRIL d00732A CDp I10 Essential (primary) hypertension A E A ETHINYL ESTRADIOL; NORETHINDRONE d03238A Bz N92 Excessive, frequent and irregular menstruation A E A ACETAMINOPHEN; HYDROCODONE d03428A B M54 M79.6 Dorsalgia Pain in limb, hand, foot, fingers and toes A E A APIXABAN d07804A C Z79.0 Long term (current) use of anticoagulants and antithrombotics/antiplatelets A E A FAMOTIDINE d00141A C 99999 A E A FINASTERIDE d00563A Ei 99999 A E A FUROSEMIDE d00070A Ei 99999 A E A GABAPENTIN d03182A B E11.4 M79.2 Type 2 diabetes mellitus with neurological complications Neuralgia and neuritis, unspecified A E A INSULIN DETEMIR d05436A B R73 Elevated blood glucose level A E A ISOSORBIDE MONONITRATE d00269A C 99999 A E A METOPROLOL d00134A C I10 Essential (primary) hypertension A E A NITROGLYCERIN d00321A C R07.9 Chest pain, unspecified A E A POTASSIUM CHLORIDE d00345A C E87.6P Prevent hypokalemia A E A PRASUGREL d07409A Ei 99999 A E A SIMVASTATIN d00746A Ei 99999 A E A TAMSULOSIN d04121A Ei 99999 A E A TRAMADOL d03826A B M54 M79.6 Dorsalgia Pain in limb, hand, foot, fingers and toes A E A AMLODIPINE d00689A C[@ I10 Essential (primary) hypertension Ap E A CYCLOSPORINE d00079A C[@ T86.9P Prevent transplanted organ and tissue rejection Ap E A FLUDROCORTISONE d00608A C[@ I99.9 Unspecified disorder of circulatory system Ap E A LABETALOL d00016A C[@ I10 Essential (primary) hypertension Ap E A LEVOTHYROXINE d00278A C[@ E04 Other nontoxic goiter Ap E A MYCOPHENOLATE MOFETIL d03839A C[@ T86.9P Prevent transplanted organ and tissue rejection Ap E A PANTOPRAZOLE d04514A C[@ 99999 Ap E A ATORVASTATIN d04105A BZ 99999 A E 0 A . . . E @ A LEVOTHYROXINE d00278A D* E03.9 Hypothyroidism, unspecified A E @ A LISINOPRIL d00732A D I10 Essential (primary) hypertension A E P A BECLOMETHASONE d00760A CDp J45 Asthma A E P A FLUTICASONE NASAL d04283A CP J30.2 J30.9 Other seasonal allergic rhinitis Allergic rhinitis, unspecified A E ` A . . . E p A AMLODIPINE d00689A D I10 Essential (primary) hypertension A@ E p A CARVEDILOL d03847A Dc I10 Essential (primary) hypertension A@ E p A FLUTICASONE NASAL d04283A Cr J30.1 J30.2 Allergic rhinitis due to pollen Other seasonal allergic rhinitis A@ E p A HYDROCHLOROTHIAZIDE d00253A Cr I10 Essential (primary) hypertension A@ E A KETOROLAC d00273A A N20.0 Calculus of kidney A E A TAMSULOSIN d04121A A R32 Unspecified urinary incontinence A E A . . . E A . . . E A LISINOPRIL d00732A C 99999 A@ E A METFORMIN d03807A Dc E11 Type 2 diabetes mellitus A@ E A RANITIDINE d00021A C 99999 A@ E A SIMVASTATIN d00746A Cr E78.0 Pure hypercholesterolemia A@ E A . . . E A . . . E A . . . E A ETONOGESTREL d04772A CDp Z79.3 Long term (current) use of hormonal contraceptives A E A . . . E A OSELTAMIVIR d04462A A0 J09 Influenza due to certain identified influenza viruses A E A PROPRANOLOL d00032A C- R00 Abnormalities of heart beat A0 E A VALACYCLOVIR d03838A A0 B02 Zoster [herpes zoster] A0 E A VENLAFAXINE d03181A C- F41.9 Anxiety disorder, unspecified A0 E 0 A . . . E @ A . . . E P A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A C I10 Essential (primary) hypertension A E ` A . . . E p A . . . E A AMOXICILLIN d00088A B J01.9 N30 Acute sinusitis, unspecified Cystitis Ap E A AMPHETAMINE d00803A Dc F90 Attention-deficit hyperactivity disorders Ap E A ETHINYL ESTRADIOL; NORETHINDRONE d03238A C Z79.3 Long term (current) use of hormonal contraceptives Ap E A LOSARTAN d03821A C- I10 Essential (primary) hypertension Ap E A MONTELUKAST d04289A C- J30.9 R05 Allergic rhinitis, unspecified Cough Ap E A VENLAFAXINE d03181A C F41.9 Anxiety disorder, unspecified Ap E A ZALEPLON d04452A B G47.9 Sleep disorder, unspecified Ap E A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A E A LOSARTAN d03821A B[ I10 Essential (primary) hypertension A E A . . . E A . . . E A . . . E A ACETAMINOPHEN; HYDROCODONE d03428A A0 M54 Dorsalgia A` E A LEVOTHYROXINE d00278A D E03.9 Hypothyroidism, unspecified A` E A LISINOPRIL d00732A Dc I10 Essential (primary) hypertension A` E A MELOXICAM d04532A A M54 Dorsalgia A` E A PREDNISONE d00350A AP M54 Dorsalgia A` E A TIMOLOL OPHTHALMIC d04037A D H40 Glaucoma A` E A . . . E A . . . E A . . . E A . . . E A ALLOPURINOL d00023A Cr E79.9 Disorder of purine and pyrimidine metabolism, unspecified A E A DABIGATRAN d07137A C[@ D75.9P Prevent blood clots A E A DIGOXIN d00210A Cr I49.9 Cardiac arrhythmia, unspecified A E A FLUTICASONE; VILANTEROL d08100A C J44.9 Chronic obstructive pulmonary disease, unspecified A E A HYDROCHLOROTHIAZIDE d00253A Cr I10 Essential (primary) hypertension A E A LABETALOL d00016A Cr I10 Essential (primary) hypertension A E A LOSARTAN d03821A C I10 Essential (primary) hypertension A E A OMEPRAZOLE d00325A Cr K21 Gastro-esophageal reflux disease A E 0 A . . . E @ A BENZOYL PEROXIDE; CLINDAMYCIN TOPICAL d04742A B[ L70 Acne A E @ A FLUORIDE TOPICAL d04397A B= K02 Dental caries A E P A . . . E ` A HYDROCHLOROTHIAZIDE d00253A D I10 Essential (primary) hypertension A E ` A METOPROLOL d00134A D I10 Essential (primary) hypertension A E p A BECLOMETHASONE d00760A CDp J45 Asthma A E p A MONTELUKAST d04289A Cr J30.9 Allergic rhinitis, unspecified A E A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E A AMLODIPINE d00689A B I10 Essential (primary) hypertension Ap E A GEMFIBROZIL d00245A B I63.P Prevent stroke Ap E A LORAZEPAM d00149A CDp F41.9 Anxiety disorder, unspecified Ap E A LOSARTAN d03821A C- I10 Essential (primary) hypertension Ap E A PIOGLITAZONE d04442A C E11 Type 2 diabetes mellitus Ap E A SIMVASTATIN d00746A B E78.0 Pure hypercholesterolemia Ap E A TESTOSTERONE d00558A C E29.1 Testicular hypofunction Ap E A . . . E A ACETAMINOPHEN; BUTALBITAL; CAFFEINE d03455A C- R51 Headache A0 E A CYCLOBENZAPRINE d00963A D M54 Dorsalgia A0 E A IBUPROFEN d00015A C- M54 Dorsalgia A0 E 0 A ESTRADIOL TOPICAL d04210A B Z79.890 Hormone replacement therapy A E @ A GLIMEPIRIDE d03864A C- E11 Type 2 diabetes mellitus Ap E @ A IRBESARTAN d04222A CDp I10 Essential (primary) hypertension Ap E @ A LINAGLIPTIN d07767A C E11 Type 2 diabetes mellitus Ap E @ A METFORMIN d03807A C E11 Type 2 diabetes mellitus Ap E @ A METOPROLOL d00134A C E11 Type 2 diabetes mellitus Ap E @ A NIFEDIPINE d00051A C- I10 Essential (primary) hypertension Ap E @ A OMEPRAZOLE d00325A C K30 Functional dyspepsia Ap E P A . . . E ` A ACETAMINOPHEN; HYDROCODONE d03428A C M54 Dorsalgia A E ` A AMLODIPINE d00689A B I10 Essential (primary) hypertension A E ` A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A E ` A CAPECITABINE d04311A B C80.1 Malignant (primary) neoplasm, unspecified A E ` A DULOXETINE d05355A C F32.9 F41.9 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified A E ` A HYDROCHLOROTHIAZIDE d00253A Dc I10 Essential (primary) hypertension A E ` A IBUPROFEN d00015A C M54 Dorsalgia A E ` A INSULIN ISOPHANE (NPH) d04370A Dc E11 Type 2 diabetes mellitus A E ` A INSULIN REGULAR d04369A Dc E11 Type 2 diabetes mellitus A E ` A LISINOPRIL d00732A C I10 Essential (primary) hypertension A E ` A METOPROLOL d00134A B I10 Essential (primary) hypertension A E ` A ONDANSETRON d00867A B R11.P Prevent nausea or vomiting A E ` A PROCHLORPERAZINE d00355A B R11 Nausea and vomiting A E ` A TEMOZOLOMIDE d04451A B C80.1 Malignant (primary) neoplasm, unspecified A E p A ALLOPURINOL d00023A D"8 M1A Chronic gout AP E p A GLIPIZIDE d00246A B E11 Type 2 diabetes mellitus AP E p A LISINOPRIL d00732A D E11.2P Prevent diabetic kidney disease AP E p A METFORMIN d03807A Dc E11 Type 2 diabetes mellitus AP E p A SIMVASTATIN d00746A Dc E78.0 Pure hypercholesterolemia AP E A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E A 99999 . . A E A . . . E A MONTELUKAST d04289A Ap J30.9 Allergic rhinitis, unspecified A E A VALACYCLOVIR d03838A Dc A60.9 Anogenital herpesviral infection, unspecified A E A . . . E A ALPRAZOLAM d00168A C[@ G47.9 Sleep disorder, unspecified AP E A DIVALPROEX SODIUM d03833A CDp G43 Migraine AP E A PANTOPRAZOLE d04514A C[@ K21 Gastro-esophageal reflux disease AP E A SERTRALINE d00880A C[@ F41.9 Anxiety disorder, unspecified AP E A SPIRONOLACTONE d00373A C R60.9 Edema, unspecified AP E 0 A CEFDINIR d04256A Ap T78.40 Allergy, unspecified A E 0 A FLUTICASONE NASAL d04283A Ap J30.9 Allergic rhinitis, unspecified A E @ A . . . E P A IRBESARTAN d04222A C I10 Essential (primary) hypertension A E P A ROSUVASTATIN d04851A C E78.0 Pure hypercholesterolemia A E ` A . . . E p A ACETAMINOPHEN; HYDROCODONE d03428A C- M54 Dorsalgia B E p A ALBUTEROL d00749A D* J45 Asthma B E p A ALPRAZOLAM d00168A C- F41.9 Anxiety disorder, unspecified B E p A ESCITALOPRAM d04812A CP F41.9 Anxiety disorder, unspecified B E p A FLUTICASONE; SALMETEROL d04611A C[@ J45 Asthma B E p A GABAPENTIN d03182A C- M54 Dorsalgia B E p A GLIMEPIRIDE d03864A D E11 Type 2 diabetes mellitus B E p A METFORMIN d03807A Dc E11 Type 2 diabetes mellitus B E p A METOPROLOL d00134A Cr I10 Essential (primary) hypertension B E p A MONTELUKAST d04289A C- J45 Asthma B E p A PREDNISONE d00350A D; J45 Asthma B E p A RAMIPRIL d00728A CP I10 Essential (primary) hypertension B E p A RANITIDINE d00021A CP K21 Gastro-esophageal reflux disease B E p A SIMVASTATIN d00746A Cr E78.1 Pure hyperglyceridemia B E p A THEOPHYLLINE d00142A D* J45 Asthma B E p A TIOTROPIUM d04829A C[@ Z79.0 Long term (current) use of anticoagulants and antithrombotics/antiplatelets B E A AMPHETAMINE; DEXTROAMPHETAMINE d04035A Dc F90 Attention-deficit hyperactivity disorders A E A . . . E A AMLODIPINE; BENAZEPRIL d03829A Ap N28.9 R60.9 Disorder of kidney and ureter, unspecified Edema, unspecified A E A CLONAZEPAM d00197A Cr F41.0 M62.83 R45 Panic disorder [episodic paroxysmal anxiety] without agoraphobia Muscle spasm Symptoms and signs involving emotional state A E A FUROSEMIDE d00070A C[@ N18.9 N28.9 R60.9 Chronic kidney disease, unspecified Disorder of kidney and ureter, unspecified Edema, unspecified A E A GLIMEPIRIDE d03864A CDp E11 Type 2 diabetes mellitus A E A OMEGA-3 POLYUNSATURATED FATTY ACIDS d00497A C 99999 A E A OXYCODONE d00329A B M54 M79.2 M79.7 Dorsalgia Neuralgia and neuritis, unspecified Fibromyalgia A E A SUCRALFATE d00377A CDp K25 Gastric ulcer A E A TAMSULOSIN d04121A A R35 Polyuria A E A . . . E A . . . E A . . . E A CYPROHEPTADINE d00790A CDp G43 Migraine A E A POLYETHYLENE GLYCOL 3350 d05350A C K59.0 Constipation A E A . . . E A ALLOPURINOL d00023A D M10.9P Prevent gout AP E A AMLODIPINE d00689A D 99999 AP E A LISINOPRIL d00732A D 99999 AP E A METOPROLOL d00134A D I10 Essential (primary) hypertension AP E A OMEPRAZOLE d00325A D K21 Gastro-esophageal reflux disease AP E A . . . E A . . . E 0 A ALBUTEROL d00749A C- J45 Asthma A E @ A . . . E P A . . . E ` A ACETAMINOPHEN; HYDROCODONE d03428A0 Cr M25.5 M79.6 T14.9 Pain in joint Pain in limb, hand, foot, fingers and toes Unspecified injury B E ` A AMLODIPINE d00689A0 CDp I10 Essential (primary) hypertension B E ` A ARIPIPRAZOLE d04825A0 Cr R51 Headache B E ` A ATORVASTATIN d04105A0 CDp E78.0 Pure hypercholesterolemia B E ` A CYCLOBENZAPRINE d00963A0 A G47.0 M62.83 M79.1 Insomnia Muscle spasm Myalgia B E ` A LIDOCAINE; MENTHOL TOPICAL d08259A0 CDp M25.5 M54 M79.6 Pain in joint Dorsalgia Pain in limb, hand, foot, fingers and toes B E ` A LIRAGLUTIDE d07466A0 C E11 R73 Type 2 diabetes mellitus Elevated blood glucose level B E ` A LISINOPRIL d00732A0 CDp I10 Essential (primary) hypertension B E ` A MELOXICAM d04532A0 C- M13 M19.9 Other arthritis Osteoarthritis, unspecified site B E ` A METFORMIN d03807A0 C- E11 Type 2 diabetes mellitus B E ` A MIRTAZAPINE d04025A0 C9 G47.9 Sleep disorder, unspecified B E ` A PRAZOSIN d00138A0 C9 G47.9 Sleep disorder, unspecified B E ` A RIZATRIPTAN d04328A0 Cr G43 Migraine B E ` A SERTRALINE d00880A0 CDp F32.9 F41.9 G43 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified Migraine B E ` A TOPIRAMATE d04115A0 Cr G43 Migraine B E ` A ZOLPIDEM d00910A0 C9 F41.9 G47.9 Anxiety disorder, unspecified Sleep disorder, unspecified B E p A . . . E A . . . E A . . . E A . . . E A . . . E A METOPROLOL d00134A C- I10 Essential (primary) hypertension A0 E A TELMISARTAN d04364A C I10 Essential (primary) hypertension A0 E A VALSARTAN d04113A C- I10 Essential (primary) hypertension A0 E A GLIPIZIDE d00246A Ap E11 Type 2 diabetes mellitus A E A METFORMIN d03807A Ap E11 Type 2 diabetes mellitus A E A ATORVASTATIN d04105A Cr E78.0 Pure hypercholesterolemia Ap E A IBUPROFEN d00015A C R52 Pain, unspecified Ap E A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified Ap E A LISINOPRIL d00732A C[@ I10 Essential (primary) hypertension Ap E A METFORMIN d03807A Ei 99999 Ap E A METHADONE d00050A Dc F11.23 Opioid dependence with withdrawal Ap E A METOPROLOL d00134A Cr I21.P Prevent heart attack/myocardial infarction Ap E A . . . E A HYDROCORTISONE TOPICAL d03205A Ap L20.9 Atopic dermatitis, unspecified A E A TRIAMCINOLONE TOPICAL d03206A A L20.9 Atopic dermatitis, unspecified A E A ATORVASTATIN d04105A C[@ E78.0P Prevent high cholesterol A0 E A ATORVASTATIN d04105A C[@ E78.0P Prevent high cholesterol A0 E A METFORMIN d03807A C[@ R73 Elevated blood glucose level A0 E A INSULIN ISOPHANE; INSULIN REGULAR d04374A CDp E10 Type 1 diabetes mellitus A E A METFORMIN d03807A B[ R73 Elevated blood glucose level A E 0 A AMLODIPINE d00689A C I21.P I50.9 Prevent heart attack/myocardial infarction Heart failure, unspecified A E 0 A CARVEDILOL d03847A C I50.9 Heart failure, unspecified A E 0 A ESOMEPRAZOLE d04749A C K30 Functional dyspepsia A E 0 A ESOMEPRAZOLE d04749A D K21 Gastro-esophageal reflux disease A E 0 A FUROSEMIDE d00070A B R60.9 Edema, unspecified A E 0 A FUROSEMIDE d00070A C R60.9 Edema, unspecified A E 0 A ISOSORBIDE MONONITRATE d00269A C I21.P I50.9 Prevent heart attack/myocardial infarction Heart failure, unspecified A E 0 A LEFLUNOMIDE d04349A C 55555 A E 0 A LEVOTHYROXINE d00278A0 D9 E03.9 Hypothyroidism, unspecified A E 0 A LOPERAMIDE d01025A C R19.7 Diarrhea, unspecified A E 0 A POTASSIUM CHLORIDE d00345A B E87.6 Hypokalemia A E @ A . . . E P A CHLORTHALIDONE d00192A CDp R60.9 Edema, unspecified A@ E P A HYDROCHLOROTHIAZIDE; TELMISARTAN d04737A C I10 Essential (primary) hypertension A@ E P A METFORMIN d03807A CDp E11 R73 Type 2 diabetes mellitus Elevated blood glucose level A@ E P A PROPRANOLOL d00032A C I10 Essential (primary) hypertension A@ E ` A ACETAMINOPHEN; CODEINE d03423A D T14.9 Unspecified injury Ap E ` A LEVOCETIRIZINE d05851A B= R09.81 Nasal congestion Ap E ` A LOSARTAN d03821A Cr I10 Essential (primary) hypertension Ap E ` A MELOXICAM d04532A B M06.9 Rheumatoid arthritis, unspecified Ap E ` A METHSCOPOLAMINE d00989A B= R09.3 Abnormal sputum Ap E ` A PANTOPRAZOLE d04514A Cr K21 Gastro-esophageal reflux disease Ap E ` A UMECLIDINIUM; VILANTEROL d08188A B R05 Cough Ap E p A . . . E A TAMSULOSIN d04121A C N40 Enlarged prostate A0 E A TESTOSTERONE d00558A C[@ E29.1 Testicular hypofunction A0 E A THYROID DESICCATED d00655A C E03.9 Hypothyroidism, unspecified A0 E A CODEINE; PROMETHAZINE d03357A Ap J01.9 Acute sinusitis, unspecified AP E A LEVOTHYROXINE d00278A C[@ E03.9 Hypothyroidism, unspecified AP E A METOPROLOL d00134A C[@ I10 Essential (primary) hypertension AP E A TRAMADOL d03826A B M54 Dorsalgia AP E A ZOLPIDEM d00910A C- G47.0 Insomnia AP E A ALBUTEROL d00749A C- J44.9 Chronic obstructive pulmonary disease, unspecified A E A AMOXICILLIN d00088A Ap K04.7P Prevent tooth infection A E A ATORVASTATIN d04105A CDp E78.0 Pure hypercholesterolemia A E A CARVEDILOL d03847A D I10 Essential (primary) hypertension A E A CLOPIDOGREL d04258A C I21.P Prevent heart attack/myocardial infarction A E A LEVOTHYROXINE d00278A C- E03.9 Hypothyroidism, unspecified A E A LISINOPRIL d00732A D I10 Essential (primary) hypertension A E A SPIRONOLACTONE d00373A CDp R60.9 Edema, unspecified A E A . . . E A . . . E A . . . E A ALBUTEROL d00749A C J45 Asthma A0 E A FLUTICASONE; SALMETEROL d04611A CDp J45 Asthma A0 E A HYDROXYZINE d00907A C J30.9 Allergic rhinitis, unspecified A0 E A CYPROHEPTADINE d00790A C- R10 Abdominal and pelvic pain A E A DICYCLOMINE d00999A C K58 Irritable bowel syndrome A E A . . . E A ALBUTEROL d00749A B J45 Asthma A E A . . . E 0 A . . . E @ A . . . E P A . . . E ` A OMEPRAZOLE d00325A C- K21 Gastro-esophageal reflux disease A E p A AMLODIPINE d00689A C- I10 Essential (primary) hypertension A E A . . . E A . . . E A DEXMETHYLPHENIDATE d04777A B[ R41 Other symptoms and signs involving cognitive functions and awareness A E A . . . E A . . . E A LISINOPRIL d00732A C I10 Essential (primary) hypertension A E A . . . E A POLYMYXIN B; TRIMETHOPRIM OPHTHALMIC d03529A B H04 Disorders of lacrimal system A E A CYCLOBENZAPRINE d00963A CDp M62.83 M79.1 Muscle spasm Myalgia A0 E A IBUPROFEN d00015A D% M19.9 Osteoarthritis, unspecified site A0 E A MELOXICAM d04532A CDp M19.9 Osteoarthritis, unspecified site A0 E A HYDROCHLOROTHIAZIDE; LOSARTAN d03830A D I10 Essential (primary) hypertension A E A LEVOTHYROXINE d00278A B E03.9 Hypothyroidism, unspecified A E A FAMCICLOVIR d03775A C A60.9 Anogenital herpesviral infection, unspecified A0 E A OMEPRAZOLE d00325A D K21 Gastro-esophageal reflux disease A0 E A TAMSULOSIN d04121A C N40 Enlarged prostate A0 E 0 A . . . E @ A VALSARTAN d04113A C I10 Essential (primary) hypertension A E P A AMOXICILLIN; CLAVULANATE d00089A A A49.9 Bacterial infection, unspecified A E P A MUPIROCIN TOPICAL d01267A A R21 Rash and other nonspecific skin eruption A E ` A BACLOFEN d00967A CP M62.83 Muscle spasm A E p A ESCITALOPRAM d04812A B F32.9 F41.9 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified A E p A TRAZODONE d00395A B F32.9 G47.0 Major depressive disorder, single episode, unspecified Insomnia A E A . . . E A LEVOTHYROXINE d00278A C- 99999 AP E A LOSARTAN d03821A D I10 Essential (primary) hypertension AP E A POTASSIUM CHLORIDE d00345A Cr M85.9 Disorder of bone density and structure, unspecified AP E A PRIMIDONE d00352A C- R25.1 Tremor, unspecified AP E A SERTRALINE d00880A D 99999 AP E A FLUTICASONE; SALMETEROL d04611A B J45 Asthma A E A LEVOCETIRIZINE d05851A B T78.40 Allergy, unspecified A E A FLUTICASONE; SALMETEROL d04611A C J45 Asthma A E A . . . E A . . . E A CLONIDINE d00044A A F90 Attention-deficit hyperactivity disorders A E A DEXMETHYLPHENIDATE d04777A B F90 Attention-deficit hyperactivity disorders A E A . . . E ! A . . . E ! A LISINOPRIL d00732A C[@ I10 Essential (primary) hypertension A E ! A MELOXICAM d04532A A M13 Other arthritis A E ! A ALENDRONATE d03849A C"0 M81 Osteoporosis without current pathological fracture A E !0 A AMOXICILLIN d00088A A J02 Acute pharyngitis A E !@ A . . . E !P A . . . E !` A . . . E !p A . . . E ! A EMPAGLIFLOZIN; LINAGLIPTIN d08344A B E11 Type 2 diabetes mellitus AP E ! A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified AP E ! A LOSARTAN d03821A C- I10 Essential (primary) hypertension AP E ! A ROSUVASTATIN d04851A B E78.0 Pure hypercholesterolemia AP E ! A ZAFIRLUKAST d04053A D J30.9 J44.9 J45 Allergic rhinitis, unspecified Chronic obstructive pulmonary disease, unspecified Asthma AP E ! A ATORVASTATIN d04105A C[@ E78.0 Pure hypercholesterolemia A E ! A BUPROPION d00181A B= F17.2 F32.9 Nicotine dependence Major depressive disorder, single episode, unspecified A E ! A CITALOPRAM d04332A C- F32.9 Major depressive disorder, single episode, unspecified A E ! A CYCLOBENZAPRINE d00963A C- M62.83 Muscle spasm A E ! A FAMOTIDINE d00141A C- K30 Functional dyspepsia A E ! A LORAZEPAM d00149A C- F41.9 Anxiety disorder, unspecified A E ! A MORPHINE d00308A C G89 M25.5 M54 Pain, not elsewhere classified Pain in joint Dorsalgia A E ! A PREGABALIN d05508A C- E11.4 M79.2 Type 2 diabetes mellitus with neurological complications Neuralgia and neuritis, unspecified A E ! A PROCHLORPERAZINE d00355A C- R11 Nausea and vomiting A E ! A TEMAZEPAM d00384A C- G47.9 Sleep disorder, unspecified A E ! A TRAZODONE d00395A C- F32.9 Major depressive disorder, single episode, unspecified A E ! A AMLODIPINE d00689A B I10 Essential (primary) hypertension A0 E ! A ROSUVASTATIN d04851A B E78.0 Pure hypercholesterolemia A0 E ! A TAMSULOSIN d04121A C R35 Polyuria A0 E ! A ATORVASTATIN d04105A C 99999 A E ! A CLOPIDOGREL d04258A C N28.9 Disorder of kidney and ureter, unspecified A E ! A DAPAGLIFLOZIN d07928A Ap E11 Type 2 diabetes mellitus A E ! A DOXAZOSIN d00726A C 99999 A E ! A FINASTERIDE d00563A C 99999 A E ! A FUROSEMIDE d00070A C 99999 A E ! A GABAPENTIN d03182A CP M79.2 Neuralgia and neuritis, unspecified A E ! A GLIPIZIDE d00246A D E11 Type 2 diabetes mellitus A E ! A LISINOPRIL d00732A C E78.0 Pure hypercholesterolemia A E ! A METOPROLOL d00134A CP 99999 A E ! A OMEGA-3 POLYUNSATURATED FATTY ACIDS d00497A C"0 M19.9 Osteoarthritis, unspecified site A E ! A . . . E ! A . . . E " A . . . E " A CEFDINIR d04256A Ap H66.9 Otitis media, unspecified A E " A . . . E "0 A OXYBUTYNIN d00328A C N32.81 Overactive bladder A E "@ A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A B I10 Essential (primary) hypertension A@ E "@ A MECLIZINE d00859A A R42 Dizziness and giddiness A@ E "@ A METFORMIN d03807A D E11 Type 2 diabetes mellitus A@ E "@ A SIMVASTATIN d00746A Cr E78.0 Pure hypercholesterolemia A@ E "P A . . . E "` A ALPRAZOLAM d00168A B F41.9 Anxiety disorder, unspecified A E "p A ALENDRONATE d03849A C M81 Osteoporosis without current pathological fracture AP E "p A PREDNISONE d00350A D E78.0 Pure hypercholesterolemia AP E "p A PROCHLORPERAZINE d00355A Cr R11 Nausea and vomiting AP E "p A TACROLIMUS d03752A D L40 Psoriasis AP E "p A TRAMADOL d03826A C M54 Dorsalgia AP E " A . . . E " A CARVEDILOL d03847A D I50.9 Heart failure, unspecified A@ E " A LISINOPRIL d00732A D I10 Essential (primary) hypertension A@ E " A LOVASTATIN d00280A C E78.0 Pure hypercholesterolemia A@ E " A SPIRONOLACTONE d00373A D I50.9 Heart failure, unspecified A@ E " A ALBUTEROL d00749A B J45 R06.9P R09.81 Asthma Prevent breathing difficulty Nasal congestion A E " A FLUTICASONE d01296A Bz J98.9 Respiratory disorder, unspecified A E " A ENALAPRIL d00013A C I10 Essential (primary) hypertension A E " A INSULIN ISOPHANE; INSULIN REGULAR d04374A C E11 Type 2 diabetes mellitus A E " A . . . E " A . . . E " A ALLOPURINOL d00023A C- E79.9 Disorder of purine and pyrimidine metabolism, unspecified A E " A BUMETANIDE d00179A C I50.9 Heart failure, unspecified A E " A CARVEDILOL d03847A C"@ I10 Essential (primary) hypertension A E " A FLUORIDE TOPICAL d04397A C"0 K02 Dental caries A E " A GLIPIZIDE d00246A C"@ E11 Type 2 diabetes mellitus A E " A HYDROXYCHLOROQUINE d00817A Dc M06.9 Rheumatoid arthritis, unspecified A E " A LEVOTHYROXINE d00278A D E03.9 Hypothyroidism, unspecified A E " A OMEPRAZOLE d00325A C- K30 Functional dyspepsia A E " A ROFLUMILAST d07684A C- J44.9 Chronic obstructive pulmonary disease, unspecified A E " A SIMVASTATIN d00746A Dc I21.P Prevent heart attack/myocardial infarction A E " A SITAGLIPTIN d05896A C[@ E11 Type 2 diabetes mellitus A E " A TRAZODONE d00395A C- F32.9 G47.0 Major depressive disorder, single episode, unspecified Insomnia A E " A . . . E # A . . . E # A . . . E # A . . . E #0 A . . . E #@ A APIXABAN d07804A C D75.9P Prevent blood clots AP E #@ A CLARITHROMYCIN d00097A B J18.9 Pneumonia, unspecified organism AP E #@ A METOPROLOL d00134A C- R00 Abnormalities of heart beat AP E #@ A SACUBITRIL; VALSARTAN d08369A C- I49.9 Cardiac arrhythmia, unspecified AP E #@ A TAMSULOSIN d04121A B R35 Polyuria AP E #P A ATORVASTATIN d04105A Cr 99999 A` E #P A CITALOPRAM d04332A Dc F32.9 Major depressive disorder, single episode, unspecified A` E #P A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A C[@ I63.P Prevent stroke A` E #P A INSULIN GLARGINE d04538A D E11 Type 2 diabetes mellitus A` E #P A METFORMIN d03807A C[@ 99999 A` E #P A SPIRONOLACTONE d00373A Cr 99999 A` E #` A . . . E #p A . . . E # A . . . E # A ESTRADIOL d00537A C N95 Menopausal and other perimenopausal disorders A0 E # A METFORMIN d03807A CP E11 Type 2 diabetes mellitus A0 E # A METOPROLOL d00134A C I49.9 R00 Cardiac arrhythmia, unspecified Abnormalities of heart beat A0 E # A . . . E # A . . . E # A ATORVASTATIN d04105A B* E78.0 Pure hypercholesterolemia A E # A SUMATRIPTAN d03160A D G43 Migraine A E # A DEXMETHYLPHENIDATE d04777A C- F90 Attention-deficit hyperactivity disorders A E # A LISINOPRIL d00732A D I10 Essential (primary) hypertension A E # A ETHINYL ESTRADIOL; NORETHINDRONE d03238A C- N92 N94 Excessive, frequent and irregular menstruation Pain and other conditions associated with female genital organs and menstrual cycle A0 E # A QUETIAPINE d04220A CDp F41.9 Anxiety disorder, unspecified A0 E # A SERTRALINE d00880A CDp F41.9 Anxiety disorder, unspecified A0 E $ A LOSARTAN d03821A CDp I10 Essential (primary) hypertension A E $ A ATORVASTATIN d04105A B= E78.0 Pure hypercholesterolemia A E $ A CARVEDILOL d03847A B= I50.9 Heart failure, unspecified A E $ A CLOPIDOGREL d04258A B= D75.9P Prevent blood clots A E $ A DICLOFENAC TOPICAL d04722A CDp M79.2 Neuralgia and neuritis, unspecified A E $ A GABAPENTIN d03182A CP F32.9 M79.2 Major depressive disorder, single episode, unspecified Neuralgia and neuritis, unspecified A E $ A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A C I10 Essential (primary) hypertension A E $ A LIDOCAINE TOPICAL d00683A C- M79.2 Neuralgia and neuritis, unspecified A E $ A METFORMIN d03807A CDp E11 R73 Type 2 diabetes mellitus Elevated blood glucose level A E $ A SAXAGLIPTIN d07467A CDp F32.9 Major depressive disorder, single episode, unspecified A E $ A . . . E $0 A ATORVASTATIN d04105A D E78.0 Pure hypercholesterolemia A E $0 A INSULIN ASPART d04697A C[@ E11 Type 2 diabetes mellitus A E $0 A INSULIN GLARGINE d04538A C[@ E11 Type 2 diabetes mellitus A E $0 A LOSARTAN d03821A D I10 Essential (primary) hypertension A E $0 A MYCOPHENOLATE MOFETIL d03839A D T86.9P Prevent transplanted organ and tissue rejection A E $0 A POTASSIUM CHLORIDE d00345A Cr R25.2 Cramp and spasm A E $0 A SIROLIMUS d04453A D T86.9P Prevent transplanted organ and tissue rejection A E $0 A TACROLIMUS d03752A D Z79 Long term (current) drug therapy A E $@ A . . . E $P A LISINOPRIL d00732A C- I10 Essential (primary) hypertension A E $` A . . . E $p A METOPROLOL d00134A Cr I10 Essential (primary) hypertension A0 E $p A SIMVASTATIN d00746A Cr E78.0 Pure hypercholesterolemia A0 E $p A VALSARTAN d04113A C[@ I21.P Prevent heart attack/myocardial infarction A0 E $ A . . . E $ A ATORVASTATIN d04105A C E78.0P I21.P Prevent high cholesterol Prevent heart attack/myocardial infarction A E $ A CARBAMAZEPINE d00058A Ei G40 Epilepsy and recurrent seizures A E $ A EZETIMIBE d04824A CDp I21.P Prevent heart attack/myocardial infarction A E $ A FUROSEMIDE d00070A Ei I10 Essential (primary) hypertension A E $ A IRBESARTAN d04222A CDp I50.9 Heart failure, unspecified A E $ A LOPERAMIDE d01025A Ei R19.7 Diarrhea, unspecified A E $ A MESALAMINE d01031A Ei K58 Irritable bowel syndrome A E $ A METOPROLOL d00134A Ei I50.9 Heart failure, unspecified A E $ A ALBUTEROL d00749A C[@ J44.9 Chronic obstructive pulmonary disease, unspecified A E $ A AMLODIPINE d00689A CDp I10 Essential (primary) hypertension A E $ A ATENOLOL; CHLORTHALIDONE d03258A Cr I10 Essential (primary) hypertension A E $ A ATORVASTATIN d04105A A E78.0 Pure hypercholesterolemia A E $ A CLOBETASOL TOPICAL d01288A A` L20.9 Atopic dermatitis, unspecified A E $ A FUROSEMIDE d00070A C R60.9 Edema, unspecified A E $ A GABAPENTIN d03182A C M79.2 Neuralgia and neuritis, unspecified A E $ A IBUPROFEN d00015A C M19.9 Osteoarthritis, unspecified site A E $ A INDOMETHACIN d00039A B M19.9 Osteoarthritis, unspecified site A E $ A MELOXICAM d04532A A0 M19.9 Osteoarthritis, unspecified site A E $ A METFORMIN d03807A C- E11 Type 2 diabetes mellitus A E $ A OMEPRAZOLE d00325A C K31.9 T88.7P Disease of stomach and duodenum, unspecified Prevent drug side effect A E $ A PREGABALIN d05508A A0 M79.2 Neuralgia and neuritis, unspecified A E $ A TIOTROPIUM d04829A C[@ J44.9 Chronic obstructive pulmonary disease, unspecified A E $ A CETIRIZINE d03827A C J45 T78.40 Asthma Allergy, unspecified A0 E $ A FLUTICASONE d01296A Ap J45 Asthma A0 E $ A FLUTICASONE NASAL d04283A C J45 Asthma A0 E $ A AMLODIPINE; BENAZEPRIL d03829A Cr I10 Essential (primary) hypertension A@ E $ A ASPIRIN d00170A Cr I21.P Prevent heart attack/myocardial infarction A@ E $ A HYDROCHLOROTHIAZIDE d00253A C- I10 Essential (primary) hypertension A@ E $ A SIMVASTATIN d00746A Cr E78.0 Pure hypercholesterolemia A@ E $ A ALENDRONATE d03849A0 C M81 Osteoporosis without current pathological fracture A E $ A AMOXICILLIN; CLAVULANATE d00089A AP J01.9 J02 J06.9 Acute sinusitis, unspecified Acute pharyngitis Acute upper respiratory infection, unspecified A E $ A APIXABAN d07804A0 C I63.P Prevent stroke A E $ A ATORVASTATIN d04105A C I10 Essential (primary) hypertension A E $ A BACLOFEN d00967A B M62.83 Muscle spasm A E $ A LEVOTHYROXINE d00278A Cr E03.9 Hypothyroidism, unspecified A E $ A PANTOPRAZOLE d04514A C K27 Peptic ulcer, site unspecified A E $ A RANITIDINE d00021A C K27 Peptic ulcer, site unspecified A E $ A SPIRONOLACTONE d00373A C I10 Essential (primary) hypertension A E $ A . . . E $ A . . . E % A . . . E % A METHYLPHENIDATE d00900A C F90 Attention-deficit hyperactivity disorders A E % A . . . E %0 A . . . E %@ A . . . E %P A METFORMIN d03807A B= E11 Type 2 diabetes mellitus A E %` A MESALAMINE d01031A CDp K50 Crohn's disease [regional enteritis] A` E %` A METFORMIN d03807A Cr E11 Type 2 diabetes mellitus A` E %` A PANTOPRAZOLE d04514A C 99999 A` E %` A PRAVASTATIN d00348A C 99999 A` E %` A PREDNISONE d00350A B D89.9 Disorder involving the immune mechanism, unspecified A` E %` A PROPRANOLOL d00032A Cr 99999 A` E %p A . . . E % A . . . E % A BUPROPION d00181A C F32.9 Major depressive disorder, single episode, unspecified A` E % A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified A` E % A LORAZEPAM d00149A C- F41.9 Anxiety disorder, unspecified A` E % A PROPRANOLOL d00032A C- G43 R25.1 Migraine Tremor, unspecified A` E % A RALOXIFENE d04261A CDp Z90 Acquired absence of organs, not elsewhere classified A` E % A VENLAFAXINE d03181A C- F32.9 F41.9 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified A` E % A IBUPROFEN d00015A C N94 Pain and other conditions associated with female genital organs and menstrual cycle A E % A SUMATRIPTAN d03160A CDp G43 Migraine A E % A . . . E % A . . . E % A . . . E % A . . . E % A ATORVASTATIN d04105A Ei E78.0 Pure hypercholesterolemia A` E % A CLOPIDOGREL d04258A C- I21.P Prevent heart attack/myocardial infarction A` E % A FUROSEMIDE d00070A C R60.9 Edema, unspecified A` E % A ISOSORBIDE d00653A C- R07.9 Chest pain, unspecified A` E % A METOPROLOL d00134A C- I10 Essential (primary) hypertension A` E % A TIZANIDINE d04102A C M62.83 Muscle spasm A` E & A . . . E & A ASPIRIN d00170A CDp I21.P Prevent heart attack/myocardial infarction A` E & A HYDROXYZINE d00907A C F20 Schizophrenia A` E & A INSULIN GLARGINE d04538A C E11 Type 2 diabetes mellitus A` E & A LISINOPRIL d00732A Cr I21.P Prevent heart attack/myocardial infarction A` E & A METFORMIN d03807A Cr E11 Type 2 diabetes mellitus A` E & A PAROXETINE d03157A D F41.0 Panic disorder [episodic paroxysmal anxiety] without agoraphobia A` E & A . . . E &0 A . . . E &@ A LATANOPROST OPHTHALMIC d04017A Dc H40 Glaucoma A0 E &@ A LOSARTAN d03821A D I10 Essential (primary) hypertension A0 E &@ A METOPROLOL d00134A Dc I10 Essential (primary) hypertension A0 E &P A . . . E &` A . . . E &p A AMOXICILLIN d00088A CDp A49.9P Prevent bacterial infection A E &p A AMOXICILLIN; CLAVULANATE d00089A A N39.0 Urinary tract infection, site not specified A E &p A CARVEDILOL d03847A Cr R00 Abnormalities of heart beat A E &p A DICLOFENAC d00848A B= M19.9 Osteoarthritis, unspecified site A E &p A FAMOTIDINE d00141A AP K21 Gastro-esophageal reflux disease A E &p A LOSARTAN d03821A Cr I10 Essential (primary) hypertension A E &p A OXYBUTYNIN d00328A C N32.81 Overactive bladder A E &p A PHENAZOPYRIDINE d00337A A N30 N32.9 R39.1 Cystitis Bladder disorder, unspecified Other difficulties with micturition A E &p A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia A E &p A TEMAZEPAM d00384A C G47.9 Sleep disorder, unspecified A E & A ALPRAZOLAM d00168A CDp F41.9 Anxiety disorder, unspecified A E & A CITALOPRAM d04332A CDp F32.9 Major depressive disorder, single episode, unspecified A E & A GLIPIZIDE d00246A C E11 Type 2 diabetes mellitus A E & A INSULIN GLARGINE d04538A CDp E11 Type 2 diabetes mellitus A E & A INSULIN LISPRO d04373A C- E11 Type 2 diabetes mellitus A E & A LOSARTAN d03821A C"0 I10 Essential (primary) hypertension A E & A METFORMIN d03807A C[@ E11 Type 2 diabetes mellitus A E & A OXYCODONE d00329A C- M54 Dorsalgia A E & A PREDNISONE d00350A C"0 D89.9 Disorder involving the immune mechanism, unspecified A E & A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia A E & A . . . E & A AMIODARONE d00002A0 Ei 99999 A E & A ASPIRIN d00170A0 Ei Z79.0 Long term (current) use of anticoagulants and antithrombotics/antiplatelets A E & A INSULIN ISOPHANE (NPH) d04370A0 Ei R73 Elevated blood glucose level A E & A INSULIN REGULAR d04369A0 Ei E11 Type 2 diabetes mellitus A E & A LEVOTHYROXINE d00278A0 Ei 99999 A E & A POTASSIUM CHLORIDE d00345A0 Ei 99999 A E & A SACUBITRIL; VALSARTAN d08369A0 B I50.9 Heart failure, unspecified A E & A SIMVASTATIN d00746A0 Ei 99999 A E & A TAMSULOSIN d04121A0 Ei 99999 A E & A TORSEMIDE d03189A0 Ei 99999 A E & A WARFARIN d00022A0 Ei Z79.0 Long term (current) use of anticoagulants and antithrombotics/antiplatelets A E & A . . . E & A . . . E & A . . . E & A APIXABAN d07804A B I48.9 Unspecified atrial fibrillation and atrial flutter A` E & A INSULIN GLARGINE d04538A C E11 Type 2 diabetes mellitus A` E & A LINAGLIPTIN d07767A C E11 R73 Type 2 diabetes mellitus Elevated blood glucose level A` E & A METFORMIN d03807A D E11 R73 Type 2 diabetes mellitus Elevated blood glucose level A` E & A METOPROLOL d00134A Cr I48.9 Unspecified atrial fibrillation and atrial flutter A` E & A VALSARTAN d04113A CDp I10 Essential (primary) hypertension A` E & A AMLODIPINE d00689A CDp I10 Essential (primary) hypertension A0 E & A METOPROLOL d00134A CDp I10 Essential (primary) hypertension A0 E & A PRAVASTATIN d00348A CDp E78.0 Pure hypercholesterolemia A0 E ' A FLECAINIDE d00234A D I49.9 Cardiac arrhythmia, unspecified A E ' A SIMVASTATIN d00746A CDp E78.0 Pure hypercholesterolemia A E ' A . . . E ' A . . . E '0 A . . . E '@ A 77777 . . A E 'P A CETIRIZINE d03827A C- J30.1 Allergic rhinitis due to pollen AP E 'P A FLUTICASONE d01296A CDp R06.2 Wheezing AP E 'P A HYDROCODONE d03075A C M54 Dorsalgia AP E 'P A MONTELUKAST d04289A C- J30.9 Allergic rhinitis, unspecified AP E 'P A PREGABALIN d05508A CDp M79.2 Neuralgia and neuritis, unspecified AP E '` A . . . E 'p A . . . E ' A . . . E ' A AMLODIPINE d00689A CDp I10 Essential (primary) hypertension A@ E ' A LEVOTHYROXINE d00278A CDp E03.9 Hypothyroidism, unspecified A@ E ' A ROSUVASTATIN d04851A CDp E78.0 Pure hypercholesterolemia A@ E ' A TRAZODONE d00395A CDp G47.0 Insomnia A@ E ' A AMLODIPINE d00689A C& I10 Essential (primary) hypertension A0 E ' A LOSARTAN d03821A C I10 Essential (primary) hypertension A0 E ' A NEBIVOLOL d05265A C[@ I10 Essential (primary) hypertension A0 E ' A . . . E ' A AMLODIPINE; OLMESARTAN d06905A D* I10 Essential (primary) hypertension A@ E ' A LEVOTHYROXINE d00278A D6. E03.9 Hypothyroidism, unspecified A@ E ' A RISEDRONATE d04300A D M81 Osteoporosis without current pathological fracture A@ E ' A ROSUVASTATIN d04851A D E78.0 Pure hypercholesterolemia A@ E ' A . . . E ' A CIPROFLOXACIN d00011A Ap K51 Ulcerative colitis A0 E ' A METRONIDAZOLE d00108A Ap K51 Ulcerative colitis A0 E ' A ONDANSETRON d00867A Ap R11 Nausea and vomiting A0 E ' A ACETAMINOPHEN; OXYCODONE d03431A C M13 M54 Other arthritis Dorsalgia A E ' A ATORVASTATIN d04105A Cr E78.0 Pure hypercholesterolemia A E ' A BUSPIRONE d00182A C F41.9 Anxiety disorder, unspecified A E ' A CITALOPRAM d04332A Cr F32.9 Major depressive disorder, single episode, unspecified A E ' A GEMFIBROZIL d00245A C E78.0 Pure hypercholesterolemia A E ' A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A C I10 Essential (primary) hypertension A E ' A MELOXICAM d04532A Cr M79.1 Myalgia A E ' A OMEPRAZOLE d00325A Dc K21 Gastro-esophageal reflux disease A E ' A TIZANIDINE d04102A Cr M62.83 Muscle spasm A E ' A TOPIRAMATE d04115A Cr G43 Migraine A E ' A TRAZODONE d00395A C G47.0 G47.9 Insomnia Sleep disorder, unspecified A E ( A AZITHROMYCIN d00091A A0 J06.9 Acute upper respiratory infection, unspecified A E ( A . . . E ( A LISINOPRIL d00732A C I10 Essential (primary) hypertension A E (0 A ATORVASTATIN d04105A Cr E78.0 Pure hypercholesterolemia A E (0 A GABAPENTIN d03182A Ei R52 Pain, unspecified A E (0 A GLIPIZIDE d00246A Ei E11 Type 2 diabetes mellitus A E (0 A HYDROCHLOROTHIAZIDE d00253A D I99.9 Unspecified disorder of circulatory system A E (0 A INSULIN LISPRO; INSULIN LISPRO PROTAMINE d04510A Ei E11 Type 2 diabetes mellitus A E (0 A ISOSORBIDE DINITRATE d00268A D I51.9P Prevent heart disease A E (0 A LOSARTAN d03821A Ei I10 Essential (primary) hypertension A E (0 A METFORMIN d03807A D E11 Type 2 diabetes mellitus A E (0 A SITAGLIPTIN d05896A Ei E11 Type 2 diabetes mellitus A E (@ A . . . E (P A ETONOGESTREL d04772A C Z79.3 Long term (current) use of hormonal contraceptives A E (` A . . . E (p A DERMATOLOGICAL AGENTS - UNSPECIFIED c00136A B[ L70 Acne A E ( A . . . E ( A AMLODIPINE d00689A Cr I10 Essential (primary) hypertension A E ( A SIMVASTATIN d00746A Cr E78.0 Pure hypercholesterolemia A E ( A AMITRIPTYLINE d00146A C- G47.0 Insomnia AP E ( A DONEPEZIL d04099A C- R41 Other symptoms and signs involving cognitive functions and awareness AP E ( A HYDROCHLOROTHIAZIDE d00253A C- I10 Essential (primary) hypertension AP E ( A METFORMIN d03807A C- E11 R73 Type 2 diabetes mellitus Elevated blood glucose level AP E ( A RAMIPRIL d00728A C- I10 Essential (primary) hypertension AP E ( A CITALOPRAM d04332A D 55555 A E ( A ESZOPICLONE d05421A D G47.0 Insomnia A E ( A SULFAMETHOXAZOLE; TRIMETHOPRIM d00124A B= L70 Acne A E ( A . . . E ( A . . . E ( A . . . E ) A . . . E ) A ATORVASTATIN d04105A B= E78.0 Pure hypercholesterolemia A E ) A ESCITALOPRAM d04812A C F41.9 Anxiety disorder, unspecified A E ) A GEMFIBROZIL d00245A C E78.1 Pure hyperglyceridemia A E ) A HYDROCHLOROTHIAZIDE d00253A B= I10 Essential (primary) hypertension A E ) A LEVOTHYROXINE d00278A Dc E03.9 Hypothyroidism, unspecified A E ) A METFORMIN d03807A B E11 Type 2 diabetes mellitus A E ) A POTASSIUM CHLORIDE d00345A B= E87.6 Hypokalemia A E ) A QUETIAPINE d04220A C F32.9 Major depressive disorder, single episode, unspecified A E ) A TRAZODONE d00395A B[ G47.0 Insomnia A E ) A . . . E )0 A . . . E )@ A . . . E )P A AMOXICILLIN d00088A A K04.7 Periapical abscess without sinus A E )` A . . . E )p A ATORVASTATIN d04105A C- E78.0 Pure hypercholesterolemia A@ E )p A HYDROCHLOROTHIAZIDE d00253A D I10 Essential (primary) hypertension A@ E )p A HYDROCORTISONE TOPICAL d03205A D K64.9 Unspecified hemorrhoids A@ E )p A NAPROXEN d00019A C- M25.5 Pain in joint A@ E ) A CLONIDINE d00044A C- F90 Attention-deficit hyperactivity disorders A E ) A . . . E ) A . . . E ) A . . . E ) A . . . E ) A . . . E ) A . . . E ) A TRAZODONE d00395A CDp G47.9 Sleep disorder, unspecified A E * A . . . E * A . . . E * A ANTIHYPERTENSIVE AGENTS - UNSPECIFIED h00024A CDp I10 Essential (primary) hypertension A E * A IBUPROFEN d00015A C M1A Chronic gout A E *0 A ALBUTEROL d00749A C J45 Asthma A` E *0 A CETIRIZINE d03827A C- T78.40 Allergy, unspecified A` E *0 A EPINASTINE OPHTHALMIC d04898A C- T78.40 Allergy, unspecified A` E *0 A FLUTICASONE; SALMETEROL d04611A C J45 Asthma A` E *0 A MONTELUKAST d04289A C- J30.9 R06.2 Allergic rhinitis, unspecified Wheezing A` E *0 A POLYETHYLENE GLYCOL 3350 d05350A C K59.0 Constipation A` E *@ A . . . E *P A ATORVASTATIN d04105A CDp E78.0 Pure hypercholesterolemia A E *` A . . . E *p A . . . E * A . . . E * A DESOXIMETASONE TOPICAL d01291A CDp L20.9 Atopic dermatitis, unspecified A0 E * A FLUTICASONE; SALMETEROL d04611A C J45 Asthma A0 E * A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified A0 E * A ALBUTEROL d00749A C J20.9 Acute bronchitis, unspecified A0 E * A BUDESONIDE; FORMOTEROL d04795A C J20.9 Acute bronchitis, unspecified A0 E * A LEVOTHYROXINE d00278A CDp E03.9 Hypothyroidism, unspecified A0 E * A FLUCONAZOLE d00071A B B37 Candidiasis A E * A . . . E * A ALENDRONATE d03849A C[@ M81 Osteoporosis without current pathological fracture A E * A . . . E * A . . . E + A . . . E + A . . . E + A GUANFACINE d00717A CDp F90 Attention-deficit hyperactivity disorders A E + A METHYLPHENIDATE d00900A CDp F90 Attention-deficit hyperactivity disorders A E +0 A . . . E +@ A . . . E +P A . . . E +` A ALLOPURINOL d00023A D M1A Chronic gout A` E +` A AMLODIPINE d00689A C- I10 Essential (primary) hypertension A` E +` A DEXAMETHASONE; TOBRAMYCIN OPHTHALMIC d03536A B[ H57.9 Unspecified disorder of eye and adnexa A` E +` A LISINOPRIL d00732A C- I10 Essential (primary) hypertension A` E +` A SPIRONOLACTONE d00373A C I10 Essential (primary) hypertension A` E +` A VENLAFAXINE d03181A C- F43.9 Reaction to severe stress, unspecified A` E +p A . . . E + A . . . E + A ACYCLOVIR d00001A CDp A60.9 Anogenital herpesviral infection, unspecified A E + A ALBUTEROL d00749A D J45 Asthma A E + A LAMOTRIGINE d03809A C[@ F32.9 Major depressive disorder, single episode, unspecified A E + A LORAZEPAM d00149A C- F41.9 Anxiety disorder, unspecified A E + A LURASIDONE d07705A C[@ F20 Schizophrenia A E + A MIRTAZAPINE d04025A CDp G47.0 Insomnia A E + A OXYCODONE d00329A A G89 Pain, not elsewhere classified A E + A TRAMADOL d03826A A M54 Dorsalgia A E + A . . . E + A OFLOXACIN OTIC d04265A A H66.9P Prevent ear infection A E + A ETONOGESTREL d04772A0 CDp Z79.3 Long term (current) use of hormonal contraceptives A E + A METHADONE d00050A C F11.23 Opioid dependence with withdrawal A E + A METFORMIN d03807A B R73 Elevated blood glucose level A E + A LORAZEPAM d00149A A G47.0 Insomnia A@ E + A MORPHINE d00308A A R07.9 Chest pain, unspecified A@ E + A MORPHINE d00308A A 99999 A@ E + A RANITIDINE d00021A A 99999 A@ E + A . . . E , A ARIPIPRAZOLE d04825A C- F29 Unspecified psychosis not due to a substance or known physiological condition A0 E , A FENOFIBRATE d04286A B[ E78.1 Pure hyperglyceridemia A0 E , A LITHIUM d00061A C- F39 Unspecified mood [affective] disorder A0 E , A CLONAZEPAM d00197A CP F32.9 F41.9 G40 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified Epilepsy and recurrent seizures A E , A CYCLOBENZAPRINE d00963A C M54 M62.83 M79.1 Dorsalgia Muscle spasm Myalgia A E , A DILTIAZEM d00045A Ei I10 Essential (primary) hypertension A E , A DULOXETINE d05355A CP F32.9 F41.9 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified A E , A GABAPENTIN d03182A CP F41.9 G99.8 Anxiety disorder, unspecified Other specified disorders of nervous system in diseases classified elsewhere A E , A HYDROMORPHONE d00255A Cr M25.5 M54 R10 Pain in joint Dorsalgia Abdominal and pelvic pain A E , A HYDROXYZINE d00907A CP F41.9 Anxiety disorder, unspecified A E , A METOCLOPRAMIDE d00298A Cr K21 R11 Gastro-esophageal reflux disease Nausea and vomiting A E , A ONDANSETRON d00867A Cr R11 Nausea and vomiting A E , A PANTOPRAZOLE d04514A B K21 K30 Gastro-esophageal reflux disease Functional dyspepsia A E , A QUETIAPINE d04220A Cr G47.0 G47.9 Insomnia Sleep disorder, unspecified A E , A . . . E ,0 A FLUTICASONE; SALMETEROL d04611A C J44.9 Chronic obstructive pulmonary disease, unspecified AP E ,0 A MONTELUKAST d04289A Cr J30.9 Allergic rhinitis, unspecified AP E ,0 A NIFEDIPINE d00051A Dc I10 Essential (primary) hypertension AP E ,0 A PRAVASTATIN d00348A Dc E78.0 Pure hypercholesterolemia AP E ,0 A TIOTROPIUM d04829A C J44.9 Chronic obstructive pulmonary disease, unspecified AP E ,@ A SERTRALINE d00880A D* F32.9 Major depressive disorder, single episode, unspecified A E ,@ A TRAZODONE d00395A D* F41.9 Anxiety disorder, unspecified A E ,P A FUROSEMIDE d00070A Cr I51.9 Heart disease, unspecified A E ,P A GABAPENTIN d03182A Cr M79.2 Neuralgia and neuritis, unspecified A E ,P A GLIPIZIDE d00246A Cr R73 Elevated blood glucose level A E ,P A ISOSORBIDE MONONITRATE d00269A Cr I20.9 I21.P Angina pectoris, unspecified Prevent heart attack/myocardial infarction A E ,P A LATANOPROST OPHTHALMIC d04017A Cr H40 Glaucoma A E ,P A LEVOTHYROXINE d00278A Cr E78.0 Pure hypercholesterolemia A E ,P A LOSARTAN d03821A Cr 99999 A E ,P A METOPROLOL d00134A Cr I63.P Prevent stroke A E ,P A OMEPRAZOLE d00325A Cr R10 Abdominal and pelvic pain A E ,P A POTASSIUM CHLORIDE d00345A Cr E87.6 Hypokalemia A E ,P A WARFARIN d00022A Cr I48.9 Unspecified atrial fibrillation and atrial flutter A E ,` A . . . E ,p A . . . E , A . . . E , A . . . E , A . . . E , A . . . E , A . . . E , A LEVOTHYROXINE d00278A C E03.9 Z90 Hypothyroidism, unspecified Acquired absence of organs, not elsewhere classified A E , A . . . E , A . . . E - A ATORVASTATIN d04105A Bz E78.0 Pure hypercholesterolemia A E - A . . . E - A . . . E -0 A . . . E -@ A . . . E -P A . . . E -` A AMIODARONE d00002A C I49.9 Cardiac arrhythmia, unspecified A0 E -` A AMLODIPINE; BENAZEPRIL d03829A C I10 Essential (primary) hypertension A0 E -` A METFORMIN d03807A C E11 Type 2 diabetes mellitus A0 E -p A AMLODIPINE d00689A D I10 I21.P Essential (primary) hypertension Prevent heart attack/myocardial infarction A E -p A FAMOTIDINE d00141A D I21.P Prevent heart attack/myocardial infarction A E -p A HYDROCHLOROTHIAZIDE d00253A D R60.9 Edema, unspecified A E -p A LOSARTAN d03821A D I21.P Prevent heart attack/myocardial infarction A E -p A POTASSIUM CHLORIDE d00345A D I51.9 Heart disease, unspecified A E -p A PRAVASTATIN d00348A D E78.0 Pure hypercholesterolemia A E -p A SOTALOL d00371A D I49.9 Cardiac arrhythmia, unspecified A E -p A WARFARIN d00022A B D75.9P Prevent blood clots A E - A AMLODIPINE; BENAZEPRIL d03829A Dc I10 Essential (primary) hypertension A@ E - A BENAZEPRIL d00730A Dc I10 Essential (primary) hypertension A@ E - A PANTOPRAZOLE d04514A Bz K30 Functional dyspepsia A@ E - A TADALAFIL d04896A C- N52.9 Male erectile dysfunction, unspecified A@ E - A . . . E - A . . . E - A . . . E - A . . . E - A AMOXICILLIN d00088A A J02 Acute pharyngitis A E - A . . . E - A ALBUTEROL d00749A D J45 Asthma A E - A ATENOLOL d00004A D I48.9 Unspecified atrial fibrillation and atrial flutter A E - A FELODIPINE d00231A D I10 Essential (primary) hypertension A E - A HYDROCHLOROTHIAZIDE d00253A D I10 Essential (primary) hypertension A E - A INSULIN ISOPHANE; INSULIN REGULAR d04374A C[@ E11 Type 2 diabetes mellitus A E - A LISINOPRIL d00732A D I10 Essential (primary) hypertension A E - A METFORMIN d03807A D E11 Type 2 diabetes mellitus A E - A RIVAROXABAN d07356A C- I48.9 Unspecified atrial fibrillation and atrial flutter A E - A ROSUVASTATIN d04851A D E78.0 Pure hypercholesterolemia A E . A . . . E . A . . . E . A . . . E .0 A ETHINYL ESTRADIOL; NORGESTIMATE d03781A Cr Z79.3 Long term (current) use of hormonal contraceptives A E .@ A . . . E .P A ALBUTEROL d00749A C[@ J45 Asthma A` E .P A ALBUTEROL d00749A C[@ J45 Asthma A` E .P A DEXMETHYLPHENIDATE d04777A CDp F90 Attention-deficit hyperactivity disorders A` E .P A DEXMETHYLPHENIDATE d04777A CDp F90 Attention-deficit hyperactivity disorders A` E .P A MONTELUKAST d04289A C[@ J45 Asthma A` E .P A VALPROIC ACID d00083A C G40 Epilepsy and recurrent seizures A` E .` A . . . E .p A . . . E . A . . . E . A LANSOPRAZOLE d03828A C- B96.81 Helicobacter pylori [H. pylori] as the cause of diseases classified elsewhere A` E . A LEVOTHYROXINE d00278A D E03.9 Hypothyroidism, unspecified A` E . A MELOXICAM d04532A AP M79.1 Myalgia A` E . A MONTELUKAST d04289A C R06.9 Unspecified abnormalities of breathing A` E . A NIFEDIPINE d00051A C I10 Essential (primary) hypertension A` E . A NITROFURANTOIN d00112A A0 N39.0 Urinary tract infection, site not specified A` E . A . . . E . A . . . E . A BUSPIRONE d00182A C[@ F41.9 Anxiety disorder, unspecified A E . A . . . E . A ALBUTEROL d00749A CP J45 Asthma AP E . A ALBUTEROL d00749A C J45 Asthma AP E . A ALBUTEROL d00749A D J45 Asthma AP E . A MOMETASONE TOPICAL d01300A C L20.9 Atopic dermatitis, unspecified AP E . A MONTELUKAST d04289A D J30.9 Allergic rhinitis, unspecified AP E . A . . . E / A . . . E / A . . . E / A . . . E /0 A . . . E /@ A CELECOXIB d04380A C M13 M79.1 Other arthritis Myalgia A` E /@ A GABAPENTIN d03182A C M79.2 Neuralgia and neuritis, unspecified A` E /@ A GLIMEPIRIDE d03864A C R73 Elevated blood glucose level A` E /@ A PIOGLITAZONE d04442A C E11 Type 2 diabetes mellitus A` E /@ A RAMIPRIL d00728A C E11.2 Type 2 diabetes mellitus with kidney complications A` E /@ A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia A` E /P A ACETAMINOPHEN; HYDROCODONE d03428A C 55555 AP E /P A ALPRAZOLAM d00168A CDp F41.9 Anxiety disorder, unspecified AP E /P A AMLODIPINE d00689A B[ I10 Essential (primary) hypertension AP E /P A CYANOCOBALAMIN d00413A C- E63.9 Nutritional deficiency, unspecified AP E /P A SERTRALINE d00880A D# F32.9 Major depressive disorder, single episode, unspecified AP E /` A . . . E /p A ATORVASTATIN d04105A0 C E78.0 Pure hypercholesterolemia A E /p A AZITHROMYCIN d00091A0 C T86.9P Prevent transplanted organ and tissue rejection A E /p A GLIPIZIDE d00246A0 C- E11 Type 2 diabetes mellitus A E /p A ITRACONAZOLE d00102A0 C B37 Candidiasis A E /p A METOCLOPRAMIDE d00298A0 C K21 Gastro-esophageal reflux disease A E /p A MYCOPHENOLATE MOFETIL d03839A0 C T86.9P Prevent transplanted organ and tissue rejection A E /p A OMEPRAZOLE d00325A0 C R12 Heartburn A E /p A PREDNISONE d00350A0 C T86.9P Prevent transplanted organ and tissue rejection A E /p A SULFAMETHOXAZOLE; TRIMETHOPRIM d00124A0 C T86.9P Prevent transplanted organ and tissue rejection A E /p A TACROLIMUS d03752A0 C T86.9P Prevent transplanted organ and tissue rejection A E / A ATENOLOL d00004A D I10 Essential (primary) hypertension A E / A FUROSEMIDE d00070A D R60.9 Edema, unspecified A E / A GEMFIBROZIL d00245A C E78.0 Pure hypercholesterolemia A E / A LISINOPRIL d00732A D I10 Essential (primary) hypertension A E / A METFORMIN d03807A Dc E11 Type 2 diabetes mellitus A E / A OMEPRAZOLE d00325A C K21 Gastro-esophageal reflux disease A E / A TERAZOSIN d00386A D N40 Enlarged prostate A E / A WARFARIN d00022A C D75.9P Prevent blood clots A E / A . . . E / A . . . E / A CITALOPRAM d04332A A G47.0 Insomnia A E / A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia AP E / A BUSPIRONE d00182A A F41.9 Anxiety disorder, unspecified AP E / A LISINOPRIL d00732A CDp I10 Essential (primary) hypertension AP E / A LOSARTAN d03821A B E87.6 Hypokalemia AP E / A RANITIDINE d00021A C- K57 Diverticular disease of intestine AP E / A . . . E / A . . . E / A . . . E 0 A AMLODIPINE d00689A C E78.0 Pure hypercholesterolemia A E 0 A BRIMONIDINE OPHTHALMIC d04048A CDp H40 Glaucoma A E 0 A BRINZOLAMIDE OPHTHALMIC d04301A C H40 Glaucoma A E 0 A HYDROCHLOROTHIAZIDE; LOSARTAN d03830A C I10 Essential (primary) hypertension A E 0 A INSULIN GLARGINE d04538A C[@ E11 Type 2 diabetes mellitus A E 0 A LOVASTATIN d00280A Cr E78.0 Pure hypercholesterolemia A E 0 A METFORMIN d03807A D E11 Type 2 diabetes mellitus A E 0 A METOPROLOL d00134A Cr I10 Essential (primary) hypertension A E 0 A SPIRONOLACTONE d00373A CDp I10 Essential (primary) hypertension A E 0 A . . . E 0 A ALLOPURINOL d00023A B M1A Chronic gout A E 0 A FLUOXETINE d00236A B F32.9 F41.9 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified A E 00 A . . . E 0@ A . . . E 0P A . . . E 0` A . . . E 0p A INSULIN LISPRO; INSULIN LISPRO PROTAMINE d04510A C E11 Type 2 diabetes mellitus A E 0p A LISINOPRIL d00732A C E11.2P Prevent diabetic kidney disease A E 0 A . . . E 0 A ROSUVASTATIN d04851A C E78.0 Pure hypercholesterolemia A E 0 A THYROID DESICCATED d00655A A E03.9 Hypothyroidism, unspecified A E 0 A ACETAMINOPHEN; HYDROCODONE d03428A Cr M79.1 Myalgia A` E 0 A AMLODIPINE d00689A C I10 Essential (primary) hypertension A` E 0 A ESOMEPRAZOLE d04749A C K30 Functional dyspepsia A` E 0 A GABAPENTIN d03182A C 99999 A` E 0 A PREDNISONE d00350A Ei M19.9 Osteoarthritis, unspecified site A` E 0 A VALSARTAN d04113A C I10 Essential (primary) hypertension A` E 0 A . . . E 0 A . . . E 0 A ACETAMINOPHEN; HYDROCODONE d03428A A M54 Dorsalgia A@ E 0 A METOPROLOL d00134A C I10 Essential (primary) hypertension A@ E 0 A OLMESARTAN d04801A C I10 Essential (primary) hypertension A@ E 0 A SPIRONOLACTONE d00373A C I10 Essential (primary) hypertension A@ E 0 A . . . E 0 A APIXABAN d07804A B D75.9P Prevent blood clots A` E 0 A ATORVASTATIN d04105A C E78.0 I10 Pure hypercholesterolemia Essential (primary) hypertension A` E 0 A METFORMIN d03807A Cr E11 Type 2 diabetes mellitus A` E 0 A METOPROLOL d00134A B I10 Essential (primary) hypertension A` E 0 A TORSEMIDE d03189A D R60.9 Edema, unspecified A` E 0 A VERAPAMIL d00048A D I48.9 Unspecified atrial fibrillation and atrial flutter A` E 1 A . . . E 1 A ETHINYL ESTRADIOL; NORETHINDRONE d03238A C N92 Excessive, frequent and irregular menstruation A E 1 A . . . E 10 A 77777 . . A E 1@ A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A0 E 1@ A HYDROCHLOROTHIAZIDE d00253A C[@ R60.9 Edema, unspecified A0 E 1@ A LEVOTHYROXINE d00278A D"8 E03.9 Hypothyroidism, unspecified A0 E 1P A . . . E 1` A . . . E 1p A ATORVASTATIN d04105A B R60.9 Edema, unspecified A@ E 1p A DICLOFENAC d00848A A0 E78.0 Pure hypercholesterolemia A@ E 1p A HYDROCODONE d03075A A0 M79.6 T14.9 Pain in limb, hand, foot, fingers and toes Unspecified injury A@ E 1p A RISPERIDONE d03180A A0 F31.9 Bipolar disorder, unspecified A@ E 1 A . . . E 1 A . . . E 1 A . . . E 1 A ESOMEPRAZOLE d04749A C[@ K30 Functional dyspepsia A E 1 A . . . E 1 A . . . E 1 A AMOXICILLIN d00088A A H66.9 Otitis media, unspecified A E 1 A . . . E 2 A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A C- I10 Essential (primary) hypertension A0 E 2 A IBUPROFEN d00015A C- M25.5 Z96 Pain in joint Presence of other functional implants A0 E 2 A METOPROLOL d00134A C- I10 Essential (primary) hypertension A0 E 2 A METFORMIN d03807A C- E11 Type 2 diabetes mellitus A E 2 A . . . E 20 A LISINOPRIL d00732A C I10 Essential (primary) hypertension A0 E 20 A METFORMIN d03807A C E11 Type 2 diabetes mellitus A0 E 20 A NIFEDIPINE d00051A C I10 Essential (primary) hypertension A0 E 2@ A PRAVASTATIN d00348A CDp E78.0 Pure hypercholesterolemia A E 2@ A TRAMADOL d03826A Cr M54 Dorsalgia A E 2P A . . . E 2` A . . . E 2p A . . . E 2 A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified A E 2 A METFORMIN d03807A C R73 Elevated blood glucose level A E 2 A DICLOFENAC d00848A B< M54 Dorsalgia A@ E 2 A LEVOTHYROXINE d00278A D E03.9 Hypothyroidism, unspecified A@ E 2 A LISINOPRIL d00732A BZ E11.2P Prevent diabetic kidney disease A@ E 2 A OLOPATADINE OPHTHALMIC d04117A Cr H10.1 Acute atopic conjunctivitis A@ E 2 A . . . E 2 A AMLODIPINE d00689A Cr I10 Essential (primary) hypertension A E 2 A OMEPRAZOLE d00325A C R12 Heartburn A E 2 A SOMATROPIN d00577A C Z79.890 Hormone replacement therapy A E 2 A . . . E 2 A . . . E 2 A . . . E 3 A . . . E 3 A ALBUTEROL d00749A B[ R06.02 R06.2 Shortness of breath Wheezing A E 3 A OSELTAMIVIR d04462A A J09 Influenza due to certain identified influenza viruses A E 30 A . . . E 3@ A LEVOTHYROXINE d00278A C"0 E03.9 Hypothyroidism, unspecified A E 3@ A SILDENAFIL d04299A C"0 N52.9 Male erectile dysfunction, unspecified A E 3P A DIAZEPAM d00148A C M62.83 Muscle spasm A@ E 3P A LOSARTAN d03821A C I10 Essential (primary) hypertension A@ E 3P A METFORMIN d03807A C E11 Type 2 diabetes mellitus A@ E 3P A SIMVASTATIN d00746A C E78.0P Prevent high cholesterol A@ E 3` A . . . E 3p A . . . E 3 A METRONIDAZOLE d00108A Ap B37 Candidiasis A E 3 A . . . E 3 A . . . E 3 A FLUTICASONE NASAL d04283A A J30.9 Allergic rhinitis, unspecified A E 3 A . . . E 3 A . . . E 3 A . . . E 3 A AMOXICILLIN d00088A A H66.9 Otitis media, unspecified A E 3 A CEFDINIR d04256A A@ H66.9 Otitis media, unspecified A E 4 A . . . E 4 A DORZOLAMIDE; TIMOLOL OPHTHALMIC d04303A B H40 Glaucoma A E 4 A EXEMESTANE d04461A C9 C50 Malignant neoplasm of breast A E 4 A ALLOPURINOL d00023A D M10.9P Prevent gout AP E 4 A ESOMEPRAZOLE d04749A CDp K30 Functional dyspepsia AP E 4 A LISINOPRIL d00732A CDp I10 Essential (primary) hypertension AP E 4 A PANTOPRAZOLE d04514A B B96.81 Helicobacter pylori [H. pylori] as the cause of diseases classified elsewhere AP E 4 A ROSUVASTATIN d04851A CDp E78.0 Pure hypercholesterolemia AP E 40 A . . . E 4@ A . . . E 4P A . . . E 4` A LISINOPRIL d00732A C I10 Essential (primary) hypertension A E 4` A SERTRALINE d00880A CDp F41.9 Anxiety disorder, unspecified A E 4p A . . . E 4 A . . . E 4 A AMPHETAMINE; DEXTROAMPHETAMINE d04035A B[ F90 F99 Attention-deficit hyperactivity disorders Mental disorder, not otherwise specified A E 4 A CLONIDINE d00044A A@ G47.0 Insomnia A E 4 A . . . E 4 A ACETAMINOPHEN; HYDROCODONE d03428A D M54 Dorsalgia A0 E 4 A CYCLOBENZAPRINE d00963A D M54 Dorsalgia A0 E 4 A IBUPROFEN d00015A D M54 Dorsalgia A0 E 4 A OMEPRAZOLE d00325A Cr R12 Heartburn A E 4 A LEVOTHYROXINE d00278A D E03.9 Hypothyroidism, unspecified A E 4 A FAMOTIDINE d00141A B 99999 A E 4 A AZITHROMYCIN d00091A AP J40 Bronchitis, not specified as acute or chronic A0 E 4 A DOXYCYCLINE d00037A A J18.9 Pneumonia, unspecified organism A0 E 4 A OLMESARTAN d04801A CDp I10 Essential (primary) hypertension A0 E 5 A ATORVASTATIN d04105A Cr E78.0 Pure hypercholesterolemia A E 5 A AZITHROMYCIN d00091A AP J00 Acute nasopharyngitis [common cold] A E 5 A CARVEDILOL d03847A CDp I10 Essential (primary) hypertension A E 5 A GABAPENTIN d03182A B M79.2 Neuralgia and neuritis, unspecified A E 5 A GLIPIZIDE d00246A D E11 Type 2 diabetes mellitus A E 5 A HYDROCHLOROTHIAZIDE; VALSARTAN d04293A CDp I10 Essential (primary) hypertension A E 5 A METFORMIN d03807A D E11 Type 2 diabetes mellitus A E 5 A NAPROXEN d00019A C- M19.9 Osteoarthritis, unspecified site A E 5 A PANTOPRAZOLE d04514A C- K21 Gastro-esophageal reflux disease A E 5 A . . . E 5 A . . . E 50 A ETHINYL ESTRADIOL; NORGESTIMATE d03781A C Z79.3 Long term (current) use of hormonal contraceptives A E 5@ A AMLODIPINE d00689A B I21.P Prevent heart attack/myocardial infarction A E 5@ A ATORVASTATIN d04105A B E78.0 Pure hypercholesterolemia A E 5@ A BUSPIRONE d00182A C F41.9 Anxiety disorder, unspecified A E 5@ A CETIRIZINE d03827A B 99999 A E 5@ A DIVALPROEX SODIUM d03833A C F32.9 Major depressive disorder, single episode, unspecified A E 5@ A HYDROCHLOROTHIAZIDE d00253A C- I10 Essential (primary) hypertension A E 5@ A QUETIAPINE d04220A C F33.9 Major depressive disorder, recurrent, unspecified A E 5@ A SERTRALINE d00880A C F41.0 Panic disorder [episodic paroxysmal anxiety] without agoraphobia A E 5P A APIXABAN d07804A Cr D75.9P Prevent blood clots A E 5P A CARVEDILOL d03847A Dc I50.9 Heart failure, unspecified A E 5P A FUROSEMIDE d00070A D I50.9 Heart failure, unspecified A E 5P A GABAPENTIN d03182A B[ M79.2 Neuralgia and neuritis, unspecified A E 5P A HYDRALAZINE d00132A C- I10 Essential (primary) hypertension A E 5P A LOSARTAN d03821A B[ I50.9 Heart failure, unspecified A E 5P A METHADONE d00050A Cr G89 Pain, not elsewhere classified A E 5P A OXYCODONE d00329A C T14.9 Unspecified injury A E 5P A POTASSIUM CHLORIDE d00345A D E87.6 Hypokalemia A E 5P A SIMVASTATIN d00746A Dc E78.0 Pure hypercholesterolemia A E 5` A ATOVAQUONE d01120A B# B99.9 Unspecified infectious disease A0 E 5` A CIPROFLOXACIN d00011A BF R19.7 Diarrhea, unspecified A0 E 5` A MUPIROCIN TOPICAL d01267A B# L08.9 Local infection of the skin and subcutaneous tissue, unspecified A0 E 5p A . . . E 5 A SIMVASTATIN d00746A D> E78.0 Pure hypercholesterolemia A E 5 A TERAZOSIN d00386A D> N40 Enlarged prostate A E 5 A . . . E 5 A FAMOTIDINE; IBUPROFEN d07764A A M54 Dorsalgia A@ E 5 A HYDROCODONE d03075A C M54 Dorsalgia A@ E 5 A LEVOTHYROXINE d00278A D E03.9 Hypothyroidism, unspecified A@ E 5 A OMEPRAZOLE d00325A C K25.P Prevent gastric ulcer A@ E 5 A . . . E 5 A ALLOPURINOL d00023A C M1A Chronic gout A` E 5 A COBICISTAT; DARUNAVIR d08305A C B20 Human immunodeficiency virus [HIV] disease A` E 5 A LOSARTAN d03821A CDp I10 Essential (primary) hypertension A` E 5 A METOPROLOL d00134A CDp I10 Essential (primary) hypertension A` E 5 A OMEPRAZOLE d00325A CDp K21 Gastro-esophageal reflux disease A` E 5 A RALTEGRAVIR d07048A Cr B20 Human immunodeficiency virus [HIV] disease A` E 5 A . . . E 5 A . . . E 5 A . . . E 6 A ALENDRONATE d03849A C M81 Osteoporosis without current pathological fracture Ap E 6 A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia Ap E 6 A DILTIAZEM d00045A Cr I10 Essential (primary) hypertension Ap E 6 A FAMOTIDINE d00141A Cr K30 Functional dyspepsia Ap E 6 A LOSARTAN d03821A C I10 Essential (primary) hypertension Ap E 6 A METFORMIN d03807A C E11 Type 2 diabetes mellitus Ap E 6 A OMEPRAZOLE d00325A C K30 Functional dyspepsia Ap E 6 A . . . E 6 A . . . E 60 A . . . E 6@ A . . . E 6P A . . . E 6` A BACLOFEN d00967A Bz M62.83 Muscle spasm A0 E 6` A CLONAZEPAM d00197A B M62.83 Muscle spasm A0 E 6` A LEVETIRACETAM d04499A Bz G40 Epilepsy and recurrent seizures A0 E 6p A TRIAMCINOLONE TOPICAL d03206A B L20.9 Atopic dermatitis, unspecified A E 6 A . . . E 6 A AMPHETAMINE; DEXTROAMPHETAMINE d04035A C F90 Attention-deficit hyperactivity disorders A E 6 A CETIRIZINE d03827A Cr T78.40 Allergy, unspecified A E 6 A CLOPIDOGREL d04258A Cr I49.9 Cardiac arrhythmia, unspecified A E 6 A CYANOCOBALAMIN d00413A Cr D64.9 Anemia, unspecified A E 6 A DILTIAZEM d00045A Cr I20.9 Angina pectoris, unspecified A E 6 A DOCUSATE d01021A Cr K59.0 Constipation A E 6 A FLUOXETINE d00236A Cr F43.1 Post-traumatic stress disorder (PTSD) A E 6 A FLUTICASONE NASAL d04283A C J30.2 Other seasonal allergic rhinitis A E 6 A INSULIN GLARGINE d04538A C E11 Type 2 diabetes mellitus A E 6 A LOSARTAN d03821A Cr I10 I50.9 Essential (primary) hypertension Heart failure, unspecified A E 6 A METFORMIN d03807A D E11 Type 2 diabetes mellitus A E 6 A RANITIDINE d00021A Cr K30 Functional dyspepsia A E 6 A TORSEMIDE d03189A Cr R60.9 Edema, unspecified A E 6 A . . . E 6 A ATORVASTATIN d04105A Cr E78.0 Pure hypercholesterolemia A0 E 6 A LISINOPRIL d00732A Cr I10 Essential (primary) hypertension A0 E 6 A OLANZAPINE d04050A D"8 F29 Unspecified psychosis not due to a substance or known physiological condition A0 E 6 A AMOXICILLIN d00088A Ap K04.7 Periapical abscess without sinus A E 6 A . . . E 6 A . . . E 7 A AMLODIPINE d00689A CDp I10 Essential (primary) hypertension AP E 7 A FINASTERIDE d00563A CDp N40 Enlarged prostate AP E 7 A LOSARTAN d03821A B= I10 Essential (primary) hypertension AP E 7 A METFORMIN d03807A B= E11.P Prevent diabetes AP E 7 A TAMSULOSIN d04121A CDp N40 Enlarged prostate AP E 7 A ARMODAFINIL d06842A C[@ G47.9 Sleep disorder, unspecified A E 7 A CYCLOBENZAPRINE d00963A Cr M79.7 Fibromyalgia A E 7 A ESOMEPRAZOLE d04749A C- K21 Gastro-esophageal reflux disease A E 7 A ETODOLAC d00851A B[ M19.9 Osteoarthritis, unspecified site A E 7 A GABAPENTIN d03182A C M79.7 Fibromyalgia A E 7 A HYDROXYCHLOROQUINE d00817A B= M06.9 Rheumatoid arthritis, unspecified A E 7 A TOPIRAMATE d04115A D G43 Migraine A E 7 A TRAMADOL d03826A C M79.7 Fibromyalgia A E 7 A VENLAFAXINE d03181A Dc G43.P Prevent migraine A E 7 A . . . E 70 A DOXYCYCLINE d00037A B L08.9 Local infection of the skin and subcutaneous tissue, unspecified A E 7@ A . . . E 7P A . . . E 7` A . . . E 7p A . . . E 7 A . . . E 7 A . . . E 7 A . . . E 7 A CEFDINIR d04256A A J40 Bronchitis, not specified as acute or chronic Ap E 7 A DOXAZOSIN d00726A CP 99999 Ap E 7 A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A CP R60.9 Edema, unspecified Ap E 7 A METFORMIN d03807A D R73 Elevated blood glucose level Ap E 7 A METHYLPREDNISOLONE d00293A A J20.9 Acute bronchitis, unspecified Ap E 7 A POTASSIUM CHLORIDE d00345A CP E87.6 Hypokalemia Ap E 7 A PRAVASTATIN d00348A CP E78.0 Pure hypercholesterolemia Ap E 7 A AZITHROMYCIN d00091A A0 J20.9 Acute bronchitis, unspecified A E 7 A AMOXICILLIN d00088A A@ J00 Acute nasopharyngitis [common cold] A E 7 A PREDNISOLONE d00084A A J00 R09.81 Acute nasopharyngitis [common cold] Nasal congestion A E 7 A LEVOTHYROXINE d00278A B[ E03.9 Hypothyroidism, unspecified AP E 7 A LISINOPRIL d00732A CDp I10 Essential (primary) hypertension AP E 7 A MELOXICAM d04532A C M13 Other arthritis AP E 7 A METFORMIN d03807A CDp E11 Type 2 diabetes mellitus AP E 7 A SIMVASTATIN d00746A CDp E78.0 Pure hypercholesterolemia AP E 7 A . . . E 8 A AMLODIPINE d00689A C- I10 Essential (primary) hypertension A E 8 A SPIRONOLACTONE d00373A BZ I10 Essential (primary) hypertension A E 8 A 99999 . . A E 8 A . . . E 80 A . . . E 8@ A . . . E 8P A . . . E 8` A AMOXICILLIN d00088A Ap J02.0 Streptococcal pharyngitis A E 8` A BROMPHENIRAMINE; DEXTROMETHORPHAN; PSEUDOEPHEDRINE d03368A A J02.0 Streptococcal pharyngitis A E 8p A 99999 . . A E 8 A SUMATRIPTAN d03160A BZ G43 Migraine A E 8 A TOPIRAMATE d04115A C M79.7 Fibromyalgia A E 8 A . . . E 8 A . . . E 8 A BROMFENAC OPHTHALMIC d05518A0 C- H57.9 Unspecified disorder of eye and adnexa A` E 8 A FLUTICASONE NASAL d04283A0 C T78.40 Allergy, unspecified A` E 8 A FUROSEMIDE d00070A0 C R60.9 Edema, unspecified A` E 8 A LEVOTHYROXINE d00278A0 D# E03.9 Hypothyroidism, unspecified A` E 8 A PANTOPRAZOLE d04514A0 C"0 K25.P K30 Prevent gastric ulcer Functional dyspepsia A` E 8 A PRAVASTATIN d00348A0 CL E78.0 Pure hypercholesterolemia A` E 8 A DIVALPROEX SODIUM d03833A B G47.9 Sleep disorder, unspecified A E 8 A ETHINYL ESTRADIOL; NORGESTIMATE d03781A C[@ N92 Excessive, frequent and irregular menstruation A E 8 A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A0 E 8 A LEVOTHYROXINE d00278A Cr E03.9 Hypothyroidism, unspecified A0 E 8 A RALOXIFENE d04261A Cr M85.9 Disorder of bone density and structure, unspecified A0 E 9 A . . . E 9 A . . . E 9 A . . . E 90 A 99999 . . AP E 90 A AMOXICILLIN d00088A Ap K04.7 Periapical abscess without sinus AP E 90 A GABAPENTIN d03182A B M25.5 Pain in joint AP E 90 A METFORMIN d03807A Ei E11 Type 2 diabetes mellitus AP E 90 A OMEPRAZOLE d00325A Ei R51 Headache AP E 9@ A . . . E 9P A . . . E 9` A . . . E 9p A . . . E 9 A . . . E 9 A . . . E 9 A . . . E 9 A . . . E 9 A CLOPIDOGREL d04258A D/ D75.9P Prevent blood clots A0 E 9 A PANTOPRAZOLE d04514A Cr K21 K25 K30 Gastro-esophageal reflux disease Gastric ulcer Functional dyspepsia A0 E 9 A VERAPAMIL d00048A C- I10 Essential (primary) hypertension A0 E 9 A . . . E 9 A . . . E 9 A AMLODIPINE d00689A C I10 Essential (primary) hypertension A E 9 A LOSARTAN d03821A C I10 Essential (primary) hypertension A E : A CEPHALEXIN d00096A A L08.9 Local infection of the skin and subcutaneous tissue, unspecified A` E : A ENALAPRIL d00013A C- I10 Essential (primary) hypertension A` E : A LEVOTHYROXINE d00278A C- E03.9 Hypothyroidism, unspecified A` E : A RIVAROXABAN d07356A C"0 D75.9P Prevent blood clots A` E : A ROSUVASTATIN d04851A C"0 E78.0 Pure hypercholesterolemia A` E : A SULFAMETHOXAZOLE; TRIMETHOPRIM d00124A A L08.9 Local infection of the skin and subcutaneous tissue, unspecified A` E : A CEFDINIR d04256A A H66.9 Otitis media, unspecified A E : A . . . E :0 A CLONIDINE d00044A C[@ G47.0 Insomnia A E :0 A METHYLPHENIDATE d00900A Cr F90 Attention-deficit hyperactivity disorders A E :@ A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A@ E :@ A FLUTICASONE NASAL d04283A B= R09.81 Nasal congestion A@ E :@ A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified A@ E :@ A TELMISARTAN d04364A C- I10 Essential (primary) hypertension A@ E :P A SULFAMETHOXAZOLE; TRIMETHOPRIM d00124A A@ T14.9 Unspecified injury A E :` A . . . E :p A . . . E : A . . . E : A . . . E : A . . . E : A . . . E : A . . . E : A . . . E : A . . . E : A . . . E ; A LOSARTAN d03821A B I10 Essential (primary) hypertension A E ; A METOPROLOL d00134A B I21.P Prevent heart attack/myocardial infarction A E ; A . . . E ; A . . . E ;0 A ATORVASTATIN d04105A Cr E78.0 Pure hypercholesterolemia A E ;0 A BUPROPION d00181A B R45 Symptoms and signs involving emotional state A E ;0 A CYCLOBENZAPRINE d00963A A M79.1 Myalgia A E ;0 A FENOFIBRATE d04286A Cr E78.0 Pure hypercholesterolemia A E ;0 A HYDROCODONE d03075A A M54 Dorsalgia A E ;0 A INSULIN ASPART d04697A Cr E11 Type 2 diabetes mellitus A E ;0 A INSULIN DETEMIR d05436A Cr E11 Type 2 diabetes mellitus A E ;0 A LISINOPRIL d00732A C I10 Essential (primary) hypertension A E ;0 A LORAZEPAM d00149A A F41.9 G47.0 Anxiety disorder, unspecified Insomnia A E ;0 A METOPROLOL d00134A D I50.9 Heart failure, unspecified A E ;0 A TERAZOSIN d00386A C N40 Enlarged prostate A E ;0 A WARFARIN d00022A D D75.9P Prevent blood clots A E ;@ A . . . E ;P A . . . E ;` A ATENOLOL d00004A Dc I10 Essential (primary) hypertension AP E ;` A EZETIMIBE d04824A D E78.0 E78.1 Pure hypercholesterolemia Pure hyperglyceridemia AP E ;` A LOSARTAN d03821A Dc I10 Essential (primary) hypertension AP E ;` A PANTOPRAZOLE d04514A C[@ K30 Functional dyspepsia AP E ;` A SIMVASTATIN d00746A D= E78.0 E78.1 Pure hypercholesterolemia Pure hyperglyceridemia AP E ;p A LOSARTAN d03821A B I10 Essential (primary) hypertension A E ; A . . . E ; A . . . E ; A LISINOPRIL d00732A Cr I10 Essential (primary) hypertension A E ; A METFORMIN d03807A CDp E11.P Prevent diabetes A E ; A . . . E ; A . . . E ; A MONTELUKAST d04289A B= R05 Cough A0 E ; A MOXIFLOXACIN OPHTHALMIC d04860A Ap H10 Conjunctivitis A0 E ; A NYSTATIN TOPICAL d04399A AP B35 Dermatophytosis A0 E ; A . . . E ; A . . . E < A . . . E < A APIXABAN d07804A CDp D75.9P Prevent blood clots A0 E < A LOSARTAN d03821A C[@ I10 Essential (primary) hypertension A0 E < A PANTOPRAZOLE d04514A Cr K30 Functional dyspepsia A0 E < A . . . E <0 A . . . E <@ A . . . E
A ALBUTEROL d00749A D J45 Asthma A E > A ETHINYL ESTRADIOL; LEVONORGESTREL d03242A B Z79.3 Long term (current) use of hormonal contraceptives A E > A ALLOPURINOL d00023A Dc M10.9 Gout, unspecified AP E > A CHLORTHALIDONE d00192A Dc I10 Essential (primary) hypertension AP E > A GABAPENTIN d03182A B[ M79.2 Neuralgia and neuritis, unspecified AP E > A LISINOPRIL d00732A D I10 Essential (primary) hypertension AP E > A LOVASTATIN d00280A C- E78.0 Pure hypercholesterolemia AP E > A . . . E >0 A BRIMONIDINE OPHTHALMIC d04048A C- H40 Glaucoma Ap E >0 A CARVEDILOL d03847A C[@ I10 Essential (primary) hypertension Ap E >0 A FLUTICASONE NASAL d04283A C J30.9 R09.81 Allergic rhinitis, unspecified Nasal congestion Ap E >0 A GLIPIZIDE d00246A C- E11 Type 2 diabetes mellitus Ap E >0 A LISINOPRIL d00732A C[@ I10 Essential (primary) hypertension Ap E >0 A METFORMIN d03807A C[@ E11 Type 2 diabetes mellitus Ap E >0 A MONTELUKAST d04289A C[@ J30.9 Allergic rhinitis, unspecified Ap E >@ A . . . E >P A BUPROPION d00181A D F32.9 Major depressive disorder, single episode, unspecified A E >P A LISDEXAMFETAMINE d06663A C F90 Attention-deficit hyperactivity disorders A E >` A . . . E >p A . . . E > A ALBUTEROL d00749A A` R05 R06.2 Cough Wheezing A0 E > A MONTELUKAST d04289A A` T78.40 Allergy, unspecified A0 E > A PREDNISONE d00350A A L50 Urticaria A0 E > A . . . E > A ARIPIPRAZOLE d04825A C F32.9 F41.9 G47.0 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified Insomnia A E > A LURASIDONE d07705A A0 F41.9 G47.0 Anxiety disorder, unspecified Insomnia A E > A . . . E > A CETIRIZINE d03827A D J30.1 T78.40 Allergic rhinitis due to pollen Allergy, unspecified A@ E > A LISINOPRIL d00732A Cr E78.0 Pure hypercholesterolemia A@ E > A OMEPRAZOLE d00325A D K30 Functional dyspepsia A@ E > A WARFARIN d00022A Cr Z79.0 Long term (current) use of anticoagulants and antithrombotics/antiplatelets A@ E > A . . . E > A . . . E > A AMLODIPINE d00689A C- K21 Gastro-esophageal reflux disease A` E > A CHOLESTYRAMINE d00193A C- E78.0 Pure hypercholesterolemia A` E > A DICYCLOMINE d00999A Cr R10 Abdominal and pelvic pain A` E > A NAPROXEN d00019A C M19.9 Osteoarthritis, unspecified site A` E > A PANTOPRAZOLE d04514A C[@ K22 Other diseases of esophagus A` E > A SUCRALFATE d00377A CDp K31.9 Disease of stomach and duodenum, unspecified A` E ? A . . . E ? A . . . E ? A . . . E ?0 A . . . E ?@ A . . . E ?P A ALLOPURINOL d00023A C M1A Chronic gout A E ?P A BUMETANIDE d00179A C R60.9 Edema, unspecified A E ?P A COLCHICINE d00150A C[@ M1A Chronic gout A E ?P A FAMOTIDINE d00141A C K30 Functional dyspepsia A E ?P A GLIPIZIDE d00246A C E11 Type 2 diabetes mellitus A E ?P A LISINOPRIL d00732A C I10 Essential (primary) hypertension A E ?P A METFORMIN; SITAGLIPTIN d06720A C E11 Type 2 diabetes mellitus A E ?P A PREGABALIN d05508A Cr E11.4 Type 2 diabetes mellitus with neurological complications A E ?P A SOTALOL d00371A C I49.9 Cardiac arrhythmia, unspecified A E ?P A WARFARIN d00022A C R00 Abnormalities of heart beat A E ?` A ATORVASTATIN d04105A B E78.0 Pure hypercholesterolemia AP E ?` A BUSPIRONE d00182A CDp F41.9 Anxiety disorder, unspecified AP E ?` A ESCITALOPRAM d04812A CDp F32.9 F43.1 Major depressive disorder, single episode, unspecified Post-traumatic stress disorder (PTSD) AP E ?` A SULFASALAZINE d00379A D% K51 Ulcerative colitis AP E ?` A TRAMADOL d03826A C- M25.5 M54 T14.9 Pain in joint Dorsalgia Unspecified injury AP E ?p A PANTOPRAZOLE d04514A C R12 Heartburn A E ? A DULAGLUTIDE d08290A B E11 Type 2 diabetes mellitus Ap E ? A GABAPENTIN d03182A Cr M79.2 Neuralgia and neuritis, unspecified Ap E ? A LISINOPRIL d00732A D I10 Essential (primary) hypertension Ap E ? A METFORMIN d03807A C E11 Type 2 diabetes mellitus Ap E ? A OMEPRAZOLE d00325A D K21 Gastro-esophageal reflux disease Ap E ? A SIMVASTATIN d00746A D E78.0 Pure hypercholesterolemia Ap E ? A TRAZODONE d00395A C G47.0 Insomnia Ap E ? A AMOXICILLIN d00088A Ap K04.7 Periapical abscess without sinus A E ? A LEVOTHYROXINE d00278A C[@ E07.9 Disorder of thyroid, unspecified A E ? A . . . E ? A . . . E ? A . . . E ? A AMLODIPINE d00689A B I10 Essential (primary) hypertension A E ? A ATORVASTATIN d04105A B I21.P Prevent heart attack/myocardial infarction A E ? A HYDRALAZINE d00132A Ei I50.9 Heart failure, unspecified A E ? A INSULIN ASPART d04697A D9 E11 Type 2 diabetes mellitus A E ? A INSULIN GLARGINE d04538A D9 E11 Type 2 diabetes mellitus A E ? A ISOSORBIDE d00653A B H40 Glaucoma A E ? A METOPROLOL d00134A B I50.9 Heart failure, unspecified A E ? A RANOLAZINE d05719A B I20.9 Angina pectoris, unspecified A E ? A TICAGRELOR d07721A Ei 99999 A E ? A LISINOPRIL d00732A C I10 Essential (primary) hypertension A E ? A METOPROLOL d00134A C- I10 Essential (primary) hypertension A E ? A AMLODIPINE; BENAZEPRIL d03829A C I10 Essential (primary) hypertension A0 E ? A DESVENLAFAXINE d07113A Dc F32.9 Major depressive disorder, single episode, unspecified A0 E ? A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A C I10 Essential (primary) hypertension A0 E @ A ATORVASTATIN d04105A Cr E78.0 Pure hypercholesterolemia AP E @ A FAMOTIDINE d00141A C- K30 Functional dyspepsia AP E @ A FUROSEMIDE d00070A C- I10 Essential (primary) hypertension AP E @ A GABAPENTIN d03182A C- M79.2 Neuralgia and neuritis, unspecified AP E @ A INSULIN ISOPHANE (NPH) d04370A C E11 Type 2 diabetes mellitus AP E @ A AMLODIPINE d00689A C- I10 Essential (primary) hypertension A E @ A LEVOTHYROXINE d00278A C- E03.9 Hypothyroidism, unspecified A E @ A . . . E @0 A AMLODIPINE d00689A CDp I10 Essential (primary) hypertension A E @@ A . . . E @P A 99999 . . A E @P A LISINOPRIL d00732A CDp I10 Essential (primary) hypertension A E @` A ATORVASTATIN d04105A Cr E78.0 Pure hypercholesterolemia A E @` A CILOSTAZOL d04382A CDp I70 Atherosclerosis A E @` A CLOPIDOGREL d04258A CDp D75.9P Prevent blood clots A E @` A INSULIN GLARGINE d04538A C E11 Type 2 diabetes mellitus A E @` A ISOSORBIDE MONONITRATE d00269A Cr R07.9 Chest pain, unspecified A E @` A LISINOPRIL d00732A C I10 Essential (primary) hypertension A E @` A MELOXICAM d04532A C M06.9 Rheumatoid arthritis, unspecified A E @` A METFORMIN d03807A C E11 Type 2 diabetes mellitus A E @` A METOPROLOL d00134A CDp I10 Essential (primary) hypertension A E @` A OXYBUTYNIN d00328A Cr N32.81 R35 Overactive bladder Polyuria A E @` A PANTOPRAZOLE d04514A Cr K21 Gastro-esophageal reflux disease A E @` A PIOGLITAZONE d04442A C[@ E11 Type 2 diabetes mellitus A E @p A . . . E @ A ETONOGESTREL d04772A C Z79.3 Long term (current) use of hormonal contraceptives A E @ A MONTELUKAST d04289A CDp J45 R06.9 Asthma Unspecified abnormalities of breathing A E @ A . . . E @ A . . . E @ A . . . E @ A . . . E @ A AMLODIPINE d00689A C I10 Essential (primary) hypertension A E @ A ATENOLOL d00004A C I10 Essential (primary) hypertension A E @ A CLONIDINE d00044A C I10 Essential (primary) hypertension A E @ A GABAPENTIN d03182A C E11.4 Type 2 diabetes mellitus with neurological complications A E @ A GLIMEPIRIDE d03864A C E11 Type 2 diabetes mellitus A E @ A LEVOTHYROXINE d00278A C E05 Thyrotoxicosis [hyperthyroidism] A E @ A LISINOPRIL d00732A C I21.P Prevent heart attack/myocardial infarction A E @ A METFORMIN d03807A C R73 Elevated blood glucose level A E @ A NAPROXEN d00019A B M19.9 Osteoarthritis, unspecified site A E @ A TAMSULOSIN d04121A C R35 Polyuria A E @ A . . . E @ A MONTELUKAST d04289A Bz R06.2 Wheezing A E A A . . . E A A . . . E A A . . . E A0 A LACTULOSE d01024A B K59.0 Constipation A E A@ A RANITIDINE d00021A BL K21 Gastro-esophageal reflux disease A E AP A CITALOPRAM d04332A C- F32.9 Major depressive disorder, single episode, unspecified A E AP A NAPROXEN d00019A C- N94 Pain and other conditions associated with female genital organs and menstrual cycle A E A` A . . . E Ap A . . . E A A . . . E A A INSULIN LISPRO d04373A D E10 Type 1 diabetes mellitus A E A A LOSARTAN d03821A C I10 Essential (primary) hypertension A E A A . . . E A A AZITHROMYCIN d00091A AP J40 Bronchitis, not specified as acute or chronic A E A A . . . E A A DULOXETINE d05355A B[ R45 Symptoms and signs involving emotional state A0 E A A INSULIN ASPART d04697A D E11 Type 2 diabetes mellitus A0 E A A LEVOTHYROXINE d00278A C"0 E03.9 Hypothyroidism, unspecified A0 E A A TELMISARTAN d04364A D I10 Essential (primary) hypertension A E B A . . . E B A ABATACEPT d05694A C M06.9 Rheumatoid arthritis, unspecified A@ E B A HYDROXYCHLOROQUINE d00817A CDp M06.9 Rheumatoid arthritis, unspecified A@ E B A LEFLUNOMIDE d04349A CDp M06.9 Rheumatoid arthritis, unspecified A@ E B A SULFASALAZINE d00379A CDp M06.9 Rheumatoid arthritis, unspecified A@ E B A . . . E B0 A . . . E B@ A TRETINOIN TOPICAL d01244A A L70 Acne A E BP A 99999 . . A E B` A . . . E Bp A MINOCYCLINE d00110A A L70 Acne A E B A DICYCLOMINE d00999A A K58 Irritable bowel syndrome A E B A LEVOTHYROXINE d00278A D E03.9 Hypothyroidism, unspecified A E B A . . . E B A . . . E B A . . . E B A . . . E B A . . . E B A ETHINYL ESTRADIOL; NORETHINDRONE d03238A D Z79.3 Long term (current) use of hormonal contraceptives A E B A GEMFIBROZIL d00245A C[@ E78.0 Pure hypercholesterolemia A E C A . . . E C A . . . E C A . . . E C0 A . . . E C@ A . . . E CP A . . . E C` A . . . E Cp A . . . E C A OMEPRAZOLE d00325A CDp K30 Functional dyspepsia A0 E C A OXYBUTYNIN d00328A C[@ R35 Polyuria A0 E C A ROSUVASTATIN d04851A C E78.0 Pure hypercholesterolemia A0 E C A . . . E C A . . . E C A . . . E C A . . . E C A ETHINYL ESTRADIOL; NORGESTIMATE d03781A B Z79.3 Long term (current) use of hormonal contraceptives A E C A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A D I10 Essential (primary) hypertension A E C A INSULIN GLARGINE d04538A D E11 Type 2 diabetes mellitus A E C A ISOSORBIDE MONONITRATE d00269A D I21.P Prevent heart attack/myocardial infarction A E C A LIRAGLUTIDE d07466A Cr R73 Elevated blood glucose level A E C A METFORMIN d03807A D E11 Type 2 diabetes mellitus A E C A METOPROLOL d00134A D I49.9 Cardiac arrhythmia, unspecified A E C A PANTOPRAZOLE d04514A D K21 Gastro-esophageal reflux disease A E C A SIMVASTATIN d00746A D E78.0 Pure hypercholesterolemia A E C A ALPRAZOLAM d00168A C F32.9 F41.9 G47.0 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified Insomnia A E C A BUSPIRONE d00182A C F32.9 F33.9 F41.9 Major depressive disorder, single episode, unspecified Major depressive disorder, recurrent, unspecified Anxiety disorder, unspecified A E C A CARVEDILOL d03847A C I10 I49.9 Essential (primary) hypertension Cardiac arrhythmia, unspecified A E C A CLONIDINE d00044A C[@ F41.9 I10 Anxiety disorder, unspecified Essential (primary) hypertension A E C A FUROSEMIDE d00070A CDp I10 N28.9 R60.9 Essential (primary) hypertension Disorder of kidney and ureter, unspecified Edema, unspecified A E C A LOSARTAN d03821A C I10 Essential (primary) hypertension A E C A METFORMIN d03807A C- E11 Type 2 diabetes mellitus A E C A PAROXETINE d03157A B F31.9 F32.9 F41.9 Bipolar disorder, unspecified Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified A E C A POTASSIUM CHLORIDE d00345A C- E87.6 Hypokalemia A E C A TRIMETHOPRIM d00123A AP A49.9P Prevent bacterial infection A E C A ZOLPIDEM d00910A B= G47.9 Sleep disorder, unspecified A E D A . . . E D A . . . E D A . . . E D0 A BUPRENORPHINE; NALOXONE d04819A C F11.23 Opioid dependence with withdrawal A E D@ A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A E D@ A EMPAGLIFLOZIN d08275A B R73 Elevated blood glucose level A E D@ A ESCITALOPRAM d04812A B F32.9 Major depressive disorder, single episode, unspecified A E D@ A FINASTERIDE d00563A CDp N40 Enlarged prostate A E D@ A GLIMEPIRIDE d03864A C E11 Type 2 diabetes mellitus A E D@ A LATANOPROST OPHTHALMIC d04017A Cr H40 Glaucoma A E D@ A METFORMIN d03807A C R73 Elevated blood glucose level A E D@ A OMEPRAZOLE d00325A C"0 K21 Gastro-esophageal reflux disease A E D@ A RAMIPRIL d00728A C I10 Essential (primary) hypertension A E D@ A TRAZODONE d00395A C- G47.9 Sleep disorder, unspecified A E DP A METHYLPHENIDATE d00900A B= F90 Attention-deficit hyperactivity disorders A E DP A TRAZODONE d00395A B= G47.0 Insomnia A E D` A . . . E Dp A AMPHETAMINE; DEXTROAMPHETAMINE d04035A C F90 Attention-deficit hyperactivity disorders A@ E Dp A LURASIDONE d07705A C F31.9 Bipolar disorder, unspecified A@ E Dp A QUETIAPINE d04220A CDp G47.0 Insomnia A@ E Dp A TRAMADOL d03826A D= M79.7 Fibromyalgia A@ E D A . . . E D A . . . E D A BUPROPION d00181A B F32.9 Major depressive disorder, single episode, unspecified A E D A GABAPENTIN d03182A B B02 M79.2 Zoster [herpes zoster] Neuralgia and neuritis, unspecified A E D A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A C"0 I10 Essential (primary) hypertension A0 E D A PROPRANOLOL d00032A C"0 99999 A0 E D A SERTRALINE d00880A C"0 F41.9 Anxiety disorder, unspecified A0 E D A . . . E D A ATORVASTATIN d04105A Cr E78.0 Pure hypercholesterolemia A E D A BRIMONIDINE OPHTHALMIC d04048A CDp H40 Glaucoma A E D A FLUOXETINE d00236A D F32.9 Major depressive disorder, single episode, unspecified A E D A ISOSORBIDE MONONITRATE d00269A A` I10 I21.P Essential (primary) hypertension Prevent heart attack/myocardial infarction A E D A LEVOTHYROXINE d00278A D E03.9 Hypothyroidism, unspecified A E D A MELOXICAM d04532A B M54 Dorsalgia A E D A METOPROLOL d00134A C R07.9 Chest pain, unspecified A E D A NIFEDIPINE d00051A D' I10 Essential (primary) hypertension A E D A PREDNISONE d00350A D 55555 A E D A TIZANIDINE d04102A B[ M54 Dorsalgia A E D A TRAZODONE d00395A CDp G47.0 Insomnia A E D A TROSPIUM d04929A C- R35 Polyuria A E D A IBUPROFEN d00015A B K08.4 Partial loss of teeth A E D A . . . E E A . . . E E A AMLODIPINE d00689A C I10 Essential (primary) hypertension Ap E E A ATORVASTATIN d04105A B[ E78.0 Pure hypercholesterolemia Ap E E A BENAZEPRIL d00730A CDp I10 Essential (primary) hypertension Ap E E A GLIMEPIRIDE d03864A C E11 Type 2 diabetes mellitus Ap E E A METFORMIN d03807A Dc E11 Type 2 diabetes mellitus Ap E E A PIOGLITAZONE d04442A C E11 Type 2 diabetes mellitus Ap E E A SERTRALINE d00880A C F41.9 Anxiety disorder, unspecified Ap E E A CARVEDILOL d03847A C I50.9 Heart failure, unspecified A@ E E A HYDRALAZINE d00132A Cr I10 Essential (primary) hypertension A@ E E A LOSARTAN d03821A Cr I50.9 Heart failure, unspecified A@ E E A PRAVASTATIN d00348A C I21.P Prevent heart attack/myocardial infarction A@ E E0 A . . . E E@ A . . . E EP A . . . E E` A . . . E Ep A . . . E E A AMLODIPINE d00689A Cr I10 Essential (primary) hypertension A0 E E A HYDROCHLOROTHIAZIDE; LOSARTAN d03830A C- I10 Essential (primary) hypertension A0 E E A SERTRALINE d00880A C F41.9 Anxiety disorder, unspecified A0 E E A . . . E E A . . . E E A . . . E E A . . . E E A . . . E E A . . . E E A . . . E F A . . . E F A . . . E F A . . . E F0 A . . . E F@ A ETHINYL ESTRADIOL; NORETHINDRONE d03238A B= Z79.3 Long term (current) use of hormonal contraceptives A E FP A . . . E F` A . . . E Fp A AMLODIPINE d00689A C[@ I10 Essential (primary) hypertension A0 E Fp A LOSARTAN d03821A C[@ I10 Essential (primary) hypertension A0 E Fp A TRAZODONE d00395A CDp G47.0 Insomnia A0 E F A . . . E F A AMLODIPINE d00689A D I10 Essential (primary) hypertension AP E F A ATORVASTATIN d04105A D E78.0 Pure hypercholesterolemia AP E F A BENAZEPRIL d00730A D I10 Essential (primary) hypertension AP E F A GLIPIZIDE d00246A D E11 R73 Type 2 diabetes mellitus Elevated blood glucose level AP E F A METFORMIN d03807A D% E11 R73 Type 2 diabetes mellitus Elevated blood glucose level AP E F A . . . E F A . . . E F A . . . E F A ALLOPURINOL d00023A D# E79.9 M10.9 Disorder of purine and pyrimidine metabolism, unspecified Gout, unspecified A0 E F A IBUPROFEN d00015A CDp M1A Chronic gout A0 E F A SIMVASTATIN d00746A Cr E78.0 Pure hypercholesterolemia A0 E F A DILTIAZEM d00045A C- I10 Essential (primary) hypertension A E F A FUROSEMIDE d00070A Ei R60.9 R73 Edema, unspecified Elevated blood glucose level A E F A GABAPENTIN d03182A C- R52 Pain, unspecified A E F A GLIPIZIDE d00246A C E11 Type 2 diabetes mellitus A E F A LINACLOTIDE d07902A Bz K59.0 Constipation A E F A LOVASTATIN d00280A C[@ E78.0 Pure hypercholesterolemia A E F A METHOTREXATE d00060A B= R21 Rash and other nonspecific skin eruption A E F A QUINAPRIL d00365A C[@ I10 Essential (primary) hypertension A E F A SITAGLIPTIN d05896A C"@ E11 Type 2 diabetes mellitus A E F A TIZANIDINE d04102A CDp M62.83 Muscle spasm A E F A . . . E G A METHYLPHENIDATE d00900A Bz F90 Attention-deficit hyperactivity disorders A E G A LEVETIRACETAM d04499A C G40 Epilepsy and recurrent seizures A E G A . . . E G0 A ALPRAZOLAM d00168A D F41.9 Anxiety disorder, unspecified A@ E G0 A ATORVASTATIN d04105A C E78.0 M85.9 Pure hypercholesterolemia Disorder of bone density and structure, unspecified A@ E G0 A LEVOTHYROXINE d00278A C P E03.9 Hypothyroidism, unspecified A@ E G0 A LISINOPRIL d00732A Cr I10 Essential (primary) hypertension A@ E G@ A FLUTICASONE TOPICAL d04284A B L20.9 Atopic dermatitis, unspecified A E GP A . . . E G` A ALBUTEROL d00749A Ap R06.2 Wheezing A E G` A PREDNISOLONE d00084A AP B34.9 Viral infection, unspecified A E Gp A . . . E G A LOSARTAN d03821A CDp I10 Essential (primary) hypertension A E G A . . . E G A . . . E G A . . . E G A . . . E G A . . . E G A AMLODIPINE d00689A C- I10 Essential (primary) hypertension AP E G A GLIPIZIDE d00246A C- E11 Type 2 diabetes mellitus AP E G A LOSARTAN d03821A C- I10 Essential (primary) hypertension AP E G A METOPROLOL d00134A C- I10 R07.9 Essential (primary) hypertension Chest pain, unspecified AP E G A SIMVASTATIN d00746A C- E78.0 Pure hypercholesterolemia AP E G A . . . E H A 99999 . . A E H A . . . E H A . . . E H0 A GABAPENTIN d03182A C M54 Dorsalgia A0 E H0 A PREGABALIN d05508A B M79.2 Neuralgia and neuritis, unspecified A0 E H0 A VALSARTAN d04113A Ap I10 Essential (primary) hypertension A0 E H@ A . . . E HP A METOPROLOL d00134A C I10 Essential (primary) hypertension A E H` A GABAPENTIN d03182A C- M54 Dorsalgia AP E H` A GEMFIBROZIL d00245A C- E78.0 Pure hypercholesterolemia AP E H` A GLIMEPIRIDE d03864A C- R73 Elevated blood glucose level AP E H` A HYDROCHLOROTHIAZIDE; LOSARTAN d03830A C- I10 Essential (primary) hypertension AP E H` A METFORMIN d03807A C- R73 Elevated blood glucose level AP E Hp A . . . E H A CARVEDILOL d03847A C I10 Essential (primary) hypertension A` E H A COLCHICINE d00150A C[@ M1A Chronic gout A` E H A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified A` E H A LOSARTAN d03821A C I10 Essential (primary) hypertension A` E H A METOLAZONE d00299A C R60.9 Edema, unspecified A` E H A PRAVASTATIN d00348A C E78.0 Pure hypercholesterolemia A` E H A . . . E H A FLUTICASONE NASAL d04283A C J30.2 Other seasonal allergic rhinitis A E H A MONTELUKAST d04289A B J42 R06.2 Unspecified chronic bronchitis Wheezing A E H A . . . E H A FLUORIDE TOPICAL d04397A B[ K02 Dental caries A E H A GENTAMICIN d00014A A H10 Conjunctivitis A E H A . . . E H A . . . E H A AMLODIPINE; BENAZEPRIL d03829A C I10 Essential (primary) hypertension A0 E H A CLOPIDOGREL d04258A B I21.P Prevent heart attack/myocardial infarction A0 E H A METFORMIN d03807A Bz E11 Type 2 diabetes mellitus A0 E I A CITALOPRAM d04332A C F39 F84 F90 Unspecified mood [affective] disorder Pervasive developmental disorders Attention-deficit hyperactivity disorders AP E I A FLUTICASONE; SALMETEROL d04611A Cr J45 Asthma AP E I A GUANFACINE d00717A Cr F90 F91 R41 Attention-deficit hyperactivity disorders Conduct disorders Other symptoms and signs involving cognitive functions and awareness AP E I A METHYLPHENIDATE d00900A C F90 Attention-deficit hyperactivity disorders AP E I A MONTELUKAST d04289A Cr J30.9 J45 Allergic rhinitis, unspecified Asthma AP E I A . . . E I A FLUTICASONE NASAL d04283A C J30.2 J30.9 R09.81 Other seasonal allergic rhinitis Allergic rhinitis, unspecified Nasal congestion A E I0 A METHYLPHENIDATE d00900A C- F90 Attention-deficit hyperactivity disorders A E I@ A . . . E IP A . . . E I` A IBUPROFEN d00015A Bz M54 Dorsalgia A E Ip A ACYCLOVIR d00001A Dc B00.9 Herpesviral infection, unspecified A E I A . . . E I A ACETAMINOPHEN; HYDROCODONE d03428A C- M54 M79.2 Dorsalgia Neuralgia and neuritis, unspecified A0 E I A LINACLOTIDE d07902A C- K21 Gastro-esophageal reflux disease A0 E I A PANTOPRAZOLE d04514A B K59.0 Constipation A0 E I A . . . E I A . . . E I A PREDNISONE d00350A C L20.9 Atopic dermatitis, unspecified A E I A BUPROPION d00181A C"0 F39 F41.9 Unspecified mood [affective] disorder Anxiety disorder, unspecified A E I A . . . E I A . . . E J A ALLOPURINOL d00023A C- M10.9P Prevent gout AP E J A ATORVASTATIN d04105A C- I63.P Prevent stroke AP E J A CITALOPRAM d04332A C- F41.9 Anxiety disorder, unspecified AP E J A GLIMEPIRIDE d03864A C- E11 Type 2 diabetes mellitus AP E J A METOPROLOL d00134A C- I10 Essential (primary) hypertension AP E J A . . . E J A ETHINYL ESTRADIOL; NORETHINDRONE d03238A C Z79.3 Long term (current) use of hormonal contraceptives A E J A FLUTICASONE NASAL d04283A Cr J30.2 Other seasonal allergic rhinitis A E J0 A 99999 . . A E J@ A AMLODIPINE d00689A D I10 Essential (primary) hypertension Ap E J@ A ATORVASTATIN d04105A D E78.0 Pure hypercholesterolemia Ap E J@ A DONEPEZIL d04099A C R41 Other symptoms and signs involving cognitive functions and awareness Ap E J@ A GLIMEPIRIDE d03864A D E11 Type 2 diabetes mellitus Ap E J@ A LEVOTHYROXINE d00278A D E07.9 Disorder of thyroid, unspecified Ap E J@ A MEMANTINE d04899A B R41 Other symptoms and signs involving cognitive functions and awareness Ap E J@ A RIVAROXABAN d07356A CDp I80.3 Phlebitis and thrombophlebitis of lower extremities, unspecified Ap E JP A HYDROCORTISONE TOPICAL d03205A B[ R21 Rash and other nonspecific skin eruption A E J` A . . . E Jp A . . . E J A . . . E J A . . . E J A HYDROCHLOROTHIAZIDE d00253A C I10 Essential (primary) hypertension AP E J A LABETALOL d00016A C I10 Essential (primary) hypertension AP E J A METFORMIN d03807A B[ R73 Elevated blood glucose level AP E J A RISPERIDONE d03180A B G47.0 Insomnia AP E J A TRAZODONE d00395A CDp G47.0 Insomnia AP E J A ESTRADIOL d00537A D Z79.890 Hormone replacement therapy A0 E J A LEVOTHYROXINE d00278A D E03.9 Hypothyroidism, unspecified A0 E J A VALSARTAN d04113A D R60.9 Edema, unspecified A0 E J A FAMOTIDINE d00141A Ap R10 Abdominal and pelvic pain A E J A TRAZODONE d00395A Ap R51 Headache A E J A DULOXETINE d05355A C"0 F32.9 Major depressive disorder, single episode, unspecified A E J A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified A E J A MYCOPHENOLATE MOFETIL d03839A C- T86.9P Prevent transplanted organ and tissue rejection A E J A PANCRELIPASE d01002A D/ 55555 A E J A PREDNISONE d00350A C T86.9P Prevent transplanted organ and tissue rejection A E J A SUMATRIPTAN d03160A C G43 Migraine A E J A TACROLIMUS d03752A C- T86.9P Prevent transplanted organ and tissue rejection A E J A TRAZODONE d00395A C F41.9 G47.0 Anxiety disorder, unspecified Insomnia A E J A VALGANCICLOVIR d04755A C- B35 Dermatophytosis A E J A . . . E J A CETIRIZINE d03827A CDp J30.1 J30.9 T78.40 Allergic rhinitis due to pollen Allergic rhinitis, unspecified Allergy, unspecified A E K A HYDROXYZINE d00907A C F41.9 Anxiety disorder, unspecified A E K A RANITIDINE d00021A C K30 R12 Functional dyspepsia Heartburn A E K A HYDROCHLOROTHIAZIDE; LOSARTAN d03830A Cr I10 Essential (primary) hypertension Ap E K A MELOXICAM d04532A CDp M79.1 Myalgia Ap E K A METOPROLOL d00134A CP I10 Essential (primary) hypertension Ap E K A OXCARBAZEPINE d04513A C- M79.2 Neuralgia and neuritis, unspecified Ap E K A SIMVASTATIN d00746A Cr E78.0 Pure hypercholesterolemia Ap E K A TAMSULOSIN d04121A C N40 Enlarged prostate Ap E K A TIZANIDINE d04102A B G47.9 M62.83 M79.1 Sleep disorder, unspecified Muscle spasm Myalgia Ap E K A . . . E K0 A ALLOPURINOL d00023A C E79.9 Disorder of purine and pyrimidine metabolism, unspecified A E K0 A LOSARTAN d03821A CDp I10 Essential (primary) hypertension A E K@ A ETHINYL ESTRADIOL; NORGESTREL d03241A C Z79.3 Long term (current) use of hormonal contraceptives A E KP A . . . E K` A . . . E Kp A . . . E K A . . . E K A . . . E K A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A C- I10 Essential (primary) hypertension A E K A METFORMIN d03807A CDp E11 Type 2 diabetes mellitus A E K A . . . E K A AMLODIPINE d00689A C- I10 Essential (primary) hypertension A@ E K A GLIPIZIDE d00246A C E11 Type 2 diabetes mellitus A@ E K A LISINOPRIL d00732A C I10 Essential (primary) hypertension A@ E K A PIOGLITAZONE d04442A C E11 Type 2 diabetes mellitus A@ E K A BUPROPION d00181A A F41.9 Anxiety disorder, unspecified A E K A OMEPRAZOLE d00325A B= K21 Gastro-esophageal reflux disease A E K A . . . E K A . . . E L A LISINOPRIL d00732A B= N39.0 Urinary tract infection, site not specified A E L A METFORMIN d03807A B= E11 Type 2 diabetes mellitus A E L A CYCLOBENZAPRINE d00963A C M54 Dorsalgia A@ E L A GABAPENTIN d03182A B M79.2 Neuralgia and neuritis, unspecified A@ E L A IBUPROFEN d00015A C M54 Dorsalgia A@ E L A LOSARTAN d03821A C I10 Essential (primary) hypertension A@ E L A . . . E L0 A . . . E L@ A . . . E LP A ESCITALOPRAM d04812A CDp F32.9 Major depressive disorder, single episode, unspecified A E L` A . . . E Lp A . . . E L A . . . E L A . . . E L A CLONAZEPAM d00197A Cr F41.9 Anxiety disorder, unspecified A` E L A FLUOXETINE d00236A Cr F41.9 Anxiety disorder, unspecified A` E L A METOPROLOL d00134A C I10 Essential (primary) hypertension A` E L A NAPROXEN d00019A Cr M19.9 Osteoarthritis, unspecified site A` E L A OMEPRAZOLE d00325A C K21 Gastro-esophageal reflux disease A` E L A PRAVASTATIN d00348A C E78.0 Pure hypercholesterolemia A` E L A . . . E L A . . . E L A LISINOPRIL d00732A B I10 Essential (primary) hypertension A E L A METFORMIN d03807A B E11 Type 2 diabetes mellitus A E L A . . . E L A CLONIDINE d00044A Cr G47.0 Insomnia AP E L A DEXMETHYLPHENIDATE d04777A C[@ F90 Attention-deficit hyperactivity disorders AP E L A DEXMETHYLPHENIDATE d04777A C[@ F90 Attention-deficit hyperactivity disorders AP E L A GUANFACINE d00717A Cr F90 Attention-deficit hyperactivity disorders AP E L A ZIPRASIDONE d04747A C"@ F39 R45 Unspecified mood [affective] disorder Symptoms and signs involving emotional state AP E M A . . . E M A . . . E M A LEVETIRACETAM d04499A C G40 Epilepsy and recurrent seizures A0 E M A PHENYTOIN d00143A CDp G40 Epilepsy and recurrent seizures A0 E M A SERTRALINE d00880A B= F99 Mental disorder, not otherwise specified A0 E M0 A AMLODIPINE d00689A A I10 Essential (primary) hypertension A E M@ A . . . E MP A . . . E M` A . . . E Mp A BENAZEPRIL d00730A CP I10 Essential (primary) hypertension Ap E Mp A CARVEDILOL d03847A CDp I10 I21.P I48.9 Essential (primary) hypertension Prevent heart attack/myocardial infarction Unspecified atrial fibrillation and atrial flutter Ap E Mp A DABIGATRAN d07137A C- D75.9P Prevent blood clots Ap E Mp A HYDROCHLOROTHIAZIDE d00253A C R60.9 Edema, unspecified Ap E Mp A PANTOPRAZOLE d04514A C K30 Functional dyspepsia Ap E Mp A SIMVASTATIN d00746A Dc E78.0 Pure hypercholesterolemia Ap E Mp A TERAZOSIN d00386A CP N40 Enlarged prostate Ap E M A . . . E M A . . . E M A FLUOXETINE d00236A Dc F32.9 Major depressive disorder, single episode, unspecified A E M A . . . E M A . . . E M A BUPRENORPHINE; NALOXONE d04819A C F11.23 Opioid dependence with withdrawal A0 E M A CITALOPRAM d04332A C F32.9 Major depressive disorder, single episode, unspecified A0 E M A HYDROXYZINE d00907A C- F41.9 Anxiety disorder, unspecified A0 E M A ALBUTEROL d00749A C J45 Asthma A E M A PREDNISONE d00350A A@ R09.8 Other specified symptoms and signs involving the circulatory and respiratory systems A E M A . . . E N A . . . E N A . . . E N A . . . E N0 A . . . E N@ A . . . E NP A . . . E N` A CHLORTHALIDONE d00192A Cr R60.9 Edema, unspecified A@ E N` A LAMOTRIGINE d03809A C[@ F32.9 F39 Major depressive disorder, single episode, unspecified Unspecified mood [affective] disorder A@ E N` A QUETIAPINE d04220A C F39 Unspecified mood [affective] disorder A@ E N` A ZOLPIDEM d00910A C G47.0 Insomnia A@ E Np A . . . E N A ALLOPURINOL d00023A Cr M10.9P Prevent gout A E N A AMLODIPINE d00689A Cr I10 Essential (primary) hypertension A E N A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A E N A CARVEDILOL d03847A C I10 Essential (primary) hypertension A E N A CLOPIDOGREL d04258A Cr I49.9 I80.3 Cardiac arrhythmia, unspecified Phlebitis and thrombophlebitis of lower extremities, unspecified A E N A HYDROCHLOROTHIAZIDE d00253A Cr I10 Essential (primary) hypertension A E N A LOSARTAN d03821A C I10 Essential (primary) hypertension A E N A METFORMIN d03807A C- E11 Type 2 diabetes mellitus A E N A OMEPRAZOLE d00325A Cr K21 K30 Gastro-esophageal reflux disease Functional dyspepsia A E N A OXYBUTYNIN d00328A CDp N32.81 Overactive bladder A E N A TAMSULOSIN d04121A CDp N40 Enlarged prostate A E N A HYDROCHLOROTHIAZIDE; LOSARTAN d03830A C[@ I10 Essential (primary) hypertension A E N A . . . E N A OMEPRAZOLE d00325A C K21 Gastro-esophageal reflux disease A E N A . . . E N A AMLODIPINE d00689A C- I10 Essential (primary) hypertension A E N A ALBUTEROL d00749A B= J45 Asthma A E N A ATORVASTATIN d04105A C- E78.0 Pure hypercholesterolemia A E N A CARBIDOPA; LEVODOPA d03473A C G20 Parkinson's disease A E N A GLIPIZIDE d00246A C[@ E11 Type 2 diabetes mellitus A E N A LISINOPRIL d00732A C[@ I10 Essential (primary) hypertension A E N A METFORMIN d03807A Dc E11 Type 2 diabetes mellitus A E N A METOPROLOL d00134A Dc I10 Essential (primary) hypertension A E N A OXYBUTYNIN d00328A CDp I10 Essential (primary) hypertension A E N A POTASSIUM CHLORIDE d00345A C E87.6 Hypokalemia A E N A TRAMADOL d03826A C- M54 Dorsalgia A E O A . . . E O A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia A E O A . . . E O0 A AMLODIPINE d00689A Ei I10 Essential (primary) hypertension A` E O0 A ATORVASTATIN d04105A B E78.0 Pure hypercholesterolemia A` E O0 A CHLORTHALIDONE d00192A C- I10 Essential (primary) hypertension A` E O0 A FUROSEMIDE d00070A B= R60.9 Edema, unspecified A` E O0 A INSULIN ISOPHANE; INSULIN REGULAR d04374A D# E11 Type 2 diabetes mellitus A` E O0 A LISINOPRIL d00732A Ei I10 Essential (primary) hypertension A` E O@ A ATORVASTATIN d04105A C[@ E78.0 Pure hypercholesterolemia AP E O@ A CLOPIDOGREL d04258A C[@ I21.P Prevent heart attack/myocardial infarction AP E O@ A GABAPENTIN d03182A C[@ M79.2 Neuralgia and neuritis, unspecified AP E O@ A LEVOTHYROXINE d00278A C[@ E04 Other nontoxic goiter AP E O@ A SERTRALINE d00880A C[@ R45 Symptoms and signs involving emotional state AP E OP A ETHINYL ESTRADIOL d00229A C"0 Z79.3 Long term (current) use of hormonal contraceptives A E O` A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A0 E O` A SPIRONOLACTONE d00373A CDp I10 Essential (primary) hypertension A0 E O` A VALSARTAN d04113A D I10 Essential (primary) hypertension A0 E Op A ALBUTEROL d00749A Dc J45 Asthma A E Op A FLUTICASONE NASAL d04283A B= H93.9 Unspecified disorder of ear A E O A CYCLOBENZAPRINE d00963A A M54 M79.1 T14.9 Dorsalgia Myalgia Unspecified injury A@ E O A METFORMIN d03807A CDp E11 Type 2 diabetes mellitus A@ E O A NAPROXEN d00019A Ap M54 M79.1 T14.9 Dorsalgia Myalgia Unspecified injury A@ E O A OMEPRAZOLE d00325A C- K21 Gastro-esophageal reflux disease A@ E O A . . . E O A . . . E O A UREA TOPICAL d00651A C- L98.9 Disorder of the skin and subcutaneous tissue, unspecified A E O A FLUTICASONE NASAL d04283A C[@ R09.8 T78.40 Other specified symptoms and signs involving the circulatory and respiratory systems Allergy, unspecified A E O A TRIAMCINOLONE TOPICAL d03206A B L20.9 Atopic dermatitis, unspecified A E O A . . . E O A ANTIGOUT AGENTS - UNSPECIFIED c00194A CDp M10.9 Gout, unspecified A0 E O A ANTIHYPERLIPIDEMIC AGENTS - UNSPECIFIED c00019A CDp E78.0 Pure hypercholesterolemia A0 E O A ANTIHYPERTENSIVE AGENTS - UNSPECIFIED h00024A CDp I10 Essential (primary) hypertension A0 E O A ALBUTEROL d00749A C- J44.9 Chronic obstructive pulmonary disease, unspecified A E O A ATORVASTATIN d04105A Ei 99999 A E O A CLOPIDOGREL d04258A Ei 99999 A E O A LISINOPRIL d00732A Ei 99999 A E O A METOPROLOL d00134A Ei 99999 A E O A TAMSULOSIN d04121A Ei 99999 A E O A TIOTROPIUM d04829A C J44.9 Chronic obstructive pulmonary disease, unspecified A E O A TIOTROPIUM d04829A Ei 99999 A E P A AMLODIPINE d00689A D F99 I10 Mental disorder, not otherwise specified Essential (primary) hypertension A E P A CARVEDILOL d03847A D I10 Essential (primary) hypertension A E P A DULAGLUTIDE d08290A CDp R73 Elevated blood glucose level A E P A GLIMEPIRIDE d03864A D R73 Elevated blood glucose level A E P A HYDROCHLOROTHIAZIDE d00253A D I10 R60.9 Essential (primary) hypertension Edema, unspecified A E P A METFORMIN d03807A D R73 Elevated blood glucose level A E P A PRAVASTATIN d00348A D E78.0 Pure hypercholesterolemia A E P A TESTOSTERONE d00558A C E29.1 Testicular hypofunction A E P A ETHINYL ESTRADIOL; NORETHINDRONE d03238A B[ Z79.3 Long term (current) use of hormonal contraceptives A E P A . . . E P0 A . . . E P@ A FLUTICASONE; SALMETEROL d04611A C& J45 Asthma A E P@ A TOPIRAMATE d04115A D G40 Epilepsy and recurrent seizures A E PP A . . . E P` A . . . E Pp A . . . E P A . . . E P A GLIPIZIDE d00246A C[@ E11 Type 2 diabetes mellitus A@ E P A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A C[@ I10 Essential (primary) hypertension A@ E P A METFORMIN d03807A C- E11 Type 2 diabetes mellitus A@ E P A SIMVASTATIN d00746A C- E78.0 Pure hypercholesterolemia A@ E P A . . . E P A ATORVASTATIN d04105A Dc E78.0 Pure hypercholesterolemia A` E P A FLECAINIDE d00234A D I48.9 Unspecified atrial fibrillation and atrial flutter A` E P A LEVOTHYROXINE d00278A D E03.9 Hypothyroidism, unspecified A` E P A MONTELUKAST d04289A D J30.9 Allergic rhinitis, unspecified A` E P A OLMESARTAN d04801A C- I10 Essential (primary) hypertension A` E P A VERAPAMIL d00048A D I10 Essential (primary) hypertension A` E P A . . . E P A . . . E P A HYDROCHLOROTHIAZIDE d00253A C- I10 Essential (primary) hypertension A E P A POTASSIUM CHLORIDE d00345A C E87.6 Hypokalemia A E P A OMEPRAZOLE d00325A C ` K21 Gastro-esophageal reflux disease A0 E P A SUCRALFATE d00377A C- K21 Gastro-esophageal reflux disease A0 E P A TRAZODONE d00395A C[@ G47.9 Sleep disorder, unspecified A0 E Q A COLCHICINE d00150A Cr M1A Chronic gout A@ E Q A LISINOPRIL d00732A CDp I10 Essential (primary) hypertension A@ E Q A METFORMIN d03807A C E11 Type 2 diabetes mellitus A@ E Q A METOPROLOL d00134A Cr I10 Essential (primary) hypertension A@ E Q A CETIRIZINE d03827A B[ T78.40 Allergy, unspecified A E Q A . . . E Q0 A . . . E Q@ A . . . E QP A . . . E Q` A BENZONATATE d00796A A R05 Cough A E Q` A OSELTAMIVIR d04462A A J09 Influenza due to certain identified influenza viruses A E Qp A . . . E Q A . . . E Q A AMLODIPINE d00689A0 D I10 Essential (primary) hypertension A` E Q A ATORVASTATIN d04105A0 D E78.0 Pure hypercholesterolemia A` E Q A CLOPIDOGREL d04258A0 D I21.P Prevent heart attack/myocardial infarction A` E Q A GLIPIZIDE d00246A0 D E11 Type 2 diabetes mellitus A` E Q A HYDROCHLOROTHIAZIDE; LOSARTAN d03830A0 D I10 Essential (primary) hypertension A` E Q A METFORMIN d03807A0 D E11 Type 2 diabetes mellitus A` E Q A AMITRIPTYLINE d00146A C- F32.9 G47.0 Major depressive disorder, single episode, unspecified Insomnia A@ E Q A CLONIDINE d00044A C- G47.0 Insomnia A@ E Q A HYDROXYZINE d00907A C- F41.9 G47.0 Anxiety disorder, unspecified Insomnia A@ E Q A MELOXICAM d04532A B= M13 Other arthritis A@ E Q A AMLODIPINE d00689A Cr I10 Essential (primary) hypertension AP E Q A ATORVASTATIN d04105A Cr E78.0 Pure hypercholesterolemia AP E Q A CYCLOSPORINE OPHTHALMIC d04836A B H04 Disorders of lacrimal system AP E Q A TAFLUPROST OPHTHALMIC d07478A C H40 Glaucoma AP E Q A TIMOLOL OPHTHALMIC d04037A B H40 Glaucoma AP E Q A . . . E Q A BUSPIRONE d00182A CDp F41.9 Anxiety disorder, unspecified A0 E Q A METHYLPHENIDATE d00900A CDp F90 Attention-deficit hyperactivity disorders A0 E Q A QUETIAPINE d04220A C- F29 Unspecified psychosis not due to a substance or known physiological condition A0 E Q A 99999 . . A0 E Q A FLUOXETINE d00236A C"0 F32.9 Major depressive disorder, single episode, unspecified A0 E Q A GABAPENTIN d03182A B M79.2 Neuralgia and neuritis, unspecified A0 E Q A . . . E R A AMLODIPINE d00689A C I10 Essential (primary) hypertension A@ E R A GABAPENTIN d03182A C M79.2 Neuralgia and neuritis, unspecified A@ E R A IBUPROFEN d00015A C M13 Other arthritis A@ E R A METOPROLOL d00134A C I10 Essential (primary) hypertension A@ E R A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A0 E R A LOSARTAN d03821A C I10 Essential (primary) hypertension A0 E R A METHOTREXATE d00060A B M06.9 Rheumatoid arthritis, unspecified A0 E R A . . . E R0 A AMITRIPTYLINE d00146A B G47.0 Insomnia AP E R0 A ETHINYL ESTRADIOL; NORETHINDRONE d03238A B N92 N94 Excessive, frequent and irregular menstruation Pain and other conditions associated with female genital organs and menstrual cycle AP E R0 A FLUOXETINE d00236A B F32.9 F41.9 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified AP E R0 A METFORMIN d03807A C- E11 Type 2 diabetes mellitus AP E R0 A NAPROXEN d00019A B G43 Migraine AP E R@ A . . . E RP A . . . E R` A . . . E Rp A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A0 E Rp A LOSARTAN d03821A C I10 Essential (primary) hypertension A0 E Rp A METFORMIN d03807A C- E11 Type 2 diabetes mellitus A0 E R A . . . E R A DIVALPROEX SODIUM d03833A C F84 Pervasive developmental disorders A E R A RISPERIDONE d03180A Dc F84 Pervasive developmental disorders A E R A . . . E R A . . . E R A . . . E R A AMLODIPINE d00689A C I10 Essential (primary) hypertension A` E R A ATENOLOL d00004A C I10 Essential (primary) hypertension A` E R A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A` E R A IRBESARTAN d04222A C I10 Essential (primary) hypertension A` E R A PANTOPRAZOLE d04514A C K21 Gastro-esophageal reflux disease A` E R A RALOXIFENE d04261A C C50.P Prevent breast cancer A` E R A BENZTROPINE d00175A Cr F99 Mental disorder, not otherwise specified AP E R A CARBAMAZEPINE d00058A Cr F31.9 F32.9 F99 Bipolar disorder, unspecified Major depressive disorder, single episode, unspecified Mental disorder, not otherwise specified AP E R A CHLORPROMAZINE d00064A Cr F20 F31.9 F41.9 Schizophrenia Bipolar disorder, unspecified Anxiety disorder, unspecified AP E R A LORAZEPAM d00149A Cr F41.0 F41.9 Panic disorder [episodic paroxysmal anxiety] without agoraphobia Anxiety disorder, unspecified AP E R A VENLAFAXINE d03181A Cr F31.9 F32.9 F41.9 Bipolar disorder, unspecified Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified AP E R A . . . E S A . . . E S A . . . E S A . . . E S0 A . . . E S@ A ATENOLOL d00004A C I10 Essential (primary) hypertension AP E S@ A GABAPENTIN d03182A C F41.9 M79.2 Anxiety disorder, unspecified Neuralgia and neuritis, unspecified AP E S@ A MELOXICAM d04532A C M06.9 M54 Rheumatoid arthritis, unspecified Dorsalgia AP E S@ A PAROXETINE d03157A D ^ F32.9 Major depressive disorder, single episode, unspecified AP E S@ A QUETIAPINE d04220A B F20 F29 G47.0 Schizophrenia Unspecified psychosis not due to a substance or known physiological condition Insomnia AP E SP A TAMSULOSIN d04121A C N40 Enlarged prostate A E S` A LEVOTHYROXINE d00278A D# E03.9 Hypothyroidism, unspecified A E Sp A ACETAMINOPHEN; CODEINE d03423A Cr M13 Other arthritis B E Sp A ALFUZOSIN d04797A Cr R35 Polyuria B E Sp A AMLODIPINE d00689A C- I10 Essential (primary) hypertension B E Sp A ATORVASTATIN d04105A CDp E78.0 Pure hypercholesterolemia B E Sp A CARISOPRODOL d00960A Cr M62.83 Muscle spasm B E Sp A ETANERCEPT d04365A Dc M06.9 Rheumatoid arthritis, unspecified B E Sp A FINASTERIDE d00563A Cr N40 Enlarged prostate B E Sp A FLUOXETINE d00236A B= F32.9 F41.9 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified B E Sp A LINAGLIPTIN d07767A C- E11 Type 2 diabetes mellitus B E Sp A LISINOPRIL d00732A C[@ I10 Essential (primary) hypertension B E Sp A MELOXICAM d04532A D M06.9 Rheumatoid arthritis, unspecified B E Sp A METFORMIN d03807A C E11 Type 2 diabetes mellitus B E Sp A METOPROLOL d00134A C I10 Essential (primary) hypertension B E Sp A MISOPROSTOL d00303A D K31.9 Disease of stomach and duodenum, unspecified B E Sp A NIZATIDINE d00322A C K21 Gastro-esophageal reflux disease B E Sp A PREDNISONE d00350A C M06.9 Rheumatoid arthritis, unspecified B E Sp A REPAGLINIDE d04267A C E11 Type 2 diabetes mellitus B E Sp A TEMAZEPAM d00384A Cr G47.0 G47.9 Insomnia Sleep disorder, unspecified B E S A . . . E S A . . . E S A ATORVASTATIN d04105A Cr E78.0 Pure hypercholesterolemia A@ E S A AZITHROMYCIN d00091A A0 J42 Unspecified chronic bronchitis A@ E S A RAMIPRIL d00728A C I99.9 Unspecified disorder of circulatory system A@ E S A WARFARIN d00022A CP D75.9P Prevent blood clots A@ E S A GLIPIZIDE d00246A Cr E11 Type 2 diabetes mellitus A0 E S A METOPROLOL d00134A Cr I10 Essential (primary) hypertension A0 E S A SIMVASTATIN d00746A Cr E78.0 Pure hypercholesterolemia A0 E S A . . . E S A . . . E S A NAPROXEN d00019A CDp Z79 Long term (current) drug therapy A E S A DULOXETINE d05355A Dc F33.9 Major depressive disorder, recurrent, unspecified A0 E S A LISINOPRIL d00732A C I10 Essential (primary) hypertension A0 E S A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia A0 E T A ANTI-INFECTIVES - UNSPECIFIED c00001A A J02.0 Streptococcal pharyngitis A E T A . . . E T A . . . E T0 A . . . E T@ A . . . E TP A . . . E T` A METHYLPHENIDATE d00900A Cr F90 Attention-deficit hyperactivity disorders A E Tp A . . . E T A ALENDRONATE d03849A B M81.P Prevent bone loss/osteoporosis A E T A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified A E T A . . . E T A ALBUTEROL d00749A A R05 Cough A E T A . . . E T A AMLODIPINE d00689A C- I10 Essential (primary) hypertension A@ E T A LEVOTHYROXINE d00278A C- E07.9 Disorder of thyroid, unspecified A@ E T A METOPROLOL d00134A C- R00 Abnormalities of heart beat A@ E T A PRAVASTATIN d00348A C- E78.0 Pure hypercholesterolemia A@ E T A HYDROXYZINE d00907A A L23 Allergic contact dermatitis A E T A PREDNISONE d00350A A L23 Allergic contact dermatitis A E T A . . . E U A BACLOFEN d00967A D M79.1 Myalgia A0 E U A FAMOTIDINE d00141A D K30 Functional dyspepsia A0 E U A HYDROCHLOROTHIAZIDE d00253A D I10 Essential (primary) hypertension A0 E U A . . . E U A . . . E U0 A . . . E U@ A AMLODIPINE d00689A B I10 Essential (primary) hypertension A E UP A ACETAMINOPHEN; BUTALBITAL; CAFFEINE d03455A C- G43 Migraine Ap E UP A AMITRIPTYLINE d00146A C[@ G43 Migraine Ap E UP A ESOMEPRAZOLE d04749A A0 K30 Functional dyspepsia Ap E UP A ESTRADIOL d00537A C G43.P Prevent migraine Ap E UP A ONDANSETRON d00867A Cr R11 Nausea and vomiting Ap E UP A PHENDIMETRAZINE d00809A B E66 Overweight and obesity Ap E UP A PREDNISONE d00350A B G43 Migraine Ap E U` A . . . E Up A . . . E U A . . . E U A . . . E U A IBUPROFEN d00015A B G89 Pain, not elsewhere classified A E U A . . . E U A . . . E U A . . . E U A AMLODIPINE d00689A CDp I10 Essential (primary) hypertension AP E U A EMPAGLIFLOZIN; METFORMIN d08384A C R73 Elevated blood glucose level AP E U A GLIPIZIDE d00246A C R73 Elevated blood glucose level AP E U A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A C I10 Essential (primary) hypertension AP E U A PIOGLITAZONE d04442A C E11 Type 2 diabetes mellitus AP E U A BENZONATATE d00796A C 99999 B E U A CONJUGATED ESTROGENS d00541A Cr Z79.890 Hormone replacement therapy B E U A CYCLOBENZAPRINE d00963A D* M62.83 Muscle spasm B E U A FESOTERODINE d07162A Cr N32.81 Overactive bladder B E U A FORMOTEROL; MOMETASONE d07660A CDp J45 Asthma B E U A FUROSEMIDE d00070A D1 I10 I51.9 Essential (primary) hypertension Heart disease, unspecified B E U A HYDROXYZINE d00907A Dc L23 Allergic contact dermatitis B E U A LAMOTRIGINE d03809A C 99999 B E U A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified B E U A LIDOCAINE TOPICAL d00683A D M62.83 Muscle spasm B E U A LORAZEPAM d00149A D* G47.0 Insomnia B E U A MEMANTINE d04899A C G40 Epilepsy and recurrent seizures B E U A OLMESARTAN d04801A C I10 Essential (primary) hypertension B E U A OLOPATADINE OPHTHALMIC d04117A CDp H10 H57.9 Conjunctivitis Unspecified disorder of eye and adnexa B E U A OMEPRAZOLE d00325A Cr K21 Gastro-esophageal reflux disease B E U A PROMETHAZINE d00787A Dc R11 Nausea and vomiting B E U A PROPRANOLOL d00032A D# I10 R25.1 Essential (primary) hypertension Tremor, unspecified B E U A RIVASTIGMINE d04537A C R41 Other symptoms and signs involving cognitive functions and awareness B E U A ROSUVASTATIN d04851A C E78.0 Pure hypercholesterolemia B E V A ACETAMINOPHEN; HYDROCODONE d03428A B G89 Pain, not elsewhere classified A0 E V A IBUPROFEN d00015A B G89 Pain, not elsewhere classified A0 E V A OXYCODONE d00329A A G89 Pain, not elsewhere classified A0 E V A ALBUTEROL d00749A B[ J45 Asthma A@ E V A IBUPROFEN d00015A B R50.9 Fever, unspecified A@ E V A NYSTATIN TOPICAL d04399A A L30.9 Dermatitis, unspecified A@ E V A PREDNISOLONE d00084A A J45 Asthma A@ E V A . . . E V0 A . . . E V@ A . . . E VP A . . . E V` A . . . E Vp A . . . E V A . . . E V A . . . E V A . . . E V A VENLAFAXINE d03181A B F41.9 Anxiety disorder, unspecified A E V A ZOLPIDEM d00910A D G47.0 Insomnia A E V A . . . E V A AMLODIPINE d00689A C I10 Essential (primary) hypertension A E V A . . . E V A . . . E W A . . . E W A . . . E W A . . . E W0 A . . . E W@ A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A` E W@ A CLOPIDOGREL d04258A CDp D75.9P Prevent blood clots A` E W@ A GLIMEPIRIDE d03864A C E11 Type 2 diabetes mellitus A` E W@ A METOPROLOL d00134A CDp I10 Essential (primary) hypertension A` E W@ A QUETIAPINE d04220A C[@ F20 Schizophrenia A` E W@ A VENLAFAXINE d03181A C F41.9 Anxiety disorder, unspecified A` E WP A . . . E W` A AZITHROMYCIN d00091A AP J01.9 Acute sinusitis, unspecified A E Wp A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A@ E Wp A EMPAGLIFLOZIN d08275A B[ E11 Type 2 diabetes mellitus A@ E Wp A LISINOPRIL d00732A C I10 Essential (primary) hypertension A@ E Wp A METFORMIN d03807A C E11 Type 2 diabetes mellitus A@ E W A . . . E W A BUPROPION d00181A B F32.9 Major depressive disorder, single episode, unspecified A@ E W A GABAPENTIN d03182A0 Bz M54 M81 Dorsalgia Osteoporosis without current pathological fracture A@ E W A LIDOCAINE; PRILOCAINE TOPICAL d03655A0 B= T14.9 Unspecified injury A@ E W A OXYCODONE d00329A0 C[@ M54 Dorsalgia A@ E W A AMOXICILLIN d00088A CDp K04.7P Prevent tooth infection A E W A ATORVASTATIN d04105A C[@ E78.0 Pure hypercholesterolemia A E W A CARVEDILOL d03847A C[@ I51.9 Heart disease, unspecified A E W A COLCHICINE d00150A C M1A Chronic gout A E W A FUROSEMIDE d00070A C[@ I51.9 Heart disease, unspecified A E W A INSULIN GLARGINE d04538A CDp E11 Type 2 diabetes mellitus A E W A INSULIN LISPRO d04373A C- E11 Type 2 diabetes mellitus A E W A LEVOFLOXACIN d04109A A R05 Cough A E W A LOSARTAN d03821A C[@ I10 Essential (primary) hypertension A E W A OMEPRAZOLE d00325A C[@ K21 Gastro-esophageal reflux disease A E W A MONTELUKAST d04289A Cr J45 Asthma A E W A CLONIDINE d00044A B F41.9 F43.1 F84 Anxiety disorder, unspecified Post-traumatic stress disorder (PTSD) Pervasive developmental disorders AP E W A DEXTROMETHORPHAN; QUINIDINE d07707A B 55555 AP E W A DIVALPROEX SODIUM d03833A C F20 F32.9 F39 Schizophrenia Major depressive disorder, single episode, unspecified Unspecified mood [affective] disorder AP E W A HYDROXYZINE d00907A B F20 F32.9 F84 Schizophrenia Major depressive disorder, single episode, unspecified Pervasive developmental disorders AP E W A OMEPRAZOLE d00325A B[ K21 Gastro-esophageal reflux disease AP E W A . . . E W A DILTIAZEM d00045A DK I10 Essential (primary) hypertension A E W A GLIPIZIDE d00246A D E11 Type 2 diabetes mellitus A E W A HYDROCHLOROTHIAZIDE d00253A D# I10 Essential (primary) hypertension A E W A INSULIN GLARGINE d04538A C E11 Type 2 diabetes mellitus A E W A LOSARTAN d03821A D# I10 Essential (primary) hypertension A E W A METFORMIN d03807A DNk E11 Type 2 diabetes mellitus A E W A METOPROLOL d00134A C[@ I48.9 Unspecified atrial fibrillation and atrial flutter A E W A OMEPRAZOLE d00325A D K30 Functional dyspepsia A E W A PRAVASTATIN d00348A D E78.0 Pure hypercholesterolemia A E W A RIVAROXABAN d07356A C[@ I48.9 Unspecified atrial fibrillation and atrial flutter A E W A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A` E W A ESCITALOPRAM d04812A C F41.9 Anxiety disorder, unspecified A` E W A INSULIN GLARGINE d04538A D E11 Type 2 diabetes mellitus A` E W A INSULIN LISPRO d04373A D E11 Type 2 diabetes mellitus A` E W A LORAZEPAM d00149A D* F41.9 Anxiety disorder, unspecified A` E W A METOPROLOL d00134A A I10 Essential (primary) hypertension A` E X A . . . E X Ap . . . E X A TRAMADOL d03826A C I10 Essential (primary) hypertension A E X0 A . . . E X@ A ACETAMINOPHEN; OXYCODONE d03431A C M54 Dorsalgia B E X@ A ALPRAZOLAM d00168A C- F41.9 Anxiety disorder, unspecified B E X@ A AZELASTINE NASAL d04068A B J30.9 Allergic rhinitis, unspecified B E X@ A BACLOFEN d00967A C M79.1 Myalgia B E X@ A BUPROPION d00181A Dc F32.9 Major depressive disorder, single episode, unspecified B E X@ A CLOPIDOGREL d04258A C D75.9P Prevent blood clots B E X@ A ESCITALOPRAM d04812A Dc F41.9 Anxiety disorder, unspecified B E X@ A FUROSEMIDE d00070A B I51.9 Heart disease, unspecified B E X@ A ISOSORBIDE MONONITRATE d00269A C I20.9 Angina pectoris, unspecified B E X@ A LISINOPRIL d00732A C I10 Essential (primary) hypertension B E X@ A METOPROLOL d00134A C I20.9 Angina pectoris, unspecified B E X@ A MONTELUKAST d04289A C J44.9 Chronic obstructive pulmonary disease, unspecified B E X@ A OMEPRAZOLE d00325A C K21 Gastro-esophageal reflux disease B E X@ A OXYMORPHONE d00833A Cr M79.1 Myalgia B E X@ A PRAVASTATIN d00348A C E78.0 Pure hypercholesterolemia B E X@ A PREGABALIN d05508A D M79.7 Fibromyalgia B E X@ A ZOLPIDEM d00910A C G47.0 Insomnia B E XP A . . . E X` A . . . E Xp A . . . E X A . . . E X A LISDEXAMFETAMINE d06663A C"0 F90 Attention-deficit hyperactivity disorders A E X A . . . E X A ACETAMINOPHEN; BUTALBITAL; CAFFEINE d03455A C- G43 Migraine A E X A AMITRIPTYLINE d00146A C- G43 Migraine A E X A CARVEDILOL d03847A Cr I50.9 Heart failure, unspecified A E X A CLONIDINE d00044A C[@ I10 Essential (primary) hypertension A E X A GABAPENTIN d03182A C M54 Dorsalgia A E X A HYDRALAZINE d00132A Cr I50.9 Heart failure, unspecified A E X A IBUPROFEN d00015A C M54 Dorsalgia A E X A LOSARTAN d03821A C[@ I10 Essential (primary) hypertension A E X A MONTELUKAST d04289A Cr R06.9 Unspecified abnormalities of breathing A E X A PRAZOSIN d00138A B G47.9 Sleep disorder, unspecified A E X A SPIRONOLACTONE d00373A Cr I50.9 Heart failure, unspecified A E X A TRAZODONE d00395A CDp G47.0 Insomnia A E X A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A Ap I10 Essential (primary) hypertension A E X A FLUTICASONE; SALMETEROL d04611A C J43 J44.9 Emphysema Chronic obstructive pulmonary disease, unspecified A` E X A LEVOTHYROXINE d00278A D E03.9 Hypothyroidism, unspecified A` E X A LOVASTATIN d00280A D E78.0 Pure hypercholesterolemia A` E X A RANITIDINE d00021A CDp K21 Gastro-esophageal reflux disease A` E X A RISPERIDONE d03180A C F20 Schizophrenia A` E X A TRAZODONE d00395A D' F29 G47.0 G47.9 Unspecified psychosis not due to a substance or known physiological condition Insomnia Sleep disorder, unspecified A` E X A . . . E X A . . . E Y A AMIODARONE d00002A C- I49.9 Cardiac arrhythmia, unspecified AP E Y A FUROSEMIDE d00070A C- R60.9 Edema, unspecified AP E Y A LISINOPRIL d00732A C- I10 Essential (primary) hypertension AP E Y A METOPROLOL d00134A C- I51.9 Heart disease, unspecified AP E Y A WARFARIN d00022A C- I49.9 Cardiac arrhythmia, unspecified AP E Y A CLONAZEPAM d00197A A@ F32.9 G47.0 Major depressive disorder, single episode, unspecified Insomnia A0 E Y A LORAZEPAM d00149A BK F41.9 Anxiety disorder, unspecified A0 E Y A VENLAFAXINE d03181A B[ F32.9 Major depressive disorder, single episode, unspecified A0 E Y A . . . E Y0 A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia Ap E Y0 A CHLORTHALIDONE d00192A CDp I10 Essential (primary) hypertension Ap E Y0 A HYDRALAZINE d00132A C- I10 Essential (primary) hypertension Ap E Y0 A INSULIN GLARGINE d04538A Cr E11 Type 2 diabetes mellitus Ap E Y0 A LOSARTAN d03821A C I10 Essential (primary) hypertension Ap E Y0 A METFORMIN d03807A C E11 Type 2 diabetes mellitus Ap E Y0 A NIFEDIPINE d00051A B I10 Essential (primary) hypertension Ap E Y@ A LISINOPRIL d00732A C I10 Essential (primary) hypertension A0 E Y@ A VERAPAMIL d00048A C I10 Essential (primary) hypertension A0 E Y@ A ZOLPIDEM d00910A B G47.0 Insomnia A0 E YP A . . . E Y` A BUPROPION d00181A CDp F32.9 Major depressive disorder, single episode, unspecified A0 E Y` A IBANDRONATE d05357A C M85.9 Disorder of bone density and structure, unspecified A0 E Y` A OMEPRAZOLE d00325A C K30 Functional dyspepsia A0 E Yp A . . . E Y A . . . E Y A . . . E Y A AMLODIPINE d00689A B I10 Essential (primary) hypertension A E Y A CHLORTHALIDONE d00192A B I10 Essential (primary) hypertension A E Y A AMLODIPINE d00689A C I10 Essential (primary) hypertension A0 E Y A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A0 E Y A CARVEDILOL d03847A Cr I10 Essential (primary) hypertension A0 E Y A . . . E Y A . . . E Y A . . . E Y A AMLODIPINE d00689A D9 I10 Essential (primary) hypertension Ap E Y A ATORVASTATIN d04105A D# E78.0 Pure hypercholesterolemia Ap E Y A CETIRIZINE d03827A B T78.40 Allergy, unspecified Ap E Y A HYDROCHLOROTHIAZIDE d00253A CDp I10 Essential (primary) hypertension Ap E Y A MONTELUKAST d04289A C J42 Unspecified chronic bronchitis Ap E Y A RIVAROXABAN d07356A Bz I63 Cerebral infarction Ap E Y A SOTALOL d00371A D I49.9 Cardiac arrhythmia, unspecified Ap E Z A GLIPIZIDE d00246A Ei E11 Type 2 diabetes mellitus A E Z A LISINOPRIL d00732A Ei I10 Essential (primary) hypertension A E Z A . . . E Z A . . . E Z0 A . . . E Z@ A . . . E ZP A . . . E Z` A ETHINYL ESTRADIOL; ETONOGESTREL d04773A C- Z79.3 Long term (current) use of hormonal contraceptives A E Z` A FLUOXETINE d00236A B[ F41.9 Anxiety disorder, unspecified A E Zp A ALBUTEROL d00749A D- J45 Asthma A E Z A . . . E Z A DESMOPRESSIN d00583A B[ R32 Unspecified urinary incontinence A E Z A MONTELUKAST d04289A B[ R06.2 Wheezing A E Z A . . . E Z A . . . E Z A . . . E Z A . . . E Z A DEXTROAMPHETAMINE d00804A C- F90 Attention-deficit hyperactivity disorders A0 E Z A IMIPRAMINE d00259A C- R32 Unspecified urinary incontinence A0 E Z A LEVOTHYROXINE d00278A C- E03.9 Hypothyroidism, unspecified A0 E Z A ETONOGESTREL d04772A Cr Z79.3 Long term (current) use of hormonal contraceptives A E [ A TRIAMCINOLONE TOPICAL d03206A0 Cr L20.9 Atopic dermatitis, unspecified A E [ A AMLODIPINE d00689A C 99999 AP E [ A ATENOLOL d00004A C I10 Essential (primary) hypertension AP E [ A COLCHICINE d00150A C- M10.9 Gout, unspecified AP E [ A LOSARTAN d03821A C- I10 Essential (primary) hypertension AP E [ A MELOXICAM d04532A Cr M19.9 Osteoarthritis, unspecified site AP E [ A . . . E [0 A . . . E [@ A . . . E [P A . . . E [` A CYCLOBENZAPRINE d00963A B= M54 Dorsalgia A0 E [` A NAPROXEN d00019A B= M19.9 M54 M79.2 Osteoarthritis, unspecified site Dorsalgia Neuralgia and neuritis, unspecified A0 E [` A PANTOPRAZOLE d04514A C- K21 Gastro-esophageal reflux disease A0 E [p A LISINOPRIL d00732A C I10 Essential (primary) hypertension A E [p A METFORMIN; PIOGLITAZONE d05635A C E11 Type 2 diabetes mellitus A E [ A ALLOPURINOL d00023A CDp M10.9P Prevent gout A0 E [ A CEPHALEXIN d00096A Ap N30 Cystitis A0 E [ A SULFAMETHOXAZOLE; TRIMETHOPRIM d00124A A N39.0 Urinary tract infection, site not specified A0 E [ A . . . E [ A . . . E [ A ALENDRONATE d03849A D0z M81 Osteoporosis without current pathological fracture A E [ A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A E [ A BISOPROLOL; HYDROCHLOROTHIAZIDE d03744A C I10 Essential (primary) hypertension A E [ A DILTIAZEM d00045A C I10 Essential (primary) hypertension A E [ A ESTRADIOL d00537A D0z Z79.890 Hormone replacement therapy A E [ A FESOTERODINE d07162A C R39.1 Other difficulties with micturition A E [ A FUROSEMIDE d00070A D0z I10 I51.9 R60.9 Essential (primary) hypertension Heart disease, unspecified Edema, unspecified A E [ A LEVOTHYROXINE d00278A D0z E06 Thyroiditis A E [ A NORTRIPTYLINE d00144A D G43 Migraine A E [ A ROPINIROLE d04215A D G25.81 Restless legs syndrome A E [ A SERTRALINE d00880A Dc F39 F41.9 M79.7 Unspecified mood [affective] disorder Anxiety disorder, unspecified Fibromyalgia A E [ A TOPIRAMATE d04115A D G43 Migraine A E [ A LOSARTAN d03821A D# I10 Essential (primary) hypertension A E [ A . . . E [ A . . . E [ A . . . E \ A . . . E \ A ATENOLOL d00004A C I10 Essential (primary) hypertension A0 E \ A ATORVASTATIN d04105A C[@ E78.0 Pure hypercholesterolemia A0 E \ A OMEPRAZOLE d00325A C- K21 Gastro-esophageal reflux disease A0 E \ A ENALAPRIL d00013A C I10 Essential (primary) hypertension A E \ A SERTRALINE d00880A Dc F41.9 Anxiety disorder, unspecified A E \0 A ESTRADIOL d00537A B N95 Menopausal and other perimenopausal disorders A@ E \0 A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A C- I10 Essential (primary) hypertension A@ E \0 A MONTELUKAST d04289A C J30.9 Allergic rhinitis, unspecified A@ E \0 A PANTOPRAZOLE d04514A C K21 Gastro-esophageal reflux disease A@ E \@ A . . . E \P A . . . E \` A AMOXICILLIN; CLAVULANATE d00089A A K04.7 Periapical abscess without sinus A E \` A IBUPROFEN d00015A Ap K08.8 Other specified disorders of teeth and supporting structures A E \p A HYDROXYCHLOROQUINE d00817A D M06.9 Rheumatoid arthritis, unspecified A@ E \p A METHOTREXATE d00060A D M06.9 Rheumatoid arthritis, unspecified A@ E \p A PAROXETINE d03157A Ei F41.9 Anxiety disorder, unspecified A@ E \p A SULFASALAZINE d00379A D M06.9 Rheumatoid arthritis, unspecified A@ E \ A DARIFENACIN d05422A C N32.81 Overactive bladder A0 E \ A GABAPENTIN d03182A C- M79.2 Neuralgia and neuritis, unspecified A0 E \ A POLYETHYLENE GLYCOL 3350 d05350A D K59.0 Constipation A0 E \ A . . . E \ A . . . E \ A . . . E \ A LISINOPRIL d00732A C[@ I10 Essential (primary) hypertension A E \ A . . . E \ A FUROSEMIDE d00070A C I50.9 Heart failure, unspecified A@ E \ A LEVOTHYROXINE d00278A D9 E03.9 Hypothyroidism, unspecified A@ E \ A METOPROLOL d00134A C I49.9 Cardiac arrhythmia, unspecified A@ E \ A PANTOPRAZOLE d04514A D K21 Gastro-esophageal reflux disease A@ E \ A . . . E ] A . . . E ] A ALBUTEROL d00749A B J44.9 Chronic obstructive pulmonary disease, unspecified A E ] A BUDESONIDE; FORMOTEROL d04795A B J44.9 Chronic obstructive pulmonary disease, unspecified A E ] A HYDROXYZINE d00907A B F41.9 Anxiety disorder, unspecified A E ] A METOPROLOL d00134A B[ R00 Abnormalities of heart beat A E ] A OMEPRAZOLE d00325A CDp R12 Heartburn A E ] A QUETIAPINE d04220A B= G47.9 Sleep disorder, unspecified A E ] A SERTRALINE d00880A B F31.9 Bipolar disorder, unspecified A E ] A TIZANIDINE d04102A B F31.9 Bipolar disorder, unspecified A E ] A TRAZODONE d00395A D G47.9 Sleep disorder, unspecified A E ] A AMPHETAMINE; DEXTROAMPHETAMINE d04035A C[@ F90 Attention-deficit hyperactivity disorders A E ] A AMPHETAMINE; DEXTROAMPHETAMINE d04035A C[@ F90 Attention-deficit hyperactivity disorders A E ]0 A . . . E ]@ A . . . E ]P A . . . E ]` A 77777 . . A E ]p A . . . E ] A 99999 . . A E ] A . . . E ] A SIMVASTATIN d00746A Ap E78.0 Pure hypercholesterolemia A E ] A DIVALPROEX SODIUM d03833A C- F31.9 Bipolar disorder, unspecified A0 E ] A HALOPERIDOL d00027A C- G47.0 Insomnia A0 E ] A MEDROXYPROGESTERONE d00284A Cr Z79.3 Long term (current) use of hormonal contraceptives A0 E ] A . . . E ] A ATENOLOL d00004A D I21.P Prevent heart attack/myocardial infarction A@ E ] A ATORVASTATIN d04105A D E78.0 Pure hypercholesterolemia A@ E ] A LEVOTHYROXINE d00278A D E03.9 Hypothyroidism, unspecified A@ E ] A LISINOPRIL d00732A D I21.P Prevent heart attack/myocardial infarction A@ E ] A LINAGLIPTIN; METFORMIN d07825A D= E11 Type 2 diabetes mellitus A0 E ] A LISINOPRIL d00732A D= I10 N19 Essential (primary) hypertension Unspecified kidney failure A0 E ] A PRAVASTATIN d00348A D= E78.0 Pure hypercholesterolemia A0 E ] A BENAZEPRIL d00730A0 D* I10 Essential (primary) hypertension A E ] A CABERGOLINE d04112A0 C D49.9 Neoplasm of unspecified behavior of unspecified site A E ] A LEVOTHYROXINE d00278A0 C E03.9 Hypothyroidism, unspecified A E ] A METFORMIN d03807A0 C E11 Type 2 diabetes mellitus A E ] A METHOCARBAMOL d00965A0 A M79.1 Myalgia A E ] A PRAVASTATIN d00348A0 C E78.0 Pure hypercholesterolemia A E ] A PREDNISONE d00350A0 C M35 Other systemic involvement of connective tissue A E ] A TRAZODONE d00395A0 Cr G47.0 Insomnia A E ^ A . . . E ^ A . . . E ^ A INSULIN ISOPHANE (NPH) d04370A Bz E11 Type 2 diabetes mellitus A E ^ A INSULIN LISPRO d04373A Bz 55555 A E ^0 A . . . E ^@ A BRIMONIDINE OPHTHALMIC d04048A B H40 Glaucoma A E ^P A ATORVASTATIN d04105A C[@ E78.0 Pure hypercholesterolemia Ap E ^P A BISOPROLOL d00709A C- I10 Essential (primary) hypertension Ap E ^P A CEPHALEXIN d00096A Ap L08.9 Local infection of the skin and subcutaneous tissue, unspecified Ap E ^P A CLONAZEPAM d00197A Ap F41.9 Anxiety disorder, unspecified Ap E ^P A DOXYCYCLINE d00037A Ap L08.9 Local infection of the skin and subcutaneous tissue, unspecified Ap E ^P A LOSARTAN d03821A CDp I10 Essential (primary) hypertension Ap E ^P A TORSEMIDE d03189A B I51.9 Heart disease, unspecified Ap E ^` A LISDEXAMFETAMINE d06663A C F90 Attention-deficit hyperactivity disorders A E ^p A . . . E ^ A . . . E ^ A CLONIDINE d00044A C"@ G47.0 Insomnia A0 E ^ A METHYLPHENIDATE d00900A B F90 Attention-deficit hyperactivity disorders A0 E ^ A OXCARBAZEPINE d04513A B= F31.9 Bipolar disorder, unspecified A0 E ^ A . . . E ^ A . . . E ^ A LISINOPRIL d00732A C I10 Essential (primary) hypertension A E ^ A ALBUTEROL d00749A C- J45.P Prevent asthma A E ^ A . . . E ^ A . . . E _ A . . . E _ A . . . E _ A . . . E _0 A . . . E _@ A NEBIVOLOL d05265A C I49.9 Cardiac arrhythmia, unspecified A@ E _@ A QUINAPRIL d00365A Dc I10 Essential (primary) hypertension A@ E _@ A RANITIDINE d00021A Cr K30 Functional dyspepsia A@ E _@ A SPIRONOLACTONE d00373A D I10 Essential (primary) hypertension A@ E _P A . . . E _` A ALBUTEROL d00749A C- J45 Asthma A` E _` A AMLODIPINE d00689A D I10 Essential (primary) hypertension A` E _` A ETRAVIRINE d07076A D B20 Human immunodeficiency virus [HIV] disease A` E _` A FLUTICASONE NASAL d04283A C- R09.81 Nasal congestion A` E _` A RALTEGRAVIR d07048A D B20 Human immunodeficiency virus [HIV] disease A` E _` A ZIDOVUDINE d00034A D B20 Human immunodeficiency virus [HIV] disease A` E _p A . . . E _ A FINASTERIDE d00563A B[ L65.9 Nonscarring hair loss, unspecified A E _ A MINOCYCLINE d00110A C L71 Rosacea A E _ A . . . E _ A . . . E _ A . . . E _ A . . . E _ A . . . E _ A . . . E _ A CONJUGATED ESTROGENS TOPICAL d04396A C N39.0P Prevent urinary tract infection A E _ A LEVOTHYROXINE d00278A D# E03.9 Hypothyroidism, unspecified A E ` A BETAMETHASONE TOPICAL d03197A Ap L65.9 Nonscarring hair loss, unspecified A E ` A . . . E ` A GABAPENTIN d03182A C M79.7 Fibromyalgia A E ` A HYDROCHLOROTHIAZIDE; LOSARTAN d03830A C I10 Essential (primary) hypertension A E `0 A . . . E `@ A . . . E `P A . . . E `` A AMPHETAMINE; DEXTROAMPHETAMINE d04035A B F90 R41 Attention-deficit hyperactivity disorders Other symptoms and signs involving cognitive functions and awareness A E `` A VENLAFAXINE d03181A B F32.9 F33.9 F41.9 Major depressive disorder, single episode, unspecified Major depressive disorder, recurrent, unspecified Anxiety disorder, unspecified A E `p A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A E `p A CARVEDILOL d03847A CDp I10 I48.9 Essential (primary) hypertension Unspecified atrial fibrillation and atrial flutter A E `p A CHLORTHALIDONE d00192A CDp I10 I50.9 Essential (primary) hypertension Heart failure, unspecified A E `p A CITALOPRAM d04332A C F32.9 F41.9 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified A E `p A CLOPIDOGREL d04258A CDp D75.9P I49.9 I80.3 Prevent blood clots Cardiac arrhythmia, unspecified Phlebitis and thrombophlebitis of lower extremities, unspecified A E `p A FINASTERIDE d00563A C N40 R35 R39.1 Enlarged prostate Polyuria Other difficulties with micturition A E `p A FLUTICASONE NASAL d04283A C J30.9 R09.81 Allergic rhinitis, unspecified Nasal congestion A E `p A RANITIDINE d00021A B= K30 Functional dyspepsia A E `p A RIVASTIGMINE d04537A C R41 Other symptoms and signs involving cognitive functions and awareness A E `p A TAMSULOSIN d04121A C N40 Enlarged prostate A E `p A WARFARIN d00022A D D75.9P I63 I80.3 Prevent blood clots Cerebral infarction Phlebitis and thrombophlebitis of lower extremities, unspecified A E ` A . . . E ` A CEPHALEXIN d00096A A K04.7P Prevent tooth infection A E ` A METHOXSALEN d01434A B1 M06.9 Rheumatoid arthritis, unspecified A E ` A PREDNISONE d00350A B= M06.9 Rheumatoid arthritis, unspecified A E ` A 99999 . . A E ` A HYDROCHLOROTHIAZIDE d00253A CDp I10 Essential (primary) hypertension A E ` A METOPROLOL d00134A CDp I10 Essential (primary) hypertension A E ` A . . . E ` A LEVONORGESTREL d00557A B Z79.3 Long term (current) use of hormonal contraceptives A E ` A HYDROCORTISONE; NEOMYCIN; POLYMYXIN B OTIC d03543A Bz H93.9 Unspecified disorder of ear A E a A GLIPIZIDE d00246A D E11 Type 2 diabetes mellitus A0 E a A INSULIN GLARGINE d04538A C E11 Type 2 diabetes mellitus A0 E a A METFORMIN d03807A D E11 Type 2 diabetes mellitus A0 E a A . . . E a A DEXLANSOPRAZOLE d07395A C K21 Gastro-esophageal reflux disease A0 E a A LISINOPRIL d00732A C I10 Essential (primary) hypertension A0 E a A PRAVASTATIN d00348A CDp E78.0 Pure hypercholesterolemia A0 E a0 A . . . E a@ A AMLODIPINE d00689A C[@ I10 Essential (primary) hypertension A` E a@ A ATORVASTATIN d04105A CDp E78.0 Pure hypercholesterolemia A` E a@ A HYDROCHLOROTHIAZIDE d00253A CDp R60.9 Edema, unspecified A` E a@ A LISINOPRIL d00732A C[@ I10 Essential (primary) hypertension A` E a@ A PANTOPRAZOLE d04514A CDp K25 Gastric ulcer A` E a@ A TRAMADOL d03826A C- M06.9 Rheumatoid arthritis, unspecified A` E aP A . . . E a` A . . . E ap A AMLODIPINE d00689A CDp I10 Essential (primary) hypertension A@ E ap A ATORVASTATIN d04105A CDp E78.0 Pure hypercholesterolemia A@ E ap A HYDROCHLOROTHIAZIDE; LOSARTAN d03830A B I10 Essential (primary) hypertension A@ E ap A METOPROLOL d00134A B I10 Essential (primary) hypertension A@ E a A . . . E a A FLUTICASONE d01296A C J45 Asthma A0 E a A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia A0 E a A TERAZOSIN d00386A C R39.1 Other difficulties with micturition A0 E a A INSULIN GLARGINE d04538A D E11 Type 2 diabetes mellitus A@ E a A LIRAGLUTIDE d07466A C E66 Overweight and obesity A@ E a A LISINOPRIL d00732A C I10 Essential (primary) hypertension A@ E a A PRAVASTATIN d00348A Cr E78.0 Pure hypercholesterolemia A@ E a A . . . E a A ALLOPURINOL d00023A B= N19 Unspecified kidney failure A E a A ATORVASTATIN d04105A CDp I10 Essential (primary) hypertension A E a A BUPROPION d00181A CDp F41.9 Anxiety disorder, unspecified A E a A CALCIUM ACETATE d03689A B N19 Unspecified kidney failure A E a A CARVEDILOL d03847A CDp I10 Essential (primary) hypertension A E a A CINACALCET d05218A CDp 99999 A E a A HYDRALAZINE d00132A CDp I10 Essential (primary) hypertension A E a A LOSARTAN d03821A CDp I10 Essential (primary) hypertension A E a A METRONIDAZOLE d00108A CDp I10 Essential (primary) hypertension A E a A SPIRONOLACTONE d00373A CDp I10 Essential (primary) hypertension A E a A TAMSULOSIN d04121A CDp I10 Essential (primary) hypertension A E a A . . . E a A ALBUTEROL d00749A C R06.02 Shortness of breath A E a A BUDESONIDE; FORMOTEROL d04795A C J45 Asthma A E a A . . . E b A ATORVASTATIN d04105A DGJ E63.9 Nutritional deficiency, unspecified A@ E b A LEVOTHYROXINE d00278A DGJ E03.9 Hypothyroidism, unspecified A@ E b A LISINOPRIL d00732A DGJ E03.9 Hypothyroidism, unspecified A@ E b A METFORMIN d03807A DGJ E11 Type 2 diabetes mellitus A@ E b A . . . E b A . . . E b0 A . . . E b@ A OLANZAPINE d04050A B G47.0 Insomnia A E bP A . . . E b` A . . . E bp A . . . E b A CLOPIDOGREL d04258A C D75.9P I21.P Prevent blood clots Prevent heart attack/myocardial infarction A0 E b A METOPROLOL d00134A C I10 Essential (primary) hypertension A0 E b A PANTOPRAZOLE d04514A C K21 Gastro-esophageal reflux disease A0 E b A HYDROCHLOROTHIAZIDE d00253A C I10 Essential (primary) hypertension A E b A PROPRANOLOL d00032A C I10 Essential (primary) hypertension A E b A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A E b A CLOPIDOGREL d04258A C D75.9P Prevent blood clots A E b A CYCLOBENZAPRINE d00963A Dc M62.83 Muscle spasm A E b A LISINOPRIL d00732A C R00 Abnormalities of heart beat A E b A METOPROLOL d00134A C I10 Essential (primary) hypertension A E b A MINOCYCLINE d00110A CDp L70 Acne A E b A OXYCODONE d00329A Dc M54 M79.1 Dorsalgia Myalgia A E b A RANITIDINE d00021A C K30 Functional dyspepsia A E b A . . . E b A . . . E b A . . . E b A METOPROLOL d00134A Cr I50.9 N28.9 Heart failure, unspecified Disorder of kidney and ureter, unspecified A E b A . . . E c A . . . E c A BENAZEPRIL d00730A B= I10 Essential (primary) hypertension A E c A . . . E c0 A ALLOPURINOL d00023A Ei M1A Chronic gout B E c0 A CARBIDOPA; LEVODOPA d03473A C G40 Epilepsy and recurrent seizures B E c0 A CITALOPRAM d04332A D M62.83 Muscle spasm B E c0 A CYCLOBENZAPRINE d00963A D I51.9 Heart disease, unspecified B E c0 A FINASTERIDE d00563A D M62.83 Muscle spasm B E c0 A GABAPENTIN d03182A D 99999 B E c0 A GLIPIZIDE d00246A D 99999 B E c0 A INSULIN DETEMIR d05436A B[ E11 Type 2 diabetes mellitus B E c0 A LEVETIRACETAM d04499A D 99999 B E c0 A LISINOPRIL d00732A D 99999 B E c0 A LOVASTATIN d00280A D 99999 B E c0 A METOPROLOL d00134A D 99999 B E c0 A OMEPRAZOLE d00325A D K21 Gastro-esophageal reflux disease B E c0 A POTASSIUM CHLORIDE d00345A D 99999 B E c0 A RANITIDINE d00021A A0 K22 Other diseases of esophagus B E c0 A RIVAROXABAN d07356A D I63 Cerebral infarction B E c@ A . . . E cP A . . . E c` A . . . E cp A . . . E c A LISINOPRIL d00732A C I10 Essential (primary) hypertension A E c A . . . E c A CELECOXIB d04380A D M13 M79.2 M79.7 Other arthritis Neuralgia and neuritis, unspecified Fibromyalgia A@ E c A MIRABEGRON d07876A B N32.81 Overactive bladder A@ E c A SIMVASTATIN d00746A D E78.0 Pure hypercholesterolemia A@ E c A VENLAFAXINE d03181A D# F32.9 Major depressive disorder, single episode, unspecified A@ E c A AMLODIPINE d00689A C I10 Essential (primary) hypertension A@ E c A ATENOLOL d00004A C I10 Essential (primary) hypertension A@ E c A LISINOPRIL d00732A C I10 Essential (primary) hypertension A@ E c A PRAVASTATIN d00348A C E78.0 Pure hypercholesterolemia A@ E c A . . . E c A ATORVASTATIN d04105A B E78.0 Pure hypercholesterolemia A E c A HYDROCHLOROTHIAZIDE d00253A B I10 Essential (primary) hypertension A E c A CELECOXIB d04380A CDp M06.9 Rheumatoid arthritis, unspecified A@ E c A LEVOTHYROXINE d00278A D= E03.9 Hypothyroidism, unspecified A@ E c A OMEPRAZOLE d00325A CDp K21 Gastro-esophageal reflux disease A@ E c A QUETIAPINE d04220A C G47.0 Insomnia A@ E c A . . . E d A CELECOXIB d04380A C M19.9 Osteoarthritis, unspecified site Ap E d A LEVOTHYROXINE d00278A D E03.9 Hypothyroidism, unspecified Ap E d A METOPROLOL d00134A C I10 Essential (primary) hypertension Ap E d A OMEPRAZOLE d00325A C K30 Functional dyspepsia Ap E d A PRAVASTATIN d00348A C E78.0 Pure hypercholesterolemia Ap E d A PREGABALIN d05508A Dc M79.2 Neuralgia and neuritis, unspecified Ap E d A VALSARTAN d04113A C- I10 Essential (primary) hypertension Ap E d A . . . E d A GLIPIZIDE d00246A C E11 Type 2 diabetes mellitus A0 E d A LISINOPRIL d00732A CDp I10 Essential (primary) hypertension A0 E d A METFORMIN d03807A CP E11 Type 2 diabetes mellitus A0 E d0 A . . . E d@ A . . . E dP A . . . E d` A OXAZEPAM d00040A D# F41.9 Anxiety disorder, unspecified A E d` A ROSUVASTATIN d04851A C E78.0 Pure hypercholesterolemia A E dp A AMLODIPINE d00689A C I10 Essential (primary) hypertension AP E dp A AMOXICILLIN d00088A Ap K04.7 Periapical abscess without sinus AP E dp A ATENOLOL d00004A C I10 Essential (primary) hypertension AP E dp A ATORVASTATIN d04105A B= E78.0 Pure hypercholesterolemia AP E dp A GABAPENTIN d03182A B[ M79.2 Neuralgia and neuritis, unspecified AP E d A . . . E d A FUROSEMIDE d00070A Cr I10 Essential (primary) hypertension A E d A LISINOPRIL d00732A C I10 Essential (primary) hypertension A E d A . . . E d A LISINOPRIL d00732A C- I10 Essential (primary) hypertension A E d A OMEPRAZOLE d00325A Dc K21 Gastro-esophageal reflux disease A E d A AMLODIPINE d00689A C I10 Essential (primary) hypertension A0 E d A HYDROCHLOROTHIAZIDE d00253A C I10 Essential (primary) hypertension A0 E d A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia A0 E d A . . . E d A . . . E d A . . . E e A . . . E e A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A E e A . . . E e0 A . . . E e@ A BUPROPION d00181A D F32.9 Major depressive disorder, single episode, unspecified AP E e@ A BUSPIRONE d00182A C- F41.9 Anxiety disorder, unspecified AP E e@ A LEVOMILNACIPRAN d08114A C F32.9 Major depressive disorder, single episode, unspecified AP E e@ A LEVOTHYROXINE d00278A D E03.9 Hypothyroidism, unspecified AP E e@ A TOPIRAMATE d04115A C[@ F31.9 Bipolar disorder, unspecified AP E eP A . . . E e` A CETIRIZINE d03827A B= T78.40 Allergy, unspecified A E ep A . . . E e A . . . E e A . . . E e A ACYCLOVIR d00001A C B02 Zoster [herpes zoster] A@ E e A ATENOLOL d00004A C I10 Essential (primary) hypertension A@ E e A PAROXETINE d03157A CDp F32.9 F41.9 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified A@ E e A PREDNISONE d00350A D L93 M06.9 Lupus erythematosus Rheumatoid arthritis, unspecified A@ E e A AMLODIPINE d00689A C I10 Essential (primary) hypertension A E e A TAMSULOSIN d04121A Dc R39.9 Unspecified symptoms and signs involving the genitourinary system A E e A . . . E e A ETHINYL ESTRADIOL; ETONOGESTREL d04773A Bz Z79.3 Long term (current) use of hormonal contraceptives A E e A . . . E f A AMLODIPINE d00689A C I25.9 Chronic ischemic heart disease, unspecified A` E f A ATORVASTATIN d04105A D* E78.0 Pure hypercholesterolemia A` E f A CHLORTHALIDONE d00192A Cr I10 Essential (primary) hypertension A` E f A METFORMIN d03807A C R73 Elevated blood glucose level A` E f A METOPROLOL d00134A Dc I10 Essential (primary) hypertension A` E f A RAMIPRIL d00728A C I10 Essential (primary) hypertension A` E f A . . . E f A . . . E f0 A ATORVASTATIN d04105A C[@ I10 Essential (primary) hypertension AP E f0 A CLOPIDOGREL d04258A C I10 Essential (primary) hypertension AP E f0 A LEVOTHYROXINE d00278A C- E03.9 Hypothyroidism, unspecified AP E f0 A METOPROLOL d00134A C- I10 Essential (primary) hypertension AP E f0 A RAMIPRIL d00728A C- I10 Essential (primary) hypertension AP E f@ A ATORVASTATIN d04105A Cr E78.0 Pure hypercholesterolemia A E fP A . . . E f` A ALBUTEROL d00749A Dc J45 Asthma A E fp A . . . E f A . . . E f A . . . E f A 77777 . . A E f A ETHINYL ESTRADIOL; NORGESTIMATE d03781A A` N92 Z79.3 Excessive, frequent and irregular menstruation Long term (current) use of hormonal contraceptives A E f A . . . E f A METHYLPHENIDATE d00900A B F90 Attention-deficit hyperactivity disorders A E f A ALBUTEROL d00749A CDp J45 R05 Asthma Cough A E f A BUDESONIDE; FORMOTEROL d04795A B= J45 R05 R06.2 Asthma Cough Wheezing A E f A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified A E f A QUETIAPINE d04220A C F32.9 Major depressive disorder, single episode, unspecified A E g A ATORVASTATIN d04105A CDp E78.0 Pure hypercholesterolemia A E g A METOPROLOL d00134A CDp I21.P Prevent heart attack/myocardial infarction A E g A . . . E g A . . . E g0 A ACETAMINOPHEN; HYDROCODONE d03428A Cr M13 M79.1 Other arthritis Myalgia A E g0 A ALBUTEROL d00749A Cr J43 J44.9 R06.9P Emphysema Chronic obstructive pulmonary disease, unspecified Prevent breathing difficulty A E g0 A BUDESONIDE; FORMOTEROL d04795A Cr J42 J43 J44.9 Unspecified chronic bronchitis Emphysema Chronic obstructive pulmonary disease, unspecified A E g0 A GABAPENTIN d03182A C[@ M79.2 M79.7 Neuralgia and neuritis, unspecified Fibromyalgia A E g0 A METHOTREXATE d00060A Cr M06.9 Rheumatoid arthritis, unspecified A E g0 A ONDANSETRON d00867A A R11 Nausea and vomiting A E g0 A PANTOPRAZOLE d04514A C- K27 Peptic ulcer, site unspecified A E g0 A SILDENAFIL d04299A CDp N52.9 Male erectile dysfunction, unspecified A E g@ A BACLOFEN d00967A C M54 M62.83 Dorsalgia Muscle spasm A E g@ A BUSPIRONE d00182A C F41.9 Anxiety disorder, unspecified A E g@ A CITALOPRAM d04332A C F32.9 Major depressive disorder, single episode, unspecified A E g@ A DICLOFENAC d00848A C M54 Dorsalgia A E g@ A HYDROXYZINE d00907A C F41.9 G47.0 Anxiety disorder, unspecified Insomnia A E g@ A LEVOCETIRIZINE d05851A C R09.81 Nasal congestion A E g@ A LEVOTHYROXINE d00278A B E07.9 Disorder of thyroid, unspecified A E g@ A MILNACIPRAN d06635A B M79.7 Fibromyalgia A E g@ A OMEPRAZOLE d00325A Ap K21 Gastro-esophageal reflux disease A E gP A . . . E g` A . . . E gp A DEXMETHYLPHENIDATE d04777A C F90 Attention-deficit hyperactivity disorders A E g A GEMFIBROZIL d00245A Dc E78.0 Pure hypercholesterolemia A E g A IBUPROFEN d00015A A` K08.8 Other specified disorders of teeth and supporting structures A E g A METFORMIN d03807A D E11 Type 2 diabetes mellitus A E g A . . . E g A AMLODIPINE d00689A CDp I10 Essential (primary) hypertension A E g A HYDROCHLOROTHIAZIDE; LOSARTAN d03830A CDp I10 Essential (primary) hypertension A E g A . . . E g A . . . E g A . . . E h A . . . E h A . . . E h A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified A0 E h A MONTELUKAST d04289A C"@ J30.9 Allergic rhinitis, unspecified A0 E h A PILOCARPINE d04031A D* M35 Other systemic involvement of connective tissue A0 E h0 A . . . E h@ A HYDROCHLOROTHIAZIDE d00253A C I10 Essential (primary) hypertension A E h@ A OMEPRAZOLE d00325A C K21 Gastro-esophageal reflux disease A E hP A . . . E h` A . . . E hp A . . . E h A ENALAPRIL d00013A C I10 Essential (primary) hypertension A E h A HYDROCHLOROTHIAZIDE d00253A C I10 Essential (primary) hypertension A E h A . . . E h A CLONIDINE d00044A B F41.9 G47.9 Anxiety disorder, unspecified Sleep disorder, unspecified A0 E h A METHYLPHENIDATE d00900A C- F90 Attention-deficit hyperactivity disorders A0 E h A SERTRALINE d00880A C F41.9 Anxiety disorder, unspecified A0 E h A TAMOXIFEN d00381A C[@ C50.P Prevent breast cancer A E h A TOPIRAMATE d04115A C- M25.5 M54 Pain in joint Dorsalgia A E h A . . . E h A . . . E h A ROSUVASTATIN d04851A C E78.0 Pure hypercholesterolemia A E h A THYROID DESICCATED d00655A C E03.9 Hypothyroidism, unspecified A E h A BUPROPION d00181A C F17.2 Nicotine dependence A` E h A ELUXADOLINE d08401A Cr K58 Irritable bowel syndrome A` E h A LEVOTHYROXINE d00278A Cr E03.9 Hypothyroidism, unspecified A` E h A LOPERAMIDE d01025A C R19.7 Diarrhea, unspecified A` E h A MELOXICAM d04532A Cr M79.1 Myalgia A` E h A OMEPRAZOLE d00325A Cr K21 Gastro-esophageal reflux disease A` E i A . . . E i A AMLODIPINE; BENAZEPRIL d03829A D I10 Essential (primary) hypertension A E i A SIMVASTATIN d00746A D E78.0 Pure hypercholesterolemia A E i A 99999 . . A E i0 A . . . E i@ A . . . E iP A CYANOCOBALAMIN d00413A D0z D64.9 Anemia, unspecified A E iP A ESOMEPRAZOLE d04749A B R12 Heartburn A E i` A . . . E ip A AMLODIPINE d00689A C I10 Essential (primary) hypertension A E ip A CELECOXIB d04380A C M06.9 Rheumatoid arthritis, unspecified A E ip A EMPAGLIFLOZIN d08275A B= E11 Type 2 diabetes mellitus A E ip A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A C I10 Essential (primary) hypertension A E ip A LANSOPRAZOLE d03828A C K21 Gastro-esophageal reflux disease A E ip A METHOTREXATE d00060A C M06.9 Rheumatoid arthritis, unspecified A E ip A PRAVASTATIN d00348A C E78.0 Pure hypercholesterolemia A E ip A TRAMADOL d03826A C M06.9 Rheumatoid arthritis, unspecified A E i A AMLODIPINE d00689A D# I10 Essential (primary) hypertension A0 E i A HYDROCHLOROTHIAZIDE; TRIAMTERENE d03052A Dc I10 Essential (primary) hypertension A0 E i A METOPROLOL d00134A D I10 Essential (primary) hypertension A0 E i A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified A E i A . . . E i A . . . E i A IBUPROFEN d00015A Ap K08.8 Other specified disorders of teeth and supporting structures A E i A . . . E i A APREMILAST d08247A Bz L40 Psoriasis A E i A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A C I10 Essential (primary) hypertension A E i A . . . E j A . . . E j A . . . E j A . . . E j0 A AMLODIPINE d00689A CDp I10 Essential (primary) hypertension A E j@ A . . . E jP A . . . E j` A AMLODIPINE d00689A D/ I10 Essential (primary) hypertension A` E j` A CLOPIDOGREL d04258A CDp I63.P Z79.0 Prevent stroke Long term (current) use of anticoagulants and antithrombotics/antiplatelets A` E j` A HYDROCHLOROTHIAZIDE d00253A D/ I10 R60.9 Essential (primary) hypertension Edema, unspecified A` E j` A LOSARTAN d03821A D/ I10 Essential (primary) hypertension A` E j` A METFORMIN d03807A D E11 R73 Type 2 diabetes mellitus Elevated blood glucose level A` E j` A PANTOPRAZOLE d04514A D K30 Functional dyspepsia A` E jp A AMLODIPINE d00689A C 99999 AP E jp A HYOSCYAMINE d00985A Ei G25.81 Restless legs syndrome AP E jp A LEVOTHYROXINE d00278A Ei E07.9 Disorder of thyroid, unspecified AP E jp A METOPROLOL d00134A C I21.P Prevent heart attack/myocardial infarction AP E jp A RAMIPRIL d00728A Ei I10 Essential (primary) hypertension AP E j A . . . E j A . . . E j A 99999 . . A E j A ATENOLOL d00004A D I10 Essential (primary) hypertension A E j A LISINOPRIL d00732A C I10 Essential (primary) hypertension A E j A . . . E j A . . . E j A AMOXICILLIN d00088A A J01.9 Acute sinusitis, unspecified A E j A MUPIROCIN TOPICAL d01267A B L08.9 Local infection of the skin and subcutaneous tissue, unspecified A E j A SULFAMETHOXAZOLE; TRIMETHOPRIM d00124A A A49.9 Bacterial infection, unspecified A E k A . . . E k A ATORVASTATIN d04105A CDp E78.0 Pure hypercholesterolemia A E k A GEMFIBROZIL d00245A CDp E78.1 Pure hyperglyceridemia A E k A . . . E k0 A . . . E k@ A . . . E kP A . . . E k` A AMOXICILLIN d00088A A@ H66.9 J02 Otitis media, unspecified Acute pharyngitis A E kp A . . . E k A . . . E k A . . . E k A LOSARTAN d03821A CDp I10 Essential (primary) hypertension A E k A . . . E k A FLUOXETINE d00236A B F41.9 Anxiety disorder, unspecified A E k A MINOCYCLINE d00110A B L70 Acne A E k A ATORVASTATIN d04105A Dc E78.0 Pure hypercholesterolemia A@ E k A FLUOXETINE d00236A C F32.9 Major depressive disorder, single episode, unspecified A@ E k A METOPROLOL d00134A C- R00 Abnormalities of heart beat A@ E k A VALSARTAN d04113A Dc I10 Essential (primary) hypertension A@ E k A GABAPENTIN d03182A D 99999 A@ E k A MONTELUKAST d04289A D 99999 A@ E k A RISPERIDONE d03180A D 99999 A@ E k A SIMVASTATIN d00746A D 99999 A@ E k A BUPROPION d00181A C F32.9 Major depressive disorder, single episode, unspecified A E k A SERTRALINE d00880A C F32.9 Major depressive disorder, single episode, unspecified A E l A . . . E l A METHYLPHENIDATE d00900A B[ F90 Attention-deficit hyperactivity disorders A E l A SERTRALINE d00880A B[ F41.9 Anxiety disorder, unspecified A E l A . . . E l0 A LOSARTAN d03821A Cr I10 Essential (primary) hypertension A E l@ A . . . E lP A ACETAMINOPHEN; CODEINE d03423A Ap R52 Pain, unspecified A E lP A AMPHETAMINE; DEXTROAMPHETAMINE d04035A C- F41.9 F90 R41 Anxiety disorder, unspecified Attention-deficit hyperactivity disorders Other symptoms and signs involving cognitive functions and awareness A E l` A . . . E lp A ALBUTEROL d00749A Cr J45 Asthma A` E lp A CIPROFLOXACIN; DEXAMETHASONE OTIC d04890A A H60 Otitis externa A` E lp A FLUTICASONE d01296A CDp J45 Asthma A` E lp A FLUTICASONE NASAL d04283A CDp R09.81 Nasal congestion A` E lp A GLIPIZIDE d00246A C E11 Type 2 diabetes mellitus A` E lp A METFORMIN d03807A C E11 Type 2 diabetes mellitus A` E l A . . . E l A FENOFIBRATE d04286A Cr E78.1 Pure hyperglyceridemia A0 E l A ROSUVASTATIN d04851A B E78.1 Pure hyperglyceridemia A0 E l A TERAZOSIN d00386A B[ R35 Polyuria A0 E l A . . . E l A . . . E l A . . . E l A . . . E l A CYCLOBENZAPRINE d00963A C[@ M54 Dorsalgia A0 E l A GABAPENTIN d03182A CDp G25.81 Restless legs syndrome A0 E l A LORAZEPAM d00149A C[@ F41.9 Anxiety disorder, unspecified A0 E l A METFORMIN d03807A CP R73 Elevated blood glucose level A E m A AMLODIPINE d00689A C I10 Essential (primary) hypertension A E m A . . . E m A . . . E m0 A ACETAMINOPHEN; BUTALBITAL; CAFFEINE d03455A C[@ R51 Headache Ap E m0 A CIPROFLOXACIN d00011A Ap N30 N39.0 Cystitis Urinary tract infection, site not specified Ap E m0 A CYCLOBENZAPRINE d00963A C[@ M62.83 Muscle spasm Ap E m0 A ESCITALOPRAM d04812A C[@ F32.9 F41.9 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified Ap E m0 A ESTRADIOL d00537A B= Z79.890 Hormone replacement therapy Ap E m0 A MECLIZINE d00859A C- R42 Dizziness and giddiness Ap E m0 A OXYBUTYNIN d00328A Ap N39.4 R32 Other specified urinary incontinence Unspecified urinary incontinence Ap E m@ A . . . E mP A . . . E m` A BROMPHENIRAMINE; DEXTROMETHORPHAN; PSEUDOEPHEDRINE d03368A B J06.9 Acute upper respiratory infection, unspecified A E m` A CETIRIZINE d03827A B J06.9 Acute upper respiratory infection, unspecified A E mp A ANASTROZOLE d03873A C- C50.P Prevent breast cancer A0 E mp A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A0 E mp A LEVOTHYROXINE d00278A Dc E03.9 E04 Hypothyroidism, unspecified Other nontoxic goiter A0 E m A . . . E m A . . . E m A . . . E m A . . . E m A . . . E m A BUPRENORPHINE; NALOXONE d04819A B= F11.23 Opioid dependence with withdrawal A0 E m A LISINOPRIL d00732A C I10 Essential (primary) hypertension A0 E m A QUETIAPINE d04220A D F31.9 Bipolar disorder, unspecified A0 E m A . . . E m A . . . E n A BUSPIRONE d00182A B F41.9 Anxiety disorder, unspecified Ap E n A DULOXETINE d05355A C M79.7 Fibromyalgia Ap E n A HYDROCHLOROTHIAZIDE d00253A C I10 Essential (primary) hypertension Ap E n A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified Ap E n A METHOTREXATE d00060A CO M35 Other systemic involvement of connective tissue Ap E n A PREDNISONE d00350A CO M35 Other systemic involvement of connective tissue Ap E n A PREGABALIN d05508A CDp M79.2 Neuralgia and neuritis, unspecified Ap E n A CLONAZEPAM d00197A C F41.9 Anxiety disorder, unspecified A E n A CYANOCOBALAMIN d00413A Bz G47.0 N95 Insomnia Menopausal and other perimenopausal disorders A E n A GABAPENTIN d03182A C- M79.2 Neuralgia and neuritis, unspecified A E n A GLIPIZIDE d00246A C[@ E11 Type 2 diabetes mellitus A E n A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified A E n A OMEPRAZOLE d00325A C K21 Gastro-esophageal reflux disease A E n A PAROXETINE d03157A C F32.9 F41.9 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified A E n A RANITIDINE d00021A C- K21 Gastro-esophageal reflux disease A E n A ZOLPIDEM d00910A C G47.0 Insomnia A E n A . . . E n0 A . . . E n@ A ALBUTEROL d00749A B= J20.9 Acute bronchitis, unspecified A E n@ A AMOXICILLIN d00088A A H66.9 Otitis media, unspecified A E nP A ATORVASTATIN d04105A CDp E78.0 Pure hypercholesterolemia A0 E nP A INDAPAMIDE d00260A A I10 Essential (primary) hypertension A0 E nP A RAMIPRIL d00728A A@ I10 Essential (primary) hypertension A0 E n` A . . . E np A . . . E n A . . . E n A . . . E n A . . . E n A DONEPEZIL d04099A D R41 Other symptoms and signs involving cognitive functions and awareness A E n A MEMANTINE d04899A Dc R41 Other symptoms and signs involving cognitive functions and awareness A E n A GLIPIZIDE d00246A C- E11 R73 Type 2 diabetes mellitus Elevated blood glucose level AP E n A LOSARTAN d03821A C- I10 Essential (primary) hypertension AP E n A METFORMIN d03807A D ^ R73 Elevated blood glucose level AP E n A PRAVASTATIN d00348A Cr E78.0 Pure hypercholesterolemia AP E n A TAMSULOSIN d04121A Cr N40 Enlarged prostate AP E n A CARVEDILOL d03847A D I10 Z79.0 Essential (primary) hypertension Long term (current) use of anticoagulants and antithrombotics/antiplatelets A@ E n A LISINOPRIL d00732A D I10 Z79.0 Essential (primary) hypertension Long term (current) use of anticoagulants and antithrombotics/antiplatelets A@ E n A PRAVASTATIN d00348A D D75.9P E78.0 Prevent blood clots Pure hypercholesterolemia A@ E n A TRAMADOL d03826A D M25.5 Pain in joint A@ E n A . . . E n A . . . E o A . . . E o A . . . E o A . . . E o0 A ACETAMINOPHEN; HYDROCODONE d03428A Dc R52 Pain, unspecified A` E o0 A AMLODIPINE d00689A C- I10 Essential (primary) hypertension A` E o0 A AMOXICILLIN d00088A A R09.81 Nasal congestion A` E o0 A LOSARTAN d03821A Cr I10 Essential (primary) hypertension A` E o0 A MELOXICAM d04532A C M06.9 Rheumatoid arthritis, unspecified A` E o0 A MORPHINE d00308A B R52 Pain, unspecified A` E o@ A . . . E oP A . . . E o` A . . . E op A AMLODIPINE d00689A B[ I10 Essential (primary) hypertension A E op A HYDROCHLOROTHIAZIDE d00253A B[ I10 Essential (primary) hypertension A E o A . . . E o A . . . E o A . . . E o A . . . E o A AMLODIPINE d00689A C- I10 Essential (primary) hypertension A0 E o A HYDROCHLOROTHIAZIDE; TRIAMTERENE d03052A B[ I10 R60.9 Essential (primary) hypertension Edema, unspecified A0 E o A SIMVASTATIN d00746A D/ E78.0 Pure hypercholesterolemia A0 E o A . . . E o A . . . E o A . . . E p A . . . E p A ERENUMAB d08796A B G43 Migraine A E p A FLUTICASONE NASAL d04283A CDp J30.9 Allergic rhinitis, unspecified A E p A HYDROCHLOROTHIAZIDE d00253A Cr I10 R60.9 Essential (primary) hypertension Edema, unspecified A E p A IPRATROPIUM d00265A CDp J42 R06.2 Unspecified chronic bronchitis Wheezing A E p A METHOCARBAMOL d00965A C M54 Dorsalgia A E p A OMEPRAZOLE d00325A C- K21 K30 Gastro-esophageal reflux disease Functional dyspepsia A E p A SUMATRIPTAN d03160A D G43 Migraine A E p A VERAPAMIL d00048A C- G43 I10 Migraine Essential (primary) hypertension A E p A ZOLMITRIPTAN d04253A D G43 Migraine A E p A . . . E p0 A . . . E p@ A TRIAMCINOLONE TOPICAL d03206A Ap L20.9 Atopic dermatitis, unspecified A E pP A . . . E p` A ATORVASTATIN d04105A Ei E78.0 Pure hypercholesterolemia A E p` A CYANOCOBALAMIN d00413A D 99999 A E p` A FUROSEMIDE d00070A D 99999 A E p` A GABAPENTIN d03182A D 99999 A E p` A INSULIN ISOPHANE (NPH) d04370A Ei E11 Type 2 diabetes mellitus A E p` A INSULIN REGULAR d04369A Ei E11 Type 2 diabetes mellitus A E p` A LOSARTAN d03821A Ei 99999 A E p` A METFORMIN d03807A Ei 99999 A E p` A METOPROLOL d00134A Ei 99999 A E p` A POTASSIUM CHLORIDE d00345A Ei 99999 A E p` A SOTALOL d00371A Ei 99999 A E p` A VERAPAMIL d00048A Ei 99999 A E p` A WARFARIN d00022A Ei 99999 A E pp A . . . E p A ATORVASTATIN d04105A C[@ E78.0 Pure hypercholesterolemia A@ E p A GLIPIZIDE d00246A C[@ E11 Type 2 diabetes mellitus A@ E p A LOSARTAN d03821A C[@ I10 Essential (primary) hypertension A@ E p A METFORMIN d03807A C[@ E11 Type 2 diabetes mellitus A@ E p A . . . E p A . . . E p A BISOPROLOL; HYDROCHLOROTHIAZIDE d03744A C[@ I10 Essential (primary) hypertension A E p A SPIRONOLACTONE d00373A C[@ I10 Essential (primary) hypertension A E p A . . . E p A . . . E p A 99999 . . A` E p A AMLODIPINE d00689A D I10 Essential (primary) hypertension A` E p A CHLORTHALIDONE d00192A Dc R60.9 Edema, unspecified A` E p A HYDROXYCHLOROQUINE d00817A B* M06.9 Rheumatoid arthritis, unspecified A` E p A METHOTREXATE d00060A B M06.9 Rheumatoid arthritis, unspecified A` E p A PREDNISONE d00350A Cr M06.9 Rheumatoid arthritis, unspecified A` E p A AMLODIPINE d00689A Cr I10 Essential (primary) hypertension A E p A AMOXICILLIN d00088A B= M06.9 Rheumatoid arthritis, unspecified A E p A DOXEPIN d00217A B= M06.9 Rheumatoid arthritis, unspecified A E p A HALOBETASOL TOPICAL d01298A B= L29.9 Pruritus, unspecified A E p A HYDROXYCHLOROQUINE d00817A B[ M06.9 Rheumatoid arthritis, unspecified A E p A LOSARTAN d03821A Cr I10 Essential (primary) hypertension A E p A MYCOPHENOLATE MOFETIL d03839A B= L29.9 Pruritus, unspecified A E p A PREDNISONE d00350A B[ M06.9 M35 Rheumatoid arthritis, unspecified Other systemic involvement of connective tissue A E q A AMOXICILLIN d00088A A J18.9 Pneumonia, unspecified organism A E q A . . . E q A AMLODIPINE d00689A B 99999 A E q A ATORVASTATIN d04105A B[ E78.0 Pure hypercholesterolemia A E q A LOSARTAN d03821A Cr I10 Essential (primary) hypertension A E q A METAXALONE d00964A Bz 99999 A E q A METFORMIN d03807A CDp R73 Elevated blood glucose level A E q A METOPROLOL d00134A C 99999 A E q A SIMVASTATIN d00746A CDp E78.0 Pure hypercholesterolemia A E q A UMECLIDINIUM d08187A B= J45 Asthma A E q0 A . . . E q@ A LEVOTHYROXINE d00278A C- E03.9 Hypothyroidism, unspecified A E qP A ACETAMINOPHEN; CODEINE d03423A C M79.6 Pain in limb, hand, foot, fingers and toes A` E qP A ATORVASTATIN d04105A C I63 Cerebral infarction A` E qP A BRIMONIDINE; BRINZOLAMIDE OPHTHALMIC d08086A C H40 Glaucoma A` E qP A CARVEDILOL d03847A C I10 Essential (primary) hypertension A` E qP A CLOPIDOGREL d04258A C I63 Cerebral infarction A` E qP A DOXYCYCLINE d00037A C[@ B99.9 Unspecified infectious disease A` E q` A . . . E qp A NYSTATIN d01233A B B37 Candidiasis A E q A AMLODIPINE d00689A C I10 Essential (primary) hypertension A E q A METOPROLOL d00134A C I10 Essential (primary) hypertension A E q A . . . E q A AMPHETAMINE d00803A C F90 Attention-deficit hyperactivity disorders A0 E q A CLONIDINE d00044A C G47.0 Insomnia A0 E q A OLANZAPINE d04050A C F91 Conduct disorders A0 E q A . . . E q A . . . E q A . . . E q A . . . E q A ADALIMUMAB d04835A C"0 L40 Psoriasis A E q A ALBUTEROL d00749A A J45 Asthma A E q A BUSPIRONE d00182A C[@ F32.9 Major depressive disorder, single episode, unspecified A E q A CITALOPRAM d04332A Cr F41.9 Anxiety disorder, unspecified A E q A DICLOFENAC d00848A C- L40 Psoriasis A E q A GABAPENTIN d03182A C M79.7 Fibromyalgia A E q A LOSARTAN d03821A CDp I10 Essential (primary) hypertension A E q A METOPROLOL d00134A CDp I10 Essential (primary) hypertension A E q A MOMETASONE d05262A A J45 Asthma A E q A PANTOPRAZOLE d04514A C K21 Gastro-esophageal reflux disease A E q A ROSUVASTATIN d04851A C E78.0 Pure hypercholesterolemia A E r A FINASTERIDE d00563A C N40 Enlarged prostate A0 E r A SIMVASTATIN d00746A D E78.0 Pure hypercholesterolemia A0 E r A TELMISARTAN d04364A C I10 I21.P Essential (primary) hypertension Prevent heart attack/myocardial infarction A0 E r A . . . E r A ATORVASTATIN d04105A C[@ E78.0 Pure hypercholesterolemia A0 E r A LISINOPRIL d00732A C I10 Essential (primary) hypertension A0 E r A PANTOPRAZOLE d04514A Cr K21 K30 Gastro-esophageal reflux disease Functional dyspepsia A0 E r0 A HYDROCHLOROTHIAZIDE d00253A C- I10 Essential (primary) hypertension AP E r0 A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified AP E r0 A LOVASTATIN d00280A C E78.0 Pure hypercholesterolemia AP E r0 A METOPROLOL d00134A CDp I10 Essential (primary) hypertension AP E r0 A OMEPRAZOLE d00325A C K21 Gastro-esophageal reflux disease AP E r@ A . . . E rP A APIXABAN d07804A C D75.9P I21.P I48.9 Prevent blood clots Prevent heart attack/myocardial infarction Unspecified atrial fibrillation and atrial flutter A` E rP A ATORVASTATIN d04105A DDp E78.0 Pure hypercholesterolemia A` E rP A FUROSEMIDE d00070A C I51.9 R60.9 Heart disease, unspecified Edema, unspecified A` E rP A LEVOTHYROXINE d00278A DDp E03.9 Hypothyroidism, unspecified A` E rP A METOPROLOL d00134A C I10 I49.9 R00 Essential (primary) hypertension Cardiac arrhythmia, unspecified Abnormalities of heart beat A` E rP A POTASSIUM CHLORIDE d00345A C E87.6 Hypokalemia A` E r` A CITALOPRAM d04332A C F32.9 Major depressive disorder, single episode, unspecified A E rp A . . . E r A GABAPENTIN d03182A D M79.2 Neuralgia and neuritis, unspecified A0 E r A LISINOPRIL d00732A CDp I10 Essential (primary) hypertension A0 E r A METFORMIN d03807A D E11 Type 2 diabetes mellitus A0 E r A . . . E r A . . . E r A . . . E r A CLINDAMYCIN TOPICAL d01241A B= L70 Acne A E r A . . . E r A . . . E r A . . . E s A . . . E s A BACLOFEN d00967A Cr M54 Dorsalgia Ap E s A DICLOFENAC d00848A C M25.5 Pain in joint Ap E s A GABAPENTIN d03182A C"0 G99.8 Other specified disorders of nervous system in diseases classified elsewhere Ap E s A MOMETASONE TOPICAL d01300A B[ L40 Psoriasis Ap E s A NAPROXEN d00019A Cr M25.5 Pain in joint Ap E s A OMEPRAZOLE d00325A C K30 Functional dyspepsia Ap E s A TRAMADOL d03826A Cr M54 Dorsalgia Ap E s A . . . E s0 A ALBUTEROL d00749A B= R09 Other symptoms and signs involving the circulatory and respiratory system A E s0 A BUDESONIDE d04276A B= R09 Other symptoms and signs involving the circulatory and respiratory system A E s0 A CLINDAMYCIN d00043A Dc A49.9P Prevent bacterial infection A E s0 A ESCITALOPRAM d04812A D= F33.9 Major depressive disorder, recurrent, unspecified A E s0 A FUROSEMIDE d00070A B I50.9 Heart failure, unspecified A E s0 A LEVOTHYROXINE d00278A DU E03.9 Hypothyroidism, unspecified A E s0 A OMEPRAZOLE d00325A D= R12 Heartburn A E s0 A RANITIDINE d00021A C R12 Heartburn A E s0 A SOLIFENACIN d05413A D= N32.81 Overactive bladder A E s0 A SOTALOL d00371A CP I50.9 Heart failure, unspecified A E s@ A BUDESONIDE d04276A A G47.9 Sleep disorder, unspecified A E sP A DROSPIRENONE; ETHINYL ESTRADIOL d04760A C Z79.3 Long term (current) use of hormonal contraceptives A E s` A . . . E sp A FLUOXETINE d00236A D"8 F39 Unspecified mood [affective] disorder A E sp A MONTELUKAST d04289A D J30.9 R06.2 Allergic rhinitis, unspecified Wheezing A E s A . . . E s A . . . E s A . . . E s A AMOXICILLIN d00088A A0 K04.7 Periapical abscess without sinus A E s A AMLODIPINE d00689A Cr I10 Essential (primary) hypertension A@ E s A HYDROCHLOROTHIAZIDE d00253A C I10 Essential (primary) hypertension A@ E s A LISINOPRIL d00732A D= I10 Essential (primary) hypertension A@ E s A RIVAROXABAN d07356A C I80.3 Phlebitis and thrombophlebitis of lower extremities, unspecified A@ E s A . . . E s A FLUOXETINE d00236A B= F32.9 Major depressive disorder, single episode, unspecified A E s A CETIRIZINE d03827A B[ T78.40 Allergy, unspecified A E s A MONTELUKAST d04289A B* J30.2 Other seasonal allergic rhinitis A E t A ACETAMINOPHEN; HYDROCODONE d03428A C M25.5 Pain in joint B E t A ALBUTEROL d00749A0 CDp J45 Asthma B E t A ALBUTEROL d00749A0 Cr J45 Asthma B E t A ALLOPURINOL d00023A0 B M1A Chronic gout B E t A DICYCLOMINE d00999A0 C K58 Irritable bowel syndrome B E t A FLUOXETINE d00236A0 C F32.9 Major depressive disorder, single episode, unspecified B E t A FORMOTEROL; MOMETASONE d07660A0 C J45 Asthma B E t A GABAPENTIN d03182A B= M54 Dorsalgia B E t A INSULIN ASPART d04697A0 D E11 Type 2 diabetes mellitus B E t A INSULIN GLARGINE d04538A0 C- E11 Type 2 diabetes mellitus B E t A LORAZEPAM d00149A0 C F41.9 Anxiety disorder, unspecified B E t A LOSARTAN d03821A0 C I10 Essential (primary) hypertension B E t A LOVASTATIN d00280A0 C E78.0 Pure hypercholesterolemia B E t A MONTELUKAST d04289A0 C J20.9 J45 Acute bronchitis, unspecified Asthma B E t A OMEPRAZOLE d00325A0 C- K30 Functional dyspepsia B E t A TIZANIDINE d04102A B M54 Dorsalgia B E t A . . . E t A AMOXICILLIN d00088A A J02 Acute pharyngitis A E t0 A ALBUTEROL d00749A B J45 Asthma A@ E t0 A CETIRIZINE d03827A B J45 T78.40 Asthma Allergy, unspecified A@ E t0 A FLUTICASONE d01296A B J45 Asthma A@ E t0 A FLUTICASONE NASAL d04283A B J45 T78.40 Asthma Allergy, unspecified A@ E t@ A . . . E tP A . . . E t` A AMOXICILLIN d00088A A H66.9 Otitis media, unspecified A E tp A DILTIAZEM d00045A B I10 Essential (primary) hypertension A@ E tp A LOSARTAN d03821A C I10 Essential (primary) hypertension A@ E tp A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia A@ E tp A SPIRONOLACTONE d00373A C I10 Essential (primary) hypertension A@ E t A . . . E t A . . . E t A CLONAZEPAM d00197A C F41.9 F43.9 G47.9 Anxiety disorder, unspecified Reaction to severe stress, unspecified Sleep disorder, unspecified Ap E t A HYDROCHLOROTHIAZIDE; TRIAMTERENE d03052A CDp R60.9 Edema, unspecified Ap E t A LEVOTHYROXINE d00278A Dc E03.9 Hypothyroidism, unspecified Ap E t A LISINOPRIL d00732A Cr I10 Essential (primary) hypertension Ap E t A MELOXICAM d04532A CDp M13 Other arthritis Ap E t A OXYCODONE d00329A B[ M25.5 Pain in joint Ap E t A TRAZODONE d00395A CDp F43.9 G47.0 Reaction to severe stress, unspecified Insomnia Ap E t A ATORVASTATIN d04105A Bz E78.0 Pure hypercholesterolemia Ap E t A BIMATOPROST OPHTHALMIC d04754A B H40 Glaucoma Ap E t A BRIMONIDINE; TIMOLOL OPHTHALMIC d05283A B H40 Glaucoma Ap E t A BRINZOLAMIDE OPHTHALMIC d04301A B H40 Glaucoma Ap E t A CLOPIDOGREL d04258A C I51.9P Z79.0 Prevent heart disease Long term (current) use of anticoagulants and antithrombotics/antiplatelets Ap E t A DICLOFENAC d00848A C M13 M25.5 Other arthritis Pain in joint Ap E t A METOPROLOL d00134A C I10 Essential (primary) hypertension Ap E t A ATENOLOL d00004A C[@ I10 Essential (primary) hypertension A` E t A CETIRIZINE d03827A B T78.40 Allergy, unspecified A` E t A HYDROCHLOROTHIAZIDE; LOSARTAN d03830A CDp I10 Essential (primary) hypertension A` E t A PANTOPRAZOLE d04514A CDp K21 Gastro-esophageal reflux disease A` E t A RANITIDINE d00021A B K21 Gastro-esophageal reflux disease A` E t A SIMVASTATIN d00746A CDp E78.0 Pure hypercholesterolemia A` E t A AMLODIPINE d00689A D I10 Essential (primary) hypertension A@ E t A FEBUXOSTAT d07397A C M1A Chronic gout A@ E t A HYDROCHLOROTHIAZIDE d00253A CDp R52 Pain, unspecified A@ E t A OMEPRAZOLE d00325A C R12 Heartburn A@ E t A . . . E t A . . . E u A ALLOPURINOL d00023A DGJ M1A Chronic gout A E u A ATORVASTATIN d04105A D E78.0 Pure hypercholesterolemia A E u A CALCIUM ACETATE d03689A C- E83.3 Disorders of phosphorus metabolism and phosphatases A E u A EPOETIN BETA; METHOXY POLYETHYLENE GLYCOL d06911A C D64.9 Anemia, unspecified A E u A FINASTERIDE d00563A D N40 Enlarged prostate A E u A IRON SUCROSE d04725A C- D64.9 Anemia, unspecified A E u A LOSARTAN d03821A D I10 Essential (primary) hypertension A E u A SEVELAMER d04363A C- E83.3 Disorders of phosphorus metabolism and phosphatases A E u A TAMSULOSIN d04121A D N40 Enlarged prostate A E u A . . . E u A ATORVASTATIN d04105A C 99999 A E u A CITALOPRAM d04332A CDp F32.9 Major depressive disorder, single episode, unspecified A E u A INSULIN GLARGINE d04538A C- E11 Type 2 diabetes mellitus A E u A INSULIN LISPRO d04373A C E11 Type 2 diabetes mellitus A E u A MIDODRINE d04047A C 99999 A E u A PANTOPRAZOLE d04514A C 99999 A E u A PREGABALIN d05508A C- G99.8 Other specified disorders of nervous system in diseases classified elsewhere A E u A SPIRONOLACTONE d00373A C 99999 A E u A TORSEMIDE d03189A B 99999 A E u0 A . . . E u@ A . . . E uP A MINOCYCLINE d00110A B= L70 Acne A E u` A AMLODIPINE d00689A A I10 Essential (primary) hypertension A E u` A BACLOFEN d00967A A G43 Migraine A E up A . . . E u A . . . E u A . . . E u A AMLODIPINE d00689A C[@ I10 Essential (primary) hypertension A E u A CLOPIDOGREL d04258A CDp Z79.0 Long term (current) use of anticoagulants and antithrombotics/antiplatelets A E u A HYDROCHLOROTHIAZIDE d00253A Cr I10 Essential (primary) hypertension A@ E u A LISINOPRIL d00732A C I10 Essential (primary) hypertension A@ E u A METFORMIN d03807A C- E11 Type 2 diabetes mellitus A@ E u A SIMVASTATIN d00746A D E78.0 Pure hypercholesterolemia A@ E u A . . . E u A DEXMETHYLPHENIDATE d04777A C- F90 Attention-deficit hyperactivity disorders A E u A . . . E u A ATORVASTATIN d04105A C- E78.0 Pure hypercholesterolemia AP E u A CITALOPRAM d04332A C- F32.9 Major depressive disorder, single episode, unspecified AP E u A HYDROXYCHLOROQUINE d00817A C- L93 Lupus erythematosus AP E u A INTERFERON BETA-1A d04011A C G99.8 Other specified disorders of nervous system in diseases classified elsewhere AP E u A METOPROLOL d00134A C- I10 Essential (primary) hypertension AP E v A . . . E v A . . . E v A . . . E v0 A . . . E v@ A TACROLIMUS TOPICAL d04740A B L20.9 Atopic dermatitis, unspecified A E vP A . . . E v` A TRIAMCINOLONE TOPICAL d03206A C L20.9 Atopic dermatitis, unspecified A E vp A ALBUTEROL d00749A C- J45 Asthma A0 E vp A AZITHROMYCIN d00091A Ap Z90 Acquired absence of organs, not elsewhere classified A0 E vp A PREDNISONE d00350A Ap Z90 Acquired absence of organs, not elsewhere classified A0 E v A . . . E v A DESMOPRESSIN d00583A D# N32.9 Bladder disorder, unspecified A E v A . . . E v A ACETAMINOPHEN; HYDROCODONE d03428A A K08.8 Other specified disorders of teeth and supporting structures A0 E v A ATORVASTATIN d04105A D9 E78.0 Pure hypercholesterolemia A0 E v A IRBESARTAN d04222A D9 I10 Essential (primary) hypertension A0 E v A ETONOGESTREL d04772A B[ Z79.3 Long term (current) use of hormonal contraceptives A E v A LISINOPRIL d00732A B[ I10 Essential (primary) hypertension A E v A 99999 . . A E v A . . . E w A CALCIUM ACETATE d03689A C[@ E63.9 Nutritional deficiency, unspecified A E w A HYDRALAZINE d00132A Cr I10 Essential (primary) hypertension A E w A INSULIN ASPART d04697A Cr E11 Type 2 diabetes mellitus A E w A INSULIN DEGLUDEC d08054A Cr E11 Type 2 diabetes mellitus A E w A ISOSORBIDE MONONITRATE d00269A B I21.P Prevent heart attack/myocardial infarction A E w A METOCLOPRAMIDE d00298A B K31.9 R11 Disease of stomach and duodenum, unspecified Nausea and vomiting A E w A PANCRELIPASE d01002A C[@ K30 Functional dyspepsia A E w A PANTOPRAZOLE d04514A C[@ K21 Gastro-esophageal reflux disease A E w A PREGABALIN d05508A B E11.4 Type 2 diabetes mellitus with neurological complications A E w A . . . E w A . . . E w0 A AMLODIPINE d00689A CDp I10 Essential (primary) hypertension A@ E w0 A LISINOPRIL d00732A CDp I10 Essential (primary) hypertension A@ E w0 A TRAMADOL d03826A C- M54 Dorsalgia A@ E w0 A URSODIOL d01005A CDp 99999 A@ E w@ A ALBUTEROL d00749A B J44.9 Chronic obstructive pulmonary disease, unspecified A@ E w@ A ATORVASTATIN d04105A B[ E78.0 Pure hypercholesterolemia A@ E w@ A INSULIN GLARGINE d04538A B E11 Type 2 diabetes mellitus A@ E w@ A METFORMIN d03807A B[ E11 Type 2 diabetes mellitus A@ E wP A . . . E w` A . . . E wp A . . . E w A . . . E w A DEXMETHYLPHENIDATE d04777A B F90 Attention-deficit hyperactivity disorders A E w A . . . E w A . . . E w A ATORVASTATIN d04105A C 99999 A0 E w A LISINOPRIL d00732A C E78.0 I10 Pure hypercholesterolemia Essential (primary) hypertension A0 E w A METFORMIN d03807A C E78.0 Pure hypercholesterolemia A0 E w A . . . E w A . . . E w A . . . E x A . . . E x A . . . E x A . . . E x0 A AMOXICILLIN d00088A A H66.9 Otitis media, unspecified A E x@ A DOXYCYCLINE d00037A A J00 Acute nasopharyngitis [common cold] A0 E x@ A ETODOLAC d00851A A J00 Acute nasopharyngitis [common cold] A0 E x@ A PREDNISONE d00350A A J00 Acute nasopharyngitis [common cold] A0 E xP A . . . E x` A . . . E xp A . . . E x A . . . E x A . . . E x A ALLOPURINOL d00023A Dc M1A Chronic gout Ap E x A DULOXETINE d05355A CDp M79.2 Neuralgia and neuritis, unspecified Ap E x A FINASTERIDE d00563A CDp R35 Polyuria Ap E x A METFORMIN d03807A CDp E11 Type 2 diabetes mellitus Ap E x A MONTELUKAST d04289A CDp R06.9 Unspecified abnormalities of breathing Ap E x A RIVAROXABAN d07356A CDp D75.9P Prevent blood clots Ap E x A SIMVASTATIN d00746A CDp E78.0 Pure hypercholesterolemia Ap E x A ALBUTEROL d00749A C- J45 Asthma A E x A FLUTICASONE d01296A C- J45 Asthma A E x A . . . E x A . . . E x A AMIODARONE d00002A C I48.9 Unspecified atrial fibrillation and atrial flutter A` E x A AMLODIPINE d00689A C I10 Essential (primary) hypertension A` E x A FINASTERIDE d00563A Cr N42.9 Disorder of prostate, unspecified A` E x A LEVOTHYROXINE d00278A CDp E03.9 Hypothyroidism, unspecified A` E x A PRAMIPEXOLE d04145A B G25.81 Restless legs syndrome A` E x A TEMAZEPAM d00384A D G47.0 Insomnia A` E x A AMLODIPINE d00689A D I10 Essential (primary) hypertension A0 E x A HYDROCHLOROTHIAZIDE; LOSARTAN d03830A D I50.9 Heart failure, unspecified A0 E x A PRAVASTATIN d00348A D E78.0 Pure hypercholesterolemia A0 E y A . . . E y A . . . E y A . . . E y0 A . . . E y@ A . . . E yP A . . . E y` A AMOXICILLIN d00088A Ap J06.9 Acute upper respiratory infection, unspecified A0 E y` A FLUTICASONE NASAL d04283A C[@ T78.40 Allergy, unspecified A0 E y` A PHENYLEPHRINE; THONZYLAMINE d08091A A J06.9 Acute upper respiratory infection, unspecified A0 E yp A . . . E y A . . . E y A . . . E y A LEVOCETIRIZINE d05851A CDp T78.40 Allergy, unspecified A E y A MONTELUKAST d04289A CDp T78.40 Allergy, unspecified A E y A . . . E y A . . . E y A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A CDp I10 Essential (primary) hypertension A@ E y A LOVASTATIN d00280A CDp E78.0 Pure hypercholesterolemia A@ E y A MELOXICAM d04532A C M79.1 Myalgia A@ E y A OMEPRAZOLE d00325A CDp K21 Gastro-esophageal reflux disease A@ E y A . . . E y A . . . E z A 99999 . . A E z A . . . E z A AMIODARONE d00002A B I49.9 Cardiac arrhythmia, unspecified A E z A AMLODIPINE d00689A B I10 R07.9 Essential (primary) hypertension Chest pain, unspecified A E z A ATORVASTATIN d04105A CDp E78.0 Pure hypercholesterolemia A E z A CLOPIDOGREL d04258A C- D75.9P I63.P Prevent blood clots Prevent stroke A E z A FUROSEMIDE d00070A C R60.9 Edema, unspecified A E z A GLIMEPIRIDE d03864A C E11 Type 2 diabetes mellitus A E z A LISINOPRIL d00732A CDp I10 Essential (primary) hypertension A E z A METFORMIN d03807A D E11 Type 2 diabetes mellitus A E z A METOPROLOL d00134A Cr I10 Essential (primary) hypertension A E z A POTASSIUM CHLORIDE d00345A C E87.6 Hypokalemia A E z0 A AMLODIPINE d00689A C[@ I10 Essential (primary) hypertension A0 E z0 A ATORVASTATIN d04105A C[@ E78.0 Pure hypercholesterolemia A0 E z0 A LISINOPRIL d00732A C[@ I10 Essential (primary) hypertension A0 E z@ A METHYLPHENIDATE d00900A B F90 Attention-deficit hyperactivity disorders A E zP A . . . E z` A ALLOPURINOL d00023A C"@ M25.5 Pain in joint A E z` A AMITRIPTYLINE d00146A AP K31.9 Disease of stomach and duodenum, unspecified A E z` A BUMETANIDE d00179A Cr I10 Essential (primary) hypertension A E z` A DICYCLOMINE d00999A B[ R10 Abdominal and pelvic pain A E z` A LOSARTAN d03821A C"@ I10 Essential (primary) hypertension A E z` A OMEPRAZOLE d00325A B[ K31.9 Disease of stomach and duodenum, unspecified A E z` A PRAVASTATIN d00348A C"@ E78.0 Pure hypercholesterolemia A E z` A TRIAMTERENE d00396A C"@ I10 Essential (primary) hypertension A E zp A IBANDRONATE d05357A B M81 Osteoporosis without current pathological fracture A0 E zp A LISINOPRIL d00732A Cr I10 Essential (primary) hypertension A0 E zp A PRAVASTATIN d00348A CDp E78.0 Pure hypercholesterolemia A0 E z A . . . E z A . . . E z A ATORVASTATIN d04105A B E78.0 Pure hypercholesterolemia A E z A ATORVASTATIN d04105A CDp E78.0 Pure hypercholesterolemia A E z A BICALUTAMIDE d03850A Cf C61 Malignant neoplasm of prostate A E z A DONEPEZIL; MEMANTINE d08337A C- G31.9 Degenerative disease of nervous system, unspecified A E z A LATANOPROST OPHTHALMIC d04017A C[@ H40 Glaucoma A E z A LISINOPRIL d00732A B I10 Essential (primary) hypertension A E z A MIRABEGRON d07876A C- N32.81 Overactive bladder A E z A TAMSULOSIN d04121A Cf N40 Enlarged prostate A E z A TIMOLOL OPHTHALMIC d04037A C H40 Glaucoma A E z A ATORVASTATIN d04105A B E78.0 Pure hypercholesterolemia A E z A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A D I10 Essential (primary) hypertension A E z A ACETAMINOPHEN; OXYCODONE d03431A B* T14.9 Unspecified injury A E z A . . . E z A . . . E { A ACETAMINOPHEN; HYDROCODONE d03428A Cr M54 Dorsalgia Ap E { A AMITRIPTYLINE d00146A Cr G47.0 Insomnia Ap E { A AMLODIPINE d00689A Cr I10 Essential (primary) hypertension Ap E { A LISINOPRIL d00732A Cr I10 Essential (primary) hypertension Ap E { A METOPROLOL d00134A Cr I10 Essential (primary) hypertension Ap E { A SIMVASTATIN d00746A Cr E78.0 Pure hypercholesterolemia Ap E { A TAMSULOSIN d04121A Cr N40 Enlarged prostate Ap E { A FLUTICASONE TOPICAL d04284A C- L20.9 Atopic dermatitis, unspecified A E { A DUTASTERIDE d04788A C N40 Enlarged prostate A0 E { A FENOFIBRATE d04286A D E78.1 Pure hyperglyceridemia A0 E { A TAMSULOSIN d04121A C N40 Enlarged prostate A0 E {0 A . . . E {@ A ALBUTEROL d00749A C[@ J44.9 Chronic obstructive pulmonary disease, unspecified A E {@ A ALLOPURINOL d00023A CDp M10.9P Prevent gout A E {@ A FUROSEMIDE d00070A Bz I10 Essential (primary) hypertension A E {@ A INSULIN ASPART d04697A C- E11 Type 2 diabetes mellitus A E {@ A INSULIN GLARGINE d04538A CDp E11 Type 2 diabetes mellitus A E {@ A OMEPRAZOLE d00325A C- B96.81 Helicobacter pylori [H. pylori] as the cause of diseases classified elsewhere A E {@ A OXYBUTYNIN d00328A C N32.81 Overactive bladder A E {@ A PRIMIDONE d00352A C[@ G20 Parkinson's disease A E {@ A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia A E {P A . . . E {` A . . . E {p A . . . E { A . . . E { A TAMSULOSIN d04121A Cr R35 Polyuria A E { A CARVEDILOL d03847A C I10 Essential (primary) hypertension A` E { A HYDROCHLOROTHIAZIDE d00253A Cr I10 Essential (primary) hypertension A` E { A LISINOPRIL d00732A Cr I10 Essential (primary) hypertension A` E { A OMEPRAZOLE d00325A C- K21 Gastro-esophageal reflux disease A` E { A POTASSIUM CHLORIDE d00345A C"0 E87.6 Hypokalemia A` E { A PRAVASTATIN d00348A Cr E78.0 Pure hypercholesterolemia A` E { A . . . E { A AMOXICILLIN d00088A Ap J09 Influenza due to certain identified influenza viruses A E { A . . . E { A . . . E { A . . . E | A . . . E | A BUPROPION d00181A Cr F32.9 Major depressive disorder, single episode, unspecified A E | A METHYLPHENIDATE d00900A C F90 Attention-deficit hyperactivity disorders A E | A . . . E |0 A . . . E |@ A . . . E |P A AMLODIPINE d00689A A I10 Essential (primary) hypertension A@ E |P A HYDRALAZINE d00132A A I10 Essential (primary) hypertension A@ E |P A LISINOPRIL d00732A Cr I10 Essential (primary) hypertension A@ E |P A METOPROLOL d00134A A I10 Essential (primary) hypertension A@ E |` A AMLODIPINE d00689A Bz I10 Essential (primary) hypertension A E |` A MEDROXYPROGESTERONE d00284A Bz E28 Ovarian dysfunction A E |p A . . . E | A . . . E | A AMPHETAMINE; DEXTROAMPHETAMINE d04035A CDp F90 Attention-deficit hyperactivity disorders A E | A GUANFACINE d00717A C F90 Attention-deficit hyperactivity disorders A E | A . . . E | A ALPRAZOLAM d00168A D G47.0 Insomnia A E | A DILTIAZEM d00045A C R00 Abnormalities of heart beat A E | A FENOFIBRATE d04286A C[@ E78.0 Pure hypercholesterolemia A E | A METFORMIN d03807A C[@ E11 Type 2 diabetes mellitus A E | A OMEPRAZOLE d00325A Cr K21 Gastro-esophageal reflux disease A E | A PHENTERMINE d00806A B[ E66 Overweight and obesity A E | A TERAZOSIN d00386A C N40 Enlarged prostate A E | A TESTOSTERONE d00558A Cr E29.1 Testicular hypofunction A E | A . . . E | A . . . E | A . . . E | A . . . E } A SPIRONOLACTONE d00373A B R60.9 Edema, unspecified A E } A ALBUTEROL d00749A C[@ J45 Asthma A E } A . . . E }0 A . . . E }@ A AMLODIPINE d00689A Cr I10 Essential (primary) hypertension A E }P A . . . E }` A . . . E }p A . . . E } A . . . E } A HYDROCODONE d03075A D R52 Pain, unspecified A@ E } A INFLIXIMAB d04342A C"0 M06.9 Rheumatoid arthritis, unspecified A@ E } A LISINOPRIL d00732A Cr I10 Essential (primary) hypertension A@ E } A METFORMIN d03807A C E11 Type 2 diabetes mellitus A@ E } A . . . E } A . . . E } A CLONAZEPAM d00197A C- G47.0 Insomnia A E } A MECLIZINE d00859A C R42 Dizziness and giddiness A E } A ACETAMINOPHEN; TRAMADOL d04766A A M79.1 Myalgia Ap E } A ALLOPURINOL d00023A B[ M10.9P Prevent gout Ap E } A FUROSEMIDE d00070A B R60.9 Edema, unspecified Ap E } A INSULIN LISPRO d04373A C[@ E11 Type 2 diabetes mellitus Ap E } A METOPROLOL d00134A C I10 Essential (primary) hypertension Ap E } A MONTELUKAST d04289A C- J45 Asthma Ap E } A PANTOPRAZOLE d04514A B[ K30 Functional dyspepsia Ap E } A OXYCODONE d00329A C M79.6 T14.9 Pain in limb, hand, foot, fingers and toes Unspecified injury A E } A ROSUVASTATIN d04851A B[ M85.9 Disorder of bone density and structure, unspecified A E } A BISOPROLOL; HYDROCHLOROTHIAZIDE d03744A C I10 Essential (primary) hypertension A E } A LOSARTAN d03821A C I10 Essential (primary) hypertension A E ~ A . . . E ~ A . . . E ~ A ADALIMUMAB d04835A C[@ M06.9 Rheumatoid arthritis, unspecified A0 E ~ A FLUOXETINE d00236A C F41.9 Anxiety disorder, unspecified A0 E ~ A MIRTAZAPINE d04025A B F32.9 Major depressive disorder, single episode, unspecified A0 E ~0 A LEVOTHYROXINE d00278A CP E03.9 Hypothyroidism, unspecified A E ~@ A . . . E ~P A . . . E ~` A ALBUTEROL d00749A Ap J45 Asthma A0 E ~` A ALBUTEROL d00749A C- J45 Asthma A0 E ~` A MONTELUKAST d04289A B J45 Asthma A0 E ~p A . . . E ~ A . . . E ~ A MOMETASONE TOPICAL d01300A C L20.9 Atopic dermatitis, unspecified A E ~ A ETONOGESTREL d04772A C- Z79.3 Long term (current) use of hormonal contraceptives A E ~ A . . . E ~ A . . . E ~ A . . . E ~ A IBUPROFEN d00015A B[ T14.9 Unspecified injury A E ~ A NYSTATIN TOPICAL d04399A B[ B37 Candidiasis A E A . . . E A . . . E A AZITHROMYCIN d00091A A J01.9 Acute sinusitis, unspecified A E 0 A . . . E @ A . . . E P A ATENOLOL d00004A C I10 Essential (primary) hypertension A@ E P A MELOXICAM d04532A C M19.9 Osteoarthritis, unspecified site A@ E P A PANTOPRAZOLE d04514A D K25 Gastric ulcer A@ E P A SERTRALINE d00880A Dc F32.9 Major depressive disorder, single episode, unspecified A@ E ` A . . . E p A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A0 E p A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A C I10 Essential (primary) hypertension A0 E p A NABUMETONE d00310A B M54 M79.2 Dorsalgia Neuralgia and neuritis, unspecified A0 E A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A` E A FEBUXOSTAT d07397A C M1A Chronic gout A` E A FUROSEMIDE d00070A C I10 Essential (primary) hypertension A` E A GABAPENTIN d03182A C M79.2 Neuralgia and neuritis, unspecified A` E A GLIMEPIRIDE d03864A C R73 Elevated blood glucose level A` E A LOSARTAN d03821A C E87.6 Hypokalemia A` E A HYDROCHLOROTHIAZIDE; LOSARTAN d03830A C- I10 Essential (primary) hypertension A E A LEVOTHYROXINE d00278A D E03.9 Hypothyroidism, unspecified A E A PANTOPRAZOLE d04514A C"0 K21 Gastro-esophageal reflux disease A E A . . . E A LEVOTHYROXINE d00278A D; E07.9 Disorder of thyroid, unspecified A E A ROSUVASTATIN d04851A D; E78.0 Pure hypercholesterolemia A E A ALBUTEROL d00749A D= J45 Asthma Ap E A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia Ap E A DICYCLOMINE d00999A C K58 Irritable bowel syndrome Ap E A GABAPENTIN d03182A C M54 Dorsalgia Ap E A MELOXICAM d04532A C M54 Dorsalgia Ap E A PANTOPRAZOLE d04514A C K30 Functional dyspepsia Ap E A RANITIDINE d00021A C K21 Gastro-esophageal reflux disease Ap E A CLONAZEPAM d00197A D F32.9 F41.9 G47.0 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified Insomnia A E A RANITIDINE d00021A C K25 Gastric ulcer A E A ACETAMINOPHEN; OXYCODONE d03431A Ap T14.9 Unspecified injury A0 E A ATORVASTATIN d04105A Cr E78.0 Pure hypercholesterolemia A0 E A TRAMADOL d03826A Ap T14.9 Unspecified injury A0 E A . . . E A CEFUROXIME d00056A A0 J01.9 Acute sinusitis, unspecified A E A MUPIROCIN TOPICAL d01267A A0 L08.9 Local infection of the skin and subcutaneous tissue, unspecified A E A AMLODIPINE d00689A C I10 Essential (primary) hypertension A E A HYDROCHLOROTHIAZIDE d00253A C I10 Essential (primary) hypertension A E 0 A . . . E @ A ATORVASTATIN d04105A Cr I21.P Prevent heart attack/myocardial infarction A0 E @ A LEVOTHYROXINE d00278A D E03.9 Hypothyroidism, unspecified A0 E @ A METOPROLOL d00134A Cr I10 Essential (primary) hypertension A0 E P A IRBESARTAN d04222A C- I10 Essential (primary) hypertension A E P A METFORMIN d03807A B E11 Type 2 diabetes mellitus A E ` A AMLODIPINE d00689A C I10 Essential (primary) hypertension A E ` A ATENOLOL d00004A C I10 Essential (primary) hypertension A E ` A BACLOFEN d00967A C[@ M62.83 M79.2 Muscle spasm Neuralgia and neuritis, unspecified A E ` A BALSALAZIDE d04700A C K58 Irritable bowel syndrome A E ` A DULOXETINE d05355A C F32.9 Major depressive disorder, single episode, unspecified A E ` A FENOFIBRATE d04286A C E78.0 Pure hypercholesterolemia A E ` A GABAPENTIN d03182A C G40 M79.7 Epilepsy and recurrent seizures Fibromyalgia A E ` A HYDROCODONE d03075A C M79.2 R51 Neuralgia and neuritis, unspecified Headache A E ` A LEVETIRACETAM d04499A C[@ G40 Epilepsy and recurrent seizures A E ` A LEVOTHYROXINE d00278A CDp E04 Other nontoxic goiter A E ` A LOSARTAN d03821A C I10 Essential (primary) hypertension A E ` A ROPINIROLE d04215A Cr G25.81 Restless legs syndrome A E ` A TOPIRAMATE d04115A CDp G40 Epilepsy and recurrent seizures A E p A CELECOXIB d04380A B M06.9 Rheumatoid arthritis, unspecified A E A CARBAMAZEPINE d00058A C F39 Unspecified mood [affective] disorder A E A LORATADINE; PSEUDOEPHEDRINE d03818A CP H10 T78.40 Conjunctivitis Allergy, unspecified A E A LEVOTHYROXINE d00278A Ei E07.9 Disorder of thyroid, unspecified AP E A LISINOPRIL d00732A A I10 Essential (primary) hypertension AP E A METFORMIN d03807A C E11 Type 2 diabetes mellitus AP E A OLANZAPINE d04050A B F32.9 Major depressive disorder, single episode, unspecified AP E A SIMVASTATIN d00746A B[ E78.0 Pure hypercholesterolemia AP E A ESCITALOPRAM d04812A C 55555 A@ E A ETHINYL ESTRADIOL; NORGESTIMATE d03781A C[@ Z79.3 Long term (current) use of hormonal contraceptives A@ E A MELOXICAM d04532A B T14.9 Unspecified injury A@ E A TRAMADOL d03826A A T14.9 Unspecified injury A@ E A LOSARTAN d03821A B= E11.8 Type 2 diabetes mellitus with unspecified complications A0 E A METFORMIN d03807A CDp E11 Type 2 diabetes mellitus A0 E A MIRABEGRON d07876A B R35 Polyuria A0 E A . . . E A . . . E A ATORVASTATIN d04105A Cr E78.0 Pure hypercholesterolemia A E A GLIPIZIDE d00246A D* 99999 A@ E A LISINOPRIL d00732A D* E11.2P Prevent diabetic kidney disease A@ E A METFORMIN d03807A D* E11 Type 2 diabetes mellitus A@ E A SIMVASTATIN d00746A D* E78.0P Prevent high cholesterol A@ E A DOXYCYCLINE d00037A Ap A49.9 Bacterial infection, unspecified A E A METRONIDAZOLE d00108A Ap A49.9 N39.0 Bacterial infection, unspecified Urinary tract infection, site not specified A E A . . . E A . . . E 0 A BRIMONIDINE; TIMOLOL OPHTHALMIC d05283A C H40 Glaucoma AP E 0 A BUSPIRONE d00182A Cr F41.9 Anxiety disorder, unspecified AP E 0 A LATANOPROST OPHTHALMIC d04017A C H40 Glaucoma AP E 0 A LOSARTAN d03821A C[@ I10 Essential (primary) hypertension AP E 0 A METOPROLOL d00134A C[@ I10 Essential (primary) hypertension AP E @ A . . . E P A . . . E ` A . . . E p A . . . E A . . . E A CARVEDILOL d03847A C I10 Essential (primary) hypertension AP E A ENZALUTAMIDE d07900A C C61 Malignant neoplasm of prostate AP E A FLUOXETINE d00236A D# F33.9 Major depressive disorder, recurrent, unspecified AP E A GABAPENTIN d03182A C G25.81 Restless legs syndrome AP E A ROSUVASTATIN d04851A C E78.0 Pure hypercholesterolemia AP E A . . . E A AMPHETAMINE; DEXTROAMPHETAMINE d04035A Cr F90 Attention-deficit hyperactivity disorders A E A DESVENLAFAXINE d07113A C[@ F32.9 Major depressive disorder, single episode, unspecified A E A FLUTICASONE NASAL d04283A Cr R09.81 Nasal congestion A E A GABAPENTIN d03182A C- M25.5 Pain in joint A E A HYDROCHLOROTHIAZIDE d00253A C- R60.9 Edema, unspecified A E A HYDROCODONE d03075A D G43 Migraine A E A KETOROLAC d00273A B G43 Migraine A E A LEVOTHYROXINE d00278A Dc E03.9 Hypothyroidism, unspecified A E A LOSARTAN d03821A C- I10 Essential (primary) hypertension A E A MELOXICAM d04532A C- M25.5 Pain in joint A E A ROSUVASTATIN d04851A Dc E78.0 Pure hypercholesterolemia A E A SUMATRIPTAN d03160A D* G43 Migraine A E A . . . E A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia AP E A CARVEDILOL d03847A Dc I49.9 Cardiac arrhythmia, unspecified AP E A LISINOPRIL d00732A C I10 Essential (primary) hypertension AP E A RANITIDINE d00021A D* K21 Gastro-esophageal reflux disease AP E A SERTRALINE d00880A C F41.9 Anxiety disorder, unspecified AP E A . . . E A ALBUTEROL d00749A C J44.9 Chronic obstructive pulmonary disease, unspecified A E A . . . E A . . . E A . . . E 0 A . . . E @ A ATORVASTATIN d04105A Ei E78.0 Pure hypercholesterolemia A0 E @ A CARVEDILOL d03847A Ei I10 Essential (primary) hypertension A0 E @ A LISINOPRIL d00732A Ei I10 Essential (primary) hypertension A0 E P A CLONAZEPAM d00197A D G25.81 M62.83 Restless legs syndrome Muscle spasm A0 E P A FLUOXETINE d00236A D F32.9 Major depressive disorder, single episode, unspecified A0 E P A VERAPAMIL d00048A D G43 Migraine A0 E ` A CLONAZEPAM d00197A Cr G47.9 Sleep disorder, unspecified A E ` A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia A E p A . . . E A . . . E A ACETAMINOPHEN; HYDROCODONE d03428A B T14.9 Unspecified injury A E A GLYBURIDE d00248A B E11 Type 2 diabetes mellitus A E A METFORMIN d03807A B E11 Type 2 diabetes mellitus A E A . . . E A . . . E A . . . E A . . . E A OMEPRAZOLE d00325A C- K21 Gastro-esophageal reflux disease A E A . . . E A THYROID DESICCATED d00655A C"0 E03.9 Hypothyroidism, unspecified A E A . . . E 0 A . . . E @ A ALLOPURINOL d00023A C M1A Chronic gout A@ E @ A HYDROCHLOROTHIAZIDE d00253A Cr N20.0 Calculus of kidney A@ E @ A METOPROLOL d00134A C R00 Abnormalities of heart beat A@ E @ A RAMIPRIL d00728A Cr I10 Essential (primary) hypertension A@ E P A AMLODIPINE d00689A D I10 Essential (primary) hypertension A E P A CILOSTAZOL d04382A B[ I70 Atherosclerosis A E P A ENALAPRIL d00013A D I10 Essential (primary) hypertension A E P A FLUOXETINE d00236A B[ F32.9 Major depressive disorder, single episode, unspecified A E P A LEVOTHYROXINE d00278A CDp E03.9 Hypothyroidism, unspecified A E P A METOPROLOL d00134A CDp I50.9 Heart failure, unspecified A E P A OMEPRAZOLE d00325A CDp K21 Gastro-esophageal reflux disease A E P A ROSUVASTATIN d04851A CDp E78.0 Pure hypercholesterolemia A E ` A CHLORPHENIRAMINE d00191A Dc T78.40 Allergy, unspecified Ap E ` A FAMOTIDINE d00141A B K21 Gastro-esophageal reflux disease Ap E ` A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A C I10 Essential (primary) hypertension Ap E ` A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia Ap E ` A SULINDAC d00033A C M79.1 Myalgia Ap E ` A TERAZOSIN d00386A Cr N40 Enlarged prostate Ap E ` A ZOLPIDEM d00910A CP G47.9 Sleep disorder, unspecified Ap E p A AMLODIPINE d00689A D= I10 Essential (primary) hypertension A E p A LOSARTAN d03821A Cr I10 Essential (primary) hypertension A E A INSULIN GLARGINE d04538A C"0 E11 Type 2 diabetes mellitus A E A . . . E A . . . E A . . . E A . . . E A AMPHETAMINE; DEXTROAMPHETAMINE d04035A C- F90 Attention-deficit hyperactivity disorders A E A TRAMADOL d03826A B M54 Dorsalgia A E A . . . E A . . . E A FLUCONAZOLE d00071A C I10 Essential (primary) hypertension A E A RANITIDINE d00021A C K30 Functional dyspepsia A E A ALBUTEROL d00749A D J44.9 Chronic obstructive pulmonary disease, unspecified A0 E A ENALAPRIL d00013A D* I10 Essential (primary) hypertension A0 E A GABAPENTIN d03182A B M06.9 Rheumatoid arthritis, unspecified A0 E 0 A . . . E @ A AMOXICILLIN d00088A A J40 Bronchitis, not specified as acute or chronic A E P A . . . E ` A RANITIDINE d00021A B K21 Gastro-esophageal reflux disease A E p A . . . E A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia AP E A FUROSEMIDE d00070A C- R60.9 Edema, unspecified AP E A GABAPENTIN d03182A Dc M79.2 Neuralgia and neuritis, unspecified AP E A METFORMIN d03807A B E11 Type 2 diabetes mellitus AP E A POTASSIUM CHLORIDE d00345A B= E87.6 Hypokalemia AP E A OMEPRAZOLE; SODIUM BICARBONATE d05770A CDp K30 Functional dyspepsia A E A . . . E A . . . E A . . . E A ATORVASTATIN d04105A B E78.0 Pure hypercholesterolemia A E A LEVOTHYROXINE d00278A Cr E03.9 Hypothyroidism, unspecified A E A . . . E A DICLOFENAC d00848A C[@ M19.9 Osteoarthritis, unspecified site A` E A EMPAGLIFLOZIN d08275A B E11 Type 2 diabetes mellitus A` E A EXENATIDE d05529A B E11 Type 2 diabetes mellitus A` E A HYDROCHLOROTHIAZIDE; TRIAMTERENE d03052A C- I10 Essential (primary) hypertension A` E A INSULIN DETEMIR d05436A B E11 Type 2 diabetes mellitus A` E A METFORMIN d03807A B E11 Type 2 diabetes mellitus A` E A . . . E A . . . E A . . . E 0 A . . . E @ A . . . E P A FLUTICASONE; VILANTEROL d08100A B R06.9 Unspecified abnormalities of breathing A E ` A . . . E p A . . . E A . . . E A . . . E A . . . E A AMOXICILLIN d00088A A H66.9 Otitis media, unspecified A E A IBUPROFEN d00015A B R50.9 Fever, unspecified A E A AMLODIPINE d00689A C[@ I10 I21.P Essential (primary) hypertension Prevent heart attack/myocardial infarction A@ E A FUROSEMIDE d00070A C[@ K76.9 Liver disease, unspecified A@ E A METOPROLOL d00134A C[@ I10 Essential (primary) hypertension A@ E A PAROXETINE d03157A C[@ F32.9 F41.9 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified A@ E A . . . E A . . . E A 99999 . . A E A . . . E A ALBUTEROL d00749A Bz R06.2 Wheezing A E A BUDESONIDE d04276A B J42 R05 Unspecified chronic bronchitis Cough A E A . . . E 0 A ALLOPURINOL d00023A B M10.9P Prevent gout AP E 0 A ATORVASTATIN d04105A B I63.P Prevent stroke AP E 0 A FUROSEMIDE d00070A B M10.9 Gout, unspecified AP E 0 A METOPROLOL d00134A B I10 Essential (primary) hypertension AP E 0 A SERTRALINE d00880A B F32.9 Major depressive disorder, single episode, unspecified AP E @ A . . . E P A ATORVASTATIN d04105A Cr E78.0P Prevent high cholesterol A0 E P A DILTIAZEM d00045A CDp I21 ST elevation (STEMI) and non-ST elevation (NSTEMI) myocardial infarction A0 E P A LISINOPRIL d00732A Cr I10 Essential (primary) hypertension A0 E ` A ALBUTEROL d00749A C J44.9 Chronic obstructive pulmonary disease, unspecified A@ E ` A ALBUTEROL d00749A0 C J44.9 Chronic obstructive pulmonary disease, unspecified A@ E ` A BUDESONIDE; FORMOTEROL d04795A0 C J44.9 Chronic obstructive pulmonary disease, unspecified A@ E ` A TIOTROPIUM d04829A0 C J44.9 Chronic obstructive pulmonary disease, unspecified A@ E p A . . . E A HYDROCHLOROTHIAZIDE; LOSARTAN d03830A Cr I10 Essential (primary) hypertension A E A . . . E A . . . E A GLIPIZIDE d00246A0 C R20 Disturbances of skin sensation A@ E A LEVOTHYROXINE d00278A0 D E03.9 Hypothyroidism, unspecified A@ E A LISINOPRIL d00732A0 C- I10 Essential (primary) hypertension A@ E A METFORMIN d03807A0 C E11.P Prevent diabetes A@ E A . . . E A ATORVASTATIN d04105A B E78.0 Pure hypercholesterolemia A@ E A CLONIDINE d00044A C[@ I10 Essential (primary) hypertension A@ E A CLOPIDOGREL d04258A C I63 Cerebral infarction A@ E A LISINOPRIL d00732A C[@ I10 Essential (primary) hypertension A@ E A . . . E A OLOPATADINE NASAL d07132A C J30.1 Allergic rhinitis due to pollen A E A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A D E78.0 I10 Pure hypercholesterolemia Essential (primary) hypertension A E A METOPROLOL d00134A C I10 Essential (primary) hypertension A E A . . . E A LISINOPRIL d00732A Cr I10 Essential (primary) hypertension A E 0 A . . . E @ A . . . E P A . . . E ` A . . . E p A . . . E A . . . E A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A C I10 Essential (primary) hypertension A E A LEVETIRACETAM d04499A Cr G40 Epilepsy and recurrent seizures A E A . . . E A . . . E A ALBUTEROL d00749A C- J45 Asthma A@ E A ALBUTEROL d00749A Cr J45 Asthma A@ E A BUDESONIDE; FORMOTEROL d04795A B J45 Asthma A@ E A MONTELUKAST d04289A C- J45 Asthma A@ E A . . . E A . . . E A AMLODIPINE d00689A Dc I10 Essential (primary) hypertension A0 E A LEVOTHYROXINE d00278A Dc E03.9 Hypothyroidism, unspecified A0 E A OMEPRAZOLE d00325A C K21 Gastro-esophageal reflux disease A0 E A . . . E A AMLODIPINE d00689A C[@ I10 Essential (primary) hypertension A E A NAPROXEN d00019A C M79.1 Myalgia A E 0 A . . . E @ A ALPRAZOLAM d00168A CDp F41.9 Anxiety disorder, unspecified Ap E @ A CARVEDILOL d03847A Cr I50.9 Heart failure, unspecified Ap E @ A FINASTERIDE d00563A CDp N32.9 Bladder disorder, unspecified Ap E @ A HYOSCYAMINE; METHENA; MBLUE; PHENYLSAL; SODIUM BIPHOSPHATE d08274A B N32.81 Overactive bladder Ap E @ A LANSOPRAZOLE d03828A D K21 Gastro-esophageal reflux disease Ap E @ A OXYBUTYNIN d00328A C- N32.81 Overactive bladder Ap E @ A WARFARIN d00022A C D75.9P Prevent blood clots Ap E P A . . . E ` A . . . E p A . . . E A LEVOTHYROXINE d00278A D* E03.9 Hypothyroidism, unspecified A E A SIMVASTATIN d00746A D* E78.0 Pure hypercholesterolemia A E A ALLOPURINOL d00023A C M10.9P Prevent gout A E A METFORMIN d03807A C R73 Elevated blood glucose level A E A CLONIDINE d00044A C- G47.0 Insomnia A E A . . . E A . . . E A AMLODIPINE d00689A C"0 I10 Essential (primary) hypertension A E A OXYBUTYNIN d00328A C"0 N39.4 Other specified urinary incontinence A E A . . . E A . . . E A . . . E A . . . E A . . . E 0 A ACETAMINOPHEN; OXYCODONE d03431A Ei M54 Dorsalgia A` E 0 A ATORVASTATIN d04105A B E78.0 Pure hypercholesterolemia A` E 0 A GLYBURIDE d00248A C E11 Type 2 diabetes mellitus A` E 0 A HYDROCHLOROTHIAZIDE d00253A D I10 R60.9 Essential (primary) hypertension Edema, unspecified A` E 0 A METOPROLOL d00134A CP I10 Essential (primary) hypertension A` E 0 A WARFARIN d00022A CP D75.9P Prevent blood clots A` E @ A . . . E P A AMOXICILLIN; CLAVULANATE d00089A A0 J01.9 Acute sinusitis, unspecified A@ E P A DEXAMETHASONE d00206A A0 J01.9 Acute sinusitis, unspecified A@ E P A LEVOTHYROXINE d00278A A0 E03.9 Hypothyroidism, unspecified A@ E P A SIMVASTATIN d00746A A0 E78.0 Pure hypercholesterolemia A@ E ` A . . . E p A ALBUTEROL d00749A A@ J20.9 Acute bronchitis, unspecified A0 E p A CODEINE; GUAIFENESIN d03393A A@ J20.9 Acute bronchitis, unspecified A0 E p A DOXYCYCLINE d00037A A@ J40 Bronchitis, not specified as acute or chronic A0 E A FLUOXETINE d00236A C ` F41.9 Anxiety disorder, unspecified A E A . . . E A . . . E A . . . E A . . . E A AMLODIPINE d00689A C- 99999 A@ E A ASPIRIN d00170A C- D75.9P Prevent blood clots A@ E A HYDROCHLOROTHIAZIDE d00253A C- 99999 A@ E A LISINOPRIL d00732A C- 99999 A@ E A MESALAMINE d01031A A K50 K51 Crohn's disease [regional enteritis] Ulcerative colitis A0 E A ONDANSETRON d00867A Cr R11 Nausea and vomiting A0 E A SULFASALAZINE d00379A Cf K50 K51 Crohn's disease [regional enteritis] Ulcerative colitis A0 E A . . . E A HYDROCHLOROTHIAZIDE; TRIAMTERENE d03052A D)Y I10 Essential (primary) hypertension AP E A METFORMIN d03807A C E11 Type 2 diabetes mellitus AP E A METOPROLOL d00134A D)Y I10 Essential (primary) hypertension AP E A PRAVASTATIN d00348A D E78.0 Pure hypercholesterolemia AP E A ZOLPIDEM d00910A C G47.0 Insomnia AP E A . . . E A ALBUTEROL d00749A A J20.9 Acute bronchitis, unspecified A E A ALLOPURINOL d00023A D0z N20.0 Calculus of kidney A E A AMLODIPINE; BENAZEPRIL d03829A C[@ I10 Essential (primary) hypertension A E A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A E A CODEINE; GUAIFENESIN d03393A A J20.9 Acute bronchitis, unspecified A E A DULOXETINE d05355A CDp M79.2 Neuralgia and neuritis, unspecified A E A FLUTICASONE NASAL d04283A Cr J30.9 Allergic rhinitis, unspecified A E A METFORMIN d03807A Ei 99999 A E A OMEPRAZOLE d00325A C K21 Gastro-esophageal reflux disease A E A TRAZODONE d00395A C G47.0 Insomnia A E 0 A 99999 . . A E @ A CYPROHEPTADINE d00790A A R63 Symptoms and signs concerning food and fluid intake A E P A . . . E ` A . . . E p A ATORVASTATIN d04105A B E78.0 Pure hypercholesterolemia A` E p A LISINOPRIL d00732A B I10 Essential (primary) hypertension A` E p A METHOCARBAMOL d00965A D M62.83 Muscle spasm A` E p A MONTELUKAST d04289A Bz H04 J30.9 R05 Disorders of lacrimal system Allergic rhinitis, unspecified Cough A` E p A TAMSULOSIN d04121A Bz R35 Polyuria A` E p A TRAMADOL d03826A D M54 T14.9 Dorsalgia Unspecified injury A` E A . . . E A . . . E A ACETAMINOPHEN; HYDROCODONE d03428A C M25.5 M54 Pain in joint Dorsalgia B E A ALBUTEROL d00749A A J44.9 Chronic obstructive pulmonary disease, unspecified B E A ALBUTEROL; IPRATROPIUM d04066A C[@ J44.9 Chronic obstructive pulmonary disease, unspecified B E A ALPRAZOLAM d00168A Bz F41.9 Anxiety disorder, unspecified B E A ATORVASTATIN d04105A C[@ I21.P Prevent heart attack/myocardial infarction B E A CARVEDILOL d03847A C- I10 I50.9 Essential (primary) hypertension Heart failure, unspecified B E A CLOPIDOGREL d04258A C[@ I21 ST elevation (STEMI) and non-ST elevation (NSTEMI) myocardial infarction B E A ESOMEPRAZOLE d04749A C- K21 Gastro-esophageal reflux disease B E A FLUTICASONE NASAL d04283A A J30.9 Allergic rhinitis, unspecified B E A FUROSEMIDE d00070A C[@ I50.9 I51.9 Heart failure, unspecified Heart disease, unspecified B E A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified B E A LIRAGLUTIDE d07466A C E11 Type 2 diabetes mellitus B E A LISINOPRIL d00732A C I10 I50.9 Essential (primary) hypertension Heart failure, unspecified B E A LISINOPRIL d00732A C I10 Essential (primary) hypertension B E A METFORMIN d03807A C E11 Type 2 diabetes mellitus B E A NITROGLYCERIN d00321A B= I20.9 Angina pectoris, unspecified B E A POTASSIUM CHLORIDE d00345A C[@ E87.6 Hypokalemia B E A PREGABALIN d05508A C E11.4 Type 2 diabetes mellitus with neurological complications B E A ROPINIROLE d04215A Cr G25.81 Restless legs syndrome B E A . . . E A . . . E A CLONIDINE d00044A C I10 Essential (primary) hypertension A E A DILTIAZEM d00045A C- 99999 A E A DOXAZOSIN d00726A C N28.9 Disorder of kidney and ureter, unspecified A E A FAMOTIDINE d00141A C K21 Gastro-esophageal reflux disease A E A GLIPIZIDE d00246A C- E11 Type 2 diabetes mellitus A E A LOSARTAN d03821A C- 99999 A E A METOPROLOL d00134A C[@ I10 Essential (primary) hypertension A E A SIMVASTATIN d00746A C- E78.0 Pure hypercholesterolemia A E A WARFARIN d00022A D* Z79.0 Long term (current) use of anticoagulants and antithrombotics/antiplatelets A E A AMLODIPINE d00689A C I10 Essential (primary) hypertension A0 E A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A0 E A RALOXIFENE d04261A C M81 Osteoporosis without current pathological fracture A0 E A . . . E A HYDROCHLOROTHIAZIDE d00253A C I10 Essential (primary) hypertension A E A LISINOPRIL d00732A C I10 Essential (primary) hypertension A E A ONDANSETRON d00867A A R11 Nausea and vomiting A E A . . . E 0 A . . . E @ A . . . E P A AMOXICILLIN; CLAVULANATE d00089A Ap H66.9 Otitis media, unspecified A E P A CETIRIZINE d03827A Ap T78.40 Allergy, unspecified A E ` A . . . E p A . . . E A . . . E A . . . E A . . . E A . . . E A AMLODIPINE d00689A C I10 Essential (primary) hypertension A E A . . . E A DICYCLOMINE d00999A C K58 Irritable bowel syndrome A E A ATORVASTATIN d04105A C- E78.0 Pure hypercholesterolemia A E A ALBUTEROL d00749A Bz J45 Asthma A@ E A CLONIDINE d00044A C"0 G47.0 Insomnia A@ E A FLUTICASONE NASAL d04283A Bz J30.2 Other seasonal allergic rhinitis A@ E A METHYLPHENIDATE d00900A Bz F90 Attention-deficit hyperactivity disorders A@ E A . . . E A AMLODIPINE d00689A B I10 Essential (primary) hypertension A E 0 A . . . E @ A . . . E P A 99999 . . A E ` A . . . E p A . . . E A . . . E A ETHINYL ESTRADIOL; NORGESTIMATE d03781A CDp N92 Excessive, frequent and irregular menstruation A E A ASPIRIN d00170A Cr I63.P Prevent stroke A` E A CARVEDILOL d03847A C I50.9 Heart failure, unspecified A` E A CITALOPRAM d04332A C 99999 A` E A FUROSEMIDE d00070A C R60.9 Edema, unspecified A` E A POTASSIUM CHLORIDE d00345A C 99999 A` E A SPIRONOLACTONE d00373A C 99999 A` E A . . . E A RANITIDINE d00021A C K21 R12 Gastro-esophageal reflux disease Heartburn A E A PROPRANOLOL d00032A A0 R25.1 Tremor, unspecified A0 E A RIZATRIPTAN d04328A C G43 Migraine A0 E A TOPIRAMATE d04115A C G43.P Prevent migraine A0 E A . . . E A CONJUGATED ESTROGENS d00541A Dc N95 Menopausal and other perimenopausal disorders Ap E A GABAPENTIN d03182A C M79.2 Neuralgia and neuritis, unspecified Ap E A IBUPROFEN d00015A A I26 Pulmonary embolism Ap E A LISINOPRIL d00732A Cr I10 Essential (primary) hypertension Ap E A QUETIAPINE d04220A Cr G47.9 Sleep disorder, unspecified Ap E A RIVAROXABAN d07356A B I26 Pulmonary embolism Ap E A TRAZODONE d00395A Cr G47.9 Sleep disorder, unspecified Ap E A . . . E A AMLODIPINE d00689A C I10 Essential (primary) hypertension A E A METFORMIN d03807A C E11 Type 2 diabetes mellitus A E A . . . E 0 A . . . E @ A . . . E P A . . . E ` A . . . E p A HYDROCHLOROTHIAZIDE; TRIAMTERENE d03052A C"0 R60.9 Edema, unspecified A E A . . . E A BUDESONIDE; FORMOTEROL d04795A B J44.9 Chronic obstructive pulmonary disease, unspecified A@ E A FLUTICASONE; UMECLIDINIUM; VILANTEROL d08666A A J44.9 Chronic obstructive pulmonary disease, unspecified A@ E A FLUTICASONE; VILANTEROL d08100A B J44.9 Chronic obstructive pulmonary disease, unspecified A@ E A GABAPENTIN d03182A C"0 M54 Dorsalgia A@ E A . . . E A . . . E A . . . E A ATORVASTATIN d04105A Cr E78.0 Pure hypercholesterolemia A E A LISINOPRIL d00732A Cr I10 Essential (primary) hypertension A E A . . . E A . . . E A . . . E A . . . E A ESOMEPRAZOLE d04749A C K21 K46 Gastro-esophageal reflux disease Unspecified abdominal hernia A E A GEMFIBROZIL d00245A CDp E78.0 Pure hypercholesterolemia A E 0 A . . . E @ A . . . E P A CALCIUM ACETATE d03689A Cr N19 Unspecified kidney failure A E ` A . . . E p A BUPROPION d00181A CDp F32.9 Major depressive disorder, single episode, unspecified A E p A BUSPIRONE d00182A B[ F41.9 Anxiety disorder, unspecified A E A . . . E A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A E A BECLOMETHASONE d00760A D J45 Asthma A E A BENZONATATE d00796A Bz J45 Asthma A E A CARVEDILOL d03847A Bz I50.9 Heart failure, unspecified A E A CLOPIDOGREL d04258A C D75.9P Prevent blood clots A E A FUROSEMIDE d00070A C J98.9 Respiratory disorder, unspecified A E A GABAPENTIN d03182A C- G25.81 Restless legs syndrome A E A INSULIN ISOPHANE; INSULIN REGULAR d04374A D E11 Type 2 diabetes mellitus A E A ISOSORBIDE MONONITRATE d00269A B= I21.P Prevent heart attack/myocardial infarction A E A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified A E A ACETAMINOPHEN; CODEINE d03423A A K02 R52 Dental caries Pain, unspecified A E A ROSUVASTATIN d04851A B= E78.0P Prevent high cholesterol A E A ATORVASTATIN d04105A C- E78.0 Pure hypercholesterolemia A E A ESTERIFIED ESTROGENS d00542A Cr N95 Menopausal and other perimenopausal disorders A E A FLUTICASONE NASAL d04283A C- J30.1 Allergic rhinitis due to pollen A E A MEDROXYPROGESTERONE d00284A Cr N95 Menopausal and other perimenopausal disorders A E A PROPRANOLOL d00032A D F41.9 Anxiety disorder, unspecified A E A QUETIAPINE d04220A D F29 Unspecified psychosis not due to a substance or known physiological condition A E A RISPERIDONE d03180A D F41.9 Anxiety disorder, unspecified A E A SERTRALINE d00880A D F32.9 Major depressive disorder, single episode, unspecified A E A . . . E A ESTRADIOL d00537A C N95 Menopausal and other perimenopausal disorders A E A . . . E A APIXABAN d07804A C D75.9P Prevent blood clots A@ E A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A@ E A LISINOPRIL d00732A C I10 Essential (primary) hypertension A@ E A METOPROLOL d00134A C I48.9 Unspecified atrial fibrillation and atrial flutter A@ E A GLIPIZIDE d00246A Cr E11 Type 2 diabetes mellitus A0 E A METFORMIN d03807A Cr E11 Type 2 diabetes mellitus A0 E A SIMVASTATIN d00746A Cr E78.0 Pure hypercholesterolemia A0 E A . . . E 0 A . . . E @ A ETHINYL ESTRADIOL; NORETHINDRONE d03238A C Z79.3 Long term (current) use of hormonal contraceptives A E P A BETAMETHASONE TOPICAL d03197A B R21 Rash and other nonspecific skin eruption A E ` A AMLODIPINE d00689A C- I10 Essential (primary) hypertension A` E ` A FENOFIBRATE d04286A C- E78.1 Pure hyperglyceridemia A` E ` A LEVOTHYROXINE d00278A CDp E03.9 Hypothyroidism, unspecified A` E ` A LINAGLIPTIN d07767A Bz E11 R73 Type 2 diabetes mellitus Elevated blood glucose level A` E ` A LOSARTAN d03821A C- I10 Essential (primary) hypertension A` E ` A METOPROLOL d00134A C- E78.0 Pure hypercholesterolemia A` E p A . . . E A . . . E A . . . E A . . . E A . . . E A HYDROCHLOROTHIAZIDE; TRIAMTERENE d03052A Cr I10 R60.9 Essential (primary) hypertension Edema, unspecified A0 E A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified A0 E A ROSUVASTATIN d04851A C E78.0 Pure hypercholesterolemia A0 E A FLUTICASONE NASAL d04283A B J30.2 Other seasonal allergic rhinitis A E A . . . E A . . . E A . . . E A BECLOMETHASONE d00760A B* J42 Unspecified chronic bronchitis A E A . . . E 0 A ETHINYL ESTRADIOL; NORGESTIMATE d03781A B L70 Z79.3 Acne Long term (current) use of hormonal contraceptives A E @ A ACETAMINOPHEN; HYDROCODONE d03428A C M54 Dorsalgia A@ E @ A AMLODIPINE d00689A C I10 Essential (primary) hypertension A@ E @ A DULOXETINE d05355A C[@ F32.9 Major depressive disorder, single episode, unspecified A@ E @ A LURASIDONE d07705A C[@ F32.9 Major depressive disorder, single episode, unspecified A@ E P A IBUPROFEN d00015A A0 M54 Dorsalgia A E ` A LITHIUM d00061A Cr F31.9 Bipolar disorder, unspecified A E p A CLOPIDOGREL d04258A C 99999 A E p A DILTIAZEM d00045A C 99999 A E p A DULOXETINE d05355A C 99999 A E p A HYDROCHLOROTHIAZIDE d00253A C 99999 A E p A LORAZEPAM d00149A C F41.9 Anxiety disorder, unspecified A E p A METFORMIN d03807A C E11 Type 2 diabetes mellitus A E p A METOPROLOL d00134A C 99999 A E p A PANTOPRAZOLE d04514A C 99999 A E p A PRAVASTATIN d00348A C 99999 A E p A SPIRONOLACTONE d00373A C 99999 A E A . . . E A . . . E A NAPROXEN d00019A A0 T14.9 Unspecified injury A E A ATORVASTATIN d04105A C[@ E78.0 Pure hypercholesterolemia Ap E A CLOPIDOGREL d04258A C Z79.0 Long term (current) use of anticoagulants and antithrombotics/antiplatelets Ap E A FINASTERIDE d00563A C- N39.4 Other specified urinary incontinence Ap E A GABAPENTIN d03182A C- G40 Epilepsy and recurrent seizures Ap E A GALANTAMINE d04750A C[@ 55555 Ap E A MEMANTINE d04899A C G31.9 Degenerative disease of nervous system, unspecified Ap E A TAMSULOSIN d04121A C- N40 Enlarged prostate Ap E A . . . E A . . . E A DICLOFENAC d00848A B M13 Other arthritis A E A PHENYTOIN d00143A D> G40 Epilepsy and recurrent seizures A E A . . . E A ALBUTEROL d00749A C J45 Asthma A E A ASPIRIN d00170A C I50.9 Heart failure, unspecified A E A ATORVASTATIN d04105A CDp E63.9 Nutritional deficiency, unspecified A E A BUDESONIDE; FORMOTEROL d04795A C[@ J45 Asthma A E A CLONIDINE d00044A C[@ I10 Essential (primary) hypertension A E A GABAPENTIN d03182A Cr E11.4 Type 2 diabetes mellitus with neurological complications A E A INSULIN GLARGINE d04538A C E11 Type 2 diabetes mellitus A E A LISINOPRIL d00732A C[@ I10 Essential (primary) hypertension A E A OMEPRAZOLE d00325A CDp K21 Gastro-esophageal reflux disease A E A BUPROPION d00181A C[@ F32.9 Major depressive disorder, single episode, unspecified A` E A GABAPENTIN d03182A B M79.2 Neuralgia and neuritis, unspecified A` E A GLIPIZIDE d00246A Ap E11 Type 2 diabetes mellitus A` E A HYDROCHLOROTHIAZIDE; LOSARTAN d03830A C I10 Essential (primary) hypertension A` E A METFORMIN d03807A B E11 Type 2 diabetes mellitus A` E A TRAMADOL d03826A C M79.2 Neuralgia and neuritis, unspecified A` E A AMLODIPINE; BENAZEPRIL d03829A Cr I10 Essential (primary) hypertension A E 0 A . . . E @ A APIXABAN d07804A0 B D75.9P Prevent blood clots A E @ A ESCITALOPRAM d04812A0 B F32.9 Major depressive disorder, single episode, unspecified A E @ A GABAPENTIN d03182A0 B M79.2 Neuralgia and neuritis, unspecified A E @ A LEVOTHYROXINE d00278A0 B E03.9 Hypothyroidism, unspecified A E @ A MIRABEGRON d07876A0 B= N32.81 Overactive bladder A E @ A PRAMIPEXOLE d04145A0 B= G25.81 Restless legs syndrome A E @ A TRAMADOL d03826A0 B M79.2 Neuralgia and neuritis, unspecified A E @ A TRIMETHOPRIM d00123A0 B= N39.0 Urinary tract infection, site not specified A E P A . . . E ` A . . . E p A . . . E A . . . E A . . . E A CITALOPRAM d04332A C- F41.9 Anxiety disorder, unspecified A E A COLCHICINE d00150A C M1A Chronic gout A E A HYDROCHLOROTHIAZIDE d00253A C[@ R60.9 Edema, unspecified A E A INSULIN ASPART d04697A C- R73 Elevated blood glucose level A E A INSULIN GLARGINE d04538A CDp R73 Elevated blood glucose level A E A LOSARTAN d03821A D I10 Essential (primary) hypertension A E A LUBIPROSTONE d05736A CDp K59.0 Constipation A E A METOPROLOL d00134A C[@ I10 Essential (primary) hypertension A E A RANOLAZINE d05719A C[@ I99.9 Unspecified disorder of circulatory system A E A ROSUVASTATIN d04851A D E78.0 Pure hypercholesterolemia A E A . . . E A 99999 . . A E A . . . E A INSULIN ASPART d04697A C E10 Type 1 diabetes mellitus A E A INSULIN DETEMIR d05436A B E10 Type 1 diabetes mellitus A E A . . . E A . . . E A . . . E 0 A METOPROLOL d00134A CDp I10 Essential (primary) hypertension A E 0 A TRIAMTERENE d00396A C R60.9 Edema, unspecified A E @ A DEXMETHYLPHENIDATE d04777A C9 R41 Other symptoms and signs involving cognitive functions and awareness A E P A CITALOPRAM d04332A CDp F41.9 Anxiety disorder, unspecified A E ` A . . . E p A . . . E A . . . E A ALBUTEROL d00749A C J45 Asthma A E A . . . E A DEXMETHYLPHENIDATE d04777A CDp F90 Attention-deficit hyperactivity disorders A E A . . . E A . . . E A ATROPINE; DIPHENOXYLATE d03506A C- R19.7 Diarrhea, unspecified AP E A CETIRIZINE d03827A C[@ J30.1 L50 T78.40 Allergic rhinitis due to pollen Urticaria Allergy, unspecified AP E A NAPROXEN d00019A C- T14.9 Unspecified injury AP E A PREDNISONE d00350A C[@ M65.9 Synovitis and tenosynovitis, unspecified AP E A RANITIDINE d00021A C- K21 Gastro-esophageal reflux disease AP E A DICLOFENAC d00848A C- M25.5 Pain in joint A E A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia A E A TAMSULOSIN d04121A CDp N40 Enlarged prostate A E A . . . E A . . . E 0 A . . . E @ A . . . E P A AMPHETAMINE d00803A B[ F90 Attention-deficit hyperactivity disorders A E P A MONTELUKAST d04289A B J30.9 R06.9 Allergic rhinitis, unspecified Unspecified abnormalities of breathing A E ` A LOSARTAN d03821A C- I10 Essential (primary) hypertension A E p A . . . E A . . . E A ALBUTEROL d00749A CP J45 Asthma A E A . . . E A . . . E A ATORVASTATIN d04105A0 B D75.9P E78.0 R25.2 Prevent blood clots Pure hypercholesterolemia Cramp and spasm A0 E A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A Cr I10 Essential (primary) hypertension A0 E A LEVOTHYROXINE d00278A0 B E03.9 Hypothyroidism, unspecified A0 E A . . . E A ASPIRIN d00170A Dc D75.9P I21.P Prevent blood clots Prevent heart attack/myocardial infarction A E A BIMATOPROST OPHTHALMIC d04754A D# H40 Glaucoma A E A BRINZOLAMIDE OPHTHALMIC d04301A D# H40 Glaucoma A E A LISINOPRIL d00732A C 99999 A E A METFORMIN d03807A D E11 Type 2 diabetes mellitus A E A OXYBUTYNIN d00328A C R32 Unspecified urinary incontinence A E A PIOGLITAZONE d04442A D E11 Type 2 diabetes mellitus A E A PIOGLITAZONE d04442A D E11 Type 2 diabetes mellitus A E A SIMVASTATIN d00746A C 99999 A E A SITAGLIPTIN d05896A D E11 Type 2 diabetes mellitus A E A . . . E A AMOXICILLIN d00088A A J02 Acute pharyngitis A E A AMOXICILLIN d00088A A J42 Unspecified chronic bronchitis A E A PREDNISONE d00350A Ap J42 Unspecified chronic bronchitis A E A . . . E 0 A . . . E @ A 99999 . . A E @ A SIMVASTATIN d00746A B E78.0 Pure hypercholesterolemia A E P A . . . E ` A HYDROXYZINE d00907A B= F39 F41.9 Unspecified mood [affective] disorder Anxiety disorder, unspecified A E p A . . . E A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A C- I10 Essential (primary) hypertension A E A . . . E A ALBUTEROL d00749A D' J45 R05 R07.9 Asthma Cough Chest pain, unspecified A E A FLUTICASONE d01296A Cr J45.P Prevent asthma A E A ACETAMINOPHEN; TRAMADOL d04766A CDp G25.81 Restless legs syndrome AP E A AMLODIPINE; HYDROCHLOROTHIAZIDE; OLMESARTAN d07668A Cr I10 Essential (primary) hypertension AP E A ATORVASTATIN d04105A C- E78.0 Pure hypercholesterolemia AP E A METFORMIN d03807A C E11 Type 2 diabetes mellitus AP E A OMEPRAZOLE d00325A B K21 Gastro-esophageal reflux disease AP E A CLONIDINE d00044A C G47.0 Insomnia A0 E A METHYLPHENIDATE d00900A Ei F90 Attention-deficit hyperactivity disorders A0 E A SERTRALINE d00880A B F39 Unspecified mood [affective] disorder A0 E A . . . E A . . . E A . . . E A DEXMETHYLPHENIDATE d04777A C F90 Attention-deficit hyperactivity disorders A E A . . . E A . . . E 0 A . . . E @ A . . . E P A DICYCLOMINE d00999A C M62.83 Muscle spasm AP E P A INSULIN ASPART; INSULIN ASPART PROTAMINE d04839A C E11 Type 2 diabetes mellitus AP E P A INSULIN GLARGINE d04538A CDp E11 Type 2 diabetes mellitus AP E P A LISINOPRIL d00732A C[@ E11.2 Type 2 diabetes mellitus with kidney complications AP E P A SIMVASTATIN d00746A C- E78.0 Pure hypercholesterolemia AP E ` A ALPRAZOLAM d00168A CDp F41.9 Anxiety disorder, unspecified A@ E ` A METOPROLOL d00134A C I10 Essential (primary) hypertension A@ E ` A PRAVASTATIN d00348A B E78.0 Pure hypercholesterolemia A@ E ` A TAMSULOSIN d04121A B[ R35 Polyuria A@ E p A PRAVASTATIN d00348A CDp E78.0 Pure hypercholesterolemia A E A ALPRAZOLAM d00168A CDp F41.9 Anxiety disorder, unspecified AP E A CARISOPRODOL d00960A CDp M54 Dorsalgia AP E A HYDROCHLOROTHIAZIDE d00253A Dc I10 Essential (primary) hypertension AP E A IBUPROFEN d00015A CDp R52 Pain, unspecified AP E A NIFEDIPINE d00051A Dc I10 Essential (primary) hypertension AP E A . . . E A LOSARTAN d03821A C I10 Essential (primary) hypertension AP E A METFORMIN; SITAGLIPTIN d06720A CDp E11 Type 2 diabetes mellitus AP E A METOPROLOL d00134A C I10 Essential (primary) hypertension AP E A PRAVASTATIN d00348A C E78.0 Pure hypercholesterolemia AP E A VALACYCLOVIR d03838A C A60.9 Anogenital herpesviral infection, unspecified AP E A GLIMEPIRIDE d03864A Cr E11 Type 2 diabetes mellitus A0 E A LISINOPRIL d00732A C I10 Essential (primary) hypertension A0 E A METFORMIN d03807A Cr E11 Type 2 diabetes mellitus A0 E A . . . E A . . . E A . . . E A ATORVASTATIN d04105A Dc E78.0 Pure hypercholesterolemia A@ E A INSULIN GLARGINE d04538A Dc E11 Type 2 diabetes mellitus A@ E A INSULIN LISPRO d04373A D E11 Type 2 diabetes mellitus A@ E A RAMIPRIL d00728A Dc I10 Essential (primary) hypertension A@ E A . . . E A CIPROFLOXACIN d00011A A N30 Cystitis A E A GUAIFENESIN d00797A B R05 Cough A E A . . . E 0 A AMLODIPINE d00689A C I10 Essential (primary) hypertension AP E 0 A ATORVASTATIN d04105A CDp E78.0 Pure hypercholesterolemia AP E 0 A CARVEDILOL d03847A C I10 Essential (primary) hypertension AP E 0 A HYDRALAZINE d00132A C I10 Essential (primary) hypertension AP E 0 A LISINOPRIL d00732A C I10 Essential (primary) hypertension AP E @ A . . . E P A . . . E ` A . . . E p A . . . E A LISDEXAMFETAMINE d06663A C F90 Attention-deficit hyperactivity disorders A E A RISPERIDONE d03180A CDp F90 Attention-deficit hyperactivity disorders A E A . . . E A . . . E A RANITIDINE d00021A B= K21 Gastro-esophageal reflux disease A E A ALBUTEROL d00749A C[@ J45 Asthma A0 E A FLUTICASONE NASAL d04283A C[@ J30.9 Allergic rhinitis, unspecified A0 E A MOMETASONE d05262A C[@ J45 Asthma A0 E A CLONIDINE d00044A Bz F84 I10 Pervasive developmental disorders Essential (primary) hypertension A@ E A HYDRALAZINE d00132A C I10 Essential (primary) hypertension A@ E A METFORMIN d03807A BK R73 Elevated blood glucose level A@ E A OLMESARTAN d04801A Bz I10 Essential (primary) hypertension A@ E A . . . E A AMITRIPTYLINE d00146A0 B G43 Migraine A0 E A ETHINYL ESTRADIOL; NORGESTIMATE d03781A0 B N94 Pain and other conditions associated with female genital organs and menstrual cycle A0 E A SULFAMETHOXAZOLE d00119A0 B[ N39.0 Urinary tract infection, site not specified A0 E A . . . E A . . . E A . . . E 0 A FLUTICASONE d01296A C J45 Asthma A E @ A AZATHIOPRINE d00024A B[ K76.9 Liver disease, unspecified Ap E @ A LEVETIRACETAM d04499A D M79.7 Fibromyalgia Ap E @ A NALTREXONE d01406A D M79.7 Fibromyalgia Ap E @ A NITROFURANTOIN d00112A C N39.0 Urinary tract infection, site not specified Ap E @ A PREDNISONE d00350A B K76.9 Liver disease, unspecified Ap E @ A VALACYCLOVIR d03838A D B02 Zoster [herpes zoster] Ap E @ A WARFARIN d00022A D Z79.0 Long term (current) use of anticoagulants and antithrombotics/antiplatelets Ap E P A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A CDp I10 Essential (primary) hypertension A0 E P A METFORMIN d03807A CDp E11 Type 2 diabetes mellitus A0 E P A SIMVASTATIN d00746A CDp E78.0 Pure hypercholesterolemia A0 E ` A . . . E p A AMLODIPINE d00689A C- I10 Essential (primary) hypertension A0 E p A ATORVASTATIN d04105A B I99.9 Unspecified disorder of circulatory system A0 E p A AZITHROMYCIN d00091A A0 J40 Bronchitis, not specified as acute or chronic A0 E A . . . E A . . . E A . . . E A LISDEXAMFETAMINE d06663A A@ F90 Attention-deficit hyperactivity disorders A E A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E 0 A HYDROCHLOROTHIAZIDE d00253A A I10 Essential (primary) hypertension A0 E 0 A HYDROXYZINE d00907A C ` F41.9 Anxiety disorder, unspecified A0 E 0 A OMEPRAZOLE d00325A C[@ K21 Gastro-esophageal reflux disease A0 E @ A FENOFIBRATE d04286A C E78.0 Pure hypercholesterolemia A E P A DICLOFENAC d00848A B M25.5 Pain in joint A E P A MONTELUKAST d04289A B L50 Urticaria A E ` A . . . E p A . . . E A . . . E A AMPHETAMINE; DEXTROAMPHETAMINE d04035A B F90 Attention-deficit hyperactivity disorders A0 E A CLONIDINE d00044A B G47.0 Insomnia A0 E A RISPERIDONE d03180A B F90 Attention-deficit hyperactivity disorders A0 E A LEVOCETIRIZINE d05851A A T78.40 Allergy, unspecified A E A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A D* I10 Essential (primary) hypertension A E A MELOXICAM d04532A C M25.5 Pain in joint A E A FLUOXETINE d00236A B F41.9 Anxiety disorder, unspecified A E A . . . E A . . . E A ESOMEPRAZOLE d04749A C- K21 R12 Gastro-esophageal reflux disease Heartburn A E A HYDROCHLOROTHIAZIDE d00253A C[@ I10 Essential (primary) hypertension A E A . . . E A ALBUTEROL d00749A CDp J45 Asthma A E A FLUTICASONE NASAL d04283A C J30.2 Other seasonal allergic rhinitis A E A . . . E 0 A . . . E @ A AMLODIPINE d00689A B* I10 I21.P Essential (primary) hypertension Prevent heart attack/myocardial infarction AP E @ A ATORVASTATIN d04105A B[ I10 I63.P Essential (primary) hypertension Prevent stroke AP E @ A CARVEDILOL d03847A Cr I10 I50.9 Essential (primary) hypertension Heart failure, unspecified AP E @ A DULOXETINE d05355A C M19.9 Osteoarthritis, unspecified site AP E @ A HYDROCHLOROTHIAZIDE; OLMESARTAN d04878A Cr I10 Essential (primary) hypertension AP E P A ESCITALOPRAM d04812A D F32.9 Major depressive disorder, single episode, unspecified AP E P A LAMOTRIGINE d03809A D F32.9 Major depressive disorder, single episode, unspecified AP E P A LEVOTHYROXINE d00278A D E03.9 Hypothyroidism, unspecified AP E P A LORAZEPAM d00149A D F41.9 Anxiety disorder, unspecified AP E P A LURASIDONE d07705A B F32.9 Major depressive disorder, single episode, unspecified AP E ` A . . . E p A ALBUTEROL d00749A CDp J45 Asthma A E p A RISPERIDONE d03180A C/ F90 Attention-deficit hyperactivity disorders A E A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E A ACETAMINOPHEN; BUTALBITAL; CAFFEINE d03455A D R51 Headache A E A BACLOFEN d00967A B M62.83 Muscle spasm A E A DULOXETINE d05355A C- M79.7 Fibromyalgia A E A GABAPENTIN d03182A Cr M54 Dorsalgia A E A METFORMIN d03807A C"0 R73 Elevated blood glucose level A E A METOPROLOL d00134A Bz R00 Abnormalities of heart beat A E A OMEPRAZOLE d00325A D K21 Gastro-esophageal reflux disease A E A ONDANSETRON d00867A C R11 Nausea and vomiting A E A TERAZOSIN d00386A C"0 T88.7P Prevent drug side effect A E A TRAZODONE d00395A B[ G47.0 Insomnia A E A . . . E A . . . E A DORZOLAMIDE; TIMOLOL OPHTHALMIC d04303A C H40 Glaucoma Ap E A ESOMEPRAZOLE d04749A C K30 Functional dyspepsia Ap E A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified Ap E A MEMANTINE d04899A B G99.8 Other specified disorders of nervous system in diseases classified elsewhere Ap E A OMEGA-3 POLYUNSATURATED FATTY ACIDS d00497A Cr E78.0 I51.9P Pure hypercholesterolemia Prevent heart disease Ap E A PANCRELIPASE d01002A B K30 Functional dyspepsia Ap E A SILODOSIN d07354A C N40 Enlarged prostate Ap E A . . . E 0 A ATORVASTATIN d04105A B E78.0 Pure hypercholesterolemia A@ E 0 A CLOPIDOGREL d04258A D 99999 A@ E 0 A LEVOTHYROXINE d00278A B# E03.9 Hypothyroidism, unspecified A@ E 0 A METOPROLOL d00134A B I10 Essential (primary) hypertension A@ E @ A . . . E P A LISINOPRIL d00732A CDp I10 Essential (primary) hypertension AP E P A MELOXICAM d04532A A M54 Dorsalgia AP E P A METOPROLOL d00134A B R00 Abnormalities of heart beat AP E P A PRAVASTATIN d00348A C- E78.0 Pure hypercholesterolemia AP E P A TIZANIDINE d04102A B M54 Dorsalgia AP E ` A . . . E p A . . . E A . . . E A . . . E A . . . E A . . . E A LEVOTHYROXINE d00278A Cr E03.9 Hypothyroidism, unspecified A E A . . . E A FAMOTIDINE d00141A B K21 Gastro-esophageal reflux disease A E A HYDROCHLOROTHIAZIDE; TRIAMTERENE d03052A C I10 Essential (primary) hypertension A E A LORAZEPAM d00149A B F41.9 Anxiety disorder, unspecified A E A METHIMAZOLE d00290A Bz E05 Thyrotoxicosis [hyperthyroidism] A E A MONTELUKAST d04289A C[@ J30.9 Allergic rhinitis, unspecified A E A OLMESARTAN d04801A B[ I10 Essential (primary) hypertension A E A OMEGA-3 POLYUNSATURATED FATTY ACIDS d00497A C E78.1 Pure hyperglyceridemia A E A PROPRANOLOL d00032A D& I99.9 Unspecified disorder of circulatory system A E A TRAMADOL d03826A C- R51 Headache A E A . . . E A HYDROCHLOROTHIAZIDE; LOSARTAN d03830A Cr I10 Essential (primary) hypertension A E A OMEPRAZOLE d00325A B= R12 Heartburn A E A . . . E A . . . E 0 A . . . E @ A . . . E P A . . . E ` A . . . E p A . . . E A . . . E A . . . E A FENOFIBRIC ACID d07371A C- E78.0 Pure hypercholesterolemia A0 E A LOSARTAN d03821A C- I10 Essential (primary) hypertension A0 E A PRAVASTATIN d00348A C- E78.0 Pure hypercholesterolemia A0 E A . . . E A ALBUTEROL d00749A C J45 Asthma A E A . . . E A . . . E A ETHINYL ESTRADIOL; NORETHINDRONE d03238A D Z79.3 Long term (current) use of hormonal contraceptives A E A . . . E A . . . E A . . . E 0 A . . . E @ A . . . E P A . . . E ` A LEVONORGESTREL d00557A C9 Z79.3 Long term (current) use of hormonal contraceptives A E p A AMLODIPINE; BENAZEPRIL d03829A C I10 Essential (primary) hypertension A@ E p A CIMETIDINE d00140A C K21 Gastro-esophageal reflux disease A@ E p A ROSUVASTATIN d04851A C E78.0 Pure hypercholesterolemia A@ E p A VALACYCLOVIR d03838A C A60.9 Anogenital herpesviral infection, unspecified A@ E A CLINDAMYCIN TOPICAL d01241A C- L70 Acne A E A TRETINOIN d03863A C- L70 Acne A E A ALBUTEROL d00749A B J45 Asthma A E A ESTRADIOL d00537A D# C80.1P Prevent cancer A E A PAROXETINE d03157A D# F32.9 Major depressive disorder, single episode, unspecified A E A CARVEDILOL d03847A C I10 Essential (primary) hypertension A` E A GLIPIZIDE d00246A C E11 Type 2 diabetes mellitus A` E A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A C I10 Essential (primary) hypertension A` E A INSULIN GLARGINE d04538A C E11 Type 2 diabetes mellitus A` E A METFORMIN d03807A C R73 Elevated blood glucose level A` E A NIFEDIPINE d00051A B I10 Essential (primary) hypertension A` E A . . . E A ACETAMINOPHEN; HYDROCODONE d03428A B T14.9 Unspecified injury A@ E A AZITHROMYCIN d00091A A B99.9 Unspecified infectious disease A@ E A IBUPROFEN d00015A B G89 T14.9 Pain, not elsewhere classified Unspecified injury A@ E A METRONIDAZOLE TOPICAL d03208A A A49.9 Bacterial infection, unspecified A@ E A FUROSEMIDE d00070A CDp R60.9 Edema, unspecified A E A METOPROLOL d00134A CDp I10 Essential (primary) hypertension A E A . . . E A . . . E A . . . E A . . . E 0 A CITALOPRAM d04332A D= F32.9 Major depressive disorder, single episode, unspecified A0 E 0 A IBUPROFEN d00015A C- M25.5 Pain in joint A0 E 0 A TRAZODONE d00395A CDp G47.9 Sleep disorder, unspecified A0 E @ A . . . E P A COLESTIPOL d00744A C- N20.0 Calculus of kidney A` E P A DIGOXIN d00210A CDp I49.9 Cardiac arrhythmia, unspecified A` E P A DILTIAZEM d00045A CDp I10 Essential (primary) hypertension A` E P A GABAPENTIN d03182A CDp M54 Dorsalgia A` E P A TAMSULOSIN d04121A C- N20.0 Calculus of kidney A` E P A WARFARIN d00022A D& D75.9P Prevent blood clots A` E ` A . . . E p A . . . E A . . . E A . . . E A . . . E A METHYLPHENIDATE d00900A Cr F90 Attention-deficit hyperactivity disorders A0 E A MINOCYCLINE d00110A B[ L70 Acne A0 E A RISPERIDONE d03180A Cr F31.9 R45 Bipolar disorder, unspecified Symptoms and signs involving emotional state A0 E A AMLODIPINE d00689A C I10 I20.9 Essential (primary) hypertension Angina pectoris, unspecified A E A ATORVASTATIN d04105A C I21.P I63.P Prevent heart attack/myocardial infarction Prevent stroke A E A CARVEDILOL d03847A C I63 Cerebral infarction A E A HYDRALAZINE d00132A C[@ I10 Essential (primary) hypertension A E A INDAPAMIDE d00260A C 99999 A E A INSULIN ISOPHANE (NPH) d04370A C E11 Type 2 diabetes mellitus A E A INSULIN REGULAR d04369A C E11 Type 2 diabetes mellitus A E A LOSARTAN d03821A C E78.0 Pure hypercholesterolemia A E A METFORMIN d03807A C- E11 Type 2 diabetes mellitus A E A NAPROXEN d00019A B= M25.9 Joint disorder, unspecified A E A ALENDRONATE d03849A B[ M81 Osteoporosis without current pathological fracture A E A ARIPIPRAZOLE d04825A C F32.9 Major depressive disorder, single episode, unspecified A E A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A E A DEXLANSOPRAZOLE d07395A C R12 Heartburn A E A MELOXICAM d04532A CDp M13 Other arthritis A E A METOPROLOL d00134A B[ I10 Essential (primary) hypertension A E A TOPIRAMATE d04115A Bz R25.1 Tremor, unspecified A E A VENLAFAXINE d03181A Dc F32.9 Major depressive disorder, single episode, unspecified A E A . . . E A . . . E A . . . E A 77777 . . A E A . . . E 0 A . . . E @ A . . . E P A ASPIRIN d00170A CP D75.9P Prevent blood clots A E P A CYCLOBENZAPRINE d00963A C- M54 Dorsalgia A E P A DOCUSATE d01021A C[@ K59.0 Constipation A E P A ENALAPRIL d00013A C[@ I50.9 Heart failure, unspecified A E P A GLIPIZIDE d00246A CDp E11 Type 2 diabetes mellitus A E P A HYDROCODONE d03075A CP M54 Dorsalgia A E P A LEVOCETIRIZINE d05851A CDp T78.40 Allergy, unspecified A E P A MELOXICAM d04532A C M54 Dorsalgia A E P A METFORMIN d03807A C[@ E11 Type 2 diabetes mellitus A E ` A . . . E p A . . . E A . . . E A TRIAMCINOLONE TOPICAL d03206A D9 L29.9 R21 Pruritus, unspecified Rash and other nonspecific skin eruption A E A . . . E A OXYBUTYNIN d00328A Dc N32.81 Overactive bladder A E A TAMSULOSIN d04121A Cr N40 Enlarged prostate A E A . . . E A INSULIN GLARGINE d04538A B= E11 Type 2 diabetes mellitus A0 E A LOSARTAN d03821A B= I10 Essential (primary) hypertension A0 E A TENOFOVIR d04774A B= K76.9 Liver disease, unspecified A0 E A PRAVASTATIN d00348A C- E78.0 Pure hypercholesterolemia A E A . . . E A METOPROLOL d00134A CDp I10 Essential (primary) hypertension A E A . . . E A . . . E 0 A AMOXICILLIN d00088A AP H66.9 Otitis media, unspecified A E @ A . . . E P A HYDROCHLOROTHIAZIDE d00253A C I10 Essential (primary) hypertension A E P A LISINOPRIL d00732A C I10 Essential (primary) hypertension A E ` A CELECOXIB d04380A C- M25.5 Pain in joint A E ` A PANTOPRAZOLE d04514A CP K21 Gastro-esophageal reflux disease A E p A ETHINYL ESTRADIOL; NORETHINDRONE d03238A C- Z79.3 Long term (current) use of hormonal contraceptives A E A AMLODIPINE d00689A C I10 Essential (primary) hypertension A@ E A LISINOPRIL d00732A D I10 Essential (primary) hypertension A@ E A LOVASTATIN d00280A D I51.9 R07.9 Heart disease, unspecified Chest pain, unspecified A@ E A METFORMIN d03807A C E11 Type 2 diabetes mellitus A@ E A GABAPENTIN d03182A C- M06.9 Rheumatoid arthritis, unspecified A E A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E 0 A . . . E @ A AMLODIPINE d00689A B= I10 Essential (primary) hypertension A E @ A INSULIN ASPART d04697A C E11 Type 2 diabetes mellitus A E @ A INSULIN GLARGINE d04538A C E11 Type 2 diabetes mellitus A E @ A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified A E @ A LINACLOTIDE d07902A CDp K58 Irritable bowel syndrome A E @ A MYCOPHENOLATE MOFETIL d03839A C T86.9P Prevent transplanted organ and tissue rejection A E @ A PRAVASTATIN d00348A B= E78.0 Pure hypercholesterolemia A E @ A PREDNISONE d00350A C T86.9P Prevent transplanted organ and tissue rejection A E @ A TACROLIMUS d03752A C T86.9P Prevent transplanted organ and tissue rejection A E P A AMLODIPINE d00689A B I21.P Prevent heart attack/myocardial infarction AP E P A CLOPIDOGREL d04258A B D75.9P Prevent blood clots AP E P A FINASTERIDE d00563A C N40 R39.9 Enlarged prostate Unspecified symptoms and signs involving the genitourinary system AP E P A METOPROLOL d00134A D I10 Essential (primary) hypertension AP E P A ROSUVASTATIN d04851A B I21.P Prevent heart attack/myocardial infarction AP E ` A CYCLOBENZAPRINE d00963A B M79.1 Myalgia A E ` A IBUPROFEN d00015A B Z79.1 Long term (current) use of non-steroidal anti-inflammatories (NSAID) A E p A . . . E A . . . E A AMLODIPINE d00689A C I10 Essential (primary) hypertension A E A VENLAFAXINE d03181A C F41.9 Anxiety disorder, unspecified A E A . . . E A . . . E A . . . E A AMLODIPINE d00689A Ei I10 Essential (primary) hypertension A E A DIVALPROEX SODIUM d03833A Ei F32.9 F33.9 Major depressive disorder, single episode, unspecified Major depressive disorder, recurrent, unspecified A E A FAMOTIDINE d00141A B[ K21 Gastro-esophageal reflux disease A E A FENOFIBRATE d04286A Ei E78.0 Pure hypercholesterolemia A E A FLUOXETINE d00236A Ei F32.9 F33.9 F41.9 Major depressive disorder, single episode, unspecified Major depressive disorder, recurrent, unspecified Anxiety disorder, unspecified A E A INSULIN ISOPHANE; INSULIN REGULAR d04374A C- E11 Type 2 diabetes mellitus A E A LAMOTRIGINE d03809A Ei F32.9 F33.9 Major depressive disorder, single episode, unspecified Major depressive disorder, recurrent, unspecified A E A LOSARTAN d03821A Ei I10 Essential (primary) hypertension A E A METFORMIN d03807A B E11 Type 2 diabetes mellitus A E A QUETIAPINE d04220A B[ F41.9 Anxiety disorder, unspecified A E A QUETIAPINE d04220A D G47.0 Insomnia A E A ROPINIROLE d04215A Ei R25 Abnormal involuntary movements A E A ROSUVASTATIN d04851A Ei E78.0 Pure hypercholesterolemia A E A . . . E A AMLODIPINE d00689A0 C I10 Essential (primary) hypertension A@ E A ATORVASTATIN d04105A0 B E78.0 Pure hypercholesterolemia A@ E A HYDROCHLOROTHIAZIDE; LOSARTAN d03830A0 Dc I10 Essential (primary) hypertension A@ E A PANTOPRAZOLE d04514A A K25.P Prevent gastric ulcer A@ E A AMOXICILLIN; CLAVULANATE d00089A Ap J30.2 Other seasonal allergic rhinitis A0 E A FLUTICASONE NASAL d04283A Ap J30.2 Other seasonal allergic rhinitis A0 E A HYDROCHLOROTHIAZIDE; OLMESARTAN d04878A C I10 Essential (primary) hypertension A0 E A PAROXETINE d03157A C F32.9 F41.9 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified A E A . . . E 0 A . . . E @ A . . . E P A . . . E ` A . . . E p A . . . E A GEMFIBROZIL d00245A Bz E78.1 Pure hyperglyceridemia A E A TAMSULOSIN d04121A Bz N40 Enlarged prostate A E A . . . E A . . . E A . . . E A . . . E A AMLODIPINE d00689A C I10 Essential (primary) hypertension A` E A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A` E A GLIPIZIDE d00246A C E11 Type 2 diabetes mellitus A` E A INSULIN ISOPHANE (NPH) d04370A C- E11 Type 2 diabetes mellitus A` E A LOSARTAN d03821A C I10 Essential (primary) hypertension A` E A METFORMIN d03807A C E11 Type 2 diabetes mellitus A` E A AMLODIPINE d00689A CDp I10 Essential (primary) hypertension A E A . . . E A DEXMETHYLPHENIDATE d04777A B F90 Attention-deficit hyperactivity disorders A E A . . . E A . . . E 0 A ATENOLOL d00004A C- I10 Essential (primary) hypertension A E 0 A BIMATOPROST OPHTHALMIC d04754A C H40 Glaucoma A E 0 A DEXTRANOMER; SODIUM HYALURONATE d08128A C H40 Glaucoma A E 0 A DEXTROMETHORPHAN; PROMETHAZINE d03360A C R05 Cough A E 0 A DORZOLAMIDE OPHTHALMIC d03805A C H40 Glaucoma A E 0 A FLUTICASONE; SALMETEROL d04611A CDp J45 Asthma A E 0 A HYDROCHLOROTHIAZIDE; LOSARTAN d03830A C I10 Essential (primary) hypertension A E 0 A IPRATROPIUM d00265A CDp J45 Asthma A E 0 A MECLIZINE d00859A C R42 Dizziness and giddiness A E 0 A SIMVASTATIN d00746A Ei E78.0 Pure hypercholesterolemia A E 0 A TAMSULOSIN d04121A B= R39.1 Other difficulties with micturition A E 0 A TIOTROPIUM d04829A C- J45 Asthma A E @ A . . . E P A BUPROPION d00181A C- F32.9 F39 F41.9 Major depressive disorder, single episode, unspecified Unspecified mood [affective] disorder Anxiety disorder, unspecified A0 E P A ETHINYL ESTRADIOL; NORGESTIMATE d03781A C E28 N92 Z79.3 Ovarian dysfunction Excessive, frequent and irregular menstruation Long term (current) use of hormonal contraceptives A0 E P A METFORMIN d03807A C- E11.P E28 R73 Prevent diabetes Ovarian dysfunction Elevated blood glucose level A0 E ` A . . . E p A AMLODIPINE d00689A C[@ I10 Essential (primary) hypertension A` E p A ATENOLOL; CHLORTHALIDONE d03258A C[@ I10 Essential (primary) hypertension A` E p A ATORVASTATIN d04105A C[@ E78.0 Pure hypercholesterolemia A` E p A BENAZEPRIL d00730A C[@ I10 Essential (primary) hypertension A` E p A METFORMIN; SITAGLIPTIN d06720A C E11 Type 2 diabetes mellitus A` E p A OMEPRAZOLE d00325A C K21 Gastro-esophageal reflux disease A` E A ACETYLCYSTEINE d00762A C- J42 Unspecified chronic bronchitis B E A ALBUTEROL d00749A C- R06.02 Shortness of breath B E A ALENDRONATE d03849A C- M81 Osteoporosis without current pathological fracture B E A AVIBACTAM; CEFTAZIDIME d08358A C- A49.9 Bacterial infection, unspecified B E A AZITHROMYCIN d00091A C- T86.9P Prevent transplanted organ and tissue rejection B E A FLUTICASONE; SALMETEROL d04611A C- J45 Asthma B E A ISAVUCONAZONIUM d08355A C- B35 Dermatophytosis B E A MYCOPHENOLATE MOFETIL d03839A C- T86.9P Prevent transplanted organ and tissue rejection B E A NYSTATIN TOPICAL d04399A C- B35 Dermatophytosis B E A OMEPRAZOLE d00325A C- K30 Functional dyspepsia B E A PRAVASTATIN d00348A C- E78.0 Pure hypercholesterolemia B E A PREDNISONE d00350A C- T86.9P Prevent transplanted organ and tissue rejection B E A SODIUM CHLORIDE d00438A C- J30.9 Allergic rhinitis, unspecified B E A SULFAMETHOXAZOLE; TRIMETHOPRIM d00124A C- A49.9P Prevent bacterial infection B E A TACROLIMUS d03752A C- T86.9P Prevent transplanted organ and tissue rejection B E A TOBRAMYCIN d00069A C- J18.9 Pneumonia, unspecified organism B E A VALGANCICLOVIR d04755A C- H10 Conjunctivitis B E A . . . E A . . . E A AMLODIPINE d00689A Cr I10 Essential (primary) hypertension AP E A CANAGLIFLOZIN d08080A CDp E11 Type 2 diabetes mellitus AP E A METFORMIN; SITAGLIPTIN d06720A C- E11 Type 2 diabetes mellitus AP E A RAMIPRIL d00728A C E11.2P Prevent diabetic kidney disease AP E A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia AP E A . . . E A FLUTICASONE NASAL d04283A C H93.9 Unspecified disorder of ear A E A . . . E A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A@ E A LEVOTHYROXINE d00278A D E03.9 Hypothyroidism, unspecified A@ E A LISINOPRIL d00732A C I10 Essential (primary) hypertension A@ E A METFORMIN d03807A Cr E11 Type 2 diabetes mellitus A@ E A . . . E A ATORVASTATIN d04105A C[@ E78.0 Pure hypercholesterolemia A E A LEVOTHYROXINE d00278A C E07.9 Disorder of thyroid, unspecified A E A INSULIN GLARGINE d04538A C"@ R73 Elevated blood glucose level A E 0 A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified A E @ A . . . E P A . . . E ` A LISINOPRIL d00732A C I10 Essential (primary) hypertension A0 E ` A METFORMIN d03807A C[@ E11 Type 2 diabetes mellitus A0 E ` A METOPROLOL d00134A B I10 Essential (primary) hypertension A0 E p A SERTRALINE d00880A B F32.9 Major depressive disorder, single episode, unspecified A E A IBUPROFEN d00015A Ap L98.9 Disorder of the skin and subcutaneous tissue, unspecified A E A . . . E A . . . E A . . . E A AMOXICILLIN d00088A A H66.9 Otitis media, unspecified A E A . . . E A AMLODIPINE d00689A C I10 Essential (primary) hypertension A@ E A ANASTROZOLE d03873A CDp C50 Malignant neoplasm of breast A@ E A CARVEDILOL d03847A D I10 Essential (primary) hypertension A@ E A ROSUVASTATIN d04851A Cr E78.0 Pure hypercholesterolemia A@ E A . . . E A PHENTERMINE d00806A B E66 Overweight and obesity A E A ATROPINE OPHTHALMIC d03212A A0 H57.9 Unspecified disorder of eye and adnexa A E A . . . E 0 A METOPROLOL d00134A Dc I10 Essential (primary) hypertension A E @ A . . . E P A . . . E ` A BUSPIRONE d00182A C F41.9 Anxiety disorder, unspecified A E ` A CLONAZEPAM d00197A B[ F41.0 Panic disorder [episodic paroxysmal anxiety] without agoraphobia A E ` A EMPAGLIFLOZIN d08275A C E66 Overweight and obesity A E ` A GLIPIZIDE d00246A C- E11 Type 2 diabetes mellitus A E ` A INSULIN LISPRO d04373A B E11 Type 2 diabetes mellitus A E ` A LATANOPROST OPHTHALMIC d04017A C"0 H40 Glaucoma A E ` A OMEPRAZOLE d00325A C- K21 Gastro-esophageal reflux disease A E ` A ROSUVASTATIN d04851A C[@ E78.0 Pure hypercholesterolemia A E ` A SERTRALINE d00880A B[ F32.9 Major depressive disorder, single episode, unspecified A E ` A SUMATRIPTAN d03160A C G43 Migraine A E p A . . . E A . . . E A . . . E A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A E A . . . E A ATORVASTATIN d04105A Dc E78.0 Pure hypercholesterolemia A@ E A HYDROCHLOROTHIAZIDE d00253A Dc I10 Essential (primary) hypertension A@ E A LOSARTAN d03821A Dc I10 Essential (primary) hypertension A@ E A METFORMIN d03807A Dc E11 Type 2 diabetes mellitus A@ E A CYCLOBENZAPRINE d00963A0 CDp M62.83 Muscle spasm A E A EMPAGLIFLOZIN d08275A0 C[@ E11 Type 2 diabetes mellitus A E A ENALAPRIL d00013A0 C[@ I10 Essential (primary) hypertension A E A EXENATIDE d05529A0 C E11 Type 2 diabetes mellitus A E A GLYBURIDE; METFORMIN d04703A0 C[@ E11 Type 2 diabetes mellitus A E A IBUPROFEN d00015A0 CDp M54 Dorsalgia A E A PREGABALIN d05508A0 CDp M79.2 Neuralgia and neuritis, unspecified A E A SERTRALINE d00880A B[ F32.9 F41.9 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified A E A . . . E A . . . E A HYDROCHLOROTHIAZIDE; OLMESARTAN d04878A CDp I10 Essential (primary) hypertension A E A . . . E A ATORVASTATIN d04105A0 C E78.0 Pure hypercholesterolemia Ap E A CARVEDILOL d03847A C[@ I49.9 Cardiac arrhythmia, unspecified Ap E A ESOMEPRAZOLE d04749A0 C K30 Functional dyspepsia Ap E A LOSARTAN d03821A0 C I10 Essential (primary) hypertension Ap E A METFORMIN d03807A0 C E11 Type 2 diabetes mellitus Ap E A METHIMAZOLE d00290A0 C E05 Thyrotoxicosis [hyperthyroidism] Ap E A SITAGLIPTIN d05896A0 C E11 Type 2 diabetes mellitus Ap E 0 A AMIODARONE d00002A C 99999 Ap E 0 A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia Ap E 0 A LISINOPRIL d00732A C I10 Essential (primary) hypertension Ap E 0 A METOPROLOL d00134A B 99999 Ap E 0 A TORSEMIDE d03189A B I10 Essential (primary) hypertension Ap E 0 A VERAPAMIL d00048A D I10 Essential (primary) hypertension Ap E 0 A ZOLPIDEM d00910A A G47.0 Insomnia Ap E @ A . . . E P A . . . E ` A . . . E p A . . . E A OMEPRAZOLE d00325A AP K21 Gastro-esophageal reflux disease A E A AMPHETAMINE; DEXTROAMPHETAMINE d04035A C"0 F90 Attention-deficit hyperactivity disorders A E A . . . E A . . . E A AMLODIPINE d00689A C[@ I10 Essential (primary) hypertension A` E A HYDRALAZINE d00132A Cr I10 Essential (primary) hypertension A` E A LATANOPROST OPHTHALMIC d04017A D H40 Glaucoma A` E A LEVOTHYROXINE d00278A D9 E03.9 Hypothyroidism, unspecified A` E A LOSARTAN d03821A Cr I10 Essential (primary) hypertension A` E A OXYBUTYNIN d00328A C- N32.81 Overactive bladder A` E A . . . E A NIFEDIPINE d00051A D# R20 Disturbances of skin sensation A E A SIMVASTATIN d00746A D E78.0 Pure hypercholesterolemia A E A . . . E A . . . E A . . . E A 55555 A B 55555 Ap E A ALLOPURINOL d00023A C M1A Chronic gout Ap E A CHLORTHALIDONE d00192A C 99999 Ap E A GLIPIZIDE d00246A C- E11 Type 2 diabetes mellitus Ap E A LOSARTAN d03821A C 99999 Ap E A METFORMIN d03807A C E11 Type 2 diabetes mellitus Ap E A OMEPRAZOLE d00325A C K21 Gastro-esophageal reflux disease Ap E 0 A OLODATEROL; TIOTROPIUM d08362A B[ J44.9 Chronic obstructive pulmonary disease, unspecified A E @ A . . . E P A AMOXICILLIN d00088A A N39.0 Urinary tract infection, site not specified AP E P A GEMFIBROZIL d00245A D E78.0 Pure hypercholesterolemia AP E P A GLIPIZIDE d00246A C E11 Type 2 diabetes mellitus AP E P A METFORMIN d03807A C E11 Type 2 diabetes mellitus AP E P A SITAGLIPTIN d05896A C E11 Type 2 diabetes mellitus AP E ` A . . . E p A . . . E A AMLODIPINE d00689A C I10 Essential (primary) hypertension A E A CYCLOBENZAPRINE d00963A C R52 Pain, unspecified A E A LISINOPRIL d00732A Cr I10 Essential (primary) hypertension A E A METOPROLOL d00134A C I10 Essential (primary) hypertension A E A NAPROXEN d00019A C M54 Dorsalgia A E A NIACIN d00314A Cr I21.P Prevent heart attack/myocardial infarction A E A PRAVASTATIN d00348A Cr E78.0 Pure hypercholesterolemia A E A RANITIDINE d00021A B[ K21 Gastro-esophageal reflux disease A E A AMOXICILLIN d00088A A J01.9 Acute sinusitis, unspecified A E A CARVEDILOL d03847A C- I10 Essential (primary) hypertension A E A THYROID DESICCATED d00655A Cr E03.9 Hypothyroidism, unspecified A E A . . . E A BUPROPION d00181A B F32.9 Major depressive disorder, single episode, unspecified A@ E A DESMOPRESSIN d00583A B R32 Unspecified urinary incontinence A@ E A ESCITALOPRAM d04812A B F39 Unspecified mood [affective] disorder A@ E A TRAZODONE d00395A B G47.0 Insomnia A@ E A . . . E A ALBUTEROL d00749A0 CDp J44.9 Chronic obstructive pulmonary disease, unspecified A E A AMLODIPINE d00689A0 C 99999 A E A ASPIRIN d00170A0 D& I21.P Prevent heart attack/myocardial infarction A E A BUDESONIDE; FORMOTEROL d04795A0 CDp J44.9 Chronic obstructive pulmonary disease, unspecified A E A CLONIDINE d00044A0 C I10 Essential (primary) hypertension A E A LEVOTHYROXINE d00278A0 B E07.9 Disorder of thyroid, unspecified A E A LOVASTATIN d00280A0 C 99999 A E A METFORMIN d03807A0 C[@ 99999 A E A NITROGLYCERIN d00321A0 D& I51.9 Heart disease, unspecified A E A SAXAGLIPTIN d07467A0 C 99999 A E A CETIRIZINE d03827A A R09.81 Nasal congestion A E A PREDNISOLONE d00084A A R05 Cough A E A SIMVASTATIN d00746A Dc E78.0 Pure hypercholesterolemia A E A AMLODIPINE d00689A CDp I10 I21.P Essential (primary) hypertension Prevent heart attack/myocardial infarction A E A APIXABAN d07804A C 99999 A E A FINASTERIDE d00563A C[@ N40 Enlarged prostate A E A HYDROCHLOROTHIAZIDE; LOSARTAN d03830A CDp I10 Essential (primary) hypertension A E A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified A E A MECLIZINE d00859A C R42 Dizziness and giddiness A E A METOPROLOL d00134A C- I10 I51.9P Essential (primary) hypertension Prevent heart disease A E A TAMSULOSIN d04121A CDp N40 Enlarged prostate A E A . . . E 0 A LOSARTAN d03821A CDp I10 Essential (primary) hypertension A0 E 0 A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia A0 E 0 A TAMSULOSIN d04121A C N40 Enlarged prostate A0 E @ A ACARBOSE d03846A B= E11 Type 2 diabetes mellitus A E @ A DIVALPROEX SODIUM d03833A C F32.9 Major depressive disorder, single episode, unspecified A E @ A DULAGLUTIDE d08290A C- E11 Type 2 diabetes mellitus A E @ A EZETIMIBE d04824A B[ E78.0 Pure hypercholesterolemia A E @ A INSULIN DEGLUDEC d08054A C E11 Type 2 diabetes mellitus A E @ A LISINOPRIL d00732A C- I10 Essential (primary) hypertension A E @ A OMEPRAZOLE d00325A C K21 Gastro-esophageal reflux disease A E @ A PHENYTOIN d00143A D> G40 Epilepsy and recurrent seizures A E @ A PROPRANOLOL d00032A B G43 Migraine A E P A . . . E ` A AMLODIPINE d00689A Dc I10 Essential (primary) hypertension A E ` A CHLORTHALIDONE d00192A C I10 Essential (primary) hypertension A E ` A CLONIDINE d00044A C I10 Essential (primary) hypertension A E ` A DOCUSATE d01021A C K59.0 Constipation A E ` A GABAPENTIN d03182A C- E11.4 Type 2 diabetes mellitus with neurological complications A E ` A INSULIN ASPART d04697A C E11 Type 2 diabetes mellitus A E ` A INSULIN GLARGINE d04538A C E11 Type 2 diabetes mellitus A E ` A ISOSORBIDE MONONITRATE d00269A C I51.9P Prevent heart disease A E ` A LISINOPRIL d00732A Ap I10 N19 Essential (primary) hypertension Unspecified kidney failure A E ` A METOPROLOL d00134A D= I10 Essential (primary) hypertension A E ` A NITROGLYCERIN d00321A D= I20.9 Angina pectoris, unspecified A E ` A OMEPRAZOLE d00325A C[@ K21 Gastro-esophageal reflux disease A E ` A ROSUVASTATIN d04851A Cr E78.0 Pure hypercholesterolemia A E ` A SERTRALINE d00880A C- F32.9 F41.9 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified A E p A . . . E A ALBUTEROL d00749A A T78.40 Allergy, unspecified A E A PREDNISONE d00350A A T78.40 Allergy, unspecified A E A ATENOLOL d00004A D I51.9 Heart disease, unspecified A` E A ATORVASTATIN d04105A D E78.0 Pure hypercholesterolemia A` E A CLOPIDOGREL d04258A D D75.9P Prevent blood clots A` E A LEVOTHYROXINE d00278A D* E07.9 Disorder of thyroid, unspecified A` E A LOSARTAN d03821A D# I10 Essential (primary) hypertension A` E A RANITIDINE d00021A C K21 Gastro-esophageal reflux disease A` E A FLUOXETINE d00236A C F32.9 Major depressive disorder, single episode, unspecified A0 E A GUANFACINE d00717A C[@ F90 Attention-deficit hyperactivity disorders A0 E A LISDEXAMFETAMINE d06663A C"0 F90 Attention-deficit hyperactivity disorders A0 E A AMLODIPINE d00689A C- I10 Essential (primary) hypertension A E A ARIPIPRAZOLE d04825A B F32.9 Major depressive disorder, single episode, unspecified A E A ATORVASTATIN d04105A C- E78.0 Pure hypercholesterolemia A E A BUPROPION d00181A D F32.9 Major depressive disorder, single episode, unspecified A E A HYDROCHLOROTHIAZIDE; LOSARTAN d03830A C I10 Essential (primary) hypertension A E A LAMOTRIGINE d03809A CDp F39 Unspecified mood [affective] disorder A E A METHOTREXATE d00060A C M06.9 Rheumatoid arthritis, unspecified A E A VORTIOXETINE d08125A C- F32.9 Major depressive disorder, single episode, unspecified A E A . . . E A . . . E A . . . E A ESTRADIOL; NORETHINDRONE d04375A B Z79.3 Long term (current) use of hormonal contraceptives A0 E A FAMOTIDINE d00141A B= R10 Abdominal and pelvic pain A0 E A PANTOPRAZOLE d04514A C R10 Abdominal and pelvic pain A0 E A . . . E A . . . E A . . . E 0 A ACETAMINOPHEN; HYDROCODONE d03428A C M54 Dorsalgia Ap E 0 A BUPRENORPHINE d00840A B[ M54 M79.2 M79.7 Dorsalgia Neuralgia and neuritis, unspecified Fibromyalgia Ap E 0 A CLOBETASOL TOPICAL d01288A Dc L40 Psoriasis Ap E 0 A GABAPENTIN d03182A C M54 M79.2 Dorsalgia Neuralgia and neuritis, unspecified Ap E 0 A IBUPROFEN d00015A Dc M54 M79.7 Dorsalgia Fibromyalgia Ap E 0 A LIDOCAINE TOPICAL d00683A C M54 M79.7 Dorsalgia Fibromyalgia Ap E 0 A VENLAFAXINE d03181A C F32.9 F41.9 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified Ap E @ A PREDNISONE d00350A D- 55555 A E P A ALBUTEROL d00749A Ei J45 Asthma A E P A AZELASTINE NASAL d04068A Ei R06.9 Unspecified abnormalities of breathing A E P A BUDESONIDE; FORMOTEROL d04795A Ei R06.9 Unspecified abnormalities of breathing A E P A ESTRADIOL d00537A Ei N95 Menopausal and other perimenopausal disorders A E P A FUROSEMIDE d00070A Ei R60.9 Edema, unspecified A E P A LEVOTHYROXINE d00278A Ei E03.9 Hypothyroidism, unspecified A E P A LOSARTAN d03821A Ei I10 Essential (primary) hypertension A E P A MONTELUKAST d04289A Ei R06.9 Unspecified abnormalities of breathing A E P A PRAVASTATIN d00348A Ei E78.0 Pure hypercholesterolemia A E P A RIVAROXABAN d07356A C D75.9P Prevent blood clots A E P A VERAPAMIL d00048A Ei I10 Essential (primary) hypertension A E ` A . . . E p A 99999 . . A E A AMITRIPTYLINE d00146A Ei M54 Dorsalgia A E A AMLODIPINE d00689A Ei 99999 A E A APIXABAN d07804A Ei 99999 A E A INSULIN GLARGINE d04538A C[@ E11 Type 2 diabetes mellitus A E A INSULIN LISPRO d04373A C[@ E11 Type 2 diabetes mellitus A E A PRIMIDONE d00352A Ei 99999 A E A PROPRANOLOL d00032A Ei 99999 A E A TAMSULOSIN d04121A Ei 99999 A E A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E A ATORVASTATIN d04105A C[@ E78.0 Pure hypercholesterolemia AP E A ISOSORBIDE MONONITRATE d00269A C R07.9 Chest pain, unspecified AP E A METOPROLOL d00134A C- I20.9 I50.9 R07.9 Angina pectoris, unspecified Heart failure, unspecified Chest pain, unspecified AP E A TAMSULOSIN d04121A C N40 Enlarged prostate AP E A VALSARTAN d04113A C E11.2 I21.P I50.9 Type 2 diabetes mellitus with kidney complications Prevent heart attack/myocardial infarction Heart failure, unspecified AP E A . . . E 0 A . . . E @ A . . . E P A . . . E ` A GABAPENTIN d03182A CDp M54 Dorsalgia A0 E ` A MIRABEGRON d07876A C- N39.4 R32 Other specified urinary incontinence Unspecified urinary incontinence A0 E ` A ZOLPIDEM d00910A C[@ G47.0 Insomnia A0 E p A . . . E A ALLOPURINOL d00023A C"@ E79.9 Disorder of purine and pyrimidine metabolism, unspecified AP E A ATORVASTATIN d04105A B[ E78.0 Pure hypercholesterolemia AP E A HYDROCHLOROTHIAZIDE; IRBESARTAN d04245A C I10 Essential (primary) hypertension AP E A OMEPRAZOLE d00325A B K21 R12 Gastro-esophageal reflux disease Heartburn AP E A PIOGLITAZONE d04442A C R73 Elevated blood glucose level AP E A . . . E A . . . E A . . . E A FLUOXETINE d00236A C F32.9 Major depressive disorder, single episode, unspecified A E A . . . E A ETHINYL ESTRADIOL; NORETHINDRONE d03238A C- Z79.3 Long term (current) use of hormonal contraceptives A E A . . . E A . . . E A PHENTERMINE d00806A A E66 Overweight and obesity A E A . . . E 0 A . . . E @ A . . . E P A . . . E ` A CEPHALEXIN d00096A Ap L98.9 Disorder of the skin and subcutaneous tissue, unspecified A E ` A MUPIROCIN TOPICAL d01267A A L98.9 Disorder of the skin and subcutaneous tissue, unspecified A E p A . . . E A . . . E A ETHINYL ESTRADIOL; NORELGESTROMIN d04779A C Z79.3 Long term (current) use of hormonal contraceptives A E A . . . E A . . . E A . . . E A BUPROPION d00181A C F32.9 Major depressive disorder, single episode, unspecified AP E A HYDROCODONE d03075A C- M79.2 Neuralgia and neuritis, unspecified AP E A ONDANSETRON d00867A A R11 Nausea and vomiting AP E A PAROXETINE d03157A C M79.7 Fibromyalgia AP E A PREGABALIN d05508A C M79.7 Fibromyalgia AP E A AMOXICILLIN d00088A Ap J02 Acute pharyngitis A E A OSELTAMIVIR d04462A Ap J09 Influenza due to certain identified influenza viruses A E A ACETAMINOPHEN; HYDROCODONE d03428A C M19.9 Osteoarthritis, unspecified site A E A ALPRAZOLAM d00168A Cr F32.9 F41.9 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified A E A BACLOFEN d00967A Cr M19.9 Osteoarthritis, unspecified site A E A DICLOFENAC TOPICAL d04722A Cr M19.9 Osteoarthritis, unspecified site A E A FAMOTIDINE d00141A C K21 Gastro-esophageal reflux disease A E A FLUTICASONE NASAL d04283A Cr J30.2 Other seasonal allergic rhinitis A E A LAMOTRIGINE d03809A C F32.9 Major depressive disorder, single episode, unspecified A E A LIDOCAINE TOPICAL d00683A Cr M19.9 Osteoarthritis, unspecified site A E A ONDANSETRON d00867A C R11 Nausea and vomiting A E A TAMSULOSIN d04121A B= R39.1 Other difficulties with micturition A E A TEMAZEPAM d00384A Cr G47.0 Insomnia A E A ATORVASTATIN d04105A C- E78.0 Pure hypercholesterolemia A0 E A OLMESARTAN d04801A C I10 Essential (primary) hypertension A0 E A RANITIDINE d00021A C- K30 Functional dyspepsia A0 E A AMPHETAMINE; DEXTROAMPHETAMINE d04035A C F90 Attention-deficit hyperactivity disorders AP E A BUSPIRONE d00182A C F41.9 Anxiety disorder, unspecified AP E A ETHINYL ESTRADIOL; NORGESTIMATE d03781A CDp Z79.3 Long term (current) use of hormonal contraceptives AP E A LURASIDONE d07705A A0 F31.9 Bipolar disorder, unspecified AP E A QUETIAPINE d04220A C F31.9 Bipolar disorder, unspecified AP E A . . . E 0 A . . . E @ A ERYTHROMYCIN TOPICAL d03200A B L70 Acne A E P A . . . E ` A LOSARTAN d03821A C I10 Essential (primary) hypertension A E p A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E A AMLODIPINE; VALSARTAN d06662A C I10 Essential (primary) hypertension A E A ROSUVASTATIN d04851A C E78.0 Pure hypercholesterolemia A E A . . . E A . . . E A . . . E 0 A . . . E @ A . . . E P A RIZATRIPTAN d04328A B G43 Migraine A E P A TOPIRAMATE d04115A A G43 Migraine A E ` A AMOXICILLIN d00088A A J06.9 Acute upper respiratory infection, unspecified A E p A SIMVASTATIN d00746A Cr E78.0 Pure hypercholesterolemia A E p A ZALEPLON d04452A C G47.0 G47.9 Insomnia Sleep disorder, unspecified A E A . . . E A . . . E A . . . E A . . . E A DULOXETINE d05355A Cr F32.9 Major depressive disorder, single episode, unspecified A` E A LISINOPRIL d00732A D I10 Essential (primary) hypertension A` E A METFORMIN d03807A Dc E11 Type 2 diabetes mellitus A` E A PIOGLITAZONE d04442A C E11 Type 2 diabetes mellitus A` E A SIMVASTATIN d00746A CDp E78.0 Pure hypercholesterolemia A` E A VARENICLINE d05807A B= F17.2 Nicotine dependence A` E A ALENDRONATE d03849A CP M81 Osteoporosis without current pathological fracture A0 E A GLIMEPIRIDE d03864A CDp R73 Elevated blood glucose level A0 E A SIMVASTATIN d00746A Ei E78.0 Pure hypercholesterolemia A0 E A GABAPENTIN d03182A C F39 M79.7 Unspecified mood [affective] disorder Fibromyalgia Ap E A LORAZEPAM d00149A C F41.9 Anxiety disorder, unspecified Ap E A LURASIDONE d07705A CDp F32.9 Major depressive disorder, single episode, unspecified Ap E A ONDANSETRON d00867A C R11 Nausea and vomiting Ap E A OXCARBAZEPINE d04513A C F31.9 Bipolar disorder, unspecified Ap E A SULFASALAZINE d00379A C[@ K50 Crohn's disease [regional enteritis] Ap E A TAMSULOSIN d04121A Cr N20.0 Calculus of kidney Ap E A . . . E A FLUTICASONE NASAL d04283A CDp J30.2 Other seasonal allergic rhinitis A E A . . . E A . . . E 0 A . . . E @ A OMEPRAZOLE d00325A C K21 Gastro-esophageal reflux disease A E @ A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia A E P A . . . E ` A . . . E p A . . . E A CLONIDINE d00044A C G47.0 G47.9 Insomnia Sleep disorder, unspecified A0 E A CYPROHEPTADINE d00790A C"0 R63 Symptoms and signs concerning food and fluid intake A0 E A DEXMETHYLPHENIDATE d04777A CDp F90 Attention-deficit hyperactivity disorders A0 E A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E A ACETAMINOPHEN; CODEINE d03423A C T14.9 Unspecified injury A E A ECONAZOLE TOPICAL d01271A C B35 Dermatophytosis A E A GABAPENTIN d03182A C M79.2 Neuralgia and neuritis, unspecified A E A GLIPIZIDE d00246A Dc E11 Type 2 diabetes mellitus A E A INSULIN GLARGINE d04538A C E11 Type 2 diabetes mellitus A E A INSULIN GLARGINE d04538A C- E11 Type 2 diabetes mellitus A E A LISINOPRIL d00732A CDp I21.P Prevent heart attack/myocardial infarction A E A METFORMIN d03807A C E11 Type 2 diabetes mellitus A E A OMEPRAZOLE d00325A C K21 R12 Gastro-esophageal reflux disease Heartburn A E A SITAGLIPTIN d05896A Dc E11 Type 2 diabetes mellitus A E A TAMSULOSIN d04121A C Z79 Long term (current) drug therapy A E A TRIAMCINOLONE TOPICAL d03206A Dc R21 Rash and other nonspecific skin eruption A E A . . . E 0 A . . . E @ A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A C I10 Essential (primary) hypertension A E P A 99999 . . A E ` A . . . E p A . . . E A . . . E A ETHINYL ESTRADIOL; LEVONORGESTREL d03242A B Z79.3 Long term (current) use of hormonal contraceptives A E A FEXOFENADINE d04040A D T78.40 Allergy, unspecified A0 E A HYDROCHLOROTHIAZIDE d00253A C N42.9 Disorder of prostate, unspecified A0 E A TRAMADOL d03826A C M19.9 Osteoarthritis, unspecified site A0 E A . . . E A BENAZEPRIL d00730A C I10 Essential (primary) hypertension Ap E A FLUOXETINE d00236A B F32.9 Major depressive disorder, single episode, unspecified Ap E A GLIPIZIDE d00246A Dc E11 Type 2 diabetes mellitus Ap E A METFORMIN d03807A Dc E11 Type 2 diabetes mellitus Ap E A METOPROLOL d00134A C"0 I10 Essential (primary) hypertension Ap E A PRAVASTATIN d00348A Cr E78.0 Pure hypercholesterolemia Ap E A TRAZODONE d00395A B F41.9 G47.0 Anxiety disorder, unspecified Insomnia Ap E A ETHINYL ESTRADIOL; NORGESTIMATE d03781A C Z79.3 Long term (current) use of hormonal contraceptives A E A . . . E A . . . E A . . . E A . . . E A . . . E 0 A . . . E @ A HYDROCHLOROTHIAZIDE d00253A B= I10 Essential (primary) hypertension AP E @ A METOPROLOL d00134A B= I10 Essential (primary) hypertension AP E @ A RAMIPRIL d00728A B= I50.9 Heart failure, unspecified AP E @ A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia AP E @ A TICAGRELOR d07721A B= D75.9P Prevent blood clots AP E P A APIXABAN d07804A0 CDp Z79.0 Long term (current) use of anticoagulants and antithrombotics/antiplatelets A E P A ATORVASTATIN d04105A0 CDp E78.0 Pure hypercholesterolemia A E P A CARVEDILOL d03847A0 CDp I10 I50.9 Essential (primary) hypertension Heart failure, unspecified A E P A EZETIMIBE d04824A0 CDp E78.0 Pure hypercholesterolemia A E P A FUROSEMIDE d00070A0 CDp R60.9 Edema, unspecified A E P A INSULIN ASPART d04697A0 CDp E11 Type 2 diabetes mellitus A E P A INSULIN GLARGINE d04538A0 CDp E11 Type 2 diabetes mellitus A E P A OMEPRAZOLE d00325A0 CDp K21 Gastro-esophageal reflux disease A E P A SACUBITRIL; VALSARTAN d08369A0 B= I50.9 Heart failure, unspecified A E ` A ATENOLOL d00004A C[@ I10 Essential (primary) hypertension Ap E ` A GLIPIZIDE d00246A CDp E11 Type 2 diabetes mellitus Ap E ` A HYDROCHLOROTHIAZIDE d00253A C[@ I10 Essential (primary) hypertension Ap E ` A INSULIN ISOPHANE (NPH) d04370A A E11 Type 2 diabetes mellitus Ap E ` A LOSARTAN d03821A B I10 Essential (primary) hypertension Ap E ` A LOVASTATIN d00280A C[@ E78.0 Pure hypercholesterolemia Ap E ` A METFORMIN d03807A Cr E11 Type 2 diabetes mellitus Ap E p A . . . E A IRBESARTAN d04222A C I10 Essential (primary) hypertension A E A METFORMIN d03807A C E11 Type 2 diabetes mellitus A E A CYCLOBENZAPRINE d00963A A M79.1 Myalgia A0 E A RANITIDINE d00021A C K25 Gastric ulcer A0 E A TRAMADOL d03826A B M25.5 Pain in joint A0 E A . . . E A OXYCODONE d00329A B M54 Dorsalgia A E A . . . E A ATORVASTATIN d04105A Cr E78.0 Pure hypercholesterolemia A E A METFORMIN d03807A Cr E11 Type 2 diabetes mellitus A E A . . . E A AMOXICILLIN; CLAVULANATE d00089A A J42 Unspecified chronic bronchitis A E A . . . E A ANASTROZOLE d03873A C C50 Malignant neoplasm of breast A E A CARISOPRODOL d00960A C M54 T14.9 Dorsalgia Unspecified injury A E A DIAZEPAM d00148A C F41.9 Anxiety disorder, unspecified A E A IBUPROFEN d00015A D M54 Dorsalgia A E A LEVOTHYROXINE d00278A Dc C80.1 Malignant (primary) neoplasm, unspecified A E A LISINOPRIL d00732A CDp I21.P I50.9 I63.P Prevent heart attack/myocardial infarction Heart failure, unspecified Prevent stroke A E A METOPROLOL d00134A C[@ I21.P I50.9 Prevent heart attack/myocardial infarction Heart failure, unspecified A E A RANITIDINE d00021A C[@ K30 Functional dyspepsia A E A . . . E 0 A . . . E @ A ACETAMINOPHEN; HYDROCODONE d03428A B= G89 M25.5 Pain, not elsewhere classified Pain in joint A0 E @ A INDOMETHACIN d00039A Ap R60.9 Edema, unspecified A0 E @ A MELOXICAM d04532A C M25.5 Pain in joint A0 E P A . . . E ` A . . . E p A ESOMEPRAZOLE d04749A C- K30 Functional dyspepsia AP E p A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified AP E p A LISINOPRIL d00732A C[@ I10 Essential (primary) hypertension AP E p A SIMVASTATIN d00746A CDp E78.0 Pure hypercholesterolemia AP E p A ZOLPIDEM d00910A Cr G47.9 Sleep disorder, unspecified AP E A . . . E A . . . E A . . . E A DEXMETHYLPHENIDATE d04777A CDp F90 Attention-deficit hyperactivity disorders A E A . . . E A . . . E A AMOXICILLIN d00088A A J02 Acute pharyngitis A E A . . . E A GABAPENTIN d03182A Cr M79.7 Fibromyalgia AP E A LORAZEPAM d00149A C 55555 AP E A OXYCODONE d00329A Cr G89 M79.7 Pain, not elsewhere classified Fibromyalgia AP E A PREDNISONE d00350A C M79.7 N28.9 Fibromyalgia Disorder of kidney and ureter, unspecified AP E A TRAZODONE d00395A Cr G47.0 Insomnia AP E A . . . E A INSULIN ISOPHANE; INSULIN REGULAR d04374A C E11 Type 2 diabetes mellitus A E 0 A . . . E @ A BUSPIRONE d00182A C F41.9 Anxiety disorder, unspecified A@ E @ A FLUOXETINE d00236A C F32.9 Major depressive disorder, single episode, unspecified A@ E @ A GABAPENTIN d03182A C M79.2 Neuralgia and neuritis, unspecified A@ E @ A LISINOPRIL d00732A C I10 Essential (primary) hypertension A@ E P A CHLORTHALIDONE d00192A B I10 Essential (primary) hypertension A0 E P A LOSARTAN d03821A C I10 Essential (primary) hypertension A0 E P A PRAVASTATIN d00348A C[@ E78.0 Pure hypercholesterolemia A0 E ` A . . . E p A LISINOPRIL d00732A CDp 99999 A@ E p A METFORMIN d03807A C E11 Type 2 diabetes mellitus A@ E p A SEMAGLUTIDE d08688A B E11 Type 2 diabetes mellitus A@ E p A SIMVASTATIN d00746A C- 99999 A@ E A . . . E A ATORVASTATIN d04105A C- E78.0 Pure hypercholesterolemia A@ E A AZELASTINE OPHTHALMIC d04541A C H57.9 Unspecified disorder of eye and adnexa A@ E A LOSARTAN d03821A C- I10 Essential (primary) hypertension A@ E A OMEPRAZOLE d00325A C- K30 R10 Functional dyspepsia Abdominal and pelvic pain A@ E A ALBUTEROL d00749A C R06.02 Shortness of breath A E A FLUTICASONE d01296A C J45 R05 R06.2 Asthma Cough Wheezing A E A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E A MEDROXYPROGESTERONE d00284A CDp Z79.3 Long term (current) use of hormonal contraceptives A E 0 A BUPROPION d00181A Dc F32.9 Major depressive disorder, single episode, unspecified A` E 0 A CIPROFLOXACIN d00011A A N39.0 Urinary tract infection, site not specified A` E 0 A ESCITALOPRAM d04812A C R42 Dizziness and giddiness A` E 0 A GABAPENTIN d03182A C M79.7 Fibromyalgia A` E 0 A OMEPRAZOLE d00325A Dc K21 Gastro-esophageal reflux disease A` E 0 A PRAVASTATIN d00348A Dc E78.0 Pure hypercholesterolemia A` E @ A . . . E P A ATORVASTATIN d04105A C- E78.0 Pure hypercholesterolemia A E ` A . . . E p A AMLODIPINE d00689A Cr I10 Essential (primary) hypertension AP E p A GABAPENTIN d03182A CDp R20 Disturbances of skin sensation AP E p A HYDRALAZINE d00132A Cr I10 Essential (primary) hypertension AP E p A LEVOTHYROXINE d00278A Cr K31.9 Disease of stomach and duodenum, unspecified AP E p A MECLIZINE d00859A Cr R42 Dizziness and giddiness AP E A . . . E A BUPROPION d00181A CDp F31.9 F41.9 Bipolar disorder, unspecified Anxiety disorder, unspecified A0 E A ESCITALOPRAM d04812A CDp F32.9 F41.9 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified A0 E A PANTOPRAZOLE d04514A B K21 Gastro-esophageal reflux disease A0 E A ALBUTEROL d00749A A J45 Asthma A E A BUDESONIDE; FORMOTEROL d04795A B J45 Asthma A E A . . . E A GABAPENTIN d03182A D E11.4 Type 2 diabetes mellitus with neurological complications A@ E A LISINOPRIL d00732A D I10 Essential (primary) hypertension A@ E A LOVASTATIN d00280A D E78.0 Pure hypercholesterolemia A@ E A METFORMIN d03807A D E11 Type 2 diabetes mellitus A@ E A AMIODARONE d00002A Bz I49.9 Cardiac arrhythmia, unspecified A E A APIXABAN d07804A B Z79.0 Long term (current) use of anticoagulants and antithrombotics/antiplatelets A E A CARVEDILOL d03847A C I10 Essential (primary) hypertension A E A GABAPENTIN d03182A D M79.2 Neuralgia and neuritis, unspecified A E A INSULIN ASPART; INSULIN ASPART PROTAMINE d04839A Dc R73 Elevated blood glucose level A E A METFORMIN d03807A D# E11 Type 2 diabetes mellitus A E A NIFEDIPINE d00051A B[ I10 Essential (primary) hypertension A E A VALSARTAN d04113A B[ I10 Essential (primary) hypertension A E A . . . E A . . . E A HYDROCODONE d03075A Cr M19.9 M25.5 M54 Osteoarthritis, unspecified site Pain in joint Dorsalgia A E A PANTOPRAZOLE d04514A C K21 Gastro-esophageal reflux disease A E A APIXABAN d07804A C"0 Z79.0 Long term (current) use of anticoagulants and antithrombotics/antiplatelets AP E A ATORVASTATIN d04105A C- E78.0 Pure hypercholesterolemia AP E A LISINOPRIL d00732A C- I21.P Prevent heart attack/myocardial infarction AP E A METOPROLOL d00134A CDp I49.9 Cardiac arrhythmia, unspecified AP E A TAMSULOSIN d04121A C N40 Enlarged prostate AP E A . . . E 0 A ALBUTEROL d00749A C J44.9 Chronic obstructive pulmonary disease, unspecified AP E 0 A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia AP E 0 A BUDESONIDE; FORMOTEROL d04795A C J44.9 Chronic obstructive pulmonary disease, unspecified AP E 0 A OMEPRAZOLE d00325A C K30 Functional dyspepsia AP E 0 A TIOTROPIUM d04829A C J44.9 Chronic obstructive pulmonary disease, unspecified AP E @ A ATENOLOL d00004A B= I10 Essential (primary) hypertension A E @ A LABETALOL d00016A B I10 Essential (primary) hypertension A E P A CEPHALEXIN d00096A Ap 55555 A E P A SULFAMETHOXAZOLE; TRIMETHOPRIM d00124A Ap 55555 A E ` A CLONAZEPAM d00197A D F41.9 Anxiety disorder, unspecified A@ E ` A CONJUGATED ESTROGENS d00541A Dc Z79.890 Hormone replacement therapy A@ E ` A IBUPROFEN d00015A CDp M13 Other arthritis A@ E ` A OMEPRAZOLE d00325A C K21 Gastro-esophageal reflux disease A@ E p A OSELTAMIVIR d04462A AP J09 Influenza due to certain identified influenza viruses A E A . . . E A ALBUTEROL d00749A C9 R06.2 Wheezing A0 E A FLUTICASONE NASAL d04283A C9 J30.9 Allergic rhinitis, unspecified A0 E A LEVOCETIRIZINE d05851A C9 T78.40 Allergy, unspecified A0 E A . . . E A ALBUTEROL d00749A C- J45 Asthma A E A ALLOPURINOL d00023A C- M1A Chronic gout B E A AMBRISENTAN d06841A CDp I27.9 Pulmonary heart disease, unspecified B E A BRIMONIDINE OPHTHALMIC d04048A C H40 Glaucoma B E A CARVEDILOL d03847A CDp J98.9 Respiratory disorder, unspecified B E A DEXLANSOPRAZOLE d07395A C9 K21 Gastro-esophageal reflux disease B E A DULOXETINE d05355A CDp K31.9 Disease of stomach and duodenum, unspecified B E A FLUTICASONE; VILANTEROL d08100A B R06.02 Shortness of breath B E A INSULIN LISPRO d04373A B E11 Type 2 diabetes mellitus B E A LATANOPROST OPHTHALMIC d04017A C- H40 Glaucoma B E A LINACLOTIDE d07902A C K59.0 Constipation B E A POTASSIUM CHLORIDE d00345A CDp 99999 B E A PRAVASTATIN d00348A CDp E78.0 Pure hypercholesterolemia B E A PREDNISONE d00350A C[@ J44.9 Chronic obstructive pulmonary disease, unspecified B E A RANITIDINE d00021A CDp 99999 B E A RIOCIGUAT d08140A CDp I27.9 Pulmonary heart disease, unspecified B E A SPIRONOLACTONE d00373A CDp I27.9 Pulmonary heart disease, unspecified B E A TIOTROPIUM d04829A CDp J45 Asthma B E A TORSEMIDE d03189A C- J98.9 Respiratory disorder, unspecified B E A . . . E A . . . E A . . . E A . . . E A ESTRADIOL d00537A Cr N92 Excessive, frequent and irregular menstruation A0 E A LEVOTHYROXINE d00278A Cr E03.9 Hypothyroidism, unspecified A0 E A MEDROXYPROGESTERONE d00284A C N92 Excessive, frequent and irregular menstruation A0 E A . . . E 0 A . . . E @ A . . . E P A ALENDRONATE d03849A CDp M81 Osteoporosis without current pathological fracture A0 E P A ESCITALOPRAM d04812A C F32.9 Major depressive disorder, single episode, unspecified A0 E P A LAMOTRIGINE d03809A C F31.9 Bipolar disorder, unspecified A0 E ` A ATORVASTATIN d04105A B E78.0 Pure hypercholesterolemia A E ` A LISINOPRIL d00732A Cr I10 Essential (primary) hypertension A E p A . . . E A . . . E A . . . E A . . . E A . . . E A 55555 A C 99999 A E A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A E A DONEPEZIL d04099A C G31.9 Degenerative disease of nervous system, unspecified A E A LIRAGLUTIDE d07466A CDp R73 Elevated blood glucose level A E A LOSARTAN d03821A C 99999 A E A MEMANTINE d04899A C R41 Other symptoms and signs involving cognitive functions and awareness A E A METOPROLOL d00134A C 99999 A E A PREDNISONE d00350A C 99999 A E A REPAGLINIDE d04267A C R73 Elevated blood glucose level A E A ALBUTEROL d00749A CDp J45.P R06.2 Prevent asthma Wheezing A E A FLUTICASONE NASAL d04283A B= J30.9 R09.8 R09.81 Allergic rhinitis, unspecified Other specified symptoms and signs involving the circulatory and respiratory systems Nasal congestion A E A . . . E A . . . E A . . . E A AMLODIPINE d00689A D* I10 Essential (primary) hypertension A E A ATORVASTATIN d04105A D E78.0 Pure hypercholesterolemia A E A FUROSEMIDE d00070A D* R60.9 Edema, unspecified A E A LEVETIRACETAM d04499A D# G40 Epilepsy and recurrent seizures A E A LOSARTAN d03821A C I10 Essential (primary) hypertension A E A METHYLPHENIDATE d00900A B G47.9 Sleep disorder, unspecified A E A METOPROLOL d00134A D* I10 Essential (primary) hypertension A E A VENLAFAXINE d03181A C- G47.9 Sleep disorder, unspecified A E A WARFARIN d00022A D# I63 Cerebral infarction A E A DILTIAZEM d00045A C R00 Abnormalities of heart beat A E A ESOMEPRAZOLE d04749A C K30 Functional dyspepsia A E A FINASTERIDE d00563A C N40 Enlarged prostate A E A FUROSEMIDE d00070A C R60.9 Edema, unspecified A E A LOSARTAN d03821A C I10 Essential (primary) hypertension A E A METOPROLOL d00134A Dc I10 Essential (primary) hypertension A E A POTASSIUM CHLORIDE d00345A D E87.6 Hypokalemia A E A PRAVASTATIN d00348A C E78.0 Pure hypercholesterolemia A E A WARFARIN d00022A Dc D75.9P Prevent blood clots A E 0 A AMOXICILLIN d00088A Ap J02.0 Streptococcal pharyngitis A E @ A BECLOMETHASONE d00760A CDp J45 Asthma A E P A . . . E ` A . . . E p A . . . E A . . . E A CETIRIZINE d03827A CDp J30.9 Allergic rhinitis, unspecified A E A BECLOMETHASONE d00760A C- J45 Asthma A E A . . . E A . . . E A ALENDRONATE d03849A Cr M81 Osteoporosis without current pathological fracture A@ E A DILTIAZEM d00045A Dc I10 Essential (primary) hypertension A@ E A DONEPEZIL d04099A C- G30.9 G31.9 R41 Alzheimer's disease, unspecified Degenerative disease of nervous system, unspecified Other symptoms and signs involving cognitive functions and awareness A@ E A MEMANTINE d04899A CDp G30.9 G31.9 R41 Alzheimer's disease, unspecified Degenerative disease of nervous system, unspecified Other symptoms and signs involving cognitive functions and awareness A@ E A AMLODIPINE d00689A C I10 Essential (primary) hypertension AP E A CLONIDINE d00044A C I10 Essential (primary) hypertension AP E A FUROSEMIDE d00070A C I10 Essential (primary) hypertension AP E A METOPROLOL d00134A C I10 Essential (primary) hypertension AP E A POTASSIUM CHLORIDE d00345A C I10 Essential (primary) hypertension AP E A . . . E A CICLOPIROX TOPICAL d01272A C L30.9 Dermatitis, unspecified Ap E A CLOBETASOL TOPICAL d01288A C L30.9 Dermatitis, unspecified Ap E A COBICISTAT; DARUNAVIR d08305A C- B20 Human immunodeficiency virus [HIV] disease Ap E A EMTRICITABINE; RILPIVIRINE; TENOFOVIR d07796A C- B20 Human immunodeficiency virus [HIV] disease Ap E A FLUOCINOLONE TOPICAL d01293A C L23 L30.9 Allergic contact dermatitis Dermatitis, unspecified Ap E A KETOCONAZOLE TOPICAL d03202A C L20.9 Atopic dermatitis, unspecified Ap E A TRIAMCINOLONE TOPICAL d03206A C L20.9 Atopic dermatitis, unspecified Ap E A AMLODIPINE d00689A Ei I10 Essential (primary) hypertension A E A APIXABAN d07804A B I48.9 Unspecified atrial fibrillation and atrial flutter A E A ATORVASTATIN d04105A Cr E78.0 Pure hypercholesterolemia A E A HYDROCHLOROTHIAZIDE; LOSARTAN d03830A Cr I10 Essential (primary) hypertension A E A INSULIN GLARGINE d04538A C E11 Type 2 diabetes mellitus A E A METFORMIN d03807A C E11 Type 2 diabetes mellitus A E A METOPROLOL d00134A Ei I10 Essential (primary) hypertension A E A MONTELUKAST d04289A B J30.9 R06.9 Allergic rhinitis, unspecified Unspecified abnormalities of breathing A E A MONTELUKAST d04289A B[ J30.9 Allergic rhinitis, unspecified A E 0 A LEVOTHYROXINE d00278A Dc E03.9 Hypothyroidism, unspecified A@ E 0 A OMEPRAZOLE d00325A C K21 Gastro-esophageal reflux disease A@ E 0 A TRAZODONE d00395A Dc G47.9 Sleep disorder, unspecified A@ E 0 A VENLAFAXINE d03181A C F32.9 Major depressive disorder, single episode, unspecified A@ E @ A METFORMIN d03807A C- R73 Elevated blood glucose level A E P A . . . E ` A . . . E p A . . . E A . . . E A . . . E A . . . E A OMEPRAZOLE d00325A Cr K30 Functional dyspepsia A E A AMLODIPINE d00689A Dc I10 Essential (primary) hypertension Ap E A ASPIRIN d00170A C I21.P Prevent heart attack/myocardial infarction Ap E A GLIPIZIDE d00246A C 99999 Ap E A HYDROCHLOROTHIAZIDE; LOSARTAN d03830A Ei 99999 Ap E A HYDROXYZINE d00907A C F41.9 Anxiety disorder, unspecified Ap E A METFORMIN d03807A Dc E11 Type 2 diabetes mellitus Ap E A SIMVASTATIN d00746A Dc E78.0 Pure hypercholesterolemia Ap E A AMOXICILLIN d00088A A H66.9 Otitis media, unspecified A E A . . . E A CANNABIDIOL d08919A B[ F99 Mental disorder, not otherwise specified A E A LURASIDONE d07705A B= F39 Unspecified mood [affective] disorder A E A . . . E A . . . E A . . . E 0 A . . . E @ A ALLOPURINOL d00023A D* M10.9P Prevent gout Ap E @ A AMLODIPINE d00689A Cr I10 Essential (primary) hypertension Ap E @ A CARVEDILOL d03847A Cr I10 Essential (primary) hypertension Ap E @ A ESCITALOPRAM d04812A C F32.9 F41.9 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified Ap E @ A GABAPENTIN d03182A C M79.2 Neuralgia and neuritis, unspecified Ap E @ A LISINOPRIL d00732A C I10 Essential (primary) hypertension Ap E @ A TRAZODONE d00395A D,3 F32.9 G47.0 Major depressive disorder, single episode, unspecified Insomnia Ap E P A . . . E ` A . . . E p A LISINOPRIL d00732A Cr I10 Essential (primary) hypertension A E p A METFORMIN d03807A C[@ R73 Elevated blood glucose level A E A . . . E A DILTIAZEM d00045A C- I10 Essential (primary) hypertension Ap E A DULOXETINE d05355A D E11.4 Type 2 diabetes mellitus with neurological complications Ap E A GABAPENTIN d03182A CDp M79.2 Neuralgia and neuritis, unspecified Ap E A INSULIN ASPART d04697A D E11 Type 2 diabetes mellitus Ap E A INSULIN DETEMIR d05436A D E11 Type 2 diabetes mellitus Ap E A OMEPRAZOLE d00325A Cr K21 Gastro-esophageal reflux disease Ap E A ROSUVASTATIN d04851A C- E78.0 Pure hypercholesterolemia Ap E A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A@ E A CELECOXIB d04380A DGJ 55555 A@ E A FLUCONAZOLE d00071A A B35 Dermatophytosis A@ E A LISINOPRIL d00732A D I10 Essential (primary) hypertension A@ E A . . . E A . . . E A . . . E A ASPIRIN d00170A C- 99999 Ap E A ATORVASTATIN d04105A C- 99999 Ap E A GLIMEPIRIDE d03864A C- R73 Elevated blood glucose level Ap E A LISINOPRIL d00732A C- 99999 Ap E A MONTELUKAST d04289A C 99999 Ap E A OXYBUTYNIN d00328A C- 99999 Ap E A TAMSULOSIN d04121A C- 99999 Ap E A FUROSEMIDE d00070A D9 R60.9 Edema, unspecified A@ E A METFORMIN d03807A Cr E11.P Prevent diabetes A@ E A METOPROLOL d00134A Cr I10 Essential (primary) hypertension A@ E A SPIRONOLACTONE d00373A D I10 Essential (primary) hypertension A@ E A AMLODIPINE d00689A B I10 Essential (primary) hypertension A0 E A METHADONE d00050A D M54 Dorsalgia A0 E A SIMVASTATIN d00746A B E78.0 Pure hypercholesterolemia A0 E A . . . E A CIPROFLOXACIN d00011A A N30 Cystitis A E 0 A . . . E @ A . . . E P A BUPROPION d00181A C[@ F41.9 Anxiety disorder, unspecified A E ` A IBUPROFEN d00015A AP K08.8 R50.9 Other specified disorders of teeth and supporting structures Fever, unspecified A E ` A MOUTH AND THROAT PRODUCTS - UNSPECIFIED c00146A A@ B00.1 Herpesviral vesicular dermatitis A E p A FINASTERIDE d00563A Cr N42.9 Disorder of prostate, unspecified AP E p A LEVOTHYROXINE d00278A Cr I10 Essential (primary) hypertension AP E p A LISINOPRIL d00732A Cr I10 Essential (primary) hypertension AP E p A PRAVASTATIN d00348A Cr E78.0 Pure hypercholesterolemia AP E p A TAMSULOSIN d04121A Cr R35 Polyuria AP E A . . . E A . . . E A DICLOFENAC d00848A C M19.9 Osteoarthritis, unspecified site A E A . . . E A . . . E A . . . E A ALBUTEROL d00749A D J45 Asthma A E A MONTELUKAST d04289A C R06.2 R09.81 Wheezing Nasal congestion A E A . . . E A DULAGLUTIDE d08290A B R73 Elevated blood glucose level AP E A INSULIN GLARGINE d04538A B R73 Elevated blood glucose level AP E A LISINOPRIL d00732A C E11.2P Prevent diabetic kidney disease AP E A PRAVASTATIN d00348A C E78.0 Pure hypercholesterolemia AP E A SITAGLIPTIN d05896A B R73 Elevated blood glucose level AP E A . . . E A AMLODIPINE d00689A C I10 Essential (primary) hypertension A@ E A HYDROCHLOROTHIAZIDE d00253A CDp I10 Essential (primary) hypertension A@ E A LOSARTAN d03821A C I10 Essential (primary) hypertension A@ E A PRAVASTATIN d00348A C E78.0 Pure hypercholesterolemia A@ E 0 A FLUTICASONE d01296A A J45 Asthma A E 0 A IPRATROPIUM d00265A A J45 Asthma A E @ A . . . E P A . . . E ` A . . . E p A PRAVASTATIN d00348A B E78.0 Pure hypercholesterolemia A E A . . . E A . . . E A . . . E A METHYLPHENIDATE d00900A C F90 Attention-deficit hyperactivity disorders A E A . . . E A . . . E A LEVOTHYROXINE d00278A B E03.9 Hypothyroidism, unspecified A E A . . . E A . . . E A . . . E A . . . E 0 A PAROXETINE d03157A D F41.9 Anxiety disorder, unspecified A E 0 A USTEKINUMAB d07396A B L40 Psoriasis A E @ A ETHINYL ESTRADIOL; NORETHINDRONE d03238A C Z79.3 Long term (current) use of hormonal contraceptives A E P A . . . E ` A ACETAMINOPHEN; HYDROCODONE d03428A A M79.6 Pain in limb, hand, foot, fingers and toes A E ` A CEPHALEXIN d00096A A M79.6 Pain in limb, hand, foot, fingers and toes A E p A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E A ALBUTEROL d00749A0 C J44.9 Chronic obstructive pulmonary disease, unspecified B E A AMLODIPINE d00689A0 Cr I10 Essential (primary) hypertension B E A ATORVASTATIN d04105A0 C E78.0 Pure hypercholesterolemia B E A BUDESONIDE d04276A0 C J44.9 Chronic obstructive pulmonary disease, unspecified B E A CARBAMAZEPINE d00058A0 D G40 Epilepsy and recurrent seizures B E A CETIRIZINE d03827A0 C T78.40 Allergy, unspecified B E A DICLOFENAC d00848A0 Cr M19.9 Osteoarthritis, unspecified site B E A FENOFIBRATE d04286A0 C E78.1 Pure hyperglyceridemia B E A FINASTERIDE d00563A0 C N40 Enlarged prostate B E A FLUTICASONE NASAL d04283A0 Cr J30.2 Other seasonal allergic rhinitis B E A GLIPIZIDE d00246A0 Dc E11 Type 2 diabetes mellitus B E A HYDROCHLOROTHIAZIDE d00253A0 D I10 Essential (primary) hypertension B E A LISINOPRIL d00732A0 C I10 Essential (primary) hypertension B E A METFORMIN d03807A0 Dc E11 Type 2 diabetes mellitus B E A METOPROLOL d00134A0 D"8 I21.P Prevent heart attack/myocardial infarction B E A PANTOPRAZOLE d04514A0 CDp K21 Gastro-esophageal reflux disease B E A SILDENAFIL d04299A0 C N42.9 Disorder of prostate, unspecified B E A TAMSULOSIN d04121A0 Cr N40 Enlarged prostate B E A TROSPIUM d04929A0 Cr N42.9 Disorder of prostate, unspecified B E A . . . E A ACETAMINOPHEN; OXYCODONE d03431A B M54 Dorsalgia A E A AMLODIPINE d00689A B I10 Essential (primary) hypertension A E A CETIRIZINE d03827A CDp T78.40 Allergy, unspecified A E A CLONIDINE d00044A C F41.9 I10 Anxiety disorder, unspecified Essential (primary) hypertension A E A DULOXETINE d05355A CDp F32.9 F41.9 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified A E A GABAPENTIN d03182A C M54 Dorsalgia A E A HYDROXYZINE d00907A B F41.9 Anxiety disorder, unspecified A E A METOPROLOL d00134A C I49.9 Cardiac arrhythmia, unspecified A E A ONDANSETRON d00867A Bz R11.P Prevent nausea or vomiting A E A ROPINIROLE d04215A C G25.81 Restless legs syndrome A E A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia A E A ZOLPIDEM d00910A C G47.9 Sleep disorder, unspecified A E A . . . E A ESOMEPRAZOLE; NAPROXEN d07631A B= M19.9 Osteoarthritis, unspecified site A E 0 A . . . E @ A AMITRIPTYLINE d00146A CDp M62.83 Muscle spasm AP E @ A ATORVASTATIN d04105A C- E78.0 Pure hypercholesterolemia AP E @ A CHLORTHALIDONE d00192A CDp I10 Essential (primary) hypertension AP E @ A PREGABALIN d05508A CDp F41.9 Anxiety disorder, unspecified AP E @ A TIZANIDINE d04102A C- M54 Dorsalgia AP E P A INSULIN DETEMIR d05436A C E10 Type 1 diabetes mellitus A E P A INSULIN LISPRO d04373A Dc E10 Type 1 diabetes mellitus A E ` A . . . E p A HYDROCHLOROTHIAZIDE; LOSARTAN d03830A Bz I10 Essential (primary) hypertension A E p A METFORMIN d03807A B= R73 Elevated blood glucose level A E A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified A0 E A METFORMIN d03807A C R73 Elevated blood glucose level A0 E A PREDNISONE d00350A B[ M06.9 Rheumatoid arthritis, unspecified A0 E A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia A E A . . . E A . . . E A . . . E A . . . E A DEXMETHYLPHENIDATE d04777A C F90 Attention-deficit hyperactivity disorders A0 E A FLUTICASONE d01296A C J45 Asthma A0 E A MONTELUKAST d04289A C J45 Asthma A0 E A LOSARTAN d03821A C I10 Essential (primary) hypertension A E A . . . E A . . . E A LEVOTHYROXINE d00278A C[@ C80.1 E03.9 Malignant (primary) neoplasm, unspecified Hypothyroidism, unspecified A E 0 A OSELTAMIVIR d04462A AP J09 Influenza due to certain identified influenza viruses A E @ A CITALOPRAM d04332A C F41.9 Anxiety disorder, unspecified A E @ A DICLOFENAC d00848A C M19.9 Osteoarthritis, unspecified site A E @ A FAMOTIDINE d00141A Cr R12 Heartburn A E @ A GEMFIBROZIL d00245A C E78.0 Pure hypercholesterolemia A E @ A HALOPERIDOL d00027A Cr F31.9 Bipolar disorder, unspecified A E @ A LEVOTHYROXINE d00278A Cr E03.9 Hypothyroidism, unspecified A E @ A LISINOPRIL d00732A B[ I10 Essential (primary) hypertension A E @ A TRAZODONE d00395A Cr G47.9 Sleep disorder, unspecified A E P A . . . E ` A . . . E p A METFORMIN d03807A Cr E11 Type 2 diabetes mellitus A E A . . . E A . . . E A . . . E A . . . E A ASPIRIN d00170A C I21.P Prevent heart attack/myocardial infarction A0 E A BUDESONIDE; FORMOTEROL d04795A C J44.9 J45 Chronic obstructive pulmonary disease, unspecified Asthma A0 E A ROSUVASTATIN d04851A B[ 99999 A0 E A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E 0 A . . . E @ A ATENOLOL d00004A D1 I10 Essential (primary) hypertension A E @ A LEVOTHYROXINE d00278A D E03.9 Hypothyroidism, unspecified A E P A ALLOPURINOL d00023A C[@ M19.9 Osteoarthritis, unspecified site A@ E P A ATENOLOL d00004A C[@ I10 Essential (primary) hypertension A@ E P A LISINOPRIL d00732A C[@ I10 Essential (primary) hypertension A@ E P A WARFARIN d00022A C[@ D75.9P Prevent blood clots A@ E ` A . . . E p A . . . E A ATORVASTATIN d04105A D E78.0 Pure hypercholesterolemia A@ E A LOSARTAN d03821A C- I21.P I63.P Prevent heart attack/myocardial infarction Prevent stroke A@ E A METOPROLOL d00134A C- I21.P Prevent heart attack/myocardial infarction A@ E A PANTOPRAZOLE d04514A B K21 Gastro-esophageal reflux disease A@ E A LOSARTAN d03821A B= I10 Essential (primary) hypertension A E A CLOTRIMAZOLE TOPICAL d04395A A R21 Rash and other nonspecific skin eruption A@ E A HYDROXYZINE d00907A A T78.40 Allergy, unspecified A@ E A METHYLPREDNISOLONE d00293A A R21 Rash and other nonspecific skin eruption A@ E A PREDNISONE d00350A Ap T78.40 Allergy, unspecified A@ E A . . . E A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified A E A . . . E A ACYCLOVIR d00001A C B02 Zoster [herpes zoster] A E A ALENDRONATE d03849A C M81 Osteoporosis without current pathological fracture A E A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A E A CYCLOBENZAPRINE d00963A C M54 Dorsalgia A E A DULOXETINE d05355A C F32.9 Major depressive disorder, single episode, unspecified A E A FLUTICASONE NASAL d04283A CP J30.2 Other seasonal allergic rhinitis A E A METHOCARBAMOL d00965A C M54 M62.83 Dorsalgia Muscle spasm A E A MIRTAZAPINE d04025A CDp G47.0 Insomnia A E A NAPROXEN d00019A C M25.5 M54 Pain in joint Dorsalgia A E A OMEPRAZOLE d00325A C K21 Gastro-esophageal reflux disease A E A . . . E A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified A E A . . . E A . . . E 0 A ATORVASTATIN d04105A Dc E78.0 Pure hypercholesterolemia A` E 0 A CITALOPRAM d04332A B F41.9 Anxiety disorder, unspecified A` E 0 A DOXEPIN d00217A D9 F32.9 Major depressive disorder, single episode, unspecified A` E 0 A LEVOTHYROXINE d00278A B E03.9 Hypothyroidism, unspecified A` E 0 A LORAZEPAM d00149A D9 F41.9 Anxiety disorder, unspecified A` E 0 A OMEPRAZOLE d00325A D K30 Functional dyspepsia A` E @ A . . . E P A . . . E ` A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A0 E ` A MONTELUKAST d04289A D J45 Asthma A0 E ` A THYROID DESICCATED d00655A C- E03.9 Hypothyroidism, unspecified A0 E p A ATENOLOL d00004A C I10 Essential (primary) hypertension A0 E p A HYDROCHLOROTHIAZIDE d00253A C R60.9 Edema, unspecified A0 E p A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia A0 E A . . . E A ATENOLOL d00004A C I10 Essential (primary) hypertension A0 E A HYDROCHLOROTHIAZIDE d00253A C I10 Essential (primary) hypertension A0 E A LETROZOLE d04156A C- C50 Malignant neoplasm of breast A0 E A . . . E A AMLODIPINE d00689A C I10 Essential (primary) hypertension A@ E A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified A@ E A LISINOPRIL d00732A C I10 Essential (primary) hypertension A@ E A LORAZEPAM d00149A C K58 Irritable bowel syndrome A@ E A . . . E A . . . E A SUMATRIPTAN d03160A CDp G43 Migraine A E A CITALOPRAM d04332A C M79.2 Neuralgia and neuritis, unspecified A@ E A LEVOTHYROXINE d00278A CDp E07.9 Disorder of thyroid, unspecified A@ E A METOPROLOL d00134A C I10 Essential (primary) hypertension A@ E A WARFARIN d00022A C D75.9P Prevent blood clots A@ E A ALPRAZOLAM d00168A C- F41.0 F41.9 Panic disorder [episodic paroxysmal anxiety] without agoraphobia Anxiety disorder, unspecified Ap E A CELECOXIB d04380A C- M13 Other arthritis Ap E A HYDROCHLOROTHIAZIDE; OLMESARTAN d04878A D I10 Essential (primary) hypertension Ap E A ONDANSETRON d00867A B R11 Nausea and vomiting Ap E A PREGABALIN d05508A C- M79.2 Neuralgia and neuritis, unspecified Ap E A RANITIDINE d00021A D# K21 Gastro-esophageal reflux disease Ap E A SERTRALINE d00880A B F41.9 Anxiety disorder, unspecified Ap E A . . . E A . . . E 0 A . . . E @ A FLECAINIDE d00234A C- I48.9 Unspecified atrial fibrillation and atrial flutter A E P A . . . E ` A LOSARTAN d03821A Cr I10 Essential (primary) hypertension A E ` A SERTRALINE d00880A C[@ F33.9 Major depressive disorder, recurrent, unspecified A E p A LISINOPRIL d00732A CDp 99999 A` E p A METFORMIN d03807A CDp E11 Type 2 diabetes mellitus A` E p A METOPROLOL d00134A CDp I51.9P Prevent heart disease A` E p A POTASSIUM CHLORIDE d00345A CDp R60.9 Edema, unspecified A` E p A PRAVASTATIN d00348A CDp 99999 A` E p A TORSEMIDE d03189A CDp R60.9 Edema, unspecified A` E A . . . E A AMLODIPINE d00689A Dc I10 Essential (primary) hypertension Ap E A ATORVASTATIN d04105A D E78.0 Pure hypercholesterolemia Ap E A GLYBURIDE d00248A CDp E11 Type 2 diabetes mellitus Ap E A HYDROCHLOROTHIAZIDE d00253A Dc I10 Essential (primary) hypertension Ap E A METFORMIN d03807A C E11 Type 2 diabetes mellitus Ap E A METOPROLOL d00134A C- I10 Essential (primary) hypertension Ap E A OMEPRAZOLE d00325A C- K21 Gastro-esophageal reflux disease Ap E A . . . E A . . . E A LEVOTHYROXINE d00278A D1 E03.9 Hypothyroidism, unspecified A0 E A METFORMIN; PIOGLITAZONE d05635A Dc E11 Type 2 diabetes mellitus A0 E A SITAGLIPTIN d05896A C"0 E11 Type 2 diabetes mellitus A0 E A . . . E A . . . E A . . . E A AMOXICILLIN; CLAVULANATE d00089A A A49.9 Bacterial infection, unspecified A E A . . . E A SUMATRIPTAN d03160A CDp G43 Migraine A E 0 A . . . E @ A ALBUTEROL d00749A C[@ J45 Asthma A E P A . . . E ` A . . . E p A . . . E A CARVEDILOL d03847A C I21.P Prevent heart attack/myocardial infarction A0 E A ISOSORBIDE MONONITRATE d00269A D* I21.P Prevent heart attack/myocardial infarction A0 E A SIMVASTATIN d00746A D# E78.0 Pure hypercholesterolemia A0 E A MIRTAZAPINE d04025A B F32.9 F41.9 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified A E A . . . E A ALBUTEROL d00749A C J44.9 J45 Chronic obstructive pulmonary disease, unspecified Asthma B E A ALBUTEROL d00749A C R06.2 Wheezing B E A ASPIRIN d00170A D1 D75.9P Prevent blood clots B E A ATORVASTATIN d04105A Cr E78.0 Pure hypercholesterolemia B E A BUDESONIDE d04276A C J44.9 Chronic obstructive pulmonary disease, unspecified B E A CAPSAICIN TOPICAL d01321A C M79.2 Neuralgia and neuritis, unspecified B E A CARVEDILOL d03847A Cr I10 Essential (primary) hypertension B E A CLOPIDOGREL d04258A D I10 I51.9 Essential (primary) hypertension Heart disease, unspecified B E A CYCLOBENZAPRINE d00963A Cr M54 M62.83 Dorsalgia Muscle spasm B E A EMPAGLIFLOZIN d08275A B= E78.0 Pure hypercholesterolemia B E A ESCITALOPRAM d04812A Cr M79.2 Neuralgia and neuritis, unspecified B E A EZETIMIBE d04824A D9 E78.0 Pure hypercholesterolemia B E A FLUTICASONE NASAL d04283A D H57.9 Unspecified disorder of eye and adnexa B E A GABAPENTIN d03182A D9 M79.2 Neuralgia and neuritis, unspecified B E A INSULIN ASPART d04697A C E11 Type 2 diabetes mellitus B E A INSULIN GLARGINE d04538A C E11 Type 2 diabetes mellitus B E A ISOSORBIDE MONONITRATE d00269A D9 I51.9 Heart disease, unspecified B E A METFORMIN d03807A D9 E11 Type 2 diabetes mellitus B E A OMEPRAZOLE d00325A D9 K22 K25 Other diseases of esophagus Gastric ulcer B E A RANOLAZINE d05719A D* I51.9 Heart disease, unspecified B E A SERTRALINE d00880A CDp F41.9 Anxiety disorder, unspecified B E A TRAZODONE d00395A Cr G47.0 Insomnia B E A AMPHETAMINE; DEXTROAMPHETAMINE d04035A B F90 Attention-deficit hyperactivity disorders A E A PHENTERMINE d00806A C E66 R41 Overweight and obesity Other symptoms and signs involving cognitive functions and awareness A E A ATOMOXETINE d04827A B F39 Unspecified mood [affective] disorder A E A GUANFACINE d00717A C I10 Essential (primary) hypertension A E A . . . E A AMOXICILLIN; CLAVULANATE d00089A A J01.9 Acute sinusitis, unspecified A E A AMLODIPINE d00689A0 Dc I10 Essential (primary) hypertension A` E A ATORVASTATIN d04105A0 Dc E78.0 Pure hypercholesterolemia A` E A CLOPIDOGREL d04258A0 D D75.9P Prevent blood clots A` E A METFORMIN d03807A0 CDp E11 Type 2 diabetes mellitus A` E A NIACIN d00314A0 Dc E78.0 Pure hypercholesterolemia A` E A PAROXETINE d03157A0 Dc F41.9 Anxiety disorder, unspecified A` E A . . . E A MINOCYCLINE d00110A A L70 Acne A0 E A NORETHINDRONE d00555A C"0 Z79.3 Long term (current) use of hormonal contraceptives A0 E A PREDNISONE d00350A Ap R21 Rash and other nonspecific skin eruption A0 E 0 A LACOSAMIDE d07349A Bz G40 Epilepsy and recurrent seizures A E 0 A LEVETIRACETAM d04499A C- G40 Epilepsy and recurrent seizures A E @ A CLONIDINE d00044A B I10 Essential (primary) hypertension A E P A . . . E ` A ATORVASTATIN d04105A D# E78.0 Pure hypercholesterolemia A0 E ` A HYDROCHLOROTHIAZIDE; IRBESARTAN d04245A D"8 I10 Essential (primary) hypertension A0 E ` A METOPROLOL d00134A D"8 I49.9 Cardiac arrhythmia, unspecified A0 E p A . . . E A . . . E A . . . E A . . . E A LISINOPRIL d00732A C I10 Essential (primary) hypertension A E A . . . E A . . . E A . . . E A ATORVASTATIN d04105A C- I70.P Prevent atherosclerosis Ap E A DILTIAZEM d00045A C- I49.9 Cardiac arrhythmia, unspecified Ap E A FLECAINIDE d00234A C- I10 Essential (primary) hypertension Ap E A FLUTICASONE NASAL d04283A C- J30.9 Allergic rhinitis, unspecified Ap E A FUROSEMIDE d00070A C- E78.0 Pure hypercholesterolemia Ap E A LISINOPRIL d00732A C9 I10 Essential (primary) hypertension Ap E A POTASSIUM CHLORIDE d00345A C- I51.9P Prevent heart disease Ap E A AMLODIPINE d00689A C[@ I10 Essential (primary) hypertension A0 E A METOPROLOL d00134A C[@ I10 Essential (primary) hypertension A0 E A PRAVASTATIN d00348A C[@ E78.0 Pure hypercholesterolemia A0 E A . . . E A . . . E 0 A ALBUTEROL d00749A C J45 Asthma A E 0 A ALPRAZOLAM d00168A D& F41.9 Anxiety disorder, unspecified A E 0 A AMLODIPINE d00689A C I10 Essential (primary) hypertension A E 0 A GABAPENTIN d03182A CDp M79.7 Fibromyalgia A E 0 A GEMFIBROZIL d00245A C E78.0 Pure hypercholesterolemia A E 0 A HYDROCHLOROTHIAZIDE d00253A Cr I10 R60.9 Essential (primary) hypertension Edema, unspecified A E 0 A HYDROCODONE d03075A D& T14.9 Unspecified injury A E 0 A OMEPRAZOLE d00325A C K21 Gastro-esophageal reflux disease A E 0 A PRAZOSIN d00138A Cr I10 Essential (primary) hypertension A E 0 A RANITIDINE d00021A C K21 Gastro-esophageal reflux disease A E 0 A SERTRALINE d00880A D# F41.9 Anxiety disorder, unspecified A E 0 A TIOTROPIUM d04829A C J45 Asthma A E 0 A TIZANIDINE d04102A C[@ M79.7 Fibromyalgia A E 0 A ZOLPIDEM d00910A C F41.9 Anxiety disorder, unspecified A E @ A . . . E P A CLINDAMYCIN d00043A AP K04.7 Periapical abscess without sinus A0 E P A PREDNISONE d00350A0 AP B02 R52 Zoster [herpes zoster] Pain, unspecified A0 E P A VALACYCLOVIR d03838A0 A B02 Zoster [herpes zoster] A0 E ` A CLONAZEPAM d00197A B F33.9 F41.9 Major depressive disorder, recurrent, unspecified Anxiety disorder, unspecified A@ E ` A LAMOTRIGINE d03809A B F33.9 F41.9 Major depressive disorder, recurrent, unspecified Anxiety disorder, unspecified A@ E ` A LOVASTATIN d00280A B E78.0 I99.9 Pure hypercholesterolemia Unspecified disorder of circulatory system A@ E ` A QUETIAPINE d04220A B G47.0 Insomnia A@ E p A . . . E A ATORVASTATIN d04105A CP E78.0 Pure hypercholesterolemia A E A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A C I10 Essential (primary) hypertension A E A ALBUTEROL d00749A C J45 Asthma A0 E A FLUTICASONE d01296A C J45 Asthma A0 E A MONTELUKAST d04289A C J45 Asthma A0 E A . . . E ° A ATORVASTATIN d04105A C- E78.0 Pure hypercholesterolemia A` E ° A GABAPENTIN d03182A C"0 M54 Dorsalgia A` E ° A HYDROCHLOROTHIAZIDE d00253A C- I10 Essential (primary) hypertension A` E ° A LISINOPRIL d00732A C[@ I10 Essential (primary) hypertension A` E ° A TRAMADOL d03826A C"0 M54 Dorsalgia A` E ° A VALACYCLOVIR d03838A C A60.9 Anogenital herpesviral infection, unspecified A` E A . . . E A AMLODIPINE d00689A D I10 Essential (primary) hypertension A@ E A GLIMEPIRIDE d03864A D% E11 Type 2 diabetes mellitus A@ E A METFORMIN d03807A D' E11 Type 2 diabetes mellitus A@ E A VALSARTAN d04113A Bz I10 Essential (primary) hypertension A@ E A . . . E A ANTI-INFECTIVES - UNSPECIFIED c00001A A H66.9 Otitis media, unspecified A E A RANITIDINE d00021A B[ K21 Gastro-esophageal reflux disease A E A . . . E A IBUPROFEN d00015A B M54 Dorsalgia A E 0 A ATORVASTATIN d04105A Cr E78.0 Pure hypercholesterolemia A E 0 A HYDROCHLOROTHIAZIDE d00253A Cr I10 Essential (primary) hypertension A E @ A . . . E P A . . . E ` A ATORVASTATIN d04105A CDp E78.0 Pure hypercholesterolemia A0 E ` A LEVOTHYROXINE d00278A C 99999 A0 E ` A LOSARTAN d03821A CDp I10 Essential (primary) hypertension A0 E p A APIXABAN d07804A C D75.9P Prevent blood clots Ap E p A CARVEDILOL d03847A C- I99.9 Unspecified disorder of circulatory system Ap E p A FUROSEMIDE d00070A CDp I51.9 Heart disease, unspecified Ap E p A GLIPIZIDE d00246A C E11 Type 2 diabetes mellitus Ap E p A HYDRALAZINE d00132A C- R60.9 Edema, unspecified Ap E p A ISOSORBIDE DINITRATE d00268A C- 99999 Ap E p A METOLAZONE d00299A C- R60.9 Edema, unspecified Ap E À A . . . E Ð A . . . E à A . . . E ð A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E A ATORVASTATIN d04105A CDp E78.0 Pure hypercholesterolemia A E 0 A . . . E @ A . . . E P A . . . E ` A METHYLPHENIDATE d00900A Cr F90 Attention-deficit hyperactivity disorders A E p A ATORVASTATIN d04105A Cr E78.0 Pure hypercholesterolemia A E Ā A ALBUTEROL d00749A C J45 Asthma A E Ā A AMLODIPINE d00689A C I10 Essential (primary) hypertension A E Đ A FLUTICASONE; SALMETEROL d04611A A R05 Cough A E Đ A METOPROLOL d00134A C I10 Essential (primary) hypertension A E Ġ A MUPIROCIN TOPICAL d01267A A L98.9 Disorder of the skin and subcutaneous tissue, unspecified A E İ A ETHINYL ESTRADIOL; NORGESTIMATE d03781A C"0 N92 Z79.3 Excessive, frequent and irregular menstruation Long term (current) use of hormonal contraceptives A E A . . . E A . . . E A . . . E A ACETAMINOPHEN; HYDROCODONE d03428A Bz M25.5 Pain in joint A E A CARVEDILOL d03847A C R07.9 Chest pain, unspecified A E A GABAPENTIN d03182A CDp E11.4 Type 2 diabetes mellitus with neurological complications A E A GLIPIZIDE d00246A D E11 Type 2 diabetes mellitus A E A ISOSORBIDE MONONITRATE d00269A C I20.9 I21.P R07.9 Angina pectoris, unspecified Prevent heart attack/myocardial infarction Chest pain, unspecified A E A LISINOPRIL d00732A D I10 Essential (primary) hypertension A E A METFORMIN d03807A C[@ E11 Type 2 diabetes mellitus A E A NIACIN d00314A CP E78.0 Pure hypercholesterolemia A E A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia A E A . . . E A ETHINYL ESTRADIOL; NORGESTREL d03241A C N92 Z79.3 Excessive, frequent and irregular menstruation Long term (current) use of hormonal contraceptives A E 0 A METHYLPHENIDATE d00900A C[@ F90 Attention-deficit hyperactivity disorders A E @ A . . . E P A LEVOTHYROXINE d00278A D= E03.9 Hypothyroidism, unspecified A E P A LOSARTAN d03821A D I10 Essential (primary) hypertension A E ` A . . . E p A . . . E ŀ A . . . E Ő A LISINOPRIL d00732A C I10 Essential (primary) hypertension A E Š A RANITIDINE d00021A B K21 Gastro-esophageal reflux disease A E Ű A . . . E A . . . E A ALENDRONATE d03849A C M81 Osteoporosis without current pathological fracture A E A LISINOPRIL d00732A C I10 Essential (primary) hypertension A E A PROPRANOLOL d00032A B[ G43 Migraine A E A HYDROCHLOROTHIAZIDE d00253A C I10 Essential (primary) hypertension A E A LISINOPRIL d00732A C I10 Essential (primary) hypertension A E A . . . E A . . . E A CIPROFLOXACIN; DEXAMETHASONE OTIC d04890A A H60 Otitis externa A E 0 A . . . E @ A . . . E P A . . . E ` A . . . E p A . . . E ƀ A ALBUTEROL d00749A C J45 R06.2 R07.9 Asthma Wheezing Chest pain, unspecified A E ƀ A FLUTICASONE NASAL d04283A Cr J30.2 J30.9 R09.81 Other seasonal allergic rhinitis Allergic rhinitis, unspecified Nasal congestion A E Ɛ A . . . E Ơ A . . . E ư A . . . E A ALBUTEROL d00749A D* J45 Asthma A E A BUDESONIDE; FORMOTEROL d04795A C[@ J45 Asthma A E A FENOFIBRATE d04286A C- E78.0 Pure hypercholesterolemia A E A HYDROCHLOROTHIAZIDE d00253A C I10 Essential (primary) hypertension A E A LOSARTAN d03821A C I10 Essential (primary) hypertension A E A MEMANTINE d04899A C- R41 Other symptoms and signs involving cognitive functions and awareness A E A MONTELUKAST d04289A Cr J42 J45 R06.9 Unspecified chronic bronchitis Asthma Unspecified abnormalities of breathing A E A PREDNISONE d00350A D* J45 Asthma A E A ALENDRONATE d03849A C- M81 Osteoporosis without current pathological fracture A@ E A AMLODIPINE d00689A D3T I10 Essential (primary) hypertension A@ E A DOXAZOSIN d00726A D3T I10 Essential (primary) hypertension A@ E A SIMVASTATIN d00746A D3T E78.0 Pure hypercholesterolemia A@ E A . . . E A . . . E A APIXABAN d07804A B I21.P Prevent heart attack/myocardial infarction A E A CLOPIDOGREL d04258A B 99999 A E A FAMOTIDINE d00141A B 99999 A E A FUROSEMIDE d00070A B 99999 A E A INSULIN GLARGINE d04538A B E11 Type 2 diabetes mellitus A E A INSULIN LISPRO d04373A B E11 Type 2 diabetes mellitus A E A SIMVASTATIN d00746A B 99999 A E A SPIRONOLACTONE d00373A B N28.9 Disorder of kidney and ureter, unspecified A E A TAMSULOSIN d04121A B 99999 A E A . . . E A ATORVASTATIN d04105A Bz E78.0 Pure hypercholesterolemia AP E A HYDROXYZINE d00907A C- F41.9 Anxiety disorder, unspecified AP E A LURASIDONE d07705A C- F39 Unspecified mood [affective] disorder AP E A SERTRALINE d00880A CDp F32.9 Major depressive disorder, single episode, unspecified AP E A TAMOXIFEN d00381A B C50 Malignant neoplasm of breast AP E 0 A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia AP E 0 A DOXYCYCLINE d00037A B B99.9 Unspecified infectious disease AP E 0 A ENALAPRIL d00013A C I10 Essential (primary) hypertension AP E 0 A INSULIN ASPART; INSULIN ASPART PROTAMINE d04839A C- E11 Type 2 diabetes mellitus AP E 0 A MELOXICAM d04532A C[@ M79.1 R52 Myalgia Pain, unspecified AP E @ A . . . E P A LISDEXAMFETAMINE d06663A B F90 Attention-deficit hyperactivity disorders A E ` A ATORVASTATIN d04105A Ei E78.0 Pure hypercholesterolemia AP E ` A HYDROCHLOROTHIAZIDE d00253A B[ I10 Essential (primary) hypertension AP E ` A LEVOTHYROXINE d00278A C[@ E03.9 Hypothyroidism, unspecified AP E ` A LISINOPRIL d00732A C"0 I10 Essential (primary) hypertension AP E ` A RABEPRAZOLE d04448A C K21 Gastro-esophageal reflux disease AP E p A AMLODIPINE d00689A C I63.P Prevent stroke A` E p A CHLORTHALIDONE d00192A Cr I10 Essential (primary) hypertension A` E p A LINAGLIPTIN d07767A C E11 Type 2 diabetes mellitus A` E p A LISINOPRIL d00732A C I10 Essential (primary) hypertension A` E p A METFORMIN d03807A C E11 Type 2 diabetes mellitus A` E p A ROSUVASTATIN d04851A C E78.0 Pure hypercholesterolemia A` E ǀ A LISINOPRIL d00732A C I10 Essential (primary) hypertension A0 E ǀ A METFORMIN d03807A C- M19.9 Osteoarthritis, unspecified site A0 E ǀ A SIMVASTATIN d00746A C[@ E78.0 Pure hypercholesterolemia A0 E ǐ A . . . E Ǡ A ALLOPURINOL d00023A Cr M1A Chronic gout A@ E Ǡ A HYDROCHLOROTHIAZIDE; LOSARTAN d03830A Cr I10 Essential (primary) hypertension A@ E Ǡ A METFORMIN d03807A Cr E11 R73 Type 2 diabetes mellitus Elevated blood glucose level A@ E Ǡ A SIMVASTATIN d00746A Cr E78.0 Pure hypercholesterolemia A@ E ǰ A . . . E A ALBUTEROL d00749A C- J45 Asthma A0 E A AMPHETAMINE; DEXTROAMPHETAMINE d04035A C F90 Attention-deficit hyperactivity disorders A0 E A BUDESONIDE; FORMOTEROL d04795A C[@ J45 Asthma A0 E A ALBUTEROL d00749A D J45 Asthma A E A DILTIAZEM d00045A C[@ I10 Essential (primary) hypertension A E A FLUTICASONE; SALMETEROL d04611A D J45 Asthma A E A HYDROCHLOROTHIAZIDE; TRIAMTERENE d03052A Cr I10 Essential (primary) hypertension A E A MONTELUKAST d04289A Cr J45 Asthma A E A OMEPRAZOLE d00325A Dc K21 Gastro-esophageal reflux disease A E A PENTOXIFYLLINE d00336A C[@ I70 Atherosclerosis A E A TRAMADOL d03826A CDp M54 M79.6 Dorsalgia Pain in limb, hand, foot, fingers and toes A E A . . . E A . . . E A ALBUTEROL d00749A C R06.02 Shortness of breath A@ E A FINASTERIDE d00563A C N40 Enlarged prostate A@ E A FLUTICASONE d01296A C J45 Asthma A@ E A TAMSULOSIN d04121A C N40 Enlarged prostate A@ E A . . . E A HYDROCORTISONE TOPICAL d03205A Bz L20.9 Atopic dermatitis, unspecified A E 0 A . . . E @ A . . . E P A INSULIN DETEMIR d05436A B E11 Type 2 diabetes mellitus A0 E P A METFORMIN d03807A B E11 Type 2 diabetes mellitus A0 E P A SIMVASTATIN d00746A C E11 Type 2 diabetes mellitus A0 E ` A ATAZANAVIR d04882A0 D# B20 Human immunodeficiency virus [HIV] disease A0 E ` A EMTRICITABINE; TENOFOVIR d05352A0 D# B20 Human immunodeficiency virus [HIV] disease A0 E ` A RITONAVIR d03984A0 D# B20 Human immunodeficiency virus [HIV] disease A0 E p A . . . E Ȁ A . . . E Ȑ A FLECAINIDE d00234A CDp I49.9 Cardiac arrhythmia, unspecified A` E Ȑ A HYDROCHLOROTHIAZIDE d00253A D I10 Essential (primary) hypertension A` E Ȑ A LISINOPRIL d00732A D I10 Essential (primary) hypertension A` E Ȑ A METFORMIN d03807A D E11 Type 2 diabetes mellitus A` E Ȑ A PRAVASTATIN d00348A D E78.0 Pure hypercholesterolemia A` E Ȑ A RIVAROXABAN d07356A CDp I49.9 Cardiac arrhythmia, unspecified A` E Ƞ A ALLOPURINOL d00023A C M1A Chronic gout A E Ƞ A CITALOPRAM d04332A D F41.9 Anxiety disorder, unspecified A E Ƞ A CYANOCOBALAMIN d00413A D D64.9 Anemia, unspecified A E Ƞ A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A D I10 Essential (primary) hypertension A E Ƞ A LABETALOL d00016A B I10 Essential (primary) hypertension A E Ƞ A OMEPRAZOLE d00325A D K21 Gastro-esophageal reflux disease A E Ƞ A POTASSIUM CHLORIDE d00345A D E87.6 Hypokalemia A E Ƞ A SIMVASTATIN d00746A D E78.0 Pure hypercholesterolemia A E Ƞ A TAMSULOSIN d04121A D N40 Enlarged prostate A E Ȱ A ATORVASTATIN d04105A B E78.0 Pure hypercholesterolemia A@ E Ȱ A GLIPIZIDE d00246A B R73 Elevated blood glucose level A@ E Ȱ A LINAGLIPTIN d07767A B E11 Type 2 diabetes mellitus A@ E Ȱ A METFORMIN d03807A C E11 Type 2 diabetes mellitus A@ E A . . . E A . . . E A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A0 E A CYCLOSPORINE OPHTHALMIC d04836A C"0 H04 Disorders of lacrimal system A0 E A LOSARTAN d03821A BZ I10 Essential (primary) hypertension A0 E A . . . E A . . . E A . . . E A . . . E 0 A . . . E @ A . . . E P A . . . E ` A . . . E p A . . . E ɀ A . . . E ɐ A . . . E ɠ A . . . E ɰ A . . . E A . . . E A LOSARTAN d03821A Cr I10 Essential (primary) hypertension A E A SIMVASTATIN d00746A Cr E78.0P Prevent high cholesterol A E A . . . E A . . . E A . . . E A . . . E A . . . E 0 A ALBUTEROL d00749A B R06.02 R06.9P Shortness of breath Prevent breathing difficulty A0 E 0 A CHLORTHALIDONE d00192A B I10 Essential (primary) hypertension A0 E 0 A FLUTICASONE d01296A B R06.9 Unspecified abnormalities of breathing A0 E @ A . . . E P A . . . E ` A NEBIVOLOL d05265A C[@ I10 Essential (primary) hypertension A E ` A SERTRALINE d00880A C F32.9 Major depressive disorder, single episode, unspecified A E p A HYDROCHLOROTHIAZIDE; VALSARTAN d04293A D I10 Essential (primary) hypertension A0 E p A NIACIN d00314A C E78.0 Pure hypercholesterolemia A0 E p A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia A0 E ʀ A . . . E ʐ A ALLOPURINOL d00023A C- M1A Chronic gout A E ʐ A AMLODIPINE d00689A CDp I10 Essential (primary) hypertension A E ʐ A ATORVASTATIN d04105A Cr E78.0 Pure hypercholesterolemia A E ʐ A CARVEDILOL d03847A C- I10 Essential (primary) hypertension A E ʐ A CYCLOSPORINE OPHTHALMIC d04836A C- H04 Disorders of lacrimal system A E ʐ A FUROSEMIDE d00070A Cr R60.9 Edema, unspecified A E ʐ A HYDRALAZINE d00132A B= I10 Essential (primary) hypertension A E ʐ A LISINOPRIL d00732A C[@ I10 Essential (primary) hypertension A E ʐ A METHIMAZOLE d00290A CDp E05 Thyrotoxicosis [hyperthyroidism] A E ʐ A TRAVOPROST OPHTHALMIC d04753A Cr H40 Glaucoma A E ʠ A . . . E ʰ A . . . E A . . . E A . . . E A NAPROXEN d00019A C I10 Essential (primary) hypertension A E A . . . E A . . . E A . . . E A . . . E 0 A MINOCYCLINE d00110A B L70 Acne A E 0 A SPIRONOLACTONE d00373A B L70 Acne A E @ A ALENDRONATE d03849A C M81.P Prevent bone loss/osteoporosis A E @ A METFORMIN d03807A D E11 Type 2 diabetes mellitus A E P A BENAZEPRIL d00730A CDp I10 Essential (primary) hypertension A0 E P A HYDROCHLOROTHIAZIDE; SPIRONOLACTONE d03247A C[@ I10 Essential (primary) hypertension A0 E P A METOPROLOL d00134A C I10 Essential (primary) hypertension A0 E ` A BACLOFEN d00967A B 55555 A@ E ` A GABAPENTIN d03182A A M85.9 Disorder of bone density and structure, unspecified A@ E ` A LEVOTHYROXINE d00278A CP E03.9 Hypothyroidism, unspecified A@ E ` A TEMAZEPAM d00384A A` G47.0 Insomnia A@ E p A . . . E ˀ A . . . E ː A . . . E ˠ A BETHANECHOL d01427A B[ 99999 A E ˠ A LANSOPRAZOLE d03828A B[ K21 Gastro-esophageal reflux disease A E ˰ A MECLIZINE d00859A Cr R42 Dizziness and giddiness A E A . . . E A . . . E A AMOXICILLIN d00088A A J42 Unspecified chronic bronchitis A E A CETIRIZINE d03827A A J30.9 Allergic rhinitis, unspecified A E A INSULIN GLARGINE d04538A D E11 Type 2 diabetes mellitus A E A TAMSULOSIN d04121A C N40 Enlarged prostate A E A DICLOFENAC; MISOPROSTOL d04271A Cr M19.9 Osteoarthritis, unspecified site AP E A FUROSEMIDE d00070A D# R60.9 Edema, unspecified AP E A GABAPENTIN d03182A C- M79.2 Neuralgia and neuritis, unspecified AP E A METOPROLOL d00134A D I10 Essential (primary) hypertension AP E A POTASSIUM CHLORIDE d00345A Cr E87.6 Hypokalemia AP E A METHYLPHENIDATE d00900A C F90 Attention-deficit hyperactivity disorders A E A . . . E 0 A . . . E @ A FUROSEMIDE d00070A Cr I10 Essential (primary) hypertension A0 E @ A HYDROCHLOROTHIAZIDE d00253A C I10 Essential (primary) hypertension A0 E @ A LEVOTHYROXINE d00278A D E03.9 Hypothyroidism, unspecified A0 E P A ACETAMINOPHEN; OXYCODONE d03431A Cr G43 Migraine A E P A ALBUTEROL d00749A D J45 Asthma A E P A FLUTICASONE NASAL d04283A D J30.2 Other seasonal allergic rhinitis A E P A LINACLOTIDE d07902A C"0 K59.0 Constipation A E P A MELOXICAM d04532A C M13 Other arthritis A E P A OMEPRAZOLE d00325A C K21 Gastro-esophageal reflux disease A E P A SUMATRIPTAN d03160A Cr G43 Migraine A E P A TRAZODONE d00395A C G47.9 Sleep disorder, unspecified A E ` A METFORMIN d03807A C[@ E11.P R73 Prevent diabetes Elevated blood glucose level A E p A . . . E ̀ A ATENOLOL d00004A Dc I10 Essential (primary) hypertension AP E ̀ A HYDROCHLOROTHIAZIDE d00253A Dc I10 Essential (primary) hypertension AP E ̀ A LEVOTHYROXINE d00278A Dc E03.9 Hypothyroidism, unspecified AP E ̀ A METFORMIN d03807A C- E11 Type 2 diabetes mellitus AP E ̀ A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia AP E ̐ A . . . E ̠ A BUPROPION d00181A C F32.9 Major depressive disorder, single episode, unspecified AP E ̠ A CLOPIDOGREL d04258A D I99.9 Unspecified disorder of circulatory system AP E ̠ A EZETIMIBE d04824A D E78.0 Pure hypercholesterolemia AP E ̠ A OMEGA-3 POLYUNSATURATED FATTY ACIDS d00497A D E78.0 Pure hypercholesterolemia AP E ̠ A SIMVASTATIN d00746A C- E78.0 Pure hypercholesterolemia AP E ̰ A . . . E A . . . E A BUPROPION d00181A Dc F32.9 F41.9 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified A@ E A MIRTAZAPINE d04025A Dc G47.9 Sleep disorder, unspecified A@ E A PRAVASTATIN d00348A C E78.0 Pure hypercholesterolemia A@ E A RAMIPRIL d00728A D* I10 Essential (primary) hypertension A@ E A LISINOPRIL d00732A C- I10 Essential (primary) hypertension A E A . . . E A . . . E A . . . E A . . . E 0 A CARBIDOPA d00184A CDp G20 Parkinson's disease A0 E 0 A LOSARTAN d03821A C I10 Essential (primary) hypertension A0 E 0 A PRAVASTATIN d00348A C E78.0 Pure hypercholesterolemia A0 E @ A . . . E P A ALBUTEROL d00749A B* B34.9 Viral infection, unspecified A E P A AMOXICILLIN; CLAVULANATE d00089A A H66.9 Otitis media, unspecified A E ` A BACLOFEN d00967A C 99999 A E ` A IBUPROFEN d00015A C M54 Dorsalgia A E ` A LISINOPRIL d00732A C 99999 A E ` A METFORMIN d03807A C E11 Type 2 diabetes mellitus A E ` A METOPROLOL d00134A C 99999 A E ` A OMEPRAZOLE d00325A B R12 Heartburn A E ` A QUETIAPINE d04220A C 99999 A E ` A RISPERIDONE d03180A C 99999 A E ` A TRAZODONE d00395A C G47.9 Sleep disorder, unspecified A E p A LISDEXAMFETAMINE d06663A B F90 Attention-deficit hyperactivity disorders A E ̀ A . . . E ͐ A . . . E ͠ A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia AP E ͠ A CANAGLIFLOZIN; METFORMIN d08280A B E11 R73 Type 2 diabetes mellitus Elevated blood glucose level AP E ͠ A FLUTICASONE NASAL d04283A C H93.9 Unspecified disorder of ear AP E ͠ A GLIPIZIDE d00246A C R73 Elevated blood glucose level AP E ͠ A IBUPROFEN d00015A B= M79.6 Pain in limb, hand, foot, fingers and toes AP E Ͱ A . . . E A . . . E A . . . E A ATORVASTATIN d04105A Dc E78.0 Pure hypercholesterolemia A` E A DIPYRIDAMOLE d00213A C D75.9P Prevent blood clots A` E A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A D# I10 Essential (primary) hypertension A` E A OMEGA-3 POLYUNSATURATED FATTY ACIDS d00497A C E78.1 Pure hyperglyceridemia A` E A OMEPRAZOLE d00325A D K21 Gastro-esophageal reflux disease A` E A TRAMADOL d03826A D M19.9 Osteoarthritis, unspecified site A` E A . . . E A . . . E A ALBUTEROL; IPRATROPIUM d04066A C R06.2 R06.9P Wheezing Prevent breathing difficulty A E A FLUTICASONE; SALMETEROL d04611A C R06.9 Unspecified abnormalities of breathing A E A . . . E 0 A . . . E @ A ASPIRIN d00170A C"0 55555 AP E @ A ENALAPRIL d00013A B 55555 AP E @ A LEVOTHYROXINE d00278A C$ E03.9 Hypothyroidism, unspecified AP E @ A OMEPRAZOLE d00325A C K21 Gastro-esophageal reflux disease AP E @ A RANITIDINE d00021A C K21 Gastro-esophageal reflux disease AP E P A AMOXICILLIN d00088A Ap J03 Acute tonsillitis A E ` A INSULIN ASPART d04697A Cr E10 Type 1 diabetes mellitus A E ` A INSULIN DEGLUDEC d08054A Cr E10 Type 1 diabetes mellitus A E p A . . . E A DONEPEZIL d04099A B R41 Other symptoms and signs involving cognitive functions and awareness A E A FLUCONAZOLE d00071A B B35 Dermatophytosis A E ΐ A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A E ΐ A METHIMAZOLE d00290A B E05 Thyrotoxicosis [hyperthyroidism] A E Π A LISINOPRIL d00732A Cr I10 Essential (primary) hypertension A0 E Π A METOPROLOL d00134A CDp I10 Essential (primary) hypertension A0 E Π A PROCHLORPERAZINE d00355A B[ R11 Nausea and vomiting A0 E ΰ A . . . E A . . . E A ETHINYL ESTRADIOL; NORGESTIMATE d03781A Cr Z79.3 Long term (current) use of hormonal contraceptives A E A ALBUTEROL d00749A C[@ J45 Asthma A E A ATORVASTATIN d04105A C[@ E78.0 Pure hypercholesterolemia A E A BUPROPION d00181A Cr F32.9 Major depressive disorder, single episode, unspecified A E A DIAZEPAM d00148A Cr F41.9 Anxiety disorder, unspecified A E A FLUTICASONE; SALMETEROL d04611A C[@ J98.9 Respiratory disorder, unspecified A E A LEVETIRACETAM d04499A C R25.1 Tremor, unspecified A E A MORPHINE d00308A CP R52 Pain, unspecified A E A MORPHINE d00308A CP M25.5 Pain in joint A E A OMEPRAZOLE d00325A C K31.9 Disease of stomach and duodenum, unspecified A E A SERTRALINE d00880A Cr F32.9 Major depressive disorder, single episode, unspecified A E A CLINDAMYCIN d00043A Ap H57.9 Unspecified disorder of eye and adnexa A E A TOBRAMYCIN OPHTHALMIC d03222A Ap H57.9 Unspecified disorder of eye and adnexa A E A . . . E A EXEMESTANE d04461A B[ C50 Malignant neoplasm of breast A E A ZOLPIDEM d00910A D G47.0 Insomnia A E A . . . E 0 A . . . E @ A . . . E P A . . . E ` A ALBUTEROL d00749A CDp J45 Asthma A E ` A AMLODIPINE d00689A C- I10 Essential (primary) hypertension A E ` A BUDESONIDE; FORMOTEROL d04795A CDp J45 Asthma A E ` A CLONAZEPAM d00197A C F41.9 Anxiety disorder, unspecified A E ` A HYDROCHLOROTHIAZIDE; LOSARTAN d03830A C I10 Essential (primary) hypertension A E ` A MOMETASONE NASAL d04223A CDp J30.9 Allergic rhinitis, unspecified A E ` A MONTELUKAST d04289A CDp J45 R06.2 Asthma Wheezing A E ` A TIOTROPIUM d04829A B J45 R06.2 Asthma Wheezing A E ` A VILAZODONE d07740A Cr F32.9 Major depressive disorder, single episode, unspecified A E p A ALBUTEROL d00749A A R06.9 Unspecified abnormalities of breathing A E π A . . . E ϐ A . . . E Ϡ A . . . E ϰ A . . . E A AMLODIPINE d00689A C I10 Essential (primary) hypertension A E A FLUOXETINE d00236A C- F32.9 F41.9 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified A E A . . . E A AMITRIPTYLINE d00146A C G43 Migraine A` E A BACLOFEN d00967A B M54 Dorsalgia A` E A METOPROLOL d00134A B= R00 Abnormalities of heart beat A` E A PANTOPRAZOLE d04514A C K21 R12 Gastro-esophageal reflux disease Heartburn A` E A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia A` E A VENLAFAXINE d03181A C F32.9 Major depressive disorder, single episode, unspecified A` E A . . . E A . . . E A . . . E A ANTIHISTAMINES - UNSPECIFIED c00123A B L20.9 Atopic dermatitis, unspecified A E A PIMECROLIMUS TOPICAL d04784A B L20.9 Atopic dermatitis, unspecified A E 0 A . . . E @ A . . . E P A . . . E ` A . . . E p A . . . E Ѐ A . . . E А A CETIRIZINE d03827A B T78.40 Allergy, unspecified A E А A PRAVASTATIN d00348A C E78.0 Pure hypercholesterolemia A E Р A . . . E а A . . . E A . . . E A . . . E A LAMOTRIGINE d03809A C[@ G40 Epilepsy and recurrent seizures A E A ETHINYL ESTRADIOL; NORGESTIMATE d03781A C"0 Z79.3 Long term (current) use of hormonal contraceptives A E A . . . E A TESTOSTERONE d00558A Cr M81 Osteoporosis without current pathological fracture A E A ETHINYL ESTRADIOL; LEVONORGESTREL d03242A C) Z79.3 Long term (current) use of hormonal contraceptives A E A MONTELUKAST d04289A C) J45 Asthma A E 0 A . . . E @ A . . . E P A . . . E ` A DONEPEZIL d04099A Ei G31.9 R41 Degenerative disease of nervous system, unspecified Other symptoms and signs involving cognitive functions and awareness AP E ` A DULOXETINE d05355A Ei N39.4 Other specified urinary incontinence AP E ` A LEVOTHYROXINE d00278A Ei E03.9 Hypothyroidism, unspecified AP E ` A METFORMIN d03807A Ei E11 Type 2 diabetes mellitus AP E ` A PIOGLITAZONE d04442A Ei E11 Type 2 diabetes mellitus AP E p A . . . E р A LISINOPRIL d00732A C- I10 Essential (primary) hypertension A E ѐ A ALBUTEROL d00749A Ap J20.9 J42 Acute bronchitis, unspecified Unspecified chronic bronchitis A E Ѡ A DIPHENHYDRAMINE d00212A CDp 99999 Ap E Ѡ A DONEPEZIL d04099A CDp 99999 Ap E Ѡ A FINASTERIDE d00563A Cr 99999 Ap E Ѡ A FLUTICASONE NASAL d04283A CDp 99999 Ap E Ѡ A PRAVASTATIN d00348A C9 99999 Ap E Ѡ A RISPERIDONE d03180A C- 99999 Ap E Ѡ A TAMSULOSIN d04121A B 99999 Ap E Ѱ A AMLODIPINE d00689A C I10 Essential (primary) hypertension Ap E Ѱ A GLIPIZIDE d00246A C E11 Type 2 diabetes mellitus Ap E Ѱ A LOSARTAN d03821A C I10 Essential (primary) hypertension Ap E Ѱ A METFORMIN d03807A C E11 Type 2 diabetes mellitus Ap E Ѱ A PANTOPRAZOLE d04514A C K30 Functional dyspepsia Ap E Ѱ A PRAVASTATIN d00348A C E78.0 Pure hypercholesterolemia Ap E Ѱ A TAMSULOSIN d04121A C N40 Enlarged prostate Ap E A ACETAMINOPHEN; HYDROCODONE d03428A C M79.6 Pain in limb, hand, foot, fingers and toes A E A ALBUTEROL d00749A D' J42 Unspecified chronic bronchitis A E A CIPROFLOXACIN d00011A A N39.0 Urinary tract infection, site not specified A E A CLONIDINE d00044A C I10 Essential (primary) hypertension A E A ESCITALOPRAM d04812A D F32.9 Major depressive disorder, single episode, unspecified A E A GABAPENTIN d03182A B[ M79.2 Neuralgia and neuritis, unspecified A E A LEVOTHYROXINE d00278A D' E03.9 Hypothyroidism, unspecified A E A LORAZEPAM d00149A D G47.9 Sleep disorder, unspecified A E A METFORMIN d03807A C E11 Type 2 diabetes mellitus A E A PRAVASTATIN d00348A C E78.0 Pure hypercholesterolemia A E A TOPIRAMATE d04115A C G43 Migraine A E A FLUTICASONE; VILANTEROL d08100A Bz J98.9 Respiratory disorder, unspecified A E A MONTELUKAST d04289A C J45 Asthma A E A . . . E A . . . E A FLUTICASONE NASAL d04283A CDp R09.81 Nasal congestion A@ E A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A C I10 Essential (primary) hypertension A@ E A LEVOCETIRIZINE d05851A C R09.81 Nasal congestion A@ E A LOVASTATIN d00280A C E78.0 Pure hypercholesterolemia A@ E A . . . E A METOPROLOL d00134A C I10 Essential (primary) hypertension A E 0 A . . . E @ A . . . E P A . . . E ` A . . . E p A AMPHETAMINE; DEXTROAMPHETAMINE d04035A B= F90 Attention-deficit hyperactivity disorders A E Ҁ A . . . E Ґ A ALLOPURINOL d00023A CDp E79.9 Disorder of purine and pyrimidine metabolism, unspecified A E Ґ A ATORVASTATIN d04105A C[@ I21.P Prevent heart attack/myocardial infarction A E Ґ A COLCHICINE d00150A B[ E79.9 Disorder of purine and pyrimidine metabolism, unspecified A E Ґ A FINASTERIDE d00563A CDp N40 R39.1 Enlarged prostate Other difficulties with micturition A E Ґ A HYDROCHLOROTHIAZIDE d00253A Bz M10.9 Gout, unspecified A E Ґ A LANSOPRAZOLE d03828A D K21 Gastro-esophageal reflux disease A E Ґ A LISINOPRIL d00732A CDp I10 Essential (primary) hypertension A E Ґ A METOPROLOL d00134A CDp I10 Essential (primary) hypertension A E Ґ A TAMSULOSIN d04121A CDp N40 R32 Enlarged prostate Unspecified urinary incontinence A E Ҡ A ALPRAZOLAM d00168A C- G47.9 Sleep disorder, unspecified A E Ҡ A LIFITEGRAST OPHTHALMIC d08472A C- H04 Disorders of lacrimal system A E Ҡ A OLMESARTAN d04801A B I10 Essential (primary) hypertension A E Ҡ A PRAMIPEXOLE d04145A B G25.81 Restless legs syndrome A E Ҡ A RANITIDINE d00021A C K21 Gastro-esophageal reflux disease A E Ҡ A ROSUVASTATIN d04851A C- E78.0 Pure hypercholesterolemia A E Ҡ A TAMSULOSIN d04121A B N20.0 Calculus of kidney A E Ҡ A ZOLPIDEM d00910A Cr G47.0 Insomnia A E Ұ A . . . E A ATORVASTATIN d04105A C"0 E78.0 Pure hypercholesterolemia A E A DABIGATRAN d07137A C- D75.9P Prevent blood clots A E A DOCUSATE d01021A C"0 K59.0 Constipation A E A GABAPENTIN d03182A B M54 Dorsalgia A E A INSULIN GLARGINE d04538A C- R73 Elevated blood glucose level A E A LISINOPRIL d00732A C I10 Essential (primary) hypertension A E A METFORMIN d03807A C- R73 Elevated blood glucose level A E A METHOCARBAMOL d00965A B M62.83 Muscle spasm A E A METOPROLOL d00134A C- I10 Essential (primary) hypertension A E A OMEPRAZOLE d00325A C- K21 Gastro-esophageal reflux disease A E A SILDENAFIL d04299A Bz N52.9 Male erectile dysfunction, unspecified A E A . . . E A . . . E A ALBUTEROL d00749A C J44.9 J45 Chronic obstructive pulmonary disease, unspecified Asthma A E A ALBUTEROL d00749A D* J45 Asthma A E A ALLOPURINOL d00023A C- M10.9 Gout, unspecified A E A CITALOPRAM d04332A C F41.9 Anxiety disorder, unspecified A E A CLONIDINE d00044A C I10 Essential (primary) hypertension A E A FLUTICASONE d01296A D* J44.9 J45 Chronic obstructive pulmonary disease, unspecified Asthma A E A KETOCONAZOLE TOPICAL d03202A C B35 Dermatophytosis A E A LATANOPROST OPHTHALMIC d04017A Dc H40 Glaucoma A E A METOPROLOL d00134A C I10 Essential (primary) hypertension A E A RISPERIDONE d03180A CDp F32.9 Major depressive disorder, single episode, unspecified A E A SPIRONOLACTONE d00373A C- I10 Essential (primary) hypertension A E A TORSEMIDE d03189A D I10 Essential (primary) hypertension A E A . . . E A . . . E A . . . E 0 A . . . E @ A . . . E P A . . . E ` A AMLODIPINE d00689A C I10 I21.P N28.9P Essential (primary) hypertension Prevent heart attack/myocardial infarction Prevent kidney disease AP E ` A CARVEDILOL d03847A C I10 I21.P Essential (primary) hypertension Prevent heart attack/myocardial infarction AP E ` A HYDROCHLOROTHIAZIDE d00253A C I63.P N28.9P Prevent stroke Prevent kidney disease AP E ` A LOSARTAN d03821A C I10 I63.P Essential (primary) hypertension Prevent stroke AP E ` A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia AP E p A . . . E Ӏ A ACETAMINOPHEN; CODEINE d03423A A0 M79.6 Pain in limb, hand, foot, fingers and toes AP E Ӏ A GLYBURIDE; METFORMIN d04703A C E11 R73 Type 2 diabetes mellitus Elevated blood glucose level AP E Ӏ A LISINOPRIL d00732A C I10 Essential (primary) hypertension AP E Ӏ A PREDNISONE d00350A A0 M79.6 Pain in limb, hand, foot, fingers and toes AP E Ӏ A ROSUVASTATIN d04851A C E78.0 Pure hypercholesterolemia AP E Ӑ A CYCLOBENZAPRINE d00963A CDp M25.5 M79.1 Pain in joint Myalgia A` E Ӑ A DULOXETINE d05355A C M79.1 Myalgia A` E Ӑ A INSULIN ASPART d04697A D E11 Type 2 diabetes mellitus A` E Ӑ A INSULIN GLARGINE d04538A D E11 Type 2 diabetes mellitus A` E Ӑ A LOVASTATIN d00280A D= E78.0 Pure hypercholesterolemia A` E Ӑ A METFORMIN d03807A D E11 Type 2 diabetes mellitus A` E Ӡ A . . . E Ӱ A ALBUTEROL d00749A C J45 Asthma A` E Ӱ A CETIRIZINE d03827A C H10.1 R09.81 T78.40 Acute atopic conjunctivitis Nasal congestion Allergy, unspecified A` E Ӱ A FLUOXETINE d00236A Bz F32.9 F41.9 F43.1 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified Post-traumatic stress disorder (PTSD) A` E Ӱ A FLUTICASONE NASAL d04283A C J30.1 J30.9 Allergic rhinitis due to pollen Allergic rhinitis, unspecified A` E Ӱ A HYDROCHLOROTHIAZIDE d00253A C I10 R60.9 Essential (primary) hypertension Edema, unspecified A` E Ӱ A LOSARTAN d03821A B I10 Essential (primary) hypertension A` E A . . . E A . . . E A . . . E A FESOTERODINE d07162A C N32.81 Overactive bladder A E A LETROZOLE d04156A C C50 Malignant neoplasm of breast A E A . . . E A . . . E A . . . E 0 A . . . E @ A . . . E P A . . . E ` A . . . E p A . . . E Ԁ A PANTOPRAZOLE d04514A A K30 Functional dyspepsia A0 E Ԁ A PROMETHAZINE d00787A A R11 Nausea and vomiting A0 E Ԁ A SUCRALFATE d00377A A K30 Functional dyspepsia A0 E Ԑ A . . . E Ԡ A . . . E A AMLODIPINE d00689A D I10 Essential (primary) hypertension AP E A CLOPIDOGREL d04258A D I63.P Prevent stroke AP E A FAMOTIDINE d00141A C I50.9 Heart failure, unspecified AP E A LISINOPRIL d00732A D I50.9 Heart failure, unspecified AP E A METOPROLOL d00134A D I50.9 Heart failure, unspecified AP E A SULFAMETHOXAZOLE; TRIMETHOPRIM d00124A A0 N30 Cystitis A E A . . . E A . . . E A 99999 . . A E A HYDROCODONE d03075A A R05 Cough A E A PREDNISONE d00350A A J18.9 J42 Pneumonia, unspecified organism Unspecified chronic bronchitis A E A AMLODIPINE d00689A Cr I10 Essential (primary) hypertension A@ E A CHLORTHALIDONE d00192A Cr I10 Essential (primary) hypertension A@ E A LISINOPRIL d00732A Cr I10 Essential (primary) hypertension A@ E A METFORMIN d03807A C E11.P Prevent diabetes A@ E A . . . E 0 A . . . E @ A . . . E P A . . . E ` A IMIQUIMOD TOPICAL d04125A B B34.9 Viral infection, unspecified A E p A ALBUTEROL d00749A Cr J42 Unspecified chronic bronchitis A E p A ATORVASTATIN d04105A B= E78.0 Pure hypercholesterolemia A E p A DILTIAZEM d00045A B[ 99999 A E p A GABAPENTIN d03182A B 99999 A E p A HYDROCORTISONE TOPICAL d03205A Cr R21 Rash and other nonspecific skin eruption A E p A HYDROXYZINE d00907A B 99999 A E p A LISINOPRIL d00732A C- I10 Essential (primary) hypertension A E p A METFORMIN d03807A Cr E11 Type 2 diabetes mellitus A E p A OMEPRAZOLE d00325A B[ K21 Gastro-esophageal reflux disease A E p A TRAZODONE d00395A B G43.P Prevent migraine A E p A TRIAMCINOLONE TOPICAL d03206A Cr R21 Rash and other nonspecific skin eruption A E Հ A . . . E Ր A . . . E ՠ A INSULIN ISOPHANE; INSULIN REGULAR d04374A B E11 Type 2 diabetes mellitus A E հ A . . . E A . . . E A DEXMETHYLPHENIDATE d04777A C F90 Attention-deficit hyperactivity disorders AP E A ETHINYL ESTRADIOL; LEVONORGESTREL d03242A0 B N92 Z79.3 Excessive, frequent and irregular menstruation Long term (current) use of hormonal contraceptives AP E A OXCARBAZEPINE d04513A C F39 Unspecified mood [affective] disorder AP E A QUETIAPINE d04220A C F39 Unspecified mood [affective] disorder AP E A SERTRALINE d00880A C F32.9 Major depressive disorder, single episode, unspecified AP E A . . . E A . . . E A ATORVASTATIN d04105A C- E78.0 Pure hypercholesterolemia Ap E A DILTIAZEM d00045A C I10 Essential (primary) hypertension Ap E A HYDROCHLOROTHIAZIDE d00253A C"0 I10 Essential (primary) hypertension Ap E A LOSARTAN d03821A CDp I10 Essential (primary) hypertension Ap E A OMEPRAZOLE d00325A CDp K21 Gastro-esophageal reflux disease Ap E A POTASSIUM CHLORIDE d00345A C E87.6P Prevent hypokalemia Ap E A SPIRONOLACTONE d00373A B I10 Essential (primary) hypertension Ap E A . . . E A . . . E 0 A . . . E @ A IBUPROFEN d00015A Bz Z79.1 Long term (current) use of non-steroidal anti-inflammatories (NSAID) A E P A AMPHETAMINE; DEXTROAMPHETAMINE d04035A B F90 Attention-deficit hyperactivity disorders A0 E P A FLUOXETINE d00236A C F32.9 F41.9 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified A0 E P A LORAZEPAM d00149A C F41.9 Anxiety disorder, unspecified A0 E ` A LEVOTHYROXINE d00278A D E03.9 Hypothyroidism, unspecified A E ` A SIMVASTATIN d00746A Dc E78.0 Pure hypercholesterolemia A E p A . . . E ր A . . . E A BUPROPION d00181A CDp F32.9 Major depressive disorder, single episode, unspecified AP E A CITALOPRAM d04332A C F32.9 Major depressive disorder, single episode, unspecified AP E A IRBESARTAN d04222A Bz I10 Essential (primary) hypertension AP E A MELOXICAM d04532A A Z79 Long term (current) drug therapy AP E A METFORMIN d03807A Cr E11 Type 2 diabetes mellitus AP E ֠ A DICLOFENAC d00848A B M19.9 Osteoarthritis, unspecified site A@ E ֠ A LISINOPRIL d00732A B[ 99999 A@ E ֠ A METHIMAZOLE d00290A Bz 99999 A@ E ֠ A PHENYTOIN d00143A D/ G40 Epilepsy and recurrent seizures A@ E ְ A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E 0 A . . . E @ A . . . E P A AMLODIPINE d00689A D I10 Essential (primary) hypertension A@ E P A GABAPENTIN d03182A C M79.2 Neuralgia and neuritis, unspecified A@ E P A GLIMEPIRIDE d03864A D E11 Type 2 diabetes mellitus A@ E P A HYDROCHLOROTHIAZIDE; LOSARTAN d03830A D I10 Essential (primary) hypertension A@ E ` A AMOXICILLIN d00088A A H66.9 Otitis media, unspecified A E p A AMLODIPINE d00689A C I10 Essential (primary) hypertension A E p A ATENOLOL d00004A CDp I10 Essential (primary) hypertension A E p A ATORVASTATIN d04105A Cr E78.0 Pure hypercholesterolemia A E p A BRIMONIDINE; TIMOLOL OPHTHALMIC d05283A C H40 Glaucoma A E p A CLOPIDOGREL d04258A C[@ I21.P Prevent heart attack/myocardial infarction A E p A FUROSEMIDE d00070A C I51.9 Heart disease, unspecified A E p A HYDROXYZINE d00907A C- G47.0 Insomnia A E p A INSULIN GLARGINE d04538A CDp E11 Type 2 diabetes mellitus A E p A ISOSORBIDE DINITRATE d00268A Cr R07.9 Chest pain, unspecified A E p A LOSARTAN d03821A C- I10 Essential (primary) hypertension A E p A MIRTAZAPINE d04025A C- F32.9 Major depressive disorder, single episode, unspecified A E p A NITROGLYCERIN d00321A C R07.9 Chest pain, unspecified A E p A PANTOPRAZOLE d04514A C- K21 Gastro-esophageal reflux disease A E p A SULFASALAZINE d00379A C M06.9 Rheumatoid arthritis, unspecified A E p A TRAVOPROST OPHTHALMIC d04753A CP H40 Glaucoma A E ׀ A . . . E א A ETHINYL ESTRADIOL; LEVONORGESTREL d03242A C- Z79.3 Long term (current) use of hormonal contraceptives A E נ A . . . E װ A . . . E A . . . E A LOSARTAN d03821A B I10 Essential (primary) hypertension A E A OMEPRAZOLE d00325A C K30 Functional dyspepsia A E A AMOXICILLIN d00088A B H10 Conjunctivitis A E A METOPROLOL d00134A Bz I10 Essential (primary) hypertension A E A BISOPROLOL; HYDROCHLOROTHIAZIDE d03744A D* I51.9P Z79 Prevent heart disease Long term (current) drug therapy AP E A CYCLOBENZAPRINE d00963A C- M79.1 Myalgia AP E A ESCITALOPRAM d04812A D N95 Z90 Menopausal and other perimenopausal disorders Acquired absence of organs, not elsewhere classified AP E A LEVOTHYROXINE d00278A D E03.9 Hypothyroidism, unspecified AP E A LOSARTAN d03821A D I10 Essential (primary) hypertension AP E A TADALAFIL d04896A C- N52.9 Male erectile dysfunction, unspecified A E A . . . E 0 A . . . E @ A AMLODIPINE d00689A C- I10 Essential (primary) hypertension AP E @ A GLIPIZIDE d00246A D E11 Type 2 diabetes mellitus AP E @ A LISINOPRIL d00732A D ^ I10 Essential (primary) hypertension AP E @ A METFORMIN d03807A D E11 Type 2 diabetes mellitus AP E @ A TAMSULOSIN d04121A B N40 Enlarged prostate AP E P A 99999 . . A E ` A AMLODIPINE; BENAZEPRIL d03829A Cr I10 Essential (primary) hypertension AP E ` A ATORVASTATIN d04105A C- E78.0 Pure hypercholesterolemia AP E ` A DICLOFENAC d00848A CDp M25.5 Pain in joint AP E ` A HYDROCHLOROTHIAZIDE d00253A Cr I10 R60.9 Essential (primary) hypertension Edema, unspecified AP E ` A SILDENAFIL d04299A C- N52.9 Male erectile dysfunction, unspecified AP E p A POLYETHYLENE GLYCOL 3350 d05350A B K59.0 Constipation A E A METHYLPHENIDATE d00900A B= F90 Attention-deficit hyperactivity disorders A E ؐ A BENZONATATE d00796A Ap J40 Bronchitis, not specified as acute or chronic A E ؠ A APIXABAN d07804A Cr D75.9P Prevent blood clots A E ؠ A ATORVASTATIN d04105A Cr E78.0 Pure hypercholesterolemia A E ؠ A DIGOXIN d00210A CDp I50.9 Heart failure, unspecified A E ؠ A ESCITALOPRAM d04812A Cr F41.9 Anxiety disorder, unspecified A E ؠ A FINASTERIDE d00563A C- N40 Enlarged prostate A E ؠ A FUROSEMIDE d00070A C I51.9 Heart disease, unspecified A E ؠ A INSULIN GLARGINE d04538A C E11 Type 2 diabetes mellitus A E ؠ A LIRAGLUTIDE d07466A C E11 Type 2 diabetes mellitus A E ؠ A LOSARTAN d03821A Cr I10 Essential (primary) hypertension A E ؠ A METFORMIN d03807A Cr E11 Type 2 diabetes mellitus A E ؠ A METOPROLOL d00134A C[@ I50.9 Heart failure, unspecified A E ؠ A OXYBUTYNIN d00328A CDp R32 Unspecified urinary incontinence A E ؠ A RISPERIDONE d03180A Cr F29 Unspecified psychosis not due to a substance or known physiological condition A E ؠ A TAMSULOSIN d04121A C N40 Enlarged prostate A E ذ A ETHINYL ESTRADIOL; NORGESTIMATE d03781A C- Z79.3 Long term (current) use of hormonal contraceptives A E ذ A OMEGA-3 POLYUNSATURATED FATTY ACIDS d00497A B= E78.1 Pure hyperglyceridemia A E A ATORVASTATIN d04105A C- E78.0 Pure hypercholesterolemia A E A DUTASTERIDE d04788A C N40 Enlarged prostate A E A . . . E A PANTOPRAZOLE d04514A B K21 Gastro-esophageal reflux disease A E A LEVOTHYROXINE d00278A D E03.9 Hypothyroidism, unspecified A0 E A LISINOPRIL d00732A C I10 Essential (primary) hypertension A0 E A PREDNISONE d00350A Cr N18.9 Chronic kidney disease, unspecified A0 E A ALBUTEROL d00749A C[@ J45 Asthma A E A . . . E A . . . E 0 A . . . E @ A . . . E P A . . . E ` A . . . E p A . . . E ـ A AMPHETAMINE; DEXTROAMPHETAMINE d04035A C- F90 Attention-deficit hyperactivity disorders A0 E ـ A LEVOTHYROXINE d00278A D# E03.9 Hypothyroidism, unspecified A0 E ـ A RIZATRIPTAN d04328A D G43 Migraine A0 E ِ A . . . E ٠ A AZITHROMYCIN d00091A AP J40 Bronchitis, not specified as acute or chronic A E ٰ A ESTRADIOL; LEVONORGESTREL d04914A BK N92 Excessive, frequent and irregular menstruation A E A GLIPIZIDE d00246A CP E11 Type 2 diabetes mellitus A@ E A LISINOPRIL d00732A C I10 N28.9P Essential (primary) hypertension Prevent kidney disease A@ E A METFORMIN d03807A CP E11 Type 2 diabetes mellitus A@ E A SIMVASTATIN d00746A CP E78.0 Pure hypercholesterolemia A@ E A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified A E A LISINOPRIL d00732A D I10 Essential (primary) hypertension A E A . . . E A . . . E A ATORVASTATIN d04105A CDp E78.0 Pure hypercholesterolemia A0 E A LISINOPRIL d00732A CDp I10 Essential (primary) hypertension A0 E A OXYCODONE d00329A CDp M25.5 Pain in joint A0 E A . . . E A . . . E 0 A ALBUTEROL d00749A C[@ J45 Asthma A@ E 0 A ALBUTEROL d00749A C[@ J45 Asthma A@ E 0 A BECLOMETHASONE d00760A C[@ J45 Asthma A@ E 0 A MONTELUKAST d04289A Cr J45 Asthma A@ E @ A . . . E P A FLUTICASONE NASAL d04283A CDp J30.1 J30.9 R09.81 Allergic rhinitis due to pollen Allergic rhinitis, unspecified Nasal congestion A E P A MONTELUKAST d04289A CDp J30.1 J30.9 Allergic rhinitis due to pollen Allergic rhinitis, unspecified A E ` A CEPHALEXIN d00096A B L08.9 Local infection of the skin and subcutaneous tissue, unspecified A E p A . . . E ڀ A . . . E ڐ A . . . E ڠ A . . . E ڰ A . . . E A . . . E A . . . E A GLIMEPIRIDE d03864A C E11 Type 2 diabetes mellitus A0 E A HYDROCHLOROTHIAZIDE; LOSARTAN d03830A B* I10 Essential (primary) hypertension A0 E A METFORMIN d03807A C E11 Type 2 diabetes mellitus A0 E A CEVIMELINE d04512A B= M35 Other systemic involvement of connective tissue A E A HYDROXYCHLOROQUINE d00817A B= M35 Other systemic involvement of connective tissue A E A . . . E A CLONIDINE d00044A C N95 Menopausal and other perimenopausal disorders A@ E A IBUPROFEN d00015A C- M54 Dorsalgia A@ E A OMEPRAZOLE d00325A Cr K21 Gastro-esophageal reflux disease A@ E A OXYCODONE d00329A C M54 Dorsalgia A@ E A HYDROCHLOROTHIAZIDE d00253A C R60.9 Edema, unspecified A E A NAPROXEN d00019A C M79.1 Myalgia A E 0 A AMLODIPINE d00689A B I10 Essential (primary) hypertension AP E 0 A CLONIDINE d00044A B I10 Essential (primary) hypertension AP E 0 A HYDRALAZINE d00132A B I10 Essential (primary) hypertension AP E 0 A METOPROLOL d00134A C I10 Essential (primary) hypertension AP E 0 A ROSUVASTATIN d04851A B E78.0 Pure hypercholesterolemia AP E @ A . . . E P A . . . E ` A SERTRALINE d00880A B= F32.9 F41.9 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified A E p A HYDROCHLOROTHIAZIDE d00253A C R60.9 Edema, unspecified Ap E p A LOSARTAN d03821A C I10 Essential (primary) hypertension Ap E p A METOPROLOL d00134A C I48.9 Unspecified atrial fibrillation and atrial flutter Ap E p A NIACIN d00314A C 55555 Ap E p A RIVAROXABAN d07356A C D75.9P I48.9 Prevent blood clots Unspecified atrial fibrillation and atrial flutter Ap E p A ROSUVASTATIN d04851A C E78.0 Pure hypercholesterolemia Ap E p A SPIRONOLACTONE d00373A C I51.9 Heart disease, unspecified Ap E ۀ A ETHINYL ESTRADIOL; NORETHINDRONE d03238A C- Z79.3 Long term (current) use of hormonal contraceptives A0 E ۀ A LIRAGLUTIDE d07466A A E66 Overweight and obesity A0 E ۀ A NADOLOL d00018A C- G43.P Prevent migraine A0 E ې A ATORVASTATIN d04105A C- E78.0 E78.1 Pure hypercholesterolemia Pure hyperglyceridemia A E ې A CANNABIDIOL d08919A C"@ C80.1 Malignant (primary) neoplasm, unspecified A E ې A DICYCLOMINE d00999A C K58 Irritable bowel syndrome A E ې A GABAPENTIN d03182A Cr G25.81 M54 M79.2 Restless legs syndrome Dorsalgia Neuralgia and neuritis, unspecified A E ې A HYDROCODONE d03075A D M54 T14.9 Dorsalgia Unspecified injury A E ې A HYOSCYAMINE d00985A B K57 K58 R19.7 Diverticular disease of intestine Irritable bowel syndrome Diarrhea, unspecified A E ې A PROGESTERONE d00550A C[@ N95 Z79.890 Menopausal and other perimenopausal disorders Hormone replacement therapy A E ې A SERTRALINE d00880A D F32.9 N94 R51 Major depressive disorder, single episode, unspecified Pain and other conditions associated with female genital organs and menstrual cycle Headache A E ې A TIZANIDINE d04102A B M54 R51 Dorsalgia Headache A E ۠ A . . . E ۰ A DEXMETHYLPHENIDATE d04777A CDp F90 Attention-deficit hyperactivity disorders A E A . . . E A CLOPIDOGREL d04258A Cr D75.9P Prevent blood clots A0 E A IRBESARTAN d04222A Cr I10 Essential (primary) hypertension A0 E A METOPROLOL d00134A Cr I10 Essential (primary) hypertension A0 E A LAMOTRIGINE d03809A C9 F31.9 Bipolar disorder, unspecified A E A . . . E A LEVOTHYROXINE d00278A C- E03.9 Hypothyroidism, unspecified A E A LISINOPRIL d00732A C- I10 Essential (primary) hypertension A E A . . . E A AMLODIPINE d00689A CDp I10 Essential (primary) hypertension A E A BACLOFEN d00967A CDp M25.5 M54 Pain in joint Dorsalgia A E 0 A . . . E @ A . . . E P A . . . E ` A AMLODIPINE d00689A B I10 Essential (primary) hypertension A E p A ACETAMINOPHEN; CODEINE d03423A A K05.6 Periodontal disease, unspecified A E p A IBUPROFEN d00015A A K05.6 Periodontal disease, unspecified A E ܀ A . . . E ܐ A . . . E ܠ A AMLODIPINE d00689A C- I10 Essential (primary) hypertension A@ E ܠ A HYDROCHLOROTHIAZIDE; LOSARTAN d03830A C- I10 Essential (primary) hypertension A@ E ܠ A METFORMIN d03807A CDp E11 Type 2 diabetes mellitus A@ E ܠ A RISEDRONATE d04300A B= M81 Osteoporosis without current pathological fracture A@ E ܰ A AMLODIPINE d00689A Cr I10 Essential (primary) hypertension A@ E ܰ A COLCHICINE d00150A A M1A Chronic gout A@ E ܰ A FUROSEMIDE d00070A A I10 R60.9 Essential (primary) hypertension Edema, unspecified A@ E ܰ A METOPROLOL d00134A Cr I10 Essential (primary) hypertension A@ E A . . . E A AMOXICILLIN d00088A A H66.9 J18.9 Otitis media, unspecified Pneumonia, unspecified organism A E A TRAMADOL d03826A C M54 Dorsalgia A E A AMLODIPINE d00689A B[ I10 Essential (primary) hypertension A E A . . . E A CLONIDINE d00044A Dc I10 Essential (primary) hypertension A` E A FENOFIBRATE d04286A D E78.0P Prevent high cholesterol A` E A FUROSEMIDE d00070A Dc R60.9 Edema, unspecified A` E A METOCLOPRAMIDE d00298A Dc I10 Essential (primary) hypertension A` E A METOPROLOL d00134A D# I10 Essential (primary) hypertension A` E A WARFARIN d00022A D# I48.9 Unspecified atrial fibrillation and atrial flutter A` E A . . . E 0 A AMLODIPINE; BENAZEPRIL d03829A C I10 Essential (primary) hypertension A E @ A . . . E P A . . . E ` A . . . E p A . . . E ݀ A ACETAMINOPHEN; HYDROCODONE d03428A D% M54 Dorsalgia A E ݀ A ALPRAZOLAM d00168A C F41.9 Anxiety disorder, unspecified A E ݀ A CELECOXIB d04380A B[ Z79.1 Long term (current) use of non-steroidal anti-inflammatories (NSAID) A E ݀ A HYDROCHLOROTHIAZIDE d00253A B= I10 Essential (primary) hypertension A E ݀ A INSULIN ASPART d04697A CDp E11 Type 2 diabetes mellitus A E ݀ A INSULIN GLARGINE d04538A B E11 Type 2 diabetes mellitus A E ݀ A MONTELUKAST d04289A C J44.9 J45 R06.9 Chronic obstructive pulmonary disease, unspecified Asthma Unspecified abnormalities of breathing A E ݀ A OMEPRAZOLE d00325A Bz K21 Gastro-esophageal reflux disease A E ݀ A PYRIDOSTIGMINE d00363A A` 99999 A E ݀ A RAMIPRIL d00728A C I10 Essential (primary) hypertension A E ݀ A ROSUVASTATIN d04851A C E78.0 Pure hypercholesterolemia A E ݐ A . . . E ݠ A . . . E ݰ A . . . E A AMOXICILLIN d00088A Ap Z79 Long term (current) drug therapy A E A . . . E A ETHINYL ESTRADIOL; NORGESTIMATE d03781A C[@ Z79.3 Long term (current) use of hormonal contraceptives A E A . . . E A . . . E A ACETAMINOPHEN; OXYCODONE d03431A Dc G89 M25.5 Pain, not elsewhere classified Pain in joint A0 E A DIAZEPAM d00148A C G47.9 Sleep disorder, unspecified A0 E A OXYCODONE d00329A C G89 M25.5 Pain, not elsewhere classified Pain in joint A0 E A LISINOPRIL d00732A D I10 Essential (primary) hypertension A0 E A METFORMIN d03807A C E11 Type 2 diabetes mellitus A0 E A NAPROXEN d00019A Bz T14.9 Unspecified injury A0 E 0 A ALBUTEROL d00749A C J44.9 Chronic obstructive pulmonary disease, unspecified AP E 0 A AMLODIPINE; BENAZEPRIL d03829A C I10 Essential (primary) hypertension AP E 0 A ESOMEPRAZOLE d04749A Cr K21 Gastro-esophageal reflux disease AP E 0 A IBUPROFEN d00015A C- M13 Other arthritis AP E 0 A TAMSULOSIN d04121A C N40 Enlarged prostate AP E @ A . . . E P A . . . E ` A ATORVASTATIN d04105A B E78.0 Pure hypercholesterolemia A E ` A CARVEDILOL d03847A C[@ I10 I50.9 Essential (primary) hypertension Heart failure, unspecified A E ` A FAMOTIDINE; IBUPROFEN d07764A C M25.5 Pain in joint A E ` A FUROSEMIDE d00070A Cr R60.9 Edema, unspecified A E ` A HYDROCODONE d03075A D# G89 Pain, not elsewhere classified A E ` A LISINOPRIL d00732A C[@ I10 Essential (primary) hypertension A E ` A METFORMIN d03807A B E11 Type 2 diabetes mellitus A E ` A TRAMADOL d03826A B M25.5 Pain in joint A E p A AMLODIPINE d00689A C I10 Essential (primary) hypertension A` E p A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A` E p A LOSARTAN d03821A C I10 Essential (primary) hypertension A` E p A METFORMIN d03807A C E11 Type 2 diabetes mellitus A` E p A METOPROLOL d00134A C I10 Essential (primary) hypertension A` E p A OXYBUTYNIN d00328A C N32.81 N39.4 R39.1 Overactive bladder Other specified urinary incontinence Other difficulties with micturition A` E ހ A . . . E ސ A . . . E ޠ A . . . E ް A . . . E A . . . E A . . . E A . . . E A AZITHROMYCIN d00091A AP H66.9 J20.9 Otitis media, unspecified Acute bronchitis, unspecified A@ E A CODEINE; GUAIFENESIN d03393A B J20.9 R05 Acute bronchitis, unspecified Cough A@ E A FLUVOXAMINE d03804A C F41.9 Anxiety disorder, unspecified A@ E A MONTELUKAST d04289A B J20.9 Acute bronchitis, unspecified A@ E A . . . E A ALLOPURINOL d00023A B[ M1A Chronic gout Ap E A GABAPENTIN d03182A C- M79.2 Neuralgia and neuritis, unspecified Ap E A HYDROXYCHLOROQUINE d00817A C- M06.9 M35 Rheumatoid arthritis, unspecified Other systemic involvement of connective tissue Ap E A MELOXICAM d04532A B[ M19.9 T14.9 Osteoarthritis, unspecified site Unspecified injury Ap E A OLMESARTAN d04801A Cr I10 Essential (primary) hypertension Ap E A PANTOPRAZOLE d04514A C 55555 Ap E A TRAMADOL d03826A C- M06.9 Rheumatoid arthritis, unspecified Ap E A AMLODIPINE d00689A Cr 99999 A` E A ATORVASTATIN d04105A Cr 99999 A` E A BRINZOLAMIDE OPHTHALMIC d04301A Cr H40 Glaucoma A` E A LISINOPRIL d00732A C 99999 A` E A METOPROLOL d00134A Cr 99999 A` E A TIMOLOL OPHTHALMIC d04037A Cr H40 Glaucoma A` E 0 A ALPRAZOLAM d00168A C- F41.0 F41.9 Panic disorder [episodic paroxysmal anxiety] without agoraphobia Anxiety disorder, unspecified A E 0 A ATORVASTATIN d04105A CDp E78.0 I70.P Pure hypercholesterolemia Prevent atherosclerosis A E 0 A DILTIAZEM d00045A D# I10 Essential (primary) hypertension A E 0 A IBUPROFEN d00015A D M19.9 Osteoarthritis, unspecified site A E 0 A LISINOPRIL d00732A D# I10 Essential (primary) hypertension A E 0 A OXYCODONE d00329A B G89 Pain, not elsewhere classified A E 0 A PANTOPRAZOLE d04514A D K21 Gastro-esophageal reflux disease A E 0 A VENLAFAXINE d03181A C- F32.9 Major depressive disorder, single episode, unspecified A E @ A . . . E P A BACLOFEN d00967A CDp G89 Pain, not elsewhere classified Ap E P A DIFLUNISAL d00208A C M25.5 M54 Pain in joint Dorsalgia Ap E P A HYDROMORPHONE d00255A Cr G89 Pain, not elsewhere classified Ap E P A KETAMINE d00272A CDp G89 Pain, not elsewhere classified Ap E P A LINACLOTIDE d07902A C G89 Pain, not elsewhere classified Ap E P A PANTOPRAZOLE d04514A C K31.9 Disease of stomach and duodenum, unspecified Ap E P A SCOPOLAMINE d00986A C- R11 Nausea and vomiting Ap E ` A . . . E p A . . . E ߀ A . . . E ߐ A . . . E ߠ A . . . E ߰ A . . . E A . . . E A . . . E A . . . E A LISINOPRIL d00732A C I10 Essential (primary) hypertension A E A . . . E A . . . E A . . . E 0 A 99999 . . A` E 0 A ACYCLOVIR d00001A C A60.9 Anogenital herpesviral infection, unspecified A` E 0 A GABAPENTIN d03182A C M79.2 Neuralgia and neuritis, unspecified A` E 0 A LOSARTAN d03821A C I10 Essential (primary) hypertension A` E 0 A SULFAMETHOXAZOLE d00119A C J42 Unspecified chronic bronchitis A` E 0 A TICLOPIDINE d00514A C D75.9P Prevent blood clots A` E @ A . . . E P A . . . E ` A . . . E p A . . . E A OXYBUTYNIN d00328A B N32.81 Overactive bladder A E A . . . E A . . . E A ATENOLOL d00004A Cr I10 Essential (primary) hypertension A E A NORTRIPTYLINE d00144A Dc G43 Migraine A E A . . . E A . . . E A . . . E A SERTRALINE d00880A B* F32.9 F41.9 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified A E A . . . E A METFORMIN d03807A C E11 Type 2 diabetes mellitus A E A . . . E 0 A ALLOPURINOL d00023A CDp M10.9P Prevent gout A E 0 A ATORVASTATIN d04105A C[@ E78.0 Pure hypercholesterolemia A E 0 A EXENATIDE d05529A CDp E11 Type 2 diabetes mellitus A E 0 A FENOFIBRATE d04286A CDp E78.0 E78.1 Pure hypercholesterolemia Pure hyperglyceridemia A E 0 A GLIPIZIDE d00246A B E11 Type 2 diabetes mellitus A E 0 A METFORMIN d03807A Cr E11 Type 2 diabetes mellitus A E 0 A METOPROLOL d00134A B R00 Abnormalities of heart beat A E 0 A OMEGA-3 POLYUNSATURATED FATTY ACIDS d00497A C[@ E78.1 Pure hyperglyceridemia A E 0 A PIOGLITAZONE d04442A CDp E78.1 Pure hyperglyceridemia A E @ A . . . E P A . . . E ` A . . . E p A . . . E A . . . E A . . . E A CLONAZEPAM d00197A C[@ F41.9 Anxiety disorder, unspecified A@ E A FAMOTIDINE d00141A C K21 Gastro-esophageal reflux disease A@ E A LATANOPROST OPHTHALMIC d04017A C- H40 Glaucoma A@ E A LOSARTAN d03821A CDp I10 Essential (primary) hypertension A@ E A . . . E A CLOMIPRAMINE d00876A C"@ F32.9 F41.9 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified AP E A CLONAZEPAM d00197A D F41.9 Anxiety disorder, unspecified AP E A DOCUSATE d01021A C K59.0 Constipation AP E A PRAZOSIN d00138A A0 F41.9 Anxiety disorder, unspecified AP E A TRAZODONE d00395A C G47.0 Insomnia AP E A . . . E A . . . E A FELODIPINE d00231A B I10 Essential (primary) hypertension A0 E A NITROGLYCERIN d00321A CDp R07.9 Chest pain, unspecified A0 E A PANTOPRAZOLE d04514A C K21 Gastro-esophageal reflux disease A0 E A AMLODIPINE d00689A CDp I10 Essential (primary) hypertension A E A ATORVASTATIN d04105A C- E78.0 Pure hypercholesterolemia A E A FINASTERIDE d00563A C[@ 99999 A E A FUROSEMIDE d00070A B R60.9 Edema, unspecified A E A GLIMEPIRIDE d03864A C- E11 Type 2 diabetes mellitus A E A HYDROCHLOROTHIAZIDE d00253A D I10 Essential (primary) hypertension A E A LANSOPRAZOLE d03828A Cr K21 Gastro-esophageal reflux disease A E A METFORMIN d03807A D E11 Type 2 diabetes mellitus A E A METOPROLOL d00134A C I10 Essential (primary) hypertension A E A ALPRAZOLAM d00168A C F41.9 Anxiety disorder, unspecified A0 E A AMOXICILLIN d00088A Ap N39.0 Urinary tract infection, site not specified A0 E A PAROXETINE d03157A Dc F32.9 Major depressive disorder, single episode, unspecified A0 E A . . . E 0 A . . . E @ A . . . E P A ROSUVASTATIN d04851A Cr E78.0 Pure hypercholesterolemia A E ` A . . . E p A LISINOPRIL d00732A C- I10 Essential (primary) hypertension A E p A METFORMIN d03807A C- R73 Elevated blood glucose level A E A . . . E A ALLOPURINOL d00023A Cr M10.9 Gout, unspecified A E A AMLODIPINE d00689A C[@ I10 Essential (primary) hypertension A E A ASPIRIN; BUTALBITAL; CAFFEINE d03457A A R51 Headache A E A CARBIDOPA; LEVODOPA d03473A B= G20 Parkinson's disease A E A CITALOPRAM d04332A B F32.9 Major depressive disorder, single episode, unspecified A E A CLOPIDOGREL d04258A CP D75.9P Prevent blood clots A E A DAPSONE d00098A C[@ L08.9 Local infection of the skin and subcutaneous tissue, unspecified A E A DONEPEZIL d04099A C G30.9 Alzheimer's disease, unspecified A E A DORZOLAMIDE OPHTHALMIC d03805A C[@ H40 Glaucoma A E A FUROSEMIDE d00070A B R60.9 Edema, unspecified A E A GABAPENTIN d03182A C M79.2 Neuralgia and neuritis, unspecified A E A LATANOPROST OPHTHALMIC d04017A CDp H40 Glaucoma A E A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified A E A RAMIPRIL d00728A Cr I10 Essential (primary) hypertension A E A SIMVASTATIN d00746A Cr E78.0 Pure hypercholesterolemia A E A . . . E A ALBUTEROL d00749A C[@ J45 Asthma A0 E A ALBUTEROL d00749A C J45 Asthma A0 E A BUDESONIDE d04276A0 C J45 Asthma A0 E A . . . E A . . . E A AMLODIPINE d00689A C I10 Essential (primary) hypertension A0 E A ATORVASTATIN d04105A Bz E78.0 Pure hypercholesterolemia A0 E A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified A0 E A . . . E A . . . E A . . . E A AMLODIPINE d00689A C I10 Essential (primary) hypertension A@ E A ATENOLOL d00004A C I10 I51.9P Essential (primary) hypertension Prevent heart disease A@ E A GABAPENTIN d03182A B B02 M79.2 Zoster [herpes zoster] Neuralgia and neuritis, unspecified A@ E A LOSARTAN d03821A C I10 N28.9 Essential (primary) hypertension Disorder of kidney and ureter, unspecified A@ E 0 A . . . E @ A INSULIN ASPART d04697A C[@ E11 Type 2 diabetes mellitus A E @ A INSULIN DETEMIR d05436A C[@ E11 Type 2 diabetes mellitus A E P A . . . E ` A . . . E p A AMLODIPINE d00689A C I10 Essential (primary) hypertension AP E p A FENOFIBRATE d04286A C E78.0 Pure hypercholesterolemia AP E p A LISINOPRIL d00732A C- I10 Essential (primary) hypertension AP E p A PANTOPRAZOLE d04514A CDp R12 Heartburn AP E p A ZOLPIDEM d00910A C G47.9 Sleep disorder, unspecified AP E A METFORMIN d03807A CDp E11 Type 2 diabetes mellitus A E A SIMVASTATIN d00746A C- E78.0 Pure hypercholesterolemia A E A ALLOPURINOL d00023A Dc G40 Epilepsy and recurrent seizures A E A DONEPEZIL d04099A D R41 Other symptoms and signs involving cognitive functions and awareness A E A FUROSEMIDE d00070A D I10 Essential (primary) hypertension A E A GABAPENTIN d03182A Cr M79.2 Neuralgia and neuritis, unspecified A E A LEVETIRACETAM d04499A C M79.2 Neuralgia and neuritis, unspecified A E A LISINOPRIL d00732A C I63.P Prevent stroke A E A NORTRIPTYLINE d00144A C M79.2 Neuralgia and neuritis, unspecified A E A OMEPRAZOLE d00325A C K21 Gastro-esophageal reflux disease A E A WARFARIN d00022A C D75.9P Prevent blood clots A E A . . . E A . . . E A 77777 . . A E A . . . E A . . . E A . . . E A . . . E A . . . E A AMLODIPINE d00689A Bz I10 Essential (primary) hypertension A` E A ATENOLOL d00004A D ^ I10 Essential (primary) hypertension A` E A LEVOTHYROXINE d00278A D ^ E03.9 Hypothyroidism, unspecified A` E A LOSARTAN d03821A Cr I10 Essential (primary) hypertension A` E A METFORMIN d03807A A E11 Type 2 diabetes mellitus A` E A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia A` E 0 A TAMSULOSIN d04121A C N40 Enlarged prostate A E @ A ASPIRIN d00170A D I51.9P Z79.0 Prevent heart disease Long term (current) use of anticoagulants and antithrombotics/antiplatelets A E @ A ATENOLOL d00004A D I10 Essential (primary) hypertension A E @ A DILTIAZEM d00045A D I10 Essential (primary) hypertension A E @ A EPLERENONE d04815A Cr I10 Essential (primary) hypertension A E @ A GABAPENTIN d03182A C M79.2 Neuralgia and neuritis, unspecified A E @ A GLIPIZIDE d00246A Cr E11 Type 2 diabetes mellitus A E @ A LISINOPRIL d00732A D I10 Essential (primary) hypertension A E @ A METFORMIN d03807A D E11 Type 2 diabetes mellitus A E @ A PRAVASTATIN d00348A D E78.0 Pure hypercholesterolemia A E @ A SAXAGLIPTIN d07467A C- E11 Type 2 diabetes mellitus A E @ A TERAZOSIN d00386A D R35 Polyuria A E P A . . . E ` A . . . E p A . . . E A AMLODIPINE; HYDROCHLOROTHIAZIDE; OLMESARTAN d07668A C- I10 Essential (primary) hypertension AP E A ATORVASTATIN d04105A B E78.0 Pure hypercholesterolemia AP E A GABAPENTIN d03182A C M79.2 M79.6 Neuralgia and neuritis, unspecified Pain in limb, hand, foot, fingers and toes AP E A LEVOCETIRIZINE d05851A C T78.40 Allergy, unspecified AP E A PANTOPRAZOLE d04514A C K21 Gastro-esophageal reflux disease AP E A . . . E A FENOFIBRATE d04286A CP E78.1 Pure hyperglyceridemia A E A SIMVASTATIN d00746A D E78.0 Pure hypercholesterolemia A E A . . . E A . . . E A . . . E A . . . E A DEXMETHYLPHENIDATE d04777A D F90 Attention-deficit hyperactivity disorders A E A . . . E A . . . E A . . . E 0 A ETHINYL ESTRADIOL; NORETHINDRONE d03238A C Z79.3 Long term (current) use of hormonal contraceptives A E @ A . . . E P A ATORVASTATIN d04105A B E78.0 Pure hypercholesterolemia A E P A METFORMIN d03807A C E11 Type 2 diabetes mellitus A E ` A VENLAFAXINE d03181A D= F32.9 Major depressive disorder, single episode, unspecified A E p A AMOXICILLIN d00088A A0 J06.9 Acute upper respiratory infection, unspecified A E A . . . E A . . . E A ALLOPURINOL d00023A C M1A Chronic gout A@ E A ATORVASTATIN d04105A B E78.0 Pure hypercholesterolemia A@ E A PANTOPRAZOLE d04514A B R14 Flatulence and related conditions A@ E A SPIRONOLACTONE d00373A B I99.9 Unspecified disorder of circulatory system A@ E A . . . E A . . . E A . . . E A ETHINYL ESTRADIOL; LEVONORGESTREL d03242A B[ Z79.3 Long term (current) use of hormonal contraceptives A E A RANITIDINE d00021A B[ T78.40 Allergy, unspecified A E A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia A E A . . . E A . . . E A . . . E 0 A ALBUTEROL d00749A CDp J45 R06.2 Asthma Wheezing A E 0 A MONTELUKAST d04289A B J30.9 J45 R06.2 Allergic rhinitis, unspecified Asthma Wheezing A E @ A . . . E P A . . . E ` A APIXABAN d07804A CDp I49.9 Cardiac arrhythmia, unspecified A0 E ` A ATORVASTATIN d04105A CDp E78.0 Pure hypercholesterolemia A0 E ` A DILTIAZEM d00045A CDp E78.0 Pure hypercholesterolemia A0 E p A ALBUTEROL d00749A0 B J45 Asthma A` E p A ALBUTEROL d00749A0 C- J45 Asthma A` E p A FLUTICASONE; SALMETEROL d04611A B= J45 Asthma A` E p A FLUTICASONE; SALMETEROL d04611A C J45 Asthma A` E p A IMMUNE GLOBULIN SUBCUTANEOUS d05704A C P 55555 A` E p A LIDOCAINE; PRILOCAINE TOPICAL d03655A C R20 Disturbances of skin sensation A` E A . . . E A LISINOPRIL d00732A B[ I10 Essential (primary) hypertension A E A LISINOPRIL d00732A B E11.2P Prevent diabetic kidney disease A0 E A LOVASTATIN d00280A C E78.0 Pure hypercholesterolemia A0 E A METFORMIN d03807A C- E11 Type 2 diabetes mellitus A0 E A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia AP E A GABAPENTIN d03182A B= R10 Abdominal and pelvic pain AP E A LISINOPRIL d00732A C I10 Essential (primary) hypertension AP E A METFORMIN d03807A C E11 Type 2 diabetes mellitus AP E A METOPROLOL d00134A C I10 Essential (primary) hypertension AP E A . . . E A ACETAMINOPHEN; OXYCODONE d03431A0 CDp M79.2 Neuralgia and neuritis, unspecified AP E A LEVOTHYROXINE d00278A0 C E03.9 Hypothyroidism, unspecified AP E A LIDOCAINE TOPICAL d00683A0 CDp G99.8 M79.2 Other specified disorders of nervous system in diseases classified elsewhere Neuralgia and neuritis, unspecified AP E A ONDANSETRON d00867A0 Cr R11 Nausea and vomiting AP E A TOPIRAMATE d04115A0 CDp M79.2 Neuralgia and neuritis, unspecified AP E A . . . E A . . . E A ALBUTEROL d00749A CDp J45 Asthma A E A . . . E A . . . E 0 A . . . E @ A . . . E P A . . . E ` A . . . E p A ADAPALENE TOPICAL d04015A CDp L70 Acne A E A . . . E A COLCHICINE d00150A Bz I51.9 Heart disease, unspecified A@ E A EMTRICITABINE; TENOFOVIR d05352A C B34.9P Prevent viral infection A@ E A LISINOPRIL d00732A Bz I10 Essential (primary) hypertension A@ E A PANTOPRAZOLE d04514A Bz K25.P Prevent gastric ulcer A@ E A . . . E A . . . E A AMIODARONE d00002A D I48.9 I49.9 Unspecified atrial fibrillation and atrial flutter Cardiac arrhythmia, unspecified A E A AMLODIPINE d00689A C I10 I21.P Essential (primary) hypertension Prevent heart attack/myocardial infarction A E A CARVEDILOL d03847A C I48.9 I50.9 Unspecified atrial fibrillation and atrial flutter Heart failure, unspecified A E A DICLOFENAC TOPICAL d04722A B[ M19.9 M25.5 Osteoarthritis, unspecified site Pain in joint A E A FUROSEMIDE d00070A D R60.9 Edema, unspecified A E A HYDROCODONE d03075A CDp M25.5 M54 Pain in joint Dorsalgia A E A LATANOPROST OPHTHALMIC d04017A C H40 Glaucoma A E A MIRTAZAPINE d04025A B F41.9 Anxiety disorder, unspecified A E A OMEPRAZOLE d00325A CDp K30 Functional dyspepsia A E A PRAMIPEXOLE d04145A CDp G25.81 Restless legs syndrome A E A RIVAROXABAN d07356A C I21 I48.9 I49.9 ST elevation (STEMI) and non-ST elevation (NSTEMI) myocardial infarction Unspecified atrial fibrillation and atrial flutter Cardiac arrhythmia, unspecified A E A ATORVASTATIN d04105A B E78.0 Pure hypercholesterolemia AP E A DULOXETINE d05355A C F33.9 Major depressive disorder, recurrent, unspecified AP E A GABAPENTIN d03182A CDp M79.2 M79.7 Neuralgia and neuritis, unspecified Fibromyalgia AP E A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A B= I10 R60.9 Essential (primary) hypertension Edema, unspecified AP E A INSULIN DETEMIR d05436A CDp E11 R73 Type 2 diabetes mellitus Elevated blood glucose level AP E A CIPROFLOXACIN; DEXAMETHASONE OTIC d04890A A0 A49.9P Prevent bacterial infection A E A CETIRIZINE d03827A Bz T78.40 Allergy, unspecified A E A . . . E A ADAPALENE; BENZOYL PEROXIDE TOPICAL d07382A B= L70 Acne A@ E A BENZOYL PEROXIDE; CLINDAMYCIN TOPICAL d04742A B= L70 Acne A@ E A OSELTAMIVIR d04462A Ap J09 Influenza due to certain identified influenza viruses A@ E A SULFACETAMIDE SODIUM; SULFUR TOPICAL d04032A B= L70 Acne A@ E A METHYLPHENIDATE d00900A C F90 Attention-deficit hyperactivity disorders A E 0 A BUDESONIDE; FORMOTEROL d04795A C J43 J44.9 J45 Emphysema Chronic obstructive pulmonary disease, unspecified Asthma A E 0 A CEPHALEXIN d00096A B N30 Cystitis A E 0 A CLOPIDOGREL d04258A B D75.9P I80.3 Prevent blood clots Phlebitis and thrombophlebitis of lower extremities, unspecified A E 0 A DOXEPIN d00217A CDp G47.9 Sleep disorder, unspecified A E 0 A GABAPENTIN d03182A Cr M79.2 Neuralgia and neuritis, unspecified A E 0 A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A C I10 Essential (primary) hypertension A E 0 A IPRATROPIUM d00265A Cr R06.9 Unspecified abnormalities of breathing A E 0 A LAMOTRIGINE d03809A D F31.9 Bipolar disorder, unspecified A E 0 A LITHIUM d00061A CDp F31.9 F99 Bipolar disorder, unspecified Mental disorder, not otherwise specified A E 0 A ONDANSETRON d00867A Cr R11 Nausea and vomiting A E 0 A PRAZOSIN d00138A C[@ G47.9 Sleep disorder, unspecified A E 0 A QUETIAPINE d04220A B F31.9 Bipolar disorder, unspecified A E 0 A TIZANIDINE d04102A B M54 Dorsalgia A E 0 A TRAMADOL d03826A B M54 Dorsalgia A E 0 A ZOLPIDEM d00910A CDp G47.0 Insomnia A E @ A . . . E P A ACETAMINOPHEN; HYDROCODONE d03428A A K08.8 Other specified disorders of teeth and supporting structures A E P A AMOXICILLIN d00088A A K04.7 Periapical abscess without sinus A E ` A AMLODIPINE d00689A C I10 Essential (primary) hypertension A@ E ` A BACLOFEN d00967A B M79.1 Myalgia A@ E ` A BUSPIRONE d00182A C- F41.9 Anxiety disorder, unspecified A@ E ` A ESCITALOPRAM d04812A C- F41.9 Anxiety disorder, unspecified A@ E p A . . . E A . . . E A CLONAZEPAM d00197A C- F41.9 Anxiety disorder, unspecified A` E A FUROSEMIDE d00070A B R60.9 Edema, unspecified A` E A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A C I10 Essential (primary) hypertension A` E A METOPROLOL d00134A C- I10 Essential (primary) hypertension A` E A PAROXETINE d03157A Cr F33.9 Major depressive disorder, recurrent, unspecified A` E A ROSUVASTATIN d04851A C"0 E78.0 Pure hypercholesterolemia A` E A BUDESONIDE; FORMOTEROL d04795A C- T78.40 Allergy, unspecified A E A FLUTICASONE NASAL d04283A C T78.40 Allergy, unspecified A E A . . . E A . . . E A . . . E A HYDROXYUREA d01373A C 55555 A E A PENICILLIN V POTASSIUM d07730A C- A49.9P Prevent bacterial infection A E A ACETAMINOPHEN; HYDROCODONE d03428A D M54 Dorsalgia A E A ALBUTEROL d00749A C J44.9 J45 Chronic obstructive pulmonary disease, unspecified Asthma A E A BACLOFEN d00967A C M62.83 Muscle spasm A E A FLUTICASONE; SALMETEROL d04611A C J44.9 Chronic obstructive pulmonary disease, unspecified A E A LISINOPRIL d00732A C I10 I50.9 Essential (primary) hypertension Heart failure, unspecified A E A NAPROXEN d00019A D M54 Dorsalgia A E A SERTRALINE d00880A Cr F32.9 Major depressive disorder, single episode, unspecified A E A VERAPAMIL d00048A C I10 I49.9 Essential (primary) hypertension Cardiac arrhythmia, unspecified A E A ZOLPIDEM d00910A B= G47.0 Insomnia A E A . . . E A . . . E A SULFAMETHOXAZOLE; TRIMETHOPRIM d00124A B= L70 Acne A E 0 A . . . E @ A AMLODIPINE d00689A B I10 Essential (primary) hypertension A E P A ACETAMINOPHEN; CODEINE d03423A B= M25.5 M54 Pain in joint Dorsalgia A E P A ATORVASTATIN d04105A Cr E78.0 Pure hypercholesterolemia A E P A ESCITALOPRAM d04812A C[@ F32.9 Major depressive disorder, single episode, unspecified A E P A HYDROCHLOROTHIAZIDE; VALSARTAN d04293A Dc I10 Essential (primary) hypertension A E P A MONTELUKAST d04289A C R09.81 Nasal congestion A E P A MORPHINE d00308A Bz M25.5 M54 Pain in joint Dorsalgia A E P A NIFEDIPINE d00051A Cr I10 Essential (primary) hypertension A E P A TIZANIDINE d04102A B[ M79.1 Myalgia A E ` A . . . E p A . . . E A AMLODIPINE d00689A C I10 Essential (primary) hypertension A E A HYDROCHLOROTHIAZIDE d00253A C N18.9 Chronic kidney disease, unspecified A E A AMOXICILLIN d00088A Ap J20.9 Acute bronchitis, unspecified A E A . . . E A ATROPINE OPHTHALMIC d03212A B= H57.9 Unspecified disorder of eye and adnexa A E A . . . E A GLIPIZIDE d00246A B R73 Elevated blood glucose level A@ E A LISINOPRIL d00732A C I10 Essential (primary) hypertension A@ E A METFORMIN d03807A C- R73 Elevated blood glucose level A@ E A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia A@ E A . . . E A . . . E A . . . E A . . . E A . . . E 0 A . . . E @ A AMPHETAMINE; DEXTROAMPHETAMINE d04035A C- F90 Attention-deficit hyperactivity disorders A E P A MINOCYCLINE d00110A B[ L70 Acne A E P A TRETINOIN TOPICAL d01244A B[ L70 Acne A E ` A . . . E p A . . . E A COBICISTAT; DARUNAVIR d08305A Cr B20 Human immunodeficiency virus [HIV] disease A E A EMTRICITABINE; TENOFOVIR d05352A Cr B20 Human immunodeficiency virus [HIV] disease A E A . . . E A . . . E A VENLAFAXINE d03181A C- F32.9 Major depressive disorder, single episode, unspecified A E A ALLOPURINOL d00023A0 C[@ M1A Chronic gout A E A GLIMEPIRIDE d03864A0 C E11 Type 2 diabetes mellitus A E A HYDROCHLOROTHIAZIDE d00253A0 C I10 Essential (primary) hypertension A E A LISDEXAMFETAMINE d06663A0 C R41 Other symptoms and signs involving cognitive functions and awareness A E A METFORMIN d03807A0 C E11 Type 2 diabetes mellitus A E A NEBIVOLOL d05265A0 C I10 Essential (primary) hypertension A E A RAMIPRIL d00728A0 C E11.2P Prevent diabetic kidney disease A E A ROSUVASTATIN d04851A0 C E78.0 Pure hypercholesterolemia A E A . . . E A . . . E A . . . E A CLONIDINE d00044A B[ F41.9 G47.0 Anxiety disorder, unspecified Insomnia A` E A CYPROHEPTADINE d00790A CDp R63 T78.40 Symptoms and signs concerning food and fluid intake Allergy, unspecified A` E A FAMOTIDINE d00141A C- K21 Gastro-esophageal reflux disease A` E A FLUTICASONE NASAL d04283A CDp J30.9 Allergic rhinitis, unspecified A` E A METHYLPHENIDATE d00900A C[@ F90 Attention-deficit hyperactivity disorders A` E A MONTELUKAST d04289A C J30.9 Allergic rhinitis, unspecified A` E A . . . E A . . . E 0 A . . . E @ A . . . E P A . . . E ` A ABACAVIR; DOLUTEGRAVIR; LAMIVUDINE d08284A C B20 Human immunodeficiency virus [HIV] disease Ap E ` A ATORVASTATIN d04105A Cr E78.0 Pure hypercholesterolemia Ap E ` A BETAMETHASONE d00628A C C80.1 Malignant (primary) neoplasm, unspecified Ap E ` A DARUNAVIR d05825A C B20 Human immunodeficiency virus [HIV] disease Ap E ` A RITONAVIR d03984A D B20 Human immunodeficiency virus [HIV] disease Ap E ` A TERAZOSIN d00386A Cr N40 Enlarged prostate Ap E ` A TRIAMCINOLONE TOPICAL d03206A C L20.9 Atopic dermatitis, unspecified Ap E p A . . . E A AMANTADINE d00086A CP R25 Abnormal involuntary movements A E A ATORVASTATIN d04105A C"0 E78.0 Pure hypercholesterolemia A E A BACLOFEN d00967A D G99.8 M25.9 Other specified disorders of nervous system in diseases classified elsewhere Joint disorder, unspecified A E A BENZONATATE d00796A B0 J40 R05 Bronchitis, not specified as acute or chronic Cough A E A FAMOTIDINE d00141A C"0 R12 Heartburn A E A GLATIRAMER d04111A B G99.8 Other specified disorders of nervous system in diseases classified elsewhere A E A HYDROCHLOROTHIAZIDE d00253A C"0 Z79 Long term (current) drug therapy A E A LOSARTAN d03821A C I10 Essential (primary) hypertension A E A POTASSIUM CHLORIDE d00345A Bz E87.6 Hypokalemia A E A . . . E A ATOMOXETINE d04827A C[@ F90 Attention-deficit hyperactivity disorders A E A . . . E A . . . E A DOCUSATE d01021A A K59.0 Constipation A` E A FLUCONAZOLE d00071A C- N28.9 Disorder of kidney and ureter, unspecified A` E A FUROSEMIDE d00070A C 99999 A` E A MORPHINE d00308A C G89 Pain, not elsewhere classified A` E A POTASSIUM CHLORIDE d00345A Ap 99999 A` E A PREDNISONE d00350A C C80.1 Malignant (primary) neoplasm, unspecified A` E A . . . E A . . . E A BUPROPION d00181A Cr F41.9 Anxiety disorder, unspecified AP E A LEVOTHYROXINE d00278A D' E03.9 Hypothyroidism, unspecified AP E A OMEPRAZOLE d00325A C K21 Gastro-esophageal reflux disease AP E A PRAVASTATIN d00348A C E78.0 Pure hypercholesterolemia AP E A RANITIDINE d00021A C K21 Gastro-esophageal reflux disease AP E A 99999 . . A E A AMPHETAMINE; DEXTROAMPHETAMINE d04035A Cr F90 Attention-deficit hyperactivity disorders A E A INSULIN DETEMIR d05436A CDp E11 Type 2 diabetes mellitus A E A INSULIN LISPRO d04373A Cr E11 Type 2 diabetes mellitus A E 0 A . . . E @ A CARBAMAZEPINE d00058A D M79.2 Neuralgia and neuritis, unspecified AP E @ A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified AP E @ A MONTELUKAST d04289A C- J30.9 Allergic rhinitis, unspecified AP E @ A PREGABALIN d05508A C- M79.2 Neuralgia and neuritis, unspecified AP E @ A ROPINIROLE d04215A Cr G25.81 Restless legs syndrome AP E P A DILTIAZEM d00045A CDp I49.9 Cardiac arrhythmia, unspecified A E ` A . . . E p A ARIPIPRAZOLE d04825A C- F99 Mental disorder, not otherwise specified A` E p A BUPROPION d00181A C- F32.9 Major depressive disorder, single episode, unspecified A` E p A LISINOPRIL d00732A Cr I10 Essential (primary) hypertension A` E p A MIRTAZAPINE d04025A C F99 Mental disorder, not otherwise specified A` E p A PRAVASTATIN d00348A CDp E78.0 Pure hypercholesterolemia A` E p A TAMSULOSIN d04121A CDp N42.9 Disorder of prostate, unspecified A` E A . . . E A ATORVASTATIN d04105A C- E78.0 Pure hypercholesterolemia A0 E A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified A0 E A TRAZODONE d00395A C- F32.9 G47.9 Major depressive disorder, single episode, unspecified Sleep disorder, unspecified A0 E A HYDROCHLOROTHIAZIDE d00253A C- I10 Essential (primary) hypertension A E A ALBUTEROL d00749A CP J42 J43 Unspecified chronic bronchitis Emphysema A E A AMLODIPINE d00689A CDp I99.9 Unspecified disorder of circulatory system A E A ASPIRIN d00170A C I63.P Prevent stroke A E A BUSPIRONE d00182A C- F32.9 F41.9 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified A E A CETIRIZINE d03827A Cr T78.40 Allergy, unspecified A E A CLOPIDOGREL d04258A C D75.9P Prevent blood clots A E A FLUOXETINE d00236A C- F32.9 F41.9 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified A E A HYDROXYZINE d00907A C- F41.9 Anxiety disorder, unspecified A E A LOSARTAN d03821A Dc I10 Essential (primary) hypertension A E A METOPROLOL d00134A Dc I10 Essential (primary) hypertension A E A PRAVASTATIN d00348A C E78.0 Pure hypercholesterolemia A E A TAMSULOSIN d04121A C N40 Enlarged prostate A E A TIOTROPIUM d04829A Dc J43 Emphysema A E A TRAZODONE d00395A C G47.0 Insomnia A E A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A E A FLUOXETINE d00236A C F32.9 Major depressive disorder, single episode, unspecified A E A IBUPROFEN d00015A CDp M79.1 N94 T14.9 Myalgia Pain and other conditions associated with female genital organs and menstrual cycle Unspecified injury A E A . . . E A METFORMIN d03807A A E11 Type 2 diabetes mellitus A E A . . . E A . . . E A . . . E 0 A . . . E @ A . . . E P A . . . E ` A . . . E p A . . . E A ALENDRONATE d03849A CDp M19.9 Osteoarthritis, unspecified site A E A APIXABAN d07804A C"@ D75.9P Prevent blood clots A E A ATORVASTATIN d04105A CDp E78.0 Pure hypercholesterolemia A E A CARVEDILOL d03847A C I49.9 Cardiac arrhythmia, unspecified A E A DULOXETINE d05355A C- M79.2 Neuralgia and neuritis, unspecified A E A FUROSEMIDE d00070A D I50.9 Heart failure, unspecified A E A GABAPENTIN d03182A D M79.2 Neuralgia and neuritis, unspecified A E A LISINOPRIL d00732A D# I10 Essential (primary) hypertension A E A NITROGLYCERIN d00321A D I21.P Prevent heart attack/myocardial infarction A E A SPIRONOLACTONE d00373A D I50.9 Heart failure, unspecified A E A ALPRAZOLAM d00168A Cr F41.9 Anxiety disorder, unspecified AP E A BACLOFEN d00967A C M25.5 M54 M79.1 Pain in joint Dorsalgia Myalgia AP E A CITALOPRAM d04332A B[ M79.7 Fibromyalgia AP E A FINASTERIDE d00563A C- N39.4 Other specified urinary incontinence AP E A MELOXICAM d04532A B M25.5 Pain in joint AP E A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E A AMLODIPINE d00689A C I10 Essential (primary) hypertension Ap E A AZITHROMYCIN d00091A B J44.9 Chronic obstructive pulmonary disease, unspecified Ap E A BACLOFEN d00967A D M62.83 Muscle spasm Ap E A GUAIFENESIN d00797A C R05 Cough Ap E A METFORMIN d03807A B E11 Type 2 diabetes mellitus Ap E A PREGABALIN d05508A C M79.2 Neuralgia and neuritis, unspecified Ap E A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia Ap E 0 A AMLODIPINE d00689A C E78.0 Pure hypercholesterolemia A E 0 A DAPAGLIFLOZIN d07928A C E11 Type 2 diabetes mellitus A E 0 A GLIMEPIRIDE d03864A D E11 Type 2 diabetes mellitus A E 0 A LISINOPRIL d00732A Cr 99999 A E 0 A LOSARTAN d03821A C E78.0 Pure hypercholesterolemia A E 0 A METFORMIN d03807A C E11 Type 2 diabetes mellitus A E 0 A METOPROLOL d00134A C I10 Essential (primary) hypertension A E 0 A RANITIDINE d00021A C[@ K21 Gastro-esophageal reflux disease A E @ A ALPRAZOLAM d00168A C F41.9 Anxiety disorder, unspecified AP E @ A DIVALPROEX SODIUM d03833A C- G47.0 Insomnia AP E @ A GABAPENTIN d03182A C- M79.2 Neuralgia and neuritis, unspecified AP E @ A MELOXICAM d04532A Bz Z79.1 Long term (current) use of non-steroidal anti-inflammatories (NSAID) AP E @ A OXYCODONE d00329A C M54 Dorsalgia AP E P A AMLODIPINE d00689A CDp I10 Essential (primary) hypertension A0 E P A DICLOFENAC d00848A B M54 Dorsalgia A0 E P A TIZANIDINE d04102A B M62.83 M79.1 Muscle spasm Myalgia A0 E ` A ETHINYL ESTRADIOL; NORETHINDRONE d03238A Cr Z79.3 Long term (current) use of hormonal contraceptives A E p A . . . E A ACETAMINOPHEN; TRAMADOL d04766A C- R52 Pain, unspecified A E A AMITRIPTYLINE d00146A C- F39 Unspecified mood [affective] disorder A E A APIXABAN d07804A C D75.9P Prevent blood clots A E A CYPROHEPTADINE d00790A C- T78.40 Allergy, unspecified A E A DILTIAZEM d00045A C- I10 Essential (primary) hypertension A E A DULOXETINE d05355A C- F39 Unspecified mood [affective] disorder A E A ESOMEPRAZOLE d04749A CDp K21 Gastro-esophageal reflux disease A E A GLIPIZIDE d00246A Cr E11 Type 2 diabetes mellitus A E A INSULIN GLARGINE d04538A B[ E11 Type 2 diabetes mellitus A E A LINAGLIPTIN d07767A C 99999 A E A LISINOPRIL d00732A C 99999 A E A MECLIZINE d00859A C R42 Dizziness and giddiness A E A MIRTAZAPINE d04025A C- F39 Unspecified mood [affective] disorder A E A PREGABALIN d05508A C M79.2 Neuralgia and neuritis, unspecified A E A RANITIDINE d00021A C- K31.9 Disease of stomach and duodenum, unspecified A E A CYANOCOBALAMIN d00413A C- E63.9 Nutritional deficiency, unspecified A@ E A ESOMEPRAZOLE d04749A D* K30 Functional dyspepsia A@ E A LEVOTHYROXINE d00278A CDp E03.9 Hypothyroidism, unspecified A@ E A PROPRANOLOL d00032A D1 R25.1 Tremor, unspecified A@ E A PROMETHAZINE d00787A C[@ R11 Nausea and vomiting A E A QUETIAPINE d04220A CDp G47.0 Insomnia A E A . . . E A . . . E A . . . E A AMOXICILLIN d00088A A H66.9 Otitis media, unspecified A E A OMEPRAZOLE d00325A A K21 Gastro-esophageal reflux disease A E A 99999 . . A@ E A AMOXICILLIN; CLAVULANATE d00089A A A49.9 Bacterial infection, unspecified A@ E A ENOXAPARIN d03041A B# D75.9P Prevent blood clots A@ E A IBUPROFEN d00015A B G89 Pain, not elsewhere classified A@ E A . . . E A . . . E 0 A FENOFIBRIC ACID d07371A C- E78.0 Pure hypercholesterolemia A E 0 A NEBIVOLOL d05265A C- I49.9 Cardiac arrhythmia, unspecified A E @ A LISINOPRIL d00732A C I10 Essential (primary) hypertension A E P A . . . E ` A . . . E p A AMLODIPINE d00689A B[ I10 Essential (primary) hypertension A E p A AZILSARTAN d07754A B[ I10 Essential (primary) hypertension A E p A CARVEDILOL d03847A C I10 Essential (primary) hypertension A E p A DULAGLUTIDE d08290A C E11 Type 2 diabetes mellitus A E p A FENOFIBRIC ACID d07371A C E78.0 Pure hypercholesterolemia A E p A LETROZOLE d04156A C C50 Malignant neoplasm of breast A E p A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified A E p A PRAVASTATIN d00348A C E78.0 Pure hypercholesterolemia A E A . . . E A . . . E A . . . E A . . . E A ERYTHROMYCIN OPHTHALMIC d03973A A0 H10 Conjunctivitis A E A AMLODIPINE d00689A Cr I10 Essential (primary) hypertension A0 E A LOSARTAN d03821A Cr I10 Essential (primary) hypertension A0 E A OMEPRAZOLE d00325A C[@ K21 Gastro-esophageal reflux disease A0 E A . . . E A TRIAMCINOLONE TOPICAL d03206A C[@ L20.9 Atopic dermatitis, unspecified A E A ALENDRONATE d03849A Dc M81 Osteoporosis without current pathological fracture A E A AMLODIPINE d00689A C I21.P Prevent heart attack/myocardial infarction A E A ATORVASTATIN d04105A D E78.0 Pure hypercholesterolemia A E A CELECOXIB d04380A D M19.9 Osteoarthritis, unspecified site A E A DEXLANSOPRAZOLE d07395A C K21 Gastro-esophageal reflux disease A E A GABAPENTIN d03182A C M79.2 Neuralgia and neuritis, unspecified A E A LEVOTHYROXINE d00278A Cr E03.9 Hypothyroidism, unspecified A E A METFORMIN d03807A Dc R73 Elevated blood glucose level A E A METHOTREXATE d00060A C L40 Psoriasis A E A SITAGLIPTIN d05896A Dc R73 Elevated blood glucose level A E A SUCRALFATE d00377A C K21 Gastro-esophageal reflux disease A E A TELMISARTAN d04364A Dc I21.P Prevent heart attack/myocardial infarction A E A ALLOPURINOL d00023A D E79.9 M10.9P M1A Disorder of purine and pyrimidine metabolism, unspecified Prevent gout Chronic gout A E A CELECOXIB d04380A C R51 Headache A E A DILTIAZEM d00045A A0 R51 Headache A E A FINASTERIDE d00563A C N40 Enlarged prostate A E A IBUPROFEN d00015A C M25.5 Pain in joint A E A NORTRIPTYLINE d00144A C R51 Headache A E A SILDENAFIL d04299A C N42.9 Disorder of prostate, unspecified A E A TRAZODONE d00395A CDp G47.0 Insomnia A E A . . . E 0 A . . . E @ A . . . E P A CEPHALEXIN d00096A C A49.9P Prevent bacterial infection A0 E P A OMEPRAZOLE d00325A Cr K21 Gastro-esophageal reflux disease A0 E P A PRAVASTATIN d00348A Cr E78.0 Pure hypercholesterolemia A0 E ` A . . . E p A ETHINYL ESTRADIOL; NORETHINDRONE d03238A C N92 Excessive, frequent and irregular menstruation A E p A SERTRALINE d00880A C F41.9 F99 Anxiety disorder, unspecified Mental disorder, not otherwise specified A E A . . . E A . . . E A . . . E A . . . E A CITALOPRAM d04332A C- F32.9 Major depressive disorder, single episode, unspecified A0 E A LEVOTHYROXINE d00278A C[@ E03.9 Hypothyroidism, unspecified A0 E A ROPINIROLE d04215A C G25.81 Restless legs syndrome A0 E A . . . E A CLONAZEPAM d00197A D F41.0 Panic disorder [episodic paroxysmal anxiety] without agoraphobia A E A FLUOXETINE d00236A B F32.9 F41.9 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified A E A . . . E A . . . E A . . . E A . . . E 0 A . . . E @ A . . . E P A MONTELUKAST d04289A C J30.1 J30.9 Allergic rhinitis due to pollen Allergic rhinitis, unspecified A E ` A . . . E p A ALLOPURINOL d00023A C M1A Chronic gout A@ E p A CHLORTHALIDONE d00192A C- I10 Essential (primary) hypertension A@ E p A INSULIN GLARGINE d04538A C[@ E11 Type 2 diabetes mellitus A@ E p A LOSARTAN d03821A C- I10 Essential (primary) hypertension A@ E A . . . E A LISINOPRIL d00732A C I10 Essential (primary) hypertension A0 E A OMEPRAZOLE d00325A Dc K21 Gastro-esophageal reflux disease A0 E A TRAZODONE d00395A B F32.9 G47.0 Major depressive disorder, single episode, unspecified Insomnia A0 E A . . . E A AMLODIPINE d00689A C I10 Essential (primary) hypertension A E A ACETAMINOPHEN; BUTALBITAL; CAFFEINE d03455A C G43 Migraine A0 E A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified A0 E A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia A0 E A . . . E A BENAZEPRIL d00730A Cr I10 Essential (primary) hypertension A0 E A METFORMIN d03807A CDp R73 Elevated blood glucose level A0 E A PRAVASTATIN d00348A Cr E78.0 Pure hypercholesterolemia A0 E A . . . E A . . . E A LISINOPRIL d00732A D% E11.2P Prevent diabetic kidney disease A0 E A METFORMIN d03807A D% E11 Type 2 diabetes mellitus A0 E A SIMVASTATIN d00746A D% E78.0 Pure hypercholesterolemia A0 E A CLOBETASOL TOPICAL d01288A0 B[ L98.9 Disorder of the skin and subcutaneous tissue, unspecified A E 0 A . . . E @ A AMLODIPINE d00689A Dc I10 Essential (primary) hypertension A E @ A RANITIDINE d00021A C K21 Gastro-esophageal reflux disease A E P A . . . E ` A . . . E p A NAPROXEN d00019A C- N94 Pain and other conditions associated with female genital organs and menstrual cycle A E A . . . E A ATORVASTATIN d04105A Cr I10 Essential (primary) hypertension A E A GABAPENTIN d03182A B M79.6 Pain in limb, hand, foot, fingers and toes A E A IPRATROPIUM d00265A B J45 Asthma A E A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified A E A LISINOPRIL d00732A A I10 Essential (primary) hypertension A E A METFORMIN d03807A C 99999 A E A METOPROLOL d00134A Cr I10 Essential (primary) hypertension A E A MONTELUKAST d04289A D J45 Asthma A E A . . . E A . . . E A . . . E A . . . E A DIVALPROEX SODIUM d03833A CDp F31.9 Bipolar disorder, unspecified A@ E A EFAVIRENZ; EMTRICITABINE; TENOFOVIR d05847A C B20 Human immunodeficiency virus [HIV] disease A@ E A ESCITALOPRAM d04812A Cr F32.9 Major depressive disorder, single episode, unspecified A@ E A OMEPRAZOLE d00325A Cr K21 Gastro-esophageal reflux disease A@ E A . . . E A . . . E A ACYCLOVIR d00001A C- A60.9 Anogenital herpesviral infection, unspecified AP E A ASPIRIN d00170A C I63.P N94 Prevent stroke Pain and other conditions associated with female genital organs and menstrual cycle AP E A FLUOXETINE d00236A D F42 Obsessive-compulsive disorder AP E A LISINOPRIL d00732A C- I10 Essential (primary) hypertension AP E A METHOCARBAMOL d00965A C M62.83 M79.1 Muscle spasm Myalgia AP E A . . . E 0 A ALLOPURINOL d00023A C M1A Chronic gout A E 0 A AMOXICILLIN d00088A D K04.7P Prevent tooth infection A E 0 A BETAXOLOL OPHTHALMIC d04038A Cr H40 Glaucoma A E 0 A BRIMONIDINE; BRINZOLAMIDE OPHTHALMIC d08086A Cr H40 Glaucoma A E 0 A CYCLOSPORINE OPHTHALMIC d04836A D H04 Disorders of lacrimal system A E 0 A DUTASTERIDE d04788A C R39.9 Unspecified symptoms and signs involving the genitourinary system A E 0 A FLUTICASONE NASAL d04283A Ei T78.40 Allergy, unspecified A E 0 A FUROSEMIDE d00070A C R60.9 Edema, unspecified A E 0 A LEVOTHYROXINE d00278A B E07.9 Disorder of thyroid, unspecified A E 0 A LOSARTAN d03821A Ei I10 Essential (primary) hypertension A E 0 A METOPROLOL d00134A D I51.9 Heart disease, unspecified A E 0 A TAMSULOSIN d04121A Ei R39.1 Other difficulties with micturition A E 0 A ZOLPIDEM d00910A C G47.0 Insomnia A E @ A DAPAGLIFLOZIN d07928A C E11 Type 2 diabetes mellitus A@ E @ A FEBUXOSTAT d07397A C E79.9 Disorder of purine and pyrimidine metabolism, unspecified A@ E @ A HYDROCHLOROTHIAZIDE; IRBESARTAN d04245A C N28.9P Prevent kidney disease A@ E @ A METFORMIN d03807A C E11 Type 2 diabetes mellitus A@ E P A . . . E ` A ALBUTEROL d00749A C' J44.9 Chronic obstructive pulmonary disease, unspecified A0 E ` A NIFEDIPINE d00051A C' I10 Essential (primary) hypertension A0 E ` A UMECLIDINIUM d08187A C' J44.9 Chronic obstructive pulmonary disease, unspecified A0 E p A . . . E A . . . E A AMLODIPINE d00689A C"0 I10 Essential (primary) hypertension A0 E A HYDROCHLOROTHIAZIDE d00253A B I10 R60.9 Essential (primary) hypertension Edema, unspecified A0 E A LISINOPRIL d00732A C"0 I10 Essential (primary) hypertension A0 E A ALBUTEROL d00749A C- R06.9 Unspecified abnormalities of breathing AP E A ALBUTEROL d00749A C J45 Asthma AP E A BUDESONIDE d04276A C J45 Asthma AP E A CETIRIZINE d03827A B T78.40 Allergy, unspecified AP E A FLUTICASONE NASAL d04283A B R09.8 Other specified symptoms and signs involving the circulatory and respiratory systems AP E A METOPROLOL d00134A Dc I10 Essential (primary) hypertension A E A . . . E A AMLODIPINE d00689A A I10 Essential (primary) hypertension A E A CLINDAMYCIN d00043A A K04.7 Periapical abscess without sinus A E A . . . E A . . . E A . . . E A . . . E A AMPHETAMINE; DEXTROAMPHETAMINE d04035A B F90 Attention-deficit hyperactivity disorders A E 0 A ATORVASTATIN d04105A C E11.2P Prevent diabetic kidney disease AP E 0 A DIVALPROEX SODIUM d03833A D# G40 Epilepsy and recurrent seizures AP E 0 A LEVETIRACETAM d04499A D# G40 Epilepsy and recurrent seizures AP E 0 A LISINOPRIL d00732A C- E11.2P Prevent diabetic kidney disease AP E 0 A METFORMIN d03807A C- E11 Type 2 diabetes mellitus AP E @ A . . . E P A . . . E ` A 99999 . . A0 E ` A CLOPIDOGREL d04258A D I63.P Prevent stroke A0 E ` A HYDROCHLOROTHIAZIDE d00253A C I10 Essential (primary) hypertension A0 E p A . . . E A AMIODARONE d00002A CDp I49.9 Cardiac arrhythmia, unspecified B E A AMLODIPINE d00689A C[@ I10 Essential (primary) hypertension B E A ATORVASTATIN d04105A C[@ E78.0 Pure hypercholesterolemia B E A FUROSEMIDE d00070A CDp R60.9 Edema, unspecified B E A HYDRALAZINE d00132A D:u I10 Essential (primary) hypertension B E A ISOSORBIDE d00653A CDp I20.9 Angina pectoris, unspecified B E A LEVOTHYROXINE d00278A DU E03.9 Hypothyroidism, unspecified B E A LOSARTAN d03821A C[@ I10 Essential (primary) hypertension B E A METOCLOPRAMIDE d00298A Bz R10 Abdominal and pelvic pain B E A NITROGLYCERIN d00321A C[@ R07.9 Chest pain, unspecified B E A ONDANSETRON d00867A Bz R11 Nausea and vomiting B E A PANTOPRAZOLE d04514A B K21 Gastro-esophageal reflux disease B E A SERTRALINE d00880A DU F32.9 F41.9 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified B E A SITAGLIPTIN d05896A B E11 Type 2 diabetes mellitus B E A TRAMADOL d03826A Bz R10 Abdominal and pelvic pain B E A WARFARIN d00022A C[@ Z79.0 Long term (current) use of anticoagulants and antithrombotics/antiplatelets B E A . . . E A . . . E A . . . E A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A E A MONTELUKAST d04289A C R06.2 Wheezing A E A . . . E A RANITIDINE d00021A B K21 Gastro-esophageal reflux disease A E A . . . E A . . . E A . . . E A . . . E 0 A . . . E @ A AMOXICILLIN d00088A AP J00 R05 Acute nasopharyngitis [common cold] Cough A E P A LORAZEPAM d00149A CDp F41.9 Anxiety disorder, unspecified A0 E P A OMEPRAZOLE d00325A B K30 Functional dyspepsia A0 E P A SERTRALINE d00880A B F32.9 Major depressive disorder, single episode, unspecified A0 E ` A . . . E p A . . . E A . . . E A PANTOPRAZOLE d04514A C[@ K21 K30 Gastro-esophageal reflux disease Functional dyspepsia A E A VENLAFAXINE d03181A C[@ F32.9 F41.9 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified A E A . . . E A . . . E A . . . E A . . . E A AMLODIPINE d00689A B I10 Essential (primary) hypertension A0 E A HYDRALAZINE d00132A B I10 Essential (primary) hypertension A0 E A ISOSORBIDE DINITRATE d00268A B I10 Essential (primary) hypertension A0 E A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified A E A . . . E A EZETIMIBE d04824A C E78.0 Pure hypercholesterolemia Ap E A GABAPENTIN d03182A C M79.2 Neuralgia and neuritis, unspecified Ap E A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified Ap E A LIDOCAINE TOPICAL d00683A Ei 99999 Ap E A METOPROLOL d00134A C I10 Essential (primary) hypertension Ap E A OMEPRAZOLE d00325A CP K30 Functional dyspepsia Ap E A PROPAFENONE d00358A C I49.9 Cardiac arrhythmia, unspecified Ap E A POLYMYXIN B; TRIMETHOPRIM OPHTHALMIC d03529A Ap H10 Conjunctivitis A E 0 A . . . E @ A AMLODIPINE d00689A Cr I10 Essential (primary) hypertension AP E @ A ASPIRIN d00170A CDp I21.P Prevent heart attack/myocardial infarction AP E @ A ATORVASTATIN d04105A B E78.0 Pure hypercholesterolemia AP E @ A CANAGLIFLOZIN d08080A C E11 Type 2 diabetes mellitus AP E @ A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A C"0 I10 Essential (primary) hypertension AP E P A . . . E ` A . . . E p A AMPHETAMINE d00803A C- F90 Attention-deficit hyperactivity disorders A0 E p A BACLOFEN d00967A Cr M62.83 Muscle spasm A0 E p A ZONISAMIDE d04527A C[@ G40 Epilepsy and recurrent seizures A0 E A . . . E A . . . E A . . . E A ANTIHYPERTENSIVE AGENTS - UNSPECIFIED h00024A C I10 Essential (primary) hypertension A0 E A CARBAMAZEPINE d00058A D G40 Epilepsy and recurrent seizures A0 E A LOVASTATIN d00280A C E78.0 Pure hypercholesterolemia A0 E A . . . E A . . . E A PREDNISONE d00350A B R52 Pain, unspecified A E A ALBUTEROL d00749A CDp J45 Asthma A E A FLUTICASONE d01296A CDp J45 Asthma A E A 99999 . . A E A . . . E A . . . E 0 A . . . E @ A . . . E P A AMLODIPINE d00689A D* I10 Essential (primary) hypertension A E P A CARVEDILOL d03847A Bz I10 Essential (primary) hypertension A E P A DOXAZOSIN d00726A Bz I10 Essential (primary) hypertension A E P A GLIPIZIDE d00246A Dc E11 Type 2 diabetes mellitus A E P A LEVOTHYROXINE d00278A D* E03.9 Hypothyroidism, unspecified A E P A LOSARTAN d03821A D* I10 Essential (primary) hypertension A E P A METFORMIN d03807A Dc E11 Type 2 diabetes mellitus A E P A OMEPRAZOLE d00325A Dc K21 Gastro-esophageal reflux disease A E P A SIMVASTATIN d00746A D* E78.0 Pure hypercholesterolemia A E ` A ATORVASTATIN d04105A B I21.P Prevent heart attack/myocardial infarction A0 E ` A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A B I10 Essential (primary) hypertension A0 E ` A METFORMIN d03807A B R73 Elevated blood glucose level A0 E p A AMLODIPINE d00689A D I10 Essential (primary) hypertension A E p A ATORVASTATIN d04105A D E78.0P Prevent high cholesterol A E p A CHLORTHALIDONE d00192A D I10 Essential (primary) hypertension A E p A CLOPIDOGREL d04258A D D75.9P Prevent blood clots A E p A DIVALPROEX SODIUM d03833A C G40 Epilepsy and recurrent seizures A E p A FLUTICASONE NASAL d04283A CDp J30.9 Allergic rhinitis, unspecified A E p A GLIPIZIDE d00246A D E11 Type 2 diabetes mellitus A E p A LISINOPRIL d00732A D I10 Essential (primary) hypertension A E p A METOPROLOL d00134A D I10 Essential (primary) hypertension A E p A RANITIDINE d00021A C[@ K30 Functional dyspepsia A E A . . . E A . . . E A . . . E A NAPROXEN d00019A C- G89 Pain, not elsewhere classified A E A HYDROCODONE d03075A A T14.9 Unspecified injury A E A OXYCODONE d00329A A T14.9 Unspecified injury A E A ACETAMINOPHEN; HYDROCODONE d03428A Cr M54 Dorsalgia A E A AMLODIPINE d00689A C 99999 A E A ATORVASTATIN d04105A C 99999 A E A FINASTERIDE d00563A C 99999 A E A GABAPENTIN d03182A C M79.2 Neuralgia and neuritis, unspecified A E A LISINOPRIL d00732A C I10 Essential (primary) hypertension A E A METHOCARBAMOL d00965A C M62.83 Muscle spasm A E A NAPROXEN d00019A C M54 Dorsalgia A E A TERAZOSIN d00386A C 99999 A E A . . . E A . . . E A ALBUTEROL d00749A AP R06.02 Shortness of breath A@ E A AZITHROMYCIN d00091A AP J18.9 Pneumonia, unspecified organism A@ E A DEXTROMETHORPHAN; PROMETHAZINE d03360A AP R05 Cough A@ E A LISINOPRIL d00732A D I10 Essential (primary) hypertension A@ E A AMLODIPINE; BENAZEPRIL d03829A CDp I10 Essential (primary) hypertension A` E A ASPIRIN d00170A Cr Z79.0 Long term (current) use of anticoagulants and antithrombotics/antiplatelets A` E A CHLORTHALIDONE d00192A CDp I10 Essential (primary) hypertension A` E A CLOPIDOGREL d04258A C Z79.0 Long term (current) use of anticoagulants and antithrombotics/antiplatelets A` E A ISOSORBIDE MONONITRATE d00269A B I20.9 Angina pectoris, unspecified A` E A ROSUVASTATIN d04851A C- E78.0 Pure hypercholesterolemia A` E A . . . E 0 A . . . E @ A . . . E P A ALBUTEROL d00749A B J42 Unspecified chronic bronchitis A E P A BUDESONIDE d04276A B J40 Bronchitis, not specified as acute or chronic A E ` A . . . E p A . . . E A METFORMIN; SITAGLIPTIN d06720A B E11 Type 2 diabetes mellitus A E A METOPROLOL d00134A C I10 Essential (primary) hypertension A E A . . . E A ALBUTEROL d00749A B J44.9 Chronic obstructive pulmonary disease, unspecified Ap E A ANASTROZOLE d03873A CDp C80.1P Prevent cancer Ap E A ATENOLOL d00004A C I10 Essential (primary) hypertension Ap E A BUDESONIDE; FORMOTEROL d04795A C J44.9 Chronic obstructive pulmonary disease, unspecified Ap E A CHOLESTYRAMINE d00193A C R19.7 Diarrhea, unspecified Ap E A LEVOFLOXACIN d04109A Ap J18.9 Pneumonia, unspecified organism Ap E A PREDNISONE d00350A B J18.9 Pneumonia, unspecified organism Ap E A AMLODIPINE d00689A0 C- I10 Essential (primary) hypertension A E A ATORVASTATIN d04105A0 C E78.0 Pure hypercholesterolemia A E A HYDROCHLOROTHIAZIDE d00253A0 C- I10 Essential (primary) hypertension A E A INSULIN GLARGINE d04538A0 C R73 Elevated blood glucose level A E A LISINOPRIL d00732A0 C I10 Essential (primary) hypertension A E A METFORMIN d03807A0 C- E11 Type 2 diabetes mellitus A E A METOPROLOL d00134A0 C I10 Essential (primary) hypertension A E A PIOGLITAZONE d04442A0 C- E11 Type 2 diabetes mellitus A E A . . . E A . . . E A ALPRAZOLAM d00168A Cr F33.9 F41.9 Major depressive disorder, recurrent, unspecified Anxiety disorder, unspecified Ap E A ESCITALOPRAM d04812A C F32.9 F41.9 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified Ap E A LISINOPRIL d00732A C I10 Essential (primary) hypertension Ap E A METOPROLOL d00134A C I10 Essential (primary) hypertension Ap E A OMEPRAZOLE d00325A Cr K21 Gastro-esophageal reflux disease Ap E A OXYBUTYNIN d00328A C N32.9 Bladder disorder, unspecified Ap E A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia Ap E A MONTELUKAST d04289A C J30.9 Allergic rhinitis, unspecified A E A . . . E A ATORVASTATIN d04105A B E78.0 Pure hypercholesterolemia A@ E A IBUPROFEN d00015A A K08.8 Other specified disorders of teeth and supporting structures A@ E A METFORMIN d03807A C E11 Type 2 diabetes mellitus A@ E A TRAMADOL d03826A B[ M79.6 Pain in limb, hand, foot, fingers and toes A@ E A AMLODIPINE d00689A CDp 99999 A E A FUROSEMIDE d00070A C[@ 99999 A E A GABAPENTIN d03182A C- 99999 A E A ISOSORBIDE MONONITRATE d00269A C[@ 99999 A E A METFORMIN d03807A C[@ 99999 A E A METOPROLOL d00134A C[@ 99999 A E A OMEPRAZOLE d00325A Cr 99999 A E A SIMVASTATIN d00746A CDp 99999 A E A VALSARTAN d04113A Cr 99999 A E 0 A . . . E @ A CHLORHEXIDINE TOPICAL d01231A B K04.7P Prevent tooth infection A E @ A FLUORIDE TOPICAL d04397A B[ K02 Dental caries A E P A . . . E ` A . . . E p A . . . E A . . . E A FAMOTIDINE; IBUPROFEN d07764A B[ T14.9 Unspecified injury A E A . . . E A . . . E A DONEPEZIL d04099A Cr G31.9 R41 Degenerative disease of nervous system, unspecified Other symptoms and signs involving cognitive functions and awareness A E A ALENDRONATE d03849A C- M81 Osteoporosis without current pathological fracture A E A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A E A BUPROPION d00181A C F32.9 Major depressive disorder, single episode, unspecified A E A EZETIMIBE d04824A C 99999 A E A HYDROCHLOROTHIAZIDE d00253A C R60.9 Edema, unspecified A E A MECLIZINE d00859A C R42 Dizziness and giddiness A E A MEMANTINE d04899A C R41 Other symptoms and signs involving cognitive functions and awareness A E A OMEPRAZOLE d00325A C K25 Gastric ulcer A E A . . . E A ATORVASTATIN d04105A CDp E78.0 Pure hypercholesterolemia A@ E A BUDESONIDE; FORMOTEROL d04795A B J44.9 J45 Chronic obstructive pulmonary disease, unspecified Asthma A@ E A LISINOPRIL d00732A CDp I10 Essential (primary) hypertension A@ E A METOPROLOL d00134A C- R00 Abnormalities of heart beat A@ E A . . . E A METFORMIN d03807A C R73 Elevated blood glucose level A E A ESCITALOPRAM d04812A C[@ F32.9 Major depressive disorder, single episode, unspecified A E 0 A ACETAMINOPHEN; HYDROCODONE d03428A D M54 Dorsalgia Ap E 0 A ALPRAZOLAM d00168A C F41.0 Panic disorder [episodic paroxysmal anxiety] without agoraphobia Ap E 0 A DIVALPROEX SODIUM d03833A CP F39 Unspecified mood [affective] disorder Ap E 0 A MELOXICAM d04532A B= M19.9 Osteoarthritis, unspecified site Ap E 0 A OMEPRAZOLE d00325A B K21 Gastro-esophageal reflux disease Ap E 0 A PREGABALIN d05508A C- M79.2 Neuralgia and neuritis, unspecified Ap E 0 A TIZANIDINE d04102A C M62.83 Muscle spasm Ap E @ A . . . E P A HYDROCHLOROTHIAZIDE d00253A Cr R60.9 Edema, unspecified AP E P A LOSARTAN d03821A C I10 Essential (primary) hypertension AP E P A LOVASTATIN d00280A C E78.0 Pure hypercholesterolemia AP E P A METOPROLOL d00134A C I10 Essential (primary) hypertension AP E P A RANITIDINE d00021A Cr K30 Functional dyspepsia AP E ` A . . . E p A . . . E A BUPROPION d00181A B= G47.9 Sleep disorder, unspecified A E A QUETIAPINE d04220A Ei F31.9 F32.9 Bipolar disorder, unspecified Major depressive disorder, single episode, unspecified A E A . . . E A . . . E A AMPHETAMINE; DEXTROAMPHETAMINE d04035A C- F90 Attention-deficit hyperactivity disorders A E A . . . E A . . . E A . . . E A . . . E A . . . E A ETHINYL ESTRADIOL; NORGESTIMATE d03781A B= Z79.3 Long term (current) use of hormonal contraceptives A E A . . . E 0 A 99999 . . A E 0 A DOXAZOSIN d00726A C R39.9 Unspecified symptoms and signs involving the genitourinary system A E @ A . . . E P A . . . E ` A FLUTICASONE NASAL d04283A D J30.2 J30.9 Other seasonal allergic rhinitis Allergic rhinitis, unspecified A E ` A IBUPROFEN d00015A D M54 N94 R51 Dorsalgia Pain and other conditions associated with female genital organs and menstrual cycle Headache A E p A . . . E A . . . E A MONTELUKAST d04289A Cr J30.9 Allergic rhinitis, unspecified A E A . . . E A METOPROLOL d00134A D"8 I10 Essential (primary) hypertension A E A PRAVASTATIN d00348A D"8 E78.0 Pure hypercholesterolemia A E A . . . E A ALLOPURINOL d00023A Cr M1A Chronic gout A@ E A ASPIRIN d00170A C I21.P Prevent heart attack/myocardial infarction A@ E A FENOFIBRATE d04286A Cr E78.0 Pure hypercholesterolemia A@ E A FINASTERIDE d00563A C N40 Enlarged prostate A@ E A . . . E A . . . E A . . . E A . . . E A . . . E 0 A . . . E @ A DICLOFENAC d00848A A M06.9 Rheumatoid arthritis, unspecified AP E @ A FENOFIBRATE d04286A C- E78.0 Pure hypercholesterolemia AP E @ A HYDROCHLOROTHIAZIDE; OLMESARTAN d04878A CDp I10 Essential (primary) hypertension AP E @ A PANTOPRAZOLE d04514A B K21 Gastro-esophageal reflux disease AP E @ A TERAZOSIN d00386A C- N40 Enlarged prostate AP E P A . . . E ` A LISINOPRIL d00732A D I10 Essential (primary) hypertension A E ` A TAMOXIFEN d00381A D C50 Malignant neoplasm of breast A E p A . . . E A . . . E A . . . E A HYDROXYPROGESTERONE d00554A B= 55555 A E A . . . E A . . . E A ESCITALOPRAM d04812A B F32.9 F33.9 F41.9 Major depressive disorder, single episode, unspecified Major depressive disorder, recurrent, unspecified Anxiety disorder, unspecified A E A AMLODIPINE d00689A C I10 Essential (primary) hypertension A@ E A ATENOLOL d00004A D I10 Essential (primary) hypertension A@ E A LISINOPRIL d00732A Cr I10 Essential (primary) hypertension A@ E A SIMVASTATIN d00746A CDp E78.0 Pure hypercholesterolemia A@ E A . . . E A ALLOPURINOL d00023A Dc E79.9 Disorder of purine and pyrimidine metabolism, unspecified AP E A CARVEDILOL d03847A Cr I50.9 Heart failure, unspecified AP E A FUROSEMIDE d00070A Cr R60.9 Edema, unspecified AP E A GLIMEPIRIDE d03864A D E11 R73 Type 2 diabetes mellitus Elevated blood glucose level AP E A LISINOPRIL d00732A Cr I50.9 Heart failure, unspecified AP E A . . . E A FLUTICASONE NASAL d04283A B= J30.2 R09.8 Other seasonal allergic rhinitis Other specified symptoms and signs involving the circulatory and respiratory systems A E 0 A . . . E @ A . . . E P A . . . E ` A AMLODIPINE d00689A Ei I10 Essential (primary) hypertension A0 E ` A GLIPIZIDE d00246A C E11 Type 2 diabetes mellitus A0 E ` A ILOPERIDONE d07441A CDp F20 Schizophrenia A0 E p A . . . E A . . . E A AMOXICILLIN d00088A A@ J02 Acute pharyngitis A E A ARIPIPRAZOLE d04825A B F31.9 Bipolar disorder, unspecified A E A SERTRALINE d00880A C F31.9 Bipolar disorder, unspecified A E A ETHINYL ESTRADIOL; NORETHINDRONE d03238A B[ Z79.890 Hormone replacement therapy A@ E A LEVOTHYROXINE d00278A D0z E03.9 Hypothyroidism, unspecified A@ E A LOSARTAN d03821A C I10 Essential (primary) hypertension A@ E A LOVASTATIN d00280A C[@ E78.0 Pure hypercholesterolemia A@ E A ALBUTEROL d00749A Dc J45 Asthma A0 E A BUDESONIDE; FORMOTEROL d04795A Dc J45 Asthma A0 E A VALSARTAN d04113A D I10 Essential (primary) hypertension A0 E A . . . E A . . . E A . . . E A ATORVASTATIN d04105A Dc E78.0 Pure hypercholesterolemia A E A CARVEDILOL d03847A C I21.P Prevent heart attack/myocardial infarction A E A CELECOXIB d04380A C T14.9 Unspecified injury A E A DILTIAZEM d00045A Ei 99999 A E A DORZOLAMIDE OPHTHALMIC d03805A D H40 Glaucoma A E A FEBUXOSTAT d07397A D E79.9 Disorder of purine and pyrimidine metabolism, unspecified A E A FINASTERIDE d00563A B N42.9 Disorder of prostate, unspecified A E A FUROSEMIDE d00070A C R06.9 Unspecified abnormalities of breathing A E A GLIPIZIDE d00246A C E11 Type 2 diabetes mellitus A E A ISOSORBIDE DINITRATE d00268A C I51.9 Heart disease, unspecified A E A LATANOPROST OPHTHALMIC d04017A D H40 Glaucoma A E A LOSARTAN d03821A C I10 Essential (primary) hypertension A E A MIRABEGRON d07876A B N42.9 Disorder of prostate, unspecified A E A TERAZOSIN d00386A D N42.9 Disorder of prostate, unspecified A E A ACETAMINOPHEN; HYDROCODONE d03428A C M54 Dorsalgia A` E A ATORVASTATIN d04105A C[@ E78.0 Pure hypercholesterolemia A` E A GABAPENTIN d03182A C M54 Dorsalgia A` E A MELOXICAM d04532A C M54 Dorsalgia A` E A MELOXICAM d04532A C Z79 Long term (current) drug therapy A` E A METOPROLOL d00134A C[@ I10 Essential (primary) hypertension A` E A . . . E 0 A AMOXICILLIN d00088A B H66.9 K08.8 Otitis media, unspecified Other specified disorders of teeth and supporting structures A@ E 0 A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified A@ E 0 A METHYLPREDNISOLONE d00293A B J45 Asthma A@ E 0 A TRAZODONE d00395A B G47.0 Insomnia A@ E @ A ALBUTEROL d00749A C- J45 Asthma A E P A . . . E ` A AMOXICILLIN d00088A A@ J02 Acute pharyngitis A E ` A MONTELUKAST d04289A CDp J30.9 Allergic rhinitis, unspecified A E p A AZATHIOPRINE d00024A C K50 Crohn's disease [regional enteritis] AP E p A GABAPENTIN d03182A C K50 Crohn's disease [regional enteritis] AP E p A MESALAMINE d01031A C K50 Crohn's disease [regional enteritis] AP E p A ONDANSETRON d00867A C- K50 Crohn's disease [regional enteritis] AP E p A PREDNISONE d00350A C K50 Crohn's disease [regional enteritis] AP E A MEMANTINE d04899A B 99999 A0 E A RIVASTIGMINE d04537A B 99999 A0 E A WARFARIN d00022A B 99999 A0 E A . . . E A . . . E A . . . E A . . . E A OSELTAMIVIR d04462A AP J09 Influenza due to certain identified influenza viruses A E A . . . E A . . . E A . . . E A . . . E A . . . E 0 A ETHINYL ESTRADIOL; NORGESTIMATE d03781A C) L70 Acne A E @ A . . . E P A . . . E ` A . . . E p A 99999 . . A0 E p A BENZTROPINE d00175A Bz R25.2 Cramp and spasm A0 E p A TRAZODONE d00395A Bz F32.9 Major depressive disorder, single episode, unspecified A0 E A FLUTICASONE NASAL d04283A B J30.2 Other seasonal allergic rhinitis A E A . . . E A OMEPRAZOLE d00325A B K22 Other diseases of esophagus A E A USTEKINUMAB d07396A C"0 K50 Crohn's disease [regional enteritis] A E A . . . E A AMLODIPINE d00689A C- I10 Essential (primary) hypertension A E A LOSARTAN d03821A C- I10 Essential (primary) hypertension A E A . . . E A . . . E A . . . E A ALPRAZOLAM d00168A0 C[@ F41.9 Anxiety disorder, unspecified A E A BUDESONIDE; FORMOTEROL d04795A0 D J44.9 Chronic obstructive pulmonary disease, unspecified A E A DOXYCYCLINE d00037A Ap J18.9 Pneumonia, unspecified organism A E A LEVETIRACETAM d04499A0 Dc F31.9 Bipolar disorder, unspecified A E A METHOTREXATE d00060A0 D M06.9 Rheumatoid arthritis, unspecified A E A OMEPRAZOLE d00325A0 C K21 Gastro-esophageal reflux disease A E A PREDNISONE d00350A AP J44.9 Chronic obstructive pulmonary disease, unspecified A E A QUETIAPINE d04220A0 CDp F32.9 G47.0 Major depressive disorder, single episode, unspecified Insomnia A E A TOPIRAMATE d04115A0 C F31.9 Bipolar disorder, unspecified A E A TRAMADOL d03826A0 B[ M54 Dorsalgia A E A TRAZODONE d00395A0 Cr G47.0 Insomnia A E A VENLAFAXINE d03181A0 Dc F32.9 Major depressive disorder, single episode, unspecified A E A ATORVASTATIN d04105A B[ E78.0 Pure hypercholesterolemia Ap E A ERTUGLIFLOZIN d08689A B E11 Type 2 diabetes mellitus Ap E A INSULIN DETEMIR d05436A B R73 Elevated blood glucose level Ap E A LANSOPRAZOLE d03828A B B96.81 Helicobacter pylori [H. pylori] as the cause of diseases classified elsewhere Ap E A LEVOTHYROXINE d00278A D= E03.9 Hypothyroidism, unspecified Ap E A LISINOPRIL d00732A B I10 Essential (primary) hypertension Ap E A METFORMIN d03807A C E11 Type 2 diabetes mellitus Ap E A . . . E 0 A . . . E @ A . . . E P A . . . E ` A . . . E p A . . . E A 99999 . . A@ E A INSULIN LISPRO d04373A Cr E11 Type 2 diabetes mellitus A@ E A LISINOPRIL d00732A C I10 Essential (primary) hypertension A@ E A METFORMIN d03807A C E11 Type 2 diabetes mellitus A@ E A AMLODIPINE d00689A C[@ I10 Essential (primary) hypertension Ap E A CHLORTHALIDONE d00192A C 99999 Ap E A ENALAPRIL d00013A C I10 Essential (primary) hypertension Ap E A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified Ap E A METFORMIN d03807A CDp E11 Type 2 diabetes mellitus Ap E A OMEPRAZOLE d00325A C[@ K21 Gastro-esophageal reflux disease Ap E A PRAVASTATIN d00348A C[@ E78.0 Pure hypercholesterolemia Ap E A . . . E A . . . E A . . . E A ATORVASTATIN d04105A B E78.0 Pure hypercholesterolemia A0 E A CARVEDILOL d03847A CDp I10 Essential (primary) hypertension A0 E A HYDROCHLOROTHIAZIDE; LOSARTAN d03830A B I10 Essential (primary) hypertension A0 E A . . . E A DONEPEZIL d04099A CDp R41 Other symptoms and signs involving cognitive functions and awareness AP E A METFORMIN d03807A Cr R73 Elevated blood glucose level AP E A OMEPRAZOLE d00325A C- K30 Functional dyspepsia AP E A PREGABALIN d05508A CDp M79.6 Pain in limb, hand, foot, fingers and toes AP E A TEMAZEPAM d00384A D G47.0 Insomnia AP E A GLIPIZIDE d00246A Cr E11 Type 2 diabetes mellitus A0 E A HYDROCHLOROTHIAZIDE; LOSARTAN d03830A Cr I10 Essential (primary) hypertension A0 E A METFORMIN d03807A Cr E11 Type 2 diabetes mellitus A0 E A . . . E A ALFUZOSIN d04797A Cr R39.9 Unspecified symptoms and signs involving the genitourinary system A E A ALPRAZOLAM d00168A C"0 F41.9 Anxiety disorder, unspecified A E A DALFAMPRIDINE d07546A Cr G99.8 Other specified disorders of nervous system in diseases classified elsewhere A E A DILTIAZEM d00045A D I10 Essential (primary) hypertension A E A FLUOXETINE d00236A CDp F32.9 F41.9 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified A E A GALANTAMINE d04750A C- R41 Other symptoms and signs involving cognitive functions and awareness A E A HYDRALAZINE d00132A CDp I10 Essential (primary) hypertension A E A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A Dc I10 Essential (primary) hypertension A E A LISINOPRIL d00732A Dc I10 Essential (primary) hypertension A E A METFORMIN d03807A Dc E11 Type 2 diabetes mellitus A E A METHENAMINE d00106A C[@ N39.0P Prevent urinary tract infection A E 0 A ETHINYL ESTRADIOL; NORGESTIMATE d03781A B= L70 Acne A E @ A CLONAZEPAM d00197A CDp F41.9 Anxiety disorder, unspecified A E @ A MIRTAZAPINE d04025A CDp F41.9 Anxiety disorder, unspecified A E P A ATORVASTATIN d04105A C[@ E78.0 Pure hypercholesterolemia A0 E P A FLUTICASONE; SALMETEROL d04611A C J45 Asthma A0 E P A OMEPRAZOLE d00325A CDp K21 Gastro-esophageal reflux disease A0 E ` A HYDROCODONE d03075A B= M25.5 Pain in joint A0 E ` A MELOXICAM d04532A B= M19.9 Osteoarthritis, unspecified site A0 E ` A SILDENAFIL d04299A C"0 N52.9 Male erectile dysfunction, unspecified A0 E p A . . . E A MONTELUKAST d04289A C J30.9 R05 Allergic rhinitis, unspecified Cough A E A LISINOPRIL d00732A Ap I10 Essential (primary) hypertension A E A . . . E A . . . E A ALBUTEROL d00749A C[@ R06.2 R07.9 Wheezing Chest pain, unspecified A E A EMTRICITABINE; RILPIVIRINE; TENOFOVIR d07796A CP B20 Human immunodeficiency virus [HIV] disease A0 E A LISINOPRIL d00732A Dc I10 N19 Essential (primary) hypertension Unspecified kidney failure A0 E A METFORMIN d03807A Dc E11 Type 2 diabetes mellitus A0 E A . . . E A . . . E A . . . E A SERTRALINE d00880A C- F31.9 Bipolar disorder, unspecified A E A . . . E 0 A METOPROLOL d00134A C I10 Essential (primary) hypertension A E 0 A VERAPAMIL d00048A C- I10 Essential (primary) hypertension A E @ A . . . E P A . . . E ` A . . . E p A . . . E A LISDEXAMFETAMINE d06663A CDp F90 Attention-deficit hyperactivity disorders A E A AMLODIPINE d00689A A I10 Essential (primary) hypertension A` E A FOSINOPRIL d00242A C[@ I10 Essential (primary) hypertension A` E A LEVOTHYROXINE d00278A Cr E03.9 Hypothyroidism, unspecified A` E A METFORMIN d03807A C[@ R73 Elevated blood glucose level A` E A PRAVASTATIN d00348A C P I63.P Prevent stroke A` E A SPIRONOLACTONE d00373A C- I10 Essential (primary) hypertension A` E A IBANDRONATE d05357A B M81 Osteoporosis without current pathological fracture A E A . . . E A 99999 . . A E A CITALOPRAM d04332A D F41.0 F41.9 Panic disorder [episodic paroxysmal anxiety] without agoraphobia Anxiety disorder, unspecified A@ E A GLIMEPIRIDE d03864A Bz E11 Type 2 diabetes mellitus A@ E A LOSARTAN d03821A CDp I10 Essential (primary) hypertension A@ E A METFORMIN d03807A B[ E11 Type 2 diabetes mellitus A@ E A . . . E A . . . E A DULOXETINE d05355A A F32.9 Major depressive disorder, single episode, unspecified A0 E A IBUPROFEN d00015A C G99.8 Other specified disorders of nervous system in diseases classified elsewhere A0 E A TERBINAFINE d04012A A B35 Dermatophytosis A0 E A . . . E A GABAPENTIN d03182A C M79.2 Neuralgia and neuritis, unspecified A0 E A METOPROLOL d00134A C I10 Essential (primary) hypertension A0 E A PANTOPRAZOLE d04514A D K27 Peptic ulcer, site unspecified A0 E 0 A NEBIVOLOL d05265A C[@ I10 Essential (primary) hypertension A E @ A FLUTICASONE NASAL d04283A C J30.2 Other seasonal allergic rhinitis A0 E @ A HYDROCHLOROTHIAZIDE; VALSARTAN d04293A D I10 Essential (primary) hypertension A0 E @ A PANTOPRAZOLE d04514A D K21 Gastro-esophageal reflux disease A0 E P A AMLODIPINE d00689A C I10 Essential (primary) hypertension A E P A CITALOPRAM d04332A CDp F32.9 Major depressive disorder, single episode, unspecified A E P A GLIPIZIDE d00246A C E11 Type 2 diabetes mellitus A E P A HYDROCHLOROTHIAZIDE d00253A D I10 R60.9 Essential (primary) hypertension Edema, unspecified A E P A INSULIN ASPART; INSULIN ASPART PROTAMINE d04839A D E11 Type 2 diabetes mellitus A E P A LISINOPRIL d00732A C I10 Essential (primary) hypertension A E P A MELOXICAM d04532A B[ M13 Other arthritis A E P A METOPROLOL d00134A D I10 Essential (primary) hypertension A E P A OMEPRAZOLE d00325A Cr B96.81 Helicobacter pylori [H. pylori] as the cause of diseases classified elsewhere A E P A SIMVASTATIN d00746A Cr E78.0 Pure hypercholesterolemia A E ` A . . . E p A . . . E A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A E A METFORMIN d03807A C E11 Type 2 diabetes mellitus A E A . . . E A CITALOPRAM d04332A C F32.9 F41.9 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified A E A VARENICLINE d05807A B8 F17.2 Nicotine dependence A E A . . . E A . . . E A . . . E A . . . E A DONEPEZIL d04099A0 Ei 99999 Ap E A FLUTICASONE NASAL d04283A0 C- T78.40 Allergy, unspecified Ap E A MEMANTINE d04899A0 Ei 99999 Ap E A METFORMIN d03807A0 Ei 99999 Ap E A PRAVASTATIN d00348A0 Ei 99999 Ap E A QUETIAPINE d04220A0 Ei 99999 Ap E A SERTRALINE d00880A0 Ei 99999 Ap E A . . . E A ALBUTEROL d00749A C- J45 Asthma Ap E A BUPROPION d00181A C[@ F32.9 F41.9 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified Ap E A CLONAZEPAM d00197A C F41.9 Anxiety disorder, unspecified Ap E A FLUOXETINE d00236A C F32.9 F41.9 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified Ap E A FLUTICASONE d01296A CDp R06.9 Unspecified abnormalities of breathing Ap E A FLUTICASONE; SALMETEROL d04611A CDp J44.9 Chronic obstructive pulmonary disease, unspecified Ap E A TIOTROPIUM d04829A CDp J44.9 Chronic obstructive pulmonary disease, unspecified Ap E A . . . E 0 A . . . E @ A . . . E P A . . . E ` A ALBUTEROL d00749A C J45 Asthma A E ` A CLONAZEPAM d00197A Cr F41.9 Anxiety disorder, unspecified A E ` A DULOXETINE d05355A Cr F33.9 M79.7 Major depressive disorder, recurrent, unspecified Fibromyalgia A E ` A GABAPENTIN d03182A C M79.7 Fibromyalgia A E ` A LISINOPRIL d00732A CDp I10 Essential (primary) hypertension A E ` A MONTELUKAST d04289A C J45 Asthma A E ` A OMEPRAZOLE d00325A C[@ K25 K27 K87 Gastric ulcer Peptic ulcer, site unspecified Disorders of gallbladder, biliary tract and pancreas in diseases classified elsewhere A E ` A PREDNISONE d00350A B J45 Asthma A E p A . . . E A . . . E A DOXAZOSIN d00726A D N40 Enlarged prostate A0 E A FINASTERIDE d00563A D N40 Enlarged prostate A0 E A LATANOPROST OPHTHALMIC d04017A B H40 Glaucoma A0 E A ASPIRIN d00170A C Z79.0 Long term (current) use of anticoagulants and antithrombotics/antiplatelets A E A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A C I10 Essential (primary) hypertension A E A . . . E A ATENOLOL d00004A C- I10 Essential (primary) hypertension A` E A ATORVASTATIN d04105A CDp E78.0 Pure hypercholesterolemia A` E A DULAGLUTIDE d08290A C E11 Type 2 diabetes mellitus A` E A EZETIMIBE d04824A B= E78.0 Pure hypercholesterolemia A` E A INSULIN DETEMIR d05436A CDp E11 Type 2 diabetes mellitus A` E A INSULIN LISPRO d04373A CDp E11 Type 2 diabetes mellitus A` E A . . . E A . . . E A ATORVASTATIN d04105A C- E78.0 Pure hypercholesterolemia A E A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A0 E A HYDROCHLOROTHIAZIDE d00253A C I10 Essential (primary) hypertension A0 E A LOSARTAN d03821A C I10 Essential (primary) hypertension A0 E A . . . E A PAROXETINE d03157A C F41.9 Anxiety disorder, unspecified A E 0 A . . . E @ A . . . E P A . . . E ` A . . . E p A . . . E A . . . E A ALBUTEROL d00749A CP J45 Asthma A E A IBUPROFEN d00015A CDp R51 Headache A E A . . . E A ALBUTEROL d00749A A R06.2 Wheezing A@ E A AMOXICILLIN d00088A A J02 Acute pharyngitis A@ E A IBUPROFEN d00015A A J02 Acute pharyngitis A@ E A NAPROXEN d00019A Ap T78.40 Allergy, unspecified A@ E A DIVALPROEX SODIUM d03833A CP G43 Migraine A0 E A METOPROLOL d00134A B= I51.9 Heart disease, unspecified A0 E A ROSUVASTATIN d04851A B= E78.0 Pure hypercholesterolemia A0 E A CLOPIDOGREL d04258A B D75.9P Prevent blood clots A E A HYDROCHLOROTHIAZIDE; OLMESARTAN d04878A B I10 Essential (primary) hypertension A E A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A` E A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A C I10 Essential (primary) hypertension A` E A INSULIN ASPART d04697A Cr E11 Type 2 diabetes mellitus A` E A INSULIN GLARGINE d04538A Cr E11 Type 2 diabetes mellitus A` E A METFORMIN d03807A C E11 Type 2 diabetes mellitus A` E A TAMSULOSIN d04121A C N40 Enlarged prostate A` E A BUPROPION d00181A Bz F32.9 Major depressive disorder, single episode, unspecified Ap E A GABAPENTIN d03182A C G25.81 Restless legs syndrome Ap E A HYDROCODONE d03075A C M79.6 Pain in limb, hand, foot, fingers and toes Ap E A LOSARTAN d03821A C I10 Essential (primary) hypertension Ap E A METFORMIN d03807A C E11 Type 2 diabetes mellitus Ap E A TOPIRAMATE d04115A C G40 Epilepsy and recurrent seizures Ap E A VENLAFAXINE d03181A B G47.9 Sleep disorder, unspecified Ap E A IBUPROFEN d00015A B M79.1 Myalgia A E A RANITIDINE d00021A C> K21 Gastro-esophageal reflux disease A E A HYDROCHLOROTHIAZIDE; LOSARTAN d03830A C- I10 Essential (primary) hypertension A@ E A METRONIDAZOLE TOPICAL d03208A B= L71 Rosacea A@ E A MINOCYCLINE d00110A B= L71 Rosacea A@ E A NAPROXEN d00019A C M62.83 Muscle spasm A@ E A GUANFACINE d00717A CO F91 Conduct disorders A E 0 A AMITRIPTYLINE d00146A C K58 Irritable bowel syndrome A E 0 A ATENOLOL d00004A C I48.9 Unspecified atrial fibrillation and atrial flutter A E 0 A BUPRENORPHINE d00840A C[@ M54 M79.2 Dorsalgia Neuralgia and neuritis, unspecified A E 0 A COLESEVELAM d04695A C E78.0 E78.1 Pure hypercholesterolemia Pure hyperglyceridemia A E 0 A FLUTICASONE; UMECLIDINIUM; VILANTEROL d08666A B= J42 J43 J44.9 Unspecified chronic bronchitis Emphysema Chronic obstructive pulmonary disease, unspecified A E 0 A HYOSCYAMINE d00985A D K58 Irritable bowel syndrome A E 0 A MONTELUKAST d04289A C J42 J44.9 Unspecified chronic bronchitis Chronic obstructive pulmonary disease, unspecified A E 0 A PANTOPRAZOLE d04514A B[ K21 K25.P Gastro-esophageal reflux disease Prevent gastric ulcer A E 0 A PREGABALIN d05508A D M79.2 Neuralgia and neuritis, unspecified A E 0 A ROFLUMILAST d07684A C- J42 J44.9 Unspecified chronic bronchitis Chronic obstructive pulmonary disease, unspecified A E 0 A SIMVASTATIN d00746A D E78.0 Pure hypercholesterolemia A E 0 A TAMSULOSIN d04121A C- N40 Enlarged prostate A E 0 A TRAMADOL d03826A D M25.5 M54 R10 Pain in joint Dorsalgia Abdominal and pelvic pain A E @ A . . . E P A . . . E ` A ATORVASTATIN d04105A C- E78.0 Pure hypercholesterolemia A E ` A TERAZOSIN d00386A C- I10 Essential (primary) hypertension A E p A . . . E A . . . E A . . . E A . . . E A GLYBURIDE d00248A C- E11 Type 2 diabetes mellitus A E A PROGESTERONE d00550A C[@ 55555 A E A HYDROCHLOROTHIAZIDE; LOSARTAN d03830A C- I10 Essential (primary) hypertension A E A . . . E A . . . E A ATENOLOL d00004A Dc I10 Essential (primary) hypertension AP E A LATANOPROST OPHTHALMIC d04017A D H40 Glaucoma AP E A LOSARTAN d03821A B[ I10 Essential (primary) hypertension AP E A LOVASTATIN d00280A C- E78.0 Pure hypercholesterolemia AP E A MELOXICAM d04532A C M19.9 Osteoarthritis, unspecified site AP E A GLIPIZIDE d00246A CDp R73 Elevated blood glucose level A E A INSULIN GLARGINE d04538A B E11 Type 2 diabetes mellitus A E A AMLODIPINE d00689A Bz I10 Essential (primary) hypertension A E A . . . E 0 A AMOXICILLIN d00088A A0 H66.9 Otitis media, unspecified A E @ A . . . E P A ACETAMINOPHEN; HYDROCODONE d03428A A G89 Pain, not elsewhere classified A@ E P A DICLOFENAC d00848A Ap T14.9 Unspecified injury A@ E P A DROSPIRENONE; ETHINYL ESTRADIOL d04760A B N94 Pain and other conditions associated with female genital organs and menstrual cycle A@ E P A SERTRALINE d00880A0 CDp F41.9 Anxiety disorder, unspecified A@ E ` A . . . E p A . . . E A . . . E A . . . E A BACLOFEN d00967A0 CDp M62.83 Muscle spasm B E A CAPSAICIN TOPICAL d01321A0 C M54 Dorsalgia B E A CETIRIZINE d03827A0 C T78.40 Allergy, unspecified B E A FINASTERIDE d00563A0 C N40 Enlarged prostate B E A FLUTICASONE NASAL d04283A0 C J30.9 Allergic rhinitis, unspecified B E A GABAPENTIN d03182A0 C M79.2 Neuralgia and neuritis, unspecified B E A GLIPIZIDE d00246A0 C E11 Type 2 diabetes mellitus B E A MELOXICAM d04532A0 C- M54 Dorsalgia B E A OMEPRAZOLE d00325A0 C K30 Functional dyspepsia B E A QUETIAPINE d04220A0 C F41.9 Anxiety disorder, unspecified B E A RANITIDINE d00021A0 C K30 Functional dyspepsia B E A RISPERIDONE d03180A0 C- F91 Conduct disorders B E A SERTRALINE d00880A0 C F32.9 Major depressive disorder, single episode, unspecified B E A SIMVASTATIN d00746A0 C E78.0 Pure hypercholesterolemia B E A TERAZOSIN d00386A0 C N40 Enlarged prostate B E A UREA TOPICAL d00651A0 C[@ R21 Rash and other nonspecific skin eruption B E A HYDROCHLOROTHIAZIDE; TRIAMTERENE d03052A CDp I10 Essential (primary) hypertension A E A SIMVASTATIN d00746A CDp E78.0 Pure hypercholesterolemia A E A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A C I10 Essential (primary) hypertension A E A 99999 . . A E A . . . E A . . . E A . . . E A ATORVASTATIN d04105A CDp E78.0 Pure hypercholesterolemia A@ E A GLIPIZIDE d00246A B= E11 Type 2 diabetes mellitus A@ E A LISINOPRIL d00732A CDp I10 Essential (primary) hypertension A@ E A SEMAGLUTIDE d08688A Bz E11 Type 2 diabetes mellitus A@ E A ANTIHYPERLIPIDEMIC AGENTS - UNSPECIFIED c00019. . A E A LISINOPRIL d00732A C- I10 Essential (primary) hypertension A E 0 A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A0 E 0 A LOSARTAN d03821A CDp I10 Essential (primary) hypertension A0 E 0 A SPIRONOLACTONE d00373A B E87.6 Hypokalemia A0 E @ A FLUOXETINE d00236A B F32.9 F41.9 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified A E P A LISINOPRIL d00732A Dc I10 Essential (primary) hypertension A E ` A . . . E p A . . . E A ATORVASTATIN d04105A CDp E78.0 Pure hypercholesterolemia AP E A CARVEDILOL d03847A C I50.9 Heart failure, unspecified AP E A FUROSEMIDE d00070A C I10 Essential (primary) hypertension AP E A HYDRALAZINE d00132A Cr I50.9 Heart failure, unspecified AP E A LOSARTAN d03821A C I10 Essential (primary) hypertension AP E A ALBUTEROL d00749A C[@ J45 Asthma A E A ALBUTEROL d00749A C[@ J45 Asthma A E A . . . E A . . . E A . . . E A AMPHETAMINE d00803A C F90 Attention-deficit hyperactivity disorders A E A VENLAFAXINE d03181A C F32.9 Major depressive disorder, single episode, unspecified A E A . . . E A . . . E A ALLOPURINOL d00023A C- M10.9 Gout, unspecified AP E A FAMOTIDINE d00141A Bz K30 Functional dyspepsia AP E A METOPROLOL d00134A C[@ I10 Essential (primary) hypertension AP E A PRAVASTATIN d00348A C[@ E78.0 Pure hypercholesterolemia AP E A TESTOSTERONE d00558A0 C[@ E29.1 Testicular hypofunction AP E A DONEPEZIL d04099A C G31.9 Degenerative disease of nervous system, unspecified A0 E A MEMANTINE d04899A B G31.9 Degenerative disease of nervous system, unspecified A0 E A PRAVASTATIN d00348A C E78.0P Prevent high cholesterol A0 E A FLUTICASONE NASAL d04283A A R09.81 Nasal congestion A E A IBUPROFEN d00015A A@ M06.9 Rheumatoid arthritis, unspecified A E 0 A . . . E @ A . . . E P A AMLODIPINE d00689A CDp I10 Essential (primary) hypertension Ap E P A DULAGLUTIDE d08290A B E11 Type 2 diabetes mellitus Ap E P A EMPAGLIFLOZIN; LINAGLIPTIN d08344A C E11 Type 2 diabetes mellitus Ap E P A HYDROCHLOROTHIAZIDE; VALSARTAN d04293A C- I10 Essential (primary) hypertension Ap E P A MELOXICAM d04532A C M06.9 Rheumatoid arthritis, unspecified Ap E P A METFORMIN d03807A Cr E11 Type 2 diabetes mellitus Ap E P A PRAVASTATIN d00348A C E78.0 Pure hypercholesterolemia Ap E ` A . . . E p A . . . E A ATORVASTATIN d04105A C[@ E78.0 Pure hypercholesterolemia A@ E A DOXEPIN d00217A C L50 Urticaria A@ E A OMEPRAZOLE d00325A C[@ K30 Functional dyspepsia A@ E A TAMSULOSIN d04121A C[@ N40 Enlarged prostate A@ E A ALENDRONATE d03849A CDp M81 Osteoporosis without current pathological fracture A` E A AMLODIPINE d00689A C[@ I10 Essential (primary) hypertension A` E A CYCLOSPORINE OPHTHALMIC d04836A B[ H04 Disorders of lacrimal system A` E A HYDROXYZINE d00907A B G47.9 Sleep disorder, unspecified A` E A METFORMIN d03807A C- R73 Elevated blood glucose level A` E A OLMESARTAN d04801A B I10 Essential (primary) hypertension A` E A . . . E A FLUOXETINE d00236A B F32.9 Major depressive disorder, single episode, unspecified A E A . . . E A . . . E A ALBUTEROL d00749A D J43 Emphysema A0 E A AMLODIPINE d00689A B I10 Essential (primary) hypertension A0 E A TAMSULOSIN d04121A CDp N40 Enlarged prostate A0 E A . . . E A . . . E A AMLODIPINE; HYDROCHLOROTHIAZIDE; OLMESARTAN d07668A Cr I10 Essential (primary) hypertension A` E A DOXAZOSIN d00726A Cr I10 Essential (primary) hypertension A` E A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified A` E A METFORMIN; SITAGLIPTIN d06720A C- E11 Type 2 diabetes mellitus A` E A METOPROLOL d00134A Cr I10 Essential (primary) hypertension A` E A TRAVOPROST OPHTHALMIC d04753A Cr H40 Glaucoma A` E A ETHINYL ESTRADIOL; NORETHINDRONE d03238A C N92 Excessive, frequent and irregular menstruation A E A TERBINAFINE d04012A C9 B35 Dermatophytosis A E 0 A INSULIN ASPART d04697A C E11 Type 2 diabetes mellitus A0 E 0 A INSULIN GLARGINE d04538A C E11 Type 2 diabetes mellitus A0 E 0 A METFORMIN d03807A C E11 Type 2 diabetes mellitus A0 E @ A . . . E P A HYDROCHLOROTHIAZIDE d00253A B[ R60.9 Edema, unspecified A0 E P A LISINOPRIL d00732A Dc I10 Essential (primary) hypertension A0 E P A METFORMIN d03807A Dc E11 Type 2 diabetes mellitus A0 E ` A . . . E p A LISINOPRIL d00732A CP I10 Essential (primary) hypertension A E A ALBUTEROL d00749A D* J45 Asthma Ap E A FAMOTIDINE d00141A Cr E06 E28 L65.9 Thyroiditis Ovarian dysfunction Nonscarring hair loss, unspecified Ap E A IBUPROFEN d00015A Dc G43 Migraine Ap E A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified Ap E A PANTOPRAZOLE d04514A D K21 Gastro-esophageal reflux disease Ap E A SPIRONOLACTONE d00373A C E03.9 L65.9 Hypothyroidism, unspecified Nonscarring hair loss, unspecified Ap E A TRIAMCINOLONE TOPICAL d03206A D L20.9 Atopic dermatitis, unspecified Ap E A . . . E A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A` E A FLUTICASONE NASAL d04283A C- J30.9 Allergic rhinitis, unspecified A` E A LEVETIRACETAM d04499A C G31.9 Degenerative disease of nervous system, unspecified A` E A MEMANTINE d04899A C G30.9 Alzheimer's disease, unspecified A` E A MONTELUKAST d04289A C J45 Asthma A` E A SILVER SULFADIAZINE TOPICAL d01259A B T78.40 Allergy, unspecified A` E A DOXYCYCLINE d00037A Bz L20.9 Atopic dermatitis, unspecified A@ E A ESCITALOPRAM d04812A C"0 F41.9 Anxiety disorder, unspecified A@ E A METHYLPHENIDATE d00900A Cr F90 Attention-deficit hyperactivity disorders A@ E A TOPIRAMATE d04115A B G40 R51 Epilepsy and recurrent seizures Headache A@ E A . . . E A . . . E A . . . E A AMLODIPINE d00689A B= I10 Essential (primary) hypertension Ap E A ATORVASTATIN d04105A D E78.0 Pure hypercholesterolemia Ap E A CARVEDILOL d03847A D I10 Essential (primary) hypertension Ap E A CLOPIDOGREL d04258A D Z79.0 Long term (current) use of anticoagulants and antithrombotics/antiplatelets Ap E A LEVOTHYROXINE d00278A C- E03.9 Hypothyroidism, unspecified Ap E A METFORMIN d03807A C[@ E11 Type 2 diabetes mellitus Ap E A TELMISARTAN d04364A D I10 Essential (primary) hypertension Ap E A . . . E A . . . E A . . . E 0 A ACETAMINOPHEN; HYDROCODONE d03428A CDp M54 Dorsalgia A E 0 A ALBUTEROL d00749A C R06.02 R06.2 R06.9P Shortness of breath Wheezing Prevent breathing difficulty A E 0 A AMITRIPTYLINE d00146A C- F32.9 G47.0 Major depressive disorder, single episode, unspecified Insomnia A E 0 A ATORVASTATIN d04105A CDp E78.0 Pure hypercholesterolemia A E 0 A CARVEDILOL d03847A C[@ I10 I50.9 Essential (primary) hypertension Heart failure, unspecified A E 0 A CLOPIDOGREL d04258A C D75.9P Prevent blood clots A E 0 A GABAPENTIN d03182A CDp M79.2 Neuralgia and neuritis, unspecified A E 0 A LOSARTAN d03821A CDp I10 Essential (primary) hypertension A E 0 A PANTOPRAZOLE d04514A C[@ K21 Gastro-esophageal reflux disease A E 0 A POTASSIUM CHLORIDE d00345A CDp E87.6 Hypokalemia A E @ A . . . E P A . . . E ` A BECLOMETHASONE d00760A C[@ R05 R06.2 Cough Wheezing A E p A . . . E A OMEPRAZOLE d00325A C[@ K21 K30 K57 Gastro-esophageal reflux disease Functional dyspepsia Diverticular disease of intestine A E A PANTOPRAZOLE d04514A Ap K21 Gastro-esophageal reflux disease A E A . . . E A . . . E A FLUTICASONE NASAL d04283A B 55555 A E A MONTELUKAST d04289A CDp 55555 A E A NITROFURANTOIN d00112A AP N30 Cystitis A E A APIXABAN d07804A CDp Z79.0 Long term (current) use of anticoagulants and antithrombotics/antiplatelets A0 E A DIGOXIN d00210A CDp I49.9 Cardiac arrhythmia, unspecified A0 E A METOPROLOL d00134A CDp 99999 A0 E A . . . E A . . . E A . . . E A OMEPRAZOLE d00325A C- K21 Gastro-esophageal reflux disease A E A SEVELAMER d04363A B N19 Unspecified kidney failure A E A . . . E 0 A . . . E @ A . . . E P A ROSUVASTATIN d04851A Bz E78.0 Pure hypercholesterolemia A E ` A ALPRAZOLAM d00168A B F32.9 Major depressive disorder, single episode, unspecified A0 E ` A CEFUROXIME d00056A Ap J01.9 Acute sinusitis, unspecified A0 E ` A TESTOSTERONE d00558A Dc E29.1 Testicular hypofunction A0 E p A . . . E A . . . E A CETIRIZINE d03827A C- J30.2 Other seasonal allergic rhinitis A E A MONTELUKAST d04289A C T78.40 Allergy, unspecified A E A LEVOTHYROXINE d00278A Dc E03.9 Hypothyroidism, unspecified A@ E A METFORMIN d03807A C E28 R73 Ovarian dysfunction Elevated blood glucose level A@ E A PRAVASTATIN d00348A C E78.0 Pure hypercholesterolemia A@ E A SPIRONOLACTONE d00373A Cr E28 Ovarian dysfunction A@ E A CEPHALEXIN d00096A A L08.9 Local infection of the skin and subcutaneous tissue, unspecified A E A LEVOTHYROXINE d00278A D=O E03.9 Hypothyroidism, unspecified A E A ATORVASTATIN d04105A B E78.0 Pure hypercholesterolemia A@ E A CARVEDILOL d03847A B I50.9 Heart failure, unspecified A@ E A FUROSEMIDE d00070A B R60.9 Edema, unspecified A@ E A LISINOPRIL d00732A C I10 Essential (primary) hypertension A@ E A BUMETANIDE d00179A B R60.9 Edema, unspecified A E A CARVEDILOL d03847A Cr I50.9 Heart failure, unspecified A E A FUROSEMIDE d00070A Dc R60.9 Edema, unspecified A E A GABAPENTIN d03182A Dc M79.2 Neuralgia and neuritis, unspecified A E A INSULIN ISOPHANE; INSULIN REGULAR d04374A C E11 Type 2 diabetes mellitus A E A ISOSORBIDE d00653A C 99999 A E A LISINOPRIL d00732A D I10 Essential (primary) hypertension A E A METFORMIN d03807A D> E11 Type 2 diabetes mellitus A E A PHENYTOIN d00143A Cr G40 Epilepsy and recurrent seizures A E A SERTRALINE d00880A Dc F32.9 Major depressive disorder, single episode, unspecified A E A SULFAMETHOXAZOLE; TRIMETHOPRIM d00124A C L08.9 Local infection of the skin and subcutaneous tissue, unspecified A E A TRAZODONE d00395A D= G47.9 Sleep disorder, unspecified A E A ALBUTEROL d00749A C J45 Asthma A E A ALBUTEROL d00749A C J45 Asthma A E A . . . E A 77777 . . A E A . . . E A HYDROCHLOROTHIAZIDE d00253A C I10 Essential (primary) hypertension A0 E A POTASSIUM CHLORIDE d00345A C E87.6 Hypokalemia A0 E A RANITIDINE d00021A D# K30 Functional dyspepsia A0 E 0 A PANTOPRAZOLE d04514A B K30 Functional dyspepsia A E 0 A VALACYCLOVIR d03838A A B00.1 Herpesviral vesicular dermatitis A E @ A . . . E P A ALLOPURINOL d00023A Ei N19 Unspecified kidney failure A E ` A . . . E p A . . . E A ETHINYL ESTRADIOL; NORETHINDRONE d03238A Dc Z79.3 Long term (current) use of hormonal contraceptives A E A . . . E A . . . E A ALPRAZOLAM d00168A B[ F41.9 Anxiety disorder, unspecified A E A CITALOPRAM d04332A CDp F32.9 Major depressive disorder, single episode, unspecified A E A . . . E A ADAPALENE TOPICAL d04015A C L70 Acne A E A ATORVASTATIN d04105A Cr I63.P Prevent stroke A E A TOPIRAMATE d04115A C G43 Migraine A E A . . . E A HYDROCHLOROTHIAZIDE d00253A Cr I10 Essential (primary) hypertension A@ E A LISINOPRIL d00732A C I10 Essential (primary) hypertension A@ E A ROSUVASTATIN d04851A C E78.0 Pure hypercholesterolemia A@ E A TAMSULOSIN d04121A B R39.1 Other difficulties with micturition A@ E A ZOLPIDEM d00910A C G47.0 Insomnia A E A AMOXICILLIN d00088A A A49.9P Prevent bacterial infection A E A CETIRIZINE d03827A B T78.40 Allergy, unspecified A E 0 A ATORVASTATIN d04105A C[@ E78.0 Pure hypercholesterolemia A0 E 0 A LISINOPRIL d00732A C I21.P Prevent heart attack/myocardial infarction A0 E 0 A METOPROLOL d00134A C- I10 Essential (primary) hypertension A0 E @ A . . . E P A . . . E ` A . . . E p A 99999 . . AP E p A ACETAMINOPHEN; HYDROCODONE d03428A CDp M13 M25.5 Other arthritis Pain in joint AP E p A LISINOPRIL d00732A CDp I10 Essential (primary) hypertension AP E p A METFORMIN d03807A CDp E11 Type 2 diabetes mellitus AP E p A SULFAMETHOXAZOLE d00119A C- J01.9 Acute sinusitis, unspecified AP E A CITALOPRAM d04332A C F41.9 Anxiety disorder, unspecified Ap E A CLONAZEPAM d00197A C F41.9 Anxiety disorder, unspecified Ap E A GABAPENTIN d03182A B= M79.2 Neuralgia and neuritis, unspecified Ap E A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A Dc I10 Essential (primary) hypertension Ap E A LOVASTATIN d00280A Cr E78.0 Pure hypercholesterolemia Ap E A METOPROLOL d00134A Dc R00 Abnormalities of heart beat Ap E A WARFARIN d00022A D D75.9P Prevent blood clots Ap E A METFORMIN d03807A C E11 Type 2 diabetes mellitus A E A . . . E A . . . E A ATORVASTATIN d04105A Ei 99999 A E A LISINOPRIL d00732A Ei 99999 A E A MEMANTINE d04899A Ei E66 Overweight and obesity A E A METFORMIN d03807A Ei 99999 A E A RANITIDINE d00021A Ei 99999 A E A RIVAROXABAN d07356A Ei 99999 A E A SERTRALINE d00880A Ei 99999 A E A TAMSULOSIN d04121A Ei 99999 A E A AMOXICILLIN; CLAVULANATE d00089A A J01.9 Acute sinusitis, unspecified A E A . . . E A . . . E A . . . E A . . . E A . . . E 0 A . . . E @ A . . . E P A VENLAFAXINE d03181A B K58 Irritable bowel syndrome A E ` A AMIODARONE d00002A CDp I10 Essential (primary) hypertension A E ` A AMLODIPINE d00689A Cr I10 Essential (primary) hypertension A E ` A APIXABAN d07804A B D75.9P Prevent blood clots A E ` A CLOPIDOGREL d04258A C I70.P Prevent atherosclerosis A E ` A FUROSEMIDE d00070A B[ I48.9 Unspecified atrial fibrillation and atrial flutter A E ` A ISOSORBIDE DINITRATE d00268A Cr I10 Essential (primary) hypertension A E ` A LOSARTAN d03821A B= I10 Essential (primary) hypertension A E ` A NITROGLYCERIN d00321A D R07.9 Chest pain, unspecified A E ` A PRAVASTATIN d00348A D E78.0 Pure hypercholesterolemia A E p A APIXABAN d07804A C D75.9P I21.P I63.P Prevent blood clots Prevent heart attack/myocardial infarction Prevent stroke AP E p A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia AP E p A CARVEDILOL d03847A CDp I10 I20.9 R07.9 Essential (primary) hypertension Angina pectoris, unspecified Chest pain, unspecified AP E p A DILTIAZEM d00045A CDp R07.9 Chest pain, unspecified AP E p A ISOSORBIDE MONONITRATE d00269A D I20.9 Angina pectoris, unspecified AP E A . . . E A . . . E A LISINOPRIL d00732A D I10 Essential (primary) hypertension A E A PRAVASTATIN d00348A D E78.0 Pure hypercholesterolemia A E A . . . E A . . . E A . . . E A AMOXICILLIN d00088A A J02 Acute pharyngitis A E A IBUPROFEN d00015A AP R51 Headache A E A METOPROLOL d00134A CDp I10 Essential (primary) hypertension A E A 99999 . . A@ E A AMOXICILLIN; CLAVULANATE d00089A Ap H66.9 Otitis media, unspecified A@ E A CEFDINIR d04256A A@ H66.9 Otitis media, unspecified A@ E A CIPROFLOXACIN; DEXAMETHASONE OTIC d04890A A` H66.9P Prevent ear infection A@ E A . . . E A . . . E 0 A AMLODIPINE d00689A D I10 Essential (primary) hypertension A E 0 A LEVOTHYROXINE d00278A D# E03.9 Hypothyroidism, unspecified A E @ A . . . E P A AMLODIPINE d00689A C[@ I10 Essential (primary) hypertension AP E P A ATORVASTATIN d04105A C[@ E78.0 Pure hypercholesterolemia AP E P A CARVEDILOL d03847A C[@ I10 Essential (primary) hypertension AP E P A HYDROCHLOROTHIAZIDE d00253A C[@ I10 Essential (primary) hypertension AP E P A LISINOPRIL d00732A CDp I10 Essential (primary) hypertension AP E ` A HYDROCHLOROTHIAZIDE d00253A0 D* R60.9 Edema, unspecified A@ E ` A LOSARTAN d03821A0 C I10 Essential (primary) hypertension A@ E ` A METOPROLOL d00134A0 C- I10 Essential (primary) hypertension A@ E ` A SIMVASTATIN d00746A0 C E78.0 Pure hypercholesterolemia A@ E p A . . . E A . . . E A ACYCLOVIR d00001A A B00.1 Herpesviral vesicular dermatitis A0 E A ETHINYL ESTRADIOL; NORETHINDRONE d03238A C- N92 Excessive, frequent and irregular menstruation A0 E A FLUOXETINE d00236A C F41.9 Anxiety disorder, unspecified A0 E A AMITRIPTYLINE d00146A C G47.0 Insomnia A0 E A BISOPROLOL d00709A CDp I10 Essential (primary) hypertension A0 E A FLUTICASONE NASAL d04283A B[ J30.9 Allergic rhinitis, unspecified A0 E A . . . E A . . . E A MELOXICAM d04532A C- M79.1 Myalgia A E A . . . E A . . . E A . . . E A . . . E A MONTELUKAST d04289A C- J30.9 R09.81 Allergic rhinitis, unspecified Nasal congestion A E A OSELTAMIVIR d04462A Ap J09 Influenza due to certain identified influenza viruses A E 0 A METFORMIN d03807A D"8 E11 Type 2 diabetes mellitus A0 E 0 A SAXAGLIPTIN d07467A CDp E11 Type 2 diabetes mellitus A0 E 0 A SIMVASTATIN d00746A C E78.0 I21.P Pure hypercholesterolemia Prevent heart attack/myocardial infarction A0 E @ A ATENOLOL d00004A D 99999 AP E @ A CAPTOPRIL d00006A Dc 99999 AP E @ A FENOFIBRATE d04286A Dc E78.0 Pure hypercholesterolemia AP E @ A HYDROCHLOROTHIAZIDE d00253A Dc 99999 AP E @ A METFORMIN d03807A Dc R73 Elevated blood glucose level AP E P A . . . E ` A . . . E p A . . . E A CLONIDINE d00044A D G47.0 I10 Insomnia Essential (primary) hypertension A0 E A LISINOPRIL d00732A D I10 Essential (primary) hypertension A0 E A TIMOLOL OPHTHALMIC d04037A D Z48.8 Encounter for other specified postprocedural aftercare A0 E A . . . E A HYDROCHLOROTHIAZIDE d00253A Dc I10 Essential (primary) hypertension A E A INSULIN ISOPHANE; INSULIN REGULAR d04374A D E11 Type 2 diabetes mellitus AP E A LISINOPRIL d00732A CDp E11.2P Prevent diabetic kidney disease AP E A METFORMIN d03807A C E11 Type 2 diabetes mellitus AP E A METFORMIN; SITAGLIPTIN d06720A CDp E11 Type 2 diabetes mellitus AP E A SIMVASTATIN d00746A Cr E78.0 Pure hypercholesterolemia AP E A . . . E A NORETHINDRONE d00555A Bz Z79.3 Long term (current) use of hormonal contraceptives A E A . . . E A . . . E A . . . E A LATANOPROST OPHTHALMIC d04017A C- H40 Glaucoma A E A FUROSEMIDE d00070A Cr R60.9 Edema, unspecified A@ E A GLIMEPIRIDE d03864A Cr R73 Elevated blood glucose level A@ E A PANTOPRAZOLE d04514A Cr K21 Gastro-esophageal reflux disease A@ E A RABEPRAZOLE d04448A C K21 Gastro-esophageal reflux disease A@ E 0 A . . . E @ A 99999 . . A` E @ A ANTIDIABETIC AGENTS - UNSPECIFIED c00099. . A` E @ A ANTIHYPERLIPIDEMIC AGENTS - UNSPECIFIED c00019. . A` E @ A ANTIHYPERTENSIVE AGENTS - UNSPECIFIED h00024. . A` E @ A CLINDAMYCIN d00043A A L08.9 Local infection of the skin and subcutaneous tissue, unspecified A` E @ A SULFAMETHOXAZOLE d00119A A0 B99.9 Unspecified infectious disease A` E P A . . . E ` A . . . E p A BUSPIRONE d00182A CP F41.9 Anxiety disorder, unspecified A E A . . . E A . . . E A FLUTICASONE d01296A C- J45 R05 Asthma Cough A E A LEVETIRACETAM d04499A B G40 Epilepsy and recurrent seizures A@ E A LOSARTAN d03821A B I10 Essential (primary) hypertension A@ E A METFORMIN d03807A CDp E11 Type 2 diabetes mellitus A@ E A OMEPRAZOLE d00325A C"0 K25 Gastric ulcer A@ E A . . . E A ALBUTEROL d00749A C[@ J45 Asthma A E A . . . E A ATORVASTATIN d04105A D E78.0 Pure hypercholesterolemia A@ E A INSULIN ISOPHANE (NPH) d04370A B= E11 Type 2 diabetes mellitus A@ E A METFORMIN d03807A D E11 Type 2 diabetes mellitus A@ E A TAMSULOSIN d04121A B[ N40 Enlarged prostate A@ E A . . . E A PRAVASTATIN d00348A A E78.0 Pure hypercholesterolemia A E A VERAPAMIL d00048A C R00 Abnormalities of heart beat A E A . . . E 0 A . . . E @ A . . . E P A . . . E ` A HYDROCHLOROTHIAZIDE; TRIAMTERENE d03052A Dc I10 Essential (primary) hypertension AP E ` A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified AP E ` A MELOXICAM d04532A B M79.1 Myalgia AP E ` A METOPROLOL d00134A Dc I10 Essential (primary) hypertension AP E ` A PAROXETINE d03157A D# F41.9 Anxiety disorder, unspecified AP E p A BACLOFEN d00967A D M54 Dorsalgia Ap E p A HYDROCHLOROTHIAZIDE; LOSARTAN d03830A D E11 Type 2 diabetes mellitus Ap E p A LATANOPROST OPHTHALMIC d04017A CDp H40 Glaucoma Ap E p A METFORMIN d03807A D E11 Type 2 diabetes mellitus Ap E p A METOPROLOL d00134A Cr I10 Essential (primary) hypertension Ap E p A PIOGLITAZONE d04442A D E11 Type 2 diabetes mellitus Ap E p A SIMVASTATIN d00746A D E11 Type 2 diabetes mellitus Ap E A . . . E A CYCLOBENZAPRINE d00963A A T14.9 Unspecified injury A0 E A INSULIN GLARGINE d04538A B E11 Type 2 diabetes mellitus A0 E A LOVASTATIN d00280A C- E78.0 Pure hypercholesterolemia A0 E A . . . E A . . . E A CELECOXIB d04380A D M19.9 Osteoarthritis, unspecified site A0 E A LOSARTAN d03821A C[@ I10 Essential (primary) hypertension A0 E A METOPROLOL d00134A C I49.9 Cardiac arrhythmia, unspecified A0 E A ASPIRIN d00170A D I21.P Prevent heart attack/myocardial infarction A` E A BUPROPION d00181A D F32.9 Major depressive disorder, single episode, unspecified A` E A CARVEDILOL d03847A D I10 Essential (primary) hypertension A` E A CLOPIDOGREL d04258A D I21 ST elevation (STEMI) and non-ST elevation (NSTEMI) myocardial infarction A` E A LOSARTAN d03821A C- I10 Essential (primary) hypertension A` E A TAMSULOSIN d04121A B N40 Enlarged prostate A` E A HYDROCHLOROTHIAZIDE d00253A C- I10 Essential (primary) hypertension A E A ALLOPURINOL d00023A CDp M10.9P Prevent gout A E A CARVEDILOL d03847A Cr I10 Essential (primary) hypertension A E A FLUTICASONE NASAL d04283A C[@ J30.2 Other seasonal allergic rhinitis A E A HYDRALAZINE d00132A Cr I10 Essential (primary) hypertension A E A LOSARTAN d03821A Cr I10 Essential (primary) hypertension A E A MONTELUKAST d04289A C[@ H10 J30.9 L29.9 Conjunctivitis Allergic rhinitis, unspecified Pruritus, unspecified A E A ROSUVASTATIN d04851A C[@ E78.0 Pure hypercholesterolemia A E A TORSEMIDE d03189A CDp R60.9 Edema, unspecified A E A . . . E A . . . E A CLONAZEPAM d00197A B G40 Epilepsy and recurrent seizures A@ E A LEVETIRACETAM d04499A C[@ G40 Epilepsy and recurrent seizures A@ E A LOSARTAN d03821A C[@ G40 I10 Epilepsy and recurrent seizures Essential (primary) hypertension A@ E A OXCARBAZEPINE d04513A C[@ G40 Epilepsy and recurrent seizures A@ E 0 A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A C- I10 Essential (primary) hypertension A E 0 A LEVOTHYROXINE d00278A C- E03.9 Hypothyroidism, unspecified A E @ A . . . E P A AMLODIPINE d00689A C- I10 Essential (primary) hypertension A E P A ATORVASTATIN d04105A C- E78.0 Pure hypercholesterolemia A E ` A . . . E p A . . . E A . . . E A . . . E A . . . E A . . . E A 77777 . . A E A . . . E A CETIRIZINE d03827A C T78.40 Allergy, unspecified A E A 77777 . . A E A LOSARTAN d03821A C- I10 Essential (primary) hypertension A E A AMOXICILLIN d00088A Ap J02 Acute pharyngitis A E A PREDNISONE d00350A0 A` R09 Other symptoms and signs involving the circulatory and respiratory system A E A . . . E A . . . E 0 A AMPHETAMINE d00803A0 CDp F90 Attention-deficit hyperactivity disorders A E @ A . . . E P A ALLOPURINOL d00023A C M1A Chronic gout A E P A AMLODIPINE d00689A C I10 Essential (primary) hypertension A E P A CARVEDILOL d03847A C I10 Essential (primary) hypertension A E P A CLOPIDOGREL d04258A Cr Z79.0 Long term (current) use of anticoagulants and antithrombotics/antiplatelets A E P A DOXAZOSIN d00726A B= R35 Polyuria A E P A HYDROCHLOROTHIAZIDE; LOSARTAN d03830A C I10 Essential (primary) hypertension A E P A LANSOPRAZOLE d03828A Cr K25 Gastric ulcer A E P A METFORMIN d03807A C R73 Elevated blood glucose level A E P A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia A E ` A CYCLOBENZAPRINE d00963A C M62.83 M79.1 Muscle spasm Myalgia A E p A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E A AMLODIPINE d00689A D9 I10 Essential (primary) hypertension A E A ATORVASTATIN d04105A D9 E78.0 Pure hypercholesterolemia A E A CILOSTAZOL d04382A D9 99999 A E A CINACALCET d05218A CDp K92.9 Disease of digestive system, unspecified A E A CLOPIDOGREL d04258A D9 I99.9 Unspecified disorder of circulatory system A E A CODEINE d00012A D9 M25.5 Pain in joint A E A FUROSEMIDE d00070A D9 R60.9 Edema, unspecified A E A HYDROXYZINE d00907A D9 L29.9 R21 Pruritus, unspecified Rash and other nonspecific skin eruption A E A INSULIN GLARGINE d04538A D9 E11 Type 2 diabetes mellitus A E A ISOSORBIDE MONONITRATE d00269A D9 I10 Essential (primary) hypertension A E A METOPROLOL d00134A D9 I10 Essential (primary) hypertension A E A SEVELAMER d04363A C- 55555 A E A TAMSULOSIN d04121A Cr N40 Enlarged prostate A E A TAMSULOSIN d04121A D9 N40 Enlarged prostate A E A CLOPIDOGREL d04258A B D75.9P Prevent blood clots A@ E A CONJUGATED ESTROGENS d00541A D Z79.890 Hormone replacement therapy A@ E A HYDROCHLOROTHIAZIDE; SPIRONOLACTONE d03247A D I10 Essential (primary) hypertension A@ E A SIMVASTATIN d00746A C[@ E78.0 Pure hypercholesterolemia A@ E A HYDROCHLOROTHIAZIDE; LOSARTAN d03830A D= I10 Essential (primary) hypertension A E A METOPROLOL d00134A C I10 Essential (primary) hypertension A E A . . . E 0 A PANTOPRAZOLE d04514A B K21 Gastro-esophageal reflux disease A E @ A . . . E P A ETHINYL ESTRADIOL; NORETHINDRONE d03238A C E28 Z79.3 Ovarian dysfunction Long term (current) use of hormonal contraceptives A E ` A . . . E p A . . . E A ACETAMINOPHEN; OXYCODONE d03431A C9 M54 Dorsalgia Ap E A BENZTROPINE d00175A Dc F32.9 Major depressive disorder, single episode, unspecified Ap E A CITALOPRAM d04332A C- F32.9 F41.9 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified Ap E A CLONIDINE d00044A D# I10 Essential (primary) hypertension Ap E A HYDROCHLOROTHIAZIDE; VALSARTAN d04293A C- I10 R60.9 Essential (primary) hypertension Edema, unspecified Ap E A METFORMIN d03807A Cr E11 Type 2 diabetes mellitus Ap E A TRAZODONE d00395A D F32.9 F41.9 G47.0 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified Insomnia Ap E A AZATHIOPRINE d00024A CDp 99999 A E A CARVEDILOL d03847A CDp 99999 A E A CLONIDINE d00044A CDp I10 Essential (primary) hypertension A E A DOXAZOSIN d00726A CDp I10 Essential (primary) hypertension A E A INSULIN GLARGINE d04538A C- E10 Type 1 diabetes mellitus A E A INSULIN LISPRO d04373A C E10 Type 1 diabetes mellitus A E A LOVASTATIN d00280A CDp E78.0 Pure hypercholesterolemia A E A MINOXIDIL d00135A CDp I10 Essential (primary) hypertension A E A NIFEDIPINE d00051A CDp I10 Essential (primary) hypertension A E A PANTOPRAZOLE d04514A CDp A49.9P Prevent bacterial infection A E A PREDNISONE d00350A CDp T86.9P Prevent transplanted organ and tissue rejection A E A SULFAMETHOXAZOLE d00119A CDp A49.9P Prevent bacterial infection A E A . . . E A . . . E A . . . E A ATENOLOL d00004A D* I10 Essential (primary) hypertension A0 E A ATORVASTATIN d04105A D* E78.0 Pure hypercholesterolemia A0 E A LOSARTAN d03821A D* I10 Essential (primary) hypertension A0 E A . . . E A AMLODIPINE; HYDROCHLOROTHIAZIDE; OLMESARTAN d07668A0 C I10 Essential (primary) hypertension A E A EZETIMIBE d04824A0 C E78.0 Pure hypercholesterolemia A E A AMPHETAMINE d00803A C F90 Attention-deficit hyperactivity disorders A E A . . . E A HYDROXYZINE d00907A A L29.9 Pruritus, unspecified A E 0 A . . . E @ A . . . E P A . . . E ` A GLIPIZIDE d00246A B E11.P Prevent diabetes A E p A . . . E A ANTI-INFECTIVES - UNSPECIFIED c00001A A Z79 Long term (current) drug therapy A E A BUPROPION d00181A C"0 F32.9 Major depressive disorder, single episode, unspecified AP E A CITALOPRAM d04332A D F32.9 Major depressive disorder, single episode, unspecified AP E A CYCLOBENZAPRINE d00963A A@ M79.1 Myalgia AP E A NAPROXEN d00019A A0 M79.1 Myalgia AP E A TENOFOVIR d04774A B B19 Unspecified viral hepatitis AP E A ALPRAZOLAM d00168A D* F41.0 F41.9 G47.0 Panic disorder [episodic paroxysmal anxiety] without agoraphobia Anxiety disorder, unspecified Insomnia A E A ATROPINE; DIPHENOXYLATE d03506A C K51 Ulcerative colitis A E A BUDESONIDE d04276A C K51 Ulcerative colitis A E A CARVEDILOL d03847A C- 99999 A E A FLUOXETINE d00236A B F32.9 Major depressive disorder, single episode, unspecified A E A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A D7 I10 Essential (primary) hypertension A E A LEVOTHYROXINE d00278A D@) E03.9 Hypothyroidism, unspecified A E A SIMVASTATIN d00746A C- E78.0 Pure hypercholesterolemia A E A TRAMADOL d03826A C- M79.2 Neuralgia and neuritis, unspecified A E A TRAMADOL d03826A C- M79.2 Neuralgia and neuritis, unspecified A E A TRAZODONE d00395A C G47.0 Insomnia A E A . . . E A . . . E A CLONIDINE d00044A Dc I10 Essential (primary) hypertension A` E A HYDROCHLOROTHIAZIDE; OLMESARTAN d04878A Dc I10 Essential (primary) hypertension A` E A METFORMIN d03807A C[@ E11 Type 2 diabetes mellitus A` E A MONTELUKAST d04289A A T78.40 Allergy, unspecified A` E A NEBIVOLOL d05265A C I10 Essential (primary) hypertension A` E A TIZANIDINE d04102A Cr M54 Dorsalgia A` E A ALBUTEROL d00749A C[@ J45 Asthma A E A LISDEXAMFETAMINE d06663A C- F90 Attention-deficit hyperactivity disorders A E A . . . E A ACETAMINOPHEN; HYDROCODONE d03428A B G89 Pain, not elsewhere classified A E A ATORVASTATIN d04105A B= E78.0 Pure hypercholesterolemia A E A ETHINYL ESTRADIOL; NORETHINDRONE d03238A C Z79.3 Long term (current) use of hormonal contraceptives A E A CELECOXIB d04380A Ap M79.1 Myalgia A0 E A MOMETASONE NASAL d04223A C J01.9 J30.9 R09.81 Acute sinusitis, unspecified Allergic rhinitis, unspecified Nasal congestion A0 E A PANTOPRAZOLE d04514A CDp K21 R12 Gastro-esophageal reflux disease Heartburn A0 E 0 A . . . E @ A ATORVASTATIN d04105A D I21.P Prevent heart attack/myocardial infarction AP E @ A FAMOTIDINE d00141A C K30 Functional dyspepsia AP E @ A METFORMIN d03807A CDp R73 Elevated blood glucose level AP E @ A OMEPRAZOLE d00325A A K30 Functional dyspepsia AP E @ A VENLAFAXINE d03181A C F39 Unspecified mood [affective] disorder AP E P A . . . E ` A ALLOPURINOL d00023A D9 M1A Chronic gout A` E ` A ALPRAZOLAM d00168A Cr G47.9 Sleep disorder, unspecified A` E ` A FUROSEMIDE d00070A Dc R60.9 Edema, unspecified A` E ` A MELOXICAM d04532A Cr M19.9 Osteoarthritis, unspecified site A` E ` A POTASSIUM CHLORIDE d00345A Dc E87.6P Prevent hypokalemia A` E ` A PREDNISONE d00350A D* M35 Other systemic involvement of connective tissue A` E p A . . . E A . . . E A . . . E A . . . E A . . . E A BENAZEPRIL; HYDROCHLOROTHIAZIDE d03265A Dc I10 Essential (primary) hypertension A@ E A LEVOCETIRIZINE d05851A CDp H10.1 Acute atopic conjunctivitis A@ E A METOPROLOL d00134A Dc I10 Essential (primary) hypertension A@ E A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia A@ E A . . . E A HYDROCHLOROTHIAZIDE; LOSARTAN d03830A C I10 Essential (primary) hypertension AP E A PREDNISONE d00350A A0 55555 AP E A ROSUVASTATIN d04851A C E78.0 Pure hypercholesterolemia AP E A SERTRALINE d00880A C F41.9 Anxiety disorder, unspecified AP E A VALACYCLOVIR d03838A A0 55555 AP E A AMLODIPINE d00689A Cr I10 Essential (primary) hypertension A` E A ATORVASTATIN d04105A Cr E78.0 Pure hypercholesterolemia A` E A GLIPIZIDE d00246A Cr E11 Type 2 diabetes mellitus A` E A INSULIN GLARGINE d04538A C E11 Type 2 diabetes mellitus A` E A LISINOPRIL d00732A Cr I10 Essential (primary) hypertension A` E A METFORMIN d03807A Cr E11 Type 2 diabetes mellitus A` E A ALLOPURINOL d00023A C 99999 Ap E A AMLODIPINE d00689A C 99999 Ap E A COLCHICINE d00150A C M1A Chronic gout Ap E A FUROSEMIDE d00070A C R60.9 Edema, unspecified Ap E A ISOSORBIDE MONONITRATE d00269A C 99999 Ap E A LISINOPRIL d00732A C 99999 Ap E A TAMSULOSIN d04121A C 99999 Ap E A AMIODARONE d00002A C"0 99999 A E A APIXABAN d07804A C"0 99999 A E A DILTIAZEM d00045A C"0 99999 A E A DULOXETINE d05355A C"0 99999 A E A FUROSEMIDE d00070A C"0 99999 A E A GABAPENTIN d03182A C"0 99999 A E A MONTELUKAST d04289A C"0 99999 A E A PANTOPRAZOLE d04514A C"0 99999 A E A ALENDRONATE d03849A C M81 Osteoporosis without current pathological fracture Ap E A AMLODIPINE d00689A C I10 Essential (primary) hypertension Ap E A CARVEDILOL d03847A C I10 Essential (primary) hypertension Ap E A FLUTICASONE d01296A C- R06.2 Wheezing Ap E A LEVOCETIRIZINE d05851A B J30.9 Allergic rhinitis, unspecified Ap E A OMEPRAZOLE d00325A C- K25 Gastric ulcer Ap E A VALSARTAN d04113A C I10 Essential (primary) hypertension Ap E 0 A . . . E @ A CITALOPRAM d04332A D G47.0 Insomnia A0 E @ A LEVOTHYROXINE d00278A D E03.9 Hypothyroidism, unspecified A0 E @ A OMEPRAZOLE d00325A C- K21 Gastro-esophageal reflux disease A0 E P A . . . E ` A AMITRIPTYLINE d00146A B[ R51 Headache A E ` A ETHINYL ESTRADIOL; LEVONORGESTREL d03242A B Z79.3 Long term (current) use of hormonal contraceptives A E p A . . . E A . . . E A . . . E A HYDROXYZINE d00907A C- I10 Essential (primary) hypertension A@ E A IBUPROFEN d00015A C R51 Headache A@ E A NITROFURANTOIN d00112A A J02 Acute pharyngitis A@ E A ONDANSETRON d00867A A R11 Nausea and vomiting A@ E A AMITRIPTYLINE d00146A C G47.0 Insomnia A E A BUPROPION d00181A C F32.9 Major depressive disorder, single episode, unspecified A E A CYCLOBENZAPRINE d00963A C M79.7 Fibromyalgia A E A DICLOFENAC d00848A C M79.7 Fibromyalgia A E A DULOXETINE d05355A Bz F32.9 Major depressive disorder, single episode, unspecified A E A LISINOPRIL d00732A C I10 Essential (primary) hypertension A E A METFORMIN d03807A C E11 Type 2 diabetes mellitus A E A OMEPRAZOLE d00325A C K30 Functional dyspepsia A E A OXCARBAZEPINE d04513A C M79.7 Fibromyalgia A E A . . . E A GUANFACINE d00717A Cr 55555 A E A FLUOXETINE d00236A B= F41.9 Anxiety disorder, unspecified A E A DROSPIRENONE; ETHINYL ESTRADIOL d04760A B E28 Ovarian dysfunction A0 E A LEVOTHYROXINE d00278A Dc E03.9 Hypothyroidism, unspecified A0 E A METFORMIN d03807A D E28 Ovarian dysfunction A0 E A AMLODIPINE; BENAZEPRIL d03829A C I10 Essential (primary) hypertension A0 E A HYDROCHLOROTHIAZIDE; VALSARTAN d04293A C I10 Essential (primary) hypertension A0 E A RANITIDINE d00021A B K21 Gastro-esophageal reflux disease A0 E A . . . E A AMLODIPINE d00689A C I10 Essential (primary) hypertension AP E A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia AP E A INSULIN ISOPHANE; INSULIN REGULAR d04374A C E11 Type 2 diabetes mellitus AP E A LISINOPRIL d00732A C I10 Essential (primary) hypertension AP E A METFORMIN d03807A C E11 Type 2 diabetes mellitus AP E 0 A . . . E @ A . . . E P A FAMOTIDINE d00141A B[ K30 Functional dyspepsia A E ` A AMLODIPINE d00689A C[@ I10 Essential (primary) hypertension A E ` A ATORVASTATIN d04105A B E78.0 Pure hypercholesterolemia A E ` A HYDROCHLOROTHIAZIDE d00253A C- 99999 A E ` A IBUPROFEN d00015A B M25.5 M54 M79.1 Pain in joint Dorsalgia Myalgia A E ` A LOSARTAN d03821A C- 99999 A E ` A METFORMIN d03807A C E11 Type 2 diabetes mellitus A E ` A POTASSIUM CHLORIDE d00345A B E87.6 Hypokalemia A E ` A SILDENAFIL d04299A C N52.9 Male erectile dysfunction, unspecified A E ` A TAMSULOSIN d04121A C[@ N40 Enlarged prostate A E p A . . . E A RANITIDINE d00021A Bz K30 Functional dyspepsia A E A . . . E A OMEPRAZOLE d00325A D R12 Heartburn A E A . . . E A . . . E A ATORVASTATIN d04105A D@) E78.0 Pure hypercholesterolemia A E A BENAZEPRIL d00730A D@) I10 Essential (primary) hypertension A E A CELECOXIB d04380A D@) M06.9 Rheumatoid arthritis, unspecified A E A DONEPEZIL d04099A D@) G31.9 Degenerative disease of nervous system, unspecified A E A FINASTERIDE d00563A D@) N40 Enlarged prostate A E A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified A E A POTASSIUM CHLORIDE d00345A D@) E87.6 Hypokalemia A E A RANITIDINE d00021A D@) K21 Gastro-esophageal reflux disease A E A 77777 . . A E A . . . E A . . . E A AMOXICILLIN d00088A A` J18.9 Pneumonia, unspecified organism A E A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia AP E A GLIPIZIDE d00246A C E11 Type 2 diabetes mellitus AP E A INSULIN DETEMIR d05436A C- E11 Type 2 diabetes mellitus AP E A NIFEDIPINE d00051A C I10 Essential (primary) hypertension AP E A QUINAPRIL d00365A C I10 Essential (primary) hypertension AP E 0 A ATENOLOL d00004A C I10 Essential (primary) hypertension A E 0 A BUPROPION d00181A B F32.9 Major depressive disorder, single episode, unspecified A E 0 A ESCITALOPRAM d04812A B F32.9 Major depressive disorder, single episode, unspecified A E 0 A GABAPENTIN d03182A B M19.9 Osteoarthritis, unspecified site A E 0 A HYDROCHLOROTHIAZIDE d00253A B I10 Essential (primary) hypertension A E 0 A INSULIN ASPART d04697A C- E11 Type 2 diabetes mellitus A E 0 A INSULIN GLARGINE d04538A C- E11 Type 2 diabetes mellitus A E 0 A LISINOPRIL d00732A C- I10 Essential (primary) hypertension A E 0 A SIMVASTATIN d00746A B E78.0 Pure hypercholesterolemia A E @ A ACETAMINOPHEN; HYDROCODONE d03428A AP K08.8 Other specified disorders of teeth and supporting structures A0 E @ A ATORVASTATIN d04105A B E78.0 Pure hypercholesterolemia A0 E @ A CLINDAMYCIN d00043A AP A49.9 Bacterial infection, unspecified A0 E P A AMLODIPINE d00689A C[@ I10 Essential (primary) hypertension A` E P A CARVEDILOL d03847A Cr I10 Essential (primary) hypertension A` E P A FLUTICASONE NASAL d04283A C J30.2 Other seasonal allergic rhinitis A` E P A HYDRALAZINE d00132A C I10 Essential (primary) hypertension A` E P A LOSARTAN d03821A Cr I10 Essential (primary) hypertension A` E P A MELOXICAM d04532A C M19.9 Osteoarthritis, unspecified site A` E ` A . . . E p A . . . E A . . . E A . . . E A . . . E A ATENOLOL d00004A D I10 Essential (primary) hypertension A0 E A ATORVASTATIN d04105A D E78.0 Pure hypercholesterolemia A0 E A HYDROCHLOROTHIAZIDE d00253A D R60.9 Edema, unspecified A0 E A ASPIRIN d00170A Cr Z79.0 Long term (current) use of anticoagulants and antithrombotics/antiplatelets A0 E A LISINOPRIL d00732A Cr I10 Essential (primary) hypertension A0 E A SIMVASTATIN d00746A Cr E78.0P Prevent high cholesterol A0 E A ACETAMINOPHEN; HYDROCODONE d03428A Cr M54 Dorsalgia A E A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia A E A . . . E A LISINOPRIL d00732A C I10 Essential (primary) hypertension A0 E A MECLIZINE d00859A C[@ R42 Dizziness and giddiness A0 E A TIMOLOL OPHTHALMIC d04037A C H40 Glaucoma A0 E A . . . E A HYDROCHLOROTHIAZIDE; LOSARTAN d03830A C I10 Essential (primary) hypertension A E A . . . E 0 A . . . E @ A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A E @ A BENAZEPRIL d00730A D I10 Essential (primary) hypertension A E @ A FUROSEMIDE d00070A CDp R60.9 Edema, unspecified A E @ A INSULIN ISOPHANE (NPH) d04370A D* E11 Type 2 diabetes mellitus A E @ A INSULIN REGULAR d04369A D* E11 Type 2 diabetes mellitus A E @ A METFORMIN d03807A D E11 Type 2 diabetes mellitus A E @ A OMEGA-3 POLYUNSATURATED FATTY ACIDS d00497A CDp E78.1 Pure hyperglyceridemia A E @ A OMEPRAZOLE d00325A C- K31.9 Disease of stomach and duodenum, unspecified A E @ A POTASSIUM CHLORIDE d00345A CDp Z79 Long term (current) drug therapy A E P A . . . E ` A 99999 . . A E p A CARVEDILOL d03847A C R07.9 Chest pain, unspecified A@ E p A LOSARTAN d03821A CDp I10 Essential (primary) hypertension A@ E p A MELOXICAM d04532A C M25.5 Pain in joint A@ E p A ROSUVASTATIN d04851A C- E78.0 Pure hypercholesterolemia A@ E A METHIMAZOLE d00290A Cr E05 Thyrotoxicosis [hyperthyroidism] A E A 99999 . . A E A ALBUTEROL d00749A D J45 Asthma A E A ALBUTEROL d00749A D J45 Asthma A E A FLUTICASONE d01296A C J45 Asthma A E A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E A CLOPIDOGREL d04258A B- D75.9P Prevent blood clots A0 E A COLESTIPOL d00744A Ei E78.0 Pure hypercholesterolemia A0 E A METOPROLOL d00134A B= I10 Essential (primary) hypertension A0 E 0 A GABAPENTIN d03182A B[ M79.2 Neuralgia and neuritis, unspecified A@ E 0 A HYDROCHLOROTHIAZIDE d00253A CDp I10 Essential (primary) hypertension A@ E 0 A LISINOPRIL d00732A CDp I10 Essential (primary) hypertension A@ E 0 A NAPROXEN d00019A B- M54 Dorsalgia A@ E @ A . . . E P A ACETAMINOPHEN; OXYCODONE d03431A B R10 Abdominal and pelvic pain A E P A IBUPROFEN d00015A B M79.1 Myalgia A E ` A . . . E p A . . . E A . . . E A . . . E A . . . E A . . . E A AMLODIPINE d00689A C- I10 Essential (primary) hypertension Ap E A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia Ap E A CLOPIDOGREL d04258A C D75.9P Prevent blood clots Ap E A HYDRALAZINE d00132A C- I10 Essential (primary) hypertension Ap E A INSULIN ASPART d04697A CDp E11 Type 2 diabetes mellitus Ap E A INSULIN DETEMIR d05436A CDp E11 Type 2 diabetes mellitus Ap E A POLYETHYLENE GLYCOL 3350 d05350A C K59.0 Constipation Ap E A METOPROLOL d00134A C- I10 Essential (primary) hypertension A E A . . . E A . . . E A ATENOLOL d00004A Cr I63.P Prevent stroke A E A HYDROCODONE d03075A Cr M54 Dorsalgia A E A ALBUTEROL d00749A C J45 Asthma A E A BUDESONIDE; FORMOTEROL d04795A CDp J45 Asthma A E A ALBUTEROL d00749A C J43 J44.9 R06.9P Emphysema Chronic obstructive pulmonary disease, unspecified Prevent breathing difficulty AP E A ALBUTEROL d00749A C J44.9 R06.02 R06.9P Chronic obstructive pulmonary disease, unspecified Shortness of breath Prevent breathing difficulty AP E A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia AP E A FLUTICASONE; VILANTEROL d08100A C J42 J43 J44.9 Unspecified chronic bronchitis Emphysema Chronic obstructive pulmonary disease, unspecified AP E A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A C I10 Essential (primary) hypertension AP E 0 A CLINDAMYCIN d00043A C L70 Acne A0 E 0 A SPIRONOLACTONE d00373A C L70 Acne A0 E 0 A TRETINOIN TOPICAL d01244A C"@ L70 Acne A0 E @ A . . . E P A . . . E ` A ATORVASTATIN d04105A C I21.P Prevent heart attack/myocardial infarction Ap E ` A DILTIAZEM d00045A C I48.9 Unspecified atrial fibrillation and atrial flutter Ap E ` A ISOSORBIDE MONONITRATE d00269A C I21.P Prevent heart attack/myocardial infarction Ap E ` A LANSOPRAZOLE d03828A C K21 Gastro-esophageal reflux disease Ap E ` A METFORMIN; SITAGLIPTIN d06720A C R73 Elevated blood glucose level Ap E ` A METOPROLOL d00134A C I21.P Prevent heart attack/myocardial infarction Ap E ` A WARFARIN d00022A C D75.9P Prevent blood clots Ap E p A . . . E A CEFDINIR d04256A A H66.9 Otitis media, unspecified A E A . . . E A . . . E A . . . E A . . . E A . . . E A AMPHETAMINE; DEXTROAMPHETAMINE d04035A CDp F90 Attention-deficit hyperactivity disorders A` E A ARIPIPRAZOLE d04825A Cr F31.9 Bipolar disorder, unspecified A` E A CLONAZEPAM d00197A Cr F41.9 Anxiety disorder, unspecified A` E A LAMOTRIGINE d03809A Cr F39 Unspecified mood [affective] disorder A` E A PRAZOSIN d00138A C G47.9 Sleep disorder, unspecified A` E A VENLAFAXINE d03181A C F32.9 Major depressive disorder, single episode, unspecified A` E A CLONAZEPAM d00197A CDp F32.9 F41.9 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified A0 E A MECLIZINE d00859A C- R42 Dizziness and giddiness A0 E A OMEPRAZOLE d00325A CDp K21 Gastro-esophageal reflux disease A0 E A DEXMETHYLPHENIDATE d04777A C F90 Attention-deficit hyperactivity disorders A E A . . . E A . . . E 0 A . . . E @ A . . . E P A . . . E ` A ETHINYL ESTRADIOL; NORETHINDRONE d03238A Bz N92 Excessive, frequent and irregular menstruation A E p A . . . E A . . . E A . . . E A . . . E A . . . E A ACETAMINOPHEN; HYDROCODONE d03428A D T14.9 Unspecified injury A E A AMITRIPTYLINE d00146A C- G25.81 Restless legs syndrome A E A AMLODIPINE d00689A C I10 Essential (primary) hypertension A E A CLONIDINE d00044A C I10 Essential (primary) hypertension A E A CYCLOBENZAPRINE d00963A C M62.83 Muscle spasm A E A HYDROCHLOROTHIAZIDE d00253A C R60.9 Edema, unspecified A E A OMEPRAZOLE d00325A C K21 Gastro-esophageal reflux disease A E A POTASSIUM CHLORIDE d00345A C E87.6 Hypokalemia A E A DROSPIRENONE; ETHINYL ESTRADIOL d04760A B= Z79.3 Long term (current) use of hormonal contraceptives A E A . . . E A EXENATIDE d05529A B R73 Elevated blood glucose level A0 E A PIOGLITAZONE d04442A B R73 Elevated blood glucose level A0 E A SPIRONOLACTONE d00373A C L70 Acne A0 E A . . . E A . . . E A OSELTAMIVIR d04462A A0 J09 Influenza due to certain identified influenza viruses A E 0 A . . . E @ A . . . E P A . . . E ` A . . . E p A ALPRAZOLAM d00168A Cr F41.9 G47.0 Anxiety disorder, unspecified Insomnia A0 E p A FLUOXETINE d00236A C F32.9 Major depressive disorder, single episode, unspecified A0 E p A OMEPRAZOLE d00325A C K21 Gastro-esophageal reflux disease A0 E A AMLODIPINE d00689A C- I10 Essential (primary) hypertension Ap E A BIMATOPROST OPHTHALMIC d04754A C H40 Glaucoma Ap E A DORZOLAMIDE; TIMOLOL OPHTHALMIC d04303A D* H40 Glaucoma Ap E A FUROSEMIDE d00070A Ei R60.9 Edema, unspecified Ap E A IBUPROFEN d00015A C M54 Dorsalgia Ap E A LOSARTAN d03821A B I10 Essential (primary) hypertension Ap E A POTASSIUM CHLORIDE d00345A Ei 99999 Ap E A AMLODIPINE d00689A C I10 Essential (primary) hypertension A0 E A LOSARTAN d03821A C I10 Essential (primary) hypertension A0 E A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia A0 E A APIXABAN d07804A C D75.9P Prevent blood clots Ap E A DEXLANSOPRAZOLE d07395A Cr K21 Gastro-esophageal reflux disease Ap E A ESTRADIOL d00537A D1 Z79.890 Hormone replacement therapy Ap E A OXYBUTYNIN d00328A B N39.4 Other specified urinary incontinence Ap E A PITAVASTATIN d07637A CDp E78.0 Pure hypercholesterolemia Ap E A SOTALOL d00371A C[@ I48.9 Unspecified atrial fibrillation and atrial flutter Ap E A VILAZODONE d07740A C F32.9 Major depressive disorder, single episode, unspecified Ap E A LISINOPRIL d00732A CDp I10 Essential (primary) hypertension A E A . . . E A AMLODIPINE d00689A C I10 Essential (primary) hypertension A E A IRBESARTAN d04222A C I10 Essential (primary) hypertension A E A . . . E A . . . E ! A ATORVASTATIN d04105A Cr Z79 Long term (current) drug therapy AP E ! A FUROSEMIDE d00070A Dc I10 J98.9 R60.9 Essential (primary) hypertension Respiratory disorder, unspecified Edema, unspecified AP E ! A LISINOPRIL d00732A C I10 I63.P Essential (primary) hypertension Prevent stroke AP E ! A METFORMIN d03807A D E11 R73 Type 2 diabetes mellitus Elevated blood glucose level AP E ! A REPAGLINIDE d04267A C- E11 R73 Type 2 diabetes mellitus Elevated blood glucose level AP E ! A . . . E ! A TRIAMCINOLONE TOPICAL d03206A Ap L20.9 Atopic dermatitis, unspecified A E !0 A AMLODIPINE d00689A C I10 Essential (primary) hypertension AP E !0 A CARVEDILOL d03847A B I10 Essential (primary) hypertension AP E !0 A ETHINYL ESTRADIOL; NORGESTIMATE d03781A CDp Z79.3 Long term (current) use of hormonal contraceptives AP E !0 A METFORMIN d03807A C R73 Elevated blood glucose level AP E !0 A VALACYCLOVIR d03838A C B00.9 Herpesviral infection, unspecified AP E !@ A BUPROPION d00181A B E66 Overweight and obesity AP E !@ A CHLORTHALIDONE d00192A B I10 Essential (primary) hypertension AP E !@ A GLIPIZIDE d00246A C"0 R73 Elevated blood glucose level AP E !@ A HYDROCHLOROTHIAZIDE d00253A B I10 Essential (primary) hypertension AP E !@ A METFORMIN d03807A C"0 E11 R73 Type 2 diabetes mellitus Elevated blood glucose level AP E !P A . . . E !` A . . . E !p A LISINOPRIL d00732A Bz I10 Essential (primary) hypertension A0 E !p A METFORMIN d03807A C R73 Elevated blood glucose level A0 E !p A VENLAFAXINE d03181A B F32.9 F41.9 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified A0 E ! A HYDROCHLOROTHIAZIDE; LOSARTAN d03830A C I10 Essential (primary) hypertension A E ! A DEXTROMETHORPHAN; PROMETHAZINE d03360A C- R05 Cough A0 E ! A IBUPROFEN d00015A C[@ R50.9 Fever, unspecified A0 E ! A TOBRAMYCIN d00069A A H57.9 Unspecified disorder of eye and adnexa A0 E ! A . . . E ! A . . . E ! A DIPHENHYDRAMINE d00212A B L29.9 Pruritus, unspecified A E ! A . . . E ! A ETHINYL ESTRADIOL; NORETHINDRONE d03238A C N92 N94 Excessive, frequent and irregular menstruation Pain and other conditions associated with female genital organs and menstrual cycle A E ! A CETIRIZINE d03827A B T78.40 Allergy, unspecified A@ E ! A LEVETIRACETAM d04499A Cr G40 Epilepsy and recurrent seizures A@ E ! A OMEPRAZOLE d00325A B K21 Gastro-esophageal reflux disease A@ E ! A TOPIRAMATE d04115A CDp R42 R51 Dizziness and giddiness Headache A@ E " A ALPRAZOLAM d00168A D G25.81 Restless legs syndrome Ap E " A GABAPENTIN d03182A B M79.2 Neuralgia and neuritis, unspecified Ap E " A HYDROCHLOROTHIAZIDE d00253A D R60.9 Edema, unspecified Ap E " A IBRUTINIB d08170A B= 55555 Ap E " A NITROFURANTOIN d00112A DGJ N39.0 Urinary tract infection, site not specified Ap E " A OMEPRAZOLE d00325A B K21 Gastro-esophageal reflux disease Ap E " A RANITIDINE d00021A C- K30 Functional dyspepsia Ap E " A AMLODIPINE d00689A CDp I10 Essential (primary) hypertension A0 E " A METOPROLOL d00134A CDp I10 Essential (primary) hypertension A0 E " A TRAMADOL d03826A CDp M13 Other arthritis A0 E " A . . . E "0 A . . . E "@ A . . . E "P A ALPRAZOLAM d00168A C F41.9 Anxiety disorder, unspecified A0 E "P A CLARITHROMYCIN d00097A AP Z98 Other postprocedural states A0 E "P A LOSARTAN d03821A CDp I10 Essential (primary) hypertension A0 E "` A CLINDAMYCIN TOPICAL d01241A B L70 Acne A E "` A TRETINOIN TOPICAL d01244A C L70 Acne A E "p A . . . E " A . . . E " A . . . E " A SERTRALINE d00880A CDp F32.9 N94 Major depressive disorder, single episode, unspecified Pain and other conditions associated with female genital organs and menstrual cycle A E " A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia A E " A . . . E " A ATENOLOL d00004A0 C I10 Essential (primary) hypertension A0 E " A FLUTICASONE NASAL d04283A CDp J30.9 Allergic rhinitis, unspecified A0 E " A HYDROCHLOROTHIAZIDE d00253A0 C I10 Essential (primary) hypertension A0 E " A . . . E " A ETHINYL ESTRADIOL; NORETHINDRONE d03238A C Z79.3 Long term (current) use of hormonal contraceptives A E " A DIMETHYL FUMARATE d08079A Cr G99.8 Other specified disorders of nervous system in diseases classified elsewhere A@ E " A FUROSEMIDE d00070A Cr R60.9 Edema, unspecified A@ E " A NORTRIPTYLINE d00144A Cr R51 Headache A@ E " A PROPRANOLOL d00032A CDp G43 Migraine A@ E # A ALBUTEROL d00749A CDp J45 Asthma Ap E # A AZITHROMYCIN d00091A AP J40 Bronchitis, not specified as acute or chronic Ap E # A BENZONATATE d00796A B J40 Bronchitis, not specified as acute or chronic Ap E # A DULOXETINE d05355A C"0 R52 Pain, unspecified Ap E # A FLUTICASONE; VILANTEROL d08100A B J40 Bronchitis, not specified as acute or chronic Ap E # A IBUPROFEN d00015A Bz R52 Pain, unspecified Ap E # A PREDNISONE d00350A Ap J45 Asthma Ap E # A LISINOPRIL d00732A C- I10 Essential (primary) hypertension A E # A . . . E #0 A AMOXICILLIN d00088A Ap J02 Acute pharyngitis A E #0 A PREDNISONE d00350A A0 T78.40 Allergy, unspecified A E #@ A . . . E #P A ATORVASTATIN d04105A C[@ E78.0 Pure hypercholesterolemia A@ E #P A GABAPENTIN d03182A C[@ R73 Elevated blood glucose level A@ E #P A LOSARTAN d03821A Cr I10 Essential (primary) hypertension A@ E #P A METFORMIN d03807A C[@ E11 Type 2 diabetes mellitus A@ E #` A . . . E #p A . . . E # A . . . E # A . . . E # A . . . E # A . . . E # A COLESEVELAM d04695A C E78.0 Pure hypercholesterolemia A E # A LOSARTAN d03821A C I10 Essential (primary) hypertension A E # A . . . E # A LISINOPRIL d00732A C I10 Essential (primary) hypertension A E # A METFORMIN d03807A C E11 Type 2 diabetes mellitus A E # A . . . E $ A . . . E $ A . . . E $ A . . . E $0 A . . . E $@ A . . . E $P A METOPROLOL d00134A C- I99.9 Unspecified disorder of circulatory system A E $P A SIMVASTATIN d00746A Cr I99.9 Unspecified disorder of circulatory system A E $` A . . . E $p A NITROFURANTOIN d00112A Ap N39.0 Urinary tract infection, site not specified A E $ A ALBUTEROL d00749A CDp J44.9 Chronic obstructive pulmonary disease, unspecified A E $ A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A E $ A DORZOLAMIDE OPHTHALMIC d03805A Dc H40 Glaucoma A E $ A DRONABINOL d00866A C- R63 Symptoms and signs concerning food and fluid intake A E $ A FORMOTEROL; MOMETASONE d07660A CDp J44.9 Chronic obstructive pulmonary disease, unspecified A E $ A IPRATROPIUM d00265A CDp R06.02 R06.2 Shortness of breath Wheezing A E $ A LATANOPROST OPHTHALMIC d04017A Dc H40 Glaucoma A E $ A OLODATEROL; TIOTROPIUM d08362A C R06.2 R06.9 Wheezing Unspecified abnormalities of breathing A E $ A PREDNISONE d00350A C R06.02 R06.2 Shortness of breath Wheezing A E $ A TERAZOSIN d00386A C R35 Polyuria A E $ A . . . E $ A . . . E $ A AMLODIPINE d00689A D# I10 Essential (primary) hypertension A@ E $ A ATORVASTATIN d04105A Dc E78.0 Pure hypercholesterolemia A@ E $ A MONTELUKAST d04289A C J30.1 Allergic rhinitis due to pollen A@ E $ A TAMSULOSIN d04121A C"0 N40 Enlarged prostate A@ E $ A ACETAMINOPHEN; HYDROCODONE d03428A Ap M54 Dorsalgia A E $ A ACYCLOVIR d00001A B D49.9 Neoplasm of unspecified behavior of unspecified site A E $ A CARVEDILOL d03847A Cr I50.9 Heart failure, unspecified A E $ A DEXAMETHASONE d00206A CDp M85.9 Disorder of bone density and structure, unspecified A E $ A FUROSEMIDE d00070A Cr I51.9 Heart disease, unspecified A E $ A LENALIDOMIDE d05696A Cr C80.1 Malignant (primary) neoplasm, unspecified A E $ A NITROGLYCERIN d00321A C I50.9 Heart failure, unspecified A E $ A POTASSIUM CHLORIDE d00345A Cr E87.6 Hypokalemia A E $ A PROCHLORPERAZINE d00355A A R11 Nausea and vomiting A E $ A RIVAROXABAN d07356A C I50.9 Heart failure, unspecified A E $ A SACUBITRIL; VALSARTAN d08369A CDp I50.9 Heart failure, unspecified A E $ A SPIRONOLACTONE d00373A CDp I50.9 Heart failure, unspecified A E $ A AZITHROMYCIN d00091A AP J40 Bronchitis, not specified as acute or chronic A E $ A BECLOMETHASONE d00760A C R05 Cough A E $ A . . . E % A . . . E % A . . . E % A . . . E %0 A . . . E %@ A . . . E %P A . . . E %` A ETHINYL ESTRADIOL; NORGESTIMATE d03781A CDp Z79.3 Long term (current) use of hormonal contraceptives A E %p A . . . E % A . . . E % A . . . E % A . . . E % A IBUPROFEN d00015A CDp R50.9 Fever, unspecified A E % A LISINOPRIL d00732A C I10 Essential (primary) hypertension A E % A . . . E % A . . . E % A . . . E & A AMLODIPINE d00689A D1 I10 Essential (primary) hypertension Ap E & A CARBIDOPA d00184A C G20 Parkinson's disease Ap E & A FINASTERIDE d00563A C N40 Enlarged prostate Ap E & A METFORMIN d03807A C E11 Type 2 diabetes mellitus Ap E & A OMEPRAZOLE d00325A D% K21 Gastro-esophageal reflux disease Ap E & A QUINAPRIL d00365A D I10 Essential (primary) hypertension Ap E & A ROSUVASTATIN d04851A D# E78.0 Pure hypercholesterolemia Ap E & A ALLOPURINOL d00023A C E79.9 Disorder of purine and pyrimidine metabolism, unspecified A E & A AMLODIPINE d00689A C- I10 Essential (primary) hypertension A E & A CARVEDILOL d03847A C I10 Essential (primary) hypertension A E & A CETIRIZINE d03827A C T78.40 Allergy, unspecified A E & A CLOPIDOGREL d04258A C I63.P Prevent stroke A E & A FUROSEMIDE d00070A C R60.9 Edema, unspecified A E & A GABAPENTIN d03182A C- M79.2 Neuralgia and neuritis, unspecified A E & A INSULIN ASPART d04697A C- E11 Type 2 diabetes mellitus A E & A INSULIN GLARGINE d04538A C- E11 Type 2 diabetes mellitus A E & A PRAVASTATIN d00348A C E78.0 Pure hypercholesterolemia A E & A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia Ap E & A LEVOCETIRIZINE d05851A CDp T78.40 Allergy, unspecified Ap E & A METFORMIN d03807A C[@ E11 R73 Type 2 diabetes mellitus Elevated blood glucose level Ap E & A OMEPRAZOLE d00325A C K21 Gastro-esophageal reflux disease Ap E & A PROPRANOLOL d00032A Cr R25.1 Tremor, unspecified Ap E & A RIOCIGUAT d08140A C- I27.9 Pulmonary heart disease, unspecified Ap E & A RIVAROXABAN d07356A Cr D75.9P Prevent blood clots Ap E &0 A . . . E &@ A ATENOLOL d00004A D"8 I10 Essential (primary) hypertension A0 E &@ A HYDROCHLOROTHIAZIDE; VALSARTAN d04293A B I10 Essential (primary) hypertension A0 E &@ A PRIMIDONE d00352A C R25.1 Tremor, unspecified A0 E &P A BUSPIRONE d00182A CDp F41.9 Anxiety disorder, unspecified A@ E &P A FLUOXETINE d00236A CDp F32.9 Major depressive disorder, single episode, unspecified A@ E &P A LITHIUM d00061A CDp F31.9 Bipolar disorder, unspecified A@ E &P A QUETIAPINE d04220A CDp G47.9 Sleep disorder, unspecified A@ E &` A . . . E &p A . . . E & A CLOPIDOGREL d04258A C[@ D75.9P I63 Prevent blood clots Cerebral infarction A E & A FUROSEMIDE d00070A CDp R60.9 Edema, unspecified A E & A GLIPIZIDE d00246A B R73 Elevated blood glucose level A E & A LEVOCETIRIZINE d05851A B[ T78.40 Allergy, unspecified A E & A LOSARTAN d03821A C I10 Essential (primary) hypertension A E & A METFORMIN d03807A D E11 Type 2 diabetes mellitus A E & A PANTOPRAZOLE d04514A B K21 R12 Gastro-esophageal reflux disease Heartburn A E & A SIMVASTATIN d00746A D E78.0 Pure hypercholesterolemia A E & A . . . E & A . . . E & A . . . E & A . . . E & A . . . E & A AMLODIPINE d00689A C- R07.9 Chest pain, unspecified A E & A CEFPODOXIME d00095A C R10 Abdominal and pelvic pain A E & A FUROSEMIDE d00070A C R10 Abdominal and pelvic pain A E & A HYDRALAZINE d00132A C R10 Abdominal and pelvic pain A E & A LOSARTAN d03821A C- R11 Nausea and vomiting A E & A METOPROLOL d00134A C- R11 Nausea and vomiting A E & A PANTOPRAZOLE d04514A C R10 Abdominal and pelvic pain A E & A POTASSIUM CHLORIDE d00345A C- R10 Abdominal and pelvic pain A E & A TIOTROPIUM d04829A A R06.9 Unspecified abnormalities of breathing A E & A . . . E ' A . . . E ' A IBUPROFEN d00015A A M54 Dorsalgia A E ' A LISINOPRIL d00732A C I10 Essential (primary) hypertension A0 E ' A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia A0 E ' A TOPIRAMATE d04115A Cr 99999 A0 E '0 A . . . E '@ A APIXABAN d07804A Bz D75.9P Prevent blood clots A E '@ A ATORVASTATIN d04105A C E78.0P Prevent high cholesterol A E 'P A . . . E '` A KETOCONAZOLE TOPICAL d03202A B[ L30.9 Dermatitis, unspecified A0 E '` A KETOCONAZOLE TOPICAL d03202A B[ L30.9 Dermatitis, unspecified A0 E '` A TOPICAL STEROIDS - UNSPECIFIED c00138A C L30.9 Dermatitis, unspecified A0 E 'p A ETHINYL ESTRADIOL; NORGESTIMATE d03781A D Z79.3 Long term (current) use of hormonal contraceptives A E ' A AMPHETAMINE; DEXTROAMPHETAMINE d04035A CDp F90 Attention-deficit hyperactivity disorders A0 E ' A ETHINYL ESTRADIOL; ETONOGESTREL d04773A C Z79.3 Long term (current) use of hormonal contraceptives A0 E ' A TOPIRAMATE d04115A C G43 Migraine A0 E ' A ACETAMINOPHEN; CODEINE d03423A A N94 Pain and other conditions associated with female genital organs and menstrual cycle A E ' A . . . E ' A ACETAMINOPHEN; HYDROCODONE d03428A D* R52 Pain, unspecified AP E ' A CLOPIDOGREL d04258A D Z79.0 Long term (current) use of anticoagulants and antithrombotics/antiplatelets AP E ' A GLIMEPIRIDE d03864A B E11 Type 2 diabetes mellitus AP E ' A METFORMIN d03807A D- E11 Type 2 diabetes mellitus AP E ' A SIMVASTATIN d00746A D E78.0 Pure hypercholesterolemia AP E ' A 99999 . . A E ' A SIMVASTATIN d00746A C- E78.0 Pure hypercholesterolemia A E ' A ATENOLOL; CHLORTHALIDONE d03258A C[@ I10 Essential (primary) hypertension A@ E ' A ATORVASTATIN d04105A C[@ E78.0 Pure hypercholesterolemia A@ E ' A GLIPIZIDE d00246A C[@ E11 Type 2 diabetes mellitus A@ E ' A LISINOPRIL d00732A C[@ E11.2P I10 Prevent diabetic kidney disease Essential (primary) hypertension A@ E ' A ALPRAZOLAM d00168A C[@ F41.9 Anxiety disorder, unspecified AP E ' A ATENOLOL d00004A Cr I10 I49.9 Essential (primary) hypertension Cardiac arrhythmia, unspecified AP E ' A CARIPRAZINE d08379A CDp F43.1 Post-traumatic stress disorder (PTSD) AP E ' A FLUOXETINE d00236A C[@ F32.9 Major depressive disorder, single episode, unspecified AP E ' A METFORMIN d03807A A E66 Overweight and obesity AP E ( A . . . E ( A LISINOPRIL d00732A D I10 Essential (primary) hypertension AP E ( A METFORMIN d03807A D E11 Type 2 diabetes mellitus AP E ( A PRAVASTATIN d00348A D E78.0 Pure hypercholesterolemia AP E ( A SITAGLIPTIN d05896A Cr E11 Type 2 diabetes mellitus AP E ( A TERBINAFINE d04012A A B35 Dermatophytosis AP E ( A CETIRIZINE d03827A C J30.9 Allergic rhinitis, unspecified A E (0 A . . . E (@ A . . . E (P A . . . E (` A ALBUTEROL d00749A C J45 Asthma A E (` A BENZONATATE d00796A B R05 Cough A E (` A CITALOPRAM d04332A Dc F39 Unspecified mood [affective] disorder A E (` A HYDROCHLOROTHIAZIDE; LOSARTAN d03830A C I10 Essential (primary) hypertension A E (` A LEVOTHYROXINE d00278A CP E07.9 Disorder of thyroid, unspecified A E (` A MONTELUKAST d04289A C J45 Asthma A E (` A PANTOPRAZOLE d04514A B K21 Gastro-esophageal reflux disease A E (` A SIMVASTATIN d00746A Dc E78.0 Pure hypercholesterolemia A E (p A BECLOMETHASONE d00760A Bz R06.2 Wheezing A E ( A . . . E ( A . . . E ( A 99999 . . A E ( A ANTI-INFECTIVES - UNSPECIFIED c00001A . N39.0 Urinary tract infection, site not specified A E ( A ATORVASTATIN d04105A D 99999 AP E ( A CARVEDILOL d03847A D 99999 AP E ( A GLIPIZIDE d00246A D 99999 AP E ( A LISINOPRIL d00732A D 99999 AP E ( A METFORMIN d03807A D 99999 AP E ( A . . . E ( A ATORVASTATIN d04105A Cr E78.0 Pure hypercholesterolemia A@ E ( A AZATHIOPRINE d00024A D)Y K51 Ulcerative colitis A@ E ( A DABIGATRAN d07137A C I48.9 Unspecified atrial fibrillation and atrial flutter A@ E ( A MESALAMINE d01031A D)Y K51 Ulcerative colitis A@ E ( A . . . E ( A ACETAMINOPHEN; HYDROCODONE d03428A CDp M54 Dorsalgia A@ E ( A LISINOPRIL d00732A C I10 Essential (primary) hypertension A@ E ( A METFORMIN d03807A C E11 Type 2 diabetes mellitus A@ E ( A PRAVASTATIN d00348A C E78.0 Pure hypercholesterolemia A@ E ) A ALLOPURINOL d00023A B M10.9 Gout, unspecified A@ E ) A COLCHICINE d00150A C M10.9 Gout, unspecified A@ E ) A LEVOTHYROXINE d00278A D E03.9 Hypothyroidism, unspecified A@ E ) A VALSARTAN d04113A D I10 Essential (primary) hypertension A@ E ) A RIZATRIPTAN d04328A B G43 Migraine A E ) A . . . E )0 A AMOXICILLIN d00088A A J01.9 J20.9 Acute sinusitis, unspecified Acute bronchitis, unspecified A` E )0 A ATORVASTATIN d04105A CDp E78.0 Pure hypercholesterolemia A` E )0 A LISINOPRIL d00732A C I10 Essential (primary) hypertension A` E )0 A OMEPRAZOLE d00325A D R12 Heartburn A` E )0 A PREDNISONE d00350A A J42 Unspecified chronic bronchitis A` E )0 A PSEUDOEPHEDRINE d00769A D J30.9 Allergic rhinitis, unspecified A` E )@ A . . . E )P A . . . E )` A LAMOTRIGINE d03809A Cr G40 Epilepsy and recurrent seizures A E )` A PHENYTOIN d00143A D- G40 Epilepsy and recurrent seizures A E )p A . . . E ) A . . . E ) A HYDROCHLOROTHIAZIDE d00253A Cr Z79 Long term (current) drug therapy A E ) A METHIMAZOLE d00290A Cr E05 Thyrotoxicosis [hyperthyroidism] A E ) A ALLOPURINOL d00023A B M10.9 Gout, unspecified A E ) A INDOMETHACIN d00039A A@ M1A Chronic gout A E ) A . . . E ) A . . . E ) A LOSARTAN d03821A B I10 Essential (primary) hypertension A0 E ) A METFORMIN d03807A B E11 Type 2 diabetes mellitus A0 E ) A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia A0 E ) A GUANFACINE d00717A C F41.9 Anxiety disorder, unspecified A E ) A METFORMIN d03807A Cr R73 Elevated blood glucose level A E * A . . . E * A . . . E * A . . . E *0 A . . . E *@ A . . . E *P A . . . E *` A . . . E *p A . . . E * A FUROSEMIDE d00070A C Z79 Long term (current) drug therapy Ap E * A GABAPENTIN d03182A C[@ M79.2 Neuralgia and neuritis, unspecified Ap E * A INSULIN LISPRO d04373A C[@ E11 Type 2 diabetes mellitus Ap E * A LINAGLIPTIN d07767A C"0 E11 Type 2 diabetes mellitus Ap E * A PANTOPRAZOLE d04514A C[@ K30 Functional dyspepsia Ap E * A PRAVASTATIN d00348A C[@ E78.0 Pure hypercholesterolemia Ap E * A TACROLIMUS d03752A C[@ K76.9 Liver disease, unspecified Ap E * A . . . E * A ACETAMINOPHEN; BUTALBITAL; CAFFEINE d03455A Cr G43 Migraine A E * A ACYCLOVIR d00001A C- B02 Zoster [herpes zoster] A E * A DULOXETINE d05355A C- M79.7 Fibromyalgia A E * A ESOMEPRAZOLE d04749A C K21 Gastro-esophageal reflux disease A E * A FENOFIBRATE d04286A Cr E78.1 Pure hyperglyceridemia A E * A LEVOTHYROXINE d00278A CDp E03.9 Hypothyroidism, unspecified A E * A METAXALONE d00964A A M54 Dorsalgia A E * A TIZANIDINE d04102A CDp M62.83 Muscle spasm A E * A WARFARIN d00022A C D75.9P Prevent blood clots A E * A . . . E * A . . . E * A MONTELUKAST d04289A C- J45 Asthma A E * A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A C I10 Essential (primary) hypertension A0 E * A METOPROLOL d00134A B R00 Abnormalities of heart beat A0 E * A SPIRONOLACTONE d00373A B I10 Essential (primary) hypertension A0 E * A . . . E + A ALBUTEROL d00749A C[@ J45 Asthma A0 E + A APIXABAN d07804A C I48.9 Unspecified atrial fibrillation and atrial flutter A0 E + A FLUTICASONE NASAL d04283A Cr J30.2 Other seasonal allergic rhinitis A0 E + A ALBUTEROL d00749A C J20.9 Acute bronchitis, unspecified A` E + A ASPIRIN d00170A Dc D75.9P Prevent blood clots A` E + A HYDROCHLOROTHIAZIDE d00253A D I10 Essential (primary) hypertension A` E + A METFORMIN d03807A D E11 Type 2 diabetes mellitus A` E + A OMEPRAZOLE d00325A D K21 Gastro-esophageal reflux disease A` E + A SIMVASTATIN d00746A Dc E78.0 Pure hypercholesterolemia A` E + A AMLODIPINE d00689A C I10 Essential (primary) hypertension A@ E + A IRBESARTAN d04222A D# I10 Essential (primary) hypertension A@ E + A METOPROLOL d00134A D# I10 Essential (primary) hypertension A@ E + A PRAVASTATIN d00348A Cr E78.0 Pure hypercholesterolemia A@ E +0 A ACETAMINOPHEN; HYDROCODONE d03428A C M25.5 M65.9 Pain in joint Synovitis and tenosynovitis, unspecified A@ E +0 A AMLODIPINE d00689A C- I10 Essential (primary) hypertension A@ E +0 A ATORVASTATIN d04105A C[@ E78.0P Prevent high cholesterol A@ E +0 A NAPROXEN d00019A Ap M25.5 Pain in joint A@ E +@ A AMLODIPINE d00689A C[@ I10 Essential (primary) hypertension AP E +@ A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia AP E +@ A DIVALPROEX SODIUM d03833A C[@ F39 Unspecified mood [affective] disorder AP E +@ A LACTULOSE d01024A C- K59.0 Constipation AP E +@ A METFORMIN d03807A D E11 Type 2 diabetes mellitus AP E +P A ERYTHROMYCIN TOPICAL d03200A A L70 Acne A` E +P A ETONOGESTREL d04772A C Z79.3 Long term (current) use of hormonal contraceptives A` E +P A LURASIDONE d07705A B* F43.1 G47.0 Post-traumatic stress disorder (PTSD) Insomnia A` E +P A ONDANSETRON d00867A B R11 Nausea and vomiting A` E +P A TRAZODONE d00395A B= G47.9 Sleep disorder, unspecified A` E +P A ZIPRASIDONE d04747A A F43.1 Post-traumatic stress disorder (PTSD) A` E +` A ENOXAPARIN d03041A B D75.9P Prevent blood clots A0 E +` A LEVOTHYROXINE d00278A Dc E03.9 Hypothyroidism, unspecified A0 E +` A SIMVASTATIN d00746A D E78.0 Pure hypercholesterolemia A0 E +p A . . . E + A METOPROLOL d00134A B= I10 Essential (primary) hypertension A E + A . . . E + A AMLODIPINE d00689A B= I10 Essential (primary) hypertension AP E + A LEFLUNOMIDE d04349A B M06.9 Rheumatoid arthritis, unspecified AP E + A METFORMIN d03807A C E11 Type 2 diabetes mellitus AP E + A METOPROLOL d00134A Cr I10 Essential (primary) hypertension AP E + A NAPROXEN d00019A Bz M06.9 Rheumatoid arthritis, unspecified AP E + A . . . E + A . . . E + A . . . E + A CELECOXIB d04380A B[ M19.9 Osteoarthritis, unspecified site A@ E + A GABAPENTIN d03182A CO M79.2 Neuralgia and neuritis, unspecified A@ E + A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A C I10 Essential (primary) hypertension A@ E + A TRAMADOL d03826A CO M79.2 Neuralgia and neuritis, unspecified A@ E + A 99999 . . A E + A LISINOPRIL d00732A Cr I10 Essential (primary) hypertension A E , A AMLODIPINE d00689A C I10 Essential (primary) hypertension A E , A ATENOLOL d00004A C I10 Essential (primary) hypertension A E , A CLONIDINE d00044A B M79.2 Neuralgia and neuritis, unspecified A E , A CLOPIDOGREL d04258A C- I80.3 Phlebitis and thrombophlebitis of lower extremities, unspecified A E , A GABAPENTIN d03182A A F41.9 Anxiety disorder, unspecified A E , A LOSARTAN d03821A C I10 Essential (primary) hypertension A E , A NORTRIPTYLINE d00144A C- M79.2 Neuralgia and neuritis, unspecified A E , A TAMSULOSIN d04121A C R35 Polyuria A E , A TRIAMCINOLONE TOPICAL d03206A C L20.9 R21 Atopic dermatitis, unspecified Rash and other nonspecific skin eruption A E , A . . . E , A NYSTATIN d01233A A0 B37 Candidiasis A E ,0 A . . . E ,@ A . . . E ,P A . . . E ,` A . . . E ,p A . . . E , A . . . E , A . . . E , A IRBESARTAN d04222A C I10 Essential (primary) hypertension A E , A OMEPRAZOLE d00325A B K25 Gastric ulcer A E , A . . . E , A . . . E , A INSULIN GLARGINE d04538A D# E11 Type 2 diabetes mellitus A` E , A INSULIN LISPRO d04373A D# E11 Type 2 diabetes mellitus A` E , A ISOSORBIDE MONONITRATE d00269A C I21.P Prevent heart attack/myocardial infarction A` E , A METOPROLOL d00134A C I50.9 Heart failure, unspecified A` E , A OLMESARTAN d04801A C I21.P Prevent heart attack/myocardial infarction A` E , A RANOLAZINE d05719A C I25.9 Chronic ischemic heart disease, unspecified A` E , A AZITHROMYCIN d00091A AP J02.0 Streptococcal pharyngitis A E , A . . . E - A . . . E - A . . . E - A . . . E -0 A . . . E -@ A HYDROXYCHLOROQUINE d00817A C- M06.9 Rheumatoid arthritis, unspecified AP E -@ A METHOTREXATE d00060A CDp M06.9 Rheumatoid arthritis, unspecified AP E -@ A METRONIDAZOLE TOPICAL d03208A A L71 Rosacea AP E -@ A MINOCYCLINE d00110A C L08.9 L71 Local infection of the skin and subcutaneous tissue, unspecified Rosacea AP E -@ A SULFASALAZINE d00379A CDp M06.9 Rheumatoid arthritis, unspecified AP E -P A . . . E -` A . . . E -p A CITALOPRAM d04332A Ap F32.9 F41.9 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified A@ E -p A CLOTRIMAZOLE TOPICAL d04395A B[ B35 Dermatophytosis A@ E -p A SERTRALINE d00880A Cr F32.9 F41.0 F41.9 Major depressive disorder, single episode, unspecified Panic disorder [episodic paroxysmal anxiety] without agoraphobia Anxiety disorder, unspecified A@ E -p A TRIAMCINOLONE TOPICAL d03206A B[ L23 L29.9 R21 Allergic contact dermatitis Pruritus, unspecified Rash and other nonspecific skin eruption A@ E - A . . . E - A GLIPIZIDE; METFORMIN d04823A B R73 Elevated blood glucose level A@ E - A LISINOPRIL d00732A B I10 Essential (primary) hypertension A@ E - A METFORMIN d03807A B R73 Elevated blood glucose level A@ E - A PRAVASTATIN d00348A B 99999 A@ E - A HYDROXYZINE d00907A B= F41.9 Anxiety disorder, unspecified A E - A . . . E - A MONTELUKAST d04289A Ap T78.40 Allergy, unspecified A E - A . . . E - A . . . E - A . . . E . A ALBUTEROL d00749A C J45 Asthma A E . A MONTELUKAST d04289A Cr J45 Asthma A E . A . . . E . A ALBUTEROL d00749A C J45 Asthma A E . A MONTELUKAST d04289A C J45 T78.40 Asthma Allergy, unspecified A E .0 A . . . E .@ A ESCITALOPRAM d04812A B[ F41.9 Anxiety disorder, unspecified A E .P A . . . E .` A CLOZAPINE d00199A CP F20 Schizophrenia A E .` A DESMOPRESSIN d00583A Ei R32 Unspecified urinary incontinence A E .p A . . . E . A BENAZEPRIL d00730A C N28.9P Prevent kidney disease A@ E . A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified A@ E . A METFORMIN d03807A C R73 Elevated blood glucose level A@ E . A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia A@ E . A . . . E . A BISOPROLOL d00709A C I51.9 Heart disease, unspecified A` E . A CLONIDINE d00044A C I10 Essential (primary) hypertension A` E . A FAMOTIDINE d00141A C K57 Diverticular disease of intestine A` E . A HYDRALAZINE d00132A C I10 Essential (primary) hypertension A` E . A LOSARTAN d03821A C I10 Essential (primary) hypertension A` E . A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia A` E . A ESOMEPRAZOLE d04749A A R10 Abdominal and pelvic pain A@ E . A INSULIN GLARGINE d04538A C E11 Type 2 diabetes mellitus A@ E . A METFORMIN d03807A D E11 Type 2 diabetes mellitus A@ E . A PRASUGREL d07409A C I21 ST elevation (STEMI) and non-ST elevation (NSTEMI) myocardial infarction A@ E . A . . . E . A . . . E . A . . . E . A CETIRIZINE d03827A C T78.40 Allergy, unspecified A E / A . . . E / A . . . E / A . . . E /0 A . . . E /@ A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A CDp I10 Essential (primary) hypertension A0 E /@ A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified A0 E /@ A METFORMIN d03807A CDp R73 Elevated blood glucose level A0 E /P A 77777 . . A E /` A LISINOPRIL d00732A Cr I10 Essential (primary) hypertension A E /` A METFORMIN d03807A Cr E11 Type 2 diabetes mellitus A E /p A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A E /p A CLOPIDOGREL d04258A C D75.9P Prevent blood clots A E /p A FUROSEMIDE d00070A C R60.9 Edema, unspecified A E /p A GLIMEPIRIDE d03864A D E11 Type 2 diabetes mellitus A E /p A INSULIN GLARGINE d04538A D E11 Type 2 diabetes mellitus A E /p A INSULIN LISPRO d04373A Dc E11 Type 2 diabetes mellitus A E /p A ISOSORBIDE d00653A B R07.9 Chest pain, unspecified A E /p A METFORMIN d03807A D E11 Type 2 diabetes mellitus A E /p A METOPROLOL d00134A D I50.9 Heart failure, unspecified A E /p A OMEPRAZOLE d00325A C[@ K21 Gastro-esophageal reflux disease A E /p A PREGABALIN d05508A C E11.4 Type 2 diabetes mellitus with neurological complications A E /p A TRAMADOL d03826A Cr M25.5 Pain in joint A E / A AMOXICILLIN; CLAVULANATE d00089A A H66.9 Otitis media, unspecified A E / A . . . E / A . . . E / A . . . E / A CEPHALEXIN d00096A A@ N39.0 Urinary tract infection, site not specified AP E / A GABAPENTIN d03182A C M79.2 Neuralgia and neuritis, unspecified AP E / A INSULIN ASPART d04697A C E10 Type 1 diabetes mellitus AP E / A INSULIN GLARGINE d04538A C E10 Type 1 diabetes mellitus AP E / A LISINOPRIL d00732A C I10 Essential (primary) hypertension AP E / A . . . E / A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A D I10 Essential (primary) hypertension A E / A PANTOPRAZOLE d04514A C K21 Gastro-esophageal reflux disease A E / A DOCUSATE d01021A A K59.0 Constipation A@ E / A GABAPENTIN d03182A C M79.2 Neuralgia and neuritis, unspecified A@ E / A NAPROXEN d00019A B= Z79.1 Long term (current) use of non-steroidal anti-inflammatories (NSAID) A@ E / A SUMATRIPTAN d03160A C G43 Migraine A@ E 0 A MESALAMINE d01031A C K51 Ulcerative colitis A E 0 A AMLODIPINE d00689A C I10 Essential (primary) hypertension AP E 0 A CLONIDINE d00044A C I10 Essential (primary) hypertension AP E 0 A LOSARTAN d03821A C I10 Essential (primary) hypertension AP E 0 A PRAVASTATIN d00348A C 99999 AP E 0 A SERTRALINE d00880A C F32.9 F41.9 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified AP E 0 A . . . E 00 A ATORVASTATIN d04105A B E78.0 Pure hypercholesterolemia A0 E 00 A BUPROPION d00181A B F32.9 Major depressive disorder, single episode, unspecified A0 E 00 A FINASTERIDE d00563A C[@ L65.9 Nonscarring hair loss, unspecified A0 E 0@ A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A E 0@ A CELECOXIB d04380A B M54 Dorsalgia A E 0@ A CLOPIDOGREL d04258A C[@ I63 Cerebral infarction A E 0@ A GABAPENTIN d03182A Cr M54 M79.2 Dorsalgia Neuralgia and neuritis, unspecified A E 0@ A INSULIN ISOPHANE; INSULIN REGULAR d04374A D E11 Type 2 diabetes mellitus A E 0@ A LINAGLIPTIN d07767A Bz E11 Type 2 diabetes mellitus A E 0@ A LISINOPRIL d00732A C I10 Essential (primary) hypertension A E 0@ A METFORMIN d03807A D6. E11 Type 2 diabetes mellitus A E 0P A . . . E 0` A ATORVASTATIN d04105A C- E78.0 Pure hypercholesterolemia A@ E 0` A LEVOTHYROXINE d00278A C- E03.9 Hypothyroidism, unspecified A@ E 0` A LISINOPRIL d00732A C- I10 Essential (primary) hypertension A@ E 0` A MELOXICAM d04532A C M06.9 Rheumatoid arthritis, unspecified A@ E 0p A . . . E 0 A . . . E 0 A . . . E 0 A . . . E 0 A AMPHETAMINE; DEXTROAMPHETAMINE d04035A C F90 Attention-deficit hyperactivity disorders A E 0 A PROPRANOLOL d00032A Cr G43 Migraine A E 0 A PROPRANOLOL d00032A CDp I10 Essential (primary) hypertension A E 0 A SUMATRIPTAN d03160A C G43 Migraine A E 0 A . . . E 0 A . . . E 0 A MEDROXYPROGESTERONE d00284A CDp Z79.3 Long term (current) use of hormonal contraceptives A0 E 0 A PREDNISONE d00350A B M79.1 Myalgia A0 E 0 A SUMATRIPTAN d03160A C[@ G43 Migraine A0 E 1 A . . . E 1 A . . . E 1 A ALLOPURINOL d00023A D M1A Chronic gout AP E 1 A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia AP E 1 A CARVEDILOL d03847A C I21.P Prevent heart attack/myocardial infarction AP E 1 A CLOPIDOGREL d04258A C I21.P Prevent heart attack/myocardial infarction AP E 1 A RAMIPRIL d00728A C I10 Essential (primary) hypertension AP E 10 A MECLIZINE d00859A B R42 Dizziness and giddiness A E 1@ A AMLODIPINE d00689A C- I10 Essential (primary) hypertension A E 1@ A ATORVASTATIN d04105A C- E78.0 Pure hypercholesterolemia A E 1P A PHENTERMINE d00806A B E66 Overweight and obesity A E 1` A FLUTICASONE TOPICAL d04284A C R21 Rash and other nonspecific skin eruption A E 1p A . . . E 1 A . . . E 1 A AMLODIPINE d00689A Ap I10 Essential (primary) hypertension A@ E 1 A CARVEDILOL d03847A B= I10 Essential (primary) hypertension A@ E 1 A CHLORTHALIDONE d00192A B I10 Essential (primary) hypertension A@ E 1 A LISINOPRIL d00732A Cr I10 Essential (primary) hypertension A@ E 1 A AMLODIPINE d00689A B[ I10 Essential (primary) hypertension Ap E 1 A ASPIRIN d00170A Cr Z79.0 Long term (current) use of anticoagulants and antithrombotics/antiplatelets Ap E 1 A CARVEDILOL d03847A Cr 99999 Ap E 1 A CLONIDINE d00044A Cr G47.0 Insomnia Ap E 1 A HYDRALAZINE d00132A Cr I63 Cerebral infarction Ap E 1 A HYDROCHLOROTHIAZIDE; LOSARTAN d03830A AP I10 Essential (primary) hypertension Ap E 1 A SIMVASTATIN d00746A Cr E78.0 Pure hypercholesterolemia Ap E 1 A . . . E 1 A . . . E 1 A HYDROCHLOROTHIAZIDE; LOSARTAN d03830A CDp I10 Essential (primary) hypertension A E 1 A OLODATEROL; TIOTROPIUM d08362A A J44.9 Chronic obstructive pulmonary disease, unspecified A E 1 A ACETAMINOPHEN; HYDROCODONE d03428A A M54 Dorsalgia A` E 1 A BACLOFEN d00967A A M54 Dorsalgia A` E 1 A CANNABIS d03879A C- F43.1 Post-traumatic stress disorder (PTSD) A` E 1 A IBUPROFEN d00015A A M54 Dorsalgia A` E 1 A LIDOCAINE TOPICAL d00683A A M54 Dorsalgia A` E 1 A MONTELUKAST d04289A C J30.9 Allergic rhinitis, unspecified A` E 1 A . . . E 2 A . . . E 2 A . . . E 2 A . . . E 20 A . . . E 2@ A . . . E 2P A ATORVASTATIN d04105A Bz E78.0 Pure hypercholesterolemia A0 E 2P A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A C[@ I10 Essential (primary) hypertension A0 E 2P A LEVOTHYROXINE d00278A C[@ E03.9 Hypothyroidism, unspecified A0 E 2` A SERTRALINE d00880A B F32.9 Major depressive disorder, single episode, unspecified A E 2p A . . . E 2 A DOXYCYCLINE d00037A B L70 Acne A E 2 A ATORVASTATIN d04105A C- E78.0 Pure hypercholesterolemia A0 E 2 A GLIPIZIDE d00246A C- E11 Type 2 diabetes mellitus A0 E 2 A LISINOPRIL d00732A C- I10 Essential (primary) hypertension A0 E 2 A . . . E 2 A . . . E 2 A . . . E 2 A . . . E 2 A . . . E 2 A . . . E 3 A . . . E 3 A . . . E 3 A AMIODARONE d00002A B= I49.9 Cardiac arrhythmia, unspecified A E 3 A ASPIRIN d00170A C- I21.P Prevent heart attack/myocardial infarction A E 3 A ATORVASTATIN d04105A CDp E78.0 Pure hypercholesterolemia A E 3 A BUPROPION d00181A C F32.9 Major depressive disorder, single episode, unspecified A E 3 A CARVEDILOL d03847A C- I10 Essential (primary) hypertension A E 3 A DOCUSATE d01021A C- K59.0 Constipation A E 3 A FINASTERIDE d00563A Bz N40 Enlarged prostate A E 3 A GABAPENTIN d03182A CDp M79.2 Neuralgia and neuritis, unspecified A E 3 A LOSARTAN d03821A C- I10 Essential (primary) hypertension A E 3 A METFORMIN d03807A C- E11 Type 2 diabetes mellitus A E 3 A PANTOPRAZOLE d04514A C K21 Gastro-esophageal reflux disease A E 3 A RIVAROXABAN d07356A Bz D75.9P Prevent blood clots A E 30 A . . . E 3@ A . . . E 3P A HYDROCODONE d03075A C M25.5 Pain in joint A E 3P A IBUPROFEN d00015A C M25.5 Pain in joint A E 3` A . . . E 3p A . . . E 3 A LOSARTAN d03821A Ap I10 Essential (primary) hypertension A E 3 A APIXABAN d07804A B D75.9P Prevent blood clots A E 3 A ETHINYL ESTRADIOL; NORETHINDRONE d03238A C- Z79.3 Long term (current) use of hormonal contraceptives A E 3 A SPIRONOLACTONE d00373A B L70 Acne A E 3 A . . . E 3 A . . . E 3 A . . . E 3 A LISDEXAMFETAMINE d06663A C F90 Attention-deficit hyperactivity disorders A E 3 A SERTRALINE d00880A C F32.9 Major depressive disorder, single episode, unspecified A E 3 A CLOPIDOGREL d04258A C D75.9P I51.9 Prevent blood clots Heart disease, unspecified A@ E 3 A ISOSORBIDE d00653A C I49.9 Cardiac arrhythmia, unspecified A@ E 3 A METOPROLOL d00134A D I10 Essential (primary) hypertension A@ E 3 A PIOGLITAZONE d04442A D E11 Type 2 diabetes mellitus A@ E 4 A . . . E 4 A ATORVASTATIN d04105A A E78.0 Pure hypercholesterolemia A E 4 A CITALOPRAM d04332A C F41.9 Anxiety disorder, unspecified A E 4 A METHYLPHENIDATE d00900A C F90 Attention-deficit hyperactivity disorders A E 40 A 99999 . . A E 4@ A . . . E 4P A ACYCLOVIR d00001A AP B00.1 Herpesviral vesicular dermatitis A E 4P A IBUPROFEN d00015A AP B00.1 R52 Herpesviral vesicular dermatitis Pain, unspecified A E 4` A . . . E 4p A . . . E 4 A . . . E 4 A . . . E 4 A PROPRANOLOL d00032A C F41.9 Anxiety disorder, unspecified A E 4 A . . . E 4 A SULFAMETHOXAZOLE; TRIMETHOPRIM d00124A A H66.9 Otitis media, unspecified A E 4 A . . . E 4 A NORETHINDRONE d00555A C N92 Z79.3 Excessive, frequent and irregular menstruation Long term (current) use of hormonal contraceptives A E 4 A . . . E 5 A OSELTAMIVIR d04462A Ap J09 Influenza due to certain identified influenza viruses A E 5 A ATENOLOL d00004A C[@ I10 Essential (primary) hypertension Ap E 5 A CLONIDINE d00044A D* I10 Essential (primary) hypertension Ap E 5 A DILTIAZEM d00045A C- I10 Essential (primary) hypertension Ap E 5 A FUROSEMIDE d00070A C[@ R60.9 Edema, unspecified Ap E 5 A LISINOPRIL d00732A C[@ I10 Essential (primary) hypertension Ap E 5 A METFORMIN d03807A CDp R73 Elevated blood glucose level Ap E 5 A OXYBUTYNIN d00328A C- R32 Unspecified urinary incontinence Ap E 5 A . . . E 50 A . . . E 5@ A AMPHETAMINE; DEXTROAMPHETAMINE d04035A A F90 Attention-deficit hyperactivity disorders A E 5@ A CETIRIZINE d03827A C T78.40 Allergy, unspecified A E 5@ A CYPROHEPTADINE d00790A C R63 Symptoms and signs concerning food and fluid intake A E 5@ A FAMOTIDINE d00141A B= K21 Gastro-esophageal reflux disease A E 5@ A GUANFACINE d00717A C- F90 Attention-deficit hyperactivity disorders A E 5@ A LACTULOSE d01024A C G47.0 Insomnia A E 5@ A MONTELUKAST d04289A CDp J45 Asthma A E 5@ A OMEPRAZOLE d00325A B K21 Gastro-esophageal reflux disease A E 5@ A ONDANSETRON d00867A Cr R11 Nausea and vomiting A E 5P A . . . E 5` A . . . E 5p A ALBUTEROL; IPRATROPIUM d04066A C J45 Asthma A E 5p A BACLOFEN d00967A CDp M62.83 Muscle spasm A E 5p A CARVEDILOL d03847A D I21.P Prevent heart attack/myocardial infarction A E 5p A CLOPIDOGREL d04258A D I21.P Prevent heart attack/myocardial infarction A E 5p A FLUTICASONE NASAL d04283A C J30.9 Allergic rhinitis, unspecified A E 5p A FUROSEMIDE d00070A D I51.9 Heart disease, unspecified A E 5p A GLIPIZIDE d00246A CP E11 Type 2 diabetes mellitus A E 5p A INSULIN DETEMIR d05436A C E11 Type 2 diabetes mellitus A E 5p A LISINOPRIL d00732A D I10 Essential (primary) hypertension A E 5p A LOVASTATIN d00280A C E78.0 Pure hypercholesterolemia A E 5p A METFORMIN d03807A CP E11 Type 2 diabetes mellitus A E 5p A TRAMADOL d03826A Cr M54 Dorsalgia A E 5 A . . . E 5 A . . . E 5 A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A E 5 A CARVEDILOL d03847A C I10 Essential (primary) hypertension A E 5 A CLOPIDOGREL d04258A C I21.P Prevent heart attack/myocardial infarction A E 5 A FUROSEMIDE d00070A Cr R60.9 Edema, unspecified A E 5 A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified A E 5 A OMEPRAZOLE d00325A C K21 Gastro-esophageal reflux disease A E 5 A TRAZODONE d00395A Cr G47.0 Insomnia A E 5 A ZOLPIDEM d00910A C G47.0 Insomnia A E 5 A . . . E 5 A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A E 5 A METFORMIN d03807A C E11 Type 2 diabetes mellitus A E 5 A . . . E 5 A . . . E 5 A . . . E 6 A ARIPIPRAZOLE d04825A B[ F29 Unspecified psychosis not due to a substance or known physiological condition A E 6 A ZONISAMIDE d04527A B G40 Epilepsy and recurrent seizures A E 6 A . . . E 6 A . . . E 60 A . . . E 6@ A . . . E 6P A ISOSORBIDE MONONITRATE d00269A C I20.9 Angina pectoris, unspecified A E 6` A . . . E 6p A . . . E 6 A . . . E 6 A AMLODIPINE d00689A D I10 Essential (primary) hypertension A` E 6 A CARVEDILOL d03847A DGJ I10 Essential (primary) hypertension A` E 6 A CLONIDINE d00044A D# I10 Essential (primary) hypertension A` E 6 A KETOCONAZOLE TOPICAL d03202A B L71 Rosacea A` E 6 A LEVOTHYROXINE d00278A DGJ E03.9 Hypothyroidism, unspecified A` E 6 A SIMVASTATIN d00746A DGJ E78.0 Pure hypercholesterolemia A` E 6 A CILOSTAZOL d04382A A I70 Atherosclerosis A0 E 6 A LOSARTAN d03821A D I10 Essential (primary) hypertension A0 E 6 A SIMVASTATIN d00746A D E78.0P Prevent high cholesterol A0 E 6 A . . . E 6 A . . . E 6 A . . . E 6 A ACYCLOVIR d00001A Cr A49.9P Prevent bacterial infection A@ E 6 A AMITRIPTYLINE d00146A C"0 M79.2 Neuralgia and neuritis, unspecified A@ E 6 A FUROSEMIDE d00070A C[@ R60.9 Edema, unspecified A@ E 6 A SPIRONOLACTONE d00373A C[@ R60.9 Edema, unspecified A@ E 6 A . . . E 7 A OMEPRAZOLE d00325A C K30 Functional dyspepsia A E 7 A BUPROPION d00181A A F17.2 F32.9 F41.9 Nicotine dependence Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified A0 E 7 A CETIRIZINE d03827A A T78.40 Allergy, unspecified A0 E 7 A FLUTICASONE NASAL d04283A A J30.2 Other seasonal allergic rhinitis A0 E 7 A . . . E 70 A AMOXICILLIN d00088A B J06.9 Acute upper respiratory infection, unspecified A E 7@ A BROMPHENIRAMINE; DEXTROMETHORPHAN; PSEUDOEPHEDRINE d03368A A0 T78.40 Allergy, unspecified A E 7P A METHYLPHENIDATE d00900A CDp F90 Attention-deficit hyperactivity disorders A E 7` A IBUPROFEN d00015A Ap M25.5 Pain in joint A E 7p A ESOMEPRAZOLE d04749A C K21 Gastro-esophageal reflux disease AP E 7p A FORMOTEROL; GLYCOPYRROLATE d08435A B[ J45 Asthma AP E 7p A ICOSAPENT d07891A C E78.1 Pure hyperglyceridemia AP E 7p A METOPROLOL d00134A C I10 Essential (primary) hypertension AP E 7p A TENOFOVIR d04774A C K76.9 Liver disease, unspecified AP E 7 A . . . E 7 A ACETAMINOPHEN; BUTALBITAL; CAFFEINE d03455A B G47.9 Sleep disorder, unspecified A0 E 7 A NAPROXEN d00019A C ` G89 M25.5 Z96 Pain, not elsewhere classified Pain in joint Presence of other functional implants A0 E 7 A TIZANIDINE d04102A B G47.9 Sleep disorder, unspecified A0 E 7 A . . . E 7 A . . . E 7 A . . . E 7 A . . . E 7 A . . . E 7 A DILTIAZEM d00045A C I10 Essential (primary) hypertension A0 E 7 A LEVOTHYROXINE d00278A C 55555 A0 E 7 A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia A0 E 8 A . . . E 8 A . . . E 8 A . . . E 80 A MONTELUKAST d04289A C- J30.9 Allergic rhinitis, unspecified A E 8@ A AMIODARONE d00002A C I51.9 Heart disease, unspecified B E 8@ A AMLODIPINE d00689A C I10 Essential (primary) hypertension B E 8@ A ATORVASTATIN d04105A C- E78.0 Pure hypercholesterolemia B E 8@ A BUDESONIDE; FORMOTEROL d04795A CDp J44.9 Chronic obstructive pulmonary disease, unspecified B E 8@ A FINASTERIDE d00563A C[@ 99999 B E 8@ A FLUTICASONE; SALMETEROL d04611A C J44.9 Chronic obstructive pulmonary disease, unspecified B E 8@ A FUROSEMIDE d00070A C I10 Essential (primary) hypertension B E 8@ A GABAPENTIN d03182A C M79.6 Pain in limb, hand, foot, fingers and toes B E 8@ A LISINOPRIL d00732A C I10 Essential (primary) hypertension B E 8@ A LORAZEPAM d00149A C F41.9 Anxiety disorder, unspecified B E 8@ A MECLIZINE d00859A C R42 Dizziness and giddiness B E 8@ A METOPROLOL d00134A C[@ I49.9 Cardiac arrhythmia, unspecified B E 8@ A MOUTH AND THROAT PRODUCTS - UNSPECIFIED c00146A B J02 Acute pharyngitis B E 8@ A NITROGLYCERIN d00321A C I51.9 Heart disease, unspecified B E 8@ A SUCRALFATE d00377A B J02 Acute pharyngitis B E 8@ A WARFARIN d00022A C D75.9P Prevent blood clots B E 8P A . . . E 8` A ALENDRONATE d03849A C M81 Osteoporosis without current pathological fracture A E 8` A ALPRAZOLAM d00168A C F43.9 Reaction to severe stress, unspecified A E 8` A CLONIDINE d00044A B I10 Essential (primary) hypertension A E 8` A CYCLOSPORINE OPHTHALMIC d04836A C[@ H04 Disorders of lacrimal system A E 8` A FLUVASTATIN d03183A C- E78.0 Pure hypercholesterolemia A E 8` A FUROSEMIDE d00070A D# R60.9 Edema, unspecified A E 8` A MOMETASONE NASAL d04223A C J34.9 Unspecified disorder of nose and nasal sinuses A E 8` A POTASSIUM CHLORIDE d00345A D# E87.6 Hypokalemia A E 8` A RANITIDINE d00021A CDp K21 Gastro-esophageal reflux disease A E 8` A WARFARIN d00022A D# I80.3 Phlebitis and thrombophlebitis of lower extremities, unspecified A E 8p A . . . E 8 A GABAPENTIN d03182A C R60.9 Edema, unspecified A E 8 A METOPROLOL d00134A Dc I10 Essential (primary) hypertension A E 8 A ATORVASTATIN d04105A C[@ E78.0 Pure hypercholesterolemia A E 8 A LISINOPRIL d00732A C I10 Essential (primary) hypertension A E 8 A . . . E 8 A FINASTERIDE d00563A D L65.9 Nonscarring hair loss, unspecified A E 8 A ATENOLOL d00004A C- R06.9 Unspecified abnormalities of breathing A` E 8 A FAMOTIDINE d00141A C K21 Gastro-esophageal reflux disease A` E 8 A LOSARTAN d03821A C"0 I10 Essential (primary) hypertension A` E 8 A METFORMIN d03807A C E11 Type 2 diabetes mellitus A` E 8 A PHENYTOIN d00143A Cr G40 Epilepsy and recurrent seizures A` E 8 A SIMVASTATIN d00746A C- E78.0 Pure hypercholesterolemia A` E 8 A . . . E 8 A . . . E 8 A ESTRADIOL d00537A C[@ N95 Menopausal and other perimenopausal disorders A E 8 A HYDROCODONE d03075A CDp M19.9 M25.5 Osteoarthritis, unspecified site Pain in joint A E 9 A . . . E 9 A . . . E 9 A . . . E 90 A ALENDRONATE d03849A C- M81 Osteoporosis without current pathological fracture A0 E 90 A LOSARTAN d03821A C[@ I10 Essential (primary) hypertension A0 E 90 A SIMVASTATIN d00746A C[@ E78.0 Pure hypercholesterolemia A0 E 9@ A ETHINYL ESTRADIOL; NORGESTIMATE d03781A C- N92 Z79.3 Excessive, frequent and irregular menstruation Long term (current) use of hormonal contraceptives A E 9P A . . . E 9` A HYDROCHLOROTHIAZIDE d00253A C R60.9 Edema, unspecified AP E 9` A LEVOTHYROXINE d00278A Dc E03.9 Hypothyroidism, unspecified AP E 9` A LOSARTAN d03821A C I10 Essential (primary) hypertension AP E 9` A METOPROLOL d00134A C I10 Essential (primary) hypertension AP E 9` A PITAVASTATIN d07637A Cr E78.0 Pure hypercholesterolemia AP E 9p A AMLODIPINE d00689A C I10 Essential (primary) hypertension A@ E 9p A CALCITONIN d00598A C M81 Osteoporosis without current pathological fracture A@ E 9p A SIMVASTATIN d00746A Cr E78.0 Pure hypercholesterolemia A@ E 9p A VALSARTAN d04113A D I10 Essential (primary) hypertension A@ E 9 A . . . E 9 A GABAPENTIN d03182A B F41.9 M79.2 Anxiety disorder, unspecified Neuralgia and neuritis, unspecified A E 9 A INSULIN DETEMIR d05436A A E11 Type 2 diabetes mellitus A E 9 A INSULIN LISPRO d04373A A E11 Type 2 diabetes mellitus A E 9 A PANTOPRAZOLE d04514A B K21 Gastro-esophageal reflux disease A E 9 A HYDROCHLOROTHIAZIDE; TRIAMTERENE d03052A C R60.9 Edema, unspecified A0 E 9 A METFORMIN; SITAGLIPTIN d06720A C E11 Type 2 diabetes mellitus A0 E 9 A METOPROLOL d00134A C I10 Essential (primary) hypertension A0 E 9 A . . . E 9 A . . . E 9 A . . . E : A . . . E : A . . . E : A . . . E :0 A . . . E :@ A BUPRENORPHINE; NALOXONE d04819A C F11.23 Opioid dependence with withdrawal A0 E :@ A HYDROCHLOROTHIAZIDE d00253A Cr R60.9 Edema, unspecified A0 E :@ A LISINOPRIL d00732A B I10 Essential (primary) hypertension A0 E :P A ESOMEPRAZOLE d04749A A K30 Functional dyspepsia A E :` A . . . E :p A ALENDRONATE d03849A B M81.P Prevent bone loss/osteoporosis A E :p A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A E :p A DABIGATRAN d07137A B* I49.9 Cardiac arrhythmia, unspecified A E :p A DONEPEZIL d04099A C G31.9 Degenerative disease of nervous system, unspecified A E :p A LISINOPRIL d00732A B I21.P Prevent heart attack/myocardial infarction A E :p A MEMANTINE d04899A C G31.9 Degenerative disease of nervous system, unspecified A E :p A MESALAMINE d01031A CDp K51 Ulcerative colitis A E :p A OMEPRAZOLE d00325A C- K51 Ulcerative colitis A E :p A POTASSIUM CHLORIDE d00345A C E87.6 Hypokalemia A E : A AMOXICILLIN d00088A A J02 Acute pharyngitis A E : A . . . E : A 99999 . . A E : A 55555 A0 C- J44.9 Chronic obstructive pulmonary disease, unspecified A` E : A ATORVASTATIN d04105A0 D E78.0 Pure hypercholesterolemia A` E : A BUDESONIDE; FORMOTEROL d04795A0 C J44.9 Chronic obstructive pulmonary disease, unspecified A` E : A LEVOTHYROXINE d00278A0 DGJ E03.9 Hypothyroidism, unspecified A` E : A OMEPRAZOLE d00325A0 C K30 Functional dyspepsia A` E : A PAROXETINE d03157A0 DGJ F32.9 Major depressive disorder, single episode, unspecified A` E : A . . . E : A LISINOPRIL d00732A C I10 Essential (primary) hypertension A0 E : A METFORMIN d03807A Dc E11 Type 2 diabetes mellitus A0 E : A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia A0 E : A . . . E : A . . . E ; A PENICILLIN d00116A AP N30 Cystitis A E ; A . . . E ; A . . . E ;0 A ACETAMINOPHEN; OXYCODONE d03431A0 C M54 Dorsalgia A E ;0 A ALBUTEROL d00749A0 D J45 Asthma A E ;0 A AMITRIPTYLINE d00146A0 D F41.9 Anxiety disorder, unspecified A E ;0 A AMLODIPINE d00689A0 C- I10 Essential (primary) hypertension A E ;0 A ATORVASTATIN d04105A0 C E78.0 Pure hypercholesterolemia A E ;0 A GABAPENTIN d03182A0 B M54 Dorsalgia A E ;0 A INSULIN GLARGINE d04538A0 Cr E11 Type 2 diabetes mellitus A E ;0 A INSULIN LISPRO d04373A0 Cr E11 Type 2 diabetes mellitus A E ;0 A LANSOPRAZOLE d03828A0 C R12 Heartburn A E ;0 A METFORMIN d03807A0 C E11 Type 2 diabetes mellitus A E ;@ A . . . E ;P A . . . E ;` A . . . E ;p A . . . E ; A . . . E ; A . . . E ; A ALPRAZOLAM d00168A CP F41.9 Anxiety disorder, unspecified A` E ; A ARIPIPRAZOLE d04825A C G47.0 Insomnia A` E ; A OXYCODONE d00329A B[ M54 Dorsalgia A` E ; A OXYCODONE d00329A C- M54 Dorsalgia A` E ; A ROPINIROLE d04215A C G25.81 Restless legs syndrome A` E ; A VENLAFAXINE d03181A B F32.9 Major depressive disorder, single episode, unspecified A` E ; A . . . E ; A . . . E ; A . . . E ; A . . . E ; A . . . E < A VENLAFAXINE d03181A C- F41.9 Anxiety disorder, unspecified A E < A AMLODIPINE d00689A D I10 Essential (primary) hypertension A` E < A GLIPIZIDE d00246A C R73 Elevated blood glucose level A` E < A METFORMIN d03807A D E11 Type 2 diabetes mellitus A` E < A METOPROLOL d00134A C[@ I10 Essential (primary) hypertension A` E < A PANTOPRAZOLE d04514A A K30 Functional dyspepsia A` E < A RAMIPRIL d00728A D R73 Elevated blood glucose level A` E < A ATORVASTATIN d04105A C9 E78.0 Pure hypercholesterolemia A@ E < A CLOPIDOGREL d04258A C9 Z79.0 Long term (current) use of anticoagulants and antithrombotics/antiplatelets A@ E < A LISINOPRIL d00732A C9 I10 Essential (primary) hypertension A@ E < A METOPROLOL d00134A C9 I10 R07.9 Essential (primary) hypertension Chest pain, unspecified A@ E <0 A ATORVASTATIN d04105A C[@ I21.P Prevent heart attack/myocardial infarction A@ E <0 A LISINOPRIL d00732A C I10 Essential (primary) hypertension A@ E <0 A METFORMIN d03807A C R73 Elevated blood glucose level A@ E <0 A OMEPRAZOLE d00325A C- K25 Gastric ulcer A@ E <@ A . . . E
A . . . E > A . . . E > A AMLODIPINE d00689A C- I10 Essential (primary) hypertension A@ E > A CLONIDINE d00044A C I10 Essential (primary) hypertension A@ E > A MELOXICAM d04532A C M13 Other arthritis A@ E > A SERTRALINE d00880A B F41.9 Anxiety disorder, unspecified A@ E >0 A ETHINYL ESTRADIOL; NORGESTIMATE d03781A C Z79.3 Long term (current) use of hormonal contraceptives A E >0 A SERTRALINE d00880A CDp F32.9 Major depressive disorder, single episode, unspecified A E >@ A . . . E >P A . . . E >` A ALLOPURINOL d00023A CDp M10.9P Prevent gout Ap E >` A AMLODIPINE d00689A D* I10 Essential (primary) hypertension Ap E >` A FUROSEMIDE d00070A D9 Z79 Long term (current) drug therapy Ap E >` A GLIPIZIDE d00246A D* E11 Type 2 diabetes mellitus Ap E >` A LEVOTHYROXINE d00278A D* E03.9 Hypothyroidism, unspecified Ap E >` A LISINOPRIL d00732A D* I10 Essential (primary) hypertension Ap E >` A METOPROLOL d00134A D* I10 Essential (primary) hypertension Ap E >p A ESCITALOPRAM d04812A C[@ F41.9 Anxiety disorder, unspecified AP E >p A GABAPENTIN d03182A C[@ G25.81 Restless legs syndrome AP E >p A MELOXICAM d04532A B M25.5 Pain in joint AP E >p A OMEPRAZOLE d00325A CDp K21 K92.9 Gastro-esophageal reflux disease Disease of digestive system, unspecified AP E >p A TRIAMTERENE d00396A C R60.9 Edema, unspecified AP E > A . . . E > A . . . E > A . . . E > A . . . E > A ATENOLOL d00004A0 CDp I10 Essential (primary) hypertension A@ E > A ATORVASTATIN d04105A0 CDp E78.0 Pure hypercholesterolemia A@ E > A HYDROCHLOROTHIAZIDE d00253A0 D R60.9 Edema, unspecified A@ E > A LISINOPRIL d00732A0 D I10 Essential (primary) hypertension A@ E > A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A E > A CLOPIDOGREL d04258A C- Z79.0 Long term (current) use of anticoagulants and antithrombotics/antiplatelets A E > A ESTRADIOL d00537A D N95 Menopausal and other perimenopausal disorders A E > A EZETIMIBE d04824A Cr E78.0 Pure hypercholesterolemia A E > A IMIPRAMINE d00259A C N20.0 Calculus of kidney A E > A LISINOPRIL d00732A C- E11.2P Prevent diabetic kidney disease A E > A METFORMIN d03807A B[ R73 Elevated blood glucose level A E > A PANTOPRAZOLE d04514A C K25 Gastric ulcer A E > A SITAGLIPTIN d05896A B= R73 Elevated blood glucose level A E > A ACETAMINOPHEN; HYDROCODONE d03428A CP M54 Dorsalgia A@ E > A ESCITALOPRAM d04812A C- F32.9 Major depressive disorder, single episode, unspecified A@ E > A EZETIMIBE; SIMVASTATIN d05348A CP E78.0 E78.1 Pure hypercholesterolemia Pure hyperglyceridemia A@ E > A LEVOTHYROXINE d00278A B E03.9 Hypothyroidism, unspecified A@ E > A . . . E ? A . . . E ? A SULFAMETHOXAZOLE; TRIMETHOPRIM d00124A Ap A49.9P Prevent bacterial infection A E ? A ACETAMINOPHEN; HYDROCODONE d03428A AP K08.8 Other specified disorders of teeth and supporting structures A E ? A ALFUZOSIN d04797A C N42.9 Disorder of prostate, unspecified A E ? A AMOXICILLIN d00088A AP K04.7 Periapical abscess without sinus A E ? A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A Dc I10 Essential (primary) hypertension A E ? A LISDEXAMFETAMINE d06663A C E66 F90 Overweight and obesity Attention-deficit hyperactivity disorders A E ? A OMEPRAZOLE d00325A C K30 Functional dyspepsia A E ? A PHENTERMINE d00806A C E66 Overweight and obesity A E ? A SEMAGLUTIDE d08688A B[ E66 R73 Overweight and obesity Elevated blood glucose level A E ? A SIMVASTATIN d00746A CDp I70.P Prevent atherosclerosis A E ?0 A . . . E ?@ A . . . E ?P A . . . E ?` A . . . E ?p A . . . E ? A . . . E ? A NAPROXEN d00019A B= M25.5 M54 Pain in joint Dorsalgia A E ? A . . . E ? A CETIRIZINE d03827A C R09.81 Nasal congestion A E ? A DOCUSATE d01021A C[@ K59.0 Constipation A E ? A INSULIN DETEMIR d05436A C E11 Type 2 diabetes mellitus A E ? A LISINOPRIL d00732A C- I10 Essential (primary) hypertension A E ? A METFORMIN d03807A C[@ E11 Type 2 diabetes mellitus A E ? A MYCOPHENOLATE MOFETIL d03839A C[@ N28.9 Disorder of kidney and ureter, unspecified A E ? A RANITIDINE d00021A C[@ R12 Heartburn A E ? A SIMVASTATIN d00746A CDp G47.9 Sleep disorder, unspecified A E ? A SULFAMETHOXAZOLE d00119A C[@ N39.0 Urinary tract infection, site not specified A E ? A TACROLIMUS d03752A C[@ N28.9 Disorder of kidney and ureter, unspecified A E ? A LISINOPRIL d00732A CDp I10 Essential (primary) hypertension A E ? A . . . E ? A . . . E ? A BRIMONIDINE; TIMOLOL OPHTHALMIC d05283A B= H40 Glaucoma Ap E ? A FUROSEMIDE d00070A B R60.9 Edema, unspecified Ap E ? A GLIPIZIDE d00246A D E11 Type 2 diabetes mellitus Ap E ? A LATANOPROST OPHTHALMIC d04017A C H40 Glaucoma Ap E ? A LISINOPRIL d00732A D I10 Essential (primary) hypertension Ap E ? A METFORMIN d03807A D E11 Type 2 diabetes mellitus Ap E ? A PRAVASTATIN d00348A C E78.0 Pure hypercholesterolemia Ap E @ A . . . E @ A . . . E @ A . . . E @0 A INDAPAMIDE d00260A Cr I10 Essential (primary) hypertension A@ E @0 A LEVOTHYROXINE d00278A D E04 Other nontoxic goiter A@ E @0 A POTASSIUM CHLORIDE d00345A B E87.6 Hypokalemia A@ E @0 A RAMIPRIL d00728A Cr I10 Essential (primary) hypertension A@ E @@ A . . . E @P A . . . E @` A . . . E @p A AMPHETAMINE; DEXTROAMPHETAMINE d04035A C F90 Attention-deficit hyperactivity disorders A0 E @p A CLONIDINE d00044A B F90 Attention-deficit hyperactivity disorders A0 E @p A CLONIDINE d00044A C[@ G47.0 Insomnia A0 E @ A DOXYCYCLINE d00037A A K04.7P Prevent tooth infection A E @ A APIXABAN d07804A B D75.9P Prevent blood clots A0 E @ A METOPROLOL d00134A C- I10 I49.9 Essential (primary) hypertension Cardiac arrhythmia, unspecified A0 E @ A PRAMIPEXOLE d04145A Cr G25.81 Restless legs syndrome A0 E @ A CABERGOLINE d04112A C D49.9 Neoplasm of unspecified behavior of unspecified site A0 E @ A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified A0 E @ A OLMESARTAN d04801A C I10 Essential (primary) hypertension A0 E @ A IBUPROFEN d00015A0 A M54 M79.1 T14.9 Dorsalgia Myalgia Unspecified injury A E @ A METHOCARBAMOL d00965A0 A M54 M79.1 T14.9 Dorsalgia Myalgia Unspecified injury A E @ A . . . E @ A . . . E @ A ALPRAZOLAM d00168A C- F41.9 Anxiety disorder, unspecified A E @ A ESTRADIOL d00537A C Z79.890 Hormone replacement therapy A E @ A . . . E A A . . . E A A . . . E A A GLIPIZIDE d00246A C E11 Type 2 diabetes mellitus A` E A A INSULIN ASPART d04697A CDp E11 Type 2 diabetes mellitus A` E A A INSULIN DETEMIR d05436A CDp E11 Type 2 diabetes mellitus A` E A A LISINOPRIL d00732A C I10 Essential (primary) hypertension A` E A A METFORMIN d03807A C E11 Type 2 diabetes mellitus A` E A A PRAVASTATIN d00348A Cr E78.0 Pure hypercholesterolemia A` E A0 A AMPHETAMINE; DEXTROAMPHETAMINE d04035A C[@ F90 Attention-deficit hyperactivity disorders A E A@ A . . . E AP A . . . E A` A . . . E Ap A . . . E A A AMLODIPINE d00689A C I10 Essential (primary) hypertension A0 E A A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A C I10 Essential (primary) hypertension A0 E A A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia A0 E A A . . . E A A AMLODIPINE d00689A Cr I10 Essential (primary) hypertension AP E A A ATENOLOL d00004A Cr I50.9 Heart failure, unspecified AP E A A CLOPIDOGREL d04258A C[@ 99999 AP E A A MONTELUKAST d04289A C J45 Asthma AP E A A SIMVASTATIN d00746A Ei 99999 AP E A A ACYCLOVIR d00001A D T86.9P Prevent transplanted organ and tissue rejection A E A A ASPIRIN d00170A D I99.9 Unspecified disorder of circulatory system A E A A LOPERAMIDE d01025A Ap R19.7 Diarrhea, unspecified A E A A METOPROLOL d00134A D ^ I10 Essential (primary) hypertension A E A A MYCOPHENOLATE MOFETIL d03839A D T86.9P Prevent transplanted organ and tissue rejection A E A A OMEPRAZOLE d00325A C K59.0 Constipation A E A A PREDNISONE d00350A D N18.9 Chronic kidney disease, unspecified A E A A SIMVASTATIN d00746A D 99999 A E A A TACROLIMUS d03752A D N19 Unspecified kidney failure A E A A . . . E A A . . . E A A AMLODIPINE d00689A0 Cr I10 Essential (primary) hypertension A E A A CARVEDILOL d03847A0 Cr I10 Essential (primary) hypertension A E A A DULAGLUTIDE d08290A0 B[ E11 Type 2 diabetes mellitus A E A A EMPAGLIFLOZIN d08275A0 B E11 Type 2 diabetes mellitus A E A A FEXOFENADINE d04040A0 C T78.40 Allergy, unspecified A E A A IMIPRAMINE d00259A0 Cr R32 Unspecified urinary incontinence A E A A LATANOPROST OPHTHALMIC d04017A0 Dc H40 Glaucoma A E A A LISINOPRIL d00732A0 C I10 Essential (primary) hypertension A E A A OLOPATADINE OPHTHALMIC d04117A0 Cr H10.1 Acute atopic conjunctivitis A E A A PANTOPRAZOLE d04514A B K21 Gastro-esophageal reflux disease A E A A PANTOPRAZOLE d04514A0 C K21 Gastro-esophageal reflux disease A E A A SIMVASTATIN d00746A0 C E78.0 Pure hypercholesterolemia A E A A SITAGLIPTIN d05896A0 B[ E11 Type 2 diabetes mellitus A E A A FUROSEMIDE d00070A B= I10 Essential (primary) hypertension Ap E A A GABAPENTIN d03182A Ei M54 Dorsalgia Ap E A A INSULIN DETEMIR d05436A Ei E11 Type 2 diabetes mellitus Ap E A A LISINOPRIL d00732A Ei 55555 Ap E A A METFORMIN d03807A Ei E11 Type 2 diabetes mellitus Ap E A A SIMVASTATIN d00746A Ei E78.0 Pure hypercholesterolemia Ap E A A SITAGLIPTIN d05896A Ei E11 Type 2 diabetes mellitus Ap E B A AMLODIPINE d00689A C I10 Essential (primary) hypertension A0 E B A LISINOPRIL d00732A CDp I10 Essential (primary) hypertension A0 E B A METFORMIN d03807A CDp R73 Elevated blood glucose level A0 E B A . . . E B A . . . E B0 A ATENOLOL d00004A D I10 Essential (primary) hypertension A E B@ A . . . E BP A ALLOPURINOL d00023A C[@ M10.9P Prevent gout Ap E BP A DOCUSATE d01021A C[@ K59.0 Constipation Ap E BP A GUAIFENESIN d00797A C- R09.3 Abnormal sputum Ap E BP A HYDROCHLOROTHIAZIDE d00253A D I10 Essential (primary) hypertension Ap E BP A OMEPRAZOLE d00325A C[@ K21 Gastro-esophageal reflux disease Ap E BP A TAMSULOSIN d04121A C[@ N40 Enlarged prostate Ap E BP A TROSPIUM d04929A C[@ R35 Polyuria Ap E B` A AMIODARONE d00002A C[@ I49.9 Cardiac arrhythmia, unspecified A` E B` A ATORVASTATIN d04105A D E78.0 Pure hypercholesterolemia A` E B` A CLOPIDOGREL d04258A D I21.P Prevent heart attack/myocardial infarction A` E B` A FERRIC CITRATE d08336A D 55555 A` E B` A ISOSORBIDE MONONITRATE d00269A C[@ I20.9 Angina pectoris, unspecified A` E B` A SEVELAMER d04363A D N19 Unspecified kidney failure A` E Bp A CLOPIDOGREL d04258A C- I63.P Prevent stroke A` E Bp A COLESEVELAM d04695A C K87 Disorders of gallbladder, biliary tract and pancreas in diseases classified elsewhere A` E Bp A DICYCLOMINE d00999A C R10 Abdominal and pelvic pain A` E Bp A ESOMEPRAZOLE d04749A D K21 Gastro-esophageal reflux disease A` E Bp A ROSUVASTATIN d04851A C- E78.0 I63.P Pure hypercholesterolemia Prevent stroke A` E Bp A TOLTERODINE d04294A C- N32.81 Overactive bladder A` E B A ALBUTEROL d00749A C J45.P Prevent asthma A E B A FLUTICASONE d01296A C J45 Asthma A E B A METHOTREXATE d00060A C"0 M06.9 Rheumatoid arthritis, unspecified A E B A . . . E B A AMLODIPINE d00689A Ei 99999 A E B A CARVEDILOL d03847A C 99999 A E B A DULAGLUTIDE d08290A C- E11 Type 2 diabetes mellitus A E B A GABAPENTIN d03182A C M79.2 Neuralgia and neuritis, unspecified A E B A LEVOTHYROXINE d00278A C E04 Other nontoxic goiter A E B A MELOXICAM d04532A Ei M06.9 M25.5 Rheumatoid arthritis, unspecified Pain in joint A E B A METFORMIN d03807A Dc E11 Type 2 diabetes mellitus A E B A PRAVASTATIN d00348A C E78.0 Pure hypercholesterolemia A E B A ATORVASTATIN d04105A Bz E78.0 Pure hypercholesterolemia A E B A AMLODIPINE d00689A C[@ I10 Essential (primary) hypertension A E B A CELECOXIB d04380A B R52 Pain, unspecified A E B A GLYBURIDE d00248A C E11 Type 2 diabetes mellitus A E B A INSULIN DEGLUDEC d08054A Cr E11 Type 2 diabetes mellitus A E B A LOSARTAN d03821A CDp I10 Essential (primary) hypertension A E B A METFORMIN d03807A C E11 Type 2 diabetes mellitus A E B A METOPROLOL d00134A C I10 Essential (primary) hypertension A E B A PANTOPRAZOLE d04514A C[@ K21 K30 R12 Gastro-esophageal reflux disease Functional dyspepsia Heartburn A E B A RANITIDINE d00021A C[@ K21 Gastro-esophageal reflux disease A E B A ROSUVASTATIN d04851A CDp E78.0 Pure hypercholesterolemia A E B A TAMSULOSIN d04121A CDp N40 R35 Enlarged prostate Polyuria A E B A BUDESONIDE; FORMOTEROL d04795A CDp J45 Asthma A E B A CLONAZEPAM d00197A C F41.9 Anxiety disorder, unspecified A E B A FLUOXETINE d00236A C F32.9 Major depressive disorder, single episode, unspecified A E B A HYDROCHLOROTHIAZIDE; LOSARTAN d03830A C I50.9 Heart failure, unspecified A E B A LEVOTHYROXINE d00278A B[ E03.9 Hypothyroidism, unspecified A E B A METOPROLOL d00134A C I10 Essential (primary) hypertension A E B A MOMETASONE NASAL d04223A C- J30.9 Allergic rhinitis, unspecified A E B A MONTELUKAST d04289A C J45 Asthma A E B A ATENOLOL d00004A Cr I10 Essential (primary) hypertension A E B A LOVASTATIN d00280A Cr E78.0 Pure hypercholesterolemia A E C A . . . E C A . . . E C A BUDESONIDE d04276A C J45 R05 R06.2 Asthma Cough Wheezing A E C A MONTELUKAST d04289A C J45 R05 R06.2 Asthma Cough Wheezing A E C0 A . . . E C@ A ETHINYL ESTRADIOL; NORGESTIMATE d03781A A Z79.3 Long term (current) use of hormonal contraceptives AP E C@ A FLUTICASONE NASAL d04283A C- J30.2 Other seasonal allergic rhinitis AP E C@ A INSULIN ASPART d04697A D E10 Type 1 diabetes mellitus AP E C@ A INSULIN GLARGINE d04538A C E10 Type 1 diabetes mellitus AP E C@ A SERTRALINE d00880A B F41.9 Anxiety disorder, unspecified AP E CP A . . . E C` A CEFDINIR d04256A A J01.9 Acute sinusitis, unspecified A E C` A MONTELUKAST d04289A B J30.9 Allergic rhinitis, unspecified A E Cp A . . . E C A HYDROCHLOROTHIAZIDE; TRIAMTERENE d03052A B= R60.9 Edema, unspecified AP E C A INSULIN DETEMIR d05436A B[ E11 Type 2 diabetes mellitus AP E C A RAMIPRIL d00728A C[@ I10 Essential (primary) hypertension AP E C A SERTRALINE d00880A C F32.9 Major depressive disorder, single episode, unspecified AP E C A SITAGLIPTIN d05896A CDp E11 Type 2 diabetes mellitus AP E C A . . . E C A . . . E C A AMLODIPINE d00689A Cr I10 Essential (primary) hypertension A@ E C A HYDROCHLOROTHIAZIDE d00253A Cr R60.9 Edema, unspecified A@ E C A LOSARTAN d03821A Cr I10 Essential (primary) hypertension A@ E C A METFORMIN d03807A Cr E11 Type 2 diabetes mellitus A@ E C A ISOTRETINOIN d01245A B L70 Acne A E C A ATORVASTATIN d04105A C[@ E78.0 Pure hypercholesterolemia A E C A CARVEDILOL d03847A CDp I10 Essential (primary) hypertension A E C A GABAPENTIN d03182A Cr M79.2 Neuralgia and neuritis, unspecified A E C A INSULIN ASPART d04697A Bz E11 Type 2 diabetes mellitus A E C A INSULIN GLARGINE d04538A Dc E11 Type 2 diabetes mellitus A E C A LISINOPRIL d00732A Cr I10 Essential (primary) hypertension A E C A PANTOPRAZOLE d04514A CDp K21 Gastro-esophageal reflux disease A E C A SEMAGLUTIDE d08688A B E11 Type 2 diabetes mellitus A E C A TORSEMIDE d03189A Cr N28.9 Disorder of kidney and ureter, unspecified A E C A THYROID DESICCATED d00655A CDp E03.9 Hypothyroidism, unspecified A E C A . . . E D A . . . E D A . . . E D A PANTOPRAZOLE d04514A B[ K21 Gastro-esophageal reflux disease A E D0 A ALLOPURINOL d00023A B E79.9 Disorder of purine and pyrimidine metabolism, unspecified A` E D0 A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A` E D0 A GLIMEPIRIDE d03864A CDp R73 Elevated blood glucose level A` E D0 A HYDROCHLOROTHIAZIDE d00253A C I10 Essential (primary) hypertension A` E D0 A LISINOPRIL d00732A C I10 Essential (primary) hypertension A` E D0 A METOPROLOL d00134A CDp I10 Essential (primary) hypertension A` E D@ A . . . E DP A . . . E D` A . . . E Dp A METOPROLOL d00134A C I10 Essential (primary) hypertension A0 E Dp A MIRABEGRON d07876A Cr N39.4 R35 Other specified urinary incontinence Polyuria A0 E Dp A TAMSULOSIN d04121A C N40 Enlarged prostate A0 E D A ASPIRIN d00170A Cr 99999 A E D A GABAPENTIN d03182A C R52 Pain, unspecified A E D A HYDROCHLOROTHIAZIDE; TRIAMTERENE d03052A CDp I10 Essential (primary) hypertension A E D A HYDROXYCHLOROQUINE d00817A C M06.9 Rheumatoid arthritis, unspecified A E D A MELOXICAM d04532A Cr M06.9 Rheumatoid arthritis, unspecified A E D A METHOTREXATE d00060A C M06.9 Rheumatoid arthritis, unspecified A E D A METOPROLOL d00134A CDp R00 Abnormalities of heart beat A E D A PANTOPRAZOLE d04514A C- K21 Gastro-esophageal reflux disease A E D A PREDNISONE d00350A C M06.9 Rheumatoid arthritis, unspecified A E D A . . . E D A GLIPIZIDE d00246A C E11 Type 2 diabetes mellitus A E D A METFORMIN d03807A C E11 Type 2 diabetes mellitus A E D A ACETAMINOPHEN; HYDROCODONE d03428A CP M25.9 Joint disorder, unspecified A E D A . . . E D A . . . E D A ATORVASTATIN d04105A CDp E78.0 Pure hypercholesterolemia A0 E D A LISINOPRIL d00732A C- I10 Essential (primary) hypertension A0 E D A METFORMIN d03807A C E11 Type 2 diabetes mellitus A0 E D A BACLOFEN d00967A C- M62.83 Muscle spasm A E D A FUROSEMIDE d00070A B R60.9 Edema, unspecified A E D A LATANOPROST OPHTHALMIC d04017A C- H40 Glaucoma A E D A LISINOPRIL d00732A C I10 Essential (primary) hypertension A E D A METFORMIN d03807A CDp E11 Type 2 diabetes mellitus A E D A METOPROLOL d00134A C I10 I50.9 Essential (primary) hypertension Heart failure, unspecified A E D A POTASSIUM CHLORIDE d00345A B E87.6 Hypokalemia A E D A WARFARIN d00022A B D75.9P Prevent blood clots A E E A ATORVASTATIN d04105A B E78.0 Pure hypercholesterolemia A0 E E A ENALAPRIL d00013A C I10 Essential (primary) hypertension A0 E E A METFORMIN d03807A C E11 Type 2 diabetes mellitus A0 E E A . . . E E A . . . E E0 A . . . E E@ A ACETAMINOPHEN; HYDROCODONE d03428A A M54 Dorsalgia Ap E E@ A ATORVASTATIN d04105A C- E78.0 Pure hypercholesterolemia Ap E E@ A BACLOFEN d00967A CDp M62.83 Muscle spasm Ap E E@ A ESCITALOPRAM d04812A Cr F32.9 Major depressive disorder, single episode, unspecified Ap E E@ A GABAPENTIN d03182A CDp M79.2 Neuralgia and neuritis, unspecified Ap E E@ A LISINOPRIL d00732A C- I10 Essential (primary) hypertension Ap E E@ A MORPHINE d00308A CDp M54 Dorsalgia Ap E EP A . . . E E` A . . . E Ep A . . . E E A CLONIDINE d00044A D I10 Essential (primary) hypertension A E E A TERAZOSIN d00386A Cr N40 Enlarged prostate A E E A WARFARIN d00022A C- I21 ST elevation (STEMI) and non-ST elevation (NSTEMI) myocardial infarction A E E A CIPROFLOXACIN d00011A C"0 B99.9 Unspecified infectious disease A E E A CLOPIDOGREL d04258A CDp Z79.0 Long term (current) use of anticoagulants and antithrombotics/antiplatelets A E E A ESTRADIOL TOPICAL d04210A A N95 Menopausal and other perimenopausal disorders A E E A FENOFIBRATE d04286A C E78.1 Pure hyperglyceridemia A E E A INSULIN GLARGINE d04538A C- R73 Elevated blood glucose level A E E A INSULIN REGULAR d04369A C- E11 Type 2 diabetes mellitus A E E A LEVOTHYROXINE d00278A CDp E03.9 Hypothyroidism, unspecified A E E A PRAVASTATIN d00348A C"0 I21.P Prevent heart attack/myocardial infarction A E E A . . . E E A . . . E E A . . . E E A . . . E E A ATENOLOL d00004A C I10 Essential (primary) hypertension A` E E A ATORVASTATIN d04105A Dc E78.0 Pure hypercholesterolemia A` E E A HYDROCHLOROTHIAZIDE d00253A C R60.9 Edema, unspecified A` E E A LISINOPRIL d00732A C I10 Essential (primary) hypertension A` E E A POTASSIUM CHLORIDE d00345A C E87.6 Hypokalemia A` E E A SERTRALINE d00880A C F41.9 Anxiety disorder, unspecified A` E F A METOPROLOL d00134A CDp I10 Essential (primary) hypertension A E F A . . . E F A ACETAMINOPHEN; TRAMADOL d04766A D M79.7 Fibromyalgia Ap E F A ALBUTEROL d00749A B R06.02 Shortness of breath Ap E F A AZELASTINE NASAL d04068A B J30.9 Allergic rhinitis, unspecified Ap E F A OLODATEROL; TIOTROPIUM d08362A B J44.9 Chronic obstructive pulmonary disease, unspecified Ap E F A OMEPRAZOLE d00325A C K30 Functional dyspepsia Ap E F A QUETIAPINE d04220A B F41.9 G31.9 Anxiety disorder, unspecified Degenerative disease of nervous system, unspecified Ap E F A TRAZODONE d00395A D G47.0 M79.7 Insomnia Fibromyalgia Ap E F0 A . . . E F@ A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A E F@ A ESCITALOPRAM d04812A B= F32.9 Major depressive disorder, single episode, unspecified A E F@ A HYDROXYZINE d00907A B F41.9 Anxiety disorder, unspecified A E F@ A HYDROXYZINE d00907A C- F41.9 Anxiety disorder, unspecified A E F@ A INSULIN GLARGINE d04538A B E11 Type 2 diabetes mellitus A E F@ A LAMOTRIGINE d03809A Bz F39 Unspecified mood [affective] disorder A E F@ A LISINOPRIL d00732A C[@ I10 Essential (primary) hypertension A E F@ A METFORMIN d03807A C E11 Type 2 diabetes mellitus A E F@ A NAPROXEN d00019A B G43 Migraine A E F@ A OMEPRAZOLE d00325A C K21 R12 Gastro-esophageal reflux disease Heartburn A E F@ A PRAZOSIN d00138A C- G47.9 Sleep disorder, unspecified A E F@ A TOPIRAMATE d04115A B G43 Migraine A E F@ A ZIPRASIDONE d04747A C F31.9 Bipolar disorder, unspecified A E FP A . . . E F` A . . . E Fp A . . . E F A FAMOTIDINE d00141A C"0 K21 Gastro-esophageal reflux disease A@ E F A FLUOXETINE d00236A C- F41.9 Anxiety disorder, unspecified A@ E F A MONTELUKAST d04289A C J30.9 R06.2 Allergic rhinitis, unspecified Wheezing A@ E F A NAPROXEN d00019A C- R51 Headache A@ E F A ACETAMINOPHEN; CODEINE d03423A C- M54 Dorsalgia A E F A METOPROLOL d00134A C R00 Abnormalities of heart beat A E F A ALBUTEROL d00749A D& J45 Asthma A E F A MELOXICAM d04532A C- L40 Psoriasis A0 E F A RANITIDINE d00021A Cr K30 Functional dyspepsia A0 E F A TRAMADOL d03826A A M13 Other arthritis A0 E F A . . . E F A DOXYCYCLINE d00037A B A49.9 Bacterial infection, unspecified A E F A . . . E F A ATORVASTATIN d04105A B E78.0 Pure hypercholesterolemia AP E F A CLOPIDOGREL d04258A B I51.9 Heart disease, unspecified AP E F A EZETIMIBE d04824A B I51.9 Heart disease, unspecified AP E F A LOSARTAN d03821A B I51.9 Heart disease, unspecified AP E F A METOPROLOL d00134A B I51.9 Heart disease, unspecified AP E G A . . . E G A . . . E G A . . . E G0 A CIPROFLOXACIN d00011A Ap R52 Pain, unspecified A E G@ A . . . E GP A . . . E G` A . . . E Gp A FLUTICASONE NASAL d04283A C"0 J30.9 Allergic rhinitis, unspecified A@ E Gp A HYDROCORTISONE TOPICAL d03205A CDp L20.9 Atopic dermatitis, unspecified A@ E Gp A LEVOCETIRIZINE d05851A C- L20.9 T78.40 Atopic dermatitis, unspecified Allergy, unspecified A@ E Gp A TRIAMCINOLONE TOPICAL d03206A CDp L20.9 Atopic dermatitis, unspecified A@ E G A ACETAMINOPHEN; HYDROCODONE d03428A C M54 Dorsalgia A` E G A BUMETANIDE d00179A CDp R60.9 Edema, unspecified A` E G A CITALOPRAM d04332A Cr F32.9 Major depressive disorder, single episode, unspecified A` E G A MELOXICAM d04532A C M19.9 Osteoarthritis, unspecified site A` E G A NICOTINE d00316A Ap F17.2 Nicotine dependence A` E G A TRAZODONE d00395A Cr F32.9 Major depressive disorder, single episode, unspecified A` E G A ATORVASTATIN d04105A Cr E78.0 Pure hypercholesterolemia A` E G A GABAPENTIN d03182A Cr E11.4 Type 2 diabetes mellitus with neurological complications A` E G A LEVOTHYROXINE d00278A CDp E03.9 Hypothyroidism, unspecified A` E G A METFORMIN d03807A Cr E11 Type 2 diabetes mellitus A` E G A METOPROLOL d00134A CDp I10 Essential (primary) hypertension A` E G A OMEPRAZOLE d00325A Cr K21 Gastro-esophageal reflux disease A` E G A . . . E G A . . . E G A ATORVASTATIN d04105A Cr E78.0 Pure hypercholesterolemia A E G A CITALOPRAM d04332A C F32.9 Major depressive disorder, single episode, unspecified A E G A FEXOFENADINE d04040A CDp R09.81 Nasal congestion A E G A GLIPIZIDE d00246A Cr E11 Type 2 diabetes mellitus A E G A LISINOPRIL d00732A Cr I51.9P Prevent heart disease A E G A LORAZEPAM d00149A C- F41.9 Anxiety disorder, unspecified A E G A MELOXICAM d04532A C M79.1 Myalgia A E G A METFORMIN; SITAGLIPTIN d06720A CDp E11 Type 2 diabetes mellitus A E G A METOPROLOL d00134A B[ I25.9 Chronic ischemic heart disease, unspecified A E G A OMEPRAZOLE d00325A CDp K21 R12 Gastro-esophageal reflux disease Heartburn A E G A . . . E G A FLUOXETINE d00236A CDp F32.9 Major depressive disorder, single episode, unspecified A E G A OMEPRAZOLE d00325A C K21 R14 Gastro-esophageal reflux disease Flatulence and related conditions A E G A CEPHALEXIN d00096A A J02 Acute pharyngitis A E H A . . . E H A . . . E H A . . . E H0 A CETIRIZINE d03827A C T78.40 Allergy, unspecified A E H@ A . . . E HP A . . . E H` A . . . E Hp A OMEPRAZOLE d00325A C"0 K21 R12 Gastro-esophageal reflux disease Heartburn A E H A AMIODARONE d00002A C- R00 Abnormalities of heart beat A` E H A LISINOPRIL d00732A C- I10 Essential (primary) hypertension A` E H A MEGESTROL d01348A B R63 Symptoms and signs concerning food and fluid intake A` E H A METOPROLOL d00134A C- I10 Essential (primary) hypertension A` E H A PANTOPRAZOLE d04514A C- B96.81 Helicobacter pylori [H. pylori] as the cause of diseases classified elsewhere A` E H A SIMVASTATIN d00746A C50 E78.0 Pure hypercholesterolemia A` E H A LEVOTHYROXINE d00278A CDp E03.9 Hypothyroidism, unspecified A E H A . . . E H A ACETAMINOPHEN; HYDROCODONE d03428A C T14.9 Unspecified injury AP E H A CYCLOBENZAPRINE d00963A B M79.1 Myalgia AP E H A ROSUVASTATIN d04851A CDp E78.0 Pure hypercholesterolemia AP E H A SERTRALINE d00880A C F32.9 Major depressive disorder, single episode, unspecified AP E H A TEMAZEPAM d00384A CDp G47.9 Sleep disorder, unspecified AP E H A . . . E H A DOCUSATE d01021A C K92.9 Disease of digestive system, unspecified Ap E H A FINASTERIDE d00563A C- N40 Enlarged prostate Ap E H A HYDROCHLOROTHIAZIDE d00253A D I51.9 Heart disease, unspecified Ap E H A METOPROLOL d00134A D I10 Essential (primary) hypertension Ap E H A SERTRALINE d00880A D F41.9 Anxiety disorder, unspecified Ap E H A SIMVASTATIN d00746A D E78.0 Pure hypercholesterolemia Ap E H A TAMSULOSIN d04121A C9 N40 Enlarged prostate Ap E H A . . . E H A . . . E I A AMLODIPINE d00689A C- I10 Essential (primary) hypertension A` E I A CLINDAMYCIN d00043A B K04.7 Periapical abscess without sinus A` E I A FLUTICASONE; SALMETEROL d04611A C- J44.9 Chronic obstructive pulmonary disease, unspecified A` E I A HYDRALAZINE d00132A D I10 Essential (primary) hypertension A` E I A HYDROCODONE d03075A B K08.8 Other specified disorders of teeth and supporting structures A` E I A LISINOPRIL d00732A C- I10 Essential (primary) hypertension A` E I A . . . E I A . . . E I0 A . . . E I@ A . . . E IP A 99999 . . A0 E IP A ATORVASTATIN d04105A D 99999 A0 E IP A METFORMIN d03807A D 99999 A0 E I` A . . . E Ip A . . . E I A AMLODIPINE d00689A B[ I10 Essential (primary) hypertension A0 E I A ATENOLOL d00004A C I10 Essential (primary) hypertension A0 E I A HYDROCHLOROTHIAZIDE d00253A B[ R60.9 Edema, unspecified A0 E I A ETHINYL ESTRADIOL; NORGESTIMATE d03781A CDp E28 Ovarian dysfunction A@ E I A LEVOTHYROXINE d00278A B E06 Thyroiditis A@ E I A METFORMIN d03807A Cr E28 Ovarian dysfunction A@ E I A NAPROXEN d00019A B Z79 Long term (current) drug therapy A@ E I A . . . E I A . . . E I A . . . E I A . . . E I A ESCITALOPRAM d04812A Dc F41.9 Anxiety disorder, unspecified A E I A LEVOTHYROXINE d00278A Dc E03.9 Hypothyroidism, unspecified A E I A DICYCLOMINE d00999A A@ R10 Abdominal and pelvic pain A` E I A METHOCARBAMOL d00965A C M25.5 M54 M62.83 Pain in joint Dorsalgia Muscle spasm A` E I A MIRTAZAPINE d04025A C F31.9 F32.9 F43.1 Bipolar disorder, unspecified Major depressive disorder, single episode, unspecified Post-traumatic stress disorder (PTSD) A` E I A NORTRIPTYLINE d00144A B= R10 Abdominal and pelvic pain A` E I A ONDANSETRON d00867A B[ R11 Nausea and vomiting A` E I A TRAZODONE d00395A CP F31.9 F32.9 F41.9 Bipolar disorder, unspecified Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified A` E J A . . . E J A HYDROCORTISONE TOPICAL d03205A Cr L20.9 Atopic dermatitis, unspecified A E J A . . . E J0 A AMOXICILLIN d00088A A H66.9 Otitis media, unspecified A E J@ A . . . E JP A . . . E J` A . . . E Jp A BENAZEPRIL d00730A C I10 Essential (primary) hypertension A E J A FOSINOPRIL d00242A C I10 Essential (primary) hypertension A E J A HYDROCODONE d03075A C M25.5 M54 Pain in joint Dorsalgia A E J A INSULIN GLARGINE d04538A B E11 Type 2 diabetes mellitus A E J A MELOXICAM d04532A C M25.5 M54 M79.6 Pain in joint Dorsalgia Pain in limb, hand, foot, fingers and toes A E J A METFORMIN d03807A D R73 Elevated blood glucose level A E J A RANITIDINE d00021A C K21 Gastro-esophageal reflux disease A E J A SAXAGLIPTIN d07467A C E11 Type 2 diabetes mellitus A E J A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia A E J A AMLODIPINE d00689A C I10 Essential (primary) hypertension A0 E J A HYDROCHLOROTHIAZIDE d00253A C I10 Essential (primary) hypertension A0 E J A PROPRANOLOL d00032A C I10 Essential (primary) hypertension A0 E J A . . . E J A ALBUTEROL d00749A Ap R05 Cough A0 E J A CODEINE; GUAIFENESIN d03393A Ap J00 Acute nasopharyngitis [common cold] A0 E J A ETHINYL ESTRADIOL; NORELGESTROMIN d04779A B= Z79.3 Long term (current) use of hormonal contraceptives A0 E J A . . . E J A . . . E J A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A C I10 Essential (primary) hypertension A E J A . . . E K A . . . E K A BETAMETHASONE; CALCIPOTRIENE TOPICAL d05044A B= L40 Psoriasis A` E K A CICLOPIROX TOPICAL d01272A C L98.9 Disorder of the skin and subcutaneous tissue, unspecified A` E K A CLOBETASOL TOPICAL d01288A C L98.9 Disorder of the skin and subcutaneous tissue, unspecified A` E K A INSULIN GLARGINE d04538A C- E11 Type 2 diabetes mellitus A` E K A INSULIN GLULISINE d05278A C- E11 Type 2 diabetes mellitus A` E K A TRIAMCINOLONE TOPICAL d03206A C L40 Psoriasis A` E K A ALBUTEROL d00749A C J45 Asthma A@ E K A DEXMETHYLPHENIDATE d04777A Cr F90 Attention-deficit hyperactivity disorders A@ E K A DEXMETHYLPHENIDATE d04777A C F90 Attention-deficit hyperactivity disorders A@ E K A SERTRALINE d00880A B F41.9 Anxiety disorder, unspecified A@ E K0 A CONTRACEPTIVES - UNSPECIFIED c00102A B Z79.3 Long term (current) use of hormonal contraceptives A E K0 A IBUPROFEN d00015A A H93.9 Unspecified disorder of ear A E K@ A . . . E KP A TOPIRAMATE d04115A CDp M54 Dorsalgia A E K` A . . . E Kp A ACETAMINOPHEN; HYDROCODONE d03428A D M25.5 T14.9 Pain in joint Unspecified injury Ap E Kp A ALBUTEROL d00749A C J45 Asthma Ap E Kp A ATORVASTATIN d04105A C"0 E78.0 Pure hypercholesterolemia Ap E Kp A FLUTICASONE; VILANTEROL d08100A C J45 Asthma Ap E Kp A LISINOPRIL d00732A C"0 E11.2 Z95 Type 2 diabetes mellitus with kidney complications Presence of cardiac and vascular implants and grafts Ap E Kp A LORAZEPAM d00149A C"0 I51.9 Heart disease, unspecified Ap E Kp A METOPROLOL d00134A C- I10 Essential (primary) hypertension Ap E K A DICYCLOMINE d00999A C"0 R10 Abdominal and pelvic pain A E K A NEBIVOLOL d05265A C9 I10 Essential (primary) hypertension A E K A . . . E K A CYPROHEPTADINE d00790A CDp L29.9 Pruritus, unspecified Ap E K A DULOXETINE d05355A Cr F32.9 M79.7 Major depressive disorder, single episode, unspecified Fibromyalgia Ap E K A FORMOTEROL; MOMETASONE d07660A C J45 Asthma Ap E K A FUROSEMIDE d00070A B[ R60.9 Edema, unspecified Ap E K A HYDROXYZINE d00907A C- F41.9 Anxiety disorder, unspecified Ap E K A IBUPROFEN d00015A B= T14.9 Unspecified injury Ap E K A LISINOPRIL d00732A B[ I10 Essential (primary) hypertension Ap E K A 99999 . . A E K A METFORMIN d03807A D E11 Type 2 diabetes mellitus A E K A METOPROLOL d00134A C I10 Essential (primary) hypertension A E K A AMLODIPINE d00689A D I10 Essential (primary) hypertension A0 E K A LISINOPRIL d00732A B[ I10 Essential (primary) hypertension A0 E K A PRAVASTATIN d00348A D E78.0 Pure hypercholesterolemia A0 E K A . . . E K A ATENOLOL d00004A D* I10 Essential (primary) hypertension A@ E K A HYDROCHLOROTHIAZIDE d00253A D I10 Essential (primary) hypertension A@ E K A LEVOTHYROXINE d00278A D E03.9 Hypothyroidism, unspecified A@ E K A SIMVASTATIN d00746A D* E78.0 Pure hypercholesterolemia A@ E L A FUROSEMIDE d00070A B M79.2 Neuralgia and neuritis, unspecified A` E L A METOPROLOL d00134A B R51 Headache A` E L A NAPROXEN d00019A B= 99999 A` E L A NITROGLYCERIN d00321A A R07.9 Chest pain, unspecified A` E L A OMEPRAZOLE d00325A A R10 Abdominal and pelvic pain A` E L A POTASSIUM CHLORIDE d00345A B= M62.83 Muscle spasm A` E L A . . . E L A . . . E L0 A . . . E L@ A . . . E LP A DICLOFENAC d00848A D M19.9 Osteoarthritis, unspecified site A E LP A SIMVASTATIN d00746A B E78.0 Pure hypercholesterolemia A E L` A LABETALOL d00016A C I10 Essential (primary) hypertension A E L` A OMEPRAZOLE d00325A D K21 Gastro-esophageal reflux disease A E Lp A . . . E L A . . . E L A . . . E L A . . . E L A . . . E L A METFORMIN d03807A C- E11 Type 2 diabetes mellitus A E L A AMLODIPINE d00689A Bz I10 Essential (primary) hypertension A E L A . . . E L A . . . E M A . . . E M A . . . E M A . . . E M0 A FEXOFENADINE d04040A C- R09.81 Nasal congestion A E M@ A . . . E MP A . . . E M` A . . . E Mp A ALLOPURINOL d00023A C- F32.9 Major depressive disorder, single episode, unspecified A` E Mp A BUPROPION d00181A B M10.9 Gout, unspecified A` E Mp A COLCHICINE d00150A B 55555 A` E Mp A ESCITALOPRAM d04812A CDp F32.9 Major depressive disorder, single episode, unspecified A` E Mp A ROFLUMILAST d07684A B J43 Emphysema A` E Mp A TAMSULOSIN d04121A C R39.1 Other difficulties with micturition A` E M A RIVAROXABAN d07356A B I80.3 Phlebitis and thrombophlebitis of lower extremities, unspecified A E M A GABAPENTIN d03182A B G47.9 Sleep disorder, unspecified A E M A METAXALONE d00964A C M54 M62.83 Dorsalgia Muscle spasm A E M A . . . E M A . . . E M A . . . E M A . . . E M A CELECOXIB d04380A B= N94 Pain and other conditions associated with female genital organs and menstrual cycle A0 E M A MEDROXYPROGESTERONE d00284A B N94 Pain and other conditions associated with female genital organs and menstrual cycle A0 E M A OXYCODONE d00329A A G89 Pain, not elsewhere classified A0 E M A . . . E N A . . . E N A ALPRAZOLAM d00168A C F41.9 Anxiety disorder, unspecified A E N A LISINOPRIL d00732A C- I10 Essential (primary) hypertension A E N A ALLOPURINOL d00023A C- M1A Chronic gout A E N A ASPIRIN d00170A C I51.9P Prevent heart disease A E N A CABERGOLINE d04112A E 77777 A E N A CINACALCET d05218A C N19 Unspecified kidney failure A E N A DORZOLAMIDE OPHTHALMIC d03805A CDp H40 Glaucoma A E N A FLUOXETINE d00236A C F41.9 Anxiety disorder, unspecified A E N A INSULIN ISOPHANE (NPH) d04370A D E11 Type 2 diabetes mellitus A E N A INSULIN REGULAR d04369A D E11 Type 2 diabetes mellitus A E N A LATANOPROST OPHTHALMIC d04017A Cr H40 Glaucoma A E N A LEVOTHYROXINE d00278A E E03.9 Hypothyroidism, unspecified A E N A LISINOPRIL d00732A C 77777 A E N A METOPROLOL d00134A E 77777 A E N A SIMVASTATIN d00746A C 77777 A E N A TAMSULOSIN d04121A E N40 Enlarged prostate A E N0 A . . . E N@ A AZELASTINE NASAL d04068A C J30.9 Allergic rhinitis, unspecified A E N@ A CLONIDINE d00044A C I10 Essential (primary) hypertension A E N@ A DORZOLAMIDE; TIMOLOL OPHTHALMIC d04303A A H40 Glaucoma A E N@ A FLUTICASONE NASAL d04283A C[@ J30.2 J30.9 Other seasonal allergic rhinitis Allergic rhinitis, unspecified A E N@ A GABAPENTIN d03182A CDp M79.2 Neuralgia and neuritis, unspecified A E N@ A METFORMIN d03807A D E11 Type 2 diabetes mellitus A E N@ A MUPIROCIN TOPICAL d01267A C L08.9 Local infection of the skin and subcutaneous tissue, unspecified A E N@ A NYSTATIN; TRIAMCINOLONE TOPICAL d03562A D L23 Allergic contact dermatitis A E N@ A OLOPATADINE NASAL d07132A D H04 Disorders of lacrimal system A E N@ A OMEPRAZOLE d00325A CP K21 Gastro-esophageal reflux disease A E N@ A PENTOXIFYLLINE d00336A D6. I99.9 Unspecified disorder of circulatory system A E N@ A PRAVASTATIN d00348A D9 E78.0 Pure hypercholesterolemia A E N@ A SPIRONOLACTONE d00373A CDp R60.9 Edema, unspecified A E N@ A VERAPAMIL d00048A Ei I10 Essential (primary) hypertension A E NP A . . . E N` A LEVOTHYROXINE d00278A CDp E03.9 Hypothyroidism, unspecified A E Np A . . . E N A . . . E N A ETHINYL ESTRADIOL; NORGESTIMATE d03781A B N92 Excessive, frequent and irregular menstruation A E N A . . . E N A DROSPIRENONE; ETHINYL ESTRADIOL d04760A CDp Z79.3 Long term (current) use of hormonal contraceptives A0 E N A FLUOXETINE d00236A B F32.9 F33.9 F41.9 Major depressive disorder, single episode, unspecified Major depressive disorder, recurrent, unspecified Anxiety disorder, unspecified A0 E N A NAPROXEN d00019A C- M25.5 Pain in joint A0 E N A . . . E N A . . . E N A AMLODIPINE d00689A CDp I10 Essential (primary) hypertension AP E N A CARVEDILOL d03847A CDp I10 Essential (primary) hypertension AP E N A LISINOPRIL d00732A CDp I10 Essential (primary) hypertension AP E N A METFORMIN d03807A C[@ E11 Type 2 diabetes mellitus AP E N A PRAVASTATIN d00348A CDp E78.0 Pure hypercholesterolemia AP E N A . . . E O A INSULIN GLARGINE d04538A D& E11 Type 2 diabetes mellitus A@ E O A INSULIN LISPRO d04373A D)Y E11 Type 2 diabetes mellitus A@ E O A OMEPRAZOLE d00325A C K21 Gastro-esophageal reflux disease A@ E O A POTASSIUM CHLORIDE d00345A B E87.6 Hypokalemia A@ E O A . . . E O A . . . E O0 A AMOXICILLIN d00088A A K04.7 Periapical abscess without sinus A@ E O0 A CLINDAMYCIN d00043A Ap K04.7 Periapical abscess without sinus A@ E O0 A CLONAZEPAM d00197A C F32.9 F41.9 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified A@ E O0 A QUETIAPINE d04220A D F32.9 G47.9 Major depressive disorder, single episode, unspecified Sleep disorder, unspecified A@ E O@ A . . . E OP A . . . E O` A . . . E Op A . . . E O A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia Ap E O A CLINDAMYCIN d00043A A@ K05.6 Periodontal disease, unspecified Ap E O A CLOPIDOGREL d04258A C I21 ST elevation (STEMI) and non-ST elevation (NSTEMI) myocardial infarction Ap E O A EMPAGLIFLOZIN d08275A C E11 R73 Type 2 diabetes mellitus Elevated blood glucose level Ap E O A GLIMEPIRIDE d03864A C E11 Type 2 diabetes mellitus Ap E O A LISINOPRIL d00732A C I10 I50.9 Essential (primary) hypertension Heart failure, unspecified Ap E O A OMEPRAZOLE d00325A B[ K21 Gastro-esophageal reflux disease Ap E O A ETONOGESTREL d04772A CDp Z79.3 Long term (current) use of hormonal contraceptives A E O A . . . E O A . . . E O A CLONIDINE d00044A C I10 Essential (primary) hypertension A` E O A FINASTERIDE d00563A C N40 Enlarged prostate A` E O A FLUOXETINE d00236A C F32.9 Major depressive disorder, single episode, unspecified A` E O A LISINOPRIL d00732A C I10 Essential (primary) hypertension A` E O A METOPROLOL d00134A C I10 R00 Essential (primary) hypertension Abnormalities of heart beat A` E O A TAMSULOSIN d04121A C N40 Enlarged prostate A` E O A . . . E O A AMLODIPINE d00689A C I10 Essential (primary) hypertension AP E O A GEMFIBROZIL d00245A C E78.0 Pure hypercholesterolemia AP E O A GLIPIZIDE d00246A C- E11 Type 2 diabetes mellitus AP E O A HYDROCHLOROTHIAZIDE; LOSARTAN d03830A C I10 Essential (primary) hypertension AP E O A METFORMIN d03807A D E11 Type 2 diabetes mellitus AP E O A . . . E P A ALENDRONATE d03849A0 C- M81 Osteoporosis without current pathological fracture Ap E P A ATORVASTATIN d04105A0 C- E78.0 Pure hypercholesterolemia Ap E P A BENAZEPRIL d00730A0 C- I10 Essential (primary) hypertension Ap E P A GLIPIZIDE d00246A0 Cr E11 Type 2 diabetes mellitus Ap E P A LABETALOL d00016A0 C- I10 Essential (primary) hypertension Ap E P A METFORMIN d03807A Cr E11 Type 2 diabetes mellitus Ap E P A SITAGLIPTIN d05896A0 Cr E11 Type 2 diabetes mellitus Ap E P A MELOXICAM d04532A CDp M54 Dorsalgia A0 E P A MIRABEGRON d07876A C R35 Polyuria A0 E P A OMEPRAZOLE d00325A C[@ K21 Gastro-esophageal reflux disease A0 E P A . . . E P0 A . . . E P@ A . . . E PP A AMLODIPINE d00689A C I21.P Prevent heart attack/myocardial infarction A E PP A CLOPIDOGREL d04258A D I21.P Prevent heart attack/myocardial infarction A E PP A FUROSEMIDE d00070A C- R60.9 Edema, unspecified A E PP A LISINOPRIL d00732A C I50.9 Heart failure, unspecified A E PP A MELOXICAM d04532A Cr M19.9 Osteoarthritis, unspecified site A E PP A METFORMIN d03807A C E11 Type 2 diabetes mellitus A E PP A METOPROLOL d00134A C I21.P Prevent heart attack/myocardial infarction A E PP A PANTOPRAZOLE d04514A C K21 K30 Gastro-esophageal reflux disease Functional dyspepsia A E PP A ROPINIROLE d04215A C- G25.81 Restless legs syndrome A E PP A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia A E P` A CIMETIDINE d00140A B B34.9 Viral infection, unspecified A0 E P` A HYDROCORTISONE TOPICAL d03205A C B34.9 Viral infection, unspecified A0 E P` A INSULIN LISPRO d04373A C- E11 Type 2 diabetes mellitus A0 E Pp A MIRABEGRON d07876A B= N32.81 Overactive bladder A E P A IBUPROFEN d00015A C N94 Pain and other conditions associated with female genital organs and menstrual cycle A E P A 99999 . . A E P A ALPRAZOLAM d00168A CDp F41.9 Anxiety disorder, unspecified Ap E P A ESCITALOPRAM d04812A C F32.9 F41.9 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified Ap E P A ESOMEPRAZOLE d04749A Cr 55555 Ap E P A EZETIMIBE d04824A C- E78.0 Pure hypercholesterolemia Ap E P A HOMATROPINE; HYDROCODONE d03340A A@ R05 Cough Ap E P A LISINOPRIL d00732A C I10 Essential (primary) hypertension Ap E P A VALACYCLOVIR d03838A D B00.1 Herpesviral vesicular dermatitis Ap E P A . . . E P A ETHINYL ESTRADIOL; NORETHINDRONE d03238A B Z79.3 Long term (current) use of hormonal contraceptives A E P A . . . E P A . . . E P A MELOXICAM d04532A A M25.5 Pain in joint A E Q A . . . E Q A BUPROPION d00181A B= F32.9 Major depressive disorder, single episode, unspecified A E Q A . . . E Q0 A . . . E Q@ A . . . E QP A . . . E Q` A ETANERCEPT d04365A B= M06.9 Rheumatoid arthritis, unspecified A E Q` A HYDROCHLOROTHIAZIDE; LOSARTAN d03830A B I10 Essential (primary) hypertension A E Qp A . . . E Q A . . . E Q A . . . E Q A CARVEDILOL d03847A D I51.9 Heart disease, unspecified A E Q A AZELASTINE NASAL d04068A C J30.9 Allergic rhinitis, unspecified A0 E Q A BROMPHENIRAMINE; DEXTROMETHORPHAN; PSEUDOEPHEDRINE d03368A A R05 Cough A0 E Q A FLUTICASONE d01296A CDp J45 Asthma A0 E Q A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A E Q A LISINOPRIL d00732A C I10 Essential (primary) hypertension A E Q A IBUPROFEN d00015A A T14.9 Unspecified injury A0 E Q A LISINOPRIL d00732A C I10 Essential (primary) hypertension A0 E Q A MONTELUKAST d04289A C- J30.9 Allergic rhinitis, unspecified A0 E Q A . . . E Q A . . . E R A . . . E R A SULFAMETHOXAZOLE; TRIMETHOPRIM d00124A B* R19.7 Diarrhea, unspecified A E R A . . . E R0 A GLYBURIDE d00248A Ap R73 Elevated blood glucose level A E R@ A AMLODIPINE d00689A Cr I10 Essential (primary) hypertension A@ E R@ A ATORVASTATIN d04105A Cr E78.0 Pure hypercholesterolemia A@ E R@ A CARVEDILOL d03847A Cr I10 Essential (primary) hypertension A@ E R@ A VALSARTAN d04113A Cr I10 Essential (primary) hypertension A@ E RP A ATORVASTATIN d04105A Cr E78.0 Pure hypercholesterolemia A0 E RP A LISINOPRIL d00732A Dc I10 Essential (primary) hypertension A0 E RP A TAMSULOSIN d04121A Ap N42.9 Disorder of prostate, unspecified A0 E R` A ALBIGLUTIDE d08251A B# E11 Type 2 diabetes mellitus A E R` A ALBUTEROL d00749A C[@ J45 Asthma A E R` A FLUTICASONE d01296A CDp J45 Asthma A E R` A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A C I10 Essential (primary) hypertension A E R` A METFORMIN d03807A CDp E11 Type 2 diabetes mellitus A E R` A NIFEDIPINE d00051A C I10 Essential (primary) hypertension A E R` A OMEPRAZOLE d00325A C[@ K21 Gastro-esophageal reflux disease A E R` A SERTRALINE d00880A CDp F32.9 F41.9 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified A E R` A SIMVASTATIN d00746A C[@ E78.0 Pure hypercholesterolemia A E Rp A ATORVASTATIN d04105A D 99999 A@ E Rp A FUROSEMIDE d00070A D 99999 A@ E Rp A METOPROLOL d00134A D 99999 A@ E Rp A OMEPRAZOLE d00325A D 99999 A@ E R A . . . E R A . . . E R A AMOXICILLIN; CLAVULANATE d00089A A A49.9P Prevent bacterial infection A E R A ALENDRONATE d03849A Dc M81 Osteoporosis without current pathological fracture A E R A AMLODIPINE d00689A Dc I10 Essential (primary) hypertension A E R A ATORVASTATIN d04105A Dc E78.0 Pure hypercholesterolemia A E R A BACLOFEN d00967A Cr M62.83 Muscle spasm A E R A CILOSTAZOL d04382A C 55555 A E R A CLOPIDOGREL d04258A C D75.9P Prevent blood clots A E R A DICLOFENAC d00848A C M19.9 Osteoarthritis, unspecified site A E R A DULOXETINE d05355A D F32.9 Major depressive disorder, single episode, unspecified A E R A GABAPENTIN d03182A Dc M79.2 Neuralgia and neuritis, unspecified A E R A GLIPIZIDE d00246A D E11 Type 2 diabetes mellitus A E R A METFORMIN d03807A D E11 Type 2 diabetes mellitus A E R A . . . E R A ATORVASTATIN d04105A0 B= E78.0 Pure hypercholesterolemia A E R A FLUOXETINE d00236A0 Bz 99999 A E R A GABAPENTIN d03182A0 B= G40 Epilepsy and recurrent seizures A E R A IBUPROFEN d00015A0 B M19.9 Osteoarthritis, unspecified site A E R A LISINOPRIL d00732A0 C[@ I10 Essential (primary) hypertension A E R A MELOXICAM d04532A0 B M13 Other arthritis A E R A PANTOPRAZOLE d04514A0 B K21 Gastro-esophageal reflux disease A E R A PREGABALIN d05508A0 B E11.4 G40 Type 2 diabetes mellitus with neurological complications Epilepsy and recurrent seizures A E R A . . . E R A 99999 . . A` E R A ARIPIPRAZOLE d04825A C F32.9 Major depressive disorder, single episode, unspecified A` E R A ESOMEPRAZOLE d04749A Cr K30 Functional dyspepsia A` E R A INSULIN ASPART d04697A C E11 Type 2 diabetes mellitus A` E R A INSULIN GLARGINE d04538A C E11 Type 2 diabetes mellitus A` E R A VENLAFAXINE d03181A C F32.9 Major depressive disorder, single episode, unspecified A` E S A AMLODIPINE d00689A C I10 Essential (primary) hypertension A E S A . . . E S A . . . E S0 A . . . E S@ A AMOXICILLIN d00088A AP J02 Acute pharyngitis A0 E S@ A HYDROCHLOROTHIAZIDE d00253A C I10 Essential (primary) hypertension A0 E S@ A RAMIPRIL d00728A C I10 Essential (primary) hypertension A0 E SP A . . . E S` A . . . E Sp A AMLODIPINE d00689A C[@ I10 Essential (primary) hypertension A E S A ALBUTEROL d00749A B= H66.9 Otitis media, unspecified A` E S A AMOXICILLIN; CLAVULANATE d00089A A H66.9 Otitis media, unspecified A` E S A AZITHROMYCIN d00091A A0 H66.9 Otitis media, unspecified A` E S A CIPROFLOXACIN OTIC d04287A A H66.9 Otitis media, unspecified A` E S A IBUPROFEN d00015A A H93.9 Unspecified disorder of ear A` E S A PREDNISOLONE d00084A A0 R07.9 Chest pain, unspecified A` E S A . . . E S A BUDESONIDE; FORMOTEROL d04795A D@) J45 Asthma A@ E S A CITALOPRAM d04332A C F41.9 Anxiety disorder, unspecified A@ E S A LOVASTATIN d00280A C[@ E78.0 Pure hypercholesterolemia A@ E S A TOPIRAMATE d04115A C- E66 Overweight and obesity A@ E S A AMLODIPINE d00689A CDp I10 Essential (primary) hypertension A` E S A ATORVASTATIN d04105A CDp E78.0 Pure hypercholesterolemia A` E S A INSULIN ISOPHANE (NPH) d04370A CDp E11 Type 2 diabetes mellitus A` E S A INSULIN REGULAR d04369A CDp E11 Type 2 diabetes mellitus A` E S A LISINOPRIL d00732A Cr I10 Essential (primary) hypertension A` E S A METFORMIN d03807A D R73 Elevated blood glucose level A` E S A . . . E S A . . . E S A AMOXICILLIN d00088A Ap H66.9 J01.9 Otitis media, unspecified Acute sinusitis, unspecified A E S A . . . E T A 99999 . . A@ E T A LISINOPRIL d00732A D E11.2 Type 2 diabetes mellitus with kidney complications A@ E T A METFORMIN d03807A C E11 Type 2 diabetes mellitus A@ E T A RANITIDINE d00021A D R12 Heartburn A@ E T A . . . E T A MONTELUKAST d04289A C"0 R09.81 Nasal congestion A E T0 A . . . E T@ A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A@ E T@ A GLIPIZIDE d00246A C R73 Elevated blood glucose level A@ E T@ A LISINOPRIL d00732A C I10 Essential (primary) hypertension A@ E T@ A METFORMIN d03807A C E11 Type 2 diabetes mellitus A@ E TP A . . . E T` A . . . E Tp A . . . E T A . . . E T A . . . E T A . . . E T A . . . E T A AMLODIPINE d00689A CDp I10 Essential (primary) hypertension A E T A PAROXETINE d03157A CDp F41.9 N95 Anxiety disorder, unspecified Menopausal and other perimenopausal disorders A E T A ALLOPURINOL d00023A B[ M1A Chronic gout A E T A LISINOPRIL d00732A Dc I10 Essential (primary) hypertension A0 E T A METFORMIN d03807A Dc E11 Type 2 diabetes mellitus A0 E T A PRAVASTATIN d00348A Dc E78.0 Pure hypercholesterolemia A0 E T A . . . E U A BRIMONIDINE OPHTHALMIC d04048A C H40 Glaucoma A@ E U A DORZOLAMIDE; TIMOLOL OPHTHALMIC d04303A C H40 Glaucoma A@ E U A LATANOPROST OPHTHALMIC d04017A C H40 Glaucoma A@ E U A LOSARTAN d03821A C"0 E78.0 Pure hypercholesterolemia A@ E U A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A@ E U A HYDROCHLOROTHIAZIDE; LOSARTAN d03830A C I10 Essential (primary) hypertension A@ E U A OMEPRAZOLE d00325A C K21 Gastro-esophageal reflux disease A@ E U A RANITIDINE d00021A C K21 Gastro-esophageal reflux disease A@ E U A . . . E U0 A . . . E U@ A . . . E UP A ATENOLOL d00004A D I10 Essential (primary) hypertension A E U` A ACETAMINOPHEN; HYDROCODONE d03428A Dc M54 Dorsalgia A E U` A BUSPIRONE d00182A B F41.9 Anxiety disorder, unspecified A E U` A DIVALPROEX SODIUM d03833A C F31.9 Bipolar disorder, unspecified A E U` A DULOXETINE d05355A C F32.9 Major depressive disorder, single episode, unspecified A E U` A ESOMEPRAZOLE d04749A D K21 Gastro-esophageal reflux disease A E U` A ETHINYL ESTRADIOL; NORETHINDRONE d03238A Dc Z79.890 Hormone replacement therapy A E U` A HYDROCHLOROTHIAZIDE; OLMESARTAN d04878A C- I10 Essential (primary) hypertension A E U` A LORAZEPAM d00149A B F41.9 Anxiety disorder, unspecified A E U` A LURASIDONE d07705A B F32.9 Major depressive disorder, single episode, unspecified A E U` A PROPRANOLOL d00032A B R25.1 Tremor, unspecified A E U` A SIMVASTATIN d00746A Dc E78.0 Pure hypercholesterolemia A E U` A ZOLPIDEM d00910A B G47.0 Insomnia A E Up A . . . E U A CITALOPRAM d04332A C F32.9 F41.9 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified A E U A ETHINYL ESTRADIOL; NORGESTREL d03241A B Z79.3 Long term (current) use of hormonal contraceptives A E U A . . . E U A . . . E U A . . . E U A ALENDRONATE d03849A CDp M19.9 Osteoarthritis, unspecified site A0 E U A IBUPROFEN d00015A CDp M54 Dorsalgia A0 E U A LISINOPRIL d00732A C- I10 Essential (primary) hypertension A0 E U A ETONOGESTREL d04772A B Z79.3 Long term (current) use of hormonal contraceptives A E U A . . . E V A ATORVASTATIN d04105A C- E78.0 Pure hypercholesterolemia A@ E V A BISOPROLOL d00709A C I10 Essential (primary) hypertension A@ E V A HYDROCHLOROTHIAZIDE; TRIAMTERENE d03052A C I10 Essential (primary) hypertension A@ E V A METFORMIN d03807A C E11 Type 2 diabetes mellitus A@ E V A . . . E V A . . . E V0 A . . . E V@ A AMITRIPTYLINE d00146A C- G43 Migraine A0 E V@ A ESCITALOPRAM d04812A C F32.9 F41.9 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified A0 E V@ A ETHINYL ESTRADIOL; NORETHINDRONE d03238A C- Z79.3 Long term (current) use of hormonal contraceptives A0 E VP A CETIRIZINE d03827A A T78.40 Allergy, unspecified A E VP A SULFAMETHOXAZOLE d00119A AP A49.9P Prevent bacterial infection A E V` A . . . E Vp A . . . E V A . . . E V A . . . E V A ACETAMINOPHEN; HYDROCODONE d03428A CDp M25.5 M54 Pain in joint Dorsalgia A E V A CARISOPRODOL d00960A CDp M25.5 M54 Pain in joint Dorsalgia A E V A . . . E V A . . . E V A . . . E V A APIXABAN d07804A Cr I48.9 Unspecified atrial fibrillation and atrial flutter A` E V A FUROSEMIDE d00070A B N28.9 Disorder of kidney and ureter, unspecified A` E V A METFORMIN d03807A C E11 Type 2 diabetes mellitus A` E V A METOPROLOL d00134A B I49.9 Cardiac arrhythmia, unspecified A` E V A POTASSIUM CHLORIDE d00345A D* E87.6 Hypokalemia A` E V A PRAVASTATIN d00348A C E78.0 Pure hypercholesterolemia A` E V A . . . E W A CLONIDINE d00044A C F41.9 Anxiety disorder, unspecified A@ E W A OXCARBAZEPINE d04513A CDp F31.9 Bipolar disorder, unspecified A@ E W A QUETIAPINE d04220A C G47.0 Insomnia A@ E W A SERTRALINE d00880A CDp F32.9 Major depressive disorder, single episode, unspecified A@ E W A . . . E W A INSULIN ISOPHANE; INSULIN REGULAR d04374A B= E11 R73 Type 2 diabetes mellitus Elevated blood glucose level A E W A NIFEDIPINE d00051A B I10 Essential (primary) hypertension A E W0 A . . . E W@ A ESCITALOPRAM d04812A0 Bz F32.9 Major depressive disorder, single episode, unspecified AP E W@ A ESOMEPRAZOLE d04749A0 C R12 Heartburn AP E W@ A FAMOTIDINE d00141A0 C K21 Gastro-esophageal reflux disease AP E W@ A LEVOTHYROXINE d00278A0 C E03.9 Hypothyroidism, unspecified AP E W@ A LURASIDONE d07705A0 C- F31.9 Bipolar disorder, unspecified AP E WP A . . . E W` A . . . E Wp A DICLOFENAC d00848A Cr M25.5 Pain in joint A E Wp A LEVOTHYROXINE d00278A D E03.9 Hypothyroidism, unspecified A E W A PENICILLIN d00116A A K04.7P Prevent tooth infection A E W A . . . E W A ATENOLOL d00004A C I10 Essential (primary) hypertension A0 E W A HYDROCHLOROTHIAZIDE d00253A D I10 Essential (primary) hypertension A0 E W A SIMVASTATIN d00746A D E78.0 Pure hypercholesterolemia A0 E W A . . . E W A AMLODIPINE d00689A CDp I10 Essential (primary) hypertension A@ E W A ATENOLOL d00004A0 CDp I10 Essential (primary) hypertension A@ E W A HYDROCHLOROTHIAZIDE d00253A C R60.9 Edema, unspecified A@ E W A METFORMIN d03807A CDp E11 Type 2 diabetes mellitus A@ E W A ZOLEDRONIC ACID d04708A A M81 Osteoporosis without current pathological fracture A E W A NYSTATIN d01233A A B37 Candidiasis A E W A ALLOPURINOL d00023A Cr M10.9 Gout, unspecified A E W A MELOXICAM d04532A Cr Z79.1 Long term (current) use of non-steroidal anti-inflammatories (NSAID) A E X A ATORVASTATIN d04105A C- E78.0 Pure hypercholesterolemia A0 E X A HYDROCHLOROTHIAZIDE d00253A C[@ I10 Essential (primary) hypertension A0 E X A OMEGA-3 POLYUNSATURATED FATTY ACIDS d00497A C- A0 E X A ALBUTEROL; IPRATROPIUM d04066A Cr R06.9P Prevent breathing difficulty A E X A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A E X A BETAMETHASONE; CLOTRIMAZOLE TOPICAL d03561A C- B35 Dermatophytosis A E X A FUROSEMIDE d00070A C I50.9 Heart failure, unspecified A E X A GABAPENTIN d03182A C- R25.2 Cramp and spasm A E X A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified A E X A METFORMIN d03807A C R73 Elevated blood glucose level A E X A METOPROLOL d00134A C I48.9 Unspecified atrial fibrillation and atrial flutter A E X A POTASSIUM CHLORIDE d00345A C E87.6 Hypokalemia A E X A WARFARIN d00022A C D75.9P Prevent blood clots A E X A . . . E X0 A . . . E X@ A . . . E XP A CETIRIZINE d03827A C- T78.40 Allergy, unspecified A E X` A IRBESARTAN d04222A C I10 Essential (primary) hypertension A0 E X` A LEVOTHYROXINE d00278A C 99999 A0 E X` A ROSUVASTATIN d04851A B= 99999 A0 E Xp A . . . E X A . . . E X A . . . E X A . . . E X A . . . E X A . . . E X A OFLOXACIN OPHTHALMIC d03977A A H10 Conjunctivitis A E X A . . . E X A DOXYCYCLINE d00037A AP R06.9 Unspecified abnormalities of breathing A0 E X A PREDNISONE d00350A AP R60.9 Edema, unspecified A0 E X A SPIRONOLACTONE d00373A AP I10 Essential (primary) hypertension A0 E Y A AMOXICILLIN; CLAVULANATE d00089A AP B99.9 Unspecified infectious disease A E Y A . . . E Y A SULFAMETHOXAZOLE; TRIMETHOPRIM d00124A A L08.9 Local infection of the skin and subcutaneous tissue, unspecified A E Y0 A . . . E Y@ A . . . E YP A . . . E Y` A . . . E Yp A . . . E Y A . . . E Y A . . . E Y A . . . E Y A . . . E Y A . . . E Y A DONEPEZIL d04099A B- R41 Other symptoms and signs involving cognitive functions and awareness A E Y A . . . E Y A . . . E Z A ALPRAZOLAM d00168A C- F41.9 Anxiety disorder, unspecified A E Z A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia A E Z A . . . E Z A . . . E Z0 A METRONIDAZOLE TOPICAL d03208A D L71 Rosacea A E Z@ A . . . E ZP A 99999 . . A E ZP A ALBUTEROL d00749A C- J45 R06.02 R06.9P Asthma Shortness of breath Prevent breathing difficulty A E Z` A . . . E Zp A ATROPINE OPHTHALMIC d03212A B= H57.9 Unspecified disorder of eye and adnexa A` E Zp A CETIRIZINE d03827A C- T78.40 Allergy, unspecified A` E Zp A FLUTICASONE d01296A C- J45 Asthma A` E Zp A LEVALBUTEROL d04427A C- J45 Asthma A` E Zp A MONTELUKAST d04289A C J45 Asthma A` E Zp A RANITIDINE d00021A C K21 Gastro-esophageal reflux disease A` E Z A AMLODIPINE d00689A Cr I10 Essential (primary) hypertension A E Z A OMEPRAZOLE d00325A C[@ K21 Gastro-esophageal reflux disease A E Z A 99999 . . A` E Z A DABIGATRAN d07137A C D75.9P Prevent blood clots A` E Z A ENALAPRIL d00013A D I10 Essential (primary) hypertension A` E Z A NIFEDIPINE d00051A D I10 Essential (primary) hypertension A` E Z A POTASSIUM CITRATE d01423A C E87.6 Hypokalemia A` E Z A TRIAMTERENE d00396A C R60.9 Edema, unspecified A` E Z A METFORMIN d03807A C E11 Type 2 diabetes mellitus A E Z A PANTOPRAZOLE d04514A C- K21 R12 Gastro-esophageal reflux disease Heartburn A E Z A AMLODIPINE d00689A C I10 Essential (primary) hypertension A` E Z A GLIPIZIDE d00246A C[@ R73 Elevated blood glucose level A` E Z A HYDROCHLOROTHIAZIDE d00253A C 99999 A` E Z A LISINOPRIL d00732A C I10 Essential (primary) hypertension A` E Z A METFORMIN d03807A C[@ R73 Elevated blood glucose level A` E Z A TAMSULOSIN d04121A C R35 Polyuria A` E Z A ATORVASTATIN d04105A Dc E78.0 Pure hypercholesterolemia A E Z A . . . E Z A . . . E Z A . . . E [ A . . . E [ A . . . E [ A . . . E [0 A . . . E [@ A DORZOLAMIDE; TIMOLOL OPHTHALMIC d04303A CH0 H40 Glaucoma A E [P A . . . E [` A . . . E [p A . . . E [ A GLIPIZIDE d00246A CDp E11 Type 2 diabetes mellitus A0 E [ A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A CDp I10 Essential (primary) hypertension A0 E [ A PRAVASTATIN d00348A C- E78.0 Pure hypercholesterolemia A0 E [ A . . . E [ A FAMOTIDINE d00141A D* K30 Functional dyspepsia A E [ A LABETALOL d00016A C I10 Essential (primary) hypertension A E [ A LISINOPRIL d00732A B I10 I21.P Essential (primary) hypertension Prevent heart attack/myocardial infarction A E [ A LOVASTATIN d00280A Cr E78.0 Pure hypercholesterolemia A E [ A . . . E [ A CYPROHEPTADINE d00790A Ap G43 Migraine A E [ A METFORMIN d03807A C[@ E11 Type 2 diabetes mellitus A0 E [ A METOPROLOL d00134A Dc I49.9 Cardiac arrhythmia, unspecified A0 E [ A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia A0 E \ A ALBUTEROL d00749A Ei J45 Asthma B E \ A BUPROPION d00181A Ei 99999 B E \ A CARVEDILOL d03847A Ei 99999 B E \ A DOCUSATE d01021A Ei K59.0 Constipation B E \ A FLUOXETINE d00236A Ei F32.9 Major depressive disorder, single episode, unspecified B E \ A FLUTICASONE NASAL d04283A C R09.81 Nasal congestion B E \ A FUROSEMIDE d00070A Ei R60.9 Edema, unspecified B E \ A GABAPENTIN d03182A Ei E11.4 Type 2 diabetes mellitus with neurological complications B E \ A INSULIN REGULAR d04369A D/ E11 Type 2 diabetes mellitus B E \ A ISOSORBIDE d00653A Ei 99999 B E \ A LISINOPRIL d00732A CDp I10 Essential (primary) hypertension B E \ A METFORMIN d03807A Ei E11 Type 2 diabetes mellitus B E \ A NYSTATIN TOPICAL d04399A C L98.9 Disorder of the skin and subcutaneous tissue, unspecified B E \ A OMEPRAZOLE d00325A Ei 99999 B E \ A OXYCODONE d00329A Ei R52 Pain, unspecified B E \ A ROSUVASTATIN d04851A Ei E78.0 Pure hypercholesterolemia B E \ A THEOPHYLLINE d00142A Ei 99999 B E \ A . . . E \ A . . . E \0 A . . . E \@ A HYDROCHLOROTHIAZIDE; LOSARTAN d03830A D I10 Essential (primary) hypertension A E \@ A METOPROLOL d00134A D I10 Essential (primary) hypertension A E \P A . . . E \` A . . . E \p A . . . E \ A ALBUTEROL d00749A C- J44.9 R06.02 Chronic obstructive pulmonary disease, unspecified Shortness of breath A E \ A AMITRIPTYLINE d00146A C[@ F32.9 F41.9 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified A E \ A BUDESONIDE d04276A C- J44.9 R06.9 Chronic obstructive pulmonary disease, unspecified Unspecified abnormalities of breathing A E \ A DICLOFENAC TOPICAL d04722A D G89 Pain, not elsewhere classified A E \ A DOXEPIN d00217A C[@ G47.9 Sleep disorder, unspecified A E \ A FORMOTEROL d04572A C- J44.9 R06.9 Chronic obstructive pulmonary disease, unspecified Unspecified abnormalities of breathing A E \ A NITROGLYCERIN d00321A Cr R07.9 Chest pain, unspecified A E \ A OXYCODONE d00329A D G89 Pain, not elsewhere classified A E \ A PREGABALIN d05508A D M79.2 M79.7 Neuralgia and neuritis, unspecified Fibromyalgia A E \ A VARENICLINE d05807A B= F17.2 Nicotine dependence A E \ A . . . E \ A . . . E \ A . . . E \ A AMOXICILLIN; CLAVULANATE d00089A A0 J01.9 Acute sinusitis, unspecified A0 E \ A CETIRIZINE d03827A A0 J01.9 R09.81 Acute sinusitis, unspecified Nasal congestion A0 E \ A PREDNISOLONE d00084A A0 R05 R09.81 Cough Nasal congestion A0 E \ A . . . E \ A . . . E \ A . . . E ] A . . . E ] A . . . E ] A FINASTERIDE d00563A B< N40 Enlarged prostate A0 E ] A METHYLPREDNISOLONE d00293A Ap R21 Rash and other nonspecific skin eruption A0 E ] A TAMSULOSIN d04121A B< N40 Enlarged prostate A0 E ]0 A . . . E ]@ A ALBUTEROL; IPRATROPIUM d04066A C- J44.9 Chronic obstructive pulmonary disease, unspecified Ap E ]@ A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia Ap E ]@ A BECLOMETHASONE d00760A D J44.9 Chronic obstructive pulmonary disease, unspecified Ap E ]@ A HYDROCHLOROTHIAZIDE d00253A Dc R60.9 Edema, unspecified Ap E ]@ A LOSARTAN d03821A C E11.2 Type 2 diabetes mellitus with kidney complications Ap E ]@ A NORTRIPTYLINE d00144A D F32.9 I10 Major depressive disorder, single episode, unspecified Essential (primary) hypertension Ap E ]@ A RANITIDINE d00021A C K21 Gastro-esophageal reflux disease Ap E ]P A 99999 . . A E ]` A AMLODIPINE d00689A D I10 Essential (primary) hypertension A0 E ]` A FENOFIBRATE d04286A B= E78.0 E78.1 Pure hypercholesterolemia Pure hyperglyceridemia A0 E ]` A TAMSULOSIN d04121A B= N40 Enlarged prostate A0 E ]p A . . . E ] A . . . E ] A CABERGOLINE d04112A B 55555 A E ] A . . . E ] A . . . E ] A . . . E ] A CITALOPRAM d04332A C- F41.9 Anxiety disorder, unspecified A E ] A ESCITALOPRAM d04812A A` F41.9 Anxiety disorder, unspecified A E ] A . . . E ] A . . . E ^ A . . . E ^ A . . . E ^ A . . . E ^0 A . . . E ^@ A . . . E ^P A . . . E ^` A . . . E ^p A ACETAMINOPHEN; BUTALBITAL; CAFFEINE d03455A B G43 Migraine A@ E ^p A ACETAMINOPHEN; CODEINE d03423A D* M54 Dorsalgia A@ E ^p A CLONAZEPAM d00197A B= G25.81 Restless legs syndrome A@ E ^p A TRAZODONE d00395A D G47.0 Insomnia A@ E ^ A . . . E ^ A . . . E ^ A FLUTICASONE NASAL d04283A B R09.81 Nasal congestion A E ^ A ETHINYL ESTRADIOL; NORGESTIMATE d03781A C Z79.3 Long term (current) use of hormonal contraceptives A E ^ A BRIMONIDINE; TIMOLOL OPHTHALMIC d05283A C H40 Glaucoma A E ^ A LATANOPROST OPHTHALMIC d04017A C H40 Glaucoma A E ^ A . . . E ^ A . . . E ^ A . . . E _ A ESCITALOPRAM d04812A B F32.9 F41.9 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified AP E _ A HYDROCHLOROTHIAZIDE; VALSARTAN d04293A C I10 Essential (primary) hypertension AP E _ A ONDANSETRON d00867A B R11 Nausea and vomiting AP E _ A RIVAROXABAN d07356A C D75.9P Prevent blood clots AP E _ A SUMATRIPTAN d03160A Cr G43 Migraine AP E _ A OMEPRAZOLE d00325A B= K25 Gastric ulcer A E _ A 55555 A B 55555 A0 E _ A ALBUTEROL d00749A B 55555 A0 E _ A PANCRELIPASE d01002A C& 55555 A0 E _0 A AMLODIPINE d00689A B[ I10 Essential (primary) hypertension Ap E _0 A HYDROCHLOROTHIAZIDE; LOSARTAN d03830A C I10 Essential (primary) hypertension Ap E _0 A MELOXICAM d04532A B M79.1 Myalgia Ap E _0 A POTASSIUM CHLORIDE d00345A Cr E87.6 Hypokalemia Ap E _0 A RABEPRAZOLE d04448A Cr K21 Gastro-esophageal reflux disease Ap E _0 A ROSUVASTATIN d04851A Cr E78.0 Pure hypercholesterolemia Ap E _0 A TRAMADOL d03826A C M13 Other arthritis Ap E _@ A . . . E _P A AMLODIPINE d00689A CP I21.P Prevent heart attack/myocardial infarction A@ E _P A LOSARTAN d03821A CP I10 Essential (primary) hypertension A@ E _P A PROPRANOLOL d00032A D1 I10 Essential (primary) hypertension A@ E _P A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia A@ E _` A . . . E _p A . . . E _ A ACETAMINOPHEN; HYDROCODONE d03428A Ap M25.5 Pain in joint AP E _ A ALBUTEROL d00749A D J45 Asthma AP E _ A BUDESONIDE; FORMOTEROL d04795A Cr J45 Asthma AP E _ A CETIRIZINE d03827A B T78.40 Allergy, unspecified AP E _ A MONTELUKAST d04289A B T78.40 Allergy, unspecified AP E _ A AMLODIPINE d00689A Ei I10 Essential (primary) hypertension A` E _ A APIXABAN d07804A Ei D75.9P Prevent blood clots A` E _ A DILTIAZEM d00045A Ei I10 Essential (primary) hypertension A` E _ A FUROSEMIDE d00070A Ei R60.9 Edema, unspecified A` E _ A METOPROLOL d00134A Cr I10 Essential (primary) hypertension A` E _ A PHENYTOIN d00143A C G40 Epilepsy and recurrent seizures A` E _ A . . . E _ A AMLODIPINE d00689A C I10 Essential (primary) hypertension A E _ A HYDROCHLOROTHIAZIDE; LOSARTAN d03830A C I10 Essential (primary) hypertension A E _ A CHLORTHALIDONE d00192A C I10 Essential (primary) hypertension A E _ A DARUNAVIR d05825A D B20 Human immunodeficiency virus [HIV] disease A E _ A EMTRICITABINE; TENOFOVIR d05352A D B20 Human immunodeficiency virus [HIV] disease A E _ A LISINOPRIL d00732A C 99999 A E _ A OXYCODONE d00329A C- M25.5 Pain in joint A E _ A RALTEGRAVIR d07048A D B20 Human immunodeficiency virus [HIV] disease A E _ A RITONAVIR d03984A D B20 Human immunodeficiency virus [HIV] disease A E _ A ROSUVASTATIN d04851A C E78.0 Pure hypercholesterolemia A E _ A . . . E _ A APIXABAN d07804A B Z79.0 Long term (current) use of anticoagulants and antithrombotics/antiplatelets A E _ A ALBUTEROL d00749A0 C J45 R06.02 R06.2 Asthma Shortness of breath Wheezing A E _ A ASPIRIN d00170A0 C I63.P Prevent stroke A E _ A IBUPROFEN d00015A0 C R52 Pain, unspecified A E _ A LORAZEPAM d00149A0 C F41.9 Anxiety disorder, unspecified A E _ A METFORMIN d03807A0 C- E11 Type 2 diabetes mellitus A E _ A METOPROLOL d00134A0 C I10 Essential (primary) hypertension A E _ A OMEPRAZOLE d00325A0 C K21 R12 Gastro-esophageal reflux disease Heartburn A E _ A PRAZOSIN d00138A0 C R42 R51 Dizziness and giddiness Headache A E _ A TADALAFIL d04896A0 C N52.9 Male erectile dysfunction, unspecified A E _ A TRAZODONE d00395A0 C G47.0 Insomnia A E _ A VENLAFAXINE d03181A0 C F32.9 Major depressive disorder, single episode, unspecified A E ` A . . . E ` A . . . E ` A LISINOPRIL d00732A D9 I10 Essential (primary) hypertension A E ` A TERAZOSIN d00386A CP N42.9 Disorder of prostate, unspecified A E `0 A INSULIN ASPART d04697A C- E11 Type 2 diabetes mellitus A@ E `0 A LIRAGLUTIDE d07466A Cr E11 Type 2 diabetes mellitus A@ E `0 A LISINOPRIL d00732A Cr I10 Essential (primary) hypertension A@ E `0 A METFORMIN d03807A D# E11 Type 2 diabetes mellitus A@ E `@ A CLONAZEPAM d00197A Cr F41.9 Anxiety disorder, unspecified A` E `@ A LISINOPRIL d00732A D I10 Essential (primary) hypertension A` E `@ A PANTOPRAZOLE d04514A C K30 Functional dyspepsia A` E `@ A SIMVASTATIN d00746A D E78.0 Pure hypercholesterolemia A` E `@ A TAMSULOSIN d04121A C R39.1 Other difficulties with micturition A` E `@ A TROSPIUM d04929A C R39.1 Other difficulties with micturition A` E `P A . . . E `` A GLIPIZIDE d00246A CDp R73 Elevated blood glucose level A@ E `` A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A C I10 Essential (primary) hypertension A@ E `` A LOVASTATIN d00280A C E78.0 Pure hypercholesterolemia A@ E `` A METFORMIN d03807A C E11 Type 2 diabetes mellitus A@ E `p A AMLODIPINE d00689A Dc I10 Essential (primary) hypertension A0 E `p A LISINOPRIL d00732A D I10 Essential (primary) hypertension A0 E `p A ROSUVASTATIN d04851A C E78.0 Pure hypercholesterolemia A0 E ` A ATORVASTATIN d04105A Cr 99999 A` E ` A CLOPIDOGREL d04258A Cr D75.9P Prevent blood clots A` E ` A DONEPEZIL d04099A Cr G30.9 Alzheimer's disease, unspecified A` E ` A HYDROXYZINE d00907A Cr I51.9 Heart disease, unspecified A` E ` A LOSARTAN d03821A Cr I99.9 Unspecified disorder of circulatory system A` E ` A MIRTAZAPINE d04025A Cr G47.0 Insomnia A` E ` A . . . E ` A DILTIAZEM d00045A C R00 Abnormalities of heart beat A@ E ` A METOPROLOL d00134A C R00 Abnormalities of heart beat A@ E ` A MIRABEGRON d07876A B[ R32 Unspecified urinary incontinence A@ E ` A WARFARIN d00022A C"0 I48.9 Unspecified atrial fibrillation and atrial flutter A@ E ` A . . . E ` A . . . E ` A . . . E ` A . . . E ` A . . . E a A . . . E a A . . . E a A . . . E a0 A AMLODIPINE d00689A Dc I10.P Prevent hypertension A E a0 A SIMVASTATIN d00746A D E78.0 Pure hypercholesterolemia A E a@ A ATENOLOL d00004A D I10 Essential (primary) hypertension AP E a@ A CLOPIDOGREL d04258A Cr D75.9P Prevent blood clots AP E a@ A EPLERENONE d04815A Cr I10 Essential (primary) hypertension AP E a@ A GABAPENTIN d03182A B M79.2 Neuralgia and neuritis, unspecified AP E a@ A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia AP E aP A BENAZEPRIL d00730A Cr I10 Essential (primary) hypertension A E aP A METOPROLOL d00134A Cr I10 Essential (primary) hypertension A E a` A . . . E ap A . . . E a A . . . E a A . . . E a A 77777 . . A E a A DICLOFENAC d00848A B= M65.9 Synovitis and tenosynovitis, unspecified A@ E a A KETOROLAC d00273A A M65.9 Synovitis and tenosynovitis, unspecified A@ E a A LEVOTHYROXINE d00278A Bz E03.9 Hypothyroidism, unspecified A@ E a A SERTRALINE d00880A Bz F32.9 Major depressive disorder, single episode, unspecified A@ E a A . . . E a A . . . E a A . . . E a A . . . E b A AMLODIPINE d00689A C I10 Essential (primary) hypertension A` E b A METFORMIN d03807A CDp R73 Elevated blood glucose level A` E b A METOPROLOL d00134A C I10 Essential (primary) hypertension A` E b A OMEPRAZOLE d00325A C K21 Gastro-esophageal reflux disease A` E b A ROSUVASTATIN d04851A Cr E78.0 Pure hypercholesterolemia A` E b A SERTRALINE d00880A C- F41.9 Anxiety disorder, unspecified A` E b A . . . E b A ETHINYL ESTRADIOL; LEVONORGESTREL d03242A CDp Z79.3 Long term (current) use of hormonal contraceptives A E b0 A . . . E b@ A BUSPIRONE d00182A B F41.9 Anxiety disorder, unspecified A E b@ A CYCLOBENZAPRINE d00963A B M35 Other systemic involvement of connective tissue A E b@ A FLUOXETINE d00236A CDp F31.9 Bipolar disorder, unspecified A E b@ A HYDROXYZINE d00907A C G47.0 Insomnia A E b@ A METOPROLOL d00134A B I10 Essential (primary) hypertension A E b@ A OMEPRAZOLE d00325A D K21 Gastro-esophageal reflux disease A E b@ A ONDANSETRON d00867A AP R11 Nausea and vomiting A E b@ A TRAZODONE d00395A C G47.0 Insomnia A E bP A ARMODAFINIL d06842A0 CDp G47.9 Sleep disorder, unspecified A E bP A CANAGLIFLOZIN d08080A0 C[@ E11 Type 2 diabetes mellitus A E bP A ESTRADIOL d00537A0 D Z79.890 Hormone replacement therapy A E bP A ESZOPICLONE d05421A0 D G47.0 Insomnia A E bP A GABAPENTIN d03182A0 C F41.9 Anxiety disorder, unspecified A E bP A HYDROXYZINE d00907A0 D F41.0 Panic disorder [episodic paroxysmal anxiety] without agoraphobia A E bP A INSULIN GLARGINE d04538A D E11 Type 2 diabetes mellitus A E bP A LAMOTRIGINE d03809A0 D F31.9 Bipolar disorder, unspecified A E bP A LIDOCAINE TOPICAL d00683A0 C M79.2 Neuralgia and neuritis, unspecified A E bP A LIDOCAINE TOPICAL d00683A0 C M79.2 Neuralgia and neuritis, unspecified A E bP A METFORMIN d03807A0 D E11 Type 2 diabetes mellitus A E bP A TRANDOLAPRIL; VERAPAMIL d04065A0 D I10 Essential (primary) hypertension A E bP A ZIPRASIDONE d04747A0 D F31.9 Bipolar disorder, unspecified A E b` A LISINOPRIL d00732A C- I10 Essential (primary) hypertension A E b` A WARFARIN d00022A C- D75.9P Prevent blood clots A E bp A MONTELUKAST d04289A Cr J30.9 Allergic rhinitis, unspecified A E b A . . . E b A AMLODIPINE d00689A0 D I10 Essential (primary) hypertension A E b A ASPIRIN d00170A0 C- 99999 A E b A CARVEDILOL d03847A0 D I10 Essential (primary) hypertension A E b A FAMOTIDINE d00141A0 D K21 Gastro-esophageal reflux disease A E b A FUROSEMIDE d00070A0 D 99999 A E b A INSULIN ISOPHANE (NPH) d04370A0 D* E11 Type 2 diabetes mellitus A E b A ISOSORBIDE MONONITRATE d00269A0 Dc 99999 A E b A SIMVASTATIN d00746A0 D E78.0 Pure hypercholesterolemia A E b A . . . E b A . . . E b A . . . E b A . . . E b A ALBUTEROL d00749A D/ J45 Asthma A E b A BUDESONIDE; FORMOTEROL d04795A CDp J45 Asthma A E b A . . . E c A AMLODIPINE d00689A C- M54 Dorsalgia A E c A ATORVASTATIN d04105A C[@ E78.0 Pure hypercholesterolemia A E c A FAMOTIDINE d00141A C- K21 Gastro-esophageal reflux disease A E c A HYDROCHLOROTHIAZIDE d00253A CDp R60.9 Edema, unspecified A E c A INSULIN ASPART d04697A C- E11 Type 2 diabetes mellitus A E c A INSULIN DETEMIR d05436A C E11 Type 2 diabetes mellitus A E c A LOSARTAN d03821A Cr I10 Essential (primary) hypertension A E c A METFORMIN d03807A Cr E11 Type 2 diabetes mellitus A E c A . . . E c A IBUPROFEN d00015A Ap M54 Dorsalgia A E c0 A METFORMIN d03807A C E11 Type 2 diabetes mellitus A E c@ A . . . E cP A . . . E c` A . . . E cp A MELOXICAM d04532A Cr M25.5 M54 T14.9 Pain in joint Dorsalgia Unspecified injury A E c A LEVOFLOXACIN d04109A A J42 Unspecified chronic bronchitis A E c A METOPROLOL d00134A C I10 Essential (primary) hypertension A E c A CARVEDILOL d03847A C- I50.9 Heart failure, unspecified A` E c A CINACALCET d05218A C- N19 Unspecified kidney failure A` E c A CLONIDINE d00044A C- I10 Essential (primary) hypertension A` E c A FUROSEMIDE d00070A C- R60.9 Edema, unspecified A` E c A MINOXIDIL d00135A C- I10 Essential (primary) hypertension A` E c A SUCROFERRIC OXYHYDROXIDE d08266A C- N18.9 Chronic kidney disease, unspecified A` E c A . . . E c A . . . E c A ATOMOXETINE d04827A C"0 F90 Attention-deficit hyperactivity disorders A@ E c A CLONIDINE d00044A C F90 Attention-deficit hyperactivity disorders A@ E c A DEXMETHYLPHENIDATE d04777A C F90 Attention-deficit hyperactivity disorders A@ E c A GUANFACINE d00717A C F90 Attention-deficit hyperactivity disorders A@ E c A BICTEGRAVIR; EMTRICITABINE; TENOFOVIR d08736A C- B20 Human immunodeficiency virus [HIV] disease A E c A . . . E c A . . . E d A . . . E d A DESOGESTREL; ETHINYL ESTRADIOL d03782A B 55555 A E d A DICYCLOMINE d00999A B K58 Irritable bowel syndrome A E d A . . . E d0 A ALBUTEROL d00749A C J45 Asthma A@ E d0 A AMOXICILLIN d00088A B= H66.9 Otitis media, unspecified A@ E d0 A BECLOMETHASONE d00760A C"0 J45 Asthma A@ E d0 A MONTELUKAST d04289A C- R06.2 Wheezing A@ E d@ A FAMOTIDINE d00141A C[@ R14 Flatulence and related conditions AP E d@ A FENOFIBRATE d04286A Cr E78.0 Pure hypercholesterolemia AP E d@ A HYDROCHLOROTHIAZIDE d00253A Cr R60.9 Edema, unspecified AP E d@ A LEVOTHYROXINE d00278A Cr E03.9 Hypothyroidism, unspecified AP E d@ A LOSARTAN d03821A Cr I10 Essential (primary) hypertension AP E dP A . . . E d` A AMPHETAMINE; DEXTROAMPHETAMINE d04035A D F90 Attention-deficit hyperactivity disorders A@ E d` A ESTRADIOL d00537A C[@ Z79.890 Hormone replacement therapy A@ E d` A OMEPRAZOLE d00325A Cr K21 Gastro-esophageal reflux disease A@ E d` A PROMETHAZINE d00787A C R11 R51 Nausea and vomiting Headache A@ E dp A . . . E d A AMLODIPINE d00689A C I10 Essential (primary) hypertension A0 E d A LOSARTAN d03821A C I10 Essential (primary) hypertension A0 E d A OMEPRAZOLE d00325A C- R12 Heartburn A0 E d A IBUPROFEN d00015A A R51 Headache A E d A . . . E d A . . . E d A ALLOPURINOL d00023A C M1A Chronic gout AP E d A ATORVASTATIN d04105A B E78.0 Pure hypercholesterolemia AP E d A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A D I10 Essential (primary) hypertension AP E d A INSULIN ASPART d04697A C E11 Type 2 diabetes mellitus AP E d A INSULIN DETEMIR d05436A C E11 Type 2 diabetes mellitus AP E d A . . . E d A . . . E d A SERTRALINE d00880A B F41.9 Anxiety disorder, unspecified A E e A PRAVASTATIN d00348A Cr E78.0 Pure hypercholesterolemia A E e A . . . E e A . . . E e0 A . . . E e@ A ACETAMINOPHEN; HYDROCODONE d03428A CP K51 Ulcerative colitis A@ E e@ A ALPRAZOLAM d00168A CDp F41.9 Anxiety disorder, unspecified A@ E e@ A SERTRALINE d00880A C F32.9 Major depressive disorder, single episode, unspecified A@ E e@ A SULFASALAZINE d00379A Cr K51 Ulcerative colitis A@ E eP A ACETAMINOPHEN; HYDROCODONE d03428A A K08.8 Other specified disorders of teeth and supporting structures A E eP A AMOXICILLIN d00088A A K04.7 Periapical abscess without sinus A E e` A . . . E ep A . . . E e A GABAPENTIN d03182A C M25.5 Pain in joint A E e A . . . E e A CARVEDILOL d03847A D I48.9 Unspecified atrial fibrillation and atrial flutter Ap E e A CLOPIDOGREL d04258A C I48.9 I50.9 Unspecified atrial fibrillation and atrial flutter Heart failure, unspecified Ap E e A DIGOXIN d00210A D I48.9 Unspecified atrial fibrillation and atrial flutter Ap E e A FUROSEMIDE d00070A D R60.9 Edema, unspecified Ap E e A POTASSIUM CHLORIDE d00345A D E87.6 Hypokalemia Ap E e A PRAVASTATIN d00348A D E78.0 Pure hypercholesterolemia Ap E e A QUINAPRIL d00365A D I50.9 Heart failure, unspecified Ap E e A LISINOPRIL d00732A C I10 Essential (primary) hypertension A E e A AMLODIPINE d00689A A I10 Essential (primary) hypertension Ap E e A CHLORTHALIDONE d00192A B I10 R60.9 Essential (primary) hypertension Edema, unspecified Ap E e A INSULIN DEGLUDEC d08054A B E10 Type 1 diabetes mellitus Ap E e A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified Ap E e A LOSARTAN d03821A C I10 Essential (primary) hypertension Ap E e A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia Ap E e A THIAMINE d03130A B D64.9 E63.9 Anemia, unspecified Nutritional deficiency, unspecified Ap E e A LEVOTHYROXINE d00278A Dc E03.9 Hypothyroidism, unspecified A E e A . . . E e A BENZOYL PEROXIDE; ERYTHROMYCIN TOPICAL d03857A Bz L70 Acne A E f A 77777 . . A E f A . . . E f A LABETALOL d00016A C[@ I10 Essential (primary) hypertension A E f A NIFEDIPINE d00051A C- I10 Essential (primary) hypertension A E f0 A . . . E f@ A ANASTROZOLE d03873A CO C80.1 Malignant (primary) neoplasm, unspecified A0 E f@ A CITALOPRAM d04332A B= F41.9 Anxiety disorder, unspecified A0 E f@ A QUETIAPINE d04220A C- F32.9 Major depressive disorder, single episode, unspecified A0 E fP A LEVOTHYROXINE d00278A Cr E03.9 Hypothyroidism, unspecified A E f` A . . . E fp A CELECOXIB d04380A B M25.5 Pain in joint Ap E fp A EZETIMIBE; SIMVASTATIN d05348A C E78.0 Pure hypercholesterolemia Ap E fp A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A D# I10 Essential (primary) hypertension Ap E fp A INSULIN GLARGINE d04538A C E11 Type 2 diabetes mellitus Ap E fp A INSULIN LISPRO d04373A Dc E11 Type 2 diabetes mellitus Ap E fp A PANTOPRAZOLE d04514A C K21 Gastro-esophageal reflux disease Ap E fp A SITAGLIPTIN d05896A C E11 Type 2 diabetes mellitus Ap E f A ALBUTEROL d00749A D J45 Asthma A E f A AMLODIPINE d00689A C I10 Essential (primary) hypertension A E f A . . . E f A . . . E f A . . . E f A . . . E f A ATORVASTATIN d04105A B E78.0 Pure hypercholesterolemia A E f A ENALAPRIL d00013A C I10 Essential (primary) hypertension A E f A LEVOTHYROXINE d00278A D- E03.9 Hypothyroidism, unspecified A E f A . . . E g A ATENOLOL d00004A D I10 Essential (primary) hypertension A` E g A FINASTERIDE d00563A B[ N40 Enlarged prostate A` E g A LOSARTAN d03821A Dc I10 Essential (primary) hypertension A` E g A PANTOPRAZOLE d04514A C K21 Gastro-esophageal reflux disease A` E g A TAMSULOSIN d04121A C[@ N40 Enlarged prostate A` E g A TRAZODONE d00395A Dc G47.9 Sleep disorder, unspecified A` E g A . . . E g A . . . E g0 A AMLODIPINE d00689A C I10 Essential (primary) hypertension A0 E g0 A DORZOLAMIDE; TIMOLOL OPHTHALMIC d04303A C H40 Glaucoma A0 E g0 A LATANOPROST OPHTHALMIC d04017A C H40 Glaucoma A0 E g@ A AMOXICILLIN d00088A Ap H66.9 Otitis media, unspecified A E gP A INSULIN ASPART d04697A B E11 Type 2 diabetes mellitus A E gP A INSULIN DETEMIR d05436A B E11 Type 2 diabetes mellitus A E g` A . . . E gp A ETHINYL ESTRADIOL; LEVONORGESTREL d03242A C Z79.3 Long term (current) use of hormonal contraceptives A E g A . . . E g A . . . E g A . . . E g A PRAVASTATIN d00348A D* E78.0 Pure hypercholesterolemia A E g A TAMSULOSIN d04121A D* N40 Enlarged prostate A E g A . . . E g A . . . E g A ALENDRONATE d03849A CDp M54 Dorsalgia AP E g A ATORVASTATIN d04105A CDp 55555 AP E g A CITALOPRAM d04332A C F41.9 Anxiety disorder, unspecified AP E g A GABAPENTIN d03182A C- M79.2 Neuralgia and neuritis, unspecified AP E g A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A CDp I10 Essential (primary) hypertension AP E g A . . . E h A ATORVASTATIN d04105A D E78.0 Pure hypercholesterolemia A E h A BUPROPION d00181A C 99999 A E h A CELECOXIB d04380A C M06.9 Rheumatoid arthritis, unspecified A E h A CLONIDINE d00044A D I10 Essential (primary) hypertension A E h A CONJUGATED ESTROGENS d00541A . N95 Menopausal and other perimenopausal disorders A E h A FLUTICASONE NASAL d04283A C- J44.9 Chronic obstructive pulmonary disease, unspecified A E h A FLUTICASONE; SALMETEROL d04611A B J44.9 Chronic obstructive pulmonary disease, unspecified A E h A HYDROCHLOROTHIAZIDE; QUINAPRIL d04509A C 99999 A E h A OMEPRAZOLE d00325A Cr R12 Heartburn A E h A VENLAFAXINE d03181A Cr M79.2 Neuralgia and neuritis, unspecified A E h A . . . E h A . . . E h0 A BENAZEPRIL; HYDROCHLOROTHIAZIDE d03265A Cr I10 Essential (primary) hypertension A E h@ A . . . E hP A . . . E h` A . . . E hp A . . . E h A ALBUTEROL d00749A CDp J45 Asthma A E h A TRIAMCINOLONE TOPICAL d03206A C L20.9 Atopic dermatitis, unspecified A E h A BENAZEPRIL d00730A D I10 Essential (primary) hypertension AP E h A CARVEDILOL d03847A D I10 Essential (primary) hypertension AP E h A MIRABEGRON d07876A B R39.1 Other difficulties with micturition AP E h A PRAMIPEXOLE d04145A B N42.9 Disorder of prostate, unspecified AP E h A ROSUVASTATIN d04851A C E78.0 Pure hypercholesterolemia AP E h A LAMOTRIGINE d03809A Cr F39 Unspecified mood [affective] disorder A E h A SERTRALINE d00880A Cr F32.9 Major depressive disorder, single episode, unspecified A E h A . . . E h A RIVAROXABAN d07356A C[@ D75.9P Prevent blood clots A E h A ATORVASTATIN d04105A C"0 E78.0 Pure hypercholesterolemia AP E h A GABAPENTIN d03182A C"0 M79.2 Neuralgia and neuritis, unspecified AP E h A LISINOPRIL d00732A Cr I10 Essential (primary) hypertension AP E h A NORTRIPTYLINE d00144A Ap G47.0 Insomnia AP E h A TAMSULOSIN d04121A Cr R35 Polyuria AP E h A . . . E h A ALLOPURINOL d00023A C N20.0 Calculus of kidney A` E h A AMLODIPINE d00689A C I10 Essential (primary) hypertension A` E h A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A` E h A LEVOTHYROXINE d00278A D9 E03.9 Hypothyroidism, unspecified A` E h A TAMSULOSIN d04121A Dc N40 Enlarged prostate A` E h A VALSARTAN d04113A Ap I10 Essential (primary) hypertension A` E i A . . . E i A . . . E i A . . . E i0 A ATORVASTATIN d04105A C"0 E78.0 Pure hypercholesterolemia A E i@ A . . . E iP A ATORVASTATIN d04105A B E78.0 Pure hypercholesterolemia A E iP A FLUTICASONE NASAL d04283A B R09.81 Nasal congestion A E i` A . . . E ip A . . . E i A HYDROCHLOROTHIAZIDE d00253A C I10 Essential (primary) hypertension A0 E i A LOSARTAN d03821A C I10 Essential (primary) hypertension A0 E i A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia A0 E i A . . . E i A . . . E i A . . . E i A . . . E i A . . . E i A . . . E i A FAMOTIDINE d00141A B* K25 Gastric ulcer A@ E i A FUROSEMIDE d00070A A I51.9 Heart disease, unspecified A@ E i A LISINOPRIL d00732A B* Z95 Presence of cardiac and vascular implants and grafts A@ E i A WARFARIN d00022A B* Z95 Presence of cardiac and vascular implants and grafts A@ E j A CEPHALEXIN d00096A Ap K04.7P Prevent tooth infection A E j A 99999 . . A E j A ALLOPURINOL d00023A D M10.9P Prevent gout A E j A ESCITALOPRAM d04812A CDp F41.9 Anxiety disorder, unspecified A E j A LISINOPRIL d00732A C I10 Essential (primary) hypertension A E j A NAPROXEN d00019A D M79.1 Myalgia A E j A OXYBUTYNIN d00328A C R32 Unspecified urinary incontinence A E j A PANTOPRAZOLE d04514A C R12 Heartburn A E j A PRAVASTATIN d00348A C E78.0 Pure hypercholesterolemia A E j A TRAZODONE d00395A Cr G47.9 Sleep disorder, unspecified A E j0 A . . . E j@ A ATORVASTATIN d04105A0 D E78.0 Pure hypercholesterolemia A E j@ A CYCLOSPORINE OPHTHALMIC d04836A0 C H04 Disorders of lacrimal system A E j@ A FLUTICASONE; SALMETEROL d04611A0 C J45 Asthma A E j@ A HYDROCODONE d03075A0 Cr M54 Dorsalgia A E j@ A IPRATROPIUM NASAL d04235A0 Cr J30.1 Allergic rhinitis due to pollen A E j@ A LATANOPROST OPHTHALMIC d04017A0 C H40 Glaucoma A E j@ A LEVOTHYROXINE d00278A0 D E03.9 Hypothyroidism, unspecified A E j@ A LISINOPRIL d00732A0 C I10 Essential (primary) hypertension A E j@ A NIFEDIPINE d00051A0 B I10 Essential (primary) hypertension A E j@ A PANTOPRAZOLE d04514A0 C K21 Gastro-esophageal reflux disease A E j@ A SERTRALINE d00880A0 D= F41.9 Anxiety disorder, unspecified A E j@ A SEVELAMER d04363A0 B[ N19 Unspecified kidney failure A E jP A . . . E j` A . . . E jp A . . . E j A AMOXICILLIN d00088A A H66.9 Otitis media, unspecified A E j A . . . E j A NAPROXEN d00019A A G43 Migraine A E j A . . . E j A ATENOLOL d00004A C I10 Essential (primary) hypertension A E j A DEXLANSOPRAZOLE d07395A CDp R12 Heartburn A E j A GLIPIZIDE d00246A C[@ E11 Type 2 diabetes mellitus A E j A HYDROCHLOROTHIAZIDE d00253A C R60.9 Edema, unspecified A E j A LISINOPRIL d00732A C I10 Essential (primary) hypertension A E j A LOVASTATIN d00280A C E78.0 Pure hypercholesterolemia A E j A MELOXICAM d04532A C M25.5 Pain in joint A E j A METFORMIN d03807A C E11 Type 2 diabetes mellitus A E j A PAROXETINE d03157A C F32.9 Major depressive disorder, single episode, unspecified A E j A . . . E j A CARBAMAZEPINE d00058A C G40 Epilepsy and recurrent seizures A0 E j A LISINOPRIL d00732A C- I10 Essential (primary) hypertension A0 E j A METFORMIN d03807A C- E11 Type 2 diabetes mellitus A0 E j A . . . E k A 99999 . . A E k A HYDROCHLOROTHIAZIDE d00253A C I10 Essential (primary) hypertension AP E k A INSULIN GLARGINE d04538A C E11 Type 2 diabetes mellitus AP E k A LISINOPRIL d00732A C I10 Essential (primary) hypertension AP E k A METFORMIN d03807A D E11 Type 2 diabetes mellitus AP E k A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia AP E k A . . . E k0 A . . . E k@ A . . . E kP A . . . E k` A . . . E kp A . . . E k A . . . E k A LORAZEPAM d00149A Cr G47.9 Sleep disorder, unspecified A E k A . . . E k A . . . E k A . . . E k A LEVOTHYROXINE d00278A D9 Z90 Acquired absence of organs, not elsewhere classified A0 E k A LISINOPRIL d00732A D I10 Essential (primary) hypertension A0 E k A SULFAMETHOXAZOLE; TRIMETHOPRIM d00124A D/ N30 Cystitis A0 E k A . . . E k A . . . E l A BUMETANIDE d00179A C I50.9 J98.9 R60.9 Heart failure, unspecified Respiratory disorder, unspecified Edema, unspecified A@ E l A CARVEDILOL d03847A C I50.9 Heart failure, unspecified A@ E l A LISINOPRIL d00732A C I50.9 Heart failure, unspecified A@ E l A SPIRONOLACTONE d00373A C I50.9 Heart failure, unspecified A@ E l A AMLODIPINE d00689A C- 99999 A0 E l A HYDROCHLOROTHIAZIDE d00253A C- 99999 A0 E l A LISINOPRIL d00732A C- 99999 A0 E l A . . . E l0 A . . . E l@ A GEMFIBROZIL d00245A CDp E78.0 E78.1 Pure hypercholesterolemia Pure hyperglyceridemia A@ E l@ A GLIMEPIRIDE d03864A C E11 Type 2 diabetes mellitus A@ E l@ A LISINOPRIL d00732A B I21.P Prevent heart attack/myocardial infarction A@ E l@ A METFORMIN d03807A Cr E11 Type 2 diabetes mellitus A@ E lP A . . . E l` A CLOBETASOL TOPICAL d01288A C L20.9 Atopic dermatitis, unspecified A0 E l` A HYDROCORTISONE TOPICAL d03205A C L29.9 Pruritus, unspecified A0 E l` A OMEPRAZOLE d00325A B K21 Gastro-esophageal reflux disease A0 E lp A ABACAVIR; DOLUTEGRAVIR; LAMIVUDINE d08284A C B20 Human immunodeficiency virus [HIV] disease A` E lp A CYCLOBENZAPRINE d00963A C- M79.1 T14.9 Myalgia Unspecified injury A` E lp A FLUOXETINE d00236A Cr F32.9 F41.9 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified A` E lp A LISINOPRIL d00732A B I10 Essential (primary) hypertension A` E lp A NAPROXEN d00019A C M79.1 Myalgia A` E lp A OXYCODONE d00329A C M79.1 T14.9 Myalgia Unspecified injury A` E l A . . . E l A . . . E l A . . . E l A . . . E l A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A C I10 Essential (primary) hypertension A0 E l A PENTOXIFYLLINE d00336A C I70 Atherosclerosis A0 E l A WARFARIN d00022A C D75.9P Prevent blood clots A0 E l A . . . E l A ALBUTEROL d00749A C J45 Asthma A E l A ALBUTEROL d00749A C J45 Asthma A E l A FLUORIDE TOPICAL d04397A CDp K05.6 Periodontal disease, unspecified A E l A FLUTICASONE d01296A C J45 Asthma A E l A FLUTICASONE NASAL d04283A Cr J45 R09.81 Asthma Nasal congestion A E l A GABAPENTIN d03182A D M54 Dorsalgia A E l A MONTELUKAST d04289A D J45 Asthma A E l A NAPROXEN d00019A D M19.9 R52 Osteoarthritis, unspecified site Pain, unspecified A E l A OMEPRAZOLE d00325A Cr K21 Gastro-esophageal reflux disease A E l A PREDNISONE d00350A C[@ J45 Asthma A E l A ZOLPIDEM d00910A D F41.9 Anxiety disorder, unspecified A E l A . . . E m A . . . E m A . . . E m A 55555 A Bz Z79.3 Long term (current) use of hormonal contraceptives A E m0 A CONTRACEPTIVES - UNSPECIFIED c00102A C- N92 Excessive, frequent and irregular menstruation A E m@ A CEFPROZIL d00073A AP J06.9 Acute upper respiratory infection, unspecified A E mP A GUANFACINE d00717A B F90 Attention-deficit hyperactivity disorders A E m` A . . . E mp A . . . E m A . . . E m A AMLODIPINE d00689A0 Cr I10 Essential (primary) hypertension A E m A CHLORHEXIDINE TOPICAL d01231A0 C- A49.9P Prevent bacterial infection A E m A DONEPEZIL d04099A0 Cr G31.9 R41 Degenerative disease of nervous system, unspecified Other symptoms and signs involving cognitive functions and awareness A E m A FUROSEMIDE d00070A0 Cr R60.9 Edema, unspecified A E m A LEVOTHYROXINE d00278A0 C E07.9 Disorder of thyroid, unspecified A E m A LOSARTAN d03821A0 Cr I10 Essential (primary) hypertension A E m A MEMANTINE d04899A0 Cr R41 Other symptoms and signs involving cognitive functions and awareness A E m A POTASSIUM CHLORIDE d00345A0 Cr R60.9 Edema, unspecified A E m A SIMVASTATIN d00746A0 Cr E78.0 Pure hypercholesterolemia A E m A . . . E m A . . . E m A . . . E m A . . . E m A DAPAGLIFLOZIN d07928A B= E11 Type 2 diabetes mellitus A@ E m A LISINOPRIL d00732A B= E11.2P Prevent diabetic kidney disease A@ E m A METFORMIN d03807A B= E11 Type 2 diabetes mellitus A@ E m A PIOGLITAZONE d04442A B= E11 Type 2 diabetes mellitus A@ E m A . . . E n A . . . E n A FLUTICASONE NASAL d04283A C[@ T78.40 Allergy, unspecified A E n A . . . E n0 A METFORMIN d03807A CDp E11 Type 2 diabetes mellitus A E n0 A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia A E n@ A . . . E nP A . . . E n` A . . . E np A . . . E n A . . . E n A . . . E n A . . . E n A . . . E n A . . . E n A RANITIDINE d00021A A K21 Gastro-esophageal reflux disease A E n A . . . E n A . . . E o A ENALAPRIL d00013A B[ I10 Essential (primary) hypertension A@ E o A INSULIN GLARGINE d04538A D E11 Type 2 diabetes mellitus A@ E o A LISINOPRIL d00732A C- K76.9P Prevent liver disease A@ E o A METFORMIN d03807A Cr R73 Elevated blood glucose level A@ E o A PROPRANOLOL d00032A C I10 Essential (primary) hypertension A E o A SUMATRIPTAN d03160A D# G43 Migraine A E o A . . . E o0 A . . . E o@ A . . . E oP A 99999 . . A E oP A ALBUTEROL d00749A C- J42 Unspecified chronic bronchitis A E oP A AMLODIPINE d00689A CDp I10 Essential (primary) hypertension A E oP A CARVEDILOL d03847A CDp I10 Essential (primary) hypertension A E oP A CLONIDINE d00044A CDp I10 Essential (primary) hypertension A E oP A CLOPIDOGREL d04258A C- D75.9P Prevent blood clots A E oP A DULOXETINE d05355A B[ M54 M79.2 Dorsalgia Neuralgia and neuritis, unspecified A E oP A HYDRALAZINE d00132A CDp I10 Essential (primary) hypertension A E oP A LEVOTHYROXINE d00278A C[@ E07.9 Disorder of thyroid, unspecified A E oP A PANTOPRAZOLE d04514A CDp K21 Gastro-esophageal reflux disease A E oP A RIVAROXABAN d07356A C- D75.9P Prevent blood clots A E oP A SUCRALFATE d00377A CDp K92.9 Disease of digestive system, unspecified A E o` A ATENOLOL d00004A C I10 Essential (primary) hypertension A@ E o` A BENAZEPRIL d00730A C I10 Essential (primary) hypertension A@ E o` A GLIPIZIDE d00246A C E11 Type 2 diabetes mellitus A@ E o` A METFORMIN d03807A C E11 Type 2 diabetes mellitus A@ E op A . . . E o A . . . E o A . . . E o A . . . E o A . . . E o A . . . E o A . . . E o A HYDROXYCHLOROQUINE d00817A C- M19.9 Osteoarthritis, unspecified site A@ E o A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified A@ E o A LISINOPRIL d00732A C I10 Essential (primary) hypertension A@ E o A PENTOSAN POLYSULFATE SODIUM d04052A Dc N32.9 Bladder disorder, unspecified A@ E o A ATORVASTATIN d04105A C[@ E78.0 Pure hypercholesterolemia AP E o A BUPROPION d00181A D- F32.9 Major depressive disorder, single episode, unspecified AP E o A FLUOXETINE d00236A D- F32.9 Major depressive disorder, single episode, unspecified AP E o A LEVOTHYROXINE d00278A D1 E03.9 Hypothyroidism, unspecified AP E o A MONTELUKAST d04289A D- J45 Asthma AP E p A . . . E p A . . . E p A . . . E p0 A . . . E p@ A 99999 . . A E p@ A ETHINYL ESTRADIOL; NORGESTIMATE d03781A C Z79.3 Long term (current) use of hormonal contraceptives A E pP A . . . E p` A . . . E pp A . . . E p A . . . E p A . . . E p A 99999 . . A E p A PHENYTOIN d00143A DGJ G40 Epilepsy and recurrent seizures A E p A CARVEDILOL d03847A C[@ I10 I99.9 Essential (primary) hypertension Unspecified disorder of circulatory system A E p A DULOXETINE d05355A C[@ F41.9 Anxiety disorder, unspecified A E p A DULOXETINE d05355A B M79.7 Fibromyalgia A E p A IBUPROFEN d00015A C M06.9 R51 Rheumatoid arthritis, unspecified Headache A E p A . . . E p A ALENDRONATE d03849A C M81 Osteoporosis without current pathological fracture A E p A METFORMIN d03807A C E11 Type 2 diabetes mellitus A E q A . . . E q A ATORVASTATIN d04105A C R52 Pain, unspecified A E q A RANITIDINE d00021A C R12 Heartburn A E q A PAROXETINE d03157A Cr F32.9 F41.9 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified A E q0 A . . . E q@ A . . . E qP A . . . E q` A CLINDAMYCIN d00043A C L70 Acne A E q` A TRETINOIN TOPICAL d01244A C- L70 Acne A E qp A . . . E q A . . . E q A ATORVASTATIN d04105A B= 99999 A` E q A CARVEDILOL d03847A B= 99999 A` E q A CEPHALEXIN d00096A B= 99999 A` E q A CLOPIDOGREL d04258A B= 99999 A` E q A FUROSEMIDE d00070A B= 99999 A` E q A LOSARTAN d03821A B= 99999 A` E q A . . . E q A . . . E q A . . . E q A . . . E q A . . . E q A ASPIRIN; DIPYRIDAMOLE d04497A0 C[@ D75.9P I63 Prevent blood clots Cerebral infarction Ap E q A ATORVASTATIN d04105A0 C[@ E78.0 Pure hypercholesterolemia Ap E q A ESCITALOPRAM d04812A0 B[ F32.9 Major depressive disorder, single episode, unspecified Ap E q A GLIPIZIDE d00246A0 C[@ 99999 Ap E q A INSULIN DETEMIR d05436A Ap E11 Type 2 diabetes mellitus Ap E q A METOPROLOL d00134A0 B[ I10 Essential (primary) hypertension Ap E q A SITAGLIPTIN d05896A0 C[@ R73 Elevated blood glucose level Ap E r A ALBUTEROL d00749A C J45 Asthma A E r A BUDESONIDE; FORMOTEROL d04795A Dc J45 Asthma A E r A HYDROCHLOROTHIAZIDE d00253A D1 I10 Essential (primary) hypertension A E r A LOSARTAN d03821A C I10 Essential (primary) hypertension A E r A METFORMIN; SITAGLIPTIN d06720A C- E11 Type 2 diabetes mellitus A E r A PIOGLITAZONE d04442A Cr E11 R73 Type 2 diabetes mellitus Elevated blood glucose level A E r A SERTRALINE d00880A D* F41.0 F41.9 Panic disorder [episodic paroxysmal anxiety] without agoraphobia Anxiety disorder, unspecified A E r A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia A E r A CARBIDOPA; LEVODOPA d03473A D G20 Parkinson's disease AP E r A GABAPENTIN d03182A D M79.2 Neuralgia and neuritis, unspecified AP E r A LEVOTHYROXINE d00278A D# E03.9 Hypothyroidism, unspecified AP E r A METOPROLOL d00134A Cr 99999 AP E r A OMEPRAZOLE d00325A D K21 Gastro-esophageal reflux disease AP E r A . . . E r0 A . . . E r@ A INSULIN ASPART d04697A Cr E10 Type 1 diabetes mellitus A E rP A . . . E r` A DESOGESTREL; ETHINYL ESTRADIOL d03782A A Z79.3 Long term (current) use of hormonal contraceptives A E rp A FUROSEMIDE d00070A Ei R60.9 Edema, unspecified A@ E rp A METOPROLOL d00134A Ei 99999 A@ E rp A SACUBITRIL; VALSARTAN d08369A C I49.9 I50.9 Cardiac arrhythmia, unspecified Heart failure, unspecified A@ E rp A TAMSULOSIN d04121A Ei 99999 A@ E r A . . . E r A . . . E r A FUROSEMIDE d00070A C R60.9 Edema, unspecified Ap E r A METOCLOPRAMIDE d00298A CDp K21 K30 Gastro-esophageal reflux disease Functional dyspepsia Ap E r A METOPROLOL d00134A C I51.9 Heart disease, unspecified Ap E r A PANTOPRAZOLE d04514A C K21 Gastro-esophageal reflux disease Ap E r A PRAMIPEXOLE d04145A D G25.81 Restless legs syndrome Ap E r A RUXOLITINIB d07812A C[@ D49.9 Neoplasm of unspecified behavior of unspecified site Ap E r A SERTRALINE d00880A C- F32.9 Major depressive disorder, single episode, unspecified Ap E r A ETHINYL ESTRADIOL; NORGESTIMATE d03781A B Z79.3 Long term (current) use of hormonal contraceptives A E r A . . . E r A FLUTICASONE NASAL d04283A C[@ J30.1 J30.9 Allergic rhinitis due to pollen Allergic rhinitis, unspecified A` E r A INSULIN DETEMIR d05436A Dc E11 Type 2 diabetes mellitus A` E r A INSULIN GLARGINE d04538A B[ E11 Type 2 diabetes mellitus A` E r A LANTHANUM CARBONATE d05395A C E83.3 Disorders of phosphorus metabolism and phosphatases A` E r A LINACLOTIDE d07902A B K58 Irritable bowel syndrome A` E r A MONTELUKAST d04289A C[@ J30.1 R06.2 Allergic rhinitis due to pollen Wheezing A` E r A EMPAGLIFLOZIN d08275A C E11 Type 2 diabetes mellitus A` E r A GLYBURIDE d00248A C- E11 Type 2 diabetes mellitus A` E r A LISINOPRIL d00732A Cr I10 Essential (primary) hypertension A` E r A LOVASTATIN d00280A C[@ E78.0 Pure hypercholesterolemia A` E r A METFORMIN d03807A D E11 Type 2 diabetes mellitus A` E r A MONTELUKAST d04289A B J45 R06.2 R06.9 Asthma Wheezing Unspecified abnormalities of breathing A` E r A . . . E s A ALFUZOSIN d04797A C- N40 R35 Enlarged prostate Polyuria A E s A AMLODIPINE d00689A C- I21.P I63.P Prevent heart attack/myocardial infarction Prevent stroke A E s A ATORVASTATIN d04105A Cr I21.P Prevent heart attack/myocardial infarction A E s A CELECOXIB d04380A Cr M79.1 Myalgia A E s A ESCITALOPRAM d04812A CDp F32.9 Major depressive disorder, single episode, unspecified A E s A FAMOTIDINE d00141A C R12 Heartburn A E s A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified A E s A LISINOPRIL d00732A Cr I21.P Prevent heart attack/myocardial infarction A E s A NEBIVOLOL d05265A C[@ I21.P Prevent heart attack/myocardial infarction A E s A TEMAZEPAM d00384A Cr G47.9 Sleep disorder, unspecified A E s A . . . E s0 A . . . E s@ A 99999 . . A E sP A . . . E s` A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A E s` A GABAPENTIN d03182A Ei 99999 A E s` A INSULIN GLARGINE d04538A C- R73 Elevated blood glucose level A E s` A LISINOPRIL d00732A Ei 99999 A E s` A PIOGLITAZONE d04442A Ei 99999 A E s` A REPAGLINIDE d04267A B[ R73 Elevated blood glucose level A E s` A SERTRALINE d00880A Ei 99999 A E s` A TRAMADOL d03826A A G43 R52 Migraine Pain, unspecified A E sp A . . . E s A . . . E s A . . . E s A ATORVASTATIN d04105A D E78.0 Pure hypercholesterolemia A E s A CLOPIDOGREL d04258A D D75.9P Prevent blood clots A E s A FINASTERIDE d00563A D N40 Enlarged prostate A E s A GLIPIZIDE d00246A B E11 Type 2 diabetes mellitus A E s A HYDROCHLOROTHIAZIDE d00253A Cr R60.9 Edema, unspecified A E s A LEVOTHYROXINE d00278A D E03.9 Hypothyroidism, unspecified A E s A LOSARTAN d03821A D I21.P Prevent heart attack/myocardial infarction A E s A METFORMIN d03807A D E11 Type 2 diabetes mellitus A E s A METOPROLOL d00134A D I21.P Prevent heart attack/myocardial infarction A E s A RANITIDINE d00021A C- K21 Gastro-esophageal reflux disease A E s A TAMSULOSIN d04121A D N40 Enlarged prostate A E s A . . . E s A . . . E s A . . . E s A ATORVASTATIN d04105A B[ E78.0 Pure hypercholesterolemia A E s A BUSPIRONE d00182A Dc F41.9 Anxiety disorder, unspecified A E s A CYANOCOBALAMIN d00413A B[ 55555 A E s A ESCITALOPRAM d04812A C F43.1 Post-traumatic stress disorder (PTSD) A E s A GLIPIZIDE d00246A C- E11 Type 2 diabetes mellitus A E s A HYDROCHLOROTHIAZIDE d00253A B[ I10 Essential (primary) hypertension A E s A INSULIN GLARGINE d04538A B= R73 Elevated blood glucose level A E s A METFORMIN d03807A C E11 Type 2 diabetes mellitus A E s A PANTOPRAZOLE d04514A C K21 Gastro-esophageal reflux disease A E s A TRAZODONE d00395A C G47.9 Sleep disorder, unspecified A E s A ACETAMINOPHEN; BUTALBITAL; CAFFEINE d03455A0 C[@ G43 Migraine A E s A TOPIRAMATE d04115A0 C[@ G43 Migraine A E t A . . . E t A 99999 . . A E t A SERTRALINE d00880A C F32.9 F41.9 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified A E t0 A . . . E t@ A . . . E tP A ALBUTEROL d00749A CP J45 Asthma A E tP A AMIODARONE d00002A C I49.9 Cardiac arrhythmia, unspecified A E tP A APIXABAN d07804A Cr D75.9P Prevent blood clots A E tP A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A E tP A CARVEDILOL d03847A C I49.9 Cardiac arrhythmia, unspecified A E tP A DULAGLUTIDE d08290A C[@ E11 Type 2 diabetes mellitus A E tP A FLUTICASONE; VILANTEROL d08100A A J42 J44.9 Unspecified chronic bronchitis Chronic obstructive pulmonary disease, unspecified A E tP A FUROSEMIDE d00070A C R60.9 Edema, unspecified A E tP A GLIPIZIDE d00246A C E11 Type 2 diabetes mellitus A E tP A HYDROCHLOROTHIAZIDE d00253A Ei I10 Essential (primary) hypertension A E tP A LOSARTAN d03821A C- I10 Essential (primary) hypertension A E tP A METFORMIN d03807A C E11 Type 2 diabetes mellitus A E t` A LEVOTHYROXINE d00278A D E03.9 Hypothyroidism, unspecified A E tp A LISINOPRIL d00732A B I10 Essential (primary) hypertension A E t A CARVEDILOL d03847A CP I49.9 I50.9 Cardiac arrhythmia, unspecified Heart failure, unspecified A0 E t A LISINOPRIL d00732A CP I50.9 Heart failure, unspecified A0 E t A SIMVASTATIN d00746A CP E78.0 Pure hypercholesterolemia A0 E t A . . . E t A DROSPIRENONE; ETHINYL ESTRADIOL d04760A CP Z79.3 Long term (current) use of hormonal contraceptives A E t A LEVOTHYROXINE d00278A CDp E03.9 Hypothyroidism, unspecified A E t A . . . E t A METFORMIN d03807A B R73 Elevated blood glucose level A E t A . . . E t A . . . E t A . . . E u A ARIPIPRAZOLE d04825A B F39 Unspecified mood [affective] disorder AP E u A CITALOPRAM d04332A C F32.9 F41.9 F90 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified Attention-deficit hyperactivity disorders AP E u A CYCLOBENZAPRINE d00963A C[@ M54 Dorsalgia AP E u A GABAPENTIN d03182A C- M79.2 Neuralgia and neuritis, unspecified AP E u A SITAGLIPTIN d05896A C[@ E11 Type 2 diabetes mellitus AP E u A . . . E u A . . . E u0 A HYDROCHLOROTHIAZIDE d00253A C I10 Essential (primary) hypertension A E u0 A POTASSIUM CHLORIDE d00345A Cr E87.6 Hypokalemia A E u@ A AZELASTINE NASAL d04068A C J30.9 Allergic rhinitis, unspecified Ap E u@ A ENALAPRIL d00013A Dc I10 Essential (primary) hypertension Ap E u@ A MONTELUKAST d04289A Cr J30.9 R06.2 Allergic rhinitis, unspecified Wheezing Ap E u@ A OXYCODONE d00329A B* M25.5 Pain in joint Ap E u@ A PRAVASTATIN d00348A Dc 99999 Ap E u@ A RISEDRONATE d04300A C- M81.P Prevent bone loss/osteoporosis Ap E u@ A ZOLPIDEM d00910A B* G47.9 Sleep disorder, unspecified Ap E uP A . . . E u` A . . . E up A TRIAMCINOLONE TOPICAL d03206A A R21 Rash and other nonspecific skin eruption A E u A . . . E u A . . . E u A . . . E u A ALBUTEROL d00749A C[@ J45 Asthma A E u A IBUPROFEN d00015A C- R51 Headache A E u A . . . E u A AMOXICILLIN d00088A A0 J00 Acute nasopharyngitis [common cold] A E u A . . . E u A . . . E v A . . . E v A . . . E v A ASPIRIN d00170A CDp D75.9P Prevent blood clots AP E v A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia AP E v A LISINOPRIL d00732A C I10 Essential (primary) hypertension AP E v A METFORMIN; SITAGLIPTIN d06720A C E11 Type 2 diabetes mellitus AP E v A VENLAFAXINE d03181A D 99999 AP E v0 A ETHINYL ESTRADIOL; ETHYNODIOL d03388A C Z79.3 Long term (current) use of hormonal contraceptives A E v@ A . . . E vP A . . . E v` A . . . E vp A 55555 A C E07.9 Disorder of thyroid, unspecified A E v A . . . E v A ATENOLOL d00004A A I10 Essential (primary) hypertension A E v A NAPROXEN d00019A B R51 Headache A E v A AMLODIPINE d00689A C- I10 Essential (primary) hypertension A@ E v A ATORVASTATIN d04105A Cr E78.0 Pure hypercholesterolemia A@ E v A GLIPIZIDE d00246A Cr E11 Type 2 diabetes mellitus A@ E v A METFORMIN d03807A Cr E11 Type 2 diabetes mellitus A@ E v A . . . E v A BUPROPION d00181A CDp F32.9 Major depressive disorder, single episode, unspecified A0 E v A ONDANSETRON d00867A B= R11 Nausea and vomiting A0 E v A RISPERIDONE d03180A Cr F29 F31.9 F99 Unspecified psychosis not due to a substance or known physiological condition Bipolar disorder, unspecified Mental disorder, not otherwise specified A0 E v A . . . E v A . . . E v A FAMOTIDINE d00141A C K21 Gastro-esophageal reflux disease A0 E v A IBUPROFEN d00015A CDp M54 Dorsalgia A0 E v A METFORMIN d03807A C R73 Elevated blood glucose level A0 E w A AMLODIPINE d00689A C I10 Essential (primary) hypertension AP E w A CITALOPRAM d04332A Cr F32.9 Major depressive disorder, single episode, unspecified AP E w A DONEPEZIL d04099A Cr G31.9 Degenerative disease of nervous system, unspecified AP E w A ESOMEPRAZOLE d04749A C K21 Gastro-esophageal reflux disease AP E w A ROSUVASTATIN d04851A Cr E78.0 Pure hypercholesterolemia AP E w A PANTOPRAZOLE d04514A C K21 Gastro-esophageal reflux disease A E w A ESOMEPRAZOLE d04749A B= K30 Functional dyspepsia A E w0 A . . . E w@ A AMLODIPINE d00689A C I10 Essential (primary) hypertension A@ E w@ A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A@ E w@ A HYDROCHLOROTHIAZIDE; LOSARTAN d03830A C I10 Essential (primary) hypertension A@ E w@ A METFORMIN d03807A C E11 Type 2 diabetes mellitus A@ E wP A . . . E w` A 99999 . . A E wp A NAPROXEN d00019A Ap T14.9 Unspecified injury A E w A . . . E w A . . . E w A ATORVASTATIN d04105A C"0 E78.0 Pure hypercholesterolemia AP E w A CLOPIDOGREL d04258A C D75.9P Prevent blood clots AP E w A DICYCLOMINE d00999A B K92.9 Disease of digestive system, unspecified AP E w A POLYETHYLENE GLYCOL 3350 d05350A B K59.0 Constipation AP E w A RISPERIDONE d03180A C- F29 Unspecified psychosis not due to a substance or known physiological condition AP E w A MONTELUKAST d04289A CDp J30.9 Allergic rhinitis, unspecified A E w A AMLODIPINE; BENAZEPRIL d03829A C I10 Essential (primary) hypertension A` E w A ATORVASTATIN d04105A C 99999 A` E w A HYDRALAZINE d00132A C I10 Essential (primary) hypertension A` E w A HYDROCHLOROTHIAZIDE d00253A0 C R60.9 Edema, unspecified A` E w A PHENOBARBITAL d00340A D G40 Epilepsy and recurrent seizures A` E w A PIOGLITAZONE d04442A0 C E11 Type 2 diabetes mellitus A` E w A . . . E w A DAPSONE d00098A C L08.9 Local infection of the skin and subcutaneous tissue, unspecified A@ E w A FLUCONAZOLE d00071A C B35 Dermatophytosis A@ E w A MIRTAZAPINE d04025A Dc G47.9 Sleep disorder, unspecified A@ E w A RIFAMPIN d00047A D B35 Dermatophytosis A@ E w A AMLODIPINE d00689A C- I10 Essential (primary) hypertension A E w A BUSPIRONE d00182A C 99999 A E w A CITALOPRAM d04332A C- F39 Unspecified mood [affective] disorder A E w A ISOSORBIDE MONONITRATE d00269A B I20.9 Angina pectoris, unspecified A E w A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified A E w A LOSARTAN d03821A C G25.81 Restless legs syndrome A E w A METOPROLOL d00134A C- I10 Essential (primary) hypertension A E w A PANTOPRAZOLE d04514A B K30 Functional dyspepsia A E x A . . . E x A . . . E x A AMLODIPINE d00689A C[@ I10 Essential (primary) hypertension A E x A OSELTAMIVIR d04462A A J09.P Prevent flu A E x0 A ATORVASTATIN d04105A B E11 Type 2 diabetes mellitus AP E x0 A GLIPIZIDE d00246A B E11 Type 2 diabetes mellitus AP E x0 A METFORMIN d03807A Cr E11 Type 2 diabetes mellitus AP E x0 A NITROFURANTOIN d00112A B N39.0P Prevent urinary tract infection AP E x0 A TRAMADOL d03826A C G89 Pain, not elsewhere classified AP E x@ A . . . E xP A BUDESONIDE; FORMOTEROL d04795A Dc J45 Asthma A@ E xP A HYDROCHLOROTHIAZIDE; VALSARTAN d04293A Dc I10 Essential (primary) hypertension A@ E xP A MONTELUKAST d04289A C T78.40 Allergy, unspecified A@ E xP A PREDNISONE d00350A C J45 Asthma A@ E x` A HYDROXYZINE d00907A B L20.9 Atopic dermatitis, unspecified A E xp A . . . E x A ETHINYL ESTRADIOL; LEVONORGESTREL d03242A B[ Z79.3 Long term (current) use of hormonal contraceptives A E x A LORAZEPAM d00149A CDp F41.9 Anxiety disorder, unspecified A E x A AMLODIPINE d00689A B I10 Essential (primary) hypertension A E x A METOPROLOL d00134A B I10 Essential (primary) hypertension A E x A ACETAMINOPHEN; HYDROCODONE d03428A C M25.5 M79.1 Pain in joint Myalgia A0 E x A LACTULOSE d01024A C K76.9 Liver disease, unspecified A0 E x A SULFAMETHOXAZOLE; TRIMETHOPRIM d00124A B= A49.9P Prevent bacterial infection A0 E x A ARIPIPRAZOLE d04825A Dc F32.9 Major depressive disorder, single episode, unspecified A@ E x A FLUOXETINE d00236A C F32.9 Major depressive disorder, single episode, unspecified A@ E x A LAMOTRIGINE d03809A Cr F32.9 Major depressive disorder, single episode, unspecified A@ E x A LISDEXAMFETAMINE d06663A C- R53 Malaise and fatigue A@ E x A . . . E x A OMEPRAZOLE d00325A B K27 Peptic ulcer, site unspecified A E x A . . . E y A . . . E y A ALENDRONATE d03849A C[@ M81 Osteoporosis without current pathological fracture A E y A ATORVASTATIN d04105A Cr E78.0 Pure hypercholesterolemia A E y A DEXAMETHASONE d00206A C R52 Pain, unspecified A E y A FUROSEMIDE d00070A C R60.9 Edema, unspecified A E y A GABAPENTIN d03182A CDp 99999 A E y A LEUCOVORIN d00275A C- M19.9 Osteoarthritis, unspecified site A E y A METFORMIN d03807A Bz R73 Elevated blood glucose level A E y A METHOTREXATE d00060A C- M19.9 Osteoarthritis, unspecified site A E y A SPIRONOLACTONE d00373A C R60.9 Edema, unspecified A E y A VERAPAMIL d00048A C[@ 99999 A E y A . . . E y0 A . . . E y@ A . . . E yP A HYDROCHLOROTHIAZIDE; LOSARTAN d03830A C I10 Essential (primary) hypertension A@ E yP A MELOXICAM d04532A C M06.9 Rheumatoid arthritis, unspecified A@ E yP A METOPROLOL d00134A C- I21.P Prevent heart attack/myocardial infarction A@ E yP A TAMSULOSIN d04121A C N40 Enlarged prostate A@ E y` A ASPIRIN d00170A C[@ I21.P I63.P Prevent heart attack/myocardial infarction Prevent stroke A E y` A ATORVASTATIN d04105A C[@ E78.0 Pure hypercholesterolemia A